PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lai, YM; Cheng, PJ; Lee, CC; Ku, CY				Lai, Yan-Ming; Cheng, Pu-Jen; Lee, Cheng-Chi; Ku, Chia-Yi			A New Ticket-Based Authentication Mechanism for Fast Handover in Mesh Network	PLOS ONE			English	Article							PRIVACY PRESERVATION; SCHEME; EFFICIENT; IDENTITY; PROTOCOL; WIMAX	Due to the ever-growing popularity mobile devices of various kinds have received worldwide, the demands on large-scale wireless network infrastructure development and enhancement have been rapidly swelling in recent years. A mobile device holder can get online at a wireless network access point, which covers a limited area. When the client leaves the access point, there will be a temporary disconnection until he/she enters the coverage of another access point. Even when the coverages of two neighboring access points overlap, there is still work to do to make the wireless connection smoothly continue. The action of one wireless network access point passing a client to another access point is referred to as the handover. During handover, for security concerns, the client and the new access point should perform mutual authentication before any Internet access service is practically gained/ provided. If the handover protocol is inefficient, in some cases discontinued Internet service will happen. In 2013, Li et al. proposed a fast handover authentication mechanism for wireless mesh network (WMN) based on tickets. Unfortunately, Li et al.'s work came with some weaknesses. For one thing, some sensitive information such as the time and date of expiration is sent in plaintext, which increases security risks. For another, Li et al.'s protocol includes the use of high-quality tamper-proof devices (TPDs), and this unreasonably high equipment requirement limits its applicability. In this paper, we shall propose a new efficient handover authentication mechanism. The new mechanism offers a higher level of security on a more scalable ground with the client's privacy better preserved. The results of our performance analysis suggest that our new mechanism is superior to some similar mechanisms in terms of authentication delay.	[Lee, Cheng-Chi] Fu Jen Catholic Univ, Dept Lib & Informat Sci, New Taipei 24205, Taiwan; [Lai, Yan-Ming; Cheng, Pu-Jen; Ku, Chia-Yi] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10617, Taiwan; [Lee, Cheng-Chi] Asia Univ, Dept Photon & Commun Engn, Taichung 413, Taiwan	Fu Jen Catholic University; National Taiwan University; Asia University Taiwan	Lee, CC (corresponding author), Fu Jen Catholic Univ, Dept Lib & Informat Sci, New Taipei 24205, Taiwan.; Lee, CC (corresponding author), Asia Univ, Dept Photon & Commun Engn, Taichung 413, Taiwan.	cclee@mail.fju.edu.tw	Lee, Cheng-Chi/AGH-0724-2022; Lee, Cheng-Chi/J-4185-2016	Lee, Cheng-Chi/0000-0002-8918-1703; Lee, Cheng-Chi/0000-0002-8918-1703; CHENG, PU-JEN/0000-0001-5892-0385	Ministry of Science and Technology, Taiwan, R.O.C. [MOST 104-2221-E-030-002]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was partially supported by the Ministry of Science and Technology, Taiwan, R.O.C., under contract no.: MOST 104-2221-E-030-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no specific funding for the rest of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the anonymous reviewers for their valuable comments and suggestions. This research was partially supported by the Ministry of Science and Technology, Taiwan, R.O.C., under contract no.: MOST 104-2221-E-030-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariffin MRK, 2012, 2012 7TH INTERNATIONAL CONFERENCE ON COMPUTING AND CONVERGENCE TECHNOLOGY (ICCCT2012), P589; BLOM R, 1985, LECT NOTES COMPUT SC, V209, P335; Chuang MC, 2013, IEEE SYST J, V7, P102, DOI 10.1109/JSYST.2012.2209276; Chuang MC, 2013, J SYST SOFTWARE, V86, P437, DOI 10.1016/j.jss.2012.09.015; Du W., 2005, ACM Transactions on Information and Systems Security, V8, P228, DOI 10.1145/1065545.1065548; Fu AM, 2014, WIRELESS PERS COMMUN, V79, P1277, DOI 10.1007/s11277-014-1930-9; Fu AM, 2013, WIRELESS PERS COMMUN, V70, P1793, DOI 10.1007/s11277-012-0781-5; Fu AM, 2012, IEEE COMMUN LETT, V16, P1744, DOI 10.1109/LCOMM.2012.091212.120575; Fu AM, 2012, COMPUT SECUR, V31, P741, DOI 10.1016/j.cose.2012.06.008; Fu AM, 2010, IEEE COMMUN LETT, V14, P1134, DOI 10.1109/LCOMM.2010.12.100818; Guo P, 2014, J INTERNET TECHNOL, V15, P929, DOI 10.6138/JIT.2014.15.6.05; He DB, 2015, MULTIMEDIA SYST, V21, P49, DOI 10.1007/s00530-013-0346-9; He DB, 2015, INFORM SCIENCES, V321, P263, DOI 10.1016/j.ins.2015.02.010; He DB, 2015, IEEE COMMUN MAG, V53, P71, DOI 10.1109/MCOM.2015.7010518; He DB, 2015, IEEE SYST J, V9, P816, DOI 10.1109/JSYST.2014.2301517; International Telegraph and Telephone Consultative Committee, 1985, GEN CHAR INT TEL CON; Islam SKH, 2015, SECUR COMMUN NETW, V8, P2214, DOI 10.1002/sec.1165; Jiang Q, 2016, J SUPERCOMPUT, V72, P3826, DOI 10.1007/s11227-015-1610-x; Jiang Q, 2016, NONLINEAR DYNAM, V83, P2085, DOI 10.1007/s11071-015-2467-5; Jiang Q, 2015, PEER PEER NETW APPL, V8, P1070, DOI 10.1007/s12083-014-0285-z; Jiang Q, 2014, WIRELESS PERS COMMUN, V77, P1489, DOI 10.1007/s11277-013-1594-x; Jiang Q, 2013, WIRELESS PERS COMMUN, V68, P1477, DOI 10.1007/s11277-012-0535-4; Khan MK, 2004, LECT NOTES COMPUT SC, V3338, P629; Khan MK, 2006, LECT NOTES COMPUT SC, V3903, P260, DOI 10.1007/11689522_24; Khan MK, 2009, IETE TECH REV, V26, P191, DOI 10.4103/0256-4602.50703; Khedr WI, 2015, IET INFORM SECUR, V9, P334, DOI 10.1049/iet-ifs.2013.0170; Kohl J, 1993, 1510 RFC NETW WORK G; Krawczyk H, 1997, 2104 RFC NETW WORK G; Lee C.C., 2015, INT J NETW SECUR, V17, P1; Lee CC, 2015, NONLINEAR DYNAM, V79, P2485, DOI 10.1007/s11071-014-1827-x; Lee CC, 2013, NONLINEAR DYNAM, V73, P125, DOI 10.1007/s11071-013-0772-4; Li C, 2013, COMPUT SECUR, V37, P124, DOI 10.1016/j.cose.2013.06.001; Li G., 2010, P 2010 6 INT C WIR C, P1; Li GS, 2011, J PARALLEL DISTR COM, V71, P906, DOI 10.1016/j.jpdc.2011.03.002; Long M, 2006, IEEE T IND INFORM, V2, P40, DOI 10.1109/TII.2005.864144; Manuel S, 2011, DESIGN CODE CRYPTOGR, V59, P247, DOI 10.1007/s10623-010-9458-9; MILLER VS, 1986, LECT NOTES COMPUT SC, V218, P417, DOI 10.1007/3-540-39799-x_31; Qazi S., 2008, P 2 INT C SIGN PROC, P1; Qi J. M., 2011, J INEQUAL APPL, V2011, P1; Simon D, 2008, 5216 RFC NETW WORK G; Sohn I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116592; Srivatsa AM, 2008, IEEE ICC, P2485; Sun JY, 2010, IEEE T PARALL DISTR, V21, P1227, DOI 10.1109/TPDS.2010.14; Tie L., 2012, P 2012 8 INT C WIR C, P1; Wienzek R, 2006, P 5 INT IFIP TC6 NET, P556; XIE Q, 2014, PLOS COMPUT BIOL, V10, DOI DOI 10.1371/JOURNAL.PONE.0102747; Xu L, 2014, COMPUT NETW, V73, P185, DOI 10.1016/j.comnet.2014.08.009; Yang X, 2016, CONCURR COMP-PRACT E, V28, P2978, DOI 10.1002/cpe.3544; Yoon E. J., 2006, INT J NETWORK SECURI, V3, P51	49	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155064	10.1371/journal.pone.0155064	http://dx.doi.org/10.1371/journal.pone.0155064			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171160	Green Submitted, gold, Green Published			2022-12-27	WOS:000376588600002
J	Barbier, EB; Hochard, JP				Barbier, Edward B.; Hochard, Jacob P.			Does Land Degradation Increase Poverty in Developing Countries?	PLOS ONE			English	Article							FOOD SECURITY; GROWTH; POOR	Land degradation is a global problem that particularly impacts the poor rural inhabitants of low and middle-income countries. We improve upon existing literature by estimating the extent of rural populations in 2000 and 2010 globally on degrading and improving agricultural land, taking into account the role of market access, and analyzing the resulting impacts on poverty. Using a variety of spatially referenced datasets, we estimate that 1.33 billion people worldwide in 2000 were located on degrading agricultural land (DAL), of which 1.26 billion were in developing countries. Almost all the world's 200 million people on remote DAL were in developing countries, which is about 6% of their rural population. There were also 1.54 billion rural people on improving agricultural land (IAL), with 1.34 billion in developing countries. We find that a lower share of people in 2000 on DAL, or a higher share on IAL, lowers significantly how much overall economic growth reduces poverty from 2000 to 2012 across 83 developing countries. As the population on DAL and IAL in developing countries grew by 13% and 15% respectively from 2000 to 2010, these changing spatial distributions of rural populations could impact significantly future poverty in developing countries.	[Barbier, Edward B.] Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA; [Hochard, Jacob P.] E Carolina Univ, Dept Econ, Greenville, NC USA; [Hochard, Jacob P.] E Carolina Univ, Inst Coastal Sci & Policy, Greenville, NC USA	University of Wyoming; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Barbier, EB (corresponding author), Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA.	ebarbier@uwyo.edu		Hochard, Jacob/0000-0002-9502-2602	Economics of Land Degradation (ELD) Initiative, through Deutsche Gesellschaft fur Internationale Zusammernabeit (GIZ), Germany [81163559]	Economics of Land Degradation (ELD) Initiative, through Deutsche Gesellschaft fur Internationale Zusammernabeit (GIZ), Germany	This research by EB JH was funded by the Economics of Land Degradation (ELD) Initiative, through financial support by the Deutsche Gesellschaft fur Internationale Zusammernabeit (GIZ), Germany, under grant #81163559. See http://eld-initiative.org/. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Adams RH, 2005, WORLD DEV, V33, P1645, DOI 10.1016/j.worlddev.2005.05.004; [Anonymous], 2008, WORD DEV REP 2008 AG; [Anonymous], 7126 WORLD BANK; Bai ZG, 2008, SOIL USE MANAGE, V24, P223, DOI 10.1111/j.1475-2743.2008.00169.x; Bai Z. G., 2010, 201008 ISRIC; Bank World, 2014, WORD DEV IND; Barbier EB, 2012, 6232 POL RES; Center for International Earth Science Information Network (CIESIN)/Columbia University International Food Policy Research Institute (IFPRI) The World Bank and Centro Internacional de Agricultura Tropical (CIAT), 2011, GLOB RUR URB MAPP PR; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; CIESIN of Columbia University Food and Agriculture Organization of United Nations International Center for Tropical Agriculture, 2005, GRIDD POP WORLD VERS; de Jong R, 2011, INT J REMOTE SENS, V32, P6823, DOI 10.1080/01431161.2010.512946; Dollar D, 2002, J ECON GROWTH, V7, P195, DOI 10.1023/A:1020139631000; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gerber N., 2014, MARGINALITY ADDRESSI, P181, DOI DOI 10.1007/978-94-007-7061-4; Global Commission on the Economy and Climate, 2014, BETT GROWTH BETT CLI; Hazell P, 2008, PHILOS T R SOC B, V363, P495, DOI 10.1098/rstb.2007.2166; Kraay A, 2006, J DEV ECON, V80, P198, DOI 10.1016/j.jdeveco.2005.02.004; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Nachtergaele FO, 2010, 17 FAO; Nelson A., 2008, TRAVEL TIME MAJOR CI; Nkonya E., 2011, 01086 IFPRI; Pilot Analysis of Global Ecosystems (PAGE), 2005, AGR; Prince SD, 1995, J BIOGEOGR, V22, P815, DOI 10.2307/2845983; Ravallion M, 2012, AM ECON REV, V102, P504, DOI 10.1257/aer.102.1.504; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Scherr SJ, 2000, FOOD POLICY, V25, P479, DOI 10.1016/S0306-9192(00)00022-1; West PC, 2014, SCIENCE, V345, P325, DOI 10.1126/science.1246067	28	51	56	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0152973	10.1371/journal.pone.0152973	http://dx.doi.org/10.1371/journal.pone.0152973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CD	27167738	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300030
J	Durnali, AG; Turkoz, FP; Yukruk, FA; Tokluoglu, S; Yazici, OK; Demirci, A; Bal, O; Buyukbas, SG; Esbah, O; Oksuzoglu, B; Alkis, N				Durnali, Ayse Gok; Turkoz, Fatma Paksoy; Yukruk, Fisun Ardic; Tokluoglu, Saadet; Yazici, Omer Kamil; Demirci, Ayse; Bal, Oznur; Buyukbas, Selay Gundogdu; Esbah, Onur; Oksuzoglu, Berna; Alkis, Necati			Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups	PLOS ONE			English	Article							HIGH-GRADE OSTEOSARCOMA; PROGNOSTIC-FACTORS; PEDIATRIC-PATIENTS; SURVIVAL; CHEMOTHERAPY; EXTREMITIES; SARCOMA	Osteosarcomas with lung metastases are rather heterogenous group. We aimed to evaluate the clinicopathological characteristics and outcomes of osteosarcoma patients with lung metastases and to compare the synchronous and metachronous lung metastatic groups. A total of 93 adolescent and adult patients with lung metastatic osteosarcoma, from March 1995 to July 2011, in a single center, were included. Sixty-five patients (69.9%) were male. The median age was 19 years (range, 14-74). Thirty-nine patients (41.9%) had synchronous lung metastases (Group A) and 54 patients (58.1%) had metachronous lung metastases (Group B). The 5-year and 10-year post-lung metastases overall survival (PLM-OS) was 17% and 15%, respectively. In multivariate analysis for PLM-OS, time to lung metastases (p = 0.010), number of metastatic pulmonary nodules (p = 0.020), presence of pulmonary metastasectomy (p = 0.007) and presence of chemotherapy for lung metastases (p<0.001) were found to be independent prognostic factors. The median PLM-OS of Group A and Group B was 16 months and 9 months, respectively. In Group B, the median PLM-OS of the patients who developed lung metastases within 12 months was 6 months, whereas that of the patients who developed lung metastases later was 16 months. Time to lung metastases, number and laterality of metastatic pulmonary nodules, chemotherapy for lung metastatic disease and pulmonary metastasectomy were independent prognostic factors for patients with lung metastatic osteosarcoma. The best PLM-OS was in the subgroup of patients treated both surgery and chemotherapy. The prognosis of the patients who developed lung metastases within 12 months after diagnosis was worst.	[Durnali, Ayse Gok; Yazici, Omer Kamil; Demirci, Ayse; Bal, Oznur; Buyukbas, Selay Gundogdu; Esbah, Onur; Oksuzoglu, Berna; Alkis, Necati] Dr AY Ankara Oncol Training & Res Hosp, Dept Med Oncol, Ankara, Turkey; [Turkoz, Fatma Paksoy] Bahcesehir Univ, Dept Med Oncol, Istanbul, Turkey; [Yukruk, Fisun Ardic] Dr AY Ankara Oncol Training & Res Hosp, Dept Pathol, Ankara, Turkey; [Tokluoglu, Saadet] Guven Hosp, Dept Med Oncol, Ankara, Turkey	Dr. Abdurrahman Yurtaslan Oncology Hospital; Bahcesehir University; Dr. Abdurrahman Yurtaslan Oncology Hospital; Guven Hastanesi	Turkoz, FP (corresponding author), Bahcesehir Univ, Dept Med Oncol, Istanbul, Turkey.	fffpaksoy@yahoo.com	Durnalı, Ayşe/AAZ-8847-2021; BAL, OZNUR/D-4160-2016; Durnalı, Ayşe/ABC-2229-2021					Aljubran AH, 2009, ANN ONCOL, V20, P1136, DOI 10.1093/annonc/mdn731; BELLI L, 1989, CANCER-AM CANCER SOC, V63, P2546, DOI 10.1002/1097-0142(19890615)63:12<2546::AID-CNCR2820631232>3.0.CO;2-X; Brennecke P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074045; Briccoli A, 2010, SURG ONCOL, V19, P193, DOI 10.1016/j.suronc.2009.05.002; Buddingh EP, 2010, PEDIATR BLOOD CANCER, V54, P216, DOI 10.1002/pbc.22293; Durnali A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0624-6; Edge S, 2010, AJCC CANC STAGING HD; Ferrari S, 2003, J CLIN ONCOL, V21, P710, DOI 10.1200/JCO.2003.03.141; Gelderblom H, 2011, EUR J CANCER, V47, P895, DOI 10.1016/j.ejca.2010.11.036; Harting MT, 2010, J CANCER RES CLIN, V136, P561, DOI 10.1007/s00432-009-0690-5; Janeway KA, 2012, CANCER-AM CANCER SOC, V118, P4597, DOI 10.1002/cncr.27414; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kempf-Bielack B, 2005, J CLIN ONCOL, V23, P559, DOI 10.1200/JCO.2005.04.063; Leary SES, 2013, CANCER-AM CANCER SOC, V119, P2645, DOI 10.1002/cncr.28111; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; PICCI P, 1985, CANCER, V56, P1515, DOI 10.1002/1097-0142(19851001)56:7<1515::AID-CNCR2820560707>3.0.CO;2-6; Rasalkar DD, 2011, PEDIATR RADIOL, V41, P227, DOI 10.1007/s00247-010-1809-1; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; SAETER G, 1995, CANCER-AM CANCER SOC, V75, P1084, DOI 10.1002/1097-0142(19950301)75:5<1084::AID-CNCR2820750506>3.0.CO;2-F; TABONE MD, 1994, J CLIN ONCOL, V12, P2614, DOI 10.1200/JCO.1994.12.12.2614	20	15	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0152621	10.1371/journal.pone.0152621	http://dx.doi.org/10.1371/journal.pone.0152621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167624	gold, Green Submitted, Green Published			2022-12-27	WOS:000376587300071
J	Raj, A; Ghule, M; Ritter, J; Battala, M; Gajanan, V; Nair, S; Dasgupta, A; Silverman, JG; Balaiah, D; Saggurti, N				Raj, Anita; Ghule, Mohan; Ritter, Julie; Battala, Madhusudana; Gajanan, Velhal; Nair, Saritha; Dasgupta, Anindita; Silverman, Jay G.; Balaiah, Donta; Saggurti, Niranjan			Cluster Randomized Controlled Trial Evaluation of a Gender Equity and Family Planning Intervention for Married Men and Couples in Rural India	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; HIV; PREVALENCE; IMPACT; WOMEN	Background Despite ongoing recommendations to increase male engagement and gender-equity (GE) counseling in family planning (FP) services, few such programs have been implemented and rigorously evaluated. This study evaluates the impact of CHARM, a three-session GE + FP counseling intervention delivered by male health care providers to married men, alone (sessions 1&2) and with their wives (session 3) in India. Methods and Findings A two-armed cluster randomized controlled trial was conducted with young married couples (N = 1081 couples) recruited from 50 geographic clusters (25 clusters randomized to CHARM and a control condition, respectively) in rural Maharashtra, India. Couples were surveyed on demographics, contraceptive behaviors, and intimate partner violence (IPV) attitudes and behaviors at baseline and 9 & 18-month follow-ups, with pregnancy testing at baseline and 18-month follow-up. Outcome effects on contraceptive use and incident pregnancy, and secondarily, on contraceptive communication and men's IPV attitudes and behaviors, were assessed using logistic generalized linear mixed models. Most men recruited from CHARM communities (91.3%) received at least one CHARM intervention session; 52.5% received the couple's session with their wife. Findings document that women from the CHARM condition, relative to controls, were more likely to report contraceptive communication at 9-month follow-up (AOR = 1.77, p = 0.04) and modern contraceptive use at 9 and 18-month follow-ups (AORs = 1.57-1.58, p = 0.05), and they were less likely to report sexual IPV at 18-month follow-up (AOR = 0.48, p = 0.01). Men in the CHARM condition were less likely than those in the control clusters to report attitudes accepting of sexual IPV at 9-month (AOR = 0.64, p = 0.03) and 18-month (AOR = 0.51, p = 0.004) follow-up, and attitudes accepting of physical IPV at 18-month follow-up (AOR = 0.64, p = 0.02). No significant effect on pregnancy was seen. Conclusions Findings demonstrate that men can be engaged in FP programming in rural India, and that such an approach inclusive of GE counseling can improve contraceptive practices and reduce sexual IPV in married couples.	[Raj, Anita; Ritter, Julie; Dasgupta, Anindita; Silverman, Jay G.] Univ Calif San Diego, Sch Med, Ctr Gender Equ & Hlth, Div Global Publ Hlth, San Diego, CA 92103 USA; [Ghule, Mohan; Nair, Saritha; Balaiah, Donta] NIRRH, Mumbai, Maharashtra, India; [Battala, Madhusudana; Saggurti, Niranjan] Populat Council, New Delhi, India; [Gajanan, Velhal] TN Med Coll & BYL Nair Ch Hosp, Mumbai, Maharashtra, India; [Gajanan, Velhal] BYL Nair Charitable Hosp, Mumbai, Maharashtra, India; [Nair, Saritha] Natl Inst Med Stat, New Delhi, India; [Saggurti, Niranjan] Bill & Melinda Gates Fdn, New Delhi, India	University of California System; University of California San Diego; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Topiwala National Medical College & B Y L Nair Charitable Hospital; Topiwala National Medical College & B Y L Nair Charitable Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute of Medical Statistics (NIMS)	Raj, A (corresponding author), Univ Calif San Diego, Sch Med, Ctr Gender Equ & Hlth, Div Global Publ Hlth, San Diego, CA 92103 USA.	anitaraj@ucsd.edu	Ritter, Julie/AAR-9358-2021	Ritter, Julie/0000-0002-5979-1869; Nair, Saritha/0000-0002-4560-6124; Saggurti, Niranjan/0000-0002-5267-8425; Dasgutpa, Anindita/0000-0003-3616-8860	National Institutes of Health, US [RO1HD61115]; Department of Biotechnology, Government of India [BT/IN/US/01/BD/2010]; CHARM Research Team; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099969] Funding Source: NIH RePORTER	National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CHARM Research Team; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institutes of Health, US (grant number: RO1HD61115); Department of Biotechnology, Government of India (grant #BT/IN/US/01/BD/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank our funders- National Institutes of Health, US (Grant number: RO1HD61115); Department of Biotechnology, Government of India (Grant #BT/IN/US/01/BD/2010).; We wish to acknowledge the efforts of the CHARM Research Team for their support and co-operation: Vaishali Ingole, Arun Jadhav, Pallavi Kamble, Reshma Kalamkar, Sagar Kadam, Umesh Mali, Sonal Pareria, Prajakta Palaye, Deepak Sonawane, Khanderao Tekale, and Sonali Yadav. We would also like to thank the village health care providers who conducted the CHARM intervention sessions, and Dr. Gopalkrishna Ramchandra Kadvekar for providing valuable consultation for the project as well as delivering intervention sessions. In addition, we wish to acknowledge John Zhu, Jennifer Yore, Ramesh Rao and the University of California, San Diego's Qualcomm Institute for their technical support in supporting development and maintenance of the MSHARE data collection and management system used in this study. We would also like to acknowledge Dr. Debbie Cheng for her early contributions to developing the study design and analysis plan for this study. Finally, this project would not be possible without the men and women who graciously participated in the CHARM intervention study. We wish to thank them for their time, participation and for sharing their stories with our team.	Ajah LO, 2015, J OBSTET GYNAECOL, V35, P628, DOI 10.3109/01443615.2014.991287; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; [Anonymous], 2016, EXPRESS HEALTHC 0125; [Anonymous], 2014, FP2020; Bandura A., 1986, SOCIAL FDN THOUGHT A; Barua A, 2004, ECON POLIT WEEKLY, V39, P5661; Connell R., 2013, GENDER POWER SOC PER; Gautham M, 2014, HEALTH POLICY PLANN, V29, pI20, DOI 10.1093/heapol/czt050; Ghule M, 2015, ASIAN J RES SOCIAL S, V5, P5; Ghule Mohan, 2015, Asian J Res Soc Sci Humanit, V5, P18, DOI 10.5958/2249-7315.2015.00132.X; Greene M, 2011, HDB GLOBAL PUBLIC HL; IIPS, 2016, NFHS 4 FACT SHEETS K; IIPS, 2007, IND NAT FAM HLTH SUR, V1; India Go, 2015, FAM PLANN INF ED COU; Jejeebhoy SJ, 2014, STUD FAMILY PLANN, V45, P183, DOI 10.1111/j.1728-4465.2014.00384.x; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Karra MV, 1997, STUD FAMILY PLANN, V28, P24, DOI 10.2307/2137968; Kunene B, 2004, INVOLVING MEN MATERN; Kyegombe N, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19232; Lundgren Rebecka, 2012, World Health Popul, V14, P44; MacDonald L., 2013, Gender and Development, V21, P31, DOI 10.1080/13552074.2013.767498; Mishra A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-41; Mwaikambo L, 2011, STUD FAMILY PLANN, V42, P67, DOI 10.1111/j.1728-4465.2011.00267.x; Pachauri S, 2001, J Indian Med Assoc, V99, P138; Pachauri S, 2014, INDIAN J MED RES, V140, P137; Pulerwitz J, 2015, AM J PUBLIC HEALTH, V105, P132, DOI 10.2105/AJPH.2014.302214; Raj A, 2014, INT J GYNECOL OBSTET, V124, P86, DOI 10.1016/j.ijgo.2013.07.027; Raj A, 2014, AIDS CARE, V26, P152, DOI 10.1080/09540121.2013.804901; Raju S, 2000, MEN SUPPORTIVE PARTN; Selvin S., 1996, STAT ANAL EPIDEMIOLO; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; Silverman JG, 2006, JAIDS-J ACQ IMM DEF, V43, P588; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Varkey LC., 2004, INVOLVING MEN MATERN; Wagman JA, 2015, LANCET GLOB HEALTH, V3, pE23, DOI 10.1016/S2214-109X(14)70344-4; Warriner I, 2012, THEORY BASED INTERVE; World Health Organization, 2001, WHOFCHGWH011; World Health Organization, 2021, VIOL WOM PREV EST 20; Yadav Kapil, 2010, Indian J Community Med, V35, P19, DOI 10.4103/0970-0218.62548; Yadav Kapil, 2009, Indian J Community Med, V34, P3, DOI 10.4103/0970-0218.45368; Yore J, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0122-3	41	53	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0153190	10.1371/journal.pone.0153190	http://dx.doi.org/10.1371/journal.pone.0153190			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CD	27167981	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300012
J	Fostad, IG; Eidet, JR; Utheim, TP; Raeder, S; Lagali, NS; Messelt, EB; Dartt, DA				Fostad, Ida G.; Eidet, Jon R.; Utheim, Tor P.; Raeder, Sten; Lagali, Neil S.; Messelt, Edvard B.; Dartt, Darlene A.			Dry Eye Disease Patients with Xerostomia Report Higher Symptom Load and Have Poorer Meibum Expressibility	PLOS ONE			English	Article							SJOGRENS-SYNDROME; CLASSIFICATION CRITERIA; INTERNATIONAL WORKSHOP; RISK-FACTORS; DIAGNOSIS; DYSFUNCTION; POPULATION; SIGNS; MOUTH; HYPOFUNCTION	The purpose of the study was to investigate if xerostomia (dry mouth) is associated with symptoms and signs of dry eye disease (DED). At the Norwegian Dry Eye Clinic, patients with symptomatic DED with different etiologies were consecutively included in the study. The patients underwent a comprehensive ophthalmological work-up and completed self-questionnaires on symptoms of ocular dryness (Ocular Surface Disease Index [OSDI] and McMonnies Dry Eye Questionnaire) and the Sjogren's syndrome (SS) questionnaire (SSQ). Three hundred and eighteen patients (52% women and 48% men) with DED were included. Patient demographics were: 0 to 19 years (1%), 20 to 39 (25%), 40 to 59 (34%), 60 to 79 (35%) and 80 to 99 (5%). Xerostomia, defined as "daily symptoms of dry mouth the last three months" (as presented in SSQ) was reported by 23% of the patients. Female sex was more common among patients with xerostomia (81%) than among non-xerostomia patients (44%; P< 0.001). Patients with xerostomia (60 +/- 15 years) were older than those without xerostomia (51 +/- 17; P< 0.001). The use of prescription drugs was more prevalent among xerostomia patients (65%) than among non-xerostomia patients (35%; P< 0.021; adjusted for age and sex). Patients with xerostomia had a higher OSDI score (19.0 +/- 10.0) than those without xerostomia (12.9 +/- 8.0; P< 0.001). Moreover, xerostomia patients had more pathological meibum expressibility (0.9 +/- 0.7) than those without xerostomia (0.7 +/- 0.8; P = 0.046). Comparisons of OSDI and ocular signs were performed after controlling for the effects of sex, age and the number of systemic prescription drugs used. In conclusion, xerostomia patients demonstrated a higher DED symptom load and had poorer meibum expressibility than non-xerostomia patients.	[Fostad, Ida G.; Utheim, Tor P.; Messelt, Edvard B.] Univ Oslo, Dept Oral Biol, Oslo, Norway; [Fostad, Ida G.; Eidet, Jon R.; Utheim, Tor P.; Raeder, Sten] Norwegian Dry Eye Clin, Oslo, Norway; [Eidet, Jon R.] Oslo Univ Hosp, Dept Ophthalmol, N-0450 Oslo, Norway; [Utheim, Tor P.] Oslo Univ Hosp, Dept Med Biochem, Unit Regenerat Med, N-0450 Oslo, Norway; [Utheim, Tor P.] Vestre Viken Hosp Trust, Dept Ophthalmol, Drammen, Norway; [Utheim, Tor P.] Buskerud & Vestfold Univ Coll, Fac Hlth Sci, Kongsberg, Norway; [Lagali, Neil S.] Linkoping Univ, Dept Ophthalmol, Inst Clin & Expt Med, Linkoping, Sweden; [Dartt, Darlene A.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA USA	University of Oslo; University of Oslo; University of Oslo; University College of Southeast Norway; Linkoping University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Fostad, IG (corresponding author), Univ Oslo, Dept Oral Biol, Oslo, Norway.; Fostad, IG (corresponding author), Norwegian Dry Eye Clin, Oslo, Norway.	ida_fostad@hotmail.com	Lagali, Neil/H-3580-2019	Lagali, Neil/0000-0003-1079-4361	NEI NIH HHS [R01 EY019470] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY019470] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akpek EK, 2009, CORNEA, V28, P493, DOI 10.1097/ICO.0b013e31818d3846; Aliko A, 2015, ORAL SURG ORAL MED O; Alves M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097921; Astor F C, 1999, Ear Nose Throat J, V78, P476; Bartlett JD, 2015, CLIN OPHTHALMOL, V9, P1719, DOI 10.2147/OPTH.S89700; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2001, SURV OPHTHALMOL, V45, pS221, DOI 10.1016/S0039-6257(00)00201-0; Bron AJ, 2014, OCUL SURF, V12, pS1, DOI 10.1016/j.jtos.2014.02.002; Cassolato Sandra F, 2003, Gerodontology, V20, P64, DOI 10.1111/j.1741-2358.2003.00064.x; Chan C., 2015, DRY EYE PRACTICAL AP, P31; Davies A, 2005, ORAL CARE ADV DIS, P97; Delli K, 2014, MONOGR ORAL SCI, V24, P109, DOI 10.1159/000358792; DEWILDE PCM, 1986, J CLIN PATHOL, V39, P406, DOI 10.1136/jcp.39.4.406; Eidet JR, 2013, 7 INT C TEAR FILM OC; Fox PC, 1998, ANN NY ACAD SCI, V842, P132, DOI 10.1111/j.1749-6632.1998.tb09641.x; Han P, 2014, J PROSTHODONTIC RES; Hopcraft MS, 2010, AUST DENT J, V55, P238, DOI 10.1111/j.1834-7819.2010.01229.x; Lemp MA, 2007, OCUL SURF, V5, P75; Matsumoto Y, 2009, GRAEF ARCH CLIN EXP, V247, P821, DOI 10.1007/s00417-008-1017-y; Nagler RM, 2004, BIOGERONTOLOGY, V5, P223, DOI 10.1023/B:BGEN.0000038023.36727.50; Narhi TO, 1999, DRUG AGING, V15, P103; Nederfors T, 1997, COMMUNITY DENT ORAL, V25, P211, DOI 10.1111/j.1600-0528.1997.tb00928.x; Nichols KK, 2011, INVEST OPHTH VIS SCI, V52, P1922, DOI 10.1167/iovs.10-6997a; Ousler GW, 2008, CORNEA, V27, P509, DOI 10.1097/ICO.0b013e31816583f6; Pajukoski H, 2001, ORAL SURG ORAL MED O, V92, P641, DOI 10.1067/moe.2001.118478; Pedersen AML, 2015, DRY MOUTH; Plemons JM, 2014, J AM DENT ASSOC, V145, P867, DOI 10.14219/jada.2014.44; Resch MD, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/543835; Saleh J, 2015, ARCH ORAL BIOL, V60, P242, DOI 10.1016/j.archoralbio.2014.10.004; Sankar V, 2014, ORAL MAXIL SURG CLIN, V26, P13, DOI 10.1016/j.coms.2013.09.001; Schaumberg DA, 2011, INVEST OPHTH VIS SCI, V52, P1994, DOI 10.1167/iovs.10-6997e; Schein OD, 1997, OPHTHALMOLOGY, V104, P1395, DOI 10.1016/S0161-6420(97)30125-0; Schein OD, 1999, ARCH INTERN MED, V159, P1359, DOI 10.1001/archinte.159.12.1359; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Schmidl D, 2015, INVESTIGATIVE OPHTHA; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Sullivan BD, 2014, ACTA OPHTHALMOL, V92, P161, DOI 10.1111/aos.12012; SYRJANEN S, 1984, AGE AGEING, V13, P159, DOI 10.1093/ageing/13.3.159; Truong S, 2014, CLIN EXP OPTOM, V97, P324, DOI 10.1111/cxo.12147; Villa A, 2011, AUST DENT J, V56, P290, DOI 10.1111/j.1834-7819.2011.01347.x; Villa A, 2015, GERODONTOLOGY; Villa A, 2015, THER CLIN RISK MANAG, V11, P45, DOI 10.2147/TCRM.S76282; Vissink A, 1996, Spec Care Dentist, V16, P95, DOI 10.1111/j.1754-4505.1996.tb00842.x; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WARDROP RW, 1989, ORAL SURG ORAL MED O, V67, P535, DOI 10.1016/0030-4220(89)90269-7; Wise RJ, 2012, SAUDI J OPHTHALMOL, V26, P349, DOI 10.1016/j.sjopt.2012.08.007	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155214	10.1371/journal.pone.0155214	http://dx.doi.org/10.1371/journal.pone.0155214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148875	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800123
J	Carlson-Jones, JAP; Paterson, JS; Newton, K; Smith, RJ; Dann, LM; Speck, P; Mitchell, JG; Wormald, PJ				Carlson-Jones, Jessica A. P.; Paterson, James S.; Newton, Kelly; Smith, Renee J.; Dann, Lisa M.; Speck, Peter; Mitchell, James G.; Wormald, Peter-John			Enumerating Virus-Like Particles and Bacterial Populations in the Sinuses of Chronic Rhinosinusitis Patients Using Flow Cytometry	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; QUANTITATIVE CYTOLOGY; STAPHYLOCOCCUS-AUREUS; COUNTING BACTERIA; NASAL SECRETIONS; BIOFILMS; MICROBIOME; DIVERSITY; CULTURE; DITHIOTHREITOL	There is increasing evidence to suggest that the sinus microbiome plays a role in the pathogenesis of chronic rhinosinusitis (CRS). However, the concentration of these microorganisms within the sinuses is still unknown. We show that flow cytometry can be used to enumerate bacteria and virus-like particles (VLPs) in sinus flush samples of CRS patients. This was achieved through trialling 5 sample preparation techniques for flow cytometry. We found high concentrations of bacteria and VLPs in these samples. Untreated samples produced the highest average bacterial and VLP counts with 3.3 +/- 0.74 x 10(7) bacteria ml(-1) and 2.4 +/- 1.23 x 10(9) VLP ml(-1) of sinus flush (n = 9). These counts were significantly higher than most of the treated samples (p < 0.05). Results showed 10(3) and 10(4) times inter-patient variation for bacteria and VLP concentrations. This wide variation suggests that diagnosis and treatment need to be personalised and that utilising flow cytometry is useful and efficient for this. This study is the first to enumerate bacterial and VLP populations in the maxillary sinus of CRS patients. The relevance of enumeration is that with increasing antimicrobial resistance, antibiotics are becoming less effective at treating bacterial infections of the sinuses, so alternative therapies are needed. Phage therapy has been proposed as one such alternative, but for dosing, the abundance of bacteria is required. Knowledge of whether phages are normally present in the sinuses will assist in gauging the safety of applying phage therapy to sinuses. Our finding, that large numbers of VLP are frequently present in sinuses, indicates that phage therapy may represent a minimally disruptive intervention towards the nasal microbiome. We propose that flow cytometry can be used as a tool to assess microbial biomass dynamics in sinuses and other anatomical locations where infection can cause disease.	[Carlson-Jones, Jessica A. P.; Paterson, James S.; Newton, Kelly; Smith, Renee J.; Dann, Lisa M.; Speck, Peter; Mitchell, James G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Wormald, Peter-John] Univ Adelaide, Dept Surg Otolaryngol Head & Neck Surg, Adelaide, SA 5005, Australia	Flinders University South Australia; University of Adelaide	Carlson-Jones, JAP (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	jessica.carlsonjones@flinders.edu.au		Newton, Kelly/0000-0001-8405-7140; Paterson, James/0000-0002-1193-5739; Speck, Peter/0000-0001-9087-258X; Mitchell, Jim/0000-0002-8445-0935	Australian Research Council	Australian Research Council(Australian Research Council)	Consumables and general support was provided by Flinders University and grants to JGM by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon Stephen T, 2011, Bacteriophage, V1, P66; Benninger MS, 2003, OTOLARYNG HEAD NECK, V129, pS1, DOI 10.1016/S0194-5998(03)01397-4; Bhattacharyya N, 2008, ANN OTO RHINOL LARYN, V117, P448, DOI 10.1177/000348940811700608; Biswas K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00134; Boase S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-210; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Carreira C, 2015, APPL ENVIRON MICROB, V81, P2149, DOI 10.1128/AEM.02863-14; Chisholm KM, 2013, INT FORUM ALLERGY RH, V3, P992, DOI 10.1002/alr.21230; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cryer J, 2004, ORL-J OTO-RHIN-LARYN, V66, P155, DOI 10.1159/000079994; Danovaro R, 2001, APPL ENVIRON MICROB, V67, P1384, DOI 10.1128/AEM.67.3.1384-1387.2001; Danovaro R., 2010, MANUAL AQUATIC VIRAL, P74, DOI [10.4319/mave.2010.978-0-9845591-0-7.74, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.74]; Drilling A, 2014, AM J RHINOL ALLERGY, V28, P3, DOI 10.2500/ajra.2014.28.4001; Feazel LM, 2012, LARYNGOSCOPE, V122, P467, DOI 10.1002/lary.22398; Ferguson BJ, 2005, AM J RHINOL, V19, P452, DOI 10.1177/194589240501900506; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Foreman A, 2009, AM J RHINOL ALLERGY, V23, P556, DOI 10.2500/ajra.2009.23.3413; Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09; Garren M, 2010, APPL ENVIRON MICROB, V76, P6128, DOI 10.1128/AEM.01100-10; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Grebski E, 2001, CHEST, V119, P1521, DOI 10.1378/chest.119.5.1521; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hajiioannou J, 2012, RES OTOLARYNGOL, V1, P6; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jiang RS, 1999, J LARYNGOL OTOL, V113, P825, DOI 10.1017/S0022215100145311; Kingdom TT, 2004, AM J OTOLARYNG, V25, P323, DOI 10.1016/j.amjoto.2004.03.003; LEE HS, 1993, LARYNGOSCOPE, V103, P533; Leruste A, 2012, APPL ENVIRON MICROB, V78, P6377, DOI 10.1128/AEM.01141-12; Lunau M, 2005, ENVIRON MICROBIOL, V7, P961, DOI 10.1111/j.1462-2920.2005.00767.x; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Mitchell JG, 2008, J MARINE SYST, V69, P328, DOI 10.1016/j.jmarsys.2006.03.026; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Ooi EH, 2008, AM J RHINOL, V22, P13, DOI 10.2500/ajr.2008.22.3127; Payne RJH, 2000, CLIN PHARMACOL THER, V68, P225, DOI 10.1067/mcp.2000.109520; Psaltis AJ, 2007, LARYNGOSCOPE, V117, P1302, DOI 10.1097/MLG.0b013e31806009b0; Ramadan HH, 2005, OTOLARYNG HEAD NECK, V132, P414, DOI 10.1016/j.otohns.2004.11.011; ROBERTSON BR, 1989, CYTOMETRY, V10, P70, DOI 10.1002/cyto.990100112; Sanclement JA, 2005, LARYNGOSCOPE, V115, P578, DOI 10.1097/01.mlg.0000161346.30752.18; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Shinogi J, 1998, LARYNGOSCOPE, V108, P703, DOI 10.1097/00005537-199805000-00014; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Williamson KE, 2003, APPL ENVIRON MICROB, V69, P6628, DOI 10.1128/AEM.69.11.6628-6633.2003; Wilson MT, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0485-x	46	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155003	10.1371/journal.pone.0155003	http://dx.doi.org/10.1371/journal.pone.0155003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171169	Green Published, gold			2022-12-27	WOS:000376588600045
J	Grueter, CC; Stoinski, TS				Grueter, Cyril C.; Stoinski, Tara S.			Homosexual Behavior in Female Mountain Gorillas: Reflection of Dominance, Affiliation, Reconciliation or Arousal?	PLOS ONE			English	Article							SOCIAL RELATIONSHIPS; ORANGUTAN CULTURES; SEXUAL-BEHAVIOR; PAN-PANISCUS; EVOLUTION; PRIMATES; MAMMALS	Humans are unique among primates for not only engaging in same-sex sexual acts, but also forming homosexual pair bonds. To shed light on the evolutionary origins of homosexuality, data on the occurrence and contexts of same-sex behavior from nonhuman primates may be of particular significance. Homosexual behavior involving females is poorly researched in most primate taxa, exceptions being Japanese macaques, rhesus macaques, Hanuman langurs and bonobos. We present data on homosexual behavior in female mountain gorillas in the Virunga Volcanoes (Rwanda) and test four functional hypotheses, namely reconciliation, affiliation, dominance expression and sexual arousal. Homosexual interactions between females involved both ventro-dorsal and ventro-ventral copulations accompanied by vocalizations and courtship displays. The only sociosexual hypothesis that received partial empirical support is the social status hypothesis, i.e., that mounting reaffirms the dominance hierarchy. There is also some limited evidence that same-sex behavior reflects an overall state of arousal or is triggered via a 'pornographic' effect. An adaptive function of female homosexual behavior is not readily apparent, and we tentatively conclude (until a more rigorous test becomes available) that it may simply be related to sexual gratification or that it is an evolutionary by-product of an adaptation.	[Grueter, Cyril C.] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Stoinski, Tara S.] Dian Fossey Gorilla Fund Int SE, Atlanta, GA USA	University of Western Australia	Grueter, CC (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia.	cyril.grueter@uwa.edu.au		Grueter, Cyril C./0000-0001-8770-8148	Max Planck Society; Dian Fossey Gorilla Fund International; Swiss National Science Foundation [PBZHP3-128152]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Dian Fossey Gorilla Fund International; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding for this study was provided by the Max Planck Society, the Dian Fossey Gorilla Fund International, and the Swiss National Science Foundation (PBZHP3-128152).; We thank Martha Robbins for providing helpful suggestions on this study, Tony Mudakikwa Prosper Uwingeli and Rosette Chantal Rugamba at Rwanda Development Board for permission to conduct research at Volcanoes National Park, the Karisoke researchers, trackers and data technicians for help with data collection under often difficult conditions, Katie Fawcett and Gaetan Nsengiyumva for administrative and logistical support, and Debra Judge, Belinda Burns and other members of the UWA Bioanthropology Lab for comments on this manuscript. Funding for this study was provided by the Max Planck Society, the Dian Fossey Gorilla Fund International, and the Swiss National Science Foundation (PBZHP3-128152). The research conducted adhered to the legal requirements of Rwanda.	AKERS JS, 1979, ARCH SEX BEHAV, V8, P63, DOI 10.1007/BF01541214; Anestis SF, 2004, INT J PRIMATOL, V25, P477, DOI 10.1023/B:IJOP.0000019163.09540.17; Bagemihl B., 1999, BIOL EXUBERANCE ANIM; Bailey NW, 2009, TRENDS ECOL EVOL, V24, P439, DOI 10.1016/j.tree.2009.03.014; Breuer T, 2007, GORILLA GAZETTE, V20, P47; CHADWICKJONES JK, 1989, J SOC BIOL STRUCT, V12, P319, DOI 10.1016/0140-1750(89)90026-2; Chapais B, 1997, ANIM BEHAV, V53, P1089, DOI 10.1006/anbe.1996.0365; Clay Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00291; Czekala N, 2000, AM J PRIMATOL, V51, P209, DOI 10.1002/1098-2345(200007)51:3<209::AID-AJP6>3.0.CO;2-6; DAGG AI, 1984, MAMMAL REV, V14, P155, DOI 10.1111/j.1365-2907.1984.tb00344.x; DEWAAL FBM, 1987, NATL GEOGR RES, V3, P318; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DIXSON AF, 1977, J ZOOL, V182, P63; Doran-Sheeny DM, 2009, AM J PRIMATOL, V71, P1011, DOI 10.1002/ajp.20743; FISCHER R B, 1978, Primates, V19, P657, DOI 10.1007/BF02373633; Fossey Diane, 1983, GORILLAS IN THE MIST; Fox EA, 2001, AM J PRIMATOL, V55, P177, DOI 10.1002/ajp.1051; Fruth Barbara, 2006, P294; FURUICHI T, 1989, INT J PRIMATOL, V10, P173, DOI 10.1007/BF02735199; Furuichi T, PRIMATES CETACEANS F, P385; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Goodall Jane, 1988, SHADOW MAN; Grueter CC, CAUSES MECH CONSEQUE; Grueter CC, 2013, AM J PRIMATOL, V75, P267, DOI 10.1002/ajp.22102; Gruter CC, 2004, PRIMATES, V45, P197; Hanby JP, 1974, ANIM BEHAV, V22, P152; Harcourt A H, 1980, J Reprod Fertil Suppl, VSuppl 28, P59; Harcourt A.H., 1981, P265; HARCOURT AH, 1979, ANIM BEHAV, V27, P325, DOI 10.1016/0003-3472(79)90166-0; HARCOURT AH, 1979, ANIM BEHAV, V27, P251, DOI 10.1016/0003-3472(79)90145-3; HARCOURT AH, 1976, NATURE, V263, P226, DOI 10.1038/263226a0; Hess J.P., 1973, P507; Hohmann G, 2000, ANIM BEHAV, V60, P107, DOI 10.1006/anbe.2000.1451; Kirkpatrick RC, 2000, CURR ANTHROPOL, V41, P385, DOI 10.1086/300145; McNeilage Alastair, 2001, Cambridge Studies in Biological and Evolutionary Anthropology, V27, P265; Murai T, 2006, AM J PRIMATOL, V68, P832, DOI 10.1002/ajp.20266; NADLER RD, 1990, KINSEY INST, V2, P138; NIEMEYER CL, 1983, ETHOL SOCIOBIOL, V4, P205, DOI 10.1016/0162-3095(83)90010-9; Parish AR, 1996, HUM NATURE-INT BIOS, V7, P61, DOI 10.1007/BF02733490; PARKER GA, 1976, J NAT HIST, V10, P241, DOI 10.1080/00222937600770171; Poiani A., 2010, ANIMAL HOMOSEXUALITY; Robbins Martha M., 2001, Cambridge Studies in Biological and Evolutionary Anthropology, V27, P29; Robbins MM, 2005, BEHAVIOUR, V142, P779, DOI 10.1163/1568539054729123; Robbins MM, 1996, ETHOLOGY, V102, P942; Ryu H, 2015, BEHAVIOUR, V152, P285, DOI 10.1163/1568539X-00003212; Sommer V, 2006, HOMOSEXUAL BEHAV ANI; SRIVASTAVA A, 1991, ARCH SEX BEHAV, V20, P487, DOI 10.1007/BF01542410; Stewart K.J., 1987, P155; Stoinski TS, 2009, AM J PRIMATOL, V71, P587, DOI 10.1002/ajp.20692; Stumpf Rebecca, 2011, PRIMATES PERSPECTIVE, V2nd, P608; TALMAGERIGGS G, 1973, FOLIA PRIMATOL, V19, P61, DOI 10.1159/000155519; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; van Schaik CP, 2003, AM J PHYS ANTHROPOL, P214; Vasey P. L., 2006, HOMOSEXUAL BEHAV ANI, P3; Vasey Paul L., 2006, P191; Vasey PL, 2002, ANN REV SEX RES, V13, P141; Vasey PL, 1998, ETHOLOGY, V104, P387; VASEY PL, 1995, INT J PRIMATOL, V16, P173, DOI 10.1007/BF02735477; WATTS DP, 1984, AM J PRIMATOL, V7, P323, DOI 10.1002/ajp.1350070403; Watts DP, 2003, CAM S BIO EVOL ANTHR, V35, P302; WATTS DP, 1994, AM J PRIMATOL, V32, P13, DOI 10.1002/ajp.1350320103; WATTS DP, 1994, BEHAV ECOL SOCIOBIOL, V34, P347, DOI 10.1007/BF01209781; WATTS DP, 1995, ETHOLOGY, V100, P158; White Frances J., 1992, P67; YAMAGIWA J, 1987, PRIMATES, V28, P1, DOI 10.1007/BF02382180; Yamagiwa Juichi, 2006, P273	66	9	10	7	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154185	10.1371/journal.pone.0154185	http://dx.doi.org/10.1371/journal.pone.0154185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167861	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300047
J	Sintusek, P; Catapano, F; Angkathunkayul, N; Marrosu, E; Parson, SH; Morgan, JE; Muntoni, F; Zhou, HY				Sintusek, Palittiya; Catapano, Francesco; Angkathunkayul, Napat; Marrosu, Elena; Parson, Simon H.; Morgan, Jennifer E.; Muntoni, Francesco; Zhou, Haiyan			Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment	PLOS ONE			English	Article							MOUSE MODEL; NERVOUS-SYSTEM; SINGLE NUCLEOTIDE; MOTOR-NEURON; RESCUE; ABNORMALITIES; OLIGOMER; SMN1; SURVIVAL; DELIVERY	Gastrointestinal (GI) defects, including gastroesophageal reflux, constipation and delayed gastric emptying, are common in patients with spinal muscular atrophy (SMA). Similar GI dysmotility has been identified in mouse models with survival of motor neuron (SMN) protein deficiency. We previously described vascular defects in skeletal muscle and spinal cord of SMA mice and we hypothesized that similar defects could be involved in the GI pathology observed in these mice. We therefore investigated the gross anatomical structure, enteric vasculature and neurons in the small intestine in a severe mouse model of SMA. We also assessed the therapeutic response of GI histopathology to systemic administration of morpholino antisense oligonucleotide (AON) designed to increase SMN protein expression. Significant anatomical and histopathological abnormalities, with striking reduction of vascular density, overabundance of enteric neurons and increased macrophage infiltration, were detected in the small intestine in SMA mice. After systemic AON treatment in neonatal mice, all the abnormalities observed were significantly restored to near-normal levels. We conclude that the observed GI histopathological phenotypes and functional defects observed in these SMA mice are strongly linked to SMN deficiency which can be rescued by systemic administration of AON. This study on the histopathological changes in the gastrointestinal system in severe SMA mice provides further indication of the complex role that SMN plays in multiple tissues and suggests that at least in SMA mice restoration of SMN production in peripheral tissues is essential for optimal outcome.	[Sintusek, Palittiya; Catapano, Francesco; Marrosu, Elena; Morgan, Jennifer E.; Muntoni, Francesco; Zhou, Haiyan] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Sintusek, Palittiya] Chulalongkorn Univ, Fac Med, King Chulalongkorn Mem Hosp, Div Gastroenterol & Hepatol,Dept Pediat, Bangkok 10330, Thailand; [Angkathunkayul, Napat] Mahidol Univ, Ramathibodi Hosp, Dept Pathol, Bangkok 10700, Thailand; [Parson, Simon H.] Univ Aberdeen, Inst Med Sci, Foresterhill, Aberdeen, Scotland; [Parson, Simon H.] Univ Edinburgh, Euan MacDonald Ctr Motor Neuron Dis Res, Edinburgh, Midlothian, Scotland	University of London; University College London; Chulalongkorn University; Mahidol University; University of Aberdeen; University of Edinburgh	Muntoni, F; Zhou, HY (corresponding author), UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.	f.muntoni@ucl.ac.uk; Haiyan.zhou@ucl.ac.uk		Parson, Simon/0000-0002-8848-8738; Catapano, Francesco/0000-0001-7324-0687	National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London; Medical Research Council [MR/L013142/1]; SMA-Europe grant; Great Ormond Street Hospital Children's Charity; Bill Marshall Fellowship; CP Charitable Trust at Great Ormond Street Hospital; UCL; SMA Trust; Euan MacDonald Centre for Motor Neurone Disease Research; National Institute for Health Research [NF-SI-0515-10022] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V0216] Funding Source: researchfish; MRC [MR/L013142/1] Funding Source: UKRI	National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SMA-Europe grant; Great Ormond Street Hospital Children's Charity; Bill Marshall Fellowship; CP Charitable Trust at Great Ormond Street Hospital; UCL; SMA Trust; Euan MacDonald Centre for Motor Neurone Disease Research; National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London (FM and HZ), the Medical Research Council grant (grant reference MR/L013142/1, FM), SMA-Europe grant (FM and HZ) and Great Ormond Street Hospital Children's Charity grants (FM and HZ). JEM is supported by Great Ormond Street Hospital Children's Charity. PS is supported by Bill Marshall Fellowship and The CP Charitable Trust at Great Ormond Street Hospital and UCL. SHP is supported by SMA Trust and Euan MacDonald Centre for Motor Neurone Disease Research.	Bain CC, 2014, CELL IMMUNOL, V291, P41, DOI 10.1016/j.cellimm.2014.03.012; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Davis RH, 2014, J CHILD NEUROL, V29, P1467, DOI 10.1177/0883073813503988; Araujo APDC, 2009, J PEDIATR-US, V155, P292, DOI 10.1016/j.jpeds.2009.01.071; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; GALVIS DA, 1992, PEDIATR PATHOL, V12, P385, DOI 10.3109/15513819209023317; Geboes K, 1998, NEUROGASTROENT MOTIL, V10, P189, DOI 10.1046/j.1365-2982.1998.00102.x; Gombash SE, 2015, HUM MOL GENET, V24, P3847, DOI 10.1093/hmg/ddv127; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hohenwalter Eric J, 2009, Semin Intervent Radiol, V26, P345, DOI 10.1055/s-0029-1242198; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Margolis KG, 2011, GASTROENTEROLOGY, V141, P588, DOI 10.1053/j.gastro.2011.04.047; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Mitrpant C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062114; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Ottesen EW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20193; Owen N, 2011, NUCLEIC ACIDS RES, V39, P7194, DOI 10.1093/nar/gkr152; Palacino J, 2015, NAT CHEM BIOL, V11, P511, DOI [10.1038/NCHEMBIO.1837, 10.1038/nchembio.1837]; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; PEARN J, 1980, LANCET, V1, P919; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Rudnik-Schoneborn S, 2010, MUSCLE NERVE, V42, P144, DOI 10.1002/mus.21654; Schreml J, 2013, EUR J HUM GENET, V21, P643, DOI 10.1038/ejhg.2012.222; Schrenk S, 2015, HISTOCHEM CELL BIOL, V143, P397, DOI 10.1007/s00418-014-1288-9; Shababi M, 2014, J ANAT, V224, P15, DOI 10.1111/joa.12083; Shababi M, 2010, HUM MOL GENET, V19, P4059, DOI 10.1093/hmg/ddq329; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Somers E, 2012, NEUROMUSCULAR DISORD, V22, P435, DOI 10.1016/j.nmd.2011.10.021; Somers E, 2016, ANN NEUROL, V79, P217, DOI 10.1002/ana.24549; Somers E, 2013, NEUROSCI LETT, V544, P100, DOI 10.1016/j.neulet.2013.03.052; Taylor JE, 1998, EUR J HUM GENET, V6, P467, DOI 10.1038/sj.ejhg.5200210; Valori CF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000830; Villanacci V, 2008, NEUROGASTROENT MOTIL, V20, P1009, DOI 10.1111/j.1365-2982.2008.01146.x; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Zhou HY, 2015, HUM MOL GENET, V24, P6265, DOI 10.1093/hmg/ddv329; Zhou HY, 2013, HUM GENE THER, V24, P331, DOI 10.1089/hum.2012.211	42	34	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155032	10.1371/journal.pone.0155032	http://dx.doi.org/10.1371/journal.pone.0155032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163330	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700026
J	Scherner, F; Pereira, CM; Duarte, G; Horta, PA; Castro, CBE; Barufi, JB; Pereira, SMB				Scherner, Fernando; Pereira, Cristiano Macedo; Duarte, Gustavo; Horta, Paulo Antunes; Barreira e Castro, Clovis; Barufi, Jose Bonomi; Barreto Pereira, Sonia Maria			Effects of Ocean Acidification and Temperature Increases on the Photosynthesis of Tropical Reef Calcified Macroalgae	PLOS ONE			English	Article							GREEN-ALGA HALIMEDA; CLIMATE-CHANGE; INORGANIC-CARBON; CALCIFICATION; RED; BRYOPSIDALES; RESPONSES; MODEL; BROWN	Climate change is a global phenomenon that is considered an important threat to marine ecosystems. Ocean acidification and increased seawater temperatures are among the consequences of this phenomenon. The comprehension of the effects of these alterations on marine organisms, in particular on calcified macroalgae, is still modest despite its great importance. There are evidences that macroalgae inhabiting highly variable environments are relatively resilient to such changes. Thus, the aim of this study was to evaluate experimentally the effects of CO2-driven ocean acidification and temperature rises on the photosynthesis of calcified macroalgae inhabiting the intertidal region, a highly variable environment. The experiments were performed in a reef mesocosm in a tropical region on the Brazilian coast, using three species of frondose calcifying macroalgae (Halimeda cuneata, Padina gymnospora, and Tricleocarpa cylindrica) and crustose coralline algae. The acidification experiment consisted of three treatments with pH levels below those occurring in the region (-0.3, -0.6, -0.9). For the temperature experiment, three temperature levels above those occurring naturally in the region (+1,+2,+4 degrees C) were determined. The results of the acidification experiment indicate an increase on the optimum quantum yield by T. cylindrica and a decline of this parameter by coralline algae, although both only occurred at the extreme acidification treatment (-0.9). The energy dissipation mechanisms of these algae were also altered at this extreme condition. Significant effects of the temperature experiment were limited to an enhancement of the photosynthetic performance by H. cuneata although only at a modest temperature increase (+1 degrees C). In general, the results indicate a possible photosynthetic adaptation and/or acclimation of the studied macroalgae to the expected future ocean acidification and temperature rises, as separate factors. Such relative resilience may be a result of the highly variable environment they inhabit.	[Scherner, Fernando; Barreto Pereira, Sonia Maria] Univ Fed Rural Pernambuco, Dept Biol, R Dom Manoel Medeiros S-N, BR-52171900 Recife, PE, Brazil; [Pereira, Cristiano Macedo; Duarte, Gustavo; Horta, Paulo Antunes; Barreira e Castro, Clovis] Inst Coral Vivo, Estr Balsa,Km 4,5, BR-45816000 Porto Seguro, BA, Brazil; [Duarte, Gustavo; Barreira e Castro, Clovis] Univ Fed Rio de Janeiro, Dept Inverterbrados, Museu Nacl, Quinta Boa Vista S-N, BR-20940040 Rio De Janeiro, RJ, Brazil; [Horta, Paulo Antunes; Barufi, Jose Bonomi] Univ Fed Santa Catarina, Dept Bot, BR-88010970 Florianopolis, SC, Brazil; [Barreto Pereira, Sonia Maria] Univ Fed Pernambuco, Programa Posgrad Saude Humana & Meio Ambiente, Rua Alto Reservatorio S-N, BR-55608680 Vitoria De Santo Antao, PE, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal do Rio de Janeiro; Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Pernambuco	Scherner, F (corresponding author), Univ Fed Rural Pernambuco, Dept Biol, R Dom Manoel Medeiros S-N, BR-52171900 Recife, PE, Brazil.	fscherner@yahoo.com	Castro, Clovis B/J-7525-2012; Duarte, Gustavo/AAM-2574-2020; Duarte, Gustavo/GYA-1749-2022; Horta, Paulo A/L-3092-2015; Fapesp, Biota/F-8655-2017	Duarte, Gustavo/0000-0002-7950-3975; Horta, Paulo A/0000-0001-7699-7589; Fapesp, Biota/0000-0002-9887-8449; Pereira, Cristiano/0000-0003-4004-8917	"Projeto Coral Vivo" (Petrobras, through the Petrobras Socioenvironmental Program); "Projeto Coral Vivo" (Arraial d'Ajuda Eco Parque); Brazilian Coordination for the Improvement of Higher Level Personnel (CAPES)	"Projeto Coral Vivo" (Petrobras, through the Petrobras Socioenvironmental Program); "Projeto Coral Vivo" (Arraial d'Ajuda Eco Parque); Brazilian Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	"Projeto Coral Vivo" and its sponsors (Petrobras, through the Petrobras Socioenvironmental Program, and Arraial d'Ajuda Eco Parque) provided logistical and financial support. F.S. was granted by the Brazilian Coordination for the Improvement of Higher Level Personnel (CAPES) with a PhD full grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge "Projeto Coral Vivo" and its sponsors (Petrobras, through the Petrobras Socioenvironmental Program, and Arraial d'Ajuda Eco Parque) for logistical and financial support. F.S. was granted by the Brazilian Coordination for the Improvement of Higher Level Personnel (CAPES).	Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Anderson B. C., 2006, THESIS FLORIDA ATLAN; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Badger M.R., 1987, BIOCH PLANTS COMPREH, P219, DOI DOI 10.1016/B978-0-12-675410-0.50010-5; Bandeira-Pedrosa ME, 2004, PHYCOLOGIA, V43, P50, DOI 10.2216/i0031-8884-43-1-50.1; BOROWITZKA MA, 1976, J EXP BOT, V27, P879, DOI 10.1093/jxb/27.5.879; BOROWITZKA MA, 1981, MAR BIOL, V62, P17, DOI 10.1007/BF00396947; BOROWITZKA MA, 1977, J PHYCOL, V13, P6, DOI 10.1111/j.1529-8817.1977.tb02879.x; Brown CJ, 2010, GLOBAL CHANGE BIOL, V16, P1194, DOI 10.1111/j.1365-2486.2009.02046.x; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; Diaz-Pulido G, 2012, J PHYCOL, V48, P32, DOI 10.1111/j.1529-8817.2011.01084.x; Egilsdottir H, 2013, MAR BIOL, V160, P2103, DOI 10.1007/s00227-012-2090-7; Gaylord B, 2015, ECOLOGY, V96, P3, DOI 10.1890/14-0802.1; Grzymski J, 1997, J PHYCOL, V33, P408, DOI 10.1111/j.0022-3646.1997.00408.x; HAGLUND K, 1992, PLANTA, V187, P275, DOI 10.1007/BF00201951; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harley CDG, 2012, J PHYCOL, V48, P1064, DOI 10.1111/j.1529-8817.2012.01224.x; Hoegh-Guldberg O, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P391, DOI 10.1007/978-94-007-0114-4_22; Hofmann LC, 2012, MAR BIOL, V159, P783, DOI 10.1007/s00227-011-1854-9; Israel A, 2002, GLOBAL CHANGE BIOL, V8, P831, DOI 10.1046/j.1365-2486.2002.00518.x; Johnson VR, 2012, GLOBAL CHANGE BIOL, V18, P2792, DOI 10.1111/j.1365-2486.2012.02716.x; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Kamenos NA, 2013, GLOBAL CHANGE BIOL, V19, P3621, DOI 10.1111/gcb.12351; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; PENTECOST A, 1978, BRIT PHYCOL J, V13, P383, DOI 10.1080/00071617800650431; Platt T., 1980, PRIMARY PRODUCTIVITY, P339, DOI [DOI 10.1007/978-1-4684-3890-1_19, 10.1007/978-1-4684-3890-1_19]; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Price NN, 2011, MAR ECOL PROG SER, V440, P67, DOI 10.3354/meps09309; Santos HF, 2014, ISME J, V8, P2272, DOI 10.1038/ismej.2014.70; Scherner F, 2013, MAR ENVIRON RES, V91, P14, DOI 10.1016/j.marenvres.2012.05.007; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; Semesi IS, 2009, ESTUAR COAST SHELF S, V84, P337, DOI 10.1016/j.ecss.2009.03.038; Sinutok S, 2012, CORAL REEFS, V31, P1201, DOI 10.1007/s00338-012-0952-6; Verbruggen H, 2005, MOL PHYLOGENET EVOL, V37, P789, DOI 10.1016/j.ympev.2005.06.015; WEFER G, 1980, NATURE, V285, P323, DOI 10.1038/285323a0; Wizemann A, 2014, CORAL REEFS, V33, P951, DOI 10.1007/s00338-014-1183-9	41	22	22	7	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154844	10.1371/journal.pone.0154844	http://dx.doi.org/10.1371/journal.pone.0154844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158820	Green Submitted, gold, Green Published			2022-12-27	WOS:000376576700019
J	Li, JQ; Wang, LH; Zhan, QW; Liu, YL; Yang, XC				Li, Jieqin; Wang, Lihua; Zhan, Qiuwen; Liu, Yanlong; Yang, Xiaocui			Transcriptome Characterization and Functional Marker Development in Sorghum Sudanense	PLOS ONE			English	Article							S. SUDANENSE; SSR MARKERS; BICOLOR; GENE; GENOME; DIVERSITY; MAIZE	Sudangrass, Sorghum sudanense, is an important forage in warm regions. But little is known about its genome. In this study, the transcriptomes of sudangrass S722 and sorghum Tx623B were sequenced by Illumina sequencing. More than 4Gb bases were sequenced for each library. For Tx623B and S722, 88.79% and 83.88% reads, respectively were matched to the Sorghum bicolor genome. A total of 2,397 differentially expressed genes (DEGs) were detected by RNA-Seq between the two libraries, including 849 up-regulated genes and 1,548 down-regulated genes. These DEGs could be divided into three groups by annotation analysis. A total of 44,495 single nucleotide polymorphisms (SNPs) were discovered by aligning S722 reads to the sorghum reference genome. Of these SNPs, 61.37% were transition, and this value did not differ much between different chromosomes. In addition, 16,928 insertion and deletion (indel) loci were identified between the two genomes. A total of 5,344 indel markers were designed, 15 of which were selected to construct the genetic map derived from the cross of Tx623A and Sa. It was indicated that the indel markers were useful and versatile between sorghum and sudangrass. Comparison of synonymous base substitutions (Ks) and non-synonymous base substitutions (Ka) between the two libraries showed that 95% orthologous pairs exhibited Ka/Ks<1.0, indicating that these genes were influenced by purifying selection. The results from this study provide important information for molecular genetic research and a rich resource for marker development in sudangrass and other Sorghum species.	[Li, Jieqin; Wang, Lihua; Zhan, Qiuwen; Liu, Yanlong; Yang, Xiaocui] Anhui Sci & Technol Univ, Coll Agr, Fengyang, Peoples R China	Anhui Science & Technology University	Zhan, QW (corresponding author), Anhui Sci & Technol Univ, Coll Agr, Fengyang, Peoples R China.	qwzhan@163.com	liu, yan/HGV-1365-2022		National Natural Science Foundation of China [31301383]; Key-construction Subject Plan of Anhui Province [WanJiaoMiKe[2014] 28]; young talent project of Anhui province [gxyqZD2016217]; key project of natural science research of Anhui provincial education department [KJ2016A177]; Key-construction Subject Plan of Anhui Science and Technology University [AKZDXK2015A03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key-construction Subject Plan of Anhui Province; young talent project of Anhui province; key project of natural science research of Anhui provincial education department; Key-construction Subject Plan of Anhui Science and Technology University	This work was supported by grants from the National Natural Science Foundation of China (31301383), the Key-construction Subject Plan of Anhui Province (No: WanJiaoMiKe[2014] 28), the young talent project of Anhui province (gxyqZD2016217), the key project of natural science research of Anhui provincial education department (KJ2016A177), and the Key-construction Subject Plan of Anhui Science and Technology University (AKZDXK2015A03).	Beek PA, 2007, J ANIM SCI, V85, P545, DOI 10.2527/jas.2006-292; Carpita NC, 2008, TRENDS PLANT SCI, V13, P415, DOI 10.1016/j.tplants.2008.06.002; Chen XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074588; DEWET JMJ, 1967, EVOLUTION, V21, P787, DOI 10.1111/j.1558-5646.1967.tb03434.x; Duran C, 2009, NUCLEIC ACIDS RES, V37, pD951, DOI 10.1093/nar/gkn650; Guo M, 2003, PLANT J, V36, P30, DOI 10.1046/j.1365-313X.2003.01852.x; Jhanwar S, 2012, PLANT BIOTECHNOL J, V10, P690, DOI 10.1111/j.1467-7652.2012.00712.x; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1797-5; Liu YL, 2015, GENET MOL RES, V14, P3854, DOI 10.4238/2015.April.22.14; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; Menz MA, 2002, PLANT MOL BIOL, V48, P483, DOI 10.1023/A:1014831302392; Milano I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028008; Muriira NG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1908-3; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Schlueter JA, 2004, GENOME, V47, P868, DOI [10.1139/g04-047, 10.1139/G04-047]; Snowden J.D., 1936, CULTIVATED RACES SOR, P274; Tan S, 2015, PLOS ONE, V10; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-469; Zhan QW, 2008, PLANT SCI, V174, P9, DOI 10.1016/j.plantsci.2007.09.007; Zhan QiuWen, 2004, Acta Agronomica Sinica, V30, P73; Zheng WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082126	27	6	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154947	10.1371/journal.pone.0154947	http://dx.doi.org/10.1371/journal.pone.0154947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152648	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000051
J	Ogbaga, CC; Stepien, P; Dyson, BC; Rattray, NJW; Ellis, DI; Goodacre, R; Johnson, GN				Ogbaga, Chukwuma C.; Stepien, Piotr; Dyson, Beth C.; Rattray, Nicholas J. W.; Ellis, David I.; Goodacre, Royston; Johnson, Giles N.			Biochemical Analyses of Sorghum Varieties Reveal Differential Responses to Drought	PLOS ONE			English	Article							COMPATIBLE SOLUTE; PLANT DEHYDRINS; GAS-CHROMATOGRAPHY; OXIDATIVE STRESS; ACCUMULATION; TOLERANCE; EXPRESSION; PROTEINS; IDENTIFICATION; RESISTANCE	We have examined the biochemical responses of two sorghum cultivars of differing drought tolerance, Samsorg 17 (more drought tolerant) and Samsorg 40 (less drought tolerant), to sustained drought. Plants were exposed to different degrees of drought and then maintained at that level for five days. Responses were examined in terms of metabolic changes and the expression of drought induced proteins-Heat Shock Proteins (HSPs) and dehydrins (DHNs). Generalised phenotypic changes were studied using Fourier transform infrared (FT-IR) Spectroscopy and non-targeted Gas Chromatography Mass Spectrometry (GC-MS) was employed to detect changes in metabolites, while changes in protein expression were examined using Western blot analysis. Different response profiles of metabolites, HSPs and DHNs were observed in the two cultivars. Metabolic changes involved variation in amino acids, polysaccharides and their derivatives. A total of 188 compounds, with 142 known metabolites and 46 unknown small molecules, were detected in the two sorghum varieties. Under water deficit conditions, Samsorg 17 accumulated sugars and sugar alcohols, while in Samsorg 40 amino acids increased in concentration. This study suggest that the two Sorghum varieties adopt distinct approaches in response to drought, with Samsorg 17 being better able to maintain leaf function under severe drought conditions.	[Ogbaga, Chukwuma C.; Stepien, Piotr; Dyson, Beth C.; Johnson, Giles N.] Univ Manchester, Fac Life Sci, Oxford Rd, Manchester, Lancs, England; [Stepien, Piotr] Wroclaw Univ Environm & Life Sci, Dept Plant Nutr, Ul Grunwaldzka, Wroclaw, Poland; [Dyson, Beth C.; Rattray, Nicholas J. W.; Ellis, David I.; Goodacre, Royston] Univ Manchester, Sch Chem, Manchester Inst Biotechnol, Manchester, Lancs, England; [Ogbaga, Chukwuma C.] Univ Illinois, Champaign, IL USA; [Dyson, Beth C.] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England	University of Manchester; Wroclaw University of Environmental & Life Sciences; University of Manchester; University of Illinois System; University of Illinois Urbana-Champaign; University of Sheffield	Ogbaga, CC (corresponding author), Univ Illinois, Champaign, IL USA.	chukwumaogbaga@gmail.com	Goodacre, Roy/AAO-3194-2021; Ellis, David Ian/D-8603-2016; Ogbaga, Chukwuma/ABD-5384-2020; Rattray, Nicholas/AAX-7283-2021; Goodacre, Roy/J-1600-2012	Goodacre, Roy/0000-0003-2230-645X; Ellis, David Ian/0000-0002-7633-7019; Ogbaga, Chukwuma/0000-0003-4951-2253; Goodacre, Roy/0000-0003-2230-645X; Johnson, Giles Nicholas/0000-0003-1536-5582; Stepien, Piotr/0000-0002-9058-6142; Rattray, Nicholas/0000-0002-3528-6905	BBSRC, The University of Manchester [BB/J004103/1]; BBSRC [BB/J004103/1]; Biotechnology and Biological Sciences Research Council [BB/J004103/1] Funding Source: researchfish	BBSRC, The University of Manchester; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	BCD was supported by BBSRC grant BB/J004103/1, The University of Manchester (http://www.manchester.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Matthew Miller for help with FT-IR data analysis. BCD was supported by a BBSRC grant (BB/J004103/1).	Akashi K, 2001, FEBS LETT, V508, P438, DOI 10.1016/S0014-5793(01)03123-4; Allagulova CR, 2003, BIOCHEMISTRY-MOSCOW+, V68, P945, DOI 10.1023/A:1026077825584; Allwood JW, 2008, PHYSIOL PLANTARUM, V132, P117, DOI 10.1111/j.1399-3054.2007.01001.x; Amtmann A, 2009, NEW PHYTOL, V181, P35, DOI 10.1111/j.1469-8137.2008.02666.x; An YY, 2013, ACTA PHYSIOL PLANT, V35, P959, DOI 10.1007/s11738-012-1139-z; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Borovskii G, 2002, BMC PLANT BIOL, V2, P1, DOI DOI 10.1186/1471-2229-2-5; Cao QH, 2012, AFR J MICROBIOL RES, V6, P6325, DOI 10.5897/AJMR11.1403; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Correia I, 2008, J SCI FOOD AGR, V88, P2598, DOI 10.1002/jsfa.3348; Demirevska K., 2008, General and Applied Plant Physiology, V34, P79; Demirevska-Kepova Klimentina, 1999, Bulgarian Journal of Plant Physiology, V25, P31; dos Reis SP, 2012, INT J MOL SCI, V13, P8628, DOI 10.3390/ijms13078628; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Ellis DI, 2006, ANALYST, V131, P875, DOI 10.1039/b602376m; Farooq M, 2013, J AGRON CROP SCI, V199, P12, DOI 10.1111/j.1439-037X.2012.00521.x; Fiehn O, 2000, ANAL CHEM, V72, P3573, DOI 10.1021/ac991142i; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; GOOD AG, 1994, PHYSIOL PLANTARUM, V90, P9, DOI 10.1111/j.1399-3054.1994.tb02185.x; Griffiths PR., 2007, FOURIER TRANSFORM IN, V2nd ed.; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Henry A, 2007, J ENVIRON QUAL, V36, P904, DOI 10.2134/jeq2006.0425sc; HoffmannThoma G, 1996, PHYSIOL PLANTARUM, V97, P277, DOI 10.1034/j.1399-3054.1996.970210.x; Jagtap V, 1998, J EXP BOT, V49, P1715, DOI 10.1093/jexbot/49.327.1715; Jiang YW, 2002, CROP SCI, V42, P202, DOI 10.2135/cropsci2002.0202; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Kishor PBK, 2014, PLANT CELL ENVIRON, V37, P300, DOI 10.1111/pce.12157; Kohli A, 2012, PHYSIOL PLANTARUM, V145, P165, DOI 10.1111/j.1399-3054.2012.01573.x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lopez CG, 2003, CROP SCI, V43, P577, DOI 10.2135/cropsci2003.0577; MADUENO F, 1993, PLANT CELL, V5, P1865, DOI 10.1105/tpc.5.12.1865; Massacci A, 1996, AUST J PLANT PHYSIOL, V23, P331, DOI 10.1071/PP9960331; Merewitz EB, 2012, J EXP BOT, V63, P1315, DOI 10.1093/jxb/err372; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mohammadkhani N, 2008, TURK J BIOL, V32, P23; Moing A, 2000, DEV CROP SCI, V26, P337; Montesinos-Pereira D, 2014, PLANT BIOLOGY, V16, P1050, DOI 10.1111/plb.12178; Nakayama H, 2000, PLANT PHYSIOL, V122, P1239, DOI 10.1104/pp.122.4.1239; Ngara R, 2012, J PROTEOMICS, V75, P4139, DOI 10.1016/j.jprot.2012.05.038; Ogbaga CC, 2014, PHYSIOL PLANTARUM, V152, P389, DOI 10.1111/ppl.12196; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Rorat T, 2006, CELL MOL BIOL LETT, V11, P536, DOI 10.2478/s11658-006-0044-0; Rouphael Y., 2012, PLANT RESPONSES DROU, P171, DOI [10.1007/978-3-642-32653-0_7, DOI 10.1007/978-3-642-32653-0_7]; Schroda M, 1999, PLANT CELL, V11, P1165, DOI 10.1105/tpc.11.6.1165; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Serraj R, 2002, PLANT CELL ENVIRON, V25, P333, DOI 10.1046/j.1365-3040.2002.00754.x; Shalata A, 2001, J EXP BOT, V52, P2207, DOI 10.1093/jexbot/52.364.2207; Sung DY, 2003, PLANT PHYSIOL, V132, P979, DOI 10.1104/pp.102.019398; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Tarpley L, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-33; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang ZN, 2010, J INTEGR PLANT BIOL, V52, P400, DOI 10.1111/j.1744-7909.2010.00921.x; Westhoff P, 2010, PLANT PHYSIOL, V154, P598, DOI 10.1104/pp.110.161729; Wood AJ, 1997, PHYSIOL PLANTARUM, V99, P144, DOI 10.1034/j.1399-3054.1997.990120.x; Xu Yan, 2011, Int J Proteomics, V2011, P529648, DOI 10.1155/2011/529648; Yobi A, 2012, PLANT J, V72, P983, DOI 10.1111/tpj.12008	58	35	35	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154423	10.1371/journal.pone.0154423	http://dx.doi.org/10.1371/journal.pone.0154423			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153323	gold, Green Published, Green Accepted			2022-12-27	WOS:000375677000019
J	Chang, CC; Few, LL; Konrad, M; Too, WCS				Chang, Ching Ching; Few, Ling Ling; Konrad, Manfred; Too, Wei Cun See			Phosphorylation of Human Choline Kinase Beta by Protein Kinase A: Its Impact on Activity and Inhibition	PLOS ONE			English	Article							CELL-CYCLE REGULATION; SACCHAROMYCES-CEREVISIAE; MUSCULAR-DYSTROPHY; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; CHOLINE/ETHANOLAMINE KINASE; PHOSPHOLIPID-METABOLISM; PHOSPHATIDYLCHOLINE; ALPHA; CANCER; CTP	Choline kinase beta (CK beta) is one of the CK isozymes involved in the biosynthesis of phosphatidylcholine. CK beta is important for normal mitochondrial function and muscle development as the lack of the ck beta gene in human and mice results in the development of muscular dystrophy. In contrast, CK alpha is implicated in tumorigenesis and has been extensively studied as an anticancer target. Phosphorylation of human CK alpha was found to regulate the enzyme's activity and its subcellular location. This study provides evidence for CK beta phosphorylation by protein kinase A (PKA). In vitro phosphorylation of CK beta by PKA was first detected by phosphoprotein staining, as well as by in-gel kinase assays. The phosphorylating kinase was identified as PKA by Western blotting. CK beta phosphorylation by MCF-7 cell lysate was inhibited by a PKA-specific inhibitor peptide, and the intracellular phosphorylation of CK beta was shown to be regulated by the level of cyclic adenosine monophosphate (cAMP), a PKA activator. Phosphorylation sites were located on CK beta residues serine-39 and serine-40 as determined by mass spectrometry and site-directed mutagenesis. Phosphorylation increased the catalytic efficiencies for the substrates choline and ATP about 2-fold, without affecting ethanolamine phosphorylation, and the S39D/S40D CK beta phosphorylation mimic behaved kinetically very similar. Remarkably, phosphorylation drastically increased the sensitivity of CK beta to hemicholinium-3 (HC-3) inhibition by about 30-fold. These findings suggest that CK beta, in concert with CK alpha, and depending on its phosphorylation status, might play a critical role as a druggable target in carcinogenesis.	[Chang, Ching Ching; Few, Ling Ling; Too, Wei Cun See] Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia; [Konrad, Manfred] Max Planck Inst Biophys Chem, Enzyme Biochem Grp, D-37077 Gottingen, Germany	Universiti Sains Malaysia; Max Planck Society	Too, WCS (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.; Konrad, M (corresponding author), Max Planck Inst Biophys Chem, Enzyme Biochem Grp, D-37077 Gottingen, Germany.	mkonrad@mpibpc.mpg.de; stweicun@usm.my	Few, Ling Ling/E-1964-2012	Few, Ling Ling/0000-0001-8296-8135	Universiti Sains Malaysia Research University (RU) Grant [1001/PPSK/812161]; Malaysian Ministry of Higher Education Fundamental Research Grant Scheme (FRGS) [203/PPSK/6171171]	Universiti Sains Malaysia Research University (RU) Grant(Universiti Sains Malaysia); Malaysian Ministry of Higher Education Fundamental Research Grant Scheme (FRGS)	This work was supported by Universiti Sains Malaysia Research University (RU) Grant (http://www.research.usm.my/default.asp?tag=23) 1001/PPSK/812161 to WCST and Malaysian Ministry of Higher Education Fundamental Research Grant Scheme (FRGS) (https://jpt.mohe.gov.my/menupenyelidik.php) 203/PPSK/6171171 to LLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agassandian M, 2012, MOL BIOL CELL, V23, P2755, DOI 10.1091/mbc.E11-10-0863; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 1998, BBA-LIPID LIPID MET, V1393, P179, DOI 10.1016/S0005-2760(98)00062-9; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brundiers R, 1999, J BIOL CHEM, V274, P35289, DOI 10.1074/jbc.274.50.35289; Carman GM, 2004, BIOCHEM CELL BIOL, V82, P62, DOI 10.1139/o03-064; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Choi MG, 2005, J BIOL CHEM, V280, P26105, DOI 10.1074/jbc.M503551200; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Colaert N, 2011, J PROTEOME RES, V10, P3840, DOI 10.1021/pr2005154; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dennis MK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201715; Eliyahu G, 2007, INT J CANCER, V120, P1721, DOI 10.1002/ijc.22293; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gruber J, 2012, FEBS J, V279, P1915, DOI 10.1111/j.1742-4658.2012.08573.x; Hernando E, 2009, ONCOGENE, V28, P2425, DOI 10.1038/onc.2009.91; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hong BS, 2010, J BIOL CHEM, V285, P16330, DOI 10.1074/jbc.M109.039024; Huffine ME, 1996, J BIOL CHEM, V271, P28898, DOI 10.1074/jbc.271.46.28898; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; Jabbur JR, 2002, CANCER BIOL THER, V1, P277, DOI 10.4161/cbt.81; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kim KH, 1999, J BIOL CHEM, V274, P9531, DOI 10.1074/jbc.274.14.9531; Kiss Z, 1999, CELL SIGNAL, V11, P149, DOI 10.1016/S0898-6568(98)00057-6; Kitchen J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-19; Kular J, 2015, J BIOL CHEM, V290, P1729, DOI 10.1074/jbc.M114.567966; Li Z, 2014, BBA-GEN SUBJECTS, V1840, P2112, DOI 10.1016/j.bbagen.2014.03.008; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Miyake T, 2012, ONCOGENE, V31, P1431, DOI 10.1038/onc.2011.332; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Oellerich T, 2009, MOL CELL PROTEOMICS, V8, P1738, DOI 10.1074/mcp.M800567-MCP200; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Pickin KA, 2008, J AM CHEM SOC, V130, P5667, DOI 10.1021/ja711244h; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489; Ramirez de Molina A, 2008, INT J BIOCHEM CELL B, V40, P1753, DOI 10.1016/j.biocel.2008.01.013; Rios PG, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333; Ryan AJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P23, DOI 10.1016/j.abb.2006.01.007; SANGHERA JS, 1989, J BIOL CHEM, V264, P1215; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Too WCS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012999; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; UCHIDA T, 1994, J BIOCHEM-TOKYO, V116, P1241, DOI 10.1093/oxfordjournals.jbchem.a124670; WIEPRECHT M, 1994, BIOCHEM J, V297, P241, DOI 10.1042/bj2970241; Wooten Marie W, 2002, Sci STKE, V2002, ppl15, DOI 10.1126/stke.2002.153.pl15; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Wu GS, 2009, BBA-MOL CELL BIOL L, V1791, P347, DOI 10.1016/j.bbalip.2009.02.006; Yu Y, 2002, J BIOL CHEM, V277, P34978, DOI 10.1074/jbc.M205316200	56	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154702	10.1371/journal.pone.0154702	http://dx.doi.org/10.1371/journal.pone.0154702			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149373	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800048
J	Kuehn, MH; Lipsett, KA; Menotti-Raymond, M; Whitmore, SS; Scheetz, TE; David, VA; O'Brien, SJ; Zhao, ZY; Jens, JK; Snella, EM; Ellinwood, NM; McLellan, GJ				Kuehn, Markus H.; Lipsett, Koren A.; Menotti-Raymond, Marilyn; Whitmore, S. Scott; Scheetz, Todd E.; David, Victor A.; O'Brien, Stephen J.; Zhao, Zhongyuan; Jens, Jackie K.; Snella, Elizabeth M.; Ellinwood, N. Matthew; McLellan, Gillian J.			A Mutation in LTBP2 Causes Congenital Glaucoma in Domestic Cats (Felis catus)	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; GROWTH-FACTOR-BETA; BINDING-PROTEIN 2; GENE; IDENTIFICATION; PHENOTYPES; SEQUENCE; SIAMESE; MEGALOCORNEA; MICROPHAKIA	The glaucomas are a group of diseases characterized by optic nerve damage that together represent a leading cause of blindness in the human population and in domestic animals. Here we report a mutation in LTBP2 that causes primary congenital glaucoma (PCG) in domestic cats. We identified a spontaneous form of PCG in cats and established a breeding colony segregating for PCG consistent with fully penetrant, autosomal recessive inheritance of the trait. Elevated intraocular pressure, globe enlargement and elongated ciliary processes were consistently observed in all affected cats by 8 weeks of age. Varying degrees of optic nerve damage resulted by 6 months of age. Although subtle lens zonular instability was a common feature in this cohort, pronounced ectopia lentis was identified in less than 10% of cats examined. Thus, glaucoma in this pedigree is attributed to histologically confirmed arrest in the early post-natal development of the aqueous humor outflow pathways in the anterior segment of the eyes of affected animals. Using a candidate gene approach, significant linkage was established on cat chromosome B3 (LOD 18.38, theta = 0.00) using tightly linked short tandem repeat (STR) loci to the candidate gene, LTBP2. A 4 base-pair insertion was identified in exon 8 of LTBP2 in affected individuals that generates a frame shift that completely alters the downstream open reading frame and eliminates functional domains. Thus, we describe the first spontaneous and highly penetrant non-rodent model of PCG identifying a valuable animal model for primary glaucoma that closely resembles the human disease, providing valuable insights into mechanisms underlying the disease and a valuable animal model for testing therapies.	[Kuehn, Markus H.; Whitmore, S. Scott; Scheetz, Todd E.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA USA; [Lipsett, Koren A.; Menotti-Raymond, Marilyn; David, Victor A.; O'Brien, Stephen J.] NCI, Lab Genom Div, Frederick, MD 21701 USA; [David, Victor A.] NCI, Basic Res Lab, Frederick, MD 21701 USA; [Lipsett, Koren A.; Zhao, Zhongyuan] Gettysburg Coll, Dept Chem, Gettysburg, PA 17325 USA; [O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg 199034, Russia; [O'Brien, Stephen J.] Nova SE Univ, Oceanog Ctr, Ft Lauderdale, FL 33314 USA; [Jens, Jackie K.; Snella, Elizabeth M.; Ellinwood, N. Matthew] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Ellinwood, N. Matthew] Iowa State Univ, Dept Vet Clin Sci, Ames, IA USA; [McLellan, Gillian J.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [McLellan, Gillian J.] Univ Wisconsin, Dept Surg Sci, Madison, WI USA; [McLellan, Gillian J.] McPherson Eye Res Inst, Madison, WI USA	University of Iowa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gettysburg College; Saint Petersburg State University; Nova Southeastern University; Iowa State University; Iowa State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	McLellan, GJ (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA.; McLellan, GJ (corresponding author), Univ Wisconsin, Dept Surg Sci, Madison, WI USA.; McLellan, GJ (corresponding author), McPherson Eye Res Inst, Madison, WI USA.	gillian.mclellan@wisc.edu	David, Victor A/I-9330-2012; OBRIEN, STEPHEN/ABD-1346-2020; Ellinwood, Norman/AAX-7005-2021; Ellinwood, Matthew/R-6419-2018	Scheetz, Todd/0000-0002-1965-5811; McLellan, Gillian/0000-0002-6505-7476; Whitmore, S. Scott/0000-0003-0161-9625; Snella, Elizabeth M/0000-0003-1482-2876; Kuehn, Markus/0000-0003-3940-198X; Ellinwood, Matthew/0000-0002-1701-5052; OBRIEN, STEPHEN/0000-0001-7857-0757	Glaucoma Research Foundation; National Institutes of Health [K08 EY018609, P30 EY0016665]; Center for Integrated Animal Genomics, Iowa State University; Battelle General Platform and Infrastructure Awards; Foundation Fighting Blindness; Research to Prevent Blindness; Russian Ministry of Science Mega-grant [11.G34.31.0068]; Intramural Research Program of the NIH, Frederick National Laboratory, Center for Cancer Research, National Cancer Institute; NATIONAL EYE INSTITUTE [R01EY022044, K08EY018609, P30EY016665] Funding Source: NIH RePORTER	Glaucoma Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integrated Animal Genomics, Iowa State University; Battelle General Platform and Infrastructure Awards; Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Russian Ministry of Science Mega-grant; Intramural Research Program of the NIH, Frederick National Laboratory, Center for Cancer Research, National Cancer Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The studies were supported by The Glaucoma Research Foundation (MHK), the National Institutes of Health Grants K08 EY018609 (GJM) and P30 EY0016665 (GJM); the Center for Integrated Animal Genomics, Iowa State University (NME and GJM), a Battelle General Platform and Infrastructure Awards (NME), and unrestricted grants to the University of Iowa Department of Ophthalmology and Visual Sciences from the Foundation Fighting Blindness and to the University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness; and in part by Russian Ministry of Science Mega-grant no. 11.G34.31.0068 (SJO). This research was supported (in part) by the Intramural Research Program of the NIH, Frederick National Laboratory, Center for Cancer Research, National Cancer Institute. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the United States government. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agarwal P, 2015, MOL VIS, V21, P612; AGUIRRE GD, 1973, VET MED SM ANIM CLIN, V68, P498; Ahonen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111941; Ahram DF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126660; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Alodhayb S, 2013, SEMIN OPHTHALMOL, V28, P131, DOI 10.3109/08820538.2013.771196; Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Azmanov DN, 2011, EUR J HUM GENET, V19, P326, DOI 10.1038/ejhg.2010.181; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Breidthardt T, 2012, CLIN SCI, V123, P557, DOI 10.1042/CS20120058; BROOKS DE, 1990, VET CLIN N AM-SMALL, V20, P775, DOI 10.1016/S0195-5616(90)50062-5; Brown Alison, 1994, Veterinary and Comparative Ophthalmology, V4, P121; Cheung CL, 2008, J CLIN ENDOCR METAB, V93, P4448, DOI 10.1210/jc.2007-2836; Decourty L, 2014, CELL REP, V6, P593, DOI 10.1016/j.celrep.2014.01.025; Desir J, 2010, EUR J HUM GENET, V18, P761, DOI 10.1038/ejhg.2010.11; Dubielzig RR, 2010, VET OCULAR PATHOLOGY, P419; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; Fuchshofer R, 2011, EXP EYE RES, V93, P165, DOI 10.1016/j.exer.2010.07.014; Gelatt KN, 1998, J GLAUCOMA, V7, P187; Gomes FE, 2011, VET OPHTHALMOL, V14, P75, DOI 10.1111/j.1463-5224.2011.00927.x; Haase M, 2014, BIOMARK MED, V8, P1207, DOI [10.2217/BMM.14.90, 10.2217/bmm.14.90]; Haji-Seyed-Javadi R, 2012, HUM MUTAT, V33, P1182, DOI 10.1002/humu.22105; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; Inoue T, 2014, HUM MOL GENET, V23, P5672, DOI 10.1093/hmg/ddu283; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; Jelodari-Mamaghani S, 2013, MOL VIS, V19, P333; Jordan T, 1996, BRIT J OPHTHALMOL, V80, P579, DOI 10.1136/bjo.80.6.579-a; Khan AO, 2011, MOL VIS, V17, P2570; Khan AO, 2011, CURR OPIN OPHTHALMOL, V22, P347, DOI 10.1097/ICU.0b013e32834922d2; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong LK, 2012, J AAPOS, V16, P501, DOI 10.1016/j.jaapos.2012.09.004; Kuchtey J, 2014, J OCULAR PHARM  0212; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Kumar A, 2010, HUM GENET, V128, P365, DOI 10.1007/s00439-010-0858-8; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Libby RT, 2003, SCIENCE, V299, P1578, DOI 10.1126/science.1080095; Lim SH, 2013, AM J OPHTHALMOL, V155, P508, DOI 10.1016/j.ajo.2012.09.012; Lyons LA, 2005, ANIM GENET, V36, P119, DOI 10.1111/j.1365-2052.2005.01253.x; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; McLellan GJ, 2013, VET OPHTHALMOL, V16, P111, DOI 10.1111/j.1463-5224.2012.01038.x; McLellan GJ, 2011, VET OPHTHALMOL, V14, P15, DOI 10.1111/j.1463-5224.2011.00912.x; Menotti-Raymond M, 2010, VET J, V186, P32, DOI 10.1016/j.tvjl.2009.08.010; Menotti-Raymond MA, 2005, J FORENSIC SCI, V50, P1061, DOI 10.1520/JFS2004317; MOLLEDA JM, 1995, J AM ANIM HOSP ASSOC, V31, P209, DOI 10.5326/15473317-31-3-209; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Prendes MA, 2013, BRIT J OPHTHALMOL, V97, P680, DOI 10.1136/bjophthalmol-2011-301132; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; RICHARDSON TM, 1985, EXP EYE RES, V41, P31, DOI 10.1016/0014-4835(85)90092-2; RIDGWAY MD, 1989, J AM ANIM HOSP ASSOC, V25, P485; Robertson IB, 2015, MATRIX BIOL, V47, P44, DOI 10.1016/j.matbio.2015.05.005; Rutz-Mendicino MM, 2011, COMPARATIVE MED, V61, P251; Schallek JB, 2012, INVEST OPHTH VIS SCI, V53, P1971, DOI 10.1167/iovs.11-8299; Schmidt-Kuntzel A, 2005, J HERED, V96, P289, DOI 10.1093/jhered/esi066; Shipley JM, 2000, MOL CELL BIOL, V20, P4879, DOI 10.1128/MCB.20.13.4879-4887.2000; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; STONE J, 1978, J COMP NEUROL, V180, P753, DOI 10.1002/cne.901800407; Teixeira LBC, 2014, MOL VIS, V20, P376; Tham YC, 2014, OPHTHALMOLOGY; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Walde I., 1993, European Journal of Companion Animal Practice, V4, P87; Weber AJ, 2013, INVEST OPHTH VIS SCI, V54, P6594, DOI 10.1167/iovs.13-12683; Weinreb RN, 2005, J GLAUCOMA, V14, P302, DOI 10.1097/01.ijg.0000169395.47921.02; Wordinger RJ, 2014, J OCULAR PHARM  0211	71	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154412	10.1371/journal.pone.0154412	http://dx.doi.org/10.1371/journal.pone.0154412			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149523	Green Published, gold			2022-12-27	WOS:000375676800029
J	Bodner, D; LaDeau, SL; Biehler, D; Kirchoff, N; Leisnham, PT				Bodner, Danielle; LaDeau, Shannon L.; Biehler, Dawn; Kirchoff, Nicole; Leisnham, Paul T.			Effectiveness of Print Education at Reducing Urban Mosquito Infestation through Improved Resident-Based Management	PLOS ONE			English	Article							WEST-NILE-VIRUS; AEDES-ALBOPICTUS DIPTERA; AEGYPTI CONTROL PROGRAM; SOURCE REDUCTION; SOCIOECONOMIC-STATUS; SPATIAL-ANALYSIS; CULICIDAE; COMMUNITY; KNOWLEDGE; IMPACT	Improving resident-based management and knowledge of mosquitoes is often an integral component of integrated mosquito management, especially in urban landscapes with considerable mosquito habitat on privately owned lands. This study tested the effectiveness of print education materials at reducing urban mosquito exposure through improving resident knowledge of, and attitudes towards, mosquitoes and mosquito management in Washington DC, USA. There was a specific focus on the removal of water-filled containers that are utilized by the developmental stages of the two most common vector species in the region, Aedes albopictus and Culex pipiens. Households in six neighborhoods that varied in socio-economic status were administered knowledge, attitude, and practice (KAP) surveys in 2010 and 2012, and had their yards surveyed for container habitats and immature mosquitoes (larvae and pupae) in 2010, 2011, and 2012. Half the households (intervention, n = 120) received education materials in 2011 and 2012 to yield a before-after control-intervention (BACI) design. Unexpectedly, residents in intervention households were more likely to show decreased concern for mosquito-borne illnesses than residents in control households, which did not receive materials. Moreover, there was a greater probability that control households reduced containers in 2012 than intervention households, particularly when they had low numbers of baseline (2010) containers. Irrespective of control, reductions in containers were associated with decreased abundances of immature mosquitoes. Overall, our findings suggest that print education materials may have unintended negative effects on resident attitudes and household management of mosquito production. We recommend that mosquito control agencies need to carefully consider their content of print messages and the effectiveness of strategies that passively convey information with little or no engagement with control professionals.	[Bodner, Danielle; Kirchoff, Nicole; Leisnham, Paul T.] Univ Maryland, Dept Environm Sci & Technol, Ecosyst Hlth & Nat Resource Management, College Pk, MD 20742 USA; [LaDeau, Shannon L.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Biehler, Dawn] Univ Maryland Baltimore Cty, Geog & Environm Syst, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland College Park; Cary Institute of Ecosystem Studies; University System of Maryland; University of Maryland Baltimore County	Leisnham, PT (corresponding author), Univ Maryland, Dept Environm Sci & Technol, Ecosyst Hlth & Nat Resource Management, College Pk, MD 20742 USA.	leisnham@umd.edu		LaDeau, Shannon/0000-0003-4825-5435; Leisnham, Paul T./0000-0003-3527-8435	USDA-NIFA; Northeastern Integrated Pest Management Center [MD-2011-00540]; NSF-Couple Natural Human Systems Program [DEB-1211797]	USDA-NIFA(United States Department of Agriculture (USDA)); Northeastern Integrated Pest Management Center; NSF-Couple Natural Human Systems Program	Funding for this work was provided by USDA-NIFA and the Northeastern Integrated Pest Management Center (MD-2011-00540) and the NSF-Couple Natural Human Systems Program (DEB-1211797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averett E, 2005, EMERG INFECT DIS, V11, P1751, DOI 10.3201/eid1111.050363; Bangs MJ, 2006, J AM MOSQUITO CONTR, V22, P565, DOI 10.2987/8756-971X(2006)22[565:APIKTT]2.0.CO;2; Barker CM, 2003, J MED ENTOMOL, V40, P403, DOI 10.1603/0022-2585-40.4.403; Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031; Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358; Becker B, 2014, INT J ENV RES PUB HE, V11, P3256, DOI 10.3390/ijerph110303256; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Carrieri M, 2003, ENVIRON ENTOMOL, V32, P1313, DOI 10.1603/0046-225X-32.6.1313; CDC, 2015, DENGUE; Centers For Disease Control and Prevention (CDC), 2015, W NIL VIR; Darsie RE, 2005, P ENTOMOL SOC WASH, V107, P892; Darsie RF, 2004, IDENTIFICATION GEOGR; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; Dowling Z, 2013, J MED ENTOMOL, V50, P764, DOI 10.1603/ME12250; Dowling Z, 2013, ECOHEALTH, V10, P36, DOI 10.1007/s10393-013-0818-6; Espinoza-Gomez F, 2002, J EPIDEMIOL COMMUN H, V56, P148, DOI 10.1136/jech.56.2.148; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Fox MH, 2006, AM J HEALTH BEHAV, V30, P483, DOI 10.5993/AJHB.30.5.5; Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807; Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Hu WB, 2007, AM J TROP MED HYG, V76, P814, DOI 10.4269/ajtmh.2007.76.814; Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x; Joshi V, 2006, J MED ENTOMOL, V43, P330, DOI 10.1603/0022-2585(2006)043[0330:IOSSAT]2.0.CO;2; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; Koenraadt CJM, 2006, AM J TROP MED HYG, V74, P692, DOI 10.4269/ajtmh.2006.74.692; Kutner M., 2005, APPL LINEAR STAT MOD; LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505; Leisnham PT, 2012, ECOHEALTH, V9, P217, DOI 10.1007/s10393-012-0773-7; LEONTSINI E, 1993, T ROY SOC TROP MED H, V87, P267, DOI 10.1016/0035-9203(93)90120-F; LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635; Manguin S, 2011, IMPORTANCE OF BIOLOGICAL INTERACTIONS IN THE STUDY OF BIODIVERSITY, P27; McNaughton D, 2010, ACTA TROP, V116, P74, DOI 10.1016/j.actatropica.2010.05.012; Reisen WK, 2009, J MED ENTOMOL, V46, P139, DOI 10.1603/033.046.0118; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Richards SL, 2008, J MED ENTOMOL, V45, P617, DOI 10.1603/0022-2585(2008)45[617:IOSROT]2.0.CO;2; Rios J, 2006, J AM MOSQUITO CONTR, V22, P254, DOI 10.2987/8756-971X(2006)22[254:DASAOW]2.0.CO;2; Rochlin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023280; SCHREIBER ET, 1995, J AM MOSQUITO CONTR, V11, P186; SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217; Tuiten W, 2009, ECOHEALTH, V6, P42, DOI 10.1007/s10393-009-0219-z; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Unlu I, 2014, T ROY SOC TROP MED H, V108, P699, DOI 10.1093/trstmh/tru139; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; WHO, 2015, WORLD MAL REP 2015; Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363	51	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155011	10.1371/journal.pone.0155011	http://dx.doi.org/10.1371/journal.pone.0155011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171195	Green Published, gold			2022-12-27	WOS:000376588600040
J	Salamin, O; Jaggi, L; Baume, N; Robinson, N; Saugy, M; Leuenberger, N				Salamin, Olivier; Jaggi, Laetitia; Baume, Norbert; Robinson, Neil; Saugy, Martial; Leuenberger, Nicolas			Circulating microRNA-122 as Potential Biomarker for Detection of Testosterone Abuse	PLOS ONE			English	Article							SERUM TESTOSTERONE; MIRNAS; CELL; QUANTIFICATION; DYSREGULATION; METABOLITES; BIOGENESIS; ANDROGENS; MARKERS; ORIGIN	MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and thus influence many cellular and physiological processes. miRNAs are also present in cell-free body fluids such as plasma or serum, and these circulating miRNAs are very stable, sensitive, and specific biomarkers of pathophysiological states. In this study, we investigated whether circulating miRNAs could serve as biomarkers of exogenous testosterone administration. Misuse of testosterone as a performance-enhancing drug is thought to be widespread in sports. Detection of testosterone through the urinary steroid profile of the Athlete Biological Passport faces several obstacles, indicating that new biomarkers are required. To this end, we analyzed plasma miRNA levels by high-throughput quantitative real-time PCR. Plasma samples were obtained before and at several time points after transdermal and oral testosterone administration. Screening identified three potential candidate miRNAs that were altered by both routes of testosterone administration. Longitudinal monitoring of these candidates revealed that variation in two of them (miR-150 and miR-342), relative to the corresponding levels in control samples, was testosterone-independent. However, levels of the liver-specific miR-122 increased 3.5-fold 1 day after drug intake. Given that testosterone is metabolized by the liver, this observation suggests that miR-122 in cell-free fluids may be used as a sensitive biomarker of testosterone misuse via multiple dosing routes and could therefore be integrated into a blood-based multiparametric follow-up.	[Leuenberger, Nicolas] Univ Ctr Legal Med, Swiss Lab Doping Analyses, Lausanne, Switzerland; Univ Ctr Legal Med, Swiss Lab Doping Analyses, Geneva, Switzerland; CHU Vaudois, Lausanne, Switzerland; Univ Lausanne, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Leuenberger, N (corresponding author), Univ Ctr Legal Med, Swiss Lab Doping Analyses, Lausanne, Switzerland.	Nicolas.leuenberger@chuv.ch	Salamin, Olivier/GRO-1276-2022	Salamin, Olivier/0000-0003-0388-1352				Andreasen D, 2010, METHODS, V50, pS6, DOI 10.1016/j.ymeth.2010.01.006; Badoud F, 2013, J STEROID BIOCHEM, V138, P222, DOI 10.1016/j.jsbmb.2013.05.018; Bagchus WM, 2003, PHARMACOTHERAPY, V23, P319, DOI 10.1592/phco.23.3.319.32104; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Brown GA, 1999, J APPL PHYSIOL, V87, P2274, DOI 10.1152/jappl.1999.87.6.2274; Brown GA, 2002, J APPL PHYSIOL, V92, P142, DOI 10.1152/jappl.2002.92.1.142; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Delic D, 2010, STEROIDS, V75, P998, DOI 10.1016/j.steroids.2010.06.010; Eberhard Nieschlag H.M.B., 2012, TESTOSTERONE ACTION; Fabregat A, 2011, DRUG TEST ANAL, V3, P828, DOI 10.1002/dta.351; Fabregat A, 2011, STEROIDS, V76, P1367, DOI 10.1016/j.steroids.2011.07.005; Falcone G, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0148-3; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gutsol A A, 2014, Tsitologiia, V56, P500; Hata A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005825; He Y, 2014, ONCOGENE, V33, P3887, DOI 10.1038/onc.2013.346; He YQ, 2015, CLIN CHEM, V61, P1138, DOI 10.1373/clinchem.2015.241190; Juul A, 2009, J CLIN ENDOCR METAB, V94, P1005, DOI 10.1210/jc.2008-1984; Kavitha N, 2014, ASIAN PAC J CANCER P, V15, P7489, DOI 10.7314/APJCP.2014.15.18.7489; Kelly BN, 2014, DRUG TEST ANAL, V6, P234, DOI 10.1002/dta.1469; Krucken J, 2005, INFECT IMMUN, V73, P436, DOI 10.1128/IAI.73.1.436-443.2005; Kuuranne T, 2014, BRIT J SPORT MED, V48, P848, DOI 10.1136/bjsports-2014-093510; Leuenberger N, 2013, ANAL BIOANAL CHEM, V405, P9617, DOI 10.1007/s00216-013-7340-0; Leuenberger N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066309; Leuenberger N, 2011, DRUG TEST ANAL, V3, P771, DOI 10.1002/dta.370; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; McMurray RW, 2001, PATHOBIOLOGY, V69, P44, DOI 10.1159/000048757; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ponzetto F, 2016, ANAL BIOANAL CHEM, V408, P705, DOI 10.1007/s00216-015-9185-1; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Rane A, 2012, BRIT J CLIN PHARMACO, V74, P3, DOI 10.1111/j.1365-2125.2012.04294.x; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Saudan C, 2006, BRIT J SPORT MED, V40, P21, DOI 10.1136/bjsm.2006.027482; Senmaru T, 2013, METABOLISM, V62, P851, DOI 10.1016/j.metabol.2012.12.007; Shi Q, 2016, J CELL PHYSIOL, V231, P751, DOI 10.1002/jcp.25174; Solbach P, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0288-0; Strahm E, 2009, BRIT J SPORT MED, V43, P1126, DOI 10.1136/bjsm.2008.056242; Trigunaite A, 2015, CELL IMMUNOL, V294, P87, DOI 10.1016/j.cellimm.2015.02.004; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; WADA, 2015, PROH LIST 2015; *WADA, 2004, REP EV GUID TEST EP; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; World Anti-Doping Agency (WADA), 2014, ABP OP GUID; YU MW, 1993, CANCER RES, V53, P790	48	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155248	10.1371/journal.pone.0155248	http://dx.doi.org/10.1371/journal.pone.0155248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171140	Green Submitted, gold, Green Published			2022-12-27	WOS:000376588600027
J	De Castro, LFP; Dopson, M; Friedman, R				De Castro, Luis Felipe Pineda; Dopson, Mark; Friedman, Ran			Biological Membranes in Extreme Conditions: Simulations of Anionic Archaeal Tetraether Lipid Membranes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; X-RAY-SCATTERING; FORCE-FIELD; SULFOLOBUS-ACIDOCALDARIUS; ACIDOPHILIC MICROORGANISMS; STRUCTURAL-PROPERTIES; METAL RESISTANCE; BILAYERS; PRESSURE; HYDRATION	In contrast to the majority of organisms that have cells bound by di-ester phospholipids, archaeal membranes consist of di- and tetraether phospholipids. Originating from organisms that withstand harsh conditions (e.g., low pH and a wide range of temperatures) such membranes have physical properties that make them attractive materials for biological research and biotechnological applications. We developed force-field parameters based on the widely used Generalized Amber Force Field (GAFF) to enable the study of anionic tetraether membranes of the model archaean Sulfolobus acidocaldarius by computer simulations. The simulations reveal that the physical properties of these unique membranes depend on the number of cyclopentane rings included in each lipid unit, and on the size of cations that are used to ensure charge neutrality. This suggests that the biophysical properties of Sulfolobus acidocaldarius cells depend not only on the compositions of their membranes but also on the media in which they grow.	[De Castro, Luis Felipe Pineda; Friedman, Ran] Linnaeus Univ, Dept Chem & Biomed Sci, Computat Chem & Biochem Res Grp CCBG, S-39182 Kalmar, Sweden; [De Castro, Luis Felipe Pineda; Friedman, Ran] Linnaeus Univ, Ctr Excellence Biomat Chem, S-39182 Kalmar, Sweden; [Dopson, Mark] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Syst Biol Microorganisms Res Grp SBMR, S-39182 Kalmar, Sweden; [De Castro, Luis Felipe Pineda] Univ Gdansk, Lab Mol Modeling, Ul Wita Stwosza 63, PL-80308 Gdansk, Poland	Linnaeus University; Linnaeus University; Linnaeus University; Fahrenheit Universities; University of Gdansk	Friedman, R (corresponding author), Linnaeus Univ, Dept Chem & Biomed Sci, Computat Chem & Biochem Res Grp CCBG, S-39182 Kalmar, Sweden.; Friedman, R (corresponding author), Linnaeus Univ, Ctr Excellence Biomat Chem, S-39182 Kalmar, Sweden.	ran.friedman@lnu.se	Friedman, Ran/P-7363-2019; Castro, Luis/A-5442-2008; Dopson, Mark/A-7028-2013; /A-1582-2008	Friedman, Ran/0000-0001-8696-3104; Castro, Luis/0000-0002-4261-8699; /0000-0001-8696-3104	Carl Tryggers Foundation [11:146, CTS 12:140, CTS 11:146]; Royal Swedish Academy of Sciences [FOA12V-021]	Carl Tryggers Foundation; Royal Swedish Academy of Sciences	This study was supported by the Carl Tryggers Foundation, project numbers 11:146 and CTS 12:140 (http://www.carltryggersstiftelse.se/), and The Royal Swedish Academy of Sciences, project number FOA12V-021 (http://www.kva.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Wataru Shinoda for providing us snapshots of MD simulations of TEP membrane models and two anonymous reviewers for thoughtful suggestions. This study was supported by the Carl Tryggers Foundation, project numbers CTS 11:146 and CTS 12:140; and the Royal Swedish Academy of Sciences, project number FOA12V-021. The simulations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) at the center for scientific and technical computing at Lund University (LUNARC).	Bagatolli L, 2000, BIOPHYS J, V79, P416, DOI 10.1016/S0006-3495(00)76303-X; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Braun AR, 2011, BIOPHYS J, V100, P2112, DOI 10.1016/j.bpj.2011.03.009; Bulacu M, 2012, BIOMACROMOLECULES, V13, P196, DOI [10.1021/bm201454J, 10.1021/bm201454j]; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chong PLG, 2005, BIOPHYS J, V89, P1841, DOI 10.1529/biophysj.105.063933; Chong PLG, 2003, J PHYS CHEM B, V107, P8694, DOI 10.1021/jp034584d; Chugunov AO, 2014, SCI REP-UK, V4, DOI 10.1038/srep07462; Cournia Z, 2015, J MEMBRANE BIOL, V248, P611, DOI 10.1007/s00232-015-9802-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Domanski J, 2010, J MEMBRANE BIOL, V236, P255, DOI 10.1007/s00232-010-9296-8; Dopson M, 2003, MICROBIOL-SGM, V149, P1959, DOI 10.1099/mic.0.26296-0; Dopson M, 2014, APPL MICROBIOL BIOT, V98, P8133, DOI 10.1007/s00253-014-5982-2; Edholm O, 2008, CURR TOP MEMBR, V60, P91, DOI 10.1016/S1063-5823(08)00003-3; Feller SE, 1999, J CHEM PHYS, V111, P1281, DOI 10.1063/1.479313; Feller SE, 2000, CURR OPIN COLLOID IN, V5, P217, DOI 10.1016/S1359-0294(00)00058-3; Feller SE, 1997, BIOPHYS J, V73, P2269, DOI 10.1016/S0006-3495(97)78259-6; Filippov A, 2009, CHEM PHYS LIPIDS, V159, P81, DOI 10.1016/j.chemphyslip.2009.03.007; Friedman R, 2013, J CHEM EDUC, V90, P1018, DOI 10.1021/ed4000525; Friedman R, 2011, J PHYS CHEM B, V115, P9213, DOI 10.1021/jp112155m; Gabriel JL, 2000, CHEM PHYS LIPIDS, V105, P193, DOI 10.1016/S0009-3084(00)00126-2; Gasteiger J., 1990, TETRAHEDRON COMPUT M, V3, P537, DOI DOI 10.1016/0898-5529(90)90156-3; Gattin Z, 2009, CHEM-EUR J, V15, P6389, DOI 10.1002/chem.200802523; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jurkiewicz P, 2012, BBA-BIOMEMBRANES, V1818, P609, DOI 10.1016/j.bbamem.2011.11.033; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lee SJ, 2008, BIOPHYS J, V94, P3565, DOI 10.1529/biophysj.107.116335; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lyubartsev AP, 2011, SOFT MATTER, V7, P25, DOI 10.1039/c0sm00457j; Marcus Y, 2006, CHEM REV, V106, P4585, DOI 10.1021/cr040087x; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; MORII H, 1994, J BIOL CHEM, V269, P10492; Nicolas JP, 2005, LIPIDS, V40, P1023, DOI 10.1007/s11745-005-1465-2; Oger PM, 2013, BIOPHYS CHEM, V183, P42, DOI 10.1016/j.bpc.2013.06.020; Pandit SA, 2002, BIOPHYS J, V82, P1818, DOI 10.1016/S0006-3495(02)75532-X; Pastor RW, 2011, J PHYS CHEM LETT, V2, P1526, DOI 10.1021/jz200167q; Pikuta EV, 2007, CRIT REV MICROBIOL, V33, P183, DOI 10.1080/10408410701451948; Poger D, 2012, J CHEM THEORY COMPUT, V8, P4807, DOI 10.1021/ct300675z; Polak A, 2014, LANGMUIR, V30, P8308, DOI 10.1021/la5014208; Reif MM, 2013, J CHEM THEORY COMPUT, V9, P1247, DOI 10.1021/ct300874c; Rivkina EM, 2000, APPL ENVIRON MICROB, V66, P3230, DOI 10.1128/AEM.66.8.3230-3233.2000; Rosa MD, 1983, J MEMBRANE SCI, V16, P287, DOI [10.1016/S0376-7388(00)81316-2, DOI 10.1016/S0376-7388(00)81316-2]; Shinoda K, 2007, PHYS CHEM CHEM PHYS, V9, P643, DOI 10.1039/b611543h; Shinoda W, 2005, BIOPHYS J, V89, P3195, DOI 10.1529/biophysj.105.060962; Shinoda W, 2003, J COMPUT CHEM, V24, P920, DOI 10.1002/jcc.10249; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Sprott GD, 2001, ELS; Takai K, 2008, P NATL ACAD SCI USA, V105, P10949, DOI 10.1073/pnas.0712334105; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Westall F, 2002, ESA SPEC PUBL, V518, P131	58	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155287	10.1371/journal.pone.0155287	http://dx.doi.org/10.1371/journal.pone.0155287			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167213	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300008
J	Kawasaki, A; Hasebe, N; Hidaka, M; Hirano, F; Sada, KE; Kobayashi, S; Yamada, H; Furukawa, H; Yamagata, K; Sumida, T; Miyasaka, N; Tohma, S; Ozaki, S; Matsuo, S; Hashimoto, H; Makino, H; Arimura, Y; Harigai, M; Tsuchiya, N				Kawasaki, Aya; Hasebe, Narumi; Hidaka, Misaki; Hirano, Fumio; Sada, Ken-ei; Kobayashi, Shigeto; Yamada, Hidehiro; Furukawa, Hiroshi; Yamagata, Kunihiro; Sumida, Takayuki; Miyasaka, Nobuyuki; Tohma, Shigeto; Ozaki, Shoichi; Matsuo, Seiichi; Hashimoto, Hiroshi; Makino, Hirofumi; Arimura, Yoshihiro; Harigai, Masayoshi; Tsuchiya, Naoyuki			Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study	PLOS ONE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; HLA-DR; WEGENERS-GRANULOMATOSIS; ASSOCIATION; ANTIGENS; ALLELE; HAPLOTYPE; DISEASE	Among antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV), granulomatosis with polyangiitis (GPA) and proteinase 3-ANCA-positive AAV (PR3-AAV) are prevalent in European populations, while microscopic polyangiitis (MPA) and myeloperoxidase-ANCA-positive AAV (MPO-AAV) are predominant in the Japanese. We previously demonstrated association of DRB1*09:01-DQB1*03:03 haplotype, a haplotype common in East Asians but rare in the European populations, with MPA/MPO-AAV, suggesting that a population difference in HLA-class II plays a role in the epidemiology of this disease. To gain further insights, we increased the sample size and performed an extended association study of DRB1 and DPB1 with AAV subsets in 468 Japanese patients with AAV classified according to the European Medicines Agency algorithm (MPA: 285, GPA: 92, eosinophilic GPA [EGPA]: 56, unclassifiable: 35) and 596 healthy controls. Among these patients, 377 were positive for MPO-ANCA and 62 for PR3-ANCA. The significance level was set at alpha = 3.3x10(-4) by applying Bonferroni correction. The association of DRB1*09:01 with MPO-AAV was confirmed (allele model, P = 2.1x10(-4), odds ratio [OR] = 1.57). Protective association of DRB1*13:02 was detected against MPO-AAV (allele model, P = 2.3x10(-5), OR = 0.42) and MPA (dominant model, P = 2.7x10(-4), OR = 0.43). A trend toward increased frequency of DPB1*04:01, the risk allele for GPA in European populations, was observed among Japanese patients with PR3-AAV when conditioned on DRB1*13:02 (P-adjusted = 0.0021, ORadjusted = 3.48). In contrast, the frequency of DPB1*04: 01 was decreased among Japanese patients with MPO-AAV, and this effect lost significance when conditioned on DRB1*13:02 (P-adjusted = 0.16), suggesting that DRB1*13:02 or other allele(s) in linkage disequilibrium may be responsible for the protection. The differential association of DPB1*04:01 with PR3-AAV and MPO-AAV and difference in DPB1*04:01 allele frequencies between populations supported the hypothesis that the HLA-class II population difference may account in part for these epidemiologic characteristics. Furthermore, taken together with our previous observations, the haplotype carrying DRB1*13:02 was suggested to be a shared protective factor against multiple autoimmune diseases.	[Kawasaki, Aya; Hasebe, Narumi; Hidaka, Misaki; Furukawa, Hiroshi; Tsuchiya, Naoyuki] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan; [Kawasaki, Aya; Hasebe, Narumi; Furukawa, Hiroshi; Tsuchiya, Naoyuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Biomed Sci, Tsukuba, Ibaraki, Japan; [Kawasaki, Aya; Hidaka, Misaki; Furukawa, Hiroshi; Tsuchiya, Naoyuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Masters Program Med Sci, Tsukuba, Ibaraki, Japan; [Hirano, Fumio; Harigai, Masayoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pharmacovigilance, Tokyo, Japan; [Hirano, Fumio; Miyasaka, Nobuyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Rheumatol, Tokyo, Japan; [Sada, Ken-ei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Kobayashi, Shigeto] Juntendo Univ, Koshigaya Hosp, Dept Internal Med, Koshigaya, Japan; [Yamada, Hidehiro; Ozaki, Shoichi] St Marianna Univ, Sch Med, Dept Internal Med, Kawasaki, Kanagawa, Japan; [Furukawa, Hiroshi; Tohma, Shigeto] Sagamihara Hosp, Natl Hosp Org, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Yamagata, Kunihiro] Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki, Japan; [Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med Rheumatol, Tsukuba, Ibaraki, Japan; [Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Hashimoto, Hiroshi] Juntendo Univ, Sch Med, Tokyo 113, Japan; [Makino, Hirofumi] Okayama Univ Hosp, Okayama, Japan; [Arimura, Yoshihiro] Kyorin Univ, Sch Med, Dept Internal Med 1, Tokyo, Japan; [Harigai, Masayoshi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Okayama University; Juntendo University; Saint Marianna University; University of Tsukuba; University of Tsukuba; Nagoya University; Juntendo University; Okayama University; Kyorin University; Tokyo Women's Medical University	Kawasaki, A; Tsuchiya, N (corresponding author), Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan.; Kawasaki, A; Tsuchiya, N (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Biomed Sci, Tsukuba, Ibaraki, Japan.; Kawasaki, A; Tsuchiya, N (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Masters Program Med Sci, Tsukuba, Ibaraki, Japan.	a-kawasaki@umin.net; tsuchiya-tky@umin.net	Hirano, Fumio/AGY-2476-2022; Hashimoto, Hiroshi/AAD-3667-2020; Tsuchiya, Naoyuki/CAA-4545-2022	Hirano, Fumio/0000-0002-5169-0692; Tsuchiya, Naoyuki/0000-0002-6776-5580; Sada, Ken-ei/0000-0003-1020-0818; Kobayashi, Shigeto/0000-0002-1939-3380	Health and Labour Science Research Grants for the Research on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan; Japan Agency for Medical Research and Development; Japan Rheumatism Foundation; Japan Allergy Foundation; Japan College of Rheumatology; SENSHIN Medical Research Foundation	Health and Labour Science Research Grants for the Research on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Rheumatism Foundation(Japan Rheumatism Foundation); Japan Allergy Foundation; Japan College of Rheumatology; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This work was supported by Health and Labour Science Research Grants for the Research on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/index.html); the Japan Agency for Medical Research and Development "The strategic study group to establish evidences for the treatment guidelines of intractable vasculitis" and "The study group for strategic exploration of drug seeds for ANCA-associated vasculitis and construction of clinical evidence" (http://www.amed.go.jp/); the Japan Rheumatism Foundation (http://www.rheuma-net.or.jp/rheuma/); the Japan Allergy Foundation (http://www.jaanet.org/); the Japan College of Rheumatology (http://www.ryumachi-jp.com/); and the SENSHIN Medical Research Foundation (https://www.smrf.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fujimoto S, 2011, RHEUMATOLOGY, V50, P1916, DOI 10.1093/rheumatology/ker205; Furukawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087792; Gencik M, 1999, CLIN EXP IMMUNOL, V117, P412; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; HAGEN EC, 1995, KIDNEY INT, V48, P801, DOI 10.1038/ki.1995.353; Heckmann M, 2008, ANN RHEUM DIS, V67, P972, DOI 10.1136/ard.2007.077693; Kawabata Y, 2002, DIABETES, V51, P545, DOI 10.2337/diabetes.51.2.545; Luo H, 2011, HUM IMMUNOL, V72, P422, DOI 10.1016/j.humimm.2011.02.017; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; MATSUKI K, 1990, J CLIN INVEST, V86, P392, DOI 10.1172/JCI114724; Menconi F, 2010, P NATL ACAD SCI USA, V107, P16899, DOI 10.1073/pnas.1009511107; Nakamaru Y., 1996, Rhinology (Utrecht), V34, P163; Oka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099453; PAPIHA SS, 1992, ANN RHEUM DIS, V51, P246, DOI 10.1136/ard.51.2.246; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Sada KE, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4550; Shimane K, 2013, RHEUMATOLOGY, V52, P1172, DOI 10.1093/rheumatology/kes427; SPENCER SJW, 1992, KIDNEY INT, V41, P1059, DOI 10.1038/ki.1992.161; Terao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040067; Tsuchiya N, 2006, GENES IMMUN, V7, P81, DOI 10.1038/sj.gene.6364262; Tsuchiya N, 2003, J RHEUMATOL, V30, P1534; Tsuchiya N, 2013, CLIN EXP NEPHROL, V17, P628, DOI 10.1007/s10157-012-0691-6; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Watts RA, 2015, RHEUMATOLOGY, V54, P359, DOI 10.1093/rheumatology/keu321; Xie G, 2013, ARTHRITIS RHEUM-US, V65, P2457, DOI 10.1002/art.38036	26	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154393	10.1371/journal.pone.0154393	http://dx.doi.org/10.1371/journal.pone.0154393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166610	gold, Green Published			2022-12-27	WOS:000376587300080
J	Yamaguchi, T; Higuchi, H; Onodera, H; Hokkirigawa, K; Masani, K				Yamaguchi, Takeshi; Higuchi, Hironari; Onodera, Hiroshi; Hokkirigawa, Kazuo; Masani, Kei			Misalignment of the Desired and Measured Center of Pressure Describes Falls Caused by Slip during Turning	PLOS ONE			English	Article							CENTER-OF-MASS; AGE-RELATED DIFFERENCES; DYNAMIC STABILITY; REQUIRED COEFFICIENT; PARKINSONS-DISEASE; BALANCE RECOVERY; GAIT; WALKING; OLDER; KINEMATICS	In this study, desired center of pressure (dCOP) was introduced to evaluate dynamic postural stability. The dCOP is defined as a virtual point on the ground, where the moment around the body center of mass (COM) becomes zero when dCOP and the measured COP (mCOP) coincide. We hypothesized that, when the misalignment of the dCOP and mCOP (dCOP-mCOP) increases up to a certain value due to a large perturbation during walking, it becomes difficult to make a compensatory step and to recover balance of COM and to continue gait. Here we tested this hypothesis in slipping during turning. The study involved twelve healthy young adult males with an average age of 21.5 +/- 1.9 yrs. The subjects were asked to (1) walk straight and turn 60 degrees to the right with the right foot (spin turn) on a dry floor surface, and (2) walk straight and 60 degrees spin turn to the right on a slippery lubricated surface. The dCOP-mCOP during turning in the slip trial with fall were significantly larger, particularly in x-direction (i.e., the medial-lateral direction during straight walk), than that in no-slip trial and slip trial without fall. The receiver operating characteristic (ROC) analysis indicated that the dCOP-mCOP in x-direction is good indicator of falling (area under the curve (AUC) = 0.93) and the threshold in the dCOP-mCOP in x-direction to distinguish for fall or no-fall was 0.55 m. These results support our hypothesis in slipping during turning.	[Yamaguchi, Takeshi; Higuchi, Hironari; Hokkirigawa, Kazuo] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Yamaguchi, Takeshi] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan; [Onodera, Hiroshi] Univ Tokyo, Sch Engn, Photon Sci Ctr, Bukyo ku, Tokyo, Japan; [Onodera, Hiroshi] Univ Tokyo, Dept Elect Engn, Sch Engn, Bukyo ku, 7-3-1 Hongo, Tokyo 113, Japan; [Masani, Kei] Univ Toronto, Inst Biomat & Biomed Engn, Rehabil Engn Lab, Toronto, ON, Canada; [Masani, Kei] Univ Hlth Network, Toronto Rehabil Inst, Lyndhurst Ctr, Rehabil Engn Lab, Toronto, ON, Canada	Tohoku University; Tohoku University; University of Tokyo; University of Tokyo; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Yamaguchi, T (corresponding author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan.; Yamaguchi, T (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan.	yamatake@gdl.mech.tohoku.ac.jp	Yamaguchi, Takeshi T/D-3550-2017; Masani, Kei/B-4991-2010; YAMAGUCHI, Takeshi/ABF-8367-2021	Yamaguchi, Takeshi T/0000-0002-5063-9924; Masani, Kei/0000-0002-0207-3241; 	 [22760110];  [25420080]	; 	This work was supported by: Grant-in-Aid for the Young Scientists (B) (22760110); Grant-in-Aid for Scientific Research (C) (25420080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW J, 1993, HUM FACTORS, V35, P731, DOI 10.1177/001872089303500411; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bierbaum S, 2011, J BIOMECH, V44, P1921, DOI 10.1016/j.jbiomech.2011.04.027; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Caderby T, 2014, J BIOMECH, V47, P417, DOI 10.1016/j.jbiomech.2013.11.011; Calandre L, 2005, NEUROLOGIA, V20, P232; CAMPBELL A J, 1981, Age and Ageing, V10, P264, DOI 10.1093/ageing/10.4.264; Carbonneau E, 2014, GAIT POSTURE, V39, P365, DOI 10.1016/j.gaitpost.2013.08.013; Cheng KC, 2012, J GERONTOL A-BIOL, V67, P1238, DOI 10.1093/gerona/gls116; Fino P, 2014, J BIOMECH, V47, P1395, DOI 10.1016/j.jbiomech.2014.01.032; FORSTER A, 1995, BRIT MED J, V311, P83, DOI 10.1136/bmj.311.6997.83; Gamus B, 2015, SIAM J APPL DYN SYST, V14, P609, DOI 10.1137/140956816; Hak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082842; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hase K, 1999, J NEUROPHYSIOL, V81, P2914, DOI 10.1152/jn.1999.81.6.2914; Herr H, 2008, J EXP BIOL, V211, P467, DOI 10.1242/jeb.008573; Marjorie JH, 2008, ARCH PHYS MED REHAB, V89, P1708, DOI 10.1016/j.apmr.2008.01.023; Hohne A, 2011, J BIOMECH, V44, P2194, DOI 10.1016/j.jbiomech.2011.06.012; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Hof AL, 2007, J BIOMECH, V40, P451, DOI 10.1016/j.jbiomech.2005.12.016; Hof AL, 2007, GAIT POSTURE, V25, P250, DOI 10.1016/j.gaitpost.2006.04.013; Hsiao-Wecksler ET, 2008, J ELECTROMYOGR KINES, V18, P179, DOI 10.1016/j.jelekin.2007.06.007; Hur P, 2010, IEEE T NEUR SYS REH, V18, P461, DOI 10.1109/TNSRE.2010.2052133; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kim S, 2005, SAFETY SCI, V43, P425, DOI 10.1016/j.ssci.2005.08.004; Maki BE, 1997, PHYS THER, V77, P488, DOI 10.1093/ptj/77.5.488; Maki BE, 2000, J GERONTOL A-BIOL, V55, pM270, DOI 10.1093/gerona/55.5.M270; Maki BE, 2006, AGE AGEING, V35, P12, DOI 10.1093/ageing/afl078; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Redfern M. S., 1984, P 1984 INT C OCC ERG; Rogers MW, 2003, EXERC SPORT SCI REV, V31, P182, DOI 10.1097/00003677-200310000-00005; Rosenblatt NJ, 2010, GAIT POSTURE, V31, P380, DOI 10.1016/j.gaitpost.2010.01.002; RUBENSTEIN LZ, 1988, J AM GERIATR SOC, V36, P266, DOI 10.1111/j.1532-5415.1988.tb01811.x; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Takenaka T., 2006, AGE AGEING S2, V35, pS5; Taylor MJD, 2005, HUM MOVEMENT SCI, V24, P558, DOI 10.1016/j.humov.2005.07.005; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; Yamaguchi T, 2013, GAIT POSTURE, V38, P209, DOI 10.1016/j.gaitpost.2012.11.007; Yamaguchi T, 2012, J BIOMECH, V45, P2624, DOI 10.1016/j.jbiomech.2012.08.006; Yang F, 2014, J BIOMECH, V47, P3876, DOI 10.1016/j.jbiomech.2014.10.006; Yang F, 2011, J BIOMECH, V44, P2243, DOI 10.1016/j.jbiomech.2011.05.039; Yang F, 2009, ANN BIOMED ENG, V37, P2606, DOI 10.1007/s10439-009-9798-7	44	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155418	10.1371/journal.pone.0155418	http://dx.doi.org/10.1371/journal.pone.0155418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166954	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300062
J	Zhurakovskaya, E; Paasonen, J; Shatillo, A; Lipponen, A; Salo, R; Aliev, R; Tanila, H; Grohn, O				Zhurakovskaya, Ekaterina; Paasonen, Jaakko; Shatillo, Artem; Lipponen, Arto; Salo, Raimo; Aliev, Rubin; Tanila, Heikki; Grohn, Olli			Global Functional Connectivity Differences between Sleep-Like States in Urethane Anesthetized Rats Measured by fMRI	PLOS ONE			English	Article							BRAIN ACTIVITY; REM-SLEEP; MODEL; SYSTEM	Sleep is essential for nervous system functioning and sleep disorders are associated with several neurodegenerative diseases. However, the macroscale connectivity changes in brain networking during different sleep states are poorly understood. One of the hindering factors is the difficulty to combine functional connectivity investigation methods with spontaneously sleeping animals, which prevents the use of numerous preclinical animal models. Recent studies, however, have implicated that urethane anesthesia can uniquely induce different sleep-like brain states, resembling rapid eye movement (REM) and non-REM (NREM) sleep, in rodents. Therefore, the aim of this study was to assess changes in global connectivity and topology between sleep-like states in urethane anesthetized rats, using blood oxygenation level dependent (BOLD) functional magnetic resonance imaging. We detected significant changes in corticocortical (increased in NREM-like state) and corticothalamic connectivity (increased in REM-like state). Additionally, in graph analysis the modularity, the measure of functional integration in the brain, was higher in NREM-like state than in REM-like state, indicating a decrease in arousal level, as in normal sleep. The fMRI findings were supported by the supplementary electrophysiological measurements. Taken together, our results show that macroscale functional connectivity changes between sleep states can be detected robustly with resting-state fMRI in urethane anesthetized rats. Our findings pave the way for studies in animal models of neurodegenerative diseases where sleep abnormalities are often one of the first markers for the disorder development.	[Zhurakovskaya, Ekaterina; Paasonen, Jaakko; Shatillo, Artem; Lipponen, Arto; Salo, Raimo; Tanila, Heikki; Grohn, Olli] Univ Eastern Finland, Dept Neurobiol, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Zhurakovskaya, Ekaterina; Aliev, Rubin] Moscow Inst Phys & Technol, Dept Control & Appl Math, Moscow, Russia; [Aliev, Rubin] Inst Theoret & Expt Biophys, Pushchino, Moscow Region, Russia; [Aliev, Rubin] Fed Biomed Agcy Russia, Fed Sci & Clin Ctr, Moscow, Russia	University of Eastern Finland; Moscow Institute of Physics & Technology; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Grohn, O (corresponding author), Univ Eastern Finland, Dept Neurobiol, AI Virtanen Inst Mol Sci, Kuopio, Finland.	olli.grohn@uef.fi	Aliev, Rubin/G-3819-2011	Aliev, Rubin/0000-0003-3102-3769; Paasonen, Ekaterina/0000-0003-2365-865X; Salo, Raimo/0000-0003-3610-236X; Lipponen, Arto/0000-0001-6201-6647; Paasonen, Jaakko/0000-0002-1529-596X	CIMO fellowship [TM-14-9364]	CIMO fellowship	The study was funded by CIMO fellowship TM-14-9364 (www.cimo.fi) awarded to EZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann S, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0430-8; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boly M, 2012, P NATL ACAD SCI USA, V109, P5856, DOI 10.1073/pnas.1111133109; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Dimitriadis SI, 2009, BRAIN TOPOGR, V22, P119, DOI 10.1007/s10548-008-0071-4; Gregory GG, 2002, J NEUROPHYSIOL, V88, P2589, DOI 10.1152/jn.00861.2001; Hale JR, 2016, NEUROIMAGE, V125, P657, DOI 10.1016/j.neuroimage.2015.10.041; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Marshall O, 2015, HUM BRAIN MAPP, V36, P3912, DOI 10.1002/hbm.22886; Massimini M, 2010, COGN NEUROSCI-UK, V1, P176, DOI 10.1080/17588921003731578; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Nasrallah FA, 2015, NEUROIMAGE, V117, P29, DOI 10.1016/j.neuroimage.2015.05.035; Paasonen J, 2016, EUR NEUROPSYCHOPHARM, V26, P518, DOI 10.1016/j.euroneuro.2015.12.034; Pagliardini S, 2013, RESP PHYSIOL NEUROBI, V188, P324, DOI 10.1016/j.resp.2013.05.035; Pagliardini S, 2012, J NEUROSCI, V32, P11259, DOI 10.1523/JNEUROSCI.0948-12.2012; Peter-Derex L, 2015, SLEEP MED REV, V19, P29, DOI 10.1016/j.smrv.2014.03.007; Picchioni Dante, 2014, Sleep, V37, P387, DOI 10.5665/sleep.3422; Revel FG, 2009, NEUROSCI BIOBEHAV R, V33, P874, DOI 10.1016/j.neubiorev.2009.03.002; SPOORMAKER VI, 2012, FRONT NEUROL, V3, P1, DOI DOI 10.3389/FNEUR.2012.00080; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Tagliazucchi E, 2013, NEUROIMAGE, V70, P327, DOI 10.1016/j.neuroimage.2012.12.073; Veasey SC, 2000, SLEEP, V23, P1025; Wilson DA, 2011, NEUROSCI LETT, V497, P69, DOI 10.1016/j.neulet.2011.04.031; Xu F, 2011, J CEREBR BLOOD F MET, V31, P58, DOI 10.1038/jcbfm.2010.153; ZOCCOLI G, 1994, BRAIN RES, V641, P46, DOI 10.1016/0006-8993(94)91813-9	29	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155343	10.1371/journal.pone.0155343	http://dx.doi.org/10.1371/journal.pone.0155343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168145	Green Published, gold			2022-12-27	WOS:000376587300042
J	Reddy, AG; Das, AK; Odelu, V; Yoo, KY				Reddy, Alavalapati Goutham; Das, Ashok Kumar; Odelu, Vanga; Yoo, Kee-Young			An Enhanced Biometric Based Authentication with Key-Agreement Protocol for Multi-Server Architecture Based on Elliptic Curve Cryptography	PLOS ONE			English	Article							PASSWORD AUTHENTICATION; PROVABLY SECURE; SMART-CARD; SCHEME; EFFICIENT	Biometric based authentication protocols for multi-server architectures have gained momentum in recent times due to advancements in wireless technologies and associated constraints. Lu et al. recently proposed a robust biometric based authentication with key agreement protocol for a multi-server environment using smart cards. They claimed that their protocol is efficient and resistant to prominent security attacks. The careful investigation of this paper proves that Lu et al.'s protocol does not provide user anonymity, perfect forward secrecy and is susceptible to server and user impersonation attacks, man-in-middle attacks and clock synchronization problems. In addition, this paper proposes an enhanced biometric based authentication with key-agreement protocol for multi-server architecture based on elliptic curve cryptography using smartcards. We proved that the proposed protocol achieves mutual authentication using Burrows-Abadi-Needham (BAN) logic. The formal security of the proposed protocol is verified using the AVISPA (Automated Validation of Internet Security Protocols and Applications) tool to show that our protocol can withstand active and passive attacks. The formal and informal security analyses and performance analysis demonstrates that the proposed protocol is robust and efficient compared to Lu et al.'s protocol and existing similar protocols.	[Reddy, Alavalapati Goutham; Yoo, Kee-Young] Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu, South Korea; [Das, Ashok Kumar] Int Inst Informat Technol, Ctr Secur Theory & Algorithm Res, Hyderabad, Andhra Pradesh, India; [Odelu, Vanga] Indian Inst Technol, Dept Math, Kharagpur 721302, W Bengal, India	Kyungpook National University; International Institute of Information Technology Hyderabad; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Yoo, KY (corresponding author), Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu, South Korea.	yook@knu.ac.kr	Vanga, Odelu/AAD-3174-2021; Das, Ashok Kumar/U-2790-2019; vanga, odelu/B-5428-2017; Das, Ashok Kumar Umar/K-7202-2017	Das, Ashok Kumar/0000-0002-5196-9589; vanga, odelu/0000-0001-6903-0361; ALAVALAPATI, GOUTHAM REDDY/0000-0002-4335-8331	BK21 Plus project (SW Human Resource Development Program for Supporting Smart Life) - Ministry of Education, School of Computer Science and Engineering, Kyungpook National University, Korea [21A20131600005]; Institute for Information & communications Technology Promotion (IITP) grant - Korea government (MSIP) [Self-Organized Software platform (SoSp) for Welfare Devices] [10041145]	BK21 Plus project (SW Human Resource Development Program for Supporting Smart Life) - Ministry of Education, School of Computer Science and Engineering, Kyungpook National University, Korea; Institute for Information & communications Technology Promotion (IITP) grant - Korea government (MSIP) [Self-Organized Software platform (SoSp) for Welfare Devices]	This work was supported by the BK21 Plus project (SW Human Resource Development Program for Supporting Smart Life) funded by the Ministry of Education, School of Computer Science and Engineering, Kyungpook National University, Korea (21A20131600005), and Institute for Information & communications Technology Promotion (IITP) grant funded by the Korea government (MSIP) [No. 10041145, Self-Organized Software platform (SoSp) for Welfare Devices].	Amin R, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0351-y; Armando A, 2005, LECT NOTES COMPUT SC, V3576, P281; AVISPA, SPAN SEC PROT AN AVI; Awasthi AK, 2004, IEEE T CONSUM ELECTR, V50, P583, DOI 10.1109/TCE.2004.1309430; Basin D., 2005, INT J INF SEC, V4, P181, DOI [10.1007/s10207-004-0055-7, DOI 10.1007/S10207-004-0055-7]; BURROWS M, 1990, ACM T COMPUT SYST, V8, P18, DOI [10.1145/77648.77649, 10.1145/74851.74852]; Chen CT, 2015, SECUR COMMUN NETW, V8, P1608, DOI 10.1002/sec.1109; Chien HY, 2002, COMPUT SECUR, V21, P372, DOI 10.1016/S0167-4048(02)00415-7; Chuang MC, 2014, EXPERT SYST APPL, V41, P1411, DOI 10.1016/j.eswa.2013.08.040; Das AK., 2013, NETWORKING SCI, V2, P12, DOI DOI 10.1007/S13119-012-0009-8; Das AK, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0276-5; DOLEV D, 1983, IEEE T INFORM THEORY, V29, P198, DOI 10.1109/TIT.1983.1056650; Fan CI, 2009, IEEE T INF FOREN SEC, V4, P933, DOI 10.1109/TIFS.2009.2031942; Guo DL, 2014, WIRELESS PERS COMMUN, V78, P475, DOI 10.1007/s11277-014-1762-7; Hafizul Islam S. K., 2014, Journal of Electronics (China), V31, P473, DOI 10.1007/s11767-014-4002-0; Hsiang HC, 2009, COMPUT STAND INTER, V31, P1118, DOI 10.1016/j.csi.2008.11.002; Huang CH, 2012, SECUR COMMUN NETW, V5, P331, DOI 10.1002/sec.332; Islam S. H., 2015, INT J AD HO IN PRESS; Islam SKH, 2016, INT J COMMUN SYST, V29, P1708, DOI 10.1002/dac.2793; Islam SKH, 2015, WIRELESS PERS COMMUN, V84, P2013, DOI 10.1007/s11277-015-2542-8; Islam SKH, 2015, J KING SAUD UNIV-COM, V27, P211, DOI 10.1016/j.jksuci.2014.03.018; Islam SKH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131368; Islam SKH, 2014, WIRELESS PERS COMMUN, V79, P1975, DOI 10.1007/s11277-014-1968-8; Islam SKH, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0135-9; Islam S. K. Hafizul, 2014, INT J INFORM SCI, V3, P35, DOI DOI 10.12785/ISL/030105; Islam SH, 2012, THEOR APPL INFORM, V24, P293, DOI [10.2478/v10179-012-0018-z, DOI 10.2478/V10179-012-0018-Z]; Juang WS, 2004, IEEE T CONSUM ELECTR, V50, P251, DOI 10.1109/TCE.2004.1277870; Kocher P., 1999, Advances in Cryptology - CRYPTO'99. 19th Annual International Cryptology Conference. Proceedings, P388; LAMPORT L, 1981, COMMUN ACM, V24, P770, DOI 10.1145/358790.358797; Lee CC, 2014, NONLINEAR DYNAM, V76, P853, DOI 10.1007/s11071-013-1174-3; Lee CC, 2012, INT J SECUR APPL, V6, P203; Lee CC, 2011, EXPERT SYST APPL, V38, P13863, DOI 10.1016/j.eswa.2011.04.190; Lee JK, 2002, ELECTRON LETT, V38, P554, DOI 10.1049/el:20020380; Li CS, 2011, J STAT COMPUT SIM, V81, P1081, DOI 10.1080/00949651003677410; Li CT, 2015, J INF SCI ENG, V31, P1975; Li X, 2013, MATH COMPUT MODEL, V58, P85, DOI 10.1016/j.mcm.2012.06.033; Li X, 2012, J NETW COMPUT APPL, V35, P763, DOI 10.1016/j.jnca.2011.11.009; Liao YP, 2009, COMPUT STAND INTER, V31, P24, DOI 10.1016/j.csi.2007.10.007; Lin CH, 2004, COMPUT STAND INTER, V27, P19, DOI 10.1016/j.csi.2004.03.003; Lin H, 2015, WIRELESS PERS COMMUN, V84, P2351, DOI 10.1007/s11277-015-2708-4; Lu YR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126323; Lv C, 2013, J NETW COMPUT APPL, V36, P498, DOI 10.1016/j.jnca.2012.04.006; Messerges TS, 2002, IEEE T COMPUT, V51, P541, DOI 10.1109/TC.2002.1004593; Mir O, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0265-8; Mishra D, 2014, EXPERT SYST APPL, V41, P8129, DOI 10.1016/j.eswa.2014.07.004; Nam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116709; Odelu V, 2015, IEEE T INF FOREN SEC, V10, P1953, DOI 10.1109/TIFS.2015.2439964; Reddy AG, 2015, 30TH ANNUAL ACM SYMPOSIUM ON APPLIED COMPUTING, VOLS I AND II, P169, DOI 10.1145/2695664.2695666; Song RG, 2010, COMPUT STAND INTER, V32, P321, DOI 10.1016/j.csi.2010.03.008; Sood SK, 2011, J NETW COMPUT APPL, V34, P609, DOI 10.1016/j.jnca.2010.11.011; Tsai JL, 2008, COMPUT SECUR, V27, P115, DOI 10.1016/j.cose.2008.04.001; Von Oheimb D., 2005, P APPSEM 2005 WORKSH, P1; Wang RC, 2009, IEEE COMMUN LETT, V13, P157, DOI 10.1109/LCOMM.2009.081884; Xue KP, 2014, J COMPUT SYST SCI, V80, P195, DOI 10.1016/j.jcss.2013.07.004; Yang WH, 1999, COMPUT SECUR, V18, P727, DOI 10.1016/S0167-4048(99)80136-9; Yoon EJ, 2013, J SUPERCOMPUT, V63, P235, DOI 10.1007/s11227-010-0512-1	56	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154308	10.1371/journal.pone.0154308	http://dx.doi.org/10.1371/journal.pone.0154308			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163786	Green Submitted, Green Published, gold			2022-12-27	WOS:000376585700005
J	Wada, K; Higuchi, Y; Smith, DR				Wada, Koji; Higuchi, Yoshiyuki; Smith, Derek R.			Assessing the Impact of Nationwide Smoking Cessation Interventions among Employed, Middle-Aged Japanese Men, 2005-2010	PLOS ONE			English	Article							PASSIVE SMOKING; SOCIAL SUPPORT; LIFE-STYLE; FOLLOW-UP; TOBACCO; POPULATION; HEALTH; EDUCATION; GENDER; COHORT	Background A variety of tobacco control interventions have become available in Japan over the past decade, however, the magnitude to which they have impacted on smoking rates may have varied by socioeconomic status such as job content, particularly for middle-aged men who were formerly long-term smokers. We conducted a longitudinal study to investigate the differences between smoking cessation strategies among a national sample of middle-aged Japanese employed men between 2005 and 2010. Methods Data was extracted from a previous longitudinal survey of middle-aged and elderly people that had been conducted by the Ministry of Health, Labour and Welfare. In 2005, 16,738 Japanese men aged 50-59 years were recruited and sent a questionnaire in each year of the study. We analyzed data for individuals who reported being current smokers at baseline. Cox's discrete time proportional hazard regression analysis was used to examine potential associations between smoking cessation and socioeconomic factors. Results Of the 6187 employed, male smokers who participated in 2005, 31% subsequently quit smoking during the 5-year follow-up period. Those working in manufacturing, transportation, or security were less likely to have quit smoking than those working in management. Having no marital partner, never having been married, or those experiencing psychological distress were significantly less likely to have quit smoking during this time. Conclusions Although almost one-third of middle-aged, male smokers quit their habit between 2005 and 2010; the uptake of this national strategy appears to have been far from uniform across Japanese society. Socioeconomic factors such as occupation, marital status and psychological distress were negatively correlated with quitting, suggesting that these groups should be more aggressively targeted in further interventions.	[Wada, Koji] Natl Ctr Global Hlth & Med, Int Hlth Cooperat, Tokyo, Japan; [Higuchi, Yoshiyuki] Fukuoka Univ Educ, Dept Hlth & Phys Educ, Fukuoka 81141, Japan; [Smith, Derek R.] Univ Newcastle, Fac Hlth & Med, Sch Hlth Sci, Ourimbah, NSW, Australia	National Center for Global Health & Medicine - Japan; Fukuoka University Education; University of Newcastle	Wada, K (corresponding author), Natl Ctr Global Hlth & Med, Int Hlth Cooperat, Tokyo, Japan.	kwada-sgy@umin.ac.jp			Japan Society for the Promotion of Science, KAKENHI [25460812]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, KAKENHI Grant-in-Aid for Scientific Research C, Grant Number 25460812. The funders had no role in the study design, data collection or analysis, decision to publish, or manuscript preparation.	Cahill K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003440.pub4; Fernandez E, 2006, NICOTINE TOB RES, V8, P29, DOI 10.1080/14622200500264432; Fujiwara H, 2010, CIRC J, V74, P628, DOI 10.1253/circj.CJ-10-0165; Fukuda Y, 2005, ANN EPIDEMIOL, V15, P365, DOI 10.1016/j.annepidem.2004.09.003; Hagimoto A, 2010, ADDICTION, V105, P164, DOI 10.1111/j.1360-0443.2009.02735.x; Hu LZ, 2007, J OCCUP HEALTH, V49, P443, DOI 10.1539/joh.49.443; Iwasaki M, 2005, ANN EPIDEMIOL, V15, P286, DOI 10.1016/j.annepidem.2004.08.011; Japan Health Promotion and Fitness Foundation, TIM TREND PREV SMOK; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; MERMELSTEIN R, 1986, J CONSULT CLIN PSYCH, V54, P447, DOI 10.1037/0022-006X.54.4.447; MERMELSTEIN R, 1983, J CONSULT CLIN PSYCH, V51, P465, DOI 10.1037/0022-006X.51.3.465; Ministry of Health Labour and Welfare, LONG SURV MIDDL AG E; Mino Y, 2001, PREV MED, V32, P371, DOI 10.1006/pmed.2000.0803; Nakata A, 2008, PREV MED, V46, P451, DOI 10.1016/j.ypmed.2008.01.024; Satomura Kazunari, 2008, Tob Induc Dis, V4, P3, DOI 10.1186/1617-9625-4-3; Sekijima K, 2005, TOHOKU J EXP MED, V206, P187, DOI 10.1620/tjem.206.187; Smith DR, 2011, PUBLIC HEALTH, V125, P179, DOI 10.1016/j.puhe.2011.02.008; Smith DR, 2009, PUBLIC HEALTH, V123, P817, DOI 10.1016/j.puhe.2009.10.014; Smith DR, 2008, IND HEALTH, V46, P77, DOI 10.2486/indhealth.46.77; Smith DR, 2013, J EPIDEMIOL, V23, P4, DOI 10.2188/jea.JE20120121; Smith Derek R, 2008, Tob Induc Dis, V4, P10, DOI 10.1186/1617-9625-4-10; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub4; Takagi D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1184; Tanihara S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006658; Wang NR, 2005, J EPIDEMIOL, V15, P155, DOI 10.2188/jea.15.155	25	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155151	10.1371/journal.pone.0155151	http://dx.doi.org/10.1371/journal.pone.0155151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8BN	27163286	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700007
J	Balestro, E; Calabrese, F; Turato, G; Lunardi, F; Bazzan, E; Marulli, G; Biondini, D; Rossi, E; Sanduzzi, A; Rea, F; Rigobello, C; Gregori, D; Baraldo, S; Spagnolo, P; Cosio, MG; Saetta, M				Balestro, Elisabetta; Calabrese, Fiorella; Turato, Graziella; Lunardi, Francesca; Bazzan, Erica; Marulli, Giuseppe; Biondini, Davide; Rossi, Emanuela; Sanduzzi, Alessandro; Rea, Federico; Rigobello, Chiara; Gregori, Dario; Baraldo, Simonetta; Spagnolo, Paolo; Cosio, Manuel G.; Saetta, Marina			Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							PATHOGENESIS; CLASSIFICATION; MANAGEMENT; PHENOTYPES; PNEUMONIA; TARGET	The clinical course in idiopathic pulmonary fibrosis (IPF) is highly heterogeneous, with some patients having a slow progression and others an accelerated clinical and functional decline. This study aims to clinically characterize the type of progression in IPF and to investigate the pathological basis that might account for the observed differences in disease behavior. Clinical and functional data were analyzed in 73 IPF patients, followed long-time as candidates for lung transplantation. The forced vital capacity (FVC) change/year (< or >= 10% predicted) was used to define "slow" or "rapid" disease progression. Pathological abnormalities were quantified in the explanted lung of 41 out of 73 patients undergoing lung transplantation. At diagnosis, slow progressors (n = 48) showed longer duration of symptoms and lower FVC than rapid progressors (n = 25). Eleven slow and 3 rapid progressors developed an acute exacerbation (AE) during follow-up. Quantitative lung pathology showed a severe innate and adaptive inflammatory infiltrate in rapid progressors, markedly increased compared to slow progressors and similar to that observed in patients experiencing AE. The extent of inflammation was correlated with the yearly FVC decline (r = 0.52, p = 0.005). In conclusion an innate and adaptive inflammation appears to be a prominent feature in the lung of patients with IPF and could contribute to determining of the rate of disease progression.	[Balestro, Elisabetta; Calabrese, Fiorella; Turato, Graziella; Lunardi, Francesca; Bazzan, Erica; Marulli, Giuseppe; Biondini, Davide; Rossi, Emanuela; Rea, Federico; Rigobello, Chiara; Gregori, Dario; Baraldo, Simonetta; Spagnolo, Paolo; Cosio, Manuel G.; Saetta, Marina] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Sanduzzi, Alessandro] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Cosio, Manuel G.] McGill Univ, Meakins Christie Labs, Div Resp, Montreal, PQ, Canada	University of Padua; University of Naples Federico II; McGill University	Saetta, M (corresponding author), Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy.	marina.saetta@unipd.it	Bazzan, Erica/G-3123-2018; Baraldo, Simonetta/AAE-3862-2021; Gregori, Dario/F-9974-2012	Bazzan, Erica/0000-0003-2956-0880; Baraldo, Simonetta/0000-0001-8923-7511; Gregori, Dario/0000-0001-7906-0580; Lunardi, Francesca/0000-0001-5792-4683; SAETTA, MARINA/0000-0002-1547-2102; Biondini, Davide/0000-0002-0726-0812; Balestro, Elisabetta/0000-0003-1373-8197; TURATO, GRAZIELLA/0000-0003-1895-6388	University of Padova	University of Padova	This work was funded by the University of Padova (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Andersson CK, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-139; Ballarin A, 2012, AM J RESP CRIT CARE, V186, P233, DOI 10.1164/rccm.201112-2142OC; Baraldo S, 2015, AM J RESP CRIT CARE, V191, P402, DOI 10.1164/rccm.201403-0529OC; Baran CP, 2007, AM J RESP CRIT CARE, V176, P78, DOI 10.1164/rccm.200609-1279OC; Bazzan E, 2013, CHEST, V143, P98, DOI 10.1378/chest.11-3220; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Collard HR, 2007, HISTOPATHOLOGY, V50, P258, DOI 10.1111/j.1365-2559.2006.02554.x; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; CRYSTAL RG, 1984, NEW ENGL J MED, V310, P154, DOI 10.1056/NEJM198401193100304; DePianto DJ, 2015, THORAX, V70, P48, DOI 10.1136/thoraxjnl-2013-204596; Gilani SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008959; Hunninghake GM, 2014, NEW ENGL J MED, V370, P2142, DOI 10.1056/NEJMe1403448; Kahloon RA, 2013, AM J RESP CRIT CARE, V187, P768, DOI 10.1164/rccm.201203-0506OC; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kim Dong Soon, 2006, Proc Am Thorac Soc, V3, P285, DOI 10.1513/pats.200601-005TK; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; MEIERSYDOW J, 1994, SEMIN RESP CRIT CARE, V15, P77, DOI 10.1055/s-2007-1006351; Moore BB, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00056; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Parra ER, 2007, RESPIRATION, V74, P159, DOI 10.1159/000097133; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Ryu JH, 1998, MAYO CLIN PROC, V73, P1085, DOI 10.4065/73.11.1085; SCADDING JG, 1967, THORAX, V22, P291, DOI 10.1136/thx.22.4.291; Schmidt SL, 2014, CHEST, V145, P579, DOI 10.1378/chest.13-0844; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Shinoda H, 2009, RESPIRATION, V78, P285, DOI 10.1159/000207617; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Taille C, 2011, AM J RESP CRIT CARE, V183, P759, DOI 10.1164/rccm.201001-0076OC; Todd NW, 2013, J INFLAMM RES, V6, P63, DOI 10.2147/JIR.S40673; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Vuga LJ, 2014, AM J RESP CRIT CARE, V189, P966, DOI 10.1164/rccm.201309-1592OC; Wuyts WA, 2013, EUR RESPIR J, V41, P1207, DOI 10.1183/09031936.00073012; Xue JM, 2013, J IMMUNOL, V191, P2089, DOI 10.4049/jimmunol.1203476	40	70	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154516	10.1371/journal.pone.0154516	http://dx.doi.org/10.1371/journal.pone.0154516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159038	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700010
J	Ogada, PA; Moualeu, DP; Poehling, HM				Ogada, Pamella Akoth; Moualeu, Dany Pascal; Poehling, Hans-Michael			Predictive Models for Tomato Spotted Wilt Virus Spread Dynamics, Considering Frankliniella occidentalis Specific Life Processes as Influenced by the Virus	PLOS ONE			English	Article							VECTOR COMPETENCE; TRANSMISSION CHARACTERISTICS; EPIDEMIC DEVELOPMENT; PLANT-VIRUSES; INSECT VECTOR; VOLATILE CUES; THRIPS-TABACI; DISEASE; TOSPOVIRUS; TEMPERATURE	Several models have been studied on predictive epidemics of arthropod vectored plant viruses in an attempt to bring understanding to the complex but specific relationship between the three cornered pathosystem (virus, vector and host plant), as well as their interactions with the environment. A large body of studies mainly focuses on weather based models as management tool for monitoring pests and diseases, with very few incorporating the contribution of vector's life processes in the disease dynamics, which is an essential aspect when mitigating virus incidences in a crop stand. In this study, we hypothesized that the multiplication and spread of tomato spotted wilt virus (TSWV) in a crop stand is strongly related to its influences on Frankliniella occidentalis preferential behavior and life expectancy. Model dynamics of important aspects in disease development within TSWV-F. occidentalis-host plant interactions were developed, focusing on F. occidentalis' life processes as influenced by TSWV. The results show that the influence of TSWV on F. occidentalis preferential behaviour leads to an estimated increase in relative acquisition rate of the virus, and up to 33% increase in transmission rate to healthy plants. Also, increased life expectancy; which relates to improved fitness, is dependent on the virus induced preferential behaviour, consequently promoting multiplication and spread of the virus in a crop stand. The development of vector-based models could further help in elucidating the role of tri-trophic interactions in agricultural disease systems. Use of the model to examine the components of the disease process could also boost our understanding on how specific epidemiological characteristics interact to cause diseases in crops. With this level of understanding we can efficiently develop more precise control strategies for the virus and the vector.	[Ogada, Pamella Akoth; Poehling, Hans-Michael] Leibniz Univ Hannover, Dept Phytomed, Inst Hort Prod Syst, Herrenhauser Str 2, D-30419 Hannover, Germany; [Moualeu, Dany Pascal] Leibniz Univ Hannover, Dept Vegetable Syst Modelling, Inst Hort Prod Syst, Herrenhauser Str 2, D-30419 Hannover, Germany	Leibniz University Hannover; Leibniz University Hannover	Ogada, PA (corresponding author), Leibniz Univ Hannover, Dept Phytomed, Inst Hort Prod Syst, Herrenhauser Str 2, D-30419 Hannover, Germany.	ogada@ipp.uni-hannover.de	Moualeu-Ngangue, Dany/C-6608-2018	Moualeu-Ngangue, Dany/0000-0003-3356-7209	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The funding institution was the Deutsche Forschungsgemeinschaft (DFG), to PAO, http://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista RC, POTENTIAL TOMATO SPO; Bosque-Perez NA, 2011, VIRUS RES, V159, P201, DOI 10.1016/j.virusres.2011.04.020; Carmo-Sousa M, 2014, VIRUS RES, V186, P38, DOI 10.1016/j.virusres.2013.12.012; Chappell TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073321; Chatzivassiliou EK, 2002, PHYTOPATHOLOGY, V92, P603, DOI 10.1094/PHYTO.2002.92.6.603; De Assis  FM, 2004, PHYTOPATHOLOGY, V94, P333, DOI 10.1094/PHYTO.2004.94.4.333; de Assis FM, 2002, PHYTOPATHOLOGY, V92, P729, DOI 10.1094/PHYTO.2002.92.7.729; De Wolf ED, 2007, ANNU REV PHYTOPATHOL, V45, P203, DOI 10.1146/annurev.phyto.44.070505.143329; Doring TF, 2009, P ROY SOC B-BIOL SCI, V276, P121, DOI 10.1098/rspb.2008.0858; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jeger MJ, 2015, ARTHROPOD-PLANT INTE, V9, P107, DOI 10.1007/s11829-015-9363-2; Jeger MJ, 2009, J THEOR BIOL, V258, P198, DOI 10.1016/j.jtbi.2009.01.012; Jeger MJ, 1998, IMA J MATH APPL MED, V15, P1; Jimenez-Martinez ES, 2004, ENVIRON ENTOMOL, V33, P1207, DOI 10.1603/0046-225X-33.5.1207; Jones RAC, 2010, ANNU REV PHYTOPATHOL, V48, P179, DOI 10.1146/annurev-phyto-073009-114444; Kritzman A, 2002, ARCH VIROL, V147, P2143, DOI 10.1007/s00705-002-0871-x; Madden L.V., 1983, P159; MADDEN LV, 1990, RES POPUL ECOL, V32, P47, DOI 10.1007/BF02512589; Madden LV, 2000, PHYTOPATHOLOGY, V90, P576, DOI 10.1094/PHYTO.2000.90.6.576; Magarey RD, 2007, PLANT DIS, V91, P336, DOI 10.1094/PDIS-91-4-0336; Maris PC, 2004, PHYTOPATHOLOGY, V94, P706, DOI 10.1094/PHYTO.2004.94.7.706; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Medina-Ortega KJ, 2009, ENVIRON ENTOMOL, V38, P836, DOI 10.1603/022.038.0337; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Moritz G, 2004, VIRUS RES, V100, P143, DOI 10.1016/j.virusres.2003.12.022; Morsello SC, 2010, ENTOMOL EXP APPL, V134, P260, DOI 10.1111/j.1570-7458.2009.00959.x; Morsello SC, 2009, ENTOMOL EXP APPL, V130, P138, DOI 10.1111/j.1570-7458.2008.00801.x; Nagata T, 1999, J GEN VIROL, V80, P507, DOI 10.1099/0022-1317-80-2-507; Nagata T., 2001, P51, DOI 10.1016/B978-012327681-0/50006-6; Nagata T, 2002, J GEN VIROL, V83, P663, DOI 10.1099/0022-1317-83-3-663; Naidu RA, 2008, PLANT PATHOL, V57, P190, DOI 10.1111/j.1365-3059.2007.01707.x; Ogada PA, 2013, J APPL ENTOMOL, V137, P488, DOI 10.1111/jen.12023; Ohnishi J, 2001, PHYTOPATHOLOGY, V91, P1149, DOI 10.1094/PHYTO.2001.91.12.1149; Olatinwo RO, 2008, PHYTOPATHOLOGY, V98, P1066, DOI 10.1094/PHYTO-98-10-1066; Rajabaskar D, 2014, VIRUS RES, V186, P32, DOI 10.1016/j.virusres.2013.11.005; Robb K., 1989, ANAL FRANKLINEILLA O, P135; Robb K.L., 1988, OHIO FLORISTS ASS B, V699, P2; Roosien BK, 2013, ENVIRON ENTOMOL, V42, P1299, DOI 10.1603/EN13062; SAKIMURA K, 1963, PHYTOPATHOLOGY, V53, P412; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Shalileh S, 2016, ENV ENTOMOL IN PRESS; SHERWOOD JL, 2000, ENCY PLANT PATHOLOGY, P1030; Shrestha A, 2012, ENTOMOL EXP APPL, V145, P260, DOI 10.1111/eea.12011; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; Stafford-Banks CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094447; Stumpf CF, 2007, ENTOMOL EXP APPL, V123, P139, DOI 10.1111/j.1570-7458.2007.00541.x; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Ullman D, 1997, THRIPS CROP PESTS; Ullman D, 1993, PHYTOPATHOLOGY; ULLMAN DE, 1995, NATO ADV SCI INST SE, V276, P135; ULLMAN DE, 1992, PHYTOPATHOLOGY, V82, P1333, DOI 10.1094/Phyto-82-1333; van de Wetering F, 1999, ENTOMOL EXP APPL, V93, P105, DOI 10.1046/j.1570-7458.1999.00567.x; vandeWetering F, 1996, PHYTOPATHOLOGY, V86, P900, DOI 10.1094/Phyto-86-900; Werner BJ, 2009, ENVIRON ENTOMOL, V38, P1429, DOI 10.1603/022.038.0511; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; WIJKAMP I, 1995, PHYTOPATHOLOGY, V85, P1069, DOI 10.1094/Phyto-85-1069; WIJKAMP I, 1993, PHYTOPATHOLOGY, V83, P986, DOI 10.1094/Phyto-83-986; WIJKAMP I, 1993, J GEN VIROL, V74, P341, DOI 10.1099/0022-1317-74-3-341; Wijkamp I, 1996, PROPAGATION TOMATO S, P285; YUDIN LS, 1990, PLANT DIS, V74, P211, DOI 10.1094/PD-74-0211; Zitter TA, VEGETABLE CROPS TOMA	64	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154533	10.1371/journal.pone.0154533	http://dx.doi.org/10.1371/journal.pone.0154533			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159134	Green Published, gold			2022-12-27	WOS:000376576700011
J	He, SZ; Tong, XL; Lu, KP; Lu, YR; Luo, JW; Yang, WH; Chen, M; Han, MJ; Hu, H; Lu, C; Dai, FY				He, Songzhen; Tong, Xiaoling; Lu, Kunpeng; Lu, Yaru; Luo, Jiangwen; Yang, Wenhao; Chen, Min; Han, Min-jin; Hu, Hai; Lu, Cheng; Dai, Fangyin			Comparative Analysis of Transcriptomes among Bombyx mori Strains and Sexes Reveals the Genes Regulating Melanic Morph and the Related Phenotypes	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; BLACK-AND-WHITE; MULTICOPPER OXIDASE; CUTICULAR PROTEIN; CUTICLE FORMATION; LIFE-SPAN; SILKWORM; DROSOPHILA; LACCASE-2; IDENTIFICATION	As a source of insect polymorphism, melanism plays an important role in ecological adaption and usually endows advantageous phenotypic-effects on insects. However, due to the mechanistic diversity, there are knowledge gaps in the molecular mechanisms underlying melanism and the related phenotypes. In silk moths, a recessive melanic mutant (sex-controlled melanism, sml) strain exhibits extended adult longevity. We took a transcriptome approach to perform a comparative analysis between this sml strain and a wild-type strain (Dazao). Our analysis resulted in the identification of 59 unique differentially expressed genes in the melanic mutant. Two key genes (laccase2 and yellow) involved in melanin formation were significantly up-regulated in melanic individuals. The laccase2 B-type isoform (BGIBMGA006746) was found to likely participate in the silkworm cuticular melanism process at late pupal stage. Moreover, we discovered 22 cuticular protein encoding genes with the possible function in melanin transport and/or maintenance. Based on our findings, we presume that the longer survival of the melanic sml male moths might be associated with the enhanced antioxidant defense systems and a reduction in the insulin/IGF-1 signaling pathway (IIS). These findings will facilitate the understanding of the molecular basis underlying melanism and the derived phenotypic-effects.	[He, Songzhen; Tong, Xiaoling; Lu, Kunpeng; Lu, Yaru; Luo, Jiangwen; Yang, Wenhao; Chen, Min; Han, Min-jin; Hu, Hai; Lu, Cheng; Dai, Fangyin] Southwest Univ, State Key Lab Silkworm Genome Biol, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing 400715, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China	Dai, FY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing 400715, Peoples R China.	fydai@swu.edu.cn	Yang, wenhao/GXG-5965-2022	Tong, Xiaoling/0000-0002-2649-899X; Han, Min-Jin/0000-0003-1784-8676	National Natural Science Foundation of China [31372379, 31472153]; Hi-Tech Research and Development 863 Program of China [2013AA102507]; Chongqing Youth Science and Technology Talent Training Project [cstc2014kjrc-qnrc80001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development 863 Program of China(National High Technology Research and Development Program of China); Chongqing Youth Science and Technology Talent Training Project	This work was funded by National Natural Science Foundation of China (No. 31372379, No. 31472153), Hi-Tech Research and Development 863 Program of China Grant (No. 2013AA102507), and Chongqing Youth Science and Technology Talent Training Project (cstc2014kjrc-qnrc80001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersen SO, 2011, INSECT BIOCHEM MOLEC, V41, P620, DOI 10.1016/j.ibmb.2011.03.015; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Asano T, 2014, INSECT BIOCHEM MOLEC, V55, P61, DOI 10.1016/j.ibmb.2014.10.004; Banno YF., 2005, GUIDE SILKWORM MUTAN; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BICKER G, 1989, NATURE, V337, P33, DOI 10.1038/337033a0; BRAKEFIELD PM, 1987, TRENDS ECOL EVOL, V2, P117, DOI 10.1016/0169-5347(87)90051-6; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Chen C, 2015, BIOGERONTOLOGY; Cornman RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-22; Dai F, 2013, SCI SERICULTURE, V39, P0442; Dai FY, 2010, J BIOL CHEM, V285, P19553, DOI 10.1074/jbc.M109.096743; Dai FY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10885; Dittmer NT, 2009, INSECT BIOCHEM MOLEC, V39, P596, DOI 10.1016/j.ibmb.2009.06.006; Fabrizio P, 2003, GENETICS, V163, P35; Fang SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1287-9; Fujii T, 2013, INSECT BIOCHEM MOLEC, V43, P594, DOI 10.1016/j.ibmb.2013.03.009; Futahashi R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-46; Futahashi R, 2011, INSECT BIOCHEM MOLEC, V41, P191, DOI 10.1016/j.ibmb.2010.12.003; Futahashi R, 2010, EVOL DEV, V12, P157, DOI 10.1111/j.1525-142X.2010.00401.x; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Gershenson S.M., 1994, Vestnik Zoologii, V6, P46; Gilbert L.E., 1988, Journal of Research on the Lepidoptera, V26, P141; Gorman MJ, 2008, INSECT BIOCHEM MOLEC, V38, P817, DOI 10.1016/j.ibmb.2008.07.001; Gorman MJ, 2012, INSECT BIOCHEM MOLEC, V42, P193, DOI 10.1016/j.ibmb.2011.11.010; HALL JC, 1990, ANNU REV GENET, V24, P659; He NJ, 2007, INSECT BIOCHEM MOLEC, V37, P135, DOI 10.1016/j.ibmb.2006.10.011; Hu YG, 2013, ARCH INSECT BIOCHEM, V83, P41, DOI 10.1002/arch.21096; Ito K., 2015, Heredity, V116, P52; Ito K, 2010, J BIOL CHEM, V285, P5624, DOI 10.1074/jbc.M109.035741; Janssen JM, 2001, EVOL DEV, V3, P415, DOI 10.1046/j.1525-142X.2001.01046.x; Kettlewell B, 1973, EVOLUTION MELANISM S; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KYRIACOU CP, 1978, ANIM BEHAV, V26, P1195, DOI 10.1016/0003-3472(78)90109-4; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Cheng, 2003, Scientia Agricultura Sinica, V36, P968; Majerus M, 1998, MELANISM EVOLUTION A; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Meng Y, 2009, J BIOL CHEM, V284, P11698, DOI 10.1074/jbc.M900485200; MITCHELL HK, 1971, J EXP ZOOL, V176, P429, DOI 10.1002/jez.1401760406; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; Ninomiya Y, 2006, J INSECT PHYSIOL, V52, P638, DOI 10.1016/j.jinsphys.2006.03.002; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Qiao L, 2014, GENETICS, V196, P1103, DOI 10.1534/genetics.113.158766; Qiao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042968; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Suzuki Y, 2002, INSECT BIOCHEM MOLEC, V32, P599, DOI 10.1016/S0965-1748(01)00136-9; Tang L, 2010, INSECT BIOCHEM MOLEC, V40, P228, DOI 10.1016/j.ibmb.2010.01.010; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; van't Hof AE, 2011, SCIENCE, V332, P958, DOI 10.1126/science.1203043; van't Hof AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010889; Verhoog MD, 1998, ANIM BEHAV, V56, P683, DOI 10.1006/anbe.1998.0801; Verhoog MD, 1996, PROCEEDINGS OF THE SECTION EXPERIMENTAL AND APPLIED ENTOMOLOGY OF THE NETHERLANDS ENTOMOLOGICAL SOCIETY (N.E.V.), VOL 7, 1996, P127; WALTER MF, 1991, DEV BIOL, V147, P32, DOI 10.1016/S0012-1606(05)80005-3; Wang XY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1200-y; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Wicker-Thomas C, 2008, J INSECT PHYSIOL, V54, P1423, DOI 10.1016/j.jinsphys.2008.08.005; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yatsu J, 2009, INSECT BIOCHEM MOLEC, V39, P254, DOI 10.1016/j.ibmb.2008.12.005; Young M, 2010, METHOD GENE ONTOLOGY	69	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155061	10.1371/journal.pone.0155061	http://dx.doi.org/10.1371/journal.pone.0155061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153103	Green Published, gold			2022-12-27	WOS:000375677000063
J	Vyth, R; Leval, A; Eriksson, B; Ericson, EL; Marions, L; Hergens, MP				Vyth, Rebecka; Leval, Amy; Eriksson, Bjorn; Ericson, Eva-Lena; Marions, Lena; Hergens, Maria-Pia			Gonorrhoea Diagnostic and Treatment Uncertainties: Risk Factors for Culture Negative Confirmation after Positive Nucleic Acid Amplification Tests	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; GONOCOCCAL-INFECTION; CHLAMYDIA	Gonorrhoea incidence has increased substantially in Stockholm during the past years. These increases have coincided with changes in testing practice from solely culture-based to nucleic acid amplification tests (NAAT). Gonorrhoea NAAT is integrated with Chlamydia trachomatis testing and due to opportunistic screening for chlamydia, testing prevalence for gonorrhoea has increased substantially in the Stockholm population. The aim of this study was to examine epidemiological risk-factors for discordant case which are NAAT positive but culture negative. These discordant cases are especially problematic as they give rise to diagnostic and treatment uncertainties with risk for subsequent sequelae. All gonorrhoea cases from Stockholm county during 2011-2012 with at least one positive N. gonorrhoea NAAT test and follow-up cultures were included (N = 874). Data were analysed using multi-variate and stratified logistic regression models. Results showed that women were 4-times more likely (OR 4.9; 95% CI 2.4-6.7) than men to have discordant cultures. Individuals tested for gonorrhoea without symptoms were 2.3 times more likely (95% CI 1.5-3.5) than those with symptoms to be discordant. NAAT method and having one week or more between NAAT and culture testing were also indicative of an increased likelihood for discordance. Using NAAT should be based on proper clinical or epidemiological indications and, when positive, followed-up with a culture-based test within one week if possible. Routine gonorrhoea testing is not recommended in low prevalence populations.	[Vyth, Rebecka; Leval, Amy; Eriksson, Bjorn; Hergens, Maria-Pia] Dept Communicable Dis Control & Prevent, Stockholm, Stockholm Count, Sweden; [Leval, Amy; Eriksson, Bjorn; Hergens, Maria-Pia] Karolinska Inst, Infect Dis Unit, Dept Med, Stockholm, Sweden; [Ericson, Eva-Lena] Karolinska Univ Hosp, Div Clin Microbiol, Stockholm, Sweden; [Marions, Lena] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Vyth, R (corresponding author), Dept Communicable Dis Control & Prevent, Stockholm, Stockholm Count, Sweden.	rebecka.vyth@sll.se		Marions, Lena/0000-0002-5930-4485				Andric B, 2013, SOUTH MED J, V106, P321, DOI 10.1097/SMJ.0b013e318291b3c2; [Anonymous], 2008, 200813011 NAT BOARD; [Anonymous], 2012, 2012511 NAT BOARD HL; [Anonymous], 2010, GON INF MED DOCT; Benzaken AS, 2006, SEX TRANSM INFECT, V82, pV26, DOI 10.1136/sti.2006.022566; de Coul ELMO, 2014, INT J STD AIDS, V25, P40, DOI 10.1177/0956462413491736; Fowler T, 2013, INT J STD AIDS, V24, P185, DOI 10.1177/0956462412472443; Hook EW FN, 2013, CHOOSING TESTS SEXUA; Ison C, 2006, SEX TRANSM INFECT, V82, P515, DOI 10.1136/sti.2006.022731; Ison CA, 2013, SEX TRANSM INFECT, V89, P197, DOI 10.1136/sextrans-2012-050829; Killick V, 2012, Int J STD AIDS, V23, pe1, DOI 10.1258/ijsa.2009.009527; Low N, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001598; Moncada J, 2008, J CLIN MICROBIOL, V46, P1614, DOI 10.1128/JCM.02301-07; Rao GG, 2009, SEX TRANSM INFECT, V85, P531, DOI 10.1136/sti.2009.036525; Sherrard J, 1996, GENITOURIN MED, V72, P422; Stockholm S, 2013, ANN REPORT; Su WH, 2011, J CHIN MED ASSOC, V74, P430, DOI 10.1016/j.jcma.2011.08.012; Tabrizi SN, 2011, J CLIN MICROBIOL, V49, P3610, DOI 10.1128/JCM.01217-11; Unemo M, 2012, EURO SURVEILL, V17; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/FMB.12.117, 10.2217/fmb.12.117]; Velicko I, 2012, EURO SURVEILL, V17; Zenilman JM, 2013, SEXUALLY TRANSMITTED DISEASES: VACCINES, PREVENTION, AND CONTROL, 2ND EDITION, P411, DOI 10.1016/B978-0-12-391059-2.00016-4	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155017	10.1371/journal.pone.0155017	http://dx.doi.org/10.1371/journal.pone.0155017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152704	Green Submitted, gold, Green Published			2022-12-27	WOS:000375677000060
J	Morin, TJ; Shropshire, T; Liu, X; Briggs, K; Huynh, C; Tabard-Cossa, V; Wang, HY; Dunbar, WB				Morin, Trevor J.; Shropshire, Tyler; Liu, Xu; Briggs, Kyle; Huynh, Cindy; Tabard-Cossa, Vincent; Wang, Hongyun; Dunbar, William B.			Nanopore-Based Target Sequence Detection	PLOS ONE			English	Article							SOLID-STATE NANOPORES; NUCLEIC-ACID ANALYSIS; DOUBLE-STRANDED DNA; DUPLEX DNA; BIS-PNA; DISEASE; TRANSLOCATION; SENSORS; SINGLE; QUANTIFICATION	The promise of portable diagnostic devices relies on three basic requirements: comparable sensitivity to established platforms, inexpensive manufacturing and cost of operations, and the ability to survive rugged field conditions. Solid state nanopores can meet all these requirements, but to achieve high manufacturing yields at low costs, assays must be tolerant to fabrication imperfections and to nanopore enlargement during operation. This paper presents a model for molecular engineering techniques that meets these goals with the aim of detecting target sequences within DNA. In contrast to methods that require precise geometries, we demonstrate detection using a range of pore geometries. As a result, our assay model tolerates any pore-forming method and in- situ pore enlargement. Using peptide nucleic acid (PNA) probes modified for conjugation with synthetic bulk-adding molecules, pores ranging 15-50 nm in diameter are shown to detect individual PNA-bound DNA. Detection of the CFTR Delta F508 gene mutation, a codon deletion responsible for similar to 66% of all cystic fibrosis chromosomes, is demonstrated with a 26-36 nm pore size range by using a size-enhanced PNA probe. A mathematical framework for assessing the statistical significance of detection is also presented.	[Morin, Trevor J.; Shropshire, Tyler; Liu, Xu; Huynh, Cindy; Wang, Hongyun; Dunbar, William B.] Two Pore Guys Inc, Santa Cruz, CA USA; [Briggs, Kyle; Tabard-Cossa, Vincent] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Wang, Hongyun; Dunbar, William B.] Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA	University of Ottawa; University of California System; University of California Santa Cruz	Dunbar, WB (corresponding author), Two Pore Guys Inc, Santa Cruz, CA USA.; Dunbar, WB (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA.	dunbar@soe.ucsc.edu	Tabard-Cossa, Vincent/M-5202-2013; Liu, Xu/L-7856-2019; Briggs, Kyle/AAE-8202-2020	Tabard-Cossa, Vincent/0000-0003-4375-717X; Liu, Xu/0000-0003-3248-0929; Briggs, Kyle/0000-0002-0183-6585	Two Pore Guys, Inc (TPG); Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation	Two Pore Guys, Inc (TPG); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work done in Santa Cruz was performed and financially supported by Two Pore Guys, Inc (TPG). The work done at the University of Ottawa was financially supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Canada Foundation for Innovation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Beamish E, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/40/405301; Bentin T, 2003, BIOCHEMISTRY-US, V42, P13987, DOI 10.1021/bi0351918; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bonora GM, 2007, NUCLEOS NUCLEOT NUCL, V26, P661, DOI 10.1080/15257770701490548; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Briggs K, 2014, SMALL, V10, P2077, DOI 10.1002/smll.201303602; Carlsen AT, 2014, NANO LETT, V14, P5488, DOI 10.1021/nl501340d; Carlsen AT, 2014, ACS NANO, V8, P4754, DOI 10.1021/nn501694n; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Drmanac S, 1998, NAT BIOTECHNOL, V16, P54, DOI 10.1038/nbt0198-54; Duffy MJ, 2013, CLIN CHEM, V59, P1447, DOI 10.1373/clinchem.2012.200477; EGHOLM M, 1995, NUCLEIC ACIDS RES, V23, P217, DOI 10.1093/nar/23.2.217; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; GRIFFITH MC, 1995, J AM CHEM SOC, V117, P831, DOI 10.1021/ja00107a033; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hansen GI, 2001, J MOL BIOL, V307, P67, DOI 10.1006/jmbi.2000.4487; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Jagerszki G, 2007, NANO LETT, V7, P1609, DOI [10.1021/nl0705438, 10.1021/nI0705438]; Kowalczyk SW, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/31/315101; Kowalczyk SW, 2012, P INT C NAN BIOAN AP, P24; Kwok H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092880; Leishman Shaneen J, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5781; Liu X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7222; Lu B, 2011, BIOPHYS J, V101, P70, DOI 10.1016/j.bpj.2011.05.034; Maitra RD, 2012, ELECTROPHORESIS, V33, P3418, DOI 10.1002/elps.201200272; Malouli Daniel, 2014, Virol Rep, V3-4, P18; Marshall MM, 2012, SCANNING, V34, P101, DOI 10.1002/sca.21003; Marx V, 2015, NAT METHODS, V12, P1015, DOI 10.1038/nmeth.3625; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moreau-Marquis S, 2013, FASEB J; Morin TJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002895; Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006; Nielsen P E, 1999, Curr Issues Mol Biol, V1, P89; Peng XL, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.06.005; Plesa C, 2015, NANO LETT, V15, P3153, DOI 10.1021/acs.nanolett.5b00249; Plesa C, 2015, NANO LETT, V15, P732, DOI 10.1021/nl504375c; Raillon C, 2012, NANOSCALE, V4, P4916, DOI 10.1039/c2nr30951c; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Rosenstein JK, 2012, NAT METHODS, V9, P487, DOI [10.1038/NMETH.1932, 10.1038/nmeth.1932]; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Shim J, 2015, ACS NANO, V9, P290, DOI 10.1021/nn5045596; Shim J, 2013, SCI REP-UK, V3, DOI [10.1038/srep01389, 10.1038/srep02325]; Singer A, 2012, NANO LETT, V12, P1722, DOI 10.1021/nl300372a; Singer A, 2010, NANO LETT, V10, P738, DOI 10.1021/nl100058y; Smeets RMM, 2008, P NATL ACAD SCI USA, V105, P417, DOI 10.1073/pnas.0705349105; Storm AJ, 2005, NANO LETT, V5, P1193, DOI 10.1021/nl048030d; Syvanen AC, 1999, HUM MUTAT, V13, P1; Tahvildari R, 2015, LAB CHIP, V15, P1407, DOI 10.1039/c4lc01366b; Tian K, 2013, ACS NANO, V7, P3962, DOI 10.1021/nn305789z; Tillmar AO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083761; Uddin A, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/15/155501; Vayssier-Taussat M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081439; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; Wang HY, 2013, ACS NANO, V7, P3876, DOI 10.1021/nn401180j; Wanunu M, 2008, BIOPHYS J, V95, P4716, DOI 10.1529/biophysj.108.140475; Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/nnano.2010.202, 10.1038/NNANO.2010.202]; Wanunu M, 2009, NANO LETT, V9, P3498, DOI 10.1021/nl901691v; Wright S. J., 1999, NUMERICAL OPTIMIZATI; Yang JJ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285310; Yu JS, 2015, ACS NANO, V9, P5289, DOI 10.1021/acsnano.5b00784	64	39	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154426	10.1371/journal.pone.0154426	http://dx.doi.org/10.1371/journal.pone.0154426			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149679	Green Submitted, gold, Green Published			2022-12-27	WOS:000375676800031
J	Parrilla, M; Leon-Lobera, F; Lillo, C; Arevalo, R; Aijon, J; Lara, JM; Velasco, A				Parrilla, Marta; Leon-Lobera, Fernando; Lillo, Concepcion; Arevalo, Rosario; Aijon, Jose; Manuel Lara, Juan; Velasco, Almudena			Sox10 Expression in Goldfish Retina and Optic Nerve Head in Controls and after the Application of Two Different Lesion Paradigms	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; GANGLION-CELL AXONS; OLIGODENDROCYTE PRECURSORS; VISUAL PATHWAY; FIBER LAYER; LAMINA-CRIBROSA; ADULT ZEBRAFISH; SCHWANN-CELLS; GLIAL-CELLS; REGENERATION	The mammalian central nervous system (CNS) is unable to regenerate. In contrast, the CNS of fish, including the visual system, is able to regenerate after damage. Moreover, the fish visual system grows continuously throughout the life of the animal, and it is therefore an excellent model to analyze processes of myelination and re-myelination after an injury. Here we analyze Sox10(+) oligodendrocytes in the goldfish retina and optic nerve in controls and after two kinds of injuries: cryolesion of the peripheral growing zone and crushing of the optic nerve. We also analyze changes in a major component of myelin, myelin basic protein (MBP), as a marker for myelinated axons. Our results show that Sox10(+) oligodendrocytes are located in the retinal nerve fiber layer and along the whole length of the optic nerve. MBP was found to occupy a similar location, although its loose appearance in the retina differed from the highly organized MBP+ axon bundles in the optic nerve. After optic nerve crushing, the number of Sox10(+) cells decreased in the crushed area and in the optic nerve head. Consistent with this, myelination was highly reduced in both areas. In contrast, after cryolesion we did not find changes in the Sox10(+) population, although we did detect some MBP- degenerating areas. We show that these modifications in Sox10(+) oligodendrocytes are consistent with their role in oligodendrocyte identity, maintenance and survival, and we propose the optic nerve head as an excellent area for research aimed at better understanding of de-and remyelination processes.	[Parrilla, Marta; Leon-Lobera, Fernando; Lillo, Concepcion; Arevalo, Rosario; Aijon, Jose; Manuel Lara, Juan; Velasco, Almudena] Univ Salamanca, Inst Neurociencias Castilla & Leon, E-37008 Salamanca, Spain; [Leon-Lobera, Fernando; Lillo, Concepcion; Arevalo, Rosario; Aijon, Jose; Manuel Lara, Juan; Velasco, Almudena] IBSAL, Salamanca, Spain; [Parrilla, Marta] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60054 Frankfurt, Germany	University of Salamanca; Goethe University Frankfurt	Velasco, A (corresponding author), Univ Salamanca, Inst Neurociencias Castilla & Leon, E-37008 Salamanca, Spain.; Velasco, A (corresponding author), IBSAL, Salamanca, Spain.	malmu@usal.es	Lillo, Concepcion/A-6321-2009; Arévalo, Rosario/L-5649-2014	Lillo, Concepcion/0000-0001-5814-9826; Arévalo, Rosario/0000-0001-5849-1736	MICINN (The Ministry of Science and Innovation, Spain) [BFU-2009-11179]; Spanish Ministerio de Educacion (FPU program)	MICINN (The Ministry of Science and Innovation, Spain); Spanish Ministerio de Educacion (FPU program)(German Research Foundation (DFG))	This work was supported by MICINN (The Ministry of Science and Innovation, Spain) (BFU-2009-11179). Junta de Castilla y Leon (Red de Terapia Celular y Grupo de Excelencia). F. Leon-Lobera was funded by the Spanish Ministerio de Educacion (FPU program).	Ankerhold R, 1999, J NEUROBIOL, V41, P572, DOI 10.1002/(SICI)1097-4695(199912)41:4<572::AID-NEU12>3.3.CO;2-#; Arata N, 2003, BRAIN RES, V961, P179, DOI 10.1016/S0006-8993(02)03888-X; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BASTMEYER M, 1993, GLIA, V8, P1, DOI 10.1002/glia.440080102; BASTMEYER M, 1991, J NEUROSCI, V11, P626; BENOWITZ LI, 1983, J NEUROSCI, V3, P2153; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; BUNT SM, 1982, J COMP NEUROL, V206, P209, DOI 10.1002/cne.902060302; Carre JL, 2002, NEUROSCI LETT, V330, P17, DOI 10.1016/S0304-3940(02)00709-7; Chierzi S, 2001, RESTOR NEUROL NEUROS, V19, P109; Cho SS, 1999, BRAIN RES, V816, P229, DOI 10.1016/S0006-8993(98)01117-2; DAVILA JC, 1987, J ANAT, V151, P189; Dunlop SA, 2002, J COMP NEUROL, V446, P276, DOI 10.1002/cne.10213; EASTER SS, 1984, J NEUROSCI, V4, P2173; FFRENCHCONSTANT C, 1988, J NEUROCYTOL, V17, P13, DOI 10.1007/BF01735374; Fujita Y, 2000, TISSUE CELL, V32, P293, DOI 10.1054/tice.2000.0115; Fujita Y, 2001, TISSUE CELL, V33, P129, DOI 10.1054/tice.2000.0152; Gao LM, 2006, J NEUROSCI, V26, P7619, DOI 10.1523/JNEUROSCI.0855-06.2006; GRAFSTEIN B, 1969, EXP NEUROL, V25, P494, DOI 10.1016/0014-4886(69)90093-4; Grafstein B, 1986, RETINA MODEL CELL 2; Hitchcock PF, 2004, ZEBRAFISH, V1, P257, DOI 10.1089/zeb.2004.1.257; Jimeno D, 2003, EXP NEUROL, V179, P210, DOI 10.1016/S0014-4886(02)00020-1; JOHNS PR, 1977, J COMP NEUROL, V176, P331, DOI 10.1002/cne.901760303; Lillo C, 1998, J NEUROCYTOL, V27, P593, DOI 10.1023/A:1006974311861; Lillo C, 2002, J HISTOCHEM CYTOCHEM, V50, P1289, DOI 10.1177/002215540205001002; Lillo C, 2001, J NEUROCYTOL, V30, P475, DOI 10.1023/A:1015684932550; Matsukawa T, 2004, BIOL PHARM BULL, V27, P445, DOI 10.1248/bpb.27.445; Morcos Y, 1997, GLIA, V21, P163, DOI 10.1002/(SICI)1098-1136(199710)21:2<163::AID-GLIA1>3.3.CO;2-N; Munzel EJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0077-y; Munzel EJ, 2012, GLIA, V60, P253, DOI 10.1002/glia.21260; MURRAY M, 1982, J COMP NEUROL, V209, P352, DOI 10.1002/cne.902090405; NAKAZAWA T, 1993, GLIA, V8, P114, DOI 10.1002/glia.440080207; Nona SN, 1998, RESTOR NEUROL NEUROS, V12, P1; Nona SN, 2000, J NEUROCYTOL, V29, P285, DOI 10.1023/A:1026575805331; NONA SN, 1992, J NEUROCYTOL, V21, P391, DOI 10.1007/BF01191504; Ono K, 1997, NEURON, V19, P283, DOI 10.1016/S0896-6273(00)80939-3; Park HC, 2005, J NEUROSCI, V25, P6836, DOI 10.1523/JNEUROSCI.0981-05.2005; Parrilla M, 2013, BRAIN RES, V1492, P18, DOI 10.1016/j.brainres.2012.11.014; Parrilla M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032348; Parrilla M, 2009, BRAIN RES, V1255, P75, DOI 10.1016/j.brainres.2008.12.010; PERRONEBIZZOZERO NI, 1987, J NEUROCHEM, V48, P644, DOI 10.1111/j.1471-4159.1987.tb04141.x; PERRY VH, 1990, J NEUROCYTOL, V19, P265, DOI 10.1007/BF01217304; Pol SU, 2013, EXP NEUROL; QUITSCHKE W, 1983, J NEUROCHEM, V41, P1137, DOI 10.1111/j.1471-4159.1983.tb09063.x; READHEAD C, 1990, ANN NY ACAD SCI, V605, P280; REICHENBACH A, 1988, J HIRNFORSCH, V29, P481; Santos E, 2006, J NEUROBIOL, V66, P1115, DOI 10.1002/neu.20256; SCHNITZER J, 1985, J COMP NEUROL, V240, P128, DOI 10.1002/cne.902400203; Schweitzer J, 2003, GLIA, V41, P301, DOI 10.1002/glia.10192; Schweitzer J, 2007, MOL CELL NEUROSCI, V35, P194, DOI 10.1016/j.mcn.2007.02.018; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Takada N, 2010, GLIA, V58, P996, DOI 10.1002/glia.20981; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Tsai HH, 2002, TRENDS NEUROSCI, V25, P173, DOI 10.1016/S0166-2236(00)02096-8; Velasco A, 1997, BRAIN RES BULL, V43, P327, DOI 10.1016/S0361-9230(97)00014-2; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; WOLBURG H, 1981, EXP BRAIN RES, V43, P199; Won MH, 2000, MICROSC RES TECHNIQ, V50, P151, DOI 10.1002/1097-0029(20000715)50:2<151::AID-JEMT7>3.0.CO;2-5	59	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154703	10.1371/journal.pone.0154703	http://dx.doi.org/10.1371/journal.pone.0154703			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149509	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800049
J	Rong, PY; Yunusova, Y; Wang, J; Zinman, L; Pattee, GL; Berry, JD; Perry, B; Green, JR				Rong, Panying; Yunusova, Yana; Wang, Jun; Zinman, Lorne; Pattee, Gary L.; Berry, James D.; Perry, Bridget; Green, Jordan R.			Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech Subsystems	PLOS ONE			English	Article							BULBAR; TONGUE; SYSTEM	Purpose To determine the mechanisms of speech intelligibility impairment due to neurologic impairments, intelligibility decline was modeled as a function of co-occurring changes in the articulatory, resonatory, phonatory, and respiratory subsystems. Method Sixty-six individuals diagnosed with amyotrophic lateral sclerosis (ALS) were studied longitudinally. The disease-related changes in articulatory, resonatory, phonatory, and respiratory subsystems were quantified using multiple instrumental measures, which were subjected to a principal component analysis and mixed effects models to derive a set of speech subsystem predictors. A stepwise approach was used to select the best set of subsystem predictors to model the overall decline in intelligibility. Results Intelligibility was modeled as a function of five predictors that corresponded to velocities of lip and jaw movements (articulatory), number of syllable repetitions in the alternating motion rate task (articulatory), nasal airflow (resonatory), maximum fundamental frequency (phonatory), and speech pauses (respiratory). The model accounted for 95.6% of the variance in intelligibility, among which the articulatory predictors showed the most substantial independent contribution (57.7%). Conclusion Articulatory impairments characterized by reduced velocities of lip and jaw movements and resonatory impairments characterized by increased nasal airflow served as the subsystem predictors of the longitudinal decline of speech intelligibility in ALS. Declines in maximum performance tasks such as the alternating motion rate preceded declines in intelligibility, thus serving as early predictors of bulbar dysfunction. Following the rapid decline in speech intelligibility, a precipitous decline in maximum performance tasks subsequently occurred.	[Rong, Panying; Perry, Bridget; Green, Jordan R.] MGH Inst Hlth Profess, Dept Commun Sci & Disorders, Boston, MA USA; [Yunusova, Yana] Univ Toronto, Dept Speech Language Pathol, Toronto, ON, Canada; [Wang, Jun] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA; [Wang, Jun] Univ Texas Dallas, Callier Ctr Commun Disorders, Richardson, TX 75083 USA; [Zinman, Lorne] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Pattee, Gary L.] Neurol Associates PC, Lincoln, NE USA; [Berry, James D.] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Toronto; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Massachusetts General Hospital	Green, JR (corresponding author), MGH Inst Hlth Profess, Dept Commun Sci & Disorders, Boston, MA USA.	jgreen2@mghihp.edu	Yunusova, Yana/E-3428-2010; Green, Jordan/N-3585-2019	Yunusova, Yana/0000-0002-2353-2275; Green, Jordan/0000-0002-1464-1373; Rong, Panying/0000-0001-7067-0083; Perry, Bridget J./0000-0002-4219-2552	National Institute of Health-National Institute of Deafness and Other Communication Disorders [R01 DC009890, R01 DC0135470]; ALS Society of Canada; Canadian Institute of Health Research CIHR Planning Grant [FRN126682]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009890, R01DC013547] Funding Source: NIH RePORTER	National Institute of Health-National Institute of Deafness and Other Communication Disorders; ALS Society of Canada; Canadian Institute of Health Research CIHR Planning Grant(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by the following grants: National Institute of Health-National Institute of Deafness and Other Communication Disorders (http://www.nidcd.nih.gov/Pages/default.aspx) Grants R01 DC009890 & R01 DC0135470 (PI: JG); ALS Society of Canada (https://www.als.ca/en) Denise Ramsay Discovery Grant (PI: YY); Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/47631.html) CIHR Planning Grant FRN126682 (PI: YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Aggarwal S, 2008, NEUROTHERAPEUTICS, V5, P516, DOI 10.1016/j.nurt.2008.08.002; Ball LJ, 2001, J NEUROL SCI, V191, P43, DOI 10.1016/S0022-510X(01)00623-2; Bhatt JM, 2007, EXPERT OPIN INV DRUG, V16, P1197, DOI 10.1517/13543784.16.8.1197; Blain CRV, 2007, AMYOTROPH LATERAL SC, V8, P348, DOI 10.1080/17482960701548139; Bunton K, 2001, CLIN LINGUIST PHONET, V15, P181; CARPENTER RJ, 1978, OTOLARYNG HEAD NECK, V86, P479, DOI 10.1177/019459987808600319; Clark HM, 2003, AM J SPEECH-LANG PAT, V12, P400, DOI 10.1044/1058-0360(2003/086); CULLINAN WL, 1971, PERCEPT MOTOR SKILL, V32, P395, DOI 10.2466/pms.1971.32.2.395; De Bodt MS, 2002, J COMMUN DISORD, V35, P283, DOI 10.1016/S0021-9924(02)00065-5; Delorey R, 1999, J MED SPEECH-LANG PA, V7, P19; DEPAUL R, 1993, J SPEECH HEAR RES, V36, P1158, DOI 10.1044/jshr.3606.1158; DEPAUL R, 1988, NEUROLOGY, V38, P281, DOI 10.1212/WNL.38.2.281; GAWEL MJ, 1981, BRIT J DISORD COMMUN, V16, P51; Ghosh Jayanta K., 2006, INTRO BAYESIAN ANAL; Gordon Paul H, 2005, Curr Neurol Neurosci Rep, V5, P48, DOI 10.1007/s11910-005-0023-2; Green JR, 2013, AMYOTROPH LAT SCL FR, V14, P494, DOI 10.3109/21678421.2013.817585; HIROSE H, 1982, FOLIA PHONIATR, V34, P106, DOI 10.1159/000265636; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd, P28; Kataoka R, 2001, J ACOUST SOC AM, V109, P2181, DOI 10.1121/1.1360717; Kelhetter KM, 2013, THESIS U ARIZONA; Kent R. D., 1996, AM J SPEECH-LANG PAT, V5, P7, DOI [DOI 10.1044/1058-0360.0503.07, 10.1044/1058-0360.0503.0, DOI 10.1044/1058-0360.0503.0]; KENT RD, 1987, J SPEECH HEAR DISORD, V52, P367, DOI 10.1044/jshd.5204.367; KENT RD, 1991, J SPEECH HEAR RES, V34, P1269, DOI 10.1044/jshr.3406.1269; KENT RD, 1990, J SPEECH HEAR DISORD, V55, P721, DOI 10.1044/jshd.5504.721; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; Kim H, 2011, FOLIA PHONIATR LOGO, V63, P187, DOI 10.1159/000318881; LANGMORE SE, 1994, J SPEECH HEAR RES, V37, P28, DOI 10.1044/jshr.3701.28; Lee JM, 2014, J SPEECH LANG HEAR R, V57, P1666, DOI 10.1044/2014_JSLHR-S-13-0292; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Liss JM, 2002, J ACOUST SOC AM, V112, P3022, DOI 10.1121/1.1515793; Mefferd AS, 2012, J COMMUN DISORD, V45, P35, DOI 10.1016/j.jcomdis.2011.09.002; MULLIGAN M, 1994, J SPEECH HEAR RES, V37, P496, DOI 10.1044/jshr.3703.496; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; RAMIG LO, 1990, J SPEECH HEAR DISORD, V55, P2, DOI 10.1044/jshd.5501.02; Rong P, INTERSPEECH 2015, P2967; Rong PY, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/183027; Rong PY, 2012, J SPEECH LANG HEAR R, V55, P1438, DOI 10.1044/1092-4388(2012/11-0142); ROSENFIELD DB, 1991, J VOICE, V5, P224, DOI 10.1016/S0892-1997(05)80190-0; Singh D, 2011, J NEUROL SCI, V306, P76, DOI 10.1016/j.jns.2011.03.039; Solomon NP, 2000, J SPEECH LANG HEAR R, V43, P256, DOI 10.1044/jslhr.4301.256; Tjaden K., 1995, AM J SPEECH-LANG PAT, V4, P39, DOI [10.1044/1058-0360.0401.39, DOI 10.1044/1058-0360.0401.39]; TURNER GS, 1995, J SPEECH HEAR RES, V38, P1001, DOI 10.1044/jshr.3805.1001; Weismer G, 2001, FOLIA PHONIATR LOGO, V53, P1, DOI 10.1159/000052649; Yorkston K., 2007, SENTENCE INTELLIGIBI; Yorkston KM., 1993, J MED SPEECH-LANG PA, V1, P35, DOI DOI 10.1044/1058-0360.0404.139; Yunusova Y, 2011, JOVE-J VIS EXP, DOI 10.3791/2422; Yunusova Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147573; Yunusova Y, 2012, FOLIA PHONIATR LOGO, V64, P94, DOI 10.1159/000336890; Yunusova Y, 2010, J COMMUN DISORD, V43, P6, DOI 10.1016/j.jcomdis.2009.07.003	51	57	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154971	10.1371/journal.pone.0154971	http://dx.doi.org/10.1371/journal.pone.0154971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27148967	Green Published, gold			2022-12-27	WOS:000375676800104
J	Aprelikova, O; Tomlinson, CC; Hoenerhoff, M; Hixon, JA; Durum, SK; Qiu, TH; He, SP; Burkett, S; Liu, ZY; Swanson, SM; Green, JE				Aprelikova, Olga; Tomlinson, Christine C.; Hoenerhoff, Mark; Hixon, Julie A.; Durum, Scott K.; Qiu, Ting-hu; He, Siping; Burkett, Sandra; Liu, Zi-Yao; Swanson, Steven M.; Green, Jeffrey E.			Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases	PLOS ONE			English	Article							MAMMARY-TUMOR PROGRESSION; TRANSGENIC MICE; C-MYC; PROSTATE; CARCINOMA; ADENOCARCINOMA; IDENTIFICATION; IMMUNOTHERAPY; TUMORIGENESIS; FEATURES	Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is associated with a poor prognosis and for which no targeted therapies currently exist. In order to improve preclinical testing for TNBC that relies primarily on using human xenografts in immunodeficient mice, we have developed a novel immunocompetent syngeneic murine tumor transplant model for basal-like triple-negative breast cancer. The C3(1)/SV40-T/t-antigen (C3(1)/Tag) mouse mammary tumor model in the FVB/N background shares important similarities with human basal-like TNBC. However, these tumors or derived cell lines are rejected when transplanted into wt FVB/N mice, likely due to the expression of SV40 T-antigen. We have developed a sub-line of mice (designated REAR mice) that carry only one copy of the C3(1)/Tag-antigen transgene resulting from a spontaneous transgene rearrangement in the original founder line. Unlike the original C3(1)/Tag mice, REAR mice do not develop mammary tumors or other phenotypes observed in the original C3(1)/Tag transgenic mice. REAR mice are more immunologically tolerant to SV40 T-antigen driven tumors and cell lines in an FVB/N background (including prostate tumors from TRAMP mice), but are otherwise immunologically intact. This transplant model system offers the ability to synchronously implant the C3(1)/Tag tumor-derived M6 cell line or individual C3(1)/Tag tumors from various stages of tumor development into the mammary fat pads or tail veins of REAR mice. C3(1)/Tag tumors or M6 cells implanted into the mammary fat pads spontaneously metastasize at a high frequency to the lung and liver. M6 cells injected by tail vein can form brain metastases. We demonstrate that irradiated M6 tumor cells or the same cells expressing GM-CSF can act as a vaccine to retard tumor growth of implanted tumor cells in the REAR model. Preclinical studies performed in animals with an intact immune system should more authentically replicate treatment responses in human patients.	[Aprelikova, Olga; Tomlinson, Christine C.; Hoenerhoff, Mark; Qiu, Ting-hu; He, Siping; Liu, Zi-Yao; Green, Jeffrey E.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Hixon, Julie A.; Durum, Scott K.] NCI, Mol Immunoregulat Lab, NIH, Frederick, MD 21701 USA; [Burkett, Sandra] NCI, Comparat Mol Cytogenet Core, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Swanson, Steven M.] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA; [Hoenerhoff, Mark] Univ Michigan, Sch Med, Unit Lab Anim Med, In Vivo Anim Core, Ann Arbor, MI USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Green, JE (corresponding author), NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.	jegreen@nih.gov		Burkett, Sandra/0000-0002-5476-4028; durum, scott/0000-0003-1307-9582	Intramural Research Program of the NIH; NCI; CCR; NATIONAL CANCER INSTITUTE [ZIABC009287, ZIABC011150] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the NIH, CCR, and NCI.	Amundadottir LT, 1996, ONCOGENE, V13, P757; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Calvo A, 2002, INT J CANCER, V101, P224, DOI 10.1002/ijc.10589; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Fueyo J, 1998, NAT MED, V4, P685, DOI 10.1038/nm0698-685; Gandellini P, 2015, SEMIN CANCER BIOL, V35, P96, DOI 10.1016/j.semcancer.2015.08.008; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Green JE, 2001, CANCER RES, V61, P7449; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Holzer RG, 2003, BREAST CANCER RES TR, V77, P65, DOI 10.1023/A:1021175931177; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lin NU, 2008, CANCER-AM CANCER SOC, V113, P2638, DOI 10.1002/cncr.23930; Liu ML, 1998, ONCOGENE, V17, P2403, DOI 10.1038/sj.onc.1202456; Lohr F, 2000, MOL THER, V2, P195, DOI 10.1006/mthe.2000.0114; Mahler JF, 1996, TOXICOL PATHOL, V24, P710, DOI 10.1177/019262339602400606; Malumbres M, 1997, BIOTECHNIQUES, V22, P1114, DOI 10.2144/97226st03; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; Palmieri Diane, 2006, Breast Dis, V26, P139; Palmieri D, 2009, CLIN CANCER RES, V15, P6148, DOI 10.1158/1078-0432.CCR-09-1039; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Pulaski BA, 2000, CANCER RES, V60, P2710; Savas P, 2016, NAT REV CLIN ONCOL, V13, P228, DOI 10.1038/nrclinonc.2015.215; Shafer-Weaver Kimberly, 2003, J Transl Med, V1, P14, DOI 10.1186/1479-5876-1-14; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Shibata MA, 1996, CANCER RES, V56, P4894; Shultz Leonard D, 2014, Cold Spring Harb Protoc, V2014, P694, DOI 10.1101/pdb.top073585; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Wakefield LM, 2003, COMPARATIVE MED, V53, P424; Whittle JR, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0523-1; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zhou B, 2014, J CLIN INVEST, V124, P553, DOI 10.1172/JCI69804	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155262	10.1371/journal.pone.0155262	http://dx.doi.org/10.1371/journal.pone.0155262			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171183	Green Submitted, Green Published, gold			2022-12-27	WOS:000376588600037
J	Kristian, SA; Ota, T; Bubeck, SS; Cho, R; Groff, BC; Kubota, T; Destito, G; Laudenslager, J; Koriazova, L; Tahara, T; Kanda, Y				Kristian, Sascha A.; Ota, Takayuki; Bubeck, Sarah S.; Cho, Rebecca; Groff, Brian C.; Kubota, Tsuguo; Destito, Giuseppe; Laudenslager, John; Koriazova, Lilia; Tahara, Tomoyuki; Kanda, Yutaka			Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae	PLOS ONE			English	Article							PROLINE-RICH REGION; HETEROLOGOUS PSPA; IMMUNIZATION; INFECTIONS; ADULTS; ASSAY; MICE; PHAGOCYTOSIS; PREVENTION; DEPOSITION	A proof-of-concept study evaluating the potential of Streptococcus pneumoniae Pneumococcal Surface Protein A (PspA) as a passive immunization target was conducted. We describe the generation and isolation of several broadly reactive mouse anti-PspA monoclonal antibodies (mAbs). MAb 140H1 displayed (i) 98% strain coverage, (ii) activity in complement deposition and opsonophagocytic killing (OPK) assays, which are thought to predict the in vivo efficacy of anti-pneumococcal mAbs, (iii) efficacy in mouse sepsis models both alone and in combination with standard-of-care antibiotics, and (iv) therapeutic activity in a mouse pneumonia model. Moreover, we demonstrate that antibody engineering can significantly enhance anti-PspA mAb effector function. We believe that PspA has promising potential as a target for the therapy of invasive pneumococcal disease by mAbs, which could be used alone or in conjunction with standard-of-care antibiotics.	[Kristian, Sascha A.; Bubeck, Sarah S.; Cho, Rebecca; Groff, Brian C.; Destito, Giuseppe; Laudenslager, John; Koriazova, Lilia] Kyowa Kirin Pharmaceut Res Inc, 9420 Athena Circle, La Jolla, CA 92037 USA; [Ota, Takayuki; Kubota, Tsuguo; Tahara, Tomoyuki; Kanda, Yutaka] Kyowa Hakko Kirin Co Ltd, R&D Div, Chiyoda Ku, 1-6-1 Otemachi, Tokyo 1008185, Japan	Kyowa Kirin Ltd	Bubeck, SS (corresponding author), Kyowa Kirin Pharmaceut Res Inc, 9420 Athena Circle, La Jolla, CA 92037 USA.	sarah.bubeck@kyowakirin.com			Kyowa Hakko Kirin Co., Ltd. Japan	Kyowa Hakko Kirin Co., Ltd. Japan	This work was supported by Kyowa Hakko Kirin Co., Ltd. Japan (http://www.kyowakirin.com/index.html). All named authors are or were employees of Kyowa Kirin Pharmaceutical Research, Inc. or Kyowa Hakko Kirin Co., Ltd., Japan at the time of their involvement in the reported study. Kyowa Hakko Kirin Co., Ltd., Japan provided funding for the research of the study and provided support in the form of salaries for authors SK, TO, SB, RC, BG, TK, GD, JL, LK, TT, and YK, but no individuals employed by the funder, other than the named authors, had any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Brooks-Walter A, 1999, INFECT IMMUN, V67, P6533; Dalia AB, 2011, CELL HOST MICROBE, V10, P486, DOI 10.1016/j.chom.2011.09.009; Daniels CC, 2010, INFECT IMMUN, V78, P2163, DOI 10.1128/IAI.01199-09; Genschmer KR, 2013, VACCINE, V32, P39, DOI 10.1016/j.vaccine.2013.10.080; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Hollingshead SK, 2006, J MED MICROBIOL, V55, P215, DOI 10.1099/jmm.0.46268-0; Huang SS, 2011, VACCINE, V29, P3398, DOI 10.1016/j.vaccine.2011.02.088; Khan N, 2015, CLIN VACCINE IMMUNOL, V22, P99, DOI 10.1128/CVI.00001-14; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; LEATHERBARROW RJ, 1984, MOL IMMUNOL, V21, P321, DOI 10.1016/0161-5890(84)90103-2; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MCDANIEL LS, 1994, MICROB PATHOGENESIS, V17, P323, DOI 10.1006/mpat.1994.1078; McDaniel LS, 1998, INFECT IMMUN, V66, P4748, DOI 10.1128/IAI.66.10.4748-4754.1998; Melin M, 2012, VACCINE, V30, P7157, DOI 10.1016/j.vaccine.2012.10.004; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Moffitt KL, 2011, CURR OPIN IMMUNOL, V23, P407, DOI 10.1016/j.coi.2011.04.002; Moreno AT, 2010, CLIN VACCINE IMMUNOL, V17, P439, DOI 10.1128/CVI.00430-09; Musher DM, 2002, NEW ENGL J MED, V346, P630, DOI 10.1056/NEJM200202213460820; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Natsume A, 2008, CANCER RES, V68, P3863, DOI 10.1158/0008-5472.CAN-07-6297; Ochs MM, 2008, MICROB PATHOGENESIS, V44, P204, DOI 10.1016/j.micpath.2007.09.007; Presta LG, 2006, ADV DRUG DELIVER REV, V58, P640, DOI 10.1016/j.addr.2006.01.026; Rajam G, 2010, CLIN VACCINE IMMUNOL, V17, P1823, DOI 10.1128/CVI.00366-10; Romero-Steiner S, 2006, CLIN VACCINE IMMUNOL, V13, P165, DOI 10.1128/CVI.13.2.165-169.2006; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Rose CE, 2011, CLIN VACCINE IMMUNOL, V18, P135, DOI 10.1128/CVI.00370-10; Shibata-Koyama M, 2009, EXP HEMATOL, V37, P309, DOI 10.1016/j.exphem.2008.11.006; SHITARA K, 1993, CANCER IMMUNOL IMMUN, V36, P373, DOI 10.1007/BF01742253; Syrogiannopoulos GA, 1997, CLIN INFECT DIS, V25, P188, DOI 10.1086/514526; Van Bambeke F, 2007, DRUGS, V67, P2355, DOI 10.2165/00003495-200767160-00005; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weisman LE, 2009, ANTIMICROB AGENTS CH, V53, P2879, DOI 10.1128/AAC.01565-08; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08	39	7	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154616	10.1371/journal.pone.0154616	http://dx.doi.org/10.1371/journal.pone.0154616			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171010	Green Published, gold			2022-12-27	WOS:000376588600058
J	Hansen, MS; Wetterslev, J; Pipper, CB; Ostervig, R; Asghar, MS; Dahl, JB				Hansen, Morten Sejer; Wetterslev, Jorn; Pipper, Christian Bressen; Ostervig, Rebecca; Asghar, Mohammad Sohail; Dahl, Jorgen Berg			The Area of Secondary Hyperalgesia following Heat Stimulation in Healthy Male Volunteers: Inter- and Intra-Individual Variance and Reproducibility	PLOS ONE			English	Article							HEAT/CAPSAICIN SENSITIZATION MODEL; HUMAN EXPERIMENTAL PAIN; CAPSAICIN SENSITIZATION; POSTOPERATIVE PAIN; MORPHINE ANALGESIA; SEX-DIFFERENCES; PREDICTION; SKIN; ASSOCIATION; ANXIETY	Introduction Clinical pain models can be applied when investigating basic physiologic pain responses in healthy volunteers. Several pain models exist; however, only few have been adequately validated. Our primary aim with this prospective study was to investigate the intra-and inter-individual variation in secondary hyperalgesia elicited by brief thermal sensitization (45 degrees C for 3 min) in healthy volunteers. Material and Methods Fifty healthy volunteers were included. Areas of secondary hyperalgesia following brief thermal sensitization were investigated by 2 observers on 4 experimental days, with a minimum interval of 7 days. Additionally, heat pain detection threshold and pain during thermal stimulation (45 degrees C for 1 min.), and the psychological tests Pain Catastrophizing Scale and Hospital Anxiety and Depression Score were applied. Results For areas of secondary hyperalgesia, an intra-observer intra-person correlation of 0.85, 95% CI [0.78, 0.90], an intra-observer inter-person correlation of 0.03, 95% CI [0.00, 0.16], and a coefficient of variation of 0.17, 95% CI [0.14, 0.21] was demonstrated. Four percent of the study population had areas of secondary hyperalgesia both below the 1st and above the 3rd quartile considering all included participants. Heat pain detection threshold predicted area of secondary hyperalgesia with an adjusted R-2 of 0.20 (P = 0.0006). Conclusions We have demonstrated a low intra-individual, and a high inter-individual variation in thermally induced secondary hyperalgesia. We conclude that brief thermal sensitization produce secondary hyperalgesia with a high level of reproducibility, which can be applied to investigate different phenotypes related to secondary hyperalgesia in healthy volunteers.	[Hansen, Morten Sejer] Rigshosp, Ctr Head & Orthoped, Dept Anesthesiol 4231, DK-2100 Copenhagen, Denmark; [Wetterslev, Jorn] Ctr Clin Intervent Res, Copenhagen Trial Unit, Dept 7812, Copenhagen, Denmark; [Pipper, Christian Bressen] Univ Copenhagen, Fac Hlth, Sect Biostat, Copenhagen, Denmark; [Ostervig, Rebecca; Asghar, Mohammad Sohail] Rigshosp, Ctr Head & Orthoped, Dept Anesthesiol 4231, DK-2100 Copenhagen, Denmark; [Dahl, Jorgen Berg] Bispebjerg Hosp, Dept Anesthesiol, DK-2400 Copenhagen, Denmark; [Dahl, Jorgen Berg] Frederiksberg Univ Hosp, Dept Anesthesiol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Hansen, MS (corresponding author), Rigshosp, Ctr Head & Orthoped, Dept Anesthesiol 4231, DK-2100 Copenhagen, Denmark.	morten.sejer.hansen@regionh.dk	Wetterslev, Jørn/ABF-1251-2020; Hansen, Morten/S-7809-2016	Wetterslev, Jørn/0000-0001-7778-1771; Pipper, Christian Bressen/0000-0003-0261-616X	Doctor Fritz Karner and Wife's Foundation (in Danish: Laege Fritz Karner og Hustrus Fond); Foundation for Medical Science's Advancement (in Danish: Fonden for Laegevidenskabens Fremme) [14-84]	Doctor Fritz Karner and Wife's Foundation (in Danish: Laege Fritz Karner og Hustrus Fond); Foundation for Medical Science's Advancement (in Danish: Fonden for Laegevidenskabens Fremme)	This work was supported by Doctor Fritz Karner and Wife's Foundation (in Danish: Laege Fritz Karner og Hustrus Fond), no grant number available, no URL available: MSH and JBD received the funding. The Foundation for Medical Science's Advancement (in Danish: Fonden for Laegevidenskabens Fremme), grant number: 14-84, URL: http://www.apmollerfonde.dk/ansoegning/laegefonden.aspx: JBD recieved the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT FV, 1992, PSYCHOPHARMACOLOGY, V108, P60, DOI 10.1007/BF02245286; Alabas OA, 2012, EUR J PAIN, V16, P1211, DOI 10.1002/j.1532-2149.2012.00121.x; AREZZO JC, 1993, NEUROLOGY, V43, P1050; Asghar MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114840; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Campesi Ilaria, 2012, Handb Exp Pharmacol, P265, DOI 10.1007/978-3-642-30726-3_13; Cavallone LF, 2013, J PAIN RES, V6, P771, DOI 10.2147/JPR.S53437; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Choi JC, 2012, ANAESTHESIA, V67, P1146, DOI 10.1111/j.1365-2044.2012.07267.x; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Dirks J, 2003, J PAIN, V4, P122, DOI 10.1054/jpai.2003.10; Dirks J, 2002, ANESTHESIOLOGY, V97, P102, DOI 10.1097/00000542-200207000-00015; Dirks J, 2001, REGION ANESTH PAIN M, V26, P414, DOI 10.1097/00115550-200109000-00005; Erpelding N, 2012, PAIN, V153, P1602, DOI 10.1016/j.pain.2012.03.012; Frymoyer AR, 2007, J PAIN, V8, P19, DOI 10.1016/j.jpain.2006.05.010; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Granot M, 2005, CLIN J PAIN, V21, P439, DOI 10.1097/01.ajp.0000135236.12705.2d; HANDWERKER HO, 1993, PHYSIOL REV, V73, P639, DOI 10.1152/physrev.1993.73.3.639; Hansen MS, 2015, ACTA ANAESTH SCAND, V59, P1094, DOI 10.1111/aas.12555; Hansen MS, 2015, THE AREA OF SECONDAR; Iacovides S, 2015, EUR J PAIN, V19, P1389, DOI 10.1002/ejp.714; Jensen MT, 2006, J PAIN, V7, P211, DOI 10.1016/j.jpain.2005.10.013; Khambam SKR, 2011, CURR THER RES CLIN E, V72, P233, DOI 10.1016/j.curtheres.2011.11.001; Koppert W, 2001, ANESTHESIOLOGY, V95, P395, DOI 10.1097/00000542-200108000-00022; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; LIEBERMAN HR, 1983, J PSYCHIAT RES, V17, P135, DOI 10.1016/0022-3956(82)90015-2; Martinez V, 2012, PAIN, V153, P1478, DOI 10.1016/j.pain.2012.04.004; McCormack K, 1998, PAIN, V78, P79, DOI 10.1016/S0304-3959(98)00146-8; Mikkelsen S, 2001, BRIT J ANAESTH, V86, P871, DOI 10.1093/bja/86.6.871; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; MOINICHE S, 1993, BRIT J ANAESTH, V71, P201, DOI 10.1093/bja/71.2.201; Okifuji A, 2015, J PAIN RES, V8, P399, DOI 10.2147/JPR.S55598; Papaioannou M, 2009, PAIN MED, V10, P1452, DOI 10.1111/j.1526-4637.2009.00730.x; Pedersen JL, 1998, PAIN, V76, P377, DOI 10.1016/S0304-3959(98)00070-0; Petersen KL, 2014, PAIN, V155, P929, DOI 10.1016/j.pain.2014.01.019; Petersen KL, 2008, PAIN, V137, P395, DOI 10.1016/j.pain.2007.09.019; Petersen KL, 1999, NEUROREPORT, V10, P1511, DOI 10.1097/00001756-199905140-00022; Petersen KL, 1997, PAIN, V70, P167, DOI 10.1016/S0304-3959(96)03316-7; Petersen KL, 2001, ANESTHESIOLOGY, V94, P15, DOI 10.1097/00000542-200101000-00008; Reddy KSK, 2012, J RES MED SCI, V17, P587; Ruscheweyh R, 2010, J PAIN, V11, P728, DOI 10.1016/j.jpain.2009.10.016; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; Siao Peter, 2003, Phys Med Rehabil Clin N Am, V14, P261, DOI 10.1016/S1047-9651(02)00122-5; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Treede RD, 2006, HAND CLINIC, V81, P3, DOI 10.1016/S0072-9752(06)80005-9; Werner MU, 2013, ACTA ANAESTH SCAND, V57, P957, DOI 10.1111/aas.12150; Werner MU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062733; Werner MU, 2004, ANESTHESIOLOGY, V100, P115, DOI 10.1097/00000542-200401000-00020; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Ziegler EA, 1999, BRAIN, V122, P2245, DOI 10.1093/brain/122.12.2245; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155284	10.1371/journal.pone.0155284	http://dx.doi.org/10.1371/journal.pone.0155284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167119	Green Submitted, gold, Green Published			2022-12-27	WOS:000376587300094
J	Laterra, P; Barral, P; Carmona, A; Nahuelhual, L				Laterra, Pedro; Barral, Paula; Carmona, Alejandra; Nahuelhual, Laura			Focusing Conservation Efforts on Ecosystem Service Supply May Increase Vulnerability of Socio-Ecological Systems	PLOS ONE			English	Article							POVERTY ALLEVIATION; DECISION-MAKING; FRAMEWORK; AMERICA; SUPPORT; LINKING	Growing concern about the loss of ecosystem services (ES) promotes their spatial representation as a key tool for the internalization of the ES framework into land use policies. Paradoxically, mapping approaches meant to inform policy decisions focus on the magnitude and spatial distribution of the biophysical supply of ES, largely ignoring the social mechanisms by which these services influence human wellbeing. If social mechanisms affecting ES demand, enhancing it or reducing it, are taken more into account, then policies are more effective. By developing and applying a new mapping routine to two distinct socio-ecological systems, we show a strong spatial uncoupling between ES supply and socio-ecological vulnerability to the loss of ES, under scenarios of land use and cover change. Public policies based on ES supply might not only fail at detecting priority conservation areas for the wellbeing of human societies, but may also increase their vulnerability by neglecting areas of currently low, but highly valued ES supply.	[Laterra, Pedro] Consejo Nacl Invest Cient & Tecn, Fdn Bariloche, Ave Bustillo 9500, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Barral, Paula] INTA, EEA Balcarce, CC 276, RA-7620 Buenos Aires, DF, Argentina; [Carmona, Alejandra; Nahuelhual, Laura] Ctr Climate & Resilience Res CR2, Santiago, Chile; [Nahuelhual, Laura] Univ Austral Chile, Inst Econ Agr, Casilla 567, Valdivia, Chile; [Nahuelhual, Laura] Ctr Invest Dinam Ecosistemas Marinos Altas Latitu, Santiago, Chile	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidad Austral de Chile	Laterra, P (corresponding author), Consejo Nacl Invest Cient & Tecn, Fdn Bariloche, Ave Bustillo 9500, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	pedro.laterra@conicet.gov.ar	BITOUN, RACHEL Elisabeth/AAC-9538-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Barral, Maria Paula/0000-0001-7834-491X	Fondo para la Investigacion Cientiifica y Tecnologica FONCYT (ANPCYT) [PICT 12-0607, AEGA223022, PNNAT1128052, AGR 327/10, 389/12]; Fondo Nacional de Ciencia y Tecnologia FONDECYT (CONICYT) [1110741, 1151187]; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias FONDAP (CONICYT) [15150003, 15110009]; BEST-P Inter-American Institute for Global Change Research - US National Science Foundation [CRN3095, GEO- 1128040]; Programa Iberoamericano de Ciencia y Tecnologia para el Desarrollo (CYTED) [VESPLAN-413RT0472]	Fondo para la Investigacion Cientiifica y Tecnologica FONCYT (ANPCYT); Fondo Nacional de Ciencia y Tecnologia FONDECYT (CONICYT); Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias FONDAP (CONICYT); BEST-P Inter-American Institute for Global Change Research - US National Science Foundation; Programa Iberoamericano de Ciencia y Tecnologia para el Desarrollo (CYTED)	This study was funded by grants Fondo para la Investigacion Cientiifica y Tecnologica FONCYT (ANPCYT) PICT 12-0607, AEGA223022 and PNNAT1128052 (INTA), AGR 327/10 and 389/12 (UNMdP) to PL; Fondo Nacional de Ciencia y Tecnologia FONDECYT (CONICYT) No 1110741 and 1151187, Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias FONDAP (CONICYT) No 15150003 and No 15110009 to LN; BEST-P Inter-American Institute for Global Change Research CRN3095 which is supported by the US National Science Foundation (grant GEO- 1128040) to LN and PL; and Programa Iberoamericano de Ciencia y Tecnologia para el Desarrollo (CYTED, red VESPLAN-413RT0472) to PL and LN.	Abson DJ, 2012, APPL GEOGR, V35, P515, DOI 10.1016/j.apgeog.2012.08.004; Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Bagstad KJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06523-190264; Bagstad KJ, 2013, ECOSYST SERV, V5, pE27, DOI 10.1016/j.ecoser.2013.07.004; Beier CM, 2008, ECOSYSTEMS, V11, P923, DOI 10.1007/s10021-008-9170-z; Berkes F., 2000, LINKING SOCIAL ECOLO; Borras SM, 2012, J PEASANT STUD, V39, P845, DOI 10.1080/03066150.2012.679931; Brace C, 2010, PROGR HUM GEOGR, P1; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Burkhard B, 2011, ECOL INDIC, V11, P168, DOI 10.1016/j.ecolind.2009.07.004; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Daw T, 2011, ENVIRON CONSERV, V38, P370, DOI 10.1017/S0376892911000506; de Chazal J, 2008, GLOBAL ENVIRON CHANG, V18, P508, DOI 10.1016/j.gloenvcha.2008.04.005; De Lange HJ, 2010, SCI TOTAL ENVIRON, V408, P3871, DOI 10.1016/j.scitotenv.2009.11.009; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fisher JA, 2014, ECOSYST SERV, V7, P34, DOI 10.1016/j.ecoser.2013.08.002; Carcamo PF, 2013, OCEAN COAST MANAGE, V84, P193, DOI 10.1016/j.ocecoaman.2013.08.003; Gadgil M., 1995, ECOLOGY AND EQUITY; GALLOPIN GC, 1991, INT SOC SCI J, V43, P707; Gallopin GC, 2006, GLOBAL ENVIRON CHANG, V16, P293, DOI 10.1016/j.gloenvcha.2006.02.004; Game ET, 2013, CONSERV BIOL, V27, P480, DOI 10.1111/cobi.12051; Gret-Regamey A, 2013, J ENVIRON MANAGE, V127, pS145, DOI 10.1016/j.jenvman.2012.07.028; Haines-Young R, 2000, ECOSYSTEM ECOLOGY NE, P110; Kok M, 2014, REG ENVIRON CHANGE, V16, P229; Laterra P, 2015, ECOSER COLLABORATIVE; Laterra P, 2012, AGR ECOSYST ENVIRON, V154, P56, DOI 10.1016/j.agee.2011.05.013; Li HB, 2006, SCALING AND UNCERTAINTY ANALYSIS IN ECOLOGY: METHODS AND APPLICATIONS, P45; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Martinez-Harms MJ, 2008, J NAT CONSERV, V16, P72, DOI 10.1016/j.jnc.2008.02.002; MEA, 2005, EC HUM WELL BEING SY, DOI DOI 10.1119/1.2344558; Metzger MJ, 2006, AGR ECOSYST ENVIRON, V114, P69, DOI 10.1016/j.agee.2005.11.025; Metzger MJ, 2005, INT J APPL EARTH OBS, V7, P253, DOI 10.1016/j.jag.2005.06.011; Nahuelhual L, 2015, ECOSYST SERV, V13, P162, DOI 10.1016/j.ecoser.2015.03.005; Nelson E, 2012, FRONT ECOL ENVIRON, V7, P4; Nelson Erik J, 2010, F1000 Biol Rep, V2, P53, DOI 10.3410/B2-53; Nowak P, 2006, SOC NATUR RESOUR, V19, P153, DOI 10.1080/08941920500394816; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Turner R.K., 2008, VALUING ECOSYSTEM SE; Turner RK, 2004, ENVIRON RESOUR ECON, V39, P25; Viglizzo EF, 2006, ECOL ECON, V57, P140, DOI 10.1016/j.ecolecon.2005.03.025	41	26	28	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155019	10.1371/journal.pone.0155019	http://dx.doi.org/10.1371/journal.pone.0155019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CD	27167737	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300039
J	Perez-Lopez, AM; Soria-Gila, ML; Marsden, ER; Lilienkampf, A; Bradley, M				Perez-Lopez, Ana M.; Lourdes Soria-Gila, M.; Marsden, Emma R.; Lilienkampf, Annamaria; Bradley, Mark			Fluorogenic Substrates for In Situ Monitoring of Caspase-3 Activity in Live Cells	PLOS ONE			English	Article							ACTIVITY-BASED PROBES; PENETRATING PEPTIDES; APOPTOSIS; CLEAVAGE; CANCER; INHIBITORS; DISCOVERY; DNA	The in situ detection of caspase-3 activity has applications in the imaging and monitoring of multiple pathologies, notably cancer. A series of cell penetrating FRET-based fluorogenic substrates were designed and synthesised for the detection of caspase-3 in live cells. A variety of modifications of the classical caspase-3 and caspase-7 substrate sequence Asp-Glu-Val-Asp were carried out in order to increase caspase-3 affinity and eliminate caspase-7 cross-reactivity. To allow cellular uptake and good solubility, the substrates were conjugated to a cationic peptoid. The most selective fluorogenic substrate 27, FAM-Ahx-Asp-Leu-Pro-Asp-Lys(MR)-Ahx, conjugated to the cell penetrating peptoid at the C-terminus, was able to detect and quantify caspase-3 activity in apoptotic cells without cross-reactivity by caspase-7.	[Perez-Lopez, Ana M.; Marsden, Emma R.; Lilienkampf, Annamaria; Bradley, Mark] Univ Edinburgh, Sch Chem, EaStCHEM, Joseph Black Bldg,West Mains Rd, Edinburgh EH9 3FJ, Midlothian, Scotland; [Lourdes Soria-Gila, M.] Univ Granada, Sch Pharm, Dept Med & Organ Chem, Campus Cartuja S-N, E-18071 Granada, Spain	University of Edinburgh; University of Granada	Bradley, M (corresponding author), Univ Edinburgh, Sch Chem, EaStCHEM, Joseph Black Bldg,West Mains Rd, Edinburgh EH9 3FJ, Midlothian, Scotland.	mark.bradley@ed.ac.uk			Ramon Areces Foundation; Caja Madrid Foundation; Spanish Ministry of Economy and Competitiveness [FPI BES-2010-030257, EEBB-I-13-07131]; Engineering and Physical Sciences Research Council [EP/K03197X/1] Funding Source: researchfish; EPSRC [EP/K03197X/1] Funding Source: UKRI	Ramon Areces Foundation; Caja Madrid Foundation; Spanish Ministry of Economy and Competitiveness(Spanish Government); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Ramon Areces and Caja Madrid Foundations to AMPL and Spanish Ministry of Economy and Competitiveness to MLSG (graduate student fellowships FPI BES-2010-030257 and EEBB-I-13-07131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agniswamy J, 2007, FEBS J, V274, P4752, DOI 10.1111/j.1742-4658.2007.05994.x; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; D'Amelio M, 2012, TRENDS NEUROSCI, V35, P700, DOI 10.1016/j.tins.2012.06.004; Demon D, 2009, MOL CELL PROTEOMICS, V8, P2700, DOI 10.1074/mcp.M900310-MCP200; Devarajan E, 2002, ONCOGENE, V21, P8843, DOI 10.1038/sj.onc.1206044; Dhaliwal K, 2011, FARADAY DISCUSS, V149, P107, DOI 10.1039/c005410k; Edgington LE, 2013, J AM CHEM SOC, V135, P174, DOI 10.1021/ja307083b; Edgington LE, 2012, CHEM BIOL, V19, P340, DOI 10.1016/j.chembiol.2011.12.021; Edgington LE, 2009, NAT MED, V15, P967, DOI 10.1038/nm.1938; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fara MA, 2006, TETRAHEDRON LETT, V47, P1011, DOI 10.1016/j.tetlet.2005.11.127; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Healy E, Topical Drug Delivery, Patent No. [WO 2007113531, 2007113531]; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jarver P, 2004, DRUG DISCOV TODAY, V9, P395, DOI 10.1016/S1359-6446(04)03042-9; Jong T, 2015, BIOCONJUGATE CHEM, V26, P1759, DOI 10.1021/acs.bioconjchem.5b00307; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kumar P, 2006, BRIT J DERMATOL, V155, P237; Lam AP, 2010, GENE THER, V17, P439, DOI 10.1038/gt.2010.31; Langel U, 2002, PHARM TOXICOLOGY BOC, P245; Laxman B, 2002, P NATL ACAD SCI USA, V99, P16551, DOI 10.1073/pnas.252644499; Leyva MJ, 2010, CHEM BIOL, V17, P1189, DOI 10.1016/j.chembiol.2010.08.014; Lien S, 2004, PROTEIN J, V23, P413, DOI 10.1023/B:JOPC.0000039555.92058.51; Mackay M, 2016, MOL BIOSYST, V12, P693, DOI 10.1039/c5mb00730e; Cardenas-Maestre JM, 2014, MACROMOL BIOSCI, V14, P923, DOI 10.1002/mabi.201300525; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Paulick MG, 2008, CURR OPIN GENET DEV, V18, P97, DOI 10.1016/j.gde.2007.12.001; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Potten CS, 1997, COMP BIOCHEM PHYS B, V118, P473, DOI 10.1016/S0305-0491(97)00219-8; Saunders PA, 2000, ANAL BIOCHEM, V284, P114, DOI 10.1006/abio.2000.4690; Savitsky AP, 2012, THERANOSTICS, V2, P215, DOI 10.7150/thno.3885; Snyder EL, 2004, PHARM RES-DORDR, V21, P389, DOI 10.1023/B:PHAM.0000019289.61978.f5; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Tanuma S, 1996, APOPTOSIS NORMAL DEV, P39; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Unciti-Broceta A, 2009, BIOORGAN MED CHEM, V17, P959, DOI 10.1016/j.bmc.2008.02.068; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Vickers CJ, 2014, ACS CHEM BIOL, V9, P2199, DOI 10.1021/cb500586p; Vickers CJ, 2013, ACS CHEM BIOL, V8, P1558, DOI 10.1021/cb400209w; Vives E, 2003, CURR PROTEIN PEPT SC, V4, P125, DOI 10.2174/1389203033487306; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wu H, 2011, J AM CHEM SOC, V133, P1946, DOI 10.1021/ja109597v; Wyllie AH, 1999, BRIT J CANCER, V80, P34	52	8	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0153209	10.1371/journal.pone.0153209	http://dx.doi.org/10.1371/journal.pone.0153209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168077	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300038
J	Dong, S; Wang, X				Dong, S.; Wang, X.			A Rotational Pressure-Correction Scheme for Incompressible Two-Phase Flows with Open Boundaries	PLOS ONE			English	Article							PHASE-FIELD SIMULATIONS; DIFFUSE INTERFACE MODEL; NAVIER-STOKES EQUATIONS; LARGE DENSITY RATIOS; VARIABLE-DENSITY; PROJECTION METHOD; ELEMENT METHOD; FLUIDS; ALGORITHM; BUBBLES	Two-phase outflows refer to situations where the interface formed between two immiscible incompressible fluids passes through open portions of the domain boundary. We present several new forms of open boundary conditions for two-phase outflow simulations within the phase field framework, as well as a rotational pressure correction based algorithm for numerically treating these open boundary conditions. Our algorithm gives rise to linear algebraic systems for the velocity and the pressure that involve only constant and time-independent coefficient matrices after discretization, despite the variable density and variable viscosity of the two-phase mixture. By comparing simulation results with theory and the experimental data, we show that the method produces physically accurate results. We also present numerical experiments to demonstrate the long-term stability of the method in situations where large density contrast, large viscosity contrast, and backflows occur at the two-phase open boundaries.	[Dong, S.; Wang, X.] Purdue Univ, Dept Math, Ctr Computat & Appl Math, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dong, S (corresponding author), Purdue Univ, Dept Math, Ctr Computat & Appl Math, W Lafayette, IN 47907 USA.	sdong@purdue.edu	Dong, Suchuan/L-4050-2019		US National Science Foundation [DMS-1318820, DMS-1522537]; US Office of Naval Research [N000141110028]; Natural Science Foundation of China [11571157]; US NSF [DMS-1318820, DMS-1522537]; US ONR [N000141110028]; NSFC [11571157]; Direct For Mathematical & Physical Scien [1318820] Funding Source: National Science Foundation; Division Of Mathematical Sciences [1522537] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); US Office of Naval Research(Office of Naval Research); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US NSF(National Science Foundation (NSF)); US ONR(Office of Naval Research); NSFC(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was partially supported by the US National Science Foundation (DMS-1318820, DMS-1522537), the US Office of Naval Research (N000141110028), and the Natural Science Foundation of China (No. 11571157). There was no additional external funding received for this study.; This work was partially supported by US NSF (DMS-1318820, DMS-1522537) and US ONR (N000141110028), and NSFC (No. 11571157).	Albadawi A, 2013, INT J MULTIPHAS FLOW, V53, P11, DOI 10.1016/j.ijmultiphaseflow.2013.01.005; Badalassi VE, 2003, J COMPUT PHYS, V190, P371, DOI 10.1016/S0021-9991(03)00280-8; BELL JB, 1992, J COMPUT PHYS, V101, P334, DOI 10.1016/0021-9991(92)90011-M; Brenn G, 2006, CHEM ENG SCI, V61, P3795, DOI 10.1016/j.ces.2005.12.016; Calgaro C, 2008, J COMPUT PHYS, V227, P4671, DOI 10.1016/j.jcp.2008.01.017; Clift R., 2005, BUBBLES DROPS PARTIC; Desmarais JL, 2014, J COMPUT PHYS, V263, P393, DOI 10.1016/j.jcp.2014.01.032; Ding H, 2007, J COMPUT PHYS, V226, P2078, DOI 10.1016/j.jcp.2007.06.028; Dodd MS, 2014, J COMPUT PHYS, V273, P416, DOI 10.1016/j.jcp.2014.05.024; Dong S, 2015, J COMPUT PHYS, V291, P254, DOI 10.1016/j.jcp.2015.03.012; Dong S, 2015, J COMPUT PHYS, V283, P98, DOI 10.1016/j.jcp.2014.11.039; Dong S, 2014, J COMPUT PHYS, V276, P691, DOI 10.1016/j.jcp.2014.08.002; Dong S, 2014, J COMPUT PHYS, V266, P47, DOI 10.1016/j.jcp.2014.02.011; Dong S, 2014, J COMPUT PHYS, V261, P83, DOI 10.1016/j.jcp.2013.12.042; Dong S, 2012, COMPUT METHOD APPL M, V247, P179, DOI 10.1016/j.cma.2012.07.023; Dong S, 2012, J COMPUT PHYS, V231, P5788, DOI 10.1016/j.jcp.2012.04.041; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gottlieb D., 1977, CBMS NSF REGIONAL C; Guermond JL, 2006, COMPUT METHOD APPL M, V195, P6011, DOI 10.1016/j.cma.2005.10.010; Guermond JL, 2011, SIAM J NUMER ANAL, V49, P917, DOI 10.1137/090768758; Guermond JL, 2009, J COMPUT PHYS, V228, P2834, DOI 10.1016/j.jcp.2008.12.036; Guermond JL, 2000, J COMPUT PHYS, V165, P167, DOI 10.1006/jcph.2000.6609; KARNIADAKIS G. E., 2005, SPECTRAL HP ELEMENT; Lenzinger M, 2010, NONLINEAR ANAL-THEOR, V73, P840, DOI 10.1016/j.na.2010.03.040; Li Y, 2013, J COMPUT PHYS, V242, P124, DOI 10.1016/j.jcp.2013.02.010; Liu C, 2003, PHYSICA D, V179, P211, DOI 10.1016/S0167-2789(03)00030-7; Liu C, 2007, SIAM J NUMER ANAL, V45, P1287, DOI 10.1137/050629008; Lou Q, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.063301; Magnaudet J, 2000, ANNU REV FLUID MECH, V32, P659, DOI 10.1146/annurev.fluid.32.1.659; Munkejord ST, 2006, COMMUN NUMER METH EN, V22, P781, DOI 10.1002/cnm.849; PROSPERETTI A, 1981, PHYS FLUIDS, V24, P1217, DOI 10.1063/1.863522; Puckett EG, 1997, J COMPUT PHYS, V130, P269, DOI 10.1006/jcph.1996.5590; Pyo JH, 2007, J COMPUT PHYS, V221, P181, DOI 10.1016/j.jcp.2006.06.013; Richard D, 2000, EUROPHYS LETT, V50, P769, DOI 10.1209/epl/i2000-00547-6; Shen J, 2010, SIAM J SCI COMPUT, V32, P1159, DOI 10.1137/09075860X; SHERWIN SJ, 1995, COMPUT METHOD APPL M, V123, P189, DOI 10.1016/0045-7825(94)00745-9; Son G, 2001, NUMER HEAT TR B-FUND, V39, P45, DOI 10.1080/104077901460678; Wu MM, 2002, PHYS FLUIDS, V14, pL49, DOI 10.1063/1.1485767; Yue PT, 2006, J COMPUT PHYS, V219, P47, DOI 10.1016/j.jcp.2006.03.016; Yue PT, 2004, J FLUID MECH, V515, P293, DOI 10.1017/S0022112004000370; Zheng X, 2011, J COMPUT PHYS, V230, P8573, DOI 10.1016/j.jcp.2011.08.009	43	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154565	10.1371/journal.pone.0154565	http://dx.doi.org/10.1371/journal.pone.0154565			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163909	Green Submitted, Green Published, gold			2022-12-27	WOS:000376585700002
J	Wen, TX; Zhang, ZN; Wong, KKL				Wen, Tingxi; Zhang, Zhongnan; Wong, Kelvin K. L.			Multi-Objective Algorithm for Blood Supply via Unmanned Aerial Vehicles to the Wounded in an Emergency Situation	PLOS ONE			English	Article							BEE COLONY ALGORITHM; ROUTING PROBLEM; GENETIC ALGORITHM; GREEN LOGISTICS; OPTIMIZATION; SEARCH	Unmanned aerial vehicle (UAV) has been widely used in many industries. In the medical environment, especially in some emergency situations, UAVs play an important role such as the supply of medicines and blood with speed and efficiency. In this paper, we study the problem of multi-objective blood supply by UAVs in such emergency situations. This is a complex problem that includes maintenance of the supply blood's temperature model during transportation, the UAVs' scheduling and routes' planning in case of multiple sites requesting blood, and limited carrying capacity. Most importantly, we need to study the blood's temperature change due to the external environment, the heating agent (or refrigerant) and time factor during transportation, and propose an optimal method for calculating the mixing proportion of blood and appendage in different circumstances and delivery conditions. Then, by introducing the idea of transportation appendage into the traditional Capacitated Vehicle Routing Problem (CVRP), this new problem is proposed according to the factors of distance and weight. Algorithmically, we use the combination of decomposition-based multi-objective evolutionary algorithm and local search method to perform a series of experiments on the CVRP public dataset. By comparing our technique with the traditional ones, our algorithm can obtain better optimization results and time performance.	[Wen, Tingxi; Zhang, Zhongnan] Xiamen Univ, Software Sch, Xiamen, Fujian, Peoples R China; [Wong, Kelvin K. L.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia	Xiamen University; Western Sydney University	Zhang, ZN (corresponding author), Xiamen Univ, Software Sch, Xiamen, Fujian, Peoples R China.	zhongnan_zhang@xmu.edu.cn	Wong, Kelvin/AAL-8636-2021; Wong, Kelvin Kian Loong/ABA-3915-2021	Wong, Kelvin Kian Loong/0000-0002-8600-1105	Science and Technology Key Project of Fujian Province, China [2014H0044]; Science and Technology Guiding Project of Fujian Province, China [2015H0037, 2016H0035]; Science and Technology Project of Xiamen, China [3502Z20153026]	Science and Technology Key Project of Fujian Province, China; Science and Technology Guiding Project of Fujian Province, China; Science and Technology Project of Xiamen, China	This research is supported by the Science and Technology Key Project of Fujian Province, China (No. 2014H0044); Science and Technology Guiding Project of Fujian Province, China (No. 2015H0037, No. 2016H0035); Science and Technology Project of Xiamen, China (No. 3502Z20153026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Iniesta A, 2013, EXPERT SYST APPL, V40, P4785, DOI 10.1016/j.eswa.2013.02.029; Aras N, 2011, TRANSPORT RES C-EMER, V19, P866, DOI 10.1016/j.trc.2010.08.003; Azapagic A., 1999, J CLEAN PROD, V7, P135, DOI DOI 10.1016/S0959-6526(98)00051-1; Baker BM, 2003, COMPUT OPER RES, V30, P787, DOI 10.1016/S0305-0548(02)00051-5; Bell JE, 2004, ADV ENG INFORM, V18, P41, DOI 10.1016/j.aei.2004.07.001; Berman R, 2008, PHYS TODAY, V31, P56; Bernard M, 2011, J FIELD ROBOT, V28, P914, DOI 10.1002/rob.20401; Blood S, 2006, CHINESE MED J, P429; BODIN L, 1983, COMPUT OPER RES, V10, P63, DOI 10.1016/0305-0548(83)90030-8; Chiang WC, 1996, ANN OPER RES, V63, P3, DOI 10.1007/BF02601637; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Dekker R, 2012, EUR J OPER RES, V219, P671, DOI 10.1016/j.ejor.2011.11.010; Durillo JJ, 2011, ADV ENG SOFTW, V42, P760, DOI 10.1016/j.advengsoft.2011.05.014; Gen M., 1999, GENETIC ALGORITHMS E; GENDREAU M, 1994, MANAGE SCI, V40, P1276, DOI 10.1287/mnsc.40.10.1276; Grefenstette J., 1985, PROC 1 INT C GENET A, V160, P160; Hochbaum D.S., 1996, APPROXIMATION ALGORI; Holland J, 1975, ADAPTATION NATURAL A; Kara I, 2006, EUR J OPER RES, V174, P1449, DOI 10.1016/j.ejor.2005.03.008; Lin YC, 2012, IEEE INT CONF ROBOT, P3588, DOI 10.1109/ICRA.2012.6225112; Mazzeo S., 2004, ELECT NOTES DISCRETE, V18, P181, DOI [10.1016/j.endm.2004.06.029, DOI 10.1016/J.ENDM.2004.06.029]; Novoa C, 2009, EUR J OPER RES, V196, P509, DOI 10.1016/j.ejor.2008.03.023; Osman I. H., 1996, METAHEURISTICS, P1, DOI [10.1007/978-1-4613-1361-8_1, DOI 10.1007/978-1-4613-1361-8_1]; Ro K, 2007, 45 AIAA AER SCI M EX, P8; Semsch E, 2009, 2009 IEEE/WIC/ACM INTERNATIONAL JOINT CONFERENCES ON WEB INTELLIGENCE (WI) AND INTELLIGENT AGENT TECHNOLOGIES (IAT), VOL 2, P82; Szeto WY, 2011, EUR J OPER RES, V215, P126, DOI 10.1016/j.ejor.2011.06.006; Ubeda S, 2011, INT J PROD ECON, V131, P44, DOI 10.1016/j.ijpe.2010.04.041; Vidal T, 2013, COMPUT OPER RES, V40, P475, DOI 10.1016/j.cor.2012.07.018; Vidal T, 2012, OPER RES, V60, P611, DOI 10.1287/opre.1120.1048; Wen TX, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON DATA SCIENCE AND DATA INTENSIVE SYSTEMS, P153, DOI 10.1109/DSDIS.2015.36; Zhang QF, 2007, IEEE T EVOLUT COMPUT, V11, P712, DOI 10.1109/TEVC.2007.892759; Zhang SZ, 2014, TRANSPORT RES D-TR E, V31, P85, DOI 10.1016/j.trd.2014.05.015	33	27	27	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155176	10.1371/journal.pone.0155176	http://dx.doi.org/10.1371/journal.pone.0155176			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163361	Green Published, gold, Green Submitted			2022-12-27	WOS:000376585700031
J	Manso, PPD; de Oliveira, BCEPD; de Sequeira, PC; de Souza, YRM; Ferro, JMD; da Silva, IJ; Caputo, LFG; Guedes, PT; dos Santos, AAC; Freire, MD; Bonaldo, MC; Machado, MP				de Abreu Manso, Pedro Paulo; Dias de Oliveira, Barbara Cristina E. P.; de Sequeira, Patricia Carvalho; Maia de Souza, Yuli Rodrigues; dos Santos Ferro, Jessica Maria; da Silva, Igor Jose; Goncalves Caputo, Luzia Fatima; Guedes, Priscila Tavares; Cunha dos Santos, Alexandre Araujo; Freire, Marcos da Silva; Bonaldo, Myrna Cristina; Machado, Marcelo Pelajo			Kinetic Study of Yellow Fever 17DD Viral Infection in Gallus gallus domesticus Embryos	PLOS ONE			English	Article							VIRUS-INFECTION; CHICK-EMBRYO; PATHOGENESIS; VACCINATION; PATHOLOGY; CELLS; LIVER	Yellow fever continues to be an important epidemiological problem in Africa and South America even though the disease can be controlled by vaccination. The vaccine has been produced since 1937 and is based on YFV 17DD chicken embryo infection. However, little is known about the histopathological background of virus infection and replication in this model. Here we show by morphological and molecular methods (brightfield and confocal microscopies, immunofluorescence, nested-PCR and sequencing) the kinetics of YFV 17DD infection in chicken embryos with 9 days of development, encompassing 24 to 96 hours post infection. Our principal findings indicate that the main cells involved in virus production are myoblasts with a mesenchymal shape, which also are the first cells to express virus proteins in Gallus gallus embryos at 48 hours after infection. At 72 hours post infection, we observed an increase of infected cells in embryos. Many sites are thus affected in the infection sequence, especially the skeletal muscle. We were also able to confirm an increase of nervous system infection at 96 hours post infection. Our data contribute to the comprehension of the pathogenesis of YF 17DD virus infection in Gallus gallus embryos.	[de Abreu Manso, Pedro Paulo; Dias de Oliveira, Barbara Cristina E. P.; Maia de Souza, Yuli Rodrigues; dos Santos Ferro, Jessica Maria; da Silva, Igor Jose; Goncalves Caputo, Luzia Fatima; Guedes, Priscila Tavares; Machado, Marcelo Pelajo] Fiocruz MS, Inst Oswaldo Cruz, Lab Patol, BR-21045900 Rio De Janeiro, Brazil; [de Sequeira, Patricia Carvalho; Cunha dos Santos, Alexandre Araujo; Bonaldo, Myrna Cristina] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, Brazil; [Guedes, Priscila Tavares] Univ Fed Estado Rio de Janeiro, UNIRIO, Rio De Janeiro, Brazil; [Freire, Marcos da Silva] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Lab Tecnol Virol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz	Manso, PPD (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Patol, BR-21045900 Rio De Janeiro, Brazil.	mansoppa@gmail.com	Bonaldo, Myrna/AAE-2799-2021; de Abreu Manso, Pedro Paulo/M-7326-2018; Machado, Marcelo Pelajo/I-5359-2012	de Abreu Manso, Pedro Paulo/0000-0002-7255-0429; Rodrigues Maia de Souza, Yuli/0000-0002-6202-1961; Pelajo Machado, Marcelo/0000-0002-7295-7018; Rio Branco dos Santos Ferro, Jessica Maria/0000-0002-6083-2808	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/010.001530/2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Oswaldo Cruz	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Cruz	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (www.faperj.br) (E-26/010.001530/2014), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br), and Fundacao Oswaldo Cruz (WWW.fiocruz.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018; Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010; Beck A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001910; Benchimol JL., 2001, FEBRE AMARELA DOENCA, DOI [10.7476/9788575413951, DOI 10.7476/9788575413951]; CARSON FL, 1973, AM J CLIN PATHOL, V59, P365; Manso PPD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004064; FOX JP, 1947, AM J HYG, V46, P21, DOI 10.1093/oxfordjournals.aje.a119152; Freire MS, 2005, VACCINE, V23, P2501, DOI 10.1016/j.vaccine.2004.10.035; Guedes PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090975; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; Martins RdM, 2014, VACCINE; Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MAYER P, 1903, Z WISSENSCHAFTLICHE, V20, P409; McMahon AW, 2007, VACCINE, V25, P1727, DOI 10.1016/j.vaccine.2006.11.027; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0; Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6; Monath TP CM, 2008, VACCINES; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Penna H, 1956, YF VACCINATION MONOG, P67; Post PR, 2001, MEM I OSWALDO CRUZ, V96, P849, DOI 10.1590/S0074-02762001000600019; Quaresma JAS, 2006, VIRUS RES, V116, P91, DOI 10.1016/j.virusres.2005.08.019; Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058; Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752; SEAY AR, 1981, NEUROLOGY, V31, P656, DOI 10.1212/WNL.31.6.656; Shawn F., 2005, SOUTH MED J, V98, P484, DOI [10.1097/01.SMJ.0000145879.14102.F4, DOI 10.1097/01.SMJ.0000145879.14102.F4]; Strode GK, 1951, YELLOW FEVER; TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R; TOKUYASU KT, 1984, J CELL BIOL, V98, P1961, DOI 10.1083/jcb.98.6.1961; WAKAI S, 1978, CELL TISSUE RES, V195, P195; Xiao SY, 2001, J INFECT DIS, V183, P1437, DOI 10.1086/320200; Zhou ZE, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-38	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155041	10.1371/journal.pone.0155041	http://dx.doi.org/10.1371/journal.pone.0155041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158977	Green Published, gold, Green Submitted			2022-12-27	WOS:000376576700032
J	Dotterweich, J; Tower, RJ; Brandl, A; Muller, M; Hofbauer, LC; Beilhack, A; Ebert, R; Gluer, CC; Tiwari, S; Schutze, N; Jakob, F				Dotterweich, Julia; Tower, Robert J.; Brandl, Andreas; Mueller, Marc; Hofbauer, Lorenz C.; Beilhack, Andreas; Ebert, Regina; Glueer, Claus C.; Tiwari, Sanjay; Schuetze, Norbert; Jakob, Franz			The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease	PLOS ONE			English	Article							METASTASIS SUPPRESSOR; CELL-LINES; CANCER-CELLS; GPR54; KISSPEPTIN-10; SECRETION; PROTEIN; SYSTEM; TRANSCRIPTION; MAINTENANCE	Multiple myeloma is one of the most common hematological diseases and is characterized by an aberrant proliferation of plasma cells within the bone marrow. As a result of crosstalk between cancer cells and the bone microenvironment, bone homeostasis is disrupted leading to osteolytic lesions and poor prognosis. Current diagnostic strategies for myeloma typically rely on detection of excess monoclonal immunoglobulins or light chains in the urine or serum. However, these strategies fail to localize the sites of malignancies. In this study we sought to identify novel biomarkers of myeloma bone disease which could target the malignant cells and/or the surrounding cells of the tumor microenvironment. From these studies, the KISS1 receptor (KISS1R), a G-protein-coupled receptor known to play a role in the regulation of endocrine functions, was identified as a target gene that was upregulated on mesenchymal stem cells (MSCs) and osteoprogenitor cells (OPCs) when co-cultured with myeloma cells. To determine the potential of this receptor as a biomarker, in vitro and in vivo studies were performed with the KISS1R ligand, kisspeptin, conjugated with a fluorescent dye. In vitro microscopy showed binding of fluorescently-labeled kisspeptin to both myeloma cells as well as MSCs under direct co-culture conditions. Next, conjugated kisspeptin was injected into immune-competent mice containing myeloma bone lesions. Tumor-burdened limbs showed increased peak fluorescence compared to contralateral controls. These data suggest the utility of the KISS1R as a novel biomarker for multiple myeloma, capable of targeting both tumor cells and host cells of the tumor microenvironment.	[Dotterweich, Julia; Ebert, Regina; Schuetze, Norbert; Jakob, Franz] Univ Wurzburg, Dept Orthoped, Orthoped Ctr Musculoskeletal Res, D-97070 Wurzburg, Germany; [Tower, Robert J.; Mueller, Marc; Glueer, Claus C.; Tiwari, Sanjay] Univ Hosp Schleswig Holstein, Sect Biomed Imaging, Dept Radiol & Neuroradiol, MOIN CC, Campus Kiel, Kiel, Germany; [Brandl, Andreas; Beilhack, Andreas] Univ Hosp Wurzburg, Interdisciplinary Ctr Clin Res Lab, Dept Internal Med 2, Wurzburg, Germany; [Hofbauer, Lorenz C.] Tech Univ Dresden, Med Ctr, Dept Med 3, D-01062 Dresden, Germany; [Tower, Robert J.] Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Skeletal Cell Biol & Physiol SCEBP, Leuven, Belgium	University of Wurzburg; University of Kiel; Schleswig Holstein University Hospital; University of Wurzburg; Technische Universitat Dresden; KU Leuven	Jakob, F (corresponding author), Univ Wurzburg, Dept Orthoped, Orthoped Ctr Musculoskeletal Res, D-97070 Wurzburg, Germany.	f-jakob.klh@uni-wuerzburg.de	Hofbauer, Lorenz C/G-2490-2010; Jakob, Franz/D-8526-2015; Tiwari, Sanjay/Q-1853-2016; Ebert, Regina/D-5760-2016; Glüer, Claus-Christian/C-9752-2010	Hofbauer, Lorenz C/0000-0002-8691-8423; Tiwari, Sanjay/0000-0002-3804-3300; Ebert, Regina/0000-0002-8192-869X; Glüer, Claus-Christian/0000-0003-3539-8955; Tower, Robert/0000-0001-5856-5758	Deutsche Forschungsgemeinschaft [Forschergruppe 1586 SKELMET, KFO 216]; state of Schleswig-Holstein; Wilhelm Sander Foundation; Interdisciplinary Center for Clinical Research Wurzburg [B233]; Open Access Publication Fund of the University of Wurzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); state of Schleswig-Holstein; Wilhelm Sander Foundation; Interdisciplinary Center for Clinical Research Wurzburg; Open Access Publication Fund of the University of Wurzburg	Financial support was provided by the Deutsche Forschungsgemeinschaft through the Forschergruppe 1586 SKELMET (JD, NS, RE, FJ, RJT, ST, CCG, LCH, ABr, ABe) and the KFO 216 (http://www.dfg.de/) (ABe), a research grant from the state of Schleswig-Holstein (RJT, CCG, ST: MOIN CC, Zukunftsprogramm Wirtschaft, https://www.schleswig-holstein.de/DE/Fachinhalte/F/foerderprogramme/MWAVT/efre_2007_2013.html), the Wilhelm Sander Foundation (http://www.wilhelm-sander-stiftung.de/cms/front_content.php) (RE, FJ), and the Interdisciplinary Center for Clinical Research Wurzburg (B233) (ABe) (http://www.izkf.ukw.de/). This publication was supported by the Open Access Publication Fund of the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Burger R, 2001, Hematol J, V2, P42, DOI 10.1038/sj.thj.6200075; Castellano JM, 2006, ENDOCRINOLOGY, V147, P4852, DOI 10.1210/en.2006-0117; Cho SG, 2012, CANCER METAST REV, V31, P585, DOI 10.1007/s10555-012-9367-7; Cook LM, 2011, SEMIN CANCER BIOL, V21, P113, DOI 10.1016/j.semcancer.2010.12.005; Curtis AE, 2010, AM J PHYSIOL-ENDOC M, V298, pE296, DOI 10.1152/ajpendo.00426.2009; Cvetkovic D, 2013, ENDOCRINOLOGY, V154, P1999, DOI 10.1210/en.2012-2164; De Raeve HR, 2005, HISTOL HISTOPATHOL, V20, P1227, DOI 10.14670/HH-20.1227; Derksen PWB, 2003, LEUKEMIA, V17, P764, DOI 10.1038/sj.leu.2402875; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; Dotterweich J, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-36; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; Ebert R, 2015, STEM CELL RES, V15, P231, DOI 10.1016/j.scr.2015.06.008; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Gahrton G, 2004, LANCET, V364, P1648, DOI 10.1016/S0140-6736(04)17371-6; Giuliani N, 2005, BLOOD, V106, P2472, DOI 10.1182/blood-2004-12-4986; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Heimberger T, 2013, BRIT J HAEMATOL, V160, P465, DOI 10.1111/bjh.12164; Hofgaard PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051892; Hussein MA, 2002, CURR OPIN ONCOL, V14, P31, DOI 10.1097/00001622-200201000-00006; KATAGIRI S, 1985, INT J CANCER, V36, P241, DOI 10.1002/ijc.2910360217; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Liu ZF, 2013, J CHROMATOGR B, V926, P1, DOI 10.1016/j.jchromb.2013.02.027; Makri A, 2008, CANCER TREAT REV, V34, P682, DOI 10.1016/j.ctrv.2008.05.007; Mechaly AS, 2009, BIOL REPROD, V80, P60, DOI 10.1095/biolreprod.108.072173; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Nash KT, 2006, FRONT BIOSCI-LANDMRK, V11, P647, DOI 10.2741/1824; Niida A, 2006, BIOORG MED CHEM LETT, V16, P134, DOI 10.1016/j.bmcl.2005.09.054; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; Orsini MJ, 2007, J MED CHEM, V50, P462, DOI 10.1021/jm0609824; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Regelink JC, 2013, BRIT J HAEMATOL, V162, P50, DOI 10.1111/bjh.12346; Riedel SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052398; SHIMIZU S, 1993, LEUKEMIA, V7, P274; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tomita K, 2006, BIOORGAN MED CHEM, V14, P7595, DOI 10.1016/j.bmc.2006.07.009; Vacca A, 1999, BLOOD, V93, P3064; Ziegler E, 2013, ONCOL REP, V29, P549, DOI 10.3892/or.2012.2135	47	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155087	10.1371/journal.pone.0155087	http://dx.doi.org/10.1371/journal.pone.0155087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158817	Green Published, gold			2022-12-27	WOS:000376576700041
J	Marcolin, G; Grainer, A; Reggiani, C; Bisiacchi, P; Cona, G; Petrone, N; Paoli, A				Marcolin, Giuseppe; Grainer, Alessandro; Reggiani, Carlo; Bisiacchi, Patrizia; Cona, Giorgia; Petrone, Nicola; Paoli, Antonio			Static and Dynamic Postural Changes after a Mountain Ultra-Marathon of 80 km and 5500 D+	PLOS ONE			English	Article							MUSCLE FATIGUE; LOCAL FATIGUE; ULTRAMARATHON; STABILITY; LOAD	The study aimed to investigate the effect of fatigue on static and dynamic postural stability after completing a mountain ultra-marathon. Twelve male athletes participated in the study. Postural stability was assessed before and immediately after the race. Static postural stability was evaluated on a dynamometric platform with eyes opened (OE) and closed (CE). Dynamic postural stability was assessed with OE on an instrumented plate which allowed medio-lateral oscillations. Stabilometric data were affected by fatigue in the OE condition, concerning sway path velocity (p = 0.0006), sway area velocity (p = 0.0006), area of the confidence ellipse (p = 0.0016), maximal anterior-posterior (AP) (p = 0.0017) and medio-lateral (ML) (p = 0.0039) oscillations. In the CE condition the sway path velocity (p = 0.0334), the maximal ML oscillations (p = 0.0161) and the area of the confident ellipse (p = 0.0180) were also negatively influenced. Stabilogram diffusion analysis showed in the OE condition an increase of short-term diffusion coefficients considering the anterior-posterior direction (Dfys; p = 0.0023) and the combination of the two (Dfr(2)s; p = 0.0032). Equally, long term diffusion coefficients increased considering the anterior-posterior direction (Dfyl; p = 0.0093) and the combination of the two (Dfr(2)l; p = 0.0086). In CE condition greater values were detected for medio-lateral direction (Dfxl; p = 0.033), anterior-posterior direction (Dfyl; p = 0.0459) and the combination of the two (Dfr(2)l; p = 0.0048). The dynamic postural stability test showed an increase of the time spent with the edges of the plate on the floor (p = 0.0152). Our results showed that mountain ultra-marathon altered static stability more than dynamic stability. An involvement of cognitive resources to monitor postural stability after fatiguing could be the explanation of the worsening in the automatic task (quiet standing) and of the positive compensation in the less automatic task (dynamic standing on the instrumented plate).	[Marcolin, Giuseppe; Grainer, Alessandro; Reggiani, Carlo; Paoli, Antonio] Univ Padua, Dept Biomed Sci, Padua, Italy; [Bisiacchi, Patrizia; Cona, Giorgia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Petrone, Nicola] Univ Padua, Dept Ind Engn, Padua, Italy	University of Padua; University of Padua; University of Padua	Paoli, A (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	antonio.paoli@unipd.it	Marcolin, Giuseppe/ABD-5831-2020; Paoli, Antonio/A-6151-2015	Paoli, Antonio/0000-0003-0474-4229; , Giorgia/0000-0003-1844-9327; Marcolin, Giuseppe/0000-0002-2768-3257; PETRONE, NICOLA/0000-0002-6638-484X				Baldini A, 2013, J ELECTROMYOGR KINES, V23, P1474, DOI 10.1016/j.jelekin.2013.08.003; Bove M, 2007, NEUROSCI LETT, V418, P276, DOI 10.1016/j.neulet.2007.03.036; Burdet C, 2004, SCI SPORT, V19, P308, DOI 10.1016/j.scispo.2004.02.003; Caron O, 2004, NEUROSCI LETT, V363, P18, DOI 10.1016/j.neulet.2004.03.038; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Corbeil P, 2003, GAIT POSTURE, V18, P92, DOI 10.1016/S0966-6362(02)00198-4; Cortes N, 2014, GAIT POSTURE, V39, P888, DOI 10.1016/j.gaitpost.2013.11.020; Degache F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084554; Derave W, 2002, INT J SPORTS MED, V23, P44, DOI 10.1055/s-2002-19374; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gimmon Y, 2011, J ELECTROMYOGR KINES, V21, P922, DOI 10.1016/j.jelekin.2011.08.005; Lepers R, 1997, EUR J APPL PHYSIOL, V76, P55, DOI 10.1007/s004210050212; Millet GP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-77; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Nardone A, 1998, ARCH PHYS MED REHAB, V79, P920, DOI 10.1016/S0003-9993(98)90088-0; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; Reimer RC, 2010, J SCI MED SPORT, V13, P161, DOI 10.1016/j.jsams.2009.01.001; Ruzic L, 2014, GAIT POSTURE, V39, P415, DOI 10.1016/j.gaitpost.2013.08.004; Salavati M, 2007, GAIT POSTURE, V26, P214, DOI 10.1016/j.gaitpost.2006.09.001; Saugy J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065596; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Vuillerme N, 2007, PSYCHOL RES-PSYCH FO, V71, P192, DOI 10.1007/s00426-005-0018-2; Wuthrich TU, 2015, MED SCI SPORT EXER, V47, P519, DOI 10.1249/MSS.0000000000000449	24	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155085	10.1371/journal.pone.0155085	http://dx.doi.org/10.1371/journal.pone.0155085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159563	Green Published, gold, Green Submitted			2022-12-27	WOS:000376576700040
J	Yuan, YH; Medel, M				Yuan, Yihong; Medel, Monica			Characterizing International Travel Behavior from Geotagged Photos: A Case Study of Flickr	PLOS ONE			English	Article							SOCIAL MEDIA; MIGRATION	Recent advances in multimedia and mobile technologies have facilitated large volumes of travel photos to be created and shared online. Although previous studies have utilized geotagged photos to model travel patterns at individual locations, there is limited research on how these datasets can model international travel behavior and inter-country travel flows-a crucial indicator to quantify the interactions between countries in tourism economics. Realizing the necessity to investigate the potential of geotagged photos in tourism geography, this research investigates international travel patterns from two perspectives: 1) We apply a series of indicators (radius of gyration (ROG), number of countries visited, and entropy) to measure the descriptive characteristics of international travel in different countries; 2) By constructing a gravity model of trade, we investigate how distance decay influences the magnitude of international travel flow between geographic entities, and whether (or how much) the popularity of a given destination (defined as the percentage of tourist income in national gross domestic product (GDP)) affects travel choices in different countries. The results provide valuable input to various commercial applications such as individual travel planning and destination suggestions.	[Yuan, Yihong; Medel, Monica] Texas State Univ, Dept Geog, San Marcos, TX 78666 USA	Texas State University System; Texas State University San Marcos	Yuan, YH (corresponding author), Texas State Univ, Dept Geog, San Marcos, TX 78666 USA.	yuan@txstate.edu		Yuan, Yihong/0000-0001-6266-9744				Barbier G, 2012, COMPUT MATH ORGAN TH, V18, P257, DOI 10.1007/s10588-012-9121-2; Barchiesi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128470; Bawa-Cavia A., 2011, 1 WORKSH PERV URB AP; Beiro MG, 2016, PREDICTING HUMAN MOB; Bojic I, 2015, LECT NOTES COMPUT SC, V9471, P194, DOI 10.1007/978-3-319-27433-1_14; Box G.E., 1987, EMPIRICAL MODEL BUIL, VVolume 424; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Chun Y, 2011, ANN ASSOC AM GEOGR, V101, P523, DOI 10.1080/00045608.2011.561070; Clements M, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P851; Cranshaw J, 2012, 6 INT AAAI C WEBP SO; Da Rugna J, 2012, INT SYMP COMP INTELL, P347, DOI 10.1109/CINTI.2012.6496788; Gao H, 2012, 6 INT C WEBL SOC MED, P114; Girardin F., 2007, 4 INT S LBS TEL HONG; Golledge RG., 1997, SPATIAL BEHAV GEOGRA; Golub B, 2010, AM ECON J-MICROECON, V2, P112, DOI 10.1257/mic.2.1.112; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guffey ME, 1997, ESSENTIALS BUSINESS; Hall E. T., 1976, CULTURE; Hardy D, 2012, INT J GEOGR INF SCI, V26, P1191, DOI 10.1080/13658816.2011.629618; Hasan S., 2013, P 2 ACM SIGKDD INT W; Hawelka B, 2014, CARTOGR GEOGR INF SC, V41, P260, DOI 10.1080/15230406.2014.890072; Vu HQ, 2015, TOURISM MANAGE, V46, P222, DOI 10.1016/j.tourman.2014.07.003; Johnson J, 2015, PROC CVPR IEEE, P3668, DOI 10.1109/CVPR.2015.7298990; Kalkowski S, 2015, MMCOMMONS'15: PROCEEDINGS OF THE 2015 WORKSHOP ON COMMUNITY-ORGANIZED MULTIMODAL MINING: OPPORTUNITIES FOR NOVEL SOLUTIONS, P25, DOI 10.1145/2814815.2814820; Larsen J., 2012, ROUTLEDGE HDB TOURIS, P67; Lenormand M, ARXIV 150107788V1201; Lewer JJ, 2008, ECON LETT, V99, P164, DOI 10.1016/j.econlet.2007.06.019; Liu Y, 2015, ANN ASSOC AM GEOGR, V105, P512, DOI 10.1080/00045608.2015.1018773; Liu Y, 2014, T GIS, V18, P89, DOI 10.1111/tgis.12023; Majid A, 2013, INT J GEOGR INF SCI, V27, P662, DOI 10.1080/13658816.2012.696649; Malleson N, 2014, ASE BIGDATA SOCIALCO; Mascolo C., 2004, P 7 ACM INT S MOD AN, P20, DOI [DOI 10.1145/1023663.1023669, 10.1145/1023663.1023669]; Mehta P., 2015, P 23 SIGSPATIAL INT, P1; Memon I, 2015, WIRELESS PERS COMMUN, V80, P1347, DOI 10.1007/s11277-014-2082-7; Oppermann M, 1997, GEOGRAPHY TOURISM MA; Qu Y, 2013, P SIGCHI C HUM FACT, P395, DOI DOI 10.1145/2470654.2470711; Rodrigue JP., 2013, GEOGRAPHY TRANSPORT, DOI DOI 10.4324/9781315618159-2; Roick O, 2013, T GIS, V17, P763, DOI 10.1111/tgis.12032; RYAN C, 1995, TOURISM MANAGE, V16, P327, DOI 10.1016/0261-5177(95)90001-2; Sparks B, 2009, TOURISM MANAGE, V30, P483, DOI 10.1016/j.tourman.2008.10.014; Sun Y, 2012, 9 S LOC BAS SERV MUN; Thomee B, 2015, THE NEW DATA AND NEW; Tisdell C, 2013, HANDBOOK OF TOURISM ECONOMICS: ANALYSIS, NEW APPLICATIONS AND CASE STUDIES, P3; Tranos E, 2015, ENVIRON PLANN B, V42, P4, DOI 10.1068/b39042; TripAdvisor.com, 2007, TRIPADVISOR FACT SHE; Tufekci Zeynep, 2014, ICWSM 14 P 8 INT AAA; Ullman E. L., 1980, GEOGRAPHY SPATIAL IN; VANEK J, 1964, REV ECON STAT, V46, P99, DOI 10.2307/1924081; Vega HL, 2014, ADV AIRLINE ECON, V4, P199, DOI 10.1108/S2212-160920140000004007; Wu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097010; Xia Y, 2005, THESIS U CALIFORNIA; Yuan Y, 2015, INT C LOC BAS SOC ME; Yuan YH, 2012, COMPUT ENVIRON URBAN, V36, P118, DOI 10.1016/j.compenvurbsys.2011.07.003	54	28	28	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154885	10.1371/journal.pone.0154885	http://dx.doi.org/10.1371/journal.pone.0154885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM7YQ	27159195	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700023
J	Ward, PJ; Jones, LN; Mulligan, A; Goolsby, W; Wilhelm, JC; English, AW				Ward, Patricia J.; Jones, Laura N.; Mulligan, Amanda; Goolsby, William; Wilhelm, Jennifer C.; English, Arthur W.			Optically-Induced Neuronal Activity Is Sufficient to Promote Functional Motor Axon Regeneration In Vivo	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; ELECTRICAL-STIMULATION; SCHWANN-CELLS; RECOVERY; RATS; MICE; CHANNELRHODOPSIN-2; REINNERVATION; ENHANCEMENT; ACTIVATION	Peripheral nerve injuries are common, and functional recovery is very poor. Beyond surgical repair of the nerve, there are currently no treatment options for these patients. In experimental models of nerve injury, interventions (such as exercise and electrical stimulation) that increase neuronal activity of the injured neurons effectively enhance axon regeneration. Here, we utilized optogenetics to determine whether increased activity alone is sufficient to promote motor axon regeneration. In thy-1-ChR2/YFP transgenic mice in which a subset of motoneurons express the light-sensitive cation channel, channelrhodopsin (ChR2), we activated axons in the sciatic nerve using blue light immediately prior to transection and surgical repair of the sciatic nerve. At four weeks post-injury, direct muscle EMG responses evoked with both optical and electrical stimuli as well as the ratio of these optical/electrical evoked EMG responses were significantly greater in mice that received optical treatment. Thus, significantly more ChR2+ axons successfully re-innervated the gastrocnemius muscle in mice that received optical treatment. Sections of the gastrocnemius muscles were reacted with antibodies to Synaptic Vesicle Protein 2 (SV2) to quantify the number of re-occupied motor endplates. The number of SV2+ endplates was greater in mice that received optical treatment. The number of retrogradely-labeled motoneurons following intramuscular injection of cholera toxin subunit B (conjugated to Alexa Fluor 555) was greater in mice that received optical treatment. Thus, the acute (1 hour), one-time optical treatment resulted in robust, long-lasting effects compared to untreated animals as well as untreated axons (ChR2-). We conclude that neuronal activation is sufficient to promote motor axon regeneration, and this regenerative effect is specific to the activated neurons.	[Ward, Patricia J.; Jones, Laura N.; Mulligan, Amanda; Goolsby, William; English, Arthur W.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Wilhelm, Jennifer C.] Coll Charleston, Dept Psychol, Charleston, SC 29401 USA	Emory University; College of Charleston	Ward, PJ (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA.	jill.ward@emory.edu		Ward, Patricia/0000-0002-5379-3644	National Institute of Neurological Disorders and Stroke [NS057190, NS087915]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institute of Neurological Disorders and Stroke grant numbers NS057190 (AWE) and NS087915 (PJW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Alilain WJ, 2008, J NEUROSCI, V28, P11862, DOI 10.1523/JNEUROSCI.3378-08.2008; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Boada MD, 2014, PAIN, V155, P2646, DOI 10.1016/j.pain.2014.09.030; Boeltz T, 2013, J NEUROPHYSIOL, V109, P2645, DOI 10.1152/jn.00946.2012; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Daou I, 2013, J NEUROSCI, V33, P18631, DOI 10.1523/JNEUROSCI.2424-13.2013; de Vries J, 2002, SURG NEUROL, V57, P415, DOI 10.1016/S0090-3019(02)00736-X; English AW, 2014, PHYSIOLOGY, V29, P437, DOI 10.1152/physiol.00028.2014; English AW, 2013, P NATL ACAD SCI USA, V110, P16217, DOI 10.1073/pnas.1303646110; English AW, 2009, J COMP NEUROL, V517, P245, DOI 10.1002/cne.22149; English AW, 2005, J COMP NEUROL, V490, P427, DOI 10.1002/cne.20678; English AW, 2015, THE EUROPEAN JOURNAL, DOI [10.1111/ejn.13005, DOI 10.1111/EJN.13005]; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020; Gordon T, 2009, NEUROSURGERY, V65, pA132, DOI 10.1227/01.NEU.0000335650.09473.D3; Groves ML, 2005, EXP NEUROL, V195, P278, DOI 10.1016/j.expneurol.2005.04.007; Isaacs J, 2010, J HAND SURG-AM, V35A, P491, DOI 10.1016/j.jhsa.2009.12.009; Krakowiak J, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/392591; Liu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098633; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; MacGillivray TE, 2003, J CARDIAC SURG, V18, P480, DOI 10.1046/j.0886-0440.2003.02073.x; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NIX WA, 1983, BRAIN RES, V272, P21, DOI 10.1016/0006-8993(83)90360-8; Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09669; Sabatier MJ, 2015, EXERC SPORT SCI REV, V43, P163, DOI 10.1249/JES.0000000000000047; Scholz T, 2009, J RECONSTR MICROSURG, V25, P339, DOI 10.1055/s-0029-1215529; Sharma N, 2010, EXP NEUROL, V223, P183, DOI 10.1016/j.expneurol.2009.04.031; Tam SL, 2002, J PHYSIOL-LONDON, V543, P655, DOI 10.1113/jphysiol.2001.012982; Taylor CA, 2008, AM J PHYS MED REHAB, V87, P381, DOI 10.1097/PHM.0b013e31815e6370; Thompson NJ, 2014, DEV NEUROBIOL, V74, P531, DOI 10.1002/dneu.22147; Towne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072691; Udina E, 2011, MUSCLE NERVE, V43, P500, DOI 10.1002/mus.21912; Wilhelm JC, 2012, J NEUROSCI, V32, P5002, DOI 10.1523/JNEUROSCI.1411-11.2012; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	38	26	26	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154243	10.1371/journal.pone.0154243	http://dx.doi.org/10.1371/journal.pone.0154243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152611	Green Submitted, gold, Green Published			2022-12-27	WOS:000375677000013
J	Al Hajoj, S; Varghese, B; Datijan, A; Shoukri, M; Alzahrani, A; Alkhenizan, A; AlSaif, A; Althawadi, S; Fernandez, G; Alrajhi, A				Al Hajoj, Sahal; Varghese, Bright; Datijan, Alria; Shoukri, Mohammed; Alzahrani, Ali; Alkhenizan, Abdallah; AlSaif, Abdulaziz; Althawadi, Sahar; Fernandez, Grace; Alrajhi, Abdulrahman			Interferon Gamma Release Assay versus Tuberculin Skin Testing among Healthcare Workers of Highly Diverse Origin in a Moderate Tuberculosis Burden Country	PLOS ONE			English	Article							INFECTION; TB; DIAGNOSIS; PREVALENCE; BCG	Health care workers (HCW's) are always at an increased risk of contracting tuberculosis (TB) infection. In Saudi Arabia, Interferon Gamma Release Assay (IGRA) has not been evaluated as a screening tool for latent TB infection (LTBI) among HCW's considering their high demographic diversity. During February 2012 to January 2015 a cross sectional study has been conducted in a tertiary care center with maximum demographically diverse staff population in the capital city-Riyadh. After a short interview and consenting, all the candidates were subjected to tuberculin skin test (TST) and QuantiFERON TB gold In-tube test (QFT). A logistic regression analysis was carried out for establishing the associations between putative risk factors and the diagnostic tests. The candidates were classified according to geographical origin and a detailed analysis was conducted on the impact of their origin towards the results of TST and QFT. Of the 1595 candidates enrolled, 90.6% were BCG vaccinated, female (67.9%) and mainly nurses (53.2%). Candidates with high risk of suspected or confirmed TB patient exposure were 56.1% and 76.5% of them had <10 year's work experience. TST positivity was observed in 503 (31.5%) candidates, while QFT was positive among 399 (25%). Majority of the candidates were non-Saudi (83%) and predominantly (52.4%) from Western Pacific region. Concordant results were obtained in 14.2% of positive cases and 57.7% negative cases. The disagreements between the two tests were relatively high (kappa co-efficient-0.312 +/- 0.026, p value- <0.00001) as TST positive/QFT negative discordance was 54.8% while TST negative/QFT positive discordance was 15.7%. Age of the candidates, BCG vaccination, and South East Asian origin were associated with TST positivity while Occupational TB exposure and geographical origin of the candidates were associated with QFT positivity. A regular follow up on recently TST converted candidates showed no progression to active TB. The putative factors associated with the discordance were origin of the candidate (p value <0.001), profession (p value-0.001), BCG vaccination (p value-0.001) and occupational TB exposure level (P value-0.001). The study demonstrated high level prevalence of LTBI among the demographically diverse study candidates. The agreement between QFT and TST was poor, thus QFT alone cannot be recommended in our setting for a routine LTBI screening. Origin of the candidates has strong association with the results of TST and QFT. The discordant results particularly TST negative and QFT positive needs more detailed analysis.	[Al Hajoj, Sahal; Varghese, Bright; Datijan, Alria; Fernandez, Grace] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Mycobacteriol Res Sect, Riyadh 11211, Saudi Arabia; [Shoukri, Mohammed] King Faisal Specialist Hosp & Res Ctr, Natl Biotechnol Ctr, Riyadh 11211, Saudi Arabia; [Alzahrani, Ali] King Faisal Specialist Hosp & Res Ctr, Gulf Ctr Canc Control & Prevent, Riyadh 11211, Saudi Arabia; [Alkhenizan, Abdallah; AlSaif, Abdulaziz] King Faisal Specialist Hosp & Res Ctr, Dept Family Med, Riyadh 11211, Saudi Arabia; [Althawadi, Sahar] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia; [Alrajhi, Abdulrahman] King Faisal Specialist Hosp & Res Ctr, Dept Med, POB 3354, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center	Al Hajoj, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Mycobacteriol Res Sect, Riyadh 11211, Saudi Arabia.	hajoj@kfshrc.edu.sa	Alrajhi, Abdulrahman A/Q-4359-2019					Abbas MAF, 2010, J EGYPT PUBLIC HEAL, V85, P61; Al Jahdali H, 2013, J INFECT PUBLIC HEAL, V6, P166, DOI 10.1016/j.jiph.2013.02.002; Al-Hajoj S, 2013, INFECT GENET EVOL, V16, P362, DOI 10.1016/j.meegid.2013.03.019; Al-Jahdali H, 2005, AM J INFECT CONTROL, V33, P151, DOI 10.1016/j.ajic.2005.01.005; Alzahrani Abdullah G, 2012, J Infect Public Health, V5, P22, DOI 10.1016/j.jiph.2011.10.003; Alzeer AH, 2009, ANN THORAC MED, V4, P50, DOI 10.4103/1817-1737.49412; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Caglayan V, 2011, TUBERK TORAK, V59, P43, DOI 10.5578/tt.1129; Casas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006686; Chawla Harsh, 2012, J Infect Public Health, V5, P369, DOI 10.1016/j.jiph.2012.06.003; Costa JT, 2009, EUR RESPIR J, V34, P1423, DOI 10.1183/09031936.00053809; Costa JT, 2010, REV PORT PNEUMOL, V16, P211, DOI 10.1016/S0873-2159(15)30022-2; Dosanjh DPS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028754; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; El-Helaly M, 2014, J INFECT PUBLIC HEAL, V7, P481, DOI 10.1016/j.jiph.2014.07.012; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Harada Nobuyuki, 2006, Kekkaku, V81, P681; Hassan H. A. H., 2013, British Microbiology Research Journal, V3, P116; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; Hung WT, 2015, J MICROBIOL IMMUNOL, V48, P147, DOI 10.1016/j.jmii.2013.07.008; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Lee KJ, 2010, SCAND J INFECT DIS, V42, P672, DOI 10.3109/00365548.2010.485575; Rubbo PA, 2012, J CLIN MICROBIOL, V50, P1711, DOI 10.1128/JCM.00117-12; Varghese B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077635; Varghese B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002234; Varghese B, 2013, TUBERCULOSIS, V93, P246, DOI 10.1016/j.tube.2012.12.001; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2014, GLOB TUB REP; Zwerling A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043014; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	31	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154803	10.1371/journal.pone.0154803	http://dx.doi.org/10.1371/journal.pone.0154803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148876	Green Submitted, Green Published, gold			2022-12-27	WOS:000375676800063
J	Bertuzzi, A; Conte, F; Mingrone, G; Papa, F; Salinari, S; Sinisgalli, C				Bertuzzi, Alessandro; Conte, Federica; Mingrone, Geltrude; Papa, Federico; Salinari, Serenella; Sinisgalli, Carmela			Insulin Signaling in Insulin Resistance States and Cancer: A Modeling Analysis	PLOS ONE			English	Article							SKELETAL-MUSCLE; IN-VITRO; MTOR; RECEPTOR; COMPLEX; AKT; ACTIVATION; INHIBITION; RICTOR; PHOSPHORYLATION	Insulin resistance is the common denominator of several diseases including type 2 diabetes and cancer, and investigating the mechanisms responsible for insulin signaling impairment is of primary importance. A mathematical model of the insulin signaling network (ISN) is proposed and used to investigate the dose-response curves of components of this network. Experimental data of C2C12 myoblasts with phosphatase and tensin homologue (PTEN) suppressed and data of L6 myotubes with induced insulin resistance have been analyzed by the model. We focused particularly on single and double Akt phosphorylation and pointed out insulin signaling changes related to insulin resistance. Moreover, a new characterization of the upstream signaling of the mammalian target of rapamycin complex 2 (mTORC2) is presented. As it is widely recognized that ISN proteins have a crucial role also in cell proliferation and death, the ISN model was linked to a cell population model and applied to data of a cell line of acute myeloid leukemia treated with a mammalian target of rapamycin inhibitor with antitumor activity. The analysis revealed simple relationships among the concentrations of ISN proteins and the parameters of the cell population model that characterize cell cycle progression and cell death.	[Bertuzzi, Alessandro; Conte, Federica; Papa, Federico; Sinisgalli, Carmela] CNR, Inst Syst Anal & Comp Sci A Ruberti, I-00185 Rome, Italy; [Conte, Federica; Salinari, Serenella] Univ Roma La Sapienza, Dept Comp & Syst Sci, I-00185 Rome, Italy; [Mingrone, Geltrude] Univ Cattolica Sacro Cuore, Sch Med, Dept Internal Med, I-00168 Rome, Italy; [Papa, Federico] SYSBIO Ctr Syst Biol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Mingrone, G (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Dept Internal Med, I-00168 Rome, Italy.	geltrude.mingrone@unicatt.it	Papa, Federico/AAY-4561-2020; Mingrone, Geltrude/AAB-9681-2019; Sinisgalli, Carmela/AAY-2956-2020	BERTUZZI, ALESSANDRO/0000-0003-4969-7366; Mingrone, Geltrude/0000-0003-2021-528X; Conte, Federica/0000-0003-0427-1476	SysBioNet, Italian Roadmap Research Infrastructures; Epigenomics Flagship Project (Progetto Bandiera Epigenomica), EPIGEN - Italian Ministry of Education, University and Research (MIUR); National Research Council (CNR)	SysBioNet, Italian Roadmap Research Infrastructures; Epigenomics Flagship Project (Progetto Bandiera Epigenomica), EPIGEN - Italian Ministry of Education, University and Research (MIUR); National Research Council (CNR)(Consiglio Nazionale delle Ricerche (CNR))	FP was supported by SysBioNet, Italian Roadmap Research Infrastructures 2012. Federica Conte was supported by The Epigenomics Flagship Project (Progetto Bandiera Epigenomica), EPIGEN, funded by the Italian Ministry of Education, University and Research (MIUR), and the National Research Council (CNR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertuzzi A, 1997, MATH BIOSCI, V143, P61, DOI 10.1016/S0025-5564(97)00002-3; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Cangiani A, 2010, J THEOR BIOL, V267, P614, DOI 10.1016/j.jtbi.2010.08.017; Castellani GC, 2009, P NATL ACAD SCI USA, V106, P14091, DOI 10.1073/pnas.0905988106; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Giri Lopamudra, 2004, Theor Biol Med Model, V1, P2, DOI 10.1186/1742-4682-1-2; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Ijuin T, 2012, J BIOL CHEM, V287, P6991, DOI 10.1074/jbc.M111.335539; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kim SJ, 2012, MOL CELL, V48, P875, DOI 10.1016/j.molcel.2012.09.029; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Kondapaka SB, 2004, CLIN CANCER RES, V10, P7192, DOI 10.1158/1078-0432.CCR-04-0772; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lequieu J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002263; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Miyata T, 1998, EUR J ENDOCRINOL, V138, P344, DOI 10.1530/eje.0.1380344; Nascimento EBM, 2006, DIABETES, V55, P3221, DOI 10.2337/db05-1390; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Salinari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056258; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaoka T, 2005, DIABETOLOGIA, V48, P336, DOI 10.1007/s00125-004-1636-8; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Sturrock M, 2011, J THEOR BIOL, V273, P15, DOI 10.1016/j.jtbi.2010.12.016; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Wanant S, 2000, J THEOR BIOL, V205, P355, DOI 10.1006/jtbi.2000.2069; Wang GY, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046015; Willems L, 2012, LEUKEMIA, V26, P1195, DOI 10.1038/leu.2011.339; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	55	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154415	10.1371/journal.pone.0154415	http://dx.doi.org/10.1371/journal.pone.0154415			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149630	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800030
J	Hsieh, JCF; Cramb, SM; McGree, JM; Dunn, NAM; Baade, PD; Mengersen, KL				Hsieh, Jeff Ching-Fu; Cramb, Susanna M.; McGree, James M.; Dunn, Nathan A. M.; Baade, Peter D.; Mengersen, Kerrie L.			Spatially Varying Coefficient Inequalities: Evaluating How the Impact of Patient Characteristics on Breast Cancer Survival Varies by Location	PLOS ONE			English	Article							REGRESSION; PATTERNS; MIXTURE; MODELS	An increasing number of studies have identified spatial differences in breast cancer survival. However little is known about whether the structure and dynamics of this spatial inequality are consistent across a region. This study aims to evaluate the spatially varying nature of predictors of spatial inequality in relative survival for women diagnosed with breast cancer across Queensland, Australia. All Queensland women aged less than 90 years diagnosed with invasive breast cancer from 1997 to 2007 and followed up to the end of 2008 were extracted from linked Queensland Cancer Registry and BreastScreen Queensland data. Bayesian relative survival models were fitted using various model structures ( a spatial regression model, a varying coefficient model and a finite mixture of regressions model) to evaluate the relative excess risk of breast cancer, with the use of Markov chain Monte Carlo computation. The spatially varying coefficient models revealed that some covariate effects may not be constant across the geographic regions of the study. The overall spatial patterns showed lower survival among women living in more remote areas, and higher survival among the urbanised south-east corner. Notwithstanding this, the spatial survival pattern for younger women contrasted with that for older women as well as single women. This complex spatial interplay may be indicative of different factors impacting on survival patterns for these women.	[Hsieh, Jeff Ching-Fu; McGree, James M.; Mengersen, Kerrie L.] Queensland Univ Technol, Math Sci, Brisbane, Qld 4001, Australia; [Cramb, Susanna M.; Baade, Peter D.] Canc Council Queensland, Canc Res Ctr, Brisbane, Qld, Australia; [Dunn, Nathan A. M.] Dept Hlth, Prevent Hlth Unit, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Cancer Council Queensland; Queensland Health	McGree, JM (corresponding author), Queensland Univ Technol, Math Sci, Brisbane, Qld 4001, Australia.	james.mcgree@qut.edu.au	Baade, Peter/C-4113-2009; Mengersen, Kerrie/AHC-4096-2022	Cramb, Susanna/0000-0001-9041-9531; Mengersen, Kerrie/0000-0001-8625-9168; Baade, Peter/0000-0001-8576-8868	Australian Research Council (ARC) [LP100100570]; National Health and Medical Research (NHMRC) [1005334]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by an Australian Research Council (ARC) Linkage Project between Queensland University of Technology, Cancer Council Queensland and BreastScreen Queensland (LP100100570). Peter Baade is funded by a National Health and Medical Research (NHMRC) Career development Fellowship (Level 2) (1005334). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Antoniadis A, 2010, TEST-SPAIN, V19, P257, DOI 10.1007/s11749-010-0198-y; Axelrod D, 2008, J AM COLL SURGEONS, V206, P1193, DOI 10.1016/j.jamcollsurg.2007.12.026; Baade PD, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006740; Baade PD, 2011, J EPIDEMIOL COMMUN H, V65, P1037, DOI 10.1136/jech.2010.114777; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Choi JS, 2012, STAT METHODS MED RES, V21, P445, DOI 10.1177/0962280212446318; Cramb SM, 2011, ATLAS CANC QUEENSLAN; Cramb SM, 2012, HEALTH PLACE, V18, P1412, DOI 10.1016/j.healthplace.2012.07.006; Cramb SM, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-9; Falagas ME, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1744; Gelfand AE, 2003, J AM STAT ASSOC, V98, P387, DOI 10.1198/016214503000170; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; HASTIE T, 1993, J ROY STAT SOC B MET, V55, P757; Hsieh JCF, 2015, STOCH ENV RES RISK A; Hsieh JCF, 2013, AUST NZ J STAT, V55, P351, DOI 10.1111/anzs.12059; Huang ZP, 2015, J STAT COMPUT SIM, V85, P2364, DOI 10.1080/00949655.2014.928821; Leung J, 2014, WOMEN HEALTH ISS, V24, pE139, DOI 10.1016/j.whi.2013.11.005; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McLachlan GJ, 2004, FINITE MIXTURE MODEL, DOI [10.1002/0471721182, DOI 10.1002/0471721182]; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Pitman J, 2002, COMB PROBAB COMPUT, V11, P501, DOI 10.1017/S0963548302005163; Puigpinos-Riera R, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-6; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reich BJ, 2010, BIOMETRICS, V66, P772, DOI 10.1111/j.1541-0420.2009.01333.x; Richardson S, 2004, ENVIRON HEALTH PERSP, V112, P1016, DOI 10.1289/ehp.6740; Rodeiro CLV, 2006, BIOMETRICAL J, V48, P463, DOI 10.1002/bimj.200510176; Saez M, 2012, J R STAT SOC A STAT, V175, P107, DOI 10.1111/j.1467-985X.2011.00720.x; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; Wang XF, 2014, J APPL STAT, V41, P1342, DOI 10.1080/02664763.2013.868870; Wu JCY, 2010, BREAST CANCER RES TR, V121, P671, DOI 10.1007/s10549-009-0604-x; Zou YJ, 2013, ACCIDENT ANAL PREV, V50, P1042, DOI 10.1016/j.aap.2012.08.004	34	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155086	10.1371/journal.pone.0155086	http://dx.doi.org/10.1371/journal.pone.0155086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149274	Green Published, gold			2022-12-27	WOS:000375676800117
J	Park, SW; Chung, MJ; Lee, SH; Lee, HS; Lee, HJ; Park, JY; Park, SW; Song, SY; Kim, H; Chung, JB; Bang, S				Park, Se Woo; Chung, Moon Jae; Lee, Sang Hoon; Lee, Hee Seung; Lee, Hyun Jik; Park, Jeong Yup; Park, Seung Woo; Song, Si Young; Kim, Hoguen; Chung, Jae Bock; Bang, Seungmin			Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25-and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses	PLOS ONE			English	Article							19-GAUGE TRUCUT NEEDLE; 25-GAUGE NEEDLES; EUS; ASPIRATION; LESIONS; YIELD; FNA; MULTICENTER; DIAGNOSIS; FEASIBILITY	Background and Aims Although thicker needles theoretically allow more tissue to be collected, their decreased flexibility can cause mechanical damage to the endoscope, technical failure, and sample blood contamination. The effects of needle gauge on diagnostic outcomes of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) of pancreatic mass lesions remain unknown. This study compared procurement rates of histologic cores obtained from EUS-FNB of pancreatic masses using 25- and 22-gauge core biopsy needles. Patients and Methods From March 2014 to July 2014, 66 patients with solid pancreatic mass underwent EUS-FNB with both 25- and 22-gauge core biopsy needles. Among them, 10 patients were excluded and thus 56 patients were eligible for the analyses. Needle sequences were randomly assigned, and two passes were made with each needle, consisting of 10 uniform to-and-fro movements on each pass with 10 mL syringe suction. A pathologist blinded to needle sequence evaluated specimens for the presence of histologic core. Results The mean patient age was 65.8 +/- 9.5 years (range, 44-89 years); 35 patients (62.5%) were men. The mean pancreatic mass size was 35.3 +/- 17.1 mm (range 14-122.3 mm). Twenty-eight patients (50%) had tumors at the pancreas head or uncinate process. There were no significant differences in procurement rates of histologic cores between 25-gauge (49/56, 87.5%) and 22-gauge (46/56, 82.1%, P = 0.581) needles or diagnostic accuracy using only histologic cores (98% and 95%). There were no technical failures or procedure-related adverse events. Conclusions The 25-gauge core biopsy needle could offer acceptable and comparable outcomes regarding diagnostic performance including histologic core procurement rates compared to the 22-gauge core biopsy needle, although the differences were not statistically significant.	[Park, Se Woo] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Internal Med, Div Gastroenterol,Coll Med, Gyeonggi Do, South Korea; [Chung, Moon Jae; Lee, Sang Hoon; Lee, Hee Seung; Lee, Hyun Jik; Park, Jeong Yup; Park, Seung Woo; Song, Si Young; Chung, Jae Bock; Bang, Seungmin] Yonsei Univ, Coll Med, Dept Internal Med, Severance Hosp,Div Gastroenterol, Seoul, South Korea; [Kim, Hoguen] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Hoguen] Yonsei Univ, Coll Med, Brain Korea Projects Med Sci 21, Seoul, South Korea	Hallym University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Bang, S (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Severance Hosp,Div Gastroenterol, Seoul, South Korea.	bang7028@yuhs.ac	Song, SY/E-2891-2012	Park, Jeong Youp/0000-0003-0110-8606; Bang, Seungmin/0000-0001-5209-8351; Lee, HEE SEUNG/0000-0002-2825-3160; Song, Si Young/0000-0002-1417-4314; Park, Se Woo/0000-0003-1603-7468; Park, Seung Woo/0000-0001-8230-964X; Lee, Sang Hoon/0000-0002-3619-4340; Chung, Moon Jae/0000-0002-5920-8549				Bang JY, 2012, GASTROINTEST ENDOSC, V76, P321, DOI 10.1016/j.gie.2012.03.1392; Cohen LB, 2007, GASTROENTEROLOGY, V133, P675, DOI 10.1053/j.gastro.2007.06.002; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Fabbri C, 2011, DIGEST LIVER DIS, V43, P647, DOI 10.1016/j.dld.2011.04.005; Gan SI, 2007, GASTROINTEST ENDOSC, V66, P425, DOI 10.1016/j.gie.2007.05.026; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Iglesias-Garcia J, 2011, GASTROINTEST ENDOSC, V73, P1189, DOI 10.1016/j.gie.2011.01.053; Imazu H, 2009, GASTROENT RES PRACT, V2009, DOI DOI 10.1155/2009/546390; Irisawa A, 2009, GASTROINTEST ENDOSC, V69, pS125, DOI 10.1016/j.gie.2008.12.017; Iwashita T, 2013, GASTROINTEST ENDOSC, V77, P909, DOI 10.1016/j.gie.2013.01.001; Kida Mitsuhiro, 2011, J Interv Gastroenterol, V1, P102; Kida M, 2009, GASTROINTEST ENDOSC, V69, pS102, DOI 10.1016/j.gie.2008.12.010; Larghi A, 2004, GASTROINTEST ENDOSC, V59, P185, DOI 10.1016/S0016-5107(03)02538-0; Larghi A, 2013, SURG ENDOSC, V27, P3733, DOI 10.1007/s00464-013-2957-9; Lee JH, 2009, DIGEST DIS SCI, V54, P2274, DOI 10.1007/s10620-009-0906-1; Lee JK, 2013, SCAND J GASTROENTERO, V48, P752, DOI 10.3109/00365521.2013.786127; Levy MJ, 2005, GASTROINTEST ENDOSC, V62, P417, DOI 10.1016/j.gie.2005.04.044; Levy MJ, 2002, ONCOLOGY-NY, V16, P29; Madhoun MF, 2013, ENDOSCOPY, V45, P86, DOI 10.1055/s-0032-1325992; Maluf F, 2009, ENDOSCOPY, V41, P979, DOI 10.1055/s-0029-1215192; Mesa H, 2004, DIAGN CYTOPATHOL, V31, P313, DOI 10.1002/dc.20142; Ribeiro A, 2001, GASTROINTEST ENDOSC, V53, P485, DOI 10.1067/mge.2001.112841; Sakamoto H, 2009, J GASTROEN HEPATOL, V24, P384, DOI 10.1111/j.1440-1746.2008.05636.x; Thomas T, 2009, AM J GASTROENTEROL, V104, P584, DOI 10.1038/ajg.2008.97; Varadarajulu S, 2004, ENDOSCOPY, V36, P397, DOI 10.1055/s-2004-814316; VILMANN P, 1992, GASTROINTEST ENDOSC, V38, P172, DOI 10.1016/S0016-5107(92)70385-X; Wahnschaffe U, 2009, SURG ENDOSC, V23, P2351, DOI 10.1007/s00464-009-0345-2; Yusuf TE, 2009, ENDOSCOPY, V41, P445, DOI 10.1055/s-0029-1214643	28	38	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154401	10.1371/journal.pone.0154401	http://dx.doi.org/10.1371/journal.pone.0154401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149404	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800028
J	Santos, AO; Parrini, MC; Camonis, J				Santos, Adriana O.; Parrini, Maria Carla; Camonis, Jacques			RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; GROWTH; PROLIFERATION; ONCOGENESIS; ACTIVATION; TRANSITION; PROTEIN-2	The human genome contains six genes coding for proteins validated in vitro as specific activators of the small GTPases "Ras-related protein Ral-A" and "Ras-related protein Ral-B", generically named Ral-guanine nucleotide exchange factors (RalGEF). Ral proteins are important contributors to Ras oncogenic signaling, and RAS oncogenes are important in human Non-Small Cell Lung Carcinoma (NSCLC). Therefore in this work, RalGEF contribution to oncogenic and non-oncogenic features of human NSCLC cell lines, as anchorage-dependent and independent growth, cell survival, and proliferation, was investigated. Among all human RalGEF, silencing of RGL1 and RALGPS1 had no detectable effect. However, silencing of either RGL2, RGL3, RALGDS or, to a larger extent, RALGPS2 inhibited cell population growth in anchorage dependent and independent conditions (up to 90 and 80%, respectively). RALGPS2 silencing also caused an increase in the number of apoptotic cells, up to 45% of the cell population in transformed bronchial BZR cells. In H1299 and A549, two NSCLC cell lines, RALGPS2 silencing caused an arrest of cells in the G0/G1-phase of cell cycle. Furthermore, it was associated with the modulation of important cell cycle regulators: the E3 Ubiquitin Protein Ligase S-phase kinase-associated protein 2 (Skp2) was strongly down-regulated (both at mRNA and protein levels), and its targets, the cell cycle inhibitors p27 and p21, were up-regulated. These molecular effects were not mimicked by silencing RALA, RALB, or both. However, RALB silencing caused a modest inhibition of cell cycle progression, which in H1299 cells was associated with Cyclin D1 regulation. In conclusion, RALGPS2 is implicated in the control of cell cycle progression and survival in the in vitro growth of NSCLC cell lines. This function is largely independent of Ral GTPases and associated with modulation of Skp2, p27 and p21 cell cycle regulators.	[Santos, Adriana O.; Parrini, Maria Carla; Camonis, Jacques] PSL Res Univ, Inst Curie, INSERM U830, Paris, France; [Camonis, Jacques] Inst Curie, Translat Res Dept, Biophen Project, Paris, France; [Santos, Adriana O.] Univ Beira Interior, CICS UBI Hlth Sci Res Ctr, Covilha, Portugal; [Santos, Adriana O.] Univ Beira Interior, FCS Fac Hlth Sci, Covilha, Portugal	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universidade da Beira Interior; Universidade da Beira Interior	Parrini, MC; Camonis, J (corresponding author), PSL Res Univ, Inst Curie, INSERM U830, Paris, France.; Camonis, J (corresponding author), Inst Curie, Translat Res Dept, Biophen Project, Paris, France.	maria-carla.parrini@curie.fr; jcamonis.institut.curie@gmail.com	Parrini, Maria Carla/J-5390-2016; dos Santos, Adriana Oliveira/H-4597-2011	Parrini, Maria Carla/0000-0002-7082-9792; dos Santos, Adriana Oliveira/0000-0002-1224-9191	Fondation de France [Engt 2008005019]; "Institut National de la Sante et de la Recherche Medicale" (INSERM), France [201103]; Association pour la Recherche sur le Cancer [SFI20111203931, SFI20121205710]; Ligue National contre le Cancer [RS12/75-62, RS14/75-54]; Association Christelle Bouillot	Fondation de France(Fondation de France); "Institut National de la Sante et de la Recherche Medicale" (INSERM), France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue National contre le Cancer(Ligue nationale contre le cancer); Association Christelle Bouillot	AOS's salary was supported by a grant from "Fondation de France" (Ref Engt 2008005019, http://www.fondationdefrance.org/) and a fellowship from "Institut National de la Sante et de la Recherche Medicale" (INSERM, http://www.inserm.fr/), France, as "Soutien pour la formation a la recherche translationnelle en cancerologie" (Convention no 201103). The work was supported by grants from "Fondation de France" (JC: Ref Engt 2008005019), "Association pour la Recherche sur le Cancer" (JC: SFI20111203931; MCP: SFI20121205710, http://www.fondation-arc.org/), "Ligue National contre le Cancer" (JC: RS12/75-62, MCP: RS14/75-54, http://www.ligue-cancer.net/), and by Association Christelle Bouillot (http://bouillot-christelle.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Ceriani M, 2007, EXP CELL RES, V313, P2293, DOI 10.1016/j.yexcr.2007.03.016; Ceriani M, 2010, NEUROSCI RES, V66, P290, DOI 10.1016/j.neures.2009.11.013; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Gentry LR, 2014, BBA-MOL CELL RES, V1843, P2976, DOI 10.1016/j.bbamcr.2014.09.004; Guin S, 2013, J THORAC ONCOL, V8, P1492, DOI 10.1097/JTO.0000000000000007; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; Henry DO, 2000, MOL CELL BIOL, V20, P8084, DOI 10.1128/MCB.20.21.8084-8092.2000; Hung WC, 2010, CANCER LETT, V288, P156, DOI 10.1016/j.canlet.2009.06.032; Jiang F, 2005, ONCOGENE, V24, P3409, DOI 10.1038/sj.onc.1208459; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Mott HR, 2003, J BIOL CHEM, V278, P17053, DOI 10.1074/jbc.M300155200; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Osoegawa A, 2004, J CLIN ONCOL, V22, P4165, DOI 10.1200/JCO.2004.01.035; Peschard P, 2012, CURR BIOL, V22, P2063, DOI 10.1016/j.cub.2012.09.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004; Vigil D, 2010, J BIOL CHEM, V285, P34729, DOI 10.1074/jbc.M110.116756; Wei Z, 2013, CELL SIGNAL, V25, P931, DOI 10.1016/j.cellsig.2013.01.011; Yang Q, 2014, BRIT J CANCER, V110, P1958, DOI 10.1038/bjc.2014.136; Yokoi S, 2003, CANCER SCI, V94, P344, DOI 10.1111/j.1349-7006.2003.tb01444.x	28	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154840	10.1371/journal.pone.0154840	http://dx.doi.org/10.1371/journal.pone.0154840			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149377	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800068
J	Wang, Y; Cui, HT; Wu, ZX; Wu, NP; Wang, ZL; Chen, XS; Wei, Y; Zhang, PB				Wang, Yu; Cui, Haitao; Wu, Zhenxu; Wu, Naipeng; Wang, Zongliang; Chen, Xuesi; Wei, Yen; Zhang, Peibiao			Modulation of Osteogenesis in MC3T3-E1 Cells by Different Frequency Electrical Stimulation	PLOS ONE			English	Article							OSTEOBLAST-LIKE CELLS; SCAPHOID NONUNION; BONE-FORMATION; EXPRESSION; FIELDS; OSTEOCLASTS; PROLIFERATION; OSTEOPONTIN; INVITRO; MATRIX	Electrical stimulation (ES) is therapeutic to many bone diseases, from promoting fracture regeneration to orthopedic intervention. The application of ES offers substantial therapeutic potential, while optimal ES parameters and the underlying mechanisms responsible for the positive clinical impact are poorly understood. In this study, we assembled an ES cell culture and monitoring device. Mc-3T3-E1 cells were subjected to different frequency to investigate the effect of osteogenesis. Cell proliferation, DNA synthesis, the mRNA levels of osteosis-related genes, the activity of alkaline phosphatase (ALP), and intracellular concentration of Ca2+ were thoroughly evaluated. We found that 100 Hz could up-regulate the mRNA levels of collagen I, collagen II and Runx2. On the contrary, ES could down-regulate the mRNA levels of osteopontin (OPN). ALP activity assay and Fast Blue RR salt stain showed that 100 Hz could accelerate cells differentiation. Compared to the control group, 100 Hz could promote cell proliferation. Furthermore, 1 Hz to 10 Hz could improve calcium deposition in the intracellular matrix. Overall, these results indicate that 100Hz ES exhibits superior potentialities in osteogenesis, which should be beneficial for the clinical applications of ES for the treatment of bone diseases.	[Wang, Yu; Cui, Haitao; Wu, Zhenxu; Wu, Naipeng; Wang, Zongliang; Chen, Xuesi; Zhang, Peibiao] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China; [Wang, Yu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wei, Yen] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University	Wang, ZL; Zhang, PB (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China.; Wei, Y (corresponding author), Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China.	wangzl@ciac.ac.cn; weiyen@tsinghua.edu.cn; zhangpb@ciac.ac.cn	Wei, Yen/H-5329-2012; Chen, Xuesi/ABB-5039-2020; Wang, Zongliang/L-8740-2019; Cui, Haitao/F-4359-2016; yu, wang/AAC-7847-2021	Wang, Zongliang/0000-0001-6101-8317; Cui, Haitao/0000-0002-0641-6029; 	National Natural Science Foundation of China [51203152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China, No.51203152 [www.nsfc.gov.cn] to Y. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimi O, 2011, MOLECULES, V16, P9792, DOI 10.3390/molecules16129792; Bao Y, 2013, J HUAZHONG U SCI-MED, V33, P713, DOI 10.1007/s11596-013-1185-9; BRIGHTON CT, 1985, J BONE JOINT SURG AM, V67A, P577, DOI 10.2106/00004623-198567040-00012; BRIGHTON CT, 1992, CLIN ORTHOP RELAT R, P255; Bumbasirevic M, 2013, INJURY, V44, P346, DOI 10.1016/j.injury.2013.01.016; Cho MR, 1999, FASEB J, V13, P677, DOI 10.1096/fasebj.13.6.677; Clark CC, 2014, J ORTHOP RES, V32, P894, DOI 10.1002/jor.22595; Du DJ, 2009, BIOTECHNOL BIOENG, V102, P1670, DOI 10.1002/bit.22214; DUNN AW, 1984, SOUTHERN MED J, V77, P1530, DOI 10.1097/00007611-198412000-00013; Griffin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023404; Kim IS, 2006, BBA-MOL CELL RES, V1763, P907, DOI 10.1016/j.bbamcr.2006.06.007; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Li JP, 2014, BIOELECTROMAGNETICS, V35, P170, DOI 10.1002/bem.21833; Maeno T, 2011, BONE, V49, P673, DOI 10.1016/j.bone.2011.07.023; Maruthainar N, 2000, J HAND SURG-BRIT EUR, V25B, P427; MERRY K, 1993, J CELL SCI, V104, P1013; Moghaddam-Alvandi A, 2012, UNFALLCHIRURG, V115, P518, DOI 10.1007/s00113-011-2100-0; Muller WEG, 2003, INTEGR COMP BIOL, V43, P3, DOI 10.1093/icb/43.1.3; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; OZAWA H, 1989, J CELL PHYSIOL, V138, P477, DOI 10.1002/jcp.1041380306; Paley D, 1990, Instr Course Lect, V39, P185; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Rice Ian, 2013, J Surg Orthop Adv, V22, P256; Takeuchi Y, 1996, J BIOL CHEM, V271, P3938; Wennberg C, 2000, J BONE MINER RES, V15, P1879, DOI 10.1359/jbmr.2000.15.10.1879; Wiesmann HP, 2001, BBA-MOL CELL RES, V1538, P28, DOI 10.1016/S0167-4889(00)00135-X; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393	27	25	25	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154924	10.1371/journal.pone.0154924	http://dx.doi.org/10.1371/journal.pone.0154924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149625	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800090
J	Waugh, JL; Kuster, JK; Levenstein, JM; Makris, N; Multhaupt-Buell, TJ; Sudarsky, LR; Breiter, HC; Sharma, N; Blood, AJ				Waugh, Jeff L.; Kuster, John K.; Levenstein, Jacob M.; Makris, Nikos; Multhaupt-Buell, Trisha J.; Sudarsky, Lewis R.; Breiter, Hans C.; Sharma, Nutan; Blood, Anne J.			Thalamic Volume Is Reduced in Cervical and Laryngeal Dystonias	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; WHITE-MATTER ABNORMALITIES; MOVEMENT-DISORDERS; FOCAL DYSTONIA; WRITERS CRAMP; BASAL-GANGLIA; SPASMODIC DYSPHONIA; ALZHEIMERS-DISEASE; BOTULINUM TOXIN; BRAIN STRUCTURE	Background Dystonia, a debilitating movement disorder characterized by abnormal fixed positions and/or twisting postures, is associated with dysfunction of motor control networks. While gross brain lesions can produce secondary dystonias, advanced neuroimaging techniques have been required to identify network abnormalities in primary dystonias. Prior neuroimaging studies have provided valuable insights into the pathophysiology of dystonia, but few directly assessed the gross volume of motor control regions, and to our knowledge, none identified abnormalities common to multiple types of idiopathic focal dystonia. Methods We used two gross volumetric segmentation techniques and one voxelwise volumetric technique (voxel based morphometry, VBM) to compare regional volume between matched healthy controls and patients with idiopathic primary focal dystonia (cervical, n = 17, laryngeal, n = 7). We used (1) automated gross volume measures of eight motor control regions using the FreeSurfer analysis package; (2) blinded, anatomist-supervised manual segmentation of the whole thalamus (also gross volume); and (3) voxel based morphometry, which measures local T1-weighted signal intensity and estimates gray matter density or volume at the level of single voxels, for both whole-brain and thalamus. Results Using both automated and manual gross volumetry, we found a significant volume decrease only in the thalamus in two focal dystonias. Decreases in whole-thalamic volume were independent of head and brain size, laterality of symptoms, and duration. VBM measures did not differ between dystonia and control groups in any motor control region. Conclusions Reduced thalamic gross volume, detected in two independent analyses, suggests a common anatomical abnormality in cervical dystonia and spasmodic dysphonia. Defining the structural underpinnings of dystonia may require such complementary approaches.	[Waugh, Jeff L.; Kuster, John K.; Levenstein, Jacob M.; Breiter, Hans C.; Blood, Anne J.] Massachusetts Gen Hosp, Mood & Motor Control Lab, Charlestown, MA USA; [Kuster, John K.; Breiter, Hans C.; Blood, Anne J.] Massachusetts Gen Hosp, Lab Neuroimaging & Genet, Charlestown, MA USA; [Makris, Nikos] Massachusetts Gen Hosp, Ctr Morphometr Anal, Charlestown, MA USA; [Waugh, Jeff L.; Kuster, John K.; Levenstein, Jacob M.; Multhaupt-Buell, Trisha J.; Sharma, Nutan; Blood, Anne J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Kuster, John K.; Levenstein, Jacob M.; Makris, Nikos; Breiter, Hans C.; Blood, Anne J.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Waugh, Jeff L.] Boston Childrens Hosp, Div Child Neurol, Boston, MA USA; [Sudarsky, Lewis R.; Sharma, Nutan] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Makris, Nikos] Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 75 Francis St, Boston, MA 02115 USA; [Waugh, Jeff L.; Makris, Nikos; Sudarsky, Lewis R.; Breiter, Hans C.; Sharma, Nutan; Blood, Anne J.] Harvard Univ, Sch Med, Boston, MA USA; [Breiter, Hans C.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Warren Wright Adolescent Ctr, Chicago, IL 60611 USA; [Waugh, Jeff L.; Kuster, John K.; Levenstein, Jacob M.; Makris, Nikos; Breiter, Hans C.; Blood, Anne J.] MGH, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine	Waugh, JL (corresponding author), Massachusetts Gen Hosp, Mood & Motor Control Lab, Charlestown, MA USA.; Waugh, JL (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Waugh, JL (corresponding author), Boston Childrens Hosp, Div Child Neurol, Boston, MA USA.; Waugh, JL (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Waugh, JL (corresponding author), MGH, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.	jwaugh@partners.org		Waugh, Jeff/0000-0001-7526-1342	American Academy of Neurology's Clinical Research Training Fellowship; Silverman Family Fellowship, Bachmann-Strauss Dystonia Parkinson Foundation; National Institute of Neurological Disorders and Stroke [R01NS052368, NINP50NS037409]; Dystonia Medical Research Foundation; National Institute on Drug Abuse [R01 027804]; Office of National Drug Control Policy - Counterdrug Technology Assessment Center, Washington, D.C. [DABK39-03-0098, DABK39-03-C-0098]; Warren Wright Adolescent Center at Northwestern Memorial Hospital & Northwestern University, Chicago Il; National Center for Research Resources [P41 RR14075, UL1 RR025758-01]; Mental Illness and Neuroscience Discovery (MIND) Institute; Shared Instrumentation Grants [1S10RR023043, 1S10RR023401]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS087997, P01NS037409, R01NS052368] Funding Source: NIH RePORTER	American Academy of Neurology's Clinical Research Training Fellowship; Silverman Family Fellowship, Bachmann-Strauss Dystonia Parkinson Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dystonia Medical Research Foundation; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Office of National Drug Control Policy - Counterdrug Technology Assessment Center, Washington, D.C.; Warren Wright Adolescent Center at Northwestern Memorial Hospital & Northwestern University, Chicago Il; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mental Illness and Neuroscience Discovery (MIND) Institute; Shared Instrumentation Grants; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Waugh was supported by the American Academy of Neurology's Clinical Research Training Fellowship and the Silverman Family Fellowship, Bachmann-Strauss Dystonia Parkinson Foundation. This work was supported by grants from the National Institute of Neurological Disorders and Stroke (grant number R01NS052368 to Dr. Blood, and grant number NINP50NS037409 to Dr. Breakefield with Dr. Sharma as PI of the clinical core), and a grant from the Dystonia Medical Research Foundation to Dr. Blood. Drs. Breiter, Blood, and Makris were funded by the National Institute on Drug Abuse (grant number R01 027804). Further support to Drs. Breiter and Blood came from grants (DABK39-03-0098 & DABK39-03-C-0098; The Phenotype Genotype Project in Addiction and Mood Disorder) from the Office of National Drug Control Policy - Counterdrug Technology Assessment Center, Washington, D.C. Further support was provided to Dr. Breiter by the Warren Wright Adolescent Center at Northwestern Memorial Hospital & Northwestern University, Chicago Il. The general infrastructure of the Martinos Center for Biomedical Imaging in which research on these grants was conducted, was supported by National Center for Research Resources (grant number P41 RR14075 to Dr. Rosen), and the Mental Illness and Neuroscience Discovery (MIND) Institute (Dr. Rosen). Shared processing cluster and secure storage was provided by Shared Instrumentation Grants 1S10RR023043 and 1S10RR023401. Prescreening and exams were conducted in the General Clinical Research Center, funded by National Center for Research Resources (grant number UL1 RR025758-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Armitage P., 1987, STAT METHODS MED RES; ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; Aschermann Z, 2015, MOVEMENT DISORD, V30, P1422, DOI 10.1002/mds.26306; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barra V, 2001, IEEE T MED IMAGING, V20, P549, DOI 10.1109/42.932740; Bigler ED, 2010, DEV NEUROPSYCHOL, V35, P278, DOI 10.1080/87565641003696817; Black KJ, 1998, NEUROLOGY, V51, P819, DOI 10.1212/WNL.51.3.819; Blood AJ, 2006, NEUROREPORT, V17, P1251, DOI 10.1097/01.wnr.0000230500.03330.01; Blood AJ, 2013, CURR NEUROPHARMACOL, V11, P3, DOI 10.2174/157015913804999513; Blood AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031654; Blood Anne J, 2008, Biosci Hypotheses, V1, P14, DOI 10.1016/j.bihy.2008.01.006; Castrop F, 2012, MOVEMENT DISORD, V27, P1432, DOI 10.1002/mds.24944; Ciofolo C, 2009, MED IMAGE ANAL, V13, P456, DOI 10.1016/j.media.2009.02.008; Clerx L, 2015, CURR ALZHEIMER RES, V12, P358, DOI 10.2174/1567205012666150324174813; D'Abreu A, 2011, J NEUROIMAGING, V21, pe91, DOI 10.1111/j.1552-6569.2010.00464.x; Delnooz CCS, 2015, NEUROBIOL DIS, V73, P327, DOI 10.1016/j.nbd.2014.10.013; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Draganski B, 2009, NEUROIMAGE, V47, P1141, DOI 10.1016/j.neuroimage.2009.03.057; Dresel C, 2014, J NEUROL NEUROSUR PS, V85, P1245, DOI 10.1136/jnnp-2013-307127; Eckert MA, 2005, CORTEX, V41, P304, DOI 10.1016/S0010-9452(08)70268-5; Egger K, 2007, MOVEMENT DISORD, V22, P1538, DOI 10.1002/mds.21619; Etgen T, 2006, J NEUROL NEUROSUR PS, V77, P1017, DOI 10.1136/jnnp.2005.087148; Friston KJ, 2004, NEUROIMAGE, V23, P21, DOI 10.1016/j.neuroimage.2004.04.021; Gilman JM, 2014, J NEUROSCI, V34, P5529, DOI 10.1523/JNEUROSCI.4745-13.2014; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Ha RR., 2011, INTEGRATIVE STAT SOC; Helms G, 2009, NEUROIMAGE, V47, P194, DOI 10.1016/j.neuroimage.2009.03.053; Hogikyan ND, 1999, J VOICE, V13, P557, DOI 10.1016/S0892-1997(99)80010-1; Ibanez V, 1999, NEUROLOGY, V53, P96, DOI 10.1212/WNL.53.1.96; Jinnah HA, 2013, MOVEMENT DISORD, V28, P926, DOI 10.1002/mds.25567; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; KELLEHER JF, 1990, MED HYPOTHESES, V31, P55, DOI 10.1016/0306-9877(90)90055-J; Keller SS, 2012, NEUROINFORMATICS, V10, P341, DOI 10.1007/s12021-012-9147-0; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Kirke DN, 2017, BRAIN IMAGING BEHAV, V11, P166, DOI 10.1007/s11682-016-9513-x; LEE MS, 1994, MOVEMENT DISORD, V9, P493, DOI 10.1002/mds.870090502; Lee MS, 2001, J NEUROL SCI, V182, P137, DOI 10.1016/S0022-510X(00)00463-9; Lehericy S, 2001, NEUROLOGY, V57, P1055, DOI 10.1212/WNL.57.6.1055; Mai J.K., 1997, ATLAS HUMAN BRAIN; Makris N, 2008, BIOL PSYCHIAT, V64, P192, DOI 10.1016/j.biopsych.2008.01.018; Martino D, 2011, MOVEMENT DISORD, V26, P1907, DOI 10.1002/mds.23724; Niethammer M, 2011, NEUROBIOL DIS, V42, P202, DOI 10.1016/j.nbd.2010.10.010; Obermann M, 2008, EUR J NEUROL, V15, P831, DOI 10.1111/j.1468-1331.2008.02196.x; Obermann M, 2007, MOVEMENT DISORD, V22, P1117, DOI 10.1002/mds.21495; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peller M, 2006, BRAIN, V129, P2697, DOI 10.1093/brain/awl181; Piccinin CC, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00283; Poston KL, 2012, NEUROIMAGE, V62, P2261, DOI 10.1016/j.neuroimage.2011.12.021; Preibisch C, 2001, J NEUROL, V248, P10, DOI 10.1007/s004150170263; Ramdhani RA, 2013, PRIMARY DYSTONIA CON, V3; Schicatano EJ, 1997, J NEUROPHYSIOL, V77, P2842, DOI 10.1152/jn.1997.77.5.2842; Simonyan K, 2012, CEREB CORTEX, V22, P417, DOI 10.1093/cercor/bhr120; Simonyan K, 2010, CEREB CORTEX, V20, P2749, DOI 10.1093/cercor/bhq023; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Swinscow T.D.V., 1997, STAT SQUARE ONE, DOI 10.1136/bmj.2.6042.1008; Talairach J., 1988, COPLANAR STEREOTAXIC; TSUI JKC, 1986, LANCET, V2, P245; Vasques X, 2009, J NEUROSURG, V110, P220, DOI 10.3171/2008.3.17433; Voevodskaya O, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00264; Walsh RA, 2009, J NEUROL, V256, P1307, DOI 10.1007/s00415-009-5119-1; Whitwell JL, 2007, PARKINSONISM RELAT D, V13, pS406, DOI 10.1016/S1353-8020(08)70039-7; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zheng ZZ, 2012, J NEUROL SCI, V316, P51, DOI 10.1016/j.jns.2012.01.032	66	22	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155302	10.1371/journal.pone.0155302	http://dx.doi.org/10.1371/journal.pone.0155302			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171035	Green Published, Green Submitted, gold			2022-12-27	WOS:000376588600138
J	Strumpf, H; Noesselt, T; Schoenfeld, MA; Voges, J; Panther, P; Kaufmann, J; Heinze, HJ; Hopf, JM				Strumpf, Hendrik; Noesselt, Toemme; Schoenfeld, Mircea Ariel; Voges, Juergen; Panther, Patricia; Kaufmann, Joern; Heinze, Hans-Jochen; Hopf, Jens-Max			Deep Brain Stimulation of the Pedunculopontine Tegmental Nucleus (PPN) Influences Visual Contrast Sensitivity in Human Observers	PLOS ONE			English	Article							SUPERIOR COLLICULUS; PARKINSONS-DISEASE; BASAL GANGLIA; CHOLINERGIC PROJECTION; FREQUENCY STIMULATION; COGNITIVE-PROCESSES; SPATIAL ATTENTION; SUBSTANTIA-NIGRA; SQUIRREL-MONKEY; REACTION-TIME	The parapontine nucleus of the thalamus (PPN) is a neuromodulatory midbrain structure with widespread connectivity to cortical and subcortical motor structures, as well as the spinal cord. The PPN also projects to the thalamus, including visual relay nuclei like the LGN and the pulvinar. Moreover, there is intense connectivity with sensory structures of the tegmentum in particular with the superior colliculus (SC). Given the existence and abundance of projections to visual sensory structures, it is likely that activity in the PPN has some modulatory influence on visual sensory selection. Here we address this possibility by measuring the visual discrimination performance (luminance contrast thresholds) in a group of patients with Parkinson's Disease (PD) treated with deep-brain stimulation (DBS) of the PPN to control gait and postural motor deficits. In each patient we measured the luminance-contrast threshold of being able to discriminate an orientation-target (Gabor-grating) as a function of stimulation frequency (high 60Hz, low 8/10, no stimulation). Thresholds were determined using a standard staircase-protocol that is based on parameter estimation by sequential testing (PEST). We observed that under low frequency stimulation thresholds increased relative to no and high frequency stimulation in five out of six patients, suggesting that DBS of the PPN has a frequency-dependent impact on visual selection processes at a rather elementary perceptual level.	[Strumpf, Hendrik; Schoenfeld, Mircea Ariel; Heinze, Hans-Jochen; Hopf, Jens-Max] Leibniz Inst Neurobiol, Magdeburg, Germany; [Noesselt, Toemme] Otto Von Guericke Univ, Inst Biol Psychol, Magdeburg, Germany; [Schoenfeld, Mircea Ariel; Kaufmann, Joern; Heinze, Hans-Jochen; Hopf, Jens-Max] Otto Von Guericke Univ, Neurol Clin, Magdeburg, Germany; [Voges, Juergen; Panther, Patricia] Otto Von Guericke Univ, Clin Stereotact Neurosurg, Magdeburg, Germany; [Schoenfeld, Mircea Ariel] Kliniken Schmieder, Allensbach, Germany	Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Otto von Guericke University; Otto von Guericke University	Hopf, JM (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.; Hopf, JM (corresponding author), Otto Von Guericke Univ, Neurol Clin, Magdeburg, Germany.	jens-max.hopf@med.ovgu.de	Schoenfeld, Ariel/O-7513-2019	Schoenfeld, Ariel/0000-0001-9003-4092; Noesselt, Toemme/0000-0002-9611-9713	Deutsche Forschungsgemeinschaft [SFB 779/TPA1, SFB 779/TPA11]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft, grant numbers SFB 779/TPA1 (received by J-MH and MAS) and SFB 779/TPA11 (received by H-JH).	Aizawa H, 1999, J NEUROPHYSIOL, V82, P1642, DOI 10.1152/jn.1999.82.3.1642; Alam M, 2011, BRAIN, V134, P11, DOI 10.1093/brain/awq322; Aravamuthan BR, 2007, NEUROIMAGE, V37, P694, DOI 10.1016/j.neuroimage.2007.05.050; BENINATO M, 1987, BRAIN RES, V412, P169, DOI 10.1016/0006-8993(87)91455-7; BENINATO M, 1986, J COMP NEUROL, V253, P525, DOI 10.1002/cne.902530409; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Celeghin A, 2015, CONSCIOUS COGN, V36, P414, DOI 10.1016/j.concog.2015.05.007; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Ferraye MU, 2010, BRAIN, V133, P205, DOI 10.1093/brain/awp229; Garcia-Rill E, 2004, PROG BRAIN RES, V143, P283, DOI 10.1016/S0079-6123(03)43027-6; Garcia-Rill E, 2015, J NEURAL TRANSM, V122, P225, DOI 10.1007/s00702-014-1243-x; GARCIARILL E, 1991, PROG NEUROBIOL, V36, P363, DOI 10.1016/0301-0082(91)90016-T; HALLANGER AE, 1987, J COMP NEUROL, V262, P105, DOI 10.1002/cne.902620109; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Inglis WL, 2001, BEHAV BRAIN RES, V123, P117, DOI 10.1016/S0166-4328(01)00181-4; Inglis WL, 2000, BEHAV NEUROSCI, V114, P285, DOI 10.1037//0735-7044.114.2.285; Jenkinson N, 2004, NEUROREPORT, V15, P2621, DOI 10.1097/00001756-200412030-00012; Karachi C, 2010, J CLIN INVEST, V120, P2745, DOI 10.1172/JCI42642; Kobayashi Y, 2002, J NEUROPHYSIOL, V88, P715, DOI 10.1152/jn.2002.88.2.715; Kojima J, 1997, NEUROSCI LETT, V226, P111, DOI 10.1016/S0304-3940(97)00254-1; KRAUTHAMER GM, 1995, NEUROSCIENCE, V69, P507, DOI 10.1016/0306-4522(95)00265-K; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; LAVOIE B, 1994, J COMP NEUROL, V344, P232, DOI 10.1002/cne.903440205; LAVOIE B, 1994, J COMP NEUROL, V344, P210, DOI 10.1002/cne.903440204; Martinez-Gonzalez C, 2012, EUR J NEUROSCI, V35, P723, DOI 10.1111/j.1460-9568.2012.08002.x; Matsumura M, 2005, J NEUROL, V252, P5, DOI 10.1007/s00415-005-4003-x; Mazzone P, 2005, NEUROREPORT, V16, P1877, DOI 10.1097/01.wnr.0000187629.38010.12; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Mena-Segovia J, 2004, TRENDS NEUROSCI, V27, P585, DOI 10.1016/j.tins.2004.07.009; Mena-Segovia J, 2009, J COMP NEUROL, V515, P397, DOI 10.1002/cne.22065; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Moro E, 2010, BRAIN, V133, P215, DOI 10.1093/brain/awp261; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Muthusamy KA, 2007, J NEUROSURG, V107, P814, DOI 10.3171/JNS-07/10/0814; Nandi D, 2002, J CLIN NEUROSCI, V9, P170, DOI 10.1054/jocn.2001.0943; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Obeso JA, 2008, ANN NEUROL, V64, pS30, DOI 10.1002/ana.21481; Pahapill PA, 2000, BRAIN, V123, P1767, DOI 10.1093/brain/123.9.1767; Peppe A, 2012, SLEEP, V35, P1637, DOI 10.5665/sleep.2234; Plaha P, 2005, NEUROREPORT, V16, P1883, DOI 10.1097/01.wnr.0000187637.20771.a0; REESE NB, 1995, PROG NEUROBIOL, V47, P105, DOI 10.1016/0301-0082(95)00023-O; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P713, DOI 10.1152/jn.1995.74.2.713; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; STECKLER T, 1994, BRAIN RES REV, V19, P298; Stefani A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00068; Tamietto M, 2010, J COGNITIVE NEUROSCI, V22, P888, DOI 10.1162/jocn.2009.21225; Tattersall TL, 2014, NAT NEUROSCI, V17, P449, DOI 10.1038/nn.3642; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; Thevathasan W, 2010, J NEUROL NEUROSUR PS, V81, P1099, DOI 10.1136/jnnp.2009.189324; Voges J, 2002, J NEUROSURG, V96, P269, DOI 10.3171/jns.2002.96.2.0269; Voges J, 2007, MOVEMENT DISORD, V22, P1486, DOI 10.1002/mds.21481; Winn P, 1998, BRAIN RES BULL, V47, P551, DOI 10.1016/S0361-9230(98)00136-1; Zrinzo L, 2008, BRAIN, V131, P1588, DOI 10.1093/brain/awn075; ZWEIG RM, 1989, ANN NEUROL, V26, P41, DOI 10.1002/ana.410260106	57	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155206	10.1371/journal.pone.0155206	http://dx.doi.org/10.1371/journal.pone.0155206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167979	Green Published, gold			2022-12-27	WOS:000376587300025
J	Wang, YS; Pati, P; Xu, YM; Chen, F; Stepp, DW; Huo, YQ; Rudic, RD; Fulton, DJR				Wang, Yusi; Pati, Paramita; Xu, Yiming; Chen, Feng; Stepp, David W.; Huo, Yuqing; Rudic, R. Daniel; Fulton, David J. R.			Endotoxin Disrupts Circadian Rhythms in Macrophages via Reactive Oxygen Species	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; REV-ERB-ALPHA; NF-KAPPA-B; GENE-EXPRESSION; CLOCK GENES; INCREASED SUPEROXIDE; INNATE IMMUNITY; BLOOD-PRESSURE; PROTEIN	The circadian clock is a transcriptional network that functions to regulate the expression of genes important in the anticipation of changes in cellular and organ function. Recent studies have revealed that the recognition of pathogens and subsequent initiation of inflammatory responses are strongly regulated by a macrophage-intrinsic circadian clock. We hypothesized that the circadian pattern of gene expression might be influenced by inflammatory stimuli and that loss of circadian function in immune cells can promote pro-inflammatory behavior. To investigate circadian rhythms in inflammatory cells, peritoneal macrophages were isolated from mPer2(luciferase) transgenic mice and circadian oscillations were studied in response to stimuli. Using Cosinor analysis, we found that LPS significantly altered the circadian period in peritoneal macrophages from mPer2(luciferase) mice while qPCR data suggested that the pattern of expression of the core circadian gene (Bmal1) was disrupted. Inhibition of TLR4 offered protection from the LPS-induced impairment in rhythm, suggesting a role for toll-like receptor signaling. To explore the mechanisms involved, we inhibited LPS-stimulated NO and superoxide. Inhibition of NO synthesis with L-NAME had no effect on circadian rhythms. In contrast, inhibition of superoxide with Tempol or PEG-SOD ameliorated the LPS-induced changes in circadian periodicity. In gain of function experiments, we found that overexpression of NOX5, a source of ROS, could significantly disrupt circadian function in a circadian reporter cell line (U2OS) whereas iNOS overexpression, a source of NO, was ineffective. To assess whether alteration of circadian rhythms influences macrophage function, peritoneal macrophages were isolated from Bmal1-KO and Per-TKO mice. Compared to WT macrophages, macrophages from circadian knockout mice exhibited altered balance between NO and ROS release, increased uptake of oxLDL and increased adhesion and migration. These results suggest that pro-inflammatory stimuli can disrupt circadian rhythms in macrophages and that impaired circadian rhythms may contribute to cardiovascular diseases by altering macrophage behavior.	[Wang, Yusi; Xu, Yiming; Chen, Feng; Stepp, David W.; Huo, Yuqing; Rudic, R. Daniel; Fulton, David J. R.] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA; [Pati, Paramita] Augusta Univ, Med Coll Georgia, Dept Pharmacol, Augusta, GA USA; [Chen, Feng] Nanjing Med Univ, Dept Forens Med, Nanjing, Jiangsu, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Nanjing Medical University	Rudic, RD; Fulton, DJR (corresponding author), Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA.	rrudic@augusta.edu; dfulton@augusta.edu	Chen, Feng/E-1133-2011; Rudic, Dan/B-3432-2016	Xu, Yiming/0000-0002-8866-7859; Rudic, Dan/0000-0001-9122-3127; Xu, Yiming/0000-0002-9537-3664	National Institutes of Health [RO1 HL124773, P01 HL101902-01A1]; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124773, R01HL095556] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health RO1 HL124773 (DS, DJRF), P01 HL101902-01A1 (DJRF), and by a Predoctoral Fellowship from the AHA (YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anea CB, 2012, CIRC RES, V111, P1157, DOI 10.1161/CIRCRESAHA.111.261750; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Arraj M, 2007, CHRONOBIOL INT, V24, P1231, DOI 10.1080/07420520701795357; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Barman SA, 2014, ARTERIOSCL THROM VAS, V34, P1704, DOI 10.1161/ATVBAHA.114.303848; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Chaubey S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054869; Cheng B, 2011, P NATL ACAD SCI USA, V108, P17147, DOI 10.1073/pnas.1112998108; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; Curtis AM, 2006, ANN MED, V38, P552, DOI 10.1080/07853890600995010; Curtis AM, 2015, P NATL ACAD SCI USA, V112, P7231, DOI 10.1073/pnas.1501327112; Detmers PA, 2000, J IMMUNOL, V165, P3430, DOI 10.4049/jimmunol.165.6.3430; DOHERTY DE, 1989, J IMMUNOL, V143, P3673; Durgan DJ, 2010, CIRC RES, V106, P546, DOI 10.1161/CIRCRESAHA.109.209346; Eder K, 2008, IMMUNOL LETT, V116, P178, DOI 10.1016/j.imlet.2007.12.011; Epstein SE, 1999, CIRCULATION, V100, pE20, DOI 10.1161/01.CIR.100.4.e20; GERRITY RG, 1981, AM J PATHOL, V103, P181; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Golombek DA, 2004, NEUROCHEM INT, V45, P929, DOI 10.1016/j.neuint.2004.03.023; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Gyongyosi N, 2013, FREE RADICAL BIO MED, V58, P134, DOI 10.1016/j.freeradbiomed.2012.12.016; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Haspel JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5753; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; HermundstadAM BassettDS, 2013, P NATL ACAD SCI US, V110, P6169, DOI 10.1073/pnas.1219562110; Higashimori M, 2011, ARTERIOSCL THROM VAS, V31, P50, DOI 10.1161/ATVBAHA.110.210971; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Hogenesch JB, 2011, FEBS LETT, V585, P1427, DOI 10.1016/j.febslet.2011.04.048; Homma T, 2015, BIOCHEM BIOPH RES CO, V463, P1040, DOI 10.1016/j.bbrc.2015.06.055; HOSSMANN V, 1980, CARDIOVASC RES, V14, P125, DOI 10.1093/cvr/14.3.125; Jacobs AT, 2003, J BIOL CHEM, V278, P8018, DOI 10.1074/jbc.M211642200; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; JOHNSTON RB, 1978, J EXP MED, V148, P115; Kalayoglu MV, 1998, J INFECT DIS, V177, P725, DOI 10.1086/514241; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kondratov RV, 2006, FASEB J, V20, P530, DOI 10.1096/fj.05-5321fje; Kopydlowski KM, 1999, J IMMUNOL, V163, P1537; Kunieda T, 2008, CIRC RES, V102, P607, DOI 10.1161/CIRCRESAHA.107.162230; Li Q, 2009, ANTIOXID REDOX SIGN, V11, P1249, DOI 10.1089/ARS.2008.2407; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2015, CIRC RES, V116, P307, DOI 10.1161/CIRCRESAHA.116.301313; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Marpegan L, 2005, J NEUROIMMUNOL, V160, P102, DOI 10.1016/j.jneuroim.2004.11.003; Martino TA, 2007, HYPERTENSION, V49, P1104, DOI 10.1161/HYPERTENSIONAHA.106.083568; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; Nakao A, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/614529; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Okada K, 2008, J SURG RES, V145, P5, DOI 10.1016/j.jss.2007.01.010; Paladino N, 2014, CHRONOBIOL INT, V31, P668, DOI 10.3109/07420528.2014.886588; Pan XY, 2013, CIRCULATION, V128, P1758, DOI 10.1161/CIRCULATIONAHA.113.002885; Pandey D, 2012, AM J PHYSIOL-HEART C, V302, pH1919, DOI 10.1152/ajpheart.00910.2011; Pati P, 2016, HYPERTENSION, V67, P661, DOI 10.1161/HYPERTENSIONAHA.115.06194; Perry MG, 2009, ANN RHEUM DIS, V68, P63, DOI 10.1136/ard.2007.086561; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rouzer CA, 2005, J LIPID RES, V46, P1027, DOI 10.1194/jlr.M500006-JLR200; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato S, 2014, J IMMUNOL, V192, P407, DOI 10.4049/jimmunol.1301982; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; TOFLER GH, 1987, NEW ENGL J MED, V316, P1514, DOI 10.1056/NEJM198706113162405; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; Wang XL, 2009, MOL CELL BIOL, V29, P2794, DOI 10.1128/MCB.01633-08; WEBER ET, 1995, NEUROSCI LETT, V197, P227, DOI 10.1016/0304-3940(95)11961-U; Westfall S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059808; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Xu C, 2009, CAN J CARDIOL, V25, P473, DOI 10.1016/S0828-282X(09)70122-9; Yang L, 2015, INT IMMUNOPHARMACOL, V28, P525, DOI 10.1016/j.intimp.2015.07.001; Yoshida Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028227; Young ME, 2001, CIRC RES, V88, P1142, DOI 10.1161/hh1101.091190; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang ZH, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0179-1; Zulch K J, 1967, Ger Med Mon, V12, P513	88	26	26	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155075	10.1371/journal.pone.0155075	http://dx.doi.org/10.1371/journal.pone.0155075			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168152	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300034
J	Whitney, LP; Lomas, MW				Whitney, LeAnn P.; Lomas, Michael W.			Growth on ATP Elicits a P-Stress Response in the Picoeukaryote Micromonas pusilla	PLOS ONE			English	Article							DISSOLVED ORGANIC PHOSPHORUS; SACCHAROMYCES-CEREVISIAE; PHOSPHATASE-ACTIVITY; COMMUNITY STRUCTURE; ATLANTIC-OCEAN; CARBONIC-ACID; NORTH; PHYTOPLANKTON; EXPRESSION; DIATOM	The surface waters of oligotrophic oceans have chronically low phosphate (Pi) concentrations, which renders dissolved organic phosphorus (DOP) an important nutrient source. In the subtropical North Atlantic, cyanobacteria are often numerically dominant, but picoeukaryotes can dominate autotrophic biomass and productivity making them important contributors to the ocean carbon cycle. Despite their importance, little is known regarding the metabolic response of picoeukaryotes to changes in phosphorus (P) source and availability. To understand the molecular mechanisms that regulate P utilization in oligotrophic environments, we evaluated transcriptomes of the picoeukaryote Micromonas pusilla grown under Pi-replete and -deficient conditions, with an additional investigation of growth on DOP in replete conditions. Genes that function in sulfolipid substitution and Pi uptake increased in expression with Pi-deficiency, suggesting cells were reallocating cellular P and increasing P acquisition capabilities. Pi-deficient M. pusilla cells also increased alkaline phosphatase activity and reduced their cellular P content. Cells grown with DOP were able to maintain relatively high growth rates, however the transcriptomic response was more similar to the Pi-deficient response than that seen in cells grown under Pi-replete conditions. The results demonstrate that not all P sources are the same for growth; while M. pusilla, a model picoeukaryote, may grow well on DOP, the metabolic demand is greater than growth on Pi. These findings provide insight into the cellular strategies which may be used to support growth in a stratified future ocean predicted to favor picoeukaryotes.	[Whitney, LeAnn P.; Lomas, Michael W.] Bigelow Lab Ocean Sci, East Boothbay, ME USA	Bigelow Laboratory for Ocean Sciences	Whitney, LP (corresponding author), Bigelow Lab Ocean Sci, East Boothbay, ME USA.	lwhitney@bigelow.org		Lomas, Michael/0000-0003-1209-3753	National Science Foundation through Dimensions of Biodiversity Award [1045966]; Joint Genome Institute, Small Scale Community Science Program [1042280]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	National Science Foundation through Dimensions of Biodiversity Award; Joint Genome Institute, Small Scale Community Science Program; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	This research was funded in part by the National Science Foundation through Dimensions of Biodiversity Award No. 1045966 awarded to MWL. The RNA-sequencing was performed by the Joint Genome Institute as part of the Small Scale Community Science Program awarded to LPW and MWL (project ID 1042280). The work conducted by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.	Alipanah L, 2015, J EXP BOT, V66, P6281, DOI 10.1093/jxb/erv340; Ammerman J.W., 2003, EOS T AM GEOPHYS UN, V84, P165, DOI [10.1029/2003-o180001, DOI 10.1029/2003EO180001, 10.1029/2003EO180001]; Bates NR, 2012, BIOGEOSCIENCES, V9, P2509, DOI 10.5194/bg-9-2509-2012; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; Bushnell B., BBMAP; Casey JR, 2009, AQUAT MICROB ECOL, V58, P31, DOI 10.3354/ame01348; Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9; Chung CC, 2003, APPL ENVIRON MICROB, V69, P754, DOI 10.1128/AEM.69.2.754-759.2003; Dickson A.G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Duanmu DQ, 2014, P NATL ACAD SCI USA, V111, P15827, DOI 10.1073/pnas.1416751111; DuRand MD, 2001, DEEP-SEA RES PT II, V48, P1983, DOI 10.1016/S0967-0645(00)00166-1; Dyhrman ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033768; Dyhrman ST, 2007, OCEANOGRAPHY, V20, P110, DOI 10.5670/oceanog.2007.54; Dyhrman ST, 2006, APPL ENVIRON MICROB, V72, P252, DOI 10.1128/AEM.72.1.252-260.2006; Dyhrman ST, 2003, J PLANKTON RES, V25, P1215, DOI 10.1093/plankt/fbg086; Dyhrman ST, 2002, LIMNOL OCEANOGR, V47, P1832, DOI 10.4319/lo.2002.47.6.1832; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fawcett SE, 2011, NAT GEOSCI, V4, P717, DOI [10.1038/ngeo1265, 10.1038/NGEO1265]; Frischkorn K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00375; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hansell DA, 2015, BIOGEOCHEMISTRY OF MARINE DISSOLVED ORGANIC MATTER, 2ND EDITION, P1; Hashihama F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036866; Hoppe HG, 2003, HYDROBIOLOGIA, V493, P187, DOI 10.1023/A:1025453918247; Jardillier L, 2010, ISME J, V4, P1180, DOI 10.1038/ismej.2010.36; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kruskopf MM, 2004, HYDROBIOLOGIA, V513, P59, DOI 10.1023/B:hydr.0000018166.15764.b0; Kulaev I, 1999, J BIOSCI BIOENG, V88, P111, DOI 10.1016/S1389-1723(99)80189-3; LI WKW, 1995, MAR ECOL PROG SER, V122, P1, DOI 10.3354/meps122001; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Litchman E, 2010, HYDROBIOLOGIA, V653, P15, DOI 10.1007/s10750-010-0341-5; Lomas MW, 2011, BIOGEOSCIENCES, V8, P203, DOI 10.5194/bg-8-203-2011; Lomas MW, 2010, BIOGEOSCIENCES, V7, P695, DOI 10.5194/bg-7-695-2010; Lomas MW, 2004, LIMNOL OCEANOGR, V49, P2303, DOI 10.4319/lo.2004.49.6.2303; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Maat DS, 2014, APPL ENVIRON MICROB, V80, P3119, DOI 10.1128/AEM.03639-13; Maat DS, 2015, BIOGEOSCI DISCUSS, V12, P15583; Martin P, 2011, ISME J, V5, P1057, DOI 10.1038/ismej.2010.192; Mather RL, 2008, NAT GEOSCI, V1, P439, DOI 10.1038/ngeo232; McDonald SM, 2010, MOL BIOL EVOL, V27, P2268, DOI 10.1093/molbev/msq113; Meakin NG, 2011, ISME J, V5, P1397, DOI 10.1038/ismej.2011.18; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Orchard ED, 2010, LIMNOL OCEANOGR, V55, P2161, DOI 10.4319/lo.2010.55.5.2161; Palenik B, 2015, ANNU REV MAR SCI, V7, P325, DOI 10.1146/annurev-marine-010814-015639; PERRY MJ, 1976, LIMNOL OCEANOGR, V21, P88, DOI 10.4319/lo.1976.21.1.0088; Petersen Thomas Nordahl B S, 2011, NAT METHODS, V8, P2; Pierrot D., 2006, ORNLCDIAC105A US DEP; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Reynolds S, 2014, GLOBAL BIOGEOCHEM CY, V28, P805, DOI 10.1002/2013GB004801; ROBERTSON BR, 1989, CYTOMETRY, V10, P70, DOI 10.1002/cyto.990100112; Roussenov V, 2006, GLOBAL BIOGEOCHEM CY, V20; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SANDERS JG, 1980, MAR ENVIRON RES, V3, P257, DOI 10.1016/0141-1136(80)90038-0; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; SIERACKI ME, 1993, DEEP-SEA RES PT II, V40, P213, DOI 10.1016/0967-0645(93)90014-E; Strickland JDH, 1972, CAN J FISH AQUAT SCI, V167; THEODOROU ME, 1991, PLANT PHYSIOL, V95, P1089, DOI 10.1104/pp.95.4.1089; Timmermans KR, 2005, J SEA RES, V53, P109, DOI 10.1016/j.seares.2004.05.003; Todorova T, 2007, BIOTECHNOL BIOTEC EQ, V21, P348, DOI 10.1080/13102818.2007.10817472; Torres-Valdes S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003389; Treusch AH, 2012, ISME J, V6, P481, DOI 10.1038/ismej.2011.117; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Wurch LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028949; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Yamaguchi H, 2014, J PLANKTON RES, V36, P281, DOI 10.1093/plankt/fbt091	74	11	11	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155158	10.1371/journal.pone.0155158	http://dx.doi.org/10.1371/journal.pone.0155158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167623	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300043
J	Liu, X; Wang, WG; Liu, HJ				Liu, Xin; Wang, Wei-Guo; Liu, Hai-Jun			The Efficiency of Split Panel Designs in an Analysis of Variance Model	PLOS ONE			English	Article								We consider split panel design efficiency in analysis of variance models, that is, the determination of the cross-sections series optimal proportion in all samples, to minimize parametric best linear unbiased estimators of linear combination variances. An orthogonal matrix is constructed to obtain manageable expression of variances. On this basis, we derive a theorem for analyzing split panel design efficiency irrespective of interest and budget parameters. Additionally, relative estimator efficiency based on the split panel to an estimator based on a pure panel or a pure cross-section is present. The analysis shows that the gains from split panel can be quite substantial. We further consider the efficiency of split panel design, given a budget, and transform it to a constrained nonlinear integer programming. Specifically, an efficient algorithm is designed to solve the constrained nonlinear integer programming. Moreover, we combine one at time designs and factorial designs to illustrate the algorithm's efficiency with an empirical example concerning monthly consumer expenditure on food in 1985, in the Netherlands, and the efficient ranges of the algorithm parameters are given to ensure a good solution.	[Liu, Xin] Liaoning Shihua Univ, Sch Econ & Management, Fushun, Peoples R China; [Wang, Wei-Guo] Dongbei Univ Finance & Econ, Sch Econ, Dalian, Peoples R China; [Liu, Hai-Jun] Dalian Maritime Univ, Sch Marxism, Dalian, Peoples R China	Liaoning Petrochemical University; Dongbei University of Finance & Economics; Dalian Maritime University	Wang, WG (corresponding author), Dongbei Univ Finance & Econ, Sch Econ, Dalian, Peoples R China.	wwgstudent@126.com			talent scientific research fund of LSHU; Social Science Foundation of China [15BKS073]; Natural Science Foundation of China [71171035, 71271045, 71571033, 11301060]; Program for Discipline Construction in DUFF [XKT-201411]; Outstanding scientific innovation talents program of DUFE [DUFE2014R20]	talent scientific research fund of LSHU; Social Science Foundation of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Discipline Construction in DUFF; Outstanding scientific innovation talents program of DUFE	This work is supported financially by talent scientific research fund of LSHU, Social Science Foundation of China (No. 15BKS073), Natural Science Foundation of China (No. 71171035, 71271045, 71571033, 11301060), the Program for Discipline Construction in DUFF (No. XKT-201411) and Outstanding scientific innovation talents program of DUFE (no.DUFE2014R20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailis R, 2005, SCIENCE, V308, P98, DOI 10.1126/science.1106881; Binder D.A., 1988, SAMPLING IN TIME; Campbell JE, 2008, SCIENCE, V322, P1085, DOI 10.1126/science.1164015; Chan K., 2000, SENSITIVITY ANAL; Cochran WG., 1963, SAMPLING TECHNIQUES; Dhaene G, 2014, WORKING PAPER; DUNCAN GJ, 1987, TRANSPORT RES A-POL, V21, P249, DOI 10.1016/0191-2607(87)90049-5; ECKLER AR, 1955, ANN MATH STAT, V26, P664, DOI 10.1214/aoms/1177728427; James B.T., 1997, AM STAT ASS ANN C; Kish L., 1983, STAT METHOD IMPROVEM, V28, P73; KISH L, 1986, AUSTR J STAT, V28, P1; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; NIJMAN T, 1991, J ECONOMETRICS, V49, P373, DOI 10.1016/0304-4076(91)90003-V; NIJMAN T, 1990, J ECONOMETRICS, V46, P333, DOI 10.1016/0304-4076(90)90013-J; PATTERSON HD, 1950, J ROY STAT SOC B, V12, P241; Rodriguez-Oreggia E, 2013, GLOBAL ENVIRON CHANG, V23, P351, DOI 10.1016/j.gloenvcha.2012.08.001; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Veiga A, 2014, J R STAT SOC C-APPL, V63, P65, DOI 10.1111/rssc.12020	19	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154913	10.1371/journal.pone.0154913	http://dx.doi.org/10.1371/journal.pone.0154913			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163447	gold, Green Published			2022-12-27	WOS:000376585700041
J	Yamagishi, T; Kawashima, H; Ogose, A; Ariizumi, T; Sasaki, T; Hatano, H; Hotta, T; Endo, N				Yamagishi, Tetsuro; Kawashima, Hiroyuki; Ogose, Akira; Ariizumi, Takashi; Sasaki, Taro; Hatano, Hiroshi; Hotta, Tetsuo; Endo, Naoto			Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors	PLOS ONE			English	Article							GIANT-CELL TUMOR; DENOSUMAB	The receptor-activator of nuclear kappaB ligand (RANKL) signaling pathway plays an important role in the regulation of bone growth and mediates the formation and activation of osteoclasts. Osteoclasts are involved in significant bone resorption and destruction. Denosumab is a fully human monoclonal antibody against RANKL that specifically inhibits osteoclast differentiation and bone resorption. It has been approved for use for multiple myeloma and bone metastases, as well as for giant cell tumor of bone. However, there is no previous report quantitatively, comparing RANKL expression in histologically varied bone tumors. Therefore, we analyzed the mRNA level of various bone tumors and investigated the possibility of these tumors as a new therapeutic target for denosumab. We examined RANKL mRNA expression in 135 clinical specimens of primary and metastatic bone tumors using real-time PCR. The relative quantification of mRNA expression levels was performed via normalization with RPMI8226, a human multiple myeloma cell line that is recognized to express RANKL. Of 135 cases, 64 were also evaluated for RANKL expression by using immunohistochemistry. Among all of the tumors investigated, RANKL expression and the RANKL/osteoprotegerin ratio were highest in giant cell tumor of bone. High RANKL mRNA expression was observed in cases of aneurysmal bone cyst, fibrous dysplasia, osteosarcoma, chondrosarcoma, and enchondroma, as compared to cases of multiple myeloma and bone lesions from metastatic carcinoma. RANKL-positive stromal cells were detected in six cases: five cases of GCTB and one case of fibrous dysplasia. The current study findings indicate that some primary bone tumors present new therapeutic targets for denosumab, particularly those tumors expressing RANKL and those involving bone resorption by osteoclasts.	[Yamagishi, Tetsuro; Kawashima, Hiroyuki; Ariizumi, Takashi; Hotta, Tetsuo; Endo, Naoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, Niigata, Japan; [Ogose, Akira] Uonuma Kikan Hosp, Dept Orthoped Surg, Minamiuonuma, Niigata, Japan; [Sasaki, Taro; Hatano, Hiroshi] Niigata Canc Ctr Hosp, Dept Orthoped Surg, Niigata, Japan	Niigata University	Kawashima, H (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, Niigata, Japan.	inskawa@med.niigata-u.ac.jp			Grants-in-Aid for Scientific Research [16K10849] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akeda K, 2015, SPINE, V40, pE601, DOI 10.1097/BRS.0000000000000862; Boyce AM, 2012, J BONE MINER RES, V27, P1462, DOI 10.1002/jbmr.1603; Branstetter D, 2015, J BONE ONCOL, V4, P59, DOI 10.1016/j.jbo.2015.06.002; Branstetter DG, 2012, CLIN CANCER RES, V18, P4415, DOI 10.1158/1078-0432.CCR-12-0578; Chakarun CJ, 2013, RADIOGRAPHICS, V33, P197, DOI 10.1148/rg.331125089; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Goldschlager T, 2015, J NEUROSURG-SPINE, V22, P526, DOI 10.3171/2014.10.SPINE13937; Grimaud E, 2003, AM J PATHOL, V163, P2021, DOI 10.1016/S0002-9440(10)63560-2; Henry DH, 2011, J CLIN ONCOL, V29, P1125, DOI 10.1200/JCO.2010.31.3304; Lee JA, 2011, PEDIATR BLOOD CANCER, V56, P738, DOI 10.1002/pbc.22720; Lewiecki EM, 2010, CURR MED RES OPIN, V26, P2807, DOI 10.1185/03007995.2010.533651; Lin Haung, 2000, AM J PATHOL, V156, P761; Mak IWY, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01332; Pelle DW, 2014, TRANSL RES, V164, P139, DOI 10.1016/j.trsl.2014.03.005; Thomas D, 2010, LANCET ONCOL, V11, P275, DOI 10.1016/S1470-2045(10)70010-3; Thomas DM, 2009, CURR OPIN ONCOL, V21, P338, DOI 10.1097/CCO.0b013e32832c951d; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	19	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154680	10.1371/journal.pone.0154680	http://dx.doi.org/10.1371/journal.pone.0154680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163152	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700037
J	Radhakrishna, U; Albayrak, S; Alpay-Savasan, Z; Zeb, A; Turkoglu, O; Sobolewski, P; Bahado-Singh, RO				Radhakrishna, Uppala; Albayrak, Samet; Alpay-Savasan, Zeynep; Zeb, Amna; Turkoglu, Onur; Sobolewski, Paul; Bahado-Singh, Ray O.			Genome-Wide DNA Methylation Analysis and Epigenetic Variations Associated with Congenital Aortic Valve Stenosis (AVS)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LARGE GENE LISTS; RISK-FACTORS; FAMILIAL HYPERCHOLESTEROLEMIA; CONTROLLED TRIAL; BLOOD SPOTS; DEFECTS; ARRAY; MALFORMATIONS; EPIDEMIOLOGY	Congenital heart defect (CHD) is the most common cause of death from congenital anomaly. Among several candidate epigenetic mechanisms, DNA methylation may play an important role in the etiology of CHDs. We conducted a genome-wide DNA methylation analysis using an Illumina Infinium 450k human methylation assay in a cohort of 24 new-borns who had aortic valve stenosis (AVS), with gestational-age matched controls. The study identified significantly-altered CpG methylation at 59 sites in 52 genes in AVS subjects as compared to controls (either hypermethylated or demethylated). Gene Ontology analysis identified biological processes and functions for these genes including positive regulation of receptor-mediated endocytosis. Consistent with prior clinical data, the molecular function categories as determined using DAVID identified low-density lipoprotein receptor binding, lipoprotein receptor binding and identical protein binding to be over-represented in the AVS group. A significant epigenetic change in the APOA5 and PCSK9 genes known to be involved in AVS was also observed. A large number CpG methylation sites individually demonstrated good to excellent diagnostic accuracy for the prediction of AVS status, thus raising possibility of molecular screening markers for this disorder. Using epigenetic analysis we were able to identify genes significantly involved in the pathogenesis of AVS.	[Radhakrishna, Uppala; Alpay-Savasan, Zeynep; Zeb, Amna; Turkoglu, Onur; Sobolewski, Paul; Bahado-Singh, Ray O.] Oakland Univ, Dept Obstet & Gynecol, William Beaumont Sch Med, Royal Oak, MI USA; [Albayrak, Samet] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA	Oakland University; Wayne State University	Radhakrishna, U (corresponding author), Oakland Univ, Dept Obstet & Gynecol, William Beaumont Sch Med, Royal Oak, MI USA.	Uppala.radhakrishna@beaumont.edu			Beaumont Health System, Royal Oak, Michigan	Beaumont Health System, Royal Oak, Michigan	The present study was supported by Beaumont Health System, Royal Oak, Michigan; however, no grant number is available.	Abuhamad A., 2021, PRACTICAL GUIDE FETA, P548; Ailes EC, 2014, PRENATAL DIAG, V34, P214, DOI 10.1002/pd.4282; Altorok N, 2015, ANN RHEUM DIS, V74, P1612, DOI 10.1136/annrheumdis-2014-205303; Arrington CB, 2012, CIRC-CARDIOVASC GENE, V5, P175, DOI 10.1161/CIRCGENETICS.111.961797; Arsenault BJ, 2014, ARTERIOSCL THROM VAS, V34, P457, DOI 10.1161/ATVBAHA.113.302730; Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237; Bahado-Singh RO, 2015, J MATERN-FETAL NEO M, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Chui MCK, 2001, CLIN CARDIOL, V24, P52, DOI 10.1002/clc.4960240109; Click ES, 2011, AM J MED GENET A, V155A, P1673, DOI 10.1002/ajmg.a.34024; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Csaky-Szunyogh M, 2014, PEDIATR CARDIOL, V35, P108, DOI 10.1007/s00246-013-0749-6; Czeizel AE, 2004, BIRTH DEFECTS RES A, V70, P853, DOI 10.1002/bdra.20086; Daca-Roszak P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2202-0; Docherty LE, 2014, J MED GENET, V51, P229, DOI 10.1136/jmedgenet-2013-102116; Friedman WF, 1995, HEART DIS INFANTS CH; Gu Z., COMPLEXHEATMAP MAKIN; Helmer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080461; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutter CM, 2004, AM J EPIDEMIOL, V160, P430, DOI 10.1093/aje/kwh238; Joo JE, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-23; Kehler L, 2015, BIOMED REP, V3, P869, DOI 10.3892/br.2015.510; Khoshnood B, 2012, HEART, V98, P1667, DOI 10.1136/heartjnl-2012-302543; Knowles R, 2005, HEALTH TECHNOL ASSES, V9, P1; Le Gal G, 2005, HEART, V91, P247, DOI 10.1136/hrt.2004.037093; Li YX, 2011, THESIS HONG KONG U S, V1, P1; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lindstrand A, 2010, CLIN GENET, V77, P145, DOI 10.1111/j.1399-0004.2009.01289.x; Liu He-kun, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P335; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Loffredo CA, 2000, AM J MED GENET, V97, P319, DOI 10.1002/1096-8628(200024)97:4<319::AID-AJMG1283>3.0.CO;2-E; Marti-Carvajal AJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006612.pub2; McBride KL, 2005, BIRTH DEFECTS RES A, V73, P555, DOI 10.1002/bdra.20169; McGregor TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010286; MONTELEONE PL, 1969, CIRCULATION, V39, P611, DOI 10.1161/01.CIR.39.5.611; Pan H, 2012, EPIGENETICS-US, V7, P1173, DOI 10.4161/epi.22102; Patel SS, 2013, PEDIATR CARDIOL, V34, P1535, DOI 10.1007/s00246-013-0775-4; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Probst V, 2006, CIRCULATION, V113, P856, DOI 10.1161/CIRCULATIONAHA.105.569467; Rabus MB, 2009, J CARDIAC SURG, V24, P146, DOI 10.1111/j.1540-8191.2009.00814.x; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; Sheffield VC, 1997, HUM MOL GENET, V6, P117, DOI 10.1093/hmg/6.1.117; Sheng W, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-31; Wang J, 2008, NAT CLIN PRACT CARD, V5, P730, DOI 10.1038/ncpcardio1326; Wilhelm-Benartzi CS, 2013, BRIT J CANCER, V109, P1394, DOI 10.1038/bjc.2013.496; Wong NC, 2008, BIOTECHNIQUES, V45, P423, DOI 10.2144/000112945	51	30	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154010	10.1371/journal.pone.0154010	http://dx.doi.org/10.1371/journal.pone.0154010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152866	gold, Green Submitted, Green Published			2022-12-27	WOS:000375677000009
J	Marcovecchio, ML; Florio, R; Verginelli, F; De Lellis, L; Capelli, C; Verzilli, D; Chiarelli, F; Mohn, A; Cama, A				Marcovecchio, M. Loredana; Florio, Rosalba; Verginelli, Fabio; De Lellis, Laura; Capelli, Cristian; Verzilli, Delfina; Chiarelli, Francesco; Mohn, Angelika; Cama, Alessandro			Low AMY1 Gene Copy Number Is Associated with Increased Body Mass Index in Prepubertal Boys	PLOS ONE			English	Article							AMYLASE; ADIPOSITY; OBESITY	Background Genome-wide association studies have identified more than 60 single nucleotide polymorphisms associated with Body Mass Index (BMI). Additional genetic variants, such as copy number variations (CNV), have also been investigated in relation to BMI. Recently, the highly polymorphic CNV in the salivary amylase (AMY1) gene, encoding an enzyme implicated in the first step of starch digestion, has been associated with obesity in adults and children. We assessed the potential association between AMY1 copy number and a wide range of BMI in a population of Italian school-children. Methods 744 children (354 boys, 390 girls, mean age (+/- SD): 8.4 +/- 1.4years) underwent anthropometric assessments (height, weight) and collection of saliva samples for DNA extraction. AMY1 copies were evaluated by quantitative PCR. Results A significant increase of BMI z-score by decreasing AMY1 copy number was observed in boys (beta: -0.117, p = 0.033), but not in girls. Similarly, waist circumference (beta: -0.155, p = 0.003, adjusted for age) was negatively influenced by AMY1 copy number in boys. Boys with 8 or more AMY1 copy numbers presented a significant lower BMI z-score (p = 0.04) and waist circumference (p = 0.01) when compared to boys with less than 8 copy numbers. Conclusions In this pediatric-only, population-based study, a lower AMY1 copy number emerged to be associated with increased BMI in boys. These data confirm previous findings from adult studies and support a potential role of a higher copy number of the salivary AMY1 gene in protecting from excess weight gain.	[Marcovecchio, M. Loredana; Chiarelli, Francesco; Mohn, Angelika] Univ G dAnnunzio, Dept Paediat, Chieti, Italy; [Florio, Rosalba; Verginelli, Fabio; De Lellis, Laura; Verzilli, Delfina; Cama, Alessandro] Univ G dAnnunzio, Dept Pharm, Chieti, Italy; [Marcovecchio, M. Loredana; Verginelli, Fabio; Chiarelli, Francesco; Mohn, Angelika; Cama, Alessandro] Univ G dAnnunzio, Ctr Excellence Aging, Clin Res Ctr, Chieti, Italy; [Capelli, Cristian] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Oxford	Mohn, A (corresponding author), Univ G dAnnunzio, Dept Paediat, Chieti, Italy.; Mohn, A (corresponding author), Univ G dAnnunzio, Ctr Excellence Aging, Clin Res Ctr, Chieti, Italy.	amohn@unich.it	de lellis, laura/AAQ-8789-2020; CAMA, Alessandro/J-3964-2018	CAMA, Alessandro/0000-0003-3647-1368; Capelli, Cristian/0000-0001-9348-9084; VERGINELLI, Fabio/0000-0002-8636-2517; Maria Loredana, Marcovecchio/0000-0002-4415-316X; DE LELLIS, Laura/0000-0002-6460-2508	Italian Ministry of Education, University and Research (MIUR) [PRIN 2008SWXEAX]; "L'Oreal Italia per le Donne e la Scienza" (For Women in Science) fellowship	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); "L'Oreal Italia per le Donne e la Scienza" (For Women in Science) fellowship	This study was supported in part by a grant from the Italian Ministry of Education, University and Research (MIUR): PRIN 2008SWXEAX. At the time of the study, MLM was supported by a "L'Oreal Italia per le Donne e la Scienza" (For Women in Science) fellowship. The authors confirm that the study funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MK, 2015, CURR OBES REP, V4, P401, DOI 10.1007/s13679-015-0173-8; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Cama A, 2013, ACTA NEUROPATHOL, V126, P575, DOI 10.1007/s00401-013-1165-y; Carpenter D, 2015, HUM MOL GENET, V24, P3472, DOI 10.1093/hmg/ddv098; Choi YJ, 2015, DIABETIC MED, V32, P1588, DOI 10.1111/dme.12808; Curia MC, 2012, GASTROENTEROLOGY, V142, P71, DOI 10.1053/j.gastro.2011.09.048; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mandel AL, 2012, J NUTR, V142, P853, DOI 10.3945/jn.111.156984; Marcovecchio ML, 2014, HORM RES PAEDIAT, V82, P187, DOI 10.1159/000365103; Mejia-Bentez MA, 2015, DIABETOLOGIA, V58, P290, DOI 10.1007/s00125-014-3441-3; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Santos JL, 2012, J NUTRIGENET NUTRIGE, V5, P117, DOI 10.1159/000339951; Shinozaki K, 2014, OBES RES CLIN PRACT, V8, pE382, DOI 10.1016/j.orcp.2013.07.005; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Usher CL, 2015, NAT GENET, V47, P921, DOI 10.1038/ng.3340; Viljakainen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131883; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398	19	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154961	10.1371/journal.pone.0154961	http://dx.doi.org/10.1371/journal.pone.0154961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149670	Green Published, gold			2022-12-27	WOS:000375676800101
J	Chen, YY; Xu, ZS; Xiong, AS				Chen, Yi-Yun; Xu, Zhi-Sheng; Xiong, Ai-Sheng			Identification and Characterization of DcUSAGT1, a UDP-Glucose: Sinapic Acid Glucosyltransferase from Purple Carrot Taproots	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHESIS; CELL-CULTURES; GENES; METABOLISM; 3-O-GLUCOSYLTRANSFERASE; GLYCOSYLTRANSFERASES; EXPRESSION; CAROTA	Purple carrots accumulate abundant cyanidin-based anthocyanins in taproots. UDP-glucose: sinapic acid glucosyltransferase (USAGT) can transfer the glucose moiety to the carboxyl group of sinapic acid thereby forming the ester bond between the carboxyl-C and the C1 of glucose (1-O-sinapoylglucose). 1-O-sinapoylglucose can serve as an acyl donor in acylation of anthocyanins and generate cyanidin 3-xylosyl (sinapoylglucosyl) galactoside in purple carrots. This final product helps stabilize the accumulation of anthocyanins. In this study, a gene named DcUSAGT1 encoding USAGT was cloned from 'Deep purple' carrot taproots. Enzymatic activity was determined using high performance liquid chromatography (HPLC). The optimal temperature and pH value were 30 degrees C and 7.0, respectively. Kinetic analysis suggested a Km (sinapic acid) of 0.59 mM. Expression profiles of DcUSAGT1 showed high expression levels in the taproots of all the three purple carrot cultivars but low expression levels in those of non-purple carrot cultivars. The USAGT activity of different carrots in vitro indicated that crude enzyme extracted from the purple carrot taproots rather than non-purple carrot taproots exhibited USAGT activity. These results indicated that DcUSAGT1 may influence anthocyanin biosynthesis of purple carrot taproots.	[Chen, Yi-Yun; Xu, Zhi-Sheng; Xiong, Ai-Sheng] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, 1 Weigang, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Xiong, AS (corresponding author), Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, 1 Weigang, Nanjing, Jiangsu, Peoples R China.	xiongaisheng@njau.edu.cn		Xiong, Ai-Sheng/0000-0002-7900-5001	New Century Excellent Talents in University [NCET-11-0670]; Jiangsu Natural Science Foundation [BK20130027]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Priority Academic Program Development of Jiangsu Higher Education Institutions	New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Priority Academic Program Development of Jiangsu Higher Education Institutions	The research was supported by the New Century Excellent Talents in University (NCET-11-0670), Jiangsu Natural Science Foundation (BK20130027), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by the New Century Excellent Talents in University (NCET-11-0670), Jiangsu Natural Science Foundation (BK20130027), Priority Academic Program Development of Jiangsu Higher Education Institutions.	Alessandro MS, 2013, THEOR APPL GENET, V126, P415, DOI 10.1007/s00122-012-1989-1; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bohm H.G., 1994, FOODNAHRUNG, V38, P343, DOI [10.1002/food.19940380317, DOI 10.1002/FOOD.19940380317]; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Budahn H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00504; Chen YY, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0319-0; Glassgen WE, 1998, PLANTA, V204, P490, DOI 10.1007/s004250050283; HALAWEISH FT, 1990, PLANT SCI, V71, P179, DOI 10.1016/0168-9452(90)90007-B; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kovinich N, 2010, PHYTOCHEMISTRY, V71, P1253, DOI 10.1016/j.phytochem.2010.05.009; Kubo A, 2004, ARCH BIOCHEM BIOPHYS, V429, P198, DOI 10.1016/j.abb.2004.06.021; Lim EK, 2001, J BIOL CHEM, V276, P4344, DOI 10.1074/jbc.M007263200; Luby CH, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.15; Milkowski C, 2000, PLANTA, V211, P883, DOI 10.1007/s004250000411; Milkowski C, 2010, PLANTA, V232, P19, DOI 10.1007/s00425-010-1168-z; Montilla EC, 2011, J AGR FOOD CHEM, V59, P3385, DOI 10.1021/jf104724k; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Nishihara M, 2011, BIOTECHNOL LETT, V33, P433, DOI 10.1007/s10529-010-0461-z; POULTON JE, 1977, PLANTA, V136, P53, DOI 10.1007/BF00387925; REED DW, 1993, ARCH BIOCHEM BIOPHYS, V305, P526, DOI 10.1006/abbi.1993.1456; SALEH NAM, 1976, PLANTA, V133, P41, DOI 10.1007/BF00386004; Schrader O, 2003, CARYOLOGIA, V56, P149, DOI 10.1080/00087114.2003.10589318; STRACK D, 1980, Z NATURFORSCH C, V35, P204; Tian C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117569; Wang GL, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.28; Whetten RW, 1998, ANNU REV PLANT PHYS, V49, P585, DOI 10.1146/annurev.arplant.49.1.585; Xu ZS, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau096; Xu ZS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0262-y; Yildiz M, 2013, THEOR APPL GENET, V126, P1689, DOI 10.1007/s00122-013-2084-y	30	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154938	10.1371/journal.pone.0154938	http://dx.doi.org/10.1371/journal.pone.0154938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171142	Green Published, Green Submitted, gold			2022-12-27	WOS:000376588600069
J	Duggal, A; Pinto, R; Rubenfeld, G; Fowler, RA				Duggal, Abhijit; Pinto, Ruxandra; Rubenfeld, Gordon; Fowler, Robert A.			Global Variability in Reported Mortality for Critical Illness during the 2009-10 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Regression to Guide Reporting of Outcomes during Disease Outbreaks	PLOS ONE			English	Review							NEWCASTLE-OTTAWA SCALE; CRITICAL-CARE; METAANALYSIS; BURDEN	Purpose To determine how patient, healthcare system and study-specific factors influence reported mortality associated with critical illness during the 2009-2010 Influenza A (H1N1) pandemic. Methods Systematic review with meta-regression of studies reporting on mortality associated with critical illness during the 2009-2010 Influenza A (H1N1) pandemic. Data Sources Medline, Embase, LiLACs and African Index Medicus to June 2009-March 2016. Results 226 studies from 50 countries met our inclusion criteria. Mortality associated with H1N1-related critical illness was 31% (95% CI 28-34). Reported mortality was highest in South Asia (61% [95% CI 50-71]) and Sub-Saharan Africa (53% [95% CI 29-75]), in comparison to Western Europe (25% [95% CI 22-30]), North America (25% [95% CI 22-27]) and Australia (15% [95% CI 13-18]) (P<0.0001). High income economies had significantly lower reported mortality compared to upper middle income economies and lower middle income economies respectively (P<0.0001). Mortality for the first wave was non- significantly higher than wave two (P = 0.66). There was substantial variability in reported mortality among the specific subgroups of patients: unselected critically ill adults (27% [95% CI 24-30]), acute respiratory distress syndrome (37% [95% CI 32-44]), acute kidney injury (44% [95% CI 26-64]), and critically ill pregnant patients (10% [95% CI 5-19]). Conclusion Reported mortality for outbreaks and pandemics may vary substantially depending upon selected patient characteristics, the number of patients described, and the region and economic status of the outbreak location. Outcomes from a relatively small number of patients from specific regions may lead to biased estimates of outcomes on a global scale.	[Duggal, Abhijit; Rubenfeld, Gordon; Fowler, Robert A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Duggal, Abhijit] Cleveland Clin, Dept Crit Care, Resp Inst, Cleveland, OH 44106 USA; [Pinto, Ruxandra; Rubenfeld, Gordon; Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Trauma Emergency & Crit Care Program, Toronto, ON M4N 3M5, Canada; [Rubenfeld, Gordon; Fowler, Robert A.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Rubenfeld, Gordon; Fowler, Robert A.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; Cleveland Clinic Foundation; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	Duggal, A (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Duggal, A (corresponding author), Cleveland Clin, Dept Crit Care, Resp Inst, Cleveland, OH 44106 USA.	Duggala2@ccf.org	Duggal, Abhijit/J-2921-2016	Duggal, Abhijit/0000-0003-4220-2359	Heart and Stroke Foundation, Ontario Provincial Office	Heart and Stroke Foundation, Ontario Provincial Office(Heart & Stroke Foundation of Ontario)	This work was supported by a personnel award from the Heart and Stroke Foundation, Ontario Provincial Office for Dr. Robert A. Fowler.	Adhikari NKJ, 2011, CURR OPIN CRIT CARE, V17, P620, DOI 10.1097/MCC.0b013e32834cd39c; Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/rccm.201001-0037OC, 10.1164/201001-0037OC]; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Fowler RA, 2008, CRIT CARE, V12, DOI 10.1186/cc6984; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; ISARIC, 2014, GLOB HLTH NETWR PROT; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Konstantopoulos S, 2011, RES SYNTH METHODS, V2, P61, DOI 10.1002/jrsm.35; Levy MM, 2005, AM J RESP CRIT CARE, V171, P518, DOI 10.1164/rccm.200405-621WS; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45; Martin-Loeches I, 2011, CRIT CARE, V15, DOI 10.1186/cc10573; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Montori V GG, 2002, USERS GUIDES MED LIT, P539; Muscedere J, 2013, CHEST, V144, P39, DOI 10.1378/chest.12-1861; Organization WH, 2014, INFL LAB SURV SYST; Rice TW, 2012, CRIT CARE MED, V40, P1487, DOI 10.1097/CCM.0b013e3182416f23; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Webb SAR, 2011, CRIT CARE, V15, DOI 10.1186/cc10266	29	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155044	10.1371/journal.pone.0155044	http://dx.doi.org/10.1371/journal.pone.0155044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27170999	Green Published, Green Submitted, gold			2022-12-27	WOS:000376588600066
J	Lee, YM; Song, DE; Kim, TY; Sung, TY; Yoon, JH; Chung, KW; Hong, SJ				Lee, Yu-Mi; Song, Dong Eun; Kim, Tae Yong; Sung, Tae-Yon; Yoon, Jong Ho; Chung, Ki-Wook; Hong, Suck Joon			Risk Factors for Distant Metastasis in Patients with Minimally Invasive Follicular Thyroid Carcinoma	PLOS ONE			English	Article							EXTENSIVE VASCULAR INVASION; PROGNOSTIC-FACTORS; COMPLETION THYROIDECTOMY; STAGING SYSTEMS; CANCER; TUMORS; CYTOKERATIN-19; EXPRESSION; GALECTIN-3; DIAGNOSIS	Background Although patients with minimally invasive follicular thyroid carcinoma (MIFTC) generally have an excellent prognosis, distant metastasis occurs in some patients. Risk factors for distant metastasis have been reported, none has been found to be conclusive. This study evaluated risk factors for distant metastasis, including protein markers, in patients with MIFTC. Methods A review of patient records identified 259 patients who underwent surgery at Asan Medical Center from 1996 to 2010 and were subsequently diagnosed with MIFTC. After review of pathological slides, 120 patients with paraffin blocks suited for tissue microarrays (TMA) were included in this study. Immunohistochemical stain of TMA slides was performed by protein markers; beta-catenin, C-MET, CK19, estrogen receptor (ER) alpha, ER beta, HBME-1, MMP2, PPAR gamma and progesterone receptor. Results 120 patients included 28 males (23.3%) and 92 females (76.7%), of mean age 41.5 +/- 10.8 years (range, 13-74 years). Eight patients (6.7%) had distant metastases during follow-up. Univariate analysis showed that age (>= 45 years), male sex, and extensive vascular invasion (>= 4 foci) were associated with distant metastasis. Multivariate regression analysis showed that extensive vascular invasion was the only independent risk factor for distant metastasis (p = 0.012). Although no protein markers on TMA analysis were directly related to distant metastasis of MIFTC, CK19 expression was more frequent in patients with than without extensive vascular invasion (p = 0.036). Conclusion Extensive vascular invasion was the only independent risk factor for distant metastasis of MIFTC. No proteins markers were directly related to distant metastasis, but CK19 was associated with extensive vascular invasion.	[Lee, Yu-Mi; Sung, Tae-Yon; Yoon, Jong Ho; Chung, Ki-Wook; Hong, Suck Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea; [Song, Dong Eun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Kim, Tae Yong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Chung, KW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea.	surgeonckw@amc.seoul.kr	Kim, Tae Yong/C-1272-2009	Kim, Tae Yong/0000-0003-4982-4441; YOON, JONG HO/0000-0003-1105-3653	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [2013-572]	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea	This study was supported by a grant 2013-572 from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. (http://ails.amc.seoul.kr). Ki-Wook Chung was received this funding.; This study was supported by a grant 2013-572 from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.	Ban EJ, 2012, ANZ J SURG, V82, P136, DOI 10.1111/j.1445-2197.2011.05979.x; Calangiu CM, 2014, ROM J MORPHOL EMBRYO, V55, P919; Collini P, 2004, HISTOPATHOLOGY, V44, P35, DOI 10.1111/j.1365-2559.2004.01729.x; D'Avanzo A, 2004, CANCER-AM CANCER SOC, V100, P1123, DOI 10.1002/cncr.20081; de Matos PS, 2005, HISTOPATHOLOGY, V47, P391, DOI 10.1111/j.1365-2559.2005.02221.x; Delbridge L, 2002, ANZ J SURG, V72, P844, DOI 10.1046/j.1445-2197.2002.t01-1-02556.x; DELELLIS RA, 2004, PATHOLOGY GENETICS T; Ding SJ, 2004, MOL CELL PROTEOMICS, V3, P73, DOI 10.1074/mcp.M300094-MCP200; Goffredo P, 2013, ANN SURG ONCOL, V20, P767, DOI 10.1245/s10434-012-2697-4; Heikkila A, 2013, THYROID, V23, P456, DOI 10.1089/thy.2012.0363; Ito Y, 2007, WORLD J SURG, V31, P1417, DOI 10.1007/s00268-007-9095-2; Ito Y, 2014, ENDOCR J, V61, P265, DOI 10.1507/endocrj.EJ13-0512; Ito Y, 2013, ENDOCR J, V60, P637, DOI 10.1507/endocrj.EJ12-0419; Jang EK, 2014, THYROID, V24, P1275, DOI 10.1089/thy.2014.0053; Lang BHH, 2007, ENDOCR-RELAT CANCER, V14, P29, DOI 10.1677/erc.1.01284; Li JM, 2006, INT J BIOCHEM CELL B, V38, P961, DOI 10.1016/j.biocel.2005.08.014; Liu ZM, 2014, INT J CLIN EXP MED, V7, P2304; Lo CY, 2005, ANN SURG, V242, P708, DOI 10.1097/01.sla.0000186421.30982.d2; O'Neill CJ, 2011, EJSO-EUR J SURG ONC, V37, P181, DOI 10.1016/j.ejso.2010.11.005; Schmitt AM, 2007, AM J SURG PATHOL, V31, P1677, DOI 10.1097/PAS.0b013e31805f675d; Sugino K, 2014, ANN SURG ONCOL, V21, P2981, DOI 10.1245/s10434-014-3734-2; Sugino K, 2012, THYROID, V22, P798, DOI 10.1089/thy.2012.0051; Wiseman SM, 2008, ANN SURG ONCOL, V15, P2811, DOI 10.1245/s10434-008-0034-8	23	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155489	10.1371/journal.pone.0155489	http://dx.doi.org/10.1371/journal.pone.0155489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171147	Green Submitted, Green Published, gold			2022-12-27	WOS:000376588600119
J	Rai, MF; Sandell, LJ; Zhang, B; Wright, RW; Brophy, RH				Rai, Muhammad Farooq; Sandell, Linda J.; Zhang, Bo; Wright, Rick W.; Brophy, Robert H.			RNA Microarray Analysis of Macroscopically Normal Articular Cartilage from Knees Undergoing Partial Medial Meniscectomy: Potential Prediction of the Risk for Developing Osteoarthritis	PLOS ONE			English	Article							AGE-RELATED DECLINE; GROWTH-FACTOR-I; TRANSCRIPTOME ANALYSIS; CANDIDATE GENES; SEX-DIFFERENCES; MESSENGER-RNA; CHONDROCYTES; EXPRESSION; OBESITY; REVEALS	Objectives (i) To provide baseline knowledge of gene expression in macroscopically normal articular cartilage, (ii) to test the hypothesis that age, body-mass-index (BMI), and sex are associated with cartilage RNA transcriptome, and (iii) to predict individuals at potential risk for developing "pre-osteoarthritis" (OA) based on screening of genetic risk-alleles associated with OA and gene transcripts differentially expressed between normal and OA cartilage. Design Healthy-appearing cartilage was obtained from the medial femoral notch of 12 knees with a meniscus tear undergoing arthroscopic partial meniscectomy. Cartilage had no radiographic, magnetic-resonance-imaging or arthroscopic evidence for degeneration. RNA was subjected to Affymetrix microarrays followed by validation of selected transcripts by microfluidic digital polymerase-chain-reaction. The underlying biological processes were explored computationally. Transcriptome-wide gene expression was probed for association with known OA genetic risk-alleles assembled from published literature and for comparison with gene transcripts differentially expressed between healthy and OA cartilage from other studies. Results We generated a list of 27,641 gene transcripts in healthy cartilage. Several gene transcripts representing numerous biological processes were correlated with age and BMI and differentially expressed by sex. Based on disease-specific Ingenuity Pathways Analysis, gene transcripts associated with aging were enriched for bone/cartilage disease while the gene expression profile associated with BMI was enriched for growth-plate calcification and OA. When segregated by genetic risk-alleles, two clusters of study patients emerged, one cluster containing transcripts predicted by risk studies. When segregated by OA-associated gene transcripts, three clusters of study patients emerged, one of which is remarkably similar to gene expression pattern in OA. Conclusions Our study provides a list of gene transcripts in healthy-appearing cartilage. Preliminary analysis into groupings based on OA risk-alleles and OA-associated gene transcripts reveals a subset of patients expressing OA transcripts. Prospective studies in larger cohorts are needed to assess whether these patterns are predictive for OA.	[Rai, Muhammad Farooq; Sandell, Linda J.; Wright, Rick W.; Brophy, Robert H.] Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Orthopaed Surg,Musculoskeletal Res Ctr, St Louis, MO USA; [Sandell, Linda J.] Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Cell Biol & Physiol, St Louis, MO USA; [Sandell, Linda J.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Zhang, Bo] Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Dev Biol,Ctr Regenerat Med, St Louis, MO USA	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Rai, MF (corresponding author), Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Orthopaed Surg,Musculoskeletal Res Ctr, St Louis, MO USA.	raim@wudosis.wustl.edu	Brophy, Robert H/AAX-8562-2021; zb, aber/A-6874-2011; Farooq, Muhammad/ABE-6335-2021	Brophy, Robert H/0000-0002-2912-8265; zb, aber/0000-0003-2962-5314; Rai, Muhammad Farooq/0000-0003-4826-4331	AOSSM/Sanofi Osteoarthritis Research Grant [R01AR063757, R01AR063757 02S1, P30 AR 05723]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) [1K99AR064837]; NIDA R25 program [DA027995]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR063757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	AOSSM/Sanofi Osteoarthritis Research Grant; National Institute of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDA R25 program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	All microarrays were performed at Genome Technology Access Center of Washington University. This study was supported by the AOSSM/Sanofi Osteoarthritis Research Grant (Brophy, Rai, Wright, Sandell) and R01AR063757, R01AR063757 02S1 (Sandell, Rai) and P30 AR 05723 (Sandell). Dr. Rai is supported through Pathway to Independence Award (1K99AR064837) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health). Dr. Zhang is supported by NIDA R25 program DA027995. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Brophy RH, 2014, J BONE JOINT SURG AM, V96A, P801, DOI 10.2106/JBJS.M.00105; Cicuttini FM, 1999, OSTEOARTHR CARTILAGE, V7, P265, DOI 10.1053/joca.1998.0200; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Clockaerts S, 2010, OSTEOARTHR CARTILAGE, V18, P876, DOI 10.1016/j.joca.2010.03.014; Conde J, 2011, ANN RHEUM DIS, V70, P551, DOI 10.1136/ard.2010.132399; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Ding C, 2003, RHEUMATOLOGY, V42, P1317, DOI 10.1093/rheumatology/keg374; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Fukui N, 2003, J BONE JOINT SURG AM, V85A, P59, DOI 10.2106/00004623-200300003-00011; Gamer LW, 2001, DEV BIOL, V229, P407, DOI 10.1006/dbio.2000.9981; Geyer M, 2009, OSTEOARTHR CARTILAGE, V17, P328, DOI 10.1016/j.joca.2008.07.010; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Griffin TM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3068; Jones G, 2000, ARTHRITIS RHEUM-US, V43, P2543, DOI 10.1002/1529-0131(200011)43:11<2543::AID-ANR23>3.0.CO;2-K; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002; Loeser R.F., 2004, J SCI AGING KNOWLEDG, V2004, P31, DOI DOI 10.1126/SAGEKE.2004.29.PE31; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P705, DOI 10.1002/art.33388; Loeser RF, 2010, CLIN GERIATR MED, V26, P371, DOI 10.1016/j.cger.2010.03.002; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Lohmander LS, 2009, ANN RHEUM DIS, V68, P490, DOI 10.1136/ard.2008.089748; Louer CR, 2012, ARTHRITIS RHEUM-US, V64, P3220, DOI 10.1002/art.34533; Loughlin J, 2011, OSTEOARTHR CARTILAGE, V19, P342, DOI 10.1016/j.joca.2011.01.020; Magnussen RA, 2005, J BONE JOINT SURG AM, V87A, P1272, DOI 10.2106/JBJS.D.01936; Martin J A, 2001, Iowa Orthop J, V21, P1; Martin JA, 1997, J ORTHOP RES, V15, P491, DOI 10.1002/jor.1100150403; Martin JA, 2001, J GERONTOL A-BIOL, V56, pB172, DOI 10.1093/gerona/56.4.B172; MATSUKAWA A, 1995, J IMMUNOL, V154, P5418; Matsumoto T, 2008, ARTHRITIS RHEUM-US, V58, P3809, DOI 10.1002/art.24125; Merz D, 2003, J IMMUNOL, V171, P4406, DOI 10.4049/jimmunol.171.8.4406; Meulenbelt I, 2012, OSTEOARTHR CARTILAGE, V20, P218, DOI 10.1016/j.joca.2012.01.007; Mezhov V, 2014, OBES REV, V15, P143, DOI 10.1111/obr.12110; Ohnuma Kei, 2006, Mod Rheumatol, V16, P3; Okuda S, 2001, SPINE, V26, P2421, DOI 10.1097/00007632-200111150-00005; Peffers MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4278; Rai MF, 2013, ARTHRITIS RHEUM-US, V65, P2090, DOI 10.1002/art.37984; Rai MF, 2011, CRIT REV EUKAR GENE, V21, P131, DOI 10.1615/CritRevEukarGeneExpr.v21.i2.30; Ramos YFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103056; Reynard LN, 2013, NAT REV RHEUMATOL, V9, P573, DOI 10.1038/nrrheum.2013.121; Roos H, 1995, OSTEOARTHR CARTILAGE, V3, P261, DOI 10.1016/S1063-4584(05)80017-2; Sandell LJ, 2008, OSTEOARTHR CARTILAGE, V16, P1560, DOI 10.1016/j.joca.2008.04.027; Sato T, 2006, ARTHRITIS RHEUM-US, V54, P808, DOI 10.1002/art.21638; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Takami M, 2002, J IMMUNOL, V168, P4559, DOI 10.4049/jimmunol.168.9.4559; Tsuchiya K, 1997, J ORTHOP RES, V15, P94, DOI 10.1002/jor.1100150114; Tsuritani K, 2010, CALCIFIED TISSUE INT, V86, P47, DOI 10.1007/s00223-009-9311-1; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Webb GR, 1998, OSTEOARTHR CARTILAGE, V6, P167, DOI 10.1053/joca.1998.0109; Westacott CI, 2000, OSTEOARTHR CARTILAGE, V8, P213, DOI 10.1053/joca.1999.0292; Widmyer MR, 2013, ARTHRITIS RHEUM-US, V65, P2615, DOI 10.1002/art.38062; Xu L, 2015, OSTEOARTHR CARTILAGE, V23, P933, DOI 10.1016/j.joca.2015.02.011; Xu Y, 2012, OSTEOARTHR CARTILAGE, V20, P1029, DOI 10.1016/j.joca.2012.05.006; Zhang ZQ, 2010, ARTHRITIS RHEUM-US, V62, P1993, DOI 10.1002/art.27473	55	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155373	10.1371/journal.pone.0155373	http://dx.doi.org/10.1371/journal.pone.0155373			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171008	Green Published, gold, Green Submitted			2022-12-27	WOS:000376588600122
J	Liu, GX; Ma, HM; Xie, HY; Xuan, N; Guo, X; Fan, ZX; Rajashekar, B; Arnaud, P; Offmann, B; Picimbon, JF				Liu, Guoxia; Ma, Hongmei; Xie, Hongyan; Xuan, Ning; Guo, Xia; Fan, Zhongxue; Rajashekar, Balaji; Arnaud, Philippe; Offmann, Bernard; Picimbon, Jean-Francois			Biotype Characterization, Developmental Profiling, Insecticide Response and Binding Property of Bemisia tabaci Chemosensory Proteins: Role of CSP in Insect Defense	PLOS ONE			English	Article							NEONICOTINOID CROSS-RESISTANCE; EXPRESSION PATTERN; LINOLEIC-ACID; OS-D; GENE-EXPRESSION; HEMIPTERA; IDENTIFICATION; PHEROMONE; PURIFICATION; ALEYRODIDAE	Chemosensory proteins (CSPs) are believed to play a key role in the chemosensory process in insects. Sequencing genomic DNA and RNA encoding CSP1, CSP2 and CSP3 in the sweet potato whitefly Bemisia tabaci showed strong variation between B and Q biotypes. Analyzing CSP-RNA levels showed not only biotype, but also age and developmental stage-specific expression. Interestingly, applying neonicotinoid thiamethoxam insecticide using twenty-five different dose/time treatments in B and Q young adults showed that Bemisia CSP1, CSP2 and CSP3 were also differentially regulated over insecticide exposure. In our study one of the adult-specific gene (CSP1) was shown to be significantly up-regulated by the insecticide in Q, the most highly resistant form of B. tabaci. Correlatively, competitive binding assays using tryptophan fluorescence spectroscopy and molecular docking demonstrated that CSP1 protein preferentially bound to linoleic acid, while CSP2 and CSP3 proteins rather associated to another completely different type of chemical, i.e. alpha-pentyl-cinnamaldehyde (jasminaldehyde). This might indicate that some CSPs in whiteflies are crucial to facilitate the transport of fatty acids thus regulating some metabolic pathways of the insect immune response, while some others are tuned to much more volatile chemicals known not only for their pleasant odor scent, but also for their potent toxic insecticide activity.	[Liu, Guoxia; Ma, Hongmei; Xie, Hongyan; Xuan, Ning; Guo, Xia; Fan, Zhongxue; Picimbon, Jean-Francois] Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Peoples R China; [Rajashekar, Balaji] Univ Tartu, Inst Comp Sci, 2 Liivi, Tartu, Estonia; [Arnaud, Philippe; Offmann, Bernard] Univ Nantes, Prot Engn & Funct Unit, UMR CNRS 6286, 2 Houssiniere, Nantes, France; [Picimbon, Jean-Francois] QILU Univ Technol, Coll Bioengn, Inst Agr Microbiol, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences; University of Tartu; Nantes Universite; Qilu University of Technology	Picimbon, JF (corresponding author), Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Peoples R China.; Picimbon, JF (corresponding author), QILU Univ Technol, Coll Bioengn, Inst Agr Microbiol, Jinan, Shandong, Peoples R China.	jfpicimbon@gmail.com	Picimbon, Jean-François/AAE-7720-2020; OFFMANN, Bernard/B-5901-2011; Rajashekar, Balaji/W-8012-2018	OFFMANN, Bernard/0000-0002-6845-5883; Rajashekar, Balaji/0000-0002-1665-5584	Youth Scientific Research Foundation of SAAS [2014QNM54]; Natural Sciences Foundation of Shandong Province [ZR2010CM033, ZR2011CM046]; Shandong Province Overseas High-Level Talents Program (Taishan scholar) [tshw20091015]	Youth Scientific Research Foundation of SAAS; Natural Sciences Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Province Overseas High-Level Talents Program (Taishan scholar)	This work was supported by the Youth Scientific Research Foundation of SAAS (2014QNM54), Natural Sciences Foundation of Shandong Province (ZR2010CM033 and ZR2011CM046) and Shandong Province Overseas High-Level Talents Program (Taishan scholar, NO. tshw20091015).; We thank Dr. Xun Bu and her team for help at the sequencing platform (SAAS, Jinan). We thank Prof. Dr. Yuzhong Zhang (State Key Laboratory of Microbial technology, Shandong University, Jinan) for access to fluorescence spectroscopy. We thank Prof. Drs. Paolo Pelosi (Pisa University, Italy) and Chenzhu Wang (Institute of Zoology, China Academy of Sciences, Beijing) for the gift of Heliothis CSP antibody. We also thank Prof. Dr. Paolo Pelosi (Pisa University, Italy), Assoc. Prof. Liping Ban (College of Animal Science and Technology, China Agricultural University, Beijing) and Dr. Imma Iovinella (Pisa University, Italy) for the gift of ligand chemicals. This work was supported by the Youth Scientific Research Foundation of SAAS (2014QNM54), Natural Sciences Foundation of Shandong Province (ZR2010CM033 and ZR2011CM046) and Shandong Province Overseas High-Level Talents Program (Taishan scholar, NO. tshw20091015).	Amgalanbaatar A, 2014, J STEROID BIOCHEM, V140, P17, DOI 10.1016/j.jsbmb.2013.10.023; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Blaul B, 2014, INSECT BIOCHEM MOLEC, V51, P33, DOI 10.1016/j.ibmb.2014.05.007; BLOMQUIST GJ, 1982, INSECT BIOCHEM, V12, P349, DOI 10.1016/0020-1790(82)90093-2; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Boykin LM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-228; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Buckner JS, 1999, COMP BIOCHEM PHYS B, V124, P201, DOI 10.1016/S0305-0491(99)00117-0; Calvello M, 2005, INSECT BIOCHEM MOLEC, V35, P297, DOI 10.1016/j.ibmb.2005.01.002; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Chu D, 2007, ENVIRON ENTOMOL, V36, P1290, DOI 10.1603/0046-225X(2007)36[1290:BSADOB]2.0.CO;2; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Daniels M, 2009, J INSECT PHYSIOL, V55, P758, DOI 10.1016/j.jinsphys.2009.03.002; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Gaetschenberger H, 2012, J EXP BIOL, V215, P1313, DOI 10.1242/jeb.065276; George DR, 2010, MED VET ENTOMOL, V24, P9, DOI 10.1111/j.1365-2915.2009.00856.x; Ghanim M, 2007, PEST MANAG SCI, V63, P776, DOI 10.1002/ps.1410; Ghanim M, 2006, INSECT BIOCHEM MOLEC, V36, P857, DOI 10.1016/j.ibmb.2006.08.007; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; He YX, 2013, INT J BIOL SCI, V9, P246, DOI 10.7150/ijbs.5762; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Hosoda K, 2011, FEMS MICROBIOL LETT, V318, P68, DOI 10.1111/j.1574-6968.2011.02239.x; Hua JF, 2013, J INSECT PHYSIOL, V59, P690, DOI 10.1016/j.jinsphys.2013.04.013; Huang Y, 1998, J STORED PROD RES, V34, P11, DOI 10.1016/S0022-474X(97)00038-6; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Iovinella I, 2013, CHEM SENSES, V4, P3; Ishida Y, 2014, P NATL ACAD SCI USA, V111, P3847, DOI 10.1073/pnas.1323928111; Jacobs SP, 2005, INSECT MOL BIOL, V14, P423, DOI 10.1111/j.1365-2583.2005.00573.x; James RR, 2012, J INVERTEBR PATHOL, V109, P175, DOI 10.1016/j.jip.2011.12.005; Jansen S, 2007, ARCH INSECT BIOCHEM, V66, P135, DOI 10.1002/arch.20205; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Kulmuni J, 2013, HEREDITY, V110, P538, DOI 10.1038/hdy.2012.122; Lartigue A, 2002, J BIOL CHEM, V277, P32094, DOI 10.1074/jbc.M204371200; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leshkowitz D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-79; Lin QS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072314; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028516; Liu GX, 2014, ARCH INSECT BIOCHEM, V85, P137, DOI 10.1002/arch.21148; Liu GX, 2016, GENE, V576, P284, DOI 10.1016/j.gene.2015.10.036; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu XL, 2010, J BIOCHEM, V148, P189, DOI 10.1093/jb/mvq050; Liu YL, 2014, J EXP BIOL, V217, P1821, DOI 10.1242/jeb.102020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo C, 2010, CROP PROT, V29, P429, DOI 10.1016/j.cropro.2009.10.001; Ma DY, 2007, CROP PROT, V26, P612, DOI 10.1016/j.cropro.2006.04.027; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Nauen R, 2005, ARCH INSECT BIOCHEM, V58, P200, DOI 10.1002/arch.20043; Nauen R, 2002, PEST MANAG SCI, V58, P868, DOI 10.1002/ps.557; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Ozaki K, 2008, INSECT BIOCHEM MOLEC, V38, P969, DOI 10.1016/j.ibmb.2008.07.010; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Picimbon J.F., 2014, INT J BIOORG CHEM MO, V2, P201; Picimbon J.F., 2014, GENE TECHNOL, V4, P112, DOI [10.4172/2329-6682.1000112, DOI 10.4172/2329-6682.1000112]; Picimbon Jean-Francois, 2003, P539, DOI 10.1016/B978-012107151-6/50020-7; Picimbon JF, 2000, ARCH INSECT BIOCHEM, V44, P120, DOI 10.1002/1520-6327(200007)44:3&lt;120::AID-ARCH3&gt;3.0.CO;2-H; Picimbon JF, 1999, INSECT BIOCHEM MOLEC, V29, P973, DOI 10.1016/S0965-1748(99)00073-9; Picimbon JF, 2000, INSECT BIOCHEM MOLEC, V30, P233, DOI 10.1016/S0965-1748(99)00121-6; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; Picimbon JF, 2014, RNA DIS, V1, P1; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; Sabatier L, 2003, EUR J BIOCHEM, V270, P3398, DOI 10.1046/j.1432-1033.2003.03725.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Su YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039303; Tay WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050550; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Tomaselli S, 2006, BIOCHEMISTRY-US, V45, P10606, DOI 10.1021/bi060998w; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tufail M, 2014, ENTOMOL SCI, V17, P269, DOI 10.1111/ens.12086; Wang R, 2016, J ASIA-PAC ENTOMOL, V19, P195, DOI 10.1016/j.aspen.2016.01.005; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZQ, 2011, J MED ENTOMOL, V48, P366, DOI 10.1603/ME10127; Wanner KW, 2005, INSECT MOL BIOL, V14, P289, DOI 10.1111/j.1365-2583.2005.00559.x; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Xia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068185; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Xuan N, 2015, INSECT SCI, V22, P203, DOI 10.1111/1744-7917.12116; Xuan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086932; Yang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061820; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077295; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou XH, 2013, BIOL CHEM, V394, P43, DOI 10.1515/hsz-2012-0114; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	94	49	51	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154706	10.1371/journal.pone.0154706	http://dx.doi.org/10.1371/journal.pone.0154706			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167733	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300009
J	Sidorova, YA; Perepechaeva, ML; Pivovarova, EN; Markel, AL; Lyakhovich, VV; Grishanova, AY				Sidorova, Yulia A.; Perepechaeva, Maria L.; Pivovarova, Elena N.; Markel, Arkady L.; Lyakhovich, Vyacheslav V.; Grishanova, Alevtina Y.			Menadione Suppresses Benzo(a)pyrene-Induced Activation of Cytochromes P450 1A: Insights into a Possible Molecular Mechanism	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; POLYCYCLIC AROMATIC-HYDROCARBONS; CCAAT/ENHANCER-BINDING-PROTEIN; HEP G2 CELLS; RAT-LIVER; MEDIATED INDUCTION; CYP1A1 EXPRESSION; GENE-EXPRESSION; KNOCKOUT MICE; VITAMIN-A	Oxidative reactions that are catalyzed by cytochromes P450 1A (CYP1A) lead to formation of carcinogenic derivatives of arylamines and polycyclic aromatic hydrocarbons (PAHs), such as the widespread environmental pollutant benzo(a) pyrene (BP). These compounds upregulate CYP1A at the transcriptional level via an arylhydrocarbon receptor (AhR)-dependent signaling pathway. Because of the involvement of AhR-dependent genes in chemically induced carcinogenesis, suppression of this signaling pathway could prevent tumor formation and/or progression. Here we show that menadione (a water-soluble analog of vitamin K-3) inhibits BP-induced expression and enzymatic activity of both CYP1A1 and CYP1A2 in vivo (in the rat liver) and BP-induced activity of CYP1A1 in vitro. Coadministration of BP and menadione reduced DNA-binding activity of AhR and increased DNA-binding activity of transcription factors Oct-1 and CCAAT/enhancer binding protein (C/EBP), which are known to be involved in negative regulation of AhR-dependent genes, in vivo. Expression of another factor involved in downregulation of CYP1A-pAhR repressor (AhRR)-was lower in the liver of the rats treated with BP and menadione, indicating that the inhibitory effect of menadione on CYP1A is not mediated by this protein. Furthermore, menadione was well tolerated by the animals: no signs of acute toxicity were detected by visual examination or by assessment of weight gain dynamics or liver function. Taken together, our results suggest that menadione can be used in further studies on animal models of chemically induced carcinogenesis because menadione may suppress tumor formation and possibly progression.	[Sidorova, Yulia A.; Perepechaeva, Maria L.; Lyakhovich, Vyacheslav V.; Grishanova, Alevtina Y.] Inst Mol Biol & Biophys, Novosibirsk, Russia; [Pivovarova, Elena N.; Markel, Arkady L.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Fed Res Ctr, Novosibirsk 630090, Russia; [Sidorova, Yulia A.] Univ Helsinki, Inst Biotechnol, Viikki Bioctr, POB 56, Helsinki, Finland	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Helsinki	Sidorova, YA (corresponding author), Inst Mol Biol & Biophys, Novosibirsk, Russia.; Sidorova, YA (corresponding author), Univ Helsinki, Inst Biotechnol, Viikki Bioctr, POB 56, Helsinki, Finland.	ysidorova@gmail.com	Perepechaeva, Maria/AAG-1840-2020; Grishanova, Alevtina/C-1759-2014; Sidorova, Yulia/L-5340-2019	Perepechaeva, Maria/0000-0001-5791-3714; Grishanova, Alevtina/0000-0002-5894-1159; Sidorova, Yulia/0000-0001-8230-0530	Russian Foundation for Basic Research [05-04-48327 -a]; Presidium Russian Academy of Science "Molecular and Cellular Biology"	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium Russian Academy of Science "Molecular and Cellular Biology"	This work was supported by the Russian Foundation for Basic Research (project no.No 05-04-48327 -a) (www.rfbr.ru) and the grant from Presidium Russian Academy of Science "Molecular and Cellular Biology" (http://www.ras.ru/presidium.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backlund M, 2004, MOL PHARMACOL, V65, P416, DOI 10.1124/mol.65.2.416; Backlund M, 1997, J BIOL CHEM, V272, P31755, DOI 10.1074/jbc.272.50.31755; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bhat R, 1996, INT J BIOCHEM CELL B, V28, P217; Billiard SM, 2006, TOXICOL SCI, V92, P526, DOI 10.1093/toxsci/kfl011; Boffetta P, 1997, CANCER CAUSE CONTROL, V8, P444, DOI 10.1023/A:1018465507029; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; Cespedes MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015382; Chang CY, 1998, MOL CELL BIOL, V18, P525, DOI 10.1128/MCB.18.1.525; Chang Thomas K H, 2007, Drug Metab Lett, V1, P13; CHEN YH, 1995, J BIOL CHEM, V270, P22548, DOI 10.1074/jbc.270.38.22548; Cho IJ, 2003, J BIOL CHEM, V278, P44103, DOI 10.1074/jbc.M307597200; Ciolino HP, 1998, BIOCHEM PHARMACOL, V56, P197, DOI 10.1016/S0006-2952(98)00143-9; DeLuca HF, 1978, FAT SOLUBLE VITAMINS, Vxii; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; DENISON MS, 1990, MOL CELL ENDOCRINOL, V69, P51, DOI 10.1016/0303-7207(90)90088-P; FLOREANI M, 1990, TOXICOL APPL PHARM, V105, P333, DOI 10.1016/0041-008X(90)90194-Y; Fukuda I, 2005, BIOSCI BIOTECH BIOCH, V69, P883, DOI 10.1271/bbb.69.883; Gambone CJ, 2002, MOL PHARMACOL, V61, P334, DOI 10.1124/mol.61.2.334; Gharavi N, 2005, J PHARM SCI-US, V94, P493, DOI 10.1002/jps.20267; Ghosh A, 2012, EUR J CANCER PREV, V21, P32, DOI 10.1097/CEJ.0b013e32834a7e2b; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRISHANOVA AY, 1992, CYTOCHROME P-450 : BIOCHEMISTRY AND BIOPHYSICS, P525; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harper PA, 2006, BIOCHEM PHARMACOL, V72, P267, DOI 10.1016/j.bcp.2006.01.007; Hestermann EV, 2003, MOL CELL BIOL, V23, P7920, DOI 10.1128/MCB.23.21.7920-7925.2003; Inouye K, 1999, BIOCHEM BIOPH RES CO, V262, P565, DOI 10.1006/bbrc.1999.1240; Ito SJ, 2007, J CLIN INVEST, V117, P1940, DOI 10.1172/JCI31647; Kang ZC, 1999, NUTR CANCER, V35, P175, DOI 10.1207/S15327914NC352_12; Karchner SI, 2002, J BIOL CHEM, V277, P6949, DOI 10.1074/jbc.M110779200; Kensler TW, 2003, NAT REV CANCER, V3, P321, DOI 10.1038/nrc1076; Kim IS, 2011, J MICROBIOL, V49, P816, DOI 10.1007/s12275-011-1154-6; Kishkun AA, 1988, LAB DELO, V11, P41; Korashy HM, 2008, TOXICOL IN VITRO, V22, P154, DOI 10.1016/j.tiv.2007.08.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemaire G, 2004, LIFE SCI, V74, P2265, DOI 10.1016/j.lfs.2003.09.056; Leyden Webb J, 1963, ENZYME METABOLIC INH; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma Q, 2001, CURR DRUG METAB, V2, P149, DOI 10.2174/1389200013338603; Malone CS, 2006, J MOL BIOL, V362, P173, DOI 10.1016/j.jmb.2006.07.046; Maniatis T., 1982, MOL CLONING; Marinkovic N, 2010, ARH HIG RADA TOKSIKO, V61, P445, DOI 10.2478/10004-1254-61-2010-2024; Markovets AM, 2011, AGING-US, V3, P44; Mohammadi-Bardbori A, 2012, CHEM RES TOXICOL, V25, P1878, DOI 10.1021/tx300169e; Mukai R, 2010, ARCH BIOCHEM BIOPHYS, V501, P134, DOI 10.1016/j.abb.2010.05.002; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Niestroy J, 2011, TOXICOL IN VITRO, V25, P671, DOI 10.1016/j.tiv.2011.01.008; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652; Piper JT, 1998, INT J BIOCHEM CELL B, V30, P445, DOI 10.1016/S1357-2725(98)00015-6; Sagredo C, 2009, CHEM RES TOXICOL, V22, P584, DOI 10.1021/tx8003664; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Sidorova YA, 2005, B EXP BIOL MED+, V140, P517, DOI 10.1007/s10517-006-0012-8; Sidorova YA, 2005, TOXICOL LETT, V155, P253, DOI 10.1016/j.toxlet.2004.10.001; Sidorova YA, 2004, B EXP BIOL MED+, V137, P231, DOI 10.1023/B:BEBM.0000031556.47763.04; SOUSA RL, 1985, ARCH BIOCHEM BIOPHYS, V240, P345, DOI 10.1016/0003-9861(85)90040-2; Uno S, 2001, BIOCHEM BIOPH RES CO, V289, P1049, DOI 10.1006/bbrc.2001.6110; Wang H, 2001, BRIT J PHARMACOL, V133, P713, DOI 10.1038/sj.bjp.0704102; Wen X, 2005, CARCINOGENESIS, V26, P803, DOI 10.1093/carcin/bgi015; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Yang YM, 2005, TOXICOL SCI, V85, P727, DOI 10.1093/toxsci/kfi130; Yuan W, 1997, ARCH BIOCHEM BIOPHYS, V339, P55, DOI 10.1006/abbi.1996.9818; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	66	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155135	10.1371/journal.pone.0155135	http://dx.doi.org/10.1371/journal.pone.0155135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167070	Green Submitted, Green Published, gold			2022-12-27	WOS:000376587300058
J	Theisen, D; Rada, I; Brau, A; Gette, P; Seil, R				Theisen, Daniel; Rada, Isabel; Brau, Amelie; Gette, Paul; Seil, Romain			Muscle Activity Onset Prior to Landing in Patients after Anterior Cruciate Ligament Injury: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACL INJURY; RETURN; RISK; RECONSTRUCTION; ACTIVATION; MECHANISMS; STRATEGIES; SPORTS	Muscle activation during landing is paramount to stabilise lower limb joints and avoid abnormal movement patterns. Delayed muscle activity onset measured by electromyography (EMG) has been suggested to be associated with anterior cruciate ligament (ACL) injury. Therefore, the aim of this systematic review and meta-analysis was to test the hypothesis if ACL-injured patients display different results for muscle onset timing during standard deceleration tasks compared to healthy control participants. PubMed, Embase, Scopus and ScienceDirect databases were systematically searched over the period from January 1980 to February 2015, yielding a total of 1461 citations. Six studies meeting inclusion criteria underwent quality assessment, data extraction and re-computing procedures for the meta-analysis. The quality was rated "moderate" for 2 studies and "poor" for 4. Patients included and procedures used were highly heterogeneous. The tasks investigated were single leg hopping, decelerating from running or walking, tested on a total of 102 ACL-injured participants and 86 controls. EMG analyses of the muscles vastus lateralis, vastus medialis, lateral and medial hamstrings revealed trivial and non-significant standardised mean differences (SMD<0.20; p>0.05) between patients and control participants. Furthermore, no differences were found between the contralateral leg of patients and controls for muscle activity onset of the medial and lateral gastrocnemius (SMD<0.20; p>0.05). Based on 3 studies, the involved legs of ACL-injured patients showed overall earlier muscle activity onset compared to control participants for the medial gastrocnemius (SMD = 0.5; p = 0.05). Similar results were found for the lateral gastrocnemius (SMD = 2.1; p<0.001), with a greater effect size but based only on a single study. We conclude that there are no differences between leg muscles of ACL-injured patients and healthy controls regarding the muscle activity onset during landing. However, current evidence is scarce and weak, which highlights the need for further research in this area.	[Theisen, Daniel; Brau, Amelie; Gette, Paul; Seil, Romain] Luxembourg Inst Hlth, Sports Med Res Lab, Luxembourg, Luxembourg; [Rada, Isabel] Univ Finis Terrae, Fac Med, Exercise Sci Lab, Santiago, Chile; [Seil, Romain] Ctr Hosp Luxembourg, Dept Orthoped, Luxembourg, Luxembourg	Luxembourg Institute of Health; Universidad Finis Terrae; Luxembourg Hospital Center	Theisen, D (corresponding author), Luxembourg Inst Hlth, Sports Med Res Lab, Luxembourg, Luxembourg.	daniel.theisen@lih.lu	Seil, Romain/AAX-7873-2020	Rada, Isabel/0000-0002-6990-4951; Theisen, Daniel/0000-0002-9699-3013; Seil, Romain/0000-0001-8806-9384	Luxembourg Ministry of Sports; National Olympic Committee	Luxembourg Ministry of Sports; National Olympic Committee	This study has been supported by the Luxembourg Ministry of Sports and the National Olympic Committee.; We thank Ngianga-Bakwin Kandala and Valery Bocquet, as well as the reviewers of this journal for their constructive comments on the manuscript. This study has been supported by the Luxembourg Ministry of Sports and the National Olympic Committee.	Auchincloss CC, 2009, J NEUROSCI METH, V182, P85, DOI 10.1016/j.jneumeth.2009.05.027; Barber-Westin SD, 2011, ARTHROSCOPY, V27, P1697, DOI 10.1016/j.arthro.2011.09.009; Bencke J, 2011, J ELECTROMYOGR KINES, V21, P371, DOI 10.1016/j.jelekin.2010.10.008; Boden BP, 2009, AM J SPORT MED, V37, P252, DOI 10.1177/0363546508328107; Bryant AL, 2009, J ELECTROMYOGR KINES, V19, P988, DOI 10.1016/j.jelekin.2008.06.001; Chmielewski TL, 2005, J ELECTROMYOGR KINES, V15, P83, DOI 10.1016/j.jelekin.2004.07.003; Cochrane JL, 2007, J SCI MED SPORT, V10, P96, DOI 10.1016/j.jsams.2006.05.015; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Fox AS, 2014, SPORTS MED, V44, P815, DOI 10.1007/s40279-014-0168-8; Gokeler A, 2010, SCAND J MED SCI SPOR, V20, pE12, DOI 10.1111/j.1600-0838.2008.00873.x; Harms M, 2009, PHYSIOTHERAPY, V95, P237, DOI 10.1016/j.physio.2009.10.001; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hopkins W.G., 2002, SCALE MAGNITUDES EFF; Ingersoll CD, 2008, CLIN SPORT MED, V27, P383, DOI 10.1016/j.csm.2008.03.004; Kasovic M, 2011, INT ORTHOP, V35, P681, DOI 10.1007/s00264-010-1050-4; Klyne DM, 2012, J ELECTROMYOGR KINES, V22, P446, DOI 10.1016/j.jelekin.2012.01.013; LASS P, 1991, ACTA ORTHOP SCAND, V62, P9, DOI 10.3109/17453679108993083; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindstrom M, 2010, KNEE SURG SPORT TR A, V18, P106, DOI 10.1007/s00167-009-0886-x; McGrath TM, 2016, J SPORT SCI, V34, P289, DOI 10.1080/02640414.2015.1050601; Merletti R., 1999, J ELECTROMYOGR KINES, V9, P3, DOI DOI 10.1201/9781420036985.AX2; Mohammadi F, 2013, J BONE JOINT SURG AM, V95A, P1271, DOI [10.2106/JBJS.L00724, 10.2106/JBJS.L.00724]; Munn J, 2010, J SCI MED SPORT, V13, P2, DOI 10.1016/j.jsams.2009.03.004; Nyland J, 2014, KNEE, V21, P1191, DOI 10.1016/j.knee.2014.07.017; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Palmieri-Smith RM, 2008, J ELECTROMYOGR KINES, V18, P973, DOI 10.1016/j.jelekin.2007.03.007; Paterno MV, 2012, CLIN J SPORT MED, V22, P116, DOI 10.1097/JSM.0b013e318246ef9e; Pieter Clarys Jan, 2010, Asian J Sports Med, V1, P69; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Rudolph KS, 2001, KNEE SURG SPORT TR A, V9, P62, DOI 10.1007/s001670000166; Santello M, 2005, GAIT POSTURE, V21, P85, DOI 10.1016/j.gaitpost.2004.01.005; Saunders N, 2014, KNEE, V21, P789, DOI 10.1016/j.knee.2014.01.005; Scholes CJ, 2014, GAIT POSTURE, V39, P284, DOI 10.1016/j.gaitpost.2013.07.127; Solnik S, 2008, ACTA BIOENG BIOMECH, V10, P65; Srivastava T.N, 2008, STAT MANAGEMENT; Steele JR, 1999, CLIN BIOMECH, V14, P247, DOI 10.1016/S0268-0033(98)00071-0; Svoboda SJ, 2014, CLIN SPORT MED, V33, P633, DOI 10.1016/j.csm.2014.06.008; Thomee R, 2011, KNEE SURG SPORT TR A, V19, P1798, DOI 10.1007/s00167-011-1669-8; Weissgerber TL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002128; Yabroudi MA, 2013, CLIN SPORT MED, V32, P165, DOI 10.1016/j.csm.2012.08.016	42	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155277	10.1371/journal.pone.0155277	http://dx.doi.org/10.1371/journal.pone.0155277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166929	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300066
J	Tola, HH; Shojaeizadeh, D; Tol, A; Garmaroudi, G; Yekaninejad, MS; Kebede, A; Ejeta, LT; Kassa, D; Klinkenberg, E				Tola, Habteyes Hailu; Shojaeizadeh, Davoud; Tol, Azar; Garmaroudi, Gholamreza; Yekaninejad, Mir Saeed; Kebede, Abebaw; Ejeta, Luche Tadesse; Kassa, Desta; Klinkenberg, Eveline			Psychological and Educational Intervention to Improve Tuberculosis Treatment Adherence in Ethiopia Based on Health Belief Model: A Cluster Randomized Control Trial	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; TB TREATMENT; NONADHERENCE; INTERRUPTIONS; POPULATION; DEFAULT; RUSSIA; IMPACT	Background Treatment non-adherence results in treatment failure, prolonged transmission of disease and emergence of drug resistance. Although the problem widely investigated, there remains an information gap on the effectiveness of different methods to improve treatment adherence and the predictors of non-adherence in resource limited countries based on theoretical models. This study aimed to evaluate the impact of psychological counseling and educational intervention on tuberculosis (TB) treatment adherence based on Health Belief Model (HBM). Methodology A cluster randomized control trial was conducted in Addis Ababa from May to December, 2014. Patients were enrolled into study consecutively from 30 randomly selected Health Centers (HCs) (14 HCs intervention and 16 HCs control groups). A total of 698 TB patients, who were on treatment for one month to two months were enrolled. A structured questionnaire was administered to both groups of patients at baseline and endpoint of study. Control participants received routine directly-observed anti-TB therapy and the intervention group additionally received combined psychological counseling and adherence education. Treatment non-adherence level was the main outcome of the study, and multilevel logistic regression was employed to assess the impact of intervention on treatment adherence. Results At enrollment, the level of non-adherence among intervention (19.4%) and control (19.6%) groups was almost the same. However, after intervention, non-adherence level decreased among intervention group from 19.4 (at baseline) to 9.5% (at endpoint), while it increased among control group from 19.4%(baseline) to 25.4%(endpoint). Psychological counseling and educational interventions resulted in significant difference with regard to non-adherence level between intervention and control groups (Adjusted OR = 0.31, 95% Confidence Interval (CI) (0.18-0.53), p < 0.001)). Conclusion Psychological counseling and educational interventions, which were guided by HBM, significantly decreased treatment non-adherence level among intervention group. Provision of psychological counseling and health education to TB patients who are on regular treatment is recommended. This could be best achieved if these interventions are guided by behavioral theories and incorporated into the routine TB treatment strategy.	[Tola, Habteyes Hailu; Shojaeizadeh, Davoud; Tol, Azar; Garmaroudi, Gholamreza; Ejeta, Luche Tadesse] Tehran Univ Med Sci Int Campus, Sch Publ Hlth, Dept Hlth Educ & Promot, Tehran, Iran; [Tola, Habteyes Hailu; Kebede, Abebaw; Kassa, Desta] Ethiopian Publ Hlth Inst, TB HIV Res Directorate, Addis Ababa, Ethiopia; [Yekaninejad, Mir Saeed] Tehran Univ Med Sci Int Campus, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Klinkenberg, Eveline] KNCV TB Fdn, The Hague, Netherlands; [Klinkenberg, Eveline] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam	Tola, HH; Shojaeizadeh, D (corresponding author), Tehran Univ Med Sci Int Campus, Sch Publ Hlth, Dept Hlth Educ & Promot, Tehran, Iran.; Tola, HH (corresponding author), Ethiopian Publ Hlth Inst, TB HIV Res Directorate, Addis Ababa, Ethiopia.	habtetola@gmail.com; shojae5@yahoo.com	Ejeta, Luche Tadesse/J-8021-2019; Kempker, Russell/F-5776-2017; Tola, Habteyes/V-7520-2019; Yekaninejad, Mir Saeed/L-6752-2016	Ejeta, Luche Tadesse/0000-0003-3529-8516; Tola, Habteyes/0000-0002-2889-956X; Yekaninejad, Mir Saeed/0000-0003-3648-5276; Kebede, Abebaw/0000-0002-6154-7275	KNCV Tuberculosis Foundation; USAID/TB CARE-I through Ethiopian National TB Research Advisory Committee (TRAC) [AA/gt/130/14]; Ethiopian Public Health Institute; FOGARTY INTERNATIONAL CENTER [D43TW009127] Funding Source: NIH RePORTER	KNCV Tuberculosis Foundation; USAID/TB CARE-I through Ethiopian National TB Research Advisory Committee (TRAC)(United States Agency for International Development (USAID)); Ethiopian Public Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by KNCV Tuberculosis Foundation, USAID/TB CARE-I through Ethiopian National TB Research Advisory Committee (TRAC), Grant Number AA/gt/130/14, http://www.kncvtbc.org/HHT; Ethiopian Public Health Institute, http://www.ephi.gov.et/. The sponsors participated in trial implementation supervision.	Adane AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078791; Álvarez Payero M., 2014, Farm Hosp., V38, P328, DOI [10.7399/FH.2014.38.4.7660, 10.7399/fh.2014.38.4.7660]; [Anonymous], 2003, ADHERENCE LONG TERM; Atkins S, 2011, IMPROVING ADHERENCE; Baral SC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-46; BARNHOORN F, 1992, SOC SCI MED, V34, P291, DOI 10.1016/0277-9536(92)90271-Q; Cramm JM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-72; DiMatteo MR, 2007, MED CARE, V45, P521, DOI 10.1097/MLR.0b013e318032937e; Elbireer S, 2011, TROP MED INT HEALTH, V16, P981, DOI 10.1111/j.1365-3156.2011.02800.x; Ethiopia Federal Ministry of Health, 2010, HLTH SECT DEV PROGR; Ethiopian Central Statistical Agency (CSA, 2010, POP HOUS CENS REP CO; Ethiopian Federal Minster of Health, 2013, GUID CLIN PROGR MAN, P9; Ethiopian Federal Minster of Health of Ethiopian/Ethiopian Public Health Institute, 2005, 1 ROUND TB DRUG RES; Ethiopian Public Health Institute, 2014, EPHI TB HIV SURV REL; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Glanz K, 2008, HLTH BEHAV HLTH ED; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Hirpa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-782; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Hovstadius B, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-326; Jakubowiak W, 2009, INT J INFECT DIS, V13, P362, DOI 10.1016/j.ijid.2008.07.015; Jakubowiak WM, 2008, TUBERCULOSIS, V88, P495, DOI 10.1016/j.tube.2008.03.004; Kaliakbarova G, 2013, PSYCHOSOCIAL SUPPORT, P60; Kalichman Seth C, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P367, DOI 10.1177/1545109709352884; Kavan MG, 2009, AM FAM PHYSICIAN, V79, P785; Kebede A, N AM J MED SCI AD, V2, P67; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2005, PSYCHOL MED, V35, P1073, DOI 10.1017/S0033291705004538; Kiros YK, 2014, PUBLIC HEALTH ACTION, V4, pS31, DOI 10.5588/pha.14.0054; Kulkarni PY, 2013, ANN MED HEALTH SCI R, V3, P67, DOI 10.4103/2141-9248.109507; Lee Shinwon, 2013, Chonnam Med J, V49, P27, DOI 10.4068/cmj.2013.49.1.27; Liefooghe R, 1999, INT J TUBERC LUNG D, V3, P1073; Llongo I., 2004, INT J CLIN HLTH PSYC, V4, P69; M'Imunya JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006591.pub2; MORISKY DE, 1990, HEALTH EDUC QUART, V17, P253, DOI 10.1177/109019819001700303; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Nahid P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-1; Naidoo P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-396; Pachi A, 2013, TUBERC RES TREAT, V2013, P37; Pettit AC, 2013, INT J TUBERC LUNG D, V17, P486, DOI 10.5588/ijtld.12.0133; Poss JE, 1998, SOC SCI MED, V47, P195, DOI 10.1016/S0277-9536(98)00062-8; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Sendagire I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035908; Shargie EB, 2007, PLOSE MED, V4; Tesfaye H, 2007, PLOS MED, V4, P772, DOI 10.1371/journal.pmed.0040165; The Department of Immunization Vaccines and Biological. Module, 2008, TRAINING MIDLEVEL MA, P1; Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380; van den Boogaard J, 2011, TROP MED INT HEALTH, V16, P693, DOI 10.1111/j.1365-3156.2011.02755.x; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wood Angela M, 2004, Clin Trials, V1, P368	50	62	65	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155147	10.1371/journal.pone.0155147	http://dx.doi.org/10.1371/journal.pone.0155147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CD	27167378	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300081
J	Wagner, GJ; Ngo, V; Goutam, P; Glick, P; Musisi, S; Akena, D				Wagner, Glenn J.; Ngo, Victoria; Goutam, Prodyumna; Glick, Peter; Musisi, Seggane; Akena, Dickens			A Structured Protocol Model of Depression Care versus Clinical Acumen: A Cluster Randomized Trial of the Effects on Depression Screening, Diagnostic Evaluation, and Treatment Uptake in Ugandan HIV Clinics	PLOS ONE			English	Article							MENTAL-HEALTH; ANTIDEPRESSANT TREATMENT; ANTIRETROVIRAL THERAPY; HIV/AIDS; PROGRAMS; VALIDITY; BEHAVIOR; OUTCOMES; ILLNESS; IMPACT	Depression is common among people living with HIV, and it has consequences for both HIV prevention and treatment response, yet depression treatment is rarely integrated into HIV care in sub-Saharan Africa, partly due to the paucity of mental health professionals. We conducted a cluster randomized controlled trial of two task-shifting models to facilitating depression care delivered by medical providers: one that utilized a structured protocol, and one that relied on clinical acumen, in 10 HIV clinics in Uganda. Both models started with routine depression screening of all clients at triage using the 2-item Patient Health Questionnaire (PHQ-2), from which we enrolled 1252 clients (640 at structured protocol clinics, 612 at clinical acumen clinics) who had screened positive over 12 months. We compared the two models on (1) proportion of all client participants, and those clinically depressed (based on survey-administered 9-item PHQ-9>9), who received post-screening evaluation for depression using the PHQ-9; and (2) proportion of clinically depressed who were prescribed antidepressant therapy. Linear probability regression analyses were conducted using a wild cluster bootstrap to control for clustering; patient characteristics, clinic size and time fixed effects were included as covariates. Among all client participants, those in the structured protocol arm were far more likely to have received further evaluation by a medical provider using the PHQ-9 (84% vs. 49%; beta = .33; p = .01). Among the clinically depressed clients (n = 369), the advantage of the structured protocol model over clinical acumen was not statistically significant with regard to PHQ-9 depression evaluation (93% vs. 68%; beta = .21; p = .14) or prescription of antidepressants (69% vs. 58%; beta = .10; p = .50), in part because only 30% of clients who screened positive were clinically depressed. These findings reveal that in both models depression care practices were widely adopted by providers, and depression care reached most depressed clients. The structured protocol model is advantageous for ensuring that positively screened clients receive a depression evaluation, but the two models performed equally well in ensuring the treatment of depressed clients in the context of strong supervision support.	[Wagner, Glenn J.; Ngo, Victoria; Goutam, Prodyumna; Glick, Peter] RAND Corp, Santa Monica, CA USA; [Musisi, Seggane; Akena, Dickens] Makerere Univ, Dept Psychiat, Kampala, Uganda	RAND Corporation; Makerere University	Wagner, GJ (corresponding author), RAND Corp, Santa Monica, CA USA.	gwagner@rand.org		Ngo, Victoria/0000-0001-8564-7695	National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080916, R01MH098996] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The funder (National Institute of Mental Health) provided support in the form of salaries for authors GW, VN, PG (third author), PG (fourth author), SM and DA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aarons GA, 2006, PSYCHIAT SERV, V57, P1162, DOI 10.1176/appi.ps.57.8.1162; Akena D, ACCURACY PH IN PRESS; Akincigil A, 2011, AIDS BEHAV, V15, P1819, DOI 10.1007/s10461-011-9938-6; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Beidas RS, 2011, ADM POLICY MENT HLTH, V38, P223, DOI 10.1007/s10488-011-0338-z; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Brandt R, 2009, AJAR-AFR J AIDS RES, V8, P123, DOI 10.2989/AJAR.2009.8.2.1.853; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Caskey J., STATA ADO FILE CGMWI; Collins PY, 2006, AIDS, V20, P1571, DOI 10.1097/01.aids.0000238402.70379.d4; Ferrando SJ, 2002, PSYCHIAT QUART, V73, P33, DOI 10.1023/A:1012840717735; Gaynes BN, 2008, J GEN INTERN MED, V23, P551, DOI 10.1007/s11606-008-0522-3; Glasgow RE, 2001, PATIENT EDUC COUNS, V44, P119, DOI 10.1016/S0738-3991(00)00186-5; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Mast TC, 2004, AIDS CARE, V16, P81, DOI 10.1080/09540120310001633994; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Okello ES, 2007, QUAL HEALTH RES, V17, P14, DOI 10.1177/1049732306296433; Olatunji B, 2006, TOP HIV MED, V14, P116; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Pence BW, 2015, AIDS, V29, P1975, DOI 10.1097/QAD.0000000000000797; Pence BW, 2014, AIDS BEHAV, V18, P1142, DOI 10.1007/s10461-014-0727-x; Pence BW, 2007, JAIDS-J ACQ IMM DEF, V44, P159, DOI 10.1097/QAI.0b013e31802c2f51; Pyne JM, 2011, ARCH INTERN MED, V171, P23, DOI 10.1001/archinternmed.2010.395; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Taljaard M, 2008, PAEDIATR PERINAT EP, V22, P117, DOI 10.1111/j.1365-3016.2007.00901.x; Trivedi Madhukar H, 2004, Prim Care Companion J Clin Psychiatry, V6, P12; Wagner GJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-248; Wagner GJ, 2012, PSYCHOSOM MED, V74, P883, DOI 10.1097/PSY.0b013e31826629db; Wagner GJ, 2012, AIDS BEHAV, V16, P1862, DOI 10.1007/s10461-011-0051-7; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Yun LWH, 2005, JAIDS-J ACQ IMM DEF, V38, P432, DOI 10.1097/01.qai.0000147524.19122.fd; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	33	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0153132	10.1371/journal.pone.0153132	http://dx.doi.org/10.1371/journal.pone.0153132			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CD	27167852	Green Published, gold			2022-12-27	WOS:000376587300002
J	Zhao, SJ; Zhong, ZS; Qi, GX; Shi, LY; Chen, L; Tian, W				Zhao, Shi-jie; Zhong, Zhao-shuang; Qi, Guo-xian; Shi, Li-ye; Chen, Ling; Tian, Wen			Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis	PLOS ONE			English	Article							NEOINTIMAL TISSUE PROLIFERATION; ACUTE MYOCARDIAL-INFARCTION; IMPAIRED GLUCOSE-TOLERANCE; LOW-DOSE PIOGLITAZONE; DRUG-ELUTING STENTS; BARE-METAL STENT; CLINICAL-OUTCOMES; CARDIOVASCULAR EVENTS; SYSTEMATIC REVIEWS; MELLITUS	Background The benefits of pioglitazone in patients with type 2 diabetes mellitus (T2DM) after percutaneous coronary intervention (PCI) is unclear. Objectives To evaluate the effect of pioglitazone on prevention of in-stent restenosis (ISR) in patients with T2DM after PCI. Methods All full-text published relevant studies compared the effect of pioglitazone with control group (placebo or no pioglitazone treatment) on ISR in patients with T2DM after PCI were identified by searching the databases including PubMed, EMBASE, Cochrane Library and ISI Web of Science through October 2015. The endpoints were defined as the rate of ISR, late lumen loss, in-stent neointimal volume, target lesion revascularization (TLR) and major adverse cardiac events (MACE). Results Six studies (5 RCTs and 1 retrospective study), comprising 503 patients, were included into this meta-analysis. In the pioglitazone group, as compared with the control group, the risk ratio for ISR was 0.48 (I-2 = 14.5%, P = 0.322; 95% CI 0.35 to 0.68, P<0.001), the risk ratio for TLR was 0.58 (I-2 = 6.0%, P = 0.363; 95% CI 0.38 to 0.87, P = 0.009). The result showed there was no association between the use of pioglitazone and the events of MACE (I-2 = 36.7%, P = 0.209; RR 0.56, 95% CI 0.30 to 1.05, P = 0.071). For the considerable heterogeneity, further analysis was not suitable for the endpoints of late lumen loss (I-2 = 81.9%, P<0.001) and neointimal volume (I-2 = 75.9%, P = 0.016). Conclusions The treatment of pioglitazone was associated with a reduction in ISR and TLR in T2DM patients suffering from PCI, except the incidence of MACE.	[Zhao, Shi-jie; Qi, Guo-xian; Shi, Li-ye; Chen, Ling; Tian, Wen] China Med Univ, Affiliated Hosp 1, Dept Geriatr Cardiol, Shenyang, Peoples R China; [Zhong, Zhao-shuang] Shenyang Med Coll, Cent Hosp, Dept Resp, Shenyang, Peoples R China	China Medical University; Shenyang Medical College	Tian, W (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Geriatr Cardiol, Shenyang, Peoples R China.	dr_wentian@163.com		Tian, wen/0000-0001-8257-6350				Abizaid A, 1998, J AM COLL CARDIOL, V32, P584, DOI 10.1016/S0735-1097(98)00286-1; Ahn CM, 2011, J AM COLL CARDIOL, V57, pE1914, DOI 10.1016/S0735-1097(11)61914-1; Barlaka E, 2015, CARDIOVASC THER; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cheang WS, 2013, CIRC J, V77, P2664, DOI 10.1253/circj.CJ-13-0647; Delhaye C, 2010, AM J CARDIOL, V105, P826, DOI 10.1016/j.amjcard.2009.10.064; Erdmann E, 2016, DIABETES OBES METAB, V18, P266, DOI 10.1111/dom.12608; Gilbert RE, 2013, CIRC J, V77, P849, DOI 10.1253/circj.CJ-13-0236; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Guerra E, 2014, EXPERT OPIN PHARMACO, V15, P2155, DOI 10.1517/14656566.2014.948844; Henney JE, 2000, JAMA-J AM MED ASSOC, V283, P2228, DOI 10.1001/jama.283.17.2228-b; Hong SJ, 2006, HEART, V92, P1119, DOI 10.1136/hrt.2005.075960; Hong SJ, 2015, CIRC J, V79, P880, DOI 10.1253/circj.CJ-14-0964; Hong SJ, 2010, CATHETER CARDIO INTE, V76, P924, DOI 10.1002/ccd.22369; Joner M, 2007, ARTERIOSCL THROM VAS, V27, P182, DOI 10.1161/01.ATV.0000251021.28725.e8; Kasai T, 2008, ATHEROSCLEROSIS, V197, P612, DOI 10.1016/j.atherosclerosis.2007.08.030; Kilburn SA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004299.pub2; Kitoga M, 2008, DIABETES METAB, V34, P62, DOI 10.1016/j.diabet.2007.09.002; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Lee HW, 2013, YONSEI MED J, V54, P1313, DOI 10.3349/ymj.2013.54.6.1313; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Mizoguchi M, 2011, JACC-CARDIOVASC IMAG, V4, P1110, DOI 10.1016/j.jcmg.2011.08.007; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moussa I, 2004, CIRCULATION, V109, P2273, DOI 10.1161/01.CIR.0000129767.45513.71; Nishio K, 2006, DIABETES CARE, V29, P101, DOI 10.2337/diacare.29.1.101; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nitta Y, 2013, JACC-CARDIOVASC IMAG, V6, P1172, DOI 10.1016/j.jcmg.2013.09.004; Okura H, 2013, CURR VASC PHARMACOL, V11, P399; Oremus M, 2001, DEMENT GERIATR COGN, V12, P232, DOI 10.1159/000051263; Ozawa T, 2009, J CARDIOL, V53, P402, DOI 10.1016/j.jjcc.2009.01.011; Patel D, 2011, JACC-CARDIOVASC INTE, V4, P353, DOI 10.1016/j.jcin.2010.10.016; Roiron C, 2006, HEART, V92, P641, DOI 10.1136/hrt.2005.061622; Saremi A, 2013, ARTERIOSCL THROM VAS, V33, P393, DOI 10.1161/ATVBAHA.112.300346; Satoh N, 2003, DIABETES CARE, V26, P2493, DOI 10.2337/diacare.26.9.2493; Silva JA, 1999, AM HEART J, V138, P446, DOI 10.1016/S0002-8703(99)70146-8; Takagi T, 2003, AM HEART J, V146, DOI 10.1016/S0002-8703(03)00146-7; Takagi T, 2002, J DIABETES COMPLICAT, V16, P50, DOI 10.1016/S1056-8727(01)00190-8; Takagi Tsutomu, 2005, J Cardiol, V45, P139; Takagi T, 2009, JACC-CARDIOVASC INTE, V2, P524, DOI 10.1016/j.jcin.2009.04.007; Woods TC, 2004, ANNU REV MED, V55, P169, DOI 10.1146/annurev.med.55.091902.105243; Yang TH, 2005, AM J CARDIOL, V96, P1389, DOI 10.1016/j.amjcard.2005.07.043; Yeh HT, 2012, CLIN THER, V34, P885, DOI 10.1016/j.clinthera.2012.02.024; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yokoyama J, 2007, HEART VESSELS, V22, P146, DOI 10.1007/s00380-006-0951-z	45	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155273	10.1371/journal.pone.0155273	http://dx.doi.org/10.1371/journal.pone.0155273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163676	gold, Green Published, Green Submitted			2022-12-27	WOS:000376585700017
J	Salomoni, S; van den Hoorn, W; Hodges, P				Salomoni, Sauro; van den Hoorn, Wolbert; Hodges, Paul			Breathing and Singing: Objective Characterization of Breathing Patterns in Classical Singers	PLOS ONE			English	Article							PROFESSIONAL OPERATIC SINGERS; CHEST-WALL MOVEMENTS; RIB CAGE; SUBGLOTTAL PRESSURE; HUMAN DIAPHRAGM; RESPIRATORY KINEMATICS; FUNDAMENTAL-FREQUENCY; SPEECH PRODUCTION; COUNTRY SINGERS; LUNG-VOLUME	Singing involves distinct respiratory kinematics (i.e. movements of rib cage and abdomen) to quiet breathing because of different demands on the respiratory system. Professional classical singers often advocate for the advantages of an active control of the abdomen on singing performance. This is presumed to prevent shortening of the diaphragm, elevate the rib cage, and thus promote efficient generation of subglottal pressure during phonation. However, few studies have investigated these patterns quantitatively and inter-subject variability has hindered the identification of stereotypical patterns of respiratory kinematics. Here, seven professional classical singers and four untrained individuals were assessed during quiet breathing, and when singing both a standard song and a piece of choice. Several parameters were extracted from respiratory kinematics and airflow, and principal component analysis was used to identify typical patterns of respiratory kinematics. No group differences were observed during quiet breathing. During singing, both groups adapted to rhythmical constraints with decreased time of inspiration and increased peak airflow. In contrast to untrained individuals, classical singers used greater percentage of abdominal contribution to lung volume during singing and greater asynchrony between movements of rib cage and abdomen. Classical singers substantially altered the coordination of rib cage and abdomen during singing from that used for quiet breathing. Despite variations between participants, principal component analysis revealed consistent pre-phonatory inward movements of the abdominal wall during singing. This contrasted with untrained individuals, who demonstrated synchronous respiratory movements during all tasks. The inward abdominal movements observed in classical singers elevates intra-abdominal pressure and may increase the length and the pressure-generating capacity of rib cage expiratory muscles for potential improvements in voice quality.	[Salomoni, Sauro; van den Hoorn, Wolbert; Hodges, Paul] Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia	University of Queensland	Hodges, P (corresponding author), Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	p.hodges@uq.edu.au	Salomoni, Sauro E/M-5425-2014; Hodges, Paul W/B-6578-2008	Salomoni, Sauro E/0000-0001-7616-9003; Hodges, Paul W/0000-0002-1206-9107	National Health and Medical Research Council (NHMRC) of Australia [ID1002190]; NHMRC [ID455863, ID631717]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	PH was supported by a Senior Principal Research Fellowship (ID1002190) from the National Health and Medical Research Council (NHMRC) of Australia. The study was supported by a Centre of Clinical Research Excellence Grant (ID455863) and Program Grant (ID631717) from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 1996, J APPL PHYSIOL, V80, P1379, DOI 10.1152/jappl.1996.80.4.1379; AKERLUND L, 1994, J VOICE, V8, P263, DOI 10.1016/S0892-1997(05)80298-X; Aliverti A, 2003, J APPL PHYSIOL, V94, P621, DOI 10.1152/japplphysiol.00329.2002; BAKEN RJ, 1979, J SPEECH HEAR RES, V22, P862, DOI 10.1044/jshr.2204.862; Binazzi B, 2006, ACTA PHYSIOL, V186, P233, DOI 10.1111/j.1748-1716.2006.01529.x; Bjorkner E, 2008, J VOICE, V22, P533, DOI 10.1016/j.jvoice.2006.12.007; BOUHUYS A, 1966, J APPL PHYSIOL, V21, P483, DOI 10.1152/jappl.1966.21.2.483; BOYNTON BR, 1991, J APPL PHYSIOL, V70, P1235, DOI 10.1152/jappl.1991.70.3.1235; Brown Jr WS, 1991, J VOICE; Carroll LM, 1996, J VOICE, V10, P139, DOI 10.1016/S0892-1997(96)80040-3; Carry PY, 1997, CHEST, V111, P910, DOI 10.1378/chest.111.4.910; CAVALLO SA, 1985, J SPEECH HEAR RES, V28, P79, DOI 10.1044/jshr.2801.79; Chihara K, 1996, J APPL PHYSIOL, V81, P437, DOI 10.1152/jappl.1996.81.1.437; Cleveland TF, 1997, J VOICE, V11, P403, DOI 10.1016/S0892-1997(97)80035-5; Collyer S, 2006, J SPEECH LANG HEAR R, V49, P412, DOI 10.1044/1092-4388(2006/032); Collyer S, 2008, J SPEECH LANG HEAR R, V51, P612, DOI 10.1044/1092-4388(2008/044); Collyer S, 2009, LOGOP PHONIATR VOCO, V34, P100, DOI 10.1080/14015430903008780; De Troyer A, 2005, PHYSIOL REV, V85, P717, DOI 10.1152/physrev.00007.2004; De Troyer A, 1998, J PHYSIOL-LONDON, V513, P915, DOI 10.1111/j.1469-7793.1998.915ba.x; De Troyer A, 2012, J APPL PHYSIOL, V112, P529, DOI 10.1152/japplphysiol.01067.2011; ESTENNE M, 1990, J APPL PHYSIOL, V68, P2075, DOI 10.1152/jappl.1990.68.5.2075; Foulds-Elliott S D, 2000, Logoped Phoniatr Vocol, V25, P151, DOI 10.1080/140154300750067539; GRIFFIN B, 1995, J VOICE, V9, P45, DOI 10.1016/S0892-1997(05)80222-X; HAN JN, 1993, EUR RESPIR J, V6, P722; HIXON TJ, 1973, J SPEECH HEAR RES, V16, P78, DOI 10.1044/jshr.1601.78; Hixon TJ, 1988, J VOICE, V2, P13; Hodge FS, 2001, J VOICE, V15, P503, DOI 10.1016/S0892-1997(01)00050-9; Hodges PW, 2000, J PHYSIOL-LONDON, V522, P165, DOI 10.1111/j.1469-7793.2000.t01-1-00165.xm; Hodges PW, 2000, J APPL PHYSIOL, V89, P967, DOI 10.1152/jappl.2000.89.3.967; HOIT JD, 1986, J SPEECH HEAR RES, V29, P313, DOI 10.1044/jshr.2903.313; Hoit JD, 1996, J VOICE, V10, P39, DOI 10.1016/S0892-1997(96)80017-8; Hug F, 2010, J APPL PHYSIOL, V108, P1727, DOI 10.1152/japplphysiol.01305.2009; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Iwarsson J, 2001, J VOICE, V15, P384, DOI 10.1016/S0892-1997(01)00040-6; KONNO K, 1967, J APPL PHYSIOL, V22, P407, DOI 10.1152/jappl.1967.22.3.407; Leanderson R, 1988, J VOICE, V2, P2, DOI [10.1016/S0892-1997(88)80051-1, DOI 10.1016/S0892-1997(88)80051-1]; Macdonald I, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.04.006; Mandros C, 2008, EUR J APPL PHYSIOL, V102, P425, DOI 10.1007/s00421-007-0603-8; MCFARLAND DH, 1992, J SPEECH HEAR RES, V35, P971, DOI 10.1044/jshr.3505.971; Morris RJ, 1987, J VOICE; Pettersen V, 2004, Logoped Phoniatr Vocol, V29, P56; Pettersen V, 2005, J VOICE, V19, P238, DOI 10.1016/j.jvoice.2004.02.006; Pettersen V, 2004, J VOICE, V18, P500, DOI 10.1016/j.jvoice.2003.11.001; Prisk GK, 2002, PEDIATR PULM, V34, P462, DOI 10.1002/ppul.10204; Reilly KJ, 2009, J SPEECH LANG HEAR R, V52, P223, DOI 10.1044/1092-4388(2008/06-0215); Sand Susanne, 2005, Logoped Phoniatr Vocol, V30, P51, DOI 10.1080/14015430510006712; SMITH J, 1987, J APPL PHYSIOL, V62, P1893, DOI 10.1152/jappl.1987.62.5.1893; Spillane KW, 1989, NATS J, V45, P9; SUNDBERG J, 1974, J ACOUST SOC AM, V55, P838, DOI 10.1121/1.1914609; Tang YQ, 2003, J APPL PHYSIOL, V95, P571, DOI 10.1152/japplphysiol.00196.2003; Thomasson M, 2001, J VOICE, V15, P373, DOI 10.1016/S0892-1997(01)00039-X; Thomasson M, 1999, J VOICE, V13, P529, DOI 10.1016/S0892-1997(99)80008-3; Thomasson M, 1997, LOGOP PHONIATR VOCO, V22, P61; Thorpe CW, 2001, J VOICE, V15, P86, DOI 10.1016/S0892-1997(01)00009-1; Titze I, 1992, J ACOUST SOC AM, V1, P1; Titze IR, 1999, J ACOUST SOC AM, V105, P2933, DOI 10.1121/1.426906; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; WATSON P J, 1989, Journal of Voice, V3, P24, DOI 10.1016/S0892-1997(89)80118-3; WATSON PJ, 1985, J SPEECH HEAR RES, V28, P104, DOI 10.1044/jshr.2801.104; WATSON PJ, 1990, J VOICE, V4, P120, DOI 10.1016/S0892-1997(05)80136-5; Winslow C, 2003, AM J PHYS MED REHAB, V82, P803, DOI 10.1097/01.PHM.0000078184.08835.01; WINTER DA, 1987, ELECTROEN CLIN NEURO, V67, P402, DOI 10.1016/0013-4694(87)90003-4	62	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155084	10.1371/journal.pone.0155084	http://dx.doi.org/10.1371/journal.pone.0155084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159498	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700039
J	Martinez, AG; Rodriguez, BE; Roca, AP; Ruiz, AM				Gago Martinez, Andrea; Escontrela Rodriguez, Blanca; Planas Roca, Antonio; Martiez Ruiz, Alberto			Intravenous Ibuprofen for Treatment of Post-Operative Pain: A Multicenter, Double Blind, Placebo-Controlled, Randomized Clinical Trial	PLOS ONE			English	Article							PREEMPTIVE ANALGESIA; OPIOID ANALGESIA; IV-IBUPROFEN; CANCER PAIN; MANAGEMENT; ESTABLISHMENT; ANESTHESIA; SEVERITY; SURGERY; NAUSEA	Background Non-steroidal anti-inflammatory drugs are often used as components of multimodal therapy for postoperative pain management, but their use is currently limited by its side effects. The specific objective of this study was to evaluate the efficacy and safety of a new formulation of intravenous (IV) ibuprofen for the management of postoperative pain in a European population. Methods and Findings A total of 206 patients from both abdominal and orthopedic surgery, were randomly assigned in 1: 1 ratio to receive 800 mg IV-ibuprofen or placebo every 6 hours; all patients had morphine access through a patient controlled analgesia pump. The primary outcome measure was median morphine consumption within the first 24 hours following surgery. The mean +/- SEM of morphine requirements was reduced from 29,8 +/- 5,25 mg to 14,22 +/- 3,23 mg (p = 0,015) and resulted in a decrease in pain at rest (p = 0,02) measured by Visual Analog Scale (VAS) from mean +/- SEM 3.34 +/- 0,35 to 0.86 +/- 0.24, and also in pain during movement (p = 0,02) from 4.32 +/- 0,36 to 1.90 +/- 0,30 in the ibuprofen treatment arm; while in the placebo group VAS score at rest ranged from 4.68 +/- 0,40 to 2.12 +/- 0,42 and during movement from 5.66 +/- 0,42 to 3.38 +/- 0,44. Similar treatment-emergent adverse events occurred across both study groups and there was no difference in the overall incidence of these events. Conclusions Perioperative administration of IV-Ibuprofen 800 mg every 6 hours in abdominal surgery patient's decreases morphine requirements and pain score. Furthermore IV-Ibuprofen was safe and well tolerate. Consequently we consider appropriate that protocols for management of postoperative pain include IV-Ibuprofen 800 mg every 6 hours as an option to offer patients an analgesic benefit while reducing the potentially risks associated with morphine consumption.	[Gago Martinez, Andrea; Escontrela Rodriguez, Blanca; Martiez Ruiz, Alberto] Cruces Univ Hosp, Dept Anesthesia Resuscitat & Pain Therapy, Baracaldo, Vizkaya, Spain; [Planas Roca, Antonio] Princess Univ Hosp, Dept Anesthesia Resuscitat & Pain Therapy, Madrid, Spain	Hospital Universitario Cruces	Martinez, AG (corresponding author), Cruces Univ Hosp, Dept Anesthesia Resuscitat & Pain Therapy, Baracaldo, Vizkaya, Spain.	andreamaria.gagomartinez@osakidetza.eus		MARTINEZ RUIZ, ALBERTO/0000-0002-7274-563X; , Planas/0000-0001-8567-1441; Gago, Andrea/0000-0003-2446-2659	Biomendi Laboratories	Biomendi Laboratories	The authors have no support or funding to report. Biomendi Laboratories sponsored this trial, all centres were paid for their participation as usual in these cases, but the authors of this article received no specific funding for this work and do not have an economic relation with the sponsors. The funders had no role in the data analysis that was carried out by Pivotal.es. The authors of this article have requested the Biomendi Laboratories permission for publishing and they have accepted; but they had no relation with the decision to publish and the preparation of this manuscript, which is the exclusive responsibility of the authors.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; Bookstaver P Brandon, 2010, J Pain Res, V3, P67; Brinkmann A, 1998, INTENS CARE MED, V24, P322, DOI 10.1007/s001340050574; Budd K, 2006, BIOMED PHARMACOTHER, V60, P310, DOI 10.1016/j.biopha.2006.06.015; Buvanendran A, 2009, CURR OPIN ANESTHESIO, V22, P588, DOI 10.1097/ACO.0b013e328330373a; Candiotti KA, 2005, ANESTHESIOLOGY, V102, P543, DOI 10.1097/00000542-200503000-00011; Carr DB, 1999, LANCET, V353, P2051, DOI 10.1016/S0140-6736(99)03313-9; Coulbault L, 2006, CLIN PHARMACOL THER, V79, P316, DOI 10.1016/j.clpt.2006.01.007; Dihle A, 2006, CLIN J PAIN, V22, P617, DOI 10.1097/01.ajp.0000210905.57546.c1; Ducharme J, 2000, ANN EMERG MED, V35, P592, DOI 10.1016/S0196-0644(00)70033-3; Gottschalk A, 2001, AM FAM PHYSICIAN, V63, P1979; Habib AS, 2004, CAN J ANAESTH, V51, P326, DOI 10.1007/BF03018236; Jahr JS, 2011, ANESTHESIOLOGY NEWS, V37, P1; Kehlet H, 2003, LANCET, V362, P1921, DOI 10.1016/S0140-6736(03)14966-5; KEHLET H, 1993, ANESTH ANALG, V77, P1048; Kroll PB, 2012, PAIN MANAG, V2, P47, DOI [10.2217/pmt.11.68, 10.2217/PMT.11.68]; Kroll PB, 2011, PAIN PRACT, V11, P23, DOI 10.1111/j.1533-2500.2010.00402.x; Macintyre PE, 1996, PAIN, V64, P357, DOI 10.1016/0304-3959(95)00128-X; MAX MB, 1995, JAMA-J AM MED ASSOC, V274, P1874, DOI 10.1001/jama.1995.03530230060032; Raffa Robert B, 2013, Pain Manag Nurs, V14, pe67, DOI 10.1016/j.pmn.2011.04.002; Rathmell JP, 2006, REGION ANESTH PAIN M, V31, P1, DOI 10.1016/j.rapm.2006.05.002; Rosa J, 2014, REV MEX ANEST, V37, P18; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Shilling AM, 2013, MORPHINE METASTASIS, P123, DOI [10.1007/978-94-007-5678-6_9, DOI 10.1007/978-94-007-5678-6_9]; Singla N, 2010, PAIN MED, V11, P1284, DOI 10.1111/j.1526-4637.2010.00896.x; Smith H, 2010, DRUG AGING, V27, P417, DOI 10.2165/11536540-000000000-00000; Southworth S, 2009, CLIN THER, V31, P1922, DOI 10.1016/j.clinthera.2009.08.026; Vadivelu Nalini, 2010, Yale Journal of Biology and Medicine, V83, P11; Voscopoulos C, 2010, BRIT J ANAESTH, V105, pI69, DOI 10.1093/bja/aeq323; Wheeler M, 2002, J PAIN, V3, P159, DOI 10.1054/jpai.2002.123652; WOOLF CJ, 1993, ANESTH ANALG, V77, P362, DOI 10.1213/00000539-199377020-00026	32	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154004	10.1371/journal.pone.0154004	http://dx.doi.org/10.1371/journal.pone.0154004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152748	Green Published, gold, Green Submitted			2022-12-27	WOS:000375677000008
J	Nishi, N; Miyamoto, T; Waku, T; Tanaka, N; Hagiwara, Y				Nishi, Naoto; Miyamoto, Takuya; Waku, Tomonori; Tanaka, Naoki; Hagiwara, Yoshimichi			Ice Growth Inhibition in Antifreeze Polypeptide Solution by Short-Time Solution Preheating	PLOS ONE			English	Article							PROTEINS; ENHANCEMENT	The objective of this study is to enhance the inhibition of ice growth in the aqueous solution of a polypeptide, which is inspired by winter flounder antifreeze protein. We carried out measurements on unidirectional freezing of the polypeptide solution. The thickness of the solution was 0.02 mm, and the concentration of polypeptide was varied from 0 to 2 mg/mL. We captured successive microscopic images of ice/solution interfaces, and measured the interface velocity from the locations of tips of the pectinate interface in the images. We also simultaneously measured the temperature by using a small thermocouple. The ice/solution interface temperature was defined by the temperature at the tips. It was found that the interface temperature was decreased with an increasing concentration of polypeptide. To try varying the activity of the polypeptide, we preheated the polypeptide solution and cooled it before carrying out the measurements. Preheating for 1-5 hours was found to cause a further decrease in the interface temperature. Furthermore, wider regions of solution and ice with inclined interfaces in the pectinate interface structure were observed, compared with the case where the solution was not preheated. Thus, the ice growth inhibition was enhanced by this preheating. To investigate the reason for this enhancement, we measured the conformation and aggregates of polypeptide in the solution. We also measured the local concentration of polypeptide. It was found that the polypeptide aggregates became larger as a result of preheating, although the polypeptide conformation was unchanged. These large aggregates caused both adsorption to the interface and the wide regions of supercooled solution in the pectinate interface structure.	[Nishi, Naoto; Miyamoto, Takuya] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Mech & Syst Engn, Sakyo Ku, Kyoto 6068585, Japan; [Waku, Tomonori; Tanaka, Naoki] Kyoto Inst Technol, Fac Mol Chem & Engn, Sakyo Ku, Kyoto 6068585, Japan; [Hagiwara, Yoshimichi] Kyoto Inst Technol, Fac Mech Engn, Sakyo Ku, Kyoto 6068585, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology; Kyoto Institute of Technology	Hagiwara, Y (corresponding author), Kyoto Inst Technol, Fac Mech Engn, Sakyo Ku, Kyoto 6068585, Japan.	yoshi@kit.ac.jp			Japan Society for the Promotion of Science [15H02220]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	YH acknowledges the financial support of the Japan Society for the Promotion of Science through the Grant-in-Aid for Scientific Research (A) (No. 15H02220). https://www.jsps.go.jp/. https://www.jsps.go.jp/english/index.html.	Amir G, 2005, J HEART LUNG TRANSPL, V24, P1915, DOI 10.1016/j.healun.2004.11.003; Bouvet VR, 2006, BIOMACROMOLECULES, V7, P565, DOI 10.1021/bm050605t; Butler MF, 2002, CRYST GROWTH DES, V2, P541, DOI [10.1021/cg025591e, 10.1021/cg02559le]; Chao HM, 1997, BIOCHEMISTRY-US, V36, P14652, DOI 10.1021/bi970817d; COGER R, 1994, J OFFSHORE MECH ARCT, V116, P173, DOI 10.1115/1.2920147; Du N., 2012, BIOINSPIRATION NANO, P57; Evans RP, 2007, COMP BIOCHEM PHYS A, V148, P556, DOI 10.1016/j.cbpa.2007.07.005; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Fletcher GL, 1999, CHEMTECH, V29, P17; Furukawa Y, 2005, J CRYST GROWTH, V275, P167, DOI 10.1016/j.jcrysgro.2004.10.085; Hagiwara Y, 2015, INT J HEAT MASS TRAN, V86, P55, DOI 10.1016/j.ijheatmasstransfer.2015.02.058; Hagiwara Y, 2012, INT J HEAT MASS TRAN, V55, P2384, DOI 10.1016/j.ijheatmasstransfer.2012.01.024; Harding MM, 1999, EUR J BIOCHEM, V264, P653, DOI 10.1046/j.1432-1327.1999.00617.x; Haymet ADJ, 1999, J AM CHEM SOC, V121, P941, DOI 10.1021/ja9801341; Kaijima T, 2015, P 52 NAT HEAT TRANSF, P1; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Kristiansen E, 2008, CRYOBIOLOGY, V57, P122, DOI 10.1016/j.cryobiol.2008.07.001; Kun H, 2007, BIOPOLYMERS, V88, P807, DOI 10.1002/bip.20844; Li B, 2002, J FOOD ENG, V54, P175, DOI 10.1016/S0260-8774(01)00209-6; Shitzer A, 2011, J HEAT TRANS-T ASME, V133, DOI 10.1115/1.4002302; Wang S, 2012, J CHEM THERMODYN, V53, P125, DOI 10.1016/j.jct.2012.04.028	21	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154782	10.1371/journal.pone.0154782	http://dx.doi.org/10.1371/journal.pone.0154782			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152720	Green Submitted, Green Published, gold			2022-12-27	WOS:000375677000034
J	Polgar, Z; Kinnunen, M; Ujvary, D; Miklosi, A; Gacsi, M				Polgar, Zita; Kinnunen, Mari; Ujvary, Dora; Miklosi, Adam; Gacsi, Marta			A Test of Canine Olfactory Capacity: Comparing Various Dog Breeds and Wolves in a Natural Detection Task	PLOS ONE			English	Article							DRUG DETECTION; FAMILIARIS; DISCRIMINATION; PERFORMANCE; BEHAVIOR; TRAITS; SEARCH; ODOR; PREDICT; LUPUS	Many dog breeds are bred specifically for increased performance in scent-based tasks. Whether dogs bred for this purpose have higher olfactory capacities than other dogs, or even wolves with whom they share a common ancestor, has not yet been studied. Indeed, there is no standard test for assessing canine olfactory ability. This study aimed to create a simple procedure that requires no pre-training and to use it to measure differences in olfactory capacity across four groups of canines: (1) dog breeds that have been selected for their scenting ability; (2) dog breeds that have been bred for other purposes; (3) dog breeds with exaggerated short-nosed features; and (4) hand-reared grey wolves. The procedure involved baiting a container with raw turkey meat and placing it under one of four identical ceramic pots. Subjects were led along the row of pots and were tasked with determining by olfaction alone which of them contained the bait. There were five levels of increasing difficulty determined by the number of holes on the container's lid. A subsample of both dogs and wolves was retested to assess reliability. The results showed that breeds selected for scent work were better than both short-nosed and non-scent breeds. In the most difficult level, wolves and scenting breeds performed better than chance, while non-scenting and short-nosed breeds did not. In the retested samples wolves improved their success; however, dogs showed no change in their performances indicating that a single test may be reliable enough to assess their capacity. Overall, we revealed measurable differences between dog breeds in their olfactory abilities and suggest that the Natural Detection Task is a good foundation for developing an efficient way of quantifying them.	[Polgar, Zita; Kinnunen, Mari; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Kinnunen, Mari] Univ Oulu, Dept Ecol, Oulu, Finland; [Ujvary, Dora] Szent Istvan Univ, Fac Agr & Environm Sci, Inst Wildlife Conservat, Godollo, Hungary; [Miklosi, Adam; Gacsi, Marta] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary	Eotvos Lorand University; University of Oulu; Hungarian University of Agriculture & Life Sciences; MTA-ELTE Comparative Ethology Research Group	Polgar, Z (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	zita@polgarweb.com	; Miklosi, Adam/N-5147-2017	Gacsi, Marta/0000-0003-3080-7545; Miklosi, Adam/0000-0003-4831-8985	Hungarian Academy of Sciences [MTA 01 031]; Hungarian Scientific Research Fund [OTKA K 84036]	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The research was supported by the Hungarian Academy of Sciences (MTA 01 031) (http://mta.hu/english/) and Hungarian Scientific Research Fund (OTKA K 84036) (http://www.otka.hu/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER RF, 1962, J COMP PHYSIOL PSYCH, V55, P773, DOI 10.1037/h0042155; Bijland LR, 2013, NETH J MED, V71, P300; Cablk ME, 2008, SENSORS-BASEL, V8, P2208, DOI 10.3390/s8042208; FENTON V, 1992, J WILDERNESS MED, V3, P292, DOI 10.1580/0953-9859-3.3.292; Fischer-Tenhagen C, 2011, APPL ANIM BEHAV SCI, V131, P63, DOI 10.1016/j.applanim.2011.01.006; Gacsi M, 2005, DEV PSYCHOBIOL, V47, P111, DOI 10.1002/dev.20082; Gacsi M, 2013, APPL ANIM BEHAV SCI, V145, P109, DOI 10.1016/j.applanim.2013.02.007; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; Gazit I, 2003, APPL ANIM BEHAV SCI, V82, P65, DOI 10.1016/S0168-1591(03)00051-0; Hall NJ, 2015, J COMP PSYCHOL, V129, P237, DOI 10.1037/a0039271; Hall NJ, 2013, LEARN MOTIV, V44, P218, DOI 10.1016/j.lmot.2013.02.004; Harvey LM, 2003, J FORENSIC SCI, V48, P811; HEPPER PG, 1988, PERCEPTION, V17, P549, DOI 10.1068/p170549; IsselTarver L, 1996, P NATL ACAD SCI USA, V93, P10897, DOI 10.1073/pnas.93.20.10897; Jezierski T, 2014, FORENSIC SCI INT, V237, P112, DOI 10.1016/j.forsciint.2014.01.013; Johnen D, 2013, APPL ANIM BEHAV SCI, V148, P201, DOI 10.1016/j.applanim.2013.09.002; King T, 2012, APPL ANIM BEHAV SCI, V137, P1, DOI 10.1016/j.applanim.2011.11.016; Lesniak A, 2008, J HERED, V99, P518, DOI 10.1093/jhered/esn057; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Lord K, 2013, ETHOLOGY, V119, P110, DOI 10.1111/eth.12044; Maejima M, 2007, APPL ANIM BEHAV SCI, V107, P287, DOI 10.1016/j.applanim.2006.10.005; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Meola SD, 2013, TOP COMPANION ANIM M, V28, P91, DOI 10.1053/j.tcam.2013.06.004; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Nathan BP, 2004, BEHAV BRAIN RES, V150, P1, DOI 10.1016/S0166-4328(03)00219-5; Packer RMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137496; PASSE DH, 1985, NEUROSCI BIOBEHAV R, V9, P431, DOI 10.1016/0149-7634(85)90021-1; PETERS RP, 1975, AM SCI, V63, P628; Polgar Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131610; Quignon P, 2012, MAMM GENOME, V23, P132, DOI 10.1007/s00335-011-9371-1; Reeve C, 2014, CANINE OLFACTION SCE, P3; Robin S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-21; Rolland Rosalind M., 2006, Journal of Cetacean Research and Management, V8, P121; Rooney NJ, 2004, APPL ANIM BEHAV SCI, V86, P123, DOI 10.1016/j.applanim.2003.12.007; Salvin HE, 2012, J VET BEHAV, V7, P3, DOI 10.1016/j.jveb.2011.04.005; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Turcsan B, 2011, APPL ANIM BEHAV SCI, V132, P61, DOI 10.1016/j.applanim.2011.03.006; Udell MAR, 2014, ANIM BEHAV, V89, P99, DOI 10.1016/j.anbehav.2013.12.012; Walker DB, 2006, APPL ANIM BEHAV SCI, V97, P241, DOI 10.1016/j.applanim.2005.07.009; Wobber V, 2009, INTERACT STUD, V10, P206, DOI 10.1075/is.10.2.06wob; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48	43	38	38	3	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154087	10.1371/journal.pone.0154087	http://dx.doi.org/10.1371/journal.pone.0154087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152412	gold, Green Published, Green Submitted			2022-12-27	WOS:000375677000011
J	Swihart, RK; Sundaram, M; Hook, TO; DeWoody, JA; Kellner, KF				Swihart, Robert K.; Sundaram, Mekala; Hook, Tomas O.; DeWoody, J. Andrew; Kellner, Kenneth F.			Performance Benchmarks for Scholarly Metrics Associated with Fisheries and Wildlife Faculty	PLOS ONE			English	Article							H-INDEX; PUBLICATION SUCCESS; SCIENCE; CITATIONS; ANESTHESIOLOGISTS; PRODUCTIVITY; IMPACT; LEVEL	Research productivity and impact are often considered in professional evaluations of academics, and performance metrics based on publications and citations increasingly are used in such evaluations. To promote evidence-based and informed use of these metrics, we collected publication and citation data for 437 tenure-track faculty members at 33 research-extensive universities in the United States belonging to the National Association of University Fisheries and Wildlife Programs. For each faculty member, we computed 8 commonly used performance metrics based on numbers of publications and citations, and recorded covariates including academic age (time since Ph.D.), sex, percentage of appointment devoted to research, and the sub-disciplinary research focus. Standardized deviance residuals from regression models were used to compare faculty after accounting for variation in performance due to these covariates. We also aggregated residuals to enable comparison across universities. Finally, we tested for temporal trends in citation practices to assess whether the "law of constant ratios", used to enable comparison of performance metrics between disciplines that differ in citation and publication practices, applied to fisheries and wildlife sub-disciplines when mapped to Web of Science Journal Citation Report categories. Our regression models reduced deviance by 1/4 to 1/2. Standardized residuals for each faculty member, when combined across metrics as a simple average or weighted via factor analysis, produced similar results in terms of performance based on percentile rankings. Significant variation was observed in scholarly performance across universities, after accounting for the influence of covariates. In contrast to findings for other disciplines, normalized citation ratios for fisheries and wildlife sub-disciplines increased across years. Increases were comparable for all sub-disciplines except ecology. We discuss the advantages and limitations of our methods, illustrate their use when applied to new data, and suggest future improvements. Our benchmarking approach may provide a useful tool to augment detailed, qualitative assessment of performance.	[Swihart, Robert K.; Sundaram, Mekala; Hook, Tomas O.; DeWoody, J. Andrew; Kellner, Kenneth F.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Hook, Tomas O.] Purdue Univ, Illinois Indiana Sea Grant Program, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Swihart, RK (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	rswihart@purdue.edu						Abramo G, 2010, J AM SOC INF SCI TEC, V61, P1275, DOI 10.1002/asi.21330; Acuna DE, 2012, NATURE, V489, P201, DOI 10.1038/489201a; Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; Aoun SG, 2013, WORLD NEUROSURG, V80, pE85, DOI 10.1016/j.wneu.2012.01.052; Belmaker J, 2010, FRONT ECOL ENVIRON, V8, P514, DOI 10.1890/10.WB.25; Benway BM, 2009, UROLOGY, V74, P30, DOI 10.1016/j.urology.2008.10.045; Bornmann L, 2008, RES EVALUAT, V17, P149, DOI 10.3152/095820208X319166; Bornmann L, 2011, J INFORMETR, V5, P346, DOI 10.1016/j.joi.2011.01.006; Bornmann L, 2009, RES EVALUAT, V18, P185, DOI 10.3152/095820209X466883; Brown OR, 2012, REDOX REP, V17, P176, DOI 10.1179/1351000212Y.0000000016; Engqvist L, 2008, TRENDS ECOL EVOL, V23, P250, DOI 10.1016/j.tree.2008.01.009; Hattie J, 1996, REV EDUC RES, V66, P507, DOI 10.3102/00346543066004507; Henzinger M, 2010, SCIENTOMETRICS, V84, P465, DOI 10.1007/s11192-009-0098-7; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Honekopp J, 2012, SCIENTOMETRICS, V90, P843, DOI 10.1007/s11192-011-0551-2; Jacso P, 2008, LIBR TRENDS, V56, P784; Jin BH, 2007, CHINESE SCI BULL, V52, P855, DOI 10.1007/s11434-007-0145-9; Kelly CD, 2006, TRENDS ECOL EVOL, V21, P167, DOI 10.1016/j.tree.2006.01.005; Laband DN, 2006, J FOREST, V104, P254; Laurance WF, 2013, BIOSCIENCE, V63, P817, DOI 10.1525/bio.2013.63.10.9; Liang LM, 2006, SCIENTOMETRICS, V69, P153, DOI 10.1007/s11192-006-0145-6; Liu Y, 2013, SCIENTOMETRICS, V96, P605, DOI 10.1007/s11192-012-0916-1; Mazloumian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049246; Minasny B, 2007, SCIENTOMETRICS, V73, P257, DOI 10.1007/s11192-007-1811-z; Pagel PS, 2011, ACTA ANAESTH SCAND, V55, P1085, DOI 10.1111/j.1399-6576.2011.02508.x; Pagel PS, 2011, ANAESTHESIA, V66, P873, DOI 10.1111/j.1365-2044.2011.06860.x; Penner O., 2014, SCI REPORTS, V3, P3052; Pepe A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046428; Perianes-Rodriguez A, 2015, SCIENTOMETRICS, V102, P1497, DOI 10.1007/s11192-014-1449-6; Petersen AM, 2011, EUR PHYS J B, V79, P67, DOI 10.1140/epjb/e2010-10647-1; Podlubny I, 2005, SCIENTOMETRICS, V64, P95, DOI 10.1007/s11192-005-0240-0; Podlubny I, 2006, RES EVALUAT, V15, P154, DOI 10.3152/147154406781775887; R Core Team, R COR TEAM R LANG EN; Robinson AP, 2013, METHODS STAT MODEL E, P141; Selek S, 2014, SCIENTOMETRICS, V99, P541, DOI 10.1007/s11192-013-1204-4; Sharma B, 2013, SURGERY, V153, P493, DOI 10.1016/j.surg.2012.09.006; Sorzano COS, 2014, SCIENTOMETRICS, V101, P1731, DOI 10.1007/s11192-014-1368-6; Swihart RK, 2016, J WILDLIFE MANAGE, V80, P563, DOI 10.1002/jwmg.1034; Thompson DF, 2012, AM J PHARM EDUC, V76, DOI 10.5688/ajpe769173; van Dijk D, 2014, CURR BIOL, V24, pR516, DOI 10.1016/j.cub.2014.04.039; van Eck NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062395; Venables WN., 2002, MODERN APPL STAT S 4; Whitley R, 1984, INTELLECTUAL SOCIAL, V1; Wildgaard L, 2014, SCIENTOMETRICS, V101, P125, DOI 10.1007/s11192-014-1423-3; Zhang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005429; Zhang ZH, 2014, SCIENTOMETRICS, V101, P1679, DOI 10.1007/s11192-014-1294-7; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	48	4	4	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155097	10.1371/journal.pone.0155097	http://dx.doi.org/10.1371/journal.pone.0155097			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152838	Green Submitted, Green Published, gold			2022-12-27	WOS:000375677000069
J	Granjeiro, EM; da Silva, GSF; Giusti, H; Oliveira, JA; Glass, ML; Garcia-Cairasco, N				Granjeiro, Erica Maria; da Silva, Glauber S. F.; Giusti, Humberto; Oliveira, Jose Antonio; Glass, Mogens Lesner; Garcia-Cairasco, Norberto			Behavioral, Ventilatory and Thermoregulatory Responses to Hypercapnia and Hypoxia in the Wistar Audiogenic Rat (WAR) Strain	PLOS ONE			English	Article							CENTRAL CHEMORECEPTION; SEROTONERGIC NEURONS; EPILEPSY; SEIZURES; MICE; WAKEFULNESS; RECRUITMENT; PHYSIOLOGY; SYSTEM; SLEEP	Introduction We investigated the behavioral, respiratory, and thermoregulatory responses elicited by acute exposure to both hypercapnic and hypoxic environments in Wistar audiogenic rats (WARs). The WAR strain represents a genetic animal model of epilepsy. Methods Behavioral analyses were performed using neuroethological methods, and flowcharts were constructed to illustrate behavioral findings. The body plethysmography method was used to obtain pulmonary ventilation (VE) measurements, and body temperature (Tb) measurements were taken via temperature sensors implanted in the abdominal cavities of the animals. Results No significant difference was observed between the WAR and Wistar control group with respect to the thermoregulatory response elicited by exposure to both acute hypercapnia and acute hypoxia (p>0.05). However, we found that the VE of WARs was attenuated relative to that of Wistar control animals during exposure to both hypercapnic (WAR: 133 +/- 11% vs. Wistar: 243 +/- 23%, p<0.01) and hypoxic conditions (WAR: 138 +/- 8% vs. Wistar: 177 +/- 8%; p<0.01). In addition, we noted that this ventilatory attenuation was followed by alterations in the behavioral responses of these animals. Conclusions Our results indicate that WARs, a genetic model of epilepsy, have important alterations in their ability to compensate for changes in levels of various arterial blood gasses. WARs present an attenuated ventilatory response to an increased PaCO2 or decreased PaO2, coupled to behavioral changes, which make them a suitable model to further study respiratory risks associated to epilepsy.	[Granjeiro, Erica Maria; da Silva, Glauber S. F.; Giusti, Humberto; Oliveira, Jose Antonio; Glass, Mogens Lesner; Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Physiol, BR-14049900 Ribeirao Preto, SP, Brazil; [Granjeiro, Erica Maria] Univ Estadual Feira de Santana UEFS, Dept Ciencias Biol DCBIO, Av Transnordestina S-N, BR-44036900 Feira De Santana, BA, Brazil; [da Silva, Glauber S. F.] Sao Paulo State Univ UNESP FCAV, Dept Morphol & Anim Physiol, Via Acesso Prof Paulo D Castellane S-N, BR-14884900 Jaboticabal, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Feira de Santana; Universidade Estadual Paulista	Garcia-Cairasco, N (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Physiol, BR-14049900 Ribeirao Preto, SP, Brazil.	ngcairas@fmrp.usp.br	da Silva, Glauber S. F./G-1617-2013; Cairasco, Norberto Garcia/E-3250-2015	da Silva, Glauber S. F./0000-0002-6269-7443; Cairasco, Norberto Garcia/0000-0001-8857-3775; Granjeiro, Erica Maria/0000-0002-6436-751X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/60768-6, 05/56447-7, 2007/50261-4, FAPESP-Cinapce 2005/56447-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil) [02417/09-0]; CAPES-National Post-Doctoral Program (PNPD) [02417/09-0]; FAPESP [2013/17606-9]; Conselho Nacional de Pesquisas (CNPq)-Research Fellowship	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES-National Post-Doctoral Program (PNPD); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisas (CNPq)-Research Fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants (06/60768-6; 05/56447-7; 2007/50261-4; FAPESP-Cinapce 2005/56447-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil) Grant (02417/09-0). EMG held CAPES-National Post-Doctoral Program (PNPD) (02417/09-0) and GSFS holds FAPESP (2013/17606-9) Young Investigator Award. NGC holds a Conselho Nacional de Pesquisas (CNPq)-Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x; BARTLETT D, 1970, RESP PHYSIOL, V10, P384, DOI 10.1016/0034-5687(70)90056-3; Bateman LM, 2008, BRAIN, V131, P3239, DOI 10.1093/brain/awn277; Bertti P, 2010, EPILEPSY BEHAV, V17, P344, DOI 10.1016/j.yebeh.2009.12.030; Bicego KC, 2007, COMP BIOCHEM PHYS A, V147, P616, DOI 10.1016/j.cbpa.2006.06.032; Blum AS, 2009, J CLIN NEUROPHYSIOL, V26, P309, DOI 10.1097/WNP.0b013e3181b7f14d; Brennan TJ, 1997, NAT GENET, V16, P387, DOI 10.1038/ng0897-387; Buchanan GF, 2014, J PHYSIOL-LONDON, V592, P4395, DOI 10.1113/jphysiol.2014.277574; Campos RR, 2003, EPILEPSIA, V44, P712, DOI 10.1046/j.1528-1157.2003.38402.x; Capovilla G, 2013, EPILEPSIA, V54, P34, DOI 10.1111/epi.12421; Corcoran AE, 2009, RESP PHYSIOL NEUROBI, V168, P49, DOI 10.1016/j.resp.2009.04.014; da Silva GSF, 2011, PFLUG ARCH EUR J PHY, V462, P407, DOI 10.1007/s00424-011-0990-x; Dal-Col MLC, 2006, EPILEPSY BEHAV, V8, P149, DOI 10.1016/j.yebeh.2005.08.010; Doretto MC, 2003, BEHAV GENET, V33, P33, DOI 10.1023/A:1021099432759; ENGEL J, 1995, EPILEPSIA, V36, pS23; Faingold CL, 2011, BRAIN RES, V1418, P104, DOI 10.1016/j.brainres.2011.08.043; Fazan R, 2011, EPILEPSY BEHAV, V22, P666, DOI 10.1016/j.yebeh.2011.09.010; Feng HJ, 2015, EPILEPSY BEHAV; Garcia-Cairasco N, 1998, PHYSIOL BEHAV, V64, P671, DOI 10.1016/S0031-9384(98)00129-2; GARCIACAIRASCO N, 1992, BEHAV BRAIN RES, V48, P49, DOI 10.1016/S0166-4328(05)80138-X; GarciaCairasco N, 1996, EPILEPSY RES, V26, P177, DOI 10.1016/S0920-1211(96)00050-2; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; MALAN A, 1973, RESP PHYSIOL, V17, P32, DOI 10.1016/0034-5687(73)90108-4; Massey CA, 2014, NATURE REV NEUROLOGY, DOI [10.1038/nmeurol.2014.64, DOI 10.1038/NMEUROL.2014.64]; Moraes MFD, 2000, EPILEPSY RES, V39, P251; Nattie E, 2000, RESP PHYSIOL, V122, P223, DOI 10.1016/S0034-5687(00)00161-4; Nattie EE, 2004, J PHYSIOL-LONDON, V556, P235, DOI 10.1113/jphysiol.2003.059766; Nattie E, 2006, J APPL PHYSIOL, V101, P1596, DOI 10.1152/japplphysiol.00347.2006; Nattie E, 2010, J APPL PHYSIOL, V108, P1417, DOI 10.1152/japplphysiol.01261.2009; Ray RS, 2011, SCIENCE, V333, P637, DOI 10.1126/science.1205295; Romcy-Pereira RN, 2003, NEUROSCIENCE, V119, P533, DOI 10.1016/S0306-4522(03)00191-X; Schmidt D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g254; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; Tejada J, 2013, EPILEPSY BEHAV, V26, P212, DOI 10.1016/j.yebeh.2012.09.029; Totola LT, 2014, 1 PANAMERICAN C PHYS; Umeoka EHL, 2011, BRAIN RES, V1381, P141, DOI 10.1016/j.brainres.2011.01.042	37	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154141	10.1371/journal.pone.0154141	http://dx.doi.org/10.1371/journal.pone.0154141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149672	Green Submitted, gold, Green Published			2022-12-27	WOS:000375676800021
J	Hayat, T; Muhammad, K; Farooq, M; Alsaedi, A				Hayat, Tasawar; Muhammad, Khursheed; Farooq, Muhammad; Alsaedi, Ahmad			Unsteady Squeezing Flow of Carbon Nanotubes with Convective Boundary Conditions	PLOS ONE			English	Article							NANOFLUID FLOW; HEAT-TRANSFER; MIXED CONVECTION; MODEL	Unsteady flow of nanofluids squeezed between two parallel plates is discussed in the presence of viscous dissipation. Heat transfer phenomenon is disclosed via convective boundary conditions. Carbon nanotubes (single-wall and multi-wall) are used as nanoparticles which are homogeneously distributed in the base fluid (water). A system of non-linear differential equations for the flow is obtained by utilizing similarity transformations through the conservation laws. Influence of various emerging parameters on the velocity and temperature profiles are sketched graphically and discussed comprehensively. Analyses of skin fraction coefficient and Nusselt number are also elaborated numerically. It is found out that velocity is smaller for squeezing parameter in the case of multi-wall carbon nanotubes when compared with single-wall carbon nanotubes.	[Hayat, Tasawar; Muhammad, Khursheed; Farooq, Muhammad] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmad] King Abdulaziz Univ, Fac Sci, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, POB 80257, Jeddah 21589, Saudi Arabia; [Farooq, Muhammad] Riphah Int Univ, Dept Math, Islamabad 44000, Pakistan	Quaid I Azam University; King Abdulaziz University	Farooq, M (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan.; Farooq, M (corresponding author), Riphah Int Univ, Dept Math, Islamabad 44000, Pakistan.	hfarooq99@yahoo.com	Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019; Farooq, Muhammad/AAX-3841-2020	Alsaedi, Ahmed/0000-0003-3452-8922; Farooq, Muhammad/0000-0002-5481-6393				Abbasbandy S, 2013, NUMER ALGORITHMS, V64, P593, DOI 10.1007/s11075-012-9680-9; Choi SUS., 1995, ASME PUBLICATIONS FE, P99; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Dib A, 2015, POWDER TECHNOL, V269, P193, DOI 10.1016/j.powtec.2014.08.074; Dong RY, 2015, RSC ADV, V5, P88719, DOI 10.1039/c5ra18901b; Dong RY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06120; Elias MM, 2013, INT COMMUN HEAT MASS, V44, P93, DOI 10.1016/j.icheatmasstransfer.2013.03.014; Gupta AK, 2015, POWDER TECHNOL, V279, P282, DOI 10.1016/j.powtec.2015.04.018; Han SH, 2014, APPL MATH LETT, V38, P87, DOI 10.1016/j.aml.2014.07.013; Hayat T, 2015, J MAGN MAGN MATER, V395, P48, DOI 10.1016/j.jmmm.2015.07.027; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4908602; Hayat T, 2015, APPL MATH MECH-ENGL, V36, P47, DOI 10.1007/s10483-015-1894-9; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148662; Hayat T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118815; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083153; Kherbeet AS, 2015, EXP THERM FLUID SCI, V65, P13, DOI 10.1016/j.expthermflusci.2015.02.023; Liao S., 2012, HOMOTOPY ANAL METHOD; Nayak RK, 2015, INT J HEAT MASS TRAN, V85, P620, DOI 10.1016/j.ijheatmasstransfer.2015.01.116; Pujari S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139446; Qayyum A, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/3/034701; Shehzad SA, 2015, J MOL LIQ, V209, P723, DOI 10.1016/j.molliq.2015.05.058; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078240; Sheikholeslami M, 2015, COMPUT METHOD APPL M, V294, P299, DOI 10.1016/j.cma.2015.06.010; Sheikholeslami M, 2013, POWDER TECHNOL, V239, P259, DOI 10.1016/j.powtec.2013.02.006; Stefan M.J., 1874, MATH NATURWISSENCHAF, V69, P713; Turkyilmazoglu M, 2014, COMPUT FLUIDS, V94, P139, DOI 10.1016/j.compfluid.2014.02.009; Ul Haq R, 2015, PHYSICA E, V73, P45, DOI 10.1016/j.physe.2015.05.007; Xue QZ, 2005, PHYSICA B, V368, P302, DOI 10.1016/j.physb.2005.07.024	28	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0152923	10.1371/journal.pone.0152923	http://dx.doi.org/10.1371/journal.pone.0152923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149208	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800006
J	Sakai, Y; Takada, T				Sakai, Yuma; Takada, Takenori			Pathogen Propagation Model with Superinfection in Vegetatively Propagated Plants on Lattice Space	PLOS ONE			English	Article							TRIENTALIS-EUROPAEA; CLONAL INTEGRATION; MOSAIC-VIRUS; LIFE-HISTORY; INFECTION; EVOLUTION; GROWTH; TRANSMISSION; VIRULENCE; MULTIPLICITY	Many clonal plants have two reproductive patterns, seed propagation and vegetative propagation. By vegetative propagation, plants reproduce the genetically identical offspring with a low mortality, because resources are supplied from the other individuals through interconnected ramets at vegetative-propagated offspring. However, the ramets transport not only resources but also systemic pathogen. Pathogens evolve to establish and spread widely within the plant population. The superinfection, which is defined as the ability that an established pathogen spreads widely by infecting to already-infected individuals with other strains of a pathogen, is important to the evolution of pathogens. We examine the dynamics of plant reproduction and pathogen propagation considering spatial structure and the effect of superinfection on genetic diversity of pathogen by analysis of several models, 1-strain and multiple-strain models, on two-dimensional square lattice. In the analysis of 1-strain model, we derive equilibrium value by mean-field approximation and pair approximation, and its local stability by Routh-Hurwitz stability criterion. In the multiple-strain models, we analyze the dynamics by numerical simulation of mean-field approximation, pair approximation and Monte Carlo simulation. Through the analyses, we show the effect of parameter values to dynamics of models, such as transition of dominant strain of pathogen, competition between plants and pathogens and density of individuals. As a result, (i) The strain with intermediate cost becomes dominant when both superinfection rate and growth rate are low. (ii) The competition between plants and pathogens occurs in the phase of coexistence of various strains by pair approximation and Monte Carlo simulation. (iii) Too high growth rate leads to the decrease of plant population in all models. (iv) Pathogens are easy to maintain their genetic diversity with low superinfection rate. However, if they do not superinfect, the maintenance becomes difficult. (v) When growth rate of plant is low, individuals are very influenced by distant individuals.	[Sakai, Yuma] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Takada, Takenori] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University	Sakai, Y (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	sakai@ees.hokudai.ac.jp			Japanese Society for the Promotion of Science (JSPS) [15H04418, 25340115, 26291087]	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded in part by Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS) for Scientific Reserch: No. 15H04418 & 25340115 & 26291087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng NH, 2000, PLANT J, V23, P349, DOI 10.1046/j.1365-313x.2000.00788.x; Day T, 2004, AM NAT, V163, pE40, DOI 10.1086/382548; Day T, 2003, TRENDS ECOL EVOL, V18, P113, DOI 10.1016/S0169-5347(02)00049-6; Ebert D, 1997, EVOLUTION, V51, P1828, DOI [10.2307/2411005, 10.1111/j.1558-5646.1997.tb05106.x]; ERIKSSON O, 1993, TRENDS ECOL EVOL, V8, P313, DOI 10.1016/0169-5347(93)90237-J; Folimonova SY, 2012, J VIROL, V86, P5554, DOI 10.1128/JVI.00310-12; Folimonova SY, 2010, J VIROL, V84, P1314, DOI 10.1128/JVI.02075-09; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Frank SA, 2001, HEREDITY, V87, P522, DOI 10.1046/j.1365-2540.2001.00911.x; FRANTZEN J, 1994, CAN J BOT, V72, P832, DOI 10.1139/b94-107; Gandon S, 2001, EVOLUTION, V55, P1056, DOI 10.1554/0014-3820(2001)055[1056:HLHATE]2.0.CO;2; GarciaGuzman G, 1997, AM J BOT, V84, P1565, DOI 10.2307/2446618; Gibbs A, 1976, EFFECTS VIRUSES PLAN; Gonzalez-Jara P, 2009, J VIROL, V83, P7487, DOI 10.1128/JVI.00636-09; Groppe K, 1999, MOL ECOL, V8, P1827, DOI 10.1046/j.1365-294x.1999.00772.x; Haraguchi Y, 2000, J THEOR BIOL, V203, P85, DOI 10.1006/jtbi.1999.1065; HARRIS TE, 1974, ANN PROBAB, V2, P969, DOI 10.1214/aop/1176996493; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; JONES RAC, 1992, AUST J AGR RES, V43, P1229, DOI 10.1071/AR9921229; Koubek T, 2008, EVOL ECOL, V22, P449, DOI 10.1007/s10682-007-9219-z; Krone SM, 1999, ANN APPL PROBAB, V9, P331; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; Li Y, 2013, J STAT PHYS, V153, P312, DOI 10.1007/s10955-013-0832-7; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Marshall C, 1996, VEGETATIO, V127, P9, DOI 10.1007/BF00054842; MATSUDA H, 1992, PROG THEOR PHYS, V88, P1035, DOI 10.1143/PTP.88.1035; MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138; MCCREA KD, 1985, OECOLOGIA, V68, P20, DOI 10.1007/BF00379467; Mendgen K, 2002, TRENDS PLANT SCI, V7, P352, DOI 10.1016/S1360-1385(02)02297-5; NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012; Pan JJ, 2002, OIKOS, V98, P37, DOI 10.1034/j.1600-0706.2002.980104.x; Piqueras J, 1999, J ECOL, V87, P995, DOI 10.1046/j.1365-2745.1999.00409.x; Piqueras J, 1998, PLANT ECOL, V136, P213, DOI 10.1023/A:1009753515163; POTTER LR, 1993, PLANT PATHOL, V42, P797, DOI 10.1111/j.1365-3059.1993.tb01567.x; SATO K, 1994, J MATH BIOL, V32, P251, DOI 10.1007/BF00163881; SATULOVSKY JE, 1994, PHYS REV E, V49, P5073, DOI 10.1103/PhysRevE.49.5073; SLADE AJ, 1987, J ECOL, V75, P1023, DOI 10.2307/2260311; Stuefer JF, 2004, EVOL ECOL, V18, P647, DOI 10.1007/s10682-004-5148-2; Van Groenendael J, 2012, ECOL MODEL, V234, P1, DOI 10.1016/j.ecolmodel.2012.03.013; van Molken T, 2008, EVOL ECOL, V22, P467, DOI 10.1007/s10682-007-9206-4; WENNSTROM A, 1992, J ECOL, V80, P71, DOI 10.2307/2261064	41	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154883	10.1371/journal.pone.0154883	http://dx.doi.org/10.1371/journal.pone.0154883			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149510	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800079
J	Carbone, L; Austin, J				Carbone, Larry; Austin, Jamie			Pain and Laboratory Animals: Publication Practices for Better Data Reproducibility and Better Animal Welfare	PLOS ONE			English	Article							SPINAL-CORD-INJURY; EXPERIMENTAL SURGICAL-PROCEDURES; KILLER-CELL ACTIVITY; SYSTEMATIC REVIEWS; NEUROPATHIC PAIN; METASTATIC COLONIZATION; LIVER-TRANSPLANTATION; REPORTING GUIDELINES; POSTERIOR PARIETAL; CRITICAL-CARE	Scientists who perform major survival surgery on laboratory animals face a dual welfare and methodological challenge: how to choose surgical anesthetics and post-operative analgesics that will best control animal suffering, knowing that both pain and the drugs that manage pain can all affect research outcomes. Scientists who publish full descriptions of animal procedures allow critical and systematic reviews of data, demonstrate their adherence to animal welfare norms, and guide other scientists on how to conduct their own studies in the field. We investigated what information on animal pain management a reasonably diligent scientist might find in planning for a successful experiment. To explore how scientists in a range of fields describe their management of this ethical and methodological concern, we scored 400 scientific articles that included major animal survival surgeries as part of their experimental methods, for the completeness of information on anesthesia and analgesia. The 400 articles (250 accepted for publication pre-2011, and 150 in 2014-15, along with 174 articles they reference) included thoracotomies, craniotomies, gonadectomies, organ transplants, peripheral nerve injuries, spinal laminectomies and orthopedic procedures in dogs, primates, swine, mice, rats and other rodents. We scored articles for Publication Completeness (PC), which was any mention of use of anesthetics or analgesics; Analgesia Use (AU) which was any use of post-surgical analgesics, and Analgesia Completeness (a composite score comprising intra-operative analgesia, extended post-surgical analgesia, and use of multimodal analgesia). 338 of 400 articles were PC. 98 of these 338 were AU, with some mention of analgesia, while 240 of 338 mentioned anesthesia only but not post-surgical analgesia. Journals' caliber, as measured by their 2013 Impact Factor, had no effect on PC or AU. We found no effect of whether a journal instructs authors to consult the ARRIVE publishing guidelines published in 2010 on PC or AC for the 150 mouse and rat articles in our 2014-15 dataset. None of the 302 articles that were silent about analgesic use included an explicit statement that analgesics were withheld, or a discussion of how pain management or untreated pain might affect results. We conclude that current scientific literature cannot be trusted to present full detail on use of animal anesthetics and analgesics. We report that publication guidelines focus more on other potential sources of bias in experimental results, under-appreciate the potential for pain and pain drugs to skew data, and thus mostly treat pain management as solely an animal welfare concern, in the jurisdiction of animal care and use committees. At the same time, animal welfare regulations do not include guidance on publishing animal data, even though publication is an integral part of the cycle of research and can affect the welfare of animals in studies building on published work, leaving it to journals and authors to voluntarily decide what details of animal use to publish. We suggest that journals, scientists and animal welfare regulators should revise current guidelines and regulations, on treatment of pain and on transparent reporting of treatment of pain, to improve this dual welfare and data-quality deficiency.	[Carbone, Larry; Austin, Jamie] Univ Calif San Francisco, Lab Anim Resource Ctr, 513 Parnassus, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Carbone, L (corresponding author), Univ Calif San Francisco, Lab Anim Resource Ctr, 513 Parnassus, San Francisco, CA 94143 USA.	larrycarbonedvm@gmail.com			United States National Science Foundation Division of Social and Economic Sciences [1455838]; National Science Foundation, Science, Technology, and Society program [1455838]; Direct For Social, Behav & Economic Scie [1455838] Funding Source: National Science Foundation	United States National Science Foundation Division of Social and Economic Sciences; National Science Foundation, Science, Technology, and Society program; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was funded by the United States National Science Foundation Division of Social and Economic Sciences. Award #1455838. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Elizabeth Yee, Patricia Carazo-Ramsey and Maritxu Ravenscroft assisted with data collection. Alicia Karas assisted with categorizing anesthetics. David Takacs provided editorial review and assistance. The work was supported by grant # 1455838 from the National Science Foundation, Science, Technology, and Society program.	[Anonymous], 2013, NATURE, V496, P398, DOI 10.1038/496398a; Avey MT, 2015, J AM ASSOC LAB ANIM, V54, P153; Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Bara M, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0026-8; Bara M, 2014, CRIT CARE, V18, DOI 10.1186/cc13694; Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; Bignami E, 2013, J CARDIOTHOR VASC AN, V27, P50, DOI 10.1053/j.jvca.2012.06.007; Buck V, 2007, NATURE, V446, P856, DOI 10.1038/446856d; Carbone L., 2014, THE IACUC HDB, V3, P211; Carbone L, 2012, J AM ASS LAB ANIMAL, V51, P1; Carbone L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021578; Caro AC, 2014, J AM ASSOC LAB ANIM, V53, P185; Chase SM, 2010, J NEUROSCI, V30, P13873, DOI 10.1523/JNEUROSCI.2325-10.2010; Cohen DB, 2006, AM J SPORT MED, V34, P362, DOI 10.1177/0363546505280428; Committee on Guidelines for Scientific Publications Involving Animal Studies, 2011, GUID DESCR AN RES SC; Committee on Recognition and Alleviation of Pain in Laboratory Animals National Research Council, 2009, REC ALL PAIN LAB AN; Coulter CA, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-12; Decosterd I, 2004, ANESTH ANALG, V99, P457; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Eisen JA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001757; Fish RE, 2008, AM COLL LAB, P1; Flecknell P., 2009, LAB ANIMAL ANAESTHES; Franchi S, 2007, BRAIN BEHAV IMMUN, V21, P767, DOI 10.1016/j.bbi.2007.01.001; Gaertner DJ, 2008, AM COLL LAB, P239, DOI 10.1016/B978-012373898-1.50014-0; Gaspani L, 2002, J NEUROIMMUNOL, V129, P18, DOI 10.1016/S0165-5728(02)00165-0; He SQ, 2010, J AM ASSOC LAB ANIM, V49, P45; Hirst TC, 2013, BRIT J CANCER, V108, P64, DOI 10.1038/bjc.2012.504; Hish GA, 2014, J AM ASSOC LAB ANIM, V53, P485; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; Hugunin KMS, 2010, SHOCK, V34, P250, DOI 10.1097/SHK.0b013e3181cdc412; Husmann K, 2015, LAB ANIM-UK, V49, P284, DOI 10.1177/0023677215570989; Institute for Laboratory Animal Research NRC, 2011, GUIDE CARE USE LAB A; Joel LA, 1999, AM J NURS, V99, P9; Jones SP, 2015, CIRC RES, V116, P572, DOI 10.1161/CIRCRESAHA.116.305462; KAMADA N, 1979, TRANSPLANTATION, V28, P47, DOI 10.1097/00007890-197907000-00011; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Knopp KL, 2015, SCAND J PAIN, V7, P58, DOI 10.1016/j.sjpain.2015.01.006; Kohn DF, 2007, J AM ASSOC LAB ANIM, V46, P97; Kolstad AM, 2012, J AM ASSOC LAB ANIM, V51, P448; Krauth D, 2013, ENVIRON HEALTH PERSP, V121, P985, DOI 10.1289/ehp.1206389; Lal S, 2000, J NEUROSURG, V92, P326, DOI 10.3171/jns.2000.92.2.0326; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lee YA, 2012, J AM ASSOC LAB ANIM, V51, P246; Leenaars M, 2015, ALTEX-ALTERN ANIM EX, V32, P149, DOI 10.14573/altex.1502161; Lemmon VP, 2014, J NEUROTRAUM, V31, P1354, DOI 10.1089/neu.2014.3400; Lipman NS, 2008, AM COLL LAB, P299; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Manolagas SC, 2014, J BONE MINER RES, V29, P2131, DOI 10.1002/jbmr.2293; Martins AR, 2015, ANIMALS, V5, P315, DOI 10.3390/ani5020315; Martucci C, 2004, PAIN, V110, P385, DOI 10.1016/j.pain.2004.04.020; Mathews K, 2014, J SMALL ANIM PRACT, V55, pE10, DOI 10.1111/jsap.12200; National Pain Management Coordinating Committee VHA, 2000, PAIN 5 VIT SIGN TOOL; Nature Publishing Group, 2015, REP CHECKL LIF SCI A; Osborne NJ, 2009, AM J BIOETHICS, V9, P55, DOI 10.1080/15265160903318343; Padberg J, 2010, J NEUROSCI, V30, P12918, DOI 10.1523/JNEUROSCI.1806-10.2010; Page GG, 2001, PAIN, V90, P191, DOI 10.1016/S0304-3959(00)00403-6; Parker JM, 2011, J AM ASSOC LAB ANIM, V50, P466; Peters JL, 2006, J ENVIRON SCI HEAL B, V41, P1245, DOI 10.1080/03601230600857130; Rice ASC, 2008, PAIN, V139, P243, DOI 10.1016/j.pain.2008.08.017; Richardson CA, 2005, ATLA-ALTERN LAB ANIM, V33, P119, DOI 10.1177/026119290503300207; Roseman M, 2011, JAMA-J AM MED ASSOC, V305, P1008, DOI 10.1001/jama.2011.257; Rousseau P, 2008, ARCH SURG-CHICAGO, V143, P98, DOI 10.1001/archsurg.2007.23; Russell WMS., 1959, MED J AUSTRALIA; Sacerdote P, 2006, PALLIATIVE MED, V20, pS9, DOI 10.1191/0269216306pm1124oa; Sacerdote P, 2012, CURR PHARM DESIGN, V18, P6034, DOI 10.2174/138161212803582496; Schwarz F, 2012, J CLIN PERIODONTOL, V39, P63, DOI 10.1111/j.1600-051X.2011.01838.x; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Steward O, 2012, EXP NEUROL, V233, P597, DOI 10.1016/j.expneurol.2011.06.017; Stewart LSA, 2003, COMPARATIVE MED, V53, P29; Stokes EL, 2009, LAB ANIM-UK, V43, P149, DOI 10.1258/la.2008.008020; Taylor K, 2010, ATLA-ALTERN LAB ANIM, V38, P495, DOI 10.1177/026119291003800613; Tilson HA, 2013, ENVIRON HEALTH PERSP, V121, pA320, DOI 10.1289/ehp.1307676; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; United States Department of Agriculture Animal Care, 2011, AN CAR RES GUID; United States Department of Agriculture Animal Care, 2013, AN CAR AN WELF INSP; Vallentin D, 2010, EUR J NEUROSCI, V32, P1380, DOI 10.1111/j.1460-9568.2010.07427.x; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010; Watzlawick R, 2014, JAMA NEUROL, V71, P91, DOI 10.1001/jamaneurol.2013.4684; Wever KE, 2014, EVIDENCE BASED PRECL, V1, P4	86	83	83	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155001	10.1371/journal.pone.0155001	http://dx.doi.org/10.1371/journal.pone.0155001			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171143	Green Published, gold			2022-12-27	WOS:000376588600097
J	Coomans, F; Hofman, A; Brinkhuis, M; van der Maas, HLJ; Maris, G				Coomans, Frederik; Hofman, Abe; Brinkhuis, Matthieu; van der Maas, Han L. J.; Maris, Gunter			Distinguishing Fast and Slow Processes in Accuracy - Response Time Data	PLOS ONE			English	Article							INSTANCE; JUDGMENT	We investigate the relation between speed and accuracy within problem solving in its simplest non-trivial form. We consider tests with only two items and code the item responses in two binary variables: one indicating the response accuracy, and one indicating the response speed. Despite being a very basic setup, it enables us to study item pairs stemming from a broad range of domains such as basic arithmetic, first language learning, intelligence-related problems, and chess, with large numbers of observations for every pair of problems under consideration. We carry out a survey over a large number of such item pairs and compare three types of psychometric accuracy-response time models present in the literature: two 'one-process' models, the first of which models accuracy and response time as conditionally independent and the second of which models accuracy and response time as conditionally dependent, and a 'two-process' model which models accuracy contingent on response time. We find that the data clearly violates the restrictions imposed by both one-process models and requires additional complexity which is parsimoniously provided by the two-process model. We supplement our survey with an analysis of the erroneous responses for an example item pair and demonstrate that there are very significant differences between the types of errors in fast and slow responses.	[Coomans, Frederik; Hofman, Abe; Brinkhuis, Matthieu; van der Maas, Han L. J.; Maris, Gunter] Univ Amsterdam, Psychol Methods, Amsterdam, Netherlands; [Coomans, Frederik] Katholieke Univ Leuven, Quantitat Psychol & Individual Differences, Leuven, Belgium; [Maris, Gunter] Cito Inst Educ Measurement, Arnhem, Netherlands; [Coomans, Frederik] Nieuwe Achtergracht 129B, NL-1081 WT Amsterdam, Netherlands	University of Amsterdam; KU Leuven	Coomans, F (corresponding author), Univ Amsterdam, Psychol Methods, Amsterdam, Netherlands.; Coomans, F (corresponding author), Katholieke Univ Leuven, Quantitat Psychol & Individual Differences, Leuven, Belgium.; Coomans, F (corresponding author), Nieuwe Achtergracht 129B, NL-1081 WT Amsterdam, Netherlands.	F.L.J.Coomans@uva.nl	Brinkhuis, Matthieu J.S./X-6308-2018	Brinkhuis, Matthieu J.S./0000-0003-1054-6683; van der Maas, Han L. J./0000-0001-8278-319X	Netherlands Organisation for Scientific Research [314-99-107]; Netherlands Organisation for Scientific Research (NWO) [314-99-107]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by The Netherlands Organisation for Scientific Research (http://www.nwo.nl/), grant number 314-99-107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The Netherlands Organisation for Scientific Research (NWO), grant number 314-99-107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCRAFT MH, 1992, COGNITION, V44, P75, DOI 10.1016/0010-0277(92)90051-I; Batchelder WH, 1999, PSYCHON B REV, V6, P57, DOI 10.3758/BF03210812; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; COONEY JB, 1988, COGNITION INSTRUCT, V5, P323, DOI 10.1207/s1532690xci0504_5; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Evans JST, 2013, PERSPECT PSYCHOL SCI, V8, P223, DOI 10.1177/1745691612460685; Klinkenberg S, 2011, COMPUT EDUC, V57, P1813, DOI 10.1016/j.compedu.2011.02.003; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Maris G, 2012, PSYCHOMETRIKA, V77, P615, DOI 10.1007/s11336-012-9288-y; Nyamsuren E, 2013, COGNITIVE SCI, V37, P146, DOI 10.1111/cogs.12001; Palmeri TJ, 1997, J EXP PSYCHOL LEARN, V23, P324, DOI 10.1037/0278-7393.23.2.324; Partchev I, 2012, INTELLIGENCE, V40, P23, DOI 10.1016/j.intell.2011.11.002; Rickard TC, 1997, J EXP PSYCHOL GEN, V126, P288, DOI 10.1037/0096-3445.126.3.288; SIEGLER RS, 1988, J EXP PSYCHOL GEN, V117, P258, DOI 10.1037/0096-3445.117.3.258; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van der Linden WJ, 2007, PSYCHOMETRIKA, V72, P287, DOI 10.1007/s11336-006-1478-z; van der Linden WJ, 2009, J EDUC MEAS, V46, P247, DOI 10.1111/j.1745-3984.2009.00080.x; Van der Maas HLJ, 2005, AM J PSYCHOL, V118, P29	19	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155149	10.1371/journal.pone.0155149	http://dx.doi.org/10.1371/journal.pone.0155149			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CD	27167518	Green Published, gold			2022-12-27	WOS:000376587300029
J	Moleda, P; Fronczyk, A; Safranow, K; Majkowska, L				Moleda, Piotr; Fronczyk, Aneta; Safranow, Krzysztof; Majkowska, Lilianna			Is Uric Acid a Missing Link between Previous Gestational Diabetes Mellitus and the Development of Type 2 Diabetes at a Later Time of Life?	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; METABOLIC SYNDROME; RISK; INSULIN; HYPERURICEMIA; INFLAMMATION; ASSOCIATION; GLUCOSE	Introduction A high level of uric acid (UA) is a strong, independent risk factor for type 2 diabetes mellitus. The relationship between UA levels and the development of type 2 diabetes in women with previous gestational diabetes mellitus (pGDM) remains unclear. The aim of study was to evaluate the UA levels in pGDM women in relation to their current nutritional status and carbohydrate metabolism. Material and Methods 199 women with pGDM diagnoses based on oral glucose tolerance tests (OGTTs) 5-12 years previously and a control group of 50 women without pGDM. The assessment included anthropometric parameters, body composition (Tanita SC-330S), current OGTT, insulin resistance index (HOMA-IR), beta-cell function (HOMA-%B), HbA1c, lipids, and uric acid. Results No differences between groups were found in terms of age, time from the index pregnancy, anthropometric parameters, lipids or creatinine levels. The incidences of overweight and obesity were similar. Carbohydrate abnormalities were more frequent in the pGDM group than the control group (43.2% vs 12.0% p<0.001). The women with pGDM had significantly higher fasting glucose, HbA1c, glucose and insulin levels in the OGTTs, but similar HOMA-IR values. Their UA levels were significantly higher (258 +/- 58 vs 230 +/- 50 mu mol/L, p<0.005) and correlated with BMI and the severity of carbohydrate disorders. The normal weight and normoglycemic pGDM women also demonstrated higher UA levels than a similar control subgroup (232 +/- 48 vs 208 +/- 48 mu mol/L, p<0.05). Multivariate analysis revealed significant correlations of UA level with BMI (beta = 0.38, 95% CI 0.25-0.51, p<0.0001), creatinine level (beta = 0.23, 95% CI 0.11-0.35, p<0.0005), triglycerides (beta = 0.20, 95% CI 0.07-0.33, p<0.005) and family history of diabetes (beta = 0.13, 95% CI 0.01-0.25, p<0.05). In logistic regression analysis, the association between higher UA level (defined as value >= 297 mu mol/L) and presence of any carbohydrate metabolism disorder (IFG, IGT or diabetes) was statistically significant (odds ratio 3.62 [95% CI 1.8-7.3], p<0.001). Conclusions Higher UA levels may be associated with the development of type 2 diabetes in pGDM women, also in these with normal body weights.	[Moleda, Piotr; Fronczyk, Aneta; Majkowska, Lilianna] Pomeranian Med Univ, Dept Diabetol & Internal Med, Szczecin, Poland; [Safranow, Krzysztof] Pomeranian Med Univ, Dept Biochem & Med Chem, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University	Moleda, P (corresponding author), Pomeranian Med Univ, Dept Diabetol & Internal Med, Szczecin, Poland.	pmoleda@wp.pl	Safranow, Krzysztof/B-5127-2015; Fronczyk, Aneta/N-2417-2014; Majkowska, Lilianna/O-5016-2014; Molęda, Piotr/A-6852-2015	Safranow, Krzysztof/0000-0001-9415-2758; Fronczyk, Aneta/0000-0002-1036-4938; Molęda, Piotr/0000-0002-1148-5483	Ministry of Science and Higher Education [N 402 069 32/2047]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by a scientific grant from the Ministry of Science and Higher Education as research project no. N 402 069 32/2047 to LM.	[Anonymous], 2006, DEF DIAGN DIAB MELL; Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Bobulescu A, 2012, ADV CHRONIC KIDNEY D, V19, P358, DOI 10.1053/j.ackd.2012.07.009; Caliskan M, 2014, ECHOCARDIOGR-J CARD, V31, P1182, DOI 10.1111/echo.12597; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Gill A, 2013, J CLIN DIAGN RES, V7, P1295, DOI 10.7860/JCDR/2013/6017.3121; Hunger-Dathe W, 2006, EXP CLIN ENDOCR DIAB, V114, P11, DOI 10.1055/s-2005-873015; Jia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078284; Jia ZT, 2013, DIABETES RES CLIN PR, V101, P88, DOI 10.1016/j.diabres.2013.03.026; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Karoli Ritu, 2015, Heart Views, V16, P13, DOI 10.4103/1995-705X.152995; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Laughon SK, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.065; Li Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep10003; Ling Yan, 2012, Zhonghua Yi Xue Za Zhi, V92, P541; Lv Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056864; Maged AM, 2014, J MATERN-FETAL NEO M, V27, P1108, DOI 10.3109/14767058.2013.850489; MODAN M, 1987, DIABETOLOGIA, V30, P713, DOI 10.1007/BF00296994; Nagahama K, 2015, HYPERTENS RES, V38, P213, DOI 10.1038/hr.2014.161; Patetsios P, 2001, AM J CARDIOL, V88, P188, DOI 10.1016/S0002-9149(01)01621-6; Pingmuangkaew P, 2015, INDIAN J CLIN BIOCHE, V30, P286, DOI 10.1007/s12291-014-0462-0; Robles-Cervantes JA, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/107904; Roca-Rodriguez MM, 2014, J ENDOCRINOL INVEST, V37, P503, DOI 10.1007/s40618-013-0045-6; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Shimodaira M, 2014, HORM METAB RES, V46, P950, DOI 10.1055/s-0034-1389996; Tang W, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/709691; The Seventh Report of the Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure, 2004, NIH PUBLICATION, V04-5230; Villegas R, 2012, NUTR METAB CARDIOVAS, V22, P409, DOI 10.1016/j.numecd.2010.07.012; VUORINENMARKKOLA H, 1994, J CLIN ENDOCR METAB, V78, P25, DOI 10.1210/jc.78.1.25; Wang TG, 2011, ENDOCRINE, V40, P109, DOI 10.1007/s12020-011-9449-2; Wolak T, 2012, HYPERTENS PREGNANCY, V31, P307, DOI 10.3109/10641955.2010.507848; Wu SH, 2015, BIOMARKERS, V20, P225, DOI 10.3109/1354750X.2015.1068852; Zajdenverg L, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-63; ZAVARONI I, 1993, J INTERN MED, V234, P25, DOI 10.1111/j.1365-2796.1993.tb00700.x; Zhang YN, 2013, MOL CELL ENDOCRINOL, V375, P89, DOI 10.1016/j.mce.2013.04.027	39	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154921	10.1371/journal.pone.0154921	http://dx.doi.org/10.1371/journal.pone.0154921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166795	gold, Green Submitted, Green Published			2022-12-27	WOS:000376587300054
J	Parsons, SDC; McGill, K; Doyle, MB; Goosen, WJ; van Helden, PD; Gormley, E				Parsons, Sven D. C.; McGill, Kevina; Doyle, Mairead B.; Goosen, Wynand J.; van Helden, Paul D.; Gormley, Eamonn			Antigen-Specific IP-10 Release Is a Sensitive Biomarker of Mycobacterium bovis Infection in Cattle	PLOS ONE			English	Article							BUFFALOS SYNCERUS-CAFFER; DIFFERENTIAL-DIAGNOSIS; INTERFERON-GAMMA; WHOLE-BLOOD; TUBERCULOSIS; NEUTROPHILS; DISEASE; ESAT-6; ASSAYS; CELLS	The most widely used ante-mortem diagnostic tests for tuberculosis in cattle are the tuberculin skin test and the interferon-gamma (IFN-gamma) release assay, both of which measure cell-mediated immune responses to Mycobacterium bovis infection. However, limitations in the performance of these tests results in a failure to identify all infected animals. In attempting to increase the range of diagnostic tests for tuberculosis, measurement of the cytokine IP-10 in antigen-stimulated blood has previously been shown to improve the detection of M. tuberculosis and M. bovis infection, in humans and African buffaloes (Syncerus caffer), respectively. In the present study, 60 cattle were identified by the single intradermal comparative tuberculin test as tuberculosis reactors (n = 24) or non-reactors (n = 36) and the release of IFN-gamma and IP-10 in antigen-stimulated whole blood from these animals was measured using bovine specific ELISAs. There was a strong correlation between IP-10 and IFN-gamma production in these samples. Moreover, measurement of the differential release of IP-10 in response to stimulation with M. bovis purified protein derivative (PPD) and M. avium PPD distinguished between reactor and non-reactor cattle with a sensitivity of 100% (95% CI, 86%-100%) and a specificity of 97% (95% CI, 85%-100%). These results suggest that IP-10 might prove valuable as a diagnostic biomarker of M. bovis infection in cattle.	[Parsons, Sven D. C.; Goosen, Wynand J.; van Helden, Paul D.] Univ Stellenbosch, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, SAMRC Ctr TB Res,Div Mol Biol & Human Genet, Cape Town, South Africa; [McGill, Kevina; Doyle, Mairead B.; Gormley, Eamonn] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland	National Research Foundation - South Africa; Stellenbosch University; University College Dublin	Parsons, SDC (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, SAMRC Ctr TB Res,Div Mol Biol & Human Genet, Cape Town, South Africa.	sparsons@sun.ac.za		Parsons, Sven/0000-0002-9033-9686; Goosen, Wynand/0000-0001-6614-9084	Department of Agriculture, Food & the Marine (DAFM); South African National Research Foundation through the Centre of Excellence in Biomedical TB Research [41744]	Department of Agriculture, Food & the Marine (DAFM); South African National Research Foundation through the Centre of Excellence in Biomedical TB Research	EG: Bovine tuberculosis research at UCD Dublin is funded by the Department of Agriculture, Food & the Marine (DAFM) (http://www.agriculture.gov.ie/). PvH: Funding is received from the South African National Research Foundation through the Centre of Excellence in Biomedical TB Research, Grant number: 41744 (http://www.nrf.ac.za/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass KE, 2013, CLIN VACCINE IMMUNOL, V20, P1827, DOI 10.1128/CVI.00519-13; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Cassatella MA, 1997, EUR J IMMUNOL, V27, P111, DOI 10.1002/eji.1830270117; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Goosen WJ, 2015, CLIN VACCINE IMMUNOL, V22, P974, DOI 10.1128/CVI.00324-15; Goosen WJ, 2014, VET IMMUNOL IMMUNOP, V162, P198, DOI 10.1016/j.vetimm.2014.10.008; Gormley E, 2006, VET MICROBIOL, V112, P171, DOI 10.1016/j.vetmic.2005.11.029; Hope JC, 2005, CLIN EXP IMMUNOL, V141, P432, DOI 10.1111/j.1365-2249.2005.02882.x; Molesworth-Kenyon SJ, 2005, J LEUKOCYTE BIOL, V77, P552, DOI 10.1189/jlb.0904485; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Pollock JM, 2000, VET REC, V146, P659, DOI 10.1136/vr.146.23.659; Re F, 2004, J IMMUNOL, V173, P7548, DOI 10.4049/jimmunol.173.12.7548; ROTHEL JS, 1990, AUST VET J, V67, P134, DOI 10.1111/j.1751-0813.1990.tb07730.x; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Taubert A, 2008, VET RES COMMUN, V32, P35, DOI 10.1007/s11259-007-9001-2; Thom A, 2004, VET IMMUNOL IMMUNOP, V102, P399, DOI 10.1016/j.vetimm.2004.08.005; Vordermeier HM, 2001, CLIN DIAGN LAB IMMUN, V8, P571, DOI 10.1128/CDLI.8.3.571-578.2001; Vordermeier M, 2011, VET MICROBIOL, V151, P8, DOI 10.1016/j.vetmic.2011.02.020; Waters WR, 2012, CLIN VACCINE IMMUNOL, V19, P346, DOI 10.1128/CVI.05657-11; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	24	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155440	10.1371/journal.pone.0155440	http://dx.doi.org/10.1371/journal.pone.0155440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167122	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300004
J	Ruiz-Jarabo, I; Gonzalez-Wevar, CA; Oyarzun, R; Fuentes, J; Poulin, E; Bertran, C; Vargas-Chacoff, L				Ruiz-Jarabo, Ignacio; Gonzalez-Wevar, Claudio A.; Oyarzun, Ricardo; Fuentes, Juan; Poulin, Elie; Bertran, Carlos; Vargas-Chacoff, Luis			Isolation Driven Divergence in Osmoregulation in Galaxias maculatus (Jenyns, 1848) (Actinopterygii: Osmeriformes)	PLOS ONE			English	Article							H+-ATPASE ACTIVITY; SALMON SALMO-SALAR; FRESH-WATER; DIFFERENTIAL EXPRESSION; LANDLOCKED POPULATIONS; SEAWATER ACCLIMATION; ADAPTIVE DIVERGENCE; GENE-EXPRESSION; NA+/K+-ATPASE; LIFE-HISTORY	Background Marine species have colonized extreme environments during evolution such as freshwater habitats. The amphidromous teleost fish, Galaxias maculatus is found mainly migrating between estuaries and rivers, but some landlocked populations have been described in lakes formed during the last deglaciation process in the Andes. In the present study we use mtDNA sequences to reconstruct the historical scenario of colonization of such a lake and evaluated the osmoregulatory shift associated to changes in habitat and life cycle between amphidromous and landlocked populations. Results Standard diversity indices including the average number of nucleotide differences (Pi) and the haplotype diversity index (H) indicated that both populations were, as expected, genetically distinctive, being the landlocked population less diverse than the diadromous one. Similarly, pairwise G(ST) and N-ST comparison detected statistically significant differences between both populations, while genealogy of haplotypes evidenced a recent founder effect from the diadromous stock, followed by an expansion process in the lake. To test for physiological differences, individuals of both populations were challenged with a range of salinities from 0 to 30 ppt for 8 days following a period of progressive acclimation. The results showed that the landlocked population had a surprisingly wider tolerance to salinity, as landlocked fish survival was 100% from 0 to 20 ppt, whereas diadromous fish survival was 100% only from 10 to 15 ppt. The activity of ATPase enzymes, including Na+/K+-ATPase (NKA), and H+-ATPase (HA) was measured in gills and intestine. Activity differences were detected between the populations at the lowest salinities, including differences in ATPases other than NKA and HA. Population differences in mortality are not reflected in enzyme activity differences, suggesting divergence in other processes. Conclusions These results clearly demonstrate the striking adaptive changes of G. maculatus osmoregulatory system, especially at hyposmotic environments, associated to a drastic shift in habitat and life cycle at a scale of a few thousand years.	[Ruiz-Jarabo, Ignacio; Fuentes, Juan] Univ Algarve, Ctr Marine Sci CCMar, Campus Gambelas, P-8005139 Faro, Portugal; [Gonzalez-Wevar, Claudio A.] Univ Magallanes, GAIA Antart, Ave Bulnes 01855, Punta Arenas, Chile; [Gonzalez-Wevar, Claudio A.; Poulin, Elie] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Lab Ecol Mol,Inst Milenio Ecol & Biodiversidad IE, Las Palmeras 3425, Santiago, Chile; [Bertran, Carlos; Vargas-Chacoff, Luis] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Casilla 567, Valdivia, Chile; [Vargas-Chacoff, Luis] Univ Austral Chile, Ctr Fondap Invest Altas Latitudes IDEAL, Casilla 567, Valdivia, Chile	Universidade do Algarve; Universidad de Magallanes; Universidad de Chile; Universidad Austral de Chile; Universidad Austral de Chile	Vargas-Chacoff, L (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Casilla 567, Valdivia, Chile.; Vargas-Chacoff, L (corresponding author), Univ Austral Chile, Ctr Fondap Invest Altas Latitudes IDEAL, Casilla 567, Valdivia, Chile.	luis.vargas@uach.cl	Fuentes, Juan/I-6663-2013; González-Wevar, Claudio Alejandro/AAD-6513-2021; Vargas-Chacoff, Luis LVCh/A-5855-2012; Poulin, Elie/C-2654-2012; Oyarzún-Salazar, Ricardo/HGU-6035-2022; Ruiz-Jarabo, I./AAA-6194-2020	Fuentes, Juan/0000-0003-0430-8734; Poulin, Elie/0000-0001-7736-0969; Oyarzun-Salazar, Ricardo/0000-0003-3177-399X; Vargas-Chacoff, Luis/0000-0002-0497-2582; Ruiz-Jarabo, Ignacio/0000-0002-3918-0921	University of Cadiz [UCA 2009-074-FPI]; Instituto de Ecologia y Biodiversidad (IEB) [P05-002 ICM, PFB 023]; Fondecyt (Chile) [1151375, 1160877]; Fondap-IDEAL (Chile) [15150003]; Fondecyt [3120075];  [11140087]	University of Cadiz; Instituto de Ecologia y Biodiversidad (IEB); Fondecyt (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondap-IDEAL (Chile); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); 	This work was partially supported by a Ph.D. scholarship from the University of Cadiz (UCA 2009-074-FPI) to I. R-J. It was also partly supported by the grants Fondecyt 1151375, 1160877 and Fondap-IDEAL 15150003 (Chile) to L.V-C, the post doctorate fellowship (Fondecyt 3120075) and Initiation Project 11140087 to C.A.G-W. We also thank Instituto de Ecologia y Biodiversidad (IEB) projects P05-002 ICM and PFB 023 to E.P. and C.A.G-W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Arjona FJ, 2007, COMP BIOCHEM PHYS A, V148, P413, DOI 10.1016/j.cbpa.2007.05.026; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Bystriansky JS, 2011, J EXP BIOL, V214, P2435, DOI 10.1242/jeb.050633; CAMPOS H, 1973, HYDROBIOLOGIA, V43, P301; Carrea C, 2013, FRESHWATER BIOL, V58, P36, DOI 10.1111/fwb.12036; Chapman A, 2006, ENVIRON BIOL FISH, V77, P21, DOI 10.1007/s10641-006-9051-2; Chapman A, 2009, NEW ZEAL J MAR FRESH, V43, P563, DOI 10.1080/00288330909510022; CHESSMAN BC, 1975, FRESHWATER BIOL, V5, P135, DOI 10.1111/j.1365-2427.1975.tb00127.x; Chester ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091925; Cooper WJ, 2010, PLOS ONE, V5, pA38, DOI 10.1371/journal.pone.0009551; Cussac V, 2004, J BIOGEOGR, V31, P103, DOI 10.1046/j.0305-0270.2003.01000.x; Di-Poi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098980; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Filatov DA, 2009, BIOINFORMATICS, V25, P3189, DOI 10.1093/bioinformatics/btp572; Fuentes J, 1997, AQUACULT INT, V5, P217, DOI 10.1023/A:1018387317893; Fuentes J., 1997, P135; Gonzalez-Wevar CA, 2011, MOL ECOL, V20, P1936, DOI 10.1111/j.1365-294X.2011.05065.x; Gonzalez-Wevar CA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-139; Gregorio SF, 2013, J EXP BIOL, V216, P470, DOI 10.1242/jeb.073742; Grosell M, 2006, J EXP BIOL, V209, P2813, DOI 10.1242/jeb.02345; Guffey S, 2011, AM J PHYSIOL-REG I, V301, pR1682, DOI 10.1152/ajpregu.00059.2011; Hata H, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0090-4; Hawkings GS, 2004, J EXP BIOL, V207, P905, DOI 10.1242/jeb.00844; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Himes CMT, 2008, J BIOGEOGR, V35, P1415, DOI 10.1111/j.1365-2699.2008.01895.x; Hune M, 2015, POLAR BIOL, V38, P607, DOI 10.1007/s00300-014-1623-6; Hwang PP, 2013, PFLUG ARCH EUR J PHY, V465, P1233, DOI 10.1007/s00424-013-1269-1; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Kitano J, 2010, CURR BIOL, V20, P2124, DOI 10.1016/j.cub.2010.10.050; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurenson LJB, 2012, J FISH BIOL, V81, P1085, DOI 10.1111/j.1095-8649.2012.03383.x; Lee CE, 2011, EVOLUTION, V65, P2229, DOI 10.1111/j.1558-5646.2011.01308.x; Lemmetyinen J, 2013, ANN ZOOL FENN, V50, P16, DOI 10.5735/086.050.0102; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIN H, 1993, J EXP BIOL, V180, P163; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marshall WS, 2002, J EXP ZOOL, V293, P264, DOI 10.1002/jez.10127; McCairns RJS, 2010, EVOLUTION, V64, P1029, DOI 10.1111/j.1558-5646.2009.00886.x; McCormick SD, 2009, J EXP BIOL, V212, P3994, DOI 10.1242/jeb.037275; McCormick SD, 2013, FISH PHYSIOL, V32, P1; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; McCormick SD, 2009, INTEGR COMP BIOL, V49, P408, DOI 10.1093/icb/icp044; Moernaut J, 2009, SEDIMENT GEOL, V213, P121, DOI 10.1016/j.sedgeo.2008.12.002; Nilsen TO, 2007, J EXP BIOL, V210, P2885, DOI 10.1242/jeb.002873; Nunez JJ, 2011, MOL PHYLOGENET EVOL, V58, P343, DOI 10.1016/j.ympev.2010.11.026; Piironen J, 2013, ANN ZOOL FENN, V50, P1; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rolland J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001775; Ruiz-Jarabo I, 2015, AQUAC RES, V46, P10, DOI 10.1111/are.12424; Ruzzante DE, 2008, MOL ECOL, V17, P2234, DOI 10.1111/j.1365-294X.2008.03738.x; Salinas MP, 2011, DIVERSIDAD GENETICA; Schultz ET, 2013, FISH PHYSL EURYHALIN, V32, P478; Shrimpton JM, 2013, FISH PHYSIOL, V32, P327, DOI 10.1016/B978-0-12-396951-4.00007-4; Smith HW, 1930, AM J PHYSIOL, V93, P480, DOI 10.1152/ajplegacy.1930.93.2.480; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tatur A, 2002, QUATERN INT, V89, P135, DOI 10.1016/S1040-6182(01)00085-4; Urbina MA, 2013, J COMP PHYSIOL B, V183, P345, DOI 10.1007/s00360-012-0719-y; Urbina MA, 2012, J COMP PHYSIOL B, V182, P1057, DOI 10.1007/s00360-012-0678-3; Velotta JP, 2015, EVOLUTION, V69, P2676, DOI 10.1111/evo.12774; Velotta JP, 2014, OECOLOGIA, V175, P1081, DOI 10.1007/s00442-014-2961-3; Volland S, 2007, QUATERN INT, V161, P32, DOI 10.1016/j.quaint.2006.10.025; Waters JM, 1999, MOL PHYLOGENET EVOL, V11, P1, DOI 10.1006/mpev.1998.0554; Waters JM, 2001, EVOLUTION, V55, P587, DOI 10.1554/0014-3820(2001)055[0587:CALOTM]2.0.CO;2; Whitehead A, 2012, J EXP BIOL, V215, P1293, DOI 10.1242/jeb.062075; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zattara EE, 2005, J BIOGEOGR, V32, P5, DOI 10.1111/j.1365-2699.2004.01164.x; Zemlak TS, 2010, BMC EVOLUTIONARY BIO, V10, P1	75	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154766	10.1371/journal.pone.0154766	http://dx.doi.org/10.1371/journal.pone.0154766			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168069	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300055
J	Taha, MK; Claus, H; Lappann, M; Veyrier, FJ; Otto, A; Becher, D; Deghmane, AE; Frosch, M; Hellenbrand, W; Hong, E; du Chatelet, IP; Prior, K; Harmsen, D; Vogel, U				Taha, Muhamed-Kheir; Claus, Heike; Lappann, Martin; Veyrier, Frederic J.; Otto, Andreas; Becher, Dorte; Deghmane, Ala-Eddine; Frosch, Matthias; Hellenbrand, Wiebke; Hong, Eva; du Chatelet, Isabelle Parent; Prior, Karola; Harmsen, Dag; Vogel, Ulrich			Evolutionary Events Associated with an Outbreak of Meningococcal Disease in Men Who Have Sex with Men	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; SEQUENCE; COMPLEMENT; DIVERSITY; PROTEINS; DATABASE; BINDING; ANIA	Meningococci spread via respiratory droplets, whereas the closely related gonococci are transmitted sexually. Several outbreaks of invasive meningococcal disease have been reported in Europe and the United States among men who have sex with men (MSM). We recently identified an outbreak of serogroup C meningococcal disease among MSM in Germany and France. In this study, genomic and proteomic techniques were used to analyze the outbreak isolates. In addition, genetically identical urethritis isolates were recovered from France and Germany and included in the analysis. Genome sequencing revealed that the isolates from the outbreak among MSM and from urethritis cases belonged to a clade within clonal complex 11. Proteome analysis showed they expressed nitrite reductase, enabling anaerobic growth as previously described for gonococci. Invasive isolates from MSM, but not urethritis isolates, further expressed functional human factor H binding protein associated with enhanced survival in a newly developed transgenic mouse model expressing human factor H, a complement regulatory protein. In conclusion, our data suggest that urethritis and outbreak isolates followed a joint adaptation route including adaption to the urogenital tract.	[Taha, Muhamed-Kheir; Veyrier, Frederic J.; Deghmane, Ala-Eddine; Hong, Eva] Inst Pasteur, Invas Bacterial Infect Unit, Paris, France; [Taha, Muhamed-Kheir; Veyrier, Frederic J.; Deghmane, Ala-Eddine; Hong, Eva] Natl Reference Ctr Meningococci, Paris, France; [Claus, Heike; Lappann, Martin; Frosch, Matthias; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, Reference Lab Meningococci & Haemophilus Influenz, D-97070 Wurzburg, Germany; [Otto, Andreas; Becher, Dorte] Univ Greifswald, Dept Microbial Prote & Mass Spectrometry, Greifswald, Germany; [Hellenbrand, Wiebke] Robert Koch Inst, Immunizat Unit, Berlin, Germany; [du Chatelet, Isabelle Parent] Inst Veille Sanit, St Maurice, France; [Prior, Karola; Harmsen, Dag] Univ Munster, Dept Periodontol, D-48149 Munster, Germany; [Veyrier, Frederic J.] Univ Quebec, INRS Inst Armand Frappier Inst Natl Rech Sci, Quebec City, PQ, Canada	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Wurzburg; Ernst Moritz Arndt Universitat Greifswald; Robert Koch Institute; Institute of Public Health Surveillance; University of Munster; University of Quebec	Taha, MK (corresponding author), Inst Pasteur, Invas Bacterial Infect Unit, Paris, France.; Taha, MK (corresponding author), Natl Reference Ctr Meningococci, Paris, France.; Vogel, U (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, Reference Lab Meningococci & Haemophilus Influenz, D-97070 Wurzburg, Germany.	mktaha@pasteur.fr; vogel_u@ukw.de	veyrier, Frederic/AAF-9229-2020; Deghmane, Ala-Eddine/CAF-2140-2022; Becher, Dorte/B-4454-2015	Becher, Dorte/0000-0002-9630-5735	Institut de Veille Sanitaire; Institut Pasteur; Robert Koch Institute, Berlin, Germany; European Community's Seventh Framework Program under in the framework of the EU PathoNGenTrace project [FP7/2007-201, 278864]; ERA-NET PathoGenomics [ANR-08-PATH-003-01]; Bundesministerium fur Bildung und Forschung grant Medizinische Infektionsgenomik: Proteomics von Meningokokken und Pneumokokken, Teilprojekt Wurzbug, Foerderkennzeichen [0315828D, 0315828A]; Wellcome Trust; European Union	Institut de Veille Sanitaire; Institut Pasteur(European Commission); Robert Koch Institute, Berlin, Germany; European Community's Seventh Framework Program under in the framework of the EU PathoNGenTrace project; ERA-NET PathoGenomics; Bundesministerium fur Bildung und Forschung grant Medizinische Infektionsgenomik: Proteomics von Meningokokken und Pneumokokken, Teilprojekt Wurzbug, Foerderkennzeichen(Federal Ministry of Education & Research (BMBF)); Wellcome Trust(Wellcome Trust); European Union(European Commission)	The French Reference Laboratory is funded by the Institut de Veille Sanitaire and the Institut Pasteur. The German Reference Laboratory is funded by the Robert Koch Institute, Berlin, Germany. The genomics work was funded by the European Community's Seventh Framework Program [grant number FP7/2007-2013 to DH] under Grant Agreement No 278864 in the framework of the EU PathoNGenTrace project. The animal work was also supported by a grant from the ERA-NET PathoGenomics (ANR-08-PATH-003-01). The proteome work was funded by Bundesministerium fur Bildung und Forschung grant Medizinische Infektionsgenomik: Proteomics von Meningokokken und Pneumokokken, Teilprojekt Wurzbug, Foerderkennzeichen 0315828D, to UV and 0315828A to DB. This publication made use of the Neisseria Multilocus Sequence Typing website (http://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford. The development of this site has been funded by the Wellcome Trust and European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The French Reference Laboratory is funded by the Institut de Veille Sanitaire and the Institut Pasteur. The German Reference Laboratory is funded by the Robert Koch Institute, Berlin, Germany. The genomics work was funded by the European Community's Seventh Framework Program [grant number FP7/2007-2013 to DH] under Grant Agreement No 278864 in the framework of the EU PathoNGenTrace project. The animal work was also supported by a grant from the ERA- NET PathoGenomics (ANR-08-PATH-003-01). The proteome work was funded by Bundesministerium fur Bildung und Forschung grant Medizinische Infektionsgenomik: Proteomics von Meningokokken und Pneumokokken, Teilprojekt Wurzburg, Foerderkennzeichen 0315828D, to U.V. and 0315828A to D.B. This publication made use of the Neisseria Multilocus Sequence Typing website (http://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford. The development of this site has been funded by the Wellcome Trust and European Union. We thank the Centre d'Ingenierie Genetique Murine at the Institut Pasteur for their technical support in the construction of the transgenic mice.	ASHTON FE, 1991, J CLIN MICROBIOL, V29, P2489, DOI 10.1128/JCM.29.11.2489-2493.1991; Aubert L, 2015, EUROSURVEILLANCE, V20; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Bonn F, 2014, ANAL CHEM, V86, P7421, DOI 10.1021/ac501189j; Brehony C, 2014, CLIN VACCINE IMMUNOL, V21, P847, DOI 10.1128/CVI.00133-14; Cardinale JA, 2005, MOL MICROBIOL, V58, P177, DOI 10.1111/j.1365-2958.2005.04807.x; Chatelet I. P. du, 2012, Bulletin Epidemiologique Hebdomadaire, P569; Clarke SC, 2001, J CLIN MICROBIOL, V39, P3066, DOI 10.1128/JCM.39.9.3066-3071.2001; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Diggle MA, 2002, J MOL MICROB BIOTECH, V4, P515; ECDC, 2011, SURV INV BACT DIS EU; Elias J, 2007, J CLIN MICROBIOL, V45, P159, DOI 10.1128/JCM.01322-06; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Hayakawa K, 2014, EMERG INFECT DIS, V20, P1585, DOI 10.3201/eid2009.140349; Hong E, 2012, VACCINE, V31, P183, DOI 10.1016/j.vaccine.2012.10.072; Householder TC, 1999, J BACTERIOL, V181, P541, DOI 10.1128/JB.181.2.541-551.1999; JANDA WM, 1983, J CLIN MICROBIOL, V17, P85, DOI 10.1128/JCM.17.1.85-91.1983; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jongerius I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003528; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Ku SC, 2009, BIOCHEM BIOPH RES CO, V378, P84, DOI 10.1016/j.bbrc.2008.11.025; Lappann M, 2013, J BACTERIOL, V195, P4425, DOI 10.1128/JB.00625-13; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marcus U, 2006, SEX TRANSM DIS, V33, P11, DOI 10.1097/01.olq.0000187224.10428.31; Marcus U, 2013, EUROSURVEILLANCE, V18; Robert Koch-Institut, 2013, EPIDEMIOLOGISCHES B, V30, P281; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Schmink S, 2007, J CLIN MICROBIOL, V45, P3768, DOI 10.1128/JCM.01190-07; Stefanelli P, 2008, IUBMB LIFE, V60, P629, DOI 10.1002/iub.95; Sullivan CB, 2006, MOL BIOTECHNOL, V32, P219, DOI 10.1385/MB:32:3:219; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Urra E, 2005, EUR J CLIN MICROBIOL, V24, P51, DOI 10.1007/s10096-004-1257-7; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Vogel U, 2012, J CLIN MICROBIOL, V50, P1889, DOI 10.1128/JCM.00038-12; Vu DM, 2012, INFECT IMMUN, V80, P643, DOI 10.1128/IAI.05604-11; Weiss D, 2013, EUROSURVEILLANCE, V18; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	43	57	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154047	10.1371/journal.pone.0154047	http://dx.doi.org/10.1371/journal.pone.0154047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167067	Green Published, Green Accepted, gold			2022-12-27	WOS:000376587300035
J	Folayan, MO; Harrison, A; Brown, B; Odetoyinbo, M; Stockman, JK; Ajuwon, AJ; Caceres, CF				Folayan, Morenike Oluwatoyin; Harrison, Abigail; Brown, Brandon; Odetoyinbo, Morolake; Stockman, Jamila K.; Ajuwon, Ademola J.; Caceres, Carlos F.			Associations between Forced Sexual Initiation, HIV Status, Sexual Risk Behavior, Life Stressors, and Coping Strategies among Adolescents in Nigeria	PLOS ONE			English	Article							SOCIAL SUPPORT; TRANSACTIONAL SEX; PARTNER VIOLENCE; WOMEN; ABUSE; INFECTION; CALL; PREVALENCE; PREVENTION; SYMPTOMS	Objectives Some individuals experience their first sexual intercourse through physically forced sex, which affects the way they experience and cope with stress. We examined differences in sexual risk behavior, experience of stressors, and use of stress-coping strategies among adolescents in Nigeria based on their history of forced sexual initiation and HIV status. Methods We analyzed data from 436 sexually active 10-19-year-old adolescents recruited through a population-based survey from 12 Nigerian states. Using Lazarus and Folkman's conceptual framework of stress and coping, we assessed if adolescents who reported forced sexual initiation were more likely to report HIV sexual risk practices, to report as stressors events related to social expectations, medical care and body images, and loss and grief, and to use more avoidance than adaptive coping strategies to manage stress. We also assessed if HIV status affected experience of stressors and use of coping strategies. Results Eighty-one adolescents (18.6%) reported a history of forced sexual initiation; these participants were significantly more likely to report anal sex practices (OR: 5.04; 95% CI: 2.14-11.87), and transactional sex (OR: 2.80; 95% CI: 1.56-4.95). Adolescents with no history of forced sexual initiation were more likely to identify as stressors, life events related to social expectations (OR: 1.03; 95% CI: 0.96-1.11) and loss and grief (OR: 1.34; 95% CI: 0.73-2.65), but not those related to medical care and body images (OR: 0.63; 95% CI: 0.34-1.18). They were also more likely to use adaptive responses (OR: 1.48; 95% CI: 0.62-3.50) than avoidance responses (OR: 0.90; 95% CI: 0.49-1.64) to cope with stress, though these differences were not significant. More adolescents with a history of forced sexual initiation who were HIV positive identified as stressors, life events related to medical care and body images (p = 0.03) and loss and grief (p = 0.009). Adolescents reporting forced sexual initiation and HIV-negative status were significantly less likely to use religion as a coping strategy (OR: 0.28; 95% CI: 0.09-0.83). Conclusion History of forced sexual initiation and HIV status affected perception of events as stressors and use of specific coping strategies. Our study findings could inform best practice interventions and policies to prevent and address forced sexual initiation among adolescents in Nigeria and other countries.	[Folayan, Morenike Oluwatoyin] Obafemi Awolowo Univ, Inst Publ Hlth, Ife, Osun State, Nigeria; [Folayan, Morenike Oluwatoyin] Obafemi Awolowo Univ, Dept Child Dent Hlth, Ife, Osun State, Nigeria; [Harrison, Abigail] Brown Univ, Dept Behav & Social Sci, Sch Publ Hlth, Providence, RI 02912 USA; [Brown, Brandon] Univ Calif Riverside, Sch Med, Ctr Healthy Communities, Div Clin Sci, Riverside, CA 92521 USA; [Odetoyinbo, Morolake] Posit Act Treatment Access, Lagos, Nigeria; [Stockman, Jamila K.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, San Diego, CA 92103 USA; [Ajuwon, Ademola J.] Univ Ibadan, Dept Hlth Promot & Educ, Coll Med, Ibadan, Oyo State, Nigeria; [Caceres, Carlos F.] Univ Peruana Cayetano Heredia, Ctr Interdisciplinary Studies Sexual AIDS & Soc, SMP, Lima, Peru	Obafemi Awolowo University; Obafemi Awolowo University; Brown University; University of California System; University of California Riverside; University of California System; University of California San Diego; University of Ibadan; Universidad Peruana Cayetano Heredia	Folayan, MO (corresponding author), Obafemi Awolowo Univ, Inst Publ Hlth, Ife, Osun State, Nigeria.; Folayan, MO (corresponding author), Obafemi Awolowo Univ, Dept Child Dent Hlth, Ife, Osun State, Nigeria.	toyinukpong@yahoo.co.uk	DSILVA, BROOKE/HCI-4879-2022; Stockman, Jamila/AAK-8960-2020; Folayan, Morenike/A-8632-2018	Folayan, Morenike/0000-0002-9008-7730; Caceres, Carlos F./0000-0002-8101-0790	BIARI, Brown University, USA; Ford Foundation, Nigeria; National Institutes of Health [K01DA031593]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA031593] Funding Source: NIH RePORTER	BIARI, Brown University, USA; Ford Foundation, Nigeria; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by BIARI, Brown University, USA to MOF and the Ford Foundation, Nigeria to MO. JKS was supported by the National Institutes of Health (Grant #K01DA031593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BIARI, Brown University, USA, provided support for the corresponding author to spend time in the university to conduct data analysis and manuscript writing. Funding for the primary study was received by Morolake Odetoyinbo from the Ford Foundation, Nigeria. Dr. Stockman was supported by the National Institutes of Health (Grant #K01DA031593). We acknowledge Dr Bimbo Philips, who assisted with the statistical analysis and Victoria Zolfaghari who assisted with reviewing and editing the paper.	Aboki H, 2014, AFR J REPROD HEALTH, V18, P109; Ajuwon AJ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-310; Allen S., 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Bal S, 2003, CHILD ABUSE NEGLECT, V27, P1377, DOI 10.1016/j.chiabu.2003.06.002; Bal S, 2003, CHILD ABUSE NEGLECT, V27, P883, DOI 10.1016/S0145-2134(03)00137-6; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Bloomberg, 2015, MOST STRESS OUT COUN; Caceres CF, 2000, J ADOLESCENT HEALTH, V27, P361, DOI 10.1016/S1054-139X(00)00096-3; Camara M, 2017, INT J ADOLESC YOUTH, V22, P123, DOI 10.1080/02673843.2013.875480; Campbell JC, 2013, AM J REPROD IMMUNOL, V69, P41, DOI 10.1111/aji.12026; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; CLEEN Foundation, NAT CRIM VICT SURV 2; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; COMPAS BE, 1993, J ADOLESCENCE, V16, P331, DOI 10.1006/jado.1993.1028; Croll J., 2005, GUUIDELINES ADOLESCE; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Fawole OI, 2002, HEALTH EDUC, V102, P230, DOI [DOI 10.1108/09654280210444100, 10.1108/09654280210444100]; Federal Ministry of Health, 2010, TECHN REP 2010 NAT H; Federal Ministry of Health, 2005, NAT HIV AIDS REPR HL; Federal Ministry of Health, 2007, NAT HIV AIDS REPR HL; Federal Ministry of Health, 2010, HIV STI INT BIOL BEH; Federal Ministry of Health, 2008, HIV STI INT BIOL BEH; Folayan MO, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.26356; Folayan MO, 2014, AFR J REPROD HEALTH, V18, P93; Folayan MO, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-83; Folayan MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129106; FOLKMAN S, 1984, J PERS SOC PSYCHOL, V46, P839, DOI 10.1037/0022-3514.46.4.839; FRAZIER PA, 1994, J COUNS DEV, V72, P633, DOI 10.1002/j.1556-6676.1994.tb01694.x; Garcia-Moreno C, 2015, LANCET, V385, P1685, DOI 10.1016/S0140-6736(14)61830-4; Gospodarevskaya E, 2013, J CHILD SEX ABUS, V22, P277, DOI 10.1080/10538712.2013.743953; Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717; Heger A, 2002, CHILD ABUSE NEGLECT, V26, P645, DOI 10.1016/S0145-2134(02)00339-3; Heise L., 1995, SEXUAL COERCION REPR; Homma Y, 2012, J ADOLESCENT HEALTH, V51, P18, DOI 10.1016/j.jadohealth.2011.12.032; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Jackson S, 1978, WOMENS STUDIES INT Q, V1, P27, DOI 10.1016/s0148-0685(78)90311-1; Jewkes R., 2012, Journal of AIDS and Clinical Research, V3, P158; Jewkes R, 2015, LANCET, V385, P1580, DOI 10.1016/S0140-6736(14)61683-4; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024256; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; JOHNSON BK, 1991, CHILD ABUSE NEGLECT, V15, P293, DOI 10.1016/0145-2134(91)90073-M; Klot JF, 2013, AM J REPROD IMMUNOL, V69, P5, DOI 10.1111/aji.12033; Lazarus R.S., 1991, EMOTION ADAPTATION; Lazarus R.S., 1984, EMOTION ADAPTATION; Leiner AS, 2012, J CONSULT CLIN PSYCH, V80, P317, DOI 10.1037/a0026814; Madigan S, 2014, CHILD ABUSE NEGLECT, V38, P1160, DOI 10.1016/j.chiabu.2014.04.002; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Murphy DA, 2000, J ADOLESCENT HEALTH, V27, P391, DOI 10.1016/S1054-139X(00)00158-0; NAMIR S, 1987, J APPL SOC PSYCHOL, V17, P309, DOI 10.1111/j.1559-1816.1987.tb00316.x; National Agency for the Control of AIDS, 2013, PRES COMPR RESP PLAN; NICHOLSON WD, 1990, J CONSULT CLIN PSYCH, V58, P873, DOI 10.1037/0022-006X.58.6.873; Nigerian Population Commission, 2013, NIG DEM HLTH SURV; Odimegwu C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-465; Okigbo CLC, 2014, AFR J REPROD HEALTH, V18, P133; Positive Action for Treatment Access, 2013, SEX REPR HLTH NEEDS; Raj A, 2000, Matern Child Health J, V4, P125, DOI 10.1023/A:1009526422148; Silverman JG, 2015, JAMA-J AM MED ASSOC, V314, P516, DOI 10.1001/jama.2015.7376; Sloan-Power EM, 2013, J INTERPERS VIOLENCE, V28, P1741, DOI 10.1177/0886260512469101; Springer KW, 2003, J GEN INTERN MED, V18, P864, DOI 10.1046/j.1525-1497.2003.20918.x; Stock JL., 2000, MATERN CHILD HLTH J, V4, P125, DOI [10.1023/A:1009526422148, DOI 10.1023/A:1009526422148]; Stockman JK, 2013, AIDS BEHAV, V17, P832, DOI 10.1007/s10461-012-0361-4; Temmerman M, 2015, LANCET, V385, pE38, DOI 10.1016/S0140-6736(14)61840-7; Thompson NJ, 1997, CHILD ABUSE NEGLECT, V21, P149, DOI 10.1016/S0145-2134(96)00140-8; Vickerman KA, 2009, CLIN PSYCHOL REV, V29, P431, DOI 10.1016/j.cpr.2009.04.004; Widom CS, 1999, AM J PSYCHIAT, V156, P1223; WOLF TM, 1991, J CLIN PSYCHIAT, V52, P171; World Health Organization, 2012, WHORHR1237	69	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155210	10.1371/journal.pone.0155210	http://dx.doi.org/10.1371/journal.pone.0155210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8BN	27163436	Green Submitted, Green Published, gold			2022-12-27	WOS:000376585700008
J	Shen, HC; Wei, JY; Chu, SY; Chung, PC; Hsu, TC; Yu, HH				Shen, Hung-Chang; Wei, Jia-Yi; Chu, Sao-Yu; Chung, Pei-Chi; Hsu, Tsai-Chi; Yu, Hung-Hsiang			Morphogenetic Studies of the Drosophila DA1 Ventral Olfactory Projection Neuron	PLOS ONE			English	Article							ANTENNAL LOBE; ORGANIZATION; SPECIFICITY; EXPRESSION; SYSTEM; BRAIN; TOOLS; DSCAM; MAP	In the Drosophila olfactory system, odorant information is sensed by olfactory sensory neurons and relayed from the primary olfactory center, the antennal lobe (AL), to higher olfactory centers via olfactory projection neurons (PNs). A major portion of the AL is constituted with dendrites of four groups of PNs, anterodorsal PNs (adPNs), lateral PNs (lPNs), lateroventral PNs (lvPNs) and ventral PNs (vPNs). Previous studies have been focused on the development and function of adPNs and lPNs, while the investigation on those of lvPNs and vPNs received less attention. Here, we study the molecular and cellular mechanisms underlying the morphogenesis of a putative male-pheromone responding vPN, the DA1 vPN. Using an intersection strategy to remove background neurons labeled within a DA1 vPN-containing GAL4 line, we depicted morphological changes of the DA1 vPN that occurs at the pupal stage. We then conducted a pilot screen using RNA interference knock-down approach to identify cell surface molecules, including Down syndrome cell adhesion molecule 1 and Semaphorin-1a, that might play essential roles for the DA1 vPN morphogenesis. Taken together, by revealing molecular and cellular basis of the DA1 vPN morphogenesis, we should provide insights into future comprehension of how vPNs are assembled into the olfactory neural circuitry.	[Shen, Hung-Chang; Wei, Jia-Yi; Chu, Sao-Yu; Chung, Pei-Chi; Hsu, Tsai-Chi; Yu, Hung-Hsiang] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Shen, Hung-Chang; Yu, Hung-Hsiang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Yu, HH (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.; Yu, HH (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	samhhyu@gate.sinica.edu.tw	Yu, Hung-Hsiang/AGP-0497-2022	Yu, Hung-Hsiang/0000-0002-2430-9251; Chu, Sao-Yu/0000-0002-5295-1663; Chu, Sao-Yu/0000-0002-0663-9492	Ministry of Science and Technology [MOST103-2321-B-001-023]; Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan; Ministry of Science and Technology, Taiwan [MOST103-2321-B-001-023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Ministry of Science and Technology, Taiwan grant# MOST103-2321-B-001-023 (https://www.most.gov.tw/?l=ch). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing the transgenic RNAi fly stocks used in this study. This work was supported by the Ministry of Science and Technology (MOST103-2321-B-001-023) and the Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan.	Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Hong WZ, 2014, GENETICS, V196, P17, DOI 10.1534/genetics.113.154336; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Missaire M, 2015, DEV NEUROBIOL, V75, P569, DOI 10.1002/dneu.22267; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Shi L, 2007, J NEUROSCI, V27, P6723, DOI 10.1523/JNEUROSCI.1517-07.2007; Sweeney LB, 2011, NEURON, V72, P734, DOI 10.1016/j.neuron.2011.09.026; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu HH, 2013, CURR BIOL, V23, P633, DOI 10.1016/j.cub.2013.02.057; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	21	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155384	10.1371/journal.pone.0155384	http://dx.doi.org/10.1371/journal.pone.0155384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163287	Green Submitted, Green Published, gold			2022-12-27	WOS:000376585700030
J	Upadhyay, SK; Singh, H; Dixit, S; Mendu, V; Verma, PC				Upadhyay, Santosh Kumar; Singh, Harpal; Dixit, Sameer; Mendu, Venugopal; Verma, Praveen C.			Molecular Characterization of Vitellogenin and Vitellogenin Receptor of Bemisia tabaci	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; RNA INTERFERENCE; FAMILIAL HYPERCHOLESTEROLEMIA; COCKROACH; GENES; CLONING; SILKWORM; SEQUENCE; CALCIUM	Vitellogenin (Vg) plays vital role in oocytes and embryo development in insects. Vg is synthesized in the fat body, moves through haemolymph and accumulates in oocytes. Vitellogenin receptors (VgR) present on the surface of oocytes, are responsible for Vg transportation from haemolymph to oocytes. Here, we cloned and characterized these genes from Bemisia tabaci Asia1 (BtA1) species. The cloned BtA1Vg and BtA1VgR genes consisted of 6,330 and 5,430 bp long open reading frames, which encoded 2,109 and 1,809 amino acid (AA) residues long protein. The BtA1Vg protein comprised LPD_N, DUF1943 and VWFD domains, typical R/KXXR/K, DGXR and GL/ICG motifs, and polyserine tracts. BtA1VgR protein contained 12 LDLa, 10 LDLb and 7 EGF domains, and a trans-membrane and cytoplasmic region at C-terminus. Phylogenetic analyses indicated evolutionary association of BtA1Vg and BtA1VgR with the homologous proteins from various insect species. Silencing of BtA1VgR by siRNA did not affect the transcript level of BtA1Vg. However, BtA1Vg protein accumulation in oocytes was directly influenced with the expression level of BtA1VgR. Further, BtA1VgR silencing caused significant mortality and reduced fecundity in adult white-flies. The results established the role of BtA1VgR in transportation of BtA1Vg in oocytes. Further, these proteins are essential for fecundity, and therefore these can be potential RNAi targets for insect control in crop plants.	[Upadhyay, Santosh Kumar] Panjab Univ, Dept Bot, Chandigarh 160014, India; [Singh, Harpal; Dixit, Sameer; Verma, Praveen C.] CSIR, CSIR Natl Bot Res Inst, Rana Pratap Marg, Lucknow 226001, Uttar Pradesh, India; [Mendu, Venugopal] Texas Tech Univ, Dept Plant & Soil Sci, FBRI, Food Technol Bldg, Lubbock, TX 79409 USA	Panjab University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Texas Tech University System; Texas Tech University	Upadhyay, SK (corresponding author), Panjab Univ, Dept Bot, Chandigarh 160014, India.; Verma, PC (corresponding author), CSIR, CSIR Natl Bot Res Inst, Rana Pratap Marg, Lucknow 226001, Uttar Pradesh, India.	santoshpandit16@gmail.com; praveencverma@nbri.res.in	Mendu, Venugopal/O-5072-2018; Upadhyay, Santosh/ABD-2302-2020; Verma, Praveen C/F-9709-2010	Mendu, Venugopal/0000-0002-4985-2672; Upadhyay, Santosh/0000-0001-6991-0502; Verma, Praveen C/0000-0002-3732-0564	CSIR-EMPOWER Project, Council of Scientific and Industrial Research CSIR, New Delhi, India [OLP0078]; DST, India	CSIR-EMPOWER Project, Council of Scientific and Industrial Research CSIR, New Delhi, India; DST, India(Department of Science & Technology (India))	PCV received the CSIR-EMPOWER Project (OLP0078), Council of Scientific and Industrial Research CSIR, New Delhi, India. SKU is thankful to DST, India for a DST-INSPIRE Faculty fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Grant from CSIR-EMPOWER Project (OLP0078), Council of Scientific and Industrial Research CSIR, New Delhi, India is acknowledged. Authors are thankful to Panjab University, Chandigarh, India and CSIR-NBRI, Lucknow, India for providing research facility. SKU is thankful to DST, India for DST-INSPIRE Faculty fellowship.	Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; Babin PJ, 1999, J MOL EVOL, V49, P150, DOI 10.1007/PL00006528; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Chen ME, 2004, INSECT MOL BIOL, V13, P195, DOI 10.1111/j.0962-1075.2004.00477.x; Cheng Lu, 2013, Acta Entomologica Sinica, V56, P584; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; DHADIALLA TS, 1992, INSECT BIOCHEM MOLEC, V22, P803, DOI 10.1016/0965-1748(92)90107-P; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Goulas A, 1996, J PROTEIN CHEM, V15, P1, DOI 10.1007/BF01886805; Guo JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043567; Hagedorn HH, 1998, ADVINSECT PHYSL UK; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Houndete TA, 2010, PEST MANAG SCI, V66, P1181, DOI 10.1002/ps.2008; Krishnan M., 2008, Journal of Endocrinology and Reproduction, V12, P13; Lin Y, 2004, ACTA ZOOL SINICA, V51, P117; Lin Y, 2013, J BIOL CHEM, V288, P13345, DOI 10.1074/jbc.M113.462556; Liu QN, 2011, B INSECTOL, V64, P167; Lu K, 2015, J INSECT PHYSIOL, V73, P20, DOI 10.1016/j.jinsphys.2015.01.007; Noriega FG, 2014, JUVENILE HORMONE BIO; Palumbo JC, 2001, CROP PROT, V20, P739, DOI 10.1016/S0261-2194(01)00117-X; Qian C, 2013, AFRIC J BIOTECH, V10, P996; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; Sappington TW, 1996, P NATL ACAD SCI USA, V93, P8934, DOI 10.1073/pnas.93.17.8934; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Sappington TW, 2005, SCIENCE, P229; SCHONBAUM CP, 1995, P NATL ACAD SCI USA, V92, P1485, DOI 10.1073/pnas.92.5.1485; Shu YH, 2011, INSECT MOL BIOL, V20, P61, DOI 10.1111/j.1365-2583.2010.01054.x; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Taborsky G, J INORG BIOCH, V44, P65; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Tufail M, 2005, INSECT MOL BIOL, V14, P389, DOI 10.1111/j.1365-2583.2005.00570.x; Tufail M, 2002, INSECT BIOCHEM MOLEC, V32, P1469, DOI 10.1016/S0965-1748(02)00067-X; Tufail M, 2001, ARCH INSECT BIOCHEM, V48, P72, DOI 10.1002/arch.1059; Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Tufail M, 2007, INSECT BIOCHEM MOLEC, V37, P235, DOI 10.1016/j.ibmb.2006.11.007; Tufail M, 2014, ENTOMOL SCI, V17, P269, DOI 10.1111/ens.12086; Upadhyay SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126751; Upadhyay SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083692; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Upadhyay SK, 2010, PROTEOMICS, V10, P4431, DOI 10.1002/pmic.201000152; Van Antwerpen R, 2005, REPRO BIOL, V12, P265; Vassiliou V, 2011, INSECT SCI, V18, P30, DOI 10.1111/j.1744-7917.2010.01387.x; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Zhong R, 2015, INT J MOL SCI, V16, P4759, DOI 10.3390/ijms16034759	52	54	59	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155306	10.1371/journal.pone.0155306	http://dx.doi.org/10.1371/journal.pone.0155306			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159161	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700056
J	Savage, RD; Fowler, RA; Rishu, AH; Bagshaw, SM; Cook, D; Dodek, P; Hall, R; Kumar, A; Lamontagne, F; Lauzier, F; Marshall, J; Martin, CM; McIntyre, L; Muscedere, J; Reynolds, S; Stelfox, HT; Daneman, N				Savage, Rachel D.; Fowler, Robert A.; Rishu, Asgar H.; Bagshaw, Sean M.; Cook, Deborah; Dodek, Peter; Hall, Richard; Kumar, Anand; Lamontagne, Francois; Lauzier, Francois; Marshall, John; Martin, Claudio M.; McIntyre, Lauralyn; Muscedere, John; Reynolds, Steven; Stelfox, Henry T.; Daneman, Nick			The Effect of Inadequate Initial Empiric Antimicrobial Treatment on Mortality in Critically Ill Patients with Bloodstream Infections: A Multi-Centre Retrospective Cohort Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ANTIFUNGAL THERAPY; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; RISK-FACTORS; CANDIDEMIA; OUTCOMES; MANAGEMENT; DIAGNOSIS; DISEASE	Hospital mortality rates are elevated in critically ill patients with bloodstream infections. Given that mortality may be even higher if appropriate treatment is delayed, we sought to determine the effect of inadequate initial empiric treatment on mortality in these patients. A retrospective cohort study was conducted across 13 intensive care units in Canada. We defined inadequate initial empiric treatment as not receiving at least one dose of an antimicrobial to which the causative pathogen(s) was susceptible within one day of initial blood culture. We evaluated the association between inadequate initial treatment and hospital mortality using a random effects multivariable logistic regression model. Among 1,190 patients (1,097 had bacteremia and 93 had candidemia), 476 (40%) died and 266 (22%) received inadequate initial treatment. Candidemic patients more often had inadequate initial empiric therapy (64.5% versus 18.8%), as well as longer delays to final culture results (4 vs 3 days) and appropriate therapy (2 vs 0 days). After adjustment, there was no detectable association between inadequate initial treatment and mortality among bacteremic patients (Odds Ratio (OR): 1.02, 95% Confidence Interval (CI) 0.70-1.48); however, candidemic patients receiving inadequate treatment had nearly three times the odds of death (OR: 2.89, 95% CI: 1.05-7.99). Inadequate initial empiric antimicrobial treatment was not associated with increased mortality in bacteremic patients, but was an important risk factor in the subgroup of candidemic patients. Further research is warranted to improve early diagnostic and risk prediction methods in candidemic patients.	[Savage, Rachel D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Savage, Rachel D.; Fowler, Robert A.; Rishu, Asgar H.; Daneman, Nick] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Fowler, Robert A.] Univ Toronto, Dept Med, Div Crit Care Med, Toronto, ON, Canada; [Fowler, Robert A.; Daneman, Nick] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bagshaw, Sean M.] Univ Alberta, Fac Med & Dent, Div Crit Care Med, Edmonton, AB, Canada; [Cook, Deborah] McMaster Univ, Dept Med Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Dodek, Peter; Reynolds, Steven] Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Dodek, Peter] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada; [Hall, Richard] Dalhousie Univ, Fac Med, Dept Crit Care Med, Halifax, NS, Canada; [Hall, Richard] Nova Scotia Hlth Author, Halifax, NS, Canada; [Kumar, Anand] Univ Manitoba, Dept Med, Sect Crit Care Med, Winnipeg, MB, Canada; [Kumar, Anand] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Kumar, Anand] Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada; [Lamontagne, Francois] CHU Sherbrooke, Ctr Rech, Sherbrooke, PQ J1H 5N4, Canada; [Lamontagne, Francois] Univ Sherbrooke, Serv Med Interne, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Lauzier, Francois] Univ Laval, CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada; [Lauzier, Francois] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Lauzier, Francois] Univ Laval, Dept Aanesthesiol & Soins Intensifs, Quebec City, PQ, Canada; [Marshall, John] St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Marshall, John] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Martin, Claudio M.] Univ Western Ontario, Dept Med, London, ON, Canada; [Martin, Claudio M.] London Hlth Sci Ctr, Crit Care, London, ON, Canada; [McIntyre, Lauralyn] Ottawa Hosp, Div Crit Care, Dept Med, Ottawa, ON, Canada; [Muscedere, John] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Muscedere, John] Kingston Gen Hosp, Dept Crit Care Med, Kingston, ON K7L 2V7, Canada; [Stelfox, Henry T.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Daneman, Nick] Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada; [Daneman, Nick] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Alberta; McMaster University; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; Dalhousie University; University of Manitoba; University of Manitoba; University of Manitoba; University of Sherbrooke; University of Sherbrooke; Laval University; Laval University; Laval University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Western University (University of Western Ontario); London Health Sciences Centre; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada; Queens University - Canada; University of Calgary; University of Toronto; University of Toronto	Daneman, N (corresponding author), Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada.; Daneman, N (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Daneman, N (corresponding author), Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada.; Daneman, N (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	Nick.Daneman@sunnybrook.ca	Muscedere, John/AAH-9291-2021; Martin, Claudio/G-3327-2011; Lauzier, Francois/B-9237-2015	Lauzier, Francois/0000-0002-6530-5513; Stelfox, Henry/0000-0003-1231-1490; McIntyre, Lauren/0000-0002-0077-3359; Lamontagne, Francois/0000-0002-0360-3427	Ontario Ministry of Health; Long-Term Care Academic Health Sciences Alternate Funding Plan Innovation Fund Award; Physician Services Incorporated of Ontario; Canadian Institute of Health Research; Heart and Stroke Foundation (Ontario); Fonds de recherche du Quebec-Sante; Alberta Innovates - Health Solution	Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Long-Term Care Academic Health Sciences Alternate Funding Plan Innovation Fund Award; Physician Services Incorporated of Ontario; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation (Ontario)(Heart & Stroke Foundation of CanadaHeart & Stroke Foundation of Ontario); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Alberta Innovates - Health Solution	This multicentre observational study was supported by operating funds from the Ontario Ministry of Health and Long-Term Care Academic Health Sciences Alternate Funding Plan Innovation Fund Award (https://ifpoc.org/), and a research grant of Physician Services Incorporated of Ontario (http://psifoundation.org/ForApplicants/HealthResearchGrants.php). ND is supported by a Clinician Scientist salary award from the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca). DC is a Chair of the Canadian Institutes of Health Research. RAF is supported by a Clinician Scientist salary award from the Heart and Stroke Foundation (Ontario). F. Lauzier and F. Lamontagne hold a career award from the Fonds de recherche du Quebec-Sante. SMB holds a Canada Research Chair in Critical Care Nephrology and an Independent Investigator Award from Alberta Innovates - Health Solution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2011, DIAGN MICR INFEC DIS, V69, P307, DOI 10.1016/j.diagmicrobio.2010.10.026; Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; Avni T, 2011, J CLIN MICROBIOL, V49, P665, DOI 10.1128/JCM.01602-10; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Bloos F, 2013, J CRIT CARE, V28, P2, DOI 10.1016/j.jcrc.2012.07.011; Chahoud J, 2013, INT J ANTIMICROB AG, V42, pS29, DOI 10.1016/j.ijantimicag.2013.04.008; Daneman N, 2015, CRIT CARE M IN PRESS; de Smet AMGA, 2011, LANCET INFECT DIS, V11, P372, DOI 10.1016/S1473-3099(11)70035-4; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Garrouste-Orgeas M, 2006, CLIN INFECT DIS, V42, P1118, DOI 10.1086/500318; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Harbarth S, 2002, ARCH SURG-CHICAGO, V137, P1353, DOI 10.1001/archsurg.137.12.1353; Harbarth S, 2002, ARCH SURG, V137, P1359; Hranjec T, 2012, LANCET INFECT DIS, V12, P774, DOI 10.1016/S1473-3099(12)70151-2; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kollef M, 2012, CLIN INFECT DIS, V54, P1739, DOI 10.1093/cid/cis305; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Laupland KB, 2006, J HOSP INFECT, V63, P124, DOI 10.1016/j.jhin.2005.12.016; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; McGregor JC, 2007, CLIN INFECT DIS, V45, P329, DOI 10.1086/519283; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Muskett H, 2011, CRIT CARE, V15, DOI 10.1186/cc10574; Odabasi Z, 2004, CLIN INFECT DIS, V39, P199, DOI 10.1086/421944; Parkins MD, 2007, J ANTIMICROB CHEMOTH, V60, P613, DOI 10.1093/jac/dkm212; Peralta G, 2007, J ANTIMICROB CHEMOTH, V60, P855, DOI 10.1093/jac/dkm279; Posteraro B, 2011, CRIT CARE, V15, DOI 10.1186/cc10507; Ramphal R, 2005, CHEMOTHERAPY, V51, P171, DOI 10.1159/000086574; Sader HS, 2014, DIAGN MICR INFEC DIS, V78, P443, DOI 10.1016/j.diagmicrobio.2013.11.025; Schuster MG, 2008, ANN INTERN MED, V149, P83, DOI 10.7326/0003-4819-149-2-200807150-00004; Sexton DJ, 2011, CRIT CARE MED, V39, P199, DOI 10.1097/CCM.0b013e318202e68f; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Thom KA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-116; Tumbarello M, 2007, J CLIN MICROBIOL, V45, P1843, DOI 10.1128/JCM.00131-07; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vittinghoff E, 2012, REGRESSION METHODS B; Zaragoza R, 2003, CLIN MICROBIOL INFEC, V9, P412, DOI 10.1046/j.1469-0691.2003.00656.x; Zilberberg MD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-150; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zimmerli W, 2010, NEW ENGL J MED, V362, P1022, DOI 10.1056/NEJMcp0910753	41	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154944	10.1371/journal.pone.0154944	http://dx.doi.org/10.1371/journal.pone.0154944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152615	Green Published, gold, Green Submitted			2022-12-27	WOS:000375677000049
J	Xue, T; Song, CN; Wang, Q; Wang, Y; Chen, G				Xue, Tuo; Song, Chunnian; Wang, Qing; Wang, Yan; Chen, Guangju			Investigations of the CLOCK and BMAL1 Proteins Binding to DNA: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							AMBER FORCE-FIELD; LOOP-HELIX DOMAIN; E-BOX; CRYSTAL-STRUCTURE; DIFFERENTIAL REGULATION; CONTINUUM SOLVENT; RESPONSE ELEMENT; GENE-EXPRESSION; MESSENGER-RNA; FREE-ENERGIES	The circadian locomotor output cycles kaput (CLOCK), and brain and muscle ARNT-like 1 (BMAL1) proteins are important transcriptional factors of the endogenous circadian clock. The CLOCK and BMAL1 proteins can regulate the transcription-translation activities of the clock-related genes through the DNA binding. The hetero-/homo-dimerization and DNA combination of the CLOCK and BMAL1 proteins play a key role in the positive and negative transcriptional feedback processes. In the present work, we constructed a series of binary and ternary models for the bHLH/bHLH-PAS domains of the CLOCK and BMAL1 proteins, and the DNA molecule, and carried out molecular dynamics simulations, free energy calculations and conformational analysis to explore the interaction properties of the CLOCK and BMAL1 proteins with DNA. The results show that the bHLH domains of CLOCK and BMAL1 can favorably form the heterodimer of the bHLH domains of CLOCK and BMAL1 and the homodimer of the bHLH domains of BMAL1. And both dimers could respectively bind to DNA at its H1-H1 interface. The DNA bindings of the H1 helices in the hetero- and homo-bHLH dimers present the rectangular and diagonal binding modes, respectively. Due to the function of the alpha-helical forceps in these dimers, the tight gripping of the H1 helices to the major groove of DNA would cause the decrease of interactions at the H1-H2 interfaces in the CLOCK and BMAL1 proteins. The additional PAS domains in the CLOCK and BMAL1 proteins affect insignificantly the interactions of the CLOCK and BMAL1 proteins with the DNA molecule due to the flexible and long loop linkers located at the middle of the PAS and bHLH domains. The present work theoretically explains the interaction mechanisms of the bHLH domains of the CLOCK and BMAL1 proteins with DNA.	[Xue, Tuo; Song, Chunnian; Wang, Qing; Wang, Yan; Chen, Guangju] Beijing Normal Univ, Coll Chem, Key Lab Theoret & Computat Photochem, Minist Educ, Beijing 100875, Peoples R China	Beijing Normal University	Wang, Y; Chen, G (corresponding author), Beijing Normal Univ, Coll Chem, Key Lab Theoret & Computat Photochem, Minist Educ, Beijing 100875, Peoples R China.	wangy@bnu.edu.cn; gjchen@bnu.edu.cn			National Science Foundation of China [21271029, 21131003, 21073015, 21573020]; Major State Basic Research Development Programs [2011CB808500]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Programs(National Basic Research Program of China)	The authors acknowledge research support from the National Science Foundation of China (Nos. 21271029, 21131003, 21073015, and 21573020), and the Major State Basic Research Development Programs (Grant No. 2011CB808500).	Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bose S, 2010, ENDOCRINOLOGY, V151, P2287, DOI 10.1210/en.2009-1252; Bouard C, 2014, J BIOMOL STRUCT DYN, V32, P226, DOI 10.1080/07391102.2012.762722; Branden C., 1999, INTRO PROTEIN STRUCT; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Case D. A., 2006, AMBER 9; Chapman-Smith A, 2004, J BIOL CHEM, V279, P5353, DOI 10.1074/jbc.M310041200; Chaudhary J, 1999, MOL ENDOCRINOL, V13, P774, DOI 10.1210/me.13.5.774; Cheatham TE, 1998, J BIOMOL STRUCT DYN, V16, P265, DOI 10.1080/07391102.1998.10508245; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Gao X, 2012, BIOPHYS J, V102, P2149, DOI 10.1016/j.bpj.2012.03.042; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Huffman JL, 2001, J BIOL CHEM, V276, P40537, DOI 10.1074/jbc.M105675200; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; Jayaram B, 1998, J AM CHEM SOC, V120, P10629, DOI 10.1021/ja981307p; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Li CQ, 2014, J PHYS CHEM B, V118, P1273, DOI 10.1021/jp411111g; Maia AM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-184; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Michel G, 1999, THEOR CHEM ACC, V101, P51, DOI 10.1007/s002140050405; Nome RA, 2007, P NATL ACAD SCI USA, V104, P20799, DOI 10.1073/pnas.0701281105; Oishi K, 2000, BIOCHEM BIOPH RES CO, V268, P164, DOI 10.1006/bbrc.1999.2054; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pandini A, 2005, PROTEIN ENG DES SEL, V18, P127, DOI 10.1093/protein/gzi017; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sheyn D, 2010, ADV DRUG DELIVER REV, V62, P683, DOI 10.1016/j.addr.2010.01.002; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Sokkar P, 2012, J MOL MODEL, V18, P1691, DOI 10.1007/s00894-011-1150-0; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Steeves TDL, 1999, GENOMICS, V57, P189, DOI 10.1006/geno.1998.5675; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ueshima T, 2012, GENE, V510, P118, DOI 10.1016/j.gene.2012.08.022; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Vreede J, 2003, J BIOL CHEM, V278, P18434, DOI 10.1074/jbc.M301701200; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang ZX, 2013, CELL RES, V23, P213, DOI 10.1038/cr.2012.170; Wibley J, 1996, BBA-PROTEIN STRUCT M, V1294, P138, DOI 10.1016/0167-4838(96)00008-8; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yang B, 2010, J PHYS CHEM B, V114, P16020, DOI 10.1021/jp1086416; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yap KL, 2002, VECTOR GEOMETRY MAPP, V2, P317; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zhao JM, 2006, P NATL ACAD SCI USA, V103, P11561, DOI 10.1073/pnas.0601567103; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	80	5	5	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155105	10.1371/journal.pone.0155105	http://dx.doi.org/10.1371/journal.pone.0155105			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153104	gold, Green Published			2022-12-27	WOS:000375677000071
J	Bojikian, KD; Chen, CL; Wen, JC; Zhang, QQ; Xin, C; Gupta, D; Mudumbai, RC; Johnstone, MA; Wang, RKK; Chen, PP				Bojikian, Karine D.; Chen, Chieh-Li; Wen, Joanne C.; Zhang, Qinqin; Xin, Chen; Gupta, Divakar; Mudumbai, Raghu C.; Johnstone, Murray A.; Wang, Ruikang K.; Chen, Philip P.			Optic Disc Perfusion in Primary Open Angle and Normal Tension Glaucoma Eyes Using Optical Coherence Tomography-Based Microangiography	PLOS ONE			English	Article							VISUAL-FIELD DEFECTS; BLOOD-FLOW; FLUORESCEIN ANGIOGRAPHY; NERVE HEAD; INTRAOCULAR-PRESSURE; LATANOPROST; ASSOCIATION; VELOCITY; RETINA; DAMAGE	Purpose To investigate optic disc perfusion differences in normal, primary open-angle glaucoma (POAG), and normal tension glaucoma (NTG) eyes using optical microangiography (OMAG) based optical coherence tomography (OCT) angiography technique. Design Cross-sectional, observational study. Subjects Twenty-eight normal, 30 POAG, and 31 NTG subjects. Methods One eye from each subject was scanned with a 68 kHz Cirrus HD-OCT 5,000-based OMAG prototype system centered at the optic nerve head (ONH) (Carl Zeiss Meditec Inc, Dublin, CA). Microvascular images were generated from the OMAG dataset by detecting the differences in OCT signal between consecutive B-scans. The pre-laminar layer (preLC) was isolated by a semi-automatic segmentation program. Main Outcome Measures Optic disc perfusion, quantified as flux, vessel area density, and normalized flux (flux normalized by the vessel area) within the ONH. Results Glaucomatous eyes had significantly lower optic disc perfusion in preLC in all three perfusion metrics (p<0.0001) compared to normal eyes. The visual field (VF) mean deviation ( MD) and pattern standard deviation (PSD) were similar between the POAG and NTG groups, and no differences in optic disc perfusion were observed between POAG and NTG. Univariate analysis revealed significant correlation between optic disc perfusion and VF MD, VF PSD, and rim area in both POAG and NTG groups (p <= 0.0288). However, normalized optic disc perfusion was correlated with some structural measures (retinal nerve fiber layer thickness and ONH cup/disc ratio) only in POAG eyes. Conclusions Optic disc perfusion detected with OMAG was significantly reduced in POAG and NTG groups compared to normal controls, but no difference was seen between POAG and NTG groups with similar levels of VF damage. Disc perfusion was significantly correlated with VF MD, VF PSD, and rim area in glaucomatous eyes. Vascular changes at the optic disc as measured using OMAG may provide useful information for diagnosis and monitoring of glaucoma.	[Bojikian, Karine D.; Chen, Chieh-Li; Wen, Joanne C.; Gupta, Divakar; Mudumbai, Raghu C.; Johnstone, Murray A.; Wang, Ruikang K.; Chen, Philip P.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Chen, Chieh-Li; Zhang, Qinqin; Xin, Chen; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Xin, Chen] Capital Med Univ, Beijing Anzhen Hosp, Dept Ophthalmol, Beijing, Peoples R China	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Capital Medical University	Chen, PP (corresponding author), Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.	pchen@uw.edu	Johnstone, Murray/ABG-3511-2020; Wang, Ruikang/L-3889-2019	Johnstone, Murray/0000-0003-2136-2433; Wang, Ruikang/0000-0001-5169-8822; Chen, Philip/0000-0001-9558-9492	National Institutes of Health [NEI R01-EY024158]; Carl Zeiss Meditec Inc.; Research to Prevent Blindness (New York, NY); NATIONAL EYE INSTITUTE [R01EY024158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl Zeiss Meditec Inc.; Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by the National Institutes of Health contract NEI R01-EY024158; Carl Zeiss Meditec Inc.; Research to Prevent Blindness (New York, NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116018; An L, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3642638; CAPRIOLI J, 1984, AM J OPHTHALMOL, V97, P730, DOI 10.1016/0002-9394(84)90505-1; CAPRIOLI J, 1985, ARCH OPHTHALMOL-CHIC, V103, P1145; DRANCE SM, 1988, AM J OPHTHALMOL, V105, P35, DOI 10.1016/0002-9394(88)90118-3; FAZIO P, 1990, ARCH OPHTHALMOL-CHIC, V108, P705, DOI 10.1001/archopht.1990.01070070091042; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Flammer J, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-14; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; GASSER P, 1991, AM J OPHTHALMOL, V111, P585, DOI 10.1016/S0002-9394(14)73703-1; HAMARD P, 1994, BRIT J OPHTHALMOL, V78, P449, DOI 10.1136/bjo.78.6.449; HITCHINGS RA, 1983, BRIT J OPHTHALMOL, V67, P818, DOI 10.1136/bjo.67.12.818; HITCHINGS RA, 1977, BRIT J OPHTHALMOL, V61, P126, DOI 10.1136/bjo.61.2.126; Huber K, 2004, ACTA OPHTHALMOL SCAN, V82, P426, DOI 10.1111/j.1395-3907.2004.00269.x; Ishibashi S, 2006, J GLAUCOMA, V15, P354, DOI 10.1097/01.ijg.0000212264.96864.3e; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; KING D, 1986, AM J OPHTHALMOL, V101, P204, DOI 10.1016/0002-9394(86)90596-9; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Kurita N, 2006, JPN J OPHTHALMOL, V50, P547, DOI 10.1007/s10384-006-0375-4; Leibovitch I, 2005, J GLAUCOMA, V14, P384, DOI 10.1097/01.ijg.0000176932.06606.6e; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; LEWIS RA, 1983, AM J OPHTHALMOL, V96, P148, DOI 10.1016/S0002-9394(14)77781-5; Liu CJL, 2002, OPHTHALMOLOGY, V109, P2241, DOI 10.1016/S0161-6420(02)01247-2; MOTOLKO M, 1982, ARCH OPHTHALMOL-CHIC, V100, P1074, DOI 10.1001/archopht.1982.01030040052005; Mozaffarieh M, 2013, CURR OPIN PHARMACOL, V13, P43, DOI 10.1016/j.coph.2012.10.001; Oettli A, 2011, J GLAUCOMA, V20, P303, DOI 10.1097/IJG.0b013e3181e666a1; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Reif R, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/509783; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; Shields MB, 2012, J GLAUCOMA, V21, P141, DOI 10.1097/IJG.0b013e31820719f6; SHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Sommer A, 2011, ARCH OPHTHALMOL-CHIC, V129, P785, DOI 10.1001/archophthalmol.2011.117; Stalmans I, 2009, EUR J OPHTHALMOL, V19, P580, DOI 10.1177/112067210901900410; Su WW, 2006, INVEST OPHTH VIS SCI, V47, P3390, DOI 10.1167/iovs.06-0024; Suzuki J, 2004, JPN J OPHTHALMOL, V48, P340, DOI 10.1007/s10384-004-0072-0; Thonginnetra O, 2010, J GLAUCOMA, V19, P151, DOI 10.1097/IJG.0b013e318193c45c; Tokunaga T, 2004, JPN J OPHTHALMOL, V48, P380, DOI 10.1007/s10384-003-0071-6; Wang RK, 2010, OPT LETT, V35, P1467, DOI 10.1364/OL.35.001467; Wang Y, 2009, BRIT J OPHTHALMOL, V93, P634, DOI 10.1136/bjo.2008.150276; YAMAZAKI Y, 1995, BRIT J OPHTHALMOL, V79, P732, DOI 10.1136/bjo.79.8.732; YANNUZZI LA, 1986, OPHTHALMOLOGY, V93, P611; Yaoeda K, 2003, ACTA OPHTHALMOL SCAN, V81, P253, DOI 10.1034/j.1600-0420.2003.00073.x; Yin X, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086020; Yousefi S, 2014, PHYS MED BIOL, V59, P6693, DOI 10.1088/0031-9155/59/22/6693; Yousefi S, 2013, BIOMED OPT EXPRESS, V4, P1214, DOI 10.1364/BOE.4.001214; Zhang AQ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.100901; Zhang QQ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.6.066008	48	89	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154691	10.1371/journal.pone.0154691	http://dx.doi.org/10.1371/journal.pone.0154691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149261	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800047
J	Chin, JH; Moon, YJ; Jo, JY; Han, YA; Kim, HR; Lee, EH; Choi, IC				Chin, Ji-Hyun; Moon, Young-Jin; Jo, Jun-Young; Han, Yun A.; Kim, Hyeong Ryul; Lee, Eun-Ho; Choi, In-Cheol			Association between Postoperatively Developed Atrial Fibrillation and Long-Term Mortality after Esophagectomy in Esophageal Cancer Patients: An Observational Study	PLOS ONE			English	Article							ANGIOTENSIN-II; THORACIC-SURGERY; RISK ANALYSIS; INFLAMMATION; ANTAGONIST; CARCINOMA; INDICATOR; OUTCOMES; HYPOXIA	Background Newly developed atrial fibrillation (AF) in patients who have undergone an esophagectomy increases the incidence of postoperative complications. However, the clinical implications of AF have not been fully elucidated in these patients. This retrospective observational study investigated the predictors for AF and the effect of AF on the mortality in esophageal cancer patients undergoing esophagectomy. Methods This study evaluated 583 patients undergoing esophagectomy, from January 2005 to April 2012. AF was defined as newly developed postoperative AF requiring treatment. The risk factors for AF and the association between AF and mortality were evaluated. The long-term mortality was the all-cause mortality, for which the cutoff date was May 31, 2014. Results AF developed in 63 patients (10.8%). Advanced age (odds ratio [OR] 1.099, 95% confidence interval [CI] 1.056-1.144, P < 0.001), preoperative calcium channel blocker (CCB) (OR 2.339, 95% CI 1.143-4.786, P = 0.020), and angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) (OR 0.206, 95% CI 0.067-0.635, P = 0.006) were associated with the incidence of AF. The Kaplan-Meier curve showed a significantly lower survival rate in the AF group compared to the non-AF group (P = 0.045), during a median follow-up of 50.7 months. The multivariable analysis revealed associations between AF and the 1-year mortality (hazard ratio [HR] 2.556, 95% CI 1.430-4.570, P = 0.002) and between AF and the long-term mortality (HR 1.507, 95% CI 1.003-2.266, P = 0.049). Conclusions In esophageal cancer patients, the advanced age and the preoperative medications (CCB, ACEI or ARB) were associated with the incidence of AF. Furthermore, postoperatively developed AF was associated with mortality in esophageal cancer patients after esophagectomy, suggesting that a close surveillance might be required in patients who showed AF during postoperative period.	[Chin, Ji-Hyun; Moon, Young-Jin; Jo, Jun-Young; Han, Yun A.; Lee, Eun-Ho; Choi, In-Cheol] Univ Ulsan, Dept Anaesthesiol & Pain Med, Asan Med Ctr, Coll Med, Seoul, South Korea; [Kim, Hyeong Ryul] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Lee, EH (corresponding author), Univ Ulsan, Dept Anaesthesiol & Pain Med, Asan Med Ctr, Coll Med, Seoul, South Korea.	leho@naver.com	Lee, Eun-Ho/AAI-7269-2020	Lee, Eun-Ho/0000-0002-6369-7429				Allessie MA, 2001, CIRCULATION, V103, P769; Amar D, 1996, ANN THORAC SURG, V61, P1506, DOI 10.1016/0003-4975(96)00111-7; Bartels H, 1998, BRIT J SURG, V85, P840; Bhayani NH, 2013, JAMA SURG, V148, P733, DOI 10.1001/jamasurg.2013.2356; Blencowe NS, 2012, ANN SURG, V255, P658, DOI 10.1097/SLA.0b013e3182480a6a; Cardinale D, 2007, CIRCULATION, V115, P1339, DOI 10.1161/CIRCULATIONAHA.106.647008; Chen YJ, 2006, BRIT J PHARMACOL, V147, P12, DOI 10.1038/sj.bjp.0706445; Chouaib S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00021; Coffelt SB, 2014, NATURE, V507, P48, DOI 10.1038/nature13062; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Farmakis D, 2014, J AM COLL CARDIOL, V63, P945, DOI 10.1016/j.jacc.2013.11.026; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Healey JS, 2005, CURR OPIN CARDIOL, V20, P31; HUDSON REB, 1960, BRIT HEART J, V22, P153; Imperatori A, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-4; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Lainscak M, 2008, INT J CARDIOL, V128, P311, DOI 10.1016/j.ijcard.2007.12.078; LAW SYK, 1994, WORLD J SURG, V18, P339, DOI 10.1007/BF00316812; Li DS, 2001, CIRCULATION, V104, P2608, DOI 10.1161/hc4601.099402; Ma JY, 2006, WORLD J GASTROENTERO, V12, P449, DOI 10.3748/wjg.v12.i3.449; Mc Cormack O, 2014, ANN SURG, V260, P772, DOI 10.1097/SLA.0000000000000960; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Murthy SC, 2003, J THORAC CARDIOV SUR, V126, P1162, DOI 10.1016/S0022-5223(03)00974-7; Nakashima H, 2000, CIRCULATION, V101, P2612, DOI 10.1161/01.CIR.101.22.2612; Ojima T, 2014, SURG TODAY, V44, P839, DOI 10.1007/s00595-013-0616-3; Ostenfeld EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102861; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Rao VP, 2012, EUR J CARDIO-THORAC, V42, P438, DOI 10.1093/ejcts/ezs085; Sanders P, 2003, CIRCULATION, V108, P1461, DOI 10.1161/01.CIR.0000090688.49283.67; SHORT DS, 1954, BRIT HEART J, V16, P208; SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356; Stawicki SPA, 2011, GEN THORAC CARDIOVAS, V59, P399, DOI 10.1007/s11748-010-0713-9; Stippel DL, 2005, DIS ESOPHAGUS, V18, P267, DOI 10.1111/j.1442-2050.2005.00487.x; Vaporciyan AA, 2004, J THORAC CARDIOV SUR, V127, P779, DOI 10.1016/j.jtcvs.2003.07.011; von Lewinski D, 2008, EUR J HEART FAIL, V10, P1172, DOI 10.1016/j.ejheart.2008.09.014	35	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154931	10.1371/journal.pone.0154931	http://dx.doi.org/10.1371/journal.pone.0154931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148877	Green Published, gold			2022-12-27	WOS:000375676800093
J	Gardner, AG; Gerald, JNF; Menz, J; Shepherd, KA; Howarth, DG; Jabaily, RS				Gardner, Andrew G.; Gerald, Jonathan N. Fitz; Menz, John; Shepherd, Kelly A.; Howarth, Dianella G.; Jabaily, Rachel S.			Characterizing Floral Symmetry in the Core Goodeniaceae with Geometric Morphometrics	PLOS ONE			English	Article							COROLLA SHAPE; NECTAR SPURS; EVOLUTION; FLOWER; SELECTION; DIVERSIFICATION; FAMILY; PLANT; EXPRESSION; MORPHOLOGY	Core Goodeniaceae is a clade of similar to 330 species primarily distributed in Australia. Considerable variation in flower morphology exists within this group and we aim to use geometric morphometrics to characterize this variation across the two major subclades: Scaevola sensu lato (s. l.) and Goodenia s. l., the latter of which was hypothesized to exhibit greater variability in floral symmetry form. We test the hypothesis that floral morphological variation can be adequately characterized by our morphometric approach, and that discrete groups of floral symmetry morphologies exist, which broadly correlate with subjectively determined groups. From 335 images of 44 species in the Core Goodeniaceae, two principal components were computed that describe >98% of variation in all datasets. Increasing values of PC1 ventralize the dorsal petals (increasing the angle between them), whereas increasing values of PC2 primarily ventralize the lateral petals (decreasing the angle between them). Manipulation of these two morphological "axes" alone was sufficient to recreate any of the general floral symmetry patterns in the Core Goodeniaceae. Goodenia s. l. exhibits greater variance than Scaevola s. l. in PC1 and PC2, and has a significantly lower mean value for PC1. Clustering clearly separates fan-flowers (with dorsal petals at least 120 degrees separated) from the others, whereas the distinction between pseudo-radial and bilabiate clusters is less clear and may form a continuum rather than two distinct groups. Transitioning from the average fan-flower to the average non-fanflower is described almost exclusively by PC1, whereas PC2 partially describes the transition between bilabiate and pseudo-radial morphologies. Our geometric morphometric method accurately models Core Goodeniaceae floral symmetry diversity.	[Gardner, Andrew G.; Gerald, Jonathan N. Fitz; Menz, John; Jabaily, Rachel S.] Rhodes Coll, Dept Biol, 2000 N Pkwy, Memphis, TN 38112 USA; [Shepherd, Kelly A.] Dept Parks & Wildlife, Sci & Conservat Div, Kensington, WA, Australia; [Howarth, Dianella G.] St Johns Univ, Dept Biol Sci, Queens, NY USA; [Gardner, Andrew G.] Calif State Univ Stanislaus, Dept Biol Sci, Turlock, CA 95382 USA	Saint John's University; California State University System; California State University Stanislaus	Gardner, AG (corresponding author), Rhodes Coll, Dept Biol, 2000 N Pkwy, Memphis, TN 38112 USA.	andyggardner@gmail.com		Jabaily, Rachel/0000-0002-4218-3533; Shepherd, Kelly Anne/0000-0003-1627-7891	National Science Foundation of the U.S.A [NSF DEB 1256946]; Direct For Biological Sciences [1256946, 1256963] Funding Source: National Science Foundation	National Science Foundation of the U.S.A(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation of the U.S.A. [NSF DEB 1256946 to R.S.J., D.G.H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; BARTLETT MS, 1946, J ROY STAT SOC B, V8, P128; Benitez-Vieyra S, 2009, J EVOLUTION BIOL, V22, P2354, DOI 10.1111/j.1420-9101.2009.01840.x; Broholm SK, 2008, P NATL ACAD SCI USA, V105, P9117, DOI 10.1073/pnas.0801359105; Busch A, 2007, P NATL ACAD SCI USA, V104, P16714, DOI 10.1073/pnas.0705338104; Carolin R.C., 1992, FLORA AUSTR, V35, P4; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; Dumortier BCJ, 1929, ANAL FAMILLES PLANTE; Fambrini M, 2011, GENETICA, V139, P1521, DOI 10.1007/s10709-012-9652-y; Fernandez-Mazuecos M, 2013, ANN BOT-LONDON, V112, P1705, DOI 10.1093/aob/mct214; Foster DJ, 2008, J EVOLUTION BIOL, V21, P263, DOI 10.1111/j.1420-9101.2007.01449.x; Gardner AG, 2016, MOL PHYLOGENET EVOL, V94, P605, DOI 10.1016/j.ympev.2015.10.003; Gomez JM, 2008, P ROY SOC B-BIOL SCI, V275, P2241, DOI 10.1098/rspb.2008.0512; Gomez JM, 2006, AM NAT, V168, P531, DOI 10.1086/507048; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Heinrichs J, 2010, MOL PHYLOGENET EVOL, V56, P1105, DOI 10.1016/j.ympev.2010.05.004; Hodges SA, 1995, P ROY SOC B-BIOL SCI, V262, P343, DOI 10.1098/rspb.1995.0215; Howarth DG, 2006, P NATL ACAD SCI USA, V103, P9101, DOI 10.1073/pnas.0602827103; Howarth DG, 2011, ANN BOT-LONDON, V107, P1521, DOI 10.1093/aob/mcr049; Jabaily RS, 2014, J BIOGEOGR, V41, P2057, DOI 10.1111/jbi.12363; Jabaily RS, 2012, TAXON, V61, P419, DOI 10.1002/tax.612012; Kaczorowski RL, 2012, FUNCT ECOL, V26, P577, DOI 10.1111/j.1365-2435.2012.01982.x; Kim M, 2008, SCIENCE, V322, P1116, DOI 10.1126/science.1164371; Kitazawa MS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004145; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Gomez JM, 2010, INT J PLANT SCI, V171, P987, DOI 10.1086/656475; Medel R, 2003, ECOLOGY, V84, P1721, DOI 10.1890/01-0688; Polly P. D., 2014, GEOMETRIC MORPHOMETR; Preston JC, 2009, TRENDS PLANT SCI, V14, P147, DOI 10.1016/j.tplants.2008.12.005; Rohlf FJ, 2003, TPSDIG2; Sablowski R, 2015, J EXP BOT, V66, P1065, DOI 10.1093/jxb/eru514; Savriama Y, 2012, NEW PHYTOL, V196, P945, DOI 10.1111/j.1469-8137.2012.04312.x; Shipunov AB, 2005, BIOL J LINN SOC, V85, P1, DOI 10.1111/j.1095-8312.2005.00468.x; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Specht CD, 2015, NEW PHYTOL, V206, P74, DOI 10.1111/nph.13198; Tahtiharju S, 2012, MOL BIOL EVOL, V29, P1155, DOI 10.1093/molbev/msr283; van der Niet T, 2010, TRENDS PLANT SCI, V15, P423, DOI 10.1016/j.tplants.2010.05.005; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P135, DOI 10.1016/B978-0-12-386903-6.00006-X	45	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154736	10.1371/journal.pone.0154736	http://dx.doi.org/10.1371/journal.pone.0154736			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148960	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800054
J	Smith, RL; Gallicchio, L; Miller, SR; Zacur, HA; Flaws, JA				Smith, Rebecca Lee; Gallicchio, Lisa; Miller, Susan R.; Zacur, Howard A.; Flaws, Jodi A.			Risk Factors for Extended Duration and Timing of Peak Severity of Hot Flashes	PLOS ONE			English	Article							MENOPAUSAL VASOMOTOR SYMPTOMS; CIGARETTE-SMOKING; LONGITUDINAL ANALYSIS; NATURAL MENOPAUSE; WOMENS HEALTH; BODY-MASS; ASSOCIATION; ESTROGEN; FLUSHES; LIFE	Objective To identify risk factors associated with the duration of hot flashes and the time of peak hot flash severity in mid-life women. Methods A cohort of 647 women reporting hot flashes were followed for 1-7 years, with survey data and hormone measurements. Survival analysis determined the association of risk factors with the duration of hot flashes. Linear regression determined the association of risk factors with the time of peak severity. Final models were determined through stepwise model selection. Results Average hot flash duration was 2.5 years (range: 1-33), with peak severity on average at 2.96 years (range: 1-20). Duration of hot flashes was associated with race, education, menopause status, smoking history, BMI, alcohol consumption, leisure activity levels, and levels of estradiol and progesterone. In the final model, only race, alcohol consumption, leisure activity, and menopause were retained. White women had significantly shorter hot flash durations than non-white women. Women consuming at least 12 alcoholic drinks in the previous year had a significantly shorter duration of hot flashes with a smaller effect of hot flash duration on increasing in time to peak severity compared to those who consumed less than 12 alcoholic drinks in that year. Higher serum progesterone levels were associated with later peak severity if the duration of the hot flashes was less than 2 years and an earlier peak severity otherwise. Conclusions These results suggest that some behaviors (such as moderate alcohol consumption) are associated with shorter durations of hot flashes, and that progesterone was associated with the dynamics of hot flash severity.	[Smith, Rebecca Lee] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA; [Gallicchio, Lisa] Mercy Med Ctr, Weinberg Ctr Womens Hlth & Med, Prevent & Res Ctr, Baltimore, MD USA; [Miller, Susan R.; Zacur, Howard A.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Flaws, Jodi A.] Univ Illinois, Coll Vet Med, Dept Comparat Biomed, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Mercy Medical Center - Maryland; Johns Hopkins University; University of Illinois System; University of Illinois Urbana-Champaign	Smith, RL (corresponding author), Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA.	rlsdvm@illinois.edu	zacur, howard/W-2170-2019	Flaws, Jodi/0000-0001-5579-9268; Smith, Rebecca/0000-0002-8343-794X	National Institute on Aging [R01 AG18400]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by a grant from the National Institute on Aging (R01 AG18400) (JAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, REV R ENT; Avis NE, 2015, JAMA INTERN MED, V175, P531, DOI 10.1001/jamainternmed.2014.8063; BARON JA, 1984, AM J EPIDEMIOL, V119, P9, DOI 10.1093/oxfordjournals.aje.a113730; Berendsen HHG, 2000, MATURITAS, V36, P155, DOI 10.1016/S0378-5122(00)00151-1; Cochran CJ, 2008, OBSTET GYNECOL, V112, P1037, DOI 10.1097/AOG.0b013e318189a8e2; Cramer DW, 1996, MATURITAS, V23, P319, DOI 10.1016/0378-5122(96)00992-9; Crandall CJ, 2011, J BONE MINER RES, V26, P840, DOI 10.1002/jbmr.259; Elavsky S, 2005, MATURITAS, V52, P374, DOI 10.1016/j.maturitas.2004.07.014; Fisher TE, 2012, MATURITAS, V71, P217, DOI 10.1016/j.maturitas.2011.12.006; Freedman RR, 2001, AM J HUM BIOL, V13, P453, DOI 10.1002/ajhb.1077; Freeman EW, 2014, MENOPAUSE, V21, P924, DOI [10.1097/GME.0000000000000196, 10.1097/gme.0000000000000196]; Gallicchio L, 2005, AM J OBSTET GYNECOL, V193, P1353, DOI 10.1016/j.ajog.2005.04.001; Gallicchio L, 2008, MATURITAS, V59, P114, DOI 10.1016/j.maturitas.2008.01.003; Gallicchio L, 2014, J WOMENS HEALTH, V23, P231, DOI 10.1089/jwh.2013.4526; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Gold EB, 2006, AM J PUBLIC HEALTH, V96, P1226, DOI 10.2105/AJPH.2005.066936; Kapoor D, 2005, EUR J ENDOCRINOL, V152, P491, DOI 10.1530/eje.1.01867; KAUFMAN DW, 1980, AM J PUBLIC HEALTH, V70, P420, DOI 10.2105/AJPH.70.4.420; KHAW KT, 1988, NEW ENGL J MED, V318, P1705, DOI 10.1056/NEJM198806303182601; KRONENBERG F, 1987, CAN J PHYSIOL PHARM, V65, P1312, DOI 10.1139/y87-208; Loprinzi CL, 2008, MENOPAUSE, V15, P655, DOI 10.1097/gme.0b013e3181679150; Lucero MA, 1997, ANN PHARMACOTHER, V31, P915; MICHNOVICZ JJ, 1986, NEW ENGL J MED, V315, P1305, DOI 10.1056/NEJM198611203152101; Miller SR, 2006, MATURITAS, V54, P260, DOI 10.1016/j.maturitas.2005.12.001; Mishra G, 2006, SOC SCI MED, V62, P93, DOI 10.1016/j.socscimed.2005.05.015; Moilanen J, 2010, MATURITAS, V67, P368, DOI 10.1016/j.maturitas.2010.08.007; R Development Core Team, 2014, R LANG ENV STAT COMP; Riley EH, 2004, J GEN INTERN MED, V19, P740, DOI 10.1007/s11606-004-0002-3; Rodgers J, 2005, HEALTH QUAL LIFE OUT, V41, P1, DOI DOI 10.1186/1477-7525-3-RECEIVED; Schilling C, 2007, MATURITAS, V57, P120, DOI 10.1016/j.maturitas.2006.11.009; Smith RL, 2015, MATURITAS, V82, P123, DOI 10.1016/j.maturitas.2015.06.029; Tanko LB, 2004, MENOPAUSE, V11, P104, DOI 10.1097/01.GME.0000079740.18541.DB; Thurston RC, 2008, CIRCULATION, V118, P1234, DOI 10.1161/CIRCULATIONAHA.108.776823; TORGERSON DJ, 1994, MATURITAS, V19, P83, DOI 10.1016/0378-5122(94)90057-4; Venables WN., 2002, MODERN APPL STAT S 4; Visvanathan K, 2005, OBSTET GYNECOL, V106, P1372, DOI 10.1097/01.AOG.0000187308.67021.98; Whiteman MK, 2003, J WOMEN HEALTH GEN-B, V12, P459, DOI 10.1089/154099903766651586; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Woods NF, 2007, J WOMENS HEALTH, V16, P667, DOI 10.1089/jwh.2006.0138; Ziv-Gal A, 2010, J WOMENS HEALTH, V19, P1905, DOI 10.1089/jwh.2009.1852	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155079	10.1371/journal.pone.0155079	http://dx.doi.org/10.1371/journal.pone.0155079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149066	Green Submitted, Green Published, gold			2022-12-27	WOS:000375676800115
J	Soni, S; Raaijmakers, AJA; Raaijmakers, LM; Damen, JMA; van Stuijvenberg, L; Vos, MA; Heck, AJR; van Veen, TAB; Scholten, A				Soni, Siddarth; Raaijmakers, Antonia J. A.; Raaijmakers, Linsey M.; Damen, J. Mirjam A.; van Stuijvenberg, Leonie; Vos, Marc A.; Heck, Albert J. R.; van Veen, Toon A. B.; Scholten, Arjen			A Proteomics Approach to Identify New Putative Cardiac Intercalated Disk Proteins	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; SKELETAL-MUSCLE; HEART; MUTATIONS; JUNCTION; GENE; IDENTIFICATION; DOMAIN; PLAKOGLOBIN; FLOTILLIN-1	Aims Synchronous beating of the heart is dependent on the efficient functioning of the cardiac intercalated disk (ID). The ID is composed of a complex protein network enabling electrical continuity and chemical communication between individual cardiomyocytes. Recently, several different studies have shed light on increasingly prevalent cardiac diseases involving the ID. Insufficient knowledge of its composition makes it difficult to study these disease mechanisms in more detail and therefore here we aim expand the ID proteome. Here, using a combination of general membrane enrichment, in-depth quantitative proteomics and an intracellular location driven bioinformatics approach, we aim to discover new putative ID proteins in rat ventricular tissue. Methods and Results General membrane isolation, enriched amongst others also with ID proteins as based on presence of the established markers connexin-43 and n-cadherin, was performed using centrifugation. By mass spectrometry, we quantitatively evaluated the level of 3455 proteins in the enriched membrane fraction (EMF) and its counterpart, the soluble cytoplasmic fraction. These data were stringently filtered to generate a final set of 97 enriched, putative ID proteins. These included Cx43 and n-cadherin, but also many interesting novel candidates. We selected 4 candidates (Flotillin-2 (FLOT2), Nexilin (NEXN), Popeye-domain-containg-protein 2 (POPDC2) and thioredoxin-related-transmembrane-protein 2 (TMX2)) and confirmed their co-localization with n-cadherin in the ID of human and rat heart cryo-sections, and isolated dog cardiomyocytes. Conclusion The presented proteomics dataset of putative new ID proteins is a valuable resource for future research into this important molecular intersection of the heart.	[Soni, Siddarth; Raaijmakers, Antonia J. A.; van Stuijvenberg, Leonie; Vos, Marc A.; van Veen, Toon A. B.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Med Physiol, Utrecht, Netherlands; [Soni, Siddarth; Raaijmakers, Linsey M.; Damen, J. Mirjam A.; Heck, Albert J. R.; Scholten, Arjen] Univ Utrecht, Biomol Mass Spectrometry & Prote, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Soni, Siddarth; Raaijmakers, Linsey M.; Damen, J. Mirjam A.; Heck, Albert J. R.; Scholten, Arjen] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Raaijmakers, Linsey M.; Damen, J. Mirjam A.; Heck, Albert J. R.; Scholten, Arjen] Netherlands Prote Ctr, Utrecht, Netherlands; [Scholten, Arjen] Janssen, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Johnson & Johnson; Janssen Pharmaceuticals	van Veen, TAB (corresponding author), Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Med Physiol, Utrecht, Netherlands.	A.A.B.vanVeen@umcutrecht.nl	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404	Netherlands CardioVascular Research Initiative": the Dutch Heart Foundation, Dutch Federation of University Medical Centres; Netherlands Organisation for Health Research and Development; Royal Netherlands Academy of Sciences (CVON-PREDICT); Utrecht University Focus Massa; Netherlands Proteomics Centre; European Union [262067]; Netherlands Organization for Scientific Research (NWO) [184.032.201]	Netherlands CardioVascular Research Initiative": the Dutch Heart Foundation, Dutch Federation of University Medical Centres; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences (CVON-PREDICT); Utrecht University Focus Massa; Netherlands Proteomics Centre; European Union(European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The authors acknowledge the support from the Netherlands CardioVascular Research Initiative": the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences (CVON-PREDICT, MAV, TABvV, LvS), the Utrecht University Focus & Massa (TABvV and AS) and The Netherlands Proteomics Centre (AS and AJRH). Part of the proteomics research was performed within the framework of the PRIME-XS project, grant number 262067, funded by the European Union 7th Framework Program. AJRH acknowledges funding from the Netherlands Organization for Scientific Research (NWO) who support the large-scale proteomics facility Proteins@Work (project 184.032.201). The funders provided support in the form of salaries for authors (SS, LvS, JMAD, LMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andree B, 2000, DEV BIOL, V223, P371, DOI 10.1006/dbio.2000.9751; Aye TT, 2010, MOL BIOSYST, V6, P1917, DOI 10.1039/c004495d; Bennett PM, 2006, MOL BIOL CELL, V17, P2091, DOI 10.1091/mbc.E05-12-1109; Brand T, 2014, BIOCHEM SOC T, V42, P295, DOI 10.1042/BST20130264; Bruzzone R, 1996, BIOESSAYS, V18, P709, DOI 10.1002/bies.950180906; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Edgar AJ, 2001, INT J BIOCHEM CELL B, V33, P53, DOI 10.1016/S1357-2725(00)00069-8; Estigoy Colleen B, 2009, Biophys Rev, V1, P43, DOI 10.1007/s12551-008-0007-y; Ferreira-Cornwell MC, 2002, J CELL SCI, V115, P1623; Froese A, 2012, J CLIN INVEST, V122, P1119, DOI 10.1172/JCI59410; FROMAGET C, 1992, DIFFERENTIATION, V51, P9, DOI 10.1111/j.1432-0436.1992.tb00675.x; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; HOYT RH, 1989, CIRC RES, V64, P563, DOI 10.1161/01.RES.64.3.563; Lindskog C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1686-y; MAKOWSKI L, 1977, J CELL BIOL, V74, P629, DOI 10.1083/jcb.74.2.629; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Nalos L, 2012, BRIT J PHARMACOL, V165, P467, DOI 10.1111/j.1476-5381.2011.01558.x; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Noorman M, 2009, J MOL CELL CARDIOL, V47, P23, DOI 10.1016/j.yjmcc.2009.03.016; Peng M, 2012, NAT METHODS, V9, P524, DOI 10.1038/nmeth.2031; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; RAYNS DG, 1969, J CELL BIOL, V42, P322, DOI 10.1083/jcb.42.1.322; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; SEVERS NJ, 1989, CIRC RES, V65, P1458, DOI 10.1161/01.RES.65.5.1458; SJOSTRAND FS, 1954, EXPERIENTIA, V10, P369, DOI 10.1007/BF02160542; Syrris P, 2007, EUR HEART J, V28, P581, DOI 10.1093/eurheartj/hl380; Syrris P, 2006, AM J HUM GENET, V79, P978, DOI 10.1086/509122; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Thiene G, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-45; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; van Veen TAB, 2002, J MOL CELL CARDIOL, V34, P1411, DOI 10.1006/jmcc.2002.2102; VANBREEMEN VL, 1953, ANAT REC, V117, P49, DOI 10.1002/ar.1091170106; VANKEMPEN MJA, 1991, CIRC RES, V68, P1638, DOI 10.1161/01.RES.68.6.1638; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; WEIDMANN S, 1952, J PHYSIOL-LONDON, V118, P348, DOI 10.1113/jphysiol.1952.sp004799; WEIDMANN S, 1966, J PHYSIOL-LONDON, V187, P323, DOI 10.1113/jphysiol.1966.sp008092	40	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0152231	10.1371/journal.pone.0152231	http://dx.doi.org/10.1371/journal.pone.0152231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148881	Green Published, gold			2022-12-27	WOS:000375676800003
J	Sullivan, HW; Aikin, KJ; Chung-Davies, E; Wade, M				Sullivan, Helen W.; Aikin, Kathryn J.; Chung-Davies, Eunice; Wade, Michael			Prescription Drug Promotion from 2001-2014: Data from the US Food and Drug Administration	PLOS ONE			English	Article							CONSUMER; TELEVISION; EXPOSURE	The volume of prescription drug promotion over time is often measured by assessing changes in ad spending. However, this method obscures the fact that some types of advertising are more expensive than others. Another way to measure the changes in prescription drug promotion over time is to assess the number of promotional pieces submitted to the U.S. Food and Drug Administration (FDA). Form FDA 2253 collects information such as the date submitted and the type of material submitted. We analyzed data from Forms FDA 2253 received from 2001-2014. We examined the frequency of submissions by audience (consumer and healthcare professional) and type of promotional material. There was a noted increase in prescription drug promotion submissions across all media in the early 2000s. Although non-Internet promotion submissions have since plateaued, Internet promotion continued to increase. These results can help public health advocates and regulators focus attention and resources.	[Sullivan, Helen W.; Aikin, Kathryn J.; Chung-Davies, Eunice; Wade, Michael] US FDA, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Sullivan, HW (corresponding author), US FDA, Silver Spring, MD USA.	Helen.Sullivan@fda.hhs.gov		Sullivan, Helen/0000-0001-7621-7554				Abrams T., 2012, FOOD DRUG LAW I ADV; Alperstein Neil M, 2014, Health Mark Q, V31, P231, DOI 10.1080/07359683.2014.936291; [Anonymous], 2014, OTHER POSTMARKETING; Brownfield ED, 2004, J HEALTH COMMUN, V9, P491, DOI 10.1080/10810730490523115; Bulik BS, 2011, AD AGE; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Gilbody S, 2005, QUAL SAF HEALTH CARE, V14, P246, DOI 10.1136/qshc.2004.012781; Hesse BW, 2010, NEW ENGL J MED, V362, P859, DOI 10.1056/NEJMc0909595; Kornfield R, 2015, AM J PREV MED, V48, P575, DOI 10.1016/j.amepre.2014.12.001; Kornfield R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055504; Krahn J., 2013, WHAT ARE ADULTS DOIN; Liang BA, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1775; Mackey TK, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0885-1; Makovsky PR, 2016, 6 ANN MAK KELT PULS; Mintzes B, 2012, ANNU REV PUBL HEALTH, V33, P259, DOI 10.1146/annurev-publhealth-031811-124540; Niederdeppe J, 2013, J GEN INTERN MED, V28, P886, DOI 10.1007/s11606-013-2379-3; Pew Research Center, 2015, HLTH FACT SHEET; Sheehan KB, 2007, J ADVERTISING, V36, P123, DOI 10.2753/JOA0091-3367360310; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; U.S. Food and Drug Administration, 2015, OPDP FDA 2253 REQ AD	21	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155035	10.1371/journal.pone.0155035	http://dx.doi.org/10.1371/journal.pone.0155035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149513	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800109
J	Zaccaria, E; Wells, JM; van Baarlen, P				Zaccaria, Edoardo; Wells, Jerry M.; van Baarlen, Peter			Metabolic Context of the Competence-Induced Checkpoint for Cell Replication in Streptococcus suis	PLOS ONE			English	Article							PHENOLIC-ACID DECARBOXYLASE; GENETIC-TRANSFORMATION; STIMULATING PEPTIDE; TOOL; INTEGRATION; PNEUMONIAE; ANNOTATION; LIFE	Natural genetic transformation is a transient, rapidly progressing energy-consuming process characterized by expression of the transformasome and competence-associated regulatory genes. This transient state is tightly controlled to avoid potentially adverse effects of genetic recombination on genome integrity during cell division. We investigated the global response of Streptococcus suis to exposure to the SigX competence-inducing peptide (XIP), and thus to the activation of the competence machinery, using time series analysis together with PCA analysis, gene clustering followed by heatmap visualisation, and GO enrichment analysis. We explored the possible regulatory link between metabolism and competence, and predicted the physiological adaptation of S. suis during competence induction, progression and exit using transcriptome analysis. We showed that competence development is associated with a suppression of basal metabolism, which may have consequences for the microbe's resilience to fluctuations in the environment, as competence is costly in terms of use of energy and protein translation. Furthermore our data suggest that several basal metabolic pathways are incompatible with activation of competence in S. suis. This study also showed that targeting specific pathways during the development of competence, might render S. suis more vulnerable toward novel antibiotic therapies.	[Zaccaria, Edoardo; Wells, Jerry M.; van Baarlen, Peter] Wageningen Univ, Host Microbe Interact, Anim Sci, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	van Baarlen, P (corresponding author), Wageningen Univ, Host Microbe Interact, Anim Sci, NL-6700 AP Wageningen, Netherlands.	peter.vanbaarlen@wur.nl	Zaccaria, Edoardo/AAP-9740-2020	van Baarlen, Peter/0000-0003-3530-5472	European Commission as part of the Framework Programme 7, Marie Curie Initial Training Network-STARS [PITN-GA-2009-238490]	European Commission as part of the Framework Programme 7, Marie Curie Initial Training Network-STARS	This work was supported by the European Commission, as part of the Framework Programme 7, Marie Curie Initial Training Network-STARS (Contract No. PITN-GA-2009-238490).	Ahn SJ, 2014, J BACTERIOL, V196, P3735, DOI 10.1128/JB.01942-14; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Attaiech L, 2015, MBIO, V6, DOI 10.1128/mBio.00662-15; Briley K, 2011, MOL MICROBIOL, V81, P23, DOI 10.1111/j.1365-2958.2011.07695.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Greeff A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-161; Desai K, 2012, J BACTERIOL, V194, P3774, DOI 10.1128/JB.00337-12; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fontaine L, 2015, INFECT GENET EVOL, V33, P343, DOI 10.1016/j.meegid.2014.09.010; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Gardan R, 2013, J BACTERIOL, V195, P1845, DOI 10.1128/JB.02196-12; Gardan R, 2009, J BACTERIOL, V191, P4647, DOI 10.1128/JB.00257-09; Gury J, 2004, APPL ENVIRON MICROB, V70, P2146, DOI 10.1128/AEM.70.4.2146-2153.2004; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Mirouze N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005299; Monnet V, 2003, CELL MOL LIFE SCI, V60, P2100, DOI 10.1007/s00018-003-3054-3; Morrison DA, 1997, MICROB DRUG RESIST, V3, P27, DOI 10.1089/mdr.1997.3.27; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Oggioni MR, 2004, ANTIMICROB AGENTS CH, V48, P4725, DOI 10.1128/AAC.48.12.4725-4732.2004; Peterson S, 2000, J BACTERIOL, V182, P6192, DOI 10.1128/JB.182.21.6192-6202.2000; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Slager J, 2014, CELL, V157, P395, DOI 10.1016/j.cell.2014.01.068; Tran NP, 2008, J BACTERIOL, V190, P3213, DOI 10.1128/JB.01936-07; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Wenderska IB, 2012, FEMS MICROBIOL LETT, V336, P104, DOI 10.1111/j.1574-6968.2012.02660.x; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zaccaria E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099394; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	35	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0153571	10.1371/journal.pone.0153571	http://dx.doi.org/10.1371/journal.pone.0153571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149631	Green Published, gold			2022-12-27	WOS:000375676800010
J	Lee, SY; Chieh, HF; Lin, CJ; Jou, IM; Kuo, LC; Su, FC				Lee, Su-Ya; Chieh, Hsiao-Feng; Lin, Chien-Ju; Jou, I-Ming; Kuo, Li-Chieh; Su, Fong-Chin			The Potential Risk Factors Relevant to Lateral Epicondylitis by Wrist Coupling Posture	PLOS ONE			English	Article							CARPI RADIALIS BREVIS; WORKING POPULATION; MUSCLE IMBALANCE; TENNIS PLAYERS; UPPER-LIMB; STRENGTH; FORCE; ELBOW; ACTIVATION; GENERATION	The use of awkward wrist postures and unskilled techniques might induce lateral epicondylitis. This study thus investigated the effects of wrist deviation combined with extension and movement velocity on the dynamic performances of the wrist muscles during the coupling posture via a custom-made bi-planar isokinetic dynamometer. Thirty subjects were recruited to perform the isokinetic testing. We measured the muscle strengths and activities for the wrist extensors and flexors during concentric and eccentric contractions at three movement velocities, 30 degrees s(-1), 90 degrees s(-1), and 180 degrees s(-1), combined with three wrist postures, neutral position (NP), radial deviation (RD), and ulnar deviation (UD). The root mean square (RMS) of the electromyographic signal in the extensor digitorum communis (EDC), normalized peak torque of extensors, and ratio of normalized peak torque between wrist extensors and flexors, were all greater in the NP than RD and UD in both contractions. The ratio of RMS between EDC and flexor digitorum superficialis (FDS) had a significantly greater value in RD than UD during the concentric contraction. The EDC showed significantly higher activity at the fast velocity in both contractions. Nevertheless, a significantly higher RMS of the electromyographic signal between EDC and FDS and the ratio of strength between wrist extensors and flexors were found at slow velocity in both contractions. The wrist deviation combined with extension and movement velocity of the wrist joint should thus be considered as influential factors which might alter the dynamic performances, and may result in further injury of the elbow joint.	[Lee, Su-Ya; Chieh, Hsiao-Feng; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan; [Jou, I-Ming] Natl Cheng Kung Univ Hosp, Dept Orthoped, Tainan 70428, Taiwan; [Lin, Chien-Ju; Kuo, Li-Chieh; Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan; [Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University	Su, FC (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.; Kuo, LC; Su, FC (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan.; Kuo, LC (corresponding author), Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan 701, Taiwan.	jkkuo@mail.ncku.edu.tw; fcsu@mail.ncku.edu.tw	SU, FONG-CHIN/C-8094-2011; Lin, Chien-Ju/AAP-5725-2020; Chieh, Hsiao-Feng/AAP-5236-2020; Kuo, Li-Chieh/ABC-3826-2021	SU, FONG-CHIN/0000-0002-3870-4842; Lin, Chien-Ju/0000-0001-9571-8610; Chieh, Hsiao-Feng/0000-0001-8844-8026; Kuo, Li-Chieh/0000-0001-7728-0096; Kuo, Li-Chieh/0000-0002-5644-655X	Ministry of Science and Technology of Taiwan [MOST 101-2221-E-006-128-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (MOST 101-2221-E-006-128-MY3). The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 1998, AM J SPORT MED, V26, P231, DOI 10.1177/03635465980260021201; Alizadehkhaiyat O, 2007, J ELECTROMYOGR KINES, V17, P428, DOI 10.1016/j.jelekin.2006.04.007; Alizadehkhaiyat O, 2007, J ORTHOP RES, V25, P1651, DOI 10.1002/jor.20458; Beck T W, 2004, Electromyogr Clin Neurophysiol, V44, P431; Bilodeau M, 2003, J ELECTROMYOGR KINES, V13, P83, DOI 10.1016/S1050-6411(02)00050-0; Cram J, 1998, INTRO SURFACE ELECTR; Dorf ER, 2007, J HAND SURG-AM, V32A, P882, DOI 10.1016/j.jhsa.2007.04.010; DUDLEY GA, 1990, J APPL PHYSIOL, V69, P2215, DOI 10.1152/jappl.1990.69.6.2215; Ellenbecker TS, 2006, BRIT J SPORT MED, V40, P411, DOI 10.1136/bjsm.2005.023358; Fagarasanu M, 2004, CLIN BIOMECH, V19, P671, DOI 10.1016/j.clinbiomech.2004.05.004; Fan JZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623191; Fan ZJ, 2009, AM J IND MED, V52, P479, DOI 10.1002/ajim.20700; Friedman PJ, 1998, ARCH PHYS MED REHAB, V79, P816, DOI 10.1016/S0003-9993(98)90362-8; Garg R, 2014, J HAND SURG-AM, V39, P634, DOI 10.1016/j.jhsa.2013.12.031; GRIMBY G, 1985, SPORTS MED, V2, P309, DOI 10.2165/00007256-198502050-00001; GULCH RW, 1994, INT J SPORTS MED, V15, pS2, DOI 10.1055/s-2007-1021103; Haahr JP, 2003, OCCUP ENVIRON MED, V60, P322, DOI 10.1136/oem.60.5.322; Herquelot E, 2013, AM J IND MED, V56, P400, DOI 10.1002/ajim.22140; Hiemstra LA, 2004, CLIN J SPORT MED, V14, P274, DOI 10.1097/00042752-200409000-00005; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; Kellis E, 1998, MED SCI SPORT EXER, V30, P1616, DOI 10.1097/00005768-199811000-00010; KORNECKI S, 1992, J BIOMECH, V25, P235, DOI 10.1016/0021-9290(92)90023-T; LAMOREAUX L, 1995, CLIN ORTHOP RELAT R, P152; Ljung BO, 1999, J BIOMECH, V32, P199, DOI 10.1016/S0021-9290(98)00152-3; Loren GJ, 1996, J BIOMECH, V29, P331, DOI 10.1016/0021-9290(95)00055-0; Lucado AM, 2012, J ORTHOP SPORT PHYS, V42, P1025, DOI 10.2519/jospt.2012.4095; Riek S, 1999, CLIN BIOMECH, V14, P477, DOI 10.1016/S0268-0033(98)90097-3; Roman-Liu D, 2013, GAIT POSTURE, V37, P340, DOI 10.1016/j.gaitpost.2012.07.027; Webber S, 1997, J APPL PHYSIOL, V83, P40, DOI 10.1152/jappl.1997.83.1.40; Welter TG, 2000, MOTOR CONTROL, V4, P420, DOI 10.1123/mcj.4.4.420; Werner RA, 2005, J OCCUP REHABIL, V15, P393, DOI 10.1007/s10926-005-5945-6	31	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155379	10.1371/journal.pone.0155379	http://dx.doi.org/10.1371/journal.pone.0155379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171198	gold, Green Submitted, Green Published			2022-12-27	WOS:000376588600144
J	Liu, D; Li, SM; Chen, WJ; Zhang, B; Liu, DC; Liu, BL; Zhang, HG				Liu, Di; Li, Shiming; Chen, Wenjie; Zhang, Bo; Liu, Dengcai; Liu, Baolong; Zhang, Huaigang			Transcriptome Analysis of Purple Pericarps in Common Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHESIS; GRAIN COLOR; GENES; RICE; BLUE; PIGMENTATION	Wheat (Triticum aestivum L.) cultivars possessing purple grain arethought to be more nutritious because of high anthocyanin contents in the pericarp. Comparative transcriptome analysis of purple (cv Gy115) and white pericarps was carried out using next-generation sequencing technology. There were 23,642 unigenes significantly differentially expressed in the purple and white pericarps, including 9945 up-regulated and 13,697 down-regulated. The differentially expressed unigenes were mainly involved in encoding components of metabolic pathways, The flavonoid biosynthesis pathway was the most represented in metabolic pathways. In the transcriptome of purple pericarp in Gy115, most structural and regulatory genes biosynthesizing anthocyanin were identified, and had higher expression levels than in white pericarp. The largestunigene of anthocyanin biosynthesis in Gy115 was longer than the reference genes, which implies that high-throughput sequencing could isolate the genes of anthocyanin biosynthesis in tissues or organs with high anthocyanin content. Based on present and previous results, three unigenes of MYB gene on chromosome 7BL and three unigenes of MYC on chromosome 2AL were predicted as candidate genes for the purple grain trait. This article was the first to provide a systematic overview comparing the transcriptomes of purple and white pericarps in common wheat, which should be very valuable for identifying the key genes for the purple pericarp trait.	[Liu, Di; Li, Shiming; Chen, Wenjie; Zhang, Bo; Liu, Dengcai; Liu, Baolong; Zhang, Huaigang] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota AEPB, Qinghai 810008, Xining, Peoples R China; [Liu, Di; Li, Shiming; Chen, Wenjie; Zhang, Bo; Liu, Dengcai; Liu, Baolong; Zhang, Huaigang] Qinghai Prov Key Lab Crop Mol Breeding, Xining 810008, Peoples R China	Chinese Academy of Sciences	Liu, BL; Zhang, HG (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota AEPB, Qinghai 810008, Xining, Peoples R China.; Liu, BL; Zhang, HG (corresponding author), Qinghai Prov Key Lab Crop Mol Breeding, Xining 810008, Peoples R China.	blliu@nwipb.cas.cn; hgzhang@nwipb.ac.cn	陈, 文杰·/HHN-5495-2022	陈, 文杰·/0000-0003-0556-7391; Liu, Dengcai/0000-0001-5508-1125	National Natural Science Foundation of China [31071417]; West Light Foundation of Chinese Academy of Sciences; Basic Research Projects of Qinghai Province [2015-ZJ-701]; The Pilot Projects of Designer Breeding by Molecular Module	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); Basic Research Projects of Qinghai Province; The Pilot Projects of Designer Breeding by Molecular Module	This work was supported by: 1) National Natural Science Foundation of China (Grant Numbers: 31071417) URL http://www.nsfc.gov.cn/publish/portal1/. BLL received the funding, 2) The West Light Foundation of Chinese Academy of Sciences. http://english.cas.cn/. BLL received the funding, 3) Basic Research Projects of Qinghai Province (2015-ZJ-701). BLL received the funding, and 4) The Pilot Projects of Designer Breeding by Molecular Module. HGZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ESM, 2006, J AGR FOOD CHEM, V54, P4696, DOI 10.1021/jf0606609; Abdel-Aal ESM, 2008, J AGR FOOD CHEM, V56, P11171, DOI 10.1021/jf802168c; Arbuzova VS, 1998, CEREAL RES COMMUN, V26, P39; Bolton FE, 1968, DISS ABSTR         B, V29, P844; Dobrovolskaya O, 2006, EUPHYTICA, V150, P355, DOI 10.1007/s10681-006-9122-7; Dorn KM, 2013, PLANT J, V75, P1028, DOI 10.1111/tpj.12267; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Gion K, 2012, GENETIC ENG FLORICUL, P209; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo J, 2008, AFR J BIOTECHNOL, V7, P4966; Hu JP, 1996, GENETICS, V142, P1021; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Khlestkina EK, 2010, EUPHYTICA, V171, P65, DOI 10.1007/s10681-009-9994-4; Khlestkina E. K., 2013, RUSS J GENET APPL RE, V3, P54, DOI [DOI 10.1134/S2079059713010085, 10.1134/S2079059713010085]; Khlestkina EK, 2002, THEOR APPL GENET, V104, P632, DOI 10.1007/s00122-001-0788-x; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Marienhagen J, 2013, J BIOTECHNOL, V163, P166, DOI 10.1016/j.jbiotec.2012.06.001; NEUMAN PR, 1983, GENETICS, V103, P313; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Romualdi C, 2013, PHYSIOL GENOMICS, V12, P159; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; SHARMAN BC, 1958, NATURE, V181, P929, DOI 10.1038/181929a0; Shoeva OY, 2014, MOLECULES, V19, P20266, DOI 10.3390/molecules191220266; Tereshchenko OY, 2013, J CEREAL SCI, V57, P10, DOI 10.1016/j.jcs.2012.09.010; Tereshchenko OY, 2012, CEREAL RES COMMUN, V40, P334, DOI 10.1556/CRC.40.2012.3.2; Wang CX, 2007, CHINESE SCI BULL, V52, P3097, DOI 10.1007/s11434-007-0472-x; Xu WJ, 2015, TRENDS PLANT SCI, V20, P176, DOI 10.1016/j.tplants.2014.12.001; ZEVEN AC, 1991, EUPHYTICA, V56, P243, DOI 10.1007/BF00042371; Zhang N, 2014, MOL BIOL REP, V41, P505, DOI 10.1007/s11033-013-2886-7; Zhang Y, 2014, CURR OPIN PLANT BIOL, V19, P81, DOI 10.1016/j.pbi.2014.05.011	33	20	21	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155428	10.1371/journal.pone.0155428	http://dx.doi.org/10.1371/journal.pone.0155428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171148	gold, Green Published, Green Submitted			2022-12-27	WOS:000376588600151
J	Samson, RS; Levy, S; Schneider, T; Smith, AK; Smith, SA; Cohen-Adad, J; Wheeler-Kingshott, CAMG				Samson, Rebecca S.; Levy, Simon; Schneider, Torben; Smith, Alex K.; Smith, Seth A.; Cohen-Adad, Julien; Wheeler-Kingshott, Claudia A. M. Gandini			ZOOM or Non-ZOOM? Assessing Spinal Cord Diffusion Tensor Imaging Protocols for Multi-Centre Studies	PLOS ONE			English	Article							HUMAN OPTIC-NERVE; OF-THE-ART; MULTIPLE-SCLEROSIS; MATTER DEMYELINATION; MRI; MOTION; FIELD; RESOLUTION; REDUCTION; ARTIFACTS	The purpose of this study was to develop and evaluate two spinal cord (SC) diffusion tensor imaging (DTI) protocols, implemented at multiple sites (using scanners from two different manufacturers), one available on any clinical scanner, and one using more advanced options currently available in the research setting, and to use an automated processing method for unbiased quantification. DTI parameters are sensitive to changes in the diseased SC. However, imaging the cord can be technically challenging due to various factors including its small size, patient-related and physiological motion, and field inhomogeneities. Rapid acquisition sequences such as Echo Planar Imaging (EPI) are desirable but may suffer from image distortions. We present a multi-centre comparison of two acquisition protocols implemented on scanners from two different vendors (Siemens and Philips), one using a reduced field-of-view (rFOV) EPI sequence, and one only using options available on standard clinical scanners such as outer volume suppression (OVS). Automatic analysis was performed with the Spinal Cord Toolbox for unbiased and reproducible quantification of DTI metrics in the white matter. Images acquired using the rFOV sequence appear less distorted than those acquired using OVS alone. SC DTI parameter values obtained using both sequences at all sites were consistent with previous measurements made at 3T. For the same scanner manufacturer, DTI parameter inter-site SDs were smaller for the rFOV sequence compared to the OVS sequence. The higher inter-site reproducibility (for the same manufacturer and acquisition details, i.e. ZOOM data acquired at the two Philips sites) of rFOV compared to the OVS sequence supports the idea that making research options such as rFOV more widely available would improve accuracy of measurements obtained in multi-centre clinical trials. Future multi-centre studies should also aim to match the rFOV technique and signal-to-noise ratios in all sequences from different manufacturers/sites in order to avoid any bias in measured DTI parameters and ensure similar sensitivity to pathological changes.	[Samson, Rebecca S.; Schneider, Torben; Wheeler-Kingshott, Claudia A. M. Gandini] UCL Inst Neurol, NMR Res Unit, Queen Sq MS Ctr, Dept Neuroinflammat, London, England; [Levy, Simon; Cohen-Adad, Julien] Ecole Polytech, Inst Biomed Engn, Montreal, PQ H3C 3A7, Canada; [Levy, Simon; Cohen-Adad, Julien] Univ Montreal, Funct Neuroimaging Unit, Montreal, PQ, Canada; [Schneider, Torben] Philips Healthcare, Guildford, Surrey, England; [Smith, Alex K.; Smith, Seth A.] Vanderbilt Univ, Inst Imaging Sci VUIIS, 221 Kirkland Hall, Nashville, TN 37235 USA; [Smith, Alex K.; Smith, Seth A.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Smith, Seth A.] Vanderbilt Univ, Dept Radiol & Radiol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Wheeler-Kingshott, Claudia A. M. Gandini] C Mondino Natl Neurol Inst, Brain MRI Ctr 3T, Pavia, Italy; [Wheeler-Kingshott, Claudia A. M. Gandini] Univ Pavia, Dept Brain & Behav Sci, Via Palestro 3, I-27100 Pavia, Italy	University of London; University College London; Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Philips; Philips Healthcare; Vanderbilt University; Vanderbilt University; Vanderbilt University; IRCCS Fondazione Casimiro Mondino; University of Pavia	Samson, RS (corresponding author), UCL Inst Neurol, NMR Res Unit, Queen Sq MS Ctr, Dept Neuroinflammat, London, England.	r.samson@ucl.ac.uk	Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019	Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300; Smith, Alex/0000-0001-8005-9982; Levy, Simon/0000-0002-6492-2990; Samson, Rebecca/0000-0002-0197-702X	International Spinal Research Trust [IMG007]; Wings for Life; MS Society of the UK [892]; Department of Health's NIHR Biomedical Research Centres funding scheme (UK); EPSRC [EP/I027084/1]; Fonds de Recherche du Quebec - Sante [28826]; Fonds de Recherche du Quebec - Nature et Technologies [2015-PR-182754]; Natural Sciences and Engineering Research Council of Canada [435897-2013]; Quebec BioImaging Network; NIH/NINDS [5R21NS087465-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087465] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/I027084/1] Funding Source: researchfish; International Spinal Research Trust [IMG007 - DTI study] Funding Source: researchfish	International Spinal Research Trust; Wings for Life; MS Society of the UK; Department of Health's NIHR Biomedical Research Centres funding scheme (UK)(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Fonds de Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Fonds de Recherche du Quebec - Nature et Technologies; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec BioImaging Network; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); International Spinal Research Trust	This work was supported by the International Spinal Research Trust (IMG007) (http://www.spinal-research.org/), Wings for Life (http://www.wingsforlife.com/en/), the MS Society of the UK (892) (https://www.mssociety.org.uk/), the Department of Health's NIHR Biomedical Research Centres funding scheme (UK) (http://www.nihr.ac.uk/about/biomedicalresearch-centres.htm), EPSRC EP/I027084/1 (https://www.epsrc.ac.uk/), the Fonds de Recherche du Quebec - Sante [28826] (http://www.frqs.gouv.qc.ca/ en/), the Fonds de Recherche du Quebec - Nature et Technologies [2015-PR-182754] (http://www.frq.gouv.qc.ca/en/), the Natural Sciences and Engineering Research Council of Canada [435897-2013] (http:// www.nserc-crsng.gc.ca/index_eng.asp), the Quebec BioImaging Network (https://www.rbiq-qbin.qc.ca/en), and NIH/NINDS 5R21NS087465-02 (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Dr. Finsterbusch for providing the 2DRF sequence on the Siemens site. The study was funded by the International Spinal Research Trust (IMG007), Wings for Life, the MS Society of the UK (892), the Department of Health's NIHR Biomedical Research Centres funding scheme (UK), EPSRC EP/I027084/1, the Fonds de Recherche du Quebec-Sante [28826], the Fonds de Recherche du Quebec-Nature et Technologies [2015-PR-182754], the Natural Sciences and Engineering Research Council of Canada [435897-2013], the Quebec BioImaging Network, and NIH/NINDS 5R21NS087465-02.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Brander A, 2014, ACTA RADIOL, V55, P478, DOI 10.1177/0284185113499752; Clark CA, 2000, J MAGN RESON, V142, P358, DOI 10.1006/jmre.1999.1955; Cohen-Adad J, 2014, 20 ANN M OHBM HAMB G, P3633; Cook P. A., 2006, P 14 ANN M ISMRM SEA, P2759; Dietrich O, 2008, EUR J RADIOL, V65, P29, DOI 10.1016/j.ejrad.2007.11.005; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Dowell NG, 2009, J MAGN RESON IMAGING, V29, P454, DOI 10.1002/jmri.21656; FEINBERG DA, 1985, RADIOLOGY, V156, P743, DOI 10.1148/radiology.156.3.4023236; Finsterbusch J, 2011, 19 SCI M INT SOC MAG, P174; Finsterbusch J, 2009, J MAGN RESON IMAGING, V29, P987, DOI 10.1002/jmri.21717; Fonov V, 2013, P 21 ANN M ISMRM SAL, P1119; Gilmore CP, 2009, MULT SCLER, V15, P180, DOI 10.1177/1352458508096876; Gilmore CP, 2009, J NEUROL NEUROSUR PS, V80, P182, DOI 10.1136/jnnp.2008.148767; Gilmore CP, 2006, BRAIN PATHOL, V16, P202, DOI 10.1111/j.1750-3639.2006.00018.x; Grech-Sollars M, 2015, NMR BIOMED, V28, P468, DOI 10.1002/nbm.3269; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kearney H, 2015, J NEUROL NEUROSUR PS, V86, P608, DOI 10.1136/jnnp-2014-308241; Kharbanda HS, 2006, MAGN RESON MED, V56, P334, DOI 10.1002/mrm.20959; Latour LL, 2002, MAGNET RESON MED, V48, P478, DOI 10.1002/mrm.10238; Levy S, 2015, NEUROIMAGE, V119, P262, DOI 10.1016/j.neuroimage.2015.06.040; MIKULIS DJ, 1994, RADIOLOGY, V192, P117, DOI 10.1148/radiology.192.1.8208922; Mohammadi S, 2013, NEUROIMAGE, V70, P377, DOI 10.1016/j.neuroimage.2012.12.058; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Skaare ST, 2011, DIFFUSION MRI THEORY, P182; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; Stroman PW, 2001, MAGN RESON IMAGING, V19, P27, DOI 10.1016/S0730-725X(01)00226-0; Symms MR, 2000, ZONALLY MAGNIFIED OB; TSUKAGOSHI H, 1980, J NEUROL SCI, V47, P463, DOI 10.1016/0022-510X(80)90100-8; Uda T, 2011, J CRANIOVERTEBRAL JU, V2, P77, DOI 10.4103/0974-8237.100060; Verma T, 2014, MAGN RESON MED, V72, P1629, DOI 10.1002/mrm.25075; Wheeler-Kingshott CA, 2014, NEUROIMAGE, V84, P1082, DOI 10.1016/j.neuroimage.2013.07.014; Wheeler-Kingshott CAM, 2006, MAGN RESON MED, V56, P446, DOI 10.1002/mrm.20964; Wheeler-Kingshott CAM, 2002, NEUROIMAGE, V16, P93, DOI 10.1006/nimg.2001.1022; Wheeler-Kingshott CAM, 2002, MAGN RESON MED, V47, P24, DOI 10.1002/mrm.10016; Wilm BJ, 2009, NMR BIOMED, V22, P174, DOI 10.1002/nbm.1298; Xu JQ, 2013, NEUROIMAGE, V67, P64, DOI 10.1016/j.neuroimage.2012.11.014	39	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155557	10.1371/journal.pone.0155557	http://dx.doi.org/10.1371/journal.pone.0155557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171194	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000376588600162
J	Banerjee, A; Sindhava, V; Vuyyuru, R; Jha, V; Hodewadekar, S; Manser, T; Atchison, ML				Banerjee, Anupam; Sindhava, Vishal; Vuyyuru, Raja; Jha, Vibha; Hodewadekar, Suchita; Manser, Tim; Atchison, Michael L.			YY1 Is Required for Germinal Center B Cell Development	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YY1; POLYCOMB-GROUP PROTEINS; HISTONE H3; PCG RECRUITMENT; REPO DOMAIN; DNA-BINDING; IN-VIVO; EXPRESSION; LYMPHOMAGENESIS; METHYLATION	YY1 has been implicated as a master regulator of germinal center B cell development as YY1 binding sites are frequently present in promoters of germinal center-expressed genes. YY1 is known to be important for other stages of B cell development including the pro-B and pre-B cells stages. To determine if YY1 plays a critical role in germinal center development, we evaluated YY1 expression during B cell development, and used a YY1 conditional knock-out approach for deletion of YY1 in germinal center B cells (CRE driven by the immunoglobulin heavy chain gamma 1 switch region promoter; gamma 1-CRE). We found that YY1 is most highly expressed in germinal center B cells and is increased 3 fold in splenic B cells activated by treatment with anti-IgM and anti-CD40. In addition, deletion of the yy1 gene by action of gamma 1-CRE recombinase resulted in significant loss of GC cells in both un-immunized and immunized contexts with corresponding loss of serum IgG1. Our results show a crucial role for YY1 in the germinal center reaction.	[Banerjee, Anupam; Sindhava, Vishal; Jha, Vibha; Hodewadekar, Suchita; Atchison, Michael L.] Univ Penn, Sch Vet Med, Dept Biomed Sci, 3800 Spruce St, Philadelphia, PA 19104 USA; [Vuyyuru, Raja; Manser, Tim] Thomas Jefferson Univ, Dept Microbiol & Immunol, 233 South Tenth St, Philadelphia, PA 19107 USA; [Vuyyuru, Raja] Bristol Myers Squibb Co, Dept Immunooncol, Lawrenceville, NJ 08648 USA	University of Pennsylvania; Jefferson University; Bristol-Myers Squibb	Atchison, ML (corresponding author), Univ Penn, Sch Vet Med, Dept Biomed Sci, 3800 Spruce St, Philadelphia, PA 19104 USA.	atchison@vet.upenn.edu			 [R01 AI079002];  [R01 GM111384];  [W81XWH-14-1-0171]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111384] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 AI079002 http://www.niaid.nih.gov, R01 GM111384 http://www.nigms.nih.gov, and W81XWH-14-1-0171 http://mrmc.amedd.army.mil.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Basu A, 2014, NUCLEIC ACIDS RES, V42, P2208, DOI 10.1093/nar/gkt1187; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Caganova M, 2013, J CLIN INVEST, V123, P5009, DOI 10.1172/JCI70626; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Calame K, 2007, GENE DEV, V21, P1145, DOI 10.1101/gad.1559007; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Duke JL, 2013, J IMMUNOL, V190, P3878, DOI 10.4049/jimmunol.1202547; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Green MR, 2011, P NATL ACAD SCI USA, V108, P2873, DOI 10.1073/pnas.1019537108; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pan X, 2013, EMBO J, V32, P1168, DOI 10.1038/emboj.2013.66; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Raaphorst FM, 2000, J IMMUNOL, V164, P1, DOI 10.4049/jimmunol.164.1.1; Recaldin T, 2016, CLIN EXP IMMUNOL, V183, P65, DOI 10.1111/cei.12702; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Srinivasan L, 2005, J CELL BIOCHEM, V96, P689, DOI 10.1002/jcb.20562; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; Wilkinson F, 2010, J CELL BIOCHEM, V109, P478, DOI 10.1002/jcb.22424; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Zaprazna K, 2012, MOL CELL BIOL, V32, P1542, DOI 10.1128/MCB.05989-11	40	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155311	10.1371/journal.pone.0155311	http://dx.doi.org/10.1371/journal.pone.0155311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167731	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300108
J	Svahn, SL; Varemo, L; Gabrielsson, BG; Peris, E; Nookaew, I; Grahnemo, L; Sandberg, AS; Asterholm, IW; Jansson, JO; Nielsen, J; Johansson, ME				Svahn, Sara L.; Varemo, Leif; Gabrielsson, Britt G.; Peris, Eduard; Nookaew, Intawat; Grahnemo, Louise; Sandberg, Ann-Sofie; Asterholm, Ingrid Wernstedt; Jansson, John-Olov; Nielsen, Jens; Johansson, Maria E.			Six Tissue Transcriptomics Reveals Specific Immune Suppression in Spleen by Dietary Polyunsaturated Fatty Acids	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; DECREASE BACTERIAL LOAD; ADIPOSE-TISSUE; METABOLIC SYNDROME; INCREASE SURVIVAL; GENE-EXPRESSION; OBESE MICE; INFLAMMATION; LIVER; OMEGA-3-FATTY-ACIDS	Dietary polyunsaturated fatty acids (PUFA) are suggested to modulate immune function, but the effects of dietary fatty acids composition on gene expression patterns in immune organs have not been fully characterized. In the current study we investigated how dietary fatty acids composition affects the total transcriptome profile, and especially, immune related genes in two immune organs, spleen (SPL) and bone marrow cells (BMC). Four tissues with metabolic function, skeletal muscle (SKM), white adipose tissue (WAT), brown adipose tissue (BAT), and liver (LIV), were investigated as a comparison. Following 8 weeks on low fat diet (LFD), high fat diet (HFD) rich in saturated fatty acids (HFD-S), or HFD rich in PUFA (HFD-P), tissue transcriptomics were analyzed by microarray and metabolic health assessed by fasting blood glucose level, HOMA-IR index, oral glucose tolerance test as well as quantification of crown-like structures in WAT. HFD-P corrected the metabolic phenotype induced by HFD-S. Interestingly, SKM and BMC were relatively inert to the diets, whereas the two adipose tissues (WAT and BAT) were mainly affected by HFD per se (both HFD-S and HFD-P). In particular, WAT gene expression was driven closer to that of the immune organs SPL and BMC by HFDs. The LIV exhibited different responses to both of the HFDs. Surprisingly, the spleen showed a major response to HFD-P (82 genes differed from LFD, mostly immune genes), while it was not affected at all by HFD-S (0 genes differed from LFD). In conclusion, the quantity and composition of dietary fatty acids affected the transcriptome in distinct manners in different organs. Remarkably, dietary PUFA, but not saturated fat, prompted a specific regulation of immune related genes in the spleen, opening the possibility that PUFA can regulate immune function by influencing gene expression in this organ.	[Svahn, Sara L.; Peris, Eduard; Asterholm, Ingrid Wernstedt; Jansson, John-Olov; Johansson, Maria E.] Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Varemo, Leif; Gabrielsson, Britt G.; Nookaew, Intawat; Sandberg, Ann-Sofie; Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn, S-41296 Gothenburg, Sweden; [Nookaew, Intawat] Oak Ridge Natl Lab, Comparat Genom Grp, Biosci Div, Oak Ridge, TN USA; [Grahnemo, Louise] Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Nookaew, Intawat] Univ Arkansas Med Sci, Coll Med, Dept Biomed Informat, Little Rock, AR 72205 USA	Chalmers University of Technology; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Arkansas System; University of Arkansas Medical Sciences	Svahn, SL (corresponding author), Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden.	maria.e.johansson@neuro.gu.se	Grahnemo, Louise/H-9407-2017; sandberg, ann-sofie/B-6857-2016; Asterholm, Ingrid Wernstedt/AAK-3682-2020; Nielsen, Jens/Q-1347-2017	Grahnemo, Louise/0000-0001-5276-6612; sandberg, ann-sofie/0000-0002-9681-3342; Varemo, Leif/0000-0003-4153-5354; Peris Franquet, Eduard/0000-0002-9237-3263; Wernstedt Asterholm, Ingrid/0000-0002-0755-5784; Nielsen, Jens/0000-0002-9955-6003	Swedish Research Council [K2013-54X-09894-19-3, 2012-1601, 2010-2667]; Swedish Society of Medicine; Sahlgrenska Center for Cardiovascular Metabolic Research (CMR) [A305:188]; Swedish Strategic Foundation; EC FP7 [Full4Health FP7-KBBE-2010-4-266408]; Knut and Alice Wallenberg Foundation; Magnus Bergvall Foundation; Langmanska Kulturfonden; Stiftelsen Gamla trotjanarinnor; OE och Edla Johanssons vetenskapliga Stiftelse; Lars Hiertas Foundation; Ake Wiberg Foundation; NovoNordisk Excellence Project Award; Diabetesfonden; Diabetes Wellness Research Foundation; Stiftelsen Tornspiran; Novo Nordisk Fonden [NNF12OC1016065] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Sahlgrenska Center for Cardiovascular Metabolic Research (CMR); Swedish Strategic Foundation; EC FP7(European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Magnus Bergvall Foundation; Langmanska Kulturfonden; Stiftelsen Gamla trotjanarinnor; OE och Edla Johanssons vetenskapliga Stiftelse; Lars Hiertas Foundation; Ake Wiberg Foundation; NovoNordisk Excellence Project Award; Diabetesfonden; Diabetes Wellness Research Foundation; Stiftelsen Tornspiran; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swedish Research Council (K2013-54X-09894-19-3, 2012-1601 and 2010-2667), the Swedish Society of Medicine, the Sahlgrenska Center for Cardiovascular Metabolic Research (CMR, no. A305:188), which is supported by the Swedish Strategic Foundation, EC FP7 funding (Full4Health FP7-KBBE-2010-4-266408), the Knut and Alice Wallenberg Foundation, the Magnus Bergvall Foundation, Langmanska Kulturfonden, Stiftelsen Gamla trotjanarinnor, OE och Edla Johanssons vetenskapliga Stiftelse, the Lars Hiertas Foundation, the Ake Wiberg Foundation, NovoNordisk Excellence Project Award, Diabetesfonden, Diabetes Wellness Research Foundation and Stiftelsen Tornspiran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rangel-Zuniga OA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1725-8; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Calder PC, 2012, MOL NUTR FOOD RES, V56, P1073, DOI 10.1002/mnfr.201100710; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Dessi Mariarita, 2013, ISRN Inflamm, V2013, P191823, DOI 10.1155/2013/191823; Flock MR, 2011, CURR ATHEROSCLER REP, V13, P499, DOI 10.1007/s11883-011-0205-0; Hammamieh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090425; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Janczyk W, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-85; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kim J, 2015, INT J OBES LOND; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kolehmainen M, 2015, AM J CLIN NUTR, V101, P228, DOI 10.3945/ajcn.114.092783; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Oarada M, 2000, BBA-MOL CELL BIOL L, V1487, P1, DOI 10.1016/S1388-1981(00)00076-7; Oliveira V, 2015, ENDOCRINOLOGY, V156, P4033, DOI 10.1210/en.2014-1880; Oliveira V, 2015, ENDOCRINOLOGY; Philp LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117494; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saraswathi V, 2007, J NUTR, V137, P1776, DOI 10.1093/jn/137.7.1776; Schumann J, 2015, EUR J PHARM; Schwab U, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.25145; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Spadaro L, 2008, DIGEST LIVER DIS, V40, P194, DOI 10.1016/j.dld.2007.10.003; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Svahn SL, 2016, INFECT IMMUN, V84, P1205, DOI 10.1128/IAI.01391-15; Svahn SL, 2015, INFECT IMMUN, V83, P514, DOI 10.1128/IAI.02349-14; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	44	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155099	10.1371/journal.pone.0155099	http://dx.doi.org/10.1371/journal.pone.0155099			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166587	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300089
J	Wilson, SE; Rosella, LC; Wang, J; Le Saux, N; Crowcroft, NS; Harris, T; Bolotin, S; Deeks, SL				Wilson, Sarah E.; Rosella, Laura C.; Wang, Jun; Le Saux, Nicole; Crowcroft, Natasha S.; Harris, Tara; Bolotin, Shelly; Deeks, Shelley L.			Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects	PLOS ONE			English	Article							ACUTE GASTROENTERITIS HOSPITALIZATIONS; DIARRHEA-ASSOCIATED HOSPITALIZATIONS; HEALTH-CARE UTILIZATION; US CHILDREN; UNITED-STATES; INDIRECT PROTECTION; LESS-THAN-5 YEARS; VACCINE PROGRAM; OLDER CHILDREN; REDUCTION	Objective To evaluate the direct and indirect population impact of rotavirus (RV) immunization on hospitalizations and emergency department (ED) visits for acute gastroenteritis (AGE) in Ontario before and after the publicly-funded RV immunization program. Methods Administrative data was used to identify ED visits and hospitalizations for all Ontarians using ICD-10 codes. We used two outcome definitions: RV-specific AGE (RV-AGE) and codes representing RV-, other viral and cause unspecified AGE ("overall AGE"). The preprogram and public program periods were August 1, 2005 to July 31, 2011; and August 1, 2011 to March 31, 2013, respectively. A negative binominal regression model that included the effect of time was used to calculate rates and rate ratios (RRs) and 95% confidence intervals (CIs) for RV-AGE and overall AGE between periods, after adjusting for age, seasonality and secular trends. Analyses were conducted for all ages combined and age stratified. Results Relative to the pre-program period, the adjusted RRs for RV-AGE and overall AGE hospitalizations in the public program period were 0.29 (95% CI: 0.22-0.39) and 0.68 (95% CI: 0.62-0.75), respectively. Significant reductions in RV-AGE hospitalizations were noted overall and for the following age bands: < 12 months, 12-23 months, 24-35 months, 3-4 years, and 5-19 years. Significant declines in overall AGE hospitalizations were observed across all age bands, including older adults > = 65 years (RR 0.80, 95% CI: 0.72-0.90). The program was associated with adjusted RRs of 0.32 (95% CI: 0.20-0.52) for RV-AGE ED visits and 0.90 (95% CI: 0.85-0.96) for overall AGE ED visits. Conclusions This large, population-based study provides evidence of the impact of RV vaccine in preventing hospitalizations and ED visits for RV-AGE and overall AGE, including herd effects.	[Wilson, Sarah E.; Rosella, Laura C.; Wang, Jun; Crowcroft, Natasha S.; Harris, Tara; Bolotin, Shelly; Deeks, Shelley L.] Publ Hlth Ontario, Toronto, ON, Canada; [Wilson, Sarah E.; Rosella, Laura C.; Crowcroft, Natasha S.; Bolotin, Shelly; Deeks, Shelley L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Wilson, Sarah E.; Rosella, Laura C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Le Saux, Nicole] Childrens Hosp Eastern Ontario, Div Infect Dis, Ottawa, ON K1H 8L1, Canada; [Le Saux, Nicole] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Crowcroft, Natasha S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Toronto	Wilson, SE (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Wilson, SE (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Wilson, SE (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	sarah.wilson@oahpp.ca		Wilson, Sarah/0000-0002-8239-0094	Public Health Ontario; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC	Public Health Ontario; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC	This project was funded by Public Health Ontario (http://www.publichealthontario.ca) and conducted at the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Lauren Ramsay for her assistance with the preparation of several figures presented in this manuscript, GSK Canada and Merck Frosst Canada for their provision of private RV vaccine sales data to the project team, and to the Public Health Division of the Ontario Ministry of Health and Long-Term Care (MOHLTC) who provided access to the vaccine distribution data through the Ontario Government Pharmacy and Medical Supply Service (OGPMSS). This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario MOHLTC. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and information compiled and provided by CIHI. However, the analyses, conclusions, opinions and statements expressed herein are those of the authors, and not necessarily those of CIHI.	Anderson EJ, 2013, CLIN INFECT DIS, V56, P755, DOI 10.1093/cid/cis1010; [Anonymous], 2010, Canada Communicable Disease Report, V36, P1; Braeckman T, 2011, PEDIATR INFECT DIS J, V30, pS21, DOI 10.1097/INF.0b013e3181fefc51; Brisson M, 2010, PEDIATR INFECT DIS J, V29, P73, DOI 10.1097/INF.0b013e3181b41506; Buigues Rene-Pierre, 2002, Can J Infect Dis, V13, P239; Canadian Immunization Committee, REC ROT PROGR CAN IM; Canadian Institute for Health Information, 2009, COD STAND VERS 2009; Comeau JL, 2016, VACCINE, V34, P893, DOI 10.1016/j.vaccine.2016.01.007; Cortes JE, 2011, NEW ENGL J MED, V365, P1108, DOI 10.1056/NEJMoa1000446; Cortese MM, 2010, PEDIATR INFECT DIS J, V29, P489, DOI 10.1097/INF.0b013e3181d95b53; Coyle D, 2012, CAN J INFECT DIS MED, V23, P71, DOI 10.1155/2012/327054; Curns AT, 2010, J INFECT DIS, V201, P1617, DOI 10.1086/652403; Desai R, 2012, CLIN INFECT DIS, V55, pE28, DOI 10.1093/cid/cis443; Field EJ, 2010, PEDIATRICS, V126, pE506, DOI 10.1542/peds.2010-0443; Gastanaduy PA, 2013, JAMA-J AM MED ASSOC, V310, P851, DOI 10.1001/jama.2013.170800; Givon-Lavi N, 2015, VACCINE, V33, P1934, DOI 10.1016/j.vaccine.2015.02.062; GlaxoSmithKline Inc, 2014, PROD MON ROTARIX; Hsu VP, 2005, PEDIATRICS, V115, P78, DOI 10.1542/peds.2004-0860; do Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024; Jayasinghe S, 2013, VACCINE, V31, P967, DOI 10.1016/j.vaccine.2012.11.099; Lambert SB, 2009, MED J AUSTRALIA, V191, P157, DOI 10.5694/j.1326-5377.2009.tb02727.x; Le Saux N, 2012, PEDIATR INFECT DIS J, V31, P159, DOI 10.1097/INF.0b013e3182375011; Leshem E, 2015, JAMA-J AM MED ASSOC, V313, P2282, DOI 10.1001/jama.2015.5571; Leshem E, 2014, PEDIATRICS, V134, P15, DOI 10.1542/peds.2013-3849; Lopman BA, 2011, J INFECT DIS, V204, P980, DOI 10.1093/infdis/jir492; Merck Frosst Canada Ltd, 2013, PROD MON ROTATEQ; Molto Y, 2011, PEDIATR INFECT DIS J, V30, pS16, DOI 10.1097/INF.0b013e3181fefc68; National Advisory Committee on Immunization (NACI), 2008, Can Commun Dis Rep, V34, P1; Patel MM, 2007, PEDIATR INFECT DIS J, V26, P914, DOI 10.1097/INF.0b013e31812e52fd; Paulke-Korinek M, 2011, VACCINE, V29, P2791, DOI 10.1016/j.vaccine.2011.01.104; Public Health Agency of Canada (PHAC), PUBL FUND IMM PROGR; Quintanar-Solares M, 2011, PEDIATR INFECT DIS J, V30, pS11, DOI 10.1097/INF.0b013e3181fefb32; Raes M, 2011, PEDIATR INFECT DIS J, V30, pE120, DOI 10.1097/INF.0b013e318214b811; Sanford C, 2015, HUM VACC IMMUNOTHER, V11, P870, DOI 10.1080/21645515.2015.1012028; Saux N. le, 2011, Journal of Infection Prevention, V12, P159, DOI 10.1177/1757177411402409; Senecal M, 2006, CAN PUBL HLTH ASS 97; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Wilson Sarah E, 2015, BMC Res Notes, V8, P439, DOI 10.1186/s13104-015-1412-5; Wong K., 2014, ONT PUBL HLTH C MARC ONT PUBL HLTH C MARC; Yen C, 2011, PEDIATRICS, V127, pE9, DOI 10.1542/peds.2010-1393	40	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154340	10.1371/journal.pone.0154340	http://dx.doi.org/10.1371/journal.pone.0154340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168335	Green Published, gold			2022-12-27	WOS:000376587300079
J	Alluri, H; Wilson, RL; Shaji, CA; Wiggins-Dohlvik, K; Patel, S; Liu, Y; Peng, X; Beeram, MR; Davis, ML; Huang, JH; Tharakan, B				Alluri, Himakarnika; Wilson, Rickesha L.; Shaji, Chinchusha Anasooya; Wiggins-Dohlvik, Katie; Patel, Savan; Liu, Yang; Peng, Xu; Beeram, Madhava R.; Davis, Matthew L.; Huang, Jason H.; Tharakan, Binu			Melatonin Preserves Blood-Brain Barrier Integrity and Permeability via Matrix Metalloproteinase-9 Inhibition	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; CEREBROSPINAL-FLUID; IN-VITRO; INJURY; INTERLEUKIN-1; MICE; METALLOPROTEINASES; HYPERPERMEABILITY; DYSFUNCTION; OCCLUDIN	Microvascular hyperpermeability that occurs at the level of the blood-brain barrier (BBB) often leads to vasogenic brain edema and elevated intracranial pressure following traumatic brain injury (TBI). At a cellular level, tight junction proteins (TJPs) between neighboring endothelial cells maintain the integrity of the BBB via TJ associated proteins particularly, zonula occludens-1 (ZO-1) that binds to the transmembrane TJPs and actin cytoskeleton intracellularly. The pro-inflammatory cytokine, interleukin-1 beta (IL-1 beta) as well as the proteolytic enzymes, matrix metalloproteinase-9 (MMP-9) are key mediators of trauma-associated brain edema. Recent studies indicate that melatonin a pineal hormone directly binds to MMP-9 and also might act as its endogenous inhibitor. We hypothesized that melatonin treatment will provide protection against TBI-induced BBB hyperpermeability via MMP-9 inhibition. Rat brain microvascular endothelial cells grown as monolayers were used as an in vitro model of the BBB and a mouse model of TBI using a controlled cortical impactor was used for all in vivo studies. IL-1 beta (10 ng/mL; 2 hours)-induced endothelial monolayer hyperpermeability was significantly attenuated by melatonin (10 mu g/mL; 1 hour), GM6001 (broad spectrum MMP inhibitor; 10 mu M; 1 hour), MMP-9 inhibitor-1 (MMP-9 specific inhibitor; 5 nM; 1 hour) or MMP-9 siRNA transfection (48 hours) in vitro. Melatonin and MMP-9 inhibitor-1 pretreatment attenuated IL-1 beta-induced MMP-9 activity, loss of ZO-1 junctional integrity and f-actin stress fiber formation. IL-1 beta treatment neither affected ZO-1 protein or mRNA expression or cell viability. Acute melatonin treatment attenuated BBB hyperpermeability in a mouse controlled cortical impact model of TBI in vivo. In conclusion, one of the protective effects of melatonin against BBB hyperpermeability occurs due to enhanced BBB integrity via MMP-9 inhibition. In addition, acute melatonin treatment provides protection against BBB hyperpermeability in a mouse model of TBI indicating its potential as a therapeutic agent for brain edema when established in humans.	[Alluri, Himakarnika; Wilson, Rickesha L.; Shaji, Chinchusha Anasooya; Wiggins-Dohlvik, Katie; Patel, Savan; Tharakan, Binu] Texas A&M Univ, Coll Med, Dept Surg, Baylor Scott & White Hlth,Hlth Sci Ctr, Temple, TX 76508 USA; [Liu, Yang; Peng, Xu; Davis, Matthew L.] Texas A&M Univ, Coll Med, Dept Med Physiol, Hlth Sci Ctr, Temple, TX 76508 USA; [Beeram, Madhava R.] Texas A&M Univ, Coll Med, Dept Pediat, Baylor Scott & White Hlth,Hlth Sci Ctr, Temple, TX 76508 USA; [Huang, Jason H.] Texas A&M Univ, Coll Med, Dept Neurosurg, Baylor Scott & White Hlth,Hlth Sci Ctr, Temple, TX 76508 USA; [Wilson, Rickesha L.] Univ Connecticut, Sch Med, Dept Surg, Farmington, CT USA	Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Connecticut	Tharakan, B (corresponding author), Texas A&M Univ, Coll Med, Dept Surg, Baylor Scott & White Hlth,Hlth Sci Ctr, Temple, TX 76508 USA.	btharakan@medicine.tamhsc.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	Baylor Scott and White Health Academic Operations	Baylor Scott and White Health Academic Operations	We acknowledge the Baylor Scott and White Health Academic Operations for financial Support and Texas A&M University Health Science Center Integrated Microscopy and Imaging Laboratory for the use of Olympus confocal laser microscope. We also acknowledge Mr. Glen Cryer for his help with manuscript preparation.	Adderley SP, 2015, AM J PHYSIOL-CELL PH, V309, pC51, DOI 10.1152/ajpcell.00096.2015; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Amin ARMR, 2003, GENES CELLS, V8, P515, DOI 10.1046/j.1365-2443.2003.00652.x; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Blamire AM, 2000, J NEUROSCI, V20, P8153; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; Breslin JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117970; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; Chen F, 2009, HEPATOLOGY, V50, P1914, DOI 10.1002/hep.23203; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Coisne C, 2011, ANTIOXID REDOX SIGN, V15, P1285, DOI 10.1089/ars.2011.3929; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Dong LP, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/370804; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Rigor RR, 2012, AM J PHYSIOL-CELL PH, V302, pC1513, DOI 10.1152/ajpcell.00371.2011; Rudra DS, 2013, J PINEAL RES, V54, P398, DOI 10.1111/jpi.12034; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Simao F, 2012, J CEREBR BLOOD F MET, V32, P884, DOI 10.1038/jcbfm.2012.2; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Stagg HW, 2013, J TRAUMA ACUTE CARE, V75, P1040, DOI 10.1097/TA.0b013e3182aa9c79; Vermeer PD, 2009, AM J PHYSIOL-LUNG C, V296, pL751, DOI 10.1152/ajplung.90578.2008; Wiggins-Dohlvik K, 2014, AM J SURG, V208, P954, DOI 10.1016/j.amjsurg.2014.08.014; Wiggins-Dohlvik K, 2014, J TRAUMA ACUTE CARE, V77, P899, DOI 10.1097/TA.0000000000000346; Wu BH, 2010, TRANSL STROKE RES, V1, P57, DOI 10.1007/s12975-009-0002-z	28	85	89	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154427	10.1371/journal.pone.0154427	http://dx.doi.org/10.1371/journal.pone.0154427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152411	Green Published, gold			2022-12-27	WOS:000375677000020
J	Dang, BJ; Mao, DQ; Luo, Y				Dang, Bingjun; Mao, Daqing; Luo, Yi			Complete Nucleotide Sequence of IncP-1 beta Plasmid pDTC28 Reveals a Non-Functional Variant of the bla(GES)-Type Gene	PLOS ONE			English	Article							ACINETOBACTER-BAUMANNII; ESCHERICHIA-COLI; RESISTANCE GENES; CARBAPENEM RESISTANCE; BETA-LACTAMASES; TREATMENT-PLANT; EMERGENCE; TRANSPOSON; BLA(GES-5); MERCURY	Plasmid pDTC28 was isolated from the sediments of Haihe River using E. coli CV601 (gfp-tagged) as recipient and indigenous bacteria from the sediment as donors. This plasmid confers reduced susceptibility to tetracycline and sulfamethoxazole. The complete sequence of plasmid pDTC28 was 61,503 bp in length with an average G+C content of 64.09%. Plasmid pDTC28 belongs to the IncP-1 beta group by phylogenetic analysis. The backbones of plasmid pDTC28 and other IncP-1 beta plasmids are very classical and conserved, whereas the accessory regions of these plasmids are diverse. A bla(GES)-5-like gene was found on the accessory region, and this bla(GES)-5-like gene contained 18 silent mutations and 7 missense mutations compared with the bla(GES)-5 gene. The mutations resulted in 7 amino acid substitutions in GES-5 carbapenemase, causing the loss of function of the bla(GES)-5-like gene on plasmid pDTC28 against carbapenems and even beta-lactams. The enzyme produced by the bla(GES)-5-like gene cassette may be a new variant of GES-type enzymes. Thus, the plasmid sequenced in this study will expand our understanding of GES-type beta-lactamases and provide insights into the genetic platforms used for the dissemination of GES-type genes.	[Dang, Bingjun; Mao, Daqing] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China; [Dang, Bingjun; Luo, Yi] Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China	Tianjin University; Nankai University	Mao, DQ (corresponding author), Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.; Luo, Y (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China.	mao@tju.edu.cn; luoy@nankai.edu.cn			National Science Fund for Distinguished Young Scholars [41525013]; National Natural Science Foundation of China [31270542, 41473085]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Fund for Distinguished Young Scholars (41525013), National Natural Science Foundation of China (Grants 31270542 and 41473085).; We are greatly thankful to Professor Holger Heuer (Julius Kuhn-Institut) for providing Escherichia coli CV601 and Escherichia coli J53. This work was supported by the National Science Fund for Distinguished Young Scholars (41525013) and the National Natural Science Foundation of China (Grants 31270542 and 41473085).	Biehle LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143845; Bonnin RA, 2013, ANTIMICROB AGENTS CH, V57, P183, DOI 10.1128/AAC.01384-12; Boyd D, 2015, MICROB DRUG RESIST, V21, P253, DOI 10.1089/mdr.2014.0205; Chen TL, 2010, ANTIMICROB AGENTS CH, V54, P4575, DOI 10.1128/AAC.00764-10; Chen ZL, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN VEHICLES AND TRANSPORTATION SYSTEMS (CIVTS), P1, DOI [10.1109/NSSMIC.2014.7430851, 10.1109/CIVTS.2014.7009470]; Corvec S, 2007, ANTIMICROB AGENTS CH, V51, P1530, DOI 10.1128/AAC.01132-06; da Fonseca EL, 2007, J ANTIMICROB CHEMOTH, V59, P576, DOI 10.1093/jac/dkl517; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Gales AC, 2003, J ANTIMICROB CHEMOTH, V52, P699, DOI 10.1093/jac/dkg416; Girlich D, 2012, APPL ENVIRON MICROB, V78, P1292, DOI 10.1128/AEM.06841-11; Hammoudi D, 2015, INT J INFECT DIS, V36, P56, DOI 10.1016/j.ijid.2015.05.015; Heuer H, 2002, FEMS MICROBIOL ECOL, V42, P289, DOI 10.1111/j.1574-6941.2002.tb01019.x; Kim J, 2011, ANTIMICROB AGENTS CH, V55, P2974, DOI 10.1128/AAC.01703-10; Kotsakis SD, 2010, ANTIMICROB AGENTS CH, V54, P4864, DOI 10.1128/AAC.00771-10; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Loftie-Eaton W, 2012, PLASMID, V67, P15, DOI 10.1016/j.plasmid.2011.10.001; Marchaim D, 2008, ANTIMICROB AGENTS CH, V52, P1413, DOI 10.1128/AAC.01103-07; Moller AK, 2014, FEMS MICROBIOL ECOL, V87, P52, DOI 10.1111/1574-6941.12189; Oosterkamp MJ, 2011, J BACTERIOL, V193, P5028, DOI 10.1128/JB.00365-11; Papagiannitsis CC, 2015, ANTIMICROB AGENTS CH, V59, P5065, DOI 10.1128/AAC.00937-15; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2010, J ANTIMICROB CHEMOTH, V65, P1594, DOI 10.1093/jac/dkq166; Poirel L, 2009, ANTIMICROB AGENTS CH, V53, P2492, DOI 10.1128/AAC.00033-09; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Rasmussen BA, 1996, ANTIMICROBIAL AGENTS, V40; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Schluter A, 2005, PLASMID, V54, P135, DOI 10.1016/j.plasmid.2005.03.001; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.26570-0; Sen D, 2011, APPL ENVIRON MICROB, V77, P7975, DOI 10.1128/AEM.05439-11; Shen P, 2009, ANTIMICROB AGENTS CH, V53, P4333, DOI 10.1128/AAC.00260-09; Shi JB, 2005, ENVIRON INT, V31, P357, DOI 10.1016/j.envint.2004.08.008; Smalla K, 2006, APPL ENVIRON MICROB, V72, P7253, DOI 10.1128/AEM.00922-06; Sone Y, 2013, BIOL PHARM BULL, V36, P1835; Sota M, 2003, J BACTERIOL, V185, P6741, DOI 10.1128/JB.185.22.6741-6745.2003; Trefault N, 2004, ENVIRON MICROBIOL, V6, P655, DOI 10.1111/j.1462-2920.2004.00596.x; Xiong JH, 2013, ANTIMICROB AGENTS CH, V57, P3775, DOI 10.1128/AAC.00423-13; YAKOBSON E, 1983, MOL GEN GENET, V192, P436, DOI 10.1007/BF00392187; Yano H, 2013, MICROBIOL-SGM, V159, P2303, DOI 10.1099/mic.0.068387-0; Yoshii A, 2015, MOL PLANT PATHOL, V16, P288, DOI 10.1111/mpp.12182; Zhou ZH, 2011, ANTIMICROB AGENTS CH, V55, P5347, DOI 10.1128/AAC.00425-11	44	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154975	10.1371/journal.pone.0154975	http://dx.doi.org/10.1371/journal.pone.0154975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152950	Green Published, gold			2022-12-27	WOS:000375677000054
J	Hoins, M; Eberlein, T; Grossmann, CH; Brandenburg, K; Reichart, GJ; Rost, B; Sluijs, A; Van de Waal, DB				Hoins, Mirja; Eberlein, Tim; Grossmann, Christian H.; Brandenburg, Karen; Reichart, Gert-Jan; Rost, Bjoern; Sluijs, Appy; Van de Waal, Dedmer B.			Combined Effects of Ocean Acidification and Light or Nitrogen Availabilities on C-13 Fractionation in Marine Dinoflagellates	PLOS ONE			English	Article							CARBON-ISOTOPE FRACTIONATION; GROWTH-RATE; INORGANIC-CARBON; CO2 CONCENTRATION; PHYTOPLANKTON; ACQUISITION; PH; PHOTOSYNTHESIS; DISSOCIATION; MECHANISMS	Along with increasing oceanic CO2 concentrations, enhanced stratification constrains phytoplankton to shallower upper mixed layers with altered light regimes and nutrient concentrations. Here, we investigate the effects of elevated pCO(2) in combination with light or nitrogen-limitation on C-13 fractionation (epsilon(p)) in four dinoflagellate species. We cultured Gonyaulax spinifera and Protoceratium reticulatum in dilute batches under low-light ('LL') and high-light ('HL') conditions, and grew Alexandrium fundyense and Scrippsiella trochoidea in nitrogen-limited continuous cultures ('LN') and nitrogen-replete batches ('HN'). The observed CO2-dependency of epsilon(p) remained unaffected by the availability of light for both G. spinifera and P. reticulatum, though at HL epsilon(p) was consistently lower by about 2.7 parts per thousand over the tested CO2 range for P. reticulatum. This may reflect increased uptake of (C-13-enriched) bicarbonate fueled by increased ATP production under HL conditions. The observed CO2-dependency of epsilon(p) disappeared under LN conditions in both A. fundyense and S. trochoidea. The generally higher epsilon(p) under LN may be associated with lower organic carbon production rates and/or higher ATP: NADPH ratios. CO2-dependent epsilon(p) under non-limiting conditions has been observed in several dinoflagellate species, showing potential for a new CO2-proxy. Our results however demonstrate that light-and nitrogen-limitation also affect epsilon(p), thereby illustrating the need to carefully consider prevailing environmental conditions.	[Hoins, Mirja; Reichart, Gert-Jan; Sluijs, Appy] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands; [Hoins, Mirja; Eberlein, Tim; Grossmann, Christian H.; Brandenburg, Karen; Rost, Bjoern] Alfred Wegener Inst Helmholtz Ctr Polar & Marine, Marine Biogeosci, Bremerhaven, Germany; [Van de Waal, Dedmer B.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Reichart, Gert-Jan] Royal Netherlands Inst Sea Res NIOZ, Dept Geol, Den Hoorn, Texel, Netherlands	Utrecht University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Hoins, M (corresponding author), Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands.; Hoins, M (corresponding author), Alfred Wegener Inst Helmholtz Ctr Polar & Marine, Marine Biogeosci, Bremerhaven, Germany.	mhoins@awi.de	Rost, Bjoern/B-4447-2015; Reichart, Gert-Jan/N-6308-2018; Sluijs, Appy/B-3726-2009; Van de Waal, Dedmer B/B-8002-2012; KNAW, NIOO-KNAW/A-4320-2012	Rost, Bjoern/0000-0001-5452-5505; Reichart, Gert-Jan/0000-0002-7256-2243; Sluijs, Appy/0000-0003-2382-0215; Van de Waal, Dedmer B/0000-0001-8803-1247; KNAW, NIOO-KNAW/0000-0002-3835-159X; Brandenburg, Karen/0000-0002-9342-3349	Darwin Centre for Biogeosciences [3021]; European Research Council under the European Community's Seventh Framework Program through ERC [259627, 205150]; German Ministry of Education and Research; Dutch Ministry of Education, Culture and Science (OCW)	Darwin Centre for Biogeosciences; European Research Council under the European Community's Seventh Framework Program through ERC; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Dutch Ministry of Education, Culture and Science (OCW)	This research was funded through Darwin Centre for Biogeosciences Grant 3021, awarded to GJR and AS, and the European Research Council under the European Community's Seventh Framework Program through ERC Starting Grants #259627 to AS and #205150 to BR. DBvdW and BR thank BIOACID, financed by the German Ministry of Education and Research. This work was carried out under the program of the Netherlands Earth System Science Centre (NESSC), financially supported by the Dutch Ministry of Education, Culture and Science (OCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; [Anonymous], 2014, IPCC 5 ASSESSMENT RE; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bidigare RR, 1997, GLOBAL BIOGEOCHEM CY, V11, P279, DOI 10.1029/96GB03939; Boller AJ, 2011, GEOCHIM COSMOCHIM AC, V75, P7200, DOI [10.1016/j.gca.2011.09.017, 10.1016/j.gca.2011.08.031]; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Burkhardt S, 1999, GEOCHIM COSMOCHIM AC, V63, P3729, DOI 10.1016/S0016-7037(99)00217-3; Burkhardt S, 1999, MAR ECOL PROG SER, V184, P31, DOI 10.3354/meps184031; Cembella A.D., 1989, Journal of Applied Phycology, V1, P307, DOI 10.1007/BF00003466; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; Eberlein T, 2015, MAR ECOL PR IN PRESS; Eberlein T, 2014, PHYSIOL PLANTARUM, V151, P468, DOI 10.1111/ppl.12137; Fensome R. A., 1993, MICROPALEONTOLOGY SP, V7, P1; Freeman KH, 1992, GLOBAL BIOGEOCHEM CY, V6, P185, DOI 10.1029/92GB00190; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; Hansen PJ, 2007, MAR ECOL PROG SER, V334, P63, DOI 10.3354/meps334063; Hansen PJ, 2002, AQUAT MICROB ECOL, V28, P279, DOI 10.3354/ame028279; Hinga KR, 2002, MAR ECOL PROG SER, V238, P281, DOI 10.3354/meps238281; Hoins M, 2015, GEOCHIM COSMOCHIM AC, V160, P267, DOI 10.1016/j.gca.2015.04.001; Hoppe CJM, 2012, BIOGEOSCIENCES, V9, P2401, DOI 10.5194/bg-9-2401-2012; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; John U, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1268; John U, 2014, PROTIST, V165, P779, DOI 10.1016/j.protis.2014.10.001; Johnson P.O., 1936, STAT RES MEMOIRS; KELLER MD, 1987, J PHYCOL, V23, P633; Knap A., 1996, PROTOCOLS JOINT GLOB, V1994, P19; Kranz SA, 2010, PLANT PHYSIOL, V154, P334, DOI 10.1104/pp.110.159145; Laws EA, 1997, LIMNOL OCEANOGR, V42, P1552, DOI 10.4319/lo.1997.42.7.1552; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; Pierrot D.E, 2006, PROGRAM DEV CO2 SYST; Polovina JJ, 1995, DEEP-SEA RES PT I, V42, P1701, DOI 10.1016/0967-0637(95)00075-H; Popp BN, 1998, GEOCHIM COSMOCHIM AC, V62, P69, DOI 10.1016/S0016-7037(97)00333-5; Rau GH, 1996, MAR ECOL PROG SER, V133, P275, DOI 10.3354/meps133275; RAVEN JA, 1991, LIMNOL OCEANOGR, V36, P1701, DOI 10.4319/lo.1991.36.8.1701; Riebesell U, 2000, MAR ECOL PROG SER, V193, P295, DOI 10.3354/meps193295; ROESKE CA, 1984, BIOCHEMISTRY-US, V23, P6275, DOI 10.1021/bi00320a058; Rokitta SD, 2012, LIMNOL OCEANOGR, V57, P607, DOI 10.4319/lo.2012.57.2.0607; Rost B, 2006, PLANT CELL ENVIRON, V29, P810, DOI 10.1111/j.1365-3040.2005.01450.x; Rost B, 2002, LIMNOL OCEANOGR, V47, P120, DOI 10.4319/lo.2002.47.1.0120; Sharkey T. D., 1985, INORGANIC CARBON UPT, P389; Steidinger K.A., 2008, OCEANS HUMAN HLTH, P239; Tchernov D, 1997, CURR BIOL, V7, P723, DOI 10.1016/S0960-9822(06)00330-7; Tchernov D, 2003, PHOTOSYNTH RES, V77, P95, DOI 10.1023/A:1025869600935; Tillmann U, 2009, HARMFUL ALGAE, V8, P759, DOI 10.1016/j.hal.2009.03.005; van de Waal DB, 2014, J PLANKTON RES, V36, P889, DOI 10.1093/plankt/fbt138; Van de Waal DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065987; WALL D, 1968, Micropaleontology (New York), V14, P265, DOI 10.2307/1484690; Whitney SM, 1998, AUST J PLANT PHYSIOL, V25, P131, DOI 10.1071/PP97131; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/0016-7037(95)91550-D	58	12	12	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154370	10.1371/journal.pone.0154370	http://dx.doi.org/10.1371/journal.pone.0154370			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153107	gold, Green Published, Green Submitted			2022-12-27	WOS:000375677000017
J	Huang, Q; Song, HQ; Ji, XM; Cheng, WY; Feng, J; Wu, J; Ma, QF				Huang, Qiang; Song, Hai-qing; Ji, Xun-ming; Cheng, Wei-yang; Feng, Juan; Wu, Jian; Ma, Qing-feng			Generalization of the Right Acute Stroke Prevention Strategies in Reducing in-Hospital Delays	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; TO-IMAGING TIME; INTRAVENOUS THROMBOLYSIS; NEEDLE TIME; IMPROVEMENT; IMPLEMENTATION; INTERVENTION; OUTCOMES; REGISTRY	The aim of this study was to reduce the door-to-needle (DTN) time of intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) through a comprehensive, hospital-based implementation strategy. The intervention involved a systemic literature review, identifying barriers to rapid IVT treatment at our hospital, setting target DTN time intervals, and building an evolving model for IVT candidate selection. The rate of non-in-hospital delay (DTN time <= 60 min) was set as the primary endpoint. A total of 348 IVT cases were enrolled in the study (202 and 146 in the pre- and post-intervention group, respectively). The median age was 61 years in both groups; 25.2% and 26.7% of patients in the pre- and post-intervention groups, respectively, were female. The post-intervention group had higher rates of dyslipidemia and minor stroke [defined as National Institutes of Health Stroke Scale (NIHSS) <= 3]; less frequent atrial fibrillation; higher numbers of current smokers, heavy drinkers, referrals, and multi-model head imaging cases; and lower NIHSS scores and blood sugar level (all P < 0.05). All parameters including DTN, door-to-examination, door-to-imaging, door-to-laboratory, and final-test-to-needle times were improved post-intervention (all P < 0.05), with net reductions of 63, 2, 4, 28, and 23 min, respectively. The rates of DTN time <= 60 min and onset-to-needle time <= 180 min were significantly improved by the intervention (pre: 9.9% vs. post: 60.3%; P < 0.001 and pre: 23.3% vs. post: 53.4%; P < 0.001, respectively), which was accompanied by an increase in the rate of neurological improvement (pre: 45.5% vs. post: 59.6%; P = 0.010), while there was no change in incidence of mortality or systemic intracranial hemorrhage at discharge (both P > 0.05). These findings indicate that it is possible to achieve a DTN time <= 60 min for up to 60% of hospitals in the current Chinese system, and that this logistical change can yield a notable improvement in the outcome of IVT patients.	[Huang, Qiang; Song, Hai-qing; Cheng, Wei-yang; Feng, Juan; Ma, Qing-feng] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Ji, Xun-ming] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China; [Huang, Qiang; Wu, Jian] Tsinghua Univ, Med Ctr, Beijing Tsinghua Changgung Hosp, Dept Neurol, Beijing 100084, Peoples R China	Capital Medical University; Capital Medical University; Tsinghua University	Ma, QF (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China.; Wu, J (corresponding author), Tsinghua Univ, Med Ctr, Beijing Tsinghua Changgung Hosp, Dept Neurol, Beijing 100084, Peoples R China.	wujianxuanwu@126.com; m.qingfeng@163.com	Ji, Xunming/AAN-3370-2021					Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Ahmed N, 2013, JAMA NEUROL, V70, P837, DOI 10.1001/jamaneurol.2013.406; Blumenthal D, 2015, NEW ENGL J MED, V372, P1281, DOI 10.1056/NEJMp1410425; Breuer L, 2013, EUR NEUROL, V69, P317, DOI 10.1159/000345702; Casolla B, 2013, J NEUROL, V260, P635, DOI 10.1007/s00415-012-6693-1; Dirks M, 2011, STROKE, V42, P1325, DOI 10.1161/STROKEAHA.110.596940; Ebinger M, 2014, JAMA-J AM MED ASSOC, V311, P1622, DOI 10.1001/jama.2014.2850; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Ferrari J, 2013, J NEUROL, V260, P2271, DOI 10.1007/s00415-013-6964-5; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Fonarow GC, 2011, STROKE, V42, P2983, DOI 10.1161/STROKEAHA.111.621342; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Gadhia J, 2010, STROKE, V41, P300, DOI 10.1161/STROKEAHA.109.566935; Huang Q, 2015, PLOS ONE, V10; [黄镪 Huang Qiang], 2016, [中国脑血管病杂志, Chinese Journal of Cerebrovascular Diseases], V13, P13; Huang Q, 2015, INT J STROKE, V10, pE80, DOI 10.1111/ijs.12568; Itrat A, 2015, JAMA NEUROL, P1; Lahr MMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079049; Liu M., 2015, CHIN J NEUROL, V48, P246; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Nolte CH, 2013, J STROKE CEREBROVASC, V22, P149, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.004; Rudd M, 2012, EMERG MED J, V29, P704, DOI 10.1136/emermed-2011-200582; Sauser K, 2014, JAMA NEUROL, V71, P1155, DOI 10.1001/jamaneurol.2014.1528; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Scott PA, 2013, LANCET NEUROL, V12, P139, DOI 10.1016/S1474-4422(12)70311-3; Soulleihet V, 2014, AM J EMERG MED, V32, P225, DOI 10.1016/j.ajem.2013.11.018; Thortveit ET, 2014, ACTA NEUROL SCAND, V130, P248, DOI 10.1111/ane.12204; Wang YL, 2011, STROKE, V42, P1658, DOI 10.1161/STROKEAHA.110.604249	28	5	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154972	10.1371/journal.pone.0154972	http://dx.doi.org/10.1371/journal.pone.0154972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152854	gold, Green Submitted, Green Published			2022-12-27	WOS:000375677000053
J	Bellomo, F; Taranta, A; Petrini, S; Venditti, R; Rocchetti, MT; Rega, LR; Corallini, S; Gesualdo, L; De Matteis, MA; Emma, F				Bellomo, Francesco; Taranta, Anna; Petrini, Stefania; Venditti, Rossella; Rocchetti, Maria Teresa; Rega, Laura Rita; Corallini, Serena; Gesualdo, Loreto; De Matteis, Maria Antonietta; Emma, Francesco			Carboxyl-Terminal SSLKG Motif of the Human Cystinosin-LKG Plays an Important Role in Plasma Membrane Sorting	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; BATTEN-DISEASE; PROTEIN; TRAFFICKING; TRANSPORTER; LYSOSOMES; RECEPTORS; GLUTAMATE; REQUIRES; CLN3	Cystinosin mediates an ATP-dependent cystine efflux from lysosomes and causes, if mutated, nephropathic cystinosis, a rare inherited lysosomal storage disease. Alternative splicing of the last exon of the cystinosin sequence produces the cystinosin-LKG isoform that is characterized by a different C-terminal region causing changes in the subcellular distribution of the protein. We have constructed RFP-tagged proteins and demonstrated by site-directed mutagenesis that the carboxyl-terminal SSLKG sequence of cystinosin-LKG is an important sorting motif that is required for efficient targeting the protein to the plasma membrane, where it can mediate H+ coupled cystine transport. Deletion of the SSLKG sequence reduced cystinosin-LKG expression in the plasma membrane and cystine transport by approximately 30%, and induced significant accumulation of the protein in the Golgi apparatus and in lysosomes. Cystinosin-LKG, unlike the canonical isoform, also moves to the lysosomes by the indirect pathway, after endocytic retrieval from the plasma membrane, mainly by a clathrin-mediated endocytosis. Nevertheless, silencing of AP-2 triggers the clathrin-independent endocytosis, showing the complex adaptability of cystinosin-LKG trafficking.	[Bellomo, Francesco; Taranta, Anna; Rega, Laura Rita; Corallini, Serena; Emma, Francesco] Bambino Gesu Childrens Hosp & Res Inst, Div Nephrol & Dialysis, Dept Nephrol Urol, Rome, Italy; [Petrini, Stefania] Bambino Gesu Childrens Hosp & Res Inst, Confocal Microscopy Core Facil, Rome, Italy; [Venditti, Rossella; De Matteis, Maria Antonietta] Telethon Inst Genet & Med TIGEM, Pozzuoli, NA, Italy; [Rocchetti, Maria Teresa; Gesualdo, Loreto] Univ Bari Aldo Moro, Nephrol Dialysis & Transplantat Unit, Dept Emergency & Organ Transplantat DETO, Bari, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita degli Studi di Bari Aldo Moro	Bellomo, F (corresponding author), Bambino Gesu Childrens Hosp & Res Inst, Div Nephrol & Dialysis, Dept Nephrol Urol, Rome, Italy.	francesco.bellomo@opbg.net	Venditti, Rossella/AAT-4281-2020; Taranta, Anna/AAA-6113-2020; Bellomo, Francesco/K-2142-2012; Rocchetti, Maria Teresa/AAA-6771-2019; Rocchetti, Maria Teresa/N-2212-2018; Petrini, Stefania/I-1464-2018; Rocchetti, Maria Teresa/AAQ-1881-2021; Emma, Francesco/H-2116-2012; Rega, Laura Rita/AAB-7477-2019; Gesualdo, Loreto/K-7751-2016; De Matteis, Maria Antonietta/AHE-5161-2022	Venditti, Rossella/0000-0002-1884-6501; Bellomo, Francesco/0000-0003-2912-8764; Rocchetti, Maria Teresa/0000-0002-2397-6474; Petrini, Stefania/0000-0002-3249-0003; Rocchetti, Maria Teresa/0000-0002-2397-6474; Emma, Francesco/0000-0002-0383-3468; Gesualdo, Loreto/0000-0002-4861-0911; De Matteis, Maria Antonietta/0000-0003-0053-3061; Rega, Laura Rita/0000-0003-4847-366X; Taranta, Anna/0000-0002-7606-9085	Cystinosis Research Network (Lake Forest, IL, USA); Cystinosis Research Foundation (Irvine, CA, USA)	Cystinosis Research Network (Lake Forest, IL, USA); Cystinosis Research Foundation (Irvine, CA, USA)	This work was supported by grants of Cystinosis Research Network (Lake Forest, IL, USA) and Cystinosis Research Foundation (Irvine, CA, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants of Cystinosis Research Network (Lake Forest, IL, USA) and Cystinosis Research Foundation (Irvine, CA, USA)	Andrzejewska Z, 2015, TRAFFIC, V16, P712, DOI 10.1111/tra.12277; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; BANNAI S, 1981, J BIOL CHEM, V256, P5770; Bellomo F, 2010, FREE RADICAL BIO MED, V48, P865, DOI 10.1016/j.freeradbiomed.2010.01.011; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Cherqui S, 2001, J BIOL CHEM, V276, P13314, DOI 10.1074/jbc.M010562200; Chung JJ, 2002, TRENDS CELL BIOL, V12, P146, DOI 10.1016/S0962-8924(01)02241-3; Garafalo SD, 2015, MOL BIOL CELL, V26, P1887, DOI 10.1091/mbc.E14-06-1048; Iglesias DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042840; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Kyttala A, 2004, MOL BIOL CELL, V15, P1313, DOI 10.1091/mbc.E03-02-0120; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Mao QW, 2003, FEBS LETT, V555, P351, DOI 10.1016/S0014-5793(03)01274-2; Nakamura M, 2013, METHOD ENZYMOL, V521, P203, DOI 10.1016/B978-0-12-391862-8.00011-9; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pols MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2360; Ruivo R, 2012, P NATL ACAD SCI USA, V109, pE210, DOI 10.1073/pnas.1115581109; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Seatter MJ, 2004, CELL SIGNAL, V16, P21, DOI 10.1016/S0898-6568(03)00095-0; Syres K, 2009, BLOOD, V114, P2542, DOI 10.1182/blood-2009-03-213934; Taranta A, 2008, AM J PHYSIOL-RENAL, V294, pF1101, DOI 10.1152/ajprenal.00413.2007; Taranta A, 2012, HISTOCHEM CELL BIOL, V138, P351, DOI 10.1007/s00418-012-0958-8; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Yeagy BA, 2011, KIDNEY INT, V79, P1198, DOI 10.1038/ki.2010.537; Yura K, 2006, GENE, V380, P63, DOI 10.1016/j.gene.2006.05.015	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154805	10.1371/journal.pone.0154805	http://dx.doi.org/10.1371/journal.pone.0154805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148969	Green Published, gold			2022-12-27	WOS:000375676800064
J	Moussaoui, N; Larauche, M; Biraud, M; Molet, J; Million, M; Mayer, E; Tache, Y				Moussaoui, Nabila; Larauche, Muriel; Biraud, Mandy; Molet, Jenny; Million, Mulugeta; Mayer, Emeran; Tache, Yvette			Limited Nesting Stress Alters Maternal Behavior and In Vivo Intestinal Permeability in Male Wistar Pup Rats	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; IRRITABLE-BOWEL-SYNDROME; EARLY-LIFE STRESS; ANIMAL-MODELS; NEONATAL STRESS; ADULT RATS; BARRIER FUNCTION; BREAST-MILK; DEPRIVATION; MATURATION	A few studies indicate that limited nesting stress (LNS) alters maternal behavior and the hypothalamic pituitary adrenal (HPA) axis of dams and offspring in male Sprague Dawley rats. In the present study, we evaluated the impact of LNS on maternal behavior in Wistar rats, and on the HPA axis, glycemia and in vivo intestinal permeability of male and female offspring. Intestinal permeability is known to be elevated during the first week postnatally and influenced by glucocorticoids. Dams and neonatal litters were subjected to LNS or normal nesting conditions (control) from days 2 to 10 postnatally. At day 10, blood was collected from pups for determination of glucose and plasma corticosterone by enzyme immunoassay and in vivo intestinal permeability by oral gavage of fluorescein isothiocyanate-dextran 4kDa. Dams exposed to LNS compared to control showed an increase in the percentage of time spent building a nest (118%), self-grooming (69%), and putting the pups back to the nest (167%). LNS male and female pups exhibited a reduction of body weight by 5% and 4%, adrenal weights/100g body weight by 17% and 18%, corticosterone plasma levels by 64% and 62% and blood glucose by 11% and 12% respectively compared to same sex control pups. In male LNS pups, intestinal permeability was increased by 2.7-fold while no change was observed in females compared to same sex control. There was no sex difference in any of the parameters in control pups except the body weight. These data indicate that Wistar dams subjected to LNS during the first postnatal week have an altered repertoire of maternal behaviors which affects the development of the HPA axis in both sexes and intestinal barrier function in male offspring.	[Moussaoui, Nabila; Larauche, Muriel; Biraud, Mandy; Million, Mulugeta; Mayer, Emeran; Tache, Yvette] Univ Calif Los Angeles, Dept Med, Div Digest Dis, Ctr Neurobiol Stress,CURE Digest Dis Res Ctr, Los Angeles, CA 90073 USA; [Moussaoui, Nabila; Larauche, Muriel; Biraud, Mandy; Million, Mulugeta; Mayer, Emeran; Tache, Yvette] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90073 USA; [Moussaoui, Nabila; Larauche, Muriel; Biraud, Mandy; Million, Mulugeta; Mayer, Emeran; Tache, Yvette] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Molet, Jenny] Univ Calif Irvine, Dept Anat Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Irvine	Moussaoui, N (corresponding author), Univ Calif Los Angeles, Dept Med, Div Digest Dis, Ctr Neurobiol Stress,CURE Digest Dis Res Ctr, Los Angeles, CA 90073 USA.; Moussaoui, N (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90073 USA.; Moussaoui, N (corresponding author), VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.	NMoussaoui@mednet.ucla.edu			National Institute of Health [P50 DK-64539, DK-41301, R01 DK-57238, K01 DK088937]; VA Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064539, K01DK088937, R01DK078676, P30DK041301] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health grants P50 DK-64539 and Center Grant DK-41301 (Animal Model Core), R01 DK-57238, K01 DK088937, and VA Career Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2005, PAIN, V113, P141, DOI 10.1016/j.pain.2004.10.002; Avishai-Eliner S, 2001, J NEUROENDOCRINOL, V13, P799, DOI 10.1046/j.1365-2826.2001.00698.x; Barreau F, 2004, GASTROENTEROLOGY, V127, P524, DOI 10.1053/j.gastro.2004.05.019; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Barreau F, 2007, PEDIATR RES, V62, P240, DOI 10.1203/PDR.0b013e3180db2949; Barreau F, 2007, J PHYSIOL-LONDON, V580, P347, DOI 10.1113/jphysiol.2006.120907; Bradford K, 2012, CLIN GASTROENTEROL H, V10, P385, DOI 10.1016/j.cgh.2011.12.018; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; Chen M, 2011, WORLD J GASTROENTERO, V17, P2933, DOI 10.3748/wjg.v17.i24.2933; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; Cummins AG, 2002, GUT, V51, P748, DOI 10.1136/gut.51.5.748; Downs R, 2014, MED HYPOTHESES, V83, P649, DOI 10.1016/j.mehy.2014.09.005; Ellenbroek BA, 2000, NEUROPSYCHOPHARMACOL, V23, P99, DOI 10.1016/S0893-133X(00)00088-9; Enthoven L, 2010, INT J DEV NEUROSCI, V28, P217, DOI 10.1016/j.ijdevneu.2009.10.006; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Gilles EE, 1996, PEDIATR NEUROL, V15, P114, DOI 10.1016/0887-8994(96)00153-1; Gordon CJ, 2016, PHYSIOL BEHAV, V153, P56, DOI 10.1016/j.physbeh.2015.10.025; Green PG, 2011, PAIN, V152, P2549, DOI 10.1016/j.pain.2011.07.021; Guo YM, 2015, NEUROREPORT, V26, P13, DOI 10.1097/WNR.0000000000000292; HENNING SJ, 1978, AM J PHYSIOL, V235, pE451, DOI 10.1152/ajpendo.1978.235.5.E451; Ivy AS, 2008, NEUROSCIENCE, V154, P1132, DOI 10.1016/j.neuroscience.2008.04.019; Koe AS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.217; Kuznetsov S V, 2011, Zh Evol Biokhim Fiziol, V47, P318; Ladd CO, 2000, PROG BRAIN RES, V122, P81; Larauche M, 2012, EXP NEUROL, V233, P49, DOI 10.1016/j.expneurol.2011.04.020; Larauche M, 2011, J NEUROGASTROENTEROL, V17, P213, DOI 10.5056/jnm.2011.17.3.213; LEVINE S, 1991, DEV PSYCHOBIOL, V24, P547, DOI 10.1002/dev.420240803; Lu L, 2011, AM J PHYSIOL-GASTR L, V300, pG425, DOI 10.1152/ajpgi.00011.2010; Lyons DM, 2010, DEV PSYCHOBIOL, V52, P616, DOI 10.1002/dev.20500; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; McIntosh J, 1999, DEV BRAIN RES, V113, P97, DOI 10.1016/S0165-3806(99)00005-X; Molet J, 2014, DEV PSYCHOBIOL, V56, P1675, DOI 10.1002/dev.21230; Molle RD, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.126; Moussaoui N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088382; Neu J, 2007, AM J CLIN NUTR, V85, p629S, DOI 10.1093/ajcn/85.2.629S; O'Mahony SM, 2011, PSYCHOPHARMACOLOGY, V214, P71, DOI 10.1007/s00213-010-2010-9; Oines E, 2012, PHYSIOL BEHAV, V105, P1058, DOI 10.1016/j.physbeh.2011.11.024; Pacha J, 2003, PEDIATR RES, V53, P808, DOI 10.1203/01.PDR.0000058923.08017.6F; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Pohl CS, 2015, AM J PHYSIOL-GASTR L, V309, pG927, DOI 10.1152/ajpgi.00206.2015; Prusator DK, 2015, NEUROGASTROENT MOTIL, V27, P72, DOI 10.1111/nmo.12472; Quaroni A, 1999, AM J PHYSIOL-GASTR L, V277, pG1027, DOI 10.1152/ajpgi.1999.277.5.G1027; Rao R, 2015, J CLIN MED, V4, P1729, DOI 10.3390/jcm4091729; ROSENFELD P, 1992, NEUROSCI BIOBEHAV R, V16, P553, DOI 10.1016/S0149-7634(05)80196-4; Rosztoczy A, 2003, NEUROGASTROENT MOTIL, V15, P679, DOI 10.1046/j.1350-1925.2003.00451.x; Schmidt M, 2004, J NEUROENDOCRINOL, V16, P52, DOI 10.1111/j.1365-2826.2004.01123.x; Smotherman WP, DEV PSYCHOBIOL, V198, P169; Solomon NS, 2001, PEDIATR RES, V49, P782, DOI 10.1203/00006450-200106000-00012; SUCHECKI D, 1995, PSYCHONEUROENDOCRINO, V20, P169, DOI 10.1016/0306-4530(94)00051-B; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vazquez DM, 1998, PSYCHONEUROENDOCRINO, V23, P663; VERNON RG, 1972, BIOCHEM J, V127, P531, DOI 10.1042/bj1270531; Wagner CL, 2008, CLIN REV ALLERG IMMU, V34, P191, DOI 10.1007/s12016-007-8032-3; Walker CD, 1997, J NEUROENDOCRINOL, V9, P25, DOI 10.1046/j.1365-2826.1997.00544.x; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49	57	32	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155037	10.1371/journal.pone.0155037	http://dx.doi.org/10.1371/journal.pone.0155037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149676	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800111
J	Murata, Y; Higo, N				Murata, Yumi; Higo, Noriyuki			Development and Characterization of a Macaque Model of Focal Internal Capsular Infarcts	PLOS ONE			English	Article							MOTOR CORTEX LESION; CORTICOSPINAL TRACT; NONHUMAN-PRIMATES; INCREASED EXPRESSION; MANUAL DEXTERITY; ISCHEMIC-STROKE; LACUNAR STROKE; HUMAN BRAIN; RECOVERY; MONKEYS	Several studies have used macaque monkeys with lesions induced in the primary motor cortex (M1) to investigate the recovery of motor function after brain damage. However, in human stroke patients, the severity and outcome of motor impairments depend on the degree of damage to the white matter, especially that in the posterior internal capsule, which carries corticospinal tracts. To bridge the gap between results obtained in M1-lesioned macaques and the development of clinical intervention strategies, we established a method of inducing focal infarcts at the posterior internal capsule of macaque monkeys by injecting endothelin-1 (ET-1), a vasoconstrictor peptide. The infarcts expanded between 3 days and 1 week after ET-1 injection. The infarct volume in each macaque was negatively correlated with precision grip performance 3 days and 1 week after injection, suggesting that the degree of infarct expansion may have been a cause of the impairment in hand movements during the early stage. Although the infarct volume decreased and gross movement improved, impairment of dexterous hand movements remained until the end of the behavioral and imaging experiments at 3 months after ET-1 injection. A decrease in the abundance of large neurons in M1, from which the descending motor tracts originate, was associated with this later-stage impairment. The present model is useful not only for studying neurological changes underlying deficits and recovery but also for testing therapeutic interventions after white matter infarcts in primates.	[Murata, Yumi; Higo, Noriyuki] Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Higo, N (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Tsukuba, Ibaraki, Japan.	n.higo@aist.go.jp	Murata, Yumi/M-7663-2016	Murata, Yumi/0000-0002-6318-2951	Japan Society for the Promotion of Science (JSPS) [24800090, 15K21666]; Ministry of Education, Culture, Sports, Science & Technology (MEXT) of Japan [15H01674]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science & Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research KAKENHI (Grant Numbers 24800090 and 15K21666) from Japan Society for the Promotion of Science (JSPS; http://www.jsps.go.jp/english/e-grants/index.html) and Grant-in-Aid for Scientific Research on Innovative Areas "Understanding brain plasticity on body representations to promote their adaptive functions" (Grant Number 15H01674) from Ministry of Education, Culture, Sports, Science & Technology (MEXT; http://embodied-brain.org/eng/about) of Japan to Y.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboix A, 2009, EXPERT REV NEUROTHER, V9, P179, DOI 10.1586/14737175.9.2.179; Bailey EL, 2009, STROKE, V40, pE451, DOI 10.1161/STROKEAHA.108.528430; Baron JC, 2014, J CEREBR BLOOD F MET, V34, P2, DOI 10.1038/jcbfm.2013.188; Blasi F, 2015, J CEREBR BLOOD F MET, V35, P977, DOI 10.1038/jcbfm.2015.7; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Darling WG, 2011, J INTEGR NEUROSCI, V10, P353, DOI 10.1142/S0219635211002737; FISHER CM, 1965, NEUROLOGY, V15, P774, DOI 10.1212/WNL.15.8.774; Friel KM, 1998, SOMATOSENS MOT RES, V15, P173, DOI 10.1080/08990229870745; Frost SB, 2006, BEHAV BRAIN RES, V169, P206, DOI 10.1016/j.bbr.2006.01.014; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; FUXE K, 1991, NEUROSCI LETT, V123, P107, DOI 10.1016/0304-3940(91)90169-T; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Higo N, 2003, J COMP NEUROL, V467, P135, DOI 10.1002/cne.10850; Higo N, 2007, BRAIN RES, V1171, P30, DOI 10.1016/j.brainres.2007.07.054; Higo N, 2014, NEUROSCI RES, V78, P9, DOI 10.1016/j.neures.2013.09.008; Higo N, 2010, J COMP NEUROL, V518, P2633, DOI 10.1002/cne.22356; Higo N, 2009, J COMP NEUROL, V516, P493, DOI 10.1002/cne.22121; JONES EG, 1977, J COMP NEUROL, V175, P391, DOI 10.1002/cne.901750403; Kaas JH, 2008, BRAIN RES BULL, V75, P384, DOI 10.1016/j.brainresbull.2007.10.009; Kleinschnitz C, 2005, J CEREBR BLOOD F MET, V25, P1548, DOI 10.1038/sj.jcbfm.9600151; Lecrux C, 2008, STROKE, V39, P448, DOI 10.1161/STROKEAHA.107.492934; Loo LS, 2002, NEUROSCIENCE, V112, P993, DOI 10.1016/S0306-4522(02)00043-X; MACCUMBER MW, 1990, P NATL ACAD SCI USA, V87, P2359, DOI 10.1073/pnas.87.6.2359; Mack WJ, 2003, NEUROL RES, V25, P846, DOI 10.1179/016164103771953943; MAYHEW TM, 1992, J NEUROCYTOL, V21, P313, DOI 10.1007/BF01191700; Micheli S, 2012, FRONT NEUROL NEUROSC, V30, P94, DOI 10.1159/000333426; Morecraft RJ, 2002, BRAIN, V125, P176, DOI 10.1093/brain/awf011; Murata Y, 2008, J NEUROPHYSIOL, V99, P773, DOI 10.1152/jn.01001.2007; Murata Y, 2015, NEUROSCI RES, V98, P64, DOI 10.1016/j.neures.2015.04.007; Murata Y, 2015, J NEUROSCI, V35, P84, DOI 10.1523/JNEUROSCI.1737-14.2015; MURRAY EA, 1981, J COMP NEUROL, V195, P339, DOI 10.1002/cne.901950212; Naidoo V, 2004, J CHEM NEUROANAT, V27, P87, DOI 10.1016/j.jchemneu.2003.12.002; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Puentes S, 2015, NEUROSCIENCE, V284, P400, DOI 10.1016/j.neuroscience.2014.10.015; Puentes S, 2012, BRAIN RES, V1469, P43, DOI 10.1016/j.brainres.2012.06.042; Rosso C, 2011, NEURORADIOLOGY, V53, P763, DOI 10.1007/s00234-011-0916-5; Schiemanck SK, 2008, J REHABIL MED, V40, P96, DOI 10.2340/16501977-0130; Schmahmann J.D., 2009, FIBER PATHWAYS BRAIN; Tanaka Y, 2008, STROKE, V39, P205, DOI 10.1161/STROKEAHA.107.489906; TOYOSHIMA K, 1982, J HIRNFORSCH, V23, P257; Vilensky JA, 2002, INT J PRIMATOL, V23, P1319, DOI 10.1023/A:1021135122571; Wannier T, 2005, J NEUROTRAUM, V22, P703, DOI 10.1089/neu.2005.22.703; Weatherall D., 2006, USE NONHUMAN PRIMATE; Wenzelburger R, 2005, BRAIN, V128, P64, DOI 10.1093/brain/awh317; West GA, 2009, J CEREBR BLOOD F MET, V29, P1175, DOI 10.1038/jcbfm.2009.43; Yamamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065701; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YOSHIMOTO S, 1990, BRAIN RES, V508, P283, DOI 10.1016/0006-8993(90)90407-3; Zhao B, 2014, NEURAL REGEN RES, V9, P2087, DOI 10.4103/1673-5374.147936	49	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154752	10.1371/journal.pone.0154752	http://dx.doi.org/10.1371/journal.pone.0154752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149111	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800056
J	Galam, S; Javarone, MA				Galam, Serge; Javarone, Marco Alberto			Modeling Radicalization Phenomena in Heterogeneous Populations	PLOS ONE			English	Article							OPINION DYNAMICS; PERCOLATION; TERRORISM; PHYSICS	The phenomenon of radicalization is investigated within a mixed population composed of core and sensitive subpopulations. The latest includes first to third generation immigrants. Respective ways of life may be partially incompatible. In case of a conflict core agents behave as inflexible about the issue. In contrast, sensitive agents can decide either to live peacefully adjusting their way of life to the core one, or to oppose it with eventually joining violent activities. The interplay dynamics between peaceful and opponent sensitive agents is driven by pairwise interactions. These interactions occur both within the sensitive population and by mixing with core agents. The update process is monitored using a Lotka-Volterra-like Ordinary Differential Equation. Given an initial tiny minority of opponents that coexist with both inflexible and peaceful agents, we investigate implications on the emergence of radicalization. Opponents try to turn peaceful agents to opponents driving radicalization. However, inflexible core agents may step in to bring back opponents to a peaceful choice thus weakening the phenomenon. The required minimum individual core involvement to actually curb radicalization is calculated. It is found to be a function of both the majority or minority status of the sensitive subpopulation with respect to the core subpopulation and the degree of activeness of opponents. The results highlight the instrumental role core agents can have to hinder radicalization within the sensitive subpopulation. Some hints are outlined to favor novel public policies towards social integration.	[Galam, Serge] CNRS, CEVIPOF Ctr Polit Res, Paris, France; [Galam, Serge] Sci Po, Paris, France; [Javarone, Marco Alberto] Univ Cagliari, Dept Math & Comp Sci, Cagliari, Italy	Centre National de la Recherche Scientifique (CNRS); Institut d'Etudes Politiques Paris (Sciences Po); University of Cagliari	Javarone, MA (corresponding author), Univ Cagliari, Dept Math & Comp Sci, Cagliari, Italy.	marcojavarone@gmail.com	Javarone, Marco/AFU-9191-2022; Galam, Serge/B-1105-2019	Javarone, Marco/0000-0003-0514-9544; Galam, Serge/0000-0002-9003-5420	Fondazione Banco di Sardegna;  [DGA-2012 60 0013 00470 75 01]	Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); 	This work was supported by Fondazione Banco di Sardegna, and in part, by convention DGA-2012 60 0013 00470 75 01.; MAJ would like to thank Fondazione Banco di Sardegna for supporting his work. This work was supported in part by a convention DGA-2012 60 0013 00470 75 01.	Alizadeh M, 2015, JASSS-J ARTIF SOC S, V18, DOI 10.18564/jasss.2733; [Anonymous], 2015, NETWORK TERROR DAESH; [Anonymous], 2015, MONDE; [Anonymous], 2016, NBC NEWS; Aronson E, 2006, SOCIAL PSYCHOL; Bailey NTJ, 1975, MATH THEORY INFECT D; Battiston F, 2016, PHYSICA D IN PRESS; Borum R., 2011, J STRATEGIC SECURITY, V4, P7, DOI [10.5038/1944-0472.4.4.1, DOI 10.5038/1944-0472.4.4.1]; Buechel B, 2015, J ECON DYN CONTROL, V52, P240, DOI 10.1016/j.jedc.2014.12.006; Burghardt K, 2014, COMPETING OPINIONS S; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cheon T, 2016, PHYS LETT A, V380, P429, DOI 10.1016/j.physleta.2015.11.012; Crokidakis N, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062122; Crokidakis N, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.013310; Crokidakis N, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.061127; D'Orsogna MR, 2015, PHYS LIFE REV, V12, P1, DOI 10.1016/j.plrev.2014.11.001; Dixit AK, 2007, P NATL ACAD SCI USA, V104, P7351, DOI 10.1073/pnas.0702071104; Galam S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046123; Galam S, 2003, PHYSICA A, V330, P139, DOI 10.1016/j.physa.2003.08.035; Galam S, 2003, PHYSICA A, V323, P695, DOI 10.1016/S0378-4371(03)00006-2; Galam S, 2002, EUR PHYS J B, V26, P269; Galam S, 2008, INT J MOD PHYS C, V19, P409, DOI 10.1142/S0129183108012297; Galam S, 2007, PHYSICA A, V381, P366, DOI 10.1016/j.physa.2007.03.034; Garcia-Diaz C, 2013, ADV COMPLEX SYST, V16, DOI 10.1142/S0219525913500197; Goncalves S, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30082-6; Gracia-Lazaro C, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.067101; HAINES HH, 1984, SOC PROBL, V32, P31, DOI 10.1525/sp.1984.32.1.03a00030; Hebdo Charlie, 2015, MONDE; Javarone MA, 2016, EUR PHYS J B, V89, DOI 10.1140/epjb/e2016-60901-5; Javarone MA, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/10/P10002; Javarone MA, 2015, LECT NOTES COMPUT SC, V8852, P112, DOI 10.1007/978-3-319-15168-7_15; Javarone MA, 2014, PHYSICA A, V414, P19, DOI 10.1016/j.physa.2014.07.018; Javarone MA, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/08/P08013; Javarone MA, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40662-5; Kelling GeorgeL., 1997, FIXING BROKEN WINDOW; Kruglanski AW, 2014, ADV POLITICAL PSYCHO, V35; Lagorio C, 2009, PHYSICA A, V388, P755, DOI 10.1016/j.physa.2008.10.045; Li Q, 2013, J STAT PHYS, V151, P92, DOI 10.1007/s10955-012-0625-4; McMillon D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088923; Nizamani S, 2014, PHYSICA A, V416, P620, DOI 10.1016/j.physa.2014.09.006; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Oliveira M, 2015, STUD COMPUT INTELL, V597, P219, DOI 10.1007/978-3-319-16112-9_22; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perc M, 2013, CHAOS SOLITON FRACT, V56, P1, DOI 10.1016/j.chaos.2013.06.002; Pickering W, 2016, PREPRINT; Qian S, 2015, PHYSICA A, V432, P187, DOI 10.1016/j.physa.2015.03.029; Sood V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.178701; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Thompson R., 2011, J STRATEGIC SECURITY, V4, P167, DOI [10.5038/1944-0472.4.4.8, DOI 10.5038/1944-0472.4.4.8]; Tomassini M., 2014, P C GEN EV COMP COMP; White S, 2015, LECT NOTES COMPUT SC, V8852, P102, DOI 10.1007/978-3-319-15168-7_14; Wu ZX, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026108; Xie J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011130	53	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155407	10.1371/journal.pone.0155407	http://dx.doi.org/10.1371/journal.pone.0155407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166677	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300063
J	Groisman, IJ; Godard, B				Groisman, Iris Jaitovich; Godard, Beatrice			Impact of Next Generation Sequencing on the Organization and Funding of Returning Research Results: Survey of Canadian Research Ethics Boards Members	PLOS ONE			English	Article							INCIDENTAL FINDINGS; GENETIC RESEARCH; GENOMIC RESEARCH; CHAIR PERSPECTIVES; INFORMED-CONSENT; PARTICIPANTS; CHALLENGES	Research Ethics Boards (REBs) are expected to evaluate protocols planning the use of Next Generation Sequencing technologies (NGS), assuring that any genomic finding will be properly managed. As Canadian REBs play a central role in the disclosure of such results, we deemed it important to examine the views and experience of REB members on the return of aggregated research results, individual research results (IRRs) and incidental findings (IFs) in current genomic research. With this intent, we carried out a web-based survey, which showed that 59.7% of respondents viewed the change from traditional sequencing to NGS as more than a technical substitution, and that 77% of respondents agreed on the importance of returning aggregated research results, the most compelling reasons being the recognition of participants' contribution and increasing the awareness of scientific progress. As for IRRs specifically, 50% of respondents were in favour of conveying such information, even when they only indicated the probability that a condition may develop. Current regulations and risk to participants were considered equally important, and much more than financial costs, when considering the return of IRRs and IFs. Respondents indicated that the financial aspect of offering genetic counseling was the least important matter when assessing it as a requisite. Granting agencies were named as mainly responsible for funding, while the organizing and returning of IRRs and IFs belonged to researchers. However, views in these matters differ according to respondents' experience. Our results draw attention to the need for improved guidance when considering the organizational and financial aspects of returning genetic research results, so as to better fulfill the ethical and moral principles that are to guide such undertakings.	[Groisman, Iris Jaitovich; Godard, Beatrice] Univ Montreal, Inst Rech Sante Publ, Grp Rech Omics Eth, Montreal, PQ, Canada	Universite de Montreal	Godard, B (corresponding author), Univ Montreal, Inst Rech Sante Publ, Grp Rech Omics Eth, Montreal, PQ, Canada.	beatrice.godard@umontreal.ca	Godard, Beatrice/N-6992-2019		Genome Quebec grant	Genome Quebec grant	This research and the work presented in the manuscript have been supported by a Genome Quebec grant (http://www.genomequebec.com/en/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRIC POL STAT ETH CO; Apold VS, 2011, ACCOUNT RES, V18, P31, DOI 10.1080/08989621.2011.542681; Ayuso C, 2015, PHARMACOGENOMICS J, V15, P1, DOI 10.1038/tpj.2014.62; Beskow Laura M, 2012, IRB, V34, P1; Beskow LM, 2012, GENET MED, V14, P490, DOI 10.1038/gim.2011.62; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; Bredenoord AL, 2011, TRENDS GENET, V27, P41, DOI 10.1016/j.tig.2010.11.004; Burke W, 2014, AM J MED GENET C, V166, P105, DOI 10.1002/ajmg.c.31393; CHAMBERLAIN JS, 1993, AM J HUM GENET, V52, P792; Chan B, 2012, AM J BIOETHICS, V12, P1, DOI 10.1080/15265161.2012.699138; Dal-Re R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001584; Dressler LG, 2012, GENET MED, V14, P215, DOI 10.1038/gim.2011.10; Edwards KL, 2012, GENET MED, V14, P236, DOI 10.1038/gim.2011.57; Egalite N, 2014, J GENET COUNS, V23, P661, DOI 10.1007/s10897-014-9703-x; Fabsitz RR, 2010, CIRC-CARDIOVASC GENE, V3, P574, DOI 10.1161/CIRCGENETICS.110.958827; Fernandez CV, 2004, CAN MED ASSOC J, V170, P1417, DOI 10.1503/cmaj.1031668; Groisman IJ, 2015, J CLIN RES BIOETH, V6, P231, DOI [10.4172/2155-9627.1000231, DOI 10.4172/2155-9627.1000231]; Groisman IJ, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-80; Kaye J, 2010, EUR J HUM GENET, V18, P398, DOI 10.1038/ejhg.2009.191; Keane MA, 2008, J LAW MED ETHICS, V36, P352, DOI 10.1111/j.1748-720X.2008.00279.x; Knoppers BM, 2006, EUR J HUM GENET, V14, P1170, DOI 10.1038/sj.ejhg.5201690; Mathieu G, 2013, INT J NEUROPSYCHOPH, V16, P2119, DOI 10.1017/S1461145713000527; Middleton A, 2015, LANCET, V385, P1289, DOI 10.1016/S0140-6736(14)62119-X; Network of Applied Genetic Medicine of Quebec, 2013, STAT PRINC RET RES R; Shaw D, 2015, BIOETHICA FORUM, V8, P47; Simon CM, 2011, J EMPIR RES HUM RES, V6, P53, DOI 10.1525/jer.2011.6.4.53; Williams JK, 2012, GENET TEST MOL BIOMA, V16, P508, DOI 10.1089/gtmb.2011.0248; Wolf SM, 2013, ANNU REV GENOM HUM G, V14, P557, DOI 10.1146/annurev-genom-091212-153506	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154965	10.1371/journal.pone.0154965	http://dx.doi.org/10.1371/journal.pone.0154965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167380	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300050
J	Ortiz-Soto, ME; Seibel, J				Ortiz-Soto, Maria Elena; Seibel, Juergen			Expression of Functional Human Sialyltransferases ST3Gal1 and ST6Gal1 in Escherichia coli	PLOS ONE			English	Article							DISULFIDE BOND; GLYCOSYLATION; PROTEINS; ALPHA-2,3-SIALYLTRANSFERASE; GLYCOSYLTRANSFERASES; PURIFICATION; SOLUBILITY; REVEALS; CLONING; CHARGE	Sialyltransferases (STs) are disulfide-containing, type II transmembrane glycoproteins that catalyze the transfer of sialic acid to proteins and lipids and participate in the synthesis of the core structure oligosaccharides of human milk. Sialic acids are found at the outermost position of glycostructures, playing a key role in health and disease. Sialylation is also essential for the production of recombinant therapeutic proteins (RTPs). Despite their importance, availability of sialyltransferases is limited due to the low levels of stable, soluble and active protein produced in bacterial expression systems, which hampers biochemical and structural studies on these enzymes and restricts biotechnological applications. We report the successful expression of active human sialyltransferases ST3Gal1 and ST6Gal1 in commercial Escherichia coli strains designed for production of disulfide-containing proteins. Fusion of hST3Gal1 with different solubility enhancers and substitution of exposed hydrophobic amino acids by negatively charged residues (supercharging-like approach) were performed to promote solubility and folding. Co-expression of sialyltransferases with the chaperon/foldases sulfhydryl oxidase, protein disulfide isomerase and disulfide isomerase C was explored to improve the formation of native disulfide bonds. Active sialyltransferases fused with maltose binding protein (MBP) were obtained in sufficient amounts for biochemical and structural studies when expressed under oxidative conditions and co-expression of folding factors increased the yields of active and properly folded sialyltransferases by 20%. Mutation of exposed hydrophobic amino acids increased recovery of active enzyme by 2.5-fold, yielding about 7 mg of purified protein per liter culture. Functionality of recombinant enzymes was evaluated in the synthesis of sialosides from the beta-D-galactoside substrates lactose, N-acetyllactosamine and benzyl 2-acetamido-2-deoxy-3-O-(beta-D-galactopyranosyl)-alpha-D-galactopyranoside.	[Ortiz-Soto, Maria Elena; Seibel, Juergen] Univ Wurzburg, Inst Organ Chem, Hubland, D-97074 Wurzburg, Germany	University of Wurzburg	Seibel, J (corresponding author), Univ Wurzburg, Inst Organ Chem, Hubland, D-97074 Wurzburg, Germany.	seibel@chemie.uni-wuerzburg.de	Seibel, Juergen/A-6908-2015	Seibel, Juergen/0000-0002-8036-4853; Ortiz-Soto, Maria Elena/0000-0002-4597-6360	German Academic Exchange Service (DAAD) [A/09/78904]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	MEOS received a scholarship from the German Academic Exchange Service (DAAD) for postdoctoral studies (A/09/78904).	Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Bork K, 2009, J PHARM SCI-US, V98, P3499, DOI 10.1002/jps.21684; Chen C, 2000, GLYCOBIOLOGY, V10, P531, DOI 10.1093/glycob/10.5.531; Datta AK, 2001, J BIOL CHEM, V276, P15200, DOI 10.1074/jbc.M010542200; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; Der BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064363; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hidari KIPJ, 2005, GLYCOCONJUGATE J, V22, P1, DOI 10.1007/s10719-005-0845-9; Hirano Y, 2012, J BIOCHEM, V151, P197, DOI 10.1093/jb/mvr133; Jeanneau C, 2004, J BIOL CHEM, V279, P13461, DOI 10.1074/jbc.M311764200; Kramer RM, 2012, BIOPHYS J, V102, P1907, DOI 10.1016/j.bpj.2012.01.060; Kuhn B, 2013, ACTA CRYSTALLOGR D, V69, P1826, DOI 10.1107/S0907444913015412; Lauber J, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-014-0186-0; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Miklos AE, 2012, CHEM BIOL, V19, P449, DOI 10.1016/j.chembiol.2012.01.018; Narimatsu H, 2006, CURR OPIN STRUC BIOL, V16, P567, DOI 10.1016/j.sbi.2006.09.001; Nguyen VD, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-1; Nomine Y, 2001, PROTEIN ENG, V14, P297, DOI 10.1093/protein/14.4.297; Pasek M, 2010, BIOCHEM BIOPH RES CO, V394, P679, DOI 10.1016/j.bbrc.2010.03.051; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rakic B, 2013, GLYCOBIOLOGY, V23, P536, DOI 10.1093/glycob/cwt001; Rao FV, 2009, NAT STRUCT MOL BIOL, V16, P1186, DOI 10.1038/nsmb.1685; Raran-Kurussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049589; REARICK JI, 1979, J BIOL CHEM, V254, P4444; Ribitsch D, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0138-8; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Shang J, 1999, EUR J BIOCHEM, V265, P580, DOI 10.1046/j.1432-1327.1999.00733.x; Simeonov P, 2011, PROTEIN ENG DES SEL, V24, P261, DOI 10.1093/protein/gzq104; Skretas G, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-50; Tsuji S, 1996, GLYCOBIOLOGY, V6, pR5; Vallejo-Ruiz V, 2001, BBA-PROTEIN STRUCT M, V1549, P161, DOI 10.1016/S0167-4838(01)00257-6; Wang LB, 2016, BBA-PROTEINS PROTEOM, V1864, P143, DOI 10.1016/j.bbapap.2015.07.007; Zhang YB, 2004, PROTEIN EXPRES PURIF, V36, P207, DOI 10.1016/j.pep.2004.04.020	38	19	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155410	10.1371/journal.pone.0155410	http://dx.doi.org/10.1371/journal.pone.0155410			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166796	Green Published, gold			2022-12-27	WOS:000376587300036
J	Wolf, S; Wu, WL; Jones, C; Perwitasari, O; Mahalingam, S; Tripp, RA				Wolf, Stefan; Wu, Weilin; Jones, Cheryl; Perwitasari, Olivia; Mahalingam, Suresh; Tripp, Ralph A.			MicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) Replication	PLOS ONE			English	Article							VIRUS-INFECTION; A549 CELLS; INHIBIT; LUNG; MICE	Influenza A viruses are important pathogens of humans and animals. While seasonal influenza viruses infect humans every year, occasionally animal-origin viruses emerge to cause pandemics with significantly higher morbidity and mortality rates. In March 2013, the public health authorities of China reported three cases of laboratory confirmed human infection with avian influenza A (H7N9) virus, and subsequently there have been many cases reported across South East Asia and recently in North America. Most patients experience severe respiratory illness, and morbidity with mortality rates near 40%. No vaccine is currently available and the use of antivirals is complicated due the frequent emergence of drug resistant strains. Thus, there is an imminent need to identify new drug targets for therapeutic intervention. In the current study, a high-throughput screening (HTS) assay was performed using microRNA (miRNA) inhibitors to identify new host miRNA targets that reduce influenza H7N9 replication in human respiratory (A549) cells. Validation studies lead to a top hit, hsa-miR-664a-3p, that had potent antiviral effects in reducing H7N9 replication (TCID50 titers) by two logs. In silico pathway analysis revealed that this microRNA targeted the LIF and NEK7 genes with effects on pro-inflammatory factors. In follow up studies using siR-NAs, anti-viral properties were shown for LIF. Furthermore, inhibition of hsa-miR-664a-3p also reduced virus replication of pandemic influenza A strains H1N1 and H3N2.	[Wolf, Stefan; Wu, Weilin; Jones, Cheryl; Perwitasari, Olivia; Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Wolf, Stefan; Mahalingam, Suresh] Griffith Univ, Inst Glyc, Southport, Qld 4215, Australia	University System of Georgia; University of Georgia; Griffith University	Tripp, RA (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu			National Institute of Allergy and Infectious 473 Diseases, National Institutes of Health [HHSN272201400004C]; Georgia Research Alliance; Griffith University (GUPRS/GUPIRS scholarship); National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN272201400004C]; Griffith University; GUPRS/GUPIRS	National Institute of Allergy and Infectious 473 Diseases, National Institutes of Health; Georgia Research Alliance; Griffith University (GUPRS/GUPIRS scholarship); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Griffith University(Griffith University); GUPRS/GUPIRS	This work was supported by the National Institute of Allergy and Infectious 473 Diseases, National Institutes of Health (HHSN272201400004C), Georgia Research Alliance, and Griffith University (GUPRS/GUPIRS scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (HHSN272201400004C), and funding from the Georgia Research Alliance. Special thanks go to Griffith University, which supported the work behind this study with a GUPRS/GUPIRS scholarship. The authors declare no financial interest.	Alvarez R, 2009, ANTIMICROB AGENTS CH, V53, P3952, DOI 10.1128/AAC.00014-09; [Anonymous], 2013, BMJ, V346, pf2069, DOI 10.1136/bmj.f2069; Bakre A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066796; Canada Go, 2015, GOV CAN BRIT COL CON; CDC, 2014, AVIAN INFLUENZA A H7; Chi Y, 2013, J INFECT DIS, V208, P1962, DOI 10.1093/infdis/jit440; Conly Jm, 2006, Can J Infect Dis Med Microbiol, V17, P11; Deng YB, 2015, GENET MOL RES, V14, P10087, DOI 10.4238/2015.August.21.16; Feng YL, 2015, J CLIN PATHOL, V68, P57, DOI 10.1136/jclinpath-2014-202441; Foronjy RF, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0041-4; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gebert LFR, 2014, NUCLEIC ACIDS RES, V42, P609, DOI 10.1093/nar/gkt852; Hirsch AJ, 2010, FUTURE MICROBIOL, V5, P303, DOI 10.2217/FMB.09.121; Hsieh HP, 2007, STRATEGIES DEV ANTIV; Huang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101788; Huang YT, 2000, J CLIN MICROBIOL, V38, P422; Jefferson T., 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001169.pub3, DOI 10.1002/14651858.CD001169.PUB3]; Josset L, 2014, MBIO, V5, DOI 10.1128/mBio.01102-13; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Ku SH, 2016, ADV DRUG DELIVER REV, V104, P16, DOI 10.1016/j.addr.2015.10.015; Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li YK, 2013, CELL MOL IMMUNOL, V10, P65, DOI 10.1038/cmi.2012.55; Li YK, 2012, CELL MOL IMMUNOL, V9, P497, DOI 10.1038/cmi.2012.35; Loveday EK, 2015, J GEN VIROL, V96, P30, DOI 10.1099/vir.0.068585-0; Marjuki H, 2015, J INFECT DIS, V211, P249, DOI 10.1093/infdis/jiu447; Mei L, 2013, BIOSCI TRENDS, V7, P64, DOI 10.5582/bst.2013.v7.2.64; Meliopoulos VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037169; Moorthy Ns Fau-Poongavanam V, 2014, VIRAL M2 ION CHANNEL; Morrison J, 2015, EXPERT OPIN THER TAR, V19, P447, DOI 10.1517/14728222.2015.1006198; Pan HY, 2011, CARDIOVASC RES, V89, P595, DOI 10.1093/cvr/cvq358; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; REED L. J., 1938, AMER JOUR HYG, V27, P493; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Szretter KJ, 2005, CURRENT PROTOCOLS MI; Tambyah PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076811; Torrecilla J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/161794; van der Ree MH, 2016, ALIMENT PHARM THER, V43, P102, DOI 10.1111/apt.13432; van Rooij E, 2014, EMBO MOL MED, V6, P851, DOI 10.15252/emmm.201100899; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Zhang H, 2015, GENE THER, V22, P653, DOI 10.1038/gt.2015.31; Zhang N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/239462; Zhao GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092987; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhou Z, 2015, CELL RES, V25, P39, DOI 10.1038/cr.2014.130; Zhu Z, 2014, VIRUSES-BASEL, V6, P1525, DOI 10.3390/v6041525	46	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155104	10.1371/journal.pone.0155104	http://dx.doi.org/10.1371/journal.pone.0155104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166678	Green Published, gold			2022-12-27	WOS:000376587300061
J	Kirkman, SP; Yemane, DG; Lamont, T; Meyer, MA; Pistorius, PA				Kirkman, Stephen P.; Yemane, Dawit G.; Lamont, Tarron; Meyer, Michael A.; Pistorius, Pierre A.			Foraging Behavior of Subantarctic Fur Seals Supports Efficiency of a Marine Reserve's Design	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; PRINCE EDWARD ISLANDS; ARCTOCEPHALUS-TROPICALIS; NORTH PACIFIC; OCEANOGRAPHIC FEATURES; SURFACE TEMPERATURES; HABITAT SELECTION; FRONTS SOUTH; OCEAN; ECOLOGY	Foraging behaviour of marine top predators is increasingly being used to identify areas of ecological importance. This is largely enabled by the ability of many such species to forage extensively in search of prey that is often concentrated in oceanographically productive areas. To identify important habitat in the Southern Indian Ocean within and around South Africa's Prince Edward Islands' Marine Protected Area (MPA), satellite transmitters were deployed on 12 lactating Subantarctic fur seals Arctocephalus tropicalis at Prince Edward Island (PEI) itself. Switching state space models were employed to correct ARGOS tracks and estimate behavioural states for locations along predicted tracks, namely travelling or area restricted search (ARS). A random forest model showed that distance from the study colony, longitude and distance from the Subantarctic Front were the most important predictors of suitable foraging habitat (inferred from ARS). Model-predicted suitable habitat occurred within the MPA in relatively close access to the colony during summer and autumn, but shifted northwards concurrently with frontal movements in winter and spring. The association of ARS with the MPA during summer-autumn was highly significant, highlighting the effectiveness of the recently declared reserve's design for capturing suitable foraging habitat for this and probably other marine top predator species.	[Kirkman, Stephen P.; Lamont, Tarron; Meyer, Michael A.] Dept Environm Affairs Branch Oceans & Coasts, Cape Town, South Africa; [Yemane, Dawit G.] Dept Agr Forestry & Fisheries, Fisheries Management, Cape Town, South Africa; [Pistorius, Pierre A.] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa	Nelson Mandela University	Kirkman, SP (corresponding author), Dept Environm Affairs Branch Oceans & Coasts, Cape Town, South Africa.	spkirkman@gmail.com	Kirkman, Stephen/AAA-9139-2021	Kirkman, Stephen/0000-0001-5428-7375; Pistorius, Pierre/0000-0001-6561-7069; Lamont, Tarron/0000-0001-8464-891X	South Africa's Department of Environmental Affairs	South Africa's Department of Environmental Affairs	South Africa's Department of Environmental Affairs provided logistic and financial support for the Prince Edward Island autumn survey.	Ansorge IJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022588; Ansorge IJ, 1999, POLAR BIOL, V21, P135, DOI 10.1007/s003000050344; Ansorge IJ, 2003, J MARINE SYST, V39, P1, DOI 10.1016/S0924-7963(02)00243-9; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Bailleul F, 2005, MAR ECOL PROG SER, V293, P273, DOI 10.3354/meps293273; Beauplet G, 2004, MAR ECOL PROG SER, V273, P211, DOI 10.3354/meps273211; Bester MN, 2009, AFR J MAR SCI, V31, P451, DOI 10.2989/AJMS.2009.31.3.19.1007; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bradshaw CJA, 2004, ICES J MAR SCI, V61, P1014, DOI 10.1016/j.icesjms.2004.07.012; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2014, RANDOMFOREST BREIMAN; CARR T, 1985, S AFR J ZOOL, V20, P77; Ceia FR, 2015, OECOLOGIA, V177, P431, DOI 10.1007/s00442-014-3109-1; CHENEY RE, 1983, J GEOPHYS RES-OCEANS, V88, P4343, DOI 10.1029/JC088iC07p04343; Clarke M.R, 1986, HDB IDENTIFICATION C; Costa DP, 2012, ANNU REV ECOL EVOL S, V43, P73, DOI 10.1146/annurev-ecolsys-102710-145045; Costa DP, 2010, INTEGR COMP BIOL, V50, P1018, DOI 10.1093/icb/icq054; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; DANIAULT N, 1985, J GEOPHYS RES-OCEANS, V90, P1877, DOI 10.1029/JC090iC06p11877; DAVID JHM, 1990, S AFR J WILDL RES, V20, P5; David JHM, 1983, S AFRICAN J ZOOLOGY, V28, P61; de Bruyn PJN, 2009, MAR ECOL PROG SER, V394, P263, DOI 10.3354/meps08292; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Durgadoo JV, 2011, S AFR J SCI, V107, P14, DOI 10.4102/sajs.v107i11/12.673; Durgadoo JV, 2010, ANTARCT SCI, V22, P211, DOI 10.1017/S0954102010000088; Eckert SA, 2006, MAR BIOL, V149, P1257, DOI 10.1007/s00227-006-0262-z; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Georges JY, 2000, MAR ECOL PROG SER, V196, P291, DOI 10.3354/meps196291; Gon O, 1990, FISHES SO OCEAN, V1; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; HECHT T, 1987, South African Journal of Antarctic Research, V17, P1; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Hofmeyr G, 2008, ARCT TROP IUCN RED L; Hofmeyr GJG, 2010, AFR ZOOL, V45, P144, DOI 10.3377/004.045.0112; Hoskins AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117997; Jonker FC, 1998, ANTARCT SCI, V10, P21, DOI 10.1017/S0954102098000042; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kahle D, 2015, GGMAP SPATIAL VISUAL; KERLEY GIH, 1983, S AFR J WILDL RES, V13, P71; Kirkman SP, 2002, AFR ZOOL, V37, P13; Kuhn M., 2013, PACKAGEAPPLIEDPREDIC, DOI DOI 10.1007/978-1-4614-6849-3; Lea MA, 2003, ICES J MAR SCI, V60, P990, DOI 10.1016/S1054-3139(03)00101-2; Lea MA, 2008, MAR ECOL PROG SER, V358, P273, DOI 10.3354/meps07305; Lombard AT, 2007, ANTARCT SCI, V19, P39, DOI 10.1017/S0954102007000077; Luque SP, 2007, MAR BIOL, V152, P213, DOI 10.1007/s00227-007-0677-1; LUTJEHARMS JRE, 1980, DEEP-SEA RES, V27, P145, DOI 10.1016/0198-0149(80)90093-X; LUTJEHARMS JRE, 1984, DEEP-SEA RES, V31, P1461, DOI 10.1016/0198-0149(84)90082-7; Lutjeharms JRE, 2002, S AFR J SCI, V98, P304; Maheu C, 2003, AVISO NEWSLETTER, V9; Makhado AB, 2013, POLAR BIOL, V36, P1609, DOI 10.1007/s00300-013-1380-y; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Nel D, 2008, WWF S AFRICA REPORT; Nel DC, 2001, MAR ECOL PROG SER, V217, P15, DOI 10.3354/meps217015; Nel DC, 2002, IBIS, V144, pE141, DOI 10.1046/j.1474-919X.2002.00092.x; O'Hara PD, 2006, DEEP-SEA RES PT II, V53, P359, DOI 10.1016/j.dsr2.2006.01.011; PERISSINOTTO R, 1992, MAR ECOL PROG SER, V80, P15, DOI 10.3354/meps080015; Perissinotto R, 2000, J MARINE SYST, V24, P327, DOI 10.1016/S0924-7963(99)00093-7; Piatt JF, 2006, DEEP-SEA RES PT II, V53, P387, DOI 10.1016/j.dsr2.2006.01.008; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Pujol M-I, 2013, 20 YEAR REFERENCE PE; R Core Team, 2021, R LANGUAGE ENV STAT; Raymond B, 2015, ECOGRAPHY, V38, P121, DOI 10.1111/ecog.01021; Ridgeway G., 2015, GBM GEN BOOSTED REGR; Robinson SA, 2000, MARINE FRESHWATER RE, V53, P1071; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Tosh CA, 2012, AQUAT BIOL, V17, P71, DOI 10.3354/ab00463; Verrier D, 2009, AM J PHYSIOL-REG I, V297, pR1582, DOI 10.1152/ajpregu.90857.2008; Wege M, 2015, ANTARCT SCI, V27, P251, DOI 10.1017/S0954102014000716; Wege M, 2013, THESIS U PRETORIA S; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Wickham H, 2015, PLYR TOOLS SPLITTING; Wickham H., 2015, GGPLOT2 IMPLEMENTATI; Wickham H., 2014, RESHAPE2 FLEXIBLY RE; Womble JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055386; Zanre R, 2011, AFR ZOOL, V46, P185, DOI 10.3377/004.046.0111	81	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0152370	10.1371/journal.pone.0152370	http://dx.doi.org/10.1371/journal.pone.0152370			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163373	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700020
J	Zhang, L; Voskuijl, W; Mouzaki, M; Groen, AK; Alexander, J; Bourdon, C; Wang, A; Versloot, CJ; Di Giovanni, V; Wanders, RJA; Bandsma, R				Zhang, Ling; Voskuijl, Wieger; Mouzaki, Marialena; Groen, Albert K.; Alexander, Jennifer; Bourdon, Celine; Wang, Alice; Versloot, Christian J.; Di Giovanni, Valeria; Wanders, Ronald J. A.; Bandsma, Robert			Impaired Bile Acid Homeostasis in Children with Severe Acute Malnutrition	PLOS ONE			English	Article							MALNOURISHED CHILDREN; MALABSORPTION; ABSORPTION; 7-ALPHA-HYDROXY-4-CHOLESTEN-3-ONE; KWASHIORKOR; ENTEROPATHY; RECEPTORS; DIARRHEA; DISEASE; SERUM	Objective Severe acute malnutrition (SAM) is a major cause of mortality in children under 5 years and is associated with hepatic steatosis. Bile acids are synthesized in the liver and participate in dietary fat digestion, regulation of energy expenditure, and immune responses. The aim of this work was to investigate whether SAM is associated with clinically relevant changes in bile acid homeostasis. Design An initial discovery cohort with 5 healthy controls and 22 SAM-patients was used to identify altered bile acid homeostasis. A follow up cohort of 40 SAM-patients were then studied on admission and 3 days after clinical stabilization to assess recovery in bile acid metabolism. Recruited children were 6-60 months old and admitted for SAM in Malawi. Clinical characteristics, feces and blood were collected on admission and prior to discharge. Bile acids, 7ahydroxy-4-cholesten-3-one (C4) and FGF-19 were quantified. Results On admission, total serum bile acids were higher in children with SAM than in healthy controls and glycine-conjugates accounted for most of this accumulation with median and interquartile range (IQR) of 24.6 mu mol/L [8.6-47.7] compared to 1.9 mu mol/L [1.7-3.3] (p = 0.01) in controls. Total serum bile acid concentrations did not decrease prior to discharge. On admission, fecal conjugated bile acids were lower and secondary bile acids higher at admission compared to pre-discharge, suggesting increased bacterial conversion. FGF19 (Fibroblast growth factor 19), a marker of intestinal bile acid signaling, was higher on admission and was associated with decreased C4 concentrations as a marker of bile acid synthesis. Upon recovery, fecal calprotectin, a marker of intestinal inflammation, was lower. Conclusion SAM is associated with increased serum bile acid levels despite reduced synthesis rates. In SAM, there tends to be increased deconjugation of bile acids and conversion from primary to secondary bile acids, which may contribute to the development of liver disease.	[Zhang, Ling; Alexander, Jennifer; Bourdon, Celine; Wang, Alice; Versloot, Christian J.; Di Giovanni, Valeria; Bandsma, Robert] Hosp Sick Children, Res Inst, Physiol & Expt Med Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Voskuijl, Wieger] Univ Malawi, Dept Paediat & Children Hlth, Coll Med, P Bag 360, Blantyre, Malawi; [Voskuijl, Wieger] Emma Childrens Hosp AMC, Global Child Hlth Grp, Amsterdam, Netherlands; [Mouzaki, Marialena; Bandsma, Robert] Hosp Sick Children, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Groen, Albert K.; Bandsma, Robert] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Groningen, Netherlands; [Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; [Bandsma, Robert] Hosp Sick Children, Ctr Global Child Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Malawi; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bandsma, R (corresponding author), Hosp Sick Children, Res Inst, Physiol & Expt Med Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Bandsma, R (corresponding author), Hosp Sick Children, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada.; Bandsma, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Groningen, Netherlands.; Bandsma, R (corresponding author), Hosp Sick Children, Ctr Global Child Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	robert.bandsma@sickkids.ca		Voskuijl, Wieger/0000-0001-5825-2831				Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Bandsma RHJ, 2010, PEDIATR RES, V68, P423, DOI 10.1203/PDR.0b013e3181f2b959; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BOWIE MD, 1967, AM J CLIN NUTR, V20, P89, DOI 10.1093/ajcn/20.2.89; Brown EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8806; Camilleri M, 2009, NEUROGASTROENT MOTIL, V21, P734, DOI 10.1111/j.1365-2982.2009.01288.x; Campbell DI, 2003, PEDIATR RES, V54, P306, DOI 10.1203/01.PDR.0000076666.16021.5E; DOHERTY JF, 1992, ARCH DIS CHILD, V67, P1348, DOI 10.1136/adc.67.11.1348; Ferdinandusse S, 2005, J BIOL CHEM, V280, P18658, DOI 10.1074/jbc.M414311200; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; Honda A, 2007, J LIPID RES, V48, P458, DOI 10.1194/jlr.D600032-JLR200; Barrasa JI, 2011, APOPTOSIS, V16, P1054, DOI 10.1007/s10495-011-0633-x; Irena AH, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-110; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li YY, 2013, BIOCHEM PHARMACOL, V86, P1517, DOI 10.1016/j.bcp.2013.08.015; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; MCCANCE RA, 1970, ARCH DIS CHILD, V45, P410, DOI 10.1136/adc.45.241.410; MEHTA HC, 1984, BRIT J NUTR, V51, P1, DOI 10.1079/BJN19840003; MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341; Mouzaki M, 2015, CURR DRUG TARGETS; Munch A, 2007, SCAND J GASTROENTERO, V42, P1167, DOI 10.1080/00365520701320463; Murphy JL, 2002, ARCH DIS CHILD, V87, P522, DOI 10.1136/adc.87.6.522; OMOIKE IU, 1989, J PEDIATR GASTR NUTR, V9, P314, DOI 10.1097/00005176-198910000-00009; Pattni S, 2009, BRIT MED BULL, V92, P79, DOI 10.1093/bmb/ldp032; PIMPARKAR BD, 1977, AM J GASTROENTEROL, V67, P580; Raimondi F, 2008, AM J PHYSIOL-GASTR L, V294, pG906, DOI 10.1152/ajpgi.00043.2007; Rizzo Giovanni, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P289, DOI 10.2174/1568008054863781; Roberts EA, 2005, FRONT BIOSCI-LANDMRK, V10, P2306, DOI 10.2741/1699; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; SCHNEIDER RE, 1974, AM J CLIN NUTR, V27, P788, DOI 10.1093/ajcn/27.8.788; Setchell KDR, 1997, GASTROENTEROLOGY, V112, P226, DOI 10.1016/S0016-5085(97)70239-7; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; STELLWAG EJ, 1979, J LIPID RES, V20, P325; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Svegliati-Baroni G, 2005, GASTROENTEROLOGY, V128, P1042, DOI 10.1053/j.gastro.2005.01.007; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; VITERI FE, 1974, MED CLIN N AM, V58, P1487, DOI 10.1016/S0025-7125(16)32085-5; Wagner M, 2010, SEMIN LIVER DIS, V30, P160, DOI 10.1055/s-0030-1253225; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2013, GUID UPD MAN SEV AC	42	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155143	10.1371/journal.pone.0155143	http://dx.doi.org/10.1371/journal.pone.0155143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163928	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700027
J	Brass, DM; Spencer, JC; Li, ZW; Potts-Kant, E; Reilly, SM; Dunkel, MK; Latoche, JD; Auten, RL; Hollingsworth, JW; Fattman, CL				Brass, David M.; Spencer, Jennifer C.; Li, Zhuowei; Potts-Kant, Erin; Reilly, Sarah M.; Dunkel, Mary K.; Latoche, Joseph D.; Auten, Richard L.; Hollingsworth, John W.; Fattman, Cheryl L.			RETRACTION: Innate Immune Activation by Inhaled Lipopolysaccharide, Independent of Oxidative Stress, Exacerbates Silica-Induced Pulmonary Fibrosis in Mice (Retraction of vol 7, e40789, 2012)	PLOS ONE			English	Retraction														Latoche, Joseph/0000-0002-4800-5623				Brass DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040789	1	17	18	7	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155388	10.1371/journal.pone.0155388	http://dx.doi.org/10.1371/journal.pone.0155388			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158821	Green Published, gold			2022-12-27	WOS:000376576700063
J	Tian, TT; Gao, J; Li, N; Li, YY; Lu, M; Li, ZW; Lu, ZH; Li, J; Shen, L				Tian, Tiantian; Gao, Jing; Li, Na; Li, Yanyan; Lu, Ming; Li, Zhongwu; Lu, Zhihao; Li, Jie; Shen, Lin			Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; FOLLOW-UP; PROGNOSTIC-FACTORS; DIAGNOSIS; SURVIVAL; SERUM; STREPTOZOCIN; CHEMOTHERAPY; CARCINOMAS; CISPLATIN	Chromogranin A (CgA), present in the chromaffin granules of neuroendocrine cells, is a useful biomarker for the diagnosis of patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This study was conducted to investigate the potential role of circulating CgA in monitoring clinical response in Chinese patients with advanced GEP-NETs. Eighty patients with advanced GEP-NETs treated in Peking University Cancer Hospital from September 2011 to May 2014 and 65 healthy individuals were included in this study. Serum CgA levels were analyzed for relationship with patient's baseline characteristics and clinical outcome. Median CgA levels were significantly higher in patients with advanced GEP-NETs than in healthy individuals (93.8 ng/mL vs. 37.1 ng/mL; P<0.01), as well as significantly higher in patients with carcinoid syndrome or liver metastasis than in those without carcinoid syndrome (298.8 ng/mL vs. 82.9 ng/mL; P = 0.011) or liver metastasis (137.0 ng/mL vs. 64.4 ng/mL; P = 0.023). A CgA cutoff value of 46.2 ng/mL was used in this study with a sensitivity of 78.8% and specificity of 73.8%. Patients with CgA levels higher than 46.2 ng/mL had a worse prognosis than patients with CgA levels lower than 46.2 ng/mL (P = 0.045). Notably, a weak correlation was observed between changes in serum CgA levels and clinical response to the IP regimen as well as SSAs. Our data also indicate that serum CgA could be a useful indicator of patient prognosis though there is more research required in order to validate such claims.	[Tian, Tiantian; Gao, Jing; Li, Na; Li, Yanyan; Lu, Ming; Lu, Zhihao; Li, Jie; Shen, Lin] Peking Univ Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Beijing, Peoples R China; [Li, Zhongwu] Peking Univ Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Dept Pathol, Beijing, Peoples R China	Peking University; Peking University	Li, J; Shen, L (corresponding author), Peking Univ Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Beijing, Peoples R China.	xiaotong10241@sina.com; lin100@medmail.com.cn			National Natural Science Foundation of China [81172110]; National High Technology Research and Development Program [2012AA02A 504]; National Basic Research Program of China [2014CBA02002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (grant number: No. 81172110, website: http://www.nsfc.gov.cn/publish/portal1/, the author who received the funding: LS); National High Technology Research and Development Program (grant number: No. 2012AA02A 504, website: http://www.863.gov.cn/, the author who received the funding: LS); and National Basic Research Program of China (No. 2014CBA02002, website: http://www.973.gov.cn, the author who received the funding: LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2009, ENDOCR-RELAT CANCER, V16, P885, DOI 10.1677/ERC-09-0042; Arnold R, 2008, CLIN GASTROENTEROL H, V6, P820, DOI 10.1016/j.cgh.2008.02.052; Bajetta E, 1999, CANCER, V86, P858, DOI 10.1002/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO;2-8; Belli Susana Haydee, 2009, Acta Gastroenterol Latinoam, V39, P184; Bergestuen DS, 2009, SCAND J GASTROENTERO, V44, P1084, DOI 10.1080/00365520903082432; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Chou WC, 2012, NEUROENDOCRINOLOGY, V95, P344, DOI 10.1159/000333853; Clancy TE, 2006, DIGEST DIS SCI, V51, P877, DOI 10.1007/s10620-006-9345-4; Edge SB, 2010, AJCC CANC STAGING MA; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Eriksson B, 1996, DIGESTION, V57, P77, DOI 10.1159/000201402; Ferrari L, 2004, INT J BIOL MARKER, V19, P295, DOI 10.1177/172460080401900407; Kocha W, 2010, CURR ONCOL, V17, P49; Korse CM, 2012, EUR J CANCER, V48, P662, DOI 10.1016/j.ejca.2011.08.012; Kouvaraki MA, 2004, J CLIN ONCOL, V22, P4762, DOI 10.1200/JCO.2004.04.024; Kulke MH, 2015, J NATL COMPR CANC NE, V13, P78, DOI 10.6004/jnccn.2015.0011; Lu ZH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0664-y; Modlin IM, 2010, ANN SURG ONCOL, V17, P2427, DOI 10.1245/s10434-010-1006-3; Nehar D, 2004, CLIN ENDOCRINOL, V60, P644, DOI 10.1111/j.1365-2265.2004.02030.x; Singh S, 2012, EXPERT REV GASTROENT, V6, P313, DOI [10.1586/EGH.12.15, 10.1586/egh.12.15]; Stridsberg M, 2003, J ENDOCRINOL, V177, P337, DOI 10.1677/joe.0.1770337; Syversen U, 2004, SCAND J GASTROENTERO, V39, P969, DOI 10.1080/00365520410003362; Turner NC, 2010, BRIT J CANCER, V102, P1106, DOI 10.1038/sj.bjc.6605618; Vezzosi D, 2011, INT J BIOL MARKER, V26, P94, DOI 10.5301/JBM.2011.8327; Walter T, 2012, EUR J CANCER, V48, P1766, DOI 10.1016/j.ejca.2011.11.005; Wang YH, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000247; Woltering EA, 2006, PANCREAS, V33, P250, DOI 10.1097/01.mpa.0000235302.73615.d4; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, J CLIN ENDOCR METAB, V96, P3741, DOI 10.1210/jc.2011-0666; Zatelli MC, 2007, ENDOCR-RELAT CANCER, V14, P473, DOI 10.1677/ERC-07-0001	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154679	10.1371/journal.pone.0154679	http://dx.doi.org/10.1371/journal.pone.0154679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159453	gold, Green Published, Green Submitted			2022-12-27	WOS:000376576700015
J	Wu, JX; Hadoke, PWF; Takov, K; Korczak, A; Denvir, MA; Smith, LB				Wu, Junxi; Hadoke, Patrick W. F.; Takov, Kaloyan; Korczak, Agnieszka; Denvir, Martin A.; Smith, Lee B.			Influence of Androgen Receptor in Vascular Cells on Reperfusion following Hindlimb Ischaemia	PLOS ONE			English	Article							SKELETAL-MUSCLE; ANGIOGENESIS; IMPROVES; MODEL	Aims Studies in global androgen receptor knockout (G-ARKO) and orchidectomised mice suggest that androgen accelerates reperfusion of the ischaemic hindlimb by stimulating angiogenesis. This investigation used novel, vascular cell-specific ARKO mice to address the hypothesis that the impaired hindlimb reperfusion in G-ARKO mice was due to loss of AR from cells in the vascular wall. Methods and Results Mice with selective deletion of AR ( ARKO) from vascular smoothmuscle cells (SM-ARKO), endothelial cells (VE-ARKO), or both (SM/VE-ARKO) were compared with wild type (WT) controls. Hindlimb ischaemia was induced in these mice by ligation and removal of the femoral artery. Post-operative reperfusion was reduced in SM-ARKO and SM/VE-ARKO mice. Immunohistochemistry indicated that this was accompanied by a reduced density of smooth muscle actin-positive vessels but no change in the density of isolectin B4-positive vessels in the gastrocnemius muscle. Deletion of AR from the endothelium (VE-ARKO) did not alter post-operative reperfusion or vessel density. In an ex vivo (aortic ring culture) model of angiogenesis, AR was not detected in vascular outgrowths and angiogenesis was not altered by vascular ARKO or by exposure to dihydrotestosterone (DHT 10(-10)-10(-7)M; 6 days). Conclusion These results suggest that loss of AR from vascular smoothmuscle, but not from the endothelium, contributes to impaired reperfusion in the ischaemic hindlimb of G-ARKO. Impaired reperfusion was associated with reduced collateral formation rather than reduced angiogenesis.	[Wu, Junxi; Smith, Lee B.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Wu, Junxi; Hadoke, Patrick W. F.; Takov, Kaloyan; Korczak, Agnieszka; Denvir, Martin A.] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Smith, LB (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	Lee.Smith@ed.ac.uk	Denvir, Martin A/ABA-3141-2021; Takov, Kaloyan/O-1013-2017; Wu, Junxi/L-3779-2016	Takov, Kaloyan/0000-0002-8642-6306; Wu, Junxi/0000-0002-1334-887X; Smith, Lee/0000-0002-4103-3074	British Heart Foundation Project Grant [PG/11/72/29334]; MRC Programme Grant [G1100354]; BHF Centre for Research Excellence, Edinburgh; British Heart Foundation [PG/11/72/29334] Funding Source: researchfish; Medical Research Council [G1100354, MR/N002970/1] Funding Source: researchfish; MRC [MR/N002970/1, G1100354] Funding Source: UKRI	British Heart Foundation Project Grant(British Heart Foundation); MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BHF Centre for Research Excellence, Edinburgh; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is funded by a British Heart Foundation Project Grant award to LBS, PWFH, and MAD (PG/11/72/29334), an MRC Programme Grant award to LBS (G1100354), and the BHF Centre for Research Excellence, Edinburgh.	Altuwaijri S, 2004, ENDOCRINE, V25, P27, DOI 10.1385/ENDO:25:1:27; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Chambon C, 2010, P NATL ACAD SCI USA, V107, P14327, DOI 10.1073/pnas.1009536107; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Kawano H, 2003, P NATL ACAD SCI USA, V100, P9416, DOI 10.1073/pnas.1533500100; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Leblanc AJ, 2012, MICROCIRCULATION, V19, P676, DOI 10.1111/j.1549-8719.2012.00207.x; Levanon K, 2006, PATHOBIOLOGY, V73, P149, DOI 10.1159/000095561; Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104; MacLean HE, 2008, FASEB J, V22, P2676, DOI 10.1096/fj.08-105726; Monks DA, 2004, J COMP NEUROL, V473, P59, DOI 10.1002/cne.20088; Niiyama H, 2009, J VISUALIZED EXPT JO; Nunes SS, 2010, MICROVASC RES, V79, P10, DOI 10.1016/j.mvr.2009.10.001; O'Hara Laura, 2012, BMC Res Notes, V5, P16, DOI 10.1186/1756-0500-5-16; Peng XZ, 2011, AM J PHYSIOL-HEART C, V300, pH2027, DOI 10.1152/ajpheart.00004.2011; Pronsato L, 2012, J ENDOCRINOL, V212, P371, DOI 10.1530/JOE-11-0234; Serra C, 2013, J GERONTOL A-BIOL, V68, P17, DOI 10.1093/gerona/gls083; Shepherd BR, 2004, ARTERIOSCL THROM VAS, V24, P898, DOI 10.1161/01.ATV.0000124103.86943.1e; Sieveking DP, 2010, J EXP MED, V207, P345, DOI 10.1084/jem.20091924; Torres-Estay V, 2015, J ENDOCRINOL, V224, pR131, DOI 10.1530/JOE-14-0611; Wahlberg E, 2003, J VASC SURG, V38, P198, DOI 10.1016/S0741-5214(03)00151-4; Wu JX, 2014, CARDIOVASC RES, V103, P281, DOI 10.1093/cvr/cvu142; Yoshida S, 2013, CIRCULATION, V128, P60, DOI 10.1161/CIRCULATIONAHA.113.001533; Zachary I, 2011, HEART, V97, P181, DOI 10.1136/hrt.2009.180414	26	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154987	10.1371/journal.pone.0154987	http://dx.doi.org/10.1371/journal.pone.0154987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159530	Green Accepted, gold, Green Published			2022-12-27	WOS:000376576700028
J	Maiguy-Foinard, A; Blanchemain, N; Barthelemy, C; Decaudin, B; Odou, P				Maiguy-Foinard, Aurelie; Blanchemain, Nicolas; Barthelemy, Christine; Decaudin, Bertrand; Odou, Pascal			Influence of a Double-Lumen Extension Tube on Drug Delivery: Examples of Isosorbide Dinitrate and Diazepam	PLOS ONE			English	Article							CERTIFIED REFERENCE MATERIALS; POLYVINYL-CHLORIDE; FLOW-RATE; INFUSION; STERILIZATION; NITROGLYCERIN; FEASIBILITY; IRRADIATION; MIGRATION; PHTHALATE	Purpose Plastic materials such as polyurethane (PUR), polyethylene (PE), polypropylene (PP) and polyvinyl chloride (PVC) are widely used in double-lumen extension tubing. The purposes of our study were to 1) compare in vitro drug delivery through the double extension tubes available on the market 2) assess the plastic properties of PUR in infusion devices and their impact on drug delivery. Methods The study compared eight double-lumen extension tubes in PUR, co-extruded (PE/PVC) plastic and plasticised PVC from different manufacturers. Isosorbide dinitrate and diazepam were used as model compounds to evaluate their sorption on the internal surface of the infusion device. Control experiments were performed using norepinephrine known not to absorb to plastics. Drug concentrations delivered at the egress of extension tubes were determined over time by an analytical spectrophotometric UV-Vis method. The main characteristics of plastics were also determined. Results Significant differences in the sorption phenomenon were observed among the eight double-lumen extension tubes and between pairs of extension tubes. Mean concentrations of isosorbide dinitrate delivered at the egress of double-lumen extension tubes after a 150-minute infusion (mean values +/- standard deviation in percentage of the initial concentrations in the prepared syringes) ranged between 80.53 +/- 1.66 (one of the PUR tubes) and 92.84 +/- 2.73 (PE/PVC tube). The same parameters measured during diazepam infusion ranged between 48.58 +/- 2.88 (one of the PUR tubes) and 85.06 +/- 3.94 (PE/PVC tube). The double-lumen extension tubes in PUR were either thermosetting (resin) or thermoplastic according to reference. Conclusions Clinicians must be aware of potential drug interactions with extension tube materials and so must consider their nature as well as the sterilisation method used before selecting an infusion device.	[Maiguy-Foinard, Aurelie; Barthelemy, Christine; Decaudin, Bertrand; Odou, Pascal] Univ Lille, EA 7365, GRITA, Grp Rech Formes Injectables & Technol Associees, F-59000 Lille, France; [Maiguy-Foinard, Aurelie; Decaudin, Bertrand; Odou, Pascal] CHU Lille, Inst Pharm, F-59000 Lille, France; [Blanchemain, Nicolas] Univ Lille, F-59000 Lille, France; [Blanchemain, Nicolas] INSERM, U1008, Controlled Drug Delivery Syst & Biomat, F-59000 Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Decaudin, B (corresponding author), Univ Lille, EA 7365, GRITA, Grp Rech Formes Injectables & Technol Associees, F-59000 Lille, France.; Decaudin, B (corresponding author), CHU Lille, Inst Pharm, F-59000 Lille, France.	bertrand.decaudin@univ-lille2.fr	Nicolas, Blanchemain/GWV-3651-2022; BARTHELEMY, Christine/A-8968-2017; Decaudin, Bertrand/E-5828-2010	BARTHELEMY, Christine/0000-0001-9774-1857; Decaudin, Bertrand/0000-0001-8267-5594	Department of Biopharmacy, Galenic and Hospital Pharmacy, Lille 2 University, UDSL, EA GRIIOT, UFR Pharmacie, Lille, France	Department of Biopharmacy, Galenic and Hospital Pharmacy, Lille 2 University, UDSL, EA GRIIOT, UFR Pharmacie, Lille, France	This study was funded by intramural funds from the Department of Biopharmacy, Galenic and Hospital Pharmacy, Lille 2 University, UDSL, EA GRIIOT, UFR Pharmacie, Lille, France.	Al Salloum H, 2015, INT J PHARM, VS0378-5173, P30353; Baccaro S, 2003, NUCL INSTRUM METH B, V208, P195, DOI 10.1016/S0168-583X(03)00886-3; Bartels K, 2009, ANESTH ANALG, V109, P1156, DOI 10.1213/ane.0b013e3181b220c9; da Silva FF, 2008, POLYM DEGRAD STABIL, V93, P2199, DOI 10.1016/j.polymdegradstab.2008.07.024; Decaudin B, 2009, ANESTH ANALG, V109, P1147, DOI 10.1213/ane.0b013e3181ae06e3; DEMUYNCK C, 1993, J PHARM PHARMACOL, V45, P139; Foinard A, 2013, Ann Fr Anesth Reanim, V32, pe107, DOI 10.1016/j.annfar.2013.06.017; Goullet D, 1992, Agressologie, V33 Spec No 3, P121; Hewson MP, 2000, J PAEDIATR CHILD H, V36, P216, DOI 10.1046/j.1440-1754.2000.00488.x; Hsieh Kuo-Huang, 1997, HDB THERMOPLASTICS, V16, P381; Jenke D, 2002, PDA J PHARM SCI TECH, V56, P332; Kambia NK, 2005, J PHARMACEUT BIOMED, V37, P259, DOI 10.1016/j.jpba.2004.10.020; Lovich MA, 2005, ANESTH ANALG, V100, P1048, DOI 10.1213/01.ANE.0000146942.51020.88; MARTENS HJ, 1990, AM J HOSP PHARM, V47, P369, DOI 10.1093/ajhp/47.2.369; Matthews I. P., 1994, Clinical Materials, V15, P191, DOI 10.1016/0267-6605(94)90082-5; Murray KA, 2013, EUR POLYM J, V49, P1782, DOI 10.1016/j.eurpolymj.2013.03.034; Nair PD, 1995, J BIOMATER APPL, V10, P121, DOI 10.1177/088532829501000203; SHINTANI H, 1995, J BIOMATER APPL, V10, P23, DOI 10.1177/088532829501000102; SHINTANI H, 1989, J ANAL TOXICOL, V13, P354, DOI 10.1093/jat/13.6.354; Shintani H, 1995, Biomed Instrum Technol, V29, P513; Stoffers NH, 2005, FOOD ADDIT CONTAM, V22, P173, DOI 10.1080/02652030400028076; Stoffers NH, 2004, FOOD ADDIT CONTAM, V21, P1203, DOI 10.1080/02652030400023911; Takehisa H, 2005, INT J PHARMACEUT, V297, P30, DOI 10.1016/j.ijpharm.2005.02.015; Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.3.CO;2-H; Treleano A, 2009, INT J PHARMACEUT, V369, P30, DOI 10.1016/j.ijpharm.2008.10.024; YLIRUUSI JK, 1982, AM J HOSP PHARM, V39, P1018, DOI 10.1093/ajhp/39.6.1018; YLIRUUSI JK, 1986, AM J HOSP PHARM, V43, P2795, DOI 10.1093/ajhp/43.11.2795; Zahid Najam, 2008, Diabetes Res Clin Pract, V80, pe11, DOI 10.1016/j.diabres.2008.02.013	28	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154917	10.1371/journal.pone.0154917	http://dx.doi.org/10.1371/journal.pone.0154917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153224	Green Published, gold			2022-12-27	WOS:000375677000046
J	Decio, P; Vieira, AS; Dias, NB; Palma, MS; Bueno, OC				Decio, Pamela; Vieira, Alexsandro Santana; Dias, Nathalia Baptista; Palma, Mario Sergio; Bueno, Odair Correa			The Postpharyngeal Gland: Specialized Organ for Lipid Nutrition in Leaf-Cutting Ants	PLOS ONE			English	Article							FATTY ACYL-COENZYME; HYMENOPTERA; PROTEIN; ACID; EXPRESSION; QUEENS; ENERGY	There are several hypotheses about the possible functions of the postpharyngeal gland (PPG) in ants. The proposed functions include roles as cephalic or gastric caeca and diverticulum of the digestive tract, mixing of hydrocarbons, nestmate recognition, feeding larvae, and the accumulation of lipids inside this gland, whose origin is contradictory. The current study aimed to investigate the functions of these glands by examining the protein expression profile of the PPGs of Atta sexdens rubropilosa (Hymenoptera, Formicidae). Mated females received lipid supplementation and their glands were extracted and analyzed using a proteomic approach. The protocol used combined two-dimensional electrophoresis and shotgun strategies, followed by mass spectrometry. We also detected lipid beta-oxidation by immunofluorescent marking of acyl-CoA dehydrogenase. Supplying ants with lipids elicited responses in the glandular cells of the PPG; these included increased expression of proteins related to defense mechanisms and signal transduction and reorganization of the cytoskeleton due to cell expansion. In addition, some proteins in PPG were overexpressed, especially those involved in lipid and energy metabolism. Part of the lipids may be reduced, used for the synthesis of fatty alcohol, transported to the hemolymph, or may be used as substrate for the synthesis of acetyl-CoA, which is oxidized to form molecules that drive oxidative phosphorylation and produce energy for cellular metabolic processes. These findings suggest that this organ is specialized for lipid nutrition of adult leaf-cutting ants and characterized like a of diverticulum foregut, with the ability to absorb, store, metabolize, and mobilize lipids to the hemolymph. However, we do not rule out that the PPG may have other functions in other species of ants.	[Decio, Pamela; Vieira, Alexsandro Santana; Bueno, Odair Correa] Univ Estadual Paulista, Inst Biociencias, Ctr Estudos Insetos Sociais, Sao Paulo, Brazil; [Dias, Nathalia Baptista; Palma, Mario Sergio] Univ Estadual Paulista, Inst Biociencias, Ctr Estudos Insetos Sociais, Lab Biol Estrutural & Zooquim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista	Vieira, AS; Bueno, OC (corresponding author), Univ Estadual Paulista, Inst Biociencias, Ctr Estudos Insetos Sociais, Sao Paulo, Brazil.	alexsvieira@yahoo.com.br; odaircb@rc.unesp.br	Palma, Mario Sergio/E-7800-2012; Fapesp, Biota/F-8655-2017; Palma, Mario/N-3903-2019	Palma, Mario Sergio/0000-0002-7363-8211; Fapesp, Biota/0000-0002-9887-8449; 	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [130347/2011-6, 157837/2015-7, 306910/2011-0]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/12541-3, 2011/51684-1]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), grant 130347/2011-6 to Decio, grant 157837/2015-7 to Vieira, grant 306910/2011-0 to Bueno, and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), grant 2012/12541-3 to Vieira, grant 2011/51684-1 to Palma.; This work was financed by the CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), grant 130347/2011-6 to Decio, grant 157837/2015-7 to Vieira, grant 306910/2011-0 to Bueno and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), grant 2012/12541-3 to Vieira, grant 2011/51684-1 to Palma. We are grateful to CEIS (Centro de Estudos de Insetos Sociais) all team of Laboratorio de Biologia e Estrutural e Zooquimica from UNESP-Univ. Estadual Paulista, Campus Rio Claro-SP and Dr. Pablo H. Nunes for the technical support in confocal microscopy.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Augustin JO, 2011, INSECT SOC, V58, P197, DOI 10.1007/s00040-010-0137-7; Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; AYRE G. L., 1963, ENTOMOL EXP APPL, V6, P165; BAGNERES AG, 1991, EXPERIENTIA, V47, P106, DOI 10.1007/BF02041269; Borchers T, 1994, CELL LIPIDS; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bueno OC, 2008, INSETOS SOCIAIS BIOL, P96; Caetano, 2002, FORMIGAS BIOL ANATOM; Caetano FH, 1998, THESIS U STATE SAO P; Chapman P. J., 1967, Bulletin of the New York State Agricultural Experiment Station, VNo. 814, P1; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Decio P, 2013, MICRON, V45, P22, DOI 10.1016/j.micron.2012.10.008; DELAGE-DARCHEN B, 1976, Annee Biologique, V15, P63; Pinto JRAD, 2012, J PROTEOME RES, V11, P4643, DOI 10.1021/pr300451g; Eelen D, 2006, ACTA ZOOL-STOCKHOLM, V87, P101, DOI 10.1111/j.1463-6395.2006.00212.x; Falco JRP, 1992, COMP ULTRAESTRUTURAL; FORBES JAMES, 1961, JOUR NEW YORK ENT SOC, V69, P92; Fujihara RT, 2012, REV BRAS ENTOMOL, V56, P73, DOI 10.1590/S0085-56262012005000015; GAMA V, 1985, Revista Brasileira de Biologia, V45, P317; Gama V, 1982, NATURALIA, V7, P145; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Graves PR, 2002, MICROBIOL MOL BIOL R, V66, P39, DOI 10.1128/MMBR.66.1.39-63.2002; Herzner G, 2007, ARTHROPOD STRUCT DEV, V36, P123, DOI 10.1016/j.asd.2006.08.006; Herzner G, 2011, ZOOLOGY, V114, P36, DOI 10.1016/j.zool.2010.10.002; HESLER LS, 1986, SOUTHWEST ENTOMOL, P1; Holldobler B., 1990, pi; Huber PC, 2008, QUIM NOVA, V31, P1170, DOI 10.1590/S0100-40422008000500046; Janet C., 1905, ANATOMIE TETE LASIUS; Karp G, 2005, BIOL CELULAR MOL; Knoops Bernard, 2007, V44, P27; Lofgren C.S., 1986, P36; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; Morgan E. David, 2008, Myrmecological News, V11, P79; Nelson DL, 2012, PRINCIPIOS BIOQUIMIC; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Peck JW, 2002, J BIOL CHEM, V277, P43924, DOI 10.1074/jbc.M203569200; PEREGRIN.DJ, 1973, INSECT SOC, V20, P355, DOI 10.1007/BF02226088; PEREGRINE DJ, 1974, INSECT SOC, V21, P417, DOI 10.1007/BF02331569; PHILLIPS SA, 1980, ANN ENTOMOL SOC AM, V73, P257, DOI 10.1093/aesa/73.3.257; Riparbelli MG, 2002, J CELL SCI, V115, P913; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Silva AMS, 2007, SAUDE AMBIENTE, V2, P1; SOROKER V, 1994, NATURWISSENSCHAFTEN, V81, P510; Sumida S, 2010, J ECON ENTOMOL, V103, P676, DOI 10.1603/EC09159; Touchard A, 2014, J PROTEOMICS, V105, P217, DOI 10.1016/j.jprot.2014.01.009; Vieira AS, 2015, MICRON, V68, P8, DOI 10.1016/j.micron.2014.08.004; Vieira AS, 2016, SOCIOBIOLOGY UNPUB; VINSON SB, 1980, J INSECT PHYSIOL, V26, P645, DOI 10.1016/0022-1910(80)90035-9; Voet D, 2008, FUNDAMENTOS BIOQUIMI; Wiese MD, 2006, TOXICON, V47, P208, DOI 10.1016/j.toxicon.2005.10.018; ZYLBERBERG L, 1974, J MICROSC-PARIS, V21, P331	54	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154891	10.1371/journal.pone.0154891	http://dx.doi.org/10.1371/journal.pone.0154891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149618	Green Submitted, Green Published, gold			2022-12-27	WOS:000375676800080
J	Franke, M; Degen, J				Franke, Michael; Degen, Judith			Reasoning in Reference Games: Individual-vs. Population-Level Probabilistic Modeling	PLOS ONE			English	Article							CHOICE; MEMORY; IMPLICATURES; ROBUST	Recent advances in probabilistic pragmatics have achieved considerable success in modeling speakers' and listeners' pragmatic reasoning as probabilistic inference. However, these models are usually applied to population-level data, and so implicitly suggest a homogeneous population without individual differences. Here we investigate potential individual differences in Theory-of-Mind related depth of pragmatic reasoning in so-called reference games that require drawing ad hoc Quantity implicatures of varying complexity. We show by Bayesian model comparison that a model that assumes a heterogenous population is a better predictor of our data, especially for comprehension. We discuss the implications for the treatment of individual differences in probabilistic models of language use.	[Franke, Michael] Univ Tubingen, Dept Linguist, Wilhelmstr 19, D-72072 Tubingen, Germany; [Degen, Judith] Stanford Univ, Dept Psychol, 450 Serra Mall, Stanford, CA 94305 USA	Eberhard Karls University of Tubingen; Stanford University	Franke, M (corresponding author), Univ Tubingen, Dept Linguist, Wilhelmstr 19, D-72072 Tubingen, Germany.	mchfranke@gmail.com		Degen, Judith/0000-0003-2513-0234	Swiss National Science Foundation; Institutional Strategy of the University of Tubingen (German Research Foundation) [ZUK 63]; Priority Program XPrag.de (German Research Foundation) [Schwerpunktprogramm 1727]; Deutsche Forschungsgemeinschaft; University of Tubingen	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institutional Strategy of the University of Tubingen (German Research Foundation); Priority Program XPrag.de (German Research Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This work was supported by an Early Postdoc.Mobility Award of the Swiss National Science Foundation (snf.ch) to JD. MF is supported by the Institutional Strategy of the University of Tubingen (German Research Foundation ZUK 63, dfg.de). Both authors gratefully acknowledge support by Priority Program XPrag.de (German Research Foundation Schwerpunktprogramm 1727, dfg.de). We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibali MW., 2005, SPAT COGN COMPUT, V5, P307, DOI [10.1207/s15427633scc0504_2, DOI 10.1207/S15427633SCC0504_2]; Anderson J. R., 1990, ADAPTIVE CHARACTER T; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Baumann P, 2014, P COGSCI; Benz A., 2012, J LOGIC LANG INFORM, V21, P97, DOI DOI 10.1007/s10849-011-9149-6; Benz A, 2007, TOPOI-INT REV PHILOS, V26, P63, DOI 10.1007/s11245-006-9007-3; Bott L, 2004, J MEM LANG, V51, P437, DOI 10.1016/j.jml.2004.05.006; Breheny R, 2006, COGNITION, V100, P434, DOI 10.1016/j.cognition.2005.07.003; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Brown-Schmidt S, 2009, PSYCHON B REV, V16, P893, DOI 10.3758/PBR.16.5.893; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Crawford VP, 2007, AM ECON REV, V97, P1731, DOI 10.1257/aer.97.5.1731; Crawford VP, 2003, AM ECON REV, V93, P133, DOI 10.1257/000282803321455197; David Lewis, 1969, CONVENTION PHILOS ST; Degen J., 2012, P 16 WORKSH SEM PRAG, P2; Degen J., 2013, P 35 ANN M COGN SCI, P376; Degen J, 2015, COGNITIVE SCI, V39, P667, DOI 10.1111/cogs.12171; DICKEY JM, 1970, ANN MATH STAT, V41, P214, DOI 10.1214/aoms/1177697203; ESTES WK, 1956, PSYCHOL BULL, V53, P134, DOI 10.1037/h0045156; Estes WK, 2005, PSYCHON B REV, V12, P403, DOI 10.3758/BF03193784; FARRELL J, 1993, GAME ECON BEHAV, V5, P514, DOI 10.1006/game.1993.1029; Farrell J, 1996, J ECON PERSPECT, V10, P103, DOI 10.1257/jep.10.3.103; Fine AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077661; Fox D, 2007, PALG STUD PRAGM LANG, P71; Frank M., 2011, P 33 ANN M COGN SCI, V33, P2134; Frank MC, 2012, SCIENCE, V336, P998, DOI 10.1126/science.1218633; Franke M., 2009, SIGNAL ACT GAME THEO; Franke M., 2014, P COGSCI 2014, P487; Franke M, 2016, Z SPRACHWISS, V35, P3, DOI 10.1515/zfs-2016-0002; Franke M, 2014, PALG STUD PRAGM LANG, P170; Franke M, 2011, SEMANT PRAGMAT, V4, DOI 10.3765/sp.4.1; Fraundorf SH, 2012, PSYCHOL AGING, V27, P88, DOI 10.1037/a0024138; Gatt A, 2013, P 35 ANN M COGN SCI; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gillespie M, 2014, COGNITION, V132, P174, DOI 10.1016/j.cognition.2014.03.012; Goodman ND, 2013, TOP COGN SCI, V5, P173, DOI 10.1111/tops.12007; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Grodner D.J., 2011, PROCESSING ACQUISITI, P239, DOI DOI 10.7551/MITPRESS/9780262015127.003.0010; Groenendijk Jeroen, 1984, STUDIES SEMANTICS QU; Hedden T, 2002, COGNITION, V85, P1, DOI 10.1016/S0010-0277(02)00054-9; Ho TH, 1998, AM ECON REV, V88, P947; Horn LR, 2000, J PRAGMATICS, V32, P289, DOI 10.1016/S0378-2166(99)00053-3; Jager G, 2014, ERKENNTNIS, V79, P673, DOI 10.1007/s10670-013-9462-3; Jager G., 2009, P SINN BEDEUTUNG, P1; Jaynes E.T., 2003, PROBABILITY THEORY L; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jones M, 2011, BEHAV BRAIN SCI, V34, P215, DOI [10.1017/S0140525X10003134, 10.1017/S0140525X11001439]; Kamide Y, 2012, COGNITION, V124, P66, DOI 10.1016/j.cognition.2012.03.001; Kao JT, 2014, P COGSCI; Kao JT, 2014, P NATL ACAD SCI USA, V111, P12002, DOI 10.1073/pnas.1407479111; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kleinschmidt DF, 2015, PSYCHOL REV, V122, P148, DOI 10.1037/a0038695; Lassiter D, 2014, P SALT; Lee MD, 2011, J MATH PSYCHOL, V55, P1, DOI 10.1016/j.jmp.2010.08.013; Lee Michael D., 2015, BAYESIAN COGNITIVE M; Luce D., 1959, INDIVIDUAL CHOICE BE; Marcus GF, 2013, PSYCHOL SCI, V24, P2351, DOI 10.1177/0956797613495418; Marr D., 1982, VISION COMPUTATIONAL; MATSUMOTO Y, 1995, LINGUIST PHILOS, V18, P21, DOI 10.1007/BF00984960; MCFADDEN D, 1976, ANN ECON SOC MEAS, V5, P363; Meijering B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045961; Morey RD, J MATH PSYC IN PRESS; Myung I, 2000, MEMORY COGNITIONY, V28, P823; Parikh P., 2001, THE USE OF LANGUAGE; Parikh P., 1992, TARK 92, P85; Pavan S, 2013, LINGUIST PHILOS, V36, P261, DOI 10.1007/s10988-013-9138-0; Plummer M., 2003, P 3 INT WORKSH DISTR; Pogue A, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02035; Qing C., 2014, P 36 ANN C COGN SCI, P1204; Qing CY, 2015, BAYESIAN NATURAL LANGUAGE SEMANTICS AND PRAGMATICS, P201, DOI 10.1007/978-3-319-17064-0_9; RABIN M, 1990, J ECON THEORY, V51, P144, DOI 10.1016/0022-0531(90)90055-O; Regier T., 2014, P 36 ANN M COGN SCI, V36, P2009; Rohde H., 2012, P 16 WORKSH SEM PRAG, P107; Rothschild D, 2013, PHILOS PERSPECT, V27, P438, DOI 10.1111/phpe.12024; Schulz K, 2006, LINGUIST PHILOS, V29, P205, DOI 10.1007/s10988-005-3760-4; SIDMAN M, 1952, PSYCHOL BULL, V49, P263, DOI 10.1037/h0063643; Slevc LR, 2011, J EXP PSYCHOL LEARN, V37, P1503, DOI 10.1037/a0024350; Sobel J, 2008, ENCY COMPLEXITY SYST; Spector B., 2006, QUESTIONS DYNAMIC SE, P229; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; STECHOW AV, 1984, LINGUISTICS, V22, P3; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tessler MH, 2014, P COGSCI; van Rooij Robert, 2012, Journal of Logic, Language and Information, V21, P461, DOI 10.1007/s10849-012-9163-3; von der Malsburg T, 2011, J MEM LANG, V65, P109, DOI 10.1016/j.jml.2011.02.004; Wagenmakers EJ, 2010, COGNITIVE PSYCHOL, V60, P158, DOI 10.1016/j.cogpsych.2009.12.001	87	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154854	10.1371/journal.pone.0154854	http://dx.doi.org/10.1371/journal.pone.0154854			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27149675	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800071
J	Quiros-Roldan, E; Raffetti, E; Donato, F; Magoni, M; Pezzoli, C; Ferraresi, A; Brianese, N; Castelnuovo, F; Foca, E; Castelli, F				Quiros-Roldan, Eugenia; Raffetti, Elena; Donato, Francesco; Magoni, Michele; Pezzoli, Chiara; Ferraresi, Alice; Brianese, Nigritella; Castelnuovo, Filippo; Foca, Emanuele; Castelli, Francesco			Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; FRAMINGHAM RISK SCORE; INFLAMMATORY MARKERS; ACTIVATION; EVENTS; ATHEROSCLEROSIS; METAANALYSES; PREDICTION; MORTALITY	Neutrophil to lymphocyte ratio (NLR) has been shown to predict occurrence of cardiovascular events in the general population. The aim of our study was to evaluate the role of NLR to predict major cardiovascular disease (CVD) events in HIV-infected subjects. We performed a retrospective cohort study of HIV-infected patients residing in the Local Health Authority (LHA) of Brescia, northern Italy, from 2000 to 2012. The incidence of CVD events in HIV-positive patients was compared with that expected in the general population living in the same area, computing standardized incidence ratios (SIRs). To evaluate the predictive role of NLR, univariate and multivariate Cox regression models were applied, computing hazard ratios (HRs). A total of 3766 HIV-infected patients (mean age 38.1 years, 71.3% males) were included (person-years 28768.6). A total of 134 CVD events occurred in 119 HIV-infected patients. A 2-fold increased risk (SIR 2.02) of CVD was found in HIV-infected patients compared to the general population. NLR levels measured at baseline and during follow-up were independently associated with CVD incidence, when also adjusting for both traditional CVD risk factors and HIV-related factors (HR 3.05 for NLR >= 1.2). The area under the receiver operating characteristics (ROC) curve showed a modest, not statistically significant, increase, from 0.81 to 0.83, with addition of NLR to Framingham risk score model covariates. In conclusion an elevated NLR is a predictor of risk CVD in HIV-infected patients, independently from the traditional CVD risk factors.	[Quiros-Roldan, Eugenia; Donato, Francesco; Pezzoli, Chiara; Ferraresi, Alice; Brianese, Nigritella; Foca, Emanuele; Castelli, Francesco] Univ Brescia, Univ Dept Infect & Trop Dis, Brescia, Italy; [Quiros-Roldan, Eugenia; Donato, Francesco; Pezzoli, Chiara; Ferraresi, Alice; Brianese, Nigritella; Foca, Emanuele; Castelli, Francesco] Brescia Spedali Civili Gen Hosp, Brescia, Italy; [Raffetti, Elena] Univ Brescia, Unit Hyg Epidemiol & Publ Hlth, Brescia, Italy; [Magoni, Michele] Local Hlth Agcy Brescia Prov, Brescia, Italy; [Castelnuovo, Filippo] Brescia Spedali Civili Gen Hosp, Hosp Div Infect & Trop Dis, Brescia, Italy	University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; Hospital Spedali Civili Brescia	Raffetti, E (corresponding author), Univ Brescia, Unit Hyg Epidemiol & Publ Hlth, Brescia, Italy.	elena.raffetti@gmail.com	Donato, Francesco/AAQ-7477-2021; ROLDAN, Maria Eugenia QUIROS/K-7586-2015	ROLDAN, Maria Eugenia QUIROS/0000-0003-1452-9100; Castelli, Francesco/0000-0001-9161-7804; FOCA', Emanuele/0000-0003-4395-5379; DONATO, Francesco/0000-0002-1402-1019; Raffetti, Elena/0000-0001-8742-3986				Bastard JP, 2015, J ANTIMICROB CHEMOTH, V70, P1816, DOI 10.1093/jac/dkv036; Benites-Zapata VA, 2015, AM J CARDIOL, V115, P57, DOI 10.1016/j.amjcard.2014.10.008; Breslow N E, 1987, IARC Sci Publ, P1; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; European AIDS Clinical Society, 2014, EUR GUID TREATM HIV; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Friis-Moller N, 2016, EUR J PREV CARDIOL, V23, P214, DOI 10.1177/2047487315579291; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Law MG, 2006, HIV MED, V7, P218, DOI 10.1111/j.1468-1293.2006.00362.x; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Liu X, 2015, AM J HYPERTENS, V28, P1339, DOI 10.1093/ajh/hpv034; Lubrano Valter, 2015, World J Exp Med, V5, P21, DOI 10.5493/wjem.v5.i1.21; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Ommen SR, 1997, AM J CARDIOL, V79, P812, DOI 10.1016/S0002-9149(96)00878-8; Paisible AL, 2015, JAIDS-J ACQ IMM DEF, V68, P209, DOI 10.1097/QAI.0000000000000419; Park JJ, 2013, AM J CARDIOL, V111, P636, DOI 10.1016/j.amjcard.2012.11.012; Parra S, 2010, HIV MED, V11, P225, DOI 10.1111/j.1468-1293.2009.00766.x; Raffetti E, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0446-8; Raffetti E, 2015, JAIDS-J ACQ IMM DEF, V69, P585, DOI 10.1097/QAI.0000000000000682; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Shah N, 2014, INT J CARDIOL, V171, P390, DOI 10.1016/j.ijcard.2013.12.019; Tenorio AR, 2014, J INFECT DIS, V210, P1248, DOI 10.1093/infdis/jiu254; Zouridakis EG, 2000, AM J CARDIOL, V86, P449, DOI 10.1016/S0002-9149(00)00963-2	31	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154900	10.1371/journal.pone.0154900	http://dx.doi.org/10.1371/journal.pone.0154900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148878	Green Published, gold			2022-12-27	WOS:000375676800083
J	Yin, HZ; Li, D; Yang, JY; Li, W; Qiu, J; Chen, YY				Yin, Hua-zhan; Li, Dan; Yang, Junyi; Li, Wei; Qiu, Jiang; Chen, Ying-yu			Neural Bases of Unconscious Error Detection in a Chinese Anagram Solution Task: Evidence from ERP Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; EVENT-RELATED POTENTIALS; WORKING-MEMORY PROCESSES; MEDIAL FRONTAL-CORTEX; GO/NO-GO TASK; RESPONSE CONFLICT; COGNITIVE CONTROL; BRAIN POTENTIALS; AWARENESS; NEGATIVITY	In everyday life, error monitoring and processing are important for improving ongoing performance in response to a changing environment. However, detecting an error is not always a conscious process. The temporal activation patterns of brain areas related to cognitive control in the absence of conscious awareness of an error remain unknown. In the present study, event-related potentials (ERPs) in the brain were used to explore the neural bases of unconscious error detection when subjects solved a Chinese anagram task. Our ERP data showed that the unconscious error detection (UED) response elicited a more negative ERP component (N2) than did no error (NE) and detect error (DE) responses in the 300-400-ms time window, and the DE elicited a greater late positive component (LPC) than did the UED and NE in the 900-1200-ms time window after the onset of the anagram stimuli. Taken together with the results of dipole source analysis, the N2 (anterior cingulate cortex) might reflect unconscious/automatic conflict monitoring, and the LPC (superior/medial frontal gyrus) might reflect conscious error recognition.	[Yin, Hua-zhan; Li, Dan; Chen, Ying-yu] Chongqing Normal Univ, Dept Psychol, Chongqing 401331, Peoples R China; [Yang, Junyi; Li, Wei; Qiu, Jiang] Southwest Univ SWU, Sch Psychol, Chongqing 400715, Peoples R China	Chongqing Normal University; Southwest University - China	Yin, HZ (corresponding author), Chongqing Normal Univ, Dept Psychol, Chongqing 401331, Peoples R China.; Qiu, J (corresponding author), Southwest Univ SWU, Sch Psychol, Chongqing 400715, Peoples R China.	yhz1979@sina.com; qiuj318@swu.edu.cn	chen, ying/HHS-8254-2022		Ministry of Education of Humanities and Social Science project of China [12YJC190035]; China Postdoctoral Science Foundation [2013M530759]	Ministry of Education of Humanities and Social Science project of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by the Ministry of Education of Humanities and Social Science project of China (12YJC190035), and the China Postdoctoral Science Foundation (2013M530759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2012, CEREB CORTEX, V22, P2076, DOI 10.1093/cercor/bhr287; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; Bartholow BD, 2009, J EXP SOC PSYCHOL, V45, P655, DOI 10.1016/j.jesp.2009.02.015; Belopolsky AV, 2008, J COGNITIVE NEUROSCI, V20, P2285, DOI 10.1162/jocn.2008.20161; Berti S, 2000, COGNITIVE BRAIN RES, V9, P147, DOI 10.1016/S0926-6410(99)00051-8; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Britz J, 2010, NEUROIMAGE, V49, P2774, DOI 10.1016/j.neuroimage.2009.10.033; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cerf-Ducastel B, 2006, NEUROIMAGE, V31, P386, DOI 10.1016/j.neuroimage.2005.11.009; Chris B, 2007, PSYCHOL REV, V114, P1076; Chwilla DJ, 1998, Q J EXP PSYCHOL-A, V51, P531, DOI 10.1080/713755773; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Dickter CL, 2010, PSYCHOPHYSIOLOGY, V47, P596, DOI 10.1111/j.1469-8986.2010.00963.x; Dockree PM, 2015, J INT NEUROPSYCH SOC, V21, P1; Endrass T, 2005, J PSYCHOPHYSIOL, V19, P275, DOI 10.1027/0269-8803.19.4.275; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P467, DOI 10.1111/j.1469-8986.2007.00628.x; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Forster SE, 2011, J COGNITIVE NEUROSCI, V23, P923, DOI 10.1162/jocn.2010.21458; Foucaud DB, 2007, BRAIN J NEUROLOGY, V129, P3315; Gajewski PD, 2008, BRAIN RES, V1189, P127, DOI 10.1016/j.brainres.2007.10.076; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Harty S, 2014, J NEUROSCI, V34, P3646, DOI 10.1523/JNEUROSCI.5308-13.2014; Helenius P, 2010, NEUROIMAGE, V53, P619, DOI 10.1016/j.neuroimage.2010.06.059; Hester R, 2005, NEUROIMAGE, V27, P602, DOI 10.1016/j.neuroimage.2005.04.035; Holmes AJ, 2008, NEUROPSYCHOLOGIA, V46, P2904, DOI 10.1016/j.neuropsychologia.2008.05.028; Jiang J, 2015, NEUROIMAGE, V116, P102, DOI 10.1016/j.neuroimage.2015.04.062; Juottonen K, 1996, COGNITIVE BRAIN RES, V4, P99; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; KING JW, 1995, J COGNITIVE NEUROSCI, V7, P376, DOI 10.1162/jocn.1995.7.3.376; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; KUTAS M, 1980, BIOL PSYCHOL, V11, P99, DOI 10.1016/0301-0511(80)90046-0; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Mecklinger A, 1996, COGNITIVE BRAIN RES, V4, P211, DOI 10.1016/S0926-6410(96)00034-1; Mennes M, 2008, PSYCHOPHYSIOLOGY, V45, P714, DOI 10.1111/j.1469-8986.2008.00678.x; Nan VDM, 2009, LANGUAGE LINGUISTICS, V3, P1211; Navarro-Cebrian A, 2013, J NEUROSCI, V33, P12375, DOI 10.1523/JNEUROSCI.0447-13.2013; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Novick LR, 2003, Q J EXP PSYCHOL-A, V56, P351, DOI 10.1080/02724980244000288; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Ralph JW, 2009, BRAIN RES, V1251, P213, DOI 10.1016/j.brainres.2008.11.024; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; RUCHKIN DS, 1992, COGNITIVE BRAIN RES, V1, P53, DOI 10.1016/0926-6410(92)90005-C; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Tanja E, 2007, EUROPEAN J NEUROSCIE, V26, P1714; Tatiana S, 2003, PSYCHOPHYSIOLOGY, V40, P160; Ursu S, 2009, BIOL PSYCHOL, V80, P279, DOI 10.1016/j.biopsycho.2008.10.008; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; van Gaal S, 2012, NEUROSCIENTIST, V18, P287, DOI 10.1177/1073858411404079; Van VV, 2003, PHYSIOL BEHAV, V77, P477; Veen VV, 2002, NEUROIMAGE, V14, P1302; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Vincent VV, 2002, J COGNITIVE NEUROSCI, V14, P593; Welander-Vatn A, 2013, NEUROSCI LETT, V549, P51, DOI 10.1016/j.neulet.2013.06.010; Wiersema JR, 2007, NEUROPSYCHOLOGIA, V45, P1649, DOI 10.1016/j.neuropsychologia.2007.01.004; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931	62	8	8	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154379	10.1371/journal.pone.0154379	http://dx.doi.org/10.1371/journal.pone.0154379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27149300	Green Published, gold			2022-12-27	WOS:000375676800027
J	Shen, DK; Blocker, AJ				Shen, Da-Kang; Blocker, Ariel J.			MxiA, MxiC and IpaD Regulate Substrate Selection and Secretion Mode in the T3SS of Shigella flexneri	PLOS ONE			English	Article							III PROTEIN EXPORT; SYSTEM NEEDLE TIP; PROTON MOTIVE FORCE; ESCHERICHIA-COLI; EPITHELIAL-CELLS; CHLAMYDIA-TRACHOMATIS; SPECIFICITY SWITCH; YERSINIA-PESTIS; GENE-EXPRESSION; FLII ATPASE	Type III secretion systems (T3SSs) are central virulence devices for many Gram-negative bacterial pathogens of humans, animals & plants. Upon physical contact with eukaryotic host cells, they translocate virulence-mediating proteins, known as effectors, into them during infection. T3SSs are gated from the outside by host-cell contact and from the inside via two cytoplasmic negative regulators, MxiC and IpaD in Shigella flexneri, which together control the effector secretion hierarchy. Their absence leads to premature and increased secretion of effectors. Here, we investigated where and how these regulators act. We demonstrate that the T3SS inner membrane export apparatus protein MxiA plays a role in substrate selection. Indeed, using a genetic screen, we identified two amino acids located on the surface of MxiA's cytoplasmic region (MxiA(C)) which, when mutated, upregulate late effector expression and, in the case of MxiA(1674V), also secretion. The cytoplasmic region of MxiA, but not MxiA(N373D) and MxiA(I674V), interacts directly with the C-terminus of MxiC in a two-hybrid assay. Efficient T3S requires a cytoplasmic ATPase and the proton motive force (PMF), which is composed of the Delta psi and the Delta pH. MxiA family proteins and their regulators are implicated in utilization of the PMF for protein export. However, our MxiA point mutants show similar PMF utilisation to wild-type, requiring primarily the Delta psi. On the other hand, lack of MxiC or IpaD, renders the faster T3S seen increasingly dependent on the Delta pH. Therefore, MxiA, MxiC and IpaD act together to regulate substrate selection and secretion mode in the T3SS of Shigella flexneri.	[Shen, Da-Kang] Univ Bristol, Fac Biomed Sci, Sch Cellular & Mol Med, Bristol, Avon, England; [Blocker, Ariel J.] Univ Bristol, Fac Biomed Sci, Sch Cellular & Mol Med, Bristol, Avon, England; [Blocker, Ariel J.] Univ Bristol, Fac Biomed Sci, Sch Biochem, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Blocker, AJ (corresponding author), Univ Bristol, Fac Biomed Sci, Sch Cellular & Mol Med, Bristol, Avon, England.; Blocker, AJ (corresponding author), Univ Bristol, Fac Biomed Sci, Sch Biochem, Bristol, Avon, England.	ariel.blocker@bristol.ac.uk	Blocker, Ariel/Q-6617-2016		UK Medical Research Council (MRC) [MR/J002097/1]; UK Wellcome Trust [WT104634AIA]; UK Medical Research Council [MR_J002097_1]; Wellcome Trust [WT104634AIA]; MRC [MR/J002097/1] Funding Source: UKRI; Medical Research Council [MR/J002097/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These studies were supported mainly by UK Medical Research Council (MRC) project grant MR/J002097/1 and briefly by UK Wellcome Trust Investigator Award WT104634AIA to AJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Isabel Martinez-Argudo (now University of Castilla- La Mancha, Toledo, Spain) for generating the mxiA knockout strain, initially for unrelated work, to Prof. Nigel Savery and Dr. Abigail Smith (Biochemistry, University of Bristol) for providing the materials for the bacterial two-hybrid assay, to Dr. Yusuke V Morimoto (Osaka University, Japan) and the Memorial Sloan Kettering Cancer Center (New York, USA) for providing plasmids to measure intracellular pH, to Dr. Arne Rietsch (Case Western Reserve University, Cleveland, USA) for discussions and to Dr. Dorothea Riehrich (Cellular and Molecular Medicine, University of Bristol) for the diagram used to derive Fig 1A and initially setting up the two hybrid assay system in our laboratory. This work was funded by the UK Medical Research Council (MR_J002097_1 to AJB) and the Wellcome Trust (WT104634AIA to AJB).	Abrusci P, 2013, NAT STRUCT MOL BIOL, V20, P99, DOI 10.1038/nsmb.2452; Archuleta TL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004498; Avison MB, 2000, J ANTIMICROB CHEMOTH, V46, P695, DOI 10.1093/jac/46.5.695; Bai F, 2014, SCI REP-UK, V4, DOI 10.1038/srep06528; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; BARZU S, 1993, INFECT IMMUN, V61, P3825, DOI 10.1128/IAI.61.9.3825-3831.1993; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Bongrand C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032862; Botteaux A, 2009, MOL MICROBIOL, V71, P449, DOI 10.1111/j.1365-2958.2008.06537.x; Brutinel ED, 2008, CURR OPIN MICROBIOL, V11, P128, DOI 10.1016/j.mib.2008.02.010; Cherradi Y, 2013, MOL MICROBIOL, V87, P1183, DOI 10.1111/mmi.12158; Cheung M, 2015, MOL MICROBIOL, V95, P31, DOI 10.1111/mmi.12843; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deane JE, 2008, J MOL BIOL, V377, P985, DOI 10.1016/j.jmb.2008.01.072; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Erhardt M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004800; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Ferracci F, 2005, MOL MICROBIOL, V57, P970, DOI 10.1111/j.1365-2958.2005.04738.x; Hanson BR, 2015, J BACTERIOL, V197, P3238, DOI 10.1128/JB.00379-15; Hirano T, 2009, J BACTERIOL, V191, P3938, DOI 10.1128/JB.01811-08; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Ibuki T, 2013, J BACTERIOL, V195, P466, DOI 10.1128/JB.01711-12; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; KIHARA M, 1981, J BACTERIOL, V145, P1209, DOI 10.1128/JB.145.3.1209-1221.1981; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lee PC, 2014, P NATL ACAD SCI USA, V111, pE2027, DOI 10.1073/pnas.1402658111; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Li YL, 2014, MOL MICROBIOL, V91, P494, DOI 10.1111/mmi.12474; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; Manelyte L, 2009, DNA REPAIR, V8, P1300, DOI 10.1016/j.dnarep.2009.08.005; Martinez-Argudo I, 2010, MOL MICROBIOL, V78, P1365, DOI 10.1111/j.1365-2958.2010.07413.x; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; Meitert T, 1991, Roum Arch Microbiol Immunol, V50, P45; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Miller J.H., 1972, EXPT MOL GENETICS; Minamino T, 2003, J BACTERIOL, V185, P1190, DOI 10.1128/JB.185.4.1190-1194.2003; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07579; Minamino T, 2014, BBA-MOL CELL RES, V1843, P1642, DOI 10.1016/j.bbamcr.2013.09.005; Minamino T, 2012, MOL MICROBIOL, V83, P775, DOI 10.1111/j.1365-2958.2011.07964.x; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Minamino T, 2010, J BACTERIOL, V192, P1929, DOI 10.1128/JB.01328-09; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Morimoto YV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019598; Mounier J, 1997, INFECT IMMUN, V65, P774, DOI 10.1128/IAI.65.2.774-782.1997; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Roehrich A. D., 2013, THESIS; Roehrich AD, 2013, MOL MICROBIOL, V87, P690, DOI 10.1111/mmi.12124; Roehrich AD, 2010, INFECT IMMUN, V78, P1682, DOI 10.1128/IAI.00645-09; Roehrich AD, GENETIC BIOPH UNPUB; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Shen DK, 2012, MICROBIOL-SGM, V158, P1884, DOI 10.1099/mic.0.059618-0; Shen DK, 2010, INFECT IMMUN, V78, P4999, DOI 10.1128/IAI.00470-10; Shen L, 2015, J BIOL CHEM, V290, P28141, DOI 10.1074/jbc.M115.670232; Silva-Herzog E, 2011, J BACTERIOL, V193, P3490, DOI 10.1128/JB.00203-11; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Wang D, 2008, MOL MICROBIOL, V69, P1499, DOI 10.1111/j.1365-2958.2008.06377.x; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wei HL, 2012, MOL MICROBIOL, V85, P195, DOI 10.1111/j.1365-2958.2012.08119.x; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	70	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155141	10.1371/journal.pone.0155141	http://dx.doi.org/10.1371/journal.pone.0155141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171191	Green Submitted, Green Published, gold			2022-12-27	WOS:000376588600092
J	Yako, YY; Kruger, D; Smith, M; Brand, M				Yako, Yandiswa Yolanda; Kruger, Deirdre; Smith, Martin; Brand, Martin			Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review	PLOS ONE			English	Review							ENDOTHELIAL-GROWTH-FACTOR; MACROPHAGE INHIBITORY CYTOKINE-1; COLONY-STIMULATING FACTOR; ACUTE-PHASE RESPONSE; SERUM-LEVELS; INFLAMMATORY CYTOKINES; TRANSFORMING GROWTH-FACTOR-BETA-1; HEMATOPOIETIC CYTOKINES; PROGNOSTIC-SIGNIFICANCE; GENETIC POLYMORPHISMS	Objectives A systematic review of the role of cytokines in clinical medicine as diagnostic, prognostic, or predictive biomarkers in pancreatic ductal adenocarcinoma was undertaken. Materials and Methods A systematic review was conducted according to the 2009 PRISMA guidelines. PubMed database was searched for all original articles on the topic of interest published until June 2015, and this was supplemented with references cited in relevant articles. Studies were evaluated for risk of bias using the Quality in Prognosis Studies tools. Results Forty one cytokines were investigated with relation to pancreatic ductal adenocarcinoma (PDAC) in 65 studies, ten of which were analyzed by more than three studies. Six cytokines (interleukin[IL]-1 beta, -6, -8, -10, vascular endothelial growth factor, and transforming growth factor) were consistently reported to be increased in PDAC by more than four studies; irrespective of sample type; method of measurement; or statistical analysis model used. When evaluated as part of distinct panels that included CA19-9, IL-1 beta, -6 and -8 improved the performance of CA19-9 alone in differentiating PDAC from healthy controls. For example, a panel comprising IL-1 beta, IL-8, and CA 19-9 had a sensitivity of 94.1% vs 85.9%, specificity of 100% vs 96.3%, and area under the curve of 0.984 vs 0.925. The above-mentioned cytokines were associated with the severity of PDAC. IL-2, -6, -10, VEGF, and TGF levels were reported to be altered after patients received therapy or surgery. However, studies did not show any evidence of their ability to predict treatment response. Conclusion Our review demonstrates that there is insufficient evidence to support the role of individual cytokines as diagnostic, predictive or prognostic biomarkers for PDAC. However, emerging evidence indicates that a panel of cytokines may be a better tool for discriminating PDAC from other non-malignant pancreatic diseases or healthy individuals.	[Yako, Yandiswa Yolanda; Kruger, Deirdre; Smith, Martin; Brand, Martin] Univ Witwatersrand, Fac Hlth Sci, Dept Surg, Parktown, Gauteng, South Africa	University of Witwatersrand	Kruger, D (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Surg, Parktown, Gauteng, South Africa.	Deirdre.Kruger@wits.ac.za	Kruger, Deirdre/AAF-1445-2020	Kruger, Deirdre/0000-0002-3604-7682	National Research Foundation (NRF) in South Africa	National Research Foundation (NRF) in South Africa(National Research Foundation - South Africa)	The authors would like to acknowledge the National Research Foundation (NRF) in South Africa for financial assistance.	Andrianifahanana M, 2006, AM J GASTROENTEROL, V101, P2319, DOI 10.1111/j.1572-0241.2006.00871.x; Baine MJ, 2012, CANCER BIOMARK, V11, P1, DOI 10.3233/CBM-2012-0260; Banerjee M, 2014, WORLD J DIABETES, V5, P493, DOI 10.4239/wjd.v5.i4.493; Bang S, 2006, PANCREAS, V32, P29, DOI 10.1097/01.mpa.0000191651.32420.41; Bao Y, 2013, CANCER EPIDEM BIOMAR, V22, P855, DOI 10.1158/1055-9965.EPI-12-1458; Barber MD, 2000, BRIT J CANCER, V83, P1443, DOI 10.1054/bjoc.2000.1479; Barber MD, 1999, CLIN SCI, V96, P83, DOI 10.1042/CS19980185; BASSO D, 1995, INT J CLIN LAB RES, V25, P40, DOI 10.1007/BF02592575; Bellone G, 2006, CANCER IMMUNOL IMMUN, V55, P684, DOI 10.1007/s00262-005-0047-0; Bellone G, 2009, INT J ONCOL, V34, P1701, DOI 10.3892/ijo_00000301; Bhat IA, 2014, META GENE, V2, P123, DOI 10.1016/j.mgene.2013.12.002; Blogowski W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097613; Bosetti C, 2012, MOL CARCINOGEN, V51, P3, DOI 10.1002/mc.20785; Breitbart W, 2014, PSYCHO-ONCOLOGY, V23, P339, DOI 10.1002/pon.3422; Butterfield LH, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-173; Chang YT, 2008, PANCREAS, V37, P145, DOI 10.1097/MPA.0b013e318164548a; Chen R, 2010, PANCREAS, V39, P981, DOI 10.1097/MPA.0b013e3181dac920; Chen Y, 2012, WORLD J GASTROENTERO, V18, P1123, DOI 10.3748/wjg.v18.i10.1123; CHUANG LY, 1994, CLIN BIOCHEM, V27, P485, DOI 10.1016/0009-9120(94)00053-X; Clendenen Tess V, 2010, BMC Res Notes, V3, P302, DOI 10.1186/1756-0500-3-302; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Culhaci N, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-98; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Dima SO, 2012, PANCREAS, V41, P1001, DOI 10.1097/MPA.0b013e3182546e13; Doust J, 2010, SCAND J CLIN LAB INV, V70, P40, DOI 10.3109/00365513.2010.493380; Drucker E, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-7; Duell EJ, 2006, CANCER EPIDEM BIOMAR, V15, P726, DOI 10.1158/1055-9965.EPI-05-0797; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Egberts JH, 2008, CANCER RES, V68, P1443, DOI 10.1158/0008-5472.CAN-07-5704; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Evans A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00270; FALCONER JS, 1994, ANN SURG, V219, P325, DOI 10.1097/00000658-199404000-00001; Farrow B, 2004, ANN SURG, V239, P763, DOI 10.1097/01.sla.0000128681.76786.07; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fogar P, 1998, CLIN CHIM ACTA, V277, P181, DOI 10.1016/S0009-8981(98)00125-9; Fong ZV, 2012, CANCER J, V18, P530, DOI 10.1097/PPO.0b013e31827654ea; Frick VO, 2008, PANCREATOLOGY, V8, P488, DOI 10.1159/000151776; Fujimoto K, 1998, EUR J CANCER, V34, P1439, DOI 10.1016/S0959-8049(98)00069-0; Gabitass RF, 2011, CANCER IMMUNOL IMMUN, V60, P1419, DOI 10.1007/s00262-011-1028-0; Gansauge F, 1998, CANCER LETT, V134, P193, DOI 10.1016/S0304-3835(98)00259-6; Gold DV, 2013, CANCER-AM CANCER SOC, V119, P522, DOI 10.1002/cncr.27762; Groblewska M, 2007, CLIN CHEM LAB MED, V45, P30, DOI 10.1515/CCLM.2007.025; Grote VA, 2012, BRIT J CANCER, V106, P1866, DOI 10.1038/bjc.2012.172; Gu Y, 2009, CYTOKINE, V45, P44, DOI 10.1016/j.cyto.2008.10.014; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Gunturu KS, 2013, THER ADV MED ONCOL, V5, P143, DOI 10.1177/1758834012469429; Hashimoto K, 2001, PANCREAS, V22, P341, DOI 10.1097/00006676-200105000-00002; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hocevar BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090052; Ikeda N, 1999, BRIT J CANCER, V79, P1553, DOI 10.1038/sj.bjc.6690248; Ishikawa T, 2013, INT J CANCER, V133, P1119, DOI 10.1002/ijc.28117; Itakura J, 2000, INT J CANCER, V85, P27; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kannagi Reiji, 2007, Chang Gung Med J, V30, P189; Karayiannakis AJ, 2003, CANCER LETT, V194, P119, DOI 10.1016/S0304-3835(03)00047-8; Karayiannakis AJ, 2001, ANTICANCER RES, V21, P1355; Kaur S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055171; Keane MG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005720; Komura T, 2015, CANCER SCI, V106, P672, DOI 10.1111/cas.12663; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Lam Lian, 2014, J Mol Biomark Diagn, V4, P151; Li M, 2008, CANCER SCI, V99, P733, DOI 10.1111/j.1349-7006.2008.00740.x; Lin YS, 2006, CANCER CAUSE CONTROL, V17, P1077, DOI 10.1007/s10552-006-0048-0; Liu ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103910; Mann DV, 2000, EUR J SURG ONCOL, V26, P474, DOI 10.1053/ejso.1999.0925; Martignoni ME, 2005, CLIN CANCER RES, V11, P5802, DOI 10.1158/1078-0432.CCR-05-0185; Mitsunaga S, 2013, BRIT J CANCER, V108, P2063, DOI 10.1038/bjc.2013.174; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moses AGW, 2009, ONCOL REP, V21, P1091, DOI 10.3892/or_00000328; Mroczko B, 2005, CLIN CHEM LAB MED, V43, P146, DOI 10.1515/CCLM.2005.024; Mroczko B, 2004, CLIN CHEM LAB MED, V42, P256, DOI 10.1515/CCLM.2004.047; Mroczko B, 2010, J CLIN LAB ANAL, V24, P256, DOI 10.1002/jcla.20395; Nagakawa Y, 2002, PANCREAS, V24, P169, DOI 10.1097/00006676-200203000-00008; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Noh KW, 2006, CLIN GASTROENTEROL H, V4, P782, DOI 10.1016/j.cgh.2006.03.026; Okada S, 1998, JPN J CLIN ONCOL, V28, P12, DOI 10.1093/jjco/28.1.12; Ong SL, 2008, DIGEST DIS SCI, V53, P3213, DOI 10.1007/s10620-008-0289-8; Ozkan H, 2011, PANCREATOLOGY, V11, P295, DOI 10.1159/000328963; Plate JMD, 1999, CANCER IMMUNOL IMMUN, V48, P270, DOI 10.1007/s002620050575; Poch B, 2007, LANGENBECK ARCH SURG, V392, P353, DOI 10.1007/s00423-006-0140-7; Rahbari NN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-286; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Roshani R, 2014, CANCER LETT, V345, P157, DOI 10.1016/j.canlet.2013.07.014; Rubie C, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-45; Sakamoto H, 2012, JPN J CLIN ONCOL, V42, P105, DOI 10.1093/jjco/hyr178; Schultz NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067059; Sears D, 2004, DIGEST DIS SCI, V49, P828, DOI 10.1023/B:DDAS.0000030095.71501.04; Shaw VE, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-114; Shi CJ, 2012, AM J CLIN PATHOL, V137, P847, DOI 10.1309/AJCPI83DINULUJNI; Sica GT, 2006, RADIOLOGY, V238, P780, DOI 10.1148/radiol.2383041109; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steele CW, 2013, BRIT J CANCER, V108, P997, DOI 10.1038/bjc.2013.24; Stenken JA, 2015, ANAL CHIM ACTA, V853, P95, DOI 10.1016/j.aca.2014.10.009; Talar-Wojnarowska R, 2009, DIGEST DIS SCI, V54, P683, DOI 10.1007/s10620-008-0390-z; Vasiliades G, 2012, INT J BIOL MARKER, V27, P186, DOI 10.5301/JBM.2012.9348; Vizio B, 2012, EXP THER MED, V4, P70, DOI 10.3892/etm.2012.553; Vizio B, 2010, CANCER SCI, V101, P2448, DOI 10.1111/j.1349-7006.2010.01692.x; von Bernstorff W, 2001, CLIN CANCER RES, V7, p925S; Von Marschall Z, 2000, GASTROENTEROLOGY, V119, P1358, DOI 10.1053/gast.2000.19578; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Wenger FA, 1999, LANGENBECK ARCH SURG, V384, P473, DOI 10.1007/s004230050233; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-20; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xu XJ, 2014, PANCREAS, V43, P470, DOI 10.1097/MPA.0000000000000055; Yue Hui, 2002, Hepatobiliary Pancreat Dis Int, V1, P309; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zhang PJ, 2014, INT J CANCER, V134, P2646, DOI 10.1002/ijc.28584	111	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154016	10.1371/journal.pone.0154016	http://dx.doi.org/10.1371/journal.pone.0154016			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27170998	Green Submitted, gold, Green Published			2022-12-27	WOS:000376588600034
J	Gao, YF; Rae, W; Ramakrishnan, KA; Barcenas-Morales, G; Doffinger, R; Eren, E; Faust, SN; Ottensmeier, CH; Williams, AP				Gao, Yifang; Rae, William; Ramakrishnan, Keseva Ananth; Barcenas-Morales, Gabriela; Doffinger, Rainer; Eren, Efrem; Faust, Saul N.; Ottensmeier, Christian H.; Williams, Anthony P.			Mucosal-Associated Invariant T (MAIT) Cells Are Impaired in Th17 Associated Primary and Secondary Immunodeficiencies	PLOS ONE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; HYPER-IGE SYNDROME; BACTERIAL-INFECTION; STAT1 MUTATIONS; IL-17 IMMUNITY; INBORN-ERRORS; AUTOANTIBODIES	The recently described Mucosal Associated Invariant T (MAIT) cells mediate specific recognition of bacterial and fungal vitamin B2 metabolites. As innate T cells, they possess broad effector responses, including IFN-including Iproduction, that are comparable to conventional T cell responses. Immunodeficiencies associated with systemic Th17 deficiency may also be compounded by defects in MAIT immunity. We evaluated Th17 immunity in this innate T cell compartment in primary (AD-HIES) and secondary immunodeficiency (thymoma) patients with conventional Th17 deficiency and susceptibility to fungal and bacterial disease. Our results suggest that MAIT cells are both reduced and functional deficient in STAT3 deficiency and thymoma patients with IL-12/23 autoantibodies. In contrast, thymoma patients without autoantibodies preserved the normal number and functional MAIT cells.	[Gao, Yifang; Ramakrishnan, Keseva Ananth; Ottensmeier, Christian H.; Williams, Anthony P.] Univ Southampton, Fac Med, Acad Unit Canc Sci, Southampton SO9 5NH, Hants, England; [Gao, Yifang; Ramakrishnan, Keseva Ananth; Ottensmeier, Christian H.; Williams, Anthony P.] Southampton NIHR Expt Canc Med Ctr, Southampton, Hants, England; [Barcenas-Morales, Gabriela; Doffinger, Rainer] Addenbrookes Hosp, Dept Clin Immunol, Cambridge, England; [Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England; [Rae, William; Eren, Efrem; Williams, Anthony P.] Univ Hosp Southampton NHS Fdn Trust, Dept Clin Immunol, Southampton, Hants, England	University of Southampton; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust	Williams, AP (corresponding author), Univ Southampton, Fac Med, Acad Unit Canc Sci, Southampton SO9 5NH, Hants, England.; Williams, AP (corresponding author), Southampton NIHR Expt Canc Med Ctr, Southampton, Hants, England.; Williams, AP (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Dept Clin Immunol, Southampton, Hants, England.	apw2@soton.ac.uk	Rae, William/AGX-6005-2022; Ottensmeier, Christian/ABE-9056-2020; Faust, Saul/J-9779-2014	Ottensmeier, Christian/0000-0003-3619-1657; Doffinger, R/0000-0002-9841-3617; Rae, William/0000-0003-0095-2514; Faust, Saul/0000-0003-3410-7642; Gao, Yifang/0000-0003-2817-9391; Barcenas Morales, Gabriela/0000-0003-0063-8795	Cancer Research UK; Experimental Cancer Medicine Centre, Southampton; Southampton NIHR Wellcome Trust Clinical Research Facility; National Institute for Health Research Rare Diseases Translational Research Collaboration (NIHR RD-TRC); Cancer Research UK [18161, 15951, 18158] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Experimental Cancer Medicine Centre, Southampton; Southampton NIHR Wellcome Trust Clinical Research Facility; National Institute for Health Research Rare Diseases Translational Research Collaboration (NIHR RD-TRC); Cancer Research UK(Cancer Research UK)	YG, CHO and APW are supported by Cancer Research UK and the Experimental Cancer Medicine Centre, Southampton. KAR and SNF are supported by the Southampton NIHR Wellcome Trust Clinical Research Facility. WR is supported by the National Institute for Health Research Rare Diseases Translational Research Collaboration (NIHR RD-TRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne SK, 2010, CURR OPIN ALLERGY CL, V10, P534, DOI 10.1097/ACI.0b013e3283402b41; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Chua WJ, 2012, INFECT IMMUN, V80, P3256, DOI 10.1128/IAI.00279-12; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Huppler AR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3893; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; McDonald DR, 2012, J ALLERGY CLIN IMMUN, V129, P1429, DOI 10.1016/j.jaci.2012.03.034; Meierovics A, 2013, P NATL ACAD SCI USA, V110, pE3119, DOI 10.1073/pnas.1302799110; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Puel A, 2012, CURR OPIN ALLERGY CL, V12, P616, DOI 10.1097/ACI.0b013e328358cc0b; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Wilson RP, 2015, J EXP MED, V212, P855, DOI 10.1084/jem.20141992	25	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155059	10.1371/journal.pone.0155059	http://dx.doi.org/10.1371/journal.pone.0155059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167980	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000376587300064
J	Larrad, MTM; Anchuelo, AC; Perez, CF; Barba, MP; Redondo, YL; Rios, MS				Martinez Larrad, Maria Teresa; Corbaton Anchuelo, Arturo; Fernandez Perez, Cristina; Perez Barba, Milagros; Lazcano Redondo, Yera; Serrano Rios, Manuel		SIRSG	Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; COLONY-ENHANCING FACTOR; INSULIN-RESISTANCE; PLASMA VISFATIN; SERUM VISFATIN; CIRCULATING VISFATIN; GLUCOSE-METABOLISM; CHOLESTEROL LEVELS; BLOOD-PRESSURE; VISCERAL FAT	Objectives Our aim was to investigate if genetic variations in the visfatin gene (SNPs rs7789066/rs11977021/rs4730153) could modify the cardiovascular-risk (CV-risk) despite the metabolic phenotype (obesity and glucose tolerance). In addition, we investigated the relationship between insulin sensitivity and variations in visfatin gene. Material and Methods A population-based study in rural and urban areas of the Province of Segovia, Spain, was carried out in the period of 2001-2003 years. A total of 587 individuals were included, 25.4% subjects were defined as obese (BMI >= 30 Kg/m(2)). Results Plasma visfatin levels were significantly higher in obese subjects with DM2 than in other categories of glucose tolerance. The genotype AA of the rs4730153 SNP was significantly associated with fasting glucose, fasting insulin and HOMA-IR (Homeostasis model assessment-insulin resistance) after adjustment for gender, age, BMI and waist circumference. The obese individuals carrying the CC genotype of the rs11977021 SNP showed higher circulating levels of fasting proinsulin after adjustment for the same variables. The genotype AA of the rs4730153 SNP seems to be protective from CV-risk either estimated by Framingham or SCORE charts in general population; and in obese and non-obese individuals. No associations with CV-risk were observed for other studied SNPs (rs11977021/rs7789066). Conclusions In summary, this is the first study which concludes that the genotype AA of the rs4730153 SNP appear to protect against CV-risk in obese and non-obese individuals, estimated by Framingham and SCORE charts. Our results confirm that the different polymorphisms in the visfatin gene might be influencing the glucose homeostasis in obese individuals.	[Martinez Larrad, Maria Teresa; Corbaton Anchuelo, Arturo; Fernandez Perez, Cristina; Lazcano Redondo, Yera; Serrano Rios, Manuel] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Martinez Larrad, Maria Teresa; Corbaton Anchuelo, Arturo; Fernandez Perez, Cristina; Perez Barba, Milagros; Lazcano Redondo, Yera; Serrano Rios, Manuel] Hosp Clin San Carlos IdISSC HCSC, Inst Invest Sanitaria, Madrid, Spain		Rios, MS (corresponding author), Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain.; Rios, MS (corresponding author), Hosp Clin San Carlos IdISSC HCSC, Inst Invest Sanitaria, Madrid, Spain.	manuel.serrano@salud.madrid.org	Pérez, Cristina Fernández/I-2220-2015; Pérez, Cristina Fernández/K-8078-2019; Serrano Ríos, Manuel/E-4625-2019; Corbatón-Anchuelo, Arturo/I-4390-2013	Pérez, Cristina Fernández/0000-0001-9853-6257; Pérez, Cristina Fernández/0000-0001-9853-6257; Serrano Ríos, Manuel/0000-0002-3214-1444; Corbatón-Anchuelo, Arturo/0000-0002-8775-4766	Fondo Europeo para el Desarrollo Regional [FEDER 2FD 1997/2309]; Instituto de Salud Carlos, Madrid, Spain [FIS 03/1618, III-RETIC RD06/0015/0012]; Eli Lilly Lab, Spain; Bayer Pharmaceutical Co., Spain; Fundacion Mutua Madrilena, Spain; Red de Centros RCMN [C03/08]	Fondo Europeo para el Desarrollo Regional; Instituto de Salud Carlos, Madrid, Spain; Eli Lilly Lab, Spain(Eli Lilly); Bayer Pharmaceutical Co., Spain; Fundacion Mutua Madrilena, Spain; Red de Centros RCMN	This work was supported by grants FEDER 2FD 1997/2309 from the Fondo Europeo para el Desarrollo Regional, Red de Centros RCMN (C03/08), FIS 03/1618, from Instituto de Salud Carlos III-RETIC RD06/0015/0012, Madrid, Spain. The authors also acknowledge CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion) MSR and Madrid Autonomous Community (MOIR S2010/BMD-2423) MTML. Partial support also came from Educational Grants from Eli Lilly Lab, Spain, Bayer Pharmaceutical Co., Spain MSR and Fundacion Mutua Madrilena 2008, Spain CFP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino Sr RB, 2008, CIRCULATION, V18, P499; Andrade-Oliveira V, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/681612; Arya R, 2002, DIABETES, V51, P841, DOI 10.2337/diabetes.51.3.841; Ascaso JF, 2001, MED CLIN-BARCELONA, V117, P530, DOI 10.1016/S0025-7753(01)72168-9; Bailey SD, 2006, DIABETES, V55, P2896, DOI 10.2337/db06-0189; Belo VA, 2015, INT J OBESITY, V39, P130, DOI 10.1038/ijo.2013.173; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Bottcher Y, 2006, J CLIN ENDOCR METAB, V91, P2725, DOI 10.1210/jc.2006-0149; Chen CC, 2007, METABOLISM, V56, P1216, DOI 10.1016/j.metabol.2007.04.018; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Cheng LSC, 2001, CIRCULATION, V104, P1255, DOI 10.1161/hc3601.096729; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; de Luis DA, 2010, NUTRITION, V26, P1130, DOI 10.1016/j.nut.2008.11.019; Dou QY, 2015, INT J MOL SCI, V16, P22299, DOI 10.3390/ijms160922299; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Garcia-Bermudez M, 2011, CLIN EXP RHEUMATOL, V29, P681; Garcia-Fuentes E, 2007, OBESITY, V15, P2391, DOI 10.1038/oby.2007.284; Genuth S, 2003, DIABETES CARE, V26, P3160; Hammarstedt A, 2006, J CLIN ENDOCR METAB, V91, P1181, DOI 10.1210/jc.2005-1395; Hausenloy DJ, 2009, CURR OPIN PHARMACOL, V9, P202, DOI 10.1016/j.coph.2008.10.005; Jian WX, 2006, DIABETIC MED, V23, P967, DOI 10.1111/j.1464-5491.2006.01909.x; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Korner A, 2007, J CLIN ENDOCR METAB, V92, P4783, DOI 10.1210/jc.2007-1304; Korner A, 2007, METABOLISM, V56, P772, DOI 10.1016/j.metabol.2007.01.009; Lai AP, 2013, INT J BIOL SCI, V9, P16, DOI 10.7150/ijbs.4918; Lehman DM, 2005, HUM BIOL, V77, P231, DOI 10.1353/hub.2005.0040; Liu SW, 2009, CLIN ENDOCRINOL, V71, P202, DOI 10.1111/j.1365-2265.2008.03453.x; Lopez-Bermejo A, 2006, DIABETES, V55, P2871, DOI 10.2337/db06-0259; Martinez-Larrad MT, 2005, MED CLIN-BARCELONA, V125, P481; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Oki K, 2007, CLIN ENDOCRINOL, V67, P796, DOI 10.1111/j.1365-2265.2007.02966.x; Ooi SQ, 2014, PEDIATR OBES, V9, P81, DOI 10.1111/j.2047-6310.2013.00149.x; Pagano C, 2006, J CLIN ENDOCR METAB, V91, P3165, DOI 10.1210/jc.2006-0361; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Romacho T, 2009, DIABETOLOGIA, V52, P2455, DOI 10.1007/s00125-009-1509-2; Romacho T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/946427; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sandeep S, 2007, METABOLISM, V56, P565, DOI 10.1016/j.metabol.2006.12.005; Sethi JK, 2005, TRENDS MOL MED, V11, P344, DOI 10.1016/j.molmed.2005.06.010; Song HK, 2008, AM J PHYSIOL-RENAL, V295, pF1485, DOI 10.1152/ajprenal.90231.2008; Sun Q, 2009, ANN MED, V41, P311, DOI 10.1080/07853890902729760; Takebayashi K, 2007, METABOLISM, V56, P451, DOI 10.1016/j.metabol.2006.12.001; Telejko B, 2009, DIABETES RES CLIN PR, V84, P68, DOI 10.1016/j.diabres.2008.12.017; Tilg H, 2008, CLIN SCI, V114, P275, DOI 10.1042/CS20070196; Tokunaga A, 2008, ENDOCR J, V55, P205, DOI 10.1507/endocrj.K07E-039; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Xie H, 2007, CALCIFIED TISSUE INT, V80, P201, DOI 10.1007/s00223-006-0155-7; Zhang YY, 2006, OBESITY, V14, P2119, DOI 10.1038/oby.2006.247	50	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0153976	10.1371/journal.pone.0153976	http://dx.doi.org/10.1371/journal.pone.0153976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166797	Green Published, gold			2022-12-27	WOS:000376587300067
J	Thierry, S; Vorimore, F; Rossignol, C; Scharf, S; Sachse, K; Berthon, P; Durand, B; Virlogeux-Payant, I; Borel, N; Laroucau, K				Thierry, Simon; Vorimore, Fabien; Rossignol, Christelle; Scharf, Sabine; Sachse, Konrad; Berthon, Patricia; Durand, Benoit; Virlogeux-Payant, Isabelle; Borel, Nicole; Laroucau, Karine			Oral Uptake of Chlamydia psittaci by Ducklings Results in Systemic Dissemination	PLOS ONE			English	Article							HOST-PATHOGEN INTERACTIONS; SALMONELLA-ENTERITIDIS; HORIZONTAL TRANSMISSION; FAMILY CHLAMYDIACEAE; AVIAN CHLAMYDIOSIS; INFECTION; OUTBREAK; TURKEYS; COINFECTION; PROTECTION	Enteric infections caused by Chlamydia (C.) psittaci are frequent in ducks, but mostly remain subclinical under field conditions. To emulate natural infection, we investigated the pathogenic potential of a C. psittaci field strain in orally inoculated 4-day-old ducklings. Three different challenge doses were tested and seven contact animals were also mock-inoculated with buffer in each group. Over the course of ten days, the birds were monitored for clinical symptoms and chlamydial dissemination before final examination of tissues using histopathology and immunohistochemistry. While the challenge strain disseminated systemically to all internal organs, mild signs of diarrhea were confined to ducklings inoculated with the highest dose (4.3 x 10(8) IFU/mL, Group 1). No other clinical symptoms or histopathological lesions were seen. The chlamydial load in internal organs as measured by PCR depended on the challenge dose and was unevenly distributed, i.e. high loads in spleen, liver, and distal small and large intestinal tract (ileum, cecum and rectum) vs. ten times lower values in lungs and proximal small intestinal tract (duodenum and jejunum). Notably, the C. psittaci infection of contact birds became evident on day 10 post-infection, with bacterial loads comparable to those of experimentally-infected animals, thus suggesting rapid bird-to-bird transmission of the challenge strain.	[Thierry, Simon; Vorimore, Fabien; Laroucau, Karine] ANSES, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France; [Rossignol, Christelle; Berthon, Patricia; Virlogeux-Payant, Isabelle] INRA, Infectiol & Publ Hlth UMR1282, F-37380 Nouzilly, France; [Rossignol, Christelle; Berthon, Patricia; Virlogeux-Payant, Isabelle] Univ Tours, Infectiol & Publ Hlth UMR1282, Tours, France; [Scharf, Sabine; Sachse, Konrad] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, OIE Reference Lab Chlamydiosis, Jena, Germany; [Durand, Benoit] ANSES, Hlth Anim Lab, Epidemiol Unit, Maisons Alfort, France; [Borel, Nicole] Univ Zurich Vetsuisse, Inst Vet Pathol, Zurich, Switzerland; [Sachse, Konrad] Univ Jena, Dept Bioinformat, Jena, Germany	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Universite de Tours; Friedrich Loeffler Institute; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); University of Zurich; Friedrich Schiller University of Jena	Laroucau, K (corresponding author), ANSES, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France.	karine.laroucau@anses.fr	Borel, Nicole/GPP-1073-2022; Durand, Benoit/GSE-2511-2022; Sachse, Konrad/GWC-4999-2022; Laroucau, Karine/GSO-1980-2022; Borel, Nicole/M-6204-2016	Borel, Nicole/0000-0002-1556-9262; Sachse, Konrad/0000-0003-1230-1786; Laroucau, Karine/0000-0001-7605-8602; Borel, Nicole/0000-0002-1556-9262; Virlogeux-Payant, Isabelle/0000-0003-4149-0168; Durand, Benoit/0000-0003-0669-1394				Andersen A., 2003, DIS POULTRY; ANDERSON DC, 1978, AM J EPIDEMIOL, V107, P140, DOI 10.1093/oxfordjournals.aje.a112516; Beeckman DSA, 2010, VET MICROBIOL, V141, P342, DOI 10.1016/j.vetmic.2009.09.032; Braukmann M, 2012, INFECT IMMUN, V80, P2976, DOI 10.1128/IAI.00437-12; De Boeck C, 2015, J MED MICROBIOL, V64, P565, DOI 10.1099/jmm.0.000047; DuchetSuchaux M, 1997, AVIAN DIS, V41, P559, DOI 10.2307/1592145; DuchetSuchaux M, 1995, AVIAN DIS, V39, P796, DOI 10.2307/1592416; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Gast RK, 1998, AVIAN DIS, V42, P315, DOI 10.2307/1592482; Guerin J-L, 2006, PORTAGE CHLAMYDOPHIL; Guerin JL, 2006, P 7 JOURN RECH PALM, P37; Guscetti F, 2009, VET MICROBIOL, V135, P157, DOI 10.1016/j.vetmic.2008.09.038; Harkinezhad T, 2009, VET RES, V40, DOI 10.1051/vetres/2009044; HOLT PS, 1995, AVIAN DIS, V39, P239, DOI 10.2307/1591865; Holt PS, 1998, AVIAN DIS, V42, P45, DOI 10.2307/1592575; Hulin V, 2016, APPL ENVIRON MICROB, V82, P1504, DOI 10.1128/AEM.03179-15; Kaleta EF, 2003, AVIAN PATHOL, V32, P435, DOI 10.1080/03079450310001593613; Kalmar I, 2015, VET IMMUNOL IMMUNOP, V164, P30, DOI 10.1016/j.vetimm.2014.12.014; KALTENBOECK B, 1993, J BACTERIOL, V175, P487, DOI 10.1128/JB.175.2.487-502.1993; Laroucau K, 2009, VET MICROBIOL, V135, P82, DOI 10.1016/j.vetmic.2008.09.048; Leon O, 2004, P 6 JOURN RECH PALM; Raso TD, 2004, J ZOO WILDLIFE MED, V35, P94, DOI 10.1638/02-090; Rodolakis A, 2010, VET MICROBIOL, V140, P382, DOI 10.1016/j.vetmic.2009.03.014; Sachse K, 2015, CURR CLIN MICROBIOL, V2, P10, DOI 10.1007/s40588-014-0010-y; Sachse K, 2015, SYST APPL MICROBIOL, V38, P99, DOI 10.1016/j.syapm.2014.12.004; Sachse K, 2014, VET J, V200, P347, DOI 10.1016/j.tvjl.2014.03.017; Sachse K, 2014, SYST APPL MICROBIOL, V37, P79, DOI 10.1016/j.syapm.2013.12.004; Schachter J, 1999, CHLAMYDIA, P139; Stenzel T, 2014, POULTRY SCI, V93, P3009, DOI 10.3382/ps.2014-04219; To KKW, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003318; Van Loock A, 2006, VET MICROBIOL, V112, P53, DOI 10.1016/j.vetmic.2005.10.013; Van Loock M, 2006, VET RES, V37, P745, DOI 10.1051/vetres:2006033; VANROMPAY D, 1994, AVIAN PATHOL, V23, P247, DOI 10.1080/03079459408418993; Vanrompay D, 2001, IMMUNOLOGY, V103, P106, DOI 10.1046/j.1365-2567.2001.01215.x; Vorimore F, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu016; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052; Yin LZ, 2013, AVIAN DIS, V57, P242, DOI 10.1637/10439-102612-Reg.1	37	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154860	10.1371/journal.pone.0154860	http://dx.doi.org/10.1371/journal.pone.0154860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168325	Green Published, Green Accepted, gold			2022-12-27	WOS:000376587300069
J	West, J; Ogston, S; Foerster, J				West, Jonathan; Ogston, Simon; Foerster, John			Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials	PLOS ONE			English	Article							ACTIVE RHEUMATOID-ARTHRITIS; RANDOMIZED CONTROLLED-TRIAL; CHRONIC PLAQUE PSORIASIS; PLACEBO-CONTROLLED TRIAL; ADALIMUMAB PLUS METHOTREXATE; CONTROLLED CLINICAL-TRIAL; LOW DISEASE-ACTIVITY; QUALITY-OF-LIFE; DOUBLE-BLIND; VS. METHOTREXATE	Background Methotrexate (MTX) has been used to treat psoriasis for over half a century. Even so, clinical data characterising its efficacy and safety are sparse. Objective In order to enhance the available evidence, we conducted two meta-analyses, one for efficacy and one for safety outcomes, respectively, according to PRISMA checklist. (Data sources, study criteria, and study synthesis methods are detailed in Methods). Results In terms of efficacy, only eleven studies met criteria for study design and passed a Cochrane risk of bias analysis. Based on this limited dataset, 45.2% [95% confidence interval 34.1-60.0] of patients achieve PASI75 at primary endpoint (12 or 16 weeks, respectively, n = 705 patients across all studies), compared to a calculated PASI75 of 4.4 [3.5-5.6] for placebo, yielding a relative risk of 10.2 [95% C.I. 7.1-14.7]. For safety outcomes, we extended the meta-analysis to include studies employing the same dose range of MTX for other chronic inflammatory conditions, e.g. rheumatoid arthritis, in order not to maximise capture of relevant safety data. Based on 2763 patient safety years, adverse events (AEs) were found treatment limiting in 6.9 +/- 1.4% (mean +/- s.e.) of patients treated for six months, with an adverse effect profile largely in line with that encountered in clinical practice. Finally, in order to facilitate prospective clinical audit and to help generate long-term treatment outcomes under real world conditions, we also developed an easy to use documentation form to be completed by patients without requirement for additional staff time. Limitations Meta-analyses for efficacy and safety, respectively, employed non-identical selection criteria. Conclusions These meta-analyses summarise currently available evidence on MTX in psoriasis and should be of use to gauge whether local results broadly fall within outcomes.						West, Jonathan/0000-0002-4044-5931				Akhyani M, 2010, J EUR ACAD DERMATOL, V24, P1447, DOI 10.1111/j.1468-3083.2010.03667.x; Arani SF, 2011, BRIT J DERMATOL, V164, P855, DOI 10.1111/j.1365-2133.2010.10195.x; Baranauskaite A, 2012, ANN RHEUM DIS, V71, P541, DOI 10.1136/ard.2011.152223; Barker J, 2011, BRIT J DERMATOL, V165, P1109, DOI 10.1111/j.1365-2133.2011.10615.x; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Braun J, 2008, ARTHRITIS RHEUM-US, V58, P73, DOI 10.1002/art.23144; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Capell HA, 2007, ANN RHEUM DIS, V66, P235, DOI 10.1136/ard.2006.057133; Cappelleri JC, 2013, QUAL LIFE RES, V22, P2489, DOI 10.1007/s11136-013-0384-y; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Cohen S, 2001, ARTHRITIS RHEUM-US, V44, P1984, DOI 10.1002/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B; Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266; Conway R, 2015, SEMIN ARTHRITIS RHEU, V45, P156, DOI 10.1016/j.semarthrit.2015.05.003; de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142; Dhir V, 2014, CLIN THER, V36, P1005, DOI 10.1016/j.clinthera.2014.05.063; Dogra S, 2012, CLIN EXP DERMATOL, V37, P729, DOI 10.1111/j.1365-2230.2012.04440.x; Dougados M, 1999, ANN RHEUM DIS, V58, P220, DOI 10.1136/ard.58.4.220; Emery P, 2000, RHEUMATOLOGY, V39, P655, DOI 10.1093/rheumatology/39.6.655; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Flytstrom I, 2008, BRIT J DERMATOL, V158, P116, DOI 10.1111/j.1365-2133.2007.08284.x; Heydendael VMR, 2003, NEW ENGL J MED, V349, P658, DOI 10.1056/NEJMoa021359; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Ho SGY, 2010, CLIN EXP DERMATOL, V35, P717, DOI 10.1111/j.1365-2230.2009.03693.x; Janagond AB, 2013, J EUR ACAD DERMATOL, V27, pe384, DOI 10.1111/jdv.12004; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P64, DOI 10.1136/annrheumdis-2011-201247; Kingsley GH, 2012, RHEUMATOLOGY, V51, P1368, DOI 10.1093/rheumatology/kes001; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Lajevardi V, 2015, INT J DERMATOL, V54, P95, DOI 10.1111/ijd.12585; Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Lerndal T, 2000, RHEUMATOLOGY, V39, P316, DOI 10.1093/rheumatology/39.3.316; Lu LJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P979, DOI 10.1002/art.24643; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Radmanesh M, 2011, INT J DERMATOL, V50, P1291, DOI 10.1111/j.1365-4632.2011.04967.x; Ranjan N, 2007, J DERMATOL TREAT, V18, P295, DOI 10.1080/09546630701499291; Reich K, 2011, NEW ENGL J MED, V365, P1586, DOI 10.1056/NEJMoa1010858; Rigby W, 2012, ARTHRITIS RHEUM-US, V64, P350, DOI 10.1002/art.33317; Robinson A, 2012, J AM ACAD DERMATOL, V66, P369, DOI 10.1016/j.jaad.2011.01.022; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Schmitt J, 2014, BRIT J DERMATOL, V170, P274, DOI 10.1111/bjd.12663; Smolen J, 2009, ANN RHEUM DIS, V68, P797, DOI 10.1136/ard.2008.101659; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Strand V, 1999, ARCH INTERN MED, V159, P2542, DOI 10.1001/archinte.159.21.2542; Takeuchi T, 2013, MOD RHEUMATOL, V23, P623, DOI 10.1007/s10165-012-0742-6; Tanaka Y, 2012, ANN RHEUM DIS, V71, P817, DOI 10.1136/ard.2011.200317; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; Westhovens R, 2009, ANN RHEUM DIS, V68, P1870, DOI 10.1136/ard.2008.101121; Yamamoto K, 2014, MOD RHEUMATOL, V24, P715, DOI 10.3109/14397595.2013.864224; Zhai ZF, 2015, J AM ACAD DERMATOL, V73, P991, DOI 10.1016/j.jaad.2015.08.036	51	47	52	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0153740	10.1371/journal.pone.0153740	http://dx.doi.org/10.1371/journal.pone.0153740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168193	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300077
J	Cheeseman, HM; Carias, AM; Evans, AB; Olejniczak, NJ; Ziprin, P; King, DFL; Hope, TJ; Shattock, RJ				Cheeseman, Hannah M.; Carias, Ann M.; Evans, Abbey B.; Olejniczak, Natalia J.; Ziprin, Paul; King, Deborah F. L.; Hope, Thomas J.; Shattock, Robin J.			Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; DENDRITIC CELLS; MYELOID CELLS; INTESTINAL MACROPHAGES; HUMAN-IMMUNOGLOBULIN; LANGERHANS CELLS; BLOOD MONOCYTES; IGG; INFECTION; GAMMA	The majority of new Human Immunodeficiency Virus (HIV)-1 infections are acquired via sexual transmission at mucosal surfaces. Partial efficacy (31.2%) of the Thai RV144 HIV-1 vaccine trial has been correlated with Antibody-dependent Cellular Cytotoxicity (ADCC) mediated by non-neutralizing antibodies targeting the V1V2 region of the HIV-1 envelope. This has led to speculation that ADCC and other antibody-dependent cellular effector functions might provide an important defense against mucosal acquisition of HIV-1 infection. However, the ability of antibody-dependent cellular effector mechanisms to impact on early mucosal transmission events will depend on a variety of parameters including effector cell type, frequency, the class of Fc-Receptor (FcR) expressed, the number of FcR per cell and the glycoslyation pattern of the induced antibodies. In this study, we characterize and compare the frequency and phenotype of IgG (CD16 [Fc gamma RIII], CD32 [Fc gamma RII] and CD64 [Fc gamma RI]) and IgA (CD89 [Fc alpha R]) receptor expression on effector cells within male and female genital mucosal tissue, colorectal tissue and red blood cell-lysed whole blood. The frequency of FcR expression on CD14+ monocytic cells, myeloid dendritic cells and natural killer cells were similar across the three mucosal tissue compartments, but significantly lower when compared to the FcR expression profile of effector cells isolated from whole blood, with many cells negative for all FcRs. Of the three tissues tested, penile tissue had the highest percentage of FcR positive effector cells. Immunofluorescent staining was used to determine the location of CD14+, CD11c+ and CD56+ cells within the three mucosal tissues. We show that the majority of effector cells across the different mucosal locations reside within the subepithelial lamina propria. The potential implication of the observed FcR expression patterns on the effectiveness of FcR-dependent cellular effector functions to impact on the initial events in mucosal transmission and dissemination warrants further mechanistic studies.	[Cheeseman, Hannah M.; Evans, Abbey B.; Olejniczak, Natalia J.; King, Deborah F. L.; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, Grp Mucosal Infect & Immun, London, England; [Carias, Ann M.; Hope, Thomas J.] Northwestern Univ, Feinberg Sch Med, Cell & Mol Biol Dept, Chicago, IL 60611 USA; [Ziprin, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Surg, St Marys Hosp, London, England	Imperial College London; Northwestern University; Feinberg School of Medicine; Imperial College London	Shattock, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, Grp Mucosal Infect & Immun, London, England.	r.shattock@imperial.ac.uk		Cheeseman, Hannah/0000-0001-9044-1341; Carias, Ann Marie/0000-0003-1305-254X	Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [UM1-AI100645-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a grant awarded to RJS by the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) # UM1-AI100645-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman ME, 2013, J VIROL, V87, P5468, DOI 10.1128/JVI.03403-12; Anderson D, 2011, AM J REPROD IMMUNOL, V65, P220, DOI 10.1111/j.1600-0897.2010.00941.x; Asmal M, 2011, J VIROL, V85, P5465, DOI 10.1128/JVI.00313-11; Bakema JE, 2011, MUCOSAL IMMUNOL, V4, P612, DOI 10.1038/mi.2011.36; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; Brandtzaeg P, 2010, IMMUNOL INVEST, V39, P303, DOI 10.3109/08820131003680369; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Fischetti L, 2009, AIDS, V23, P319, DOI 10.1097/QAD.0b013e328321b778; Forthal DN, 2013, JAIDS-J ACQ IMM DEF, V63, P31, DOI 10.1097/QAI.0b013e3182874d41; GESSL A, 1994, SCAND J IMMUNOL, V39, P151, DOI 10.1111/j.1365-3083.1994.tb03354.x; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; GUYRE PM, 1983, J CLIN INVEST, V72, P393, DOI 10.1172/JCI110980; Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720; Hamre R, 2003, SCAND J IMMUNOL, V57, P506, DOI 10.1046/j.1365-3083.2003.01220.x; Hardy H, 2013, NUTRIENTS, V5, P1869, DOI 10.3390/nu5061869; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Herter S, 2014, J IMMUNOL, V192, P2252, DOI 10.4049/jimmunol.1301249; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hsieh MM, 2007, ANN INTERN MED, V146, P486, DOI 10.7326/0003-4819-146-7-200704030-00004; HUSSAIN LA, 1992, CLIN EXP IMMUNOL, V90, P530; HUSSAIN LA, 1991, AIDS, V5, P1089, DOI 10.1097/00002030-199109000-00004; HUSSAIN LA, 1995, IMMUNOLOGY, V85, P475; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; KERST JM, 1993, BLOOD, V81, P1457; Kramski M, 2013, CURR HIV RES, V11, P388, DOI 10.2174/15701; Kvedaraite E, 2016, GUT, V65, P1632, DOI 10.1136/gutjnl-2014-309014; Lemos MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108954; Moller MJ, 1998, INT J CANCER, V78, P533, DOI 10.1002/(SICI)1097-0215(19981123)78:5<533::AID-IJC1>3.0.CO;2-2; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; PERUSSIA B, 1983, J EXP MED, V158, P1092, DOI 10.1084/jem.158.4.1092; PETRONI KC, 1988, J IMMUNOL, V140, P3467; Preza GC, 2014, AIDS RES HUM RETROV, V30, P241, DOI [10.1089/aid.2013.0145, 10.1089/AID.2013.0145]; Prodger JL, 2012, MUCOSAL IMMUNOL, V5, P121, DOI 10.1038/mi.2011.56; Prodger JL, 2014, J INFECT DIS, V209, P1185, DOI 10.1093/infdis/jit644; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rijken F, 2005, BRIT J DERMATOL, V152, P321, DOI 10.1111/J.1365-2133.2004.06335.X; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; Schmitz M, 2002, BLOOD, V100, P1502, DOI 10.1182/blood.V100.4.1502.h81602001502_1502_1504; SHEN L, 1987, J IMMUNOL, V139, P534; SHEN L, 1994, J IMMUNOL, V152, P4080; Smalls-Mantey A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074858; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Smith PD, 2001, J IMMUNOL, V167, P2651, DOI 10.4049/jimmunol.167.5.2651; Smythies LE, 2006, J LEUKOCYTE BIOL, V80, P492, DOI 10.1189/jlb.1005566; Sobota A, 2005, J IMMUNOL, V175, P4450, DOI 10.4049/jimmunol.175.7.4450; Su B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00289; Teillaud JL., 2012, ANTIBODY DEPENDENT C; Teirlinck AC, 2015, INFECT IMMUN, V83, P3732, DOI 10.1128/IAI.00473-15; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Trifonova RT, 2014, AM J REPROD IMMUNOL, V71, P252, DOI 10.1111/aji.12198; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; VELDE AAT, 1992, J IMMUNOL, V149, P4048; WARD KN, 1984, INFECT IMMUN, V44, P623, DOI 10.1128/IAI.44.3.623-626.1984; Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629; ZUCKERMAN SH, 1978, CRC CR REV MICROBIOL, V7, P1	64	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154656	10.1371/journal.pone.0154656	http://dx.doi.org/10.1371/journal.pone.0154656			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27164006	Green Published, gold			2022-12-27	WOS:000376585700019
J	Hou, YJ; Ma, X; Wan, WT; Long, N; Zhang, J; Tan, YT; Duan, SC; Zeng, Y; Dong, Y				Hou, Yujie; Ma, Xiao; Wan, Wenting; Long, Ni; Zhang, Jing; Tan, Yuntao; Duan, Shengchang; Zeng, Yan; Dong, Yang			Comparative Genomics of Pathogens Causing Brown Spot Disease of Tobacco: Alternaria longipes and Alternaria alternata	PLOS ONE			English	Article							HOST-SELECTIVE TOXINS; MORPHOLOGICAL SEGREGATION; CELL-DEATH; GENE; DATABASE; PLANT; TOOL; IDENTIFICATION; BIOSYNTHESIS; PATHOTYPE	The genus Alternaria is a group of infectious/contagious pathogenic fungi that not only invade a wide range of crops but also induce severe allergic reactions in a part of the human population. In this study, two strains Alternaria longipes cx1 and Alternaria alternata cx2 were isolated from different brown spot lesions on infected tobacco leaves. Their complete genomes were sequenced, de novo assembled, and comparatively analyzed. Phylogenetic analysis revealed that A. longipes cx1 and A. alternata cx2 diverged 3.3 million years ago, indicating a recent event of speciation. Seventeen non-ribosomal peptide synthetase (NRPS) genes and 13 polyketide synthase (PKS) genes in A. longipes cx1 and 13 NRPS genes and 12 PKS genes in A. alternata cx2 were identified in these two strains. Some of these genes were predicted to participate in the synthesis of non-host specific toxins (non-HSTs), such as tenuazonic acid (TeA), alternariol (AOH) and alternariol monomethyl ether (AME). By comparative genome analysis, we uncovered that A. longipes cx1 had more genes putatively involved in pathogen-plant interaction, more carbohydrate-degrading enzymes and more secreted proteins than A. alternata cx2. In summary, our results demonstrate the genomic distinction between A. longipes cx1 and A. altenata cx2. They will not only improve the understanding of the phylogenetic relationship among genus Alternaria, but more importantly provide valuable genomic resources for the investigation of plant-pathogen interaction.	[Hou, Yujie; Wan, Wenting; Long, Ni; Tan, Yuntao; Duan, Shengchang; Dong, Yang] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China; [Ma, Xiao] Yunnan Agr Univ, Longrun Pu Erh Tea Acad, Kunming, Yunnan, Peoples R China; [Zhang, Jing] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Zeng, Yan] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Dong, Yang] Yunnan Agr Univ, Biol Big Data Coll, Kunming, Yunnan, Peoples R China	Kunming University of Science & Technology; Yunnan Agricultural University; Huazhong University of Science & Technology; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan Agricultural University	Dong, Y (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.; Zeng, Y (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.; Dong, Y (corresponding author), Yunnan Agr Univ, Biol Big Data Coll, Kunming, Yunnan, Peoples R China.	zengyan@mail.kiz.ac.cn; dongyang@dongyang-lab.org		MA, Xiao/0000-0003-0044-531X				Akagi Y, 2009, EUKARYOT CELL, V8, P1732, DOI 10.1128/EC.00135-09; Andersen B, 2001, MYCOL RES, V105, P291, DOI 10.1017/S0953756201003446; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Cheng DD, 2011, PHYSIOL PLANTARUM, V141, P117, DOI 10.1111/j.1399-3054.2010.01422.x; Chu TC, 2013, P NATL ACAD SCI USA, V110, pE3417, DOI 10.1073/pnas.1314090110; Dang HX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1430-7; de Hoog GS, 2002, MYCOSES, V45, P259, DOI 10.1046/j.1439-0507.2002.00747.x; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Doyle J. J., 1987, PHYTOCHEM B, P11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Grandaubert J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-891; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hu JN, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-171; Hunt M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r47; Johnson RD, 2000, MOL PLANT MICROBE IN, V13, P742, DOI 10.1094/MPMI.2000.13.7.742; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUSABA M, 1995, CURR GENET, V28, P491, DOI 10.1007/BF00310821; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Miyamoto Y, 2008, MOL PLANT MICROBE IN, V21, P1591, DOI 10.1094/MPMI-21-12-1591; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; NISHIMURA S, 1983, ANNU REV PHYTOPATHOL, V21, P87, DOI 10.1146/annurev.py.21.090183.000511; Ospina-Giraldo MD, 2003, CURR GENET, V44, P49, DOI 10.1007/s00294-003-0419-y; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pryor BM, 2002, PHYTOPATHOLOGY, V92, P406, DOI 10.1094/PHYTO.2002.92.4.406; Roberts RG, 2000, MYCOL RES, V104, P151, DOI 10.1017/S0953756299001690; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSETT T, 1957, BIOCHEM J, V67, P390, DOI 10.1042/bj0670390; Rotem J., 1994, GENUS ALTERNARIA BIO; Saha D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040564; Simmons EG, 1999, MYCOTAXON, V70, P325; Slavov S., 2004, BIOTECHNOL BIOTEC EQ, V18, P90, DOI [10.1080/13102818.2004.10817126, DOI 10.1080/13102818.2004.10817126]; Staats CC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-822; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Tanaka A, 1999, MOL PLANT MICROBE IN, V12, P691, DOI 10.1094/MPMI.1999.12.8.691; Thomma BPHJ, 2003, MOL PLANT PATHOL, V4, P225, DOI 10.1046/J.1364-3703.2003.00173.X; Thon MR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r16; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yakimova ET, 2009, J PHYTOPATHOL, V157, P592, DOI 10.1111/j.1439-0434.2008.01535.x; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yun CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9758; Zu T, 2001, MOL GENET GENOMICS, V266, P142, DOI 10.1007/s004380100537	65	32	43	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155258	10.1371/journal.pone.0155258	http://dx.doi.org/10.1371/journal.pone.0155258			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159564	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700051
J	Leong, HT; Hug, F; Fu, SN				Leong, Hio Teng; Hug, Francois; Fu, Siu Ngor			Increased Upper Trapezius Muscle Stiffness in Overhead Athletes with Rotator Cuff Tendinopathy	PLOS ONE			English	Article							SHEAR ELASTIC-MODULUS; ACROMIO-HUMERAL DISTANCE; SHOULDER; PATTERNS; ELASTOGRAPHY; RELIABILITY; ELEVATION; PEOPLE; FORCE; PAIN	Although excessive tension of the upper trapezius (UT) is thought to contribute to rotator cuff tendinopathy, no study examined UT tension in athletes with and without rotator cuff tendinopathy. Here we used UT shear modulus measured using ultrasound shear wave elastography as an index of muscle stiffness/tension. The aims of this study were twofold: 1) to determine whether the UT muscle shear modulus is altered in athletes with rotator cuff tendinopathy compared to asymptomatic athletes, and 2) to detect optimal cut-off points of UT shear modulus in identifying athletes with rotator cuff tendinopathy. Forty-three male volleyball players (17 asymptomatic and 26 with rotator cuff tendinopathy, mean age = 22.9 +/- 3.5 years) participated in the study. UT shear modulus was quantified during active arm holding at 30 degrees and 60 degrees of shoulder abduction and passive arm positioning at 0 degrees, 30 degrees and 60 degrees of shoulder abduction. During the active tasks, the UT shear modulus was higher in athletes with rotator cuff tendinopathy than the asymptomatic athletes (p = 0.002), regardless the arm position. During the passive tasks, athletes with rotator cuff tendinopathy exhibited a higher UT shear modulus than asymptomatic athletes only at 0 degrees of shoulder abduction (13.0 +/- 2.5 kPa vs 10.2 +/- 1.8 kPa, p = 0.001). When considering the active task, an optimal cut-off shear modulus of 12.0 kPa at 30 degrees of shoulder abduction (sensitivity = 0.84, specificity = 0.57, AUC = 0.757, p = 0.008) and 9.5 kPa at 60 degrees of shoulder abduction (sensitivity = 0.88, specificity = 0.67, AUC = 0.816, p = 0.002) was detected. When considering the passive task at 0 degrees of shoulder abduction, a cut-off of 12.2 kPa was found (sensitivity = 0.73, AUC = 0.817, p = 0.001). Findings from the present study show that monitoring passive and active UT muscle shear modulus may provide important information for the prevention/rehabilitation of rotator cuff tendinopathy.	[Leong, Hio Teng; Fu, Siu Ngor] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Hug, Francois] Univ Nantes, UFR STAPS, Lab Movement Interact Performance EA 4334, F-44035 Nantes, France; [Hug, Francois] Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia	Hong Kong Polytechnic University; Nantes Universite; University of Queensland	Leong, HT (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China.	annieleonght@gmail.com		FU, Amy/0000-0003-4405-015X; Leong, Hio Teng/0000-0003-4185-4814				Antony NT, 2010, J ELECTROMYOGR KINES, V20, P191, DOI 10.1016/j.jelekin.2009.04.010; Ates F, 2015, J ELECTROMYOGR KINES, V25, P703, DOI 10.1016/j.jelekin.2015.02.005; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bouillard K, 2012, J APPL PHYSIOL, V113, P1353, DOI 10.1152/japplphysiol.00858.2012; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Chester R, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-45; Cole AK, 2013, J ATHL TRAINING, V48, P12, DOI 10.4085/1062-6050-48.1.13; Cools AM, 2003, AM J SPORT MED, V31, P542, DOI 10.1177/03635465030310041101; Crommert ME, 2015, SCAND J MED SCI SPOR, V25, pE490, DOI 10.1111/sms.12341; Desmeules F, 2004, CLIN J SPORT MED, V14, P197, DOI 10.1097/00042752-200407000-00002; Endo K, 2004, CLIN BIOMECH, V19, P1009, DOI 10.1016/j.clinbiomech.2004.07.011; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Fey A., 2007, J ORTHOP SPORT PHYS, V37, pA44; Gajdosik RL, 2001, CLIN BIOMECH, V16, P87, DOI 10.1016/S0268-0033(00)00061-9; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Hamilton Abigail, 2010, Minn Med, V93, P37; Hebert LJ, 2002, ARCH PHYS MED REHAB, V83, P60, DOI 10.1053/apmr.2002.27471; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hrysomallis C, 2010, J STRENGTH COND RES, V24; Hug F, 2015, EXERC SPORT SCI REV, V43, P125, DOI 10.1249/JES.0000000000000049; Hug F, 2015, J ORTHOP SPORT PHYS, V45, P360, DOI 10.2519/jospt.2015.5905; Hug F, 2014, EUR J APPL PHYSIOL, V114, P1057, DOI 10.1007/s00421-014-2840-y; JOHNSON G, 1994, CLIN BIOMECH, V9, P44, DOI 10.1016/0268-0033(94)90057-4; Kendall F.P., 2005, MUSCLES TESTING FUNC, Vfifth; Kibler WB, 1998, AM J SPORT MED, V26, P325; Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Leong HT, 2016, J SCI MED SPORT, V19, P970, DOI 10.1016/j.jsams.2016.03.011; Leong HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067199; Leong HT, 2012, J SCI MED SPORT, V15, P284, DOI 10.1016/j.jsams.2011.11.259; Lin JJ, 2011, J ORTHOP RES, V29, P653, DOI 10.1002/jor.21300; Ludewig PM, 2011, MANUAL THER, V16, P33, DOI 10.1016/j.math.2010.08.004; Ludewig PM, 2000, PHYS THER, V80, P276, DOI 10.1093/ptj/80.3.276; Lv FQ, 2012, ULTRASOUND MED BIOL, V38, P795, DOI 10.1016/j.ultrasmedbio.2012.01.010; Mackenzie TA, 2015, CLIN BIOMECH, V30, P641, DOI 10.1016/j.clinbiomech.2015.06.001; Michener LA, 2009, ARCH PHYS MED REHAB, V90, P1898, DOI 10.1016/j.apmr.2009.05.015; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Ostor AJK, 2005, RHEUMATOLOGY, V44, P800, DOI 10.1093/rheumatology/keh598; Phadke V, 2009, BRAZ J PHYS THER, V13, P1, DOI 10.1590/S1413-35552009005000012; Reeser JC, 2010, PM&R, V2, P27, DOI 10.1016/j.pmrj.2009.11.010; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Seitz AL, 2011, CLIN BIOMECH, V26, P1, DOI 10.1016/j.clinbiomech.2010.08.001; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Teece RM, 2008, J ORTHOP SPORT PHYS, V38, P181, DOI 10.2519/jospt.2008.2386; Tucker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091899; WARNER JJP, 1990, AM J SPORT MED, V18, P366, DOI 10.1177/036354659001800406; Wickham J, 2010, J ELECTROMYOGR KINES, V20, P212, DOI 10.1016/j.jelekin.2009.06.004	48	24	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155187	10.1371/journal.pone.0155187	http://dx.doi.org/10.1371/journal.pone.0155187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159276	Green Published, gold, Green Submitted			2022-12-27	WOS:000376576700047
J	Vereninov, IA; Yurinskaya, VE; Model, MA; Vereninov, AA				Vereninov, Igor A.; Yurinskaya, Valentina E.; Model, Michael A.; Vereninov, Alexey A.			Unidirectional Flux Balance of Monovalent Ions in Cells with Na/Na and Li/Na Exchange: Experimental and Computational Studies on Lymphoid U937 Cells	PLOS ONE			English	Article							VOLUME REGULATION; MOLECULAR-BASIS; LITHIUM; PUMP; COTRANSPORT; SODIUM; APOPTOSIS; MODEL; PH; INTEGRATION	Monovalent ion traffic across the cell membrane occurs via various pathways. Evaluation of individual fluxes in whole cell is hampered by their strong interdependence. This difficulty can be overcome by computational analysis of the whole cell flux balance. However, the previous computational studies disregarded ion movement of the self-exchange type. We have taken this exchange into account. The developed software allows determination of unidirectional fluxes of all monovalent ions via the major pathways both under the balanced state and during transient processes. We show how the problem of finding the rate coefficients can be solved by measurement of monovalent ion concentrations and some of the fluxes. Interdependence of fluxes due to the mandatory conditions of electroneutrality and osmotic balance and due to specific effects can be discriminated, enabling one to identify specific changes in ion transfer machinery under varied conditions. To test the effectiveness of the developed approach we made use of the fact that Li/Na exchange is known to be an analogue of the coupled Na/Na exchange. Thus, we compared the predicted and experimental data obtained on U937 cells under varied Li+ concentrations and following inhibition of the sodium pump with ouabain. We found that the coupled Na/Na exchange in U937 cells comprises a significant portion of the entire Na+ turnover. The data showed that the loading of the sodium pump by Li/Na exchange involved in the secondary active Li+ transport at 1-10 mM external Li+ is small. This result may be extrapolated to similar Li+ and Na+ flux relationships in erythrocytes and other cells in patients treated with Li+ in therapeutic doses. The developed computational approach is applicable for studying various cells and can be useful in education for demonstrating the effects of individual transporters and channels on ion gradients, cell water content and membrane potential.	[Vereninov, Igor A.] Peter Great St Petersburg Polytech Univ, St Petersburg, Russia; [Yurinskaya, Valentina E.; Vereninov, Alexey A.] Russian Acad Sci, Inst Cytol, Lab Cell Physiol, St Petersburg 194064, Russia; [Model, Michael A.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	Peter the Great St. Petersburg Polytechnic University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Vereninov, AA (corresponding author), Russian Acad Sci, Inst Cytol, Lab Cell Physiol, St Petersburg 194064, Russia.	verenino@gmail.com		Vereninov, Alexey/0000-0002-3602-7059; Yurinskaya, Valentina/0000-0001-9693-0779	Russian Foundation for Basic Research [12-04-01669a, 15-04-00776a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This study was supported by the Russian Foundation for Basic Research, projects no. 12-04-01669a and 15-04-00776a to AAV and VEY.	Andrini O, 2012, AM J PHYSIOL-CELL PH, V302, pC539, DOI 10.1152/ajpcell.00364.2011; Armstrong CM, 2003, P NATL ACAD SCI USA, V100, P6257, DOI 10.1073/pnas.0931278100; Aull F, 1977, BIOCH BIOPHYS ACTA; Bonnans J. F., 2013, SPRINGER SCI BUSINES; BUROVINA I. V., 1964, ZH OBSHCH BIOL, V25, P115; BUROVINA IV, 1963, DOKL AKAD NAUK SSSR+, V149, P413; Chiu CT, 2010, PHARMACOL THERAPEUT, V128, P281, DOI 10.1016/j.pharmthera.2010.07.006; Elmariah S, 2003, AM J PHYSIOL-CELL PH, V285, pC446, DOI 10.1152/ajpcell.00606.2002; Falkenberg CV, 2010, BIOPHYS J, V98, P1476, DOI 10.1016/j.bpj.2009.11.045; FLEISHMAN DG, 1984, DOKL AKAD NAUK SSSR+, V279, P758; Fleishman DG, 1982, SCHELOCHNYE ELEMENTY; Forsythe G. E., 1977, COMPUTER METHODS MAT; Fraser JA, 2004, J PHYSIOL-LONDON, V559, P459, DOI 10.1113/jphysiol.2004.065706; Fraser JA, 2007, PROG BIOPHYS MOL BIO, V94, P336, DOI 10.1016/j.pbiomolbio.2006.10.001; Girvin B, 1996, HUM PSYCHOPHARM CLIN, V11, P491, DOI 10.1002/(SICI)1099-1077(199611)11:6<491::AID-HUP819>3.0.CO;2-B; Hernandez JA, 1998, AM J PHYSIOL-CELL PH, V275, pC1067, DOI 10.1152/ajpcell.1998.275.4.C1067; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOFFMANN EK, 1979, J PHYSIOL-LONDON, V296, P61, DOI 10.1113/jphysiol.1979.sp012991; JAKOBSSON E, 1980, AM J PHYSIOL, V238, pC196, DOI 10.1152/ajpcell.1980.238.5.C196; Kemp G, 2008, CHANNELS, V2, P329, DOI 10.4161/chan.2.5.6898; LADOUX A, 1987, EUR J BIOCHEM, V170, P43, DOI 10.1111/j.1432-1033.1987.tb13665.x; Lauf PK, 2008, CELL PHYSIOL BIOCHEM, V21, P335, DOI 10.1159/000129627; Lenox RH, 2003, MOL PSYCHIATR, V8, P135, DOI 10.1038/sj.mp.4001306; LEVINSON C, 1985, J MEMBRANE BIOL, V87, P121, DOI 10.1007/BF01870658; Lew V.L., 2000, CONCISE GUIDE RED CE; LEW VL, 1986, J MEMBRANE BIOL, V92, P57, DOI 10.1007/BF01869016; LEW VL, 1991, J CLIN INVEST, V87, P100, DOI 10.1172/JCI114958; Lytle C, 1998, AM J PHYSIOL-CELL PH, V274, pC299, DOI 10.1152/ajpcell.1998.274.2.C299; Mauritz JMA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000339; NAG Library, 2015, CH E04 MINIMIZING MA; Novotny JA, 1996, AM J PHYSIOL-CELL PH, V270, pC1751, DOI 10.1152/ajpcell.1996.270.6.C1751; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Schushan M, 2010, J MOL BIOL, V396, P1181, DOI 10.1016/j.jmb.2009.12.055; Semplicini A, 2003, FRONT BIOSCI-LANDMRK, V8, pD912, DOI 10.2741/1066; Terashima K, 2006, PHILOS T R SOC A, V364, P1245, DOI 10.1098/rsta.2006.1767; Timmer RT, 2000, J GEN PHYSIOL, V116, P363, DOI 10.1085/jgp.116.3.363; Vereninov AA, 2007, CELL BIOL INT, V31, P382, DOI 10.1016/j.cellbi.2007.01.023; Vereninov AA, 2008, CELL PHYSIOL BIOCHEM, V22, P187, DOI 10.1159/000149796; Vereninov IA, 2013, ST PETERSBURG STATE, V169, P91; Vereninov IA, 2014, CELL PHYSIOL BIOCHEM, V34, P1812, DOI 10.1159/000366382; Yurinskaya VE, 2012, CELL PHYSIOL BIOCHEM, V30, P964, DOI 10.1159/000341473; Yurinskaya VE, 2011, J PHYSIOL-LONDON, V589, P2197, DOI 10.1113/jphysiol.2011.207571; Yurinskaya VE, 2005, CELL PHYSIOL BIOCHEM, V16, P155, DOI 10.1159/000089841; Yurinskaya VE, 2014, CELL TISSUE BIOL, V8, P80; Yurinskaya VE, 2010, CELL TISSUE BIOL, V4, P457, DOI DOI 10.1134/S1990519X10050081; Zerbini G, 2004, J AM SOC NEPHROL, V15, pS81, DOI 10.1097/01.ASN.0000093371.65105.8F	46	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0153284	10.1371/journal.pone.0153284	http://dx.doi.org/10.1371/journal.pone.0153284			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159324	gold, Green Published			2022-12-27	WOS:000376576700003
J	Garratt, MPD; Breeze, TD; Boreux, V; Fountain, MT; McKerchar, M; Webber, SM; Coston, DJ; Jenner, N; Dean, R; Westbury, DB; Biesmeijer, JC; Potts, SG				Garratt, M. P. D.; Breeze, T. D.; Boreux, V.; Fountain, M. T.; McKerchar, M.; Webber, S. M.; Coston, D. J.; Jenner, N.; Dean, R.; Westbury, D. B.; Biesmeijer, J. C.; Potts, S. G.			Apple Pollination: Demand Depends on Variety and Supply Depends on Pollinator Identity	PLOS ONE			English	Article							ECOSYSTEM SERVICES; FRUIT-SET; HYMENOPTERA; LANDSCAPES; HONEYBEE; YIELD; MEGACHILIDAE; ABUNDANCE; COLONIES; VISITORS	Insect pollination underpins apple production but the extent to which different pollinator guilds supply this service, particularly across different apple varieties, is unknown. Such information is essential if appropriate orchard management practices are to be targeted and proportional to the potential benefits pollinator species may provide. Here we use a novel combination of pollinator effectiveness assays (floral visit effectiveness), orchard field surveys (flower visitation rate) and pollinator dependence manipulations (pollinator exclusion experiments) to quantify the supply of pollination services provided by four different pollinator guilds to the production of four commercial varieties of apple. We show that not all pollinators are equally effective at pollinating apples, with hoverflies being less effective than solitary bees and bumblebees, and the relative abundance of different pollinator guilds visiting apple flowers of different varieties varies significantly. Based on this, the taxa specific economic benefits to UK apple production have been established. The contribution of insect pollinators to the economic output in all varieties was estimated to be 92.1M pound across the UK, with contributions varying widely across taxa: solitary bees (51.4M) pound, honeybees (21.4M) pound, bumblebees (18.6M) pound and hoverflies (0.7M) pound. This research highlights the differences in the economic benefits of four insect pollinator guilds to four major apple varieties in the UK. This information is essential to underpin appropriate investment in pollination services management and provides a model that can be used in other entomolophilous crops to improve our understanding of crop pollination ecology.	[Garratt, M. P. D.; Breeze, T. D.; Webber, S. M.; Coston, D. J.; Dean, R.; Potts, S. G.] Univ Reading, Sch Agr Policy & Dev, Ctr Agri Environm Res, Reading, Berks, England; [Boreux, V.] Univ Freiburg, Fac Environm & Nat Resources, Hugstetter Str 55, D-79106 Freiburg, Germany; [Fountain, M. T.] East Malling Res, East Malling, Kent, England; [McKerchar, M.; Westbury, D. B.] Univ Worcester, Inst Sci & Environm, Worcester, MA USA; [Jenner, N.] Avalon Produce, Kent, OH USA; [Biesmeijer, J. C.] Naturalis Biodivers Ctr, Leiden, Netherlands	University of Reading; University of Freiburg; Naturalis Biodiversity Center	Garratt, MPD (corresponding author), Univ Reading, Sch Agr Policy & Dev, Ctr Agri Environm Res, Reading, Berks, England.	M.P.Garratt@reading.ac.uk	Breeze, Tom/ABC-6373-2021; Potts, Simon G/C-7250-2008; Breeze, Tom/AAU-7068-2021; Potts, Simon/ABF-9221-2020; Garratt, Michael/AAT-2259-2020; Westbury, Duncan/AAU-7578-2021; Fountain, Michelle/GPS-8312-2022	Potts, Simon G/0000-0002-2045-980X; Breeze, Tom/0000-0002-8929-8354; Potts, Simon/0000-0002-2045-980X; Garratt, Michael/0000-0002-0196-6013; Westbury, Duncan/0000-0001-7094-0362; Biesmeijer, Koos/0000-0003-0328-0573	British Biological Science Research Council; Department for the Environment Farming and Rural Affairs; Natural Environment Research Council; Scottish Government; Wellcome Trust, under the Living with Environmental Change Partnership [BB/I000275/1]; Worshipful Company of Fruiterers, Sainsbury's Supermarkets Ltd, Waitrose and Fruition; BBSRC; Defra; NERC; Wellcome Trust, under the Living With Environmental Change Partnership; Worshipful Company of Fruiterers, Sainsbury's Supermarkets Ltd., Waitrose and Fruition; Biotechnology and Biological Sciences Research Council [BB/I000275/1, BB/I000348/1, BB/P00184X/1, 1368006] Funding Source: researchfish; BBSRC [BB/P00184X/1, BB/I000275/1, BB/I000348/1] Funding Source: UKRI	British Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for the Environment Farming and Rural Affairs; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Wellcome Trust, under the Living with Environmental Change Partnership(Wellcome Trust); Worshipful Company of Fruiterers, Sainsbury's Supermarkets Ltd, Waitrose and Fruition; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust, under the Living With Environmental Change Partnership(Wellcome Trust); Worshipful Company of Fruiterers, Sainsbury's Supermarkets Ltd., Waitrose and Fruition; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was carried out as part of the Insect Pollinators Initiative funded jointly by a grant from British Biological Science Research Council, Department for the Environment Farming and Rural Affairs, Natural Environment Research Council, the Scottish Government and the Wellcome Trust, under the Living with Environmental Change Partnership BB/I000275/1. The Worshipful Company of Fruiterers, Sainsbury's Supermarkets Ltd, Waitrose and Fruition funded some of the surveys involved in the analysis. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Avalon Produce also provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This research was carried out as part of the Insect Pollinators Initiative funded jointly by a grant from BBSRC, Defra, NERC, the Scottish Government and the Wellcome Trust, under the Living With Environmental Change Partnership. We would also like to thank the Worshipful Company of Fruiterers, Sainsbury's Supermarkets Ltd., Waitrose and Fruition for funding some of the surveys and are thankful to all the research staff involved in the work and the farmers and landowners who enabled us to carry out research on their land.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Bauer DM, 2014, MACROECONOMIC COST C; Benjamin FE, 2014, ENVIRON ENTOMOL, V43, P1574, DOI 10.1603/EN13314; Blaauw BR, 2014, J APPL ECOL, V51, P890, DOI 10.1111/1365-2664.12257; Blitzer EJ, 2016, AGR ECOSYST ENVIRON, V221, P1, DOI 10.1016/j.agee.2016.01.004; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Breeze TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082996; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Brittain C, 2013, GLOBAL CHANGE BIOL, V19, P540, DOI 10.1111/gcb.12043; Brookfield PL, 1996, J HORTIC SCI BIOTECH, V71, P265, DOI 10.1080/14620316.1996.11515405; Carreck NL, 1997, BEE WORLD, V78, P67, DOI 10.1080/0005772X.1997.11099337; Carvell C, 2011, ECOL APPL, V21, P1760, DOI 10.1890/10-0677.1; DEFRA, 2014, BAS HORT STAT; DEFRA, 2013, ORCH FRUIT SURV; DEFRA, 2014, NAT AV WHOL PRIC SEL; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Garibaldi LA, 2015, J APPL ECOL, V52, P1436, DOI 10.1111/1365-2664.12530; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garratt M.P.D., 2014, Journal of Pollination Ecology, V12, P9; Garratt MPD, 2014, AGR ECOSYST ENVIRON, V184, P34, DOI 10.1016/j.agee.2013.10.032; Gruber B, 2011, APIDOLOGIE, V42, P564, DOI 10.1007/s13592-011-0059-z; Holzschuh A, 2012, BIOL CONSERV, V153, P101, DOI 10.1016/j.biocon.2012.04.032; Hudewenz A, 2013, J AGR SCI FIRSTVIEW, V152, P770, DOI [10.1017/S0021859613000440, DOI 10.1017/80021859613000440]; Kells AR, 2003, BIOL CONSERV, V109, P165, DOI 10.1016/S0006-3207(02)00131-3; Klatt BK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2440; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kron P, 2001, HORTSCIENCE, V36, P1039, DOI 10.21273/HORTSCI.36.6.1039; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Martins KT, 2015, AGR ECOSYST ENVIRON, V200, P12, DOI 10.1016/j.agee.2014.10.018; Matsumoto S, 2009, SCI HORTIC-AMSTERDAM, V121, P73, DOI 10.1016/j.scienta.2009.01.003; MAYER D F, 1991, Journal of the Entomological Society of British Columbia, V88, P15; Melathopoulos AP, 2014, ANN APPL BIOL, V165, P387, DOI 10.1111/aab.12143; Melathopoulos AP, 2015, ECOL ECON, V109, P59, DOI 10.1016/j.ecolecon.2014.11.007; Polce C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076308; Pritchard KD, 2006, J HORTIC SCI BIOTECH, V81, P78, DOI 10.1080/14620316.2006.11512032; Ramirez F, 2013, SCI HORTIC-AMSTERDAM, V162, P188, DOI 10.1016/j.scienta.2013.08.007; Russo L, 2015, ECOL EVOL, V5, P3531, DOI 10.1002/ece3.1582; Schneider D, 2002, J HORTIC SCI BIOTECH, V77, P48, DOI 10.1080/14620316.2002.11511455; Schulp CJE, 2014, ECOL INDIC, V36, P131, DOI 10.1016/j.ecolind.2013.07.014; Sheffield CS, 2008, CAN ENTOMOL, V140, P589, DOI 10.4039/N08-011; Sheffield Cory S., 2014, Journal of Pollination Ecology, V12, P120; Stern RA, 2001, J HORTIC SCI BIOTECH, V76, P17, DOI 10.1080/14620316.2001.11511320; Thomson JD, 2001, J APPL ECOL, V38, P1032, DOI 10.1046/j.1365-2664.2001.00657.x; Vicens N, 2000, ENVIRON ENTOMOL, V29, P235, DOI 10.1603/0046-225X(2000)029[0235:PEOOCA]2.0.CO;2; Watson JC, 2011, ENVIRON ENTOMOL, V40, P621, DOI 10.1603/EN10231; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709	48	65	66	5	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0153889	10.1371/journal.pone.0153889	http://dx.doi.org/10.1371/journal.pone.0153889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152628	Green Accepted, Green Published, gold			2022-12-27	WOS:000375677000006
J	Holden, SE; Jenkins-Jones, S; Currie, CJ				Holden, Sarah E.; Jenkins-Jones, Sara; Currie, Craig J.			Association between Insulin Monotherapy versus Insulin plus Metformin and the Risk of All-Cause Mortality and Other Serious Outcomes: A Retrospective Cohort Study	PLOS ONE			English	Article							CANCER-RISK; CARDIOVASCULAR EVENTS; DIABETIC-PATIENTS; TYPE-2; SULFONYLUREAS; METAANALYSIS; THERAPIES; AGENTS	Aims To determine if concomitant metformin reduced the risk of death, major adverse cardiac events (MACE), and cancer in people with type 2 diabetes treated with insulin. Methods For this retrospective cohort study, people with type 2 diabetes who progressed to insulin with or without metformin from 2000 onwards were identified from the UK Clinical Practice Research Datalink (approximate to 7% sample of the UK population). The risks of all-cause mortality, MACE and incident cancer were evaluated using multivariable Cox models comparing insulin monotherapy with insulin plus metformin. We accounted for insulin dose. Results 12,020 subjects treated with insulin were identified, including 6,484 treated with monotherapy. There were 1,486 deaths, 579 MACE (excluding those with a history of large vessel disease), and 680 cancer events (excluding those in patients with a history of cancer). Corresponding event rates were 41.5 (95% CI 39.4-43.6) deaths, 20.8 (19.2-22.5) MACE, and 21.6 (20.0-23.3) cancer events per 1,000 person-years. The adjusted hazard ratios (aHRs) for people prescribed insulin plus metformin versus insulin monotherapy were 0.60 (95% CI 0.52-0.68) for all-cause mortality, 0.75 (0.62-0.91) for MACE, and 0.96 (0.80-1.15) for cancer. For patients who were propensity-score matched, the corresponding aHRs for all-cause mortality and cancer were 0.62 (0.52-0.75) and 0.99 (0.78-1.26), respectively. For MACE, the aHR was 1.06 (0.75-1.49) prior to 1,275 days and 1.87 (1.22-2.86) after 1,275 days post-index. Conclusions People with type 2 diabetes treated with insulin plus concomitant metformin had a reduced risk of death and MACE compared with people treated with insulin monotherapy. There was no statistically significant difference in the risk of cancer between people treated with insulin as monotherapy or in combination with metformin.	[Holden, Sarah E.; Currie, Craig J.] Cardiff Univ, Sch Med, Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [Holden, Sarah E.; Jenkins-Jones, Sara; Currie, Craig J.] Pharmatelligence, Global Epidemiol, Cardiff, S Glam, Wales	Cardiff University	Currie, CJ (corresponding author), Cardiff Univ, Sch Med, Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales.; Currie, CJ (corresponding author), Pharmatelligence, Global Epidemiol, Cardiff, S Glam, Wales.	currie@cardiff.ac.uk		Jenkins-Jones, Sara/0000-0003-3836-8102	Cardiff University	Cardiff University	S. E. H. received a fully funded PhD studentship from Cardiff University.	Andersson C, 2010, DIABETOLOGIA, V53, P2546, DOI 10.1007/s00125-010-1906-6; Beisswenger PJ, 1999, DIABETES, V48, P198, DOI 10.2337/diabetes.48.1.198; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Currie CJ, 2013, J CLIN ENDOCR METAB, V98, P668, DOI 10.1210/jc.2012-3042; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Gamble JM, 2010, DIABETES OBES METAB, V12, P47, DOI 10.1111/j.1463-1326.2009.01125.x; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Goudswaard A N, 2004, Cochrane Database Syst Rev, pCD003418, DOI 10.1002/14651858.CD003418.pub2; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hemmingsen B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1771; Holden SE, 2015, DIABETES OBES METAB, V17, P350, DOI 10.1111/dom.12412; Holden SE, 2014, DIABETES OBES METAB, V16, P533; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kooy A, 2009, ARCH INTERN MED, V169, P616, DOI 10.1001/archinternmed.2009.20; Morgan CL, 2012, J CLIN ENDOCR METAB, V97, P1; Roumie CL, 2014, JAMA-J AM MED ASSOC, V311, P2288, DOI 10.1001/jama.2014.4312; Roussel R, 2010, ARCH INTERN MED, V170, P1892, DOI 10.1001/archinternmed.2010.409; Soranna D, 2012, ONCOLOGIST, V17, P813, DOI 10.1634/theoncologist.2011-0462; Stevens RJ, 2012, DIABETOLOGIA, V55, P2593, DOI 10.1007/s00125-012-2653-7; Thakkar B, 2013, METABOLISM, V62, P922, DOI 10.1016/j.metabol.2013.01.014; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; Wheeler S, 2013, DIABETOLOGIA, V56, P1934, DOI 10.1007/s00125-013-2958-1	30	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0153594	10.1371/journal.pone.0153594	http://dx.doi.org/10.1371/journal.pone.0153594			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152598	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000375677000004
J	Hou, MM; Zhu, LD; Jin, Q				Hou, Maomao; Zhu, Lvdan; Jin, Qiu			Surface Drainage and Mulching Drip-Irrigated Tomatoes Reduces Soil Salinity and Improves Fruit Yield	PLOS ONE			English	Article							SUBSURFACE DRAINAGE; WATER-POLLUTION; ORGANIC-MATTER; FERTILIZERS; QUALITY; TRENDS; GROWTH; CHINA	A study on the effects of mulched drip irrigation combined with surface drainage on saline soil and tomatoes was conducted in coastal areas of eastern China, where the crops are subjected to excessive salt. The treatments contained three irrigation rates-200, 250 and 300 m(3)/ha-and three drain ditch depths-10, 20 and 30 cm. The contents of soil salinity, organic matter and available nutrient were observed, and the tomato plant height, stem diameter and leaf area index during different growth periods were recorded. Results showed that the total removal rate of salt from soil at a 0-1 m depth was 8.7-13.2% for the three drainages. Compared with the control, the treatments increased the content of available N (by 12.1-47.1%) and available K (by 5.0-21.9%) in the soils inside the mulch and decreased the content of available N (by 3.4-22.1%) and available K (by 7.5-16.4%) in the soils outside the mulch. For tomatoes, the plant height and the stem diameter was increased significantly by the irrigations but was not significantly affected by the drainages, and the leaf area index was increased by 0.39 similar to 1.76, 1.10 similar to 2.90 and 2.80 similar to 6.86 respectively in corresponding to the seedling, flowering and fruit-set stage. Moreover, yield-increase rates of 7.9-27.6% were found for the treatments compared to the control with a similar amount of applied water.	[Hou, Maomao] Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian Province, Peoples R China; [Zhu, Lvdan] Nanchang Inst Engn, Inst Water Conservancy & Ecol Engn, Nanchang, Jiangxi, Peoples R China; [Jin, Qiu] Inst Water Conservancy Sci Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Hou, MM (corresponding author), Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian Province, Peoples R China.	njhoumaomao@126.com			Hohai University [2015002]; Natural Science Foundation of Fujian Province [2016J05069]; Young Talent Project of Horticultural College of Fujian AF University	Hohai University; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Young Talent Project of Horticultural College of Fujian AF University	This study was supported by the Open Fund of Hohai University (2015002) received by Maomao Hou and by the Natural Science Foundation of Fujian Province (2016J05069). Funding for copyediting was provided by Young Talent Project of Horticultural College of Fujian A&F University (received by Maomao Hou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2008, J SUSTAIN AGR, V31, P57, DOI 10.1300/J064v31n04_05; Buyer JS, 2010, SOIL BIOL BIOCHEM, V42, P831, DOI 10.1016/j.soilbio.2010.01.020; Chang TT, 2013, J FOOD AGRIC ENVIRON, V11, P457; Fliessbach A, 2007, AGR ECOSYST ENVIRON, V118, P273, DOI 10.1016/j.agee.2006.05.022; Hanson B, 2004, AGR WATER MANAGE, V68, P1, DOI 10.1016/j.agwat.2004.03.003; Hanson B, 2008, VADOSE ZONE J, V7, P810, DOI 10.2136/vzj2007.0053; Hanson BR, 2009, CALIF AGR, V63, P131, DOI 10.3733/ca.v063n03p131; Hornbuckle J. W., 2005, Irrigation and Drainage Systems, V19, P145, DOI 10.1007/s10795-005-4420-0; Junli T, 2008, T CHINESE SOC AGR EN, V2008; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; [李加林 Li Jialin], 2004, [水土保持通报, Bulletin of Soil and Water Conservation], V24, P71; Liu JY, 2003, SCI CHINA SER D, V46, P373; Liu YS, 2008, J GEOGR SCI, V18, P274, DOI 10.1007/s11442-008-0274-3; Liu Z, 2002, J SOIL WATER CONSERV, V12, P102; Mahajan G, 2006, AGR WATER MANAGE, V84, P202, DOI 10.1016/j.agwat.2006.03.003; Maomao H, 2014, SCI WORLD J, V2014, P11, DOI [10.1155/2014/953675, DOI 10.1155/2014/953675]; Pan X., 2010, J ANHUI AGR SCI, V38, P13754; Pan X, 2010, J ANHUI AGR SCI, V38, P79; Pang HC, 2010, AGR WATER MANAGE, V97, P1971, DOI 10.1016/j.agwat.2009.08.020; Parris K, 2011, INT J WATER RESOUR D, V27, P33, DOI 10.1080/07900627.2010.531898; Raina JN, 2013, INDIAN J AGR SCI, V69, P114; Ritzema HP, 2008, AGR WATER MANAGE, V95, P179, DOI 10.1016/j.agwat.2007.09.012; Scheren PAGM, 2000, J ENVIRON MANAGE, V58, P235, DOI 10.1006/jema.2000.0322; Shao XH, 2012, ENRGY PROCED, V16, P747, DOI 10.1016/j.egypro.2012.01.120; Sims JT, 1998, J ENVIRON QUAL, V27, P277, DOI 10.2134/jeq1998.00472425002700020006x; Tan JL, 2009, AGR SCI CHINA, V8, P1228, DOI 10.1016/S1671-2927(08)60333-8; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Vazquez N, 2006, AGR ECOSYST ENVIRON, V112, P313, DOI 10.1016/j.agee.2005.07.009; Wang HQ, 2007, ECOL MODEL, V201, P429, DOI 10.1016/j.ecolmodel.2006.10.013; [王少丽 Wang Shaoli], 2013, [水利学报, Journal of Hydraulic Engineering], V44, P549; Yadav RL, 2000, FIELD CROP RES, V68, P219, DOI 10.1016/S0378-4290(00)00126-X; [宰松梅 Zai Songmei], 2010, [灌溉排水学报, Journal of Irrigation and Drainage], V29, P72; Zegbe-Dominguez JA, 2003, SCI HORTIC-AMSTERDAM, V98, P505, DOI 10.1016/S0304-4238(03)00036-0; Zhai YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142204; [张恒嘉 ZHANG HengJia], 2008, [灌溉排水学报, Journal of Irrigation and Drainage], V27, P81; [周和平 Zhou Heping], 2013, [水利学报, Journal of Hydraulic Engineering], V44, P1380; 黄生林, 2010, [广东农业科学, Guangdong Agricultural Sciences], V37, P71	37	23	24	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154799	10.1371/journal.pone.0154799	http://dx.doi.org/10.1371/journal.pone.0154799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153110	gold, Green Published			2022-12-27	WOS:000375677000037
J	Kharmate, G; Hosseini-Beheshti, E; Caradec, J; Chin, MY; Guns, EST				Kharmate, Geetanjali; Hosseini-Beheshti, Elham; Caradec, Josselin; Chin, Mei Yieng; Guns, Emma S. Tomlinson			Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes	PLOS ONE			English	Article							HER2 EXPRESSION; SERUM; MICROVESICLES; PROGRESSION; CELLS; OVEREXPRESSION; BIOMARKERS; MICRORNAS; INCREASE; NUMBER	Exosomes proteins and microRNAs have gained much attention as diagnostic tools and biomarker potential in various malignancies including prostate cancer (PCa). However, the role of exosomes and membrane-associated receptors, particularly epidermal growth factor receptor (EGFR) as mediators of cell proliferation and invasion in PCa progression remains unexplored. EGFR is frequently overexpressed and has been associated with aggressive forms of PCa. While PCa cells and tissues express EGFR, it is unknown whether exosomes derived from PCa cells or PCa patient serum contains EGFR. The aim of this study was to detect and characterize EGFR in exosomes derived from PCa cells, LNCaP xenograft and PCa patient serum. Exosomes were isolated from conditioned media of different PCa cell lines; LNCaP xenograft serum as well as patient plasma/serum by differential centrifugation and ultracentrifugation on a sucrose density gradient. Exosomes were confirmed by electron microscopy, expression of exosomal markers and NanoSight (TM) analysis. EGFR expression was determined by western blot analysis and ELISA. This study demonstrates that exosomes may easily be derived from PCa cell lines, serum obtained from PCa xenograft bearing mice and clinical samples derived from PCa patients. Presence of exosomal EGFR in PCa patient exosomes may present a novel approach for measuring of the disease state. Our work will allow to build on this finding for future understanding of PCa exosomes and their potential role in PCa progression and as minimal invasive biomarkers for PCa.	[Kharmate, Geetanjali; Hosseini-Beheshti, Elham; Caradec, Josselin; Guns, Emma S. Tomlinson] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Kharmate, Geetanjali; Caradec, Josselin; Chin, Mei Yieng; Guns, Emma S. Tomlinson] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Hosseini-Beheshti, Elham] Univ British Columbia, Dept Expt Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Kharmate, G (corresponding author), Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada.; Kharmate, G (corresponding author), Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada.	geetuk2@gmail.com			Terry Fox Foundation	Terry Fox Foundation	EG received funding from Terry Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of the Terry Fox Foundation for salary support which enabled completion of the work described.	Adamczyk KA, 2011, LIFE SCI, V89, P304, DOI 10.1016/j.lfs.2011.06.020; Ajit SK, 2012, SENSORS-BASEL, V12, P3359, DOI 10.3390/s120303359; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Arscott W Tristram, 2011, Biomark Med, V5, P821, DOI 10.2217/bmm.11.80; Asgeirsson KS, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1788; Aushev VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078649; Baek KH, 2012, CANCER RES TREAT, V44, P50, DOI 10.4143/crt.2012.44.1.50; Baran J, 2010, CANCER IMMUNOL IMMUN, V59, P841, DOI 10.1007/s00262-009-0808-2; Bijnsdorp IV, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22097; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Caradec J, 2014, CLIN BIOCHEM, V47, P1286, DOI 10.1016/j.clinbiochem.2014.06.011; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Cazzoli R, 2013, J THORAC ONCOL, V8, P1156, DOI 10.1097/JTO.0b013e318299ac32; Ciardiello F, 2000, CLIN CANCER RES, V6, P2053; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Corcoran C, PLOS ONE, V7, DOI [10.1371/journal.pone.0050999, DOI 10.1371/JOURNAL.PONE.0050999PONE-D-12-08982]; Culig Z, 1996, PROSTATE, V28, P392, DOI 10.1002/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO;2-C; Duijvesz D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082589; Festuccia C, 2005, ENDOCR-RELAT CANCER, V12, P983, DOI 10.1677/erc.1.00986; Hammarsten P, 2007, PROSTATE, V67, P573, DOI 10.1002/pros.20529; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hosseini-Beheshti E, 2016, ONCOTARGET, V7, P14639, DOI 10.18632/oncotarget.7052; Hosseini-Beheshti E, 2012, MOL CELL PROTEOMICS, V11, P863, DOI 10.1074/mcp.M111.014845; Huang SH, 2013, CANCER INVEST, V31, P330, DOI 10.3109/07357907.2013.789905; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Khan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046737; Leon CG, 2010, PROSTATE, V70, P390, DOI 10.1002/pros.21072; Leotoing L, 2007, J MOL ENDOCRINOL, V39, P151, DOI 10.1677/JME-07-0021; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Noerholm M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-22; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Perez-Torres M, 2008, EXP CELL RES, V314, P2907, DOI 10.1016/j.yexcr.2008.07.013; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; Sandvig K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012914; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Shah RB, 2006, PROSTATE, V66, P1437, DOI 10.1002/pros.20460; Sirotnak FM, 2002, CLIN CANCER RES, V8, P3870; Sridhar SS, 2010, AM J CLIN ONCOL-CANC, V33, P609, DOI 10.1097/COC.0b013e3181beac33; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Tomasoni S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0266; Turay D, 2016, CANCER INVEST, V34, P1, DOI 10.3109/07357907.2015.1081921; Wadai J, 2010, ANTICANCER RES, V30, P3747; Wilding G, 2006, CANCER-AM CANCER SOC, V106, P1917, DOI 10.1002/cncr.21831; Wilken JA, 2013, BIOCHEMISTRY-US, V52, P4531, DOI 10.1021/bi400437d; Yamashita T, 2013, PHARMAZIE, V68, P969, DOI 10.1691/ph.2013.3599	53	44	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154967	10.1371/journal.pone.0154967	http://dx.doi.org/10.1371/journal.pone.0154967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152724	Green Published, gold, Green Submitted			2022-12-27	WOS:000375677000052
J	Mohanty, I; Edvardsson, M; Abello, A; Eldridge, D				Mohanty, Itismita; Edvardsson, Martin; Abello, Annie; Eldridge, Deanna			Child Social Exclusion Risk and Child Health Outcomes in Australia	PLOS ONE			English	Article							CARE-SENSITIVE CONDITIONS; PREVENTABLE HOSPITALIZATIONS; VISITS; INDEX	Introduction This paper studies the relationship between the risk of child social exclusion, as measured by the Child Social Exclusion (CSE) index and its individual domains, and child health outcomes at the small area level in Australia. The CSE index is Australia's only national small-area index of the risk of child social exclusion. It includes five domains that capture different components of social exclusion: socio-economic background, education, connectedness, housing and health services. Methods The paper used data from the National Centre for Social and Economic Modelling (NATSEM), University of Canberra for the CSE Index and its domains and two key Australian Institute of Health and Welfare (AIHW) data sources for the health outcome measures: the National Hospital Morbidity Database and the National Mortality Database. Results The results show positive associations between rates of both of the negative health outcomes: potentially preventable hospitalisations (PPH) and avoidable deaths, and the overall risk of child social exclusion as well as with the index domains. This analysis at the small-area level can be used to identify and study areas with unexpectedly good or bad health outcomes relative to their estimated risk of child social exclusion. We show that children's health outcomes are worse in remote parts of Australia than what would be expected solely based on the CSE index. Conclusions The results of this study suggest that developing composite indices of the risk of child social exclusion can provide valuable guidance for local interventions and programs aimed at improving children's health outcomes. They also indicate the importance of taking a small-area approach when conducting geographic modelling of disadvantage.	[Mohanty, Itismita; Abello, Annie] Univ Canberra, Natl Ctr Social & Econ Modelling, Canberra, ACT 2601, Australia; [Mohanty, Itismita] Univ Canberra, Ctr Res & Act Publ Hlth, Canberra, ACT 2601, Australia; [Edvardsson, Martin; Eldridge, Deanna] Australian Inst Hlth & Welf, Canberra, ACT, Australia	University of Canberra; University of Canberra	Mohanty, I (corresponding author), Univ Canberra, Natl Ctr Social & Econ Modelling, Canberra, ACT 2601, Australia.; Mohanty, I (corresponding author), Univ Canberra, Ctr Res & Act Publ Hlth, Canberra, ACT 2601, Australia.	itismita.mohanty@canberra.edu.au		MOHANTY, ITISMITA/0000-0002-9013-1068	AIHW; University of Canberra External Collaboration Grants	AIHW; University of Canberra External Collaboration Grants	This research is the result of a collaborative project involving the Australian Institute of Health and Welfare (AIHW) and the National Centre for Social and Economic Modelling (NATSEM), University of Canberra. This project was jointly funded by the AIHW and the University of Canberra External Collaboration Grants 2011.	Abello A, 2012, CHILD INDIC RES, V5, P685, DOI 10.1007/s12187-012-9142-x; Adelman L., 2003, AUSTR SOCIAL POLICY; Agha MM, 2007, AMBUL PEDIATR, V7, P258, DOI 10.1016/j.ambp.2007.02.005; AIHW, 2014, BULLETIN, V121; AIHW, 2011, METEOR MET ONL REG; Ansari Z, 2000, AUSTR J PRIMARY HLTH, V6, P261; Australian Bureau of Statistics (ABS), 2008, INF PAP INTR SOC IND; Barnes H, 2007, THE SOUTH AFRICAN IN; Ben-Arieh A, 2008, CHILD INDIC RES, V1, P3, DOI 10.1007/s12187-007-9003-1; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Bradshaw J, 2009, CHILD INDIC RES, V2, P201, DOI 10.1007/s12187-008-9022-6; Burchardt T, UNDERSTANDING SOCIAL, P30; Butler DC, 2013, SOC SCI MED, V94, P9, DOI 10.1016/j.socscimed.2013.06.029; Casanova C, 1996, INT J QUAL HEALTH C, V8, P51, DOI 10.1093/intqhc/8.1.51; Cunha F, 2009, J EUR ECON ASSOC, V7, P320, DOI 10.1162/JEEA.2009.7.2-3.320; Headey B, 2005, AUST J SOC ISSUES, V40, P541; Headey B, 2005, SUST PROSP 2005 MELB; Katterl R, 2012, PHCRIS POLICY ISSUE; Lloyd, 2004, ENGLISH INDICES DEPR; Marlier E, TACKLING CHILD POVER; McLennan D, 2011, ENGLISH DEPRIVATION; McNamara J, 2009, CHILD INDIC RES, V2, P155, DOI 10.1007/s12187-008-9030-6; Miranti R., 2010, AUSTR J LABOUR EC, V13, P27; Page A., 2006, AUSTR NZ ATLAS AVOID; Page A, 2007, ATLAS AVOIDABLE HOSP; PARCHMAN ML, 1994, J FAM PRACTICE, V39, P123; Parchman ML, 1999, ARCH FAM MED, V8, P487, DOI 10.1001/archfami.8.6.487; Patsios D., 2007, MULTIDIMENSIONAL ANA; Roos LL, 2005, HEALTH SERV RES, V40, P1167, DOI 10.1111/j.1475-6773.2005.00407.x; Salmond C, 2002, NZDEP2001 INDEX DEPR; Steiner JF, 2003, AMBUL PEDIATR, V3, P324, DOI 10.1367/1539-4409(2003)003<0324:PVAHFA>2.0.CO;2; Tanton, 2009, AUSTR J LABOUR EC, V12, P41; Tanton R, 2010, POPUL SPACE PLACE, V16, P135, DOI 10.1002/psp.531; Victorian Government Department of Human Services (Vic DHS), 2002, VICT AMB CAR SENS CO; Vinson T., 2007, DROPPING EDGE DISTRI; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; Zar J. H., 1996, BIOSTATISTICAL ANAL	37	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154536	10.1371/journal.pone.0154536	http://dx.doi.org/10.1371/journal.pone.0154536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KX	27152596	gold, Green Submitted, Green Published			2022-12-27	WOS:000375677000022
J	Sun, Y; Jiang, M; Hou, BL; Lu, C; Lei, YS; Ma, ZL; Gu, XP				Sun, Yu'e; Jiang, Ming; Hou, Bailing; Lu, Cui'e; Lei, Yishan; Ma, Zhengliang; Gu, Xiaoping			Mas-Related Gene (Mrg) C Activation Attenuates Bone Cancer Pain via Modulating Gi and NR2B	PLOS ONE			English	Article							RECEPTOR AGONIST BAM8-22; ROOT GANGLION NEURONS; NEUROPATHIC PAIN; NMDA RECEPTOR; SPINAL-CORD; INTRATHECAL INJECTION; INFLAMMATORY PAIN; MICE; HYPERALGESIA; MORPHINE	Objective This study is to investigate the role of Mas-related gene (Mrg) C in the pathogenesis and treatment of bone cancer pain (BCP). Methods BCP mouse model was established by osteosarcoma cell inoculation. Pain-related behaviors were assessed with the spontaneous lifting behavior test and mechanical allodynia test. Expression levels of MrgC, Gi, and NR2B in the spinal cord were detected with Western blot analysis and immunohistochemistry. Results Pain-related behavior tests showed significantly increased spontaneous flinches (NSF) and decreased paw withdrawal mechanical threshold (PWMT) in mouse models of BCP. Western blot analysis showed that, compared with the control group and before modeling, all the expression levels of MrgC, Gi, and NR2B in the spinal cord of BCP mice were dramatically elevated, which were especially increased at day 7 after operation and thereafter, in a time-dependent manner. Moreover, the treatment of MrgC agonist BAM8-22 significantly up-regulated Gi and down-regulated NR2B expression levels, in the spinal cord of BCP mice, in a time-dependent manner. On the other hand, anti-MrgC significantly down-regulated Gi expression, while dramatically up-regulated NR2B expression, in the BCP mice. Similar results were obtained from the immunohistochemical detection. Importantly, BAM8-22 significantly attenuated the nociceptive behaviors in the BCP mice. Conclusion Our results indicated the MrgC-mediated Gi and NR2B expression alterations in the BCP mice, which might contribute to the pain hypersensitivity. These findings may provide a novel strategy for the treatment of BCP in clinic.	[Sun, Yu'e; Jiang, Ming; Hou, Bailing; Lu, Cui'e; Lei, Yishan; Ma, Zhengliang; Gu, Xiaoping] Nanjing Univ, Dept Anaesthesiol, Affiliated Drum Tower Hosp, Coll Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Ma, ZL; Gu, XP (corresponding author), Nanjing Univ, Dept Anaesthesiol, Affiliated Drum Tower Hosp, Coll Med, Nanjing 210008, Jiangsu, Peoples R China.	mazhengliang1964@nju.edu.cn; xiaopinggu@nju.edu.cn			National Natural Foundation of China [81400914, 81500954, 81371207, 81300950, 81500955]; National Natural Foundation of Jiangsu Province, China [RC2011006, XK201140]; Medical Technology Development Project of Nanjing [YKK13068]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Foundation of Jiangsu Province, China; Medical Technology Development Project of Nanjing	This study was supported by the National Natural Foundation of China (81400914, 81500954, 81371207, 81300950, and 81500955), the National Natural Foundation of Jiangsu Province, China (RC2011006 and XK201140), and the Medical Technology Development Project of Nanjing (YKK13068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi E, 2011, LIFE SCI, V89, P918, DOI 10.1016/j.lfs.2011.09.025; Boland J, 2013, CLIN MED, V13, P149, DOI 10.7861/clinmedicine.13-2-149; Brittain MK, 2012, NEUROPHARMACOLOGY, V63, P974, DOI 10.1016/j.neuropharm.2012.07.012; Cai QY, 2007, BEHAV BRAIN RES, V178, P154, DOI 10.1016/j.bbr.2006.12.014; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen T, 2006, NEUROSCIENCE, V141, P965, DOI 10.1016/j.neuroscience.2006.04.011; Chen TJ, 2008, NEUROPHARMACOLOGY, V54, P796, DOI 10.1016/j.neuropharm.2007.12.010; Colvin L, 2008, EUR J CANCER, V44, P1083, DOI 10.1016/j.ejca.2008.03.001; D'Mello R, 2011, MOL THER, V19, P1780, DOI 10.1038/mt.2011.42; Dina OA, 2009, NEUROSCIENCE, V160, P501, DOI 10.1016/j.neuroscience.2009.03.001; Doucet MV, 2013, NEUROPSYCHOPHARMACOL, V38, P1575, DOI 10.1038/npp.2013.57; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Gu XY, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0105-2; Gu XP, 2010, BRAIN RES, V1335, P83, DOI 10.1016/j.brainres.2010.03.083; Gu XP, 2010, EUR J PAIN, V14, P496, DOI 10.1016/j.ejpain.2009.09.001; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Jiang JP, 2013, BRIT J PHARMACOL, V170, P1027, DOI 10.1111/bph.12326; Lau CG, 2009, BIOCHEM SOC T, V37, P1369, DOI 10.1042/BST0371369; Liu Y, 2014, ANESTH ANALG, V118, P1345, DOI 10.1213/ANE.0000000000000202; Malin SA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-21; Mercadante S, 2007, CURR OPIN ONCOL, V19, P308, DOI 10.1097/CCO.0b013e3281214400; Pan HL, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-85; Qu XX, 2009, EXP NEUROL, V215, P298, DOI 10.1016/j.expneurol.2008.10.018; Ren BX, 2012, ANESTHESIOLOGY, V116, P122, DOI 10.1097/ALN.0b013e31823de68d; Schwei MJ, 1999, J NEUROSCI, V19, P10886, DOI 10.1523/JNEUROSCI.19-24-10886.1999; Stan TL, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.39; Wang DM, 2015, J PHARMACOL EXP THER, V354, P431, DOI 10.1124/jpet.115.225672; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	29	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154851	10.1371/journal.pone.0154851	http://dx.doi.org/10.1371/journal.pone.0154851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152740	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000042
J	Colombini, A; Brayda-Bruno, M; Lombardi, G; Croiset, SJ; Ceriani, C; Buligan, C; Barbina, M; Banfi, G; Cauci, S				Colombini, Alessandra; Brayda-Bruno, Marco; Lombardi, Giovanni; Croiset, Samantha Jennifer; Ceriani, Cristina; Buligan, Cinzia; Barbina, Mattia; Banfi, Giuseppe; Cauci, Sabina			BsmI, ApaI and TaqI Polymorphisms in the Vitamin D Receptor Gene (VDR) and Association with Lumbar Spine Pathologies: An Italian Case-Control Study	PLOS ONE			English	Article							DEGENERATIVE DISC DISEASE; RISK-FACTORS; MATRIX METALLOPROTEINASE-3; ESTROGEN-RECEPTOR; POSTMENOPAUSAL; OSTEOARTHRITIS; WOMEN; SUSCEPTIBILITY; ALLELE; IX	Three adjacent single nucleotide polymorphisms of the vitamin D receptor gene (VDR) BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236) are commonly studied in several pathologies. We aimed to evaluate the distribution of VDR BsmI, ApaI, and TaqI allele, genotype, and haplotype frequencies in an Italian cohort of 266 patients with lumbar spine disorders assessed by Magnetic Resonance Imaging and 252 asymptomatic controls. The exposure to putative risk factors was evaluated by a questionnaire. Polymorphisms were detected by PCR-RFLP and TaqMan (R) SNP Genotyping Assay. The results were statistically adjusted for the identified conventional risk factors. The three SNPs were in linkage disequilibrium. For all cases BbAaTT was a 3-fold risk factor OR = 3.38), whereas bbAATT (OR = 0.22), and bbaaTT (OR = 0.47) genotypes were found to be protective. Specifically, for patients affected by disc herniation only (n = 88) and all lumbar pathologies excluding stenosis and/or spondylolistesis (n = 215) B allele, Bb, Aa, and BbAaTT genotypes were risky, whereas b allele, bb, aa, and bbaaTT genotypes were protective. In patients affected by osteochondrosis with or without disc hernation (n = 50), T allele, Aa, and bbAaTT genotypes were risky, whereas t allele, AA, tt genotypes were protective. In patients affected by stenosis and/or spondylolistesis (n = 51) no significant associations were found. This is the first study showing an association of the three genetic VDR variants BsmI, ApaI, and TaqI and lumbar spine pathologies. Our study contributes to delineate genetic risk factors for specific subgroups of patients with lumbar spine pathologies highlighting the importance of haplotype analysis, and of detailed clinical evaluation of the patients for identification of genetic biomarkers.	[Colombini, Alessandra; Lombardi, Giovanni; Croiset, Samantha Jennifer; Ceriani, Cristina; Banfi, Giuseppe] IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Milan, Italy; [Brayda-Bruno, Marco] IRCCS Ist Ortoped Galeazzi, Dept Orthoped & Traumatol Spine Surg 3, Scoliosis Unit, Milan, Italy; [Buligan, Cinzia; Barbina, Mattia; Cauci, Sabina] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Banfi, Giuseppe] Univ Vita Salute San Raffaele, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; University of Udine; Vita-Salute San Raffaele University	Colombini, A (corresponding author), IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Milan, Italy.	alessandra.colombini@grupposandonato.it	Brayda-Bruno, Marco/B-8639-2017; Lombardi, Giovanni/I-2414-2012; Ceriani, Cristina/AHD-9870-2022; Banfi, Giuseppe/K-6585-2015; Colombini, Alessandra/I-2441-2012	Brayda-Bruno, Marco/0000-0002-8608-0114; Lombardi, Giovanni/0000-0002-8365-985X; Banfi, Giuseppe/0000-0001-9578-5338; Colombini, Alessandra/0000-0002-1800-3424; Cauci, Sabina/0000-0001-7443-1899	European Community's Seventh 567 Framework Programme (FP7) [568, HEALTH-F2-2008-201626]; Italian Ministry of Health	European Community's Seventh 567 Framework Programme (FP7); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by European Community's Seventh 567 Framework Programme (FP7, 2007-2013 under Grant Agreement 568 No. HEALTH-F2-2008-201626) and by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cheung KMC, 2006, SPINE, V31, P1143, DOI 10.1097/01.brs.0000216530.41838.d3; Colombini A, 2008, INT J BIOCHEM CELL B, V40, P837, DOI 10.1016/j.biocel.2007.12.011; Colombini A, 2015, INT J MOL SCI, V16, P3722, DOI 10.3390/ijms16023722; Colombini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097027; Colombini A, 2013, J STEROID BIOCHEM, V138, P24, DOI 10.1016/j.jsbmb.2013.03.001; Colombini A, 2012, INT J BIOCHEM CELL B, V44, P1019, DOI 10.1016/j.biocel.2012.03.012; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; Eser B, 2010, GENET TEST MOL BIOMA, V14, P313, DOI 10.1089/gtmb.2009.0202; Fang Y, 2005, AM J HUM GENET, V77, P807, DOI 10.1086/497438; Gennari L, 1998, J CLIN ENDOCR METAB, V83, P939, DOI 10.1210/jc.83.3.939; HapMap, 2016, HAPMAP SNP REPORT FO; HART DJ, 1995, J RHEUMATOL, V22, P1118; Horst-Sikorska W, 2013, MOL BIOL REP, V40, P383, DOI 10.1007/s11033-012-2072-3; Jones G, 1998, ANN RHEUM DIS, V57, P94, DOI 10.1136/ard.57.2.94; Jordan KM, 2005, J RHEUMATOL, V32, P678; Karppinen J, 2008, SPINE, V33, P1236, DOI 10.1097/BRS.0b013e318170fd0e; Kawaguchi Y, 2002, J BONE JOINT SURG AM, V84A, P2022, DOI 10.2106/00004623-200211000-00018; Koshizuka Y, 2006, EUR SPINE J, V15, P1521, DOI 10.1007/s00586-005-0005-8; Langdahl BL, 2000, EUR J CLIN INVEST, V30, P608; Leone A, 2008, IMAGING RACHIDE VECC, P27; Li YC, 2015, J GENET GENOMICS, V42, P135, DOI 10.1016/j.jgg.2015.03.006; Mayer JE, 2013, SPINE J, V13, P299, DOI 10.1016/j.spinee.2013.01.041; Nakki A, 2014, EUR SPINE J, V23, pS354, DOI 10.1007/s00586-013-2878-2; Noponen-Hietala N, 2003, ANN RHEUM DIS, V62, P1208, DOI 10.1136/ard.2003.008334; Oishi Y, 2003, BONE, V32, P405, DOI 10.1016/S8756-3282(03)00031-0; Omair Ahmad, 2012, Open Orthop J, V6, P164, DOI 10.2174/1874325001206010164; Pani MA, 2000, DIABETES, V49, P504, DOI 10.2337/diabetes.49.3.504; Rajasekaran S, 2013, SPINE J, V13, P1309, DOI 10.1016/j.spinee.2013.05.019; Sansoni V, 2016, EUR SPINE J, V25, P192, DOI 10.1007/s00586-015-4176-7; Thakkinstian A, 2004, OSTEOPOROSIS INT, V15, P729, DOI 10.1007/s00198-004-1601-x; Toktas ZO, 2015, EUR SPINE J, V24, P2432, DOI 10.1007/s00586-015-4206-5; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Uitterlinden AG, 2001, J BONE MINER RES, V16, P379, DOI 10.1359/jbmr.2001.16.2.379; Vandevyver C, 1997, J BONE MINER RES, V12, P241, DOI 10.1359/jbmr.1997.12.2.241; Videman T, 2001, Spine (Phila Pa 1976), V26, pE7; Videman T, 1998, SPINE, V23, P2477, DOI 10.1097/00007632-199812010-00002; Virtanen IM, 2007, SPINE, V32, P1129, DOI 10.1097/01.brs.0000261473.03274.5c; Xu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050243; Yuan HY, 2010, J OCCUP HEALTH, V52, P23, DOI 10.1539/joh.L8149; Zajickova K, 2003, J BONE MINER RES, V18, P1754, DOI 10.1359/jbmr.2003.18.10.1754; Zawilla NH, 2014, J OCCUP REHABIL, V24, P370, DOI 10.1007/s10926-013-9472-7; Zhu ZH, 2014, RHEUMATOLOGY, V53, P998, DOI 10.1093/rheumatology/ket418; Zintzaras E, 2006, DIS MARKERS, V22, P317, DOI 10.1155/2006/921694	44	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155004	10.1371/journal.pone.0155004	http://dx.doi.org/10.1371/journal.pone.0155004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149110	Green Submitted, Green Published, gold			2022-12-27	WOS:000375676800106
J	Li, WL; Schaeffer, RD; Otwinowski, Z; Grishin, NV				Li, Wenlin; Schaeffer, R. Dustin; Otwinowski, Zbyszek; Grishin, Nick V.			Estimation of Uncertainties in the Global Distance Test (GDT_TS) for CASP Models	PLOS ONE			English	Article							X-RAY; PREDICTIONS; PROTEINS; DYNAMICS	The Critical Assessment of techniques for protein Structure Prediction (or CASP) is a community-wide blind test experiment to reveal the best accomplishments of structure modeling. Assessors have been using the Global Distance Test (GDT_TS) measure to quantify prediction performance since CASP3 in 1998. However, identifying significant score differences between close models is difficult because of the lack of uncertainty estimations for this measure. Here, we utilized the atomic fluctuations caused by structure flexibility to estimate the uncertainty of GDT_TS scores. Structures determined by nuclear magnetic resonance are deposited as ensembles of alternative conformers that reflect the structural flexibility, whereas standard X-ray refinement produces the static structure averaged over time and space for the dynamic ensembles. To recapitulate the structural heterogeneous ensemble in the crystal lattice, we performed time-averaged refinement for X-ray datasets to generate structural ensembles for our GDT_TS uncertainty analysis. Using those generated ensembles, our study demonstrates that the time-averaged refinements produced structure ensembles with better agreement with the experimental datasets than the averaged X-ray structures with B-factors. The uncertainty of the GDT_TS scores, quantified by their standard deviations (SDs), increases for scores lower than 50 and 70, with maximum SDs of 0.3 and 1.23 for X-ray and NMR structures, respectively. We also applied our procedure to the high accuracy version of GDT-based score and produced similar results with slightly higher SDs. To facilitate score comparisons by the community, we developed a user-friendly web server that produces structure ensembles for NMR and X-ray structures and is accessible at http://prodata.swmed.edu/SEnCS. Our work helps to identify the significance of GDT_TS score differences, as well as to provide structure ensembles for estimating SDs of any scores.	[Schaeffer, R. Dustin; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Li, Wenlin; Otwinowski, Zbyszek; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Li, Wenlin; Otwinowski, Zbyszek; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Grishin, NV (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.; Grishin, NV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Grishin, NV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	grishin@chop.swmed.edu	Schaeffer, Richard/ABA-2649-2021	Otwinowski, Zbyszek/0000-0003-3640-8545; Schaeffer, R. Dustin/0000-0001-6502-1425	National Institutes of Health [GM094575]; Welch Foundation [I-1505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117080, R01GM053163, R01GM094575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health (GM094575 to NVG) and the Welch Foundation (I-1505 to NVG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Andriy Kryshtafovych and Dr. Bohdan Monastyrskyy from prediction center in UC Davis for GDT_TS score computation and helpful discussion. We also thank BioHPC clusters for computation resources. This work was supported in part by the National Institutes of Health (GM094575 to NVG) and the Welch Foundation (I-1505 to NVG).	Berendsen HJC, 2000, CURR OPIN STRUC BIOL, V10, P165, DOI 10.1016/S0959-440X(00)00061-0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernado P, 2010, NATURE, V468, P1046, DOI 10.1038/4681046a; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; Haas Juergen, 2013, Database (Oxford), V2013, pbat031, DOI 10.1093/database/bat031; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Huang YJP, 2014, PROTEINS, V82, P43, DOI 10.1002/prot.24488; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181; Kinch LN, 2016, PROTEINS, V84, P20, DOI 10.1002/prot.24982; Kinch LN, 2016, PROTEINS, V84, P164, DOI 10.1002/prot.25020; Kohn JE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000911; Kryshtafovych A, 2014, PROTEINS, V82, P112, DOI 10.1002/prot.24347; Kuzmanic A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4220; Mariani V, 2013, BIOINFORMATICS, V29, P2722, DOI 10.1093/bioinformatics/btt473; Moult J, 2003, PROTEINS, V53, P334, DOI 10.1002/prot.10556; Nabuurs SB, 2006, PLOS COMPUT BIOL, V2, P71, DOI 10.1371/journal.pcbi.0020009; Osawa M, 2012, CURR OPIN STRUC BIOL, V22, P660, DOI 10.1016/j.sbi.2012.08.007; Read RJ, 2007, PROTEINS, V69, P27, DOI 10.1002/prot.21662; WALLACE BA, 1995, PROTEIN SCI, V4, P75; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zemla A, 1999, PROTEINS, P22	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154786	10.1371/journal.pone.0154786	http://dx.doi.org/10.1371/journal.pone.0154786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149620	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800060
J	Moise, IK; Mulhall, PF				Moise, Imelda K.; Mulhall, Peter F.			Providers' Perspectives on Case Management of a Healthy Start Program: A Qualitative Study	PLOS ONE			English	Article							CARE COORDINATION; CAPACITY; CHILDREN; IMPLEMENTATION; PREVENTION; OUTCOMES; YOUTH	Although Healthy Start case managers recognized the benefits of case management for facilitating optimal service delivery to women and their families, structural factors impact effective implementation. This study investigated case managers' views of 1) the structural challenges faced in implementing case management for program participants, and 2) possible strategies to enhance case management in medical home settings. Two focus groups were conducted separately with case managers from the four program service sites to gain insight into these issues noted above. Each group was co-facilitated by two evaluators using a previously developed semi-structured interview guide. The group discussions were audio recorded and the case managers' comments were transcribed verbatim. Transcripts were analyzed using thematic analysis, a deductive approach. Data were collected in 2013 and analyzed in 2015. Case managers are challenged by externalities (demographic shifts in target populations, poverty); contractual requirements (predefined catchment neighborhoods, caseload); limited support (client incentives, tailored training, and a high staff turnover rate); and logistic difficulties (organizational issues). Their approach to case management tends to be focused on linking Although Healthy Start case managers recognized the benefits of case management for facilitating optimal service delivery to women and their families, structural factors impact effective implementation. This study investigated case managers' views of 1) the structural challenges faced in implementing case management for program participants, and 2) possible strategies to enhance case management in medical home settings. Two focus groups were conducted separately with case managers from the four program service sites to gain insight into these issues noted above. Each group was co-facilitated by two evaluators using a previously developed semi-structured interview guide. The group discussions were audio recorded and the case managers' comments were transcribed verbatim. Transcripts were analyzed using thematic analysis, a deductive approach. Data were collected in 2013 and analyzed in 2015. Case managers are challenged by externalities (demographic shifts in target populations, poverty); contractual requirements (predefined catchment neighborhoods, caseload); limited support (client incentives, tailored training, and a high staff turnover rate); and logistic difficulties (organizational issues). Their approach to case management tends to be focused on linking clients to adequate services rather than reporting performance. Case managers favored measurable deliverables rather than operational work products. A proposed solution to current challenges emphasizes and encourages the iterative learning process and shared decision making between program targets, funders and providers. Case managers are aware of the challenging environment in which they operate for their clients and for themselves. However, future interventions will require clearly identified performance measures and increased systems support.	[Moise, Imelda K.] Univ Miami, Dept Geog, Coral Gables, FL 33124 USA; [Mulhall, Peter F.] Univ Illinois, Ctr Prevent Res & Dev, Sch Social Work, Champaign, IL USA	University of Miami; University of Illinois System; University of Illinois Urbana-Champaign	Moise, IK (corresponding author), Univ Miami, Dept Geog, Coral Gables, FL 33124 USA.	moise@miami.edu	Moise, Imelda K/AAL-7226-2020	Moise, Imelda K/0000-0003-0222-780X	Illinois Department of Human and Family Services	Illinois Department of Human and Family Services	The authors wish to acknowledge the Illinois Department of Human and Family Services for funding this evaluation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli RC, 2008, PEDIATRICS, V122, pE209, DOI 10.1542/peds.2007-2254; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Betancur J, 2011, URBAN STUD, V48, P383, DOI 10.1177/0042098009360680; Brand A, 2010, MATERN CHILD HLTH J, V14, P654, DOI 10.1007/s10995-008-0421-6; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cooley WC, 2009, PEDIATRICS, V124, P358, DOI 10.1542/peds.2008-2600; Dias A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002333; Dickinson A, 2011, AGE AGEING, V40, P724, DOI 10.1093/ageing/afr111; Duggan A, 2000, PEDIATRICS, V105, P250; Goldenberg RL, 2007, AM J CLIN NUTR, V85, p584S, DOI 10.1093/ajcn/85.2.584S; Hamid S, 2006, INT FAM PLAN PERSPEC, V32, P71, DOI 10.1363/3207106; Hanks Carole A, 2006, Policy Polit Nurs Pract, V7, P297, DOI 10.1177/1527154406297427; Hanusaik N, 2010, EUR J PUBLIC HEALTH, V20, P195, DOI 10.1093/eurpub/ckp140; Health Resources and Services Admnistration, 2013, HLTH START IN EL DIS; Johnson Kay, 2012, Issue Brief (Commonw Fund), V21, P1; Keene DE, 2010, HUM ORGAN, V69, P275, DOI 10.17730/humo.69.3.gr851617m015064m; Knai C, 2014, INT J CARE COORD, V17, P83, DOI 10.1177/2053434514556686; Knodel J, 1993, SUCCESSFUL FOCUS GRO, P35, DOI DOI 10.4135/9781483349008; Kotch J., 2013, MATERNAL CHILD HLTH, V3rd; Labonte R, 2002, CAN J PUBLIC HEALTH, V93, P181, DOI 10.1007/BF03404996; LaFond AK, 2002, INT J HEALTH PLAN M, V17, P3, DOI 10.1002/hpm.649; Landy A, 2008, ENV STRATEGY IMPLEME; Mathematica PRI., 2001, CAS MAN HEART HLTH S; Matthews T J, 2015, Natl Vital Stat Rep, V64, P1; Moise IK, 2014, SUBST USE MISUSE, V49, P804, DOI 10.3109/10826084.2014.880484; Palfrey JS, 2004, PEDIATRICS, V113, P1507; PLOUGH A, 1994, HEALTH EDUC QUART, V21, P221, DOI 10.1177/109019819402100207; Rosal MC, 2004, AM J PREV MED, V27, P54, DOI 10.1016/j.amepre.2004.04.020; Safran DG, 1998, J FAM PRACTICE, V47, P213; Schoenmakers Birgitte, 2010, Int J Family Med, V2010, P184152, DOI 10.1155/2010/184152; Stange KC, 2002, INT J QUAL HEALTH C, V14, P267, DOI 10.1093/intqhc/14.4.267; Turchi R, 2014, PEDIATRICS, V133, pE1451, DOI 10.1542/peds.2014-0318; Turchi Renee M, 2009, Pediatrics, V124 Suppl 4, pS428, DOI 10.1542/peds.2009-1255O; U.S. Department of Health and Human Services, 2014, HLTH START IN EL DIS; Vanderplasschen W, 2004, PSYCHIAT SERV, V55, P913, DOI 10.1176/appi.ps.55.8.913; White Pamela, 2006, J Med Libr Assoc, V94, pE99; Zapka J, 1999, HEALTH EDUC BEHAV, V26, P714, DOI 10.1177/109019819902600511	37	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154668	10.1371/journal.pone.0154668	http://dx.doi.org/10.1371/journal.pone.0154668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27149061	Green Submitted, gold, Green Published			2022-12-27	WOS:000375676800045
J	Brusse, IA; Duvekot, JJ; Meester, I; Jansen, G; Rizopoulos, D; Steegers, EAP; Visser, GH				Brusse, Ingrid A.; Duvekot, Johannes J.; Meester, Ivette; Jansen, Gerard; Rizopoulos, Dimitris; Steegers, Eric A. P.; Visser, Gerhard H.			Electroencephalography in Normotensive and Hypertensive Pregnancies and Subsequent Quality of Life	PLOS ONE			English	Article							EEG; PREECLAMPSIA; WOMEN	Objectives To compare electroencephalography (EEG) findings during pregnancy and postpartum in women with normotensive pregnancies and pregnancies complicated by hypertensive disorders. Also the health related quality of life postpartum was related to these EEG findings. Materials and Methods An observational case-control study in a university hospital in the Netherlands. Twenty-nine normotensive and 58 hypertensive pregnant women were included. EEG's were recorded on several occasions during pregnancy and 6-8 weeks postpartum. Postpartum, the women filled out health related quality of life questionnaires. Main outcome measures were qualitative and quantitative assessments on EEG, multidimensional fatigue inventory, Short Form (36) Health Survey and EuroQoL visual analogue scale. Results In women with severe preeclampsia significantly lower alpha peak frequency, more delta and theta activity bilaterally and a higher EEG Sum Score were seen. Postpartum, these women showed impaired mental health, mental fatigue and social functioning, which could not be related to the EEG findings. Conclusions Severe preeclamptic patients show more EEG abnormalities and have impaired mental wellbeing postpartum, but these findings are not correlated.	[Brusse, Ingrid A.; Duvekot, Johannes J.; Meester, Ivette; Steegers, Eric A. P.] Univ Med Ctr, Erasmus MC, Div Obstet & Prenatal Med, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Jansen, Gerard] Univ Med Ctr, Erasmus MC, Dept Haematol, Rotterdam, Netherlands; [Rizopoulos, Dimitris] Univ Med Ctr, Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [Visser, Gerhard H.] Univ Med Ctr, Erasmus MC, Dept Clin Neurophysiol, Rotterdam, Netherlands; [Visser, Gerhard H.] SEIN Epilepsy Inst Netherlands, Heemstede, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Brusse, IA (corresponding author), Univ Med Ctr, Erasmus MC, Div Obstet & Prenatal Med, Dept Obstet & Gynaecol, Rotterdam, Netherlands.	i.brusse@erasmusmc.nl			Stichting Nuts-Ohra	Stichting Nuts-Ohra	Stichting Nuts-Ohra funded the EEG laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, J Clin Neurophysiol, V11, P111; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Aukes AM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.044; Beniczky S, 2013, EPILEPSIA, V54, P1112, DOI 10.1111/epi.12135; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Brusse I, 2008, ACTA OBSTET GYN SCAN, V87, P408, DOI 10.1080/00016340801915127; Brusse IA, 2010, OBSTET GYNECOL SURV, V65, P794, DOI 10.1097/OGX.0b013e31821286f1; Cignacco E, 1998, Praxis (Bern 1994), V87, P1019; Claus JJ, 1999, CLIN NEUROPHYSIOL, V110, P825, DOI 10.1016/S1388-2457(98)00076-5; EEGOLOFSSON O, 1971, NEUROPADIATRIE, V3, P11, DOI 10.1055/s-0028-1091798; Gaugler-Senden IPM, 2012, J MATERN-FETAL NEO M, V25, P272, DOI 10.3109/14767058.2011.573829; Hoedjes M, 2011, BIRTH-ISS PERINAT C, V38, P246, DOI 10.1111/j.1523-536X.2011.00477.x; Jansen AJG, 2007, J PSYCHOSOM RES, V63, P275, DOI 10.1016/j.jpsychores.2007.06.003; Jansen AJG, 2007, ACTA OBSTET GYN SCAN, V86, P579, DOI 10.1080/00016340701275424; Jonkman E.J., 1989, ELECTROEN CLIN NEURO, V72, P44; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Meyer EC, 1995, J DEV BEHAV PEDIATR, V16, P412; Perrins J, 1998, Intensive Crit Care Nurs, V14, P108, DOI 10.1016/S0964-3397(98)80351-0; POIDEVIN LOS, 1955, J OBSTET GYNAECOL, V62, P417; Prick BW, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-83; Roes EM, 2005, J MATERN-FETAL NEO M, V18, P39, DOI 10.1080/14767050500127740; ROYBURT M, 1991, Obstetrical and Gynecological Survey, V46, P656, DOI 10.1097/00006254-199110000-00002; SIBAI BM, 1984, OBSTET GYNECOL, V64, P261; Statistics Netherlands, 2003, STAND CLASS ED; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tatum WO, 2006, J CLIN NEUROPHYSIOL, V23, P194, DOI 10.1097/01.wnp.0000220110.92126.a6; van Luijtelaar G, 2010, J NEUROPSYCH CLIN N, V22, P208, DOI 10.1176/appi.neuropsych.22.2.208; WEINSTEIN L, 1985, OBSTET GYNECOL, V66, P657; Zeeman GG, 2009, SEMIN PERINATOL, V33, P166, DOI 10.1053/j.semperi.2009.02.003	30	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155299	10.1371/journal.pone.0155299	http://dx.doi.org/10.1371/journal.pone.0155299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167513	Green Published, gold			2022-12-27	WOS:000376587300032
J	Essler, JL; Cafazzo, S; Marshall-Pescini, S; Viranyi, Z; Kotrschal, K; Range, F				Essler, Jennifer L.; Cafazzo, Simona; Marshall-Pescini, Sarah; Viranyi, Zsofia; Kotrschal, Kurt; Range, Friederike			Play Behavior in Wolves: Using the '50:50' Rule to Test for Egalitarian Play Styles	PLOS ONE			English	Article							RANGING DOMESTIC DOGS; SOCIAL PLAY; CANIS-FAMILIARIS; CAPUCHIN MONKEYS; COOPERATION; COMPETITION; LUPUS; DOMINANCE; INEQUITY; FAIRNESS	Social play is known as a cooperative interaction between individuals involving multiple mechanisms. However, the extent to which the equality of individuals' play styles affects the interaction has not been studied in many species. Dyadic play between wolf puppies, as well as between puppies and adults, was studied to investigate both self-handicapping and offensive behaviors to determine the extent to which wolves engage in play styles where one individual does not dominate the play. Our results did not support the hypothesized '50:50' rule, which suggests that more advantaged individuals should show higher rates of self-handicapping behaviors in order to facilitate play with others. Adult wolves performed significantly less self-handicapping behaviors than their puppy partners, and they performed significantly more offensive behaviors than their puppy partners. While the '50: 50' rule was not supported at any time during our study period, dyads consisting of two puppies had significantly more equal play than dyads consisting of one puppy and one adult. These results suggest that wolf puppies are more likely to play on equal terms with similarly-aged play partners, while the dominance status of the partners dictates offensive and self-handicapping behaviors between animals of different ages.	[Essler, Jennifer L.; Cafazzo, Simona; Marshall-Pescini, Sarah; Viranyi, Zsofia; Kotrschal, Kurt; Range, Friederike] Wolf Sci Ctr, Ernstbrunn, Austria; [Essler, Jennifer L.; Marshall-Pescini, Sarah; Viranyi, Zsofia; Range, Friederike] Univ Vet Med Vienna, Messerli Res Inst, Comparat Cognit, Vienna, Austria; [Essler, Jennifer L.; Marshall-Pescini, Sarah; Viranyi, Zsofia; Range, Friederike] Med Univ Vienna, Vienna, Austria; [Essler, Jennifer L.; Marshall-Pescini, Sarah; Viranyi, Zsofia; Range, Friederike] Univ Vienna, Vienna, Austria; [Kotrschal, Kurt] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Veterinary Medicine Vienna; Medical University of Vienna; University of Vienna; University of Vienna	Essler, JL (corresponding author), Wolf Sci Ctr, Ernstbrunn, Austria.; Essler, JL (corresponding author), Univ Vet Med Vienna, Messerli Res Inst, Comparat Cognit, Vienna, Austria.; Essler, JL (corresponding author), Med Univ Vienna, Vienna, Austria.; Essler, JL (corresponding author), Univ Vienna, Vienna, Austria.	jennifer.essler@vetmeduni.ac.at		Range, Friederike/0000-0003-3127-5536; Marshall-Pescini, Sarah/0000-0002-5944-4701	European Research Council under the European Union's Seventh Framework Program by ERC Grant [311870]; Wiener Wissenschafts-, Forschungs- und Technologiefonds [CS11-026, BM1400-B19]; Austrian Science Fund [P21244-B17]; Royal Canin	European Research Council under the European Union's Seventh Framework Program by ERC Grant; Wiener Wissenschafts-, Forschungs- und Technologiefonds; Austrian Science Fund(Austrian Science Fund (FWF)); Royal Canin	JLE, SMP and FR were supported by funding from the European Research Council under the European Union's Seventh Framework Program (https://ec.europa.eu/research/fp7/index_en.cfm) by ERC Grant Agreement n. [311870]. ZV was supported by the Wiener Wissenschafts-, Forschungs- und Technologiefonds (http://www.wwtf.at/) project CS11-026. SC was supported by the Wiener Wissenschafts-, Forschungs- und Technologiefonds (http://www.wwtf.at/) project BM1400-B19. The project was further funded by funding from the Austrian Science Fund (https://www.fwf.ac.at/en/) project P21244-B17. The authors further thank many private sponsors including Royal Canin for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Wolf Science Center was established by Zsofia Viranyi, Kurt Kotrschal, and Friederike Range and we thank all the helpers who made this possible hence indirectly supporting this research. We thank Stefanie Heufelder, Anais Racca and Balint Pataky who recorded the videos, Theresa Schmidjell for coding videos, Marianne Heberlein for the statistical support, Jeremy Cain for visual art support, and many students and volunteers for their devotion and assistance with raising the animals. We thank two anonymous reviewers and the editor for comments on an earlier draft of the manuscript. We further thank many private sponsors including Royal Canin for financial support and the Game Park Ernstbrunn for hosting the Wolf Science Center.	Aldis O., 1975, PLAY FIGHTING; Bauer EB, 2007, ANIM BEHAV, V73, P489, DOI 10.1016/j.anbehav.2006.09.006; BEKOFF M, 1977, AM NAT, V111, P715, DOI 10.1086/283201; BEKOFF M, 1995, BEHAVIOUR, V132, P419, DOI 10.1163/156853995X00649; Bekoff M, 2004, ORIGINS AND NATURE OF SOCIALITY, P53; BEKOFF M, 1974, BIOSCIENCE, V24, P225, DOI 10.2307/1296803; Bekoff M, 2001, J CONSCIOUSNESS STUD, V8, P81; Bekoff M, 1998, ANIMAL PLAY, P97, DOI [10.1017/CBO9780511608575.006, DOI 10.1017/CBO9780511608575.006]; Bernal JF, 1997, ZOO BIOL, V16, P435, DOI 10.1002/(SICI)1098-2361(1997)16:5<435::AID-ZOO6>3.3.CO;2-W; Biben M., 1998, ANIMAL PLAY EVOLUTIO, P161, DOI DOI 10.1017/CBO9780511608575.009; Brosnan SF, 2006, AM J PRIMATOL, V68, P713, DOI 10.1002/ajp.20261; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; Chen M. K., 2006, SOC JUSTICE RES, V19, P201, DOI DOI 10.1007/S11211-006-0004-X; Cordoni G, 2009, BEHAVIOUR, V146, P1363, DOI 10.1163/156853909X427722; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Dubreuil D, 2006, P ROY SOC B-BIOL SCI, V273, P1223, DOI 10.1098/rspb.2005.3433; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Heufelder S, 2010, SOCIAL PLAY CAPTIVE; Lord K, 2013, BEHAV PROCESS, V92, P131, DOI 10.1016/j.beproc.2012.10.009; MacNulty DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112884; Manor R, 2004, BIOL CONSERV, V119, P231, DOI 10.1016/j.biocon.2003.11.005; McLeod PJ, 1997, BEHAV PROCESS, V39, P127, DOI 10.1016/S0376-6357(96)00056-3; Mech D., 2003, WOLVES BEHAV ECOLOGY; Mech L.D., 1970, WOLF ECOLOGY BEHAV; Miller M.N., 1998, ANIMAL PLAY EVOLUTIO, P141; Norman K, 2015, BEHAV PROCESS, V110, P88, DOI 10.1016/j.beproc.2014.09.001; Palagi E, 2008, ANIM BEHAV, V75, P887, DOI 10.1016/j.anbehav.2007.07.016; Palagi E, 2016, BIOL REV, V91, P311, DOI 10.1111/brv.12172; PANKSEPP J, 1981, DEV PSYCHOBIOL, V14, P327, DOI 10.1002/dev.420140405; Pellis SM, 2016, BEHAVIOUR; Pereira ME, 1998, FOLIA PRIMATOL, V69, P177; Price SA, 2012, SOC JUSTICE RES, V25, P140, DOI 10.1007/s11211-012-0153-z; Range F, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01582; Range F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00868; Range F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086559; Range F, 2012, SOC JUSTICE RES, V25, P170, DOI 10.1007/s11211-012-0155-x; Schmidt PA, 1997, AM NAT, V150, P513, DOI 10.1086/286079; Thompson K. V., 1998, ANIMAL PLAY EVOLUTIO, P1143; van Hoof J.A.R.A.M., 1987, Perspectives in Vertebrate Science, V4, P219; van Leeuwen EJC, 2011, BIOL LETTERS, V7, P39, DOI 10.1098/rsbl.2010.0482; Ward C, 2008, ANIM BEHAV, V76, P1187, DOI 10.1016/j.anbehav.2008.06.004; Watson DM, 1996, ETHOLOGY, V102, P336	45	15	15	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154150	10.1371/journal.pone.0154150	http://dx.doi.org/10.1371/journal.pone.0154150			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167522	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300075
J	Kadoya, M; Koyama, H; Kurajoh, M; Naka, M; Miyoshi, A; Kanzaki, A; Kakutani, M; Shoji, T; Moriwaki, Y; Yamamoto, T; Inaba, M; Namba, M				Kadoya, Manabu; Koyama, Hidenori; Kurajoh, Masafumi; Naka, Mariko; Miyoshi, Akio; Kanzaki, Akinori; Kakutani, Miki; Shoji, Takuhito; Moriwaki, Yuji; Yamamoto, Tetsuya; Inaba, Masaaki; Namba, Mitsuyoshi			Associations of Sleep Quality and Awake Physical Activity with Fluctuations in Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; HEART-RATE-VARIABILITY; CIRCADIAN-RHYTHM; APNEA SYNDROME; MENTAL STRESS; INSULIN-RESISTANCE; DURATION; NONDIPPER; DISEASE; DIPPER	Background Sleep quality and awake physical activity are important behavioral factors involved in the occurrence of cardiovascular diseases, potentially through nocturnal blood pressure (BP) changes. However, the impacts of quantitatively measured sleep quality and awake physical activity on BP fluctuation, and their relationships with several candidate causal factors for nocturnal hypertension are not well elucidated. Methods This cross-sectional study included 303 patients registered in the HSCAA study. Measurements included quantitatively determined sleep quality parameters and awake physical activity obtained by actigraph, nocturnal systolic BP (SBP) fall [100 x (1-sleep SBP/awake SBP ratio)], apnea hypopnea index, urinary sodium and cortisol secretion, plasma aldosterone concentration and renin activity, insulin resistance index, parameters of heart rate variability (HRV), and plasma brain-derived neurotrophic factor (BDNF). Results Simple regression analysis showed that time awake after sleep onset (r = -0.150), a parameter of sleep quality, and awake physical activity (r = 0.164) were significantly correlated with nocturnal SBP fall. Among those, time awake after sleep onset (beta = -0.179) and awake physical activity (beta = 0.190) were significantly and independently associated with nocturnal SBP fall in multiple regression analysis. In a subgroup of patients without taking anti-hypertensive medications, both time awake after sleep onset (beta = -0.336) and awake physical activity (beta = 0.489) were more strongly and independently associated with nocturnal SBP falls. Conclusion Sleep quality and awake physical activity were found to be significantly associated with nocturnal SBP fall, and that relationship was not necessarily confounded by candidate causal factors for nocturnal hypertension.	[Kadoya, Manabu; Koyama, Hidenori; Kurajoh, Masafumi; Naka, Mariko; Miyoshi, Akio; Kanzaki, Akinori; Kakutani, Miki; Shoji, Takuhito; Moriwaki, Yuji; Yamamoto, Tetsuya; Namba, Mitsuyoshi] Hyogo Coll Med, Dept Internal Med, Div Diabet Endocrinol & Metab, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan; [Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Endocrinol Metab & Mol Med, Osaka 5458585, Japan	Hyogo College of Medicine; Osaka Metropolitan University	Koyama, H (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Diabet Endocrinol & Metab, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	hkoyama@hyo-med.ac.jp	Koyama, Hidenori/AAU-2346-2020	Koyama, Hidenori/0000-0001-7930-2228	Ministry of Education, Culture, Sports, Science and Technology of Japan [26461371]; MSD; Pfizer Pharmaceutical Companies; Hyogo College of Medicine	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MSD; Pfizer Pharmaceutical Companies; Hyogo College of Medicine	This work is supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (26461371 to H.K.), a Grant-in-Aid for Promotion of Technological Seeds in Advanced Medicine, Hyogo College of Medicine (to T.Y.), and unrestricted research grants from MSD and Pfizer Pharmaceutical Companies (to H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Anan F, 2003, HYPERTENS RES, V26, P669, DOI 10.1291/hypres.26.669; AUBERTTULKENS G, 1987, AM REV RESPIR DIS, V136, P851, DOI 10.1164/ajrccm/136.4.851; Camm AJ, 1996, EUR HEART J, V17, P354; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Della Mea P, 2005, AM J HYPERTENS, V18, P30, DOI 10.1016/j.amjhyper.2004.08.029; Fukuda M, 2008, J HYPERTENS, V26, P583, DOI 10.1097/HJH.0b013e3282f2fded; Fukuda M, 2011, AM J PHYSIOL-RENAL, V301, pF953, DOI 10.1152/ajprenal.00167.2011; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Garcia-Ortiz L, 2014, AM J HYPERTENS, V27, P665, DOI 10.1093/ajh/hpt159; Grassi G, 2008, HYPERTENSION, V52, P925, DOI 10.1161/HYPERTENSIONAHA.108.116368; Gullette ECD, 1997, JAMA-J AM MED ASSOC, V277, P1521, DOI 10.1001/jama.277.19.1521; Hautala AJ, 2010, AM J PHYSIOL-HEART C, V298, pH874, DOI 10.1152/ajpheart.00856.2009; Hla KM, 2008, SLEEP, V31, P795, DOI 10.1093/sleep/31.6.795; IMAI Y, 1988, HYPERTENSION, V12, P11, DOI 10.1161/01.HYP.12.1.11; Jain D, 1998, J AM COLL CARDIOL, V31, P1314, DOI 10.1016/S0735-1097(98)00092-8; Kadoya M, 2015, ATHEROSCLEROSIS, V238, P409, DOI 10.1016/j.atherosclerosis.2014.12.032; Kadoya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105977; Kario K, 1999, HYPERTENSION, V34, P685, DOI 10.1161/01.HYP.34.4.685; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Kario K, 2001, HYPERTENSION, V38, P997, DOI 10.1161/hy1101.095009; Kario K, 2000, HYPERTENSION, V35, P787, DOI 10.1161/01.HYP.35.3.787; Kario K, 2009, HYPERTENS RES, V32, P537, DOI 10.1038/hr.2009.73; Kodama S, 2013, DIABETES CARE, V36, P471, DOI 10.2337/dc12-0783; Koyama H, 2010, CLIN J AM SOC NEPHRO, V5, P659, DOI 10.2215/CJN.08151109; Krantz DS, 2000, JAMA-J AM MED ASSOC, V283, P1800, DOI 10.1001/jama.283.14.1800; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Mansoor GA, 2000, AM J HYPERTENS, V13, P262, DOI 10.1016/S0895-7061(99)00147-8; MATHIAS CJ, 1991, HYPERTENSION, V18, pS22; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Parlapiano C, 2005, ENDOCR RES, V31, P371, DOI 10.1080/07435800500456895; Pepin JL, 2014, SLEEP MED REV, V18, P509, DOI 10.1016/j.smrv.2014.03.003; Rakugi H, 2013, BLOOD PRESSURE, V22, P22, DOI 10.3109/08037051.2013.818758; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Savard J, 2014, SLEEP, V37, P1305, DOI 10.5665/sleep.3918; Sherwood A, 2002, AM J HYPERTENS, V15, P111, DOI 10.1016/S0895-7061(01)02251-8; Soares-Miranda L, 2014, CIRCULATION, V129, P2100, DOI 10.1161/CIRCULATIONAHA.113.005361; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; Suzuki M, 1996, SLEEP, V19, P382, DOI 10.1093/sleep/19.5.382; Tamakoshi A, 2004, SLEEP, V27, P51; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; THORPY M, 1995, SLEEP, V18, P285; Uzu T, 1999, CIRCULATION, V100, P1635, DOI 10.1161/01.CIR.100.15.1635; Vallance JK, 2014, CANCER-AM CANCER SOC, V120, P2919, DOI 10.1002/cncr.28779	44	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155116	10.1371/journal.pone.0155116	http://dx.doi.org/10.1371/journal.pone.0155116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166822	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300007
J	Rachmi, CN; Agho, KE; Li, M; Baur, LA				Rachmi, Cut Novianti; Agho, Kingsley E.; Li, Mu; Baur, Louise Alison			Stunting, Underweight and Overweight in Children Aged 2.0-4.9 Years in Indonesia: Prevalence Trends and Associated Risk Factors	PLOS ONE			English	Article							EXCESS BODY-WEIGHT; DOUBLE BURDEN; NUTRITION TRANSITION; DUAL BURDEN; PRESCHOOL-CHILDREN; UNDERNUTRITION; MALNUTRITION; OBESITY; COUNTRIES; DETERMINANTS	Objective The double burden of malnutrition affects many low and middle-income countries. This study aimed to: a) determine temporal trends in the prevalence of underweight, stunting, and at risk of overweight/overweight or obesity in Indonesian children aged 2.0-4.9 years; and b) examine associated risk factors. Design A repeated cross-sectional survey. This is a secondary data analysis of waves 1, 2, 3, and 4 (1993, 1997, 2000, and 2007) of the Indonesian Family Life Survey, which includes 13 out of 27 provinces in Indonesia. Height, weight and BMI were expressed as z-scores (2006 WHO Child Growth Standards). Weight-for-age-z-score <-2 was categorised as underweight, height-for-age-z-score <-2 as stunted, and BMI-z-score >+1, >+2, >+3 as at-risk, overweight and obese, respectively. Results There are 938, 913, 939, and 1311 separate children in the 4 waves, respectively. The prevalence of stunting decreased significantly from waves 1 to 4 (from 50.8% to 36.7%), as did the prevalence of underweight (from 34.5% to 21.4%). The prevalence of 'at-risk'/overweight/ obesity increased from 10.3% to 16.5% (all P<0.01). Stunting and underweight were related to lower birth weight, being breastfed for 6 months or more, having parents who were underweight or had short stature, and mothers who never attended formal education. Stunting was also higher in rural areas. Being at-risk, or overweight/obese were closely related to being in the youngest age group (2-2.9 years) or male, having parents who were overweight/obese or having fathers with university education. Conclusions The double burden of malnutrition occurs in Indonesian children. Development of policy to combine the management of chronic under-nutrition and over-nutrition is required.	[Rachmi, Cut Novianti; Baur, Louise Alison] Univ Sydney, Clin Sch, Childrens Hosp Westmead, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Agho, Kingsley E.] Univ Western Sydney, Sch Sci & Hlth, Campbelltown Campus, Sydney, NSW, Australia; [Li, Mu; Baur, Louise Alison] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney; Western Sydney University; University of Sydney	Rachmi, CN (corresponding author), Univ Sydney, Clin Sch, Childrens Hosp Westmead, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia.	cut.rachmi@health.nsw.gov.au	Agho, Kingsley/AAW-5622-2021; Agho, Kingsley/AAE-9971-2020; Baur, Louise/AAE-3413-2021	Agho, Kingsley/0000-0003-4111-3207; Baur, Louise/0000-0002-4521-9482; Rachmi, Cut Novianti/0000-0002-6694-2071	Lembaga Pengelola Dana Pendidikan (LPDP), the Republic of Indonesia	Lembaga Pengelola Dana Pendidikan (LPDP), the Republic of Indonesia	This research was performed as part of Cut Novianti Rachmi's PhD studies, for which she received a scholarship from Lembaga Pengelola Dana Pendidikan (LPDP), the Republic of Indonesia. LPDP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albala C, 2001, NUTR REV, V59, P170, DOI 10.1111/j.1753-4887.2001.tb07008.x; [Anonymous], 2010, LMS GROWTH PROGRAM 2; Bardosono S, 2007, ASIA PAC J CLIN NUTR, V16, P512; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bloem MW, 2013, FOOD NUTR BULL, V34, pS8, DOI 10.1177/15648265130342S103; Bove I, 2012, EARLY HUM DEV, V88, P747, DOI 10.1016/j.earlhumdev.2012.04.002; Corp S, 2014, STATA STAT SOFTW REL; Corporation R, 2014, IND FAM LIF SURV IFL; Davison K K, 2001, Obes Rev, V2, P159, DOI 10.1046/j.1467-789x.2001.00036.x; de Onis M, 2013, MATERN CHILD NUTR, V9, P6, DOI 10.1111/mcn.12075; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Doak CM, 2000, J NUTR, V130, P2965, DOI 10.1093/jn/130.12.2965; Fernald LC, 2007, EUR J CLIN NUTR, V61, P623, DOI 10.1038/sj.ejcn.1602558; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Frankenberg E., 1995, 1993 INDONESIAN FAMI; Freire WB, 2014, AM J CLIN NUTR, V100, p1636S, DOI 10.3945/ajcn.114.083766; Huynh TTD, 2009, PUBLIC HEALTH NUTR, V12, P702, DOI 10.1017/S1368980008003017; Indonesia DK, 2014, LAP HAS RIS KES DAS; Khor GL, 2008, ASIA PAC J CLIN NUTR, V17, P111; Kroker-Lobos MF, 2014, AM J CLIN NUTR, V100, p1652S, DOI 10.3945/ajcn.114.083832; Marquis GS, 1997, INT J EPIDEMIOL, V26, P349, DOI 10.1093/ije/26.2.349; Monteiro CA, 2002, PUBLIC HEALTH NUTR, V5, P105, DOI 10.1079/PHN2001281; Monteiro CA, 2010, B WORLD HEALTH ORGAN, V88, P305, DOI 10.2471/BLT.09.069195; Nasution A, 1998, SEOUL J EC, V11, P447; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nutrition SU, SCAL NUTR MOV IND; Oddo VM, 2012, AM J CLIN NUTR, V95, P951, DOI 10.3945/ajcn.111.026070; Poh BK, 2013, BRIT J NUTR, V110, pS21, DOI 10.1017/S0007114513002092; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Ramirez-Zea M, 2014, AM J CLIN NUTR, V100, p1644S; Roemling C, 2013, ECON HUM BIOL, V11, P563, DOI 10.1016/j.ehb.2013.07.001; Sarmiento OL, 2014, AM J CLIN NUTR, V100, p1628S, DOI 10.3945/ajcn.114.083816; Sawaya AL, 1998, J NUTR, V128, p415S, DOI 10.1093/jn/128.2.415S; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Serrato C, 1995, DRU1191AID RAND; Shrimpton R, 2012, DOUBLE BURDEN MALNUT, P79525; Shrimpton R, 2013, 76192ID WORLD BANK J; Soekirman, 2011, SEHAT BUGAR BERKAT G; Stanojevic S, 2008, J PEDIATR GASTR NUTR, V47, P339, DOI 10.1097/MPG.0b013e31816eb448; Tiwari R, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-239; Uauy R, 2008, ANN MED, V40, P11, DOI 10.1080/07853890701704683; UNICEF, 2005, STATE WORLDS CHILDRE; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Waters H, 2004, INT J EPIDEMIOL, V33, P589, DOI 10.1093/ije/dyh074; WHO, 2006, WHO CHILD GROWTH STA; World Health Organisation [WHO], 2013, LONG TERM EFF BREAST; World Health Organization, 2014, WHO INT CLASS AD UND; World Health Organization, 2007, WHO GROWTH REF SCH A; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2014, WHO GLOB NUTR TARG S; World Health Organization, 2014, 1 M AD HOC WORK GROU; World Health Organization, 2011, WHO ANTHR 3 2 2 MACR	54	77	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154756	10.1371/journal.pone.0154756	http://dx.doi.org/10.1371/journal.pone.0154756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167973	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300091
J	Rao, A; Bruck, K; Methven, S; Evans, R; Stel, VS; Jager, KJ; Hooft, L; Ben-Shlomo, Y; Caskey, F				Rao, Anirudh; Bruck, Katharina; Methven, Shona; Evans, Rebecca; Stel, Vianda S.; Jager, Kitty J.; Hooft, Lotty; Ben-Shlomo, Yoav; Caskey, Fergus			Quality of Reporting and Study Design of CKD Cohort Studies Assessing Mortality in the Elderly Before and After STROBE: A Systematic Review	PLOS ONE			English	Review							NEWCASTLE-OTTAWA SCALE; EPIDEMIOLOGY STROBE; CONTROLLED-TRIALS; STATEMENT; TOOLS	Background The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement was published in October 2007 to improve quality of reporting of observational studies. The aim of this review was to assess the impact of the STROBE statement on observational study reporting and study design quality in the nephrology literature. Study Design Systematic literature review. Setting & Population European and North American, Pre-dialysis Chronic Kidney Disease (CKD) cohort studies. Selection Criteria for Studies Studies assessing the association between CKD and mortality in the elderly (> 65 years) published from 1st January 2002 to 31st December 2013 were included, following systematic searching of MEDLINE & EMBASE. Predictor Time period before and after the publication of the STROBE statement. Outcome Quality of study reporting using the STROBE statement and quality of study design using the Newcastle Ottawa Scale (NOS), Scottish Intercollegiate Guidelines Network (SIGN) and Critical Appraisal Skills Programme (CASP) tools. Results 37 papers (11 Pre & 26 Post STROBE) were identified from 3621 potential articles. Only four of the 22 STROBE items and their sub-criteria (objectives reporting, choice of quantitative groups and description of and carrying out sensitivity analysis) showed improvements, with the majority of items showing little change between the period before and after publication of the STROBE statement. Pre- and post-period analysis revealed a Manuscript STROBE score increase (median score 77.8% (Inter-quartile range [IQR], 64.7-82.0) vs 83% (IQR, 78.4-84.9, p = 0.05). There was no change in quality of study design with identical median scores in the two periods for NOS (Manuscript NOS score 88.9), SIGN (Manuscript SIGN score 83.3) and CASP (Manuscript CASP score 91.7) tools. Limitations Only 37 Studies from Europe and North America were included from one medical specialty. Assessment of study design largely reliant on good reporting. Conclusions This study highlights continuing deficiencies in the reporting of STROBE items and their sub-criteria in cohort studies in nephrology. There was weak evidence of improvement in the overall reporting quality, with no improvement in methodological quality of CKD cohort studies between the period before and after publication of the STROBE statement.	[Rao, Anirudh; Methven, Shona; Evans, Rebecca; Ben-Shlomo, Yoav; Caskey, Fergus] UK Renal Registry, Bristol, Avon, England; [Rao, Anirudh; Methven, Shona; Ben-Shlomo, Yoav; Caskey, Fergus] Southmead Hosp, Bristol, Avon, England; [Rao, Anirudh; Ben-Shlomo, Yoav; Caskey, Fergus] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Bruck, Katharina; Stel, Vianda S.; Jager, Kitty J.] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, ERA EDTA Registry, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Methven, Shona] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Hooft, Lotty] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dutch Cochrane Ctr, Utrecht, Netherlands	Southmead Hospital; University of Bristol; University of Amsterdam; University of Bristol; Utrecht University; Utrecht University Medical Center	Rao, A (corresponding author), UK Renal Registry, Bristol, Avon, England.; Rao, A (corresponding author), Southmead Hosp, Bristol, Avon, England.; Rao, A (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	anirudhrao@nhs.net	Ben-Shlomo, Yoav/ABD-2004-2021	Ben-Shlomo, Yoav/0000-0001-6648-3007; Jager, Kitty/0000-0003-0444-8569; , Katharina/0000-0002-5891-2841; Evans, Rebecca/0000-0002-7119-8187; Stel, Vianda S/0000-0002-0007-1947; Caskey, Fergus/0000-0002-5199-3925	UK Renal Registry; European Community's Seventh Framework Programme [HEALTH-F2-2009-241544]; European Renal Association-European Dialysis and Transplant Association under the Quality European Studies initiative	UK Renal Registry; European Community's Seventh Framework Programme(European Commission); European Renal Association-European Dialysis and Transplant Association under the Quality European Studies initiative	This work was part-funded by the UK Renal Registry (https://www.renalreg.org/) and forms part of AR's Doctorate of Philosophy (PhD) thesis. It was also part-funded by the European Community's Seventh Framework Programme under grant agreement number HEALTH-F2-2009-241544 (SysKID) (K.B., V.S.S., K.J.J.), and the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA-www.era-edta.org/) under the Quality European Studies initiative (K.B.). Additionally, this article was co-written by V.S.S and K.J.J on behalf of the ERA-EDTA Registry which is an official body of the ERA-EDTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Abdelhafiz SA, 2011, AGING HLTH, V7, P749; Bastuji-Garin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064733; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Carlson MDA, 2009, J PALLIAT MED, V12, P77, DOI 10.1089/jpm.2008.9690; CASP UK, CRITICAL APPRAISAL S; Cobo E, 2011, EFFECT OF USING REPO, V12, P35; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Fung AE, 2009, OPHTHALMOLOGY, V116, P286, DOI 10.1016/j.ophtha.2008.09.014; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P982, DOI 10.1016/j.jclinepi.2013.03.003; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jager KJ, 2007, KIDNEY INT, V72, P671, DOI 10.1038/sj.ki.5002397; Jager KJ, 2012, NEPHROL DIAL TRANSPL, V27, P27, DOI 10.1093/ndt/gfs277; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Johnston SC, 2006, LANCET, V367, P1319, DOI 10.1016/S0140-6736(06)68578-4; Kane RL, 2007, J CLIN EPIDEMIOL, V60, P241, DOI 10.1016/j.jclinepi.2006.06.016; Kovesdy CP, 2012, ADV CHRONIC KIDNEY D, V19, P11, DOI 10.1053/j.ackd.2011.09.004; Langan S, 2010, ARCH DERMATOL, V146, P534, DOI 10.1001/archdermatol.2010.87; Mangione F, 2011, INTERN EMERG MED, V6, P69, DOI 10.1007/s11739-011-0686-4; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Muller M, 2009, SEX TRANSM INFECT, V85, P162, DOI 10.1136/sti.2007.028985; Nijsten T, 2008, ARCH DERMATOL, V144, P1200, DOI 10.1001/archderm.144.9.1200; Novak JE, 2008, KIDNEY INT, V74, P1121, DOI 10.1038/ki.2008.286; Papathanasiou AA, 2010, ANN EPIDEMIOL, V20, P67, DOI 10.1016/j.annepidem.2009.09.007; Partsinevelou A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-106; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Poorolajal J, 2011, EPIDEMIOL HEALTH, V33, DOI 10.4178/epih/e2011005; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Shamliyan T, 2010, J CLIN EPIDEMIOL, V63, P1061, DOI 10.1016/j.jclinepi.2010.04.014; Sorensen AA, 2013, J HAND SURG-AM, V38A, P1584, DOI 10.1016/j.jhsa.2013.05.008; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sterne JAC HJ, 2014, REEVES BC ON BEHALF; Thadhani R, 2006, CLIN J AM SOC NEPHRO, V1, P1117, DOI 10.2215/CJN.00080106; Tooth L, 2005, AM J EPIDEMIOL, V161, P280, DOI 10.1093/aje/kwi042; Turner Lucy, 2012, Syst Rev, V1, P60, DOI 10.1186/2046-4053-1-60; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wells GA, THE NEWCASTLE OTTAWA; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155078	10.1371/journal.pone.0155078	http://dx.doi.org/10.1371/journal.pone.0155078			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168187	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300083
J	Allijn, IE; Vaessen, SFC; van Ufford, LCQ; Beukelman, KJ; de Winther, MPJ; Storm, G; Schiffelers, RM				Allijn, Iris E.; Vaessen, Stefan F. C.; van Ufford, Linda C. Quarles; Beukelman, Kees J.; de Winther, Menno P. J.; Storm, Gert; Schiffelers, Raymond M.			Head-to-Head Comparison of Anti-Inflammatory Performance of Known Natural Products In Vitro	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DRUG DISCOVERY; INFLAMMATION; PTEROSTILBENE; PATHWAY; IL-6	Inflammation is an important therapeutic target. Due to their potency, steroidal drugs dominate the current treatment of inflammatory disorders. However, steroidal drugs can also exert a broad range of side effects and appear not always effective. This calls for the development of alternative drugs with a different mechanism of action, which are likely to be found in the field of natural products (NPs). For many NPs strong anti-inflammatory effects have been described, but usually investigating a single compound in a single assay. In this study, eight promising NPs were selected and tested against the strong anti-inflammatory drug prednisolone. For this head-to-head comparison, in vitro assays were used which represent different pathways of the inflammatory response: TNF-alpha and IL-6 expression by macrophages, IL-8 expression by colon epithelial cells, ROS production in polymorphonuclear leukocytes and platelet activation in whole blood. Performance profiles were established which allowed us to identify curcumin, berberine chloride and epigallocatechin gallate as potential alternatives for prednisolone or other glucocorticoids in inflammation.	[Allijn, Iris E.; Storm, Gert] Univ Twente, Dept Biomat Sci & Technol, POB 217, NL-7500 AE Enschede, Netherlands; [Vaessen, Stefan F. C.] Univ Appl Sci Utrecht, Technol & Innovat, Innovat Testing Life Sci & Chem, Utrecht, Netherlands; [van Ufford, Linda C. Quarles; Beukelman, Kees J.] Univ Utrecht, Dept Pharmaceut Sci, Med Chem & Chem Biol Biomol Anal, Utrecht, Netherlands; [Beukelman, Kees J.] PhytoGeniX BV, Bunnik, Netherlands; [de Winther, Menno P. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Storm, Gert] Univ Utrecht, Dept Pharmaceut, Utrecht, Netherlands; [Schiffelers, Raymond M.] Univ Med Ctr, Clin Chem & Haematol, Utrecht, Netherlands	University of Twente; Utrecht University; University of Amsterdam; Utrecht University; Utrecht University; Utrecht University Medical Center	Allijn, IE (corresponding author), Univ Twente, Dept Biomat Sci & Technol, POB 217, NL-7500 AE Enschede, Netherlands.	i.e.allijn@utwente.nl	Storm, Gerrit/O-8696-2016; Schiffelers, Raymond/E-8786-2011; Allijn, Iris E/H-1479-2012	Schiffelers, Raymond/0000-0002-1012-9815; Allijn, Iris E/0000-0002-4026-3273; de Winther, Menno/0000-0002-4038-6636	Stichting Innovatie Alliantie [RAAK PRO-2-001 NAT-TEST]; Stichting Techniek en Wetenschap [NanoNextNL 03D.11]; PhytoGenix BV	Stichting Innovatie Alliantie; Stichting Techniek en Wetenschap; PhytoGenix BV	This work was supported by Stichting Innovatie Alliantie, RAAK PRO-2-001 NAT-TEST, http://www.regieorgaan-sia.nl/content/RAAK-regeling/raak-pro to SFCV; Stichting Techniek en Wetenschap - NanoNextNL 03D.11, http://www.nanonextnl.nl/programme/3d-drug-delivery-2/ to RMS. PhytoGenix BV provided support of salary to KJB, who is also a shareholder. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in the study design, data collection an analysis, decision to publish, or preparation of the manuscript.	Atsumi T, 2014, CANCER RES, V74, P8, DOI 10.1158/0008-5472.CAN-13-2322; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; cellsignal.com, 2014, JAK STAT SIGN IL 6 R; cellsignal.com, 2014, NF KB SIGN, P2014; Chemical Abstracts Service, 2014, SCIFINDER; Chen N, 2014, FUND CLIN PHARMACOL, V28, P268, DOI 10.1111/fcp.12019; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ericson-Neilsen W, 2014, OCHSNER J, V14, P203; Fardet L, 2007, BRIT J DERMATOL, V157, P142, DOI 10.1111/j.1365-2133.2007.07950.x; Gautam R, 2009, MED RES REV, V29, P767, DOI 10.1002/med.20156; Gero D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065994; GraphPad Software Inc, 2014, GRAPHPAD PRISM; Hannelien V, 2012, BBA-REV CANCER, V1825, P117, DOI 10.1016/j.bbcan.2011.10.008; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hsu CL, 2013, J AGR FOOD CHEM, V61, P602, DOI 10.1021/jf304487v; Huang H, 2008, INFLAMM RES, V57, P189, DOI 10.1007/s00011-007-7190-3; IKRAM M, 1975, PLANTA MED, V28, P353, DOI 10.1055/s-0028-1097869; Jenne CN, 2013, INT J LAB HEMATOL, V35, P254, DOI 10.1111/ijlh.12084; KADA T, 1985, MUTAT RES, V150, P127, DOI 10.1016/0027-5107(85)90109-5; Krane V, 2011, NAT REV NEPHROL, V7, P385, DOI 10.1038/nrneph.2011.62; KUTTAN R, 1985, CANCER LETT, V29, P197, DOI 10.1016/0304-3835(85)90159-4; LI Z, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/289264; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liverani E, 2012, BIOCHEM PHARMACOL, V83, P1364, DOI 10.1016/j.bcp.2012.02.006; Madretsma GS, 1996, IMMUNOPHARMACOLOGY, V35, P47, DOI 10.1016/0162-3109(96)00122-1; Maiorov EG, 2013, SEMIN CANCER BIOL, V23, P243, DOI 10.1016/j.semcancer.2013.05.003; Maltesen HR, 2010, RHEUMATOLOGY, V49, P2037, DOI 10.1093/rheumatology/keq213; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moraes LA, 2005, BLOOD, V106, P4167, DOI 10.1182/blood-2005-04-1723; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; Pereira GC, 2007, J PHARMACOL EXP THER, V323, P636, DOI 10.1124/jpet.107.128017; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Riegsecker S, 2013, LIFE SCI, V93, P307, DOI 10.1016/j.lfs.2013.07.006; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Sachse F, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-11; Sanner SM, 2002, STEROIDS, V67, P715, DOI 10.1016/S0039-128X(02)00024-7; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Shehzad A, 2013, BIOFACTORS, V39, P69, DOI 10.1002/biof.1066; Stefanska J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/106507; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Van den Worm E, 2001, EUR J PHARMACOL, V433, P225, DOI 10.1016/S0014-2999(01)01516-3; Violi F, 2012, THROMB RES, V129, P378, DOI 10.1016/j.thromres.2011.12.002; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Yang N, 2012, STEROIDS, V77, P1041, DOI 10.1016/j.steroids.2012.05.007	49	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155325	10.1371/journal.pone.0155325	http://dx.doi.org/10.1371/journal.pone.0155325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163931	Green Published, gold			2022-12-27	WOS:000376585700025
J	Li, ZX; Zhang, Y; Quan, XC; Yang, ZR; Zeng, XT; Ji, LN; Sun, F; Zhan, SY				Li, Zhixia; Zhang, Yuan; Quan, Xiaochi; Yang, Zhirong; Zeng, Xiantao; Ji, Linong; Sun, Feng; Zhan, Siyan			Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis	PLOS ONE			English	Review							TWICE-DAILY EXENATIDE; BETA-CELL FUNCTION; PLACEBO-CONTROLLED TRIAL; ONCE-DAILY LIXISENATIDE; HUMAN GLP-1 ANALOG; METFORMIN-TREATED PATIENTS; BIPHASIC INSULIN ASPART; DRUG-NAIVE PATIENTS; DOUBLE-BLIND; OPEN-LABEL	Objective To synthesize current evidence of the impact of Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) on hypoglycemia, treatment discontinuation and glycemic level in patients with type 2 diabetes. Design Systematic review and network meta-analysis. Data Sources Literature search (Medline, Embase, the Cochrane library), website of clinical trial, bibliographies of published systematic reviews. Eligibility Criteria Randomized controlled trials with available data comparing GLP-1 RAs with placebo or traditional anti-diabetic drugs in patients with type 2 diabetes. Data Synthesis Traditional pairwise meta-analyses within DerSimonian-Laird random effects model and network meta-analysis within a Bayesian framework were performed to calculate odds ratios for the incidence of hypoglycemia, treatment discontinuation, HbA1c < 7.0% and HbA1c < 6.5%. Ranking probabilities for all treatments were estimated to obtain a treatment hierarchy using the surface under the cumulative ranking curve (SUCRA) and mean ranks. Results 78 trials with 13 treatments were included. Overall, all GLP-1 RAs except for albiglutide increased the risk of hypoglycemia when compared to placebo. Reduction in the incidence of hypoglycemia was found for all GLP-1 RAs versus insulin (except for dulaglutide) and sulphonylureas. For the incidence of treatment discontinuation, increase was found for exenatide, liraglutide, lixisenatide and taspoglutide versus placebo, insulin and sitagliptin. For glycemic level, decrease was found for all GLP-1 RAs versus placebo. Dulaglutide, exenatide long-acting release (exe_lar), liraglutide and taspoglutide had significant lowering effect when compared with sitagliptin (HbA1c < 7.0%) and insulin (HbA1c < 6.5%). Finally, according to SUCRAs, placebo, thiazolidinediones and albiglutide had the best decrease effect on hypoglycemia; sulphanylureas, sitagliptin and insulin decrease the incidence of treatment discontinuation most; exe_lar and dulaglutide had the highest impact on glycemic level among 13 treatments. Conclusions Among 13 treatments, GLP-1 RAs had a significant reduction with glycemic level but a slight increase effect on hypoglycemia and treatment discontinuation. While albiglutide had the best decrease effect on hypoglycemia and treatment discontinuation among all GLP-1 RAs. However, further evidence is necessary for more conclusive inferences on mechanisms underlying the rise in hypoglycemia.	[Li, Zhixia; Quan, Xiaochi; Yang, Zhirong; Sun, Feng; Zhan, Siyan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Zhang, Yuan] McMaster Univ, Dept Clin Epidemiol & Biostat, 1280 Main St West, Hamilton, ON, Canada; [Zeng, Xiantao] Wuhan Univ, Zhongnan Hosp, Ctr Evidence Based & Translat Med, Wuhan 430072, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China	Peking University; McMaster University; Wuhan University; Peking University	Sun, F; Zhan, SY (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China.	sunfeng@bjmu.edu.cn; siyan-zhan@bjmu.edu.cn	Linong, Ji/AAB-6543-2020; Sun, Feng/AGF-7912-2022; Sun, Feng/E-8859-2010	Sun, Feng/0000-0003-4334-6805; Zeng, Xian-Tao/0000-0003-1262-725X; Sun, Feng/0000-0001-9212-0496	National Natural Science Foundation of China [81302508]; Research Fund for the Doctoral Program of Higher Education [20120001110015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This study is funded by National Natural Science Foundation of China (81302508) and Research Fund for the Doctoral Program of Higher Education (20120001110015).	Ahren B, 2014, DIABETES CARE, V37, P2141, DOI 10.2337/dc14-0024; Ahren B, 2013, DIABETES CARE, V36, P2543, DOI 10.2337/dc12-2006; [Anonymous], 2013, EFFECT EXENATIDE ABD; [Anonymous], 2013, GLARGINE INSULIN ORA; [Anonymous], 2011, THE EFFECT OF LIRAGL; Apovian CM, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.11.019; Barnett AH, 2007, CLIN THER, V29, P2333, DOI 10.1016/j.clinthera.2007.11.006; Bergenstal R, 2009, CURR MED RES OPIN, V25, P65, DOI 10.1185/03007990802597951 ; Bergenstal Richard M, 2012, Diabetes Ther, V3, P13, DOI 10.1007/s13300-012-0013-8; Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; Blevins T, 2011, J CLIN ENDOCR METAB, V96, P1301, DOI 10.1210/jc.2010-2081; Bolli GB, 2014, DIABETIC MED, V31, P176, DOI 10.1111/dme.12328; Bunck MC, 2009, DIABETES CARE, V32, P762, DOI 10.2337/dc08-1797; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Buse JB, 2011, ANN INTERN MED, V154, P103, DOI 10.7326/0003-4819-154-2-201101180-00300; Buse JB, 2010, DIABETES CARE, V33, P1255, DOI 10.2337/dc09-1914; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Charbonnel B, 2013, DIABETOLOGIA, V56, P1503, DOI 10.1007/s00125-013-2905-1; Cryer PE, 1997, HYPOGLYCEMIA PATHOPH; Curkendall SM, 2013, CURR MED RES OPIN, V29, P1275, DOI 10.1185/03007995.2013.821056; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Davies MJ, 2009, DIABETES OBES METAB, V11, P1153, DOI 10.1111/j.1463-1326.2009.01154.x; Davies M, 2013, DIABETES CARE, V36, P1368, DOI 10.2337/dc12-1333; Davis SN, 2007, DIABETES CARE, V30, P2767, DOI 10.2337/dc06-2532; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; DeFronzo RA, 2010, DIABETES CARE, V33, P951, DOI [10.2337/dc09-1521, 10.2337/dc10-0646]; Derosa G, 2012, DIABETIC MED, V29, P1515, DOI 10.1111/j.1464-5491.2012.03699.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diamant M, 2014, LANCET DIABETES ENDO, V2, P464, DOI 10.1016/S2213-8587(14)70029-4; Diamant M, 2012, DIABETES CARE, V35, P683, DOI 10.2337/dc11-1233; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Dungan KM, 2014, LANCET, V384, P1349, DOI 10.1016/S0140-6736(14)60976-4; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Eng C, 2014, LANCET, V384, P2228, DOI 10.1016/S0140-6736(14)61335-0; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Fonseca VA, 2012, DIABETES CARE, V35, P1225, DOI 10.2337/dc11-1935; FUKUDA M, 1988, DIABETES, V37, P81, DOI 10.2337/diabetes.37.1.81; Gallwitz B, 2012, LANCET, V379, P2270, DOI 10.1016/S0140-6736(12)60479-6; Gallwitz B, 2011, DIABETES CARE, V34, P604, DOI 10.2337/dc10-1900; Gallwitz B, 2010, DRUG SAFETY, V33, P87, DOI 10.2165/11319130-000000000-00000; Gao Y, 2009, DIABETES RES CLIN PR, V83, P69, DOI 10.1016/j.diabres.2008.09.037; Garber A, 2011, DIABETES OBES METAB, V13, P348, DOI 10.1111/j.1463-1326.2010.01356.x; Goykhman S, 2009, EXPERT OPIN PHARMACO, V10, P705, DOI [10.1517/14656560902775677 , 10.1517/14656560902775677]; Hansen KB, 2009, INT J CLIN PRACT, V63, P1154, DOI 10.1111/j.1742-1241.2009.02086.x; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Henry RR, 2013, DIABETES CARE, V36, P2559, DOI 10.2337/dc12-2410; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hollander P, 2013, OBESITY, V21, P238, DOI 10.1002/oby.20042; Home PD, 2015, DIABETES OBES METAB, V17, P179, DOI 10.1111/dom.12414; Inagaki N, 2012, CLIN THER, V34, P1892, DOI 10.1016/j.clinthera.2012.07.007; International Diabetes Federation, 2014, DIAB FACTS FIG; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Iwamoto K, 2009, ENDOCR J, V56, P951, DOI 10.1507/endocrj.K09E-147; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Ji LN, 2013, J DIABETES INVEST, V4, P53, DOI 10.1111/j.2040-1124.2012.00238.x; Kachroo Sumesh, 2015, J Manag Care Spec Pharm, V21, P243; Kadowaki T, 2011, J DIABETES INVEST, V2, P210, DOI 10.1111/j.2040-1124.2010.00084.x; Kadowaki T, 2009, ENDOCR J, V56, P415, DOI 10.1507/endocrj.K08E-296; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Khunti K, 2010, DIABETES OBES METAB, V12, P474, DOI 10.1111/j.1463-1326.2009.01186.x; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Li CJ, 2012, CARDIOVASCULAR DIABE, P11; Lindamood CA, 2015, CLIN THER, V37, P483, DOI 10.1016/j.clinthera.2015.01.003; Liutkus J, 2010, DIABETES OBES METAB, V12, P1058, DOI 10.1111/j.1463-1326.2010.01251.x; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; Mathieu C, 2014, DIABETES OBES METAB, V16, P636, DOI 10.1111/dom.12262; Menge BA, 2011, DIABETES, V60, P2160, DOI 10.2337/db11-0251; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Monami M, 2009, EUR J ENDOCRINOL, V160, P909, DOI 10.1530/EJE-09-0101; Montilla S, 2014, NUTR METAB CARDIOVAS, V24, P1346, DOI 10.1016/j.numecd.2014.07.014; Moretto TJ, 2008, CLIN THER, V30, P1448, DOI 10.1016/j.clinthera.2008.08.006; Nauck M, 2013, DIABETIC MED, V30, P109, DOI 10.1111/dme.12003; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Nauck MA, 2002, J CLIN ENDOCR METAB, V87, P1239, DOI 10.1210/jc.87.3.1239; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Nauck M, 2014, DIABETES CARE, V37, P2149, DOI 10.2337/dc13-2761; Nauck MA, 2009, DIABETES CARE, V32, P1237, DOI 10.2337/dc08-1961; Neumiller JJ, 2009, ANN PHARMACOTHER, V43, P1433, DOI 10.1345/aph.1M134; Pinget M, 2013, DIABETES OBES METAB, V15, P1000, DOI 10.1111/dom.12121; Pratley R, 2011, INT J CLIN PRACT, V65, P397, DOI 10.1111/j.1742-1241.2011.02656.x; Pratley RE, 2013, DIABETES OBES METAB, V15, P234, DOI 10.1111/dom.12009; Pratley RE, 2014, LANCET DIABETES ENDO, V2, P289, DOI 10.1016/S2213-8587(13)70214-6; Ratner R, 2010, DIABETIC MED, V27, P556, DOI 10.1111/j.1464-5491.2010.02990.x; Ratner RE, 2010, DIABETIC MED, V27, P1024, DOI 10.1111/j.1464-5491.2010.03020.x; Raz I, 2012, DIABETES CARE, V35, P485, DOI 10.2337/dc11-1942; Riddle MC, 2013, DIABETES CARE, V36, P2489, DOI 10.2337/dc12-2454; Riddle MC, 2013, DIABETES CARE, V36, P2497, DOI 10.2337/dc12-2462; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Rosenstock J, 2014, DIABETES CARE, V37, P2317, DOI 10.2337/dc14-0001; Rosenstock J, 2014, J DIABETES COMPLICAT, V28, P386, DOI 10.1016/j.jdiacomp.2014.01.012; Rosenstock J, 2013, DIABETES CARE, V36, P2945, DOI 10.2337/dc12-2709; Rosenstock J, 2013, DIABETES CARE, V36, P498, DOI 10.2337/dc12-0709; Rosenstock J, 2009, DIABETES CARE, V32, P1880, DOI 10.2337/dc09-0366; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Russell-Jones D, 2012, DIABETES CARE, V35, P252, DOI 10.2337/dc11-1107; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Scheen AJ, 2013, ANN ENDOCRINOL-PARIS, V74, P515, DOI 10.1016/j.ando.2012.06.002; Segel SA, 2002, DIABETES, V51, P724, DOI 10.2337/diabetes.51.3.724; Seino Y, 2008, DIABETES RES CLIN PR, V81, P161, DOI 10.1016/j.diabres.2008.03.018; Seino Y, 2012, DIABETES OBES METAB, V14, P910, DOI 10.1111/j.1463-1326.2012.01618.x; Seino Y, 2010, CURR MED RES OPIN, V26, P1013, DOI 10.1185/03007991003672551; Seino Y, 2014, CURR MED RES OPIN, V30, P1095, DOI 10.1185/03007995.2014.896327; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sun F, 2012, DIABETES RES CLIN PR, V98, P386, DOI 10.1016/j.diabres.2012.09.004; Trujillo JM, 2015, THER ADV ENDOCRINOL, V6, P19, DOI 10.1177/2042018814559725; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Umpierrez GE, 2011, DIABETES OBES METAB, V13, P418, DOI 10.1111/j.1463-1326.2011.01366.x; Umpierrez G, 2014, DIABETES CARE, V37, P2168, DOI 10.2337/dc13-2759; van Valkenhoef G, 2012, RES SYNTH METHODS, V3, P285, DOI 10.1002/jrsm.1054; Vilsboll T, 2003, REGUL PEPTIDES, V114, P115, DOI 10.1016/S0167-0115(03)00111-3; Wajcberg E, 2009, EXPERT OPIN PHARMACO, V10, P135, DOI [10.1517/14656560802611832 , 10.1517/14656560802611832]; Wysham C, 2014, DIABETES CARE, V37, P2159, DOI [10.2337/dc13-2760, 10.2337/dc15-er07b]; Yang W, 2011, DIABETES OBES METAB, V13, P81, DOI 10.1111/j.1463-1326.2010.01323.x; Yuan GH, 2012, CHINESE MED J-PEKING, V125, P2677, DOI 10.3760/cma.j.issn.0366-6999.2012.15.006; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zarowitz BJ, 2009, PHARMACOTHERAPY, V29, p55S, DOI 10.1592/phco.29.pt2.55S; ZINMAN B, 2010, DIABETES CARE, V33, P692; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003	122	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154206	10.1371/journal.pone.0154206	http://dx.doi.org/10.1371/journal.pone.0154206			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158818	Green Submitted, Green Published, gold			2022-12-27	WOS:000376576700008
J	Sun, RH; Chen, LD				Sun, Ranhao; Chen, Liding			Assessment of Heavy Metal Pollution in Topsoil around Beijing Metropolis	PLOS ONE			English	Article							RISK-ASSESSMENT; WASTE-WATER; GEOSTATISTICAL ANALYSES; AGRICULTURAL SOILS; NORTHERN CHINA; HEALTH-RISK; RURAL SOILS; MULTIVARIATE; CONTAMINATION; CROPS	The topsoil around Beijing metropolis, China, is experiencing impacts of rapid urbanization, intensive farming, and extensive industrial emissions. We analyzed the concentrations of Cu, Ni, Pb, Zn, Cd, and Cr from 87 topsoil samples in the pre-rainy season and 115 samples in the post-rainy season. These samples were attributed to nine land use types: forest, grass, shrub, orchard, wheat, cotton, spring maize, summer maize, and mixed farmland. The pollution index (PI) of heavy metals was calculated from the measured and background concentrations. The ecological risk index (RI) was assessed based on the PI values and toxic-response parameters. The results showed that the mean PI values of Pb, Cr, and Cd were >1 while those of Cu, Ni, and Zn were <1. All the samples had low ecological risk for Cu, Ni, Pb, Zn, and Cr while only 15.35% of samples had low ecological risk for Cd. Atmospheric transport rather than land use factors best explained the seasonal variations in heavy metal concentrations and the impact of atmospheric transport on heavy metal concentrations varied according to the heavy metal types. The concentrations of Cu, Cd, and Cr decreased from the pre- to post-rainy season, while those of Ni, Pb, and Zn increased during this period. Future research should be focused on the underlying atmospheric processes that lead to these spatial and seasonal variations in heavy metals. The policymaking on environmental management should pay close attention to potential ecological risks of Cd as well as identifying the transport pathways of different heavy metals.	[Sun, Ranhao; Chen, Liding] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, POB 934, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Chen, LD (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, POB 934, Beijing, Peoples R China.	liding@rcees.ac.cn	Sun, Ranhao/AAM-6837-2021		National Natural Science Foundation of China [41590841]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financed by the National Natural Science Foundation of China (41590841). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aelion CM, 2009, SCI TOTAL ENVIRON, V407, P2216, DOI 10.1016/j.scitotenv.2008.11.033; Candelone JP, 1996, SCI TOTAL ENVIRON, V193, P101, DOI 10.1016/S0048-9697(96)05325-9; Cao HB, 2000, RISK ANAL, V20, P613, DOI 10.1111/0272-4332.205056; Chen Tong-bin, 2004, Huanjing Kexue, V25, P117; Chu JT, 2010, THEOR APPL CLIMATOL, V99, P149, DOI 10.1007/s00704-009-0129-6; Chuan MC, 1996, WATER AIR SOIL POLL, V90, P543, DOI 10.1007/BF00282668; CNEMC, 1990, BACKGR SOIL ENV CHIN; [崔邢涛 CUI Xingtao], 2011, [现代地质, Geoscience], V25, P569; Davis HT, 2009, ENVIRON POLLUT, V157, P2378, DOI 10.1016/j.envpol.2009.03.021; de Vries W, 2013, SCI TOTAL ENVIRON, V461, P240, DOI 10.1016/j.scitotenv.2013.04.069; [董丞妍 Dong Chengyan], 2014, [地理研究, Geographical Research], V33, P2115; Giller KE, 1998, SOIL BIOL BIOCHEM, V30, P1389, DOI 10.1016/S0038-0717(97)00270-8; Grant C, 2013, PLANT SOIL, V372, P221, DOI 10.1007/s11104-013-1691-3; Guagliardi I, 2012, WATER AIR SOIL POLL, V223, P5983, DOI 10.1007/s11270-012-1333-z; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Hamad SH, 2014, SCI TOTAL ENVIRON, V494, P39, DOI 10.1016/j.scitotenv.2014.06.006; Jia L, 2010, INT J ENV RES PUB HE, V7, P395, DOI 10.3390/ijerph7020395; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; Lu AX, 2012, SCI TOTAL ENVIRON, V425, P66, DOI 10.1016/j.scitotenv.2012.03.003; Luo W, 2007, ENVIRON POLLUT, V146, P567, DOI 10.1016/j.envpol.2006.08.001; Melaku S, 2008, ENVIRON POLLUT, V155, P88, DOI 10.1016/j.envpol.2007.10.038; Nikos N, 2012, GEODERMA, V189-190, P554; Pathak AK, 2013, SCI TOTAL ENVIRON, V443, P662, DOI 10.1016/j.scitotenv.2012.11.030; Qiao M, 2011, ENVIRON MONIT ASSESS, V172, P353, DOI 10.1007/s10661-010-1339-1; Qiao QQ, 2013, ATMOS ENVIRON, V74, P182, DOI 10.1016/j.atmosenv.2013.03.039; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; SEPA, 1995, 156181995 SEPA GB; Shi RG, 2010, B ENVIRON CONTAM TOX, V85, P287, DOI 10.1007/s00128-010-0070-5; [宋伟 Song Wei], 2013, [水土保持研究, Research of Soil and Water Conservation], V20, P293; Sukreeyapongse O, 2002, J ENVIRON QUAL, V31, P1901, DOI 10.2134/jeq2002.1901; USEPA, 1996, METH 3050B AC DIG SE; Wang ShengWei, 2013, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V44, P56; Wang YC, 2012, J ENVIRON SCI, V24, P690, DOI 10.1016/S1001-0742(11)60833-4; Wang ZM, 2014, HUM ECOL RISK ASSESS, V20, P1521, DOI 10.1080/10807039.2013.867701; Wu SA, 2010, J HAZARD MATER, V179, P860, DOI 10.1016/j.jhazmat.2010.03.084; Xia XH, 2011, J HAZARD MATER, V186, P2043, DOI 10.1016/j.jhazmat.2010.12.104; Xiao R, 2011, CLEAN-SOIL AIR WATER, V39, P612, DOI 10.1002/clen.201000255; [郑景云 Zheng Jingyun], 2013, [科学通报, Chinese Science Bulletin], V58, P3088; Zheng YM, 2008, J SOIL SEDIMENT, V8, P51, DOI 10.1065/jss2007.08.245; Zou JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118082	41	16	16	10	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155350	10.1371/journal.pone.0155350	http://dx.doi.org/10.1371/journal.pone.0155350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159454	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700060
J	Tsai, LY; Chang, YW; Lee, MC; Chang, YC; Hwang, PI; Huang, YS; Cheng, CF				Tsai, Li-Yun; Chang, Yu-Wei; Lee, Ming-Che; Chang, Ying-Chen; Hwang, Pei-Ing; Huang, Yi-Shuian; Cheng, Ching-Feng			Biphasic and Stage-Associated Expression of CPEB4 in Hepatocellular Carcinoma	PLOS ONE			English	Article							TRANSLATIONAL CONTROL; CANCER; BINDING; FAMILY; PROGRESSION; METASTASIS; LANDSCAPE	Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is a sequence-specific RNA-binding protein and translational regulator, with expression associated with tumor progression. Nevertheless, CPEB4 seems to play paradoxical roles in cancers-an oncogenic promoter in pancreatic ductal adenocarcinoma (PDA) and glioblastomas but a tumor suppressor in hepatocellular carcinoma (HCC). To assess whether CPEB4-regulated carcinogenesis is tissue-specific, we reevaluated the role of CPEB4 in HCC. Although proliferation of hepatocytes appeared normal in CPEB4-knockout (KO) mice after partial hepatectomy, knockdown (KD) of CPEB4 in HepG2 liver cancer cells promoted colony formation in vitro. Moreover, the growth of CPEB4-KD cells was accelerated in an in vivo xenograft mouse model. In tumorous and adjacent non-tumorous paired liver specimens from 49 HCC patients, the protein level of CPEB4 was significantly upregulated in early-stage HCC but decreased toward late-stage HCC. This finding agrees with changes in CPEB4 mRNA level from analysis of two sets of HCC microarray data from the Gene Expression Omnibus (GEO) database. Taken together, downregulation of CPEB4 likely occurs at the late cancer stage to facilitate HCC progression. Biphasic alteration of CPEB4 expression during HCC progression suggests its complicated role in tumorigenesis.	[Tsai, Li-Yun; Chang, Ying-Chen; Cheng, Ching-Feng] Buddhist Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Chang, Yu-Wei; Huang, Yi-Shuian; Cheng, Ching-Feng] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lee, Ming-Che] Buddhist Tzu Chi Gen Hosp, Dept Surg, Hualien, Taiwan; [Lee, Ming-Che; Cheng, Ching-Feng] Tzu Chi Univ, Hualien, Taiwan; [Hwang, Pei-Ing] Mao Ying Genetech Inc, Taipei, Taiwan; [Cheng, Ching-Feng] Buddhist Tzu Chi Gen Hosp, Dept Pediat, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Academia Sinica - Taiwan; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Cheng, CF (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan.; Huang, YS; Cheng, CF (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Cheng, CF (corresponding author), Tzu Chi Univ, Hualien, Taiwan.; Cheng, CF (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Pediat, Hualien, Taiwan.	yishuian@ibms.sinica.edu.tw; chengcf@mail.tcu.edu.tw	Huang, Yi-Shuian/P-2824-2018; CHENG, Ching-Feng/AAB-8861-2019; Cheng, Ching-Feng/AAB-8523-2019	Huang, Yi-Shuian/0000-0001-9000-7748; CHENG, Ching-Feng/0000-0003-0104-0146; 	Tzu Chi General Hospital [TCRD10322, TCRD10445]; Academia Sinica [AS103TPB05]; Taiwan Ministry of Science and Technology [MoST 1032325B303001, MoST 1022628B001007MY3]; Mao Ying Genetech Inc.	Tzu Chi General Hospital; Academia Sinica(Academia Sinica - Taiwan); Taiwan Ministry of Science and Technology; Mao Ying Genetech Inc.	This work was supported by Tzu Chi General Hospital [TCRD10322 and TCRD10445 to CFC], https://www.tzuchi.com.tw/tzuchi_en/default.aspx; Academia Sinica [AS103TPB05 to YSH], https://www.sinica.edu.tw/main_e.shtml; the Taiwan Ministry of Science and Technology [MoST 1032325B303001 to CFC and MoST 1022628B001007MY3 to YSH], https://www.most.gov.tw/en/public. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mao Ying Genetech Inc. provided support in the form of salaries for authors [PIH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Caldeira J, 2012, GUT, V61, P1115, DOI 10.1136/gutjnl-2011-300427; Chang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107961; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Chen PJ, 2012, EMBO J, V31, P959, DOI 10.1038/emboj.2011.448; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; D'Ambrogio A, 2013, NAT REV CANCER, V13, P283, DOI 10.1038/nrc3485; Diehl AM, 2000, IMMUNOL REV, V174, P160, DOI 10.1034/j.1600-0528.2002.017411.x; Ell B, 2013, TRENDS CELL BIOL, V23, P603, DOI 10.1016/j.tcb.2013.06.001; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Ferracin M, 2015, EXPERT REV MOL DIAGN, V15, P1369, DOI 10.1586/14737159.2015.1081058; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen CN, 2009, APMIS, V117, P53, DOI 10.1111/j.1600-0463.2008.00015.x; Heller G, 2008, CANCER RES, V68, P44, DOI 10.1158/0008-5472.CAN-07-2531; Hu WM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000979; Hu WQ, 2014, DEV CELL, V30, P660, DOI 10.1016/j.devcel.2014.07.008; Huang WH, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0366-1; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Johnson RM, 2015, J BIOL CHEM, V290, P25717, DOI 10.1074/jbc.M115.671206; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Kinoshita A, 2015, WORLD J HEPATOL, V7, P406, DOI 10.4254/wjh.v7.i3.406; Lin Y., 1996, Annals Academy of Medicine Singapore, V25, P22; Luca R, 2013, EMBO MOL MED, V5, P1523, DOI 10.1002/emmm.201302847; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Meng X, 2014, CANCER RES, V74, P7161, DOI 10.1158/0008-5472.CAN-14-1446; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Nairismagi ML, 2012, ONCOGENE, V31, P4960, DOI 10.1038/onc.2011.650; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; OEFINGER PE, 1981, J GEN VIROL, V53, P105, DOI 10.1099/0022-1317-53-1-105; Ohtsuka M, 2015, J CLIN MED, V4, P1651, DOI 10.3390/jcm4081651; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Pflaumf J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00285; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Stumpf CR, 2013, MOL CELL, V52, P574, DOI 10.1016/j.molcel.2013.09.018; Subramaniam S, 2013, CHIN CLIN ONCOL, V2, DOI 10.3978/j.issn.2304-3865.2013.07.05; Tanenbaum ME, 2015, ELIFE, V4, DOI 10.7554/eLife.07957; Tian Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048958; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Topisirovic I, 2011, COLD SH Q B, V76, P355, DOI 10.1101/sqb.2011.76.010785; Tsai LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084978; Tsantoulis PK, 2005, EUR J CANCER, V41, P2403, DOI 10.1016/j.ejca.2005.08.005; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang XP, 2010, BIOINFORM BIOL INSIG, V4, P61, DOI 10.4137/BBI.S5087; Wang XL, 2008, HEPATO-GASTROENTEROL, V55, P2039; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; YOKOYAMA HO, 1953, CANCER RES, V13, P80; Zaccara S, 2014, CELL DEATH DIFFER, V21, P1522, DOI 10.1038/cdd.2014.79	53	6	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155025	10.1371/journal.pone.0155025	http://dx.doi.org/10.1371/journal.pone.0155025			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158894	Green Submitted, Green Published, gold			2022-12-27	WOS:000376576700031
J	Mvula, H; Heinsbroek, E; Chihana, M; Crampin, AC; Kabuluzi, S; Chirwa, G; Mwansambo, C; Costello, A; Cunliffe, NA; Heyderman, RS; French, N; Bar-Zeev, N				Mvula, Hazzie; Heinsbroek, Ellen; Chihana, Menard; Crampin, Amelia C.; Kabuluzi, Storn; Chirwa, Geoffrey; Mwansambo, Charles; Costello, Anthony; Cunliffe, Nigel A.; Heyderman, Robert S.; French, Neil; Bar-Zeev, Naor		VacSurv Consortium	Predictors of Uptake and Timeliness of Newly Introduced Pneumococcal and Rotavirus Vaccines, and of Measles Vaccine in Rural Malawi: A Population Cohort Study	PLOS ONE			English	Article							RISK-FACTORS; CHILDHOOD IMMUNIZATION; CONJUGATE VACCINE; COVERAGE; CHILDREN; DETERMINANTS; INFANTS	Background Malawi introduced pneumococcal conjugate vaccine (PCV13) and monovalent rotavirus vaccine (RV1) in 2011 and 2012 respectively, and is planning the introduction of a second-dose measles vaccine (MV). We assessed predictors of availability, uptake and timeliness of these vaccines in a rural Malawian setting. Methods Commencing on the first date of PCV13 eligibility we conducted a prospective population-based birth cohort study of 2,616 children under demographic surveillance in Karonga District, northern Malawi who were eligible for PCV13, or from the date of RV1 introduction both PCV13 and RV1. Potential predictors of vaccine uptake and timeliness for PCV13, RV1 and MV were analysed respectively using robust Poisson and Cox regression. Results Vaccine coverage was high for all vaccines, ranging from 86.9% for RV1 dose 2 to 95.4% for PCV13 dose 1. Median time delay for PCV13 dose 1 was 17 days (IQR 7-36), 19 days (IQR 8-36) for RV1 dose 1 and 20 days (IQR 3-46) for MV. Infants born to lower educated or farming mothers and those living further away from the road or clinic were at greater risk of being not fully vaccinated and being vaccinated late. Delays in vaccination were also associated with non-facility birth. Vaccine stock-outs resulted in both a delay in vaccine timeliness and in a decrease in completion of schedule. Conclusion Despite high vaccination coverage in this setting, delays in vaccination were common. We identified programmatic and socio-demographic risk factors for uptake and timeliness of vaccination. Understanding who remains most vulnerable to be unvaccinated allows for focussed delivery thereby increasing population coverage and maximising the equitable benefits of universal vaccination programmes.	[Mvula, Hazzie; Chihana, Menard; Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi; [Heinsbroek, Ellen; Cunliffe, Nigel A.; French, Neil; Bar-Zeev, Naor] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Crampin, Amelia C.] London Sch Hyg & Trop Med, London WC1, England; [Kabuluzi, Storn; Chirwa, Geoffrey] Minist Hlth, Expanded Programme Immunisat Off & Prevent Serv O, Lilongwe, Malawi; [Mwansambo, Charles] Minist Hlth, Hlth Serv, Lilongwe, Malawi; [Costello, Anthony] UCL, Inst Global Hlth, London, England; [Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Heyderman, Robert S.] UCL, Div Infect & Immun, London, England; [Heyderman, Robert S.; French, Neil; Bar-Zeev, Naor] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi	Malawi Epidemiology and Intervention Research Unit; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Liverpool School of Tropical Medicine; University of Liverpool; University of London; University College London; University of Malawi	Bar-Zeev, N (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.; Bar-Zeev, N (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	Naor.Bar-Zeev@liverpool.ac.uk	Bar-Zeev, Naor/ABF-8648-2021; Iturriza, Miren/B-4351-2013	Bar-Zeev, Naor/0000-0003-0570-4624; Heinsbroek, Ellen/0000-0002-2874-6280; Lewycka, Sonia/0000-0002-5923-9468; Heyderman, Robert/0000-0003-4573-449X; French, Neil/0000-0003-4814-8293; Crampin, Amelia/0000-0002-1513-4330; Iturriza, Miren/0000-0001-5816-6423; chihana, menard/0000-0003-2616-9894	Wellcome Trust Programme Grant [WT091909/B/10/Z]; Wellcome Trust	Wellcome Trust Programme Grant(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Programme Grant (number WT091909/B/10/Z) awarded to NAC, RSH and NF; and the Karonga Prevention Study Core Award from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Wellcome Trust Programme Grant (number WT091909/B/10/Z) awarded to NAC, RSH and NF; and the Karonga Prevention Study Core Award from the Wellcome Trust. We thank the members of the VacSurv Consortium: James Beard (University College London [UCL], London UK), Miren Iturriza-Gomara (University of Liverpool, Liverpool, UK), Carina King (UCL), Sonia Lewycka (University of Auckland, New Zealand, formerly UCL), Osamu Nakagomi (University of Nagasaki, Nagasaki, Japan), Umesh D Parashar (Centers for Disease Control & Prevention [CDC], Atlanta, GA, USA), Tambosi Phiri (Mai Mwana Project, Mchinji, Malawi), Jacqueline E Tate (CDC), Jennifer R Verani (CDC) and Cynthia G Whitney (CDC).	Abadura SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2315-z; Babalola S, 2009, MATERN CHILD HLTH J, V13, P550, DOI 10.1007/s10995-008-0386-5; Babirye JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035432; Bar-Zeev N, 2015, VACCINE, V33, P2637, DOI 10.1016/j.vaccine.2015.04.053; Bar-Zen N, 2015, LANCET INFECT DIS, V15, P422, DOI 10.1016/S1473-3099(14)71060-6; Bosch-Capblanch X, 2012, TROP MED INT HEALTH, V17, P697, DOI 10.1111/j.1365-3156.2012.02989.x; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Canavan ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095709; Clinton Health Access Initiative, 2013, ANN REPORT, P1; Crampin AC, 2012, INT J EPIDEMIOL, V41, P676, DOI 10.1093/ije/dys088; de Waroux OL, 2013, INT HEALTH, V5, P139, DOI 10.1093/inthealth/iht006; Fadnes LT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-404; Fadnes LT, 2011, VACCINE, V29, P3564, DOI 10.1016/j.vaccine.2011.02.093; Favin M, 2012, INT HEALTH, V4, P229, DOI 10.1016/j.inhe.2012.07.004; Glatman-Freedman Aharona, 2012, Hum Vaccin Immunother, V8, P293, DOI 10.4161/hv.19003; Government of Malawi, COMPR EPI MULT PLAN; Gram L, 2014, TROP MED INT HEALTH, V19, P802, DOI 10.1111/tmi.12324; Heinsbroek E, 2016, AM J EPIDEMIOL, V183, P70, DOI 10.1093/aje/kwv134; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Jahn A, 2008, TROP MED INT HEALTH, V13, P129, DOI 10.1111/j.1365-3156.2007.01982.x; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; Jani JV, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-161; Knol MJ, 2012, CAN MED ASSOC J, V184, P895, DOI 10.1503/cmaj.101715; Munthali Alister C, 2007, Malawi Med J, V19, P79; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; O'Hare B, 2014, J ROY SOC MED, V107, P148, DOI 10.1177/0141076813514575; Odutola A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1015-9; Payne S, 2014, HEALTH POLICY PLANN, V29, P193, DOI 10.1093/heapol/czt004; Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096; Sandvik B., 2009, WORLD BORDERS DATASE; Schoeps A, 2013, VACCINE, V32, P96, DOI 10.1016/j.vaccine.2013.10.063; Scott JAG, 2011, CLIN INFECT DIS, V53, P663, DOI 10.1093/cid/cir444; Spijkerman J, 2013, JAMA-J AM MED ASSOC, V310, P930, DOI 10.1001/jama.2013.228052; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wiysonge CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037905; World Health Organization, 2009, STAT WORLDS VACC IMM	36	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154997	10.1371/journal.pone.0154997	http://dx.doi.org/10.1371/journal.pone.0154997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152612	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000375677000058
J	Olesen, SW; Vora, S; Techtmann, SM; Fortney, JL; Bastidas-Oyanedel, JR; Rodriguez, J; Hazen, TC; Alm, EJ				Olesen, Scott W.; Vora, Suhani; Techtmann, Stephen M.; Fortney, Julian L.; Bastidas-Oyanedel, Juan R.; Rodriguez, Jorge; Hazen, Terry C.; Alm, Eric J.			A Novel Analysis Method for Paired-Sample Microbial Ecology Experiments	PLOS ONE			English	Article							SPECIES-ABUNDANCE; MULTIVARIATE ANALYSES; GEN. NOV.; COMMUNITIES; SEQUENCES; OIL; DATABASE	Many microbial ecology experiments use sequencing data to measure a community's response to an experimental treatment. In a common experimental design, two units, one control and one experimental, are sampled before and after the treatment is applied to the experimental unit. The four resulting samples contain information about the dynamics of organisms that respond to the treatment, but there are no analytical methods designed to extract exactly this type of information from this configuration of samples. Here we present an analytical method specifically designed to visualize and generate hypotheses about microbial community dynamics in experiments that have paired samples and few or no replicates. The method is based on the Poisson lognormal distribution, long studied in macroecology, which we found accurately models the abundance distribution of taxa counts from 16S rRNA surveys. To demonstrate the method's validity and potential, we analyzed an experiment that measured the effect of crude oil on ocean microbial communities in microcosm. Our method identified known oil degraders as well as two clades, Maricurvus and Rhodobacteraceae, that responded to amendment with oil but do not include known oil degraders. Our approach is sensitive to organisms that increased in abundance only in the experimental unit but less sensitive to organisms that increased in both control and experimental units, thus mitigating the role of "bottle effects".	[Olesen, Scott W.; Vora, Suhani; Alm, Eric J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Techtmann, Stephen M.; Fortney, Julian L.; Hazen, Terry C.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN 37996 USA; [Fortney, Julian L.; Hazen, Terry C.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Bastidas-Oyanedel, Juan R.; Rodriguez, Jorge] Masdar Inst Sci & Technol, Inst Ctr Water & Environm iWater, Abu Dhabi, U Arab Emirates	Massachusetts Institute of Technology (MIT); University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; Khalifa University of Science & Technology	Alm, EJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu	R., Jorge Rodríguez/A-9879-2008; Bastidas-Oyanedel, Juan-Rodrigo/I-3372-2016; Hazen, Terry C/C-1076-2012; R., Jorge Rodríguez/N-5916-2019	R., Jorge Rodríguez/0000-0002-5936-9676; Bastidas-Oyanedel, Juan-Rodrigo/0000-0002-2418-441X; Hazen, Terry C/0000-0002-2536-9993; R., Jorge Rodríguez/0000-0002-5936-9676; , ENIGMA/0000-0002-0894-2831; Olesen, Scott/0000-0001-5400-4945	BP Exploration/MIT Energy Initiative [6926835]; National Science Foundation [0821391, 1122374]	BP Exploration/MIT Energy Initiative; National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by BP Exploration/MIT Energy Initiative (mitei.mit.edu) under Grant No. 6926835, the National Science Foundation (nsf.gov) under Grant No. 0821391, and the National Science Foundation Graduate Research Fellowship (nsfgrfp.org) under Grant No. 1122374.	Al-Awadhi H, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-369; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bastidas-Oyanedel JR, 2010, TALANTA, V83, P482, DOI 10.1016/j.talanta.2010.09.034; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engen S, 2002, AM NAT, V160, P60, DOI 10.1086/340612; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; GRUNDY PM, 1951, BIOMETRIKA, V38, P427, DOI 10.1093/biomet/38.3-4.427; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammes F, 2010, APPL ENVIRON MICROB, V76, P1278, DOI 10.1128/AEM.01914-09; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Iwaki H, 2012, FEMS MICROBIOL LETT, V327, P142, DOI 10.1111/j.1574-6968.2011.02471.x; Jackson DA, 1997, ECOLOGY, V78, P929; Jung SW, 2010, J MICROBIOL, V48, P594, DOI 10.1007/s12275-010-0199-2; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Lo N, 2015, INT J SYST EVOL MICR, V65, P1935, DOI 10.1099/ijs.0.000199; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mishamandani S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00076; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Palleroni N. J., 2010, HDB HYDROCARBON LIPI, DOI [10.1007/978-3-540-77587-4_129, DOI 10.1007/978-3-540-77587-4_129]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Preheim SP, 2013, APPL ENVIRON MICROB, V79, P6593, DOI 10.1128/AEM.00342-13; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rivers AR, 2013, ISME J, V7, P2315, DOI 10.1038/ismej.2013.129; Techtmann SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120605; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Williamson M, 2005, J ANIM ECOL, V74, P409, DOI 10.1111/j.1365-2656.2005.00936.x	44	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154804	10.1371/journal.pone.0154804	http://dx.doi.org/10.1371/journal.pone.0154804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152415	gold, Green Published, Green Submitted			2022-12-27	WOS:000375677000038
J	Li, PX; Doshi, JA				Li, Pengxiang; Doshi, Jalpa A.			Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012	PLOS ONE			English	Article							BENEFICIARIES	Objective Since 2007, the Centers for Medicare and Medicaid Services have published 5-star quality rating measures to aid consumers in choosing Medicare Advantage Prescription Drug Plans (MAPDs). We examined the impact of these star ratings on Medicare Advantage Prescription Drug (MAPD) enrollment before and after 2012, when star ratings became tied to bonus payments for MAPDs that could be used to improve plan benefits and/or reduce premiums in the subsequent year. Methods A longitudinal design and multivariable hybrid models were used to assess whether star ratings had a direct impact on concurrent year MAPD contract enrollment (by influencing beneficiary choice) and/or an indirect impact on subsequent year MAPD contract enrollment (because ratings were linked to bonus payments). The main analysis was based on contract-year level data from 2009-2015. We compared effects of star ratings in the pre-bonus payment period (2009-2011) and post-bonus payment period (2012-2015). Extensive sensitivity analyses varied the analytic techniques, unit of analysis, and sample inclusion criteria. Similar analyses were conducted separately using stand-alone PDP contract-year data; since PDPs were not eligible for bonus payments, they served as an external comparison group. Result The main analysis included 3,866 MAPD contract-years. A change of star rating had no statistically significant effect on concurrent year enrollment in any of the pre-, post-, or pre-post combined periods. On the other hand, star rating increase was associated with a statistically significant increase in the subsequent year enrollment (a 1-star increase associated with +11,337 enrollees, p<0.001) in the post-bonus payment period but had a very small and statistically non-significant effect on subsequent year enrollment in the pre-bonus payment period. Further, the difference in effects on subsequent year enrollment was statistically significant between the pre- and post-periods (p = 0.011). Sensitivity analyses indicated that the findings were robust. No statistically significant effect of star ratings was found on concurrent or subsequent year enrollment in the pre- or post-period in the external comparison group of stand-alone PDP contracts. Conclusion Star ratings had no direct impact on concurrent year MAPD enrollment before or after the introduction of bonus payments tied to star ratings. However, after the introduction of these bonus payments, MAPD star ratings had a significant indirect impact of increasing subsequent year enrollment, likely via the reinvestment of bonuses to provide lower premiums and/or additional member benefits in the following year.	[Li, Pengxiang; Doshi, Jalpa A.] Univ Penn, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Li, Pengxiang; Doshi, Jalpa A.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Li, PX (corresponding author), Univ Penn, Div Gen Internal Med, Philadelphia, PA 19104 USA.; Li, PX (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA.	penli@mail.med.upenn.edu			Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA; NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER	Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaluck J, 2011, AM ECON REV, V101, P1180, DOI 10.1257/aer.101.4.1180; Academy of Managed Care Pharmacy Special Projects Committee, 2011, FRAM IMPR MED PLAN S; Allison PD, 2009, FIXED EFFECT REGRESS; Altman D, 2015, JAMA-J AM MED ASSOC, V314, P384, DOI 10.1001/jama.2015.7811; Centers for Medicare and Medicaid Services, PERF DAT C D; Centers for Medicare and Medicaid Services, MED ADV D; Centers for Medicare & Medicaid Services, 2011, MED HLTH PLAN QUAL C; Centers for Medicare & Medicaid Services, 2015, MED 2015 C D; Jacobson G., 2014, MEDICARE ADVANTAGE 2; Jacobson G, 2010, QUALITY RATINGS MEDI; Jacobson G, 2011, MEDICARE ADVANTAGE P; Jacobson G, 2014, ARE SENIORS CHOOSING; Layton TJ, 2015, HLTH SERV RES; Medicare, 5 STAR SPEC ENR PER; MedPAC, 2011, REPORT TO THE CONGRE; Owen JA, 2014, J AM PHARM ASSOC, V54, P228, DOI 10.1331/JAPhA.2014.13180; Reid RO, 2013, JAMA-J AM MED ASSOC, V309, P267, DOI 10.1001/jama.2012.173925; Reid RO, 2015, J GEN INTERN MED; Rice T, 2014, MED CARE RES REV, V71, P661, DOI 10.1177/1077558714556896; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Xu P, 2015, ANN INTERN MED, V162, P353, DOI 10.7326/M14-0332	21	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154357	10.1371/journal.pone.0154357	http://dx.doi.org/10.1371/journal.pone.0154357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27149092	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800025
J	Maski, MR; Thomas, RJ; Karumanchi, SA; Parikh, SM				Maski, Manish R.; Thomas, Robert J.; Karumanchi, S. Ananth; Parikh, Samir M.			Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Patients with Obstructive Sleep Apnea	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; EXTREMELY OBESE-PATIENTS; BLOOD-PRESSURE; INTERMITTENT HYPOXIA; HEART-FAILURE; RISK-FACTOR; BIOMARKERS; DISEASE; GLOMERULOSCLEROSIS; NEPHROPATHY	Background Obstructive sleep apnea (OSA) is a well-established risk factor for hypertension and cardiovascular morbidity and mortality. More recently, OSA has been implicated as an independent risk factor for chronic kidney disease. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is a well-accepted early biomarker of subclinical kidney tubular injury, preceding an increase in serum creatinine. The goal of this study was to determine if an association exists between OSA and increased urinary NGAL levels. Methods We prospectively enrolled adult patients from the sleep clinic of an academic medical center. Each underwent polysomnography and submitted a urine specimen upon enrollment. We measured NGAL and creatinine levels on all urine samples before participants received treatment with continuous positive airway pressure (CPAP), and, in a subset of OSA patients, after CPAP therapy. We compared the urinary NGAL/creatinine ratio between untreated participants with and without OSA, and within a subset of 11 OSA patients also after CPAP therapy. Results A total of 49 subjects were enrolled: 16 controls based on an apnea-hypopnea index (events with at least 4% oxygen desaturation; AHI-4%) <5 events/hour (mean AHI-4% = 0.59 +/- 0.60); 33 OSA patients based on an AHI-4% >5 events/hour (mean AHI-4% = 43.3 +/-28.1). OSA patients had a higher mean body-mass index than the control group (36.58 +/- 11.02 kg/m(2) vs. 26.81 +/- 6.55 kg/m2, respectively; p = 0.0005) and were more likely to be treated for hypertension (54.5% vs. 6.25% of group members, respectively; p = 0.0014). The groups were otherwise similar in demographics, and there was no difference in the number of diabetic subjects or in the mean serum creatinine concentration (control = 0.86 +/- 0.15 mg/dl, OSA = 0.87 +/- 0.19 mg/dl; p = 0.7956). We found no difference between the urinary NGAL-to-creatinine ratios among untreated OSA patients versus control subjects (median NGAL/creatinine = 6.34 ng/mg vs. 6.41 ng/mg, respectively; p = 0.4148). Furthermore, CPAP therapy did not affect the urinary NGAL-to-creatinine ratio (p = 0.7758 for two-tailed, paired t-test). Conclusions In this prospective case-control study comparing patients with severe, hypoxic OSA to control subjects, all with normal serum creatinine, we found no difference between urinary levels of NGAL. Furthermore, CPAP therapy did not change these levels pre- and post-treatment.	[Maski, Manish R.; Karumanchi, S. Ananth; Parikh, Samir M.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Maski, Manish R.; Thomas, Robert J.; Karumanchi, S. Ananth; Parikh, Samir M.] Harvard Univ, Sch Med, Boston, MA USA; [Thomas, Robert J.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Maski, MR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA.; Maski, MR (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	mmaski@bidmc.harvard.edu	Karumanchi, Subbian Ananth/AAI-1694-2021; Thomas, Robert/AAC-9694-2021	Thomas, Robert/0000-0002-5575-3953; Maski, Manish/0000-0003-3010-2844	NRSA; Howard Hughes Medical Institute	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	M. R. M. was supported by an institutional NRSA grant and S. A. K. was supported by funds from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019029; BAILEY RR, 1989, AUST NZ J MED, V19, P473, DOI 10.1111/j.1445-5994.1989.tb00310.x; Bruno RM, 2013, J HYPERTENS, V31, P1456, DOI 10.1097/HJH.0b013e328360f773; CHAUDHARY BA, 1988, SLEEP, V11, P69, DOI 10.1093/sleep/11.1.69; Chou YT, 2011, NEPHROL DIAL TRANSPL, V26, P2244, DOI 10.1093/ndt/gfq821; Damman K, 2011, J AM COLL CARDIOL, V57, P2233, DOI 10.1016/j.jacc.2010.10.065; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Faulx MD, 2007, SLEEP, V30, P923, DOI 10.1093/sleep/30.7.923; Fletcher EC, 1999, HYPERTENSION, V34, P309, DOI 10.1161/01.HYP.34.2.309; Gilmartin GS, 2010, AM J PHYSIOL-HEART C, V299, pH925, DOI 10.1152/ajpheart.00253.2009; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Iber C., 2007, AASM MANUAL SCORING; JENNETTE JC, 1987, AM J KIDNEY DIS, V10, P470, DOI 10.1016/S0272-6386(87)80196-8; Kato K, 2011, RESP MED, V105, P643, DOI 10.1016/j.rmed.2010.11.024; Kinebuchi SI, 2004, CLIN SCI, V107, P317, DOI 10.1042/CS20040074; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Lee YC, 2015, SLEEP, V38, P213, DOI 10.5665/sleep.4400; Leong WB, 2014, J CLIN SLEEP MED, V10, P773, DOI 10.5664/jcsm.3870; Linz D, 2014, AM J HYPERTENS, V27, P1293, DOI 10.1093/ajh/hpu036; Liu S, 2013, BIOMARKERS, V18, P95, DOI 10.3109/1354750X.2012.740687; Marcus JA, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-013-0411-y; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Nannapaneni S, 2013, WORLD J DIABETES, V4, P238, DOI 10.4239/wjd.v4.i6.238; Nicholl DDM, 2014, AM J RESP CRIT CARE, V190, P572, DOI 10.1164/rccm.201403-0526OC; Nielsen SE, 2010, DIABETIC MED, V27, P1144, DOI 10.1111/j.1464-5491.2010.03083.x; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Pennemans V, 2013, CLIN CHEM LAB MED, V51, P1795, DOI 10.1515/cclm-2013-0157; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Ryan Silke, 2008, Archives of Physiology and Biochemistry, V114, P261, DOI [10.1080/13813450802307337, 10.1080/13813450802307337 ]; Sakaguchi Y, 2013, CLIN J AM SOC NEPHRO, V8, P1502, DOI 10.2215/CJN.11931112; Sakaguchi Y, 2011, CLIN J AM SOC NEPHRO, V6, P995, DOI 10.2215/CJN.08670910; Serra A, 2008, KIDNEY INT, V73, P947, DOI 10.1038/sj.ki.5002796; Singer E, 2013, ACTA PHYSIOL, V207, P663, DOI 10.1111/apha.12054; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Tsioufis C, 2008, AM J KIDNEY DIS, V52, P285, DOI 10.1053/j.ajkd.2008.05.001; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yamauchi M, 2008, ANTIOXID REDOX SIGN, V10, P755, DOI 10.1089/ars.2007.1946; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	42	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154503	10.1371/journal.pone.0154503	http://dx.doi.org/10.1371/journal.pone.0154503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149121	Green Published, gold			2022-12-27	WOS:000375676800036
J	Sayao, JM; Bantim, RAM; Andrade, RCLP; Lima, FJ; Saraiva, AAF; Figueiredo, RG; Kellner, AWA				Sayao, Juliana M.; Bantim, Renan A. M.; Andrade, Rafael C. L. P.; Lima, Flaviana J.; Saraiva, Antonio A. F.; Figueiredo, Rodrigo G.; Kellner, Alexander W. A.			Paleohistology of Susisuchus anatoceps (Crocodylomorpha, Neosuchia): Comments on Growth Strategies and Lifestyle	PLOS ONE			English	Article							CRETACEOUS CRATO FORMATION; BONE-HISTOLOGY; ARARIPE BASIN; ROMUALDO FORMATION; SANTANA FORMATION; AGE; PTERODACTYLOIDEA; CROCODILES; PTEROSAUR; SPECIMEN	Susisuchus anatoceps is a neosuchian crocodylomorph lying outside the clade Eusuchia, and associated with the transition between basal and advanced neosuchians and the rise of early eusuchians. The specimen MPSC R1136 comprises a partially articulated postcranial skeleton and is only the third fossil assigned to this relevant taxon. Thin sections of a right rib and right ulna of this specimen have been cut for histological studies and provide the first paleohistological information of an advanced non-eusuchian neosuchian from South America. The cross-section of the ulna shows a thick cortex with 17 lines of arrested growth (LAGs), a few scattered vascular canals, and primary and secondary osteons. This bone has a free medullary cavity and a spongiosa is completely absent. Thin sections of the rib show that remodeling process was active when the animal died, with a thin cortex and a well-developed spongiosa. In the latter, few secondary osteons and 4 LAGs were identified. According to the observed data, Susisuchus anatoceps had a slow-growing histological microstructure pattern, which is common in crocodylomorphs. The high number of ulnar LAGs and the active remodeling process are indicative that this animal was at least a late subadult, at or past the age of sexual maturity. This contradicts previous studies that interpreted this and other Susisuchus anatoceps specimens as juveniles, and suggests that full-grown adults of this species were relatively small-bodied, comparable in size to modern dwarf crocodiles.	[Sayao, Juliana M.; Bantim, Renan A. M.; Andrade, Rafael C. L. P.; Lima, Flaviana J.] Univ Fed Pernambuco, Ctr Acad Vitoria, Lab Biodiversidade Nordeste, Vitoria De Santo Antao, PE, Brazil; [Saraiva, Antonio A. F.] Univ Reg Cariri, Lab Paleontol, Crato, Ceara, Brazil; [Figueiredo, Rodrigo G.] Univ Fed Espirito Santo, Dept Ciencias Biol, Vitoria, ES, Brazil; [Kellner, Alexander W. A.] Univ Fed Rio de Janeiro, Lab Sistemat & Tafon Vertebrados Fosseis, Museu Nacl, Rio De Janeiro, RJ, Brazil	Universidade Federal de Pernambuco; Universidade Regional do Cariri; Universidade Federal do Espirito Santo; Universidade Federal do Rio de Janeiro	Sayao, JM (corresponding author), Univ Fed Pernambuco, Ctr Acad Vitoria, Lab Biodiversidade Nordeste, Vitoria De Santo Antao, PE, Brazil.	jmsayao@gmail.com	Bantim, Renan/J-4076-2014; Kellner, Alexander W/H-1023-2015; Kellner, Alexander/ABE-9591-2020	Kellner, Alexander W/0000-0001-7174-9447; Kellner, Alexander/0000-0001-7174-9447; Figueiredo, Rodrigo/0000-0002-4304-6434	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [458164/2014-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; Fundacao de Amparo a Pesquisa do Estado do Espirito Santo-FAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo-FAPES	Funding was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPqto JMS (CNPQ Proc.no458164/2014-3), RAMB, RCLPA, FJL and RGF. Additional funding was provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES and the Fundacao de Amparo a Pesquisa do Estado do Espirito Santo-FAPES. AAFS acknowledge the Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico-FUNCAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr Placido Cidade Nuvens (Museu de Paleontologia da Universidade Regional do Cariri) for the access to specimen MPSC R1136, Dr. Cristiano A. Chagas (Centro Academico de Vitoria-Universidade Federal de Pernambuco) for imaging of the thin sections, as well as Matheus Barbosa and Aline M. Ghilard for helping with figures edition. We are in debt to Holly Woodward and Sarah Werning for the comments that greatly improved the manuscript. Funding was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPqto JMS (CNPQ Proc.no458164/2014-3), RAMB, RCLPA, FJL and RGF. Additional funding was provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES and the Fundacao de Amparo a Pesquisa do Estado do Espirito Santo-FAPES. AAFS acknowledge the Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico-FUNCAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams L, 2001, J ZOO WILDLIFE MED, V32, P500, DOI 10.1638/1042-7260(2001)032[0500:FPICAD]2.0.CO;2; Amprino R., 1947, ARCH BIOL SCI, V58, P315; Amson E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0192; Assine ML., 2007, B GEOCIENCIAS PETROB, V15, P371; Baez AM, 2009, CRETACEOUS RES, V30, P829, DOI 10.1016/j.cretres.2009.01.002; Bantim RAM, 2014, ZOOTAXA, V3869, P201, DOI 10.11646/zootaxa.3869.3.1; Barbosa JA, 2008, P ROY SOC B-BIOL SCI, V275, P1385, DOI 10.1098/rspb.2008.0110; BAUDINETTE RV, 1985, J COMP PHYSIOL B, V155, P373, DOI 10.1007/BF00687481; Berthou P.Y., 1994, ACTA GEOL LEOPOLDENS, V17, P539; Beurlen K., 1962, AN ACAD BRAS CIENC, V34, P365; Beurlen K., 1972, AN ACAD BRAS CIENC, V43, P411; Brito Neves BBA, 1990, S BAC AR BAC INT NOR, P21; Brock J., 1965, KROKODILE, V22; BUFFETAUT E, 1977, Palaeontology (Oxford), V20, P203; Buffetaut E., 1982, ANN PALEONTOLOGIE, V68, P327; BUFFRENIL VD, 1980, B SOC ZOOL FR, V105, P355; Campos DA, 2011, AN ACAD BRAS CIENC, V83, P317, DOI 10.1590/S0001-37652011000100020; Carvalho ID, 2007, ZOOTAXA, P35; Carvalho ID, 2011, ZOOTAXA, P19; Carvalho Ismar De Souza, 1993, Anais da Academia Brasileira de Ciencias, V65, P181; Castanet J., 1993, BONE, P245; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Chinsamy A, 2009, ANAT REC, V292, P1462, DOI 10.1002/ar.20990; Cope ED, 1886, P AM PHILOS SOC, V23, P1; Cox, 1976, MORPHOLOGY BIOL REPT, P123; da Silva JH, 2013, SPECTROCHIM ACTA A, V115, P324, DOI 10.1016/j.saa.2013.06.042; de Lima FJ, 2014, AN ACAD BRAS CIENC, V86, P1657, DOI 10.1590/0001-3765201420140339; De Margerie E, 2005, ANAT REC PART A, V282A, P49, DOI 10.1002/ar.a.20141; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles Armand, 2001, P289; DEBUFFRENIL V, 1982, ZOOMORPHOLOGY, V99, P155, DOI 10.1007/BF00310307; DERICQLES A, 1995, ANN SCI NAT ZOOL, V16, P47; Eaton M.J., 2010, CROCODILES STATUS SU, P127; Elsworth PG, 2003, J HERPETOL, V37, P363, DOI 10.1670/0022-1511(2003)037[0363:SSPICC]2.0.CO;2; Enlow D. H., 1956, Texas Journal of Science, V8, P405; Fernandez Jorge Mondejar, 2009, Paleolusitana, V1, P287; Figueiredo RG, 2011, ZOOL J LINN SOC-LOND, V163, pS273, DOI 10.1111/j.1096-3642.2011.00721.x; Figueiredo RG, 2009, PALAEONTOL Z, V83, P323, DOI 10.1007/s12542-009-0016-6; FISH FE, 1984, COPEIA, P839, DOI 10.2307/1445326; Fortier DC, 2009, PALAEONTOLOGY, V52, P991, DOI 10.1111/j.1475-4983.2009.00894.x; FRANCILLONVIEILLOT H, 1990, J HERPETOL, V24, P13, DOI 10.2307/1564284; Frey E, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P165; Frey E, 2003, CRATO FOSSIL BEDS BR, P463; Frey Eberhard, 2003, Geological Society Special Publication, V217, P55, DOI 10.1144/GSL.SP.2003.217.01.05; Frey Eberhard, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V194, P379; Games I, 1990, THESIS U ZIMBABWE HA; Hill RV, 2010, J VERTEBR PALEONTOL, V30, P154, DOI 10.1080/02724634.2010.518110; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Houssaye A, 2013, BIOL J LINN SOC, V108, P3, DOI 10.1111/j.1095-8312.2012.02002.x; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Hua S, 1996, J VERTEBR PALEONTOL, V16, P703, DOI 10.1080/02724634.1996.10011359; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Kellner AWA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081386; Kellner AWA, 2013, AN ACAD BRAS CIENC, V85, P113, DOI 10.1590/S0001-37652013000100009; Kellner AWA, 2011, ZOOL J LINN SOC-LOND, V163, pS109, DOI 10.1111/j.1096-3642.2011.00711.x; Kellner AWA, 2011, ZOOL J LINN SOC-LOND, V163, pS57, DOI 10.1111/j.1096-3642.2011.00712.x; Kellner AWA, 2010, AN ACAD BRAS CIENC, V82, P1063, DOI 10.1590/S0001-37652010000400025; Kellner Alexander W.A., 2007, Boletim do Museu Nacional Nova Serie Geologia, V75, P1; KELLNER AWA, 1987, AN ACAD BRAS CIENC, V59, P219; Kellner AWA, 1999, EPISODES, V22, P238; Kellner AWA., 1986, AN ACAD BRAS CIENC, V58, P610; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Kriloff A, 2008, J EVOLUTION BIOL, V21, P807, DOI 10.1111/j.1420-9101.2008.01512.x; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Leal M.E.C., 2004, ANN PALEONTOL, V90, P103, DOI DOI 10.1016/J.ANNPAL.2004.01.001; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Lima FJ., 2012, ESTUDOS GEOLOGICOS, V22, P99, DOI DOI 10.18190/1980-8208/ESTUD0SGE0L0GIC0S.V22N1P99-115; de Andrade RCLP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102189; Mabesoone J.M., 1994, 14 INT SED C REC BRA, P46; MABESOONE JM, 1973, PALAEOGEOGR PALAEOCL, V14, P97, DOI 10.1016/0031-0182(73)90006-0; Magnusson WE, 1992, PALEOSUCHUS TRIGONAT; Maisey J. G, 1991, SANTANA FOSSILS ILLU, P414; Marinho TD, 2013, CRETACEOUS RES, V44, P104, DOI 10.1016/j.cretres.2013.03.010; Martill DM, 2007, CRETACEOUS RES, V28, P895, DOI 10.1016/j.cretres.2007.01.002; Martill David M., 1998, Oryctos, V1, P79; Martill DM., 2007, THE CRATO FOSSIL BED; Martins-Neto RG., 2001, SIMPOSIO SOBRE A BAC, V1 e 2, P212; Mohr BAR, 2004, INT J PLANT SCI, V165, P1121, DOI 10.1086/423879; Mohr BAR, 2006, CRETACEOUS RES, V27, P464, DOI 10.1016/j.cretres.2005.08.001; Neumann VH, 2003, INT J COAL GEOL, V54, P21, DOI 10.1016/S0166-5162(03)00018-1; Neumann VH, 1999, B RESUMOS S CRETACEO, V5, P279; Nova BCV, 2011, PALAIOS, V26, P173, DOI 10.2110/palo.2010.p10-072r; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P253; Padian K, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P1; Pol D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093105; Pol D, 2009, B AM MUS NAT HIST, P1; Ponte F.C., 1996, ESTRUTURA GEOLOGICA, P4; Ponte F.C., 1990, CONGRESSO BRASILEIRO, V1, P211; Ray S, 2004, J VERTEBR PALEONTOL, V24, P634, DOI 10.1671/0272-4634(2004)024[0634:BHAGPO]2.0.CO;2; Riff D., 2012, TERRAE, V9, P12; Ross J. P., 1998, CROCODILES STATUS SU; ROXO MATHIAS G. de 0L1VEIRA, 1936, ANN ACAD BRASIL SCI, V8, P33; Salisbury SW, 2003, PALAEONTOGR ABT A, V270, P3; Sayao J.M., 2006, ESTUDOS GEOL GICOS, V16, P16; Sayao Juliana M., 2003, Geological Society Special Publication, V217, P335, DOI 10.1144/GSL.SP.2003.217.01.21; Sayao JM, 2011, AN ACAD BRAS CIENC, V83, P197, DOI 10.1590/S0001-37652011000100010; Sayao Juliana M., 2000, Boletim do Museu Nacional Nova Serie Geologia, V54, P1; Scheyer TM, 2014, ANAT REC, V297, P240, DOI 10.1002/ar.22849; Seebacher F, 2003, J EXP BIOL, V206, P1193, DOI 10.1242/jeb.00223; Silva Santos R, 1947, DIVISAO GEOLOGIA MIN, V42, P1; Souza R, 2013, J VERT PALEO PROGRAM, P158; Tennant JP, 2014, PEERJ, V2, DOI 10.7717/peerj.599; Tucker AD, 1997, MAR FRESHWATER RES, V48, P343, DOI 10.1071/MF96113; Turner AH, 2015, PEERJ, V3, DOI 10.7717/peerj.759; Valenca L. M. M., 2003, Geologica Acta, V1, P261; Viana M.S.S., 2002, SITIOS GEOLOGICOS PA, P113; Walker JA, 2000, P ROY SOC B-BIOL SCI, V267, P1875, DOI 10.1098/rspb.2000.1224; WALL WP, 1983, J PALEONTOL, V57, P197; Witton MP, 2008, PALAEONTOLOGY, V51, P1289, DOI 10.1111/j.1475-4983.2008.00811.x; Woodward AR, 1992, ALLIGATOR AGE DETERM; Woodward HN, 2014, PEERJ, V2, DOI 10.7717/peerj.422; Woodward HN, 2011, J HERPETOL, V45, P339	115	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155297	10.1371/journal.pone.0155297	http://dx.doi.org/10.1371/journal.pone.0155297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149108	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800126
J	Kim, S; Park, S; Hale, SA; Kim, S; Byun, J; Oh, AH				Kim, Suin; Park, Sungjoon; Hale, Scott A.; Kim, Sooyoung; Byun, Jeongmin; Oh, Alice H.			Understanding Editing Behaviors in Multilingual Wikipedia	PLOS ONE			English	Article							NETWORK	Multilingualism is common offline, but we have a more limited understanding of the ways multilingualism is displayed online and the roles that multilinguals play in the spread of content between speakers of different languages. We take a computational approach to studying multilingualism using one of the largest user-generated content platforms, Wikipedia. We study multilingualism by collecting and analyzing a large dataset of the content written by multilingual editors of the English, German, and Spanish editions of Wikipedia. This dataset contains over two million paragraphs edited by over 15,000 multilingual users from July 8 to August 9, 2013. We analyze these multilingual editors in terms of their engagement, interests, and language proficiency in their primary and non-primary (secondary) languages and find that the English edition of Wikipedia displays different dynamics from the Spanish and German editions. Users primarily editing the Spanish and German editions make more complex edits than users who edit these editions as a second language. In contrast, users editing the English edition as a second language make edits that are just as complex as the edits by users who primarily edit the English edition. In this way, English serves a special role bringing together content written by multilinguals from many language editions. Nonetheless, language remains a formidable hurdle to the spread of content: we find evidence for a complexity barrier whereby editors are less likely to edit complex content in a second language. In addition, we find that multilinguals are less engaged and show lower levels of language proficiency in their second languages. We also examine the topical interests of multilingual editors and find that there is no significant difference between primary and non-primary editors in each language.	[Kim, Suin; Park, Sungjoon; Kim, Sooyoung; Byun, Jeongmin; Oh, Alice H.] Korea Adv Inst Sci & Technol, Sch Comp, Daejeon, South Korea; [Hale, Scott A.] Univ Oxford, Oxford Internet Inst, Oxford, England	Korea Advanced Institute of Science & Technology (KAIST); University of Oxford	Oh, AH (corresponding author), Korea Adv Inst Sci & Technol, Sch Comp, Daejeon, South Korea.	alice.oh@kaist.edu	Oh, Alice/C-1712-2011	Kim, Suin/0000-0002-2257-2910; Hale, Scott/0000-0002-6894-4951	Korea Ministry of Science and ICT and Future Planning, UX-oriented Mobile Software Platform [10041313]; John Fell Oxford University Press (OUP) Research Fund; University of Oxford Economic and Social Research Council Impact Acceleration Account [IAA/HEIF-DIA-013]; University of Oxford Higher Education Innovation Fund (HEIF) [IAA/HEIF-DIA-013]	Korea Ministry of Science and ICT and Future Planning, UX-oriented Mobile Software Platform; John Fell Oxford University Press (OUP) Research Fund; University of Oxford Economic and Social Research Council Impact Acceleration Account; University of Oxford Higher Education Innovation Fund (HEIF)	This work was supported by Korea Ministry of Science and ICT and Future Planning, Grant 10041313, UX-oriented Mobile Software Platform; John Fell Oxford University Press (OUP) Research Fund (https://www.admin.ox.ac.uk/pras/jff/); and University of Oxford's Economic and Social Research Council Impact Acceleration Account and Higher Education Innovation Fund (HEIF) (http://www.esrc.ac.uk/collaboration/knowledge-exchange/opportunities/ImpactAccelerationAccounts.aspx), reference: IAA/HEIF-DIA-013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, UNDERSTANDING EDITIN; [Anonymous], 2015, HIST OF WIKIPEDIA; Barron-Hauwaert S, 2011, INT J BILING EDUC BI, V14, P107, DOI 10.1080/13670050.2010.538192; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bulte B, 2014, J SECOND LANG WRIT, V26, P42, DOI 10.1016/j.jslw.2014.09.005; Butler GK., 2002, STUD SECOND LANG ACQ, V24, P451, DOI DOI 10.1017/S0272263102003042; Callahan ES, 2011, J AM SOC INF SCI TEC, V62, P1899, DOI 10.1002/asi.21577; Cohen N., 2015, HUNGRY NEW CONTROL G; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; Danet Brenda, 2007, MULTILINGUAL INTERNE; Dewaele JM, 2010, EMOTIONS IN MULTIPLE LANGUAGES, P1, DOI 10.1057/9780230289505; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Fichman P, 2014, GLOBAL WIKIPEDIA INT; Geiger RS, 2013, CSCW 2013; Golbeck J., 2012, P AM SOC INFORM SCI, V49, P1, DOI DOI 10.1002/MEET.14504901327; Grosjean F., 2010, BILINGUAL LIFE REALI, DOI [10.4159/9780674056459, DOI 10.4159/9780674056459]; Hale SA, 2014, WEBSCI 14; Hale SA, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P183, DOI 10.1145/2702123.2702346; Hale SA, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P833, DOI 10.1145/2556288.2557203; Hale SA, 2012, J COMPUT-MEDIAT COMM, V17, P135, DOI 10.1111/j.1083-6101.2011.01568.x; Haugen Einar, 1969, NORWEGIAN LANGUAGE A; Hautasaari A, 2012, P 4 INT C INT COLL, P57; Hecht B, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P229; Hecht B, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P291; Herring SC, 2007, P 40 ANN HAW INT C S; Hollingshead, 2007, P WORKSH BIONLP 2007, P1, DOI DOI 10.3115/1572392.1572394; Iba T, 2010, PROCD SOC BEHV, V2, P6441, DOI 10.1016/j.sbspro.2010.04.054; Jaensch C., 2008, P 9 GEN APPR 2 LANG, V8189; Keegan B, 2013, AM BEHAV SCI, V57, P595, DOI 10.1177/0002764212469367; Kim S., 2014, P 25 ACM C HYP SOC M, P243, DOI [10.1145/2631775.2631824, DOI 10.1145/2631775.2631824]; Kittur A, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1509; Kleinz T., 2007, WIKIPEDIA ERHALT STA; Kolbitsch J, 2006, J UNIVERS COMPUT SCI, V12, P187; Lewandowski D, 2011, J AM SOC INF SCI TEC, V62, P117, DOI 10.1002/asi.21423; Lieberman MD, 2009, ICWSM; Manning C.D., 1999, FDN STAT NATURAL LAN; Marcus Mitchell, 1993, COMPUTATIONAL LINGUI, DOI DOI 10.21236/ADA273556; McEnery T.R.Xiao., 2006, CORPUS BASED LANGUAG; MdPV Ibanez, 2014, ANNOTATING ARTICLE E; Mestyan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071226; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Ortega Felipe, 2008, P 41 ANN HAW INT C S, P304, DOI DOI 10.1109/HICSS.2008.333; Masucci AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017333; Pavlenko A., 2006, EMOTIONS MULTILINGUA; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ratnaparkhi A., 1996, EMNLP, V1, P133; Ronen S, 2014, P NATL ACAD SCI USA, V111, pE5616, DOI 10.1073/pnas.1410931111; Sen SW, 2015, P SIGCHI C HUM FACT; Skut W, 1998, ESSLLI WORKSH REC AD; Sojka P., 2010, P LREC 2010 WORKSH N; Taule M, 2008, 6 INT C LANG RES EV; Toutanova K., 2003, NAACL 03; Warncke-Wang M, 2012, P 8 ANN INT S WIK OP, V20:1-20:10; WikiStats, 2015, WIKISTATS MEDIAWIKI; Yasseri T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048386	55	7	7	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155305	10.1371/journal.pone.0155305	http://dx.doi.org/10.1371/journal.pone.0155305			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171158	Green Submitted, Green Published, gold			2022-12-27	WOS:000376588600153
J	Kwon, OS; Kim, KT; Lee, E; Kim, M; Choi, SH; Li, HH; Fornace, AJ; Cho, JH; Lee, YS; Lee, JS; Lee, YJ; Cha, HJ				Kwon, Ok-Seon; Kim, Keun-Tae; Lee, Eunioo; Kim, Myoungjae; Choi, Seo-Hyun; Li, Henghong; Fornace, Albert J., Jr.; Cho, Jae-Ho; Lee, Yun-Sil; Lee, Ji-Seon; Lee, Yoon-Jin; Cha, Hyuk-Jin			Induction of MiR-21 by Stereotactic Body Radiotherapy Contributes to the Pulmonary Fibrotic Response	PLOS ONE			English	Article							ENDOTHELIAL-MESENCHYMAL TRANSITION; RADIATION-INDUCED FIBROSIS; MAMMARY EPITHELIAL-CELLS; IONIZING-RADIATION; CIRCULATING MICRORNAS; MOLECULAR-MECHANISMS; RENAL FIBROSIS; LUNG FIBROSIS; UP-REGULATION; IN-VITRO	Radiation-induced lung fibrosis, the most serious effect of lung cancer radiotherapy on normal tissue, remains a major technical obstacle to the broader application of radiotherapy to patients with lung cancer. This study describes the use of an image-guided irradiation system in mice mimicking stereotactic body radiotherapy (SBRT) to examine the molecular features of chronic fibrotic response after radiation injury. MicroRNA (miR) array analysis of injured pulmonary tissue identified a set of miRs whose expression was significantly increased in damaged lung tissue. In particular, miR-21 expression was increased at the radiation injury site, concurrent with collagen deposition. Although the inhibition of miR-21 by its specific inhibitor anti-miR-21 only marginally affected endothelial-mesenchymal transition (EndMT) in lung endothelial cells, this inhibition significantly reduced collagen synthesis in lung fibroblasts. Furthermore, ectopic expression of miR-21 was sufficient to promote a fibrotic response in lung fibroblasts, enhancing Smad2 phosphorylation concurrent with Smad7 downregulation. These findings indicate that the induction of miR-21 expression is responsible for fibrotic responses observed in mesenchymal cells at the injury site through the potentiation of TGF-beta signaling. Local targeting of miR-21 at the injured area could have potential therapeutic utility in mitigating radiation-induced lung fibrosis.	[Kwon, Ok-Seon; Kim, Keun-Tae; Cha, Hyuk-Jin] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Lee, Eunioo; Kim, Myoungjae] Wonkwang Univ, Coll Pharm, Jeonbuk, South Korea; [Lee, Eunioo; Kim, Myoungjae] Wonkwang Univ, Wonkwang Oriental Medicines Res Inst, Jeonbuk, South Korea; [Choi, Seo-Hyun; Lee, Yoon-Jin] Korea Inst Radiol & Med Sci, Div Radiat Effect, Lab Radiat Effect, Seoul, South Korea; [Li, Henghong; Fornace, Albert J., Jr.] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Cho, Jae-Ho] Yonsei Univ, Dept Radiat Oncol, Severance Hosp, Seoul 120749, South Korea; [Lee, Yun-Sil] Ewha Univ Seoul, Sch Pharm, Seoul, South Korea; [Lee, Ji-Seon] Hallym Univ, Coll Med, Hangang Sacred Heart Hosp, Burn Inst, Seoul, South Korea	Sogang University; Wonkwang University; Wonkwang University; Korea Institute of Radiological & Medical Sciences; Georgetown University; Yonsei University; Yonsei University Health System; Ewha Womans University; Hallym University	Cha, HJ (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.; Lee, YJ (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Effect, Lab Radiat Effect, Seoul, South Korea.; Lee, JS (corresponding author), Hallym Univ, Coll Med, Hangang Sacred Heart Hosp, Burn Inst, Seoul, South Korea.	jiseon80@gmail.com; yjlee8@kirams.re.kr; hjcha@sogang.ac.kr	Kim, Keuntae/GYQ-5337-2022; Lee, Yun-Sil/AAP-1378-2020; Cha, Hyuk-Jin/AAB-8508-2020	Lee, Yun-Sil/0000-0002-7538-8850; Cha, Hyuk-Jin/0000-0001-9277-2662; Kim, Keun-Tae/0000-0002-1610-3720; Cho, Jaeho/0000-0001-9966-5157	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2009-0093822, 2012055464, 2015R1D1A3A01017832]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2009-0093822 (HJC), 2012055464 (HJC) and 2015R1D1A3A01017832 (JSL)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2009-0093822, 2012055464, and 2015R1D1A3A010178).	Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Antonadou D, 2001, INT J RADIAT ONCOL, V51, P915, DOI 10.1016/S0360-3016(01)01713-8; AUMAILLEY M, 1982, BIOCHEM J, V206, P505, DOI 10.1042/bj2060505; BEHRENDS U, 1994, J INVEST DERMATOL, V103, P726, DOI 10.1111/1523-1747.ep12398607; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Ding NH, 2013, CURR DRUG TARGETS, V14, P1347; Flechsig P, 2012, CLIN CANCER RES, V18, P3616, DOI 10.1158/1078-0432.CCR-11-2855; Gaugler MH, 1997, INT J RADIAT BIOL, V72, P201, DOI 10.1080/095530097143428; Ghafoori P, 2008, ONCOLOGY-NY, V22, P37; Hashimoto N, 2010, AM J RESP CELL MOL, V43, P161, DOI 10.1165/rcmb.2009-0031OC; Hong ZY, 2014, J RADIAT RES, V55, P648, DOI 10.1093/jrr/rrt234; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kim M, 2013, INT J RADIAT BIOL, V89, P356, DOI 10.3109/09553002.2013.763193; Kumar V, 2015, PHARM RES-DORDR, V32, P341, DOI 10.1007/s11095-014-1497-x; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Li P, 2013, J ASTHMA, V50, P960, DOI 10.3109/02770903.2013.822080; Li Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep02038; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Lv LL, 2013, AM J PHYSIOL-RENAL, V305, pF1220, DOI 10.1152/ajprenal.00148.2013; Ma XD, 2013, CARCINOGENESIS, V34, P1216, DOI 10.1093/carcin/bgt044; Martin M, 2000, Cancer Radiother, V4, P369, DOI 10.1016/S1278-3218(00)00010-X; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nagata Y, 2002, INT J RADIAT ONCOL, V52, P1041, DOI 10.1016/S0360-3016(01)02731-6; Okunieff P, 2004, J CLIN ONCOL, V22, P2207, DOI 10.1200/JCO.2004.09.101; Ong CL, 2010, RADIOTHER ONCOL, V97, P431, DOI 10.1016/j.radonc.2010.10.003; Pandit KV, 2011, TRANSL RES, V157, P191, DOI 10.1016/j.trsl.2011.01.012; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Piera-Velazquez S, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S7; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; RODEMANN HP, 1995, RADIOTHER ONCOL, V35, P83, DOI 10.1016/0167-8140(95)01540-W; Roderburg C, 2014, J HEPATOL, V61, P1434, DOI 10.1016/j.jhep.2014.07.017; Schulz MH, 2013, P NATL ACAD SCI USA, V110, P15686, DOI 10.1073/pnas.1303236110; Stauder MC, 2011, RADIOTHER ONCOL, V99, P166, DOI 10.1016/j.radonc.2011.04.002; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yarnold J, 2010, RADIOTHER ONCOL, V97, P149, DOI 10.1016/j.radonc.2010.09.002; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168	42	28	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154942	10.1371/journal.pone.0154942	http://dx.doi.org/10.1371/journal.pone.0154942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171163	gold, Green Published			2022-12-27	WOS:000376588600072
J	Morriss, J; Macdonald, B; van Reekum, CM				Morriss, Jayne; Macdonald, Birthe; van Reekum, Carien M.			What Is Going On Around Here? Intolerance of Uncertainty Predicts Threat Generalization	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; ANXIETY DISORDER; TRAIT ANXIETY; CONDITIONED FEAR; PANIC DISORDER; EXTINCTION; SYMPTOMS; HUMANS; OVERGENERALIZATION; VALIDATION	Attending to stimuli that share perceptual similarity to learned threats is an adaptive strategy. However, prolonged threat generalization to cues signalling safety is considered a core feature of pathological anxiety. One potential factor that may sustain over-generalization is sensitivity to future threat uncertainty. To assess the extent to which Intolerance of Uncertainty (IU) predicts threat generalization, we recorded skin conductance in 54 healthy participants during an associative learning paradigm, where threat and safety cues varied in perceptual similarity. Lower IU was associated with stronger discrimination between threat and safety cues during acquisition and extinction. Higher IU, however, was associated with generalized responding to threat and safety cues during acquisition, and delayed discrimination between threat and safety cues during extinction. These results were specific to IU, over and above other measures of anxious disposition. These findings highlight: (1) a critical role of uncertainty-based mechanisms in threat generalization, and (2) IU as a potential risk factor for anxiety disorder development.	[Morriss, Jayne; Macdonald, Birthe; van Reekum, Carien M.] Univ Reading, Sch Psychol & Clin Language Sci, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England	University of Reading	van Reekum, CM (corresponding author), Univ Reading, Sch Psychol & Clin Language Sci, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England.	c.vanreekum@reading.ac.uk	Morriss, Jayne/AAI-3826-2021	Morriss, Jayne/0000-0002-7928-9673; Macdonald, Birthe/0000-0002-1927-6117; van Reekum, Carien M./0000-0002-1516-1101	Centre for Integrative Neuroscience and Neurodynamics (CINN) at the University of Reading; Medical Research Council (MRC) doctoral studentship [MR/J003980/1]; Medical Research Council [1372989, 1237113] Funding Source: researchfish	Centre for Integrative Neuroscience and Neurodynamics (CINN) at the University of Reading; Medical Research Council (MRC) doctoral studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Centre for Integrative Neuroscience and Neurodynamics (CINN) at the University of Reading and by a Medical Research Council (MRC) doctoral studentship (MR/J003980/1) awarded to Jayne Morriss.	[Anonymous], 1983, GEN ANXIETY DISORDER; Barrett J, 2009, PSYCHOL MED, V39, P255, DOI 10.1017/S0033291708003516; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4; Carleton RN, 2014, J ANXIETY DISORD, V28, P463, DOI 10.1016/j.janxdis.2014.04.006; Carleton RN, 2013, COGN BEHAV THERAPY, V42, P328, DOI 10.1080/16506073.2013.792100; Dugas M., 2007, COGNITIVE BEHAV TREA; Dugas MJ, 2004, GENERALIZED ANXIETY DISORDER: ADVANCES IN RESEARCH AND PRACTICE, P143; Dunsmoor JE, BIOL PSYCHI IN PRESS; Dunsmoor JE, 2011, NEUROIMAGE, V55, P1878, DOI 10.1016/j.neuroimage.2011.01.041; Dunsmoor JE, 2011, LEARN MEMORY, V18, P156, DOI 10.1101/lm.2016411; Dymond S, 2014, BEHAV THERAPY; Gentes EL, 2011, CLIN PSYCHOL REV, V31, P923, DOI 10.1016/j.cpr.2011.05.001; Gorka SM, 2014, J ANXIETY DISORD, V28, P731, DOI 10.1016/j.janxdis.2014.06.004; Greenberg T, 2013, DEPRESS ANXIETY, V30, P242, DOI 10.1002/da.22016; Greenberg T, 2013, BIOL PSYCHOL, V92, P2, DOI 10.1016/j.biopsycho.2011.12.007; Haddad ADM, 2012, J PSYCHOPATHOL BEHAV, V34, P323, DOI 10.1007/s10862-012-9284-7; Holt DJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00624; LeDoux J., 1998, EMOTIONAL BRAIN MYST; Lissek S., 2012, OXFORD HDB TRAUMATIC, DOI DOI 10.1093/OXFORDHB/9780195399066.013.0013; Lissek S., 2013, SOCIAL COGNITIVE AFF; Lissek S, 2008, BEHAV RES THER, V46, P678, DOI 10.1016/j.brat.2008.02.005; Lissek S, 2014, BIOL PSYCHIAT, V75, P909, DOI 10.1016/j.biopsych.2013.07.025; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Mahoney AEJ, 2012, J BEHAV THER EXP PSY, V43, P849, DOI 10.1016/j.jbtep.2011.12.004; McEvoy PM, 2012, BEHAV THER, V43, P533, DOI 10.1016/j.beth.2011.02.007; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Morriss J, 2015, BIOL MOOD ANXIETY DI, V5, DOI 10.1186/s13587-015-0019-8; Nelson BD, 2014, BEHAV THERAPY; Neumann DL, 2006, BIOL PSYCHOL, V73, P175, DOI 10.1016/j.biopsycho.2006.03.004; Norrholm SD, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00361; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Thibodeau MA, 2015, J ANXIETY DISORD, V31, P49, DOI 10.1016/j.janxdis.2015.01.006; Torrents-Rodas D, 2013, BIOL PSYCHOL, V92, P185, DOI 10.1016/j.biopsycho.2012.10.006; van der Heiden C, 2012, BEHAV RES THER, V50, P100, DOI 10.1016/j.brat.2011.12.005	36	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154494	10.1371/journal.pone.0154494	http://dx.doi.org/10.1371/journal.pone.0154494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CD	27167217	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000376587300106
J	Brown, RT; Goodman, L; Guzman, D; Tieu, L; Ponath, C; Kushel, MB				Brown, Rebecca T.; Goodman, Leah; Guzman, David; Tieu, Lina; Ponath, Claudia; Kushel, Margot B.			Pathways to Homelessness among Older Homeless Adults: Results from the HOPE HOME Study	PLOS ONE			English	Article							RISK-FACTORS; MENTAL-ILLNESS; LIFE-COURSE; COST-EFFECTIVENESS; HEALTH; AGE; POPULATION; PREDICTORS; CARE	Little is known about pathways to homelessness among older adults. We identified life course experiences associated with earlier versus later onset of homelessness in older homeless adults and examined current health and functional status by age at first homelessness. We interviewed 350 homeless adults, aged 50 and older, recruited via population-based sampling. Participants reported age at first episode of adult homelessness and their life experiences during 3 time periods: childhood (<18 years), young adulthood (ages 18-25), and middle adulthood (ages 26-49). We used a structured modeling approach to identify experiences associated with first adult homelessness before age 50 versus at age 50 or older. Participants reported current health and functional status, including recent mental health and substance use problems. Older homeless adults who first became homeless before 50 had more adverse life experiences (i.e., mental health and substance use problems, imprisonment) and lower attainment of adult milestones (i.e., marriage, full-time employment) compared to individuals with later onset. After multivariable adjustment, adverse experiences were independently associated with experiencing a first episode of homelessness before age 50. Individuals who first became homeless before age 50 had higher prevalence of recent mental health and substance use problems and more difficulty performing instrumental activities of daily living. Life course experiences and current vulnerabilities of older homeless adults with first homelessness before age 50 differed from those with later onset of homelessness. Prevention and service interventions should be adapted to meet different needs.	[Brown, Rebecca T.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Brown, Rebecca T.] San Francisco VA Med Ctr, San Francisco, CA USA; [Goodman, Leah] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Guzman, David; Tieu, Lina; Ponath, Claudia; Kushel, Margot B.] Univ Calif San Francisco, Div Gen Internal Med, Zuckerberg San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Guzman, David; Tieu, Lina; Ponath, Claudia; Kushel, Margot B.] Ctr Trauma, San Francisco, CA USA; [Guzman, David; Tieu, Lina; Ponath, Claudia; Kushel, Margot B.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kushel, MB (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, Zuckerberg San Francisco Gen Hosp, San Francisco, CA 94143 USA.; Kushel, MB (corresponding author), Ctr Trauma, San Francisco, CA USA.; Kushel, MB (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA 94143 USA.	Margot.Kushel@ucsf.edu		Tieu, Lina/0000-0002-9980-0774; Kushel, Margot/0000-0002-1361-6889; Brown, Rebecca/0000-0001-7483-4137	National Institute on Aging (NIA) at the National Institutes of Health (NIH) [K23AG045290, K24AG046372, R01AG041860, P30AG044281]; NIH National Center for Advancing Translational Sciences through the University of California, San Francisco, Clinical and Translational Science Institute [KL2TR000143]; NIH National Institute of Minority Health and Health Disparities through the University of California, San Francisco Promoting Research Opportunities Fully-Prospective Academics Transforming Health (PROFPATH) program award [R25MD006832]; UCSF Academic Senate Open Access Publishing Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG046372, P30AG044281, K23AG045290, R01AG041860] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R25MD006832] Funding Source: NIH RePORTER	National Institute on Aging (NIA) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH National Center for Advancing Translational Sciences through the University of California, San Francisco, Clinical and Translational Science Institute; NIH National Institute of Minority Health and Health Disparities through the University of California, San Francisco Promoting Research Opportunities Fully-Prospective Academics Transforming Health (PROFPATH) program award; UCSF Academic Senate Open Access Publishing Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from the National Institute on Aging (NIA) at the National Institutes of Health (NIH) [grant numbers K23AG045290 to RB, K24AG046372 to MK, R01AG041860 to MK, P30AG044281 to RB and MK]; the NIH National Center for Advancing Translational Sciences through the University of California, San Francisco, Clinical and Translational Science Institute [grant number KL2TR000143 to RB]; the NIH National Institute of Minority Health and Health Disparities through the University of California, San Francisco Promoting Research Opportunities Fully-Prospective Academics Transforming Health (PROFPATH) program award [grant number R25MD006832 to L.G.]; and the UCSF Academic Senate Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, FEBR 2015 RENT REP; [Anonymous], 2014, HOUS 1 PERM SUPP HOU; [Anonymous], 2015, HOM EM ASS RAP TRANS, P75791; [Anonymous], 2000, IMPL TRAIN EMBR LIF; [Anonymous], 2014, OP DOORS FED STRAT P; Baker K., 2014, HOUSING AM OLDER ADU; Bamberger JD, 2015, CITYSCAPE, V17, P269; Bland RC, 2001, CAN J PSYCHIAT, V46, P506, DOI 10.1177/070674370104600604; Bravo G, 1997, INT J GERIATR PSYCH, V12, P1008, DOI 10.1002/(SICI)1099-1166(199710)12:10<1008::AID-GPS676>3.0.CO;2-A; Brown RT, 2017, GERONTOLOGIST, V57, P757, DOI 10.1093/geront/gnw011; Brown RT, 2012, J GEN INTERN MED, V27, P16, DOI 10.1007/s11606-011-1848-9; Burt M, 1999, TECHNICAL REPORT; Byrne T, 2014, SOC SERV REV, V88, P234, DOI 10.1086/676142; Cable N, 2014, J EPIDEMIOL, V24, P347, DOI 10.2188/jea.JE20140045; Caton CL, 2004, AM J PUBLIC HEALTH, V84, P265; Caton CLM, 2005, AM J PUBLIC HEALTH, V95, P1753, DOI 10.2105/AJPH.2005.063321; Caton CLM, 2000, AM J PUBLIC HEALTH, V90, P258, DOI 10.2105/AJPH.90.2.258; Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR; Cohen CI, 1999, GERONTOLOGIST, V39, P5, DOI 10.1093/geront/39.1.5; Crane M, 2005, J GERONTOL B-PSYCHOL, V60, pS152, DOI 10.1093/geronb/60.3.S152; Crane M., 1997, HOMELESS TRUTHS CHAL; Crane M., 1996, REV CLIN GERONTOL, V6, P389, DOI [https://doi.org/10.1017/S0959259800002409, DOI 10.1017/S0959259800002409]; Culhane DP, 2013, ANAL SOC ISS PUB POL, V13, P228, DOI 10.1111/asap.12004; Dietz TL, 2009, J APPL GERONTOL, V28, P235, DOI 10.1177/0733464808326006; Dumont DM, 2012, ANNU REV PUBL HEALTH, V33, P325, DOI 10.1146/annurev-publhealth-031811-124614; Dunn LB, 2001, NEUROPSYCHOPHARMACOL, V24, P595, DOI 10.1016/S0893-133X(00)00218-9; GELBERG L, 1990, J AM GERIATR SOC, V38, P1220, DOI 10.1111/j.1532-5415.1990.tb01503.x; Gonyea JG, 2010, J GERONTOL SOC WORK, V53, P575, DOI 10.1080/01634372.2010.510169; Green HD, 2012, CHILD ABUSE NEGLECT, V36, P21, DOI 10.1016/j.chiabu.2011.07.005; Hahn JA, 2006, J GEN INTERN MED, V21, P775, DOI 10.1111/j.1525-1497.2006.00493.x; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hollingshead AB, 2007, AM J PUBLIC HEALTH, V97, P1756; Humeniuk R. E., 2010, ALCOHOL SMOKING SUBS; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Joint Center for Housing Studies, 2015, STAT NAT HOUS; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Mishra G, 2009, INT J EPIDEMIOL, V38, P528, DOI 10.1093/ije/dyn229; Murray ET, 2015, INT J OBESITY, V39, P1010, DOI 10.1038/ijo.2015.19; Padgett DK, 2012, AM J ORTHOPSYCHIAT, V82, P421, DOI 10.1111/j.1939-0025.2012.01159.x; Patterson ML, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-350; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rockeymoore M, 2014, RACIAL WEALTH GAP AF; Rosenheck R, 2003, ARCH GEN PSYCHIAT, V60, P940, DOI 10.1001/archpsyc.60.9.940; Sermons M. W., 2010, DEMOGRAPHICS HOMELES; Shelton KH, 2009, PSYCHIAT SERV, V60, P465, DOI 10.1176/appi.ps.60.4.465; Shinn M, 2007, J HEALTH PSYCHOL, V12, P696, DOI 10.1177/1359105307080581; STERGIOPOULOS V, 2015, JAMA-J AM MED ASSOC, V313, P905, DOI DOI 10.1001/JAMA.2015.1163; Stergiopoulos V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130281; Sullivan G, 2001, PSYCHIATR SERV, V52, P1097, DOI 10.1176/appi.ps.52.8.1097; SUSSER E, 1993, EPIDEMIOL REV, V15, P546, DOI 10.1093/oxfordjournals.epirev.a036133; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Watson DP, CARE MAJOR HLTH PROB, P187; Weiser SD, 2013, J GEN INTERN MED, V28, P91, DOI 10.1007/s11606-012-2176-4; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279; Yamane David P, 2010, Hawaii Med J, V69, P35	57	59	59	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155065	10.1371/journal.pone.0155065	http://dx.doi.org/10.1371/journal.pone.0155065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8BN	27163478	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700034
J	Gebremedhin, D; Berhe, H; Gebrekirstos, K				Gebremedhin, Destaalem; Berhe, Haftu; Gebrekirstos, Kahsu			Risk Factors for Neonatal Sepsis in Public Hospitals of Mekelle City, North Ethiopia, 2015: Unmatched Case Control Study	PLOS ONE			English	Article							DEATH	Objectives Neonatal sepsis is a leading cause of neonatal morbidity and mortality, particularly in the developing countries. Delays in the identification and treatment of neonatal sepsis are among the main contributors to the high mortality. The aim of this study was to determine the risk factors of neonatal sepsis in public hospitals of Mekelle City, Tigray Region, North Ethiopia, 2015. Methods A hospital based case control study was done in public hospitals of Mekelle City, Tigray region. Cases were neonates who had sepsis with their index mothers and controls were neonates who hadn't had sepsis with their index mothers. Hematologic findings were used to diagnose sepsis once the neonates were being clinically suspected. Cases and controls were selected using the systematic sampling technique. Data were entered using Epi info version 7 and then analyzed using SPSS window 20. The binary logistic regression model was used to test the association between dependent and independent variables and multivariable logistic regression was used to identify the associated risk factors to neonatal sepsis. Findings A total of 78 cases and 156 controls were included in this study. More than three quarters (76.8%) of cases had early onset sepsis. The multivariable logistic regression analysis showed that the possible risk factors of neonatal sepsis in this study were; history of maternal urinary tract infection or sexually transmitted infection [AOR = 5. 23; 95% CI (1.82, 15.04)], prolonged rupture of membrane [AOR = 7. 43; 95% CI (2.04, 27.1)], Place of delivery; health center delivery [AOR = 5. 7; 95% CI (1.71, 19.03)], intrapartum fever [AOR = 6. 1 95% CI (1.29, 28.31)], APGAR score <7 at 5th minute [AOR = 68. 9; 95% CI (3.63, 1308)] and not crying immediately at birth [AOR = 124. 0; 95% CI (6.5, 2379)]. Conclusion Both maternal and neonatal factors had contributed to the risk of neonatal sepsis. Strengthening of the existing risk based prevention strategies as well as improvement of institutional delivery practices are crucial.	[Gebremedhin, Destaalem] Dr Tewelde Legesse Hlth Sci Coll, Mekelle, Ethiopia; [Berhe, Haftu; Gebrekirstos, Kahsu] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University	Gebremedhin, D (corresponding author), Dr Tewelde Legesse Hlth Sci Coll, Mekelle, Ethiopia.	destaalem1@gmail.com		Gebrekidan, Kahsu Geberekirstos/0000-0002-0933-1805				Alam MM, 2014, J INFECT DEV COUNTR, V8, P67, DOI 10.3855/jidc.3136; Amare Gebrehiwot, 2012, Der Pharmacia Lettre, V4, P1811; [Anonymous], 2011, J BANGLADESH COLL PH, DOI DOI 10.3329/JBCPS.V29I4.11324; Berhanu D, 2014, COMMUNITY BASED NEON; Bhat YR, 2011, J CLIN DIAGN RES, V5, P1385; Boia M, 2010, JURNALUL PEDIAT, V8, P49; Chacko Betty, 2005, Indian Journal of Pediatrics, V72, P23; Chu SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105294; Dawodu A, 1997, J TROP PEDIATRICS, V45, P146; Demissie S., 2008, NEONATAL SEPSIS BACT; Edmond K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000213; Federal Ministry of Health, 2014, HMIS REP; Gebrehiwot A., 2012, EUR J EXP BIOL, V2, P2212; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Haque KN, 2007, J HOSP INFECT, V65, P110, DOI 10.1016/S0195-6701(07)60026-7; Qazi SA, 2009, PEDIATR INFECT DIS J, V28, pS1, DOI 10.1097/INF.0b013e31819587a9; RAGHAVAN M, 1992, Indian Journal of Pediatrics, V59, P335, DOI 10.1007/BF02821801; Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a; Shah G S, 2006, Kathmandu Univ Med J (KUMJ), V4, P187; Shitaye Demissie, 2010, Ethiop Med J, V48, P11; SIAKWA MATE, 2014, IJRMHS K A J, V4, P77; SOMAN M, 1985, AM J EPIDEMIOL, V121, P712, DOI 10.1093/aje/121.5.712; Stefanovic IM, 2011, BIOCHEM MEDICA, V21, P276; United Nations Children's Fund (UNICEF), COMM CHILD SURV PROM; Utomo MT, 2010, INDONESIAN J TROP IN, V1, P23, DOI [10.20473/IJTID.V1I1.3718, DOI 10.20473/IJTID.V1I1.3718]; Woldu M.A., 2014, PEDIATHERAPEUT, V4, P214, DOI [10.4172/2161-0665.1000214, DOI 10.4172/2161-0665.1000214]; World Health Organization, 2014, EV NEWB ACT PLAN END	27	57	58	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154798	10.1371/journal.pone.0154798	http://dx.doi.org/10.1371/journal.pone.0154798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163290	Green Published, gold, Green Submitted			2022-12-27	WOS:000376585700038
J	Mayer, M; Kaiser, N; Layer, PG; Frohns, F				Mayer, Margot; Kaiser, Nicole; Layer, Paul G.; Frohns, Florian			Cell Cycle Regulation and Apoptotic Responses of the Embryonic Chick Retina by Ionizing Radiation	PLOS ONE			English	Article							STRAND BREAK REPAIR; NEURAL STEM; DIFFERENTIATION; CHOLINESTERASES; REQUIREMENT; BRAIN; ATM; PHOSPHORYLATION; PHOTORECEPTORS; PROLIFERATION	Ionizing radiation (IR) exerts deleterious effects on the developing brain, since proliferative neuronal progenitor cells are highly sensitive to IR-induced DNA damage. Assuming a radiation response that is comparable to mammals, the chick embryo would represent a lower vertebrate model system that allows analysis of the mechanisms underlying this sensitivity, thereby contributing to the reduction, refinement and replacement of animal experiments. Thus, this study aimed to elucidate the radiation response of the embryonic chick retina in three selected embryonic stages. Our studies reveal a lack in the radiation-induced activation of a G1/S checkpoint, but rapid abrogation of G2/M progression after IR in retinal progenitors throughout development. Unlike cell cycle control, radiation-induced apoptosis (RIA) showed strong variations between its extent, dose dependency and temporal occurrence. Whereas the general sensitivity towards RIA declined with ongoing differentiation, its dose dependency constantly increased with age. For all embryonic stages RIA occurred during comparable periods after irradiation, but in older animals its maximum shifted towards earlier post-irradiation time points. In summary, our results are in good agreement with data from the developing rodent retina, strengthening the suitability of the chick embryo for the analysis of the radiation response in the developing central nervous system.	[Mayer, Margot; Kaiser, Nicole; Layer, Paul G.; Frohns, Florian] Tech Univ Darmstadt, Dev Biol & Neurogenet, Darmstadt, Germany	Technical University of Darmstadt	Frohns, F (corresponding author), Tech Univ Darmstadt, Dev Biol & Neurogenet, Darmstadt, Germany.	Frohns@bio.tu-darmstadt.de			BMBF [50WB1228];  [GRK 1657]	BMBF(Federal Ministry of Education & Research (BMBF)); 	This work was supported by the GRK 1657 and BMBF (project 50WB1228).; Special thanks to Antonia Frohns (Darmstadt, Germany) for useful discussions and final figure arrangement. This work was supported by the GRK 1657 and BMBF (project 50WB1228).	Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Borges HL, 2004, CELL DEATH DIFFER, V11, P494, DOI 10.1038/sj.cdd.4401366; Borges HL, 1999, J CELL SCI, V112, P4315; Campos CBL, 2002, NEUROSCIENCE, V112, P583, DOI 10.1016/S0306-4522(02)00096-9; Chatoo W, 2010, STEM CELLS, V28, P1412, DOI 10.1002/stem.462; Chiarini LB, 2003, J NEUROSCI RES, V74, P875, DOI 10.1002/jnr.10739; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Deckbar D, 2010, CANCER RES, V70, P4412, DOI 10.1158/0008-5472.CAN-09-3198; Fard SS, 2014, CELL CYCLE, V13, P3698, DOI 10.4161/15384101.2014.964985; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Frohns A, 2014, CURR BIOL, V24, P1080, DOI 10.1016/j.cub.2014.03.061; Frohns F, 2009, EUR J NEUROSCI, V29, P1931, DOI 10.1111/j.1460-9568.2009.06738.x; Gatz SA, 2011, J NEUROSCI, V31, P10088, DOI 10.1523/JNEUROSCI.1324-11.2011; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Layer PG, 2013, CHEM-BIOL INTERACT, V203, P269, DOI 10.1016/j.cbi.2012.09.014; LAYER PG, 1983, NEUROSCIENCE, V9, P931, DOI 10.1016/0306-4522(83)90282-8; LAYER PG, 1994, INT REV CYTOL, V151, P139, DOI 10.1016/S0074-7696(08)62632-7; LAYER PG, 1987, P NATL ACAD SCI USA, V84, P284, DOI 10.1073/pnas.84.1.284; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; LIU L, 1983, DEV BRAIN RES, V8, P223, DOI 10.1016/0165-3806(83)90007-X; Mizumatsu S, 2003, CANCER RES, V63, P4021; Nowak E, 2006, RADIAT RES, V165, P155, DOI 10.1667/RR3496.1; Pernaute B, 2014, GENE DEV, V28, P1873, DOI 10.1101/gad.245621.114; Roque T, 2012, STEM CELLS, V30, P537, DOI 10.1002/stem.1010; Saha S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0783; Shibasaki K, 2007, GENE EXPR PATTERNS, V7, P57, DOI 10.1016/j.modgep.2006.05.008; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Woodbine L, 2015, INT J RADIAT BIOL, V91, P495, DOI 10.3109/09553002.2015.1021963; Wright KM, 2004, J CELL BIOL, V167, P303, DOI 10.1083/jcb.200406073	31	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155093	10.1371/journal.pone.0155093	http://dx.doi.org/10.1371/journal.pone.0155093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163610	Green Submitted, Green Published, gold			2022-12-27	WOS:000376585700011
J	Bajor, M; Zareba-Koziol, M; Zhukova, L; Goryca, K; Poznanski, J; Wyslouch-Cieszynska, A				Bajor, Malgorzata; Zareba-Koziol, Monika; Zhukova, Liliya; Goryca, Krzysztof; Poznanski, Jaroslaw; Wyslouch-Cieszynska, Aleksandra			An Interplay of S-Nitrosylation and Metal Ion Binding for Astrocytic S100B Protein	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CALCIUM-BINDING; STRUCTURAL-CHANGES; RECOMBINANT S100-BETA; ZINC; OXIDATION; SITES; IDENTIFICATION; EXPRESSION; BIOMARKER	Mammalian S100B protein plays multiple important roles in cellular brain processes. The protein is a clinically used marker for several pathologies including brain injury, neurodegeneration and cancer. High levels of S100B released by astrocytes in Down syndrome patients are responsible for reduced neurogenesis of neural progenitor cells and induction of cell death in neurons. Despite increasing understanding of S100B biology, there are still many questions concerning the detailed molecular mechanisms that determine specific activities of S100B. Elevated overexpression of S100B protein is often synchronized with increased nitric oxide-related activity. In this work we show S100B is a target of exogenous S-nitrosylation in rat brain protein lysate and identify endogenous S-nitrosylation of S100B in a cellular model of astrocytes. Biochemical studies are presented indicating S-nitrosylation tunes the conformation of S100B and modulates its Ca2+ and Zn2+ binding properties. Our in vitro results suggest that the possibility of endogenous S-nitrosylation should be taken into account in the further studies of in vivo S100B protein activity, especially under conditions of increased NO-related activity.	[Bajor, Malgorzata; Zareba-Koziol, Monika; Zhukova, Liliya; Goryca, Krzysztof; Poznanski, Jaroslaw; Wyslouch-Cieszynska, Aleksandra] Polish Acad Sci, Inst Biochem & Biophys, Dept Biophys, Warsaw, Poland; [Bajor, Malgorzata] Med Univ Warsaw, Dept Immunol, Ctr Biostruct Res, Warsaw, Poland; [Zareba-Koziol, Monika] Polish Acad Sci, Nencki Inst, Dept Mol & Cellular Neurobiol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Medical University of Warsaw; Polish Academy of Sciences	Wyslouch-Cieszynska, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Biophys, Warsaw, Poland.	olawyslouch@gmail.com	Poznanski, Jaroslaw/F-7705-2014; Zareba-Koziol, Monika/E-1276-2015	Poznanski, Jaroslaw/0000-0003-2684-1775; Zareba-Koziol, Monika/0000-0003-3544-6259; Wyslouch Cieszynska, Aleksandra/0000-0002-7006-2456; Zhukova, Lilia/0000-0001-8607-2918; Bajor, Malgorzata/0000-0001-5778-0165	Polish Ministry of Science and Higher Education [2543/B/P01/2007/33]; National Center for Research and Development [POIG.01.01.02-00-048/09]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Center for Research and Development(National Centre for Research & Development, Poland)	This study was supported by grants from Polish Ministry of Science and Higher Education (2543/B/P01/2007/33; http://www.nauka.gov.pl/en/) to AWC and National Center for Research and Development (POIG.01.01.02-00-048/09; http://www.ncbr.gov.pl/en/) to AWC.	Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; BAUDIER J, 1983, BIOCHEMISTRY-US, V22, P3360, DOI 10.1021/bi00283a009; BAUDIER J, 1986, J BIOL CHEM, V261, P8204; BAUDIER J, 1983, BIOCHEM BIOPH RES CO, V114, P1138, DOI 10.1016/0006-291X(83)90681-2; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Charpentier TH, 2010, J MOL BIOL, V396, P1227, DOI 10.1016/j.jmb.2009.12.057; Chen C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5430; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Deloulme Jean Christophe, 2002, Methods Mol Biol, V172, P185; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2009, BIOCH BIOPHYSICA ACT, V1793; Drohat AC, 1998, BIOCHEMISTRY-US, V37, P2729, DOI 10.1021/bi972635p; Drohat AC, 1999, PROTEIN SCI, V8, P800; Durussel I, 1997, BBA-PROTEIN STRUCT M, V1343, P139, DOI 10.1016/S0167-4838(97)00106-4; Esposito G, 2006, LIFE SCI, V78, P2707, DOI 10.1016/j.lfs.2005.10.023; Esposito G, 2007, GASTROENTEROLOGY, V133, P918, DOI 10.1053/j.gastro.2007.06.009; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; GAYNOR R, 1981, LANCET, V1, P869; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hartman KG, 2013, FUTURE MED CHEM, V5, P97, DOI 10.4155/fmc.12.191; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JENSEN R, 1985, J NEUROCHEM, V45, P700, DOI 10.1111/j.1471-4159.1985.tb04048.x; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Job P, 1928, ANN CHIM FRANCE, V9, P113; Keeler C, 2013, BIOPHYS J, V105, P2843, DOI 10.1016/j.bpj.2013.11.017; Kocyla A, 2015, J INORG BIOCHEM, V152, P82, DOI 10.1016/j.jinorgbio.2015.08.024; Kohr MJ, 2011, AM J PHYSIOL-HEART C, V300, pH1327, DOI 10.1152/ajpheart.00997.2010; Koppal T, 2001, NEUROCHEM INT, V39, P401, DOI 10.1016/S0197-0186(01)00047-X; Krezel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P188, DOI 10.1016/j.abb.2007.02.017; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Lara DR, 2001, J PSYCHIATR RES, V35, P11, DOI 10.1016/S0022-3956(01)00003-6; Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.212269799; Lim SY, 2009, J LEUKOCYTE BIOL, V86, P577, DOI 10.1189/jlb.1008608; Lim SY, 2008, CYTOKINE, V43, P263, DOI 10.1016/j.cyto.2008.07.157; Linse Sara, 2002, Methods Mol Biol, V173, P15; MANI RS, 1984, FEBS LETT, V166, P258, DOI 10.1016/0014-5793(84)80091-5; Martinez-Ruiz A, 2013, ANTIOXID REDOX SIGN, V19, P1220, DOI 10.1089/ars.2012.5066; MELY Y, 1990, J NEUROCHEM, V55, P1100, DOI 10.1111/j.1471-4159.1990.tb03111.x; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Murray CI, 2012, CIRC-CARDIOVASC GENE, V5, pO1, DOI 10.1161/CIRCGENETICS.111.961425; Nakamura T, 2011, CELL DEATH DIFFER, V18, P1478, DOI 10.1038/cdd.2011.65; Nakamura T, 2013, NEURON, V78, P596, DOI 10.1016/j.neuron.2013.05.005; Nardin P, 2007, NEUROCHEM INT, V50, P774, DOI 10.1016/j.neuint.2007.01.013; Nelson MR, 2002, PROTEIN SCI, V11, P198, DOI 10.1110/ps.33302; Okamoto S, 2014, CELL REP, V8, P217, DOI 10.1016/j.celrep.2014.06.005; Ostendorp T, 2011, BBA-MOL CELL RES, V1813, P1083, DOI 10.1016/j.bbamcr.2010.10.006; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Poznanski J, 2005, BIOPHYS CHEM, V113, P137, DOI 10.1016/j.bpc.2004.08.007; Rutkowska-Wlodarczyk I, 2008, BIOCHEMISTRY-US, V47, P2710, DOI 10.1021/bi701168z; Sabel CE, 2009, ANAL BIOCHEM, V391, P74, DOI 10.1016/j.ab.2009.05.007; Sanchez-Juan P, 2006, NEUROLOGY, V67, P637, DOI 10.1212/01.wnl.0000230159.67128.00; Schroeter ML, 2013, CURR DRUG TARGETS, V14, P1237; Sokolowska M, 2009, J INORG BIOCHEM, V103, P1005, DOI 10.1016/j.jinorgbio.2009.04.011; Sorci G, 2010, CARDIOVASC PSYCHIAT, V2010; Sorci Guglielmo, 2013, World J Biol Chem, V4, P1, DOI 10.4331/wjbc.v4.i1.1; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; van Dieck J, 2009, J MOL BIOL, V394, P922, DOI 10.1016/j.jmb.2009.10.002; Wafer LN, 2012, BIOCHEMISTRY-US, V51, P7189, DOI 10.1021/bi300865g; Wilder PT, 2005, BIOCHEMISTRY-US, V44, P5690, DOI 10.1021/bi0475830; Wilder PT, 2003, BIOCHEMISTRY-US, V42, P13410, DOI 10.1021/bi035334q; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Wu CG, 2013, METHODS, V62, P151, DOI 10.1016/j.ymeth.2013.02.002; Zareba-Koziol M, 2014, MOL CELL PROTEOMICS, V13, P2288, DOI 10.1074/mcp.M113.036079; Zhukova L, 2004, BBA-MOL CELL RES, V1742, P191, DOI 10.1016/j.bbamcr.2004.10.002; Zimmer D.B., 2010, CARDIOVASC PSYCHIAT, V2010; Zivkovic ML, 2012, J BIOL CHEM, V287, P40457, DOI 10.1074/jbc.M112.418392	76	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154822	10.1371/journal.pone.0154822	http://dx.doi.org/10.1371/journal.pone.0154822			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159591	Green Submitted, Green Published, gold			2022-12-27	WOS:000376576700017
J	Etemadi, L; Mohammed, M; Thorbergsson, PT; Ekstrand, J; Friberg, A; Granmo, M; Pettersson, LME; Schouenborg, J				Etemadi, Leila; Mohammed, Mohsin; Thorbergsson, Palmi Thor; Ekstrand, Joakim; Friberg, Annika; Granmo, Marcus; Pettersson, Lina M. E.; Schouenborg, Jens			Embedded Ultrathin Cluster Electrodes for Long-Term Recordings in Deep Brain Centers	PLOS ONE			English	Article							SILICON MICROELECTRODE ARRAYS; CEREBRAL-CORTEX; NEURAL INTERFACES; TISSUE RESPONSE; PARYLENE-C; STIMULATION; IMPLANTS; MICROMOTION; SYSTEM; DEVICE	Neural interfaces which allow long-term recordings in deep brain structures in awake freely moving animals have the potential of becoming highly valuable tools in neuroscience. However, the recording quality usually deteriorates over time, probably at least partly due to tissue reactions caused by injuries during implantation, and subsequently micro-forces due to a lack of mechanical compliance between the tissue and neural interface. To address this challenge, we developed a gelatin embedded neural interface comprising highly flexible electrodes and evaluated its long term recording properties. Bundles of ultrathin parylene C coated platinum electrodes (N = 29) were embedded in a hard gelatin based matrix shaped like a needle, and coated with Kollicoat (TM) to retard dissolution of gelatin during the implantation. The implantation parameters were established in an in vitro model of the brain (0.5% agarose). Following a craniotomy in the anesthetized rat, the gelatin embedded electrodes were stereotactically inserted to a pre-target position, and after gelatin dissolution the electrodes were further advanced and spread out in the area of the subthalamic nucleus (STN). The performance of the implanted electrodes was evaluated under anesthesia, during 8 weeks. Apart from an increase in the median-noise level during the first 4 weeks, the electrode impedance and signal-to-noise ratio of single-units remained stable throughout the experiment. Histological postmortem analysis confirmed implantation in the area of STN in most animals. In conclusion, by combining novel biocompatible implantation techniques and ultra-flexible electrodes, long-term neuronal recordings from deep brain structures with no significant deterioration of electrode function were achieved.	[Etemadi, Leila; Mohammed, Mohsin; Thorbergsson, Palmi Thor; Ekstrand, Joakim; Friberg, Annika; Granmo, Marcus; Pettersson, Lina M. E.; Schouenborg, Jens] Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, Lund, Sweden	Lund University	Mohammed, M; Pettersson, LME; Schouenborg, J (corresponding author), Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, Lund, Sweden.	mohsin.mohammed@med.lu.se; lina.pettersson@med.lu.se; jens.schouenborg@med.lu.se	Mohammed, Mohsin/AAR-5333-2020	Pettersson, Lina/0000-0002-6847-8823; Ekstrand, Joakim/0000-0003-3179-8652; Etemadi, Leila/0000-0002-2432-7863; Friberg, Annika/0000-0002-0566-2981; Thorbergsson, Palmi Thor/0000-0002-7706-1966; Schouenborg, Jens/0000-0002-2815-6918	Linnaeus grant from the Swedish Research Council [600012701]; Medical Faculty at Lund University; Swedish Research Council [01013]; Knut and Alice Wallenberg foundation [KAW 2004.0119]	Linnaeus grant from the Swedish Research Council; Medical Faculty at Lund University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation)	This study was financed by a Linnaeus grant (Project number 600012701) from the Swedish Research Council (http://www.vr.se/2.5b24e27d107949d9e3880000.html) and the Medical Faculty at Lund University (http://www.med.lu.se/english), the Swedish Research Council Project 01013 as well as a grant from the Knut and Alice Wallenberg foundation (KAW 2004.0119 (https://www.wallenberg.com/kaw/). JS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorelius J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00331, 10.3389/fnins.2015.00331]; Benabid AL, 2007, EXPERT REV MED DEVIC, V4, P895, DOI 10.1586/17434440.4.6.895; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138; Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002; Boulet S, THE JOURNAL OF NEURO; Cheung KC, 2007, BIOMED MICRODEVICES, V9, P923, DOI 10.1007/s10544-006-9045-z; Cheung KC, 2007, BIOSENS BIOELECTRON, V22, P1783, DOI 10.1016/j.bios.2006.08.035; Clark CG, 2013, J PHYSIOL-LONDON, V591, P2379, DOI 10.1113/jphysiol.2013.253138; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Deepthi R., 2010, SAS TECH J, V9, P27; Desai Sharanya Arcot, 2010, Front Neuroeng, V3, P5, DOI 10.3389/fneng.2010.00005; EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202; Freire MAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027554; Gilletti A, 2006, J NEURAL ENG, V3, P189, DOI 10.1088/1741-2560/3/3/001; Gonzalez C, 1997, J NEUROSCI METH, V72, P189, DOI 10.1016/S0165-0270(96)02202-9; GRILL WM, 1994, ANN BIOMED ENG, V22, P23, DOI 10.1007/BF02368219; Halpern CH, 2008, NEUROTHERAPEUTICS, V5, P59, DOI 10.1016/j.nurt.2007.10.065; Hassler C, 2011, IEEE ENG MED BIO, P644, DOI 10.1109/IEMBS.2011.6090143; Heiduschka P, 1998, PROG NEUROBIOL, V55, P433, DOI 10.1016/S0301-0082(98)00013-6; Heim M, 2012, J PHYSIOL-PARIS, V106, P137, DOI 10.1016/j.jphysparis.2011.10.001; Hemm S, 2010, MED BIOL ENG COMPUT, V48, P611, DOI 10.1007/s11517-010-0633-y; Howard MA, 1999, IEEE T BIO-MED ENG, V46, P891, DOI 10.1109/10.771205; Jensen W, 2006, IEEE T BIO-MED ENG, V53, P934, DOI 10.1109/TBME.2006.872824; Johnson MD, 2007, J NEUROSCI METH, V160, P276, DOI 10.1016/j.jneumeth.2006.09.023; Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010; Kipke DR, 2008, J NEUROSCI, V28, P11830, DOI 10.1523/JNEUROSCI.3879-08.2008; Kipke DR, 2002, 2002 IEEE NAT S CIRC, VIv, P173; Kohler P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119340; Kozai TDY, 2009, J NEUROSCI METH, V184, P199, DOI 10.1016/j.jneumeth.2009.08.002; Leach Jennie B, 2010, Front Neuroeng, V2, P18, DOI 10.3389/neuro.16.018.2009; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lind G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02942; Lind G, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046005; Litt B, 2007, NEUROLOGY, V68, P250, DOI 10.1212/01.wnl.0000255912.43452.12; Loeb GE, 1995, J NEUROSCI METH, V63, P175, DOI 10.1016/0165-0270(95)00107-7; Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007; McMahon DBT, 2014, J NEUROPHYSIOL, V112, P1748, DOI 10.1152/jn.00052.2014; Metallo C, 2011, J NEUROSCI METH, V195, P176, DOI 10.1016/j.jneumeth.2010.12.005; Mitra P., 2007, OBSERVED BRAIN DYNAM; Muthuswamy J, 2003, P ANN INT IEEE EMBS, V25, P1941, DOI 10.1109/IEMBS.2003.1279819; Nolta NF, 2015, BIOMATERIALS, V53, P753, DOI 10.1016/j.biomaterials.2015.02.081; Polanco M, 2012, PROC SPIE, V8344, DOI 10.1117/12.917477; Polikov VS, 2006, BIOMATERIALS, V27, P5368, DOI 10.1016/j.biomaterials.2006.06.018; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Prasad A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026028; Priori A, 2013, EXP NEUROL, V245, P77, DOI 10.1016/j.expneurol.2012.09.013; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; ROBINSON DA, 1968, PR INST ELECTR ELECT, V56, P1065, DOI 10.1109/PROC.1968.6458; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Sankar Viswanath, 2014, Front Neuroeng, V7, P13, DOI 10.3389/fneng.2014.00013; Santaniello S, 2011, IEEE T NEUR SYS REH, V19, P15, DOI 10.1109/TNSRE.2010.2081377; SCHMIDT EM, 1988, MED BIOL ENG COMPUT, V26, P96, DOI 10.1007/BF02441836; Song S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16959; Sridharan A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066001; Stacey WC, 2008, NAT CLIN PRACT NEURO, V4, P190, DOI 10.1038/ncpneuro0750; Stanslaski S, 2012, IEEE T NEUR SYS REH, V20, P410, DOI 10.1109/TNSRE.2012.2183617; Suner S, 2005, IEEE T NEUR SYS REH, V13, P524, DOI 10.1109/TNSRE.2005.857687; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Tang RY, 2014, SCI CHINA INFORM SCI, V57, DOI 10.1007/s11432-013-4825-6; Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267; Townsend G, 2002, BRAIN RES PROTOC, V9, P122, DOI 10.1016/S1385-299X(02)00139-3; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; Wang C, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046010; Ward MP, 2009, BRAIN RES, V1282, P183, DOI 10.1016/j.brainres.2009.05.052; Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3; Wise KD, 2004, P IEEE, V92, P76, DOI 10.1109/JPROC.2003.820544; Witteveen JA, 2010, J VAC SCI TECHNOL B, V28, pC6K13, DOI 10.1116/1.3498764; Wood F, 2004, IEEE T BIO-MED ENG, V51, P912, DOI 10.1109/TBME.2004.826677; Xiao YH, 2004, J ELECTROANAL CHEM, V573, P43, DOI 10.1016/j.jelechem.2004.06.024; Zhang CH, 2011, ACTA BIOMATER, V7, P3746, DOI 10.1016/j.actbio.2011.06.003; Zhong YH, 2005, J CONTROL RELEASE, V106, P309, DOI 10.1016/j.jconrel.2005.05.012	74	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155109	10.1371/journal.pone.0155109	http://dx.doi.org/10.1371/journal.pone.0155109			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159159	Green Published, gold			2022-12-27	WOS:000376576700045
J	Nardi, P; Di Matteo, G; Palahi, M; Mugnozza, GS				Nardi, Pierfrancesco; Di Matteo, Giovanni; Palahi, Marc; Mugnozza, Giuseppe Scarascia			Structure and Evolution of Mediterranean Forest Research: A Science Mapping Approach	PLOS ONE			English	Article							TERRESTRIAL ECOSYSTEMS; RESEARCH PRIORITIES; RESEARCH TRENDS; KNOWLEDGE	This study aims at conducting the first science mapping analysis of the Mediterranean forest research in order to elucidate its research structure and evolution. We applied a science mapping approach based on co-term and citation analyses to a set of scientific publications retrieved from the Elsevier's Scopus database over the period 1980-2014. The Scopus search retrieved 2,698 research papers and reviews published by 159 peer-reviewed journals. The total number of publications was around 1% (N = 17) during the period 1980-1989 and they reached 3% (N = 69) in the time slice 1990-1994. Since 1995, the number of publications increased exponentially, thus reaching 55% (N = 1,476) during the period 2010-2014. Within the thirty-four years considered, the retrieved publications were published by 88 countries. Among them, Spain was the most productive country, publishing 44% (N = 1,178) of total publications followed by Italy (18%, N = 482) and France (12%, N = 336). These countries also host the ten most productive scientific institutions in terms of number of publications in Mediterranean forest subjects. Forest Ecology and Management and Annals of Forest Science were the most active journals in publishing research in Mediterranean forest. During the period 1980-1994, the research topics were poorly characterized, but they become better defined during the time slice 1995-1999. Since 2000s, the clusters become well defined by research topics. Current status of Mediterranean forest research (20092014) was represented by four clusters, in which different research topics such as biodiversity and conservation, land-use and degradation, climate change effects on ecophysiological responses and soil were identified. Basic research in Mediterranean forest ecosystems is mainly conducted by ecophysiological research. Applied research was mainly represented by land-use and degradation, biodiversity and conservation and fire research topics. The citation analyses revealed highly cited terms in the Mediterranean forest research as they were represented by fire, biodiversity, carbon sequestration, climate change and global warming. Finally, our analysis also revealed the multidisciplinary role of climate change research. This study provides a first holistic view of the Mediterranean forest research that could be useful for researchers and policy makers as they may evaluate and analyze its historical evolution, as well as its structure and scientific production. We concluded that Mediterranean forest research represents an active scientific field.	[Nardi, Pierfrancesco; Di Matteo, Giovanni] Consiglio Ric Agr & Anal Econ Agr, Res Unit Climatol & Meteorol Appl Agr, Rome, Italy; [Palahi, Marc] European Forest Inst, Joensuu, Finland; [Mugnozza, Giuseppe Scarascia] Univ Tuscia, Dept Innovat Biol Agro Food & Forest Syst, Viterbo, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Tuscia University	Nardi, P (corresponding author), Consiglio Ric Agr & Anal Econ Agr, Res Unit Climatol & Meteorol Appl Agr, Rome, Italy.	pierfrancesco.nardi@entecra.it	Nardi, Pierfrancesco/AAI-8925-2020	Nardi, Pierfrancesco/0000-0002-0305-6558; Di Matteo, Giovanni/0000-0002-5310-6509	Seventh Framework Programme [291832]	Seventh Framework Programme(European Commission)	This work was supported by Seventh Framework Programme, Grant Number: 291832.	Aguillo IF, 2012, SCIENTOMETRICS, V91, P343, DOI 10.1007/s11192-011-0582-8; Belter CW, 2013, WIRES CLIM CHANGE, V4, P417, DOI 10.1002/wcc.229; Borrett SR, 2014, ECOL MODEL, V293, P111, DOI 10.1016/j.ecolmodel.2014.02.019; Casadevall A, 2014, INFECT IMMUN, V82, P1355, DOI 10.1128/IAI.01530-13; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Cobo MJ, 2011, J AM SOC INF SCI TEC, V62, P1382, DOI 10.1002/asi.21525; Davis F., 1995, GLOBAL CHANGE MEDITE, P435, DOI DOI 10.1007/978-1-4612-4186-7_21; Di Matteo G, 2015, FOREST POLICY ECON, V50, P292, DOI 10.1016/j.forpol.2014.08.003; Dobbertin MK, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010052; Doblas-Miranda E, 2015, GLOBAL ECOL BIOGEOGR, V24, P25, DOI 10.1111/geb.12224; European Forest Institute, 2009, MED FOR RES AG MFRA; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Fernandez M., 2005, Investigacion Agraria, Sistemas y Recursos Forestales, V14, P538; Hickey GM, 2013, FOREST POLICY ECON, V37, P1, DOI 10.1016/j.forpol.2013.08.003; Karimi F, 2015, INT J GREENH GAS CON, V37, P362, DOI 10.1016/j.ijggc.2015.04.002; Lavorel S, 1998, GLOBAL ECOL BIOGEOGR, V7, P157, DOI 10.2307/2997371; Lee M. R., 2012, KNOWL-BASED SYST, V28, P47, DOI DOI 10.1016/J.KN0SYS.2011.11.016; Li JF, 2011, GLOBAL PLANET CHANGE, V77, P13, DOI 10.1016/j.gloplacha.2011.02.005; Liu XJ, 2011, BIODIVERS CONSERV, V20, P807, DOI 10.1007/s10531-010-9981-z; Malesios C, 2012, ANN FOR RES, V55, P147; McKinley DC, 2012, FOREST POLICY ECON, V21, P1, DOI 10.1016/j.forpol.2012.03.007; PETERS HPF, 1993, RES POLICY, V22, P23, DOI 10.1016/0048-7333(93)90031-C; Rizzi F, 2014, RENEW ENERG, V62, P657, DOI 10.1016/j.renene.2013.08.030; Scarascia-Mugnozza G, 2000, FOREST ECOL MANAG, V132, P97, DOI 10.1016/S0378-1127(00)00383-2; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Small H, 1999, J AM SOC INFORM SCI, V50, P799, DOI 10.1002/(SICI)1097-4571(1999)50:9<799::AID-ASI9>3.0.CO;2-G; Song YJ, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-204; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; van Eck N.J., 2011, ARXIV11092058, DOI DOI 10.48550/ARXIV.1109.2058; van Eck NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062395; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002; Zhuang YH, 2013, SCIENTOMETRICS, V96, P203, DOI 10.1007/s11192-012-0918-z	34	26	27	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155016	10.1371/journal.pone.0155016	http://dx.doi.org/10.1371/journal.pone.0155016			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158823	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700030
J	Siman, P; Filipova, A; Ticha, A; Niang, M; Bezrouk, A; Havelek, R				Siman, Pavel; Filipova, Alzbeta; Ticha, Alena; Niang, Mohamed; Bezrouk, Ales; Havelek, Radim			Effective Method of Purification of Betulin from Birch Bark: The Importance of Its Purity for Scientific and Medicinal Use	PLOS ONE			English	Article							OUTER BARK; PHARMACOLOGICAL-PROPERTIES; IONIC LIQUIDS; HEPG2 CELLS; NILE RED; ACID; EXTRACTION; TRITERPENOIDS; CYTOTOXICITY; DERIVATIVES	A new and relatively simple method for purification of betulin from birch bark extract was developed in this study. Its five purification steps are based on the differential solubility of extract components in various solvents and their crystallization and/or precipitation, on their affinity for Ca(OH)(2) in ethanol, and on the affinity of some impurities for silica gel in chloroform. In addition, all used solvents can be simply recycled. Betulin of more than 99% purity can be prepared by this method with minimal costs. Various observations including crystallization of betulin, changes in crystals during heating, and attempt of localization of betulin in outer birch bark are also described in this work. The original extract, fraction without betulinic acid and lupeol, amorphous fraction of pure betulin, final crystalline fraction of pure betulin and commercial betulin as a standard were employed to determine the antiproliferative/cytotoxic effect. We used WST-1 tetrazolium-based assays with triple negative breast cancer cell line BT-549. The decrease in cell survival showed clear relationship with the purity of the samples, being most pronounced using our final product of pure crystalline betulin. WST-1 proliferation/cytotoxicity test using triple negative breast cancer cell line BT-549 clearly showed the importance of purity of betulin for biological experiments and, apparently, for its medicinal use.	[Siman, Pavel; Filipova, Alzbeta; Niang, Mohamed; Havelek, Radim] Charles Univ Prague, Fac Med Hradec Kralove, Dept Med Biochem, CZ-50003 Hradec Kralove, Czech Republic; [Ticha, Alena] Univ Hosp Hradec Kralove, Dept Res & Dev, CZ-50005 Hradec Kralove, Czech Republic; [Bezrouk, Ales] Charles Univ Prague, Fac Med Hradec Kralove, Dept Med Biophys, CZ-50038 Hradec Kralove, Czech Republic	Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove	Havelek, R (corresponding author), Charles Univ Prague, Fac Med Hradec Kralove, Dept Med Biochem, CZ-50003 Hradec Kralove, Czech Republic.	havelekr@lfhk.cuni.cz	Bezrouk, Aleš/A-6654-2017; Filipova, Alzbeta/B-5186-2017; Šiman, Pavel/E-5977-2017; Havelek, Radim/S-5723-2016; Ticha, Alena/P-9782-2017	Bezrouk, Aleš/0000-0002-2397-3847; Šiman, Pavel/0000-0003-0351-0818; Havelek, Radim/0000-0003-0528-1334; Filipova, Alzbeta/0000-0002-5318-5892; Filipova, Alzbeta/0000-0002-3849-6449; Ticha, Alena/0000-0003-1329-1268	Charles University in Prague [PRVOUK P37/01]; MH CZ - DRO [UHHK 00179906]	Charles University in Prague; MH CZ - DRO	The authors are grateful for the financial support offered through the PRVOUK P37/01 programme initiated by Charles University in Prague and MH CZ - DRO (UHHK 00179906).	Alakurtti S, 2013, THESIS U HELSINKI HE; Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; BHAT KM, 1982, IAWA BULL, V3, P207, DOI 10.1163/22941932-90000841; Boryczka S, 2013, MOLECULES, V18, P4526, DOI 10.3390/molecules18044526; Boryczka S, 2012, J CHEM CRYSTALLOGR, V42, P345, DOI 10.1007/s10870-011-0251-z; Chen QH, 2009, ULTRASON SONOCHEM, V16, P599, DOI 10.1016/j.ultsonch.2008.11.009; Co M, 2009, GREEN CHEM, V11, P668, DOI 10.1039/b819965e; Dehelean CA, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-137; Drag M, 2009, MOLECULES, V14, P1639, DOI 10.3390/molecules14041639; Drebushchak TN, 2010, J STRUCT CHEM+, V51, P798, DOI 10.1007/s10947-010-0121-0; Duric K, 2009, BOSNIAN J BASIC MED, V9, P31; Ferreira R, 2013, RSC ADV, V3, P21285, DOI 10.1039/c3ra43868f; Ferreira R, 2013, IND CROP PROD, V44, P520, DOI 10.1016/j.indcrop.2012.10.002; Gallo MBC, 2009, INT J BIOMED PHARM S, V3, P46; Gong YH, 2004, ANTIVIR RES, V64, P127, DOI 10.1016/j.antiviral.2004.05.006; GREENSPAN P, 1985, J LIPID RES, V26, P781; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Guidoin MF, 2003, THERMOCHIM ACTA, V398, P153, DOI 10.1016/S0040-6031(02)00358-1; Holonec L, 2012, NOT BOT HORTI AGROBO, V40, P99; Hu ZW, 2013, J CHROMATOGR B, V939, P38, DOI 10.1016/j.jchromb.2013.09.005; Innocente A, 2014, CHEM BIOL DRUG DES, V83, P344, DOI 10.1111/cbdd.12251; Jager S, 2008, MOLECULES, V13, P3224, DOI 10.3390/molecules13123224; Joshi H., 2013, J PHARMACOGNOSY PHYT, V2, P145; Krasutsky PA, 2006, NAT PROD REP, V23, P919, DOI 10.1039/b606816b; Krol SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/584189; Kuznetsova SA, 2014, RUSS J BIOORG CHEM+, V40, P742, DOI 10.1134/S1068162014070073; Kuznetsova SA, 2010, CHEM SUSTAIN DEV, V18, P265; Lugemwa FN, 2012, MOLECULES, V17, P9274, DOI 10.3390/molecules17089274; Machado KE, 2009, NAT PROD COMMUN, V4, P1181; Maji A. K., 2013, International Journal of Phytomedicine, V5, P131; Melnikova N, 2012, MOLECULES, V17, P11849, DOI 10.3390/molecules171011849; Mikhailenko MA, 2011, CHEM NAT COMPD+, V47, P229, DOI 10.1007/s10600-011-9889-1; Miura N, 1999, MOL PHARMACOL, V56, P1324, DOI 10.1124/mol.56.6.1324; Moghaddam M. G., 2012, Pharmacology and Pharmacy, V3, P119, DOI 10.4236/pp.2012.32018; OCONNELL MM, 1988, PHYTOCHEMISTRY, V27, P2175, DOI 10.1016/0031-9422(88)80120-1; Orsini S, 2015, HERIT SCI, V3, DOI 10.1186/s40494-015-0032-7; Pfarr K., 2014, J IMMUNOTHERAPY CANC, V2, P175, DOI [10.1186/2051-1426-2-S3-P175, DOI 10.1186/2051-1426-2-S3-P175]; RECIO MD, 1995, PLANTA MED, V61, P182, DOI 10.1055/s-2006-958045; Regert A, 2006, J CHROMATOGR A, V1101, P245, DOI 10.1016/j.chroma.2005.09.070; Ressmann AK, 2012, GREEN CHEM, V14, P940, DOI 10.1039/c2gc16389f; Saleem M, 2009, CANCER LETT, V285, P109, DOI 10.1016/j.canlet.2009.04.033; Sarek J, 2012, METHOD PREPARATION I; Shai LJ, 2008, J ETHNOPHARMACOL, V119, P238, DOI 10.1016/j.jep.2008.06.036; Soica C, 2012, MED AROMATIC PLANTS, V01; Soica CM, 2012, NAT PROD RES, V26, P968, DOI 10.1080/14786419.2010.545352; Szuster-Ciesielska A, 2005, PHARMACOL REP, V57, P588; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Tijjani A, 2012, TROPICAL J PHARM RES, V11; Tolstikov GA, 2005, CHEM SUSTAIN DEV, V13, P1; Yin Jing, 2013, American Journal of Plant Sciences, V4, P7; Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214; Zhao GL, 2007, J PHARMACEUT BIOMED, V43, P959, DOI 10.1016/j.jpba.2006.09.026	52	33	34	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154933	10.1371/journal.pone.0154933	http://dx.doi.org/10.1371/journal.pone.0154933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152419	gold, Green Published, Green Submitted			2022-12-27	WOS:000375677000047
J	Dando, CJ; Walsh, D; Brierley, R				Dando, Coral J.; Walsh, David; Brierley, Robin			Perceptions of Psychological Coercion and Human Trafficking in the West Midlands of England: Beginning to Know the Unknown	PLOS ONE			English	Article							VICTIMS; HEALTH; POLICY	Modern slavery is less overt than historical state-sanctioned slavery because psychological abuse is typically used to recruit and then control victims. The recent UK Draft Modern Slavery Bill, and current UK government anti-slavery strategy relies heavily on a shared understanding and public cooperation to tackle this crime. Yet, UK research investigating public understanding of modern slavery is elusive. We report community survey data from 682 residents of the Midlands of England, where modern slavery is known to occur, concerning their understanding of nonphysical coercion and human trafficking (one particular form of modern slavery). Analysis of quantitative data and themed categorization of qualitative data revealed a mismatch between theoretical frameworks and understanding of psychological coercion, and misconceptions concerning the nature of human trafficking. Many respondents did not understand psychological coercion, believed that human trafficking did not affect them, and confused trafficking with immigration. The public are one of the most influential interest groups, but only if well informed and motivated towards positive action. Our findings suggest the need for strategically targeted public knowledge exchange concerning this crime.	[Dando, Coral J.; Brierley, Robin] Wolverhampton Univ, Inst Psychol, Wolverhampton WV1 1DJ, W Midlands, England; [Walsh, David] Univ Derby, Dept Law & Criminol, Derby DE22 1GB, England	University of Wolverhampton; University of Derby	Dando, CJ (corresponding author), Wolverhampton Univ, Inst Psychol, Wolverhampton WV1 1DJ, W Midlands, England.	cjdando@wlv.ac.uk		Dando, Coral J/0000-0002-6196-8475				Agency NC, 2014, NAT REF MECH; [Anonymous], 1949, TREATMENT PRISONERS; [Anonymous], 2013, DRAFT MODERN SLAVERY; Association NCJ, 2011, HUMAN TRAFFICKING ST; Baldwin SB, 2014, QUALITATIVE HLTH RES; Baldwin SB, 2011, HEALTH HUM RIGHTS, V13, P36; Bales K., 2009, THE SLAVE NEXT DOOR; Bales Kevin, 2007, ENDING SLAVERY WE FR; Bates E, 2003, HUMAN RIGHTS LAW REV, V3, P193; Bearder C., 2012, END HUMAN TRAFFICKIN; BIDERMAN A D, 1957, Bull N Y Acad Med, V33, P616; Buckley M, 2009, EUROPE-ASIA STUD, V61, P213, DOI 10.1080/09668130802630847; Davis D., 2006, INHUMAN BONDAGE RISE; Dugan E., 2013, FORCED LABOUR HUMAN, V2012; ECPAT, 2007, TRAFF CHILDR MISS; Fedderson A, 2013, THESIS; Feingold D. A., 2005, FOREIGN POLICY, V150, P26; Goodey J, 2008, CRIMINOL CRIM JUSTIC, V8, P421, DOI 10.1177/1748895808096471; Gross O, 2004, PROHIBITION TORTURE; Haynes Dina, 2006, GEO IMMIGR LJ, V21, P337; Helm T., 2012, GUARDIAN; Herzog S, 2008, J CONT CRIMINAL JUST; Honess T., 1992, CLOSED CIRCUIT TELEV; Hopper E., 2006, INTERCULT HUM RIGHTS, V1, P185; Hoyle C, 2011, SOC LEGAL STUD, V20, P313, DOI 10.1177/0964663911405394; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kangaspunta K, 2003, MAPPING INHUMAN TRAD; Kelly L, 2005, INT MIGR, V43, P235, DOI 10.1111/j.0020-7985.2005.00319.x; Kim K., 2007, U TOLEDO LAW REV, V38; Kim K, 2011, IOWA LAW REV, V96, P409; Kondracki NL, 2002, J NUTR EDUC BEHAV, V34, P224, DOI 10.1016/S1499-4046(06)60097-3; Kyle D., 2011, GLOBAL HUMAN SMUGGLI; Lipscombe Sally, 2014, HUMAN TRAFFICKING UK; Logan TK, 2007, HUMAN TRAFFICKING KE; Mazzetti M, 2009, NY TIMES, P25; McDonnell I, 2003, PUBLIC OPINION RES; Oluniyi O, 2012, MEDITERRANEAN J SOCI, P493, DOI DOI 10.5901/MJSS.2012.V3N3P493; Ormerod TC, 2015, J EXP PSYCHOL GEN, V144, P76, DOI 10.1037/xge0000030; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Segrave M., 2012, SEX TRAFFICKING; Sharapov K., 2014, UNDERSTANDING PUBLIC; Shelley L., 2007, HUMAN TRAFFICKING, P116; Shelley Louise., 2010, HUMAN TRAFFICKING GL; Srikantiah J., 2007, IMMIGRATION NATL LAW, V28, P741; Traffick ST., 2012, SENSE IT SPOT IT STO; Winterdyk J, 2010, EUR J CRIMINOL, V7, P5, DOI 10.1177/1477370809347894; Zhang S, 2010, SEX TRAFFICKING BORD; Zhang Sheldon, 2010, SEX TRAFFICKING BORD; Zimmerman C, 2011, SOC SCI MED, V73, P327, DOI 10.1016/j.socscimed.2011.05.028	49	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0153263	10.1371/journal.pone.0153263	http://dx.doi.org/10.1371/journal.pone.0153263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27149330	Green Accepted, Green Published, gold			2022-12-27	WOS:000375676800007
J	Han, JG; Chen, JS; Shao, L; Zhang, JL; Dong, XJ; Liu, PY; Chen, DJ				Han, Jungang; Chen, Junsheng; Shao, Lei; Zhang, Junliang; Dong, Xiaojing; Liu, Pengyu; Chen, Daijie			Production of the Ramoplanin Activity Analogue by Double Gene Inactivation	PLOS ONE			English	Article							POTENT ANTIBIOTIC-ACTIVITY; STAPHYLOCOCCUS-AUREUS; ACTINOPLANES SP; BIOSYNTHESIS; LIPOGLYCODEPSIPEPTIDE; STREPTOMYCES; GLYCOPEPTIDE; CHEMISTRY; BIOLOGY	Glycopeptides such as vancomycin and telavancin are essential for treating infections caused by Gram-positive bacteria. But the dwindling availability of new antibiotics and the emergence of resistant bacteria are making effective antibiotic treatment increasingly difficult. Ramoplanin, an inhibitor of bacterial cell wall biosynthesis, is a highly effective antibiotic against a wide range of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, vancomycin-intermediate resistant Clostridium difficile and vancomycin-resistant Enterococcus sp. Here, two tailoring enzyme genes in the biosynthesis of ramoplanin were deleted by double in-frame gene knockouts to produce new ramoplanin derivatives. The deschlororamoplanin A2 aglycone was purified and its structure was identified with LC-MS/MS. Deschlororamoplanin A2 aglycone and ramoplanin aglycone showed similar activity to ramoplanin A2. The results showed that alpha-1,2-dimannosyl disaccharide at Hpg(11) and chlorination at Chp(17) in the ramoplanin structure are not essential for its antimicrobial activity. This work provides new precursor compounds for the semisynthetic modification of ramoplanin.	[Han, Jungang; Chen, Junsheng; Shao, Lei; Zhang, Junliang; Dong, Xiaojing; Liu, Pengyu; Chen, Daijie] Shanghai Inst Pharmaceut Ind, State Key Lab New Drug & Pharmaceut Proc, 1320 West Beijing Rd, Shanghai 200040, Peoples R China; [Chen, Junsheng] Shanghai Jiao Tong Univ, Sch Pharm, 800 Dongchuan Rd, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University	Shao, L; Chen, DJ (corresponding author), Shanghai Inst Pharmaceut Ind, State Key Lab New Drug & Pharmaceut Proc, 1320 West Beijing Rd, Shanghai 200040, Peoples R China.	shaolei00@gmail.com; hccb001@163.com			National Natural Science Foundation of China [81373310, 81573329]; Ministry of Science and Technology of China [2012ZX09301002-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The work was supported by the National Natural Science Foundation of China (Grant No. 81373310 and 81573329) and Ministry of Science and Technology of China (Grant No. 2012ZX09301002-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, LANCET, V374, P1868, DOI 10.1016/S0140-6736(09)62076-6; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Chen JS, 2013, BIOTECHNOL LETT, V35, P1501, DOI 10.1007/s10529-013-1233-3; Cheng M, 2014, ANTIMICROB AGENTS CH, V58, P6819, DOI 10.1128/AAC.00061-14; CIABATTI R, 1989, J ANTIBIOT, V42, P254, DOI 10.7164/antibiotics.42.254; Clinical and Laboratory Standards Institute, 2009, M07A8 CLIN LAB STAND, V29; Cudic P, 2002, CHEM BIOL, V9, P897, DOI 10.1016/S1074-5521(02)00191-6; Fang X, 2006, MOL BIOSYST, V2, P69, DOI 10.1039/b515328j; Fang X, 2009, BIOORG MED CHEM LETT, V19, P6189, DOI 10.1016/j.bmcl.2009.09.001; Floss HG, 2006, J BIOTECHNOL, V124, P242, DOI 10.1016/j.jbiotec.2005.12.001; Fulco Patricia, 2006, Expert Rev Anti Infect Ther, V4, P939, DOI 10.1586/14787210.4.6.939; Hayashi N, 2004, ANTIMICROB AGENTS CH, V48, P799, DOI 10.1128/AAC.48.3.799-803.2004; Hoertz AJ, 2012, BIOORGAN MED CHEM, V20, P859, DOI 10.1016/j.bmc.2011.11.062; Jabes D, 2014, ANTIMICROB AGENTS CH, V58, P1922, DOI 10.1128/AAC.01620-13; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; McCafferty DG, 2002, BIOPOLYMERS, V66, P261, DOI 10.1002/bip.10296; Pan HX, 2013, BIOTECHNOL LETT, V35, P1685, DOI 10.1007/s10529-013-1261-z; Rew Y, 2004, J AM CHEM SOC, V126, P1041, DOI 10.1021/ja039671y; REYNOLDS PE, 1990, DRUG EXP CLIN RES, V16, P385; Sambrook J., 2001, MOL CLONING LAB MANU; Sheikh S, 2014, MED CHEM, V10, P18; Sievers S, 2010, PROTEOMICS, V10, P1685, DOI 10.1002/pmic.200900772; SOMNER EA, 1990, ANTIMICROB AGENTS CH, V34, P413, DOI 10.1128/AAC.34.3.413; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Sundlov JA, 2012, CHEM BIOL, V19, P188, DOI 10.1016/j.chembiol.2011.11.013; vanPee KH, 1996, ANNU REV MICROBIOL, V50, P375, DOI 10.1146/annurev.micro.50.1.375; Walker S, 2005, CHEM REV, V105, P449, DOI 10.1021/cr030106n; Yim G, 2014, J ANTIBIOT, V67, P31, DOI 10.1038/ja.2013.117	30	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154121	10.1371/journal.pone.0154121	http://dx.doi.org/10.1371/journal.pone.0154121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149627	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800020
J	Manzano, S; Aguado, E; Martinez, C; Megias, Z; Garcia, A; Jamilena, M				Manzano, Susana; Aguado, Encarnacion; Martinez, Cecilia; Megias, Zoraida; Garcia, Alicia; Jamilena, Manuel			The Ethylene Biosynthesis Gene CitACS4 Regulates Monoecy/Andromonoecy in Watermelon (Citrullus lanatus)	PLOS ONE			English	Article							CUCUMIS-SATIVUS L; SEX EXPRESSION; FLOWER DEVELOPMENT; INHERITANCE; INVOLVEMENT; FEMALENESS; INDUCTION; REVEALS; LEADS	Monoecious and andromonoecious cultivars of watermelon are characterised by the production of male and female flower or male and hermaphrodite flowers, respectively. The segregation analysis in the offspring of crosses between monoecious and andromonoecious lines has demonstrated that this trait is controlled by a single gene pair, being the monoecious allele M semi-dominant to the andromonoecious allele A. The two studied F1 hybrids (MA) had a predominantly monoecious phenotype since both produced not only female flowers, but also bisexual flowers with incomplete stamens, and hermaphrodite flowers with pollen. Given that in other cucurbit species andromonoecy is conferred by mutations in the ethylene biosynthesis genes CmACS7, CsACS2 and CpACS27A we have cloned and characterised CitACS4, the watermelon gene showing the highest similarity with the formers. CitACS4 encoded for a type ACS type III enzyme that is predominantly expressed in pistillate flowers of watermelon. In the andromonoecious line we have detected a missense mutation in a very conserved residue of CitACS4 (C364W) that cosegregates with the andromonoecious phenotype in two independent F2 populations, concomitantly with a reduction in ethylene production in the floral buds that will develop as hermaphrodite flowers. The gene does not however co-segregates with other sex expression traits regulated by ethylene in this species, including pistillate flowering transition and the number of pistillate flowers per plant. These data indicate that CitAC4 is likely to be involved in the biosynthesis of the ethylene required for stamen arrest during the development of female flowers. The C364W mutation would reduce the production of ethylene in pistillate floral buds, promoting the conversion of female into hermaphrodite flowers, and therefore of monoecy into andromonoecy.	[Jamilena, Manuel] Univ Almeria, Agrifood Campus Int Excellence ceiA3, Dept Biol & Geol, La Canada de San Urbano S-N, Almeria 04120, Spain; Univ Almeria, BITAL, La Canada de San Urbano S-N, Almeria 04120, Spain	Universidad de Almeria; Universidad de Almeria	Jamilena, M (corresponding author), Univ Almeria, Agrifood Campus Int Excellence ceiA3, Dept Biol & Geol, La Canada de San Urbano S-N, Almeria 04120, Spain.	mjamille@ual.es	Jamilena, Manuel/K-3331-2014; Martínez, Cecilia/AAA-5090-2020; Manzano, Susana/M-1372-2015; Jamilena, Manuel/ABE-9137-2020	Jamilena, Manuel/0000-0001-7072-0458; Jamilena, Manuel/0000-0001-7072-0458	ERDF (European Regional Development Fund) [AGL2014-54598-C2-1-R]; Spanish Ministry of Science and Innovation - Junta de Andalucia, Spain [P12-AGR-1423]; MEC, Spain	ERDF (European Regional Development Fund)(European Commission); Spanish Ministry of Science and Innovation - Junta de Andalucia, Spain; MEC, Spain(Spanish Government)	This work was supported by grant AGL2014-54598-C2-1-R, partly funded by ERDF (European Regional Development Fund) and by the Spanish Ministry of Science and Innovation, and grant P12-AGR-1423, funded by Junta de Andalucia, Spain. Z.M. and E.A. acknowledge FPU and "garantia juvenil" scholarship programmes from MEC, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso CT, 2007, J PLANT GROWTH REGUL, V26, P92, DOI 10.1007/s00344-007-0013-5; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Boualem A, 2015, SCIENCE, V350, P688, DOI 10.1126/science.aac8370; Boualem A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006144; BYERS RE, 1972, P NATL ACAD SCI USA, V69, P717, DOI 10.1073/pnas.69.3.717; Cohen Y., 1987, CUCURBIT GENET COOP, V10, P47; DENNIJS APM, 1980, EUPHYTICA, V29, P273, DOI 10.1007/BF00025124; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garcia A, 2015, 5 ISHS INT S CUC, P22; Ji GJ, 2015, SCI HORTIC-AMSTERDAM, V193, P367, DOI 10.1016/j.scienta.2015.07.039; Jiang XiangTao, 2007, Acta Horticulturae Sinica, V34, P141; KENIGSBUCH D, 1990, GENOME, V33, P317, DOI 10.1139/g90-049; Knopf RR, 2006, PLANT CELL PHYSIOL, V47, P1217, DOI 10.1093/pcp/pcj092; KUBICKI B, 1969, GENET POL, V10, P69; KUBICKI B, 1969, GENET POL, V10, P3; Levi A., 1999, Report - Cucurbit Genetics Cooperative, P41; Manzano S, 2014, PLANT PHYSIOL BIOCH, V85, P96, DOI 10.1016/j.plaphy.2014.11.004; Manzano S, 2013, J PLANT GROWTH REGUL, V32, P789, DOI 10.1007/s00344-013-9344-6; Manzano S, 2011, PLANT GROWTH REGUL, V65, P213, DOI 10.1007/s10725-011-9589-7; Manzano S, 2010, SEX PLANT REPROD, V23, P301, DOI 10.1007/s00497-010-0140-1; Manzano S, 2010, J PLANT GROWTH REGUL, V29, P73, DOI 10.1007/s00344-009-9116-5; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Martinez C, 2014, PLANTA, V239, P1201, DOI 10.1007/s00425-014-2043-0; Mibus H, 2004, THEOR APPL GENET, V109, P1669, DOI 10.1007/s00122-004-1793-7; OWENS KW, 1980, HORTSCIENCE, V15, P654; Poole CF, 1939, J HERED, V30, P21, DOI 10.1093/oxfordjournals.jhered.a104626; Poole Charles F., 1945, JOUR AGRIC RES, V71, P533; Prothro J, 2013, J AM SOC HORTIC SCI, V138, P125, DOI 10.21273/JASHS.138.2.125; Rosa J. T., 1928, HILGARDIA, V3, P233, DOI DOI 10.3733/HILG.V03N09P233; RUDICH J, 1969, PLANTA, V86, P69, DOI 10.1007/BF00385305; Rudich J., 1990, BIOL UTILIZATION CUC, P269; Rudich JZamskiE., 1985, HDB FLOWERING, V2, P272; Salman-Minkov A, 2008, PLANT CELL PHYSIOL, V49, P740, DOI 10.1093/pcp/pcn045; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Sugiyama K, 1998, J JPN SOC HORTIC SCI, V67, P185, DOI 10.2503/jjshs.67.185; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trebitsh T, 1997, PLANT PHYSIOL, V113, P987, DOI 10.1104/pp.113.3.987; Yamasaki S, 2001, PLANT CELL PHYSIOL, V42, P608, DOI 10.1093/pcp/pce076; Yoshida H, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-14; Zhang TC, 2012, COMPUT BIOL CHEM, V38, P10, DOI 10.1016/j.compbiolchem.2012.04.001; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	41	17	17	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154362	10.1371/journal.pone.0154362	http://dx.doi.org/10.1371/journal.pone.0154362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149159	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800026
J	Yang, XD; Tan, HW; Zhu, WM				Yang, Xue-Dong; Tan, Hua-Wei; Zhu, Wei-Min			SpinachDB: A Well-Characterized Genomic Database for Gene Family Classification and SNP Information of Spinach	PLOS ONE			English	Article							IDENTIFICATION; OLERACEA; METABOLISM; REVEALS; MARKERS; ACID	Spinach (Spinacia oleracea L.), which originated in central and western Asia, belongs to the family Amaranthaceae. Spinach is one of most important leafy vegetables with a high nutritional value as well as being a perfect research material for plant sex chromosome models. As the completion of genome assembly and gene prediction of spinach, we developed SpinachDB (http://222.73.98.124/spinachdb) to store, annotate, mine and analyze genomics and genetics datasets efficiently. In this study, all of 21702 spinach genes were annotated. A total of 15741 spinach genes were catalogued into 4351 families, including identification of a substantial number of transcription factors. To construct a high-density genetic map, a total of 131592 SSRs and 1125743 potential SNPs located in 548801 loci of spinach genome were identified in 11 cultivated and wild spinach cultivars. The expression profiles were also performed with RNA-seq data using the FPKM method, which could be used to compare the genes. Paralogs in spinach and the orthologous genes in Arabidopsis, grape, sugar beet and rice were identified for comparative genome analysis. Finally, the SpinachDB website contains seven main sections, including the homepage; the GBrowse map that integrates genome, genes, SSR and SNP marker information; the Blast alignment service; the gene family classification search tool; the orthologous and paralogous gene pairs search tool; and the download and useful contact information. SpinachDB will be continually expanded to include newly generated robust genomics and genetics data sets along with the associated data mining and analysis tools.	[Yang, Xue-Dong; Zhu, Wei-Min] Shanghai Acad Agr Sci, Protected Hort Inst, Shanghai, Peoples R China; [Tan, Hua-Wei] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Shanghai Academy of Agricultural Sciences; Nanjing Agricultural University	Zhu, WM (corresponding author), Shanghai Acad Agr Sci, Protected Hort Inst, Shanghai, Peoples R China.	yy17@saas.sh.cn			Natural Science Foundation of Shanghai [15ZR1436700]; Shanghai Science and Technology Talents Project [14XD1425100]; Scientific Research Project in Public Agricultural Industry [201403032]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Science and Technology Talents Project; Scientific Research Project in Public Agricultural Industry	This work was supported by Natural Science Foundation of Shanghai (15ZR1436700) and Shanghai Science and Technology Talents Project (14XD1425100) and the Scientific Research Project in Public Agricultural Industry (201403032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by Natural Science Foundation of Shanghai (15ZR1436700) and Shanghai Science and Technology Talents Project (14XD1425100) and the Scientific Research Project in Public Agricultural Industry (201403032). Thanks to Dr. Sue Mischke in USDA/ARS/Beltsville Research Center for her carefully check on our manuscript. Special thanks to the Editor and Reviewers for their suggestions and comments that helped to improve our manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Altaf-Ul-Amin M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/540297; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bevan MW, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-206; Deng XT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-267; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fang WP, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.35; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Ghosh S, 2016, METHODS MOL BIOL, V1374, P339, DOI 10.1007/978-1-4939-3167-5_18; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Jungo F, 2012, TOXICON, V60, P551, DOI 10.1016/j.toxicon.2012.03.010; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Khattak JZK, 2006, EUPHYTICA, V148, P311, DOI 10.1007/s10681-005-9031-1; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koh E, 2012, J AGR FOOD CHEM, V60, P3144, DOI 10.1021/jf300051f; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Longnecker MP, 1997, CANCER EPIDEM BIOMAR, V6, P887; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mihara M, 2010, NUCLEIC ACIDS RES, V38, pD835, DOI 10.1093/nar/gkp831; Minoche AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0729-7; Nagamura Y, 2011, PLANT CELL PHYSIOL, V52, P230, DOI 10.1093/pcp/pcq197; Onodera Y, 2011, PLANT CELL REP, V30, P965, DOI 10.1007/s00299-010-0998-2; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Rouard M, 2011, NUCLEIC ACIDS RES, V39, pD1095, DOI 10.1093/nar/gkq811; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sather DN, 2009, PLANTA, V229, P507, DOI 10.1007/s00425-008-0851-9; Sather DN, 2005, PLANTA, V222, P284, DOI 10.1007/s00425-005-1544-2; Shen D, 2013, PLANT CELL PHYSIOL, V54, pE3, DOI 10.1093/pcp/pcs176; Song W, 2010, J AGR FOOD CHEM, V58, P6621, DOI 10.1021/jf9035832; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang BY, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2014.65; Xu CX, 2015, SCI REP-UK, V5, DOI 10.1038/srep17706; Xu YB, 2012, MOL BREEDING, V29, P833, DOI 10.1007/s11032-012-9699-6; Xu ZS, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau096; Yan J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19473; Yang YJ, 2003, J AGR FOOD CHEM, V51, P4897, DOI 10.1021/jf026186y; Zhou L, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.56	40	4	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0152706	10.1371/journal.pone.0152706	http://dx.doi.org/10.1371/journal.pone.0152706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148975	Green Published, gold			2022-12-27	WOS:000375676800004
J	Zhang, ZY; Haimovich, B; Kwon, YS; Lu, T; Fyfe-Kirschner, B; Olweny, EO				Zhang, Zhiyong; Haimovich, Beatrice; Kwon, Young Suk; Lu, Tyler; Fyfe-Kirschner, Billie; Olweny, Ephrem Odoy			Unilateral Partial Nephrectomy with Warm Ischemia Results in Acute Hypoxia Inducible Factor 1-Alpha (HIF-1 alpha) and Toll-Like Receptor 4 (TLR4) Overexpression in a Porcine Model	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; GLOMERULAR-FILTRATION-RATE; REPERFUSION INJURY; RENAL TOLERANCE; SURGERY; OUTCOMES; QUALITY; TUMORS; DAMAGE	Purpose Ischemia/reperfusion (I/R) during partial nephrectomy (PN) contributes to acute kidney injury (AKI), which is inaccurately assessed using existent clinical markers of renal function. We evaluated I/R-related changes in expression in hypoxia inducible factor 1 alpha (HIF-1 alpha) and toll-like receptor 4 (TLR4), within kidney tissue and peripheral blood leukocytes (PBL) in a porcine model of PN. Materials and Methods Three adult pigs each underwent unilateral renal hilar cross clamping for 180 min followed by a 15 min reperfusion. The contralateral kidney served as control. Biopsies of clamped kidneys were obtained at baseline (time 0), every 60 min during the hypoxic phase, and post-reperfusion. Control kidneys were biopsied once at 180 min. Peripheral blood was sampled at time 0, every 30 min during the hypoxic phase, and post-reperfusion. HIF-1a and TLR4 expression in kidney tissue and PBL were analyzed by Western blotting. I/R-related histological changes were assessed. Results Expression of HIF-1a in clamped kidneys and PBL was below detection level at baseline, rising to detectable levels after 60 min of hypoxia, and continuing to rise throughout the hypoxic and reperfusion phases. Expression of TLR-4 in clamped kidneys followed a similar trend with initial detection after 30-60 min of hypoxia. Control kidneys exhibited no change in HIF-1 alpha or TLR-4 expression. I/R-related histologic changes were minimal, primarily mild tubular dilatation. Conclusions In a porcine model of PN, HIF-1 alpha and TLR4 exhibited robust, I/R-related increases in expression in kidney tissue and PBL. Further studies investigating these molecules as potential markers of AKI are warranted.	[Zhang, Zhiyong; Haimovich, Beatrice; Kwon, Young Suk; Olweny, Ephrem Odoy] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, Div Urol & Gen Surg, New Brunswick, NJ 08903 USA; [Kwon, Young Suk] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA; [Lu, Tyler] Rutgers State Univ, New Brunswick, NJ 08903 USA; [Fyfe-Kirschner, Billie] Univ Med & Dent New Jersey, Dept Pathol & Lab Med, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Olweny, EO (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, Div Urol & Gen Surg, New Brunswick, NJ 08903 USA.	eolweny@gmail.com		zhang, zhiyong/0000-0003-4061-7374; Olweny, Ephrem/0000-0002-4135-1224	New Jersey Health Foundation Inc [508593: EOO]	New Jersey Health Foundation Inc	This work was supported by New Jersey Health Foundation Inc (http://www.njhealthfoundation.org), grant #508593: EOO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2010, J AM SOC NEPHROL, V21, P1270, DOI 10.1681/ASN.2010030233; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Choi JD, 2012, J UROLOGY, V187, P802, DOI 10.1016/j.juro.2011.10.140; Choi JD, 2010, EUR UROL, V58, P900, DOI 10.1016/j.eururo.2010.08.044; Conde E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033258; ERNST CB, 1976, SURGERY, V80, P252; Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038; Girard S.D., 2011, J BIOMED BIOTECHNOL, P1; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; HESSEL SJ, 1975, INVEST RADIOL, V10, P490, DOI 10.1097/00004424-197509000-00005; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Kates M, 2011, CURR OPIN UROL, V21, P351, DOI 10.1097/MOU.0b013e32834962e9; Kim SY, 2010, IMMUNOLOGY, V129, P516, DOI 10.1111/j.1365-2567.2009.03203.x; Lane BR, 2008, J UROLOGY, V180, P2363, DOI 10.1016/j.juro.2008.08.036; Lane BR, 2013, UROL ONCOL-SEMIN ORI, V31, P682, DOI 10.1016/j.urolonc.2011.05.007; Laven BA, 2004, J UROLOGY, V172, P2471, DOI 10.1097/01.ju.0000138158.16968.8d; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Mir MC, 2015, J UROLOGY, V193, P1889, DOI 10.1016/j.juro.2015.01.093; Mir MC, 2013, UROLOGY, V82, P263, DOI 10.1016/j.urology.2013.03.068; Orvieto MA, 2005, UROLOGY, V66, P1111, DOI 10.1016/j.urology.2005.05.027; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Parekh DJ, 2013, J AM SOC NEPHROL, V24, P506, DOI 10.1681/ASN.2012080786; Patel AR, 2011, UROL ONCOL-SEMIN ORI, V29, P826, DOI 10.1016/j.urolonc.2011.02.015; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sankin A, 2012, UROLOGY, V80, P343, DOI 10.1016/j.urology.2012.04.054; Schmid Marianne, 2015, World J Nephrol, V4, P160, DOI 10.5527/wjn.v4.i2.160; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sprenkle PC, 2013, J UROLOGY, V190, P159, DOI 10.1016/j.juro.2013.01.101; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thompson RH, 2012, UROLOGY, V79, P356, DOI 10.1016/j.urology.2011.10.031; Weidemann A, 2008, J AM SOC NEPHROL, V19, P486, DOI 10.1681/ASN.2007040419; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482; Zhao HL, 2014, AM J PHYSIOL-RENAL, V306, pF801, DOI 10.1152/ajprenal.00469.2013; Zhou ZY, 2014, J SURG RES, V188, P290, DOI 10.1016/j.jss.2013.11.1086	37	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154708	10.1371/journal.pone.0154708	http://dx.doi.org/10.1371/journal.pone.0154708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149666	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800051
J	Jevsnik, M; Steyer, A; Pokorn, M; Mrvic, T; Grosek, S; Strle, F; Lusa, L; Petrovec, M				Jevsnik, Monika; Steyer, Andrej; Pokorn, Marko; Mrvic, Tatjana; Grosek, Stefan; Strle, Franc; Lusa, Lara; Petrovec, Miroslav			The Role of Human Coronaviruses in Children Hospitalized for Acute Bronchiolitis, Acute Gastroenteritis, and Febrile Seizures: A 2-Year Prospective Study	PLOS ONE			English	Article							REAL-TIME PCR; RESPIRATORY-TRACT INFECTIONS; RT-PCR; NL63 INFECTION; YOUNG-CHILDREN; HONG-KONG; HKU1; VIRUSES; ASSAYS; DISEASE	Human coronaviruses (HCoVs) are associated with a variety of clinical presentations in children, but their role in disease remains uncertain. The objective of our prospective study was to investigate HCoVs associations with various clinical presentations in hospitalized children up to 6 years of age. Children hospitalized with acute bronchiolitis (AB), acute gastroenteritis (AGE), or febrile seizures (FS), and children admitted for elective surgical procedures (healthy controls) were included in the study. In patients with AB, AGE, and FS, a nasopharyngeal (NP) swab and blood sample were obtained upon admission and the follow-up visit 14 days later, whereas in children with AGE a stool sample was also acquired upon admission; in healthy controls a NP swab and stool sample were taken upon admission. Amplification of polymerase 1b gene was used to detect HCoVs in the specimens. HCoVs-positive specimens were also examined for the presence of several other viruses. HCoVs were most often detected in children with FS (19/192, 9.9%, 95% CI: 6-15%), followed by children with AGE (19/218, 8.7%, 95% CI: 5.3-13.3%) and AB (20/308, 6.5%, 95% CI: 4.0-9.8%). The presence of other viruses was a common finding, most frequent in the group of children with AB (19/20, 95%, 95% CI: 75.1-99.8%), followed by FS (10/19, 52.6%, 95% CI: 28.9-75.6%) and AGE (7/19, 36.8%, 95% CI: 16.3-61.6%). In healthy control children HCoVs were detected in 3/156 (1.9%, 95% CI: 0.4-5.5%) NP swabs and 1/150 (0.7%, 95% CI: 0.02-3.3%) stool samples. It seems that an etiological role of HCoVs is most likely in children with FS, considering that they had a higher proportion of positive HCoVs results than patients with AB and those with AGE, and had the highest viral load; however, the co-detection of other viruses was 52.6%.	[Jevsnik, Monika; Steyer, Andrej; Petrovec, Miroslav] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Zaloska 4, Ljubljana 1000, Slovenia; [Pokorn, Marko; Mrvic, Tatjana; Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Japljeva 2, Ljubljana 1525, Slovenia; [Grosek, Stefan] Univ Ljubljana, Univ Med Ctr Ljubljana, Dept Pediat Surg & Intens Care, Bohoriceva 20, Ljubljana 1000, Slovenia; [Grosek, Stefan] Univ Ljubljana, Fac Med, Bohoriceva 20, Ljubljana 1000, Slovenia; [Lusa, Lara] Fac Med, Inst Biostat & Med Informat, Vrazov Trg 2, Ljubljana 1104, Slovenia	University of Ljubljana; University Medical Centre Ljubljana; University Medical Centre Ljubljana; University of Ljubljana; University of Ljubljana	Jevsnik, M (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Zaloska 4, Ljubljana 1000, Slovenia.	monika.jevsnik@mf.uni-lj.si	Pokorn, Marko/H-5701-2019; Grosek, Stefan/HGA-7309-2022; Lusa, Lara/C-6692-2015	Pokorn, Marko/0000-0002-2341-2791; Lusa, Lara/0000-0002-8981-2421; Jevsnik Virant, Monika/0000-0003-1754-8964	Slovenian Research Agency [P3-0083, P3-0296, P3-0343]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was supported by the Slovenian Research Agency (Research Programs P3-0083, P3-0296 and P3-0343) and institutional department funds.	Bosis S, 2007, J CLIN VIROL, V38, P251, DOI 10.1016/j.jcv.2006.11.014; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Chen YW, 2014, J MICROBIOL IMMUNOL, V47, P116, DOI 10.1016/j.jmii.2012.08.012; Chiu SS, 2005, CLIN INFECT DIS, V40, P1721, DOI 10.1086/430301; CLARKE SKR, 1979, POSTGRAD MED J, V55, P135, DOI 10.1136/pgmj.55.640.135; Daum LT, 2007, INFLUENZA OTHER RESP, V1, P167, DOI 10.1111/j.1750-2659.2007.00024.x; De Vos N, 2009, EUR J CLIN MICROBIOL, V28, P1305, DOI 10.1007/s10096-009-0780-y; Desforges M, 2014, VIRUS RES, V194, P145, DOI 10.1016/j.virusres.2014.09.011; Diallo IS, 2006, J VIROL METHODS, V131, P92, DOI 10.1016/j.jviromet.2005.07.010; Ebihara T, 2005, J MED VIROL, V75, P463, DOI 10.1002/jmv.20289; Esper F, 2010, J CLIN VIROL, V48, P131, DOI 10.1016/j.jcv.2010.03.007; Esposito S, 2006, J MED VIROL, V78, P1609, DOI 10.1002/jmv.20745; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Han TH, 2007, J CLIN VIROL, V38, P27, DOI 10.1016/j.jcv.2006.10.009; Jevsnik M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-46; Jevsnik M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-365; Jin Y, 2012, CLIN MICROBIOL INFEC, V18, P74, DOI 10.1111/j.1469-0691.2011.03541.x; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kristoffersen AW, 2011, PEDIATR INFECT DIS J, V30, P279, DOI 10.1097/INF.0b013e3181fcb159; Kuypers J, 2004, J CLIN VIROL, V31, P123, DOI 10.1016/j.jcv.2004.03.018; Kuypers J, 2007, PEDIATRICS, V119, pE70, DOI 10.1542/peds.2006-1406; Kuypers J, 2006, J CLIN MICROBIOL, V44, P2382, DOI 10.1128/JCM.00216-06; Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05; Leung TF, 2009, J CLIN MICROBIOL, V47, P3486, DOI 10.1128/JCM.00832-09; Lu XY, 2006, J CLIN MICROBIOL, V44, P3231, DOI 10.1128/JCM.00889-06; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mankoc S, 2007, J VIROL METHODS, V146, P341, DOI 10.1016/j.jviromet.2007.07.019; Matoba Y, 2015, JPN J INFECT DIS, V68, P138, DOI 10.7883/yoken.JJID.2014.266; Miller EK, 2013, PEDIATR INFECT DIS J, V32, P950, DOI 10.1097/INF.0b013e31829b7e43; Paloniemi M, 2015, J CLIN VIROL, V62, P114, DOI 10.1016/j.jcv.2014.10.017; Pene F, 2003, CLIN INFECT DIS, V37, P929, DOI 10.1086/377612; R. CoreTeam, 2015, R LANG ENV STAT COMP; Risku M, 2010, J CLIN VIROL, V48, P27, DOI 10.1016/j.jcv.2010.02.013; Scheltinga SA, 2005, J CLIN VIROL, V33, P306, DOI 10.1016/j.jcv.2004.08.021; Stempel HE, 2009, ACTA PAEDIATR, V98, P123, DOI 10.1111/j.1651-2227.2008.01023.x; STEWART JN, 1992, VIROLOGY, V191, P502, DOI 10.1016/0042-6822(92)90220-J; Suzuki A, 2005, PEDIATR INFECT DIS J, V24, P645, DOI 10.1097/01.inf.0000168846.71517.ee; Svraka S, 2009, J CLIN MICROBIOL, V47, P1674, DOI 10.1128/JCM.00307-09; Talbot HKB, 2009, J MED VIROL, V81, P853, DOI 10.1002/jmv.21443; Vabret A, 2003, CLIN INFECT DIS, V36, P985, DOI 10.1086/374222; Vabret A, 2006, CLIN INFECT DIS, V42, P634, DOI 10.1086/500136; Vabret A, 2005, EMERG INFECT DIS, V11, P1225, DOI 10.3201/eid1108.050110; van der Hoek L, 2005, PLOS MED, V2, P764, DOI 10.1371/journal.pmed.0020240; Woo P C Y, 2012, Hong Kong Med J, V18 Suppl 2, P22; Woo PCY, 2005, J INFECT DIS, V192, P1898, DOI 10.1086/497151; Wu PS, 2008, EUR J PEDIATR, V167, P75, DOI 10.1007/s00431-007-0429-8; Yeh EA, 2004, PEDIATRICS, V113, pE73, DOI 10.1542/peds.113.1.e73	48	32	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155555	10.1371/journal.pone.0155555	http://dx.doi.org/10.1371/journal.pone.0155555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171141	Green Published, Green Submitted, gold			2022-12-27	WOS:000376588600146
J	Quiroga, R; Villarreal, MA				Quiroga, Rodrigo; Villarreal, Marcos A.			Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening	PLOS ONE			English	Article							PROTEIN-LIGAND DOCKING; FORCE-FIELD; VALIDATION; ALGORITHM; SET	Autodock Vina is a very popular, and highly cited, open source docking program. Here we present a scoring function which we call Vinardo (Vina RaDii Optimized). Vinardo is based on Vina, and was trained through a novel approach, on state of the art datasets. We show that the traditional approach to train empirical scoring functions, using linear regression to optimize the correlation of predicted and experimental binding affinities, does not result in a function with optimal docking capabilities. On the other hand, a combination of scoring, minimization, and re-docking on carefully curated training datasets allowed us to develop a simplified scoring function with optimum docking performance. This article provides an overview of the development of the Vinardo scoring function, highlights its differences with Vina, and compares the performance of the two scoring functions in scoring, docking and virtual screening applications. Vinardo outperforms Vina in all tests performed, for all datasets analyzed. The Vinardo scoring function is available as an option within Smina, a fork of Vina, which is freely available under the GNU Public License v2.0 from http://smina.sf.net. Precompiled binaries, source code, documentation and a tutorial for using Smina to run the Vinardo scoring function are available at the same address.	[Quiroga, Rodrigo; Villarreal, Marcos A.] Univ Nacl Cordoba, Fac Ciencias Quim, Inst Invest Fis Quim Cordoba INFIQC, CONICET,Dept Matemat & Fis, Ciudad Univ, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Villarreal, MA (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Inst Invest Fis Quim Cordoba INFIQC, CONICET,Dept Matemat & Fis, Ciudad Univ, RA-5000 Cordoba, Argentina.	mvillarreal@unc.edu.ar	Quiroga, Rodrigo/GLT-7145-2022	Quiroga, Rodrigo/0000-0001-5015-0531	CONICET-Consejo Nacional de Investigaciones Cientificas y Tecnologicas; Secyt-UNC. Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba; FONCYT. Agencia Nacional de Promocion Cientifica y Tecnologica. Ministerio de Ciencia, Tecnologia e Innovacion Productiva	CONICET-Consejo Nacional de Investigaciones Cientificas y Tecnologicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secyt-UNC. Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); FONCYT. Agencia Nacional de Promocion Cientifica y Tecnologica. Ministerio de Ciencia, Tecnologia e Innovacion Productiva	This work was supported by CONICET-Consejo Nacional de Investigaciones Cientificas y Tecnologicas, http://www.conicet.gov.ar; Secyt-UNC. Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba, http://www.unc.edu.ar/investigacion; FONCYT. Agencia Nacional de Promocion Cientifica y Tecnologica. Ministerio de Ciencia, Tecnologia e Innovacion Productiva, http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WJ, 2014, J CHEM INF MODEL, V54, P518, DOI 10.1021/ci400534h; Chang MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011955; Dunbar JB, 2013, J CHEM INF MODEL, V53, P1842, DOI [10.1021/ci400161J, 10.1021/ci4000486]; Elkaim J, 2012, BIOCHEM J, V443, P549, DOI 10.1042/BJ20111779; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kaserer T, 2015, EUR J MED CHEM, V96, P445, DOI 10.1016/j.ejmech.2015.04.017; Koes DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134697; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Kroemer RT, 2007, CURR PROTEIN PEPT SC, V8, P312; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li H., 2012, 2012 IEEE S COMP INT; Li HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085678; Li Y, 2014, J CHEM INF MODEL, V54, P1717, DOI 10.1021/ci500081m; Liu J, 2015, J CHEM INF MODEL, V55, P475, DOI 10.1021/ci500731a; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Venkatraman V, 2010, J CHEM INF MODEL, V50, P2079, DOI 10.1021/ci100263p; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Warren GL, 2012, DRUG DISCOV TODAY, V17, P1270, DOI 10.1016/j.drudis.2012.06.011; Zhang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110884	30	112	116	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155183	10.1371/journal.pone.0155183	http://dx.doi.org/10.1371/journal.pone.0155183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171006	Green Published, gold			2022-12-27	WOS:000376588600157
J	Sun, L; St Leger, AJ; Yu, CR; He, C; Mahdi, RM; Chan, CC; Wang, HS; Morse, HC; Egwuagu, CE				Sun, Lin; St Leger, Anthony J.; Yu, Cheng-Rong; He, Chang; Mahdi, Rashid M.; Chan, Chi-Chao; Wang, Hongsheng; Morse, Herbert C., III; Egwuagu, Charles E.			Interferon Regulator Factor 8 (IRF8) Limits Ocular Pathology during HSV-1 Infection by Restraining the Activation and Expansion of CD8(+) T Cells	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; SEQUENCE BINDING-PROTEIN; TRANSCRIPTION FACTOR; GAMMA-INTERFERON; EXPRESSION; MEMORY; UVEITIS; SURVIVAL; DIFFERENTIATION; REACTIVATION	Interferon Regulatory Factor-8 (IRF8) is constitutively expressed in monocytes and B cell lineages and plays important roles in immunity to pathogens and cancer. Although IRF8 expression is induced in activated T cells, the functional relevance of IRF8 in T cell-mediated immunity is not well understood. In this study, we used mice with targeted deletion of Irf8 in T-cells (IRF8KO) to investigate the role of IRF8 in T cell-mediated responses during herpes simplex virus 1 (HSV-1) infection of the eye. In contrast to wild type mice, HSV-1-infected IRF8KO mice mounted a more robust anti-HSV-1 immune response, which included marked expansion of HSV-1-specific CD8(+) T cells, increased infiltration of inflammatory cells into the cornea and trigeminal ganglia (TG) and enhanced elimination of virus within the trigeminal ganglion. However, the consequence of the enhanced immunological response was the development of ocular inflammation, limbitis, and neutrophilic infiltration into the cornea of HSV-1-infected IRF8KO mice. Surprisingly, we observed a marked increase in virus-specific memory precursor effector cells (MPEC) in IRF8KO mice, suggesting that IRF8 might play a role in regulating the differentiation of effector CD8(+) T cells to the memory phenotype. Together, our data suggest that IRF8 might play a role in restraining excess lymphocyte proliferation. Thus, modulating IRF8 levels in T cells can be exploited therapeutically to prevent immune-mediated ocular pathology during autoimmune and infectious diseases of the eye.	[Sun, Lin; Yu, Cheng-Rong; He, Chang; Mahdi, Rashid M.; Egwuagu, Charles E.] NEI, Mol Immunol Sect, NIH, Bethesda, MD 20892 USA; [St Leger, Anthony J.] NEI, Immunoregulat Sect, NIH, Bethesda, MD 20892 USA; [Chan, Chi-Chao] NEI, Immunopathol Sect, NIH, Bethesda, MD 20892 USA; [Wang, Hongsheng; Morse, Herbert C., III] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [He, Chang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Sun Yat Sen University	Egwuagu, CE (corresponding author), NEI, Mol Immunol Sect, NIH, Bethesda, MD 20892 USA.	egwuaguc@nei.nih.gov		Yu, Cheng-Rong/0000-0001-7246-0362; St. Leger, Anthony/0000-0002-2547-200X	National Eye Institute [EY000350-15, EY000372-14]; NATIONAL EYE INSTITUTE [ZIAEY000315, ZIAEY000372, ZIAEY000280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001057] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: (i) EY000350-15: National Eye Institute CEE; (ii) EY000372-14: National Eye Institute CEE.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; COLOTTA F, 1992, BLOOD, V80, P2012; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Decman V, 2005, J VIROL, V79, P10339, DOI 10.1128/JVI.79.16.10339-10347.2005; Egwuagu CE, 2006, ONCOGENE, V25, P3670, DOI 10.1038/sj.onc.1209402; Ellis TN, 2004, IMMUNOLOGY, V112, P2, DOI 10.1111/j.1365-2567.2004.01849.x; Feldman LT, 2002, P NATL ACAD SCI USA, V99, P978, DOI 10.1073/pnas.022301899; Frank GM, 2010, J IMMUNOL, V184, P277, DOI 10.4049/jimmunol.0902373; Freeman ML, 2007, J IMMUNOL, V179, P322, DOI 10.4049/jimmunol.179.1.322; Hayashi K, 2006, J GEN VIROL, V87, P2161, DOI 10.1099/vir.0.81772-0; Hayashi Kozaburo, 2008, Semin Ophthalmol, V23, P229, DOI 10.1080/08820530802111408; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Horiuchi M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-227; Jeon S, 2013, J IMMUNOL, V190, P6277, DOI 10.4049/jimmunol.1300582; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Kim SH, 2015, J IMMUNOL, V195, P1480, DOI 10.4049/jimmunol.1500653; Lee W, 2016, CELL MOL IMMUNOL, V13, P785, DOI 10.1038/cmi.2015.72; Lee YS, 2011, IMMUNOLOGY, V132, P492, DOI 10.1111/j.1365-2567.2010.03379.x; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Minten C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049851; Miyagawa F, 2012, P NATL ACAD SCI USA, V109, P12123, DOI 10.1073/pnas.1201453109; Mosmann TR, 1997, CIBA F SYMP, V204, P148; Nelson N, 1996, J IMMUNOL, V156, P3711; Oh HM, 2011, J BIOL CHEM, V286, P30888, DOI 10.1074/jbc.M111.253500; Ouyang XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1311; Rowe AM, 2013, PROG RETIN EYE RES, V32, P88, DOI 10.1016/j.preteyeres.2012.08.002; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Shrikant PA, 2010, IMMUNOL RES, V46, P12, DOI 10.1007/s12026-009-8130-9; St Leger AJ, 2013, J IMMUNOL, V191, P2258, DOI 10.4049/jimmunol.1300585; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; Suryawanshi A, 2011, J IMMUNOL, V187, P1919, DOI 10.4049/jimmunol.1100736; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tang QZ, 1996, J EXP MED, V184, P1435, DOI 10.1084/jem.184.4.1435; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wang HS, 2014, J IMMUNOL, V193, P1766, DOI 10.4049/jimmunol.1301939; Xu FJ, 2002, J INFECT DIS, V185, P1019, DOI 10.1086/340041; Yoshida Y, 2014, IMMUNITY, V40, P187, DOI 10.1016/j.immuni.2013.11.022; Yu CR, 2015, INFLAMMATION, V38, P555, DOI 10.1007/s10753-014-9962-6; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111	45	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155420	10.1371/journal.pone.0155420	http://dx.doi.org/10.1371/journal.pone.0155420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171004	gold, Green Published, Green Submitted			2022-12-27	WOS:000376588600076
J	Buhmann, J; Desmet, F; Moens, B; Van Dyck, E; Leman, M				Buhmann, Jeska; Desmet, Frank; Moens, Bart; Van Dyck, Edith; Leman, Marc			Spontaneous Velocity Effect of Musical Expression on Self-Paced Walking	PLOS ONE			English	Article							FREQUENCY; BEAT; EXERCISE; GROOVE; SPEED; SYNCHRONIZATION; CORTEX; MODEL; GAIT	The expressive features of music can influence the velocity of walking. So far, studies used instructed (and intended) synchronization. But is this velocity effect still present with non-instructed (spontaneous) synchronization? To figure that out, participants were instructed to walk in their own comfort tempo on an indoor track, first in silence and then with tempo-matched music. We compared velocities of silence and music conditions. The results show that some music has an activating influence, increasing velocity and motivation, while other music has a relaxing influence, decreasing velocity and motivation. The influence of musical expression on the velocity of self-paced walking can be predicted with a regression model using only three sonic features explaining 56% of the variance. Phase-coherence between footfall and beat did not contribute to the velocity effect, due to its implied fixed pacing. The findings suggest that the velocity effect depends on vigor entrainment that influences both stride length and pacing. Our findings are relevant for preventing injuries, for gait improvement in walking rehabilitation, and for improving performance in sports activities.	[Buhmann, Jeska; Desmet, Frank; Moens, Bart; Van Dyck, Edith; Leman, Marc] Univ Ghent, Dept Musicol, Inst Psychoacoust & Elect Mus, B-9000 Ghent, Belgium	Ghent University	Buhmann, J (corresponding author), Univ Ghent, Dept Musicol, Inst Psychoacoust & Elect Mus, B-9000 Ghent, Belgium.	jeska.buhmann@ugent.be	Buhmann, Jeska/L-1233-2019; Van Dyck, Edith/ABE-4913-2020	Buhmann, Jeska/0000-0001-6659-6247; Moens, Bart/0000-0002-1281-9406; Leman, Marc/0000-0002-9780-2194; Van Dyck, Edith/0000-0001-7239-1918	BeatHealth [610633]; European Commission under the Seventh Framework Programme	BeatHealth; European Commission under the Seventh Framework Programme	This research has been supported by BeatHealth (contract #610633), a collaborative project funded by the European Commission under the Seventh Framework Programme (http://cordis.europa.eu/search/result_en?q=610633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; Bood RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070758; Danion F, 2003, GAIT POSTURE, V18, P69, DOI 10.1016/S0966-6362(03)00030-4; de Bruin N, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/483530; Dixon S, 2007, J NEW MUSIC RES, V36, P39, DOI 10.1080/09298210701653310; Eliakim M, 2012, J STRENGHT COND RES, V0, P1; Franek M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01361; Grafarend E. W., 2006, LINEAR NONLINEAR MOD; Heiderscheit BC, 2011, MED SCI SPORT EXER, V43, P296, DOI 10.1249/MSS.0b013e3181ebedf4; Hoffmann CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045206; Janata P, 2012, J EXP PSYCHOL GEN, V141, P54, DOI 10.1037/a0024208; Jarraya Mohamed, 2012, Asian J Sports Med, V3, P233; Karageorghis CI, 2006, J SPORT SCI, V24, P899, DOI 10.1080/02640410500298107; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Leman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067932; Leow LA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00811; Lim HBT, 2014, MED SCI SPORT EXER, V46, P407, DOI 10.1249/MSS.0b013e3182a6378c; MacDougall HG, 2005, J APPL PHYSIOL, V99, P1164, DOI 10.1152/japplphysiol.00138.2005; Madison G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00894; Mancini M, 2012, J BIOENG BIOMED SC S, VS1, P1, DOI DOI 10.4172/2155-9538.S1-007; Meister IG, 2004, COGNITIVE BRAIN RES, V19, P219, DOI 10.1016/j.cogbrainres.2003.12.005; Mendonca C, 2014, HUM MOVEMENT SCI, V33, P33, DOI 10.1016/j.humov.2013.11.006; Moens B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114234; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Nessler JA, 2010, GAIT POSTURE, V31, P527, DOI 10.1016/j.gaitpost.2010.01.013; Nombela C, 2013, NEUROSCI BIOBEHAV R, V37, P2564, DOI 10.1016/j.neubiorev.2013.08.003; Priest DL, 2004, J SPORT MED PHYS FIT, V44, P77; Roerdink M, 2011, GAIT POSTURE, V33, P690, DOI 10.1016/j.gaitpost.2011.03.001; Stephan KM, 2002, NEUROIMAGE, V15, P345, DOI 10.1006/nimg.2001.0929; Stupacher J, 2013, BRAIN COGNITION, V82, P127, DOI 10.1016/j.bandc.2013.03.003; Styns F, 2007, HUM MOVEMENT SCI, V26, P769, DOI 10.1016/j.humov.2007.07.007; Terry PC, 2012, J SCI MED SPORT, V15, P52, DOI 10.1016/j.jsams.2011.06.003; Van Dyck E, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0025-9; van Noorden L, 1999, J NEW MUSIC RES, V28, P43, DOI 10.1076/jnmr.28.1.43.3122; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; Varewyck M, 2013, J NEW MUSIC RES, V42, P267, DOI 10.1080/09298215.2013.798738; Williams DM, 2008, J SPORT EXERCISE PSY, V30, P471, DOI 10.1123/jsep.30.5.471; ZARRUGH MY, 1974, EUR J APPL PHYSIOL O, V33, P293, DOI 10.1007/BF00430237	39	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154414	10.1371/journal.pone.0154414	http://dx.doi.org/10.1371/journal.pone.0154414			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167064	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300090
J	Kim, IW; Lee, JH; Subramaniyam, S; Yun, EY; Kim, I; Park, J; Hwang, JS				Kim, In-Woo; Lee, Joon Ha; Subramaniyam, Sathiyamoorthy; Yun, Eun-Young; Kim, Iksoo; Park, Junhyung; Hwang, Jae Sam			De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus)	PLOS ONE			English	Article							BACTERIAL COMMUNITY; INSECT IMMUNITY; IDENTIFICATION; PREDICTION; DROSOPHILA; AUTOPHAGY; SEQUENCES; GENE; TOOL; GUT	Cockroaches are surrogate hosts for microbes that cause many human diseases. In spite of their generally destructive nature, cockroaches have recently been found to harbor potentially beneficial and medically useful substances such as drugs and allergens. However, genomic information for the American cockroach (Periplaneta americana) is currently unavailable; therefore, transcriptome and gene expression profiling is needed as an important resource to better understand the fundamental biological mechanisms of this species, which would be particularly useful for the selection of novel antimicrobial peptides. Thus, we performed de novo transcriptome analysis of P. americana that were or were not immunized with Escherichia coli. Using an Illumina HiSeq sequencer, we generated a total of 9.5 Gb of sequences, which were assembled into 85,984 contigs and functionally annotated using Basic Local Alignment Search Tool (BLAST), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) database terms. Finally, using an in silico antimicrobial peptide prediction method, 86 antimicrobial peptide candidates were predicted from the transcriptome, and 21 of these peptides were experimentally validated for their antimicrobial activity against yeast and gram positive and -negative bacteria by a radial diffusion assay. Notably, 11 peptides showed strong antimicrobial activities against these organisms and displayed little or no cytotoxic effects in the hemolysis and cell viability assay. This work provides prerequisite baseline data for the identification and development of novel antimicrobial peptides, which is expected to provide a better understanding of the phenomenon of innate immunity in similar species.	[Kim, In-Woo; Lee, Joon Ha; Yun, Eun-Young; Hwang, Jae Sam] Rural Dev Adm, Natl Inst Agr Sci, Dept Agr Biol, Wonju, South Korea; [Subramaniyam, Sathiyamoorthy; Park, Junhyung] Insilicogen Inc, Yongin, Gyeonggi Do, South Korea; [Kim, In-Woo; Kim, Iksoo] Chonnam Natl Univ, Coll Agr & Life Sci, Gwangju, South Korea	National Institute of Agricultural Sciences; Rural Development Administration (RDA); Chonnam National University	Hwang, JS (corresponding author), Rural Dev Adm, Natl Inst Agr Sci, Dept Agr Biol, Wonju, South Korea.; Park, J (corresponding author), Insilicogen Inc, Yongin, Gyeonggi Do, South Korea.	jhpark@insilicogen.com; hwangjs@korea.kr		Park, Junhyung/0000-0002-0805-6362	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01104304]; Insilicogen, Inc.	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Insilicogen, Inc.	This work was supported by a grant from the Next-Generation BioGreen 21 Program (Project No. PJ01104304), Rural Development Administration, Republic of Korea. Insilicogen, Inc. provided support in the form of salaries for authors [SS, JP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed A, 2010, IRAN J PUBLIC HEALTH, V39, P109; Bertino-Grimaldi D, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-609; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Bulet P, 2003, INFEC DIS S, P89; Chen W, 2013, MOL GENET GENOMICS, V288, P627, DOI 10.1007/s00438-013-0777-1; Chung Hyang Suk, 2005, Korean Journal of Parasitology, V43, P149, DOI 10.3347/kjp.2005.43.4.149; Dang HX, 2014, BIOINFORMATICS, V30, P1120, DOI 10.1093/bioinformatics/btu004; Fang Wei, 2013, Weishengwu Xuebao, V53, P984; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gomes LC, 2014, MOL CELL, V54, P224, DOI 10.1016/j.molcel.2014.03.009; Haine ER, 2007, DEV COMP IMMUNOL, V31, P456, DOI 10.1016/j.dci.2006.08.004; Hornett EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-361; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Jaramillo-Ramirez GI, 2010, NEOTROP ENTOMOL, V39, P371, DOI 10.1590/S1519-566X2010000300010; Kinfu A, 2008, T ROY SOC TROP MED H, V102, P1143, DOI 10.1016/j.trstmh.2008.05.009; Lee S, 2012, PATHOG GLOB HEALTH, V106, P218, DOI 10.1179/2047773212Y.0000000033; Lee S, 2011, INT J ANTIMICROB AG, V37, P279, DOI 10.1016/j.ijantimicag.2010.12.005; Lent DD, 2007, DEV NEUROBIOL, V67, P740, DOI 10.1002/dneu.20374; Moy RH, 2013, J INNATE IMMUN, V5, P444, DOI 10.1159/000350326; Mueller Uwe, 2008, V15, P21, DOI 10.1159/000135684; Seo MD, 2012, MOLECULES, V17, P12276, DOI 10.3390/molecules171012276; Slama K, 2006, ARCH INSECT BIOCHEM, V62, P91, DOI 10.1002/arch.20131; Stankiewicz Maria, 2012, J Toxicol, V2012, P143740, DOI 10.1155/2012/143740; Torrent M, 2011, J MED CHEM, V54, P5237, DOI 10.1021/jm200701g; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vilcinskas A, 2013, J INSECT PHYSIOL, V59, P123, DOI 10.1016/j.jinsphys.2012.08.018; Waghu FH, 2014, NUCLEIC ACIDS RES, V42, pD1154, DOI 10.1093/nar/gkt1157; Walter MC, 2009, NUCLEIC ACIDS RES, V37, pD408, DOI 10.1093/nar/gkn749; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Xiao B, 2012, CURR GENET, V58, P65, DOI 10.1007/s00294-012-0365-7; Yan T, 2005, NUCLEIC ACIDS RES, V33, pW262, DOI 10.1093/nar/gki368; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; You WG, 2014, FUNCT INTEGR GENOMIC, V14, P275, DOI 10.1007/s10142-014-0366-3; Zhou XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106932	35	45	51	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155304	10.1371/journal.pone.0155304	http://dx.doi.org/10.1371/journal.pone.0155304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167617	Green Submitted, Green Published, gold			2022-12-27	WOS:000376587300024
J	Mugii, N; Hasegawa, M; Matsushita, T; Hamaguchi, Y; Oohata, S; Okita, H; Yahata, T; Someya, F; Inoue, K; Murono, S; Fujimoto, M; Takehara, K				Mugii, Naoki; Hasegawa, Minoru; Matsushita, Takashi; Hamaguchi, Yasuhito; Oohata, Sacihe; Okita, Hirokazu; Yahata, Tetsutarou; Someya, Fujiko; Inoue, Katsumi; Murono, Shigeyuki; Fujimoto, Manabu; Takehara, Kazuhiko			Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies	PLOS ONE			English	Article							INFLAMMATORY MYOPATHY; JAPANESE PATIENTS; MYOSITIS; POLYMYOSITIS; DIAGNOSIS; PROTEIN	Objective Dysphagia develops with low frequency in patients with dermatomyositis. Our objective was to determine the clinical and laboratory features that can estimate the development of dysphagia in dermatomyositis. Methods This study included 92 Japanese patients with adult-onset dermatomyositis. The associations between dysphagia and clinical and laboratory features including disease-specific autoantibodies determined by immunoprecipitation assays were analyzed. Results Videofluoroscopy swallow study (VFSS) was performed for all patients with clinical dysphagia (n = 13, 14.1%) but not for patients without clinical dysphagia. Typical findings of dysphagia (pharyngeal pooling, n = 11 and/or nasal regurgitation, n = 4) was detected by VFSS in all patients with clinical dysphagia. Eleven patients with dysphagia (84.6%) had anti-transcription intermediary factor 1 gamma (TIF-1 gamma) antibody. By univariate analysis, the average age and the male to female ratio, internal malignancy, and anti-TIF-1 gamma antibody were significantly higher and the frequency of interstitial lung diseases and manual muscle testing (MMT) scores of sternomastoid and dertoid muscles were significantly lower in patients with dysphagia than in patients without dysphagia. Among patients with anti-TIF-1 gamma antibody, the mean age, the ratios of male to female and internal malignancy were significantly higher and mean MMT scores of sternomastoid muscle were significantly lower in patients with dysphagia compared with patients without dysphagia. By multivariable analysis, the risk of dysphagia was strongly associated with the existence of internal malignancy and ant-TIF1 gamma antibody and was also associated with reduced scores of manual muscle test of sternomastoid muscle. Dysphagia was markedly improved after the treatment against myositis in all 13 patients. Conclusion These findings indicate that dysphagia can develop frequently in patients with internal malignancy, anti-TIF-1 gamma antibody, or severe muscle weakness of sternomastoid muscle.	[Mugii, Naoki; Oohata, Sacihe; Okita, Hirokazu; Yahata, Tetsutarou] Kanazawa Univ Hosp, Dept Rehabil, Kanazawa, Ishikawa, Japan; [Hasegawa, Minoru] Univ Fukui, Fac Med Sci, Dept Dermatol, Div Med, Fukui, Fukui, Japan; [Matsushita, Takashi; Hamaguchi, Yasuhito; Takehara, Kazuhiko] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Dept Dermatol, Kanazawa, Ishikawa, Japan; [Someya, Fujiko; Inoue, Katsumi] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Div Rehabil Sci, Kanazawa, Ishikawa, Japan; [Murono, Shigeyuki] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Dept Otorhinolaryngol Head & Neck Surg, Kanazawa, Ishikawa, Japan; [Fujimoto, Manabu] Univ Tsukuba, Fac Med, Dept Dermatol, Tsukuba, Ibaraki, Japan	Kanazawa University; University of Fukui; Kanazawa University; Kanazawa University; Kanazawa University; University of Tsukuba	Hasegawa, M (corresponding author), Univ Fukui, Fac Med Sci, Dept Dermatol, Div Med, Fukui, Fukui, Japan.	minoruha@u-fukui.ac.jp	Someya, Fujiko/H-7649-2013; Matsushita, Takashi/C-4750-2015	Someya, Fujiko/0000-0001-6439-924X; Matsushita, Takashi/0000-0002-1617-086X; Fujimoto, Manabu/0000-0002-3062-4872; Hasegawa, Minoru/0000-0003-3738-2682	Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [26350565] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by funds for research on intractable diseases from the Ministry of Health, Labor, and Welfare of Japan (NM, MH, MF, KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2011, MOD RHEUMATOL, V21, P178, DOI 10.1007/s10165-010-0362-y; Betteridge ZE, 2009, ANN RHEUM DIS, V68, P1621, DOI 10.1136/ard.2008.097162; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Chinoy H, 2007, ANN RHEUM DIS, V66, P1345, DOI 10.1136/ard.2006.068502; Ebert EC, 2010, ALIMENT PHARM THER, V31, P359, DOI 10.1111/j.1365-2036.2009.04190.x; Fujimoto M, 2013, ANN RHEUM DIS, V72, P151, DOI 10.1136/annrheumdis-2012-201736; Fujimoto M, 2012, ARTHRITIS RHEUM-US, V64, P513, DOI 10.1002/art.33403; Ghirardello A, 2005, AUTOIMMUNITY, V38, P79, DOI 10.1080/08916930400022681; Gunawardena H, 2008, RHEUMATOLOGY, V47, P324, DOI 10.1093/rheumatology/kem359; Kaji K, 2007, RHEUMATOLOGY, V46, P25, DOI 10.1093/rheumatology/kel161; KOBAYASHI J, 1995, CHEST, V108, P311, DOI 10.1378/chest.108.2.311; Langdon PC, 2012, DYSPHAGIA, V27, P408, DOI 10.1007/s00455-011-9384-7; McCann LJ, 2007, RHEUMATOLOGY, V46, P1363, DOI 10.1093/rheumatology/kem131; Mimori T, 2007, CURR OPIN RHEUMATOL, V19, P523, DOI 10.1097/BOR.0b013e3282f01a8c; Oh TH, 2007, MAYO CLIN PROC, V82, P441, DOI 10.4065/82.4.441; Ponyi A, 2005, ANN NY ACAD SCI, V1051, P64, DOI 10.1196/annals.1361.047; Sato S, 2005, ARTHRITIS RHEUM-US, V52, P1571, DOI 10.1002/art.21023; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Sontheimer Richard D., 1999, Current Opinion in Rheumatology, V11, P475, DOI 10.1097/00002281-199911000-00006; Sultan SM, 2008, ARTHRITIS RHEUM, V58, P3593, DOI 10.1002/art.23963; Targoff IN, 2002, RHEUM DIS CLIN N AM, V28, P859, DOI 10.1016/S0889-857X(02)00032-7; Targoff IN, 2006, ARTHRITIS RHEUM, V54, P3682, DOI 10.1002/art.22164; Trallero-Araguas E, 2012, ARTHRITIS RHEUM-US, V64, P523, DOI 10.1002/art.33379; Williams RB, 2003, GUT, V52, P471, DOI 10.1136/gut.52.4.471	25	50	51	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154746	10.1371/journal.pone.0154746	http://dx.doi.org/10.1371/journal.pone.0154746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167831	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300070
J	O'Connell, S; OLaighin, G; Kelly, L; Murphy, E; Beirne, S; Burke, N; Kilgannon, O; Quinlan, LR				O'Connell, Sandra; OLaighin, Gearoid; Kelly, Lisa; Murphy, Elaine; Beirne, Sorcha; Burke, Niall; Kilgannon, Orlaith; Quinlan, Leo R.			These Shoes Are Made for Walking: Sensitivity Performance Evaluation of Commercial Activity Monitors under the Expected Conditions and Circumstances Required to Achieve the International Daily Step Goal of 10,000 Steps	PLOS ONE			English	Article							FREE-LIVING CONDITIONS; DWELLING OLDER-ADULTS; PHYSICAL-ACTIVITY; PEDOMETER ACCURACY; TREADMILL WALKING; HEALTHY-ADULTS; VALIDITY; RELIABILITY; DEVICE; ENOUGH	Introduction Physical activity is a vitally important part of a healthy lifestyle, and is of major benefit to both physical and mental health. A daily step count of 10,000 steps is recommended globally to achieve an appropriate level of physical activity. Accurate quantification of physical activity during conditions reflecting those needed to achieve the recommended daily step count of 10,000 steps is essential. As such, we aimed to assess four commercial activity monitors for their sensitivity/accuracy in a prescribed walking route that reflects a range of surfaces that would typically be used to achieve the recommended daily step count, in two types of footwear expected to be used throughout the day when aiming to achieve the recommended daily step count, and in a timeframe required to do so. Methods Four commercial activity monitors were worn simultaneously by participants ( n = 15) during a prescribed walking route reflective of surfaces typically encountered while achieving the daily recommended 10,000 steps. Activity monitors tested were the Garmin Vivofit (TM), New Lifestyles' NL-2000 (TM) pedometer, Withings Smart Activity Monitor Tracker ( Pulse O-2)(TM), and Fitbit One (TM). Results All activity monitors tested were accurate in their step detection over the variety of different surfaces tested (natural lawn grass, gravel, ceramic tile, tarmacadam/asphalt, linoleum), when wearing both running shoes and hard-soled dress shoes. Conclusion All activity monitors tested were accurate in their step detection sensitivity and are valid monitors for physical activity quantification over the variety of different surfaces tested, when wearing both running shoes and hard-soled dress shoes, and over a timeframe necessary for accumulating the recommended daily step count of 10,000 steps. However, it is important to consider the accuracy of activity monitors, particularly when physical activity in the form of stepping activities is prescribed as an intervention in the treatment or prevention of a disease state.	[O'Connell, Sandra; Kelly, Lisa; Murphy, Elaine; Beirne, Sorcha; Burke, Niall; Kilgannon, Orlaith; Quinlan, Leo R.] NUI Galway, Sch Med, Discipline Physiol, Galway, Ireland; [O'Connell, Sandra; OLaighin, Gearoid] NUI Galway, Sch Engn & Informat, Elect & Elect Engn, Galway, Ireland; [OLaighin, Gearoid] NUI Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland; [OLaighin, Gearoid; Quinlan, Leo R.] NUI Galway, Ctr Med Device Res, CURAM, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	OLaighin, G (corresponding author), NUI Galway, Sch Engn & Informat, Elect & Elect Engn, Galway, Ireland.; OLaighin, G (corresponding author), NUI Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.; OLaighin, G (corresponding author), NUI Galway, Ctr Med Device Res, CURAM, Galway, Ireland.	gearoid.olaighin@nuigalway.ie	Quinlan, Leo R/N-4117-2014; kelly, Lisa/GWU-9804-2022; ÓLaighin, Gearóid/A-5239-2009; ÓLaighin, Gearóid/AAC-2198-2019	Quinlan, Leo R/0000-0002-4011-6732; ÓLaighin, Gearóid/0000-0002-1885-814X; O'Connell, Sandra/0000-0002-6722-8419	Irish Research Council [EPSPG/2012/504]	Irish Research Council(Irish Research Council for Science, Engineering and Technology)	Sandra O'Connell is supported by the Irish Research Council grant number EPSPG/2012/504, under the Enterprise Partnership Scheme. The enterprise partner was the Galway Clinic, Doughiska, Co. Galway, Ireland.	Brown DK, 2013, INT J SPORTS MED, V34, P431, DOI 10.1055/s-0032-1323723; Busse M. E., 2009, Journal of Medical Engineering & Technology, V33, P33, DOI 10.1080/03091900701682606; CDC, 2008 PHYS ACT GUID A; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; Cyarto EV, 2004, MED SCI SPORT EXER, V36, P205, DOI 10.1249/01.MSS.0000113476.62469.98; Dahlgren G, 2010, GAIT POSTURE, V32, P386, DOI 10.1016/j.gaitpost.2010.06.022; Diaz KM, 2015, INT J CARDIOL, V185, P138, DOI 10.1016/j.ijcard.2015.03.038; Dondzila CJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-143; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; Giannakidou DM, 2012, EUR J APPL PHYSIOL, V112, P49, DOI 10.1007/s00421-011-1951-y; Godfrey A, 2007, MED ENG PHYS, V29, P930, DOI 10.1016/j.medengphy.2006.10.001; Grant PM, 2008, J AGING PHYS ACTIV, V16, P201, DOI 10.1123/japa.16.2.201; Harrington DM, 2011, APPL PHYSIOL NUTR ME, V36, P583, DOI [10.1139/h11-053, 10.1139/H11-053]; Harrington DM, 2011, J SPORT SCI, V29, P627, DOI 10.1080/02640414.2010.549499; Johnson M, 2015, J SPORT SCI, V33, P769, DOI 10.1080/02640414.2014.964747; Kang M, 2009, RES Q EXERCISE SPORT, V80, P648, DOI 10.5641/027013609X13088500160000; Karmisholt K, 2005, DAN MED BULL, V52, P90; Klassen TD, 2015, PHYS THER; Lee JM, 2014, MED SCI SPORT EXER, V46, P1840, DOI 10.1249/MSS.0000000000000287; Leicht AS, 2007, MED SCI SPORT EXER, V39, P1847, DOI 10.1249/mss.0b013e3181405b9f; Maddocks M, 2010, BRIT J SPORT MED, V44, P606, DOI 10.1136/bjsm.2008.051128; Murphy SL, 2009, PREV MED, V48, P108, DOI 10.1016/j.ypmed.2008.12.001; Nunan D, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-56; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Schneider PL, 2004, MED SCI SPORT EXER, V36, P331, DOI 10.1249/01.MSS.0000113486.60548.E9; Schneider PL, 2003, MED SCI SPORT EXER, V35, P1779, DOI 10.1249/01.MSS.0000089342.96098.C4; Simpson LA, 2015, J REHABIL MED; Stansfield B, 2015, MED ENG PHYS, V37, P42, DOI 10.1016/j.medengphy.2014.10.003; Storm FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118723; Takacs J, 2014, J SCI MED SPORT, V17, P496, DOI 10.1016/j.jsams.2013.10.241; Taraldsen K, 2011, PHYS THER, V91, P277, DOI 10.2522/ptj.20100159; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Tudor-Locke C, 2011, PREV MED, V53, P31, DOI 10.1016/j.ypmed.2011.01.014; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; World Health Organization, 2010, GLOBAL RECOMMENDATIO; Young DR, 2014, CIRC-HEART FAIL, V7, P21, DOI 10.1161/CIRCHEARTFAILURE.113.000529	38	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154956	10.1371/journal.pone.0154956	http://dx.doi.org/10.1371/journal.pone.0154956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167121	gold, Green Published			2022-12-27	WOS:000376587300100
J	Restivo, L; Apostolidis, T; Bouhnik, AD; Garciaz, S; Aurran, T; Julian-Reynier, C				Restivo, Lea; Apostolidis, Themis; Bouhnik, Anne-Deborah; Garciaz, Sylvain; Aurran, Therese; Julian-Reynier, Claire			Patients' Non-Medical Characteristics Contribute to Collective Medical Decision-Making at Multidisciplinary Oncological Team Meetings	PLOS ONE			English	Article							ALTERNATIVES; UNCERTAINTY; PHYSICIANS; JUDGMENTS	Background The contribution of patients' non-medical characteristics to individual physicians' decision-making has attracted considerable attention, but little information is available on this topic in the context of collective decision-making. Medical decision-making at cancer centres is currently carried out using a collective approach, at Multi-Disciplinary Team (MDT) meetings. The aim of this study was to determine how patients' non-medical characteristics are presented at MDT meetings and how this information may affect the team's final medical decisions. Design Observations were conducted at a French Cancer Centre during MDT meetings at which non-standard cases involving some uncertainty were discussed from March to May 2014. Physicians' verbal statements and predefined contextual parameters were collected with a non-participant observational approach. Non numerical data collected in the form of open notes were then coded for quantitative analysis. Univariate and multivariate statistical analyses were performed. Results In the final sample of patients' records included and discussed (N = 290), non-medical characteristics were mentioned in 32.8% (n = 95) of the cases. These characteristics corresponded to demographics in 22.8% (n = 66) of the cases, psychological data in 11.7%(n = 34), and relational data in 6.2%(n = 18). The patient's age and his/her "likeability" were the most frequently mentioned characteristics. In 17.9% of the cases discussed, the final decision was deferred: this outcome was positively associated with the patients' non-medical characteristics and with uncertainty about the outcome of the therapeutic options available. Limitations The design of the study made it difficult to draw definite cause-and-effect conclusions. Conclusion The Social Representations approach suggests that patients' non-medical characteristics constitute a kind of tacit professional knowledge that may be frequently mobilised in physicians' everyday professional practice. The links observed between patients' attributes and the medical decisions made at these meetings show that these attributes should be taken into account in order to understand how medical decisions are reached in difficult situations of this kind.	[Restivo, Lea; Apostolidis, Themis] Aix Marseille Univ, Lab Psychol Sociale EA 849, Aix En Provence, France; [Restivo, Lea; Bouhnik, Anne-Deborah; Julian-Reynier, Claire] INSERM, SESSTIM UMR912, F-13258 Marseille, France; [Restivo, Lea; Bouhnik, Anne-Deborah; Julian-Reynier, Claire] Aix Marseille Univ, IRD, UMR S912, Marseille, France; [Garciaz, Sylvain; Aurran, Therese; Julian-Reynier, Claire] Inst J Paoli I Calmettes, F-13009 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Restivo, L (corresponding author), Aix Marseille Univ, Lab Psychol Sociale EA 849, Aix En Provence, France.; Restivo, L (corresponding author), INSERM, SESSTIM UMR912, F-13258 Marseille, France.; Restivo, L (corresponding author), Aix Marseille Univ, IRD, UMR S912, Marseille, France.	lea.restivo@univ-amu.fr	Garciaz, Sylvain/AGJ-6731-2022; Bouhnik, Anne-Déborah/Q-9650-2017; Apostolidis, Themis/T-9994-2017; Bouhnik, Anne-Deborah/M-2829-2019	Garciaz, Sylvain/0000-0002-0081-1255; Bouhnik, Anne-Déborah/0000-0002-5418-4592; Apostolidis, Themis/0000-0002-3549-5547; Bouhnik, Anne-Deborah/0000-0002-5418-4592	ARC cancer research foundation	ARC cancer research foundation	This research was partly supported by the ARC cancer research foundation, which awarded a fourth-year doctoral fellowship to the corresponding author. The funders were not involved in any way in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abric J.-C., 2003, PRATIQUES SOCIALES R; [Anonymous], 2006, REUN CONC PLUR CANC; Baszanger I, 2012, SOC SCI MED, V75, P864, DOI 10.1016/j.socscimed.2012.03.023; Bourret P, 2008, SCI SOC SANTE, V26, P33; Castel P, 2008, SCI SOC SANTE, V26, P9; Castel P, 2012, B CANCER, V99, pE34, DOI 10.1684/bdc.2012.1559; CLARK JA, 1991, SOC SCI MED, V32, P853, DOI 10.1016/0277-9536(91)90241-4; Daly J., 2005, EVIDENCE BASED MED S; EISENBERG JM, 1979, ANN INTERN MED, V90, P957, DOI 10.7326/0003-4819-90-6-957; Farr R.M., 1984, SOCIAL REPRESENTATIO; Feldman HA, 1997, HEALTH SERV RES, V32, P343; Hajjaj FM, 2010, J ROY SOC MED, V103, P178, DOI 10.1258/jrsm.2010.100104; Jodelet, 1989, FOLIES REPRESENTATIO; Lamb BW, 2013, ANN SURG ONCOL, V20, P715, DOI 10.1245/s10434-012-2691-x; Lutfey KE, 2008, SOC SCI MED, V67, P1391, DOI 10.1016/j.socscimed.2008.07.005; McKinlay JB, 1996, SOC SCI MED, V42, P769, DOI 10.1016/0277-9536(95)00342-8; Morin M, 1997, MED GEN FACE SIDA; Orgerie MB, 2010, B CANCER, V97, P255, DOI 10.1684/bdc.2009.0957; REDELMEIER DA, 1995, JAMA-J AM MED ASSOC, V273, P302, DOI 10.1001/jama.273.4.302; Roswarski TE, 2006, MED DECIS MAKING, V26, P154, DOI 10.1177/0272989X06286483; Taylor C., 2010, BMJ-BRIT MED J, V340, P743; TVERSKY A, 1992, PSYCHOL SCI, V3, P358, DOI 10.1111/j.1467-9280.1992.tb00047.x; Twigg OC, 2015, PAIN MED, V16, P88, DOI 10.1111/pme.12587; Ubachs-Moust J, 2008, J MED ETHICS, V34, P863, DOI 10.1136/jme.2008.025247; Weisz G, 2007, MILBANK Q, V85, P691, DOI 10.1111/j.1468-0009.2007.00505.x; Zhang Amy Y, 2003, Oncol Nurs Forum, V30, P1022	26	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154969	10.1371/journal.pone.0154969	http://dx.doi.org/10.1371/journal.pone.0154969			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CD	27167521	Green Published, gold			2022-12-27	WOS:000376587300072
J	Antunes, TFS; Amaral, RJV; Ventura, JA; Godinho, MT; Amaral, JG; Souza, FO; Zerbini, PA; Zerbini, FM; Fernandes, PMB				Sa Antunes, Tathiana Ferreira; Vionette Amaral, Raquel J.; Ventura, Jose Aires; Godinho, Marcio Tadeu; Amaral, Josiane G.; Souza, Flavia O.; Zerbini, Poliane Alfenas; Zerbini, Francisco Murilo; Bueno Fernandes, Patricia Machado			The dsRNA Virus Papaya Meleira Virus and an ssRNA Virus Are Associated with Papaya Sticky Disease	PLOS ONE			English	Article							STATISTICAL-MODEL; RNA; ACCURACY; PROTEINS; SEQUENCE; GENOME	Papaya sticky disease, or "meleira", is one of the major diseases of papaya in Brazil and Mexico, capable of causing complete crop loss. The causal agent of sticky disease was identified as an isometric virus with a double stranded RNA (dsRNA) genome, named papaya meleira virus (PMeV). In the present study, PMeV dsRNA and a second RNA band of approximately 4.5 kb, both isolated from latex of papaya plants with severe symptoms of sticky disease, were deep-sequenced. The nearly complete sequence obtained for PMeV dsRNA is 8,814 nucleotides long and contains two putative ORFs; the predicted ORF1 and ORF2 display similarity to capsid proteins and RdRp's, respectively, from mycoviruses tentatively classified in the family Totiviridae. The sequence obtained for the second RNA is 4,515 nucleotides long and contains two putative ORFs. The predicted ORFs 1 and 2 display 48% and 73% sequence identity, respectively, with the corresponding proteins of papaya virus Q, an umbravirus recently described infecting papaya in Ecuador. Viral purification in a sucrose gradient allowed separation of particles containing each RNA. Mass spectrometry analysis indicated that both PMeV and the second RNA virus (named papaya meleira virus 2, PMeV2) were encapsidated in particles formed by the protein encoded by PMeV ORF1. The presence of both PMeV and PMeV2 was confirmed in field plants showing typical symptoms of sticky disease. Interestingly, PMeV was detected alone in asymptomatic plants. Together, our results indicate that sticky disease is associated with double infection by PMeV and PMeV2.	[Sa Antunes, Tathiana Ferreira; Vionette Amaral, Raquel J.; Ventura, Jose Aires; Bueno Fernandes, Patricia Machado] Univ Fed Espirito Santo, Nucleo Biotecnol, Vitoria, ES, Brazil; [Ventura, Jose Aires] Inst Capixaba Pesquisa Assistencia Tecn & Extensa, Vitoria, ES, Brazil; [Godinho, Marcio Tadeu; Amaral, Josiane G.; Zerbini, Francisco Murilo] Univ Fed Vicosa, Dept Fitopatol BIOAGRO, BR-36570900 Vicosa, MG, Brazil; [Souza, Flavia O.; Zerbini, Poliane Alfenas] Univ Fed Vicosa, Dept Microbiol BIOAGRO, BR-36570900 Vicosa, MG, Brazil	Universidade Federal do Espirito Santo; Universidade Federal de Vicosa	Fernandes, PMB (corresponding author), Univ Fed Espirito Santo, Nucleo Biotecnol, Vitoria, ES, Brazil.	patricia.fernandes@ufes.br	Fernandes, Patricia M B/AAL-5991-2021; Alfenas-Zerbini, Poliane/P-5430-2016; Vionette do Amaral, Raquel Juliana/E-1192-2018; Zerbini, Francisco Murilo/N-7359-2013	Fernandes, Patricia M B/0000-0003-2695-3638; Alfenas-Zerbini, Poliane/0000-0002-8203-5244; Zerbini, Francisco Murilo/0000-0001-8617-0200; Ventura, Jose Aires/0000-0003-1422-1739	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES).	Abraham AD, 2009, ARCH VIROL, V154, P791, DOI 10.1007/s00705-009-0374-0; Abreu EFM, 2015, ARCH VIROL, V160, P3143, DOI 10.1007/s00705-015-2605-x; Abreu PMV, 2015, VIRUSES-BASEL, V7, P1853, DOI 10.3390/v7041853; Alam SL, 1999, P NATL ACAD SCI USA, V96, P14177, DOI 10.1073/pnas.96.25.14177; [Anonymous], 1989, AN C BRAS FIT RIO DE; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; BOCCARDO G, 1987, ADV VIRUS RES, V32, P171, DOI 10.1016/S0065-3527(08)60477-7; Brierley I, 2007, NAT REV MICROBIOL, V5, P598, DOI 10.1038/nrmicro1704; Cai GH, 2013, VIROLOGY, V435, P341, DOI 10.1016/j.virol.2012.10.012; Chen S, 2015, ARCH VIROL, P1; Daltro CB, 2014, TROP PLANT PATHOL, V39, P104, DOI 10.1590/S1982-56762014000100013; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fauquet CM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-64; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; King A M Q, 2011, VIRUS TAXONOMY CLASS; Kitajima E. W., 1993, Fitopatologia Brasileira, V18, P118; Kozlakidis Z, 2009, VIRUS GENES, V39, P132, DOI 10.1007/s11262-009-0364-z; Kreuze J, 2014, DETECTION DIAGNOSTIC, P21, DOI DOI 10.1007/978-94-017-9020-8_2; Liu H, 2012, PLOS ONE, V7; LIVSHITS MA, 1990, J BIOMOL STRUCT DYN, V7, P1237, DOI 10.1080/07391102.1990.10508562; Maciel-Zambolim E, 2003, PLANT PATHOL, V52, P389, DOI 10.1046/j.1365-3059.2003.00855.x; Martin RR, 2011, VIRUS RES, V155, P175, DOI 10.1016/j.virusres.2010.09.020; de Araujo MMM, 2007, J VIROL METHODS, V146, P305, DOI 10.1016/j.jviromet.2007.07.022; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Perez-Brito D., 2012, African Journal of Biotechnology, V11, P13564, DOI 10.5897/AJB12.1189; Quito-Avila D, 2015, EUROPEAN J PLANT PAT, P1; Rodrigues S. P. G. O. P., 2005, SUMMA PHYTOPATHOL, V31, P281; Rodrigues SP, 2009, PLANT CELL REP, V28, P861, DOI 10.1007/s00299-009-0673-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roossinck MJ, 2010, MOL ECOL, V19, P81, DOI 10.1111/j.1365-294X.2009.04470.x; Roossinck MJ, 2013, PLANT VIRUS ECOLOGY; Ryabov EV, 2012, VIRUS TAXONOMY, P1191, DOI [10.1016/B978-0-12-384684-6.00104-X, DOI 10.1016/B978-0-12-384684-6.00104-X]; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SPEIR JA, 2008, ENCY VIROLOGY, V5, P380; Sperschneider J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq021; Taliansky ME, 2003, J GEN VIROL, V84, P1951, DOI 10.1099/vir.0.19219-0; Tapia-Tussell R, 2015, PLANT PATHOL, V64, P272, DOI 10.1111/ppa.12279; Ventura J. A., 2004, DIS FRUITS VEGETABLE, VII, P201; Yu L, 2015, APPL ENVIRON MICROB, V81, P2299, DOI 10.1128/AEM.03992-14; Zamudio-Moreno E, 2015, GENET MOL RES, V14, P1145, DOI 10.4238/2015.February.6.18	40	27	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155240	10.1371/journal.pone.0155240	http://dx.doi.org/10.1371/journal.pone.0155240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166626	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300095
J	Bomer, N; Cornelis, FMF; Ramos, YFM; den Hollander, W; Lakenberg, N; van der Breggen, R; Storms, L; Slagboom, PE; Lories, RJU; Meulenbelt, I				Bomer, Nils; Cornelis, Frederique M. F.; Ramos, Yolande F. M.; den Hollander, Wouter; Lakenberg, Nico; van der Breggen, Ruud; Storms, Lies; Slagboom, P. Eline; Lories, Rik J. U.; Meulenbelt, Ingrid			Aberrant Calreticulin Expression in Articular Cartilage of Dio2 Deficient Mice	PLOS ONE			English	Article							GENE-EXPRESSION; INHIBITION; SUSCEPTIBILITY; PATHWAY; PROTEIN; CELLS	Objective To identify intrinsic differences in cartilage gene expression profiles between wild-type-and Dio2(-/-)-mice, as a mechanism to investigate factors that contribute to prolonged healthy tissue homeostasis. Methods Previously generated microarray-data (Illumina MouseWG-6 v2) of knee cartilage of wildtype and Dio2(-/-)-mice were re-analyzed to identify differential expressed genes independent of mechanical loading conditions by forced treadmill-running. RT-qPCR and western blot analyses of overexpression and knockdown of Calr in mouse chondro-progenitor cells (ATDC5) were applied to assess the direct effect of differential Calr expression on cartilage deposition. Results Differential expression analyses of articular cartilage of Dio2(-/-) (N = 9) and wild-type-mice (N = 11) while applying a cutoff threshold (P < 0.05 (FDR) and FC > vertical bar 1,5 vertical bar) resulted in 1 probe located in Calreticulin (Calr) that was found significantly downregulated in Dio2(-/-) mice (FC = -1.731; P = 0.044). Furthermore, overexpression of Calr during early chondrogenesis in ATDC5 cells leads to decreased proteoglycan deposition and corresponding lower Aggrecan expression, whereas knocking down Calr expression does not lead to histological differences of matrix composition. Conclusion We here demonstrate that the beneficial homeostatic state of articular cartilage in Dio2(-/-) mice is accompanied with significant lower expression of Calr. Functional analyses further showed that upregulation of Calr expression could act as an initiator of cartilage destruction. The consistent association between Calr and Dio2 expression suggests that enhanced expression of these genes facilitate detrimental effects on cartilage integrity.	[Bomer, Nils; Ramos, Yolande F. M.; den Hollander, Wouter; Lakenberg, Nico; van der Breggen, Ruud; Slagboom, P. Eline; Meulenbelt, Ingrid] LUMC, Dept Mol Epidemiol, Leiden, Netherlands; [Cornelis, Frederique M. F.; Storms, Lies; Lories, Rik J. U.] Katholieke Univ Leuven, Lab Tissue Homeostasis & Dis, Skeletal Biol & Engn Res Ctr, Leuven, Belgium; [Lories, Rik J. U.] Univ Hosp Leuven, Div Rheumatol, Leuven, Belgium	Leiden University; Leiden University Medical Center (LUMC); KU Leuven; KU Leuven; University Hospital Leuven	Bomer, N (corresponding author), LUMC, Dept Mol Epidemiol, Leiden, Netherlands.	n.bomer@lumc.nl	Slagboom, P. Eline/R-4790-2016; Lories, Rik/T-2196-2017; Bomer, Nils/ABD-5238-2021; Lories, Rik/Q-8328-2019; Ramos, Yolande F. M./C-3774-2018; Meulenbelt, Ingrid/F-4756-2011	Slagboom, P. Eline/0000-0002-2875-4723; Lories, Rik/0000-0002-5986-3092; Lories, Rik/0000-0002-5986-3092; Ramos, Yolande F. M./0000-0003-1459-413X; Meulenbelt, Ingrid/0000-0001-7786-7081; Cornelis, Frederique/0000-0002-4144-5861; Bomer, Nils/0000-0001-5926-6960; den Hollander, Wouter/0000-0002-0061-9511	Treatsimilar toOA [200800]; IDEAL - European Union [259679]; FWO Vlaanderen (Flanders Research Foundation) [G.0828.11N]; Dutch Arthritis Association	Treatsimilar toOA; IDEAL - European Union; FWO Vlaanderen (Flanders Research Foundation)(FWO); Dutch Arthritis Association	The authors acknowledge support by Treat similar to OA and IDEAL, which are funded by the European Union's Seventh Framework Program (FP7/2007-2011) under respective grant agreement nos. 200800 and 259679. Furthermore, this work was supported by a grant from FWO Vlaanderen (Flanders Research Foundation) G.0828.11N and by the Dutch Arthritis Association. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Bomer N, 2016, ANN RHEUM DIS, V75, P571, DOI 10.1136/annrheumdis-2014-206608; Bomer N, 2015, ANN RHEUM DIS, V74, P1571, DOI 10.1136/annrheumdis-2013-204739; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; Daniilidis K, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-014-0138-8; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Desai D, 1996, J BIOL CHEM, V271, P15153, DOI 10.1074/jbc.271.25.15153; Ding H, 2014, CLIN EXP IMMUNOL, V178, P236, DOI 10.1111/cei.12411; Fujii Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056296; Gereben B, 2000, MOL ENDOCRINOL, V14, P1697, DOI 10.1210/me.14.11.1697; Hellingman CA, 2011, TISSUE ENG PT A, V17, P1157, DOI [10.1089/ten.TEA.2010.0043, 10.1089/ten.tea.2010.0043]; Li H, 2013, J BIOL CHEM, V288, P18172, DOI 10.1074/jbc.M112.407296; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Meulenbelt I, 2008, HUM MOL GENET, V17, P1867, DOI 10.1093/hmg/ddn082; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Ramos YFM, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0528-x; Reynard LN, 2013, NAT REV RHEUMATOL, V9, P573, DOI 10.1038/nrrheum.2013.121; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Toegel S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-13	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154999	10.1371/journal.pone.0154999	http://dx.doi.org/10.1371/journal.pone.0154999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163789	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700003
J	Massa, MG; Gisevius, B; Hirschberg, S; Hinz, L; Schmidt, M; Gold, R; Prochnow, N; Haghikia, A				Massa, Megan G.; Gisevius, Barbara; Hirschberg, Sarah; Hinz, Lisa; Schmidt, Matthias; Gold, Ralf; Prochnow, Nora; Haghikia, Aiden			Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; NEURODEGENERATION; GENERATION; PHENOTYPES; EFFICIENT; MODELS; BRAIN; ALS	As multiple sclerosis research progresses, it is pertinent to continue to develop suitable paradigms to allow for ever more sophisticated investigations. Animal models of multiple sclerosis, despite their continuing contributions to the field, may not be the most prudent for every experiment. Indeed, such may be either insufficient to reflect the functional impact of human genetic variations or unsuitable for drug screenings. Thus, we have established a cell- and patient-specific paradigm to provide an in vitro model within which to perform future genetic investigations. Renal proximal tubule epithelial cells were isolated from multiple sclerosis patients' urine and transfected with pluripotency-inducing episomal factors. Subsequent induced pluripotent stem cells were formed into embryoid bodies selective for ectodermal lineage, resulting in neural tube-like rosettes and eventually neural progenitor cells. Differentiation of these precursors into primary neurons was achieved through a regimen of neurotrophic and other factors. These patient-specific primary neurons displayed typical morphology and functionality, also staining positive for mature neuronal markers. The development of such a non-invasive procedure devoid of permanent genetic manipulation during the course of differentiation, in the context of multiple sclerosis, provides an avenue for studies with a greater cell- and human-specific focus, specifically in the context of genetic contributions to neurodegeneration and drug discovery.	[Massa, Megan G.; Gisevius, Barbara; Hirschberg, Sarah; Hinz, Lisa; Gold, Ralf; Haghikia, Aiden] Ruhr Univ Bochum, Neurol Klin, St Josef Hosp, Univ Str 150, Bochum, Germany; [Schmidt, Matthias; Prochnow, Nora] Ruhr Univ Bochum, Dept Neuroanat, Univ Str 150, Bochum, Germany; [Hinz, Lisa] Vrije Univ Amsterdam, Dept Complex Trait Genet, Ctr Neurogen & Cognit Res, Neurosci Campus Amsterdam, Amsterdam, Netherlands	Ruhr University Bochum; Ruhr University Bochum; Vrije Universiteit Amsterdam	Haghikia, A (corresponding author), Ruhr Univ Bochum, Neurol Klin, St Josef Hosp, Univ Str 150, Bochum, Germany.	aiden.haghikia@rub.de		Massa, Megan G./0000-0001-8733-1547; Gisevius, Barbara/0000-0002-6018-4441	Medical Faculty of the Ruhr-University Bochum; Fulbright grant from the German-American Fulbright Commission	Medical Faculty of the Ruhr-University Bochum; Fulbright grant from the German-American Fulbright Commission	This work was partly supported by funds of the Medical Faculty of the Ruhr-University Bochum. This paper was also partially supported through a Fulbright grant from the German-American Fulbright Commission (MGM).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; [Anonymous], 2012, LIFE TECHNOLOGIES PR; Burkhardt MF, 2013, MOL CELL NEUROSCI, V56, P355, DOI 10.1016/j.mcn.2013.07.007; Byers B, 2012, CURR NEUROL NEUROSCI, V12, P237, DOI 10.1007/s11910-012-0270-y; Cao L, 2014, MOL NEUROBIOL, P1; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ernsberger U, 1997, MECH DEVELOP, V68, P115, DOI 10.1016/S0925-4773(97)00135-4; Fitzakerley JL, 1997, HEARING RES, V114, P148, DOI 10.1016/S0378-5955(97)00158-5; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Grundken C, 2011, J NEUROSCI METH, V199, P15, DOI 10.1016/j.jneumeth.2011.04.016; Gu A, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010067, 10.1371/currents.RRN1193]; Haghikia A, 2013, TRENDS MOL MED, V19, P309, DOI 10.1016/j.molmed.2013.03.004; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Ingelfinger JR, 2002, NEW ENGL J MED, V347, P684, DOI 10.1056/NEJMe020084; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Liu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105309; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Marchetto MCN, 2010, HUM MOL GENET; Martin ED, 2003, J NEUROPHYSIOL, V89, P3029, DOI 10.1152/jn.00601.2002; Minagar A, 2004, J NEUROIMAGING, V14, p5S, DOI 10.1111/j.1552-6569.2004.tb00273.x; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Qiang L, 2013, NEURON, V78, P957, DOI 10.1016/j.neuron.2013.06.002; Richard J-P, 2014, BRAIN RES; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Winner B, 2014, HUM MOL GENET; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115	37	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155274	10.1371/journal.pone.0155274	http://dx.doi.org/10.1371/journal.pone.0155274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158987	Green Submitted, Green Published, gold			2022-12-27	WOS:000376576700054
J	Lorent, M; Giral, M; Pascual, M; Koller, MT; Steiger, J; Trebern-Launay, K; Legendre, C; Kreis, H; Mourad, G; Garrigue, V; Rostaing, L; Kamar, N; Kessler, M; Ladriere, M; Morelon, E; Buron, F; Golshayan, D; Foucher, Y				Lorent, Marine; Giral, Magali; Pascual, Manuel; Koller, Michael T.; Steiger, Jurg; Trebern-Launay, Katy; Legendre, Christophe; Kreis, Henri; Mourad, Georges; Garrigue, Valerie; Rostaing, Lionel; Kamar, Nassim; Kessler, Michele; Ladriere, Marc; Morelon, Emmanuel; Buron, Fanny; Golshayan, Dela; Foucher, Yohann			Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts	PLOS ONE			English	Article							STAGE RENAL-DISEASE; TERM-FOLLOW-UP; DIALYSIS PATIENTS; PATIENT SURVIVAL; RISK SCORE; RECIPIENTS; IMPACT; AGE; COMORBIDITY; FAILURE	After the first year post transplantation, prognostic mortality scores in kidney transplant recipients can be useful for personalizing medical management. We developed a new prognostic score based on 5 parameters and computable at 1-year post transplantation. The outcome was the time between the first anniversary of the transplantation and the patient's death with a functioning graft. Afterwards, we appraised the prognostic capacities of this score by estimating time-dependent Receiver Operating Characteristic (ROC) curves from two prospective and multicentric European cohorts: the DIVAT (Donnees Informatisees et VAlidees en Transplantation) cohort composed of patients transplanted between 2000 and 2012 in 6 French centers; and the STCS (Swiss Transplant Cohort Study) cohort composed of patients transplanted between 2008 and 2012 in 6 Swiss centers. We also compared the results with those of two existing scoring systems: one from Spain (Hernandez et al.) and one from the United States (the Recipient Risk Score, RRS, Baskin-Bey et al.). From the DIVAT validation cohort and for a prognostic time at 10 years, the new prognostic score (AUC = 0.78, 95% CI = [0.69, 0.85]) seemed to present significantly higher prognostic capacities than the scoring system proposed by Hernandez et al. (p = 0.04) and tended to perform better than the initial RRS (p = 0.10). By using the Swiss cohort, the RRS and the the new prognostic score had comparable prognostic capacities at 4 years (AUC = 0.77 and 0.76 respectively, p = 0.31). In addition to the current available scores related to the risk to return in dialysis, we recommend to further study the use of the score we propose or the RRS for a more efficient personalized follow-up of kidney transplant recipients.	[Lorent, Marine; Trebern-Launay, Katy; Foucher, Yohann] Univ Nantes, EA SPHERE Biostat Clin Res & Pharmacoepidemiol 42, Nantes, France; [Lorent, Marine; Giral, Magali; Trebern-Launay, Katy; Foucher, Yohann] CHU Nantes, INSERM, U1064, Transplantat Urol & Nephrol Inst ITUN, F-44035 Nantes 01, France; [Giral, Magali] CHU Nantes, CIC Biotherapy, F-44035 Nantes 01, France; [Pascual, Manuel; Golshayan, Dela] CHU Vaudois, Transplantat Ctr, Lausanne, Switzerland; [Pascual, Manuel; Golshayan, Dela] Univ Lausanne, Lausanne, Switzerland; [Koller, Michael T.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Steiger, Jurg] Univ Basel Hosp, Transplantat Immunol & Nephrol, CH-4031 Basel, Switzerland; [Legendre, Christophe; Kreis, Henri] Hop Necker Enfants Malad, APHP Paris, Serv Transplantat Renale & Soins Intensifs, Paris, France; [Legendre, Christophe; Kreis, Henri] Univ Paris 05, Paris, France; [Legendre, Christophe; Kreis, Henri] Sorbonne Paris Cite, Paris, France; [Mourad, Georges; Garrigue, Valerie] Hop Lapeyronie, Serv Nephrol Transplantat, Montpellier, France; [Rostaing, Lionel; Kamar, Nassim] CHU Rangueil, Serv Nephrol HTA Dialyse & Transplantat Organes, F-31054 Toulouse, France; [Rostaing, Lionel; Kamar, Nassim] Univ Toulouse 3, F-31062 Toulouse, France; [Kessler, Michele; Ladriere, Marc] CHU Brabois, Serv Transplantat Renale, Nancy, France; [Morelon, Emmanuel; Buron, Fanny] Hop Edouard Herriot, Serv Nephrol Transplantat & Immunol Clin, Lyon, France	Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Basel; University of Basel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Nancy; CHU Lyon	Giral, M (corresponding author), CHU Nantes, INSERM, U1064, Transplantat Urol & Nephrol Inst ITUN, F-44035 Nantes 01, France.; Giral, M (corresponding author), CHU Nantes, CIC Biotherapy, F-44035 Nantes 01, France.	magali.giral@chu-nantes.fr	Koller, Michael/AEN-1656-2022; Study, STCS Swiss Transplant Cohort/G-8344-2017; Foucher, Yohann/ABB-6362-2021; Kamar, Nassim/L-6462-2014	Koller, Michael/0000-0001-5574-2341; Study, STCS Swiss Transplant Cohort/0000-0002-6369-819X; Foucher, Yohann/0000-0003-0330-7457; Golshayan, Dela/0000-0001-5631-6096; Trebern-Launay, Katy/0000-0002-8310-5419; Pascual, Manuel A./0000-0001-7747-1693; Kamar, Nassim/0000-0003-1930-8964	French National Agency of Research [ANR-11-JSV1-0008-01]; French Ministry of Health (PHRC) [PROG/11/85]; Roche Laboratory; Swiss National Science Foundation [33CS30-148512]; Swiss University Hospitals and Transplant centers	French National Agency of Research(French National Research Agency (ANR)); French Ministry of Health (PHRC); Roche Laboratory(Roche Holding); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss University Hospitals and Transplant centers	This work was supported by a grant from the French National Agency of Research (ANR-11-JSV1-0008-01) for the methodological developments, by a grant from the French Ministry of Health (PHRC, PROG/11/85, 2011) for the clinical expertise and the data management and by Roche Laboratory for supporting the data collection in the DIVAT network. The STCS is supported by the Swiss National Science Foundation (grant 33CS30-148512), the Swiss University Hospitals and Transplant centers. The funders played no part in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Baskin-Bey ES, 2007, AM J KIDNEY DIS, V49, P284, DOI 10.1053/j.ajkd.2006.10.018; Carrier M, 2012, TRANSPL P, V44, P2227, DOI 10.1016/j.transproceed.2012.07.120; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cosio FG, 1998, KIDNEY INT, V53, P767, DOI 10.1046/j.1523-1755.1998.00787.x; Cosio FG, 1999, CLIN TRANSPLANT, V13, P336, DOI 10.1034/j.1399-0012.1999.130410.x; COX DR, 1972, J R STAT SOC B, V34, P187; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; FOLEY RN, 1994, AM J KIDNEY DIS, V23, P836, DOI 10.1016/S0272-6386(12)80137-5; Foucher Y, 2015, BMC NEPHROL, V16, DOI 10.1186/1471-2369-16-6; Foucher Y, 2014, TRANSPL INT, V27, P219, DOI 10.1111/tri.12241; Foucher Y, 2010, KIDNEY INT, V78, P1288, DOI 10.1038/ki.2010.232; Gill JS, 2007, KIDNEY INT, V71, P442, DOI 10.1038/sj.ki.5002072; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Heldal K, 2010, NEPHROL DIAL TRANSPL, V25, P1680, DOI 10.1093/ndt/gfp681; Hernandez D, 2009, TRANSPLANTATION, V88, P803, DOI 10.1097/TP.0b013e3181b4ac2f; HUTCHINSON TA, 1982, ANN INTERN MED, V96, P417, DOI 10.7326/0003-4819-96-4-417; Koller MT, 2013, EUR J EPIDEMIOL, V28, P347, DOI 10.1007/s10654-012-9754-y; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Lim WH, 2012, TRANSPL INT, V25, P1032, DOI 10.1111/j.1432-2277.2012.01528.x; Matas AJ, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/ajt.12019; Meier-Kriesche HU, 2000, KIDNEY INT, V58, P1311, DOI 10.1046/j.1523-1755.2000.00287.x; Moore J, 2011, EXP CLIN TRANSPLANT, V9, P32; Moore J, 2010, TRANSPLANTATION, V89, P637, DOI 10.1097/TP.0b013e3181c8b9e2; NICOL D, 1993, TRANSPLANT INT, V6, P153, DOI 10.1111/j.1432-2277.1993.tb00636.x; Ojo AO, 2000, KIDNEY INT, V57, P307, DOI 10.1046/j.1523-1755.2000.00816.x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Perme MP, 2012, BIOMETRICS, V68, P113, DOI 10.1111/j.1541-0420.2011.01640.x; Rabbat CG, 2000, J AM SOC NEPHROL, V11, P917, DOI 10.1681/ASN.V115917; Schnuelle P, 1998, J AM SOC NEPHROL, V9, P2135; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Weiner DE, 2012, AM J TRANSPLANT, V12, P2437, DOI 10.1111/j.1600-6143.2012.04101.x; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; WRIGHT LF, 1991, AM J KIDNEY DIS, V17, P25, DOI 10.1016/S0272-6386(12)80245-9	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155278	10.1371/journal.pone.0155278	http://dx.doi.org/10.1371/journal.pone.0155278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152510	Green Published, gold			2022-12-27	WOS:000375677000082
J	Xu, XD; Zhou, XY; Nan, H; Zhao, Y; Bai, Y; Ou, YM; Chen, HY				Xu, Xiaodong; Zhou, Xinyu; Nan, Hao; Zhao, Yu; Bai, Yu; Ou, Yanmei; Chen, Hongying			Aggregation of AcMNPV LEF-10 and Its Impact on Viral Late Gene Expression	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; DNA-REPLICATION; INSECT CELLS; BACULOVIRUS LATE; BINDING-PROTEIN; NUCLEOPOLYHEDROVIRUS; TRANSCRIPTION; POLYMERASE; INFECTION; SEQUENCE	The Autographa californica multiple nucleopolyhedrovirus (AcMNPV) late expression factor gene lef-10 has been identified to be required for viral late gene expression by transient expression assay. Our previous work has shown that the gene product LEF-10 can form very stable high-molecular-weight complexes, but the structure and function of the protein remain unknown. In this study, we demonstrated that LEF-10 was essential for the replication of AcMNPV, and its truncated fragment containing amino acid residues 1 to 48 were sufficient to support the virus survival. Our data also suggested that the LEF-10 could spontaneously aggregate to form punctate spots in virus infected Sf9 cells at low frequency, and the aggregation of the protein could be induced by LEF-10 over-expression. When the protein aggregated to form punctate spots, soluble LEF-10 proteins were depleted and this could result in the down-regulation of viral late gene expression.	[Xu, Xiaodong; Zhou, Xinyu; Nan, Hao; Zhao, Yu; Bai, Yu; Ou, Yanmei; Chen, Hongying] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Xu, XD; Chen, HY (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	xuxd@nwsuaf.edu.cn; chenhy@nwsuaf.edu.cn		Zhou, Xinyu/0000-0002-2045-7695; Chen, Hongying/0000-0001-8258-0683; Nan, Hao/0000-0002-4028-5974	Natural Science Basic Research Plan in Shaanxi Province of China [2011JM3002]; NWAFU Start-up grant; Fundamental Research Funds for the Central Universities	Natural Science Basic Research Plan in Shaanxi Province of China; NWAFU Start-up grant; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by Natural Science Basic Research Plan in Shaanxi Province of China (Program No. 2011JM3002), a NWAFU Start-up grant, and Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Braunagel SC, 1996, VIROLOGY, V217, P97, DOI 10.1006/viro.1996.0097; Budini M, 2015, HUM MOL GENET, V24, P9, DOI 10.1093/hmg/ddu415; Evans JT, 1997, J VIROL, V71, P3114, DOI 10.1128/JVI.71.4.3114-3119.1997; FUCHS LY, 1983, J VIROL, V48, P641, DOI 10.1128/JVI.48.3.641-646.1983; GUARINO LA, 1991, J VIROL, V65, P3676, DOI 10.1128/JVI.65.7.3676-3680.1991; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Guarino LA, 2002, J VIROL, V76, P12032, DOI 10.1128/JVI.76.23.12032-12043.2002; HANG X, 1995, J VIROL, V69, P3924, DOI 10.1128/JVI.69.6.3924-3928.1995; Hang X, 1999, J GEN VIROL, V80, P2519, DOI 10.1099/0022-1317-80-9-2519; Harrison RL, 2004, J GEN VIROL, V85, P197, DOI 10.1099/vir.0.19556-0; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Lin GY, 2002, J VIROL, V76, P2770, DOI 10.1128/JVI.76.6.2770-2779.2002; Lin GY, 2002, J VIROL, V76, P5503, DOI 10.1128/JVI.76.11.5503-5514.2002; LU A, 1995, J VIROL, V69, P975, DOI 10.1128/JVI.69.2.975-982.1995; LU A, 1992, VIROLOGY, V190, P201, DOI 10.1016/0042-6822(92)91206-A; Mainz D, 2002, J VIROL, V76, P5198, DOI 10.1128/JVI.76.10.5198-5207.2002; McDougal VV, 1999, J VIROL, V73, P4908, DOI 10.1128/JVI.73.6.4908-4918.1999; Mikhailov VS, 2002, J VIROL, V76, P2287, DOI 10.1128/JVI.76.5.2287-2297.2002; Mitchell JK, 2013, J VIROL, V87, P12592, DOI 10.1128/JVI.02501-13; MORRIS TD, 1994, GENE, V140, P147, DOI 10.1016/0378-1119(94)90538-X; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Ono C, 2012, VIRUS RES, V165, P197, DOI 10.1016/j.virusres.2012.02.016; Passarelli AL, 2007, CURR DRUG TARGETS, V8, P1103, DOI 10.2174/138945007782151324; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Rapp JC, 1998, J VIROL, V72, P10197, DOI 10.1128/JVI.72.12.10197-10206.1998; Rekas A, 2010, EUR BIOPHYS J BIOPHY, V39, P1407, DOI 10.1007/s00249-010-0595-x; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Russell RLQ, 1997, VIROLOGY, V227, P142, DOI 10.1006/viro.1996.8304; Su J, 2011, VIROLOGY, V416, P54, DOI 10.1016/j.virol.2011.04.019; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TODD JW, 1995, J VIROL, V69, P968, DOI 10.1128/JVI.69.2.968-974.1995; TOMALSKI MD, 1991, VIROLOGY, V184, P149, DOI 10.1016/0042-6822(91)90831-U; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Xu XD, 2004, VIRUS GENES, V29, P191, DOI 10.1023/B:VIRU.0000036379.15968.4a; Yamagishi J, 2007, VIROLOGY, V365, P34, DOI 10.1016/j.virol.2007.02.034; Yu W, 2013, VIRUS RES, V175, P45, DOI 10.1016/j.virusres.2013.03.022; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	43	5	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154835	10.1371/journal.pone.0154835	http://dx.doi.org/10.1371/journal.pone.0154835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152613	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000040
J	Batson, S; Greenall, G; Hudson, P				Batson, Sarah; Greenall, Gemma; Hudson, Pollyanna			Review of the Reporting of Survival Analyses within Randomised Controlled Trials and the Implications for Meta-Analysis	PLOS ONE			English	Review							PHASE-III TRIAL; RESISTANT PROSTATE-CANCER; ADVANCED BREAST-CANCER; ANDROGEN-DEPRIVATION THERAPY; PROGRESSION-FREE SURVIVAL; PLACEBO-CONTROLLED TRIAL; CELL LUNG-CANCER; DOUBLE-BLIND; OPEN-LABEL; 1ST-LINE THERAPY	Background Meta-analysis is a growing approach to evidence synthesis and network meta-analysis in particular represents an important and developing method within Health Technology Assessment (HTA). Meta-analysis of survival data is usually performed using the individual summary statistic-the hazard ratio (HR) from each randomised controlled trial (RCT). Objectives The objectives of this study are to: (i) review the methods and reporting of survival analyses in oncology RCTs; and (ii) assess the suitability and relevance of survival data reported in RCTs for inclusion into meta-analysis. Methods Five oncology journals were searched to identify Phase III RCTs published between April and July 2015. Eligible studies included those that analysed a survival outcome. Results Thirty-two RCTs reporting survival outcomes in cancer populations were identified. None of the publications reported details relating to a strategy for statistical model building, the goodness of fit of the final model, or final model validation for the analysis of survival outcomes. The majority of studies (88%) reported the use of Cox proportional hazards (PH) regression to analyse survival endpoints. However, most publications failed to report the validation of the statistical models in terms of the PH assumption. Conclusions This review highlights deficiencies in terms of reporting the methods and validity of survival analyses within oncology RCTs. We support previous recommendations to encourage authors to improve the reporting of survival analyses in journal publications. We also recommend that the final choice of a statistical model for survival should be informed by goodness of model fit to a given dataset, and that model assumptions are validated. The failure of trial investigators and statisticians to investigate the PH for RCT survival data is likely to result in clinical decisions based on inappropriate methods. The development of alternative approaches for the meta-analysis of survival outcomes when the PH assumption is implausible is required if valid clinical decisions are to be made.	[Batson, Sarah; Greenall, Gemma; Hudson, Pollyanna] DRG Abacus, Bicester, Oxon, England		Batson, S (corresponding author), DRG Abacus, Bicester, Oxon, England.	S.Batson@TeamDRG.com			DRG Abacus	DRG Abacus	This study was funded by DRG Abacus. DRG Abacus provided support in the form of salaries for authors SB, GG and PH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe T, 2015, J CLIN ONCOL, V33, P575, DOI 10.1200/JCO.2014.55.8627; Abraira V, 2013, J CLIN EPIDEMIOL, V66, P1340, DOI 10.1016/j.jclinepi.2013.06.009; Advani RH, 2015, J CLIN ONCOL, V33, P1936, DOI 10.1200/JCO.2014.57.8138; ALTMAN DG, 1995, BRIT J CANCER, V72, P511, DOI 10.1038/bjc.1995.364; Arends LR, 2008, STAT MED, V27, P4381, DOI 10.1002/sim.3311; Bakitas MA, 2015, J CLIN ONCOL, V33, P1438, DOI 10.1200/JCO.2014.58.6362; Blay JY, 2015, LANCET ONCOL, V16, P550, DOI 10.1016/S1470-2045(15)70105-1; Blay JY, 2015, LANCET ONCOL, V16, P531, DOI 10.1016/S1470-2045(15)70102-6; Bradburn MJ, 2003, BRIT J CANCER, V89, P431, DOI 10.1038/sj.bjc.6601119; Budd GT, 2015, J CLIN ONCOL, V33, P58, DOI 10.1200/JCO.2014.56.3296; Cope S, 2013, VALUE HEALTH, V16, P403, DOI 10.1016/j.jval.2012.10.019; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Fassnacht M, 2015, LANCET ONCOL, V16, P426, DOI 10.1016/S1470-2045(15)70081-1; Fizazi K, 2015, J CLIN ONCOL, V33, P723, DOI 10.1200/JCO.2014.56.5119; Gelmon KA, 2015, J CLIN ONCOL, V33, P1574, DOI 10.1200/JCO.2014.56.9590; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Hensley ML, 2015, J CLIN ONCOL, V33, P1180, DOI 10.1200/JCO.2014.58.3781; Hu XC, 2015, LANCET ONCOL, V16, P436, DOI 10.1016/S1470-2045(15)70064-1; Jansen JP, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-61; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kaufman PA, 2015, J CLIN ONCOL, V33, P594, DOI 10.1200/JCO.2013.52.4892; Kay R, 2002, DRUG INF J, V36, P571, DOI 10.1177/009286150203600312; Kitagawa R, 2015, J CLIN ONCOL, V33, P2129, DOI 10.1200/JCO.2014.58.4391; Klotz L, 2015, J CLIN ONCOL, V33, P1151, DOI 10.1200/JCO.2014.58.2973; Krug LM, 2015, LANCET ONCOL, V16, P447, DOI 10.1016/S1470-2045(15)70056-2; Love RR, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv064; Machiels JPH, 2015, LANCET ONCOL, V16, P583, DOI 10.1016/S1470-2045(15)70124-5; Maio M, 2015, J CLIN ONCOL, V33, P1191, DOI 10.1200/JCO.2014.56.6018; Martin M, 2015, J CLIN ONCOL, V33, P1045, DOI 10.1200/JCO.2014.57.2388; Mason MD, 2015, J CLIN ONCOL, V33, P2143, DOI 10.1200/JCO.2014.57.7510; Mathoulin-Pelissier S, 2008, J CLIN ONCOL, V26, P3721, DOI 10.1200/JCO.2007.14.1192; McCormick B, 2015, J CLIN ONCOL, V33, P709, DOI 10.1200/JCO.2014.57.9029; Morris MJ, 2015, J CLIN ONCOL, V33, P1356, DOI 10.1200/JCO.2014.55.3875; Ouwens MJNM, 2010, RES SYNTH METHODS, V1, P258, DOI 10.1002/jrsm.25; Pelzer U, 2015, J CLIN ONCOL, V33, P2028, DOI 10.1200/JCO.2014.55.1481; Petrylak DP, 2015, LANCET ONCOL, V16, P417, DOI 10.1016/S1470-2045(15)70025-2; Pisansky TM, 2015, J CLIN ONCOL, V33, P332, DOI 10.1200/JCO.2014.58.0662; Pivot X, 2015, J CLIN ONCOL, V33, P1564, DOI 10.1200/JCO.2014.57.1794; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Stone RM, 2015, J CLIN ONCOL, V33, P1252, DOI 10.1200/JCO.2014.57.0952; Tabernero J, 2015, LANCET ONCOL, V16, P499, DOI 10.1016/S1470-2045(15)70127-0; Tan SH, 2013, J HEALTH SERV RES PO, V18, P224, DOI 10.1177/1355819613498379; Zhou CC, 2015, J CLIN ONCOL, V33, P2197, DOI 10.1200/JCO.2014.59.4424; Zhu AX, 2015, J CLIN ONCOL, V33, P559, DOI 10.1200/JCO.2013.53.7746; Zhu AX, 2015, J CLIN ONCOLOGY	45	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154870	10.1371/journal.pone.0154870	http://dx.doi.org/10.1371/journal.pone.0154870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149107	gold, Green Published			2022-12-27	WOS:000375676800076
J	Guevara, N; Hoen, M; Truy, E; Gallego, S				Guevara, Nicolas; Hoen, Michel; Truy, Eric; Gallego, Stephane			A Cochlear Implant Performance Prognostic Test Based on Electrical Field Interactions Evaluated by eABR (Electrical Auditory Brainstem Responses)	PLOS ONE			English	Article							SPEECH-PERCEPTION; DEAFNESS CHARACTERISTICS; CHANNEL INTERACTIONS; BINAURAL INTERACTION; LANGUAGE-DEVELOPMENT; CORTICAL RESPONSES; NEURAL EXCITATION; PATHWAY ANATOMY; PITCH RANKING; SPREAD	Background Cochlear implants (CIs) are neural prostheses that have been used routinely in the clinic over the past 25 years. They allow children who were born profoundly deaf, as well as adults affected by hearing loss for whom conventional hearing aids are insufficient, to attain a functional level of hearing. The "modern" CI (i.e., a multi-electrode implant using sequential coding strategies) has yielded good speech comprehension outcomes (recognition level for monosyllabic words about 50% to 60%, and sentence comprehension close to 90%). These good average results however hide a very important interindividual variability as scores in a given patients' population often vary from 5 to 95% in comparable testing conditions. Our aim was to develop a prognostic model for patients with unilateral CI. A novel method of objectively measuring electrical and neuronal interactions using electrical auditory brainstem responses (eABRs) is proposed. Methods and Findings The method consists of two measurements: 1) eABR measurements with stimulation by a single electrode at 70% of the dynamic range (four electrodes distributed within the cochlea were tested), followed by a summation of these four eABRs; 2) Measurement of a single eABR with stimulation from all four electrodes at 70% of the dynamic range. A comparison of the eABRs obtained by these two measurements, defined as the monaural interaction component (MIC), indicated electrical and neural interactions between the stimulation channels. Speech recognition performance without lip reading was measured for each patient using a logatome test (64 "vowel-consonant-vowel"; VCV; by forced choice of 1 out of 16). eABRs were measured in 16 CI patients (CIs with 20 electrodes, Digisonic SP; Oticon Medical (R), Vallauris, France). Significant correlations were found between speech recognition performance and the ratio of the amplitude of the V wave of the eABRs obtained with the two measurements (Pearson's linear regression model, parametric correlation: r2 = 0.26, p< 0.05). Conclusions This prognostic model allowed a substantial amount of the interindividual variance in speech recognition scores to be explained. The present study used measurements of electrical and neuronal interactions by eABR to assess patients' bio-electric capacity to use multiple information channels supplied by the implant. This type of prognostic information may be valuable in several ways. On the patient level, it allows customizing of individual treatments.	[Guevara, Nicolas] CHU Nice, Univ Head & Neck Inst, 31 Ave Valombrose, F-06107 Nice 2, France; [Hoen, Michel] Oticon Med, Clin & Sci Res Dept, 2720 Chemin St Bernard, F-06220 Vallauris, France; [Truy, Eric] Hop Edouard Herriot, Dept Audiol & Otorhinolaryngol, 5 Pl dArsonval, F-69437 Lyon, France; [Gallego, Stephane] Inst Readaptat Sci & Tech, 8 Ave Rockefeller, F-69373 Lyon 08, France	CHU Nice; CHU Lyon	Guevara, N (corresponding author), CHU Nice, Univ Head & Neck Inst, 31 Ave Valombrose, F-06107 Nice 2, France.	guevara.n@chu-nice.fr	Guevara, Nicolas/AAG-4549-2021; truy, eric/J-9097-2017; Hoen, Michel/C-7721-2012	Guevara, Nicolas/0000-0002-4286-6465; truy, eric/0000-0002-1769-8623; Hoen, Michel/0000-0003-2099-8130	Nice University Hospital	Nice University Hospital	The Nice University Hospital (http://www.chu-nice.fr/recherche/nos-structures/drci) provided funding for this study. The clinical research department of the University Hospital of Nice assisted with the study design and data collection. M.H. is an employee of Oticon Medical (Vallauris, France) and received assistance in the form of salaries. The specific roles of this author are articulated in the "author contributions" section. Oticon Medical had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amlani Amyn M, 2002, Trends Amplif, V6, P81, DOI 10.1177/108471380200600302; Anderson ES, 2011, J ACOUST SOC AM, V130, P364, DOI 10.1121/1.3589255; Azadpour M, 2012, JARO-J ASSOC RES OTO, V13, P145, DOI 10.1007/s10162-011-0294-z; Berenstein CK, 2008, EAR HEARING, V29, P250, DOI 10.1097/AUD.0b013e3181645336; Bierer JA, 2004, JARO-J ASSOC RES OTO, V5, P32, DOI 10.1007/s10162-003-3057-7; Bierer JA, 2010, EAR HEARING, V31, P247, DOI 10.1097/AUD.0b013e3181c7daf4; Blamey P, 1996, Audiol Neurootol, V1, P293; Blamey P, 2013, AUDIOL NEURO-OTOL, V18, P36, DOI 10.1159/000343189; Boex C, 2003, J ACOUST SOC AM, V114, P2058, DOI 10.1121/1.1610452; Bonham BH, 2008, HEARING RES, V242, P141, DOI 10.1016/j.heares.2008.03.006; Boons T, 2012, EAR HEARING, V33, P627, DOI 10.1097/AUD.0b013e3182503e47; Boulet J, 2015, J ASS RES OTOLARYNGO; Busby PA, 2008, EAR HEARING, V29, P853, DOI 10.1097/AUD.0b013e318181a878; Cohen LT, 2005, INT J AUDIOL, V44, P559, DOI 10.1080/14992020500258743; Cohen LT, 2003, HEARING RES, V179, P72, DOI 10.1016/S0378-5955(03)00096-0; Cooper WB, 2008, EAR HEARING, V29, P618, DOI 10.1097/AUD.0b013e318174e787; Di Lella F, 2010, ACTA OTO-LARYNGOL, V130, P102, DOI 10.3109/00016480902896113; Fielden CA, 2013, J ACOUST SOC AM, V133, P4109, DOI 10.1121/1.4803909; Firszt JB, 2004, EAR HEARING, V25, P375, DOI 10.1097/01.AUD.0000134552.22205.EE; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Gallego S, 1999, ACTA OTO-LARYNGOL, V119, P234, DOI 10.1080/00016489950181738; Garcia-Lazaro JA, 2013, J NEUROSCI, V33, P19362, DOI 10.1523/JNEUROSCI.3711-13.2013; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Goehring JL, 2014, J ACOUST SOC AM, V136, P3159, DOI 10.1121/1.4900634; Guiraud J, 2007, HEARING RES, V228, P44, DOI 10.1016/j.heares.2007.01.022; Guiraud J, 2007, HEARING RES, V223, P48, DOI 10.1016/j.heares.2006.09.014; Harris MS, 2013, EAR HEARING, V34, P179, DOI 10.1097/AUD.0b013e318269ce50; Holden LK, 2013, EAR HEARING, V34, P342, DOI 10.1097/AUD.0b013e3182741aa7; Holt RF, 2012, J SPEECH LANG HEAR R, V55, P848, DOI 10.1044/1092-4388(2011/11-0143); Hughes ML, 2008, J ACOUST SOC AM, V124, P2711, DOI 10.1121/1.2990710; Hughes ML, 2013, HEARING RES, V306, P93, DOI 10.1016/j.heares.2013.09.014; Landsberger DM, 2012, HEARING RES, V284, P16, DOI 10.1016/j.heares.2011.12.009; Lenarz T, 2013, CURR PHARM BIOTECHNO, V14, P112; Lorenzi C, 2004, INT J AUDIOL, V43, P264, DOI 10.1080/14992020400050035; Marozeau J, 2015, JARO-J ASSOC RES OTO, V16, P401, DOI 10.1007/s10162-015-0511-2; Maurer J, 2002, LARYNGOSCOPE, V112, P2220, DOI 10.1097/00005537-200212000-00017; Mens LHM, 2005, OTOL NEUROTOL, V26, P957, DOI 10.1097/01.mao.0000185060.74339.9d; Noble JH, 2014, AUDIOL NEURO-OTOL, V19, P400, DOI 10.1159/000365273; Nogueira W, 2005, EURASIP J APPL SIG P, V2005, P3044, DOI 10.1155/ASP.2005.3044; PELIZZONE M, 1990, HEARING RES, V48, P287, DOI 10.1016/0378-5955(90)90069-2; Scheperle RA, 2015, EAR HEARING, V36, P430, DOI 10.1097/AUD.0000000000000143; Scheperle RA, 2015, EAR HEARING, V36, P441, DOI 10.1097/AUD.0000000000000144; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shannon RV, 2004, ACTA OTO-LARYNGOL, V124, P50, DOI 10.1080/03655230410017562; SHANNON RV, 1983, HEARING RES, V12, P1, DOI 10.1016/0378-5955(83)90115-6; Smith ZM, 2013, IEEE ENG MED BIO, P2796, DOI 10.1109/EMBC.2013.6610121; Spahr AJ, 2008, J SPEECH LANG HEAR R, V51, P1599, DOI 10.1044/1092-4388(2008/07-0254); Srinivasan AG, 2013, HEARING RES, V299, P29, DOI 10.1016/j.heares.2013.02.004; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Tang Q, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046029; TONG YC, 1986, J ACOUST SOC AM, V79, P1958, DOI 10.1121/1.393203; TONG YC, 1983, J ACOUST SOC AM, V74, P73, DOI 10.1121/1.389620; Undurraga JA, 2012, HEARING RES, V290, P21, DOI 10.1016/j.heares.2012.05.003; Van Yper LN, 2015, CLIN NEUROPHYSIOL, V126, P772, DOI 10.1016/j.clinph.2014.07.032; Warrier CM, 2011, HEARING RES, V282, P108, DOI 10.1016/j.heares.2011.09.001; WHITE MW, 1984, ARCH OTOLARYNGOL, V110, P493; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Won JH, 2014, J ACOUST SOC AM, V136, P2714, DOI 10.1121/1.4895702	59	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155008	10.1371/journal.pone.0155008	http://dx.doi.org/10.1371/journal.pone.0155008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149268	Green Published, gold			2022-12-27	WOS:000375676800107
J	Kempf, E; Lemoine, N; Tergemina-Clain, G; Turpin, A; Postel-Vinay, S; Lanoy, E; Soria, JC; Massard, C; Hollebecque, A				Kempf, Emmanuelle; Lemoine, Nathalie; Tergemina-Clain, Gabrielle; Turpin, Anthony; Postel-Vinay, Sophie; Lanoy, Emilie; Soria, Jean-Charles; Massard, Christophe; Hollebecque, Antoine			A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials	PLOS ONE			English	Article							I TRIALS; ENROLLMENT	Introduction Enrolling cancer patients in phase I clinical trials (P1s) requires that they fulfill specific criteria. Between the time they sign the consent form and the 1st administration of the experimental drug, some patients may be excluded and considered as screen failures (SFs). Our objective was to assess SF patients profiles and the reasons and risk factors for SFs. Materials and Methods All patients included in P1s at Gustave Roussy from 2008 to 2013 were reviewed retrospectively. SFs were matched with control P1 patients who were successfully enrolled. Patient and tumor characteristics, P1 types and the reasons for SF were analyzed. Results Among 1,293 patients, 192 (15%) were SF cases; 182 SF cases were matched with 182 controls: median age was 57 (48-64) and 55 (47-63), median home-cancer center distance was 69 vs 55 km, 45% vs 34% had more than 2 metastatic sites, median screening period was 14 vs 11 days, median progression-free survival during the previous line was 12 vs 14 weeks, 37% vs 29% of LDH values were above the upper limit of normal, 42% vs 36% of albumin values were < 35 g/L, respectively. Reasons for SFs were cancer progression (44%), sponsor decision unrelated to a clinical reason (25%), patient retrieval (13.5%), relevant comorbidity (13.5%). Multivariate analysis revealed that a high Royal Marsden Hospital (RMH) prognostic score was potentially associated with higher risk of SFs (OR = 2.3; 95% CI [1.0-5.7], p = 0.06). Conclusion Cancer progression led to half of the SFs in P1s. Physicians should pay attention to the RMH score at the time of patient inclusion to avoid further SFs.	[Kempf, Emmanuelle; Lemoine, Nathalie; Turpin, Anthony; Postel-Vinay, Sophie; Soria, Jean-Charles; Massard, Christophe; Hollebecque, Antoine] Gustave Roussy Canc Campus, Drug Dev Dept, Villejuif, France; [Tergemina-Clain, Gabrielle; Lanoy, Emilie] Gustave Roussy Canc Campus, Biostat & Epidemiol Unit, Villejuif, France; [Postel-Vinay, Sophie; Soria, Jean-Charles] Univ Paris 11, Univ Paris Saclay, Fac Med, Le Kremlin Bicetre, France; [Postel-Vinay, Sophie; Soria, Jean-Charles] Inserm Unit U981, Villejuif, France	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Hollebecque, A (corresponding author), Gustave Roussy Canc Campus, Drug Dev Dept, Villejuif, France.	antoine.hollebecque@gustaveroussy.fr	Soria, Jean-Charles/F-3619-2014; Turpin, Anthony/F-2481-2018; Hollebecque, Antoine/M-2695-2013; Lanoy, Emilie/A-8541-2011	Turpin, Anthony/0000-0002-2282-0101; Hollebecque, Antoine/0000-0003-2869-7551; Lanoy, Emilie/0000-0002-4789-7770				Arkenau HT, 2009, J CLIN ONCOL, V27, P2692, DOI 10.1200/JCO.2008.19.5081; Blenkowski RS, 2008, J CLIN RES BEST PRAC, V4, P1; Carden CP, 2008, LANCET ONCOL, V9, P1012, DOI 10.1016/S1470-2045(08)70257-2; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Fu SQ, 2013, ONCOLOGIST, V18, P1315, DOI 10.1634/theoncologist.2013-0202; Gerber DE, 2015, J COMP EFFECT RES, V4, P289, DOI [10.2217/CER.15.27, 10.2217/cer.15.27]; Hollebecque A, 2013, EUR J CANCER, V49, P1515, DOI 10.1016/j.ejca.2012.12.012; Ivy SP, 2010, CLIN CANCER RES, V16, P1726, DOI 10.1158/1078-0432.CCR-09-1961; Mckane A, 2013, INVEST NEW DRUG, V31, P774, DOI 10.1007/s10637-012-9894-7; Unger JM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju002; Wang D, J CLIN ONCOL, V29	11	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154895	10.1371/journal.pone.0154895	http://dx.doi.org/10.1371/journal.pone.0154895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149667	Green Submitted, gold, Green Published			2022-12-27	WOS:000375676800081
J	Mankos, M; Persson, HHJ; N'Diaye, AT; Shadman, K; Schmid, AK; Davis, RW				Mankos, Marian; Persson, Henrik H. J.; N'Diaye, Alpha T.; Shadman, Khashayar; Schmid, Andreas K.; Davis, Ronald W.			Nucleotide-Specific Contrast for DNA Sequencing by Electron Spectroscopy	PLOS ONE			English	Article							ELASTICITY	DNA sequencing by imaging in an electron microscope is an approach that holds promise to deliver long reads with low error rates and without the need for amplification. Earlier work using transmission electron microscopes, which use high electron energies on the order of 100 keV, has shown that low contrast and radiation damage necessitates the use of heavy atom labeling of individual nucleotides, which increases the read error rates. Other prior work using scattering electrons with much lower energy has shown to suppress beam damage on DNA. Here we explore possibilities to increase contrast by employing two methods, X-ray photoelectron and Auger electron spectroscopy. Using bulk DNA samples with monomers of each base, both methods are shown to provide contrast mechanisms that can distinguish individual nucleotides without labels. Both spectroscopic techniques can be readily implemented in a low energy electron microscope, which may enable label-free DNA sequencing by direct imaging.	[Mankos, Marian; Shadman, Khashayar] Electron Opt Inc, 1000 Elwell Court 110, Palo Alto, CA 94303 USA; [Persson, Henrik H. J.; Davis, Ronald W.] Stanford Univ, Stanford Genome Technol Ctr, Sch Med, 855 Calif Ave, Palo Alto, CA 94304 USA; [N'Diaye, Alpha T.; Schmid, Andreas K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, NCEM, Mol Foundry, 1 Cyclotron Rd, Berkeley, CA 94720 USA	Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mankos, M (corresponding author), Electron Opt Inc, 1000 Elwell Court 110, Palo Alto, CA 94303 USA.	marian@electronoptica.com	N'Diaye, Alpha T/D-1110-2018	N'Diaye, Alpha T/0000-0001-9429-9776	National Human Genome Research Institute (NHGRI) [R43HG006303]; US National Institutes of Health [HG000205]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, F32HG000205, R43HG006303] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was supported by grant number R43HG006303 from the National Human Genome Research Institute (NHGRI). HP and RD were supported in part by US National Institutes of Health grant HG000205. Portions of this work were performed at the Molecular Foundry, supported by the Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by Grant Number R43HG006303 from the National Human Genome Research Institute (NHGRI). H. H. J. Persson and R. W. Davis were supported in part by US National Institutes of Health grant HG000205. Portions of this work were performed at the Molecular Foundry, supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI or the National Institutes of Health. The authors would also like to thank T.H.P. Chang for his continuous support and numerous suggestions leading to this paper.	Bell DC, 2012, MICROSC MICROANAL, V18, P1049, DOI 10.1017/S1431927612012615; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; BENSIMON D, 1995, PHYS REV LETT, V74, P4754, DOI 10.1103/PhysRevLett.74.4754; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; Cocco S, 2002, CR PHYS, V3, P569, DOI 10.1016/S1631-0705(02)01345-2; Fink HW, 1997, J OPT SOC AM A, V14, P2168, DOI 10.1364/JOSAA.14.002168; Germann M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.095501; Gunawardane R. P., 2006, HDB APPL SOLID STATE, P451, DOI DOI 10.1007/0-387-37590-2_10; Latychevskaia T, 2013, PRESENT FUTURE METHO, P331; Leger JF, 1999, PHYS REV LETT, V83, P1066, DOI 10.1103/PhysRevLett.83.1066; Mankos M, 2014, ULTRAMICROSCOPY, V145, P36, DOI 10.1016/j.ultramic.2014.01.007; Mankos M, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4764095; May CJ, 2004, ANAL CHEM, V76, P1114, DOI 10.1021/ac034874q; Own CS, 2013, MICROSC MICROANAL S2, V19, P208; Persson HHJ, 2001, LANGMUIR, V17, P3643, DOI 10.1021/la001265u; Petrovykh DY, 2003, J AM CHEM SOC, V125, P5219, DOI 10.1021/ja029450c; Ptasinska S, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2961027; Rouzina I, 2001, BIOPHYS J, V80, P882, DOI 10.1016/S0006-3495(01)76067-5; Saprigin AV, 2005, SURF INTERFACE ANAL, V37, P24, DOI 10.1002/sia.1999; SEXTON BA, 1984, SURF SCI, V140, P227, DOI 10.1016/0039-6028(84)90394-7; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Storm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051906; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Zhao YD, 1999, ANAL CHIM ACTA, V388, P93, DOI 10.1016/S0003-2670(99)00065-3	24	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154707	10.1371/journal.pone.0154707	http://dx.doi.org/10.1371/journal.pone.0154707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149617	Green Submitted, Green Published, gold			2022-12-27	WOS:000375676800050
J	McClanahan, TR; Maina, JM; Graham, NAJ; Jones, KR				McClanahan, Timothy R.; Maina, Joseph M.; Graham, Nicholas A. J.; Jones, Kendall R.			Modeling Reef Fish Biomass, Recovery Potential, and Management Priorities in the Western Indian Ocean	PLOS ONE			English	Article							MARINE PROTECTED AREAS; UNDERWATER VISUAL CENSUS; HUMAN-POPULATION DENSITY; CONSERVATION; TARGETS; COLLABORATION; INFORMATION; SELECTION; TRAJECTORIES; GOVERNANCE	Fish biomass is a primary driver of coral reef ecosystem services and has high sensitivity to human disturbances, particularly fishing. Estimates of fish biomass, their spatial distribution, and recovery potential are important for evaluating reef status and crucial for setting management targets. Here we modeled fish biomass estimates across all reefs of the western Indian Ocean using key variables that predicted the empirical data collected from 337 sites. These variables were used to create biomass and recovery time maps to prioritize spatially explicit conservation actions. The resultant fish biomass map showed high variability ranging from similar to 15 to 2900 kg/ha, primarily driven by human populations, distance to markets, and fisheries management restrictions. Lastly, we assembled data based on the age of fisheries closures and showed that biomass takes similar to 25 years to recover to typical equilibrium values of similar to 1200 kg/ha. The recovery times to biomass levels for sustainable fishing yields, maximum diversity, and ecosystem stability or conservation targets once fishing is suspended was modeled to estimate temporal costs of restrictions. The mean time to recovery for the whole region to the conservation target was 8.1(+/-3SD) years, while recovery to sustainable fishing thresholds was between 0.5 and 4 years, but with high spatial variation. Recovery prioritization scenario models included one where local governance prioritized recovery of degraded reefs and two that prioritized minimizing recovery time, where countries either operated independently or collaborated. The regional collaboration scenario selected remote areas for conservation with uneven national responsibilities and spatial coverage, which could undermine collaboration. There is the potential to achieve sustainable fisheries within a decade by promoting these pathways according to their social-ecological suitability.	[McClanahan, Timothy R.; Maina, Joseph M.] Wildlife Conservat Soc, Marine Programs, Coral Reef Conservat Project, Mombasa, Kenya; [Maina, Joseph M.; Jones, Kendall R.] Univ Queensland, Sch Biol Sci, Ctr Biodivers & Conservat Sci, Australian Res Council,Ctr Excellence Environm De, St Lucia, Qld 4072, Australia; [Maina, Joseph M.] Macquarie Univ, Dept Environm Sci, N Ryde, NSW 2109, Australia; [Graham, Nicholas A. J.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld 4811, Australia; [Graham, Nicholas A. J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Jones, Kendall R.] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld 4072, Australia	University of Queensland; Macquarie University; James Cook University; Lancaster University; University of Queensland	McClanahan, TR (corresponding author), Wildlife Conservat Soc, Marine Programs, Coral Reef Conservat Project, Mombasa, Kenya.	tmcclanahan@wcs.org	Graham, Nicholas AJ/C-8360-2014; Jones, Kendall/N-2464-2015	Graham, Nicholas AJ/0000-0002-0304-7467; Jones, Kendall/0000-0003-2221-9938; Maina, Joseph/0000-0003-1268-6137	John D. and Catherine T. MacArthur Foundation; ARC Center of Excellence for Environmental Decisions (CEED); Natural Environment Research Council [ceh010010] Funding Source: researchfish	John D. and Catherine T. MacArthur Foundation; ARC Center of Excellence for Environmental Decisions (CEED)(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Western Indian Ocean Marine Science Association Marine Science for Management Program (WIOMSA-MASMA) and the John D. and Catherine T. MacArthur Foundation supported the original fieldwork. The Wildlife Conservation Society through grants from the John D. and Catherine T. MacArthur Foundation and ARC Center of Excellence for Environmental Decisions (CEED) supported the spatial modeling aspects of the study.	Abesamis RA, 2014, REV FISH BIOL FISHER, V24, P1033, DOI 10.1007/s11160-014-9362-x; Advani S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126098; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Allnutt TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028969; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barton K, 2020, MUMIN MULTIMODEL INF; Benjaminsen TA, 2012, J PEASANT STUD, V39, P335, DOI 10.1080/03066150.2012.667405; Brewer TD, 2013, CONSERV BIOL, V27, P443, DOI 10.1111/j.1523-1739.2012.01963.x; Brewer TD, 2012, GLOBAL ENVIRON CHANG, V22, P399, DOI 10.1016/j.gloenvcha.2012.01.006; Brewer TD, 2009, BIOL CONSERV, V142, P1797, DOI 10.1016/j.biocon.2009.03.021; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Buxton CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107032; Chircop A, 2010, OCEAN DEV INT LAW, V41, P1, DOI 10.1080/00908320903285398; Cinner JE, 2015, GLOBAL ENVIRON CHANG, V30, P133, DOI 10.1016/j.gloenvcha.2014.10.003; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cinner JE, 2009, MAR POLICY, V33, P489, DOI 10.1016/j.marpol.2008.11.001; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Darling ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113614; Di Marco M, 2016, CONSERV BIOL, V30, P392, DOI 10.1111/cobi.12609; Dietz T, 2013, P NATL ACAD SCI USA, V110, P14081, DOI 10.1073/pnas.1212740110; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hicks CC, 2014, P NATL ACAD SCI USA, V111, P17791, DOI 10.1073/pnas.1413473111; Hicks CC, 2011, COAST MANAGE, V39, P358, DOI 10.1080/08920753.2011.589219; Kark S, 2015, CURR OPIN ENV SUST, V12, P12, DOI 10.1016/j.cosust.2014.08.005; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Karr KA, 2015, J APPL ECOL, V52, P402, DOI 10.1111/1365-2664.12388; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Levin N, 2013, BIOSCIENCE, V63, P547, DOI 10.1525/bio.2013.63.7.8; Levin SA, 2008, BIOSCIENCE, V58, P27, DOI 10.1641/B580107; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Maire E, 2016, ECOLOGY LETT; Maire E, 2016, ECOL LETT, V19, P351, DOI 10.1111/ele.12577; Mazor T, 2013, DIVERS DISTRIB, V19, P1380, DOI 10.1111/ddi.12095; McClanahan T, COAST MANAG IN PRESS, V44, P1; McClanahan TR, 2015, J BIOGEOGR, V42, P2414, DOI 10.1111/jbi.12604; McClanahan TR, 2015, CONSERV BIOL, V29, P409, DOI 10.1111/cobi.12430; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2016, FISH FISH, V17, P417, DOI 10.1111/faf.12118; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2009, MAR ECOL PROG SER, V396, P99, DOI 10.3354/meps08279; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; McClanahan TR, 1999, CORAL REEFS, V18, P321, DOI 10.1007/s003380050205; McClanahan TR, 2012, ADAPTING CHANGING EN; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Nowlis JS, 2000, B MAR SCI, V66, P651; Pinheiro J., 2015, LINEAR NONLINEAR MIX; Pitcher TJ, 2013, MAR POLLUT BULL, V74, P506, DOI 10.1016/j.marpolbul.2013.05.045; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocliffe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103000; Rodwell Lynda D., 2002, Natural Resource Modeling, V15, P453; Salm R.V., 2000, MARINE COASTAL PROTE; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Sheppard CRC, 2012, AQUAT CONSERV, V22, P232, DOI 10.1002/aqc.1248; Singleton RL, 2014, MAR POLLUT BULL, V87, P7, DOI 10.1016/j.marpolbul.2014.07.067; Small C, 2003, J COASTAL RES, V19, P584; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tuda PM, 2015, OCEAN COAST MANAGE, V104, P36, DOI 10.1016/j.ocecoaman.2014.11.016; Verweij M, 2006, PUBLIC ADMIN, V84, P817, DOI 10.1111/j.1540-8159.2005.09566.x-i1; Watson RA, 1997, ECOL MODEL, V104, P103, DOI 10.1016/S0304-3800(97)00117-8; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Wells S, 2007, OCEAN COAST MANAGE, V50, P67, DOI 10.1016/j.ocecoaman.2006.08.012; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	76	29	30	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154585	10.1371/journal.pone.0154585	http://dx.doi.org/10.1371/journal.pone.0154585			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149673	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000375676800041
J	Mozetic, I; Grcar, M; Smailovic, J				Mozetic, Igor; Grcar, Miha; Smailovic, Jasmina			Multilingual Twitter Sentiment Classification: The Role of Human Annotators	PLOS ONE			English	Article								What are the limits of automated Twitter sentiment classification? We analyze a large set of manually labeled tweets in different languages, use them as training data, and construct automated classification models. It turns out that the quality of classification models depends much more on the quality and size of training data than on the type of the model trained. Experimental results indicate that there is no statistically significant difference between the performance of the top classification models. We quantify the quality of training data by applying various annotator agreement measures, and identify the weakest points of different datasets. We show that the model performance approaches the inter-annotator agreement when the size of the training set is sufficiently large. However, it is crucial to regularly monitor the self-and inter-annotator agreements since this improves the training datasets and consequently the model performance. Finally, we show that there is strong evidence that humans perceive the sentiment classes (negative, neutral, and positive) as ordered.	[Mozetic, Igor; Grcar, Miha; Smailovic, Jasmina] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Mozetic, I; Smailovic, J (corresponding author), Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia.	Igor.Mozetic@ijs.si; Jasmina.Smailovic@ijs.si		Mozetic, Igor/0000-0002-5466-0608	European Union [610704, 317532, 640772]; Slovenian ARRS programme Knowledge Technologies [P2-103]	European Union(European Commission); Slovenian ARRS programme Knowledge Technologies	This work was supported in part by the European Union projects SIMPOL (no. 610704), MULTIPLEX (no. 317532) and DOLFINS (no. 640772), and by the Slovenian ARRS programme Knowledge Technologies (no. P2-103).	Baccianella S, 2010, LREC 2010 - SEVENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION; Barbosa Luciano, 2010, INT C COMP LING, P36; Bergmeir C, 2012, INFORM SCIENCES, V191, P192, DOI 10.1016/j.ins.2011.12.028; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Davidov D, 2010, P 23 INT C COMP LING, P241; Demsar J, 2006, J MACH LEARN RES, V7, P1; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; dos Santos C., 2014, P 8 INT WORKSH SEM E, P647; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Gaudette L, 2009, LECT NOTES COMPUT SC, V5549, P207, DOI 10.1007/978-3-642-01818-3_25; Ggar M., 2015, THESIS J STEFAN INT; Ghosh A., 2015, PROCEEDINGS OF THE 9, P470, DOI DOI 10.18653/V1/S15-2080; Go A., 2009, CS224N PROJECT REPOR, V1; Haldenwang N, 2015, P INT C GERM SOC COM, P157; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Jiang L., 2011, P 49 ANN M ASS COMPU, V1, P151; Kiritchenko S, 2014, J ARTIF INTELL RES, V50, P723, DOI 10.1613/jair.4272; Kolchyna O, 2015, ARXIV PREPRINT ARXIV; Kouloumpis E., 2011, P INT AAAI C WEBL SO, P538; Krippendorff K., 2018, CONTENT ANAL INTRO I, V4th ed.; Liu B., 2012, SYNTHESIS LECT HUMAN, V5, P1, DOI DOI 10.2200/S00416ED1V01Y201204HLT016; Liu B., 2015, SENTIMENT ANAL MININ; Martineau J., 2009, ICWSM, P258; Martinez-Camara E, 2014, NAT LANG ENG, V20, P1, DOI 10.1017/S1351324912000332; Mohammad SM, 2015, COMPUT INTELL-US, V31, P301, DOI 10.1111/coin.12024; Mooney CZ, 1993, BOOTSTRAPPING NONPAR, DOI DOI 10.4135/9781412983532; Nemenyi P., 1963, DISTRIBUTION FREE MU; Novak PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144296; Pak A, 2010, LREC, V10, P1320, DOI DOI 10.17148/IJARCCE.2016.51274; Parikh R., 2009, CS224N, V118, P1; Ranco G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138441; Rosenthal S, 2015, P 9 INT WORKSH SEM E, P451, DOI DOI 10.18653/V1/S15-2078; Russell S.J., 2016, ARTIF INTELL; Saif Hassan, 2012, The Semantic Web. 11th International Semantic Web Conference (ISWC 2012). Proceedings, P508, DOI 10.1007/978-3-642-35176-1_32; Saif H, 2013, P 1 WORKSH EM SENT S; Saif H, 2014, LECT NOTES COMPUT SC, V8797, P324, DOI 10.1007/978-3-319-11915-1_21; Santos Cicero Dos, 2014, P COLING 2014 25 INT, P69; Sluban B., 2015, COMPUT SOC NETW, V2, P9, DOI [10.1186/s40649-015-0016-5, DOI 10.1186/S40649-015-0016-5]; Smailovic J, 2014, THESIS J STEFAN INT; Smailovic J., 2015, IEEE DSAA 2015, P1; Tang D., 2014, P 8 INT WORKSH SEM E; Tepper M., 2012, P 21 ACM INT C INF K, P1602, DOI DOI 10.1145/2396761.2398481; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL; Zollo F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138740	44	70	71	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155036	10.1371/journal.pone.0155036	http://dx.doi.org/10.1371/journal.pone.0155036			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149621	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800110
J	Foster, C; Haviland, J; Winter, J; Grimmett, C; Seymour, KC; Batehup, L; Calman, L; Corner, J; Din, A; Fenlon, D; May, CM; Richardson, A; Smith, PW				Foster, Claire; Haviland, Joanne; Winter, Jane; Grimmett, Chloe; Seymour, Kim Chivers; Batehup, Lynn; Calman, Lynn; Corner, Jessica; Din, Amy; Fenlon, Deborah; May, Christine M.; Richardson, Alison; Smith, Peter W.		Study Advisory Comm	Pre-Surgery Depression and Confidence to Manage Problems Predict Recovery Trajectories of Health and Wellbeing in the First Two Years following Colorectal Cancer: Results from the CREW Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; SELF-EFFICACY; SURVIVORS; ASSOCIATIONS; ANXIETY; STATE	Purpose This paper identifies predictors of recovery trajectories of quality of life (QoL), health status and personal wellbeing in the two years following colorectal cancer surgery. Methods 872 adults receiving curative intent surgery during November 2010 to March 2012. Questionnaires at baseline, 3, 9, 15, 24 months post-surgery assessed QoL, health status, wellbeing, confidence to manage illness-related problems (self-efficacy), social support, comorbidities, socio-demographic, clinical and treatment characteristics. Group-based trajectory analyses identified distinct trajectories and predictors for QoL, health status and wellbeing. Results Four recovery trajectories were identified for each outcome. Groups 1 and 2 fared consistently well (scores above/within normal range); 70.5% of participants for QoL, 33.3% health status, 77.6% wellbeing. Group 3 had some problems (24.2% QoL, 59.3% health, 18.2% wellbeing); Group 4 fared consistently poorly (5.3% QoL, 7.4% health, 4.2% wellbeing). Higher pre-surgery depression and lower self-efficacy were significantly associated with poorer trajectories for all three outcomes after adjusting for other important predictors including disease characteristics, stoma, anxiety and social support. Conclusions Psychosocial factors including self-efficacy and depression before surgery predict recovery trajectories in QoL, health status and wellbeing following colorectal cancer treatment independent of treatment or disease characteristics. This has significant implications for colorectal cancer management as appropriate support may be improved by early intervention resulting in more positive recovery experiences.	[Foster, Claire; Haviland, Joanne; Grimmett, Chloe; Calman, Lynn; Din, Amy; May, Christine M.] Univ Southampton, Fac Hlth Sci, Macmillan Survivorship Res Grp, Southampton SO17 1BJ, Hants, England; [Foster, Claire; Haviland, Joanne; Winter, Jane; Grimmett, Chloe; Seymour, Kim Chivers; Batehup, Lynn; Calman, Lynn; Din, Amy; Fenlon, Deborah; May, Christine M.; Richardson, Alison] Univ Southampton, Fac Hlth Sci, Southampton SO17 1BJ, Hants, England; [Winter, Jane; Richardson, Alison] Univ Hosp Southampton NHS Fdn Trust, Southampton SO16 6YD, Hants, England; [Corner, Jessica] Univ Nottingham, Execut Off, Nottingham NG7 2RD, England; [Smith, Peter W.] Univ Southampton, Social Sci, Social Stat & Demog, Southampton SO17 1BJ, Hants, England	University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Nottingham; University of Southampton	Foster, C (corresponding author), Univ Southampton, Fac Hlth Sci, Macmillan Survivorship Res Grp, Southampton SO17 1BJ, Hants, England.; Foster, C (corresponding author), Univ Southampton, Fac Hlth Sci, Southampton SO17 1BJ, Hants, England.	C.L.Foster@soton.ac.uk	Foster, Claire/N-6223-2016	Foster, Claire/0000-0002-4703-8378; Calman, Lynn/0000-0002-9964-6017; Smith, Peter/0000-0003-4423-5410; Fenlon, Deborah/0000-0001-7347-8919; Poole, Karen/0000-0002-6172-5297; Armes, Jo/0000-0002-7994-0796; Corner, Jessica/0000-0002-2240-8133; Hulme, Claire/0000-0003-2077-0419	Macmillan Cancer Support as part of the Macmillan Survivorship Research Group programme; Macmillan Survivorship Research Group; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Nottingham	Macmillan Cancer Support as part of the Macmillan Survivorship Research Group programme; Macmillan Survivorship Research Group; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Nottingham	The study was funded by Macmillan Cancer Support as part of the Macmillan Survivorship Research Group programme (Chief Investigator: CF). CF, KCS, JH, AD, CMM and LC were funded by the Macmillan Survivorship Research Group. DF was funded by the Macmillan Survivorship Research Group during recruitment for CREW and subsequently by University of Southampton. AR and PWS are funded by University of Southampton. JW is funded by University Hospital Southampton NHS Foundation Trust. JC is funded by University of Nottingham. Macmillan Cancer Support had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all CREW study participants, Carol Hill, Kerry Coleman and Bjoern Schukowsky (study administrators); Matthew Breckons, Cassandra Powers, Alex Recio-Saucedo, Bina Nausheen, Ikumi Okamoto (researchers); Jo Clough, Alison Farmer and Gaye Orr (research partners). Members of Study Advisory Committee: Jo Armes, Janis Baird, Andrew Bateman, Nick Beck, Graham Moon, Claire Hulme, Karen Poole, Susan Restorick-Banks, Paul Roderick, Claire Taylor, Jocelyn Walters, Fran Williams. The study was funded by Macmillan Cancer Support as part of the Macmillan Survivorship Research Group programme (Chief Investigator: CF). CF, KCS, JH, AD, CMM and LC were funded by the Macmillan Survivorship Research Group. DF was funded by the Macmillan Survivorship Research Group during recruitment for CREW and subsequently by University of Southampton. AR and PWS are funded by University of Southampton. JW is funded by University Hospital Southampton NHS Foundation Trust. JC is funded by University of Nottingham.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; [Anonymous], 2015, CLIN PRACT GUID ONC; Ashley L, 2014, J PSYCHOSOM RES, V77, P322, DOI 10.1016/j.jpsychores.2014.07.007; Avis NE, 2005, QUAL LIFE RES, V14, P1007, DOI 10.1007/s11136-004-2147-2; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Butow P, 2015, PSYCHO-ONCOLOGY, V24, P987, DOI 10.1002/pon.3920; Carlsson E, 2010, J WOUND OSTOMY CONT, V37, P654, DOI 10.1097/WON.0b013e3181f90f0c; Downing A, 2015, J CLIN ONCOL, V33, P616, DOI 10.1200/JCO.2014.56.6539; Dunn J, 2013, PSYCHO-ONCOLOGY, V22, P1759, DOI 10.1002/pon.3210; Dunn J, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-46; Fenlon D, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-153; Fenlon D, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-90; Foster C, 2015, J CANCER SURVIV, V9, P11, DOI 10.1007/s11764-014-0384-0; Foster C, 2011, BRIT J CANCER, V105, pS21, DOI 10.1038/bjc.2011.419; Gray NM, 2011, BRIT J CANCER, V104, P1697, DOI 10.1038/bjc.2011.155; Hornbrook MC, 2011, MED CARE, V49, P321, DOI 10.1097/MLR.0b013e31820194c8; Howsepian BA, 2009, PSYCHO-ONCOLOGY, V18, P1069, DOI 10.1002/pon.1442; Jansen L, 2011, J CLIN ONCOL, V29, P3263, DOI 10.1200/JCO.2010.31.4013; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katz MR, 2004, PSYCHO-ONCOLOGY, V13, P269, DOI 10.1002/pon.734; KNIGHT RG, 1983, BRIT J CLIN PSYCHOL, V22, P245, DOI 10.1111/j.2044-8260.1983.tb00610.x; Koroukian SM, 2010, J GERONTOL A-BIOL, V65, P322, DOI 10.1093/gerona/glp180; Lev E L, 2001, Sch Inq Nurs Pract, V15, P277; Lorig K R, 2001, Eff Clin Pract, V4, P256; Mosher CE, 2010, CLIN J PAIN, V26, P227, DOI 10.1097/AJP.0b013e3181bed0e3; National Health and Medical Research Council (HMRC), 2003, CLIN PRACT GUID PSYC; National Institute for Health and Care Excellence (NICE), 2004, IMPR SUPP PALL CAR A; Office for National Statistics, 2013, PERS WELL BEING UK; Pachler J, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004323.PUB4; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shelby RA, 2014, SUPPORT CARE CANCER, V22, P2851, DOI 10.1007/s00520-014-2269-1; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Siassi M, 2009, DIS COLON RECTUM, V52, P662, DOI 10.1007/DCR.0b013e31819ecf2e; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steginga SK, 2009, PSYCHO-ONCOL, V18, P216, DOI 10.1002/pon.1388; The International Wellbeing Group, PERS WELLB IND AD PW; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; Vissers PAJ, 2013, J CANCER SURVIV, V7, P602, DOI 10.1007/s11764-013-0299-1; Walker J, 2014, LANCET PSYCHIAT, V1, P343, DOI 10.1016/S2215-0366(14)70313-X; Whistance RN, 2009, EUR J CANCER, V45, P3017, DOI 10.1016/j.ejca.2009.08.014; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	45	48	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155434	10.1371/journal.pone.0155434	http://dx.doi.org/10.1371/journal.pone.0155434			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CQ	27171174	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000376588600107
J	Akre, MK; Starrett, GJ; Quist, JS; Temiz, NA; Carpenter, MA; Tutt, ANJ; Grigoriadis, A; Harris, RS				Akre, Monica K.; Starrett, Gabriel J.; Quist, Jelmar S.; Temiz, Nuri A.; Carpenter, Michael A.; Tutt, Andrew N. J.; Grigoriadis, Anita; Harris, Reuben S.			Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; MULTIPLE HUMAN CANCERS; BREAST-CANCER; SOMATIC HYPERMUTATION; HUMAN-PAPILLOMAVIRUS; GENOMIC DNA; HUMAN-CELLS; DOMAIN MUTATIONS; FOREIGN DNA; NUCLEAR-DNA	Molecular, cellular, and clinical studies have combined to demonstrate a contribution from the DNA cytosine deaminase APOBEC3B (A3B) to the overall mutation load in breast, head/neck, lung, bladder, cervical, ovarian, and other cancer types. However, the complete landscape of mutations attributable to this enzyme has yet to be determined in a controlled human cell system. We report a conditional and isogenic system for A3B induction, genomic DNA deamination, and mutagenesis. Human 293-derived cells were engineered to express doxycycline-inducible A3B-eGFP or eGFP constructs. Cells were subjected to 10 rounds of A3B-eGFP exposure that each caused 80-90% cell death. Control pools were subjected to parallel rounds of non-toxic eGFP exposure, and dilutions were done each round to mimic A3B-eGFP induced population fluctuations. Targeted sequencing of portions of TP53 and MYC demonstrated greater mutation accumulation in the A3B-eGFP exposed pools. Clones were generated and microarray analyses were used to identify those with the greatest number of SNP alterations for whole genome sequencing. A3B-eGFP exposed clones showed global increases in C-to-T transition mutations, enrichments for cytosine mutations within A3B-preferred trinucleotide motifs, and more copy number aberrations. Surprisingly, both control and A3B-eGFP clones also elicited strong mutator phenotypes characteristic of defective mismatch repair. Despite this additional mutational process, the 293-based system characterized here still yielded a genome-wide view of A3B-catalyzed mutagenesis in human cells and a system for additional studies on the compounded effects of simultaneous mutation mechanisms in cancer cells.	[Akre, Monica K.; Starrett, Gabriel J.; Temiz, Nuri A.; Carpenter, Michael A.; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Masonic Canc Ctr, Minneapolis, MN USA; [Quist, Jelmar S.; Tutt, Andrew N. J.; Grigoriadis, Anita] Kings Coll London, Guys Hosp, Res Oncol, Breast Canc Now Res Unit, London, England; [Harris, Reuben S.] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	Harris, RS (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Masonic Canc Ctr, Minneapolis, MN USA.; Harris, RS (corresponding author), Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN USA.	rsh@umn.edu		Akre, Monica/0000-0002-1050-7417; Tutt, Andrew/0000-0001-8715-2901; Carpenter, Michael/0000-0001-9524-5323; Grigoriadis, Anita/0000-0003-3434-201X; Starrett, Gabriel/0000-0001-5871-5306	NIHR Biomedical Research Centre at Guy's and St Thomas; Department of Defense Breast Cancer Research Program [BC121347]; Jimmy V Foundation for Cancer Research; Norwegian Centennial Chair Program; Minnesota Partnership for Biotechnology and Medical Genomics; Randy Shaver Cancer Research and Community Fund; National Science Foundation Graduate Research Fellowship [DGE 13488264]; Breast Cancer	NIHR Biomedical Research Centre at Guy's and St Thomas; Department of Defense Breast Cancer Research Program(United States Department of Defense); Jimmy V Foundation for Cancer Research; Norwegian Centennial Chair Program; Minnesota Partnership for Biotechnology and Medical Genomics; Randy Shaver Cancer Research and Community Fund; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Breast Cancer	Work in the Grigoriadis and Tutt laboratories is supported by Breakthrough Breast Cancer (recently merged with Breast Cancer Campaign forming Breast Cancer Now). JQ is on a PhD studentship in Translational Medicine from the NIHR Biomedical Research Centre at Guy's and St Thomas. Cancer studies in the Harris laboratory are supported by grants from the Department of Defense Breast Cancer Research Program (BC121347), the Jimmy V Foundation for Cancer Research, the Norwegian Centennial Chair Program, the Minnesota Partnership for Biotechnology and Medical Genomics, and the Randy Shaver Cancer Research and Community Fund. Salary support for GJS was provided by a National Science Foundation Graduate Research Fellowship (DGE 13488264). RSH is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Aynaud MM, 2012, J BIOL CHEM, V287, P39182, DOI 10.1074/jbc.M112.372722; Bacolla A, 2014, GENES-BASEL, V5, P108, DOI 10.3390/genes5010108; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Caval V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6129; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cleaver JE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1024, DOI 10.2741/cleaver; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Gehring JS, 2015, BIOINFORMATICS, V31, P3673, DOI 10.1093/bioinformatics/btv408; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0498-3; Hecht SS, 2012, INT J CANCER, V131, P2724, DOI 10.1002/ijc.27816; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Henderson S, 2015, TRENDS MOL MED, V21, P274, DOI 10.1016/j.molmed.2015.02.007; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Komori J, 2008, HEPATOLOGY, V47, P888, DOI 10.1002/hep.22125; Lackey L, 2013, CELL CYCLE, V12, P762, DOI 10.4161/cc.23713; Land AM, 2015, ONCOTARGET, V6, P39969, DOI 10.18632/oncotarget.5483; Land AM, 2013, J BIOL CHEM, V288, P17253, DOI 10.1074/jbc.M113.458661; Leonard B, 2015, CANCER RES, V75, P4538, DOI 10.1158/0008-5472.CAN-15-2171-T; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Lord CJ, 2015, ANNU REV MED, V66, P455, DOI 10.1146/annurev-med-050913-022545; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Mori S, 2015, BIOCHEM BIOPH RES CO, V460, P555, DOI 10.1016/j.bbrc.2015.03.068; Mussil B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073641; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nilsen H, 2005, ONCOGENE, V24, P3063, DOI 10.1038/sj.onc.1208480; Periyasamy M, 2015, CELL REP, V13, P108, DOI 10.1016/j.celrep.2015.08.066; Poon SL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0161-3; Poon SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006086; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Rasmussen M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r108; Rayner E, 2016, NAT REV CANCER, V16, P71, DOI 10.1038/nrc.2015.12; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Roesner LM, 2013, J CELL BIOCHEM, V114, P2405, DOI 10.1002/jcb.24591; Rucci F, 2006, GENE, V377, P150, DOI 10.1016/j.gene.2006.03.024; Shee C, 2013, ELIFE, V2, DOI 10.7554/eLife.01222; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Sieuwerts AM, 2014, HORM CANCER-US, V5, P405, DOI 10.1007/s12672-014-0196-8; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; Vieira VC, 2014, MBIO, V5, DOI 10.1128/mBio.02234-14; Warren CJ, 2015, J VIROL, V89, P688, DOI 10.1128/JVI.02383-14	64	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155391	10.1371/journal.pone.0155391	http://dx.doi.org/10.1371/journal.pone.0155391			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163364	Green Submitted, gold, Green Published			2022-12-27	WOS:000376585700032
J	Cao, S; Liu, Y; Guo, MB; Wang, GR				Cao, Song; Liu, Yang; Guo, Mengbo; Wang, Guirong			A Conserved Odorant Receptor Tuned to Floral Volatiles in Three Heliothinae Species	PLOS ONE			English	Article							CANDIDATE PHEROMONE RECEPTORS; ARMIGERA HUBNER LEPIDOPTERA; MOSQUITO ANOPHELES-GAMBIAE; SPODOPTERA-EXIGUA HUBNER; SEX-PHEROMONE; FUNCTIONAL-CHARACTERIZATION; HELICOVERPA-ARMIGERA; OLFACTORY RECEPTORS; TOBACCO BUDWORM; COTTON BOLLWORM	Odorant receptors (ORs) play an important role in insects to monitor and adapt to the external environment, such as host plant location, oviposition-site selection, mate recognition and natural enemy avoidance. In our study, we identified and characterized OR12 from three closely-related species, Helicoverpa armigera, Helicoverpa assulta, Heliothis virescens, sharing between 90 and 98% of their amino acids. The tissue expression pattern analysis in H. armigera showed that HarmOR12 was strongly expressed both in male and female antennae, but not in other tissues. Functional analysis performed in the heterologous Xenopus expression system showed that all three OR12 were tuned to six structurally related plant volatiles. Electroantennogram recordings from male and female antennae of H. armigera closely matched the data of in vitro functional studies. Our results revealed that OR12 has a conserved role in Heliothinae moths and might represent a suitable target for the control of these crop pests.	[Cao, Song; Liu, Yang; Guo, Mengbo; Wang, Guirong] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wang, GR (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	grwang@ippcaas.cn		Liu, Yang/0000-0002-3424-7111	National Natural Science Foundation of China [31230062, 31471833]; National Basic Research Program of China [2012CB114104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (31230062 to GW and 31471833 to YL) and National Basic Research Program of China (2012CB114104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco CA, 2007, FLA ENTOMOL, V90, P742, DOI 10.1653/0015-4040(2007)90[742:DOHVAH]2.0.CO;2; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Chang HT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13093; CORK A, 1992, J CHEM ECOL, V18, P403, DOI 10.1007/BF00994240; Cosse AA, 1999, J CHEM ECOL, V25, P51, DOI 10.1023/A:1020885032397; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Deka B, 2014, NATL ACAD SCI LETT, V37, P191, DOI 10.1007/s40009-013-0215-2; Dobson Heidi E.M., 1994, P47; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; Ei-Sayed AM, 2009, PEST MANAG SCI, V65, P975, DOI 10.1002/ps.1782; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gregg PC, 2010, AUST J ENTOMOL, V49, P21, DOI 10.1111/j.1440-6055.2009.00734.x; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Jiang XJ, 2014, INSECT BIOCHEM MOLEC, V48, P63, DOI 10.1016/j.ibmb.2014.02.010; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Kang L, 2004, CHINESE SCI BULL, V49, P136, DOI 10.1360/03wc0274; KLUN JA, 1980, J CHEM ECOL, V6, P177, DOI 10.1007/BF00987536; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leary GP, 2012, P NATL ACAD SCI USA, V109, P14081, DOI 10.1073/pnas.1204661109; Li HC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-582; Liu CC, 2014, INSECT MOL BIOL, V23, P487, DOI 10.1111/imb.12096; Liu CC, 2013, INSECT BIOCHEM MOLEC, V43, P747, DOI 10.1016/j.ibmb.2013.05.009; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Liu ZD, 2004, ENVIRON ENTOMOL, V33, P1570, DOI 10.1603/0046-225X-33.6.1570; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Matthews M, 1999, HELIOTHINE MOTHS AUS; Meagher RL, 2008, ENTOMOL EXP APPL, V128, P323, DOI 10.1111/j.1570-7458.2008.00711.x; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; NESBITT BF, 1979, J INSECT PHYSIOL, V25, P535, DOI 10.1016/S0022-1910(79)80012-8; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SUGIE H, 1991, APPL ENTOMOL ZOOL, V26, P151, DOI 10.1303/aez.26.151; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Zhang J, 2013, INSECT MOL BIOL, V22, P424, DOI 10.1111/imb.12033; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117054; Zhang JP, 2012, J INSECT PHYSIOL, V58, P1209, DOI 10.1016/j.jinsphys.2012.05.018	45	40	44	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155029	10.1371/journal.pone.0155029	http://dx.doi.org/10.1371/journal.pone.0155029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163122	gold, Green Published			2022-12-27	WOS:000376585700001
J	Guedira, M; Xiong, M; Hao, YF; Johnson, J; Harrison, S; Marshall, D; Brown-Guedira, G				Guedira, Mohammed; Xiong, Mai; Hao, Yuan Feng; Johnson, Jerry; Harrison, Steve; Marshall, David; Brown-Guedira, Gina			Heading Date QTL in Winter Wheat (Triticum aestivum L.) Coincide with Major Developmental Genes VERNALIZATION1 and PHOTOPERIOD1	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; SPRING GROWTH HABIT; FLOWERING TIME; IDENTIFICATION; ADAPTABILITY; REQUIREMENT; IMPROVEMENT; CULTIVARS; DURATION; PPD-B1A	In wheat (Triticum aestivum L.), time from planting to spike emergence is influenced by genes controlling vernalization requirement and photoperiod response. Characterizing the available genetic diversity of known and novel alleles of VERNALIZATION1 (VRN1) and PHOTOPERIOD1 (PPD1) in winter wheat can inform approaches for breeding climate resilient cultivars. This study identified QTL for heading date (HD) associated with multiple VRN1 and PPD1 loci in a population developed from a cross between two early flowering winter wheat cultivars. When the population was grown in the greenhouse after partial vernalization treatment, major heading date QTLs co-located with the VRN-A1 and VRN-B1 loci. Copy number variation at the VRN-A1 locus influenced HD such that RIL having three copies required longer cold exposure to transition to flowering than RIL having two VRN-A1 copies. Sequencing vrn-B1 winter alleles of the parents revealed multiple polymorphisms in the first intron that were the basis of mapping a major HD QTL coinciding with VRN-B1. A 36 bp deletion in the first intron of VRN-B1 was associated with earlier HD after partial vernalization in lines having either two or three haploid copies of VRN-A1. The VRN1 loci interacted significantly and influenced time to heading in field experiments in Louisiana, Georgia and North Carolina. The PPD1 loci were significant determinants of heading date in the fully vernalized treatment in the greenhouse and in all field environments. Heading date QTL were associated with alleles having large deletions in the upstream regions of PPD-A1 and PPD-D1 and with copy number variants at the PPD-B1 locus. The PPD-D1 locus was determined to have the largest genetic effect, followed by PPD-A1 and PPD-B1. Our results demonstrate that VRN1 and PPD1 alleles of varying strength allow fine tuning of flowering time in diverse winter wheat growing environments.	[Guedira, Mohammed; Xiong, Mai; Marshall, David; Brown-Guedira, Gina] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Hao, Yuan Feng; Johnson, Jerry] Univ Georgia, Dept Crop & Soil Sci, Griffin, GA 30223 USA; [Harrison, Steve] Louisiana State Univ, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA; [Marshall, David; Brown-Guedira, Gina] USDA ARS, Plant Sci Res Unit, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia; Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA)	Brown-Guedira, G (corresponding author), N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA.; Brown-Guedira, G (corresponding author), USDA ARS, Plant Sci Res Unit, Raleigh, NC 27695 USA.	Gina.Brown-Guedira@ars.usda.gov	Hao, Yuanfeng/ABE-5163-2020	Brown-Guedira, Gina/0000-0002-1958-2827	United States Department of Agriculture National Institute of Food and Agriculture (nifa.usda.gov) Triticeae Coordinated Agricultural Project [2011-68002-30029]	United States Department of Agriculture National Institute of Food and Agriculture (nifa.usda.gov) Triticeae Coordinated Agricultural Project	Funding was provided by the United States Department of Agriculture National Institute of Food and Agriculture (nifa.usda.gov) Triticeae Coordinated Agricultural Project (grant No. 2011-68002-30029) to GBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen A, 2014, P NATL ACAD SCI USA, V111, P10037, DOI 10.1073/pnas.1409795111; Chen YH, 2009, THEOR APPL GENET, V118, P881, DOI 10.1007/s00122-008-0946-5; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; FAO, 2009, FAOSTAT DAT AGR CROP; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; GALIBA G, 1995, THEOR APPL GENET, V90, P1174, DOI 10.1007/BF00222940; Guedira M, 2014, CROP SCI, V54, P1960, DOI 10.2135/cropsci2013.12.0833; Hao YF, 2015, THEOR APPL GENET, V128, P465, DOI 10.1007/s00122-014-2445-1; Hao YF, 2012, CROP SCI, V52, P2438, DOI 10.2135/cropsci2012.05.0317; Hao YF, 2012, MOL BREEDING, V30, P1453, DOI 10.1007/s11032-012-9731-x; Kamran A, 2014, EUPHYTICA, V197, P1, DOI 10.1007/s10681-014-1075-7; Kippes N, 2015, P NATL ACAD SCI USA, V112, pE5401, DOI 10.1073/pnas.1514883112; Kiss T, 2014, MOL BREEDING, V34, P297, DOI 10.1007/s11032-014-0034-2; Langer SM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00537; LAW CN, 1976, HEREDITY, V36, P49, DOI 10.1038/hdy.1976.5; Law CN, 1997, NEW PHYTOL, V137, P19, DOI 10.1046/j.1469-8137.1997.00814.x; Li GQ, 2013, PLANT J, V76, P742, DOI 10.1111/tpj.12326; Nishida H, 2013, MOL BREEDING, V31, P27, DOI 10.1007/s11032-012-9765-0; Seki M, 2011, BREEDING SCI, V61, P405, DOI 10.1270/jsbbs.61.405; Snape JW, 2001, EUPHYTICA, V119, P185, DOI 10.1023/A:1017594422176; STELMAKH AF, 1987, EUPHYTICA, V36, P513, DOI 10.1007/BF00041495; Tanio M, 2007, BREEDING SCI, V57, P65, DOI 10.1270/jsbbs.57.65; Trevaskis B, 2010, FUNCT PLANT BIOL, V37, P479, DOI 10.1071/FP10056; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Wang J, 2014, USERS MANUAL OF QTL; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Worland AJ, 1996, EUPHYTICA, V89, P49, DOI 10.1007/BF00015718; Worland AJ, 1998, EUPHYTICA, V100, P385, DOI 10.1023/A:1018327700985; Xiao J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5572; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	39	37	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154242	10.1371/journal.pone.0154242	http://dx.doi.org/10.1371/journal.pone.0154242			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163605	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700024
J	Marful, A; Gomez-Ariza, CJ; Barbon, A; Bajo, T				Marful, Alejandra; Gomez-Ariza, Carlos J.; Barbon, Analia; Bajo, Teresa			Forgetting "Novel" but Not "Dragon": The Role of Age of Acquisition on Intentional and Incidental Forgetting	PLOS ONE			English	Article							WORD-FREQUENCY; MEMORY INHIBITION; RETRIEVAL; INTERFERENCE; MECHANISMS; RECOGNITION; INTEGRATION; CONTEXT; IMAGERY; MODEL	Two experiments studied how the age at which words are acquired (Age of Acquisition, AoA) modulates forgetting. Experiment 1 employed the retrieval-practice paradigm to test the effect of AoA on the incidental forgetting that emerges after solving competition during retrieval (i.e., retrieval-induced forgetting, RIF). Standard RIF appeared with late-acquired words, but this effect disappeared with early-acquired words. Experiment 2 evaluated the effect of AoA on intentional forgetting by employing the list-method directed forgetting paradigm. Results showed a standard directed forgetting effect only when the to-be-forgotten words were late-acquired words. These findings point to the prominent role of AoA in forgetting processes.	[Marful, Alejandra; Gomez-Ariza, Carlos J.] Univ Jaen, Jaen, Spain; [Barbon, Analia] Int Univ La Rioja, Logrono, Spain; [Bajo, Teresa] Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain	Universidad de Jaen; Universidad Internacional de La Rioja (UNIR); University of Granada	Marful, A (corresponding author), Univ Jaen, Jaen, Spain.	mmarful@ujaen.es	Barbon, Analia/L-4028-2017; Gomez-Ariza, Carlos J./B-1621-2010; Bajo, Teresa/N-3154-2019; Bajo, Teresa/D-9927-2011; MARFUL, ALEJANDRA/AAT-8785-2020; Marful, Alejandra/B-5738-2012	Barbon, Analia/0000-0001-8633-9352; Gomez-Ariza, Carlos J./0000-0001-5889-7533; Bajo, Teresa/0000-0003-2996-8261; Bajo, Teresa/0000-0003-2996-8261; 	Spanish Ministry of Economy and Competitiveness [PSI2013-46033-P, PSI2012-33625, PSI2011-25797]; Ministry of Science [EDU2008-01111]; Andalusian Government [P12-CTS-2369]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Andalusian Government	This research was supported by grants from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/?lang_choosen=en) to AM (PSI2013-46033-P), TB (PSI2012-33625), and CJG-A (PSI2011-25797), and from the Ministry of Science (http://www.mineco.gob.es/portal/site/mineco/?lang_choosen=en) (EDU2008-01111) and the Andalusian Government (http://www.juntadeandalucia.es/) (P12-CTS-2369) to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameda J.R., 1995, DICCIONARIO FRECUENC; ANDERSON JR, 1981, MEM COGNITION, V9, P237, DOI 10.3758/BF03196958; Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68; ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; Anderson MC, 1999, J EXP PSYCHOL LEARN, V25, P608, DOI 10.1037/0278-7393.25.3.608; Anderson MC, 2001, J EXP PSYCHOL GEN, V130, P544, DOI 10.1037//0096-3445.130.3.544; Anderson MC, 2014, TRENDS COGN SCI, V18, P279, DOI 10.1016/j.tics.2014.03.002; Bauml KHT, 2010, PSYCHOL SCI, V21, P793, DOI 10.1177/0956797610370162; Bajo MT, 2006, J EXP PSYCHOL LEARN, V32, P1185, DOI 10.1037/0278-7393.32.5.1185; Bauml KH, 2002, MEMORY, V10, P215, DOI 10.1080/09658210143000362; Bjork RA, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P453; Brysbaert M, 2000, ACTA PSYCHOL, V104, P215, DOI 10.1016/S0001-6918(00)00021-4; CARROLL JB, 1973, Q J EXP PSYCHOL, V25, P85, DOI 10.1080/14640747308400325; COLTHEART V, 1986, MEM COGNITION, V14, P174, DOI 10.3758/BF03198377; Cuetos F, 2002, BRAIN LANG, V82, P344, DOI 10.1016/S0093-934X(02)00038-X; Davies R, 2013, MEM COGNITION, V41, P297, DOI 10.3758/s13421-012-0263-8; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Dewhurst SA, 1998, J EXP PSYCHOL LEARN, V24, P284, DOI 10.1037//0278-7393.24.2.284; Diez E., 2006, NIPE NORMAS INDICES; Duchon A, 2013, BEHAV RES METHODS, V45, P1246, DOI 10.3758/s13428-013-0326-1; Ellis AW, 2000, J EXP PSYCHOL LEARN, V26, P1103, DOI 10.1037//0278-7393.26.5.1103; GEISELMAN RE, 1983, J EXP PSYCHOL GEN, V112, P58, DOI 10.1037/0096-3445.112.1.58; GILHOOLY KJ, 1979, MEM COGNITION, V7, P214, DOI 10.3758/BF03197541; Gomez-Ariza C, 2003, MEMORY, V11, P505, DOI 10.1080/09658210244000090; Gomez-Ariza CJ, 2012, PSYCHON B REV, V19, P483, DOI 10.3758/s13423-012-0228-8; Goodmon LB, 2011, J EXP PSYCHOL LEARN, V37, P416, DOI 10.1037/a0021963; Hernandez AE, 2007, PSYCHOL BULL, V133, P638, DOI 10.1037/0033-2909.133.4.638; Holmes SJ, 2006, J CLIN EXP NEUROPSYC, V28, P1010, DOI 10.1080/13803390591004392; Howe ML, 2000, DEV PSYCHOL, V36, P778, DOI 10.1037//0012-1649.36.6.778; Izura C, 2011, J MEM LANG, V64, P32, DOI 10.1016/j.jml.2010.09.002; Jenkins JJ., 1963, VERBAL BEHAVIOR LEAR, P210, DOI [10.1037/11178-006, DOI 10.1037/11178-006]; Johnston RA, 2006, VIS COGN, V13, P789, DOI 10.1080/13506280544000066; Jonker TR, 2013, PSYCHOL REV, V120, P852, DOI 10.1037/a0034246; Juhasz BJ, 2005, PSYCHOL BULL, V131, P684, DOI 10.1037/0033-2909.131.5.684; MORRIS PE, 1981, MEM COGNITION, V9, P277, DOI 10.3758/BF03196961; MORRISON CM, 1995, J EXP PSYCHOL LEARN, V21, P116, DOI 10.1037/0278-7393.21.1.116; Murayama K, 2014, PSYCHOL BULL, V140, P1383, DOI 10.1037/a0037505; MYERS JL, 1984, COGNITIVE PSYCHOL, V16, P217, DOI 10.1016/0010-0285(84)90008-2; Navarrete E, 2015, MEM COGNITION, V43, P1085, DOI 10.3758/s13421-015-0525-3; Ortega A, 2015, COGN PROCESS, V16, P121, DOI 10.1007/s10339-015-0650-8; Ortega A, 2012, J EXP PSYCHOL LEARN, V38, P178, DOI 10.1037/a0024510; Pastotter B, 2007, J EXP PSYCHOL LEARN, V33, P977, DOI 10.1037/0278-7393.33.5.977; Paz-Alonso PM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.024.2009; RADVANSKY GA, 1991, J EXP PSYCHOL LEARN, V17, P940, DOI 10.1037/0278-7393.17.5.940; Roman P, 2009, PSYCHOL SCI, V20, P1053, DOI 10.1111/j.1467-9280.2009.02415.x; Sahakyan L, 2013, PSYCHOL LEARN MOTIV, V59, P131, DOI 10.1016/B978-0-12-407187-2.00004-6; SMITH EE, 1978, COGNITIVE PSYCHOL, V10, P438, DOI 10.1016/0010-0285(78)90007-5; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Storm BC, 2010, MEMORY, V18, P99, DOI 10.1080/09658210903107853; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; van Kesteren MTR, 2013, NEUROPSYCHOLOGIA, V51, P2352, DOI 10.1016/j.neuropsychologia.2013.05.027; Weller PD, 2013, J EXP PSYCHOL LEARN, V39, P1232, DOI 10.1037/a0030335	53	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155110	10.1371/journal.pone.0155110	http://dx.doi.org/10.1371/journal.pone.0155110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8BN	27163698	Green Published, gold			2022-12-27	WOS:000376585700021
J	Chai, TT; Cui, F; Mu, XY; Yang, Y; Wang, CJ; Qiu, J				Chai, Tingting; Cui, Feng; Mu, Xiyan; Yang, Yang; Wang, Chengju; Qiu, Jing			Exploration of Stereoselectivity in Embryo-Larvae (Danio rerio) Induced by Chiral PCB149 at the Bioconcentration and Gene Expression Levels	PLOS ONE			English	Article							POLYCHLORINATED BIPHENYL ATROPISOMERS; FLIGHT MASS-SPECTROMETRY; GAS-CHROMATOGRAPHY; OXIDATIVE STRESS; TOXICITY; PCBS; BIOTRANSFORMATION; DIFENOCONAZOLE; METABOLITES; FRACTIONS	This paper was designed to study stereoselective enrichment and changes in gene expression when zebrafish (Danio rerio) embryo-larvae were exposed to racemic, (-)-or (+)-PCB149 (2,2', 3,4', 5',6-hexachlorobiphenyl). Based on bioconcentration analysis, non-racemic enrichment was significantly observed after racemic exposure. No isomerization between the two isomers was found after (-)/(+)-PCB149 exposure. Furthermore, based on gene expression-data mining, CYPs genes (cyp2k6, cyp19a1b, and cyp2aa4) were differential genes after (+)-PCB149 exposure. No obvious differences of dysregulation of gene expression caused by racemic and (-)-PCB149, were observed in embryo-larvae. The above results suggested that (-)-PCB149 could be considered as the main factor causing the dysregulation of gene expression in embryo-larvae after racemic exposure; and (+)-PCB149 should be pursued apart from the racemate, when considering the toxicity of chiral PCB149. Thus, the information in our study could provide new insights to assess the environmental risk of chiral PCBs in aquatic systems.	[Chai, Tingting; Cui, Feng; Mu, Xiyan; Yang, Yang; Wang, Chengju] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China; [Chai, Tingting; Qiu, Jing] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Key Lab Agrifood Qual & Safety,Minist Agr, Beijing 100193, Peoples R China; [Mu, Xiyan] Chinese Acad Fishery Sci, Ctr Fishery Resources & Ecol Environm Res, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences	Wang, CJ (corresponding author), China Agr Univ, Coll Sci, Beijing 100094, Peoples R China.; Qiu, J (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Key Lab Agrifood Qual & Safety,Minist Agr, Beijing 100193, Peoples R China.	wangchengju@cau.edu.cn; qiujing@caas.cn	Mu, Xiyan/GLV-5152-2022		National Natural Science Foundation of China [21477161, 21177156]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 21477161 and 21177156) to JQ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barri T, 2004, ANAL CHEM, V76, P1928, DOI 10.1021/ac035089g; Buckman AH, 2006, AQUAT TOXICOL, V78, P176, DOI 10.1016/j.aquatox.2006.02.033; Buckman AH, 2011, ENVIRON SCI TECHNOL, V45, P10194, DOI 10.1021/es201541j; Busch S, 2015, J IMMUNOL, V194, P1646, DOI 10.4049/jimmunol.1402163; Chai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep19478; Chai TT, 2014, J SEP SCI, V37, P595, DOI 10.1002/jssc.201301193; Dai SH, 2014, J HAZARD MATER, V280, P612, DOI 10.1016/j.jhazmat.2014.08.034; Dang VD, 2010, ENVIRON SCI TECHNOL, V44, P2836, DOI 10.1021/es902227a; Drouillard KG, 2001, ENVIRON TOXICOL CHEM, V20, P561, DOI 10.1002/etc.5620200315; Eimon PM, 2010, APOPTOSIS, V15, P331, DOI 10.1007/s10495-009-0432-9; Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008; Galban-Malagon CJ, 2013, ENVIRON SCI TECHNOL, V47, P5578, DOI 10.1021/es400030q; Jepson PD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18573; Kania-Korwel I, 2016, ENVIRON SCI POLLUT R, V23, P2058, DOI 10.1007/s11356-015-4383-0; Kania-Korwel I, 2012, ENVIRON SCI TECHNOL, V46, P11393, DOI 10.1021/es302810t; Kannan K, 2000, HUM ECOL RISK ASSESS, V6, P181, DOI 10.1080/10807030091124491; Kubota A, 2013, TOXICOL APPL PHARM, V272, P172, DOI 10.1016/j.taap.2013.05.017; Lehmler H, 2001, PCBS RECENT ADV ENV, P61; Lehmler HJ, 2010, ENVIRON SCI TECHNOL, V44, P2757, DOI 10.1021/es902208u; Lehmler HJ, 2005, TOXICOL LETT, V156, P391, DOI 10.1016/j.toxlet.2004.12.011; Liu H, 2014, ENV TOXICOL; Lu Z, 2014, ENVIRON POLLUT, V186, P216, DOI 10.1016/j.envpol.2013.12.005; Lu Z, 2013, ENVIRON SCI TECHNOL, V47, P12184, DOI 10.1021/es402838f; Lu Z, 2011, ENVIRON SCI TECHNOL, V45, P8298, DOI 10.1021/es200673q; Morrissey JA, 2007, CHEMOSPHERE, V66, P326, DOI 10.1016/j.chemosphere.2006.04.085; Mu XY, 2015, AQUAT TOXICOL, V160, P57, DOI 10.1016/j.aquatox.2015.01.001; Mu XY, 2013, ENVIRON POLLUT, V175, P147, DOI 10.1016/j.envpol.2012.12.029; Nie DS, 2009, MOL BIOL REP, V36, P2221, DOI 10.1007/s11033-008-9437-7; Noel M, 2014, ENVIRON SCI TECHNOL, V48, P2942, DOI 10.1021/es403217r; Pamanji R, 2015, ENVIRON TOXICOL PHAR, V39, P887, DOI 10.1016/j.etap.2015.02.020; Ross MS, 2008, ENVIRON SCI TECHNOL, V42, P7181, DOI 10.1021/es8000147; Ross MS, 2011, MAR POLLUT BULL, V63, P548, DOI 10.1016/j.marpolbul.2011.02.001; Serrano R, 2000, ARCH ENVIRON CON TOX, V38, P217, DOI 10.1007/s002449910029; Sun R, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2675-4; Tabuchi M, 2006, ENVIRON HEALTH PERSP, V114, P1024, DOI 10.1289/ehp.8661; Tan GG, 2014, J PHARMACEUT BIOMED, V96, P187, DOI 10.1016/j.jpba.2014.03.028; Uno T, 2012, ENVIRON TOXICOL PHAR, V34, P1, DOI 10.1016/j.etap.2012.02.004; von Schalburg KR, 2010, COMP BIOCHEM PHYS B, V155, P118, DOI 10.1016/j.cbpb.2009.10.015; Wang-Buhler JL, 2005, COMP BIOCHEM PHYS C, V140, P207, DOI 10.1016/j.cca.2005.02.002; Warner NA, 2005, ENVIRON TOXICOL CHEM, V24, P2763, DOI 10.1897/05-121R.1; Wiberg K, 2006, ENVIRON TOXICOL CHEM, V25, P1465, DOI 10.1897/05-329R.1; Wilderman PR, 2014, TOXICOL APPL PHARM, V274, P393, DOI 10.1016/j.taap.2013.12.005; Wong CS, 2001, ENVIRON SCI TECHNOL, V35, P2448, DOI 10.1021/es0018872; Wong CS, 2000, J CHROMATOGR A, V866, P213, DOI 10.1016/S0021-9673(99)01104-8; Wu FL, 2014, ECOTOX ENVIRON SAFE, V110, P254, DOI 10.1016/j.ecoenv.2014.09.012; Yamamoto S, 2012, J BIOSCI BIOENG, V114, P170, DOI 10.1016/j.jbiosc.2012.03.023; Yang DR, 2014, TOXICOL SCI, V138, P379, DOI 10.1093/toxsci/kft334; Zheng XB, 2015, ENVIRON SCI TECHNOL, V49, P785, DOI 10.1021/es503748w; Zhu LZ, 2015, ENVIRON POLLUT, V203, P40, DOI 10.1016/j.envpol.2015.03.044; Zou D, 2014, ANAL METHODS-UK, V6, P2848, DOI 10.1039/c3ay41814f	50	6	6	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155263	10.1371/journal.pone.0155263	http://dx.doi.org/10.1371/journal.pone.0155263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158819	Green Published, gold, Green Submitted			2022-12-27	WOS:000376576700052
J	Federau, C; Gallichan, D				Federau, Christian; Gallichan, Daniel			Motion-Correction Enabled Ultra-High Resolution In-Vivo 7T-MRI of the Brain	PLOS ONE			English	Article							7 T MRI; VISUALIZATION; GRADIENT; TESLA	Objectives To demonstrate the image quality that can be obtained for multiple contrasts using ultra-high resolution MRI (highest nominal resolution: 350 mu m isotropic) at 7T using appropriate motion-correction. Materials and Methods An MRI-based fat-excitation motion navigator (which requires no additional hardware) was incorporated into T1-weighted (MP2RAGE, 350 mu m nominal isotropic resolution, total scan time 124 mins over 2 sessions. The MP2RAGE also provides quantitative T1-maps), 3D-TSE (380 mu m nominal isotropic resolution, total scan time 58 mins) and T2*-weighted protocols (3D-GRE, 380 mu m nominal isotropic resolution, total scan time 42 mins) on a 7T MR system. Images from each contrast are presented from a single healthy adult male volunteer (34 years) for direct comparison. The subject provided written consent in accordance with the local review board. Results Images of various brain structures are revealed at unprecedented quality for in-vivo MRI. The presented images permit, for example, to delimit the internal structure of the basal ganglia and thalamus. The single digitationes of the hippocampus are visible, and the gyrus dentatus can be visualized. Intracortical contrast was also observed in the neocortex, including the stria of Gennari of the primary visual cortex. Conclusions Appropriate motion-correction allows MRI scans to be performed with extended scan times enabling exceptionally high resolution scans with high image quality, with the use of a 7T scanner allowing large brain coverage for 350-380 mu m isotropic voxels with total scan times for each contrast ranging from 42 to 124 minutes.	[Federau, Christian] Stanford Univ, Dept Radiol, Neuroradiol Sect, Stanford, CA 94305 USA; [Gallichan, Daniel] Ecole Polytech Fed Lausanne, CIBM, CH-1015 Lausanne, Switzerland	Stanford University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Gallichan, D (corresponding author), Ecole Polytech Fed Lausanne, CIBM, CH-1015 Lausanne, Switzerland.	daniel.gallichan@epfl.ch	Gallichan, Daniel/AAA-9407-2019	Gallichan, Daniel/0000-0002-0143-2855	Centre d'Imagerie BioMedicale (CIBM) of the EPFL; Centre d'Imagerie BioMedicale (CIBM) of the UNIL; Centre d'Imagerie BioMedicale (CIBM) of the UNIGE; Centre d'Imagerie BioMedicale (CIBM) of the HUG; Centre d'Imagerie BioMedicale (CIBM) of the CHUV; Leenards Foundation; Jeantet Foundation; Swiss National Science Foundation [153564, 158665]	Centre d'Imagerie BioMedicale (CIBM) of the EPFL; Centre d'Imagerie BioMedicale (CIBM) of the UNIL; Centre d'Imagerie BioMedicale (CIBM) of the UNIGE; Centre d'Imagerie BioMedicale (CIBM) of the HUG; Centre d'Imagerie BioMedicale (CIBM) of the CHUV; Leenards Foundation; Jeantet Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Centre d'Imagerie BioMedicale (CIBM) of the EPFL, UNIL, UNIGE, HUG, CHUV and the Leenards and Jeantet Foundations (to DG); Swiss National Science Foundation (http://www.snf.ch), grant number 153564 (to DG); and Swiss National Science Foundation (http://www.snf.ch), grant number 158665 (to CF).	Bammer R, 2007, MAGN RESON MED, V57, P90, DOI 10.1002/mrm.21106; Blazejewska AI, 2013, NEUROLOGY, V81, P534, DOI 10.1212/WNL.0b013e31829e6fd2; Carmichael DW, 2006, NEUROIMAGE, V32, P1176, DOI 10.1016/j.neuroimage.2006.04.191; Deistung A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00710; Fessler JA, 2003, IEEE T SIGNAL PROCES, V51, P560, DOI 10.1109/TSP.2002.807005; Gallichan D, 2016, MAGN RESON MED, V75, P1030, DOI 10.1002/mrm.25670; Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kerchner GA, 2010, NEUROLOGY, V75, P1381, DOI 10.1212/WNL.0b013e3181f736a1; Maclaren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048088; Madan N, 2009, P 17 SCI M INT SOC M, P48; Mainero C, 2015, BRAIN, V138, P932, DOI 10.1093/brain/awv011; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Mugler 3rd JP, 2000, P INT SOC MAGN RESON, V8, P687; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Padormo F, 2016, NMR BIOMED, V29, P1145, DOI 10.1002/nbm.3313; Schulz J, 2012, MAGN RESON MATER PHY, V25, P443, DOI 10.1007/s10334-012-0320-0; Stucht D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133921; Tisdall MD, 2013, P 21 ANN M ISMRM SAL, P268; Trampel R, 2011, CEREB CORTEX, V21, P2075, DOI 10.1093/cercor/bhq282; Turner R, 2008, MAGN RESON IMAGING, V26, P935, DOI 10.1016/j.mri.2008.01.043; Wisse LEM, 2012, NEUROIMAGE, V61, P1043, DOI 10.1016/j.neuroimage.2012.03.023; Zeineh MM, 2014, INVEST RADIOL, V49, P278, DOI 10.1097/RLI.0000000000000015	26	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154974	10.1371/journal.pone.0154974	http://dx.doi.org/10.1371/journal.pone.0154974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159492	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000376576700027
J	Higuchi, M; Martinez-Ramirez, D; Morita, H; Topiol, D; Bowers, D; Ward, H; Warren, L; DeFranco, M; Hicks, JA; Hegland, KW; Troche, MS; Kulkarni, S; Hastings, E; Foote, KD; Okun, MS				Higuchi, Masa-aki; Martinez-Ramirez, Daniel; Morita, Hokuto; Topiol, Dan; Bowers, Dawn; Ward, Herbert; Warren, Lisa; DeFranco, Meredith; Hicks, Julie A.; Hegland, Karen W.; Troche, Michelle S.; Kulkarni, Shankar; Hastings, Erin; Foote, Kelly D.; Okun, Michael S.			Interdisciplinary Parkinson's Disease Deep Brain Stimulation Screening and the Relationship to Unintended Hospitalizations and Quality of Life	PLOS ONE			English	Article							COMPLICATIONS; COMORBIDITY; RATIONALE; SURGERY; ISSUES; CARE	Objective To investigate the impact of pre-operative deep brain stimulation (DBS) interdisciplinary assessments on post-operative hospitalizations and quality of life (QoL). Background DBS has been utilized successfully in Parkinson's disease (PD) for the treatment of tremor, rigidity, bradykinesia, off time, and motor fluctuations. Although DBS is becoming a more common management approach there are no standardized criteria for selection of DBS candidates, and sparse data exist to guide the use of interdisciplinary evaluations for DBS screening. We reviewed the outcomes of the use of an interdisciplinary model which utilized seven specialties to pre-operatively evaluate potential DBS candidates. Methods The University of Florida (UF) INFORM database was queried for PD patients who had DBS implantations performed at UF between January 2011 and February 2013. Records were reviewed to identify unintended hospitalizations, falls, and infections. Minor and major concerns or reservations from each specialty were previously documented and quantified. Clinical outcomes were assessed through the use of the Parkinson disease quality of life questionnaire (PDQ-39), and the Unified Parkinson's Disease Rating Score (UPDRS) Part III. Results A total of 164 cases were evaluated for possible DBS candidacy. There were 133 subjects who were approved for DBS surgery (81%) following interdisciplinary screening. There were 28 cases (21%) who experienced an unintended hospitalization within the first 12 months following the DBS operation. The patients identified during interdisciplinary evaluation with major or minor concerns from any specialty service had more unintended hospitalizations (93%) when compared to those without concerns (7%). When the preoperative "concern" shifted from "major" to "minor" to "no concerns," the rate of hospitalization decreased from 89% to 33% to 3%. A strong relationship was uncovered between worsened PDQ-39 at 12 months and increased hospitalization. Conclusions Unintended hospitalizations and worsened QOL scores correlated with the number and severity of concerns raised by interdisciplinary DBS evaluations. The data suggest that detailed screenings by interdisciplinary teams may be useful for more than just patient selection. These evaluations may help to stratify risk for post-operative hospitalization and QoL outcomes.	[Higuchi, Masa-aki; Martinez-Ramirez, Daniel; Morita, Hokuto; Topiol, Dan; Hastings, Erin; Okun, Michael S.] Univ Florida, Coll Med, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA; [Foote, Kelly D.; Okun, Michael S.] Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL USA; [Ward, Herbert] Univ Florida, Coll Med, Dept Psychiat, Gainesville, FL USA; [Bowers, Dawn] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Hicks, Julie A.; Hegland, Karen W.; Troche, Michelle S.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Speech Language & Hearing Sci, Gainesville, FL USA; [Warren, Lisa; DeFranco, Meredith; Kulkarni, Shankar] Univ Florida, Ctr Movement Disorders & Neurorestorat, Rehabil Serv, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Okun, MS (corresponding author), Univ Florida, Coll Med, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA.; Okun, MS (corresponding author), Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL USA.	okun@neurology.ufl.edu	Ramirez, Daniel Martinez/O-6719-2018	Ramirez, Daniel Martinez/0000-0001-8003-0610; Hastings Monari, Erin/0000-0002-4075-3360; Troche, Michelle/0000-0002-5746-5867; Foote, Kelly/0000-0002-2436-4138	National Parkinson Foundation Center of Excellence; UF INFORM database; UF Foundation [NIH NR014852]; Bachmann-Strauss Foundation	National Parkinson Foundation Center of Excellence; UF INFORM database; UF Foundation; Bachmann-Strauss Foundation	The authors' would like to acknowledge the support of the National Parkinson Foundation Center of Excellence, the UF INFORM database, the UF Foundation, NIH NR014852 (Okun) and the Bachmann-Strauss Foundation for supporting the Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminoff MJ, 2011, PARKINSONISM RELAT D, V17, P139, DOI 10.1016/j.parkreldis.2010.11.009; Antonini A, 2008, NEUROL SCI, V29, pS392, DOI 10.1007/s10072-008-1056-5; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Fenoy AJ, 2014, J NEUROSURG, V120, P132, DOI 10.3171/2013.10.JNS131225; Gerlach OHH, 2011, MOVEMENT DISORD, V26, P197, DOI 10.1002/mds.23449; Guttman M, 2004, MOVEMENT DISORD, V19, P49, DOI 10.1002/mds.10648; Hariz M, 2012, MOVEMENT DISORD, V27, P930, DOI 10.1002/mds.25007; Hariz MI, 2002, MOVEMENT DISORD, V17, pS162, DOI 10.1002/mds.10159; Hassan A, 2013, PARKINSONISM RELAT D, V19, P949, DOI 10.1016/j.parkreldis.2013.06.006; Higuchi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145623; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Lang AE, 2006, MOVEMENT DISORD, V21, pS171, DOI 10.1002/mds.20955; Lopiano L, 2001, NEUROL SCI, V22, P67, DOI 10.1007/s100720170050; Martinez-Ramirez D, 2016, J NEUROL, V263, P76, DOI 10.1007/s00415-015-7947-5; Martinez-Ramirez D, 2014, GERONTOLOGY, V60, P38, DOI 10.1159/000354880; PETO V, 1995, QUAL LIFE RES, V4, P241, DOI 10.1007/BF02260863; Resnick AS, 2010, J NEUROL, V257, P122, DOI 10.1007/s00415-009-5343-8; Shulman LM, 2001, MOVEMENT DISORD, V16, P507, DOI 10.1002/mds.1099; Temlett JA, 2006, INTERN MED J, V36, P524, DOI 10.1111/j.1445-5994.2006.01123.x; Woodford H, 2005, MOVEMENT DISORD, V20, P1104, DOI 10.1002/mds.20485	20	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0153785	10.1371/journal.pone.0153785	http://dx.doi.org/10.1371/journal.pone.0153785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159519	gold, Green Published			2022-12-27	WOS:000376576700006
J	Palopoli, N; Monzon, AM; Parisi, G; Fornasari, MS				Palopoli, Nicolas; Miguel Monzon, Alexander; Parisi, Gustavo; Silvina Fornasari, Maria			Addressing the Role of Conformational Diversity in Protein Structure Prediction	PLOS ONE			English	Article							QUALITY ASSESSMENT; INTRINSIC MOTIONS; BINDING; MODEL; COMPLEX; EVOLUTIONARY; RECOGNITION; ALLOSTERY; REVEALS; TARGETS	Computational modeling of tertiary structures has become of standard use to study proteins that lack experimental characterization. Unfortunately, 3D structure prediction methods and model quality assessment programs often overlook that an ensemble of conformers in equilibrium populates the native state of proteins. In this work we collected sets of publicly available protein models and the corresponding target structures experimentally solved and studied how they describe the conformational diversity of the protein. For each protein, we assessed the quality of the models against known conformers by several standard measures and identified those models ranked best. We found that model rankings are defined by both the selected target conformer and the similarity measure used. 70% of the proteins in our datasets show that different models are structurally closest to different conformers of the same protein target. We observed that model building protocols such as template-based or ab initio approaches describe in similar ways the conformational diversity of the protein, although for template-based methods this description may depend on the sequence similarity between target and template sequences. Taken together, our results support the idea that protein structure modeling could help to identify members of the native ensemble, highlight the importance of considering conformational diversity in protein 3D quality evaluations and endorse the study of the variability of the native structure for a meaningful biological analysis.	[Palopoli, Nicolas; Miguel Monzon, Alexander; Parisi, Gustavo; Silvina Fornasari, Maria] Univ Nacl Quilmes, Dept Ciencia & Tecnol, CONICET, Roque Saenz Pena 352,B1876BXD, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Parisi, G (corresponding author), Univ Nacl Quilmes, Dept Ciencia & Tecnol, CONICET, Roque Saenz Pena 352,B1876BXD, Buenos Aires, DF, Argentina.	gusparisi@gmail.com	Monzon, Alexander/K-8037-2019; Palopoli, Nicolas/AAH-1572-2019	Monzon, Alexander/0000-0003-0362-8218; Palopoli, Nicolas/0000-0001-7925-6436; parisi, gustavo/0000-0001-7444-1624	Argentine National Scientific and Technical Research Council (CONICET) [PIP 112201101-01002]; Universidad Nacional de Quilmes [1402/15]	Argentine National Scientific and Technical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Quilmes	This work was supported by grants from the Argentine National Scientific and Technical Research Council (CONICET), PIP 112201101-01002 and Universidad Nacional de Quilmes (1402/15). N.P., G.P. and M.S.F. are researchers of CONICET and A.M.M. is a PhD fellow of the same institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Argentine National Scientific and Technical Research Council (CONICET), PIP 112201101-01002 and Universidad Nacional de Quilmes (1402/15). N.P., G.P. and M.S.F. are researchers of CONICET and A.M.M. is a PhD fellow of the same institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brylinski M, 2008, PROTEINS, V70, P363, DOI 10.1002/prot.21510; Burra PV, 2009, P NATL ACAD SCI USA, V106, P10505, DOI 10.1073/pnas.0812152106; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Cozzetto D, 2009, PROTEINS, V77, P18, DOI 10.1002/prot.22561; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gora A, 2013, CHEM REV, V113, P5871, DOI 10.1021/cr300384w; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Gutteridge A, 2005, J MOL BIOL, V346, P21, DOI 10.1016/j.jmb.2004.11.013; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Janin J, 2013, PROTEINS, V81, P2075, DOI 10.1002/prot.24375; Zea DJ, 2013, MOL BIOL EVOL, V30, P1500, DOI 10.1093/molbev/mst065; Juritz E, 2013, MOL BIOL EVOL, V30, P79, DOI 10.1093/molbev/mss080; Juritz E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kihara D, 2009, CURR PROTEIN PEPT SC, V10, P216, DOI 10.2174/138920309788452173; Kinch LN, 2003, PROTEINS, V53, P340, DOI 10.1002/prot.10555; Konopka BM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-242; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Kryshtafovych A, 2014, PROTEINS, V82, P7, DOI 10.1002/prot.24399; Kumar S, 2000, PROTEIN SCI, V9, P10; Kuzu G, 2013, J PROTEOME RES, V12, P2641, DOI 10.1021/pr400006k; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Monzon AM, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw038; Monzon AM, 2013, BIOINFORMATICS, V29, P2512, DOI 10.1093/bioinformatics/btt405; Mills SJ, 2012, ACS CHEM BIOL, V7, P822, DOI 10.1021/cb200494d; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; Moy FJ, 2000, BIOCHEMISTRY-US, V39, P7063, DOI 10.1021/bi992760w; Nussinov R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-2; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Palopoli N, 2011, BEEP USING BEST EVOL; Parisi G, 2015, CURR OPIN STRUC BIOL, V32, P58, DOI 10.1016/j.sbi.2015.02.005; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Sethi A, 2013, MECHANISTIC UNDERSTA, V9, DOI [10.1371/journal.pcbi.1003046, DOI 10.1371/JOURNAL.PCBI.1003046]; Sonavane S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000188; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tosatto SCE, 2005, J COMPUT BIOL, V12, P1316, DOI 10.1089/cmb.2005.12.1316; Tress M, 2005, PROTEINS, V61, P8, DOI 10.1002/prot.20717; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yogurtcu ON, 2008, BIOPHYS J, V94, P3475, DOI 10.1529/biophysj.107.114835; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	55	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154923	10.1371/journal.pone.0154923	http://dx.doi.org/10.1371/journal.pone.0154923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159429	gold, Green Published, Green Submitted			2022-12-27	WOS:000376576700026
J	Dargazanli, C; Rigau, V; Eker, O; Bareiro, CR; Machi, P; Gascou, G; Arquizan, C; Ayrignac, X; Mourand, I; Corlobe, A; Lobotesis, K; Molinari, N; Costes, V; Bonafe, A; Costalat, V				Dargazanli, Cyril; Rigau, Valerie; Eker, Omer; Bareiro, Carlos Riquelme; Machi, Paolo; Gascou, Gregory; Arquizan, Caroline; Ayrignac, Xavier; Mourand, Isabelle; Corlobe, Astrid; Lobotesis, Kyriakos; Molinari, Nicolas; Costes, Valerie; Bonafe, Alain; Costalat, Vincent			High CD3+Cells in Intracranial Thrombi Represent a Biomarker of Atherothrombotic Stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ACTIVATED PLATELETS; TISSUE FACTOR; PLAQUE; INFLAMMATION; ATHEROSCLEROSIS; THROMBECTOMY; NEUTROPHILS; CELLS	Background and Purpose Approximately 30% of strokes are cryptogenic despite an exhaustive in-hospital work-up. Analysis of clot composition following endovascular treatment could provide insight into stroke etiology. T-cells already have been shown to be a major component of vulnerable atherosclerotic carotid lesions. We therefore hypothesize that T-cell content in intracranial thrombi may also be a biomarker of atherothrombotic origin. Materials and Methods We histopathologically investigated 54 consecutive thrombi retrieved after mechanical thrombectomy in acute stroke patients. First, thrombi were classified as fibrin-dominant, erythrocyte-dominant or mixed pattern. We then performed quantitative analysis of CD3+ cells on immunohistochemically-stained thrombi and compared T-cell content between "atherothrombotic", "cardioembolism" and "other causes" stroke subtypes. Results Fourteen (26%) thrombi were defined as fibrin-dominant, 15 (28%) as erythrocyte-dominant, 25 (46%) as mixed. The stroke cause was defined as "atherothrombotic" in 10 (18.5%), "cardioembolism" in 25 (46.3%), and "other causes" in 19 (35.2%). Number of T-cells was significantly higher in thrombi from the "atherothrombotic" group (53.60 +/- 28.78) than in the other causes (21.77 +/- 18.31; p < 0.0005) or the "cardioembolism" group (20.08 +/- 15.66; p < 0.0003). Conclusions The CD3+ T-cell count in intracranial thrombi was significantly higher in "atherothrombotic" origin strokes compared to all other causes. Thrombi with high content of CD3+ cells are more likely to originate from an atherosclerotic plaque.	[Dargazanli, Cyril; Eker, Omer; Bareiro, Carlos Riquelme; Machi, Paolo; Gascou, Gregory; Bonafe, Alain; Costalat, Vincent] Ctr Hosp Univ Montpellier, Gui de Chauliac Hosp, Dept Neuroradiol, F-34059 Montpellier, France; [Rigau, Valerie; Costes, Valerie] Ctr Hosp Univ Montpellier, Gui de Chauliac Hosp, Dept Pathol, F-34059 Montpellier, France; [Arquizan, Caroline; Ayrignac, Xavier; Mourand, Isabelle; Corlobe, Astrid] Ctr Hosp Univ Montpellier, Gui de Chauliac Hosp, Dept Neurol, F-34059 Montpellier, France; [Lobotesis, Kyriakos] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Imaging, London, England; [Molinari, Nicolas] Ctr Hosp Univ Montpellier, Sch Pharm, IMAG UMR 5149, F-34059 Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Montpellier; CHU de Montpellier	Dargazanli, C (corresponding author), Ctr Hosp Univ Montpellier, Gui de Chauliac Hosp, Dept Neuroradiol, F-34059 Montpellier, France.	c.dargazanli@gmail.com	molinari, nicolas/Y-9681-2019; EKER, Omer F/H-1930-2019	EKER, Omer F/0000-0002-5696-5368; ayrignac, xavier/0000-0003-3834-2981; Dargazanli, Cyril/0000-0003-1891-9157	Societe Francaise de Radiologie	Societe Francaise de Radiologie	The Societe Francaise de Radiologie have supported this work (CD).	Ahrens I, 2015, THROMB HAEMOSTASIS, V114, P994, DOI 10.1160/TH14-12-1073; Almekhlafi MA, 2008, ANN NEUROL, V64, P344, DOI 10.1002/ana.21404; Amarenco P, 2009, CEREBROVASC DIS, V27, P493, DOI 10.1159/000210432; [Anonymous], 2009, CEREBROVASCULAR DIS, V27; Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296; Bang OY, 2014, STROKE, V45, P1186, DOI 10.1161/STROKEAHA.113.003720; Boeckh-Behrens T, 2016, CLIN NEURORADIOL, V26, P189, DOI 10.1007/s00062-014-0347-x; Businaro R, 2013, J NEUROIMMUNE PHARM, V8, P15, DOI 10.1007/s11481-012-9421-9; Costalat V, 2011, STROKE, V42, P1929, DOI 10.1161/STROKEAHA.110.608976; Erdur H, 2015, STROKE, V46, P1031, DOI 10.1161/STROKEAHA.114.006886; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Jander S, 1998, STROKE, V29, P1625, DOI 10.1161/01.STR.29.8.1625; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P2320, DOI 10.1161/01.ATV.0000145573.36113.8a; Kim SK, 2015, AM J NEURORADIOL, V36, P1756, DOI 10.3174/ajnr.A4402; Kortelainen ML, 2014, CARDIOVASC PATHOL, V23, P193, DOI 10.1016/j.carpath.2014.03.001; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Marder VJ, 2006, STROKE, V37, P2086, DOI 10.1161/01.STR.0000230307.03438.94; Maugeri N, 2014, J THROMB HAEMOST, V12, P2074, DOI 10.1111/jth.12710; Maugeri N, 2015, SEMIN THROMB HEMOST, V41, P728, DOI 10.1055/s-0035-1564043; Niessen F, 2003, STROKE, V34, P2019, DOI 10.1161/01.STR.0000080941.73934.30; Niesten JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088882; Profumo E, 2013, J CARDIOVASC SURG, V54, P349; Russell JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073849; Sakai T, 2011, THROMB RES, V127, P443, DOI 10.1016/j.thromres.2011.02.001; Simons N, 2015, J NEURORADIOLOGY, V42, P86, DOI 10.1016/j.neurad.2014.01.124; Singh P, 2013, STROKE, V44, P1720, DOI 10.1161/STROKEAHA.113.000964; Spagnoli LG, 2004, JAMA-J AM MED ASSOC, V292, P1845, DOI 10.1001/jama.292.15.1845; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Tuttolomondo A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000813; Vendrell JF, 2013, AM J NEURORADIOL, V34, P603, DOI 10.3174/ajnr.A3230; Yuki I, 2012, AM J NEURORADIOL, V33, P643, DOI 10.3174/ajnr.A2842	31	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154945	10.1371/journal.pone.0154945	http://dx.doi.org/10.1371/journal.pone.0154945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152622	gold, Green Published, Green Submitted			2022-12-27	WOS:000375677000050
J	Guo, YC; Zhang, L; Dai, SX; Li, WX; Zheng, JJ; Li, GH; Huang, JF				Guo, Yi-Cheng; Zhang, Lin; Dai, Shao-Xing; Li, Wen-Xing; Zheng, Jun-Juan; Li, Gong-Hua; Huang, Jing-Fei			Independent Evolution of Winner Traits without Whole Genome Duplication in Dekkera Yeasts	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN; BRUXELLENSIS; SEQUENCE; IDENTIFICATION; NETWORK; GLUCOSE; GENES; WINE; TOOL	Dekkera yeasts have often been considered as alternative sources of ethanol production that could compete with S. cerevisiae. The two lineages of yeasts independently evolved traits that include high glucose and ethanol tolerance, aerobic fermentation, and a rapid ethanol fermentation rate. The Saccharomyces yeasts attained these traits mainly through whole genome duplication approximately 100 million years ago (Mya). However, the Dekkera yeasts, which were separated from S. cerevisiae approximately 200 Mya, did not undergo whole genome duplication (WGD) but still occupy a niche similar to S. cerevisiae. Upon analysis of two Dekkera yeasts and five closely related non-WGD yeasts, we found that a massive loss of cis-regulatory elements occurred in an ancestor of the Dekkera yeasts, which led to improved mitochondrial functions similar to the S. cerevisiae yeasts. The evolutionary analysis indicated that genes involved in the transcription and translation process exhibited faster evolution in the Dekkera yeasts. We detected 90 positively selected genes, suggesting that the Dekkera yeasts evolved an efficient translation system to facilitate adaptive evolution. Moreover, we identified that 12 vacuolar H+-ATPase (V-ATPase) function genes that were under positive selection, which assists in developing tolerance to high alcohol and high sugar stress. We also revealed that the enzyme PGK1 is responsible for the increased rate of glycolysis in the Dekkera yeasts. These results provide important insights to understand the independent adaptive evolution of the Dekkera yeasts and provide tools for genetic modification promoting industrial usage.	[Guo, Yi-Cheng] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Guo, Yi-Cheng; Zhang, Lin; Dai, Shao-Xing; Li, Wen-Xing; Zheng, Jun-Juan; Li, Gong-Hua; Huang, Jing-Fei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Zhang, Lin] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Li, Wen-Xing] Anhui Univ, Inst Hlth Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Tohoku University; Anhui University	Li, GH; Huang, JF (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	ligonghua@mail.kiz.ac.cn; huangjf@mail.kiz.ac.cn	Dai, shaoxing/ABA-8699-2020	Li, Wen-Xing/0000-0001-9984-8439; Dai, Shao-Xing/0000-0002-6919-2034; Guo, Yicheng/0000-0001-5357-660X; Li, Gong-Hua/0000-0002-9311-6613	National Basic Research Program of China [2013CB835100]; National Natural Science Foundation of China [31123005, 31401142, 31401137]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Grant No. 2013CB835100), and the National Natural Science Foundation of China (Grant No. 31123005 to JFH, No. 31401142 to SXD and NO. 31401137 to GHL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Blank LM, 2005, FEMS YEAST RES, V5, P545, DOI 10.1016/j.femsyr.2004.09.008; Blomqvist J, 2011, LETT APPL MICROBIOL, V53, P73, DOI 10.1111/j.1472-765X.2011.03067.x; Blomqvist J, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov021; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Chiarelli LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032065; Curtin CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033840; Dashko S, 2014, FEMS YEAST RES, V14, P826, DOI 10.1111/1567-1364.12161; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; FLICK JS, 1991, MOL CELL BIOL, V11, P5101, DOI 10.1128/MCB.11.10.5101; Galafassi S, 2011, J IND MICROBIOL BIOT, V38, P1079, DOI 10.1007/s10295-010-0885-4; Hagman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068734; Hoff KJ, 2013, NUCLEIC ACIDS RES, V41, pW123, DOI 10.1093/nar/gkt418; Hulin M, 2014, INT J FOOD MICROBIOL, V187, P7, DOI 10.1016/j.ijfoodmicro.2014.06.028; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Kumar S, 1999, CELL BIOCHEM BIOPHYS, V31, P141, DOI 10.1007/BF02738169; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marsit S, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov067; Mei SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106496; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Piskur J, 2012, INT J FOOD MICROBIOL, V157, P202, DOI 10.1016/j.ijfoodmicro.2012.05.008; Prochazka E, 2010, FEMS YEAST RES, V10, P545, DOI 10.1111/j.1567-1364.2010.00644.x; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; Ringel AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003871; Rozpedowska E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1305; Schifferdecker AJ, 2014, YEAST, V31, P323, DOI 10.1002/yea.3023; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; Tiukova IA, 2014, BIOTECHNOL APPL BIOC, V61, P51, DOI 10.1002/bab.1145; Tiukova IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058455; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	42	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155140	10.1371/journal.pone.0155140	http://dx.doi.org/10.1371/journal.pone.0155140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152421	Green Published, gold			2022-12-27	WOS:000375677000074
J	Hindia, MN; Rahman, TA; Ojukwu, H; Hanafi, EB; Fattouh, A				Hindia, M. N.; Rahman, T. A.; Ojukwu, H.; Hanafi, E. B.; Fattouh, A.			Enabling Remote Health-Caring Utilizing IoT Concept over LTE-Femtocell Networks	PLOS ONE			English	Article							INTERNET; COOPERATION; THINGS; GAME	As the enterprise of the "Internet of Things" is rapidly gaining widespread acceptance, sensors are being deployed in an unrestrained manner around the world to make efficient use of this new technological evolution. A recent survey has shown that sensor deployments over the past decade have increased significantly and has predicted an upsurge in the future growth rate. In health-care services, for instance, sensors are used as a key technology to enable Internet of Things oriented health-care monitoring systems. In this paper, we have proposed a two-stage fundamental approach to facilitate the implementation of such a system. In the first stage, sensors promptly gather together the particle measurements of an android application. Then, in the second stage, the collected data are sent over a Femto-LTE network following a new scheduling technique. The proposed scheduling strategy is used to send the data according to the application's priority. The efficiency of the proposed technique is demonstrated by comparing it with that of well-known algorithms, namely, proportional fairness and exponential proportional fairness.	[Hindia, M. N.; Rahman, T. A.] Univ Teknol Malaysia, Wireless Commun Ctr, Skudai 81310, Malaysia; [Ojukwu, H.; Hanafi, E. B.] Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur, Malaysia; [Fattouh, A.] King Abdulaziz Univ, Fac Comp & Informat Technol, Dept Comp Sci, Jeddah 21413, Saudi Arabia	Universiti Teknologi Malaysia; Universiti Malaya; King Abdulaziz University	Hindia, MN (corresponding author), Univ Teknol Malaysia, Wireless Commun Ctr, Skudai 81310, Malaysia.	nourhindia@hotmail.com	HINDIA, MHD NOUR/AAE-3805-2020; Hanafi, Effariza/N-1534-2015; Ojukwu, Henry/AGJ-1580-2022; Fattouh, Anas M/H-6697-2012	Hanafi, Effariza/0000-0001-6384-0435; Fattouh, Anas M/0000-0001-5488-2799	University of Malaya Research Fund (BKP) scheme [BK012-2015]; Rakan Penyelidikan RACE [CR006-2015]; High Impact Research Grant entitled, "Highly Efficient Remote Monitoring Healthcare Wearable System" from the Ministry of Higher Education Malaysia	University of Malaya Research Fund (BKP) scheme; Rakan Penyelidikan RACE; High Impact Research Grant entitled, "Highly Efficient Remote Monitoring Healthcare Wearable System" from the Ministry of Higher Education Malaysia	The authors acknowledge the University of Malaya Research Fund (BKP) scheme (BK012-2015), Rakan Penyelidikan RACE CR006-2015 and High Impact Research Grant entitled, "Highly Efficient Remote Monitoring Healthcare Wearable System" from the Ministry of Higher Education Malaysia. The gratitude also goes to the Dr. Mourad Niazi (consultant in obesity surgery).	Aijaz A, 2015, IEEE INTERNET THINGS, V2, P103, DOI 10.1109/JIOT.2015.2390775; Akyildiz IF, 2015, IEEE COMMUN MAG, V53, P32, DOI 10.1109/MCOM.2015.7060516; Akyildiz IF, 2007, COMPUT NETW, V51, P921, DOI 10.1016/j.comnet.2006.10.002; Almashaqbeh G, 2014, IEEE GLOB COMM CONF, P2436, DOI 10.1109/GLOCOM.2014.7037173; Andrews JG, 2012, IEEE J SEL AREA COMM, V30, P497, DOI 10.1109/JSAC.2012.120401; Basukala R., 2009, IEEE 1 AS HIM C NOV, V1, P1, DOI DOI 10.1109/AHICI.2009.5340336; Calin D, 2010, IEEE COMMUN MAG, V48, P26, DOI 10.1109/MCOM.2010.5394026; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; Choi JG, 2007, IEEE T VEH TECHNOL, V56, P766, DOI 10.1109/TVT.2006.889570; Constantinescu L, 2012, IEEE T INF TECHNOL B, V16, P40, DOI 10.1109/TITB.2011.2174064; Demirkol I, 2006, IEEE COMMUN MAG, V44, P115, DOI 10.1109/MCOM.2006.1632658; Dishongh TJ, 2014, WIRELESS SENSOR NETW, V1; Docksteader L, 2010, IT PROF, V12, P18, DOI 10.1109/MITP.2010.3; Fantacci R, 2014, IEEE WIREL COMMUN, V21, P113, DOI 10.1109/MWC.2014.6882303; Hindia MN, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/604752; Hindia MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121901; Hu Y, 2010, IEEE POTENTIALS, V29, P19, DOI 10.1109/MPOT.2009.934698; Huang JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023829; Jain R., 1998, QUANTITATIVE MEASURE; Jara AJ, 2013, IEEE J SEL AREA COMM, V31, P47, DOI 10.1109/JSAC.2013.SUP.0513005; Kruger CP, 2014, IEEE INTL CONF IND I, P627, DOI 10.1109/INDIN.2014.6945586; Lee MJ, 2010, IEEE J SEL AREA COMM, V28, P973, DOI 10.1109/JSAC.2010.100902; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139190; Li L, 2014, IEEE T IND INFORM, V10, P1497, DOI 10.1109/TII.2014.2306782; Megalingam RK, 2012, ANNU IEEE IND CONF, P747; Palattella MR, 2013, IEEE COMMUN SURV TUT, V15, P1389, DOI 10.1109/SURV.2012.111412.00158; Perera C, 2014, IEEE ACCESS, V2, P1660, DOI 10.1109/ACCESS.2015.2389854; Pitsillides A., 2006, M HLTH EMERGING MOBI, P247; Rezaee AA, 2014, J NETW COMPUT APPL, V37, P216, DOI 10.1016/j.jnca.2013.02.014; Sanz J, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041005; Singh D, 2014, 2014 IEEE WORLD FORUM ON INTERNET OF THINGS (WF-IOT), P287, DOI 10.1109/WF-IoT.2014.6803174; Van Gorp P, 2014, IEEE J BIOMED HEALTH, V18, P36, DOI 10.1109/JBHI.2013.2257821; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Xia CY, 2013, PHYSICA A, V392, P1577, DOI 10.1016/j.physa.2012.11.043; Xia CY, 2014, APPL MATH COMPUT, V246, P389, DOI 10.1016/j.amc.2014.08.006; Zhu N, 2015, IEEE INTELL SYST, V30, P39, DOI 10.1109/MIS.2015.57	36	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155077	10.1371/journal.pone.0155077	http://dx.doi.org/10.1371/journal.pone.0155077			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152423	Green Published, gold, Green Submitted			2022-12-27	WOS:000375677000065
J	Hochmeister, S; Engel, O; Adzemovic, MZ; Pekar, T; Kendlbacher, P; Zeitelhofer, M; Haindl, M; Meisel, A; Fazekas, F; Seifert-Held, T				Hochmeister, Sonja; Engel, Odilo; Adzemovic, Milena Z.; Pekar, Thomas; Kendlbacher, Paul; Zeitelhofer, Manuel; Haindl, Michaela; Meisel, Andreas; Fazekas, Franz; Seifert-Held, Thomas			Lipocalin-2 as an Infection-Related Biomarker to Predict Clinical Outcome in Ischemic Stroke	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; CEREBRAL-ARTERY OCCLUSION; NEUTROPHIL-GELATINASE; BRAIN-INJURY; RAT-BRAIN; IRON; ACTIVATION; MORTALITY; SYSTEM; NGAL	Objectives From previous data in animal models of cerebral ischemia, lipocalin-2 (LCN2), a protein related to neutrophil function and cellular iron homeostasis, is supposed to have a value as a biomarker in ischemic stroke patients. Therefore, we examined LCN2 expression in the ischemic brain in an animal model and measured plasma levels of LCN2 in ischemic stroke patients. Methods In the mouse model of transient middle cerebral artery occlusion (tMCAO), LCN2 expression in the brain was analyzed by immunohistochemistry and correlated to cellular nonheme iron deposition up to 42 days after tMCAO. In human stroke patients, plasma levels of LCN2 were determined one week after ischemic stroke. In addition to established predictive parameters such as age, National Institutes of Health Stroke Scale and thrombolytic therapy, LCN2 was included into linear logistic regression modeling to predict clinical outcome at 90 days after stroke. Results Immunohistochemistry revealed expression of LCN2 in the mouse brain already at one day following tMCAO, and the amount of LCN2 subsequently increased with a maximum at 2 weeks after tMCAO. Accumulation of cellular nonheme iron was detectable one week post tMCAO and continued to increase. In ischemic stroke patients, higher plasma levels of LCN2 were associated with a worse clinical outcome at 90 days and with the occurrence of post-stroke infections. Conclusions LCN2 is expressed in the ischemic brain after temporary experimental ischemia and paralleled by the accumulation of cellular nonheme iron. Plasma levels of LCN2 measured in patients one week after ischemic stroke contribute to the prediction of clinical outcome at 90 days and reflect the systemic response to post-stroke infections.	[Hochmeister, Sonja; Pekar, Thomas; Kendlbacher, Paul; Haindl, Michaela; Fazekas, Franz; Seifert-Held, Thomas] Med Univ Graz, Dept Neurol, Graz, Austria; [Engel, Odilo; Meisel, Andreas] Charite, Dept Expt Neurol, D-13353 Berlin, Germany; [Adzemovic, Milena Z.] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Pekar, Thomas] Univ Appl Sci Wiener Neustadt, Wiener Neustadt, Austria; [Kendlbacher, Paul] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Zeitelhofer, Manuel] Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, Stockholm, Sweden	Medical University of Graz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Karolinska Institutet	Seifert-Held, T (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	thomas.seifert@medunigraz.at		Engel, Odilo/0000-0002-6160-3281; Meisel, Andreas/0000-0001-7233-5342; Zeitelhofer, Manuel/0000-0002-4324-2355; Pekar, Thomas/0000-0002-2331-0488				Ay H, 2007, STROKE, V38, P2979, DOI 10.1161/STROKEAHA.107.490896; Bagnato F, 2011, BRAIN, V134, P3599, DOI 10.1093/brain/awr278; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Bolignano D, 2010, EUR J CLIN INVEST, V40, P273, DOI 10.1111/j.1365-2362.2010.02258.x; Bustamante A, 2014, EXPERT REV NEUROTHER, V14, P1391, DOI 10.1586/14737175.2014.977867; Bustamante A, 2014, J NEUROIMMUNOL, V274, P215, DOI 10.1016/j.jneuroim.2014.07.015; Carbone F, 2015, EUR J CLIN INVEST, V45, P579, DOI 10.1111/eci.12446; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Chan CPY, 2012, CLIN BIOCHEM, V45, P1308, DOI 10.1016/j.clinbiochem.2012.06.014; Daniels LB, 2012, J AM COLL CARDIOL, V59, P1101, DOI 10.1016/j.jacc.2011.11.046; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dong M, 2013, BRAIN RES, V1505, P86, DOI 10.1016/j.brainres.2013.02.008; Elneihoum AM, 1996, STROKE, V27, P1734, DOI 10.1161/01.STR.27.10.1734; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Engel O, 2011, JOVE-J VIS EXP, DOI 10.3791/2423; Fang KM, 2013, BIOL TRACE ELEM RES, V152, P66, DOI 10.1007/s12011-012-9596-1; Fassett RG, 2011, NEPHROL DIAL TRANSPL; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Ferreira AC, 2015, PROG NEUROBIOL; Gerriets T, 2004, STROKE, V35, P566, DOI 10.1161/01.STR.0000113692.38574.57; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Ip JPK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-124; Janssen PM, 2010, CEREBROVASC DIS, V29, P137, DOI 10.1159/000262309; Jha MK, 2013, EXPERT REV PROTEOMIC, V10, P43, DOI [10.1586/EPR.12.70, 10.1586/epr.12.70]; Jickling GC, 2011, NEUROTHERAPEUTICS, V8, P349, DOI 10.1007/s13311-011-0050-4; Jin Myungwon, 2014, Exp Neurobiol, V23, P155, DOI 10.5607/en.2014.23.2.155; Jin M, 2014, J CEREBR BLOOD F MET, V34, P1306, DOI 10.1038/jcbfm.2014.83; Kim Ho, 2011, Immune Netw, V11, P342, DOI 10.4110/in.2011.11.6.342; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Lee S, 2012, J NEUROSCI RES, V90, P540, DOI 10.1002/jnr.22779; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MacManus JP, 2004, J CEREBR BLOOD F MET, V24, P657, DOI 10.1097/01.WCB.0000123141.67811.91; Marques F, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00033; Nam Y, 2014, J BIOL CHEM, V289, P16773, DOI 10.1074/jbc.M113.542282; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Schroll A, 2012, EUR J IMMUNOL, V42, P3346, DOI 10.1002/eji.201142351; Weng YC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0129-z; Wu L, 2015, J NEUROCHEM, V132, P622, DOI 10.1111/jnc.13023; Xing CH, 2014, STROKE, V45, P2085, DOI 10.1161/STROKEAHA.114.005733; XU SY, 1994, SCAND J CLIN LAB INV, V54, P365, DOI 10.3109/00365519409088436; Yahalom G, 2009, STROKE, V40, P1296, DOI 10.1161/STROKEAHA.108.520882	49	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154797	10.1371/journal.pone.0154797	http://dx.doi.org/10.1371/journal.pone.0154797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152948	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000036
J	Jonas, JB; Xu, L; Wang, YX; Bi, HS; Wu, JF; Jiang, WJ; Nangia, V; Sinha, A; Zhu, D; Tao, Y; Guo, Y; You, QS; Wu, LJ; Tao, LX; Guo, XH; Ohno-Matsui, K; Panda-Jonas, S				Jonas, Jost B.; Xu, Liang; Wang, Ya Xing; Bi, Hong Sheng; Wu, Jian Feng; Jiang, Wen Jun; Nangia, Vinay; Sinha, Ajit; Zhu, Dan; Tao, Yong; Guo, Yin; You, Qi Sheng; Wu, Li Juan; Tao, Li Xin; Guo, Xiu Hua; Ohno-Matsui, Kyoko; Panda-Jonas, Songhomitra			Education-Related Parameters in High Myopia: Adults versus School Children	PLOS ONE			English	Article							REFRACTIVE-ERROR; OUTDOOR ACTIVITY; CHINESE CHILDREN; TIME OUTDOORS; AXIAL LENGTH; PREVALENCE; SINGAPORE; EYE; SUSCEPTIBILITY; ASSOCIATIONS	Purpose Since high myopia in the younger generation may differ etiologically from high myopia in older generations, we examined whether education-related parameters differ between high myopia in today's school children and high pathological myopia in today's elderly generation. Methods The investigation included the adult populations of the population-based Beijing Eye Study (BES) (3468 adults; mean age: 64.6 +/- 9.8years; range: 50-93years) and Central India Eye and Medical Study (CIEMS) (4711 adults; age: 49.+/- 13.2years; range: 30-100years), and the children and teenager populations of the Shandong Children Eye Study (SCES) (6026 children; age: 9.7 +/- 3.3years; range: 4-18years; cycloplegic refractometry), Gobi Desert Children Eye Study (1565; age: 11.9 +/- 3.5years; range: 6-21 years; cycloplegic refractometry), Beijing Pediatric Eye Study (681 children; age: 7.7 +/- 1.6years; range: 5-13 years; non-cycloplegic refractometry, calculation of axial length to corneal curvature radius ratio), Beijing Children Eye Study (15066 children; age: 13.2 +/- 3.4years; range: 7-18years; non-cycloplegic refractometry), Beijing High School Teenager Eye Study (4677 children; age: 16.9 +/- 0.7years; range: 16-18years; non-cycloplegic refractometry). Results In the BES and CIEMS, educational level did not differ significantly between, or was significantly lower in the highly myopic group (myopic refractive error >= 6 diopters) than in the non-highly myopic group. In all non-adult study populations, higher prevalence of high myopia was significantly associated with higher degree of education related parameters such as attendance of high-level schools, and more time spent for indoors near work versus time spent outdoors. Conclusions Comparing associations of old or genetic high myopia in adults with new or acquired high myopia in school children revealed that education-related parameters did not show a clear association with old or genetic high myopia, while in contrast, new high myopia showed strong associations with education. It confirms previous studies that the two forms of high myopia not only differed in age of onset, but also in associations with education as well. The data support the notion of two types of high myopia. Future studies may assess whether the risk of pathologic myopic maculopathy and high myopia associated open-angle glaucoma differs between both types of high myopia.	[Jonas, Jost B.; Xu, Liang; Wang, Ya Xing; Guo, Yin; You, Qi Sheng] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol,Beijing Ophthalmol & Visu, Beijing, Peoples R China; [Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany; [Bi, Hong Sheng; Wu, Jian Feng; Jiang, Wen Jun] Shandong Univ Tradit Chinese Med, Jinan, Shandong, Peoples R China; [Bi, Hong Sheng; Wu, Jian Feng; Jiang, Wen Jun] Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China; [Nangia, Vinay; Sinha, Ajit] Suraj Eye Inst, Nagpur, Maharashtra, India; [Zhu, Dan] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China; [Tao, Yong] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Tao, Yong] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Guo, Yin] Capital Med Univ, Tongren Eye Care Ctr, Beijing Tongren Hosp, Beijing, Peoples R China; [Wu, Li Juan; Tao, Li Xin] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Wu, Li Juan; Tao, Li Xin; Guo, Xiu Hua] Capital Med Univ, Beijing Key Lab Epidemiol, Beijing, Peoples R China; [Ohno-Matsui, Kyoko] Beijing Key Lab Epidemiol, Capital Med Univ, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Suraj Eye Institute; Inner Mongolia Medical University; Peking University; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Jonas, JB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol,Beijing Ophthalmol & Visu, Beijing, Peoples R China.; Jonas, JB (corresponding author), Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany.	Jost.Jonas@medma.uni-heidleberg.de	wang, YA XING/K-9671-2016; You, Qisheng/AAG-7153-2020; TAO, Li/HIR-4254-2022; Guo, Yin/ABC-2134-2020	wang, YA XING/0000-0003-2749-7793; You, Qisheng/0000-0003-0743-7320; Guo, Yin/0000-0003-3806-3771; Jonas, Jost/0000-0003-2972-5227; Zhu, Dan/0000-0002-8402-8929	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]; Shandong Science & Technology Department [2011GGB14097, 2011GGH21835, 2012YD18081]; Shandong Health Department [2011HD014]; Jinan Science & Technology Bureau [201102061]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg; Grants-in-Aid for Scientific Research [15H04993] Funding Source: KAKEN	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government; Shandong Science & Technology Department; Shandong Health Department; Jinan Science & Technology Bureau; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing government (7092021; 7112031); and by the Shandong Science & Technology Department (2011GGB14097, 2011GGH21835, 2012YD18081), Shandong Health Department (2011HD014), Jinan Science & Technology Bureau (201102061). We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; GROSVENOR T, 1994, OPTOMETRY VISION SCI, V71, P573, DOI 10.1097/00006324-199409000-00005; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Guo K, 2015, INVEST OPHTH VIS SCI, V56, P1769, DOI 10.1167/iovs.14-15737; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2015, JAMA-J AM MED ASSOC, V314, P1142, DOI 10.1001/jama.2015.10803; Iribarren R, 2012, INVEST OPHTH VIS SCI, V53, P5124, DOI 10.1167/iovs.12-9637; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Li SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134514; Li SM, 2015, INVEST OPHTH VIS SCI, V56, P4734, DOI 10.1167/iovs.14-15474; Liang CL, 2004, INVEST OPHTH VIS SCI, V45, P3446, DOI 10.1167/iovs.03-1058; Lin LL, 2004, ANN ACAD MED SINGAP, V33, P27; Lu B, 2009, ARCH OPHTHALMOL-CHIC, V127, P769, DOI 10.1001/archophthalmol.2009.105; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2015, ACTA OPHTHALMOL, V93, P581, DOI 10.1111/aos.12642; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Ojaimi E, 2005, OPHTHAL EPIDEMIOL, V12, P59, DOI 10.1080/09286580490921296; Pan CW, 2015, OPTOMETRY VISION SCI, V92, P258, DOI 10.1097/OPX.0000000000000516; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Wojciechowski R, 2011, CLIN GENET, V79, P301, DOI 10.1111/j.1399-0004.2010.01592.x; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Wu LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120764; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Xiang F, 2012, OPTOMETRY VISION SCI, V89, P884, DOI 10.1097/OPX.0b013e318255dc33; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; You QS, 2014, ACTA OPHTHALMOL, V92, pE398, DOI 10.1111/aos.12299	33	29	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154554	10.1371/journal.pone.0154554	http://dx.doi.org/10.1371/journal.pone.0154554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152764	Green Submitted, Green Published, gold			2022-12-27	WOS:000375677000024
J	Guthrie, DM; Declercq, A; Finne-Soveri, H; Fries, BE; Hirdes, JP				Guthrie, Dawn M.; Declercq, Anja; Finne-Soveri, Harriet; Fries, Brant E.; Hirdes, John P.			The Health and Well-Being of Older Adults with Dual Sensory Impairment (DSI) in Four Countries	PLOS ONE			English	Article							MINIMUM DATA SET; HEARING IMPAIRMENT; VISION; PREVALENCE; DEPRESSION; PEOPLE; SCALE; POPULATION; ASSOCIATION; MORTALITY	Objectives Dual sensory impairment (DSI) is a combination of vision and hearing impairments that represents a unique disability affecting all aspects of a person's life. The rates of DSI are expected to increase due to population aging, yet little is known about DSI among older adults (65+). The prevalence of DSI and client characteristics were examined among two groups, namely, older adults receiving home care services or those residing in a long-term care (LTC) facility in four countries (Canada, US, Finland, Belgium). Methods Existing data, using an interRAI assessment, were analyzed to compare older adults with DSI to all others across demographic characteristics, functional and psychosocial outcomes. Results In home care, the prevalence of DSI across the four countries ranged from 13.4% to 24.6%; in LTC facilities, it ranged from 9.7% to 33.9%. Clients with DSI were more likely to be 85+, have moderate/severe cognitive impairment, impairments in activities of daily living, and have communication difficulties. Among residents of LTC facilities, individuals with DSI were more likely to be 85+ and more likely have a diagnosis of Alzheimer's disease. Having DSI increased the likelihood of depression in both care settings, but after adjusting for other factors, it remained significant only in the home care sample. Conclusions While the prevalence of DSI cross nationally is similar to that of other illnesses such as diabetes, depression, and Alzheimer's disease, we have a limited understanding of its affects among older adults. Raising awareness of this unique disability is imperative to insure that individuals receive the necessary rehabilitation and supportive services to improve their level of independence and quality of life.	[Guthrie, Dawn M.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON N2L 3C5, Canada; [Guthrie, Dawn M.] Wilfrid Laurier Univ, Dept Hlth Sci, Waterloo, ON N2L 3C5, Canada; [Declercq, Anja] Katholieke Univ Leuven Dutch, Brussels, Belgium; [Finne-Soveri, Harriet] Natl Inst Hlth & Welf, Ageing & Serv Unit, Helsinki, Finland; [Fries, Brant E.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Fries, Brant E.] Vet Affairs Ann Arbor Healthcare Syst, Hlth Syst Res, Ann Arbor, MI USA; [Fries, Brant E.] Vet Affairs Ann Arbor Healthcare Syst, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI USA; [Hirdes, John P.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada	Wilfrid Laurier University; Wilfrid Laurier University; KU Leuven; Finland National Institute for Health & Welfare; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Waterloo	Guthrie, DM (corresponding author), Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON N2L 3C5, Canada.; Guthrie, DM (corresponding author), Wilfrid Laurier Univ, Dept Hlth Sci, Waterloo, ON N2L 3C5, Canada.	dguthrie@wlu.ca	Guthrie, Dawn/AAO-6453-2021; Declercq, Anja/AGS-7441-2022; Declercq, Anja G./G-8014-2011	Guthrie, Dawn/0000-0003-3241-6580; Declercq, Anja/0000-0003-3136-124X; Declercq, Anja G./0000-0003-3136-124X				Association CMH, 2014, FAST FACTS MENT ILLN; Bodsworth SM, 2011, BRIT J VISUAL IMPA, V29, P6, DOI 10.1177/0264619610387495; Brennan M, 2005, GERONTOLOGIST, V45, P337, DOI 10.1093/geront/45.3.337; Burrows AB, 2000, AGE AGEING, V29, P165, DOI 10.1093/ageing/29.2.165; Caban AJ, 2005, AM J PUBLIC HEALTH, V95, P1940, DOI 10.2105/AJPH.2004.056671; Campbell V A, 1999, MMWR CDC Surveill Summ, V48, P131; Canada S., 2013, CHRON OBSTR PULM DIS; Capella-McDonnall NE, 2005, INT J GERIATR PSYCH, V20, P855, DOI 10.1002/gps.1368; Carpenter I., 2013, GOOD LIFE OLD AGE, V17, P93; Chou KL, 2008, J AFFECT DISORDERS, V106, P191, DOI 10.1016/j.jad.2007.05.028; Chow CM, 2005, CAN J CARDIOL, V21, P1265; Dalby DM, 2009, J VISUAL IMPAIR BLIN, V103, P93, DOI 10.1177/0145482X0910300208; Dalby DM, 2009, J VISUAL IMPAIR BLIN, V103, P7, DOI 10.1177/0145482X0910300103; Dammeyer J, 2010, INT J AUDIOL, V49, P76, DOI 10.3109/14992020903311388; Fisher D, 2014, AGE AGEING, V43, P69, DOI 10.1093/ageing/aft122; Fisher KA, 2014, SOCIAL INDICATORS RE, V118, P1; Fletcher PC, 2013, INT J DISABILITY COM, V12; Fries BE, 2001, GERONTOLOGIST, V41, P173, DOI 10.1093/geront/41.2.173; Gopinath B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055054; Heine C, 2004, AGEING SOC, V24, P113, DOI 10.1017/S0144686X03001491; Hirdes J, 2007, INTERRAI DEAFBLIND S; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Hirdes JP, 2003, J AM GERIATR SOC, V51, P96, DOI 10.1034/j.1601-5215.2002.51017.x; Information CIfH, 2010, CAR SEN ALZH DIS OTH; Kiely KM, 2012, FRONT HUM NEUROSCI, V7, P1; Kramer SE, 2002, J AGING HEALTH, V14, P122, DOI 10.1177/089826430201400107; Landi F, 2000, MED CARE, V38, P1184, DOI 10.1097/00005650-200012000-00005; LeJeune BJ, 2003, GENERATIONS, V27, P95; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lin MY, 2004, J AM GERIATR SOC, V52, P1996, DOI 10.1111/j.1532-5415.2004.52554.x; Lupsakko T, 2002, INT J GERIATR PSYCH, V17, P808, DOI 10.1002/gps.689; Martin L, 2008, AGE AGEING, V37, P51, DOI 10.1093/ageing/afm162; McDonnall MC, 2009, AGING MENT HEALTH, V13, P569, DOI 10.1080/13607860902774410; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Morris JN, 2016, J GERIATR PSYCH NEUR, V29, P47, DOI 10.1177/0891988715598231; Munroe S., 2001, DEV NATL VOLUNTEER R; Paquay L, 2007, INT J GERIATR PSYCH, V22, P286, DOI 10.1002/gps.1671; Public Health Agency of Canada, 2011, DIAB CAN FACTS FIG P; Puts MTE, 2008, AGE AGEING, V37, P187, DOI 10.1093/ageing/afm185; Saunders Gabrielle H, 2007, Trends Amplif, V11, P243, DOI 10.1177/1084713807308365; Schneider JM, 2011, J AGING HEALTH, V23, P1309, DOI 10.1177/0898264311408418; Smith SL, 2008, J REHABIL RES DEV, V45, P597, DOI 10.1682/JRRD.2007.02.0023; Spandau UHM, 2002, GRAEF ARCH CLIN EXP, V240, P495, DOI 10.1007/s00417-002-0485-8; Viljanen A, 2013, EUR J AGEING, P1; Watson GR, 2001, J AM GERIATR SOC, V49, P317, DOI 10.1046/j.1532-5415.2001.4930317.x; Watters C, 2005, STUDY DEAF BLIND DEM; Yamada Y, 2016, J GERONTOL A-BIOL, V71, P117, DOI 10.1093/gerona/glv036; Yamazaki Y., 2014, J GEOPHYS RES SPACE, P1, DOI [10.1002/2014JA020243.Received, DOI 10.1002/2014JA020243.RECEIVED]	49	50	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155073	10.1371/journal.pone.0155073	http://dx.doi.org/10.1371/journal.pone.0155073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27148963	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800114
J	Qi, L; Tang, LJ; Xu, Y; Zhu, XM; Zhang, YD; Shi, HB; Yu, RB				Qi, Liang; Tang, Li-Jun; Xu, Yi; Zhu, Xiao-Mei; Zhang, Yu-Dong; Shi, Hai-Bin; Yu, Rong-Bin			The Diagnostic Performance of Coronary CT Angiography for the Assessment of Coronary Stenosis in Calcified Plaque	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CALCIUM SCORE; ARTERY STENOSIS; HEART-RATE; ACCURACY; CALCIFICATION; VISUALIZATION; IMPACT	Purpose To prospectively evaluate the diagnostic performance of coronary CT angiography (CCTA) for the assessment of coronary stenosis in a calcified plaque, by using conventional coronary angiography (CAG) as a standard reference. Materials and Methods Eight hundred and ninety-four patients were known to have or have been suspicious of having coronary artery disease, underwent CCTA and conventional coronary angiography (CAG). All the images acquired were assessed. The calcified plaque in CCTA was classified into four types (I-IV) according to the ratio of calcified plaque volume to vessel circumference (RVTC). Overall diagnostic accuracy was made under receiver operating characteristic curve (AUC) analysis. CAG was used as the standard reference. Results A total of 12845 segments were evaluated in 894 patients, among which 4955 calcified plaques were detected on 3645(28.4%) segments by CCTA. The overall AUC, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 0.939, 97.8%, 90.1%, 71.2% and 99.4%, respectively. In type I-II calcification, CCTA had high diagnostic performance in AUC (type I: 0.983; type II: 0.976), sensitivity (96.7%; 98.1%), specificity (99.8%; 97.0%), PPV (95.7%; 90.1%), NPV (99.8%; 99.5%) and accuracy (99.6%; 97.3%). In type III-IV calcification, CCTA has high performance in sensitivity (type III: 97.6%; type IV: 97.9%) and NPV (98.3%; 98.7%), moderate performance in AUC (0.877; 0.829), while remarkable decrease in specificity (78.7%; 67.9%), PPV (71.0%; 56.2%) and accuracy (84.9%; 76.8%). Conclusion CCTA has highest accuracy in diagnosing the coronary artery stenosis of type I-II calcified plaques, but has a significant decrease in specificity, PPV and accuracy in type III-IV calcified plaque.	[Qi, Liang; Tang, Li-Jun; Xu, Yi; Zhu, Xiao-Mei; Zhang, Yu-Dong; Shi, Hai-Bin] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Guangzhoulu 300, Nanjing, Jiangsu, Peoples R China; [Yu, Rong-Bin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hanzhonglu 140, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Shi, HB (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Guangzhoulu 300, Nanjing, Jiangsu, Peoples R China.; Yu, RB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hanzhonglu 140, Nanjing, Jiangsu, Peoples R China.	haibinshi1120@126.com; wangrenfa52@126.com						Achenbach S, 2006, EUR J RADIOL, V57, P331, DOI 10.1016/j.ejrad.2005.12.017; Almoudi M, 2012, WORLD J CARDIOL, V4, P284, DOI 10.4330/wjc.v4.i10.284; Austen W. G., 1975, AM HEART ASS CIRC, V51, P5, DOI DOI 10.1161/01.CIR.51.4.5; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Burgstahler Christof, 2007, J Cardiovasc Comput Tomogr, V1, P143, DOI 10.1016/j.jcct.2007.09.003; Cademartiri F, 2005, RADIOL MED, V109, P91; Cerci R, 2013, INT J CARDIOVAS IMAG, V29, P1619, DOI 10.1007/s10554-013-0240-8; Chen CC, 2011, INT J CARDIOVAS IMAG, V27, P37, DOI 10.1007/s10554-011-9955-6; GUSSENHOVEN EJ, 1989, J AM COLL CARDIOL, V14, P947, DOI 10.1016/0735-1097(89)90471-3; Jensen CJ, 2011, ROFO-FORTSCHR RONTG, V183, P233, DOI 10.1055/s-0029-1245813; Kruk M, 2014, JACC-CARDIOVASC IMAG, V7, P49, DOI 10.1016/j.jcmg.2013.07.013; Lei ZQ, 2013, PAK J MED SCI, V29, P107, DOI 10.12669/pjms.291.2645; Leschka S, 2005, EUR HEART J, V26, P1482, DOI 10.1093/eurheartj/ehi261; Lin CJ, 2010, CLIN RADIOL, V65, P109, DOI 10.1016/j.crad.2009.09.012; Meng LD, 2009, KOREAN J RADIOL, V10, P347, DOI 10.3348/kjr.2009.10.4.347; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Morsbach F, 2013, INT J CARDIOVAS IMAG, V29, P1129, DOI 10.1007/s10554-012-0173-7; Ong TK, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.12.027; Palumbo AA, 2009, EUR RADIOL, V19, P2127, DOI 10.1007/s00330-009-1398-2; Park MJ, 2011, INT J CARDIOVAS IMAG, V27, P43, DOI 10.1007/s10554-011-9970-7; Penzkofer T, 2014, BMC MED IMAGING, V14, DOI 10.1186/1471-2342-14-30; Pundziute G, 2007, J NUCL CARDIOL, V14, P36, DOI 10.1016/j.nuclcard.2006.11.002; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Schmermund A, 1999, J AM COLL CARDIOL, V33, P444, DOI 10.1016/S0735-1097(98)00565-8; Tsiflikas I, 2010, EUR J RADIOL, V74, P161, DOI 10.1016/j.ejrad.2009.01.039; Vavere AL, 2011, RADIOLOGY, V261, P100, DOI 10.1148/radiol.11110537; Xu L, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000805; Xu Y, 2010, INT J CARDIOVAS IMAG, V26, P75, DOI 10.1007/s10554-009-9568-5	28	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154852	10.1371/journal.pone.0154852	http://dx.doi.org/10.1371/journal.pone.0154852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149622	Green Published, gold			2022-12-27	WOS:000375676800070
J	Sha, JF; Gastman, BR; Morris, N; Mesinkovska, NA; Baron, ED; Cooper, KD; McCormick, T; Arbesman, J; Harter, ML				Sha, Jingfeng; Gastman, Brian R.; Morris, Nathan; Mesinkovska, Natasha A.; Baron, Elma D.; Cooper, Kevin D.; McCormick, Thomas; Arbesman, Joshua; Harter, Marian L.			The Response of microRNAs to Solar UVR in Skin-Resident Melanocytes Differs between Melanoma Patients and Healthy Persons	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ULTRAVIOLET-RADIATION; HIGH-THROUGHPUT; STEM-CELLS; EXPRESSION; PROGRESSION; ROLES; PATHOGENESIS; METASTASIS; PROGNOSIS	The conversion of melanocytes into cutaneous melanoma is largely dictated by the effects of solar ultraviolet radiation (UVR). Yet to be described, however, is exactly how these cells are affected by intense solar UVR while residing in their natural microenvironment, and whether their response differs in persons with a history of melanoma when compared to that of healthy individuals. By using laser capture microdissection (LCM) to isolate a pure population of melanocytes from a small area of skin that had been intermittingly exposed or unexposed to physiological doses of solar UVR, we can now report for the first time that the majority of UV-responsive microRNAs (miRNAs) in the melanocytes of a group of women with a history of melanoma are down-regulated when compared to those in the melanocytes of healthy controls. Among the miRNAs that were commonly and significantly down-regulated in each of these women were miR-193b (P<0.003), miR-342-3p (P<0.003), miR186 (P<0.007), miR-130a (P<0.007), and miR-146a (P<0.007). To identify genes potentially released from inhibition by these repressed UV-miRNAs, we analyzed databases (e.g., DIANA-TarBase) containing experimentally validated microRNA-gene interactions. In the end, this enabled us to construct UV-miRNA-gene regulatory networks consisting of individual genes with a probable gain-of-function being intersected not by one, but by several down-regulated UV-miRNAs. Most striking, however, was that these networks typified well-known regulatory modules involved in controlling the epithelial-to-mesenchymal transition and processes associated with the regulation of immune-evasion. We speculate that these pathways become activated by UVR resulting in miRNA down regulation only in melanocytes susceptible to melanoma, and that these changes could be partially responsible for empowering these cells toward tumor progression.	[Sha, Jingfeng; Harter, Marian L.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Gastman, Brian R.] Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA; [Morris, Nathan] Case Western Reserve Univ, Stat Sci Core Ctr Clin Invest, Cleveland, OH 44106 USA; [Mesinkovska, Natasha A.] Cleveland Clin, Dept Dermatol, Cleveland, OH 44195 USA; [Baron, Elma D.; Cooper, Kevin D.; McCormick, Thomas; Arbesman, Joshua] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Dermatol, Cleveland, OH 44106 USA; [Harter, Marian L.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University	Harter, ML (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.; Harter, ML (corresponding author), Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	mnh5@case.edu		McCormick, Thomas/0000-0002-3294-0326; Cooper, Kevin/0000-0002-1986-3602	National Institute of Environmental Health Sciences of the National Institutes of Health [R21ES021835, P30AR039750]; NATIONAL CANCER INSTITUTE [K12CA076917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR039750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021835] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant number R21ES021835, National Institute of Environmental Health Sciences of the National Institutes of Health to MLH, and Grant number P30AR039750, National Institute of Environmental Health Sciences of the National Institutes of Health to KDC.	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Besch R, 2014, EUR J CELL BIOL, V93, P55, DOI 10.1016/j.ejcb.2013.10.001; Bhawan J, 2005, AM J DERMATOPATH, V27, P476, DOI 10.1097/01.dad.0000179627.81172.37; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Chen YT, 1996, P NATL ACAD SCI USA, V93, P5915, DOI 10.1073/pnas.93.12.5915; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; ELICEIRI GL, 1983, MOL CELL BIOL, V3, P2151, DOI 10.1128/MCB.3.12.2151; Ferguson J., 1996, International Journal of Cosmetic Science, V18, P203, DOI 10.1111/j.1467-2494.1996.tb00151.x; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Gallagher RI, 2012, METHODS MOL BIOL, V823, P157, DOI 10.1007/978-1-60327-216-2_11; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Garofalo M, 2015, ADV DRUG DELIVER REV, V81, P53, DOI 10.1016/j.addr.2014.11.014; Ghahhari NM, 2015, EUR J CANCER, V51, P1638, DOI 10.1016/j.ejca.2015.04.021; Hartman ML, 2013, CANCER LETT, V331, P24, DOI 10.1016/j.canlet.2013.01.010; Kozubek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072699; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Leibowitz-Amit R, 2012, PIGM CELL MELANOMA R, V25, P740, DOI 10.1111/pcmr.12018; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Luo CL, 2014, EUR J CELL BIOL, V93, P11, DOI 10.1016/j.ejcb.2014.02.001; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Park KS, 2012, MOL CELLS, V34, P555, DOI 10.1007/s10059-012-0251-7; Peres J, 2014, ONCOTARGET; Peres J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-117; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Raskin L, 2013, J INVEST DERMATOL, V133, P2585, DOI 10.1038/jid.2013.197; Rastrelli M, 2014, IN VIVO, V28, P1005; Roesch A, 2015, J DTSCH DERMATOL GES, V13, P118, DOI [10.1111/ddg.12584, 10.1111/ddg.12584_suppl]; Sand M, 2013, CELL TISSUE RES, V351, P85, DOI 10.1007/s00441-012-1514-5; Schatton T, 2014, METHODS MOL BIOL, V1102, P287, DOI 10.1007/978-1-62703-727-3_16; Segura MF, 2012, CARCINOGENESIS, V33, P1823, DOI 10.1093/carcin/bgs205; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun HY, 2011, EXP BIOL MED, V236, P352, DOI 10.1258/ebm.2010.010106; Syed DN, 2013, CURR DRUG TARGETS, V14, P1128, DOI 10.2174/13894501113149990184; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vandamme N, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00352; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wehbe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049419; Weinberg R, 2010, NAT MED, V16, P758, DOI 10.1038/nm0710-758; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	49	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154915	10.1371/journal.pone.0154915	http://dx.doi.org/10.1371/journal.pone.0154915			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149382	Green Published, gold			2022-12-27	WOS:000375676800088
J	Streiff, C; Zhu, MH; Shimada, E; Sahn, DJ; Ashraf, M				Streiff, Cole; Zhu, Meihua; Shimada, Eriko; Sahn, David J.; Ashraf, Muhammad			Mitigation of Variability among 3D Echocardiography-Derived Regional Strain Values Acquired by Multiple Ultrasound Systems by Vendor Independent Analysis	PLOS ONE			English	Article							SPECKLE-TRACKING ECHOCARDIOGRAPHY; LEFT-VENTRICULAR FUNCTION; IDIOPATHIC DILATED CARDIOMYOPATHY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC-RESONANCE; MYOCARDIAL DEFORMATION; RESTRICTIVE CARDIOMYOPATHY; QUANTITATIVE-EVALUATION; INFARCTION; REPRODUCIBILITY	Introduction This study compared the variability of 3D echo derived circumferential and longitudinal strain values computed from vendor-specific and vendor-independent analyses of images acquired using ultrasound systems from different vendors. Methods Ten freshly harvested porcine hearts were studied. Each heart was mounted on a custom designed phantom and driven to simulate normal cardiac motion. Cardiac rotation was digitally controlled and held constant at 5 degrees, while pumped stroke volume (SV) ranged from 30-70ml. Full-volume image data was acquired using three different ultrasound systems from different vendors. The image data was analyzed for longitudinal and circumferential strains (LS, CS) using both vendor-specific and vendor-independent analysis packages. Results Good linear relationships were observed for each vendor-specific analysis package for both CS and LS at the mid-anterior segment, with correlation coefficients ranging from 0.82-0.91 (CS) and 0.86-0.89 (LS). Comparable linear regressions were observed for results determined by a vendor independent program (CS: R = 0.82-0.89; LS: R = 0.86-0.89). Variability between analysis packages was examined via a series of ANOVA tests. A statistical difference was found between vendor-specific analysis packages (p<0.001), while no such difference was observed between ultrasound systems when using the vendor-independent program (p>0.05). Conclusions Circumferential and longitudinal regional strain values differ when quantified by vendor-specific analysis packages; however, this variability is mitigated by use of a vendor-independent quantification method. These results suggest that echocardiograms acquired using different ultrasound systems could be meaningfully compared using vendor-independent software.	[Streiff, Cole; Zhu, Meihua; Shimada, Eriko; Sahn, David J.; Ashraf, Muhammad] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Ashraf, M (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	ashrafm@ohsu.edu	Zhu, Meihua/AAO-2377-2020	Zhu, Meihua/0000-0003-3106-806X				Badano LP, 2013, EUR HEART J-CARD IMG, V14, P285, DOI 10.1093/ehjci/jes184; Bhan A, 2014, AM J PHYSIOL-HEART C, V306, pH1371, DOI 10.1152/ajpheart.00553.2013; Bilchick KC, 2014, J AM COLL CARDIOL, V63, P1657, DOI 10.1016/j.jacc.2014.02.533; Biswas M, 2013, ECHOCARDIOGR-J CARD, V30, P88, DOI 10.1111/echo.12079; Cheng HB, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-15; Everitt MD, 2014, J AM COLL CARDIOL, V63, P1405, DOI 10.1016/j.jacc.2013.11.059; Fox PR, 2014, CARDIOVASC PATHOL, V23, P28, DOI 10.1016/j.carpath.2013.08.001; Gao H, 2014, PHYS MED BIOL, V59, P3637, DOI 10.1088/0031-9155/59/13/3637; Gayat E, 2011, J AM SOC ECHOCARDIOG, V24, P878, DOI 10.1016/j.echo.2011.04.016; Ismail TF, 2014, HEART, V100, P1851, DOI 10.1136/heartjnl-2013-305471; Kaku K, 2014, J AM SOC ECHOCARDIOG, V27, P55, DOI 10.1016/j.echo.2013.10.002; Kapetanakis S, 2011, JACC-CARDIOVASC IMAG, V4, P16, DOI 10.1016/j.jcmg.2010.09.021; Koopman LP, 2011, J AM SOC ECHOCARDIOG, V24, P37, DOI 10.1016/j.echo.2010.09.018; Lee SC, 2014, MOL GENET METAB, V112, P218, DOI 10.1016/j.ymgme.2014.04.005; Li CH, 2010, INT J CARDIOVAS IMAG, V26, P867, DOI 10.1007/s10554-010-9644-x; Liu LW, 2014, EXP THER MED, V7, P1457, DOI 10.3892/etm.2014.1617; Luis SA, 2014, J AM SOC ECHOCARDIOG, V27, P285, DOI 10.1016/j.echo.2013.11.002; Maffessanti F, 2009, AM J CARDIOL, V104, P1755, DOI 10.1016/j.amjcard.2009.07.060; Marwick TH, 2010, EUR J ECHOCARDIOGR, V11, P414, DOI 10.1093/ejechocard/jeq006; Negishi K, 2013, ULTRASOUND MED BIOL, V39, P714, DOI 10.1016/j.ultrasmedbio.2012.11.021; Negishi K, 2012, ECHOCARDIOGR-J CARD, V29, P334, DOI 10.1111/j.1540-8175.2011.01586.x; Nishii T, 2014, INT J CARDIOVAS IMAG, V30, P65, DOI 10.1007/s10554-014-0414-z; Parra DA, 2012, CURR OPIN PEDIATR, V24, P557, DOI 10.1097/MOP.0b013e328357bae3; Purevjav E, 2010, J AM COLL CARDIOL, V56, P1493, DOI 10.1016/j.jacc.2010.05.045; Risum N, 2012, J AM SOC ECHOCARDIOG, V25, P1195, DOI 10.1016/j.echo.2012.08.007; Sasaki N, 2011, PEDIATR CARDIOL, V32, P646, DOI 10.1007/s00246-011-9948-1; Soleimanifard S, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-85; Song CF, 2014, KAOHSIUNG J MED SCI, V30, P29, DOI 10.1016/j.kjms.2013.04.005; Streiff C, 2015, ECHOCARDIOGR-J CARD, V32, P332, DOI 10.1111/echo.12643; Takeuchi M, 2006, J AM SOC ECHOCARDIOG, V19, P294, DOI 10.1016/j.echo.2005.10.008; Taylor RJ, 2014, INT J CARDIOL, V175, P120, DOI 10.1016/j.ijcard.2014.04.268; Tee M, 2013, EXPERT REV CARDIOVAS, V11, P221, DOI [10.1586/erc.12.182, 10.1586/ERC.12.182]; Urbano-Moral JA, 2014, CIRC-CARDIOVASC IMAG, V7, P11, DOI 10.1161/CIRCIMAGING.113.000842; Voigt JU, 2015, EUR HEART J-CARD IMG, V16, P1, DOI 10.1093/ehjci/jeu184; Wu VCC, 2013, J AM SOC ECHOCARDIOG, V26, P1274, DOI 10.1016/j.echo.2013.07.006; Yodwut C, 2013, INT J CARDIOVAS IMAG, V29, P285, DOI 10.1007/s10554-012-0087-4; Yodwut C, 2012, J AM SOC ECHOCARDIOG, V25, P978, DOI 10.1016/j.echo.2012.06.001; Yuda S, 2014, ECHOCARDIOGR-J CARD, V31, P597, DOI 10.1111/echo.12432	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0153634	10.1371/journal.pone.0153634	http://dx.doi.org/10.1371/journal.pone.0153634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149685	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800011
J	Janssen, CIF; Jansen, D; Mutsaers, MPC; Dederen, PJWC; Geenen, B; Mulder, MT; Kiliaan, AJ				Janssen, Carola I. F.; Jansen, Diane; Mutsaers, Martina P. C.; Dederen, Pieter J. W. C.; Geenen, Bram; Mulder, Monique T.; Kiliaan, Amanda J.			The Effect of a High-Fat Diet on Brain Plasticity, Inflammation and Cognition in Female ApoE4-Knockin and ApoE-Knockout Mice	PLOS ONE			English	Article							APOLIPOPROTEIN-E-KNOCKOUT; ALZHEIMERS-DISEASE; MEMORY DEFICITS; WATER MAZE; CHOLESTEROL; IMPAIRMENT; GENDER; RISK; E4; ATHEROSCLEROSIS	Apolipoprotein E4 (ApoE4), one of three common isoforms of ApoE, is a major risk factor for late-onset Alzheimer disease (AD). ApoE-deficient mice, as well as mice expressing human ApoE4, display impaired learning and memory functions and signs of neurodegeneration. Moreover, ApoE protects against high-fat (HF) diet induced neurodegeneration by its role in the maintenance of the integrity of the blood-brain barrier. The influence of a HF diet on the progression of AD-like cognitive and neuropathological changes was assessed in wild-type (WT), human ApoE4 and ApoE-knockout (ApoE(-/-)) mice to evaluate the modulatory role of ApoE in this process. From 12 months of age, female WT, ApoE4, and ApoE(-/-) mice were fed either a standard or a HF diet (19% butter, 0.5% cholate, 1.25% cholesterol) throughout life. At 15 months of age mice performed the Morris water maze, evaluating spatial learning and memory. ApoE-/- showed increased spatial learning compared to WT mice (p = 0.009). HF diet improved spatial learning in WT mice (p = 0.045), but did not affect ApoE4 and ApoE(-/-) mice. Immunohistochemical analyses of the hippocampus demonstrated increased neuroinflammation (CD68) in the cornu ammonis 1 (CA1) region in ApoE4 (p = 0.001) and in ApoE(-/-) (p = 0.032) mice on standard diet. HF diet tended to increase CD68 in the CA1 in WT mice (p = 0.052), while it decreased in ApoE4 (p = 0.009), but ApoE(-/-) remained unaffected. A trend towards increased neurogenesis (DCX) was found in both ApoE4 (p = 0.052) and ApoE(-/-) mice (p = 0.068). In conclusion, these data suggest that HF intake induces different effects in WT mice compared to ApoE4 and ApoE(-/-) with respect to markers for cognition and neurodegeneration. We propose that HF intake inhibits the compensatory mechanisms of neuroinflammation and neurogenesis in aged female ApoE4 and ApoE(-/-) mice.	[Janssen, Carola I. F.; Jansen, Diane; Mutsaers, Martina P. C.; Dederen, Pieter J. W. C.; Geenen, Bram; Kiliaan, Amanda J.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Anat, NL-6525 ED Nijmegen, Netherlands; [Mulder, Monique T.] Erasmus Univ, Med Ctr, Lab Vasc Med, Dept Internal Med, Rotterdam, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Kiliaan, AJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Anat, NL-6525 ED Nijmegen, Netherlands.	Amanda.Kiliaan@radboudumc.nl	Geenen, Bram/D-9659-2016; Dederen, Pieter.J.W.C/E-1899-2016; Kiliaan, Amanda J/D-8778-2012	Geenen, Bram/0000-0001-7838-3097; 				Alata W, 2015, J CEREBR BLOOD F MET, V35, P86, DOI 10.1038/jcbfm.2014.172; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Arnoldussen IAC, 2014, EUR NEUROPSYCHOPHARM, V24, P1982, DOI 10.1016/j.euroneuro.2014.03.002; Bartelt A, 2011, DIABETOLOGIA, V54, P2900, DOI 10.1007/s00125-011-2274-6; Beydoun MA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.017; Birdsill AC, 2013, OBESITY, V21, P1313, DOI 10.1002/oby.20170; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Champagne D, 2002, NEUROSCIENCE, V114, P641, DOI 10.1016/S0306-4522(02)00313-5; Damoiseaux JS, 2012, J NEUROSCI, V32, P8254, DOI 10.1523/JNEUROSCI.0305-12.2012; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; de la Torre JC, 2012, BIOFACTORS, V38, P78, DOI 10.1002/biof.200; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Dhungana H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-102; Dorey E, 2014, NEUROSCI BULL, V30, P317, DOI 10.1007/s12264-013-1422-z; Fleisher A, 2005, ARCH NEUROL-CHICAGO, V62, P953, DOI 10.1001/archneur.62.6.953; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Grammas P, 2002, J ALZHEIMERS DIS, V4, P217, DOI 10.3233/JAD-2002-4311; Grootendorst J, 2004, BEHAV BRAIN RES, V148, P167, DOI 10.1016/S0166-4328(03)00188-8; Grootendorst J, 2002, BRAIN RES, V953, P281, DOI 10.1016/S0006-8993(02)03399-1; Grootendorst J, 2001, NEUROSCIENCE, V108, P237, DOI 10.1016/S0306-4522(01)00412-2; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jansen D, 2014, BRAIN STRUCT FUNCT, V219, P1841, DOI 10.1007/s00429-013-0606-7; Jansen PJ, 2009, J ALZHEIMERS DIS, V18, P319, DOI 10.3233/JAD-2009-1150; Kalaria RN, 2012, J NEUROL SCI, V322, P141, DOI 10.1016/j.jns.2012.07.032; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kim S, 2015, COMPR PSYCHIAT, V62, P114, DOI 10.1016/j.comppsych.2015.07.002; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Mahley RW, 2006, J CLIN INVEST, V116, P1226, DOI 10.1172/JCI28632; Michikawa M, 2000, J NEUROCHEM, V74, P1008, DOI 10.1046/j.1471-4159.2000.0741008.x; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Mulder M, 2001, LAB INVEST, V81, P953, DOI 10.1038/labinvest.3780307; Muller M, 2007, DEMENT GERIATR COGN, V24, P185, DOI 10.1159/000105927; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Oitzl MS, 1997, BRAIN RES, V752, P189, DOI 10.1016/S0006-8993(96)01448-5; Ophir G, 2005, NEUROBIOL DIS, V20, P709, DOI 10.1016/j.nbd.2005.05.002; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2008, HORM BEHAV, V53, P706, DOI 10.1016/j.yhbeh.2008.02.012; Rapp A, 2006, BIOCHIMIE, V88, P473, DOI 10.1016/j.biochi.2005.10.007; Rijpma A, 2013, J Neurodegener Dis, V2013, P531326, DOI 10.1155/2013/531326; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; Shi L, 2014, INT J NEUROPSYCHOPH, V17, P1863, DOI 10.1017/S1461145714000601; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; Spinney L, 2014, NATURE, V510, P26, DOI 10.1038/510026a; Stojakovic Tatjana, 2004, Semin Vasc Med, V4, P279, DOI 10.1055/s-2004-861496; Suckow MA., 2001, LAB MOUSE, DOI 10.1201/9780849376276; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Thambisetty M, 2010, ARCH NEUROL-CHICAGO, V67, P93, DOI 10.1001/archneurol.2009.913; Underwood EL, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7385314; Yin JX, 2014, CURR ALZHEIMER RES, V11, P283, DOI 10.2174/156720501103140329220007; Zerbi V, 2014, J NEUROSCI, V34, P13963, DOI 10.1523/JNEUROSCI.0684-14.2014	54	32	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155307	10.1371/journal.pone.0155307	http://dx.doi.org/10.1371/journal.pone.0155307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171180	gold, Green Published, Green Submitted			2022-12-27	WOS:000376588600140
J	Li, YP; Liu, H; Wang, PF; Wang, LY; Sun, Y; Liu, G; Zhang, P; Kang, L; Jiang, SJ; Jiang, YL				Li, Yanping; Liu, Hao; Wang, Pengfei; Wang, Liyuan; Sun, Yi; Liu, Gen; Zhang, Ping; Kang, Li; Jiang, Shijin; Jiang, Yunliang			RNA-Seq Analysis Reveals Genes Underlying Different Disease Responses to Porcine Circovirus Type 2 in Pigs	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; SWINE ALVEOLAR MACROPHAGES; EXPERIMENTAL REPRODUCTION; NEPHROPATHY SYNDROME; EXPRESSION PROFILES; IMMUNE-SYSTEM; SYNDROME PMWS; IN-VITRO; PCV2; ALPHA-1-ANTITRYPSIN	Porcine circovirus type 2 (PCV2), an economically important pathogen, causes postweaning multisystemic wasting syndrome (PMWS) and other syndrome diseases collectively known as porcine circovirus-associated disease (PCVAD). Previous studies revealed breed-dependent differences in porcine susceptibility to PCV2; however, the genetic mechanism underlying different resistance to PCV2 infection remains largely unknown. In this study, we found that Yorkshire x Landrace (YL) pigs exhibited serious clinical features typifying PCV2 disease, while the Laiwu (a Chinese indigenous pig breed, LW) pigs showed little clinical symptoms of the disease during PCV2 infection. At 35 days post infection (dpi), the PCV2 DNA copy in YL pigs was significantly higher than that in LW pigs (P < 0.05). The serum level of IL-4, IL-6, IL-8, IL-12 and TGF-beta 1 in LW pigs and TNF-alpha in YL pigs increased significantly at the early infected stages, respectively; while that of IL-10 and IFN-gamma in YL pigs was greatly increased at 35 dpi. RNA-seq analysis revealed that, at 35 dpi, 83 genes were up-regulated and 86 genes were down-regulated in the lung tissues of LW pigs, while in YL pigs, the numbers were 187 and 18, respectively. In LW pigs, the differentially expressed genes (DEGs) were mainly involved in complement and coagulation cascades, metabolism of xenobiotics by cytochrome P450, RIG-I-like receptor signaling and B cell receptor signaling pathways. Four up-regulated genes (TFPI, SERPNC1, SERPNA1, and SERPNA5) that are enriched in complement and coagulation cascades pathway were identified in the PCV2-infected LW pigs, among which the mRNA expression of SERPNA1, as well as three genes including TGF-beta 1, TGF-beta 2 and VEGF that are regulated by SERPNA1 was significantly increased (P < 0.05). We speculate that higher expression of SERPNA1 may effectively suppress excessive inflammation reaction and reduce the pathological degree of lung tissue in PCV2-infected pigs. Collectively, our findings indicate that the susceptibility to PCV2 infection depends on a genetic difference between LW and YL pigs, and SERPNA1 likely plays an important role in the resistance of LW pigs to PCV2 infection.	[Li, Yanping; Liu, Hao; Wang, Pengfei; Wang, Liyuan; Sun, Yi; Liu, Gen; Zhang, Ping; Kang, Li; Jiang, Shijin; Jiang, Yunliang] Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University	Sun, Y; Jiang, YL (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China.	sunyi@cau.edu.cn; yljiang723@aliyun.com	Jiang, Shijin/E-5096-2013	Jiang, Shijin/0000-0002-4747-8410	National Key Technology Support Program [2015BAD03B02]; Natural Science Foundation of Shandong Province [ZR2012CZ002]; Agricultural Elite Breeds Project of Shandong Province; Application of Agricultural Technology of Shandong Province	National Key Technology Support Program(National Key Technology R&D Program); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Agricultural Elite Breeds Project of Shandong Province; Application of Agricultural Technology of Shandong Province	Funders include grant (2015BAD03B02) from the National Key Technology Support Program, the Natural Science Foundation of Shandong Province (ZR2012CZ002), the Agricultural Elite Breeds Project of Shandong Province (2015) and Application of Agricultural Technology of Shandong Province(2013) to YJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 1999, J COMP PATHOL, V121, P1, DOI 10.1053/jcpa.1998.0295; Allan GM, 1998, J VET DIAGN INVEST, V10, P3, DOI 10.1177/104063879801000102; Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Allan G, 2012, VIRUS RES, V164, P4, DOI 10.1016/j.virusres.2011.09.013; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bellacen K, 2013, CELL TRANSPLANT, V22, P2119, DOI 10.3727/096368912X657701; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Carrasco L, 2000, VET REC, V146, P21, DOI 10.1136/vr.146.1.21; Chae C, 2005, VET J, V169, P326, DOI 10.1016/j.tvjl.2004.01.012; Chang HW, 2006, VET MICROBIOL, V115, P311, DOI 10.1016/j.vetmic.2006.03.010; Chang HW, 2006, VET IMMUNOL IMMUNOP, V110, P207, DOI 10.1016/j.vetimm.2005.09.016; Cheung AK, 2012, VIRUS RES, V164, P46, DOI 10.1016/j.virusres.2011.10.012; Clark E, 1997, P AM ASS SWINE PRACT; Darwich L, 2008, RES VET SCI, V84, P194, DOI 10.1016/j.rvsc.2007.04.005; Darwich L, 2004, ARCH VIROL, V149, P857, DOI 10.1007/s00705-003-0280-9; Darwich L, 2003, J GEN VIROL, V84, P3453, DOI 10.1099/vir.0.19364-0; Darwich L, 2003, J GEN VIROL, V84, P2117, DOI 10.1099/vir.0.19124-0; Darwich L, 2012, VIRUS RES, V164, P61, DOI 10.1016/j.virusres.2011.12.003; Ellis J, 1998, CAN VET J, V39, P44; Guttman O, 2015, CLIN EXP IMMUNOL, V179, P161, DOI 10.1111/cei.12476; Harms PA, 2001, VET PATHOL, V38, P528, DOI 10.1354/vp.38-5-528; Hasslung F, 2005, VET MICROBIOL, V106, P49, DOI 10.1016/j.vetmic.2004.12.011; Janciauskiene SM, 2011, RESP MED, V105, P1129, DOI 10.1016/j.rmed.2011.02.002; Kim J, 2003, VET J, V166, P251, DOI 10.1016/S1090-0233(02)00257-5; Krakowka S, 2001, VET PATHOL, V38, P31, DOI 10.1354/vp.38-1-31; Lewis EC, 2012, MOL MED, V18, P957, DOI 10.2119/molmed.2011.00196; Lopez-Soria S, 2011, VET MICROBIOL, V149, P352, DOI 10.1016/j.vetmic.2010.12.009; Mankertz A, 2012, VIRUS RES, V164, P54, DOI 10.1016/j.virusres.2011.11.001; Meerts P, 2005, J INTERF CYTOK RES, V25, P684, DOI 10.1089/jir.2005.25.684; Meerts Peter, 2006, BMC Vet Res, V2, P6, DOI 10.1186/1746-6148-2-6; Meng XJ, 2013, ANNU REV ANIM BIOSCI, V1, P43, DOI 10.1146/annurev-animal-031412-103720; Nita IM, 2007, INT J BIOCHEM CELL B, V39, P1165, DOI 10.1016/j.biocel.2007.02.017; Opriessnig T, 2006, VET PATHOL, V43, P281, DOI 10.1354/vp.43-3-281; Opriessnig T, 2009, J ANIM SCI, V87, P1582, DOI 10.2527/jas.2008-1390; Opriessnig T, 2012, VIRUS RES, V164, P20, DOI 10.1016/j.virusres.2011.09.014; Ramamoorthy S, 2009, VIRUS RES, V145, P236, DOI 10.1016/j.virusres.2009.07.009; Ramamoorthy Sheela, 2009, Animal Health Research Reviews, V10, P1, DOI 10.1017/S1466252308001461; Rosell C, 2000, VET REC, V146, P40, DOI 10.1136/vr.146.2.40; Segales J, 2004, VET MICROBIOL, V98, P151, DOI 10.1016/j.vetmic.2003.10.007; Segales J, 2002, VET QUART, V24, P109, DOI 10.1080/01652176.2002.9695132; Stevenson LS, 2006, VIRAL IMMUNOL, V19, P189, DOI 10.1089/vim.2006.19.189; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; Vincent IE, 2007, IMMUNOLOGY, V120, P47, DOI 10.1111/j.1365-2567.2006.02476.x; Wellenberg GJ, 2004, VET MICROBIOL, V99, P203, DOI 10.1016/j.vetmic.2004.01.001; Yang X, 2014, J GEN VIROL, V95, P1330, DOI 10.1099/vir.0.063644-0; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x	47	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155502	10.1371/journal.pone.0155502	http://dx.doi.org/10.1371/journal.pone.0155502			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171165	gold, Green Submitted, Green Published			2022-12-27	WOS:000376588600123
J	White, SB; Procissi, D; Chen, J; Gogineni, VR; Tyler, P; Yang, YH; Omary, RA; Larson, AC				White, Sarah Beth; Procissi, Daniele; Chen, Jeane; Gogineni, Venkateswara Rao; Tyler, Patrick; Yang, Yihe; Omary, Reed A.; Larson, Andrew C.			Characterization of CC-531 as a Rat Model of Colorectal Liver Metastases	PLOS ONE			English	Article							IRINOTECAN-ELUTING BEADS; COLON-CANCER; HEPATIC METASTASES; MOUSE MODELS; THERAPY; CHEMOEMBOLIZATION	Purpose Surgical resection of colorectal liver metastases is not achievable in more than 70% of the cases. Although the liver directed therapies have become a part of the stand of care, lack of a preclinical model impedes the assessment of toxicity and therapeutic benefits attributed several candidate drugs or treatment regimens that can be designed. In the present study we aim develop and characterize a rat colorectal liver metastasis model. Materials and Methods Growth characteristics of CC-531 cells were determined in vitro followed by subcapsular liver implantation in syngeneic WAG/Rij rats. Tumor growth progression was followed over 3 weeks by ultrasound (US) and magnetic resonance imaging (MRI). Growth characteristics were also assessed by histopathology and immunohistochemistry in harvested tumor tissues. Results The doubling time of CC-531 cells was found be under 24hrs and all the implanted rats grew tumors. US imaging showed hypoechoic masses and MRI showed contrast enhancement representing complex tumor microenvironments. Hematoxylin and Eosin staining confirmed tumor growth and uniform CD31 staining in tumor confirmed even vessel density. Conclusion CC-531 can be used as a metastatic rat tumor colorectal liver metastases model with well-defined characteristics that can be readily followed by imaging whilst having a therapeutic window for interventions.	[White, Sarah Beth; Gogineni, Venkateswara Rao] Med Coll Wisconsin, Dept Radiol, Div Vasc & Intervent Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [White, Sarah Beth; Procissi, Daniele; Chen, Jeane; Tyler, Patrick; Yang, Yihe; Larson, Andrew C.] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Chen, Jeane] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Omary, Reed A.] Vanderbilt Univ, Dept Radiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Larson, Andrew C.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Larson, Andrew C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Medical College of Wisconsin; Northwestern University; Northwestern University; Vanderbilt University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	White, SB (corresponding author), Med Coll Wisconsin, Dept Radiol, Div Vasc & Intervent Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.; White, SB (corresponding author), Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA.	sbwhite@mcw.edu		Tyler, Patrick/0000-0001-6156-8722; Procissi, Daniele/0000-0001-5350-0170	NCI CCSG [P30 CA060553]; Radiological Society of North America (RSNA) [RSD1342]; NIH [R25CA132822-03]; NATIONAL CANCER INSTITUTE [R25CA132822, P30CA060553] Funding Source: NIH RePORTER	NCI CCSG; Radiological Society of North America (RSNA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Histology was performed at Northwestern University Cell Imaging Facility generously supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. Dr. White received grant support from the Radiological Society of North America (RSNA RSD1342) and the NIH (R25CA132822-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Histology was performed at Northwestern University Cell Imaging Facility generously supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. MRI imaging was performed at the Center for Translational Imaging (CTI) at Northwestern University and the authors would like to acknowledge CTI for providing these resources for this study. Dr. White received grant support from the Radiological Society of North America (RSNA RSD1342) and the NIH (R25CA132822-03).	[Anonymous], 2012, CANC FACTS FIG 2012, P1; Benson AB, 2014, J NATL COMPR CANC NE, V12, P1028, DOI 10.6004/jnccn.2014.0099; Boni Luigi, 2005, World J Surg Oncol, V3, P69, DOI 10.1186/1477-7819-3-69; Cohen EP, 1996, LAB INVEST, V75, P349; Eichler K, 2012, INT J ONCOL, V41, P1213, DOI 10.3892/ijo.2012.1572; Ellis Leigh, 2014, Oncoscience, V1, P609; Fidler IJ, 2015, CANCER METAST REV, V34, P635, DOI 10.1007/s10555-015-9586-9; Fiorentini G, 2012, ANTICANCER RES, V32, P1387; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; Gao F, 2013, RADIAT RES, V180, P546, DOI 10.1667/RR13350.1; Gibbs P, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-897; Guo Y, 2011, AM J TRANSL RES, V3, P114; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2015, NAT REV CANCER, V15, P451, DOI 10.1038/nrc3972; Ji JH, 2013, CANCER CHEMOTH PHARM, V72, P223, DOI 10.1007/s00280-013-2190-1; Jones RP, 2013, EJSO-EUR J SURG ONC, V39, P1122, DOI 10.1016/j.ejso.2013.07.087; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; LeGolvan MP, 2010, J SURG ONCOL, V102, P898, DOI 10.1002/jso.21817; Lenarczyk M, 2013, RADIAT RES, V180, P247, DOI 10.1667/RR3292.1; Marchal F, 2005, ONCOL REP, V14, P1203; MARQUET RL, 1984, INT J CANCER, V33, P689, DOI 10.1002/ijc.2910330521; MARTIN MS, 1973, DIGESTION, V8, P22, DOI 10.1159/000197298; Martin RCG, 2010, CARDIOVASC INTER RAD, V33, P960, DOI 10.1007/s00270-010-9937-4; Moulder JE, 2014, INT J RADIAT BIOL, V90, P762, DOI 10.3109/09553002.2014.938375; NOVIKOFF AB, 1957, CANCER RES, V17, P1011; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Richardson AJ, 2013, J VASC INTERV RADIOL, V24, P1209, DOI 10.1016/j.jvir.2013.05.055; Rodenbach M, 2005, J CANCER RES CLIN, V131, P289, DOI 10.1007/s00432-004-0643-y; Soares Kevin C, 2014, J Vis Exp, P51677, DOI 10.3791/51677; Thompson SM, 2013, CARDIOVASC INTER RAD, V36, P198, DOI 10.1007/s00270-012-0466-1; White SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123888	34	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155334	10.1371/journal.pone.0155334	http://dx.doi.org/10.1371/journal.pone.0155334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171151	gold, Green Published			2022-12-27	WOS:000376588600026
J	Sun, TT; Li, WY; Li, TP; Ling, SC				Sun, Tingting; Li, Weiyun; Li, Tianpeng; Ling, Shucai			microRNA Profiling of Amniotic Fluid: Evidence of Synergy of microRNAs in Fetal Development	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; FREE MESSENGER-RNA; STEM-CELLS; PLACENTA; ONTOGENY; GROWTH; MODEL; SKIN	Amniotic fluid (AF) continuously exchanges molecules with the fetus, playing critical roles in fetal development especially via its complex components. Among these components, microRNAs are thought to be transferred between cells loaded in microvesicles. However, the functions of AF microRNAs remain unknown. To date, few studies have examined microRNAs in amniotic fluid. In this study, we employed miRCURY Locked Nucleotide Acid arrays to profile the dynamic expression of microRNAs in AF from mice on embryonic days E13, E15, and E17. At these times, 233 microRNAs were differentially expressed (p<0.01), accounting for 23% of the total Mus musculus microRNAs. These differentially-expressed microRNAs were divided into two distinct groups based on their expression patterns. Gene ontology analysis showed that the intersectional target genes of these differentially-expressed microRNAs were mainly distributed in synapse, synaptosome, cell projection, and cytoskeleton. Pathway analysis revealed that the target genes of the two groups of microRNAs were synergistically enriched in axon guidance, focal adhesion, and MAPK signaling pathways. MicroRNA-mRNA network analysis and gene-mapping showed that these microRNAs synergistically regulated cell motility, cell proliferation and differentiation, and especially the axon guidance process. Cancer pathways associated with growth and proliferation were also enriched in AF. Taken together, the results of this study are the first to show the functions of microRNAs in AF during fetal development, providing novel insights into interpreting the roles of AF microRNAs in fetal development.	[Sun, Tingting; Li, Weiyun; Ling, Shucai] Zhejiang Univ, Sch Med, Inst Neurosci & Anat, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Tianpeng] Donghua Univ, Coll Environm Sci & Engn, Shanghai 201620, Peoples R China	Zhejiang University; Donghua University	Ling, SC (corresponding author), Zhejiang Univ, Sch Med, Inst Neurosci & Anat, Hangzhou 310058, Zhejiang, Peoples R China.	lingshucai@zju.edu.cn		Sun, Ting-ting/0000-0003-3298-3075	Research Fund for the Doctoral Program of Higher Education [20090101110111]; National Natural Science Foundation of China [81371404, 81571243]	Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Research Fund for the Doctoral Program of Higher Education (No. 20090101110111) and supported by the National Natural Science Foundation of China (No. 81371404 and No.81571243).	Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; AOKI A, 1978, CELL TISSUE RES, V192, P409; Brace RA, 2014, AM J PHYSIOL-REG I, V307, pR1260, DOI 10.1152/ajpregu.00283.2014; Cho CKJ, 2010, J PROTEOME RES, V9, P3574, DOI 10.1021/pr100088k; Hollins SL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-777; Honig MG, 2004, DEV BIOL, V266, P27, DOI 10.1016/j.ydbio.2003.10.025; Hui L, 2013, OBSTET GYNECOL, V121, P1248, DOI 10.1097/AOG.0b013e318293d70b; Hui LS, 2012, HUM GENET, V131, P1751, DOI 10.1007/s00439-012-1195-x; Hui L, 2012, OBSTET GYNECOL, V119, P111, DOI 10.1097/AOG.0b013e31823d4150; Ivey K.N., 2015, COLD SPRING HARB PER, V7; Kamath-Rayne BD, 2014, REPROD SCI, V21, P6, DOI 10.1177/1933719113485292; Kang NH, 2012, CANCER GENE THER, V19, P517, DOI 10.1038/cgt.2012.30; Kang NH, 2012, CANCER GENE THER, V19, P412, DOI 10.1038/cgt.2012.15; Khoshgoo N, 2013, PEDIATR PULM, V48, P317, DOI 10.1002/ppul.22739; Larrabee PB, 2005, CLIN CHEM, V51, P1024, DOI 10.1373/clinchem.2004.047670; Larrabee PB, 2005, JAMA-J AM MED ASSOC, V293, P836, DOI 10.1001/jama.293.7.836; Li J, 2013, J BIOL CHEM, V288, P23586, DOI 10.1074/jbc.M113.489302; Massingham LJ, 2014, HUM GENET, V133, P1075, DOI 10.1007/s00439-014-1448-y; Meza-Sosa KF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00175; MOORE SJ, 1989, DEV BRAIN RES, V48, P119, DOI 10.1016/0165-3806(89)90097-7; Ogge G, 2011, J PATHOL, V223, P553, DOI 10.1002/path.2825; Rosner M, 2011, ONCOTARGET, V2, P705; Schmidt W, 1992, Adv Anat Embryol Cell Biol, V127, P1; Scott GM, 2012, J INFECT DIS, V205, P1305, DOI 10.1093/infdis/jis186; Slonim DK, 2009, P NATL ACAD SCI USA, V106, P9425, DOI 10.1073/pnas.0903909106; Sun TT, 2014, GENE, V547, P319, DOI 10.1016/j.gene.2014.06.063; Tan Kai Sen, 2014, BMC Genomics, V15, P587, DOI 10.1186/1471-2164-15-587; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Villegas R, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-19; Visscher MO, 2015, CLIN DERMATOL, V33, P271, DOI 10.1016/j.clindermatol.2014.12.003; Zwemer LM, 2015, COLD SPRING HARB PER, V5	31	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0153950	10.1371/journal.pone.0153950	http://dx.doi.org/10.1371/journal.pone.0153950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166676	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300060
J	Zhuang, Y; Li, Y; Su, W				Zhuang, Yuan; Li, Yang; Su, Wei			Influence of Anchoring on Burial Depth of Submarine Pipelines	PLOS ONE			English	Article								Since the beginning of the twenty-first century, there has been widespread construction of submarine oil-gas transmission pipelines due to an increase in offshore oil exploration. Vessel anchoring operations are causing more damage to submarine pipelines due to shipping transportation also increasing. Therefore, it is essential that the influence of anchoring on the required burial depth of submarine pipelines is determined. In this paper, mathematical models for ordinary anchoring and emergency anchoring have been established to derive an anchor impact energy equation for each condition. The required effective burial depth for submarine pipelines has then been calculated via an energy absorption equation for the protection layer covering the submarine pipelines. Finally, the results of the model calculation have been verified by accident case analysis, and the impact of the anchoring height, anchoring water depth and the anchor weight on the required burial depth of submarine pipelines has been further analyzed.	[Zhuang, Yuan; Li, Yang; Su, Wei] Wuhan Univ Technol, Sch Nav, Wuhan 430070, Hubei, Peoples R China	Wuhan University of Technology	Su, W (corresponding author), Wuhan Univ Technol, Sch Nav, Wuhan 430070, Hubei, Peoples R China.	suweihyxy@whut.edu.cn						Al-Warthan Chung JS, 1993, ISOPE 93; Alexander C, 2012, 2012 9 INT PIP C AM, P45; [Anonymous], 1998, 5461997 GBT GEN ADM; Chen KS, 1998, INT J IMPACT ENG, V21, P177, DOI 10.1016/S0734-743X(97)00083-3; Choi HS, 2001, OCEAN ENG, V28, P1325, DOI 10.1016/S0029-8018(00)00071-8; DNV, 1996, RUL SUBM PIP SYST; DNV, 2000, OFFSH STAND SUBM PIP; DNV, 2010, DNVRPF107; DNV, 2010, DNVOSF101; DNV, 2010, DNVRPF111; Electronic and Geographical Services Ltd, 1992, ARCO GAS PIP HONGKON; Estefen SF, 1992, RESIDUAL STRENGTH DA; Gao XF, 2011, CHINA OCEAN ENG, V2011; Gu WX, 1999, SHIP MANEUVERING, P156; Gu XY, 2001, ACTA MECH SINICA, V2001; Hvam C, 1990, RISK PIPE DAMAGE DRA; Jensen J, 1996, IMPACT STRENGTH CONC; Lee HH, 2011, APPL MECH MATER, V82, P810, DOI 10.4028/www.scientific.net/AMM.82.810; Liu HX, 2012, OCEAN ENG, V49, P33, DOI 10.1016/j.oceaneng.2012.04.013; Liu MM, 2014, ENG FAIL ANAL, V42, P45, DOI 10.1016/j.engfailanal.2014.03.008; Moussblli AH, 1978, CHINA OIL GAS; Putranta DD, 2013, ASME 2013 32 INT C O; Resseguier S, 2009, OMAE 2009, VOL 7, P151; Sriskandarajah T, 2002, INT OFFSHORE POLAR E, P24; TAN Jian, 2008, SHIP OCEAN ENG, V37, P142; TAYLOR N, 1986, THIN WALL STRUCT, V4, P295, DOI 10.1016/0263-8231(86)90035-2; Wang WG, 2011, T TIANJIN U, V2011; Wang YD, THESIS TIANJIN U; WANG Zaiming, 2010, J TRANSPORT INFORM S, V03, P93; Wei HY, 2003, COMMUNICATIONS SURVE, V5, P45; White DJ, 2008, MAR STRUCT, V21, P59, DOI 10.1016/j.marstruc.2007.05.001; Xuan K, 2012, STUDY ANCHORING DAMA; Yang XJ, 2009, J VIBRATION SHOCK, V28, P27; Zhang L, 2010, QUANTIFIED RISK ASSE; Zhang L, 2012, RES BURIAL DEPTH PRO	35	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154954	10.1371/journal.pone.0154954	http://dx.doi.org/10.1371/journal.pone.0154954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166952	gold, Green Submitted, Green Published			2022-12-27	WOS:000376587300052
J	Latouche, C; Natoli, A; Reddy-Luthmoodoo, M; Heywood, SE; Armitage, JA; Kingwell, BA				Latouche, Celine; Natoli, Alaina; Reddy-Luthmoodoo, Medini; Heywood, Sarah E.; Armitage, James A.; Kingwell, Bronwyn A.			MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; OFFSPRING HYPERPHAGIA; PHOSPHORYLATION; ADIPOSITY; LEADS; RATS; MITOCHONDRIA; DYSFUNCTION	Background The regulation of microRNAs (miRNAs) at different stages of the progression of type 2 diabetes mellitus (T2DM) and their role in glucose homeostasis was investigated. Methods Microarrays were used to assess miRNA expression in skeletal muscle biopsies taken from healthy individuals and patients with pre-diabetes or T2DM, and insulin resistant offspring of rat dams fed a high fat diet during pregnancy. Results Twenty-three miRNAs were differentially expressed in patients with T2DM, and 7 in the insulin resistant rat offspring compared to their controls. Among these, only one miRNA was similarly regulated: miR-194 expression was significantly reduced by 25 to 50% in both the rat model and in human with pre-diabetes and established diabetes. Knockdown of miR-194 in L6 skeletal muscle cells induced an increase in basal and insulin-stimulated glucose uptake and glycogen synthesis. This occurred in conjunction with an increased glycolysis, indicated by elevated lactate production. Moreover, oxidative capacity was also increased as we found an enhanced glucose oxidation in presence of the mitochondrial uncoupler FCCP. When miR-194 was down-regulated in vitro, western blot analysis showed an increased phosphorylation of AKT and GSK3 beta in response to insulin, and an increase in expression of proteins controlling mitochondrial oxidative phosphorylation. Conclusions Type 2 diabetes mellitus is associated with regulation of several miRNAs in skeletal muscle. Interestingly, miR-194 was a unique miRNA that appeared regulated across different stages of the disease progression, from the early stages of insulin resistance to the development of T2DM. We have shown miR-194 is involved in multiple aspects of skeletal muscle glucose metabolism from uptake, through to glycolysis, glycogenesis and glucose oxidation, potentially via mechanisms involving AKT, GSK3 and oxidative phosphorylation. MiR-194 could be down-regulated in patients with early features of diabetes as an adaptive response to facilitate tissue glucose uptake and metabolism in the face of insulin resistance.	[Latouche, Celine; Natoli, Alaina; Reddy-Luthmoodoo, Medini; Heywood, Sarah E.; Kingwell, Bronwyn A.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Armitage, James A.] Deakin Univ, Sch Med Optometry, Waurn Ponds, Vic, Australia	Baker Heart and Diabetes Institute; Deakin University	Latouche, C (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	celine.latouche@bakeridi.edu.au	Armitage, James/AAX-1294-2021; Kingwell, Bronwyn A/B-1183-2009	Armitage, James/0000-0002-3762-0911	Monash University; Heart Foundation [G11M 5728]; NHMRC; Victorian State Government	Monash University(Monash University); Heart Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government	JAA acknowledges Fellowships from the Heart Foundation and Monash University. BAK is a Senior Principal Research Fellow of the National Health and Medical Research Council of Australia. This work was supported by the Heart Foundation G11M 5728 and an NHMRC Program Grant and the OIS scheme from the Victorian State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayol SA, 2005, J PHYSIOL-LONDON, V567, P951, DOI 10.1113/jphysiol.2005.088989; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Ceddia RB, 2004, J PHYSIOL-LONDON, V555, P409, DOI 10.1113/jphysiol.2003.056291; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Dokken BB, 2005, AM J PHYSIOL-ENDOC M, V288, pE1188, DOI 10.1152/ajpendo.00547.2004; Dokken BB, 2006, AM J PHYSIOL-ENDOC M, V291, pE207, DOI 10.1152/ajpendo.00628.2005; Duarte FV, 2014, GENES-BASEL, V5, P865, DOI 10.3390/genes5040865; Gomes AP, 2012, BBA-MOL BASIS DIS, V1822, P185, DOI 10.1016/j.bbadis.2011.10.008; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Kumar M, 2012, PROTEIN CELL, V3, P726, DOI 10.1007/s13238-012-2055-0; Latouche C, 2014, J NUTR, V144, P237, DOI 10.3945/jn.113.186775; Li ZY, 2011, MOL BIOSYST, V7, P871, DOI 10.1039/c0mb00230e; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen JM, 2012, RNA BIOL, V9, P820, DOI 10.4161/rna.20162; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mao YP, 2013, PHARMACOL RES, V75, P37, DOI 10.1016/j.phrs.2013.06.005; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; McCullough DF, 2010, BIOCHEM SOC T, V38, P1565, DOI 10.1042/BST0381565; Murea Mariana, 2012, Rev Diabet Stud, V9, P6, DOI 10.1900/RDS.2012.9.6; Nelson PT, 2008, BBA-GENE REGUL MECH, V1779, P758, DOI 10.1016/j.bbagrm.2008.03.012; Nicholas LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084594; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Pandey AK, 2009, CELL PHYSIOL BIOCHEM, V23, P221, DOI 10.1159/000218169; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Pescador N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077251; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Rolo AP, 2011, CURR DRUG TARGETS, V12, P872; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Rottiers V, 2011, COLD SH Q B, V76, P225, DOI 10.1101/sqb.2011.76.011049; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-62; Zhao CJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021768, 10.1371/journal.pone.0023925]	54	47	48	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155108	10.1371/journal.pone.0155108	http://dx.doi.org/10.1371/journal.pone.0155108			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163678	Green Published, gold			2022-12-27	WOS:000376585700029
J	Kushnir, VA; Barad, DH; Albertini, DF; Darmon, SK; Gleicher, N				Kushnir, Vitaly A.; Barad, David H.; Albertini, David F.; Darmon, Sarah K.; Gleicher, Norbert			Effect of Embryo Banking on US National Assisted Reproductive Technology Live Birth Rates	PLOS ONE			English	Article							VITRO FERTILIZATION CYCLES; CLINICAL-OUTCOMES	Background Assisted Reproductive Technology (ART) reports generated by the Centers for Disease Control and Prevention (CDC) exclude embryo banking cycles from outcome calculations. Methods We examined data reported to the CDC in 2013 for the impact of embryo banking exclusion on national ART outcomes by recalculating autologous oocyte ART live birth rates. Inflation of reported fresh ART cycle live birth rates was assessed for all age groups of infertile women as the difference between fresh cycle live births with reference to number of initiated fresh cycles (excluding embryo banking cycles), as typically reported by the CDC, and fresh cycle live births with reference to total initiated fresh ART cycles (including embryo banking cycles). Results During 2013, out of 121,351 fresh non-donor ART cycles 27,564 (22.7%) involved embryo banking. The proportion of banking cycles increased with female age from 15.5% in women <35 years to 56.5% in women >44 years. Concomitantly, the proportion of thawed cycles decreased with advancing female age (P < 0.0001). Exclusion of embryo banking cycles led to inflation of live birth rates in fresh ART cycles, increasing in size in parallel to advancing female age and utilization of embryo banking, reaching 56.3% in women age >44. The inflation of live birth rates in thawed cycles could not be calculated from the publically available CDC data but appears to be even greater. Conclusions Utilization of embryo banking increased during 2013 with advancing female age, suggesting a potential age selection bias. Exclusion of embryo banking cycles from national ART outcome reports significantly inflated national ART success rates, especially among older women. Precis Exclusion of embryo banking cycles from US National Assisted Reproductive Technology outcome reports significantly inflates reported success rates especially in older women.	[Kushnir, Vitaly A.; Barad, David H.; Albertini, David F.; Darmon, Sarah K.; Gleicher, Norbert] Ctr Human Reprod, New York, NY USA; [Kushnir, Vitaly A.] Wake Forest Sch Med, Winston Salem, NC USA; [Barad, David H.] Fdn Reprod Med, New York, NY USA; [Albertini, David F.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Gleicher, Norbert] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA	Wake Forest University; University of Kansas; University of Kansas Medical Center; Rockefeller University	Kushnir, VA (corresponding author), Ctr Human Reprod, New York, NY USA.; Kushnir, VA (corresponding author), Wake Forest Sch Med, Winston Salem, NC USA.	vkushnir@thechr.com	Barad, David/AAF-4332-2021; Albertini, David/AAD-3856-2021	Albertini, David/0000-0001-6536-2828	Center for Human Reproduction; Foundation for Reproductive Medicine	Center for Human Reproduction; Foundation for Reproductive Medicine	Funded by Center for Human Reproduction (www.centerforhumanreprod.com, grant number n/a, author n/a) and Foundation for Reproductive Medicine (www.foundationforreprodmed.com, grant number n/a, author n/a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adashi EY, 2011, JAMA-J AM MED ASSOC, V306, P1135, DOI 10.1001/jama.2011.1249; [Anonymous], 2013, REP TABL ASS REPR TE; Ball D, 2014, FERTIL STERIL, V101, pE29, DOI 10.1016/j.fertnstert.2014.01.002; Centers for Disease Control and Prevention, 2012, 2012 ASS REPR TECHN; Centers for Disease Control and Prevention, 2013, 2013 ASS REPR TECHN; Doody KJ, 2014, FERTIL STERIL, V102, P27, DOI 10.1016/j.fertnstert.2014.04.048; Gleicher N, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-22; Gleicher N, 2012, J ASSIST REPROD GEN, V29, P1159, DOI 10.1007/s10815-012-9871-2; Kissin DM, 2013, FERTIL STERIL, V100, pE16, DOI 10.1016/j.fertnstert.2013.07.199; Kulak D, 2016, FERTIL STERIL, V105, P927, DOI 10.1016/j.fertnstert.2015.12.128; Kushnir VA, 2013, FERTIL STERIL, V100, pE30, DOI 10.1016/j.fertnstert.2013.08.036; Kushnir VA, 2013, FERTIL STERIL, V100, P736, DOI 10.1016/j.fertnstert.2013.05.012; Roque M, 2013, FERTIL STERIL, V99, P156, DOI 10.1016/j.fertnstert.2012.09.003; Schoolcraft WB, 2013, FERTIL STERIL, V100, P615, DOI 10.1016/j.fertnstert.2013.07.1972; Shapiro BS, 2014, FERTIL STERIL, V102, P3, DOI 10.1016/j.fertnstert.2014.04.018; Veleva Z, 2013, HUM REPROD, V28, P2425, DOI 10.1093/humrep/det251; Williams RS, 2015, AM J OBSTET GYNECOL, V212, P157, DOI 10.1016/j.ajog.2014.05.010; Yeung William S. B., 2009, Hong Kong Medical Journal, V15, P420	18	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154620	10.1371/journal.pone.0154620	http://dx.doi.org/10.1371/journal.pone.0154620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159215	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700012
J	Liu, MC; Tsai, YL; Huang, YW; Chen, HY; Hsueh, PR; Lai, SY; Chen, LC; Chou, YH; Lin, WY; Liaw, SJ				Liu, Ming-Che; Tsai, Yi-Lin; Huang, Yi-Wei; Chen, Hsing-Yu; Hsueh, Po-Ren; Lai, Szu-Yu; Chen, Li-Chia; Chou, Yi-Hwa; Lin, Wen-Yuan; Liaw, Shwu-Jen			Stenotrophomonas maltophilia PhoP, a Two-Component Response Regulator, Involved in Antimicrobial Susceptibilities	PLOS ONE			English	Article							POLYMYXIN-B RESISTANCE; ENTERICA SEROVAR TYPHIMURIUM; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; DRUG-RESISTANCE; EFFLUX PUMP; MULTIDRUG-RESISTANCE; FUNCTIONAL-ANALYSIS; PEPTIDE RESISTANCE; PROTEUS-MIRABILIS	Stenotrophomonas maltophilia, a gram-negative bacterium, has increasingly emerged as an important nosocomial pathogen. It is well-known for resistance to a variety of antimicrobial agents including cationic antimicrobial polypeptides (CAPs). Resistance to polymyxin B, a kind of CAPs, is known to be controlled by the two-component system PhoPQ. To unravel the role of PhoPQ in polymyxin B resistance of S. maltophilia, a phoP mutant was constructed. We found MICs of polymyxin B, chloramphenicol, ampicillin, gentamicin, kanamycin, streptomycin and spectinomycin decreased 2-64 fold in the phoP mutant. Complementation of the phoP mutant by the wild-type phoP gene restored all of the MICs to the wild type levels. Expression of PhoP was shown to be autoregulated and responsive to Mg2+ levels. The polymyxin B and gentamicin killing tests indicated that pretreatment of low Mg2+ can protect the wild-type S. maltophilia from killing but not phoP mutant. Interestingly, we found phoP mutant had a decrease in expression of SmeZ, an efflux transporter protein for aminoglycosides in S. maltophilia. Moreover, phoP mutant showed increased permeability in the cell membrane relative to the wild-type. In summary, we demonstrated the two-component regulator PhoP of S. maltophilia is involved in antimicrobial susceptibilities and low Mg2+ serves as a signal for triggering the pathway. Both the alteration in membrane permeability and downregulation of SmeZ efflux transporter in the phoP mutant contributed to the increased drug susceptibilities of S. maltophilia, in particular for aminoglycosides. This is the first report to describe the role of the Mg2+-sensing PhoP signaling pathway of S. maltophilia in regulation of the SmeZ efflux transporter and in antimicrobial susceptibilities. This study suggests PhoPQ TCS may serve as a target for development of antimicrobial agents against multidrug-resistant S. maltophilia.	[Liu, Ming-Che; Tsai, Yi-Lin; Lai, Szu-Yu; Chen, Li-Chia; Chou, Yi-Hwa; Lin, Wen-Yuan; Liaw, Shwu-Jen] Natl Taiwan Univ, Coll Med, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Huang, Yi-Wei] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Chen, Hsing-Yu] Taipei City Hosp, Renai Branch, Dept Clin Pathol, Taipei, Taiwan; [Hsueh, Po-Ren; Liaw, Shwu-Jen] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Taiwan University; National Taiwan University Hospital	Liaw, SJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.; Liaw, SJ (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.	sjliaw@ntu.edu.tw	Huang, Yi-Wei/K-9717-2019; Hsueh, Po-Ren/ABE-1594-2021	LIAW, SHWU-JEN/0000-0002-2666-5284; HSUEH, PO-REN/0000-0002-7502-9225; Lin, Wen-Yuan/0000-0001-5803-3081	National Science Council in Taiwan [NSC 102-2320-B-002-022-MY3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	Funding provided by National Science Council in Taiwan NSC 102-2320-B-002-022-MY3.	Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Chen CH, 2011, ANTIMICROB AGENTS CH, V55, P5826, DOI 10.1128/AAC.00317-11; Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Farrell DJ, 2010, ANTIMICROB AGENTS CH, V54, P2735, DOI 10.1128/AAC.01774-09; Flamez C, 2007, ADV EXP MED BIOL, V603, P145; Gad GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017224; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gruber CC, 2014, MBIO, V5, DOI 10.1128/mBio.01025-13; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; Hong H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107716; Huang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111784; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P2000, DOI 10.1128/AAC.01384-09; Kallipolitis BH, 2003, ANTIMICROB AGENTS CH, V47, P3421, DOI 10.1128/AAC.47.11.3421-3429.2003; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; Lee SW, 2008, J BACTERIOL, V190, P2183, DOI 10.1128/JB.01406-07; Liaw SJ, 2010, INT J ANTIMICROB AG, V35, P126, DOI 10.1016/j.ijantimicag.2009.09.015; Lin MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132843; Lin QY, 2014, ANTIMICROB AGENTS CH, V58, P5181, DOI 10.1128/AAC.00013-14; Lin YT, 2015, ANTIMICROB AGENTS CH, V59, P4067, DOI 10.1128/AAC.00372-15; Macfarlane ELA, 1999, MOL MICROBIOL, V34, P305, DOI 10.1046/j.1365-2958.1999.01600.x; Marchand I, 2004, ANTIMICROB AGENTS CH, V48, P3298, DOI 10.1128/AAC.48.9.3298-3304.2004; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; Newcombe J, 2005, J BACTERIOL, V187, P4967, DOI 10.1128/JB.187.14.4967-4975.2005; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Nishino K, 2009, BBA-PROTEINS PROTEOM, V1794, P834, DOI 10.1016/j.bbapap.2009.02.002; Nyc O, 2010, FOLIA MICROBIOL, V55, P286, DOI 10.1007/s12223-010-0043-4; Poole K, 2012, J ANTIMICROB CHEMOTH, V67, P2069, DOI 10.1093/jac/dks196; Srinivasan VB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033777; Tan CK, 2008, DIAGN MICR INFEC DIS, V60, P205, DOI 10.1016/j.diagmicrobio.2007.09.007; Tsai MH, 2012, INT J ANTIMICROB AG, V40, P151, DOI 10.1016/j.ijantimicag.2012.04.016; Wang WB, 2008, INFECT IMMUN, V76, P2051, DOI 10.1128/IAI.01557-07; Wang YP, 2003, ANTIMICROB AGENTS CH, V47, P95, DOI 10.1128/AAC.47.1.95-101.2003; Weatherspoon-Griffin N, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.565762	40	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0153753	10.1371/journal.pone.0153753	http://dx.doi.org/10.1371/journal.pone.0153753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159404	Green Published, gold			2022-12-27	WOS:000376576700004
J	Salgado-Flores, A; Hagen, LH; Ishaq, SL; Zamanzadeh, M; Wright, ADG; Pope, PB; Sundset, MA				Salgado-Flores, Alejandro; Hagen, Live H.; Ishaq, Suzanne L.; Zamanzadeh, Mirzaman; Wright, Andre-Denis G.; Pope, Phillip B.; Sundset, Monica A.			Rumen and Cecum Microbiomes in Reindeer (Rangifer tarandus tarandus) Are Changed in Response to a Lichen Diet and May Affect Enteric Methane Emissions	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; CONDENSED TANNINS; DAIRY-COWS; MOLECULAR DIVERSITY; USNIC ACID; POPULATIONS; BACTERIA; FERMENTATION; RUMINANTS; FORAGE	Reindeer (Rangifer tarandus tarandus) are large Holarctic herbivores whose heterogeneous diet has led to the development of a unique gastrointestinal microbiota, essential for the digestion of arctic flora, which may include a large proportion of lichens during winter. Lichens are rich in plant secondary metabolites, which may affect members of the gut microbial consortium, such as the methane-producing methanogenic archaea. Little is known about the effect of lichen consumption on the rumen and cecum microbiotas and how this may affect methanogenesis in reindeer. Here, we examined the effects of dietary lichens on the reindeer gut microbiota, especially methanogens. Samples from the rumen and cecum were collected from two groups of reindeer, fed either lichens (Ld: n = 4), or a standard pelleted feed (Pd: n = 3). Microbial densities (methanogens, bacteria and protozoa) were quantified using quantitative real-time PCR and methanogen and bacterial diversities were determined by 454 pyrosequencing of the 16S rRNA genes. In general, the density of methanogens were not significantly affected (p>0.05) by the intake of lichens. Methanobrevibacter constituted the main archaeal genus (>95% of reads), with Mbr. thaueri CW as the dominant species in both groups of reindeer. Bacteria belonging to the uncharacterized Ruminococcaceae and the genus Prevotella were the dominant phylotypes in the rumen and cecum, in both diets (ranging between 16-38% total sequences). Bacteria belonging to the genus Ruminococcus (3.5% to 0.6%; p = 0.001) and uncharacterized phylotypes within the order Bacteroidales (8.4% to 1.3%; p = 0.027), were significantly decreased in the rumen of lichen-fed reindeer, but not in the cecum (p = 0.2 and p = 0.087, respectively). UniFrac-based analyses showed archaeal and bacterial libraries were significantly different between diets, in both the cecum and the rumen (vegan::Adonis: pseudo-F<0.05). Based upon previous literature, we suggest that the altered methanogen and bacterial profiles may account for expected lower methane emissions from lichen-fed reindeer.	[Salgado-Flores, Alejandro; Sundset, Monica A.] UiT, Dept Arctic & Marine Biol, Tromso, Norway; [Hagen, Live H.; Pope, Phillip B.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Ishaq, Suzanne L.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Zamanzadeh, Mirzaman] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Wright, Andre-Denis G.] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ USA	UiT The Arctic University of Tromso; Norwegian University of Life Sciences; Montana State University System; Montana State University Bozeman; University of Waterloo; University of Arizona	Salgado-Flores, A (corresponding author), UiT, Dept Arctic & Marine Biol, Tromso, Norway.	sal028@post.uit.no	WRIGHT, ANDRE-DENIS/ABI-2584-2020; Pope, Phillip/AAQ-2251-2021	Pope, Phillip/0000-0002-2067-4059; Salgado, Alejandro/0000-0002-9582-3135; Hagen, Live Heldal/0000-0003-2606-5331; Ishaq, Suzanne/0000-0002-2615-8055; Sundset, Monica Alterskjaer/0000-0002-4850-262X	Reindeer Husbandry Research Fund [A36010]; University of Tromso (UiT); European Research Commission [336355 - MicroDE]; University of Tromso - The Arctic University of Norway; Arctic University of Norway	Reindeer Husbandry Research Fund; University of Tromso (UiT); European Research Commission(European CommissionEuropean Commission Joint Research Centre); University of Tromso - The Arctic University of Norway; Arctic University of Norway	Funding was provided by the Reindeer Husbandry Research Fund (http://www.reindrift.no/?id=943& Project account A36010) and the University of Tromso (UiT), The Arctic University of Norway. PBP is supported by a European Research Commission Starting Grant Fellowship (336355 - MicroDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is linked to the framework of the International Polar Year (IPY) as part of the consortium IPY#399 EALAT: Climate change and reindeer husbandry. Funding was provided by the Reindeer Husbandry Research Fund and the University of Tromso - The Arctic University of Norway. We are grateful to the staff of animal caretakers, Hans Lian and Hans Arne Solvang, for their help feeding and sampling the animals. PBP is supported by a European Research Commission Starting Grant Fellowship (336355 - MicroDE).	AAGNES TH, 1995, APPL ENVIRON MICROB, V61, P583, DOI 10.1128/AEM.61.2.583-591.1995; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banfield, 1961, NATL MUSEUM CANADA B, V177; BLAXTER KL, 1965, BRIT J NUTR, V19, P511, DOI 10.1079/BJN19650046; Bodas R, 2012, ANIM FEED SCI TECH, V176, P78, DOI 10.1016/j.anifeedsci.2012.07.010; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carulla JE, 2005, AUST J AGR RES, V56, P961, DOI 10.1071/AR05022; Cersosimo LM, 2015, MICROB ECOL, V69, P577, DOI 10.1007/s00248-014-0521-3; CHAO A, 1984, SCAND J STAT, V11, P265; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Cook WE, 2007, J WILDLIFE DIS, V43, P498, DOI 10.7589/0090-3558-43.3.498; Dailey RN, 2008, VET PATHOL, V45, P19, DOI 10.1354/vp.45-1-19; Danielsson R, 2012, APPL ENVIRON MICROB, V78, P6172, DOI 10.1128/AEM.00675-12; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ephraim E, 2005, ANIM FEED SCI TECH, V118, P243, DOI 10.1016/j.anifeedsci.2004.10.015; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Glad T, 2009, MICROB ECOL, V57, P570; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HARFOOT C G, 1978, Progress in Lipid Research, V17, P1, DOI 10.1016/0079-6832(78)90003-4; HOLTER JB, 1992, J DAIRY SCI, V75, P2165, DOI 10.3168/jds.S0022-0302(92)77976-4; Ishaq SL, 2014, MICROB ECOL, V68, P185, DOI 10.1007/s00248-014-0399-0; Johnson DE, 1996, ENVIRON MONIT ASSESS, V42, P133, DOI 10.1007/BF00394046; JONES GA, 1994, APPL ENVIRON MICROB, V60, P1374, DOI 10.1128/AEM.60.4.1374-1378.1994; King EE, 2011, APPL ENVIRON MICROB, V77, P5682, DOI 10.1128/AEM.05130-11; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Lee JH, 2013, INT J SYST EVOL MICR, V63, P4196, DOI 10.1099/ijs.0.054056-0; Li ZP, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-151; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; MATHIESEN SD, 1987, APPL ENVIRON MICROB, V53, P114, DOI 10.1128/AEM.53.1.114-118.1987; Mathiesen SD, 2000, J ZOOL, V251, P129, DOI 10.1111/j.1469-7998.2000.tb00598.x; Mathiesen SD, 2000, J ZOOL, V251, P119, DOI 10.1111/j.1469-7998.2000.tb00597.x; Mathiesen Svein D., 1999, Rangifer, V19, P91; Min BR, 2005, ANIM FEED SCI TECH, V121, P45, DOI 10.1016/j.anifeedsci.2005.02.007; Moss AR, 2000, ANN ZOOTECH, V49, P231, DOI 10.1051/animres:2000119; ORSKOV ER, 1970, BRIT J NUTR, V24, P671, DOI 10.1079/BJN19700068; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Patra AK, 2009, NUTR RES REV, V22, P204, DOI 10.1017/S0954422409990163; Pope PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038571; Puchala R, 2005, J ANIM SCI, V83, P182; ROUVIERE PE, 1988, J BIOL CHEM, V263, P7913; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shi WB, 2014, GENOME RES, V24, P1517, DOI 10.1101/gr.168245.113; Sirohi SK, 2013, GENE, V523, P161, DOI 10.1016/j.gene.2013.04.002; Skillman LC, 2006, APPL ENVIRON MICROB, V72, P200, DOI 10.1128/AEM.72.1.200-206.2006; SKOGLAND T, 1984, HOLARCTIC ECOL, V7, P345; Sliwinski BJ, 2002, ANIM FEED SCI TECH, V101, P101, DOI 10.1016/S0377-8401(02)00139-6; Storeheier PV, 2002, LICHENOLOGIST, V34, P247, DOI 10.1006/lich.2002.0394; Sundset MA, 2008, NATURWISSENSCHAFTEN, V95, P741, DOI 10.1007/s00114-008-0381-0; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Sundset MA, 2010, NATURWISSENSCHAFTEN, V97, P273, DOI 10.1007/s00114-009-0639-1; Sundset M, 2009, MICROB ECOL, V57, P335, DOI 10.1007/s00248-008-9414-7; Svihus B, 2000, J RANGE MANAGE, V53, P642, DOI 10.2307/4003160; Sylvester JT, 2004, J NUTR, V134, P3378, DOI 10.1093/jn/134.12.3378; Tan HY, 2011, ANIM FEED SCI TECH, V169, P185, DOI 10.1016/j.anifeedsci.2011.07.004; Turi J., 2002, NO TIMBERLINE FOREST, P70; Ushida K, 1997, J GEN APPL MICROBIOL, V43, P129, DOI 10.2323/jgam.43.129; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; VOGELS GD, 1980, APPL ENVIRON MICROB, V40, P608, DOI 10.1128/AEM.40.3.608-612.1980; Wallace RJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2032-0; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wright ADG, 2007, APPL ENVIRON MICROB, V73, P4206, DOI 10.1128/AEM.00103-07; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhou M, 2011, J APPL MICROBIOL, V111, P1148, DOI 10.1111/j.1365-2672.2011.05126.x; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08	74	27	29	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155213	10.1371/journal.pone.0155213	http://dx.doi.org/10.1371/journal.pone.0155213			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159387	gold, Green Published, Green Submitted			2022-12-27	WOS:000376576700048
J	Chung, KS; Kim, YS; Kim, SK; Kim, HY; Lee, SM; Seo, JB; Oh, YM; Jung, JY; Lee, SD				Chung, Kyung Soo; Kim, Young Sam; Kim, Se Kyu; Kim, Ha Yan; Lee, Sang Min; Seo, Joon Beom; Oh, Yeon Mok; Jung, Ji Ye; Lee, Sang-Do		Korean Obstructive Lung Dis Study	Functional and Prognostic Implications of the Main Pulmonary Artery Diameter to Aorta Diameter Ratio from Chest Computed Tomography in Korean COPD Patients	PLOS ONE			English	Article							HYPERTENSION; EMPHYSEMA; CT; DISEASE; ECHOCARDIOGRAPHY; ENLARGEMENT; DIMENSIONS; MORTALITY; PRESSURE; IMPACT	Background The ratio of the diameter of the main pulmonary artery (mPA) to the diameter of the aorta (Ao) on chest computed tomography is associated with diverse clinical conditions. Herein, we determined the functional and prognostic implications of the mPA/Ao ratio in Korean chronic obstructive pulmonary disease (COPD) patients. Methods The study population comprised 226 chronic obstructive pulmonary disease patients from the Korean Obstructive Lung Disease cohort who underwent chest computed tomography. We analyzed the relationships between the clinical characteristics, including pulmonary function, echocardiography findings, St. George's Respiratory Questionnaire, 6-minute walking (6MW) distance, and exacerbation with the mPA, Ao, and mPA/Ao ratio. Results The mean age was 65.8 years, and 219 (96.9%) patients were male. The mean FEV1% predicted and FEV1/FVC ratio were 61.2% and 47.3%, respectively. The mean mPA and Ao were 23.7 and 36.4 mm, respectively, and the mPA/Ao ratio was 0.66. The mPA/Ao ratio correlated negatively with the 6MW distance (G = -0.133, P = 0.025) and positively with the right ventricular pressure (G = 0.323, P = 0.001). After adjustment for potential confounders, the mPA/Ao ratio was significantly associated with 6MW distance (beta = -107.7, P = 0.017). Moreover, an mPA/Ao ratio >0.8 was a significant predictor of exacerbation at the 1-year (odds ratio 2.12, 95% confidence interval 1.27-3.52) and 3-year follow-ups (odds ratio 2.04, 95% confidence interval 1.42-2.90). Conclusions The mPA/Ao ratio is an independent predictor of exercise capacity and an mPA/Ao ratio >0.8 is a significant risk factor of COPD exacerbation.	[Chung, Kyung Soo; Kim, Young Sam; Kim, Se Kyu; Jung, Ji Ye] Yonsei Univ, Coll Med, Dept Internal Med, Div Pulmonol,Inst Chest Dis,Severance Hosp, Seoul, South Korea; [Kim, Ha Yan] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul, South Korea; [Lee, Sang Min; Seo, Joon Beom] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Lee, Sang Min; Seo, Joon Beom] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Oh, Yeon Mok; Lee, Sang-Do] Univ Ulsan, Coll Med, Dept Pulm & Crit Care Med, Asan Med Ctr, Seoul, South Korea; [Oh, Yeon Mok; Lee, Sang-Do] Univ Ulsan, Clin Res Ctr Chron Obstruct Airway Dis, Asan Med Ctr, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center	Jung, JY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Pulmonol,Inst Chest Dis,Severance Hosp, Seoul, South Korea.; Lee, SD (corresponding author), Univ Ulsan, Coll Med, Dept Pulm & Crit Care Med, Asan Med Ctr, Seoul, South Korea.; Lee, SD (corresponding author), Univ Ulsan, Clin Res Ctr Chron Obstruct Airway Dis, Asan Med Ctr, Coll Med, Seoul, South Korea.	stopyes@yuhs.ac; sdlee@amc.seoul.kr	Jung, Ji Ye/AAB-4993-2021; Seo, Joon Beom/AAQ-5445-2021	Seo, Joon Beom/0000-0003-0271-7884; Jung, Ji Ye/0000-0003-1589-4142; Chung, Kyung Soo/0000-0003-1604-8730; Kim, Young Sam/0000-0001-9656-8482	Korea Healthcare technology R&D Project, Ministry of Health and Welfare [HI10C2020, A102065]	Korea Healthcare technology R&D Project, Ministry of Health and Welfare	This research was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health and Welfare (HI10C2020 and A102065) to SDL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Barbera JA, 2013, PULM CIRC, V3, P160, DOI 10.4103/2045-8932.109949; Alhamad EH, 2011, RADIOLOGY, V260, P875, DOI 10.1148/radiol.11103532; Arcasoy SM, 2003, AM J RESP CRIT CARE, V167, P735, DOI 10.1164/rccm.200210-1130OC; Bach DS, 1998, CHEST, V114, P972, DOI 10.1378/chest.114.4.972; BARBERA JA, 1994, AM J RESP CRIT CARE, V149, P423, DOI 10.1164/ajrccm.149.2.8306040; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Boerrigter B, 2010, CHEST, V138, P1395, DOI 10.1378/chest.10-0363; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; Chaouat A, 2005, AM J RESP CRIT CARE, V172, P189, DOI 10.1164/rccm.200401-006OC; Cuttica MJ, 2010, RESP MED, V104, P1877, DOI 10.1016/j.rmed.2010.05.009; Devaraj A, 2010, RADIOLOGY, V254, P609, DOI 10.1148/radiol.09090548; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Girgis RE, 2007, CLIN CHEST MED, V28, P219, DOI 10.1016/j.ccm.2006.11.006; Hueper K, 2015, AM J RESP CRIT CARE, V192, P570, DOI 10.1164/rccm.201411-2120OC; Hurdman J, 2013, EUR RESPIR J, V41, P1292, DOI 10.1183/09031936.00079512; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Iyer AS, 2014, CHEST, V145, P824, DOI 10.1378/chest.13-1422; Joppa P, 2006, CHEST, V130, P326, DOI 10.1378/chest.130.2.326; Jorgensen K, 2007, CHEST, V131, P1050, DOI 10.1378/chest.06-2245; Kholdani C, 2015, PULM CIRC, V5, P220, DOI 10.1086/679995; Lee SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126646; Lee YK, 2008, LUNG, V186, P157, DOI 10.1007/s00408-008-9071-0; Lin FY, 2009, ACAD RADIOL, V16, P981, DOI 10.1016/j.acra.2009.02.013; Mahammedi A, 2013, J THORAC IMAG, V28, P96, DOI 10.1097/RTI.0b013e318271c2eb; Matsuoka S, 2010, ACAD RADIOL, V17, P93, DOI 10.1016/j.acra.2009.07.022; Minai OA, 2010, CHEST, V137, p39S, DOI 10.1378/chest.10-0087; Nakanishi R, 2013, AM J CARDIOL, V111, P1259, DOI 10.1016/j.amjcard.2013.01.266; Ng CS, 1999, J THORAC IMAG, V14, P270, DOI 10.1097/00005382-199910000-00007; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; Perez-Enguix D, 2007, TRANSPL P, V39, P2405, DOI 10.1016/j.transproceed.2007.07.055; Santos S, 2003, AM J RESP CRIT CARE, V167, P1250, DOI 10.1164/rccm.200210-1233OC; SCHULMAN LL, 1994, CHEST, V105, P798, DOI 10.1378/chest.105.3.798; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Sims MW, 2009, CHEST, V136, P412, DOI 10.1378/chest.08-2739; Truong QA, 2012, CIRC-CARDIOVASC IMAG, V5, P147, DOI 10.1161/CIRCIMAGING.111.968610; WEITZENBLUM E, 1981, THORAX, V36, P752, DOI 10.1136/thx.36.10.752; Wells JM, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002546; Wells JM, 2013, INT J CHRONIC OBSTR, V8, P509, DOI 10.2147/COPD.S52204; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; Williams MC, 2014, THORAX, V69, P718, DOI 10.1136/thoraxjnl-2012-203151; Zlotnick DM, 2010, NEPHROL DIAL TRANSPL, V25, P3090, DOI 10.1093/ndt/gfq141	43	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154584	10.1371/journal.pone.0154584	http://dx.doi.org/10.1371/journal.pone.0154584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152915	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000025
J	de Azevedo, AKEC; Claudino, R; Conceicao, JS; Swarowsky, A; dos Santos, MJ				de Azevedo, Alexandre Kretzer e Castro; Claudino, Renato; Conceicao, Josilene Souza; Swarowsky, Alessandra; dos Santos, Marcio Jose			Anticipatory and Compensatory Postural Adjustments in Response to External Lateral Shoulder Perturbations in Subjects with Parkinson's Disease	PLOS ONE			English	Article							FUNCTIONAL ANKLE INSTABILITY; BASAL GANGLIA; OLDER-ADULTS; MOVEMENT; BALANCE; MUSCLE; FALLS; IMPAIRMENT; STANCE; TASK	The purpose of this study was to investigate the anticipatory (APA) and compensatory (CPA) postural adjustments in individuals with Parkinson's disease (PD) during lateral instability of posture. Twenty-six subjects (13 individuals with PD and 13 healthy matched controls) were exposed to predictable lateral postural perturbations. The electromyographic (EMG) activity of the lateral muscles and the displacement of the center of pressure (COP) were recorded during four time intervals that are typical for postural adjustments, i.e., immediately before (APA1, APA2) and after (CPA1 and CPA2) the postural disturbances. The magnitude of the activity of the lateral muscles in the group with PD was lower only during the CPA time intervals and not during the anticipatory adjustments (APAs). Despite this finding, subjects with PD exhibit smaller COP excursions before and after the disturbance, probably due to lack of flexibility and proprioceptive impairments. The results of this study suggest that postural instability in subjects with PD can be partially explained by decreased postural sway, before and after perturbations, and reduced muscular activity after body disturbances. Our findings can motivate new studies to investigate therapeutic interventions that optimize the use of postural adjustment strategies in subjects with PD.	[de Azevedo, Alexandre Kretzer e Castro; Claudino, Renato] Santa Catarina State Univ, Human Movement Sci Program, Dept Phys Educ, Ctr Hlth & Sport Sci, Florianopolis, SC, Brazil; [Conceicao, Josilene Souza; Swarowsky, Alessandra; dos Santos, Marcio Jose] Santa Catarina State Univ, Phys Therapy Program, Ctr Hlth & Sport Sci, Dept Phys Therapy, Florianopolis, SC, Brazil; [dos Santos, Marcio Jose] Univ Kansas, Med Ctr, Sch Hlth Profess, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA	Universidade do Estado de Santa Catarina; Universidade do Estado de Santa Catarina; University of Kansas; University of Kansas Medical Center	dos Santos, MJ (corresponding author), Santa Catarina State Univ, Phys Therapy Program, Ctr Hlth & Sport Sci, Dept Phys Therapy, Florianopolis, SC, Brazil.; dos Santos, MJ (corresponding author), Univ Kansas, Med Ctr, Sch Hlth Profess, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA.	msantos@kumc.edu	Swarowsky, Alessandra/O-6135-2018; Swarowsky, Alessandra/B-8624-2016; claudino, renato/AAC-1854-2021	Swarowsky, Alessandra/0000-0002-0535-0208; Swarowsky, Alessandra/0000-0002-0535-0208; claudino, renato/0000-0002-8730-911X				Aruin AS, 1998, ELECTROMYOGR MOTOR C, V109, P350, DOI 10.1016/S0924-980X(98)00029-0; ARUIN AS, 1995, EXP BRAIN RES, V106, P291; Aruin AS, 1996, NEUROREPORT, V7, P1794, DOI 10.1097/00001756-199607290-00021; Ballanger B, 2008, J NEUROL NEUROSUR PS, V79, P1110, DOI 10.1136/jnnp.2007.141689; Barbosa MT, 2006, MOVEMENT DISORD, V21, P800, DOI 10.1002/mds.20806; Bazalgette D, 1987, Adv Neurol, V45, P371; Benedetti Tânia R. Bertoldo, 2007, Rev Bras Med Esporte, V13, P11, DOI 10.1590/S1517-86922007000100004; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Bienkiewicz MMN, 2014, NEUROSCIENCE, V275, P508, DOI 10.1016/j.neuroscience.2014.06.050; Bloem BR, 1996, MOVEMENT DISORD, V11, P509, DOI 10.1002/mds.870110506; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Bouisset S, 2000, EXP BRAIN RES, V132, P79, DOI 10.1007/s002210050116; CAVANAGH PR, 1979, EUR J APPL PHYSIOL, V42, P159, DOI 10.1007/BF00431022; Claudino R, 2013, CLIN NEUROPHYSIOL, V124, P1628, DOI 10.1016/j.clinph.2013.02.111; CORNFORD ME, 1995, BRAIN COGNITION, V28, P321, DOI 10.1006/brcg.1995.1261; Dimitrova D, 2004, EXP BRAIN RES, V156, P183, DOI 10.1007/s00221-003-1770-4; Dimitrova D, 2004, J NEUROPHYSIOL, V91, P489, DOI 10.1152/jn.00094.2003; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Granata KP, 2001, J ELECTROMYOGR KINES, V11, P247, DOI 10.1016/S1050-6411(01)00003-7; Hale SA, 2007, J ORTHOP SPORT PHYS, V37, P303, DOI 10.2519/jospt.2007.2322; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Horak FB, 2005, EXP NEUROL, V193, P504, DOI 10.1016/j.expneurol.2004.12.008; Hubble RP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006095; Jacobs JV, 2006, NEUROSCIENCE, V141, P999, DOI 10.1016/j.neuroscience.2006.04.014; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Kidgell DJ, 2007, J STRENGTH COND RES, V21, P466; King LA, 2008, ARCH PHYS MED REHAB, V89, P492, DOI 10.1016/j.apmr.2007.11.017; King LA, 2010, ARCH PHYS MED REHAB, V91, P1332, DOI 10.1016/j.apmr.2010.05.013; LACQUANITI F, 1987, BRAIN RES, V406, P373, DOI 10.1016/0006-8993(87)90810-9; LATASH ML, 1995, J NEUROL NEUROSUR PS, V58, P326, DOI 10.1136/jnnp.58.3.326; LATASH ML, 1995, ELECTROMYOGR MOTOR C, V97, P77, DOI 10.1016/0924-980X(94)00272-9; LAVENDER SA, 1993, SPINE, V18, P2097, DOI 10.1097/00007632-199310001-00029; Lord SR, 1999, J AM GERIATR SOC, V47, P1077, DOI 10.1111/j.1532-5415.1999.tb05230.x; Mak MKY, 2011, PHYS THER, V91, P381, DOI 10.2522/ptj.20100232; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Mancini M, 2009, EUR J NEUROL, V16, P1028, DOI 10.1111/j.1468-1331.2009.02641.x; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; Martinu K, 2013, BEHAV NEUROSCI, V127, P222, DOI 10.1037/a0031226; Massion J, 1998, NEUROSCI BIOBEHAV R, V22, P465, DOI 10.1016/S0149-7634(97)00031-6; McCollum G, 1985, BEHAV BRAIN SCI, V8; Michatowska M, 2005, FUNCT NEUROL, V20, P163; Rao G, 2003, JAMA-J AM MED ASSOC, V289, P347, DOI 10.1001/jama.289.3.347; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Ridgel AL, 2016, J SCI MED SPORT, V19, P12, DOI 10.1016/j.jsams.2015.01.005; Rietdyk S, 1999, J BIOMECH, V32, P1149, DOI 10.1016/S0021-9290(99)00116-5; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Bruin VMS, 2012, EUR NEUROL, V67, P257, DOI 10.1159/000335078; Santos MJ, 2008, J ORTHOP SPORT PHYS, V38, P150, DOI 10.2519/jospt.2008.2524; Santos MJ, 2008, EXP BRAIN RES, V184, P547, DOI 10.1007/s00221-007-1123-9; Santos MJ, 2010, J ELECTROMYOGR KINES, V20, P388, DOI 10.1016/j.jelekin.2009.06.006; Santos MJ, 2010, J ELECTROMYOGR KINES, V20, P398, DOI 10.1016/j.jelekin.2010.01.002; Santos MJ, 2009, J ELECTROMYOGR KINES, V19, P532, DOI 10.1016/j.jelekin.2007.12.002; Schenkman ML, 2001, PHYS THER, V81, P1400, DOI 10.1093/ptj/81.8.1400; Shiratori T, 2000, CLIN NEUROPHYSIOL, V111, P613, DOI 10.1016/S1388-2457(99)00300-4; Smeesters C, 2001, J BIOMECH, V34, P309, DOI 10.1016/S0021-9290(00)00200-1; Snijders Anke H, 2010, N Engl J Med, V362, pe46, DOI 10.1056/NEJMicm0810287; Steiger MJ, 1996, J NEUROL NEUROSUR PS, V61, P645, DOI 10.1136/jnnp.61.6.645; TROPP H, 1984, MED SCI SPORT EXER, V16, P64; Valkovic P, 2006, NEUROSCI LETT, V401, P92, DOI 10.1016/j.neulet.2006.02.073; Vaugoyeau M, 2011, HUM MOVEMENT SCI, V30, P405, DOI 10.1016/j.humov.2010.10.006; Verhagen E, 2005, CLIN BIOMECH, V20, P1094, DOI 10.1016/j.clinbiomech.2005.07.001; WEINRICH M, 1988, NEUROLOGY, V38, P540, DOI 10.1212/WNL.38.4.540; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Wright WG, 2007, EXP NEUROL, V208, P38, DOI 10.1016/j.expneurol.2007.07.002	65	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155012	10.1371/journal.pone.0155012	http://dx.doi.org/10.1371/journal.pone.0155012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152640	Green Published, gold, Green Submitted			2022-12-27	WOS:000375677000059
J	Santisteban, L; Teremetz, M; Bleton, JP; Baron, JC; Maier, MA; Lindberg, PG				Santisteban, Leire; Teremetz, Maxime; Bleton, Jean-Pierre; Baron, Jean-Claude; Maier, Marc A.; Lindberg, Pavel G.			Upper Limb Outcome Measures Used in Stroke Rehabilitation Studies: A Systematic Literature Review	PLOS ONE			English	Review							FUGL-MEYER ASSESSMENT; HEMIPARETIC PATIENTS; BOTULINUM-TOXIN; SPASTICITY; MOVEMENT; RECOVERY; RECOMMENDATIONS; RELIABILITY; KINEMATICS; STRATEGIES	Background Establishing which upper limb outcome measures are most commonly used in stroke studies may help in improving consensus among scientists and clinicians. Objective In this study we aimed to identify the most commonly used upper limb outcome measures in intervention studies after stroke and to describe domains covered according to ICF, how measures are combined, and how their use varies geographically and over time. Methods Pubmed, CinHAL, and PeDRO databases were searched for upper limb intervention studies in stroke according to PRISMA guidelines and477 studies were included. Results In studies 48different outcome measures were found. Only 15 of these outcome measures were used in more than 5% of the studies. The Fugl-Meyer Test (FMT) was the most commonly used measure (in 36% of studies). Commonly used measures covered ICF domains of body function and activity to varying extents. Most studies (72%) combined multiple outcome measures: the FMT was often combined with the Motor Activity Log (MAL), the Wolf Motor Function Test and the Action Research Arm Test, but infrequently combined with the Motor Assessment Scale or the Nine Hole Peg Test. Key components of manual dexterity such as selective finger movements were rarely measured. Frequency of use increased over a twelve-year period for the FMT and for assessments of kinematics, whereas other measures, such as the MAL and the Jebsen Taylor Hand Test showed decreased use over time. Use varied largely between countries showing low international consensus. Conclusions The results showed a large diversity of outcome measures used across studies. However, a growing number of studies used the FMT, a neurological test with good psychometric properties. For thorough assessment the FMT needs to be combined with functional measures. These findings illustrate the need for strategies to build international consensus on appropriate outcome measures for upper limb function after stroke.	[Santisteban, Leire] Univ Paris 05, Hop St Anne, Serv Med Phys & Readaptat, Paris, France; [Teremetz, Maxime; Maier, Marc A.; Lindberg, Pavel G.] Univ Paris 05, Sorbonne Paris Cite, CNRS, FR3636, Paris, France; [Bleton, Jean-Pierre] Fdn OPH Rothschild, Serv Neurol, Unite James Parkinson, Paris, France; [Bleton, Jean-Pierre; Baron, Jean-Claude] INSERM, U894, Ctr Psychiat & Neurosci, Paris, France; [Maier, Marc A.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lindberg, PG (corresponding author), Univ Paris 05, Sorbonne Paris Cite, CNRS, FR3636, Paris, France.	pavel.lindberg@inserm.fr	Lindberg, Pavel/P-9792-2019; Maier, Marc/HGU-9498-2022; Lindberg, Pavel G/E-5926-2017	Lindberg, Pavel/0000-0001-6976-6387; Lindberg, Pavel G/0000-0001-6976-6387; baron, jean-claude/0000-0002-5264-2588; BLETON, Jean-Pierre/0000-0002-2313-2263; Santisteban, Leire/0000-0001-7049-7655; Lindberg, Pavel/0000-0002-7507-7817				Alt Murphy M, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0292-6; Alt Murphy M, 2013, NEUROREHAB NEURAL RE, V27, P844, DOI 10.1177/1545968313491008; Auriat AM, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00226; Backman C., 1992, CAN J OCCUP THER, V59, P208, DOI DOI 10.1177/000841749205900406; Bensmail D, 2010, NEUROREHAB NEURAL RE, V24, P141, DOI 10.1177/1545968309347683; Bushnell C, 2015, CIRC-CARDIOVASC QUAL, V8, pS163, DOI 10.1161/CIRCOUTCOMES.115.002098; Causby R, 2014, PERCEPT MOTOR SKILL, V118, P765, DOI 10.2466/25.27.PMS.118k27w2; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; Reyes-Guzman ADL, 2014, CLIN BIOMECH, V29, P719, DOI 10.1016/j.clinbiomech.2014.06.013; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Duncan PW, 2000, STROKE, V31, P1429, DOI 10.1161/01.STR.31.6.1429; DUNCAN PW, 1983, PHYS THER, V63, P1606, DOI 10.1093/ptj/63.10.1606; Ellis MD, 2008, NEUROREHAB NEURAL RE, V22, P321, DOI 10.1177/1545968307313509; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gaverth J, 2014, J REHABIL MED, V46, P629, DOI 10.2340/16501977-1824; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Hsieh CL, 1998, AGE AGEING, V27, P107, DOI 10.1093/ageing/27.2.107; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK; Isa T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00191; Jette DU, 2009, PHYS THER, V89, P125, DOI 10.2522/ptj.20080234; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lemmens RJM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-21; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lin JH, 2009, PHYS THER, V89, P840, DOI 10.2522/ptj.20080285; Lindberg PG, 2007, NEUROREHAB NEURAL RE, V21, P551, DOI 10.1177/1545968307301886; Lindberg PG, 2016, EUR RADIOL, V26, P733, DOI 10.1007/s00330-015-3876-z; Lindberg PG, 2012, BRAIN RES, V1452, P96, DOI 10.1016/j.brainres.2012.03.007; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Mandon L, 2016, NEUROREHAB NEURAL RE, V30, P209, DOI 10.1177/1545968315591704; Meyer S, 2015, NEUROREHABIL NEURAL; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Noorkoiv M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-144; Nordin N, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-137; Page SJ, 2012, ARCH PHYS MED REHAB, V93, P2373, DOI 10.1016/j.apmr.2012.06.017; Parker V M, 1986, Int Rehabil Med, V8, P69; Pennati GV, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0133-x; Rand D, 2015, J STROKE CEREBROVASC, V24, P274, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.039; Roby-Brami A, 2003, BRAIN RES, V969, P217, DOI 10.1016/S0006-8993(03)02334-5; Schmidlin Eric, 2011, J Vis Exp, DOI 10.3791/3258; Sivan M, 2011, J REHABIL MED, V43, P181, DOI 10.2340/16501977-0674; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Sullivan JE, 2013, PHYS THER, V93, P1383, DOI 10.2522/ptj.20120492; Teremetz M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0054-0; Thompson-Butel AG, 2015, NEUROREHAB NEURAL RE, V29, P341, DOI 10.1177/1545968314547766; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47; Velstra IM, 2011, PM&R, V3, P846, DOI 10.1016/j.pmrj.2011.03.014; World Health Organization, INT CLASS FUNCT DIS; Yancosek KE, 2009, J HAND THER, V22, P258, DOI 10.1016/j.jht.2008.11.004	53	160	168	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154792	10.1371/journal.pone.0154792	http://dx.doi.org/10.1371/journal.pone.0154792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152853	Green Submitted, Green Published, gold			2022-12-27	WOS:000375677000035
J	Stukes, TM; Shary, JR; Wei, W; Ebeling, MD; Dezsi, KB; Shary, FS; Forestieri, NE; Hollis, BW; Wagner, CL				Stukes, Taylor M.; Shary, Judith R.; Wei, Wei; Ebeling, Myla D.; Dezsi, Kaleena B.; Shary, Frank S.; Forestieri, Nina E.; Hollis, Bruce W.; Wagner, Carol L.			Circulating Cathelicidin Concentrations in a Cohort of Healthy Children: Influence of Age, Body Composition, Gender and Vitamin D Status	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; D SUPPLEMENTATION; TUBERCULOSIS; HCAP-18; PROTEIN	Cathelicidin is an antimicrobial peptide whose circulating levels are related to vitamin D status in adults. This study sought to determine if circulating cathelicidin concentrations in healthy children are related to the age of the child, body composition and vitamin D status at birth and at the time of the study visit. Blood samples were obtained during yearly visits from 133 children, ages 2-7, whose mothers had participated in a pregnancy vitamin D supplementation RCT. Radioimmunoassay and ELISA were performed to analyze 25(OH) D and cathelicidin, respectively. Statistical analyses compared cathelicidin concentrations with concentrations of 25(OH) D at various time points (maternal levels throughout pregnancy, at birth, and child's current level); and with race/ethnicity, age, gender, BMI, percent fat, and frequency of infections using Student's t-test, chi(2), Wilcoxon ranked-sum analysis, and multi-variate regression. The cohort's median cathelicidin concentration was 28.1 ng/mL (range: 5.6-3368.6) and did not correlate with 25(OH)D, but was positively correlated with advancing age (rho = 0.236 & p = 0.005, respectively). Forty patients evaluated at two visits showed an increase of 24.0 ng/mL in cathelicidin from the first visit to the next (p<0.0001). Increased age and male gender were correlated with increased cathelicidin when controlling for race/ethnicity, percent fat, and child's current 25(OH) D concentration (p = 0.028 & p = 0.047, respectively). This study demonstrated that as children age, the concentration of cathelicidin increases. Furthermore, male gender was significantly associated with increased cathelicidin concentrations. The lack of association between vitamin D status and cathelicidin in this study may be due to the narrow range in observed 25(OH) D values and warrants additional studies for further observation.	[Stukes, Taylor M.; Shary, Judith R.; Ebeling, Myla D.; Dezsi, Kaleena B.; Shary, Frank S.; Forestieri, Nina E.; Hollis, Bruce W.; Wagner, Carol L.] Med Univ S Carolina, Dept Pediat, 171 Ashley Ave, Charleston, SC 29425 USA; [Wei, Wei] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Wagner, CL (corresponding author), Med Univ S Carolina, Dept Pediat, 171 Ashley Ave, Charleston, SC 29425 USA.	wagnercl@musc.edu		Wei, Wei/0000-0003-1263-5620	National Institute of Child Health and Human Development [R01 HD 043921]; National Institutes of Health/National Center for Research Resources [UL1 RR029882]; Thrasher Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043921] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062, UL1TR001450] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Thrasher Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by the National Institute of Child Health and Human Development R01 HD 043921 to CLW and BWH, the National Institutes of Health/National Center for Research Resources UL1 RR029882 to MUSC and the Thrasher Research Fund to CLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Albanna EAM, 2010, EGYPT J PEDIATR ALLE, V8, P81; Alvarez-Rodriguez L, 2012, J LEUKOCYTE BIOL, V91, P829, DOI 10.1189/jlb.1011523; Bhan I, 2011, J ALLERGY CLIN IMMUN, V127, P1302, DOI 10.1016/j.jaci.2010.12.1097; Chun RF, 2015, J STEROID BIOCHEM, V148, P290, DOI 10.1016/j.jsbmb.2014.07.013; COWLAND JB, 1995, FEBS LETT, V368, P173, DOI 10.1016/0014-5793(95)00634-L; Das M, 2014, EUR J CLIN NUTR, V68, P338, DOI 10.1038/ejcn.2013.268; Davidopoulou S, 2012, ARCH ORAL BIOL, V57, P865, DOI 10.1016/j.archoralbio.2012.01.008; Dixon Brian M, 2012, BMC Res Notes, V5, P575, DOI 10.1186/1756-0500-5-575; Food and Nutrition Board, 2010, DIET REF INT VIT D C; Gilbert-Diamond D, 2010, AM J CLIN NUTR, V92, P1446, DOI 10.3945/ajcn.2010.29746; Havelka AM, 2010, ACTA PAEDIATR, V99, P836, DOI 10.1111/j.1651-2227.2010.01726.x; Hebbar KB, 2014, J CLIN TRANSL ENDOCR, V1, P170, DOI 10.1016/j.jcte.2014.09.002; Herranz AS, 2010, ENDOCRINOL NUTR, V57, P256, DOI DOI 10.1016/J.END0NU.2010.04.003; Hollis BW, 2013, CALCIFIED TISSUE INT, V92, P128, DOI 10.1007/s00223-012-9607-4; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Honda JR, 2014, J MED MICROBIOL, V63, P997, DOI 10.1099/jmm.0.070888-0; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; Khor GL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-95; Lambert AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095099; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Mily A, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-23; Mulasi-Pokhriyal U, 2013, BRIT J NUTR, V109, P346, DOI 10.1017/S0007114512001043; Porcelli F, 2008, BIOCHEMISTRY-US, V47, P5565, DOI 10.1021/bi702036s; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Yamshchikov AV, 2010, AM J CLIN NUTR, V92, P603, DOI 10.3945/ajcn.2010.29411; Youssef DM, 2012, SAUDI J KIDNEY DIS T, V23, P267	29	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0152711	10.1371/journal.pone.0152711	http://dx.doi.org/10.1371/journal.pone.0152711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152524	gold, Green Published, Green Submitted			2022-12-27	WOS:000375677000003
J	Xu, G; Wang, BG				Xu, Gangming; Wang, Bin-Gui			Independent Evolution of Six Families of Halogenating Enzymes	PLOS ONE			English	Article							HYDROLASE FOLD SUPERFAMILY; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; VANADIUM HALOPEROXIDASE; ACID-PHOSPHATASE; PROTEIN; BIOSYNTHESIS; CHLOROPEROXIDASE; MECHANISM; INTERMEDIATE	Halogenated natural products are widespread in the environment, and the halogen atoms are typically vital to their bioactivities. Thus far, six families of halogenating enzymes have been identified: cofactor-free haloperoxidases (HPO), vanadium-dependent haloperoxidases (V-HPO), heme iron-dependent haloperoxidases (HI-HPO), non-heme iron-dependent halogenases (NI-HG), flavin-dependent halogenases (F-HG), and S-adenosyl-L-methionine (SAM)-dependent halogenases (S-HG). However, these halogenating enzymes with similar biological functions but distinct structures might have evolved independently. Phylogenetic and structural analyses suggest that the HPO, V-HPO, HI-HPO, NI-HG, FHG, and S-HG enzyme families may have evolutionary relationships to the alpha/beta hydrolases, acid phosphatases, peroxidases, chemotaxis phosphatases, oxidoreductases, and SAM hydroxide adenosyltransferases, respectively. These halogenating enzymes have established sequence homology, structural conservation, and mechanistic features within each family. Understanding the distinct evolutionary history of these halogenating enzymes will provide further insights into the study of their catalytic mechanisms and halogenation specificity.	[Xu, Gangming; Wang, Bin-Gui] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Nanhai Rd 7, Qingdao 266071, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Xu, G (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Nanhai Rd 7, Qingdao 266071, Peoples R China.	aericxu@gmail.com	Wang, Bin-Gui/E-6324-2015	Wang, Bin-Gui/0000-0003-0116-6195; Xu, Gangming/0000-0003-2894-7805	National Natural Science Foundation of China [31330009, 31570038, 31200042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31330009, 31570038 and 31200042).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Bitto E, 2008, PROTEINS, V70, P289, DOI 10.1002/prot.21627; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Blasiak LC, 2009, ACCOUNTS CHEM RES, V42, P147, DOI 10.1021/ar800088r; Buedenbender S, 2009, J MOL BIOL, V385, P520, DOI 10.1016/j.jmb.2008.10.057; Butler A, 2009, NATURE, V460, P848, DOI 10.1038/nature08303; Cabrita MT, 2010, MAR DRUGS, V8, P2301, DOI 10.3390/md8082301; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; de Macedo-Ribeiro S, 2008, BIOCHEMISTRY-US, V47, P929, DOI 10.1021/bi7018628; Deng H, 2006, ANGEW CHEM INT EDIT, V45, P759, DOI 10.1002/anie.200503582; Deng H, 2008, ANGEW CHEM INT EDIT, V47, P5357, DOI 10.1002/anie.200800794; Deng H, 2008, CURR OPIN CHEM BIOL, V12, P582, DOI 10.1016/j.cbpa.2008.06.036; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Dong CJ, 2004, NATURE, V427, P561, DOI 10.1038/nature02280; Dorrestein PC, 2005, P NATL ACAD SCI USA, V102, P13843, DOI 10.1073/pnas.0506964102; Dunn G, 2005, J MOL BIOL, V346, P253, DOI 10.1016/j.jmb.2004.11.033; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Elmi F, 2005, J BACTERIOL, V187, P8470, DOI 10.1128/JB.187.24.8470-8476.2005; Eustaquio AS, 2008, NAT CHEM BIOL, V4, P69, DOI 10.1038/nchembio.2007.56; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fournier JB, 2014, APPL ENVIRON MICROB, V80, P7561, DOI 10.1128/AEM.02430-14; Gribble GW, 2003, CHEMOSPHERE, V52, P289, DOI 10.1016/S0045-6535(03)00207-8; Gu LC, 2009, NATURE, V459, P731, DOI 10.1038/nature07870; Hall B.G., 2016, PHYLOGENETIC TREES M; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HECHT HJ, 1994, NAT STRUCT BIOL, V1, P532, DOI 10.1038/nsb0894-532; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; Hofrichter M, 2015, ADV EXP MED BIOL, V851, P341, DOI 10.1007/978-3-319-16009-2_13; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Ishikawa K, 2000, EMBO J, V19, P2412, DOI 10.1093/emboj/19.11.2412; Isupov MN, 2000, J MOL BIOL, V299, P1035, DOI 10.1006/jmbi.2000.3806; Khare D, 2010, P NATL ACAD SCI USA, V107, P14099, DOI 10.1073/pnas.1006738107; Kuhnel K, 2006, J BIOL CHEM, V281, P23990, DOI 10.1074/jbc.M603166200; Leblanc C, 2015, COORDIN CHEM REV, V301, P134, DOI 10.1016/j.ccr.2015.02.013; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Lin S, 2007, J AM CHEM SOC, V129, P12432, DOI 10.1021/ja072311g; Littlechild J, 2002, J MOL RECOGNIT, V15, P291, DOI 10.1002/jmr.590; Loughran NB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-101; Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Messerschmidt A, 1996, P NATL ACAD SCI USA, V93, P392, DOI 10.1073/pnas.93.1.392; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pang AH, 2015, J STRUCT BIOL, V192, P349, DOI 10.1016/j.jsb.2015.09.013; Park SY, 2004, MOL CELL, V16, P563, DOI 10.1016/j.molcel.2004.10.018; Pazy Y, 2010, P NATL ACAD SCI USA, V107, P1924, DOI 10.1073/pnas.0911185107; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Piontek K, 2013, J BIOL CHEM, V288, P34767, DOI 10.1074/jbc.M113.514521; Podzelinska K, 2010, J MOL BIOL, V397, P316, DOI 10.1016/j.jmb.2010.01.020; Rao KN, 2008, PROTEINS, V70, P572, DOI 10.1002/prot.21646; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shaw E, 2002, PROTEINS, V47, P163, DOI 10.1002/prot.10083; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; van Pee KH, 2001, ARCH MICROBIOL, V175, P250, DOI 10.1007/s002030100263; Wang BG, 2013, CHEM REV, V113, P3632, DOI 10.1021/cr9002215; Weyand M, 1999, J MOL BIOL, V293, P595, DOI 10.1006/jmbi.1999.3179; Winter JM, 2009, J BIOL CHEM, V284, P18577, DOI 10.1074/jbc.R109.001602; Wong C, 2009, J AM CHEM SOC, V131, P4872, DOI 10.1021/ja8097355; Wong SD, 2013, NATURE, V499, P320, DOI 10.1038/nature12304; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Zehner S, 2005, CHEM BIOL, V12, P445, DOI 10.1016/j.chembiol.2005.02.005; Zhu XF, 2007, J AM CHEM SOC, V129, P14597, DOI 10.1021/ja0731569	69	11	11	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154619	10.1371/journal.pone.0154619	http://dx.doi.org/10.1371/journal.pone.0154619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153321	Green Submitted, Green Published, gold			2022-12-27	WOS:000375677000028
J	Yang, JY; Niu, H; Huang, YZ; Yang, KX				Yang, Jingyu; Niu, Heng; Huang, Yingze; Yang, Kunxian			A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; CARCINOMA IN-SITU; T-CADHERIN; RASSF1A PROMOTER; DNA METHYLATION; HYPERMETHYLATION; ASSOCIATION; PROGRESSION; EXPRESSION	Background CDH13 (cadherin 13) is a special cadherin cell adhesion molecule, and the methylation of its promoter causes inactivation in a considerable number of human cancers. To explore the association between CDH13 promoter methylation and breast cancer risk and prognosis, we systematically integrated published articles to investigate the diagnostic performance of the CDH13 methylation test for breast cancer. An independent DNA methylation microarray dataset from The Cancer Genome Atlas project (TCGA) project was used to validate the results of the meta-analysis. Methods The relevant literature was searched using the PubMed, Cochrane Library, Web of Science and Google Scholar databases for articles published in English up to May 2015. Data were analyzed using random effect or fixed effect models. The effect sizes were estimated by measuring an odds ratio (OR) or hazard ratio (HR) with a 95% confidence interval (CI). A chi-squared based Q test and sensitivity analysis were performed to examine the between-study heterogeneity and the contribution of single studies to the final results, respectively. Funnel plots were constructed to evaluate publication bias. Results Seven hundred and twenty-six breast tumor samples and 422 controls were collected from 13 published studies. The data from the TCGA set include both tumor and normal samples. A significant association was observed between CDH13 promoter methylation and breast cancer, with an aggregated OR equal to 13.73 (95% CI: 8.09 similar to 23.31, z = 9.70, p<0.0001) as measured using the fixed effect model and 14.23 (95% CI: 5.06 similar to 40.05, z = 5.03, p<0.0001) as measured using a random effect model. The HR values were calculated as 0.77 (95% CI: 0.27 similar to 2.21, z = -0.49, p = 0.622) and 0.38 (95% CI: 0.09 similar to 1.69, z = -1.27, p = 0.20) for overall survival (OS) and disease-free survival (DFS), respectively, using the random effect model. This result indicated that breast cancer patients with CDH13 promoter methylation correlated non-significantly with prognosis and is therefore similar to the findings of the TCGA project. Conclusions The methylation status of CDH13 promoter was strongly associated with breast cancer risk. However, CDH13 promoter methylation was not significantly related to the OS and DFS of breast cancer and may have limited prognostic value for breast cancer patients.	[Yang, Jingyu; Niu, Heng; Yang, Kunxian] First Peoples Hosp Yunnan Prov, Chest Surg, Panlong Campus,157 Jinbi Rd, Kunming 650000, Yunnan, Peoples R China; [Huang, Yingze] Kunming Univ Sci & Technol, Fac Med, Kunming 650500, Yunnan, Peoples R China	Kunming University of Science & Technology	Huang, YZ (corresponding author), Kunming Univ Sci & Technol, Fac Med, Kunming 650500, Yunnan, Peoples R China.	huangyingze88@163.com						Barinoff J, 2013, EUR J CANCER, V49, P305, DOI 10.1016/j.ejca.2012.07.027; Bernard W, 2014, WORLD CANC REPORT 20; Chen Kang Mei, 2011, Cancers (Basel), V3, P1580, DOI 10.3390/cancers3021580; Cho YH, 2012, BREAST CANCER RES TR, V131, P197, DOI 10.1007/s10549-011-1712-y; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M. DS G, 1997, BMJ OPEN; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Feng WW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-378; Hafez Mohamed M, 2015, Asian Pac J Cancer Prev, V16, P541; Hanabata T, 2004, ONCOL REP, V12, P177; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jo H, 2006, ONCOL RES, V16, P205, DOI 10.3727/000000006783981125; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jung EJ, 2013, ANN LAB MED, V33, P431, DOI 10.3343/alm.2013.33.6.431; Kawai Y, 2010, ANN ONCOL, V21, P1612, DOI 10.1093/annonc/mdp577; Kim H, 2004, J CLIN ONCOL, V22, P2363, DOI 10.1200/JCO.2004.10.077; Kioulafa M, 2009, CLIN BIOCHEM, V42, P970, DOI 10.1016/j.clinbiochem.2009.04.003; Kong DD, 2015, BREAST CANCER RES TR, V150, P119, DOI 10.1007/s10549-015-3302-x; Kornegoor R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3220; Lewis CM, 2005, CLIN CANCER RES, V11, P166; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martins AT, 2011, BREAST CANCER RES TR, V129, P1, DOI 10.1007/s10549-010-1160-0; Misawa A, 2009, BRIT J CANCER, V100, P399, DOI 10.1038/sj.bjc.6604887; Moelans CB, 2011, J PATHOL, V225, P222, DOI 10.1002/path.2930; Pang JMB, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0423-9; Riener MO, 2008, HUM PATHOL, V39, P1621, DOI 10.1016/j.humpath.2008.02.021; Riou P, 2006, FASEB J, V20, P2291, DOI 10.1096/fj.06-6085com; Rountree MR, 2001, ONCOGENE, V20, P3156, DOI 10.1038/sj.onc.1204339; Sato M, 1998, HUM GENET, V103, P96, DOI 10.1007/s004390050790; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Sproul D, 2011, P NATL ACAD SCI USA, V108, P4364, DOI 10.1073/pnas.1013224108; Takeuchi T, 2001, HISTOL HISTOPATHOL, V16, P1287, DOI 10.14670/HH-16.1287; Tanemura A, 2009, CLIN CANCER RES, V15, P1801, DOI 10.1158/1078-0432.CCR-08-1361; Toyooka KO, 2001, CANCER RES, V61, P4556; Twelves D, 2013, BREAST CANCER RES TR, V139, P341, DOI 10.1007/s10549-013-2544-8; van Hoesel AQ, 2013, BRIT J CANCER, V108, P2033, DOI 10.1038/bjc.2013.136; Verschuur-Maes AHJ, 2012, BREAST CANCER RES TR, V136, P705, DOI 10.1007/s10549-012-2301-4; Wang S, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-219; Xu J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-243; Zhong Yun-Hua, 2015, Asian Pac J Cancer Prev, V16, P1139	41	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0149185	10.1371/journal.pone.0149185	http://dx.doi.org/10.1371/journal.pone.0149185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153114	gold, Green Submitted, Green Published			2022-12-27	WOS:000375677000001
J	Aadil, F; Bajwa, KB; Khan, S; Chaudary, NM; Akram, A				Aadil, Farhan; Bajwa, Khalid Bashir; Khan, Salabat; Chaudary, Nadeem Majeed; Akram, Adeel			CACONET: Ant Colony Optimization (ACO) Based Clustering Algorithm for VANET	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; MOBILE	A vehicular ad hoc network (VANET) is a wirelessly connected network of vehicular nodes. A number of techniques, such as message ferrying, data aggregation, and vehicular node clustering aim to improve communication efficiency in VANETs. Cluster heads (CHs), selected in the process of clustering, manage inter-cluster and intra-cluster communication. The lifetime of clusters and number of CHs determines the efficiency of network. In this paper a Clustering algorithm based on Ant Colony Optimization (ACO) for VANETs (CACONET) is proposed. CACONET forms optimized clusters for robust communication. CACONET is compared empirically with state-of-the-art baseline techniques like Multi-Objective Particle Swarm Optimization (MOPSO) and Comprehensive Learning Particle Swarm Optimization (CLPSO). Experiments varying the grid size of the network, the transmission range of nodes, and number of nodes in the network were performed to evaluate the comparative effectiveness of these algorithms. For optimized clustering, the parameters considered are the transmission range, direction and speed of the nodes. The results indicate that CACONET significantly outperforms MOPSO and CLPSO.	[Aadil, Farhan; Bajwa, Khalid Bashir; Chaudary, Nadeem Majeed; Akram, Adeel] Univ Engn & Technol, Dept Comp Engn, Taxila 45020, Pakistan; [Aadil, Farhan] COMSATS Inst Informat Technol, Dept Comp Sci, Attock 43600, Pakistan	University of Engineering & Technology Taxila; COMSATS University Islamabad (CUI)	Aadil, F (corresponding author), Univ Engn & Technol, Dept Comp Engn, Taxila 45020, Pakistan.; Aadil, F (corresponding author), COMSATS Inst Informat Technol, Dept Comp Sci, Attock 43600, Pakistan.	farhan.aadil@uettaxila.edu.pk	akram, adeel/HGA-0692-2022; Aadil, Farhan/I-4043-2013	Aadil, Farhan/0000-0001-8737-2154; Majeed, Muhammad Nadeem/0000-0002-2041-728X				Abbasi AA, 2007, COMPUT COMMUN, V30, P2826, DOI 10.1016/j.comcom.2007.05.024; Aissa M, 2015, PROCEDIA COMPUT SCI, V52, P294, DOI 10.1016/j.procs.2015.05.088; Ali H, 2012, APPL SOFT COMPUT, V12, P1913, DOI 10.1016/j.asoc.2011.05.036; Aloise D, 2009, MACH LEARN, V75, P245, DOI 10.1007/s10994-009-5103-0; Alvarez-Benitez J E, 2005, EVOLUTIONARY MULTICR; BAKER DJ, 1981, IEEE T COMMUN, V29, P1694, DOI 10.1109/TCOM.1981.1094909; Basu P, 2001, DISTR COMP SYST WORK; Chatterjee M., 2002, Cluster Computing, V5, P193, DOI 10.1023/A:1013941929408; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; del Valle Y, 2008, IEEE T EVOLUT COMPUT, V12, P171, DOI 10.1109/TEVC.2007.896686; Dewri R., 2007, P 14 ACM C COMP COMM; Dorigo M, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.329691; Er II, 2004, WIR COMM NETW C 2004; Fathian M, 2015, WIRELESS PERS COMMUN, V83, P473, DOI 10.1007/s11277-015-2404-4; Gambardella L, 1999, NEW IDEAS OPTIMIZATI; Gerla M, 1995, WIREL NETW, V1, P255, DOI 10.1007/BF01200845; Gravel M, 2002, EUR J OPER RES, V143, P218, DOI 10.1016/S0377-2217(01)00329-0; Hadded M, 2015, EV COMP CEC 2015 IEE; Jothi KR, 2015, ADV INTELL SYST, V324, P275, DOI 10.1007/978-81-322-2126-5_31; Kennedy J, 1997, EV COMP 1997 IEEE IN; Kennedy J., 1998, EVOLUTIONARY PROGRAM, VVII; Khan S, 2014, APPL SOFT COMPUT, V16, P34, DOI 10.1016/j.asoc.2013.11.012; Kumar N, 2013, PERS UBIQUIT COMPUT, V17, P1683, DOI 10.1007/s00779-012-0600-8; Leong W-F, 2006, EV COMP 2006 CEC 200; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Lipowski A, 2012, PHYSICA A, V391, P2193, DOI 10.1016/j.physa.2011.12.004; Mostaghim S, 2004, EV COMP 2004 CEC2004; Ozturk C, 2015, APPL SOFT COMPUT, V28, P69, DOI 10.1016/j.asoc.2014.11.040; Rawashdeh Zaydoun Y, 2012, EURASIP J WIREL COMM, V2012, P1, DOI DOI 10.1186/1687-1499-2012-15; Shahzad W, 2009, COMM COM INF SC, V56, P342, DOI 10.1007/978-3-642-10844-0_41; Tseng YC, 2002, WIREL NETW, V8, P153, DOI 10.1023/A:1013763825347; Turgut D, 2002, GLOB TEL C 2002 GLOB	32	63	63	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154080	10.1371/journal.pone.0154080	http://dx.doi.org/10.1371/journal.pone.0154080			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149517	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800019
J	Hoffmann, OI; Kerekes, A; Liptak, N; Hiripi, L; Bodo, S; Szaloki, G; Klein, S; Ivics, Z; Kues, WA; Bosze, Z				Hoffmann, Orsolya I.; Kerekes, Andrea; Liptak, Nandor; Hiripi, Laszlo; Bodo, Szilard; Szaloki, Gabor; Klein, Sabine; Ivics, Zoltan; Kues, Wilfried A.; Bosze, Zsuzsanna			Transposon-Based Reporter Marking Provides Functional Evidence for Intercellular Bridges in the Male Germline of Rabbits	PLOS ONE			English	Article							PRONUCLEAR MICROINJECTION; TRANSGENESIS; EXPRESSION; CELLS; RODENTS	The Sleeping Beauty transposon system was established as a robust and efficient method for germline transgenesis in different mammalian species. The generation of transgenic mice, rats, rabbits and swine carrying an identical Venus reporter construct delivered by transposon-mediated gene transfer enables comparative studies of gene expression in these lines of mammalian models. Whereas comparable expression patterns of the Venus reporter were found in somatic tissues, preliminary studies suggested that a striking difference in reporter expression may exist in mature spermatozoa of these species. Here we clearly show the differential expression of Venus reporter protein during spermatogenesis of the two compared species, the laboratory rabbit and mice. We provide evidence for the functionality of intercellular bridges in the male germline and genotype-independent transgenic phenotype of rabbit spermatids. Our data suggest that the reporter rabbit line may be a suitable tool to identify molecular mechanisms in testicular development, and may contribute to develop better animal models for male infertility in men.	[Hoffmann, Orsolya I.; Kerekes, Andrea; Liptak, Nandor; Hiripi, Laszlo; Bodo, Szilard; Bosze, Zsuzsanna] NARIC Agr Biotechnol Inst, Godollo, Hungary; [Szaloki, Gabor] Univ Debrecen, Fac Med, Dept Biophys & Cell Biol, Debrecen, Hungary; [Klein, Sabine; Kues, Wilfried A.] Friedrich Loeffler Inst, Inst Nutztiergenet, Dept Biotechnol, Neustadt, Germany; [Ivics, Zoltan] Paul Ehrlich Inst, Langen, Germany	University of Debrecen; Friedrich Loeffler Institute; Paul Ehrlich Institute	Bosze, Z (corresponding author), NARIC Agr Biotechnol Inst, Godollo, Hungary.	bosze@abc.hu	Klein, Sabine/J-5325-2019; Bosze, Zsuzsanna/N-9689-2019; Lipták, Nándor/ABD-1954-2021; Hiripi, Laszlo/AAL-8243-2021	Klein, Sabine/0000-0001-7408-8445; Hiripi, Laszlo/0000-0002-1023-0112; Liptak, Nandor/0000-0002-9406-1482; Kues, Wilfried/0000-0002-0850-8103	Orszagos Tudomanyos Kutatasi Alapprogramok /OTKA/ grant [NN 108921]; OTKA [NN 108921]	Orszagos Tudomanyos Kutatasi Alapprogramok /OTKA/ grant; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Orszagos Tudomanyos Kutatasi Alapprogramok /OTKA/ grant: NN 108921 to Z.B.; The authors would like to thank Gergely Iski for the artwork. This work was supported by OTKA grant: NN 108921 to Z.B.	Al-Gubory KH, 2006, EUR J CELL BIOL, V85, P837, DOI 10.1016/j.ejcb.2006.03.007; Baczko I, 2014, CARDIOVASCULAR RES, V103; Bodrogi L, 2006, TRANSGENIC RES, V15, P627, DOI 10.1007/s11248-006-9015-5; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; Community Reference Laboratory for GM Food and Feed, 2007, RAPP EL LEG 3 JUIN 2, P1; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; Duranthon V, 2012, TRANSGENIC RES; FAWCETT DW, 1959, J BIOPHYS BIOCHEM CY, V5, P453, DOI 10.1083/jcb.5.3.453; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060; Garrels W, 2015, BIOTECHNOL J; Garrels W, 2012, TRENDS BIOTECHNOL, V30, P386, DOI 10.1016/j.tibtech.2012.03.008; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027563; Greenbaum MP, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005850; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Haglund Kaisa, 2011, Communicative & Integrative Biology, V4, P1, DOI 10.4161/cib.4.1.13550; Hiripi L, 2010, TRANSGENIC RES, V19, P799, DOI 10.1007/s11248-009-9356-y; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ivics Z, 2014, NAT PROTOC, V9, P810, DOI 10.1038/nprot.2014.010; Ivics Z, 2014, NAT PROTOC, V9, P794, DOI 10.1038/nprot.2014.009; Ivics Z, 2014, NAT PROTOC, V9, P773, DOI 10.1038/nprot.2014.008; Katter K, 2013, FASEB J, V27, P930, DOI 10.1096/fj.12-205526; KOVACS A, 1992, BIOTECH HISTOCHEM, V67, P119, DOI 10.3109/10520299209110020; Lemos APC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028869; Vigueras-Villasenor RM, 2013, ACTA HISTOCHEM, V115, P677, DOI 10.1016/j.acthis.2013.02.004; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Murakami Takashi, 2012, Methods Mol Biol, V872, P177, DOI 10.1007/978-1-61779-797-2_12; Nagy S, 1999, THERIOGENOLOGY, V52, P1153, DOI 10.1016/S0093-691X(99)00207-1; Ricken AM, 2002, BIOL REPROD, V67, P196, DOI 10.1095/biolreprod67.1.196; Takahashi R, 2007, TRANSGENIC RES, V16, P115, DOI 10.1007/s11248-006-9043-1; Turchiano G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112712; Voigt K, 2012, MOL THER, V20, P1852, DOI 10.1038/mt.2012.126; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047	33	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154489	10.1371/journal.pone.0154489	http://dx.doi.org/10.1371/journal.pone.0154489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148973	gold, Green Published			2022-12-27	WOS:000375676800034
J	Ye, CY; Xu, MY; Wang, SD; Jiang, S; Chen, X; Zhou, XY; He, RX				Ye, Chenyi; Xu, Mingyuan; Wang, Shengdong; Jiang, Shuai; Chen, Xi; Zhou, Xiaoyu; He, Rongxin			Decreased Bone Mineral Density Is an Independent Predictor for the Development of Atherosclerosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							INTIMA-MEDIA THICKNESS; CORONARY-ARTERY-DISEASE; POSTMENOPAUSAL WOMEN; SUBCLINICAL ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; VASCULAR CALCIFICATION; CAROTID ATHEROSCLEROSIS; AORTIC CALCIFICATION; FRACTURE RISK; OSTEOPOROSIS	Background There is conflicting evidence regarding the association between decreased bone mineral density (BMD) and atherosclerosis. To this end, we performed a systematic review and meta-analysis to clarify the association. Methods To identify relevant studies, PubMed, Embase, and the Cochrane Library were systematically searched up to November 2015. All observational and comparative studies directly investigating the relationship between decreased BMD and clinical consequences of atherosclerotic vascular abnormalities, including carotid artery calcification (CAC), cardiovascular disease (CAD), and coronary artery disease (CAD) were obtained, without limitation of language or publication year. Results A total of 25 studies involving 10,299 patients were included. The incidence of atherosclerotic vascular abnormalities was significantly increased in low BMD patients, compared to patients with normal BMD (OR, 1.81, 95% CI [1.01, 2.19], p<0.00001)). Similar results were also observed for postmenopausal women (OR, 2.23, 95% CI [1.72, 2.89], p<0.00001). Subgroup analyses of osteopenia, osteoporosis, and normal BMD also revealed that the combined ORs for the incidence of atherosclerotic vascular abnormalities increased as BMD decreased. Of note, after adjusting for age, sex, body mass index (BMI) and other vascular risk factors, decreased BMD remained significantly associated with the incidence of atherosclerotic vascular abnormalities (OR, 2.96, 95% CI [2.25, 3.88], p<0.00001). Conclusions Based on the results of this study, decreased BMD is an independent predictor for the development of atherosclerosis in elderly individuals. Moreover, the risk of atherosclerotic vascular abnormalities increased as BMD decreased. Future studies focusing on individuals with different severities of atherosclerosis and comorbidities are of interest.	[Ye, Chenyi; Wang, Shengdong; Jiang, Shuai; Chen, Xi; Zhou, Xiaoyu; He, Rongxin] Zhejiang Univ, Sch Med, Dept Orthoped, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Mingyuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Plast Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	He, RX (corresponding author), Zhejiang Univ, Sch Med, Dept Orthoped, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	herongxin666@163.com			National Natural Science Foundation of China [81572124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81572124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China (No. 81572124).	AMBROSE JA, 1985, J AM COLL CARDIOL, V6, P1233, DOI 10.1016/S0735-1097(85)80207-2; Aoyagi K, 2001, CALCIFIED TISSUE INT, V69, P20, DOI 10.1007/s002230020003; Bagger YZ, 2006, J INTERN MED, V259, P598, DOI 10.1111/j.1365-2796.2006.01640.x; Barengolts EI, 1998, CALCIFIED TISSUE INT, V62, P209, DOI 10.1007/s002239900419; Beer S, 2010, OSTEOPOROSIS INT, V21, P1695, DOI 10.1007/s00198-009-1103-y; Bekker PJ, 2001, J BONE MINER RES, V16, P348, DOI 10.1359/jbmr.2001.16.2.348; Bini A, 1999, ARTERIOSCL THROM VAS, V19, P1852, DOI 10.1161/01.ATV.19.8.1852; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Bostrom K, 2001, J BIOL CHEM, V276, P14044, DOI 10.1074/jbc.M008103200; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Celczynska-Bajew L, 2011, KARDIOL POL, V69, P573; Choi SH, 2009, CLIN ENDOCRINOL, V71, P644, DOI 10.1111/j.1365-2265.2009.03535.x; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; den Uyl D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3224; Dhore CR, 2001, ARTERIOSCL THROM VAS, V21, P1998, DOI 10.1161/hq1201.100229; DOHERTY TM, 1994, CALCIFIED TISSUE INT, V54, P224, DOI 10.1007/BF00301683; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Farhat GN, 2006, J BONE MINER RES, V21, P1839, DOI 10.1359/JBMR.060903; Fodor D, 2011, SAO PAULO MED J, V129, P139, DOI 10.1590/S1516-31802011000300004; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Genant HK, 1999, OSTEOPOROSIS INT, V10, P259, DOI 10.1007/s001980050224; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Gupta G, 2006, ARCH GERONTOL GERIAT, V43, P285, DOI 10.1016/j.archger.2005.11.003; Hajsadeghi S, 2011, J SAUDI HEART ASSOC, V23, P143, DOI 10.1016/j.jsha.2011.03.001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hmamouchi I, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-388; Hofbauer LC, 2007, OSTEOPOROSIS INT, V18, P251, DOI 10.1007/s00198-006-0282-z; Hyder JA, 2007, CALCIFIED TISSUE INT, V80, P301, DOI 10.1007/s00223-007-9004-6; Hyder JA, 2010, ATHEROSCLEROSIS, V209, P283, DOI 10.1016/j.atherosclerosis.2009.09.011; Issever AS, 2013, EUR RADIOL, V23, P2823, DOI 10.1007/s00330-013-2903-1; Jorgensen L, 2004, AM J EPIDEMIOL, V160, P549, DOI 10.1093/aje/kwh252; Jorgensen L, 2001, STROKE, V32, P47, DOI 10.1161/01.STR.32.1.47; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kiel DP, 2001, CALCIFIED TISSUE INT, V68, P271, DOI 10.1007/BF02390833; Kim Nam Lee, 2014, J Bone Metab, V21, P133, DOI 10.11005/jbm.2014.21.2.133; Kong XL, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-37; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee RT, 1996, ARTERIOSCL THROM VAS, V16, P1070, DOI 10.1161/01.ATV.16.8.1070; Liang DK, 2014, J CLIN ENDOCR METAB, V99, P469, DOI 10.1210/jc.2013-2572; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Marcovitz PA, 2005, AM J CARDIOL, V96, P1059, DOI 10.1016/j.amjcard.2005.06.034; McFarlane SI, 2004, ENDOCRINE, V23, P1, DOI 10.1385/ENDO:23:1:01; Mikumo M, 2009, J BONE MINER METAB, V27, P89, DOI 10.1007/s00774-008-0014-x; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Montalcini T, 2004, AM J CARDIOL, V94, P266, DOI 10.1016/j.amjcard.2004.03.083; Ng KW, 2014, CURR OPIN PHARMACOL, V16, P58, DOI 10.1016/j.coph.2014.03.004; Pennisi P, 2010, MATURITAS, V67, P358, DOI 10.1016/j.maturitas.2010.07.013; Coutinho MDAP, 2013, CLIN MED INSIGHTS-EN, V6, P1, DOI 10.4137/CMED.S11843; Prasad M, 2014, VASC HEALTH RISK MAN, V10, P533, DOI 10.2147/VHRM.S63580; Reddy J, 2008, J CLIN ENDOCR METAB, V93, P208, DOI 10.1210/jc.2007-0693; SCHMID K, 1980, ATHEROSCLEROSIS, V37, P199, DOI 10.1016/0021-9150(80)90005-2; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Seo Seok Kyo, 2015, Obstet Gynecol Sci, V58, P144, DOI 10.5468/ogs.2015.58.2.144; Seo SK, 2009, MENOPAUSE, V16, P937, DOI 10.1097/gme.0b013e3181a15552; Shaffer JR, 2007, CALCIFIED TISSUE INT, V81, P430, DOI 10.1007/s00223-007-9079-0; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Shokry M, 2012, MIDDLE EAST FERTIL S, V17, P181, DOI 10.1016/j.mefs.2012.05.003; Sinnott B, 2006, CALCIFIED TISSUE INT, V78, P195, DOI 10.1007/s00223-005-0244-z; Smith SC, 1996, CIRCULATION, V93, P2205, DOI 10.1161/01.CIR.93.12.2205; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sumino H, 2008, HYPERTENS RES, V31, P1191, DOI 10.1291/hypres.31.1191; Tamaki J, 2009, OSTEOPOROSIS INT, V20, P53, DOI 10.1007/s00198-008-0633-z; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Tekin GO, 2008, INT J CARDIOL, V131, P66, DOI 10.1016/j.ijcard.2007.09.002; Tella SH, 2014, J STEROID BIOCHEM, V142, P155, DOI 10.1016/j.jsbmb.2013.09.008; Teng ZY, 2013, BONE, V56, P343, DOI 10.1016/j.bone.2013.07.001; van der Klift M, 2002, CALCIFIED TISSUE INT, V70, P443, DOI 10.1007/s00223-001-2076-9; Varma R, 2008, AM J CARDIOL, V101, P1103, DOI 10.1016/j.amjcard.2007.12.013; Varri M, 2014, MATURITAS, V78, P304, DOI 10.1016/j.maturitas.2014.05.017; von der Recke P, 1999, AM J MED, V106, P273, DOI 10.1016/S0002-9343(99)00028-5; Walter SD, 2007, J CLIN EPIDEMIOL, V60, P849, DOI 10.1016/j.jclinepi.2006.11.003; Wang YQ, 2015, J THORAC DIS, V7, P790, DOI 10.3978/j.issn.2072-1439.2015.04.47; Welt F G, 2001, Catheter Cardiovasc Interv, V53, P56, DOI 10.1002/ccd.1130; Yamada S, 2006, ATHEROSCLEROSIS, V188, P196, DOI 10.1016/j.atherosclerosis.2005.10.036; Yesil Y, 2012, ARCH GERONTOL GERIAT, V54, P473, DOI 10.1016/j.archger.2011.06.007; Yu XY, 2015, ARCH GERONTOL GERIAT, V61, P76, DOI 10.1016/j.archger.2015.03.011	78	54	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154740	10.1371/journal.pone.0154740	http://dx.doi.org/10.1371/journal.pone.0154740			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149062	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800055
J	Andjelkovic, M; Tadic, B; Dankulov, MM; Rajkovic, M; Melnik, R				Andjelkovic, Miroslav; Tadic, Bosiljka; Dankulov, Marija Mitrovic; Rajkovic, Milan; Melnik, Roderick			Topology of Innovation Spaces in the Knowledge Networks Emerging through Questions-And-Answers	PLOS ONE			English	Article							ONLINE; DYNAMICS	The communication processes of knowledge creation represent a particular class of human dynamics where the expertise of individuals plays a substantial role, thus offering a unique possibility to study the structure of knowledge networks from online data. Here, we use the empirical evidence from questions-and-answers in mathematics to analyse the emergence of the network of knowledge contents (or tags) as the individual experts use them in the process. After removing extra edges from the network-associated graph, we apply the methods of algebraic topology of graphs to examine the structure of higher-order combinatorial spaces in networks for four consecutive time intervals. We find that the ranking distributions of the suitably scaled topological dimensions of nodes fall into a unique curve for all time intervals and filtering levels, suggesting a robust architecture of knowledge networks. Moreover, these networks preserve the logical structure of knowledge within emergent communities of nodes, labeled according to a standard mathematical classification scheme. Further, we investigate the appearance of new contents over time and their innovative combinations, which expand the knowledge network. In each network, we identify an innovation channel as a subgraph of triangles and larger simplices to which new tags attach. Our results show that the increasing topological complexity of the innovation channels contributes to network's architecture over different time periods, and is consistent with temporal correlations of the occurrence of new tags. The methodology applies to a wide class of data with the suitable temporal resolution and clearly identified knowledge-content units.	[Andjelkovic, Miroslav; Rajkovic, Milan] Univ Belgrade, Inst Nucl Sci, Belgrade, Serbia; [Tadic, Bosiljka] Jozef Stefan Inst, Dept Theoret Phys, Ljubljana, Slovenia; [Dankulov, Marija Mitrovic] Univ Belgrade, Inst Phys Belgrade, Comp Sci Lab, Zemun Belgrade, Serbia; [Melnik, Roderick] Wilfrid Laurier Univ, Lab M2NeT, Interdisciplinary Res Inst MS2Discovery, Waterloo, ON N2L 3C5, Canada; [Melnik, Roderick] Wilfrid Laurier Univ, Dept Math, Waterloo, ON N2L 3C5, Canada; [Melnik, Roderick] BCAM, E-48009 Bilbao, Basque Country, Spain	University of Belgrade; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Belgrade; Wilfrid Laurier University; Wilfrid Laurier University; Basque Center for Applied Mathematics (BCAM)	Tadic, B (corresponding author), Jozef Stefan Inst, Dept Theoret Phys, Ljubljana, Slovenia.	bosiljka.tadic@ijs.si	MELNIK, RODERICK/AAT-9345-2021; Tadic, Bosiljka/X-3144-2019; Dankulov, Marija Mitrovic/I-3007-2012; Rajkovic, Milan/AAH-5323-2020	Dankulov, Marija Mitrovic/0000-0002-8484-3501; Rajkovic, Milan/0000-0001-5552-087X; Andjelkovic, Miroslav/0000-0002-4449-8934; Tadic, Bosiljka/0000-0002-8147-2741; Melnik, Roderick/0000-0002-1560-6684	Ministry of Education, Science, and Technological Development of the Republic of Serbia [ON174014, ON171017]; Research Agency of the Republic of Slovenia [P1-0044]; Natural Sciences and Engineering Research Council of Canada [213904]	Ministry of Education, Science, and Technological Development of the Republic of Serbia; Research Agency of the Republic of Slovenia(Slovenian Research Agency - Slovenia); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Ministry of Education, Science, and Technological Development of the Republic of Serbia (http://www.mpn.gov.rs/), under the projects ON174014, ON171017; Research Agency of the Republic of Slovenia (https://www.arrs.gov.si/en/agencija/), under the Program P1-0044; and Natural Sciences and Engineering Research Council of Canada, (http://www.nserc-crsng.gc.ca/), under the project code 213904.	Andjelkovic M, 2015, PHYSICA A, V436, P582, DOI 10.1016/j.physa.2015.05.075; Andjelkovic M, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.052817; Bandelt HJ, 2008, CONTEMP MATH, V453, P49; Blasco-Arcas L, 2014, SERV IND J, V34, P677, DOI 10.1080/02642069.2014.886190; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boudreau K., 2014, 114060 HARV U; Bowker Geoffrey, 2014, SOCIAL SCI TECHNICAL; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Carpendale JIM, 2013, SOCIAL INTERACTIONS; Dankulov MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12197; Dianati N, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.012304; Dorogovtsev S, 2010, COMPLEX NETWORKS; Estrada E, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042819; Fortino G, 2015, INFORM FUSION, V22, P50, DOI 10.1016/j.inffus.2014.03.005; Fortunato S, 2012, BOOK CITATION NETWOR; Jonsson J., 2008, LECT NOTES MATH; Kimmerle J, 2010, KNOWL MAN RES PRACT, V8, P33, DOI 10.1057/kmrp.2009.36; Kitchener RF, 2013, SOCIAL INTERACTIONS, P45; Kotsireas I, 2011, AM I PHYS, V1368; Kuhn T, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041036; Lakhani KR, 2003, RES POLICY, V32, P923, DOI 10.1016/S0048-7333(02)00095-1; Lambiotte R, 2015, IEEE T NETWORK SCI E, V1, P76, DOI DOI 10.1109/TNSE.2015.2391998; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Leibon G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067508; Maletic S, 2014, PHYSICA A, V397, P111, DOI 10.1016/j.physa.2013.12.001; Maletic S, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500555; Seraj M, 2012, J INTERACT MARK, V26, P209, DOI 10.1016/j.intmar.2012.03.002; Sloan S, 2015, QUAL MARK RES, V18, P320, DOI 10.1108/QMR-11-2013-0078; Sloot PMA, 2012, J COMPUT SCI-NETH, V3, P247, DOI 10.1016/j.jocs.2012.07.001; Tadic B, 2013, ENTROPY-SWITZ, V15, P5084, DOI 10.3390/e15125084; Thessen AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089550; Tria F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05890; Uddin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123537	33	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154655	10.1371/journal.pone.0154655	http://dx.doi.org/10.1371/journal.pone.0154655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171149	Green Published, gold			2022-12-27	WOS:000376588600150
J	Habib, MA; Black, K; Soofi, SB; Hussain, I; Bhatti, Z; Bhutta, ZA; Raynes-Greenow, C				Habib, Muhammad Atif; Black, Kirsten; Soofi, Sajid Bashir; Hussain, Imtiaz; Bhatti, Zaid; Bhutta, Zulfiqar A.; Raynes-Greenow, Camille			Prevalence and Predictors of Iron Deficiency Anemia in Children under Five Years of Age in Pakistan, A Secondary Analysis of National Nutrition Survey Data 2011-2012	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; FOOD INSECURITY; YOUNG-CHILDREN; CORD BLOOD; SUPPLEMENTATION; DETERMINANTS; DIAGNOSIS; INFANTS; IMPACT	Background Iron deficiency Anemia (IDA) in children is a recognized public health problem that impacts adversely on child morbidity, mortality and impairs cognitive development. In Pakistan information on the true prevalence and predictors of IDA is limited. This study sought to investigate IDA in children under five years of age using data from a nationally representative stratified cross-sectional survey. Methods Secondary analysis was performed on the National Nutrition Survey in Pakistan 2011-2012. We used a pre-structured instrument to collect socio demographic and nutritional data on mothers and children. We also collected Anthropometric measurements and blood samples for micronutrient deficiencies. IDA was defined as having both haemoglobin levels of < 110 g/L and ferritin levels of < 12 mu g/L. Data analysis was performed by applying univariate and multivariate techniques using logistic regression through SPSS. Findings A total of 7138 children aged between 6-59 months were included in the analysis. The prevalence of IDA was 33.2%. In multivariate regression analysis adjusted odds ratios (AOR) were calculated. Age < 24 months (AOR 1.40, 95% CI 1.18-1.55 p < 0.05), stunting (AOR 1.42 CI 1.23-1.63 p<0.05), presence of clinical anemia (AOR 5.69 CI 4.93-6.56 p<0.05), having a mother with IDA (AOR 1.72 CI 1.47-2.01 p<0.05) and household food insecurity (AOR 1.20 CI 1.10-1.40 P<0.05) were associated with IDA. Living in a rural area (AOR 0.77 CI 0.65-0.90 p<0.05) and being a female child (AOR 0.87 CI 0.76-0.98 p<0.05) were associated with reduced odds of IDA. Conclusion The prevalence of IDA amongst Pakistani children represents a moderate burden that disproportionately affects the youngest, growth retarded children, affected children are more likely to have mothers with IDA and live in areas where food security is lacking. National efforts to alleviate the burden of IDA should involve both short term vertical programs such as iron supplementation and long term horizontal programs including wheat flour fortification.	[Habib, Muhammad Atif; Black, Kirsten] Univ Sydney, Cent Clin Sch, Discipline Obstet Gynaecol & Neonatol, Sydney, NSW 2006, Australia; [Habib, Muhammad Atif; Soofi, Sajid Bashir; Hussain, Imtiaz; Bhatti, Zaid; Bhutta, Zulfiqar A.] Aga Khan Univ, Women & Child Hlth Div, Karachi, Pakistan; [Raynes-Greenow, Camille] Univ Sydney, Sydney Sch Publ Hlth, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; Aga Khan University; University of Sydney	Habib, MA (corresponding author), Univ Sydney, Cent Clin Sch, Discipline Obstet Gynaecol & Neonatol, Sydney, NSW 2006, Australia.; Habib, MA (corresponding author), Aga Khan Univ, Women & Child Hlth Div, Karachi, Pakistan.	mhab4985@uni.sydney.edu.au	Hussain, Imtiaz/GZA-6905-2022; Bhutta, Zulfiqar/L-7822-2015	Bhutta, Zulfiqar/0000-0003-0637-599X; Black, Kirsten/0000-0003-0030-2431	UNICEF; Commonwealth Department of Industry, Australia; NHMRC; University of Sydney	UNICEF; Commonwealth Department of Industry, Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney)	The National Nutrition Survey was funded by UNICEF. MAH is a PhD Students at University of Sydney and is funded through International Post graduate research scholarship and Australian Post Graduate Award funded by the Commonwealth Department of Industry, Australia; and CRG's funding through an NHMRC career development fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This manuscript is a part of MAH's thesis to fulfill the requirement for a PhD at the University of Sydney. We are grateful to the Women and Child Health Division, Aga Khan University for providing the data of National Nutrition Survey 2011-12 for secondary analysis. We are also thankful to the University of Sydney for funding MAH's PhD scholarship (IPRS/APA) and CRG's funding through an NHMRC career development fellowship. We would like to thank all the participants who took part in the study, the interviewers, the laboratory technicians, the data editors, and the data operators.	Ahmed A, 2014, CRIT REV FOOD SCI, V54, P1617, DOI 10.1080/10408398.2011.645087; Akhtar S, 2013, ASIA PAC J CLIN NUTR, V22, P340, DOI 10.6133/apjcn.2013.22.3.17; Al-Zabedi E.M., 2014, AM J HLTH RES, V2, P319, DOI DOI 10.11648/J.AJHR.20140205.26; [Anonymous], 2013, GLOB BURD DIS GEN EV; [Anonymous], MICR DEF IR DEF AN; Badham J, 2007, GUIDEBOOK NUTR ANEMI; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bernard S, 2013, ANEMIA, V2013; Bhutta ZA, 2009, FOOD NUTR BULL, V30, pS496, DOI 10.1177/15648265090304S404; Bin Nisar Y, 2016, MATERN CHILD NUTR, V12, P85, DOI 10.1111/mcn.12156; Black MM, 2011, NUTR REV, V69, pS64, DOI 10.1111/j.1753-4887.2011.00435.x; Charles C.V., 2012, PUBLIC HLTH ENV SYST, V2012, P109; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Das JK, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-67; Desalegn A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114059; El-Hioui M., 2008, Pakistan Journal of Nutrition, V7, P400, DOI 10.3923/pjn.2008.400.403; Foote EM, 2013, AM J TROP MED HYG, V88, P757, DOI 10.4269/ajtmh.12-0560; Gera T, 2007, J PEDIATR GASTR NUTR, V44, P468, DOI 10.1097/01.mpg.0000243440.85452.38; Grant FKE, 2012, J NUTR, V142, P105, DOI 10.3945/jn.111.146316; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; GUYATT GH, 1992, J GEN INTERN MED, V7, P145, DOI 10.1007/BF02598003; HAMEDANI P, 1987, CURR MED RES OPIN, V10, P480, DOI 10.1185/03007998709112407; Hashizume M, 2003, J TROP PEDIATRICS, V49, P172, DOI 10.1093/tropej/49.3.172; IBM Corp, 2010, IBM SPSS STAT WIND V; Jyothsna Kudaravalli, 2011, Annals of Biological Research, V2, P209; Kaur IP, 2011, J EXERCISE SCI PHYSI, V7, P11; Keikhaei B, 2007, FOOD NUTR BULL, V28, P406, DOI 10.1177/156482650702800405; Kugelman M, 2010, HUNGER PAINS PAKISTA; Kumar A, 2008, PEDIATRICS, V121, pE673, DOI 10.1542/peds.2007-1986; Layrisse Miguel, 2002, Food and Nutrition Bulletin, V23, P384; Lozoff Betsy, 2006, Semin Pediatr Neurol, V13, P158, DOI 10.1016/j.spen.2006.08.004; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Molla A, 1992, PREVALENCE IRON DEFI; National Institute of Population Studies (NIPS) [Pakistan] Macro International Inc, 2013, PAK DEM HLTH SURV 20; Onimawo I, 2010, AFRICAN J FOOD AGR N, V10; Pakistan Institute of Development Economics, 2004, NAT NUTR SURV 2001 2; Paracha Parvez I., 1997, JPMA (Journal of the Pakistan Medical Association), V47, P49; Park K, 2009, PUBLIC HEALTH NUTR, V12, P2120, DOI 10.1017/S1368980009005540; Pasricha SR, 2013, LANCET GLOB HEALTH, V1, pE77, DOI 10.1016/S2214-109X(13)70046-9; Pasricha SR, 2013, BLOOD, V121, P2607, DOI 10.1182/blood-2012-09-453522; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Pasricha SRS, 2010, MED J AUSTRALIA, V193, P525, DOI 10.5694/j.1326-5377.2010.tb04038.x; Rahbar Mohammad H., 2007, Toxicological and Environmental Chemistry, V89, P337, DOI 10.1080/02772240601025038; Sadighi J, 2009, PUBLIC HEALTH, V123, P794, DOI 10.1016/j.puhe.2009.09.024; Scott SP, 2014, NUTRIENTS, V6, P5915, DOI 10.3390/nu6125915; Singla PN, 1996, ACTA PAEDIATR, V85, P1327, DOI 10.1111/j.1651-2227.1996.tb13919.x; Sirdah Mahmoud Mohammed, 2014, Rev. Bras. Hematol. Hemoter., V36, P132, DOI 10.5581/1516-8484.20140030; Skalicky A, 2006, MATERN CHILD HLTH J, V10, P177, DOI 10.1007/s10995-005-0036-0; Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7; Stoltzfus RJ, 2001, J NUTR, V131, p565S, DOI 10.1093/jn/131.2.565S; Sweet DG, 2001, ARCH DIS CHILD-FETAL, V84, pF40, DOI 10.1136/fn.84.1.F40; Sylvetsky AC, 2011, INTERMITTENT IRON SU; Tazhibayev S, 2008, FOOD NUTR BULL, V29, P255, DOI 10.1177/156482650802900402; Tengco LW, 2008, J AM COLL NUTR, V27, P229, DOI 10.1080/07315724.2008.10719695; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; WHO, 2011, WHONMHNHDNMN111; WHO, 2009, ANTHR PLUS PERS COMP; WHO UNCF UNU, 2001, IR DEF AN ASS PREV C; World Food Programme (WFP) and the Centers for Disease Control and Prevention (CDC), 2005, MANUAL MEASURING INT	59	36	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155051	10.1371/journal.pone.0155051	http://dx.doi.org/10.1371/journal.pone.0155051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171139	Green Submitted, Green Published, gold			2022-12-27	WOS:000376588600108
J	Sabin, K; Zhao, JK; Calleja, JMG; Sheng, Y; Garcia, SA; Reinisch, A; Komatsu, R				Sabin, Keith; Zhao, Jinkou; Calleja, Jesus Maria Garcia; Sheng, Yaou; Garcia, Sonia Arias; Reinisch, Annette; Komatsu, Ryuichi			Availability and Quality of Size Estimations of Female Sex Workers, Men Who Have Sex with Men, People Who Inject Drugs and Transgender Women in Low- and Middle-Income Countries	PLOS ONE			English	Article							HIV-INFECTION; KEY POPULATIONS; PREVENTION; BURDEN; PLACES; NUMBER; USERS; RISK	Objective To assess the availability and quality of population size estimations of female sex workers (FSW), men who have sex with men (MSM), people who inject drug (PWID) and transgender women. Methods Size estimation data since 2010 were retrieved from global reporting databases, Global Fund grant application documents, and the peer-reviewed and grey literature. Overall quality and availability were assessed against a defined set of criteria, including estimation methods, geographic coverage, and extrapolation approaches. Estimates were compositely categorized into 'nationally adequate', 'nationally inadequate but locally adequate', 'documented but inadequate methods', 'undocumented or untimely' and 'no data.' Findings Of 140 countries assessed, 41 did not report any estimates since 2010. Among 99 countries with at least one estimate, 38 were categorized as having nationally adequate estimates and 30 as having nationally inadequate but locally adequate estimates. Multiplier, capture-recapture, census and enumeration, and programmatic mapping were the most commonly used methods. Most countries relied on only one estimate for a given population while about half of all reports included national estimates. A variety of approaches were applied to extrapolate from sites-level numbers to national estimates in two-thirds of countries. Conclusions Size estimates for FSW, MSM, PWID and transgender women are increasingly available but quality varies widely. The different approaches present challenges for data use in design, implementation and evaluation of programs for these populations in half of the countries assessed. Guidance should be further developed to recommend: a) applying multiple estimation methods; b) estimating size for a minimum number of sites; and, c) documenting extrapolation approaches.	[Sabin, Keith; Garcia, Sonia Arias] Joint United Nations Programme HIV AIDS, Strateg Informat & Evaluat Dept, Geneva, Switzerland; [Zhao, Jinkou; Sheng, Yaou; Reinisch, Annette] Global Fund Fight AIDS TB & Malaria, Tech Advice & Partnerships Dept, Geneva, Switzerland; [Zhao, Jinkou] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Calleja, Jesus Maria Garcia] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Komatsu, Ryuichi] Global Fund fight AIDS TB & Malaria, Tech Evaluat Reference Grp Support Team, Geneva, Switzerland	Jiangsu Provincial Center for Disease Control & Prevention; World Health Organization	Zhao, JK (corresponding author), Global Fund Fight AIDS TB & Malaria, Tech Advice & Partnerships Dept, Geneva, Switzerland.; Zhao, JK (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	jinkou.zhao@theglobalfund.org		Zhao, Jinkou/0000-0001-9184-3385; Sabin, Keith/0000-0002-2290-8621	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Abdul-Quader AS, 2014, CURR OPIN HIV AIDS, V9, P107, DOI 10.1097/COH.0000000000000041; Aceijas C, 2006, SEX TRANSM INFECT, V82, pIII10, DOI 10.1136/sti.2005.019471; Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Caceres C, 2006, SEX TRANSM INFECT, V82, pIII3, DOI 10.1136/sti.2005.019489; Conrad C, 2015, MMWR-MORBID MORTAL W, V64, P443; Dutta A, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9776-3; Emmanuel F, 2013, EXPERT REV ANTI-INFE, V11, P451, DOI [10.1586/ERI.13.33, 10.1586/eri.13.33]; Handcock MS, 2015, BIOMETRICS, V71, P258, DOI 10.1111/biom.12255; Khalid FJ, 2014, AIDS BEHAV, V18, pS25, DOI 10.1007/s10461-013-0517-x; Low-Beer D, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001523; Mutagoma M, 2014, INT J STD AIDS; Okal J, 2013, SEX TRANSM INFECT, V89, P366, DOI 10.1136/sextrans-2013-051071; Quaye S, 2015, AIDS BEHAV, V19, pS16, DOI 10.1007/s10461-014-0943-4; The Global Fund, GRANT PORTF; UNAIDS, 2014, 2014 PROGR REP SUBM; UNAIDS, UNAIDS REG SUPP TEAM; (UNAIDS) UJPoHA, THE GAP REP 2014; UNAIDS/WHO Working Group, 2011, GUID EST SIZ POP MOS; UNDP, 2012, RISKS RIGHTS HLTH; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; WHO UNODC UNAIDS, 2013, TECHN GUID COUNTR SE; Wilson P, 2011, ACCESS HIV PREVENTIO; Wohl DA, 2011, AIDS BEHAV, V15, P283, DOI 10.1007/s10461-010-9746-4; World Health Organization, 2013, GUID COND PROGR REV; World Health Organization United Nations Population Fund Joint United Nations Programme on HIV/AIDS Global Network of Sex Work Projects, 2012, PREV TREATM HIV OTH, P16; Yu DB, 2014, WEST PAC SURVEILL RE, V5, P43, DOI [10.5365/WPSAR.2014.5.2.008, 10.5365/wpsar.2014.5.2.008]	30	43	44	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155150	10.1371/journal.pone.0155150	http://dx.doi.org/10.1371/journal.pone.0155150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163256	Green Published, gold, Green Submitted			2022-12-27	WOS:000376585700009
J	Pandey, KR; Meltzer, DO				Pandey, Kiran Raj; Meltzer, David O.			Financial Burden and Impoverishment Due to Cardiovascular Medications in Low and Middle Income Countries: An Illustration from India	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; OF-POCKET PAYMENTS; DISEASE PREVENTION; HEALTH-CARE; TASK-FORCE; RISK; HYPERTENSION; EXPENDITURES; PREVALENCE; GUIDELINES	Background Health expenditures are a major financial burden for many persons in low and middle-income countries, where individuals often lack health insurance. We estimate the effect of purchasing cardiovascular medicines on poverty in low and middle-income populations using rural and urban India as an example. Methods We created step-up treatment regimens for prevention of ischemic heart disease for the most common cardiovascular medications in India based on their cost and relative risk reduction. Cost was measured by Government of India mandated ceiling prices in rupees (Rs. 1 = $0.016) for essential medicines plus taxes. We calculated step-wise projected incidence and intensity of impoverishment due to medicine purchase. To do this we measured the resources available to individuals as daily per-capita expenditures from the latest National Sample Survey, subtracted daily medication costs, and compared this to 2014 poverty thresholds recommended by an expert group. Findings Analysis of cost-effectiveness resulted in five primary prevention drug regimens, created by progressive addition of Aspirin 75 mg, Hydrochlorothiazide 12.5mg, Losartan 25 mg, and Atorvastatin 10 mg or 40mg. Daily cost from steps 1 to 5 increased from Rs. 0.13, Rs. 1.16, Rs. 3.81, Rs. 10.07, to Rs. 28.85. At baseline, 31% of rural and 27% percent of urban Indian population are poor at the designated poverty thresholds. The Rs. 28.85 regimen would be unaffordable to 81% and 58% of rural and urban people. A secondary prevention regimen with aspirin, hydrochlorothiazide, atenolol and atorvastatin could be unaffordable to 81% and 57% rural and urban people respectively. According to our estimates, 17% of the rural 32% of the urban adult population could benefit with these medications, and their out of pocket purchase could impoverish 17 million rural and 10 million urban people in India and increase respective poverty gaps by 2.9%. Conclusion Medication costs for cardiovascular disease have the potential to cause financial burden to a significant proportion of people in India. These costs increase the likelihood that patients will forego needed treatment and emphasize the need for programs to reduce the costs of medications for cardiovascular patients in India, including by expansion of prescription drug coverage.	[Pandey, Kiran Raj; Meltzer, David O.] Univ Chicago, Dept Med, Sect Hosp Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago	Pandey, KR (corresponding author), Univ Chicago, Dept Med, Sect Hosp Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	kpandey@medicine.bsd.uchicago.edu						Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; [Anonymous], 2013, COCHRANE DATABASE OF; Binagwaho A, 2014, LANCET, V383, P3, DOI 10.1016/S0140-6736(13)62423-X; Bivand R., 2013, SPLANCS SPATIAL SPAC; Brinda EM, 2015, J EPIDEMIOL COMMUN H, V69, P489, DOI 10.1136/jech-2014-204960; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Government of India DoP, 2013, DRUG PRIC CONTR ORD; Government of India NSSO, 2012, KEY INDICATORS OF HO; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Gupta R, 2004, J HUM HYPERTENS, V18, P73, DOI 10.1038/sj.jhh.1001633; Gupta Rajeev, 2008, Indian Heart J, V60, pB4; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; India PCo, 2014, RANG REP POV 2014; Jeemon P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000068; Johnson ML, 2004, AM J MANAG CARE, V10, P926; Joshi SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096808; Kotwani A, 2007, INDIAN J MED RES, V125, P645; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu YL, 2003, J HEALTH POPUL NUTR, V21, P216; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Narayan-Parker D., 2000, CAN ANYONE HEAR US; Niens LM, 2012, B WORLD HEALTH ORGAN, V90, P219, DOI 10.2471/BLT.10.084087; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; O'Donnell O, ANAL HLTH EQUITY USI, P213; Shahrawat R, 2012, HEALTH POLICY PLANN, V27, P213, DOI 10.1093/heapol/czr029; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; United Nations, 2012, THE FUT WE WANT; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Viera AJ, 2010, AM FAM PHYSICIAN, V82, P265; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wood S, 2014, MGCV MIXED GAM COMPU; World Bank, 2013, POV MEAS; World Health Organization, WORLD MED STRAT 2004; World Health Organization, 2014, WHO HLTH ACT INT PRO; World Health Organization, 2004, GLOB HLTH EXP DAT GE; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155293	10.1371/journal.pone.0155293	http://dx.doi.org/10.1371/journal.pone.0155293			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM7YQ	27159055	Green Published, gold			2022-12-27	WOS:000376576700055
J	Blackie, LER; Cozzolino, PJ; Sedikides, C				Blackie, Laura E. R.; Cozzolino, Philip J.; Sedikides, Constantine			Specific and Individuated Death Reflection Fosters Identity Integration	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; SELF-CONCEPT CLARITY; MORTALITY SALIENCE; DIVIDED SELF; COMPLEXITY; LIFE; GROWTH; VALUES; EVENTS; COMPARTMENTALIZATION	Identity integration is the process wherein a person assimilates multiple or conflicting identities (e.g., beliefs, values, needs) into a coherent, unified self-concept. Three experiments examined whether contemplating mortality in a specific and individuated manner (i.e., via the death reflection manipulation) facilitated outcomes indicative of identity integration. Participants in the death reflection condition (vs. control conditions) considered positive and negative life experiences as equally important in shaping their current identity (Experiment 1), regarded self-serving values and other-serving values as equally important life principles (Experiment 2), and were equally motivated to pursue growth-oriented and security-oriented needs (Experiment 3). Death reflection motivates individuals to integrate conflicting aspects of their identity into a coherent self-concept. Given that identity integration is associated with higher well-being, the findings have implications for understanding the psychological benefits of existential contemplation.	[Blackie, Laura E. R.] Univ Nottingham, Dept French & Francophone Studies, Nottingham NG7 2RD, Notts, England; [Cozzolino, Philip J.] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England; [Sedikides, Constantine] Univ Southampton, Sch Psychol, Southampton, Hants, England	University of Nottingham; University of Essex; University of Southampton	Blackie, LER (corresponding author), Univ Nottingham, Dept French & Francophone Studies, Nottingham NG7 2RD, Notts, England.	laura.blackie@nottingham.ac.uk		Sedikides, Contantine/0000-0003-4036-889X; Blackie, Laura/0000-0001-9259-2063; Cozzolino, Philip/0000-0001-9834-4933				Arndt J, 2005, PERS SOC PSYCHOL B, V31, P1327, DOI 10.1177/0146167205274690; Arndt J, 1998, PERS SOC PSYCHOL B, V24, P1216, DOI 10.1177/01461672982411008; Bauer JJ, 2010, DEV PSYCHOL, V46, P761, DOI 10.1037/a0019654; Bauer JJ, 2004, J PERS, V72, P573, DOI 10.1111/j.0022-3506.2004.00273.x; Bigler M, 2001, J SOC CLIN PSYCHOL, V20, P396, DOI 10.1521/jscp.20.3.396.22302; Blackie LER, 2011, PSYCHOL SCI, V22, P998, DOI 10.1177/0956797611415542; Burke BL, 2010, PERS SOC PSYCHOL REV, V14, P155, DOI 10.1177/1088868309352321; Campbell JD, 2003, J PERS, V71, P115, DOI 10.1111/1467-6494.t01-1-00002; CLARK LA, 1988, J PERS SOC PSYCHOL, V54, P296, DOI 10.1037/0022-3514.54.2.296; Cozzolino P.J., 2013, EXPERIENCE MEANING L, P31, DOI [https://doi.org/10.1007/978-94-007-6527-6_3, DOI 10.1007/978-94-007-6527-6_3]; Cozzolino PJ, 2006, PSYCHOL INQ, V17, P278, DOI 10.1080/10478400701366944; Cozzolino PJ, 2009, J RES PERS, V43, P399, DOI 10.1016/j.jrp.2009.01.008; Cozzolino PJ, 2004, PERS SOC PSYCHOL B, V30, P278, DOI 10.1177/0146167203260716; DONAHUE EM, 1993, J PERS SOC PSYCHOL, V64, P834, DOI 10.1037/0022-3514.64.5.834; Downie M, 2004, PERS SOC PSYCHOL B, V30, P305, DOI 10.1177/0146167203261298; Friedman RS, 2010, PSYCHOL BULL, V136, P875, DOI 10.1037/a0020495; Friedman RS, 2001, J PERS SOC PSYCHOL, V81, P1001, DOI 10.1037/0022-3514.81.6.1001; Gardner WL, 1999, PSYCHOL SCI, V10, P321, DOI 10.1111/1467-9280.00162; Gramzow RH, 2000, PERS SOC PSYCHOL B, V26, P188, DOI 10.1177/0146167200264006; GREENBERG J, 1990, J PERS SOC PSYCHOL, V58, P308, DOI 10.1037/0022-3514.58.2.308; GREYSON B, 1983, AM J PSYCHIAT, V140, P618; Halloran MJ, 2004, PERS SOC PSYCHOL B, V30, P915, DOI 10.1177/0146167204264080; Hart J, 2005, J PERS SOC PSYCHOL, V88, P999, DOI 10.1037/0022-3514.88.6.999; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Joireman J, 2005, PERS SOC PSYCHOL B, V31, P307, DOI 10.1177/0146167204271593; Kawakami K, 2012, J PERS SOC PSYCHOL, V102, P562, DOI 10.1037/a0025970; Kiang L, 2008, J RES PERS, V42, P1657, DOI 10.1016/j.jrp.2008.07.010; KLEMENC-KETIS Z., 2011, INT J MED BEHAV, V20, P7; Koch EJ, 2004, J PERS, V72, P727, DOI 10.1111/j.0022-3506.2004.00278.x; Landau MJ, 2011, SELF IDENTITY, V10, P64, DOI 10.1080/15298860903557243; Landau MJ, 2009, PERS SOC PSYCHOL B, V35, P1012, DOI 10.1177/0146167209336608; LINVILLE PW, 1985, SOC COGNITION, V3, P94, DOI 10.1521/soco.1985.3.1.94; LINVILLE PW, 1987, J PERS SOC PSYCHOL, V52, P663, DOI 10.1037/0022-3514.52.4.663; Lopez S.J., 2002, HDB POSITIVE PSYCHOL, P327; Lutz CJ, 2003, J SOC CLIN PSYCHOL, V22, P537, DOI 10.1521/jscp.22.5.537.22927; Maio GR, 2013, PSYCHOL HUMAN VALUES; Maio GR, 2010, ADV EXP SOC PSYCHOL, V42, P1, DOI 10.1016/S0065-2601(10)42001-8; Maio GR, 2009, J PERS SOC PSYCHOL, V97, P699, DOI 10.1037/a0016420; McAdams D.P., 2001, REV GEN PSYCHOL, V5, P100, DOI [10.1037/1089-2680.5.2.100, DOI 10.1037/1089-2680.5.2.100]; McAdams DP, 2001, PERS SOC PSYCHOL B, V27, P474, DOI 10.1177/0146167201274008; McConnell AR, 2011, PERS SOC PSYCHOL REV, V15, P3, DOI 10.1177/1088868310371101; McLean KC, 2008, SOC PERSONAL PSYCHOL, V2, P1685, DOI 10.1111/j.1751-9004.2008.00124.x; Molden D.C., 2008, HDB MOTIVATION SCI, P169; NOYES R, 1980, PSYCHIATRY, V43, P234, DOI 10.1080/00332747.1980.11024070; Power MJ, 2007, J CLIN PSYCHOL, V63, P187, DOI 10.1002/jclp.20341; Rafaeli-Mor E, 2002, PERS SOC PSYCHOL REV, V6, P31, DOI 10.1207/S15327957PSPR0601_2; Ring K., 1998, LESSONS LIGHT, P108; Ritchie TD, 2011, SELF IDENTITY, V10, P493, DOI 10.1080/15298868.2010.493066; Rokeach M., 1973, NATURE HUMAN VALUES; Routledge C, 2008, EUR J SOC PSYCHOL, V38, P531, DOI 10.1002/ejsp.442; Routledge C, 2010, J PERS SOC PSYCHOL, V99, P897, DOI 10.1037/a0021431; Ryan R.M., 2005, N AM J PSYCHOL, V7, P431, DOI DOI 10.1016/J.CELREP.2011.1011.1001.7; RYAN RM, 1995, J PERS, V63, P397, DOI 10.1111/j.1467-6494.1995.tb00501.x; Ryan RM, 2012, MULTIPLE IDENTITIES, P225; Sani F., 2008, SELF CONTINUITY INDI, P87; Schwartz S.H., 1979, INT OIL SPILL C P, DOI [10.7901/2169335819791493, DOI 10.7901/2169335819791493]; SCHWARTZ SH, 1990, J PERS SOC PSYCHOL, V58, P878, DOI 10.1037/0022-3514.58.5.878; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; SCHWARTZ SH, 1987, J PERS SOC PSYCHOL, V53, P550, DOI 10.1037/0022-3514.53.3.550; Sedikides C., 2012, HDB SELF IDENTITY, P327, DOI DOI 10.1177/1359105308090930; Sedikides C, 2008, CURR DIR PSYCHOL SCI, V17, P304, DOI 10.1111/j.1467-8721.2008.00595.x; Sedikides C, 2009, SOC PERSONAL PSYCHOL, V3, P899, DOI 10.1111/j.1751-9004.2009.00231.x; SHOWERS C, 1992, J PERS SOC PSYCHOL, V62, P1036, DOI 10.1037/0022-3514.62.6.1036; Showers CJ, 2007, J PERS, V75, P1181, DOI 10.1111/j.1467-6494.2007.00472.x; Showers CJ, 2002, ADVANCES IN PERSONALITY SCIENCE, P271; Solomon Sheldon, 2004, HDB EXISTENTIAL EXPT, P13; Sutin AR, 2010, J PERS, V78, P257, DOI 10.1111/j.1467-6494.2009.00615.x; Syed M, 2010, DEV PSYCHOL, V46, P1590, DOI 10.1037/a0020738; TAYLOR SE, 1991, PSYCHOL BULL, V110, P67, DOI 10.1037/0033-2909.110.1.67; Vail KE, 2012, PERS SOC PSYCHOL REV, V16, P303, DOI 10.1177/1088868312440046; Vess M, 2009, J PERS SOC PSYCHOL, V97, P728, DOI 10.1037/a0016417; Wakimoto R, 2011, PERS SOC PSYCHOL B, V37, P687, DOI 10.1177/0146167211400422; Walker WR, 2003, REV GEN PSYCHOL, V7, P203, DOI 10.1037/1089-2680.7.2.203; Weinstein N, 2011, J PERS SOC PSYCHOL, V100, P527, DOI 10.1037/a0022150; Wisman A, 2003, J PERS SOC PSYCHOL, V84, P511, DOI 10.1037/0022-3514.84.3.511; Wong PTP, 2011, DEATH STUD, V35, P99, DOI 10.1080/07481187.2011.535377; Yalom ID., 1980, EXISTENTIAL PSYCHOTH	77	3	3	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154873	10.1371/journal.pone.0154873	http://dx.doi.org/10.1371/journal.pone.0154873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KX	27152863	Green Accepted, Green Published, gold			2022-12-27	WOS:000375677000043
J	Fiocchetti, M; Cipolletti, M; Leone, S; Naldini, A; Carraro, F; Giordano, D; Verde, C; Ascenzi, P; Marino, M				Fiocchetti, Marco; Cipolletti, Manuela; Leone, Stefano; Naldini, Antonella; Carraro, Fabio; Giordano, Daniela; Verde, Cinzia; Ascenzi, Paolo; Marino, Maria			Neuroglobin in Breast Cancer Cells: Effect of Hypoxia and Oxidative Stress on Protein Level, Localization, and Anti-Apoptotic Function	PLOS ONE			English	Article							EXPRESSION; CYTOGLOBIN; 17-BETA-ESTRADIOL; AUTOPHAGY; NEURONS; GLOBIN; OXYGEN	The over-expression of human neuroglobin (NGB), a heme-protein preferentially expressed in the brain, displays anti-apoptotic effects against hypoxic/ischemic and oxidative stresses enhancing neuron survival. As hypoxic and oxidative stress injury frequently occurs in fast proliferating neoplastic tissues, here, the effect of these stressors on the level, localization, and anti-apoptotic function of NGB in wild type and NGB-stable-silenced MCF-7 breast cancer cells has been assessed. The well-known endogenous NGB inducer 17 beta-estradiol (E2) has been used as positive control. The median pO2 present in tumor microenvironment of breast cancer patients (i.e., 2% O-2) does not affect the NGB level in breast cancer cells, whereas hydrogen peroxide and lead(IV) acetate, which increase intracellular reactive oxygen species (ROS) level, enhance the NGB levels outside the mitochondria and still activate apoptosis. However, E2-induced NGB up-regulation in mitochondria completely reverse lead(IV) acetate-induced PARP cleavage. These results indicate that the NGB level could represent a marker of oxidative-stress in MCF-7 breast cancer cells; however, the NGB ability to respond to injuring stimuli by preventing apoptosis requires its re-allocation into the mitochondria. As a whole, present data might lead to a new direction in understanding NGB function in cancer opening new avenues for the therapeutic intervention.	[Fiocchetti, Marco; Cipolletti, Manuela; Leone, Stefano; Verde, Cinzia; Ascenzi, Paolo; Marino, Maria] Univ Rome Tre, Dept Sci, Viale Guglielmo Marconi 446, I-00146 Rome, Italy; [Naldini, Antonella; Carraro, Fabio] Univ Siena, Dept Mol & Dev Med, Via Aldo Moro 2, I-53100 Siena, Italy; [Giordano, Daniela; Verde, Cinzia; Ascenzi, Paolo; Marino, Maria] Biosci & BioResources Inst CNR, Via Pietro Castellino 111, I-80131 Naples, Italy; [Ascenzi, Paolo] Univ Rome Tre, Interdept Lab Electron Microscopy, Via Vasca Navale 79, I-00146 Rome, Italy	Italfarmaco; Roma Tre University; University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Roma Tre University	Marino, M (corresponding author), Univ Rome Tre, Dept Sci, Viale Guglielmo Marconi 446, I-00146 Rome, Italy.; Marino, M (corresponding author), Biosci & BioResources Inst CNR, Via Pietro Castellino 111, I-80131 Naples, Italy.	maria.marino@uniroma3.it	Marino, Maria/AAB-6357-2022; Fiocchetti, Marco/G-1486-2013; Carraro, Fabio/ABI-6098-2020	Carraro, Fabio/0000-0003-0771-042X; Cipolletti, Manuela/0000-0002-0987-2927; Leone, Stefano/0000-0001-6339-6397; GIORDANO, DANIELA/0000-0002-8891-6245; VERDE, Cinzia/0000-0001-6185-282X; Fiocchetti, Marco/0000-0002-4888-0567	Associazione Italiana Ricerca sul Cancro (AIRC, IG) [15221]; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy [PRIN 20109MXHMR_001]	Associazione Italiana Ricerca sul Cancro (AIRC, IG)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Associazione Italiana Ricerca sul Cancro (AIRC, IG#15221) to M.M. (www.airc.it) and the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (PRIN 20109MXHMR_001) to P.A. (www.istruzione.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00030; Bao WH, 2016, MOL MED REP, V13, P796, DOI 10.3892/mmr.2015.4599; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; De Marinis E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.30; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Emara M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-33; Fago A, 2008, IUBMB LIFE, V60, P398, DOI 10.1002/iub.35; Fiocchetti M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.418; Fiocchetti M, 2015, J STEROID BIOCHEM, V149, P128, DOI 10.1016/j.jsbmb.2015.02.005; Fiocchetti M, 2013, BBA-PROTEINS PROTEOM, V1834, P1744, DOI 10.1016/j.bbapap.2013.01.015; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Gorr TA, 2011, ACTA PHYSIOL, V202, P563, DOI 10.1111/j.1748-1716.2010.02205.x; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; He LH, 2000, J BIOL CHEM, V275, P12175, DOI 10.1074/jbc.275.16.12175; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hundahl C, 2006, BRAIN RES, V1085, P19, DOI 10.1016/j.brainres.2006.02.040; Jin KL, 2012, NEUROSCI LETT, V519, P47, DOI 10.1016/j.neulet.2012.05.018; Li RC, 2006, BRAIN RES, V1096, P173, DOI 10.1016/j.brainres.2006.04.063; Li WG, 2011, PROTEINS, V79, P115, DOI 10.1002/prot.22863; Maycotte P, 2014, WORLD J CLIN ONCOL, V5, P224, DOI 10.5306/wjco.v5.i3.224; Morozov AN, 2014, J CHEM INF MODEL, V54, P1997, DOI 10.1021/ci5002108; Nicolis S, 2013, CHEM RES TOXICOL, V26, P1821, DOI 10.1021/tx4001896; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Vaupel P, 2003, CANCER RES, V63, P7634; Watanabe S, 2012, J BIOL CHEM, V287, P30128, DOI 10.1074/jbc.M112.373381; Yu Z, 2009, NEUROSCIENCE, V162, P396, DOI 10.1016/j.neuroscience.2009.04.055; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995; Zhang J, 2013, MOL PHARMACOL, V83, P1109, DOI 10.1124/mol.112.083634	34	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154959	10.1371/journal.pone.0154959	http://dx.doi.org/10.1371/journal.pone.0154959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149623	Green Submitted, Green Published, gold			2022-12-27	WOS:000375676800100
J	Studer, P; Borisova, M; Schneider, A; Ayala, JA; Mayer, C; Schuppler, M; Loessner, MJ; Briers, Y				Studer, Patrick; Borisova, Marina; Schneider, Alexander; Ayala, Juan A.; Mayer, Christoph; Schuppler, Markus; Loessner, Martin J.; Briers, Yves			The Absence of a Mature Cell Wall Sacculus in Stable Listeria monocytogenes L-Form Cells Is Independent of Peptidoglycan Synthesis	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; IN-VITRO; DEFICIENT BACTERIA; DIVISION; GROWTH; MORPHOGENESIS; MEMBRANE; PROLIFERATION	L-forms are cell wall-deficient variants of otherwise walled bacteria that maintain the ability to survive and proliferate in absence of the surrounding peptidoglycan sacculus. While transient or unstable L-forms can revert to the walled state and may still rely on residual peptidoglycan synthesis for multiplication, stable L-forms cannot revert to the walled form and are believed to propagate in the complete absence of peptidoglycan. L-forms are increasingly studied as a fundamental biological model system for cell wall synthesis. Here, we show that a stable L-form of the intracellular pathogen Listeria monocytogenes features a surprisingly intact peptidoglycan synthesis pathway including glycosyl transfer, in spite of the accumulation of multiple mutations during prolonged passage in the cell wall-deficient state. Microscopic and biochemical analysis revealed the presence of peptidoglycan precursors and functional glycosyl transferases, resulting in the formation of peptidoglycan polymers but without the synthesis of a mature cell wall sacculus. In conclusion, we found that stable, non-reverting L-forms, which do not require active PG synthesis for proliferation, may still continue to produce aberrant peptidoglycan.	[Studer, Patrick; Schuppler, Markus; Loessner, Martin J.; Briers, Yves] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland; [Borisova, Marina; Schneider, Alexander; Mayer, Christoph] Univ Tubingen, Dept Microbiol Biotechnol, Tubingen, Germany; [Ayala, Juan A.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Briers, Yves] Univ Ghent, Dept Appl Biosci, B-9000 Ghent, Belgium	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eberhard Karls University of Tubingen; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Ghent University	Briers, Y (corresponding author), ETH, Inst Food Nutr & Hlth, Zurich, Switzerland.; Briers, Y (corresponding author), Univ Ghent, Dept Appl Biosci, B-9000 Ghent, Belgium.	yves.briers@ugent.be	Loessner, Martin J/B-4316-2012; Mayer, Christoph/S-8666-2017; Ayala, Juan A/AAI-4458-2021	Loessner, Martin J/0000-0002-8162-2631; Mayer, Christoph/0000-0003-4731-4851; Ayala, Juan A/0000-0002-0577-7498	Swiss National Science Foundation [144179]; Ministry of Science and Innovation (MICINN) of Spain [BFU 2009-09200]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ministry of Science and Innovation (MICINN) of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The work in the MJL lab was funded by the Swiss National Science Foundation (Project number 144179). The work at the JAA lab was supported by grant BFU 2009-09200 from the Ministry of Science and Innovation (MICINN) of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan EJ, 2009, ADV APPL MICROBIOL, V68, P1, DOI 10.1016/S0065-2164(09)01201-5; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Beasley SS, 2004, POULTRY SCI, V83, P45, DOI 10.1093/ps/83.1.45; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; Billings G, 2014, MOL MICROBIOL, V93, P883, DOI 10.1111/mmi.12703; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Born P, 2006, J BIOL CHEM, V281, P26985, DOI 10.1074/jbc.M604083200; Briers Y, 2012, BIOESSAYS, V34, P1078, DOI 10.1002/bies.201200080; Briers Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038514; Cambre A, 2015, ENVIRON MICROBIOL, V17, P1586, DOI 10.1111/1462-2920.12594; CHANG S, 1979, MOL GEN GENET, V168, P111, DOI 10.1007/BF00267940; CHARACHE P, 1970, ANN NY ACAD SCI, V174, P903, DOI 10.1111/j.1749-6632.1970.tb45610.x; Cloud-Hansen KA, 2006, NAT REV MICROBIOL, V4, P710, DOI 10.1038/nrmicro1486; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Dell'Era S, 2009, MOL MICROBIOL, V73, P306, DOI 10.1111/j.1365-2958.2009.06774.x; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Domingue GJ, 1982, CELL WALL DEFICIENT, pxi; Errington J., 2015, NAT REV MICROBIOL; Errington J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120143; Eugster MR, 2012, J BACTERIOL, V194, P6498, DOI 10.1128/JB.00808-12; Fang X, 2006, MOL BIOSYST, V2, P69, DOI 10.1039/b515328j; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; Hu YN, 2003, J AM CHEM SOC, V125, P8736, DOI 10.1021/ja035217i; Humann J, 2009, J INNATE IMMUN, V1, P88, DOI 10.1159/000181181; Jeske O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8116; Joseleau-Petit D, 2007, J BACTERIOL, V189, P6512, DOI 10.1128/JB.00273-07; Jutras BL, 2015, CURR BIOL, V25, pR496, DOI 10.1016/j.cub.2015.05.002; Kawai Y, 2014, CURR BIOL, V24, P863, DOI 10.1016/j.cub.2014.02.053; Korsak D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-239; Leaver M, 2009, NATURE, V457, P849, DOI 10.1038/nature07742; Litzinger S, 2010, J BACTERIOL, V192, P3132, DOI 10.1128/JB.01256-09; Loessner MJ, 2000, MOL MICROBIOL, V35, P324, DOI 10.1046/j.1365-2958.2000.01720.x; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Mercier R, 2014, ELIFE, V3, DOI 10.7554/eLife.04629; Mercier R, 2013, CELL, V152, P997, DOI 10.1016/j.cell.2013.01.043; Mercier R, 2012, CELL REP, V1, P417, DOI 10.1016/j.celrep.2012.03.008; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Onwuamaegbu M, 2005, J INT MED RES, V33, P1, DOI 10.1177/147323000503300101; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; PEASE PE, 1967, NATURE, V215, P936, DOI 10.1038/215936a0; Ranjit DK, 2013, J BACTERIOL, V195, P2452, DOI 10.1128/JB.00160-13; Reith J, 2011, J BACTERIOL, V193, P5386, DOI 10.1128/JB.05514-11; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; Riedel CU, 2007, APPL ENVIRON MICROB, V73, P3091, DOI 10.1128/AEM.02940-06; Rismondo J, 2015, MOL MICROBIOL, V95, P332, DOI 10.1111/mmi.12873; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schnell B, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00060; Siddiqui RA, 2006, FEMS MICROBIOL LETT, V258, P305, DOI 10.1111/j.1574-6968.2006.00237.x; Thompson RJ, 1998, INFECT IMMUN, V66, P3552, DOI 10.1128/IAI.66.8.3552-3561.1998; Uehara T, 2007, J BACTERIOL, V189, P5634, DOI 10.1128/JB.00446-07; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Young KD, 2007, J BACTERIOL, V189, P6509, DOI 10.1128/JB.01035-07; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	54	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154925	10.1371/journal.pone.0154925	http://dx.doi.org/10.1371/journal.pone.0154925			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149671	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800091
J	Di Marco, F; Terraneo, S; Imeri, G; Palumbo, G; La Briola, F; Tresoldi, S; Volpi, A; Gualandri, L; Ghelma, F; Alfano, RM; Montanari, E; Gorio, A; Lesma, E; Peron, A; Canevini, MP; Centanni, S				Di Marco, Fabiano; Terraneo, Silvia; Imeri, Gianluca; Palumbo, Giuseppina; La Briola, Francesca; Tresoldi, Silvia; Volpi, Angela; Gualandri, Lorenzo; Ghelma, Filippo; Alfano, Rosa Maria; Montanari, Emanuele; Gorio, Alfredo; Lesma, Elena; Peron, Angela; Canevini, Maria Paola; Centanni, Stefano			Women with TSC: Relationship between Clinical, Lung Function and Radiological Features in a Genotyped Population Investigated for Lymphangioleiomyomatosis	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; MICRONODULAR PNEUMOCYTE HYPERPLASIA; GROWTH FACTOR-D; SIROLIMUS; DIAGNOSIS; SEVERITY; DISEASE; SERUM; GUIDELINES; MUTATIONS	The advent of pharmacological therapies for lymphangioleiomyomatosis (LAM) has made early diagnosis important in women with tuberous sclerosis complex (TSC), although the lifelong cumulative radiation exposure caused by chest computer tomography (CT) should not be underestimated. We retrospectively investigated, in a cohort of TSC outpatients of San Paolo Hospital (Milan, Italy) 1) the role of pulmonary function tests (PFTs) for LAM diagnosis, 2) the association between LAM and other features of TSC (e.g. demography, extrapulmonary manifestations, genetic mutations, etc.), and 3) the characteristics of patients with multifocal micronodular pneumocyte hyperplasia (MMPH). Eighty-six women underwent chest CT scan; pulmonary involvement was found in 66 patients (77%; 49% LAM with or without MMPH, and 28% MMPH alone). LAM patients were older, with a higher rate of pneumothorax, presented more frequently with renal and hepatic angiomyolipomas, and tended to have a TSC2 mutation profile. PFTs, assessed in 64% of women unaffected by cognitive impairments, revealed a lower lung diffusion capacity in LAM patients. In multivariate analysis, age, but not PFTs, resulted independently associated with LAM diagnosis. Patients with MMPH alone did not show specific clinical, functional or genetic features. A mild respiratory impairment was most common in LAM-TSC patients: In conclusions, PFTs, even if indicated to assess impairment in lung function, are feasible in a limited number of patients, and are not significantly useful for LAM diagnosis in women with TSC.	[Di Marco, Fabiano; Terraneo, Silvia; Imeri, Gianluca; Palumbo, Giuseppina; Centanni, Stefano] Osped San Paolo, Resp Unit, Milan, Italy; [Di Marco, Fabiano; Terraneo, Silvia; Imeri, Gianluca; Palumbo, Giuseppina; Ghelma, Filippo; Montanari, Emanuele; Gorio, Alfredo; Lesma, Elena; Canevini, Maria Paola; Centanni, Stefano] Univ Milan, Dept Hlth Sci, Milan, Italy; [La Briola, Francesca; Peron, Angela; Canevini, Maria Paola] Osped San Paolo, Epilepsy Ctr, Milan, Italy; [Tresoldi, Silvia] Osped San Paolo, Diagnost & Intervent Radiol Unit, Dept Diagnost Serv, Milan, Italy; [Volpi, Angela] Osped San Paolo, Dept Nephrol, Milan, Italy; [Gualandri, Lorenzo] Osped San Paolo, Dermatol Clin, Milan, Italy; [Ghelma, Filippo] Osped San Paolo, Disabled Adv Med Assistance Unit, Milan, Italy; [Alfano, Rosa Maria] Osped San Paolo, Dept Human Pathol Cytogenet & Mol Pathol, Milan, Italy; [Montanari, Emanuele] Osped San Paolo, Div Urol 1, Milan, Italy; [Gorio, Alfredo; Lesma, Elena] Univ Milan, Labs Pharmacol, Milan, Italy	San Paolo-Polo Universitaria Hospital; University of Milan; San Paolo-Polo Universitaria Hospital; San Paolo-Polo Universitaria Hospital; San Paolo-Polo Universitaria Hospital; San Paolo-Polo Universitaria Hospital; San Paolo-Polo Universitaria Hospital; San Paolo-Polo Universitaria Hospital; San Paolo-Polo Universitaria Hospital; University of Milan	Di Marco, F (corresponding author), Osped San Paolo, Resp Unit, Milan, Italy.; Di Marco, F (corresponding author), Univ Milan, Dept Hlth Sci, Milan, Italy.	fabiano.dimarco@unimi.it	Peron, Angela/AAJ-2587-2020; Tresoldi, Silvia/AAL-1383-2020; MONTANARI, EMANUELE/I-8034-2015	Peron, Angela/0000-0002-1769-6548; MONTANARI, EMANUELE/0000-0002-3586-666X; Lesma, Elena/0000-0002-9096-713X; di marco, fabiano/0000-0002-1743-0504; CENTANNI, STEFANO/0000-0001-9923-535X; Tresoldi, Silvia/0000-0003-4302-2237	Regione Lombardia	Regione Lombardia(Regione Lombardia)	The study has been supported by grant from Regione Lombardia aimed to develop a database software for data collection. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen MEAPM, 2011, CLIN RADIOL, V66, P625, DOI 10.1016/j.crad.2011.02.009; [Anonymous], 1971, Br Med J, V3, P64; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; CASTRO M, 1995, CHEST, V107, P189, DOI 10.1378/chest.107.1.189; Chang WYC, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-34; CORRIN B, 1975, AM J PATHOL, V79, P348; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Cudzilo CJ, 2013, CHEST, V144, P578, DOI 10.1378/chest.12-2813; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Flum AS, 2016, J UROLOGY, V195, P834, DOI 10.1016/j.juro.2015.07.126; Franz DN, 2010, NEUROPEDIATRICS, V41, P199, DOI 10.1055/s-0030-1269906; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Glasgow CG, 2009, CHEST, V135, P1293, DOI 10.1378/chest.08-1160; Goldberg HJ, 2015, EUR RESPIR J, V46, P783, DOI 10.1183/09031936.00210714; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209; Jones AC, 2000, HUM GENET, V106, P663, DOI 10.1007/s004390050040; Krueger DA, 2013, PEDIATR NEUROL, V49, P255, DOI 10.1016/j.pediatrneurol.2013.08.002; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Maruyama H, 2001, PATHOL INT, V51, P585, DOI 10.1046/j.1440-1827.2001.01242.x; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; Muzykewicz DA, 2009, J MED GENET, V46, P465, DOI 10.1136/jmg.2008.065342; Muzykewicz DA, 2012, J COMPUT ASSIST TOMO, V36, P518, DOI 10.1097/RCT.0b013e318264e404; Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Roach ES, 2004, J CHILD NEUROL, V19, P643, DOI 10.1177/08830738040190090301; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Ryu JH, 2012, RESP MED, V106, P1586, DOI 10.1016/j.rmed.2012.07.007; Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC; Sato T, 2002, J HUM GENET, V47, P20, DOI 10.1007/s10038-002-8651-8; Seibert D, 2011, ANN INTERN MED, V154, P806, DOI 10.7326/0003-4819-154-12-201106210-00008; Seyama Kuniaki, 2006, Lymphatic Research and Biology, V4, P143, DOI 10.1089/lrb.2006.4.143; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; Strizheva GD, 2001, AM J RESP CRIT CARE, V163, P253, DOI 10.1164/ajrccm.163.1.2005004; Taveira-DaSilva Angelo M, 2014, F1000Prime Rep, V6, P116, DOI 10.12703/P6-116; Taveira-DaSilva AM, 2011, ANN INTERN MED, V154, P797, DOI 10.7326/0003-4819-154-12-201106210-00007; Taveira-DaSilva AM, 2010, LYMPHAT RES BIOL, V8, P9, DOI 10.1089/lrb.2009.0024; Taveira-DaSilva AM, 2009, CHEST, V136, P665, DOI 10.1378/chest.08-3034; Tayeira-DaSilya AM, 2015, EUR RESPIR J, V45, P171, DOI 10.1183/09031936.00088314; Tobino K, 2015, EUR J RADIOL, V84, P534, DOI 10.1016/j.ejrad.2014.12.008; Xu KF, 2013, RESP MED, V107, P263, DOI 10.1016/j.rmed.2012.10.006; Young LR, 2013, LANCET RESP MED, V1, P445, DOI 10.1016/S2213-2600(13)70090-0; Yu J, 2001, AM J RESP CRIT CARE, V164, P1537, DOI 10.1164/ajrccm.164.8.2104095; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	51	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155331	10.1371/journal.pone.0155331	http://dx.doi.org/10.1371/journal.pone.0155331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171001	Green Submitted, Green Published, gold			2022-12-27	WOS:000376588600160
J	Liang, WQ; Yu, B; Wang, YP; Qiu, GX; Shen, JX; Zhang, JG; Zhao, H; Zhao, Y; Tian, Y; Li, SG				Liang, Weiqiang; Yu, Bin; Wang, Yipeng; Qiu, Guixing; Shen, Jianxiong; Zhang, Jianguo; Zhao, Hong; Zhao, Yu; Tian, Ye; Li, Shugang			Pleural Effusion in Spinal Deformity Correction Surgery- A Report of 28 Cases in a Single Center	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; RESEARCH SOCIETY MORBIDITY; PEDICLE SCREWS; PERIOPERATIVE COMPLICATIONS; ANTERIOR INSTRUMENTATION; HEMIVERTEBRA RESECTION; MORTALITY DATABASE; GORHAMS SYNDROME; RISK-FACTORS; FUSION	Objectives To analyze the occurrence, risk factors, treatment and prognosis of postoperative pleural effusion after spinal deformity correction surgery. Methods The clinical and imaging data of 3325 patients undergoing spinal deformity correction were collected from the database of our hospital. We analyzed the therapeutic process of the 28 patients who had postoperative pleural effusion, and we identified the potential risk factors using logistic regression. Results Among the 28 patients with postoperative pleural effusion, 24 (85.7%) suffered from hemothorax, 2 (7.1%) from chylothorax, and 2 (7.1%) from subarachnoid-pleural fistula. The pleural effusion occurred on the convex side in 19 patients (67.9%), on the concave side in 4 patients (14.3%), and on both sides in 4 patients (14.3%). One patient with left hemothorax was diagnosed with kyphosis. The treatment included conservative clinical observation for 5 patients and chest tube drainage for 23 patients. One patient also underwent thoracic duct ligation and pleurodesis. All of these treatments were successful. Logistic regression analysis showed that adult patients(>= 18 years old), congenital scoliosis, osteotomy and thoracoplasty were risk factors for postoperative pleural effusion in spinal deformity correction surgery. Conclusions The incidence of postoperative pleural effusion in spinal deformity correction surgery was approximately 0.84% (28/3325), and hemothorax was the most common type. Chest tube drainage treatment was usually successful, and the prognosis was good. Adult patients (>= 18 years old), congenital scoliosis, and had undergone osteotomy or surgery with thoracoplasty were more likely to suffer from postoperative pleural effusion.	[Yu, Bin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthoped, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yu, B (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthoped, Beijing 100730, Peoples R China.	yubin19980110@126.com	Shen, Jianxiong/AAH-6200-2019; ZHAO, YU/GZL-3154-2022	Wang, Yipeng/0000-0001-9769-9839; ZHAO, YU/0000-0001-9025-2014; Qiu, Guixing/0000-0002-4597-9350				Carreon LY, 2007, J BONE JOINT SURG AM, V89A, P2427, DOI 10.2106/JBJS.F.00995; Chavanis N, 2001, ANN THORAC SURG, V72, P937, DOI 10.1016/S0003-4975(00)02417-6; D'Souza R, 2002, RESPIRATION, V69, P96, DOI 10.1159/000049379; Di Silvestre M, 2007, SPINE, V32, P1655, DOI 10.1097/BRS.0b013e318074d604; Fu KMG, 2011, J NEUROSURG-PEDIATR, V7, P37, DOI 10.3171/2010.10.PEDS10212; Gautschi OP, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.7.FOCUS11168; Grossfeld S, 1997, J PEDIATR ORTHOPED, V17, P89, DOI 10.1097/00004694-199701000-00019; Hicks JM, 2010, SPINE, V35, pE465, DOI 10.1097/BRS.0b013e3181d1021a; Lai PL, 2006, J TRAUMA, V61, P746, DOI 10.1097/01.ta.0000224899.55790.e3; Lenke LG, 2013, SPINE, V38, P119, DOI 10.1097/BRS.0b013e318269fab1; Lloyd CT, 2002, CHEST, V122, P2252, DOI 10.1378/chest.122.6.2252; Min K, 2005, EUR SPINE J, V14, P777, DOI 10.1007/s00586-005-0977-4; NAKAI S, 1986, SPINE, V11, P830, DOI 10.1097/00007632-198610000-00018; Newton PO, 2009, SPINE J, V9, P595, DOI 10.1016/j.spinee.2009.05.004; Newton PO, 2005, SPINE, V30, P392, DOI 10.1097/01.brs.0000153404.62017.75; Nyunoya T, 2003, CHEST, V123, P1280, DOI 10.1378/chest.123.4.1280; Ogura Y, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-132; Pang L, 2014, SCOLIOSIS SPINAL DIS, V9, DOI 10.1186/1748-7161-9-17; POLLACK IIF, 1990, NEUROSURGERY, V26, P519, DOI 10.1227/00006123-199003000-00023; Pugely AJ, 2014, SPINE, V39, P1225, DOI 10.1097/BRS.0000000000000365; RAMES RD, 1990, CLIN ORTHOP RELAT R, P229; Reames DL, 2011, SPINE, V36, P1484, DOI 10.1097/BRS.0b013e3181f3a326; Riantawan P, 1996, THORAX, V51, P1277, DOI 10.1136/thx.51.12.1277; Ruf M, 2009, SPINE, V34, P1791, DOI 10.1097/BRS.0b013e3181ab6290; Sansur CA, 2011, SPINE, V36, pE593, DOI 10.1097/BRS.0b013e3182059bfd; Sarwahi V, 2014, J SPINAL DISORD TECH, V27, P64, DOI 10.1097/BSD.0b013e31825bfecd; Schwab FJ, 2012, EUR SPINE J, V21, P2603, DOI 10.1007/s00586-012-2370-4; Shapiro G, 2001, CURR OPIN PEDIATR, V13, P36, DOI 10.1097/00008480-200102000-00006; Shaw R, 2016, SPINE, V41, P508, DOI 10.1097/BRS.0000000000001239; Soroceanu A, 2015, SPINE, V40, P1414, DOI 10.1097/BRS.0000000000001020; Sucato DJ, 2004, SPINE, V29, P554, DOI 10.1097/01.BRS.0000106495.91477.92; Suk SI, 2008, SPINE, V33, P1061, DOI 10.1097/BRS.0b013e31816f2888; TIE MLH, 1994, CHEST, V105, P208, DOI 10.1378/chest.105.1.208; Wang SR, 2013, EUR SPINE J, V22, P387, DOI 10.1007/s00586-012-2577-4; Weis JC, 1997, J SPINAL DISORD, V10, P371; Yang JH, 2014, EUR SPINE J, V23, P2680, DOI 10.1007/s00586-014-3299-6; Yu Bin, 2007, Chinese Medical Sciences Journal, V22, P144	37	4	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154964	10.1371/journal.pone.0154964	http://dx.doi.org/10.1371/journal.pone.0154964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167221	Green Submitted, Green Published, gold			2022-12-27	WOS:000376587300076
J	Schuster, C; Akslen, LA; Straume, O				Schuster, Cornelia; Akslen, Lars A.; Straume, Oddbjorn			Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER; PLUS BEVACIZUMAB; NAB-PACLITAXEL; FACTOR VEGF; HSP27; ANGIOGENESIS; BIOMARKERS; RESISTANCE; CELLS	The aim of this study was to identify potential predictive biomarkers in 35 patients with metastatic melanoma treated with anti-angiogenic bevacizumab monotherapy in a clinical phase II study. The immunohistochemical expression of various angiogenic factors in tissues from primary melanomas and metastases as well as their concentration in blood samples were examined. Strong expression of Heat Shock Protein 27 (HSP27) in metastases correlated significantly with complete or partial response to bevacizumab (p = 0.044). Furthermore, clinical benefit, i.e., complete or partial response or stable disease for at least 6 months, was more frequent in patients with strong expression of HSP27 in primary tumors (p = 0.046). Tissue expression of vascular endothelial growth factor (VEGF-A), its splicing variant VEGF165b or basic fibroblast growth factor (bFGF) did not correlate with response, and the concentration of HSP27, VEGF-A or bFGF measured in blood samples before treatment did not show predictive value. Further, microvessel density, proliferating microvessel density and presence of glomeruloid microvascular proliferations were assessed in sections of primary tumors and metastases. Microvessel density in primary melanomas was significantly higher in patients with clinical benefit than in non-responders (p = 0.042). In conclusion, our findings suggest that strong HSP27 expression in melanoma metastases predicts response to bevacizumab treatment.	[Schuster, Cornelia; Akslen, Lars A.] Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers CCBIO, Bergen, Norway; [Akslen, Lars A.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Straume, Oddbjorn] Haukeland Hosp, Dept Oncol & Med Phys, N-5021 Bergen, Norway; [Straume, Oddbjorn] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers CCBIO, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Akslen, LA (corresponding author), Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers CCBIO, Bergen, Norway.; Akslen, LA (corresponding author), Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.; Straume, O (corresponding author), Haukeland Hosp, Dept Oncol & Med Phys, N-5021 Bergen, Norway.; Straume, O (corresponding author), Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers CCBIO, Bergen, Norway.	lars.akslen@k1.uib.no; Oddbjorn.straume@helse-bergen.no	Schuster, Cornelia/AAX-9719-2021; Straume, Oddbjørn/C-2186-2017; Akslen, Lars A./AAG-6097-2021; Akslen, Lars A/C-1202-2017	Schuster, Cornelia/0000-0003-2665-9527; Straume, Oddbjørn/0000-0001-8867-3645; Akslen, Lars A./0000-0003-2710-9543; Akslen, Lars A/0000-0003-2710-9543	Helse Vest Research Fund [911799, 911873]; Norwegian Cancer Association [94070]; Research Council of Norway through its Centres of Excellence funding scheme [223250]; Research Council of Norway [802630]; Norwegian Cancer Society [803149]	Helse Vest Research Fund; Norwegian Cancer Association; Research Council of Norway through its Centres of Excellence funding scheme; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	Support was provided by the Helse Vest Research Fund: grant no. 911799 to OS, [http://www.helse-vest.no/en/FagOgSamarbeid/Sider/default.aspx] and the Norwegian Cancer Association: grant no. 94070 to OS, [https://kreftforeningen.no/en/]. The project was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 223250 to LAA, CCBIO, [http://www.forskningsradet.no/en/Home_page/1177315753906]; Research Council of Norway, grant 802630 to LAA, [http://www.forskningsradet.no/en/Home_page/1177315753906]; Norwegian Cancer Society, grant #803149 to LAA, [https://kreftforeningen.no/en/]; and the Helse Vest Research Fund, grant #911873 to LAA, [http://www.helse-vest.no/en/FagOgSamarbeid/Sider/default.aspx]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrne GJ, 2007, ANTICANCER RES, V27, P3481; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Choi DH, 2007, FEBS LETT, V581, P1649, DOI 10.1016/j.febslet.2007.02.075; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Curigliano G, 2005, BREAST CANCER RES TR, V93, P35, DOI 10.1007/s10549-005-3381-1; Fanelli MA, 1998, CANCER EPIDEM BIOMAR, V7, P791; FERRARA N, 1995, ANN NY ACAD SCI, V752, P246, DOI 10.1111/j.1749-6632.1995.tb17435.x; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Godar DE, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/858425; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hegde PS, 2013, CLIN CANCER RES, V19, P929, DOI 10.1158/1078-0432.CCR-12-2535; Hormbrey E, 2003, CLIN CANCER RES, V9, P4332; Hurwitz HI, 2013, ONCOLOGIST, V18, P273, DOI 10.1634/theoncologist.2012-0339; Jubb AM, 2010, LANCET ONCOL, V11, P1172, DOI 10.1016/S1470-2045(10)70232-1; Kim KB, 2012, J CLIN ONCOL, V30, P34, DOI 10.1200/JCO.2011.34.6270; Kottschade LA, 2013, CANCER-AM CANCER SOC, V119, P586, DOI 10.1002/cncr.27760; Ladstein RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-140; Lambrechts D, 2013, J CLIN ONCOL, V31, P1219, DOI 10.1200/JCO.2012.46.2762; Lelj-Garolla B, 2015, MOL CANCER THER, V14, P1107, DOI 10.1158/1535-7163.MCT-14-0866; Lev DC, 2004, J CLIN ONCOL, V22, P2092, DOI 10.1200/JCO.2004.11.070; Loupakis F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-247; Maru D, 2013, CLIN CANCER RES, V19, P2824, DOI 10.1158/1078-0432.CCR-12-3409; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Rini BI, 2011, JNCI-J NATL CANCER I, V103, P763, DOI 10.1093/jnci/djr128; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; Schuster C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038364; Seigneuric R, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00037; Serrone L, 2000, J EXP CLIN CANC RES, V19, P21; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Song TF, 2009, J INT MED RES, V37, P1375, DOI 10.1177/147323000903700512; Spitler LE, 2015, AM J CLIN ONCOL-CANC, V38, P61, DOI 10.1097/COC.0b013e318287bbae; Stefansson IM, 2006, CANCER RES, V66, P3303, DOI 10.1158/0008-5472.CAN-05-1163; Straume O, 1999, INT J ONCOL, V15, P595; Straume O, 2001, AM J PATHOL, V159, P223, DOI 10.1016/S0002-9440(10)61688-4; Straume Oddbjorn, 2003, Angiogenesis, V6, P295, DOI 10.1023/B:AGEN.0000029408.08638.aa; Straume O, 2012, P NATL ACAD SCI USA, V109, P8699, DOI 10.1073/pnas.1017909109; Streit M, 2003, ONCOGENE, V22, P3172, DOI 10.1038/sj.onc.1206457; Thuringer D, 2013, FASEB J, V27, P4169, DOI 10.1096/fj.12-226977; Tsuruta M, 2008, ONCOL REP, V20, P1165, DOI 10.3892/or_00000125; Tweedle EM, 2010, GUT, V59, P1501, DOI 10.1136/gut.2009.196626; von Moos R, 2012, ANN ONCOL, V23, P531, DOI 10.1093/annonc/mdr126; Wang F, 2012, MED ONCOL, V29, P1780, DOI 10.1007/s12032-011-0037-3; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Yu ZJ, 2010, MOL MED REP, V3, P953, DOI 10.3892/mmr.2010.372; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010	50	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155242	10.1371/journal.pone.0155242	http://dx.doi.org/10.1371/journal.pone.0155242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166673	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300037
J	Xing, YQ; Zhao, XJ; Yu, T; Liang, D; Li, J; Wei, GY; Liu, GQ; Cui, XJ; Zhao, HY; Cai, L				Xing, Yongqiang; Zhao, Xiujuan; Yu, Tao; Liang, Dong; Li, Jun; Wei, Guanyun; Liu, Guoqing; Cui, Xiangjun; Zhao, Hongyu; Cai, Lu			MiasDB: A Database of Molecular Interactions Associated with Alternative Splicing of Human Pre-mRNAs	PLOS ONE			English	Article							HISTONE MODIFICATIONS; MECHANISMS; U11-48K; GENES; SITES; SNRNP; CODE	Alternative splicing (AS) is pervasive in human multi-exon genes and is a major contributor to expansion of the transcriptome and proteome diversity. The accurate recognition of alternative splice sites is regulated by information contained in networks of protein-protein and protein-RNA interactions. However, the mechanisms leading to splice site selection are not fully understood. Although numerous databases have been built to describe AS, molecular interaction databases associated with AS have only recently emerged. In this study, we present a new database, MiasDB, that provides a description of molecular interactions associated with human AS events. This database covers 938 interactions between human splicing factors, RNA elements, transcription factors, kinases and modified histones for 173 human AS events. Every entry includes the interaction partners, interaction type, experimental methods, AS type, tissue specificity or disease-relevant information, a simple description of the functionally tested interaction in the AS event and references. The database can be queried easily using a web server (http://47.88.84.236/Miasdb). We display some interaction figures for several genes. With this database, users can view the regulation network describing AS events for 12 given genes.	[Xing, Yongqiang; Zhao, Xiujuan; Liang, Dong; Li, Jun; Wei, Guanyun; Liu, Guoqing; Cui, Xiangjun; Zhao, Hongyu; Cai, Lu] Inner Mongolia Univ Sci & Technol, Sch Life Sci & Technol, Baotou 014010, Peoples R China; [Yu, Tao] Inner Mongolia Univ Sci & Technol, Sch Sci, Baotou 014010, Peoples R China	Inner Mongolia University of Science & Technology; Inner Mongolia University of Science & Technology	Cai, L (corresponding author), Inner Mongolia Univ Sci & Technol, Sch Life Sci & Technol, Baotou 014010, Peoples R China.	nmcailu@163.com		Zhao, Hongyu/0000-0003-1477-5731	Natural Science Foundation of China [61271448, 11547150, 61361014, 61102162, 31260274]; Inner Mongolia Science & Technology Plan [20140401]; Natural Science Foundation of Inner Mongolia [2014MS0312, 2014MS0311, 2013MS0514, 2015MS0335]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inner Mongolia Science & Technology Plan; Natural Science Foundation of Inner Mongolia	This work was supported by the Natural Science Foundation of China (61271448, 11547150, 61361014, 61102162, 31260274), the Inner Mongolia Science & Technology Plan (20140401), and the Natural Science Foundation of Inner Mongolia (2014MS0312, 2014MS0311, 2013MS0514, 2015MS0335).	Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Busch A, 2013, NUCLEIC ACIDS RES, V41, pD118, DOI 10.1093/nar/gks969; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; Dralyuk I, 2000, NUCLEIC ACIDS RES, V28, P296, DOI 10.1093/nar/28.1.296; Giulietti M, 2013, NUCLEIC ACIDS RES, V41, pD125, DOI 10.1093/nar/gks997; Acuna LIG, 2013, WIRES RNA, V4, P77, DOI 10.1002/wrna.1142; Hnilicova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016727; Holste D, 2006, NUCLEIC ACIDS RES, V34, pD56, DOI 10.1093/nar/gkj048; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pD80; Huang YH, 2002, NUCLEIC ACIDS RES, V30, P186, DOI 10.1093/nar/30.1.186; Ji HK, 2001, NUCLEIC ACIDS RES, V29, P260, DOI 10.1093/nar/29.1.260; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kornblihtt AR, 2009, NAT STRUCT MOL BIOL, V16, P902, DOI 10.1038/nsmb0909-902; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Lee Y, 2007, NUCLEIC ACIDS RES, V35, pD99, DOI 10.1093/nar/gkl992; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Niemela EH, 2015, RNA BIOL, V12, P1256, DOI 10.1080/15476286.2015.1096489; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Perez-Valle J, 2012, WIRES RNA, V3, P707, DOI 10.1002/wrna.1131; Pospisil H, 2004, NUCLEIC ACIDS RES, V32, pD70, DOI 10.1093/nar/gkh136; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Shionyu M, 2009, NUCLEIC ACIDS RES, V37, pD305, DOI 10.1093/nar/gkn869; Shukla S, 2012, BBA-GENE REGUL MECH, V1819, P673, DOI 10.1016/j.bbagrm.2012.01.014; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Turunen JJ, 2013, RNA, V19, P380, DOI 10.1261/rna.036715.112; Turunen JJ, 2013, WIRES RNA, V4, P61, DOI 10.1002/wrna.1141; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Zhou HL, 2014, NUCLEIC ACIDS RES, V42, P701, DOI 10.1093/nar/gkt875	39	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155443	10.1371/journal.pone.0155443	http://dx.doi.org/10.1371/journal.pone.0155443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167218	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300059
J	Bastos, EP; Brentani, H; Pereira, CAB; Polpo, A; Lima, L; Puga, RD; Pasini, FS; Osorio, CABT; Roela, RA; Achatz, MI; Trape, AP; Gonzalez-Angulo, AM; Brentani, MM				Bastos, E. P.; Brentani, H.; Pereira, C. A. B.; Polpo, A.; Lima, L.; Puga, R. D.; Pasini, F. S.; Osorio, C. A. B. T.; Roela, R. A.; Achatz, M. I.; Trape, A. P.; Gonzalez-Angulo, A. M.; Brentani, M. M.			A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer	PLOS ONE			English	Article							INITIATION-FACTOR 4E; YOUNG-WOMEN; PROGNOSTIC-SIGNIFICANCE; POOR-PROGNOSIS; STEM-CELLS; IN-VITRO; TUMOR; EXPRESSION; MICRORNA; CARCINOMA	Breast cancer (BC) in young adult patients (YA) has a more aggressive biological behavior and is associated with a worse prognosis than BC arising in middle aged patients (MA). We proposed that differentially expressed miRNAs could regulate genes and proteins underlying aggressive phenotypes of breast tumors in YA patients when compared to those arising in MA patients. Objective: Using integrated expression analyses of miRs, their mRNA and protein targets and stromal gene expression, we aimed to identify differentially expressed profiles between tumors from YA-BC and MA-BC. Methodology and Results: Samples of ER+ invasive ductal breast carcinomas, divided into two groups: YA-BC (35 years or less) or MA-BC (50-65 years) were evaluated. Screening for BRCA1/2 status according to the BOADICEA program indicated low risk of patients being carriers of these mutations. Aggressive characteristics were more evident in YA-BC versus MA-BC. Performing qPCR, we identified eight miRs differentially expressed (miR-9, 18b, 33b, 106a, 106b, 210, 518a-3p and miR-372) between YA-BC and MA-BC tumors with high confidence statement, which were associated with aggressive clinicopathological characteristics. The expression profiles by microarray identified 602 predicted target genes associated to proliferation, cell cycle and development biological functions. Performing RPPA, 24 target proteins differed between both groups and 21 were interconnected within a network protein-protein interactions associated with proliferation, development and metabolism pathways over represented in YA-BC. Combination of eight mRNA targets or the combination of eight target proteins defined indicators able to classify individual samples into YA-BC or MA-BC groups. Fibroblast-enriched stroma expression profile analysis resulted in 308 stromal genes differentially expressed between YA-BC and MA-BC. Conclusion: We defined a set of differentially expressed miRNAs, their mRNAs and protein targets and stromal genes that distinguish early onset from late onset ER positive breast cancers which may be involved with tumor aggressiveness of YA-BC.	[Bastos, E. P.; Pasini, F. S.; Roela, R. A.; Brentani, M. M.] Univ Sao Paulo, Sch Med, Oncol & Radiol Dept, Lab Med Invest LIM 24 24, Sao Paulo, Brazil; [Brentani, H.; Lima, L.] Univ Sao Paulo, Sch Med, Inst & Dept Psychiat, Lab Med Invest LIM 23 23, Sao Paulo, Brazil; [Pereira, C. A. B.] Univ Sao Paulo, Math & Stat Inst, Sao Paulo, Brazil; [Polpo, A.] Univ Fed Sao Carlos, Dept Stat, Sao Paulo, Brazil; [Puga, R. D.] Einstein Hosp, Sao Paulo, Brazil; [Osorio, C. A. B. T.] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo, Brazil; [Achatz, M. I.] AC Camargo Canc Ctr, Dept Oncogenet, Sao Paulo, Brazil; [Trape, A. P.; Gonzalez-Angulo, A. M.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Carlos; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Bastos, EP (corresponding author), Univ Sao Paulo, Sch Med, Oncol & Radiol Dept, Lab Med Invest LIM 24 24, Sao Paulo, Brazil.	elenbastos@hotmail.com	Pasini, Fatima/D-8966-2012; Achatz, Maria Isabel/C-5751-2013; Osório, Cynthia/AAI-7427-2020; Pasini, Fatima Solange/AAA-2283-2019; de Toledo Osório, Cynthia Bueno/J-9282-2015; Roela, Rosimeire A/AAC-9377-2021; Brentani, Helena/G-6839-2011; Polpo de Campos, Adriano/G-4395-2012; Pereira, Carlos Alberto de Braganca/O-5022-2015	Achatz, Maria Isabel/0000-0001-6894-1219; Pasini, Fatima Solange/0000-0002-0361-7781; de Toledo Osório, Cynthia Bueno/0000-0002-7675-9780; Brentani, Helena/0000-0001-5192-4682; Polpo de Campos, Adriano/0000-0002-5959-1808; Pereira, Carlos Alberto de Braganca/0000-0001-6315-7484	FAPESP [2011/06752-9]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by FAPESP (2011/06752-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademuyiwa FO, 2015, CANCER-AM CANCER SOC, V121, P1469, DOI 10.1002/cncr.29178; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anders CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001373; Anders CK, 2011, J CLIN ONCOL, V29, pE18, DOI 10.1200/JCO.2010.28.9199; Azim HA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0427-5; Azim HA, 2012, CLIN CANCER RES, V18, P1341, DOI 10.1158/1078-0432.CCR-11-2599; Bacchi LM, 2010, BREAST, V19, P137, DOI 10.1016/j.breast.2010.01.002; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020; Bastos EP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101656; Ben-Hur V, 2013, CELL REP; Benz CC, 2008, CRIT REV ONCOL HEMAT, V66, P65, DOI 10.1016/j.critrevonc.2007.09.001; Bozoky B, 2013, INT J CANCER, V133, P286, DOI 10.1002/ijc.28035; Brinton LA, 2008, JNCI-J NATL CANCER I, V100, P1643, DOI 10.1093/jnci/djn344; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cailleau-Thomas A, 2000, GLYCOBIOLOGY; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cancello G, 2013, BREAST, V22, P1046, DOI 10.1016/j.breast.2013.08.006; Carraro DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057581; Chen B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-443; Chen YZ, 2011, CANCER LETT, V302, P63, DOI 10.1016/j.canlet.2010.12.014; Civelek M, 2014, NAT REV GENET, V15, P34, DOI 10.1038/nrg3575; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Davies AH, 2011, ONCOTARGET, V2, P401; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Kruijf EM, 2011, BREAST CANCER RES TR, V125, P687, DOI 10.1007/s10549-010-0855-6; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Finak G, 2008, NAT MED; Fleming JM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-27; Fonseca-Sanchez MA, 2013, ONCOL REP, V30, P2399, DOI 10.3892/or.2013.2691; Gabriel CA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2647; Gao J, 2015, PATHOL BIOL, V63, P199, DOI 10.1016/j.patbio.2015.07.001; Gentilini O, 2010, BREAST, V19, P55, DOI 10.1016/j.breast.2009.11.001; Glenisson Mathilde, 2012, Genes Cancer, V3, P63, DOI 10.1177/1947601912449832; Gonzalez-Angulo AM, 2005, CANCER-AM CANCER SOC, V103, P2466, DOI 10.1002/cncr.21070; Gwak JM, 2014, BREAST CANCER RES TR, V147, P39, DOI 10.1007/s10549-014-3069-5; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Iadevaia S, 2010, CANCER RES, V70, P6704, DOI 10.1158/0008-5472.CAN-10-0460; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2011, BREAST, V20, pS63, DOI 10.1016/S0960-9776(11)70297-1; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Leivonen SK, 2009, ONCOGENE, V28, P3926, DOI 10.1038/onc.2009.241; Li MH, 2014, INT J PHOTOENERGY, V2014, DOI 10.1155/2014/670438; Mandel K, 2013, STEM CELLS DEV, V22, P3114, DOI 10.1089/scd.2013.0249; Gonzalez-Angulo AM, 2010, J CLIN ONCOL, V28, P2777, DOI 10.1200/JCO.2009.27.0777; Marques F.P.C., 2014, OPEN J GENET, V4, P63, DOI [10.4236/ojgen.2014.41009, DOI 10.4236/OJGEN.2014.41009]; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Moura RD, 2015, BREAST, V24, P461, DOI 10.1016/j.breast.2015.04.002; Murakami Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-99; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pena-Chilet M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-529; Peng QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060321; Pereira C. A. D. B., 2014, CONFIDENCE STATEMENT; Petrelli F, 2015, BREAST CANCER RES TR, V153, P477, DOI 10.1007/s10549-015-3559-0; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Reipas KM, 2013, ONCOTARGET, V4, P329, DOI 10.18632/oncotarget.834; Rostoker R, 2015, ENDOCR RELAT CANC; Samy N, 2010, CANCER BIOMARK, V6, P63, DOI 10.3233/CBM-2009-0119; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Singer CF, 2008, BREAST CANC RES TREA; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tichy JR, 2013, J NATL COMPR CANC NE, V11, P1060, DOI 10.6004/jnccn.2013.0128; Tomita H, 2016, ONCOTARGET, DOI 10.18632/oncotarget.6920; Trape AP, 2012, CANCER GENOM PROTEOM, V9, P297; Tsai ZY, 2011, KAOHSIUNG J MED SCI, V27, P299, DOI 10.1016/j.kjms.2011.03.010; Uehara T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004921; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Uhrhammer Nancy, 2008, Int J Med Sci, V5, P197; Verghese ET, 2013, J PATHOL, V231, P388, DOI 10.1002/path.4248; Wei W, 2013, GENES IMMUN, V14, P1, DOI 10.1038/gene.2012.54; Welsby I, 2014, J BIOL CHEM, V289, P26642, DOI 10.1074/jbc.M114.589515; Willems L, 2012, CURR ONCOLREP    APR; Wu G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1214-0; Yau C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2120; Yau C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1765; Yau C, 2011, BREAST CANCER RES TR, V126, P803, DOI 10.1007/s10549-011-1345-1; Yin XD, 2014, J AM COLL SURGEONS, V218, P663, DOI 10.1016/j.jamcollsurg.2013.12.020; Zhao XX, 2015, INT J CLIN EXP PATHO, V8, P368; Zheng RH, 2015, J SURG RES, V195, P158, DOI 10.1016/j.jss.2014.12.035; Zhou S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-231	84	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154325	10.1371/journal.pone.0154325	http://dx.doi.org/10.1371/journal.pone.0154325			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152840	Green Submitted, gold, Green Published			2022-12-27	WOS:000375677000015
J	Li, GW; Chen, XL; Li, BL; Zhang, GH; Li, YP; Wu, JX				Li, Guangwei; Chen, Xiulin; Li, Boliao; Zhang, Guohui; Li, Yiping; Wu, Junxiang			Binding Properties of General Odorant Binding Proteins from the Oriental Fruit Moth, Grapholita molesta (Busck) (Lepidoptera: Tortricidae)	PLOS ONE			English	Article							PHEROMONE-BINDING; EXPRESSION PATTERNS; OLFACTORY SENSILLA; SEX-PHEROMONE; NMR STRUCTURE; MOLECULAR CHARACTERIZATION; ANTHERAEA-POLYPHEMUS; FUNCTIONAL-ANALYSIS; CHILO-SUPPRESSALIS; SOLUBLE-PROTEINS	Background The oriental fruit moth Grapholita molesta is a host-switching pest species. The adults highly depend on olfactory cues in locating optimal host plants and oviposition sites. Odorant binding proteins (OBPs) are thought to be responsible for recognizing and transporting hydrophobic odorants across the aqueous sensillum lymph to stimulate the odorant receptors (ORs) within the antennal sensilla and activate the olfactory signal transduction pathway. Exploring the physiological function of these OBPs could facilitate understanding insect chemical communications. Methodology/Principal Finding Two antennae-specific general OBPs (GOBPs) of G. molesta were expressed and purified in vitro. The binding affinities of G. molesta GOBP1 and 2 (GmolGOBP1 and 2) for sex pheromone components and host plant volatiles were measured by fluorescence ligand-binding assays. The distribution of GmolGOBP1 and 2 in the antennal sensillum were defined by whole mount fluorescence immunohistochemistry (WM-FIHC) experiments. The binding sites of GmolGOBP2 were predicted using homology modeling, molecular docking and site-directed mutagenesis. Both GmolGOBP1 and 2 are housing in sensilla basiconica and with no differences in male and female antennae. Recombinant GmolGOBP1 (rGmolGOBP1) exhibited broad binding properties towards host plant volatiles and sex pheromone components; rGmolGOBP2 could not effectively bind host plant volatiles but showed specific binding affinity with a minor sex pheromone component dodecanol. We chose GmolGOBP2 and dodecanol for further homology modeling, molecular docking, and site-directed mutagenesis. Binding affinities of mutants demonstrated that Thr9 was the key binding site and confirmed dodecanol bonding to protein involves a hydrogen bond. Combined with the pH effect on binding affinities of rGmolGOBP2, ligand binding and release of GmolGOBP2 were related to a pH-dependent conformational transition. Conclusion Two rGmolGOBPs exhibit different binding characteristics for tested ligands. rGmolGOBP1 has dual functions in recognition of host plant volatiles and sex pheromone components, while rGmolGOBP2 is mainly involved in minor sex pheromone component dodecanol perception. This study also provides empirical evidence for the predicted functions of key amino acids in recombinant protein ligand-binding characteristics.	[Li, Guangwei; Chen, Xiulin; Li, Boliao; Li, Yiping; Wu, Junxiang] Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China; [Li, Guangwei; Chen, Xiulin; Li, Boliao; Li, Yiping; Wu, Junxiang] Northwest A&F Univ, Key Lab Appl Entomol, Yangling, Shaanxi, Peoples R China; [Zhang, Guohui] Yangtze Univ, Coll Agr, Inst Entomol, Jingzhou, Hubei, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Yangtze University	Li, YP; Wu, JX (corresponding author), Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China.; Li, YP; Wu, JX (corresponding author), Northwest A&F Univ, Key Lab Appl Entomol, Yangling, Shaanxi, Peoples R China.	liyiping@nwsuaf.edu.cn; junxw@nwsuaf.edu.cn			National Natural Science Foundation of China [31272043, 31501641]; Ministry of Agriculture of the People's Republic of China [201103024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs)	This work was supported by Grant No. 31272043, Recipients: JXW, http://www.nsfc.gov.cn/, National Natural Science Foundation of China; Grant No. 31501641, Recipients: GHZ, http://www.nsfc.gov.cn/, National Natural Science Foundation of China; and Grant No. 201103024, Recipients: JXW, http://www.moa.gov.cn/, Ministry of Agriculture of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; CARDE AM, 1979, J CHEM ECOL, V5, P423, DOI 10.1007/BF00987927; CARDE RT, 1975, NATURE, V253, P348, DOI 10.1038/253348a0; Du J., 2010, J SHANXI AGR U, V30, P229, DOI DOI 10.13842/J.CNKI.ISSN1671-8151.2010.03.015; FEIXAS J, 1995, EUR J BIOCHEM, V234, P521, DOI 10.1111/j.1432-1033.1995.521_b.x; Feng L, 1997, INSECT BIOCHEM MOLEC, V27, P405, DOI 10.1016/S0965-1748(97)00012-X; Gong ZJ, 2009, INSECT MOL BIOL, V18, P405, DOI 10.1111/j.1365-2583.2009.00886.x; He XL, 2010, J CHEM ECOL, V36, P1293, DOI 10.1007/s10886-010-9870-7; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Il'ichev AL, 2007, J APPL ENTOMOL, V131, P368, DOI 10.1111/j.1439-0418.2007.01201.x; Il'ichev AL, 2009, J PLANT INTERACT, V4, P289, DOI 10.1080/17429140903267814; Jacquin-Joly E, 2000, EUR J BIOCHEM, V267, P6708, DOI 10.1046/j.1432-1327.2000.01772.x; Jiang QY, 2009, INSECT BIOCHEM MOLEC, V39, P440, DOI 10.1016/j.ibmb.2009.04.004; Jin JY, 2014, J INSECT PHYSIOL, V66, P71, DOI 10.1016/j.jinsphys.2014.05.013; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Kim MS, 1998, GENETICS, V150, P711; Krieger J, 1996, INSECT BIOCHEM MOLEC, V26, P297, DOI 10.1016/0965-1748(95)00096-8; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; LAUE M, 1994, NATURWISSENSCHAFTEN, V81, P178, DOI 10.1007/BF01134537; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Li GW, 2016, ARCH INSECT BIOCHEM, V91, P67, DOI 10.1002/arch.21309; Li GW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142193; Liu NY, 2015, INSECT MOL BIOL, V24, P167, DOI 10.1111/imb.12143; Liu SJ, 2012, ARCH INSECT BIOCHEM, V80, P123, DOI 10.1002/arch.21036; Liu ZO, 2010, J CHEM ECOL, V36, P787, DOI 10.1007/s10886-010-9811-5; Lu PF, 2012, J CHEM ECOL, V38, P1003, DOI 10.1007/s10886-012-0152-4; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maida R, 2005, J NEUROCYTOL, V34, P149, DOI 10.1007/s11068-005-5054-8; Maida R, 2000, EUR J BIOCHEM, V267, P2899, DOI 10.1046/j.1432-1327.2000.01303.x; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Myers CT, 2007, J ECON ENTOMOL, V100, P421, DOI 10.1603/0022-0493(2007)100[421:EOOHPA]2.0.CO;2; Najar-Rodriguez A, 2013, J CHEM ECOL, V39, P418, DOI 10.1007/s10886-013-0262-7; Nardi JB, 2003, CELL TISSUE RES, V313, P321, DOI 10.1007/s00441-003-0766-5; Natale D, 2004, J APPL ENTOMOL, V128, P22, DOI 10.1046/j.1439-0418.2003.00802.x; Natale D, 2003, B ENTOMOL RES, V93, P335, DOI 10.1079/BER2003250; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; Pinero JC, 2008, J INSECT PHYSIOL, V54, P333, DOI 10.1016/j.jinsphys.2007.10.002; RICE RE, 1972, J ECON ENTOMOL, V65, P1212, DOI 10.1093/jee/65.4.1212; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Song YQ, 2014, J INTEGR AGR, V13, P2709, DOI 10.1016/S2095-3119(13)60686-3; Song Yue-Qin, 2014, Acta Entomologica Sinica, V57, P274; STEINBRECHT RA, 1995, CELL TISSUE RES, V282, P203, DOI 10.1007/BF00319112; Thode AB, 2008, J MOL BIOL, V376, P1360, DOI 10.1016/j.jmb.2007.12.063; VANDENBERG MJ, 1991, J INSECT PHYSIOL, V37, P79, DOI 10.1016/0022-1910(91)90022-R; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; Vogt RG, 2002, J EXP BIOL, V205, P719; VOGT RG, 1991, J NEUROSCI, V11, P2972; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Xu XZ, 2010, BIOCHEMISTRY-US, V49, P1469, DOI 10.1021/bi9020132; Yin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033589; Zhang GH, 2012, J CHEM ECOL, V38, P427, DOI 10.1007/s10886-012-0102-1; Zhang TT, 2012, J INSECT PHYSIOL, V58, P941, DOI 10.1016/j.jinsphys.2012.04.010; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015	61	26	36	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155096	10.1371/journal.pone.0155096	http://dx.doi.org/10.1371/journal.pone.0155096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152703	Green Submitted, Green Published, gold			2022-12-27	WOS:000375677000068
J	Siemieniuch, MJ; Szostek, AZ; Gajos, K; Kozdrowski, R; Nowak, M; Okuda, K				Siemieniuch, Marta J.; Szostek, Anna Z.; Gajos, Katarzyna; Kozdrowski, Roland; Nowak, Marcin; Okuda, Kiyoshi			Type of Inflammation Differentially Affects Expression of Interleukin 1 beta and 6, Tumor Necrosis Factor-alpha and Toll-Like Receptors in Subclinical Endometritis in Mares	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; EQUINE ENDOMETRIUM; BOVINE ENDOMETRIUM; PREGNANCY RATES; ESTROUS-CYCLE; STROMAL CELLS; BIOPSY; RESISTANT; DIAGNOSIS; GENES	Mares that fail to conceive or lose their embryos, without showing typical signs of clinical endometritis, should be suspected of subclinical endometritis (SE). In this study, the question was addressed: does SE fully activate selected mechanisms of innate immunity in mares? For this aim, expression of mRNAs for Toll-like Receptor 2 and 4 (TLR 2/4), interleukin 1 beta (IL-1 beta), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF) was examined in control mares versus either mares suffering from chronic endometritis (ChE) or subacute suppurative endometritis (SSE). The concentrations of IL-1 beta, IL-6 and TNF-alpha in supernatants from endometrial tissue cultures after 4 h incubation were measured using the enzyme immunoassay (EIA) method. Eighty-two warmblood mares, of known breeding history, were enrolled in this study. Based on histopathological assessment, mares were classified as suffering from ChE, SSE or as being healthy. In addition, immuno-localization of both TLR2 and TLR4 as well as TNF-alpha was investigated in the equine endometria. The mRNA expression of TLR2 (P < 0.01), IL-1 beta (P < 0.0001), IL-6 (P < 0.0001) and TLR4 and TNF (P < 0.05) was up-regulated in endometria of mares suffering from SSE compared with unaffected mares. Concentrations of IL-6 and TNF-alpha were increased only in mares exhibiting SSE, compared with unaffected (P < 0.01 for both) and ChE mares (P < 0.05 for both). Immuno-localization of TNF-alpha and TLRs was confirmed, both in unaffected and SE-affected endometria, and was present in the luminal and glandular epithelia and stromal cells. The severity of inflammation impacts the immune response and fosters activation of innate immunity mechanisms, as observed in the endometria of mares. The intracellular localization of TLRs and TNF-alpha in the endometria indicates a key role of endometrial epithelial and stromal cells in the immune response and inflammation.	[Siemieniuch, Marta J.; Szostek, Anna Z.] Polish Acad Sci, Dept Reprod Immunol & Pathol, Olsztyn, Poland; [Siemieniuch, Marta J.; Szostek, Anna Z.; Okuda, Kiyoshi] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan; [Gajos, Katarzyna] EQUI MED Equine Practice, Chojnice, Poland; [Kozdrowski, Roland] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Wroclaw, Poland; [Nowak, Marcin] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Wroclaw, Poland	Polish Academy of Sciences; Okayama University; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences	Siemieniuch, MJ (corresponding author), Polish Acad Sci, Dept Reprod Immunol & Pathol, Olsztyn, Poland.; Siemieniuch, MJ (corresponding author), Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan.	m.siemieniuch@pan.olsztyn.pl	SZÓSTEK-MIODUCHOWSKA, Anna/AAL-3367-2021; Nowak, Marcin/A-8768-2017; OKUDA, Kiyoshi/AAC-8606-2020; Kozdrowski, Roland/S-8222-2016; Szóstek-Mioduchowska, Anna/H-7253-2017	SZÓSTEK-MIODUCHOWSKA, Anna/0000-0003-4204-1698; Nowak, Marcin/0000-0002-2468-107X; Szóstek-Mioduchowska, Anna/0000-0003-4204-1698; SIEMIENIUCH, Marta J./0000-0002-5117-9659; Kozdrowski, Roland/0000-0002-5155-8835	NCN [DEC-2011/01/B/NZ5/04173]; KNOW Consortium "Health Animal-Safety Food", MSHE [05-1/KNOW2/2015]; Domestic Grants for Young Scientists from Foundation of Polish Science (FNP, Program Start, Poland); JSPS [P-14082]; Grants-in-Aid for Scientific Research [26292136] Funding Source: KAKEN	NCN; KNOW Consortium "Health Animal-Safety Food", MSHE; Domestic Grants for Young Scientists from Foundation of Polish Science (FNP, Program Start, Poland); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the NCN, DEC-2011/01/B/NZ5/04173 and KNOW Consortium "Health Animal-Safety Food", MS&HE, decision no. 05-1/KNOW2/2015. AZS was supported by Domestic Grants for Young Scientists from Foundation of Polish Science (FNP, Program Start, Poland) and a JSPS post-doctoral fellow (P-14082).	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Aresu L, 2012, J VET SCI, V13, P171, DOI 10.4142/jvs.2012.13.2.171; Bergfelt D. R., 2011, Equine reproduction, Volume 2, P2055; Buczkowska J, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-27; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Christoffersen M, 2015, THERIOGENOLOGY, V84, P1283, DOI 10.1016/j.theriogenology.2015.07.007; Christoffersen M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-41; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Figueiredo MD, 2009, VET IMMUNOL IMMUNOP, V131, P65, DOI 10.1016/j.vetimm.2009.03.013; Fumuso E, 2003, VET IMMUNOL IMMUNOP, V96, P31, DOI 10.1016/S0165-2427(03)00137-5; Gabler C, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-152; Gajos K, 2015, THERIOGENOLOGY, V84, P457, DOI 10.1016/j.theriogenology.2015.03.038; Galvao A, 2013, REPROD FERT DEVELOP, V25, P985, DOI 10.1071/RD12153; Ginther OJ, 2007, ANIM REPROD SCI, V99, P213, DOI 10.1016/j.anireprosci.2006.05.018; Healy LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07060; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Herath S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-55; Jursza E, 2015, THERIOGENOLOGY, V83, P596, DOI 10.1016/j.theriogenology.2014.10.023; Jursza E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/689280; KENNEY RM, 1978, J AM VET MED ASSOC, V172, P241; Kenney RM, 1986, CURRENT THERAPY THER, V2, P726; Kilgenstein HJ, 2015, RES VET SCI, V99, P171, DOI 10.1016/j.rvsc.2015.01.005; LeBlanc MM, 2010, REPROD DOMEST ANIM, V45, P21, DOI 10.1111/j.1439-0531.2010.01634.x; LeBlanc MM, 2009, REPROD DOMEST ANIM, V44, P10, DOI 10.1111/j.1439-0531.2009.01485.x; LeBlanc MM, 2007, THERIOGENOLOGY, V68, P403, DOI 10.1016/j.theriogenology.2007.04.038; Nielsen JM, 2005, THERIOGENOLOGY, V64, P510, DOI 10.1016/j.theriogenology.2005.05.034; Overbeck W, 2011, THERIOGENOLOGY, V75, P1311, DOI 10.1016/j.theriogenology.2010.12.002; Petersen MR, 2015, VET MICROBIOL, V179, P119, DOI 10.1016/j.vetmic.2015.06.006; PIERSON RA, 1985, THERIOGENOLOGY, V23, P795, DOI 10.1016/0093-691X(85)90155-4; Portus BJ, 2005, EQUINE VET J, V37, P515, DOI 10.2746/042516405775314844; Ricketts S W, 1975, Equine Vet J, V7, P102, DOI 10.1111/j.2042-3306.1975.tb03243.x; RICKETTS SW, 1991, EQUINE VET J, V23, P185, DOI 10.1111/j.2042-3306.1991.tb02751.x; Riddle WT, 2007, THERIOGENOLOGY, V68, P395, DOI 10.1016/j.theriogenology.2007.05.050; Schoon HA, 1997, PFERDEHEILKUNDE, V13, P453, DOI 10.21836/PEM19970506; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012906; Szostek AZ, 2012, THERIOGENOLOGY, V78, P768, DOI 10.1016/j.theriogenology.2012.03.024; Szostek AZ, 2014, CYTOKINE, V67, P85, DOI 10.1016/j.cyto.2014.02.005; Szostek AZ, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109447; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tortorella C, 2014, FERTIL STERIL, V101, P242, DOI 10.1016/j.fertnstert.2013.09.041; Turner ML, 2014, ENDOCRINOLOGY, V155, P1453, DOI 10.1210/en.2013-1822; Walter J, 2012, ANIM REPROD SCI, V132, P178, DOI 10.1016/j.anireprosci.2012.05.012; Woodward EM, 2013, REPRODUCTION, V145, P289, DOI 10.1530/REP-12-0452; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	47	22	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154934	10.1371/journal.pone.0154934	http://dx.doi.org/10.1371/journal.pone.0154934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152525	Green Published, gold			2022-12-27	WOS:000375677000048
J	Sladitschek, HL; Neveu, PA				Sladitschek, Hanna L.; Neveu, Pierre A.			Bidirectional Promoter Engineering for Single Cell MicroRNA Sensors in Embryonic Stem Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; EXPRESSION PROFILES; REGULATED MICRORNA; SMALL RNAS; GENE; MOUSE; DICER; DIFFERENTIATION; BIOGENESIS; IDENTIFICATION	MicroRNAs have emerged as important markers and regulators of cell identity. Precise measurements of cellular miRNA levels rely traditionally on RNA extraction and thus do not allow to follow miRNA expression dynamics at the level of single cells. Non-invasive miRNA sensors present an ideal solution but they critically depend on the performance of suitable ubiquitous promoters that reliably drive expression both in pluripotent and differentiated cell types. Here we describe the engineering of bidirectional promoters that drive the expression of precise ratiometric fluorescent miRNA sensors in single mouse embryonic stem cells (mESCs) and their differentiated derivatives. These promoters are based on combinations of the widely used CAG, EF1 alpha and PGK promoters as well as the CMV and PGK enhancers. miR-142-3p, which is known to be bimodally expressed in mESCs, served as a model miRNA to gauge the precision of the sensors. The performance of the resulting miRNA sensors was assessed by flow cytometry in single stable transgenic mESCs undergoing self-renewal or differentiation. EF1 alpha promoters arranged back-to-back failed to drive the robustly correlated expression of two transgenes. Back-to-back PGK promoters were shut down during mESC differentiation. However, we found that a back-to-back arrangement of CAG promoters with four CMV enhancers provided both robust expression in mESCs undergoing differentiation and the best signal-to-noise for measurement of miRNA activity in single cells among all the sensors we tested. Such a bidirectional promoter is therefore particularly well suited to study the dynamics of miRNA expression during cell fate transitions at the single cell level.	[Sladitschek, Hanna L.; Neveu, Pierre A.] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Baden Wurttembe, Germany	European Molecular Biology Laboratory (EMBL)	Neveu, PA (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Baden Wurttembe, Germany.	neveu@embl.de		Neveu, Pierre/0000-0003-4939-3418; Sladitschek-Martens, Hanna Lucie/0000-0001-8910-1999	European Molecular Biology Laboratory	European Molecular Biology Laboratory	The study was funded by the European Molecular Biology Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Caron L, 2005, ONCOGENE, V24, P6281, DOI 10.1038/sj.onc.1208781; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Chilton JM, 2008, J BIOTECHNOL, V138, P42, DOI 10.1016/j.jbiotec.2008.07.1996; Chung SM, 2002, STEM CELLS, V20, P139, DOI 10.1634/stemcells.20-2-139; COLLINS J, 1980, COLD SPRING HARB SYM, V45, P409, DOI 10.1101/SQB.1981.045.01.055; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hoppe PS, 2014, NAT CELL BIOL, V16, P919, DOI 10.1038/ncb3042; Huang PC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/104716; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kobayashi Naoya, 2005, Birth Defects Res C Embryo Today, V75, P10, DOI 10.1002/bdrc.20031; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee JY, 2008, J NUCL MED, V49, P285, DOI 10.2967/jnumed.107.042507; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; MCBURNEY MW, 1994, DEV DYNAM, V200, P278, DOI 10.1002/aja.1002000403; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Neveu P, 2010, CELL STEM CELL, V7, P671, DOI 10.1016/j.stem.2010.11.012; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Norrman K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012413; Orban TI, 2009, STEM CELLS, V27, P1077, DOI 10.1002/stem.45; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Pennacchio LA, 2013, NAT REV GENET, V14, P288, DOI 10.1038/nrg3458; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sladitschek HL, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156525; Sladitschek HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124958; Tian WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029551; Torres-Padilla ME, 2014, DEVELOPMENT, V141, P2173, DOI 10.1242/dev.102624; TSVETKOV S, 1989, EXP CELL RES, V180, P94, DOI 10.1016/0014-4827(89)90215-2; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wang G, 2011, SCI CHINA LIFE SCI, V54, P418, DOI 10.1007/s11427-011-4171-0; Wang R, 2008, STEM CELLS DEV, V17, P279, DOI 10.1089/scd.2007.0084; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	78	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155177	10.1371/journal.pone.0155177	http://dx.doi.org/10.1371/journal.pone.0155177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152616	Green Published, gold, Green Submitted			2022-12-27	WOS:000375677000076
J	Treda, C; Popeda, M; Ksiazkiewicz, M; Grzela, DP; Walczak, MP; Banaszczyk, M; Peciak, J; Stoczynska-Fidelus, E; Rieske, P				Treda, Cezary; Popeda, Marta; Ksiazkiewicz, Magdalena; Grzela, Dawid P.; Walczak, Maciej P.; Banaszczyk, Mateusz; Peciak, Joanna; Stoczynska-Fidelus, Ewelina; Rieske, Piotr			EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; KINASE; ENDOCYTOSIS; APOPTOSIS; SURVIVAL; PATHWAY; UBIQUITINATION; DIMERIZATION; DOWNSTREAM	The Epidermal Growth Factor Receptor (EGFR) and its mutations contribute in various ways to tumorigenesis and biology of human cancers. They are associated with tumor proliferation, progression, drug resistance and the process of apoptosis. There are also reports that overexpression and activation of wild-type EGFR may lead to cell apoptosis. To study this phenomenon, we overexpressed in an AD293 cell line two most frequently observed forms of the EGFR receptor: wild-type and the constitutively active mutant-EGFR variant III (EGFRvIII). Then, we compared the effect of EGF stimulation on cell viability and downstream EGFR signaling. AD293 cells overexpressing wild-type EGFR, despite a significant proliferation increase in serum supplemented medium, underwent apoptosis after EGF stimulation in serum free conditions. EGFRvIII expressing cells, however, were unaffected by either serum starvation or EGF treatment. The effect of EGF was completely neutralized by tyrosine kinase inhibitors (TKIs), indicating the specificity of this observation. Moreover, apoptosis was not prevented by inhibiting EGFR downstream proteins (PI3K, AKT and mTOR). Here we showed another EGFR function, dependent on environmental factors, which could be employed in therapy and drug design. We also proposed a new tool for EGFR inhibitor analysis.	[Treda, Cezary; Popeda, Marta; Ksiazkiewicz, Magdalena; Grzela, Dawid P.; Walczak, Maciej P.; Banaszczyk, Mateusz; Peciak, Joanna; Stoczynska-Fidelus, Ewelina; Rieske, Piotr] Celther Polska Ltd, Dept Res & Dev, Lodz, Poland; [Banaszczyk, Mateusz; Peciak, Joanna; Stoczynska-Fidelus, Ewelina; Rieske, Piotr] Med Univ Lodz, Dept Tumor Biol, Lodz, Poland	Medical University Lodz	Treda, C (corresponding author), Celther Polska Ltd, Dept Res & Dev, Lodz, Poland.	cezarytreda@celther.com	Rieske, Piotr/M-4821-2015; Grzela, Dawid P/G-6395-2015; Pęciak, Joanna/W-3441-2018; Stoczynska-Fidelus, Ewelina/S-9948-2016; Stoczynska-Fidelus, Ewelina/M-4871-2015	Rieske, Piotr/0000-0002-2970-0970; Grzela, Dawid P/0000-0002-0667-6488; Pęciak, Joanna/0000-0003-0911-4795; Stoczynska-Fidelus, Ewelina/0000-0002-7779-3075; Treda, Cezary/0000-0001-5348-3155; Popeda, Marta/0000-0002-4596-4837	Polish Agency for Enterprise Development [UDAPOIG 01.04.00-10-012/11-00]	Polish Agency for Enterprise Development	This study was sponsored by Polish Agency for Enterprise Development, Grant No. UDAPOIG 01.04.00-10-012/11-00. ESF, PR and SP participated in acquisition of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanazi I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120337; Alanazi I, 2013, APOPTOSIS, V18, P1291, DOI 10.1007/s10495-013-0887-6; ARMSTRONG DK, 1994, CANCER RES, V54, P5280; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bienkowski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065444; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Chakraborty S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6811; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Fan QW, 2013, CANCER CELL, V24, P438, DOI 10.1016/j.ccr.2013.09.004; Freudlsperger C, 2011, EXPERT OPIN THER TAR, V15, P63, DOI 10.1517/14728222.2011.541440; GILL GN, 1981, NATURE, V293, P305, DOI 10.1038/293305a0; Greenall SA, 2015, ONCOGENE, V34, P5277, DOI 10.1038/onc.2014.448; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Heukers R, 2013, J CELL SCI, V126, P4900, DOI 10.1242/jcs.128611; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Hyatt DC, 2008, EXP CELL RES, V314, P3415, DOI 10.1016/j.yexcr.2008.08.020; Jin X, 2011, CANCER RES, V71, P7125, DOI 10.1158/0008-5472.CAN-11-1330; Kancha RK, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-39; Kottke TJ, 1999, J BIOL CHEM, V274, P15927, DOI 10.1074/jbc.274.22.15927; Latha K, 2013, INT J CANCER, V132, P509, DOI 10.1002/ijc.27690; Li L, 2015, ONCOGENE, V34, P129, DOI 10.1038/onc.2013.534; Li L, 2014, ONCOGENE, V33, P4253, DOI 10.1038/onc.2013.400; Luwor RB, 2004, ONCOGENE, V23, P6095, DOI 10.1038/sj.onc.1207870; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nishimura Y, 2007, HISTOCHEM CELL BIOL, V127, P541, DOI 10.1007/s00418-007-0281-y; Panieri E, 2010, AGING-US, V2, P487, DOI 10.18632/aging.100183; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Rush JS, 2012, J BIOL CHEM, V287, P712, DOI 10.1074/jbc.M111.294470; Schmidt MHH, 2003, P NATL ACAD SCI USA, V100, P6505, DOI 10.1073/pnas.1031790100; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Shinojima N, 2003, CANCER RES, V63, P6962; Sigismund S, 2013, EMBO J, V32, P2140, DOI 10.1038/emboj.2013.149; Stoczynska-Fidelus E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087136; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Ymer Susie I, 2011, Cancers (Basel), V3, P2032, DOI 10.3390/cancers3022032; Zhang JY, 2006, ACTA BIOCHIM POL, V53, P525	49	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155230	10.1371/journal.pone.0155230	http://dx.doi.org/10.1371/journal.pone.0155230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153109	Green Published, gold, Green Submitted			2022-12-27	WOS:000375677000081
J	Cold, ER; Freyria, NJ; Martinez, JM; Robledo, JAF				Cold, Emma R.; Freyria, Nastasia J.; Martinez, Joaquin Martinez; Robledo, Jose A. Fernandez			An Agar-Based Method for Plating Marine Protozoan Parasites of the Genus Perkinsus	PLOS ONE			English	Article							IN-VITRO CULTURE; CLAM MACOMA-BALTHICA; RIBOSOMAL-RNA LOCUS; TRYPANOSOMA-BRUCEI; SUPEROXIDE DISMUTASES; PROTISTAN PARASITE; EASTERN OYSTER; SACCHAROMYCES-CEREVISIAE; EXTRACELLULAR PROTEINS; CRASSOSTREA-VIRGINICA	The genus Perkinsus includes protozoan parasites of mollusks responsible for losses in the aquaculture industry and hampering the recovery of natural shellfish beds worldwide, and they are a key taxon for understanding intracellular parasitism adaptations. The ability to propagate the parasite in liquid media, in the absence of the host, has been crucial for improving understanding of its biology; however, alternative techniques to grow the parasite are needed to explore other basic aspects of the Perkinsus spp. biology. We optimized a DME: Ham's F12-5% FBS-containing solid agar medium for plating Perkinsus marinus. This solid medium supported trophozoite propagation both by binary fission and schizogony. Colonies were visible to the naked eye 17 days after plating. We tested the suitability of this method for several applications, including the following: 1) Subcloning P. marinus isolates: single discrete P. marinus colonies were obtained from DME: Ham's F12-5% FBS-0.75% agar plates, which could be further propagated in liquid medium; 2) Subcloning engineered Perkinsus mediterraneus MOE[MOE]: GFP by streaking cultures on plates; 3) Chemical susceptibility: Infusing the DME: Ham's F12-5% FBS-0.75% agar plates with triclosan resulted in inhibition of the parasite propagation in a dose-dependent manner. Altogether, our plating method has the potential for becoming a key tool for investigating diverse aspects of Perkinsus spp. biology, developing new molecular tools, and for biotechnological applications.	[Cold, Emma R.; Freyria, Nastasia J.; Martinez, Joaquin Martinez; Robledo, Jose A. Fernandez] Bigelow Lab Ocean Sci, East Boothbay, ME USA; [Cold, Emma R.] Bigelow Lab Ocean Sci, Res Experiences Undergrad REU NSF Program 2015, Boothbay, ME USA; [Freyria, Nastasia J.] Univ Toulon & Var, Toulon, France	Bigelow Laboratory for Ocean Sciences; Bigelow Laboratory for Ocean Sciences; Universite de Toulon	Robledo, JAF (corresponding author), Bigelow Lab Ocean Sci, East Boothbay, ME USA.	jfernandez-robledo@bigelow.org			Bigelow Laboratory for Ocean Sciences; National Science Foundation [OCE0755142]; EAGER [IOS1550399]; Gordon and Betty Moore Foundation [GBMF4962]; Division Of Earth Sciences [1460861] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1550399] Funding Source: National Science Foundation	Bigelow Laboratory for Ocean Sciences; National Science Foundation(National Science Foundation (NSF)); EAGER; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by institutional funds from Bigelow Laboratory for Ocean Sciences, supported by the National Science Foundation grants OCE0755142 (REU Program), EAGER IOS1550399, and by Gordon and Betty Moore Foundation (GBMF4962). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2003, ANAL BIOCHEM, V318, P132, DOI 10.1016/S0003-2697(03)00192-1; Ascenso RMT, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-179; Asojo OA, 2006, ACTA CRYSTALLOGR F, V62, P1072, DOI 10.1107/S1744309106040425; AZEVEDO C, 1989, J PARASITOL, V75, P627, DOI 10.2307/3282915; AZEVEDO C, 1990, DIS AQUAT ORGAN, V9, P63, DOI 10.3354/dao009063; Barberio C, 2007, CAN J MICROBIOL, V53, P223, DOI 10.1139/W06-132; Blackbourn J, 1998, CAN J ZOOL, V76, P942, DOI 10.1139/cjz-76-5-942; BRUN R, 1979, ACTA TROP, V36, P289; Bushek David, 1994, Annual Review of Fish Diseases, V4, P201, DOI 10.1016/0959-8030(94)90029-9; CARRUTHERS VB, 1992, P NATL ACAD SCI USA, V89, P8818, DOI 10.1073/pnas.89.18.8818; Casas SM, 2008, J EUKARYOT MICROBIOL, V55, P34, DOI 10.1111/j.1550-7408.2008.00301.x; Chen L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003979; Coss CA, 2001, J EUKARYOT MICROBIOL, V48, P52, DOI 10.1111/j.1550-7408.2001.tb00415.x; Coss CA, 2001, J EUKARYOT MICROBIOL, V48, P38, DOI 10.1111/j.1550-7408.2001.tb00414.x; Deschamps P, 2008, EUKARYOT CELL, V7, P872, DOI 10.1128/EC.00461-07; Earnhart CG, 2004, APPL ENVIRON MICROB, V70, P421, DOI 10.1128/AEM.70.1.421-431.2004; Fernandez-Boo S, 2014, J INVERTEBR PATHOL, V118, P47, DOI 10.1016/j.jip.2014.02.011; Fernandez-Boo S, 2015, DIS AQUAT ORGAN, V113, P245, DOI 10.3354/dao02835; Fernandez-Robledo JA, 2008, BIOCHEM BIOPH RES CO, V375, P215, DOI 10.1016/j.bbrc.2008.07.162; Fernandez-Robledo JA, 2010, TRENDS PARASITOL, V26, P244, DOI 10.1016/j.pt.2010.02.004; Garreis KA, 1996, FISH SHELLFISH IMMUN, V6, P581, DOI 10.1006/fsim.1996.0054; GAUTHIER JD, 1995, J INVERTEBR PATHOL, V66, P156, DOI 10.1006/jipa.1995.1079; GAUTHIER JD, 1993, J INVERTEBR PATHOL, V62, P321, DOI 10.1006/jipa.1993.1122; de Prado EG, 2014, YEAST, V31, P431, DOI 10.1002/yea.3036; GOLDBERG SS, 1980, J PARASITOL, V66, P677, DOI 10.2307/3280531; Joseph SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-228; KLEINSCHUSTER SJ, 1993, NAUTILUS, V107, P76; LAPEYRE JF, 1993, J EUKARYOT MICROBIOL, V40, P304, DOI 10.1111/j.1550-7408.1993.tb04920.x; LEE MGS, 1989, MOL BIOCHEM PARASIT, V34, P193, DOI 10.1016/0166-6851(89)90011-X; Leite RB, 2011, HERBICIDES, THEORY AND APPLICATIONS, P567; Lin Z, 2011, BIOCHEMISTRY-US, V50, P6340, DOI 10.1021/bi200343h; Lund ED, 2005, DIS AQUAT ORGAN, V67, P217, DOI 10.3354/dao067217; Marquis ND, 2015, PARASITOL INT, V64, P299, DOI 10.1016/j.parint.2015.04.001; McLaughlin SM, 2000, COMP BIOCHEM PHYS B, V126, P587, DOI 10.1016/S0305-0491(00)00231-5; MILES MA, 1988, PARASITOL TODAY, V4, P289, DOI 10.1016/0169-4758(88)90023-3; Mondragon A, 1999, PARASITOLOGY, V118, P461, DOI 10.1017/S0031182099004230; Montes JF, 1997, PARASITOLOGY, V114, P339, DOI 10.1017/S003118209600861X; Muniaraj M, 2010, TROP BIOMED, V27, P657; Panko C, 2006, J SHELLFISH RES, V25, P760; Perkins FO, 1996, J SHELLFISH RES, V15, P67; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Reece KS, 2001, MAR BIOL, V139, P1047, DOI 10.1007/s002270100657; Resto YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111051; Robledo J.A.F., 2008, MOL BIOCHEM PARASIT, V157, P44; Robledo JAF, 1999, J PARASITOL, V85, P650, DOI 10.2307/3285738; Robledo JAF, 2002, J EUKARYOT MICROBIOL, V49, P414, DOI 10.1111/j.1550-7408.2002.tb00221.x; Robledo JAF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100872; Schott EJ, 2003, EXP PARASITOL, V105, P232, DOI 10.1016/j.exppara.2003.12.012; Schott EJ, 2003, GENE, V309, P1, DOI 10.1016/S0378-1119(03)00469-4; Schott EJ, 2003, MOL BIOCHEM PARASIT, V126, P81, DOI 10.1016/S0166-6851(02)00271-2; Shridhar S, 2013, INT J PARASITOL-DRUG, V3, P85, DOI 10.1016/j.ijpddr.2013.03.001; Suttle CA, 2010, MANUAL AQUATIC VIRAL, P92, DOI DOI 10.4319/MAVE.2010.978-0-9845591-0-7.92; Suttle CA, 2010, MANUAL AQUATIC VIRAL, P118, DOI DOI 10.4319/MAVE.2010.978-0-9845591-0-7.118; Vassella E, 1996, MOL BIOCHEM PARASIT, V82, P91, DOI 10.1016/0166-6851(96)02727-2; WANG AL, 1991, PARASITOL TODAY, V7, P76, DOI 10.1016/0169-4758(91)90198-W; Wijayalath W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087435; Zhang HA, 2011, PROTIST, V162, P154, DOI 10.1016/j.protis.2010.03.003	57	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155015	10.1371/journal.pone.0155015	http://dx.doi.org/10.1371/journal.pone.0155015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149378	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800108
J	Han, W; Zhu, YF; Su, YJ; Li, GH; Qu, L; Zhang, HY; Wang, KH; Zou, JM; Liu, HL				Han, Wei; Zhu, Yunfen; Su, Yijun; Li, Guohui; Qu, Liang; Zhang, Huiyong; Wang, Kehua; Zou, Jianmin; Liu, Honglin			High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers for Measuring Puberty Onset in Chicken (Gallus gallus)	PLOS ONE			English	Article							EXPRESSION PROFILE; MICRORNAS; IDENTIFICATION; SERUM; AGE; RNAS; ASSOCIATION; MENARCHE; SYSTEM; OVARY	There are still no highly sensitive and unique biomarkers for measurement of puberty onset. Circulating miRNAs have been shown to be promising biomarkers for diagnosis of various diseases. To identify circulating miRNAs that could be served as biomarkers for measuring chicken (Gallus gallus) puberty onset, the Solexa deep sequencing was performed to analyze the miRNA expression profiles in serum and plasma of hens from two different pubertal stages, before puberty onset (BO) and after puberty onset (AO). 197 conserved and 19 novel miRNAs (reads > 10) were identified as serum/plasma-expressed miRNAs in the chicken. The common miRNA amounts and their expression changes from BO to AO between serum and plasma were very similar, indicating the different treatments to generate serum and plasma had quite small influence on the miRNAs. 130 conserved serum-miRNAs were showed to be differentially expressed (reads > 10, P < 0.05) from BO to AO, with 68 up-regulated and 62 down-regulated. 4829 putative genes were predicted as the targets of the 40 most differentially expressed miRNAs (|log2(fold-change)|> 1.0, P < 0.01). Functional analysis revealed several pathways that were associated with puberty onset. Further quantitative real-time PCR (RT-qPCR) test found that a seven-miRNA panel, including miR-29c, miR-375, miR-215, miR-217, miR-19b, miR-133a and let-7a, had great potentials to serve as novel biomarkers for measuring puberty onset in chicken. Due to highly conserved nature of miRNAs, the findings could provide cues for measurement of puberty onset in other animals as well as humans.	[Han, Wei; Zhu, Yunfen; Su, Yijun; Li, Guohui; Qu, Liang; Zhang, Huiyong; Wang, Kehua; Zou, Jianmin] Chinese Acad Agr Sci, Poultry Inst, Natl Chickens Genet Resources, Yangzhou, Jiangsu, Peoples R China; [Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Nanjing Agricultural University	Zou, JM (corresponding author), Chinese Acad Agr Sci, Poultry Inst, Natl Chickens Genet Resources, Yangzhou, Jiangsu, Peoples R China.; Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	jqszjm@163.com; liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Natural Science Foundation of China [31201799]; Agricultural breed, technology and model innovation of Jiangsu Province [SXGC(2015)300]; Agricultural science and technology innovation project of Jiangsu Province [CX(15)1009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural breed, technology and model innovation of Jiangsu Province; Agricultural science and technology innovation project of Jiangsu Province	This research was supported by the National Natural Science Foundation of China (31201799) received by WH, Agricultural breed, technology and model innovation of Jiangsu Province SXGC(2015)300 received by WH and Agricultural science and technology innovation project of Jiangsu Province CX(15)1009 received by JMZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akat KM, 2014, P NATL ACAD SCI USA, V111, P11151, DOI 10.1073/pnas.1401724111; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Becker C, 2011, ANALYST, V136, P1204, DOI 10.1039/c0an00703j; Botta-Orfila T, 2014, J NEUROSCI RES, V92, P1071, DOI 10.1002/jnr.23377; Boulan L, 2013, CURR BIOL, V23, P473, DOI 10.1016/j.cub.2013.01.072; Carletti MZ, 2009, J ANIM SCI, V87, pE29, DOI 10.2527/jas.2008-1331; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Dorn L. D., 2006, APPL DEV SCI, V10, P30, DOI [10.1207/s1532480xads1001_3, DOI 10.1207/S1532480XADS1001_3]; Dorn LD, 2011, J RES ADOLESCENCE, V21, P180, DOI 10.1111/j.1532-7795.2010.00722.x; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Frost RJ, 2009, P NATL ACAD SCI USA, V108, P21075; Gajdos ZKZ, 2008, J CLIN ENDOCR METAB, V93, P4290, DOI 10.1210/jc.2008-0981; Gifford JAH, 2015, REPRODUCTION, V150, pR137, DOI 10.1530/REP-14-0685; Han W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129738; Kang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-352; Kolesarova A, 2015, PHYSIOL RES, V64, P379, DOI 10.33549/physiolres.932838; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Li J, 2015, PROTEIN CELL, V6, P391, DOI 10.1007/s13238-015-0156-2; Ling YH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-339; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomniczi A, 2013, HORM BEHAV, V64, P175, DOI 10.1016/j.yhbeh.2012.09.013; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Luo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011744; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Paczoska-Eliasiewicz HE, 2006, DOMEST ANIM ENDOCRIN, V31, P211, DOI 10.1016/j.domaniend.2005.10.005; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Pirola CJ, 2015, GUT, V64, P800, DOI 10.1136/gutjnl-2014-306996; Qin H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-154; Roa J, 2012, TRENDS ENDOCRIN MET, V21, P519; Rom S, 2015, J CEREBR BLOOD F MET, V35, P1957, DOI 10.1038/jcbfm.2015.154; Sangiao-Alvarellos S, 2013, ENDOCRINOLOGY, V154, P942, DOI 10.1210/en.2012-2006; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Squadrito ML, 2014, CELL REP, V8, P1432, DOI 10.1016/j.celrep.2014.07.035; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wu J, 2014, REPROD DOMEST ANIM, V49, P32, DOI 10.1111/rda.12217; Yang CH, 2013, INT J CANCER, V132, P116, DOI 10.1002/ijc.27657; Yingling VR, 2006, BONE, V38, P67, DOI 10.1016/j.bone.2005.07.001; Zheng Y, 2014, CELL STRESS CHAPERON, V19, P973, DOI 10.1007/s12192-014-0521-8; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	47	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154958	10.1371/journal.pone.0154958	http://dx.doi.org/10.1371/journal.pone.0154958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149515	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800099
J	Mbugi, EV; Katale, BZ; Streicher, EM; Keyyu, JD; Kendall, SL; Dockrell, HM; Michel, AL; Rweyemamu, MM; Warren, RM; Matee, MI; van Helden, PD; Couvin, D; Rastogi, N				Mbugi, Erasto V.; Katale, Bugwesa Z.; Streicher, Elizabeth M.; Keyyu, Julius D.; Kendall, Sharon L.; Dockrell, Hazel M.; Michel, Anita L.; Rweyemamu, Mark M.; Warren, Robin M.; Matee, Mecky I.; van Helden, Paul D.; Couvin, David; Rastogi, Nalin			Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African Countries	PLOS ONE			English	Article							DAR-ES-SALAAM; ANTITUBERCULOSIS DRUG-RESISTANCE; PULMONARY TUBERCULOSIS; INTERFERON-GAMMA; STRAINS; FAMILY; RISK; PREDOMINANCE; PREVALENCE; INFECTION	The aim of this study was to assess and characterize Mycobacterium tuberculosis complex (MTBC) genotypic diversity in Tanzania, as well as in neighbouring East and other several African countries. We used spoligotyping to identify a total of 293 M. tuberculosis clinical isolates (one isolate per patient) collected in the Bunda, Dar es Salaam, Ngorongoro and Serengeti areas in Tanzania. The results were compared with results in the SITVIT2 international database of the Pasteur Institute of Guadeloupe. Genotyping and phylogeographical analyses highlighted the predominance of the CAS, T, EAI, and LAM MTBC lineages in Tanzania. The three most frequent Spoligotype International Types (SITs) were: SIT21/CAS1-Kili (n = 76; 25.94%), SIT59/LAM11-ZWE (n = 22; 7.51%), and SIT126/EAI5 tentatively reclassified as EAI3-TZA (n = 18; 6.14%). Furthermore, three SITs were newly created in this study (SIT4056/EAI5 n = 2, SIT4057/T1 n = 1, and SIT4058/EAI5 n = 1). We noted that the East-African-Indian (EAI) lineage was more predominant in Bunda, the Manu lineage was more common among strains isolated in Ngorongoro, and the Central-Asian (CAS) lineage was more predominant in Dar es Salaam (p-value <0.0001). No statistically significant differences were noted when comparing HIV status of patients vs. major lineages (p-value = 0.103). However, when grouping lineages as Principal Genetic Groups (PGG), we noticed that PGG2/3 group (Haarlem, LAM, S, T, and X) was more associated with HIV-positive patients as compared to PGG1 group (Beijing, CAS, EAI, and Manu) (p-value = 0.03). This study provided mapping of MTBC genetic diversity in Tanzania (containing information on isolates from different cities) and neighbouring East African and other several African countries highlighting differences as regards to MTBC genotypic distribution between Tanzania and other African countries. This work also allowed underlining of spoli-gotyping patterns tentatively grouped within the newly designated EAI3-TZA lineage (remarkable by absence of spacers 2 and 3, and represented by SIT126) which seems to be specific to Tanzania. However, further genotyping information would be needed to confirm this specificity.	[Mbugi, Erasto V.] Muhimbili Univ Hlth & Allied Sci, Dept Biochem, POB 65001, Dar Es Salaam, Tanzania; [Mbugi, Erasto V.; Katale, Bugwesa Z.; Matee, Mecky I.] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, POB 65001, Dar Es Salaam, Tanzania; [Streicher, Elizabeth M.; Warren, Robin M.; van Helden, Paul D.] Univ Stellenbosch, Div Human Genet & Mol Biol, South African Med Res Council MRC,Ctr TB Res, DST NRF Ctr Excellence Biomed TB Res,Fac Hlth Sci, POB 241, ZA-8000 Cape Town, South Africa; [Katale, Bugwesa Z.; Keyyu, Julius D.] Tanzania Wildlife Res Inst TAWIRI, POB 661, Arusha, Tanzania; [Kendall, Sharon L.] Univ London London Sch Hyg & Trop Med, Dept Immunol & Infect, Keppel St, London WC1E 7HT, England; [Dockrell, Hazel M.] Univ London Royal Vet Coll, Royal Coll St, London NW1 0TU, England; [Michel, Anita L.] Univ Pretoria, Dept Vet Trop Dis, Fac Vet Sci, ZA-0002 Pretoria, South Africa; [Rweyemamu, Mark M.] Sokoine Univ Agr, Southern African Ctr Infect Dis Surveillance, Morogoro, Tanzania; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranatl TB Reference Lab, BP 484, Abymes 97183, Guadeloupe, France	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; National Research Foundation - South Africa; Stellenbosch University; University of London; London School of Hygiene & Tropical Medicine; University of London; University of London Royal Veterinary College; University of Pretoria; Sokoine University of Agriculture	Mbugi, EV (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Biochem, POB 65001, Dar Es Salaam, Tanzania.; Mbugi, EV (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, POB 65001, Dar Es Salaam, Tanzania.	erasto.mbugi@sacids.org	Streicher, Elizabeth M/I-7780-2018; Michel, Anita/N-8996-2014; Streicher, Elizabeth/O-9597-2019; Mbugi, Erasto/CAG-4121-2022	Streicher, Elizabeth M/0000-0003-3901-1981; Michel, Anita/0000-0001-9240-2653; Streicher, Elizabeth/0000-0003-3901-1981; Warren, Robin/0000-0001-5741-7358; Couvin, David/0000-0002-7897-9023; Kendall, Sharon/0000-0003-3277-3035; mbugi, erasto/0000-0002-9943-4671	Wellcome Trust [WT087546MA]; MUHAS Sida Sarec Small Grant [000/3177]; Southern African Centre for Infectious Disease Surveillance (SACIDS); Wellcome Trust [WT087546MA]; MUHAS Sida Sarec Small Grant [000/3177]; Southern African Centre for Infectious Disease Surveillance (SACIDS); Biotechnology and Biological Sciences Research Council [BB/N004590/1] Funding Source: researchfish; BBSRC [BB/N004590/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MUHAS Sida Sarec Small Grant; Southern African Centre for Infectious Disease Surveillance (SACIDS); Wellcome Trust(Wellcome TrustEuropean Commission); MUHAS Sida Sarec Small Grant; Southern African Centre for Infectious Disease Surveillance (SACIDS); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust Grant [WT087546MA] to EVM, MMR and MIM and by MUHAS Sida Sarec Small Grant [000/3177] to EVM, MIM and BZK. The Southern African Centre for Infectious Disease Surveillance (SACIDS) provided a Postdoctoral Research Fellowship to EVM and PhD candidacy for BZK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MM, 2014, INT J MYCOBACT, V3, P184, DOI 10.1016/j.ijmyco.2014.07.006; Albanna AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025075; Arora J, 2009, INFECT GENET EVOL, V9, P832, DOI 10.1016/j.meegid.2009.05.008; Belay M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238532; Bennett KP, 2011, BIOINF BIOM WORKSH B; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brown T, 2010, EMERG INFECT DIS, V16, P272, DOI 10.3201/eid1602.091032; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cadmus S, 2011, J CLIN MICROBIOL, V49, P220, DOI 10.1128/JCM.01241-10; Chang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043018; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Chonde TM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-427; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Douglas JT, 2003, J CLIN MICROBIOL, V41, P2723, DOI 10.1128/JCM.41.6.2723-2726.2003; Durnez Lies, 2011, Veterinary Medicine International, V2011, P1, DOI 10.4061/2011/495074; Eldholm V, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-76; Ferdinand Severine, 2005, Infection Genetics and Evolution, V5, P340, DOI 10.1016/j.meegid.2004.10.002; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Flores-Trevino S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118095; GAGNEUX S, 2006, P NATL ACAD SCI US; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Helal ZH, 2009, J CLIN MICROBIOL, V47, P2794, DOI 10.1128/JCM.00360-09; Holm LL, 2014, PEDIATRICS, V134, pE1568, DOI 10.1542/peds.2014-1570; Honeyborne I, 2014, J CLIN MICROBIOL, V52, P3064, DOI 10.1128/JCM.01128-14; Ignatova A, 2006, J MED MICROBIOL, V55, P1413, DOI 10.1099/jmm.0.46575-0; Ismail F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114832; Kabali C, 2013, TUBERCULOSIS, V93, P461, DOI 10.1016/j.tube.2013.01.001; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kibiki GS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-51; Lahey T, 2013, J INFECT DIS, V208, P1629, DOI 10.1093/infdis/jit396; Lahey T, 2013, CLIN INFECT DIS, V56, P151, DOI 10.1093/cid/cis798; Levy S, 2012, BIOSCIENCE, V62, P625, DOI 10.1525/bio.2012.62.7.3; Lukoye D, 2014, ANTIMICROB AGENTS CH, V58, P3853, DOI 10.1128/AAC.02338-13; Maeda S, 2014, TUBERCULOSIS, V94, P649, DOI 10.1016/j.tube.2014.09.005; Mallard K, 2010, J CLIN MICROBIOL, V48, P4512, DOI 10.1128/JCM.01683-10; Matee M, 2009, APMIS, V117, P263, DOI 10.1111/j.1600-0463.2008.02429.x; Mbugi EV, 2015, TUBERCULOSIS, V95, P170, DOI 10.1016/j.tube.2014.11.006; Mbugi Erasto V., 2012, Onderstepoort j. vet. res., V79, P01; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Mfinanga G S, 2007, Tanzan Health Res Bull, V9, P164; Mfinanga Godfrey S, 2009, Health Res Policy Syst, V7, P6, DOI 10.1186/1478-4505-7-6; Mfinanga SGM, 2014, TANZANIA J HLTH RES, V16; Mpagama SG, 2014, ANTIMICROB AGENTS CH, V58, P782, DOI 10.1128/AAC.01549-13; Ngadaya ES, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-278; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Pholwat S, 2014, TUBERCULOSIS, V94, P20, DOI 10.1016/j.tube.2013.10.006; Phyu S, 2009, J CLIN MICROBIOL, V47, P335, DOI 10.1128/JCM.01812-08; Rahim Z, 2007, J CLIN MICROBIOL, V45, P3791, DOI 10.1128/JCM.01247-07; Range N, 2001, INT J TUBERC LUNG D, V5, P405; Reddy EA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-89; Reiling N, 2013, MBIO, V4, DOI 10.1128/mBio.00250-13; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Semvua HH, 2015, THER DRUG MONIT, V37, P22, DOI 10.1097/FTD.0000000000000108; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Tang C, 2008, BIOINFORMATICS, V24, P2414, DOI 10.1093/bioinformatics/btn434; Thomas SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027584; Vellarikkal SK, 2013, GENOME ANNOUNCEMENTS, V1; Viegas SO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071999; WHO, 2014, GLOB TUB REP; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	67	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154571	10.1371/journal.pone.0154571	http://dx.doi.org/10.1371/journal.pone.0154571			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149626	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000375676800040
J	Vahia, MN; Ladiwala, U; Mahathe, P; Mathur, D				Vahia, Mayank N.; Ladiwala, Uma; Mahathe, Pavan; Mathur, Deepak			Population Dynamics of Early Human Migration in Britain	PLOS ONE			English	Article								Background Early human migration is largely determined by geography and human needs. These are both deterministic parameters when small populations move into unoccupied areas where conflicts and large group dynamics are not important. The early period of human migration into the British Isles provides such a laboratory which, because of its relative geographical isolation, may allow some insights into the complex dynamics of early human migration and interaction. Method and Results We developed a simulation code based on human affinity to habitable land, as defined by availability of water sources, altitude, and flatness of land, in choosing the path of migration. Movement of people on the British island over the prehistoric period from their initial entry points was simulated on the basis of data from the megalithic period. Topographical and hydro-shed data from satellite databases was used to define habitability, based on distance from water bodies, flatness of the terrain, and altitude above sea level. We simulated population movement based on assumptions of affinity for more habitable places, with the rate of movement tempered by existing populations. We compared results of our computer simulations with genetic data and show that our simulation can predict fairly accurately the points of contacts between different migratory paths. Such comparison also provides more detailed information about the path of peoples' movement over similar to 2000 years before the present era. Conclusions We demonstrate an accurate method to simulate prehistoric movements of people based upon current topographical satellite data. Our findings are validated by recently-available genetic data. Our method may prove useful in determining early human population dynamics even when no genetic information is available.	[Vahia, Mayank N.; Mahathe, Pavan; Mathur, Deepak] Tata Inst Fundamental Res, Homi Bhabha Rd, Bombay 400005, Maharashtra, India; [Ladiwala, Uma] Univ Bombay, UM DAE Ctr Excellence Basic Sci, Bombay 400098, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); UM-DAE Centre for Excellence in Basic Sciences; University of Mumbai	Vahia, MN (corresponding author), Tata Inst Fundamental Res, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	vahia@tifr.res.in	Mathur, Deepak/K-5000-2019	Mathur, Deepak/0000-0002-2322-6331				Ackland GJ, 2007, P NATL ACAD SCI USA, V104, P8714, DOI 10.1073/pnas.0702469104; [Anonymous], 2006, WHAT IS ENV HIST; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Cohen JE, 1998, P NATL ACAD SCI USA, V95, P14009, DOI 10.1073/pnas.95.24.14009; Davison K, 2006, J ARCHAEOL SCI, V33, P641, DOI 10.1016/j.jas.2005.09.017; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; FREEDMAN HI, 1989, MATH BIOSCI, V95, P111, DOI 10.1016/0025-5564(89)90055-2; Gamble C, 1994, PREHISTORY GLOBAL CO; Jackson MO, 2003, GROUP FORMATION EC; Kummu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020578; Leslie S, 2015, NATURE, V519, P309, DOI 10.1038/nature14230; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MCCLOUGHAN P, 1995, J IND ECON, V43, P405, DOI 10.2307/2950552; Petraglia M.D., 2007, EVOLUTION HIST HUMAN; PIAZZA A, 1995, P NATL ACAD SCI USA, V92, P5836, DOI 10.1073/pnas.92.13.5836; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rice SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007130; Weidlich Wand Haag G, 1999, INTEGRATED MODEL TRA; Winney B, 2012, EUR J HUM GENET, V20, P203, DOI 10.1038/ejhg.2011.127	19	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154641	10.1371/journal.pone.0154641	http://dx.doi.org/10.1371/journal.pone.0154641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27148959	gold, Green Submitted, Green Published			2022-12-27	WOS:000375676800044
J	Warholm, P; Light, S				Warholm, Per; Light, Sara			Identification of a Non-Pentapeptide Region Associated with Rapid Mycobacterial Evolution	PLOS ONE			English	Article							POLYMORPHIC TANDEM REPEAT; GENOME EVOLUTION; TUBERCULOSIS; PROTEINS; PPE; DATABASE; PFAM; PE	A large portion of the coding capacity of Mycobacterium tuberculosis is devoted to the production of proteins containing several copies of the pentapeptide-2 repeat, namely the PE/PPE_MPTR proteins. Protein domain repeats have a variety of binding properties and are involved in protein-protein interactions as well as binding to other ligands such as DNA and RNA. They are not as common in prokaryotes, compared to eukaryotes, but the enrichment of pentapeptide-2 repeats in Mycobacteria constitutes an exception to that rule. The genes encoding the PE/PPE_MPTR proteins have undergone many rearrangements and here we have identified the expansion patterns across the Mycobacteria. We have performed a reclassification of the PE/PPE_MPTR proteins using cohesive regions rather than sparse domain architectures. It is clear that these proteins have undergone large insertions of several pentapeptide-2 domains appearing adjacent to one another in a repetitive pattern. Further, we have identified a non-pentapeptide motif associated with rapid mycobacterial evolution. The sequence composition of this region suggests a different structure compared to pentapeptide-2 repeats. By studying the evolution of the PE/PPE_MPTR proteins, we have distinguished features pertaining to tuberculosis-inducing species. Further studies of the non-pentapeptide region associated with repeat expansions promises to shed light on the pathogenicity of Mycobacterium tuberculosis.	[Warholm, Per] Stockholm Univ, Sci Life Lab, Dept Biochem & Biophys, SE-12171 Solna, Sweden; [Light, Sara] Stockholm Univ, Sci Life Lab, Bioinformat Infrastruct Life Sci, Dept Biochem & Biophys, SE-12171 Solna, Sweden	Stockholm University; Stockholm University	Light, S (corresponding author), Stockholm Univ, Sci Life Lab, Bioinformat Infrastruct Life Sci, Dept Biochem & Biophys, SE-12171 Solna, Sweden.	sara.light@scilifelab.se		Warholm, Per/0000-0002-2242-7721	Bioinformatics Infrastructure for Life Science (BILS); Science for Life Laboratory (SciLifeLab); SciLifeLab	Bioinformatics Infrastructure for Life Science (BILS); Science for Life Laboratory (SciLifeLab); SciLifeLab	SL was funded by Bioinformatics Infrastructure for Life Science (BILS) and Science for Life Laboratory (SciLifeLab). PW was financed by SciLifeLab.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 1998, PROTEIN SCI, V7, P1477, DOI 10.1002/pro.5560070625; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Bjorklund AK, 2010, J MOL BIOL, V402, P38, DOI 10.1016/j.jmb.2010.07.011; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BRIGHAM EO, 1967, IEEE SPECTRUM, V4, P63, DOI 10.1109/MSPEC.1967.5217220; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; HERMANS PWM, 1992, J BACTERIOL, V174, P4157, DOI 10.1128/jb.174.12.4157-4165.1992; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; Karboul A, 2008, J BACTERIOL, V190, P7838, DOI 10.1128/JB.00827-08; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Light S, 2012, J STRUCT BIOL, V179, P289, DOI 10.1016/j.jsb.2012.02.010; Martincorena I, 2012, NATURE, V485, P95, DOI 10.1038/nature10995; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; McEvoy CRE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-237; McGuire AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-120; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; Sreenu VB, 2007, J BIOSCIENCES, V32, P3, DOI 10.1007/s12038-007-0002-7; Sreenu VB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-78; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van den Braak N, 2004, J MICROBIOL METH, V56, P49, DOI 10.1016/j.mimet.2003.09.018; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Zvi A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-18	45	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154059	10.1371/journal.pone.0154059	http://dx.doi.org/10.1371/journal.pone.0154059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149271	Green Submitted, Green Published, gold			2022-12-27	WOS:000375676800017
J	Benoist, G; Mokhtari, M; Deschildre, A; Khen-Dunlop, N; Storme, L; Benachi, A; Delacourt, C				Benoist, Gregoire; Mokhtari, Mostafa; Deschildre, Antoine; Khen-Dunlop, Naziha; Storme, Laurent; Benachi, Alexandra; Delacourt, Christophe			Risk of Readmission for Wheezing during Infancy in Children with Congenital Diaphragmatic Hernia	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MORBIDITY; SURVIVORS; LUNG; PREDICTION; FETUSES; REPAIR; LIFE	Rationale Congenital diaphragmatic hernia (CDH) is associated with a high incidence of respiratory problems, even after initial hospital discharge. These problems are likely to lead to re-hospitalization during infancy, although actual frequency of readmissions is unknown. Objective We aimed to determine the rate of hospitalization for wheezing in infants with CDH between the time of initial discharge and 24 months of age, and to identify factors associated with readmission. Methods Data about infants with CDH born in three French reference tertiary centers between January 2009 and March 2013 who were alive at hospital discharge, were extracted from a prospective national database. Results Ninety-two children were identified, and 86 were included in the analysis. In total, 116 wheezing episodes requiring a doctor's visit occurred in 50 infants (58%) before 24 months of age. Twenty-two children (26%) were readmitted at least once for wheezing exacerbations. RSV was present in 6 of 15 (40%) of children with available nasal samples at first readmission, and 1 of 5 (20%) at second readmission. Thoracic herniation of the liver, low gestational age, longer initial hospitalization, need for oxygen therapy at home, and eczema were all significantly associated with readmission for wheezing exacerbations. Fifty-three infants (62%) received palivizumab prophylaxis, but there was no association with the overall rate of readmission for wheezing exacerbations or RSV-related hospitalization. Conclusions The rate of readmission for wheezing among infants with CDH is high, and significantly influenced by several prenatal and neonatal factors. Palivizumab prophylaxis was not associated with the rate of readmission.	[Benoist, Gregoire; Delacourt, Christophe] AP HP, Pneumol Pediat, Paris, France; [Benoist, Gregoire; Delacourt, Christophe] Ctr Reference Malad Resp Rares, Paris, France; [Mokhtari, Mostafa] AP HP, Reanimat Pediat, Le Kremlin Bicetre, France; [Deschildre, Antoine; Storme, Laurent] CHRU, Pneumol Pediat, Lille, France; [Khen-Dunlop, Naziha] AP HP, Chirurg Pediat, Paris, France; [Benachi, Alexandra] AP HP, Gynecol Obstet, Paris, France; [Benachi, Alexandra] Ctr Reference Hernies Diaphragmat, Clamart, France; [Khen-Dunlop, Naziha; Delacourt, Christophe] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite	Delacourt, C (corresponding author), AP HP, Pneumol Pediat, Paris, France.; Delacourt, C (corresponding author), Ctr Reference Malad Resp Rares, Paris, France.; Delacourt, C (corresponding author), Univ Paris 05, Paris, France.	christophe.delacourt@nck.aphp.fr	Delacourt, Christophe/K-6161-2019	Khen-Dunlop, Naziha/0000-0003-4537-229X				Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Cauley RP, 2015, J PEDIATR SURG, V50, P849, DOI 10.1016/j.jpedsurg.2014.12.007; Che D, 2012, ARCH PEDIATRIE, V19, P700, DOI 10.1016/j.arcped.2012.04.015; Deprest JA, 2009, SEMIN FETAL NEONAT M, V14, P8, DOI 10.1016/j.siny.2008.08.010; Done E, 2013, ULTRASOUND OBST GYN, V42, P77, DOI 10.1002/uog.12445; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Harting MT, 2014, SEMIN FETAL NEONAT M, V19, P370, DOI 10.1016/j.siny.2014.09.004; HISLOP A, 1976, THORAX, V31, P450, DOI 10.1136/thx.31.4.450; Ijsselstijn H, 1997, AM J RESP CRIT CARE, V155, P174, DOI 10.1164/ajrccm.155.1.9001308; Jani J, 2008, ULTRASOUND OBST GYN, V32, P793, DOI 10.1002/uog.6234; Jani JC, 2009, ULTRASOUND OBST GYN, V33, P64, DOI 10.1002/uog.6141; Kotecha S, 2012, EUR RESPIR J, V39, P820, DOI 10.1183/09031936.00066511; Masumoto K, 2008, PEDIATR INT, V50, P459, DOI 10.1111/j.1442-200X.2008.02580.x; Muratore CS, 2001, J PEDIATR SURG, V36, P133, DOI 10.1053/jpsu.2001.20031; Murray J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089186; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Resch Bernhard, 2014, Open Microbiol J, V8, P71, DOI 10.2174/1874285801408010071; Spoel M, 2012, PEDIATR CRIT CARE ME, V13, pE133, DOI 10.1097/PCC.0b013e3182231872; Turner SW, 2004, AM J RESP CRIT CARE, V169, P921, DOI 10.1164/rccm.200307-891OC	20	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155556	10.1371/journal.pone.0155556	http://dx.doi.org/10.1371/journal.pone.0155556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171167	Green Submitted, gold, Green Published			2022-12-27	WOS:000376588600121
J	Shipway, JR; O'Connor, R; Stein, D; Cragg, SM; Korshunova, T; Martynov, A; Haga, T; Distel, DL				Shipway, J. R.; O'Connor, R.; Stein, D.; Cragg, S. M.; Korshunova, T.; Martynov, A.; Haga, T.; Distel, D. L.			Zachsia zenkewitschi (Teredinidae), a Rare and Unusual Seagrass Boring Bivalve Revisited and Redescribed	PLOS ONE			English	Article							SHIPWORMS	The sea-grass borer Zachsia zenkewitschi belongs to a group of economically and ecologically important bivalves, commonly referred to as shipworms. The sole recognized representative of the genus Zachsia, this species displays an unusual life history and reproductive strategy that is now understood to include: environmental sex determination of free swimming larvae, extreme sexual and size dimorphism between males and females, internal fertilization, maintenance of often large harems of male dwarfs within a specialized cavity of the female mantle, and complex maternal care of larvae in specialized brood pouches within the gill. It is also the only shipworm species known to burrow in sea grass rhizomes rather than terrestrial wood. Although Z. zenkewitschi is rare and little studied, understanding of its biology and anatomy has evolved substantially, rendering some aspects of its original description inaccurate. Moreover, no existing type specimens are known for this species. In light of these facts, we designate a neotype from among specimens recently collected at the type location, and undertake a re-description of this species, accounting for recent reinterpretation of its life history and functional anatomy.	[Shipway, J. R.; Stein, D.; Distel, D. L.] Northeastern Univ, Ctr Marine Sci, Ocean Genome Legacy, Nahant, MA 01908 USA; [O'Connor, R.] Tufts Med Ctr, Boston, MA USA; [Cragg, S. M.] Univ Portsmouth, Inst Marine Sci, Sch Biol Sci, Portsmouth P04 9LY, Hants, England; [Korshunova, T.] Koltzov Inst Dev Biol RAS, 26 Vavilov St, Moscow 119334, Russia; [Martynov, A.] Moscow MV Lomonosov State Univ, Zool Museum, Bolshaya Nikitskaya St 6, Moscow 125009, Russia; [Haga, T.] Toyohashi Museum Nat Hist, 1-238 Oana,Oiwa Cho, Toyohashi, Aichi 4413147, Japan	Northeastern University; Tufts Medical Center; University of Portsmouth; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Lomonosov Moscow State University	Distel, DL (corresponding author), Northeastern Univ, Ctr Marine Sci, Ocean Genome Legacy, Nahant, MA 01908 USA.	d.distel@neu.edu	Distel, Daniel/A-8047-2017; Korshunova, Tatiana/T-7821-2017; OConnor, Roberta/AAG-6277-2020; Martynov, Alexander/AAE-3682-2021; Cragg, Simon/C-8463-2011	Distel, Daniel/0000-0002-3860-194X; OConnor, Roberta/0000-0003-2757-754X; Shipway, J. Reuben/0000-0002-6838-1917; Cragg, Simon/0000-0003-1082-7653	National Science Foundation [IOS-1258090, IOS-1442759]; National Institutes of Health [1U01TW008163]; Russian Science Foundation [14-50-00029]; BBSRC [BB/L001926/1];  [237855]; Division Of Integrative Organismal Systems [1442759] Funding Source: National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/L001926/1, BB/H531543/1] Funding Source: researchfish; BBSRC [BB/H531543/1] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [U19TW008163, U01TW008163] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by National Science Foundation Grants IOS-1258090 and IOS-1442759, National Institutes of Health Grant 1U01TW008163 (RS, DD, DS), the Russian Science Foundation Grant 14-50-00029 (morphological study, depository of specimens) (AM, TK). This work was also supported by BBSRC grant number BB/L001926/1, and Grant-in-Aid for JSPS Fellows to TH (No. 237855). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank: Adam Baldinger and the Harvard Museum of Comparative Zoology; Akihiro Dazai (Shizugawa Nature Center, Minami-sanriku), Yoichi Hamamura (Hiroshima), Yoshimasa Hayase (Tokai Aquanauts Ltd., Shizuoka), Hiroshi Namikawa (National Museum of Nature and Science, Tsukuba) and Katsuhiko Tanaka (Tokai University, Shizuoka) for collection of Japanese specimens; Enrico Schwabe and the Bavarian State Zoological Collection, Munich, for resending reference specimens; Lev Moskalev (Shirshov Institute of Oceanology RAS, Moscow) and Gary Rosenberg (Academy of Natural Sciences, Philadelphia) for providing useful information and comments on the manuscript. This research was supported by National Science Foundation Grants IOS-1258090 and IOS- 1442759, National Institutes of Health Grant 1U01TW008163, the Russian Science Foundation Grant 14-50-00029 (morphological study, depository of specimens), BBSRC grant number BB/L001926/1, Grant-in-Aid for JSPS Fellows to TH (No. 237855) and Laurie Mazzola, Joanna Bybee and the molecular sequencing group at New England Biolabs for providing sequencing services. Finally, we thank the editor and anonymous referee for their helpful comments and valuable input.	BULATOFF G. A., 1933, ZOOL ANZ, V104, P165; Cragg SM., 2008, ECOLOGY PAPUA 1, P539; De Moraes DT, 2003, J MOLLUS STUD, V69, P311, DOI 10.1093/mollus/69.4.311; Distel DL, 2011, MOL PHYLOGENET EVOL, V61, P245, DOI 10.1016/j.ympev.2011.05.019; Distel DL, 2003, ACS SYM SER, V845, P253; Drozdov A. L., 1999, Biologiya Morya (Vladivostok), V25, P66; Haga Takuma, 2006, Venus (Tokyo), V65, P263; Higo S., 1999, CATALOGUE BIBLIO MAR; Huber M., 2015, COMPENDIUM BIVALVES; Loosanoff V. L., 1963, Advances in Marine Biology, V1, P1, DOI 10.1016/S0065-2881(08)60257-6; MacIntosh H, 2012, MAR ECOL PROG SER, V461, P95, DOI 10.3354/meps09823; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Miller R. C., 1924, University of California Publications in Zoology, V26, P41; NAIR NB, 1971, ADV MAR BIOL, V9, P335, DOI 10.1016/S0065-2881(08)60345-4; POPHAM JD, 1974, CELL TISSUE RES, V150, P291; Sasaki Takenori, 2006, Chiribotan, V36, P136; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Toth GB, 2015, PLOS ONE, P10; Turner R., 1988, BIODETERIORATION, V7, P743; TURNER RD, 1983, SCIENCE, V219, P1077, DOI 10.1126/science.219.4588.1077; TURNER RD, 1983, BIOL MORYA-VLAD+, P27; Turner RD, 1966, SURVEY ILLUSTRATED C; Vaughn D, 2010, INTEGR COMP BIOL, V50, P552, DOI 10.1093/icb/icq037; Voight JR, 2015, J MOLLUS STUD, V81, P175, DOI 10.1093/mollus/eyv008; Vollrath F, 1998, TRENDS ECOL EVOL, V13, P159, DOI 10.1016/S0169-5347(97)01283-4; Yakovlev YM, 1989, BIOL COASTAL WATERS; Yakovlev Yuri M., 1998, Korean Journal of Malacology, V14, P1	27	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155269	10.1371/journal.pone.0155269	http://dx.doi.org/10.1371/journal.pone.0155269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171209	gold, Green Published			2022-12-27	WOS:000376588600161
J	Littlejohns, TJ; Kos, K; Henley, WE; Lang, IA; Annweiler, C; Beauchet, O; Chaves, PHM; Kestenbaum, BR; Kuller, LH; Langa, KM; Lopez, OL; Llewellyn, DJ				Littlejohns, Thomas J.; Kos, Katarina; Henley, William E.; Lang, Iain A.; Annweiler, Cedric; Beauchet, Olivier; Chaves, Paulo H. M.; Kestenbaum, Bryan R.; Kuller, Lewis H.; Langa, Kenneth M.; Lopez, Oscar L.; Llewellyn, David J.			Vitamin D and Risk of Neuroimaging Abnormalities	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; WHITE-MATTER ABNORMALITIES; OLDER-ADULTS; CARDIOVASCULAR-DISEASE; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; BRAIN; VOLUME; ASSOCIATION; DEMENTIA	Vitamin D deficiency has been linked with an increased risk of incident all-cause dementia and Alzheimer's disease. The aim of the current study was to explore the potential mechanisms underlying these associations by determining whether low vitamin D concentrations are associated with the development of incident cerebrovascular and neurodegenerative neuroimaging abnormalities. The population consisted of 1,658 participants aged >= 65 years from the US-based Cardiovascular Health Study who were free from prevalent cardiovascular disease, stroke and dementia at baseline in 1992-93. Serum 25-hydroxyvitamin D (25(OH) D) concentrations were determined by liquid chromatography-tandem mass spectrometry from blood samples collected at baseline. The first MRI scan was conducted between 1991-1994 and the second MRI scan was conducted between 1997-1999. Change in white matter grade, ventricular grade and presence of infarcts between MRI scan one and two were used to define neuroimaging abnormalities. During a mean follow-up of 5.0 years, serum 25(OH) D status was not significantly associated with the development of any neuroimaging abnormalities. Using logistic regression models, the multivariate adjusted odds ratios (95% confidence interval) for worsening white matter grade in participants who were severely 25(OH) D deficient (<25 nmol/L) and deficient (>= 25-50 nmol/L) were 0.76 (0.35-1.66) and 1.09 (0.76-1.55) compared to participants with sufficient concentrations (>= 50 nmol/L). The multivariate adjusted odds ratios for ventricular grade in participants who were severely 25(OH) D deficient and deficient were 0.49 (0.20-1.19) and 1.12 (0.79-1.59) compared to those sufficient. The multivariate adjusted odds ratios for incident infarcts in participants who were severely 25 (OH) D deficient and deficient were 1.95 (0.84-4.54) and 0.73 (0.47-1.95) compared to those sufficient. Overall, serum vitamin D concentrations could not be shown to be associated with the development of cerebrovascular or neurodegenerative neuroimaging abnormalities in Cardiovascular Health Study participants.	[Littlejohns, Thomas J.] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Kos, Katarina] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England; [Littlejohns, Thomas J.; Kos, Katarina; Henley, William E.; Lang, Iain A.; Llewellyn, David J.] Univ Exeter, Sch Med, Exeter, Devon, England; [Annweiler, Cedric; Beauchet, Olivier] Angers Univ Hosp, Div Geriatr, Dept Neurosci, Angers, France; [Chaves, Paulo H. M.] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Kestenbaum, Bryan R.] Univ Washington, Div Nephrol, Kidney Res Inst, Seattle, WA 98195 USA; [Kuller, Lewis H.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Langa, Kenneth M.] Univ Michigan Hlth Syst, Div Gen Med, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Gerontol, Inst Social Res, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Veteran Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Lopez, Oscar L.] Univ Pittsburgh, Div Gen Med, Dept Neurol & Psychiat, Pittsburgh, PA USA	University of Oxford; University of Oxford; University of Exeter; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; State University System of Florida; Florida International University; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Llewellyn, DJ (corresponding author), Univ Exeter, Sch Med, Exeter, Devon, England.	david.llewellyn@exeter.ac.uk	Kos, Katarina/G-6772-2014; Llewellyn, David/AAZ-2859-2021; Beauchet, Olivier/AAP-8108-2020; Chaves, Paulo/D-5878-2016; Littlejohns, Thomas/GMY-4044-2022	Chaves, Paulo/0000-0001-8013-7928; Llewellyn, David/0000-0002-2441-4246; Kos, Katarina/0000-0003-3761-2249; Littlejohns, Thomas/0000-0003-1177-6923; Langa, Kenneth/0000-0002-2798-1836; Lang, Iain/0000-0002-8473-2350	Cardiovascular Health Study [HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086]; National Heart, Lung, and Blood Institute (NHLBI) [HL080295]; National Institute of Neurological Disorders and Stroke (NINDS); National Institute on Aging (NIA) [AG023629, AG20098, AG15928, HL084443]; Alzheimer's Association [NIRG-11-200737]; Mary Kinross Charitable Trust; James Tudor Foundation; Halpin Trust; Age Related Diseases and Health Trust; Norman Family Charitable Trust; National Institute for Health Research (NIHR); National Institute for Health Research [KMRF-2013-02-02] Funding Source: researchfish	Cardiovascular Health Study; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); Mary Kinross Charitable Trust; James Tudor Foundation; Halpin Trust; Age Related Diseases and Health Trust; Norman Family Charitable Trust; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Cardiovascular Health Study was supported by contracts HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, and grant HL080295 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by AG023629, AG20098, AG15928 and HL084443 from the National Institute on Aging (NIA). A full list of principal CHS investigators and institutions can be found at chs-nhlbi.org. Additional support was also provided by NIRG-11-200737 from the Alzheimer's Association, the Mary Kinross Charitable Trust, the James Tudor Foundation, the Halpin Trust, the Age Related Diseases and Health Trust, and the Norman Family Charitable Trust (to D.J.L.). This research was supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon and Exeter NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The National Institutes of Health was involved in the original design and conduct of the Cardiovascular Health Study and in the data collection methods.	Afzal S, 2014, ALZHEIMERS DEMENT, V10, P296, DOI 10.1016/j.jalz.2013.05.1765; Annweiler C, 2014, EUR J NEUROL, V21, P1436, DOI 10.1111/ene.12511; Annweiler C, 2011, DEMENT GERIATR COGN, V32, P273, DOI 10.1159/000334944; Annweiler C, 2015, EXP GERONTOL, V63, P41, DOI 10.1016/j.exger.2015.01.049; Annweiler C, 2015, MATURITAS, V80, P312, DOI 10.1016/j.maturitas.2014.12.011; Annweiler C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087314; Annweiler C, 2013, J AM GERIATR SOC, V61, P1026, DOI 10.1111/jgs.12249; Annweiler C, 2013, MOL NUTR FOOD RES, V57, P267, DOI 10.1002/mnfr.201200418; Bowman GL, 2012, NEUROLOGY, V78, P241, DOI 10.1212/WNL.0b013e3182436598; Brondum-Jacobsen P, 2013, ANN NEUROL, V73, P38, DOI 10.1002/ana.23738; Brouwer-Brolsma EM, 2015, J NUTR, V145, P1817, DOI 10.3945/jn.115.214197; BRYAN RN, 1994, AM J NEURORADIOL, V15, P1625; Buell JS, 2010, NEUROLOGY, V74, P18, DOI 10.1212/WNL.0b013e3181beecb7; Chung PW, 2015, STROKE, V46, P248, DOI 10.1161/STROKEAHA.114.007706; de Boer IH, 2012, ANN INTERN MED, V156, P627, DOI 10.7326/0003-4819-156-9-201205010-00004; Farid K, 2012, NUCL MED COMMUN, V33, P1048, DOI 10.1097/MNM.0b013e32835674c4; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Hooshmand B, 2014, J GERONTOL A-BIOL, V69, P1132, DOI 10.1093/gerona/glu022; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Littlejohns TJ, 2014, NEUROLOGY, V83, P920, DOI 10.1212/WNL.0000000000000755; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P1217, DOI 10.1001/archneur.55.9.1217; Lopez OL, 2003, NEUROEPIDEMIOLOGY, V22, P1, DOI 10.1159/000067110; MANOLIO TA, 1994, STROKE, V25, P318, DOI 10.1161/01.STR.25.2.318; Michos ED, 2014, JAMA NEUROL, V71, P863, DOI 10.1001/jamaneurol.2014.755; Phinney KW, 2008, AM J CLIN NUTR, V88, p511S, DOI 10.1093/ajcn/88.2.511S; Prager JM, 2014, AM J NEURORADIOL, V35, P1145, DOI 10.3174/ajnr.A3840; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sakurai T, 2014, J AM GERIATR SOC, V62, P1993, DOI 10.1111/jgs.13048; Turetsky A, 2015, J STROKE CEREBROVASC, V24, P1555, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.051; Walhovd KB, 2014, NEUROBIOL AGING, V35, P1055, DOI 10.1016/j.neurobiolaging.2013.11.011; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	34	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154896	10.1371/journal.pone.0154896	http://dx.doi.org/10.1371/journal.pone.0154896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166613	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000376587300105
J	Sato, K; Yamashita, T; Haruki, Y; Ohuchi, H; Kinoshita, M; Shichida, Y				Sato, Keita; Yamashita, Takahiro; Haruki, Yoshihiro; Ohuchi, Hideyo; Kinoshita, Masato; Shichida, Yoshinori			Two UV-Sensitive Photoreceptor Proteins, Opn5m and Opn5m2 in Ray-Finned Fish with Distinct Molecular Properties and Broad Distribution in the Retina and Brain	PLOS ONE			English	Article							ANCIENT-LONG OPSIN; DEEP BRAIN; DIFFERENTIAL EXPRESSION; CONE PHOTORECEPTOR; VERTEBRATE; GENES; GENOME; IDENTIFICATION; MELANOPSINS; KISSPEPTIN	Opn5 is a group within the opsin family of proteins that is responsible for visual and non-visual photoreception in animals. It consists of several subgroups, including Opn5m, the only subgroup containing members found in most vertebrates, including mammals. In addition, recent genomic information has revealed that some ray-finned fishes carry paralogous genes of Opn5m while other fishes have no such genes. Here, we report the molecular properties of the opsin now called Opn5m2 and its distributions in both the retina and brain. Like Opn5m, Opn5m2 exhibits UV light-sensitivity when binding to 11-cis-retinal and forms a stable active state that couples with Gi subtype of G protein. However, Opn5m2 does not bind all-trans-retinal and exhibits exclusive binding to 11-cis-retinal, whereas many bistable opsins, including fish Opn5m, can bind directly to all-trans-retinal as well as 11-cis-retinal. Because medaka fish has lost the Opn5m2 gene from its genome, we compared the tissue distribution patterns of Opn5m in medaka fish, zebrafish, and spotted gar, in addition to the distribution patterns of Opn5m2 in zebrafish and spotted gar. Opn5m expression levels showed a gradient along the dorsal-ventral axis of the retina, and preferential expression was observed in the ventral retina in the three fishes. The levels of Opn5m2 showed a similar gradient with preferential expression observed in the dorsal retina. Opn5m expression was relatively abundant in the inner region of the inner nuclear layer, while Opn5m2 was expressed in the outer edge of the inner nuclear layer. Additionally, we could detect Opn5m expression in several brain regions, including the hypothalamus, of these fish species. Opn5m2 expression could not be detected in zebrafish brain, but was clearly observed in limited brain regions of spotted gar. These results suggest that ray-finned fishes can generally utilize UV light information for non-image-forming photoreception in a wide range of cells in the retina and brain.	[Sato, Keita; Yamashita, Takahiro; Haruki, Yoshihiro; Shichida, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan; [Ohuchi, Hideyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cytol & Histol, Okayama, Japan; [Kinoshita, Masato] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto, Japan	Kyoto University; Okayama University; Kyoto University	Shichida, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan.	shichida@rh.biophys.kyoto-u.ac.jp		Sato, Keita/0000-0002-7089-2951	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25251036, 15H00812, 25440167]; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Shimizu Foundation for Immunology and Neuroscience and Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Shimizu Foundation for Immunology and Neuroscience and Takeda Science Foundation	This work was supported by Grants-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, to YS (25251036), TY (15H00812 and 25440167), and grants from The Naito Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, The Shimizu Foundation for Immunology and Neuroscience and Takeda Science Foundation to TY (MEXT: http://www.jsps.go.jp/index.html; Naito Foundation: https://www.naito-f.or.jp/jp/index.php; Mochida Memorial Foundation: http://www.mochida.co.jp/zaidan/; The Shimizu Foundation for Immunology and Neuroscience: http://www.shimizu-immun-neurosci.or.jp/outline/index.html; Takeda Science Foundation: http://www.takeda-sci.or.jp/).	Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; Buhr ED, 2015, P NATL ACAD SCI USA, V112, P13093, DOI 10.1073/pnas.1516259112; Buhr ED, 2014, P NATL ACAD SCI USA, V111, P8625, DOI 10.1073/pnas.1323350111; Cheng N, 2009, NATURE, V460, P899, DOI 10.1038/nature08175; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; Davies WIL, 2015, GENOME RES, V25, P1666, DOI 10.1101/gr.189886.115; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; Drivenes O, 2003, J COMP NEUROL, V456, P84, DOI 10.1002/cne.10523; Fischer RM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001585; Forger NG, 2009, J NEUROENDOCRINOL, V21, P393, DOI 10.1111/j.1365-2826.2009.01825.x; Hiraki T, 2014, ENDOCRINOLOGY, V155, P1021, DOI 10.1210/en.2013-1806; Kanda S, 2008, ENDOCRINOLOGY, V149, P2467, DOI 10.1210/en.2007-1503; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kitahashi T, 2009, ENDOCRINOLOGY, V150, P821, DOI 10.1210/en.2008-0940; Kojima D, 2000, J NEUROSCI, V20, P2845; Kojima D, 2008, J NEUROCHEM, V104, P1364, DOI 10.1111/j.1471-4159.2007.05093.x; Kojima D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026388; Koyanagi M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0174-9; Koyanagi M, 2014, BBA-BIOENERGETICS, V1837, P710, DOI 10.1016/j.bbabio.2013.09.003; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Louis A, 2015, NUCLEIC ACIDS RES, V43, pD682, DOI 10.1093/nar/gku1112; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Matsuyama T, 2012, BIOCHEMISTRY-US, V51, P5454, DOI 10.1021/bi3004999; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Nakane Y, 2014, CURR BIOL, V24, pR596, DOI 10.1016/j.cub.2014.05.038; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Ohuchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031534; Philp AR, 2000, J EXP BIOL, V203, P1925; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Sakai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141238; Sato K, 2011, BIOCHEMISTRY-US, V50, P10484, DOI 10.1021/bi201212z; Schartl M, 2013, NAT GENET, V45, P567, DOI 10.1038/ng.2604; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Song Y, 2015, J NEUROENDOCRINOL, V27, P198, DOI 10.1111/jne.12251; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang HP, 2015, ENDOCRINOLOGY, V156, P589, DOI 10.1210/en.2014-1204; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Tomonari S, 2008, DEV DYNAM, V237, P1910, DOI 10.1002/dvdy.21611; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Tsujimura T, 2007, P NATL ACAD SCI USA, V104, P12813, DOI 10.1073/pnas.0704061104; Yamashita T, 2014, J BIOL CHEM, V289, P3991, DOI 10.1074/jbc.M113.514075; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	49	14	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155339	10.1371/journal.pone.0155339	http://dx.doi.org/10.1371/journal.pone.0155339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167972	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300103
J	Xu, J; Li, C; Li, Y; Walline, J; Zheng, LL; Fu, YY; Yao, DQ; Zhu, HD; Liu, XH; Chai, YF; Wang, Z; Yu, XZ				Xu, Jun; Li, Chen; Li, Yan; Walline, Joseph; Zheng, Liangliang; Fu, Yangyang; Yao, Dongqi; Zhu, Huadong; Liu, Xiaohe; Chai, Yanfen; Wang, Zhong; Yu, Xuezhong			Influence of Chest Compressions on Circulation during the Peri-Cardiac Arrest Period in Porcine Models	PLOS ONE			English	Article							CORONARY PERFUSION-PRESSURE; TIDAL CARBON-DIOXIDE; EXPERIMENTAL CARDIOPULMONARY RESUSCITATION; EMERGENCY CARDIOVASCULAR CARE; ASSOCIATION GUIDELINES UPDATE; VENTRICULAR-FIBRILLATION; MYOCARDIAL-PERFUSION; LIFE-SUPPORT; SWINE MODEL; SURVIVAL	Objective Starting chest compressions immediately after a defibrillation shock might be harmful, if the victim already had a return of spontaneous circulation (ROSC) and yet was still being subjected to external compressions at the same time. The objective of this study was to study the influence of chest compressions on circulation during the peri-cardiac arrest period. Design Prospective, randomized controlled study. Setting Animal experimental center in Peking Union Medical Collage Hospital, Beijing, China. Subjects Healthy 3-month-old male domestic pigs. Interventions 44 pigs (28 +/- 2 kg) were randomly assigned to three groups: Group I (non-arrested with compressions) (n = 12); Group II (arrested with compressions only) (n = 12); Group III (ROSC after compressions and defibrillation) (n = 20). In Groups I and II, compressions were performed to a depth of 5cm (Ia and IIa, n = 6) or a depth of 3cm (Ib and IIb, n = 6) respectively, while in Group III, the animals which had just achieved ROSC (n = 18) were compressed to a depth of 5cm (IIIa, n = 6), a depth of 3cm (IIIb, n = 6), or had no compressions (IIIc, n = 6). Hemodynamic parameters were collected and analyzed. Measurements and Findings Hemodynamics were statistically different between Groups Ia and Ib when different depths of compressions were performed (p < 0.05). In Group II, compressions were beneficial and hemodynamics correlated with the depth of compressions (p < 0.05). In Group III, compressions that continued after ROSC produced a reduction in arterial pressure (p < 0.05). Conclusions Chest compressions might be detrimental to hemodynamics in the early post-ROSC stage. The deeper the compressions were, the better the effect on hemodynamics during cardiac arrest, but the worse the effect on hemodynamics after ROSC.	[Xu, Jun; Li, Yan; Zheng, Liangliang; Fu, Yangyang; Yao, Dongqi; Zhu, Huadong; Yu, Xuezhong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Emergency Dept, Beijing 100730, Peoples R China; [Li, Chen; Liu, Xiaohe; Chai, Yanfen] Tianjin Med Univ, Gen Hosp, Emergency Dept, Tianjin, Peoples R China; [Walline, Joseph] St Louis Univ Hosp, Dept Surg, Div Emergency Med, St Louis, MO USA; [Wang, Zhong] Beijing Tsinghua Changgung Hosp, Emergency Dept, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Tianjin Medical University; Saint Louis University	Yu, XZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Emergency Dept, Beijing 100730, Peoples R China.	yxzpumch@126.com	Walline, Joseph/A-4001-2019; Walline, Joseph/K-6667-2019	Walline, Joseph/0000-0001-9582-1044; Walline, Joseph/0000-0001-9582-1044; Zhu, Huadong/0000-0002-1592-3188	Capital Health Research and Development Fund [2011-4001-04]; National Health and Family Planning Commission of the People's Republic of China Special Research Fund [201502019]	Capital Health Research and Development Fund; National Health and Family Planning Commission of the People's Republic of China Special Research Fund	This study received funding from the Capital Health Research and Development Fund (2011-4001-04), URL: http://www.bjhbkj.com/, to JX; and the National Health and Family Planning Commission of the People's Republic of China Special Research Fund (201502019), URL: http://www.moh.gov.cn/qjjys/s3577/201401/e9f3635e7acb47778225ccb729ffec62.shtml, to XY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akinci E, 2014, PAK J MED SCI, V30, P16, DOI 10.12669/pjms.301.4024; Benditt DG, 2010, CIRCULATION, V121, P10, DOI 10.1161/CIR.0b013e3181cd3c9f; Berdowski J, 2010, CIRC-ARRHYTHMIA ELEC, V3, P72, DOI 10.1161/CIRCEP.109.902114; Breckwoldt J, 2009, RESUSCITATION, V80, P1108, DOI 10.1016/j.resuscitation.2009.06.028; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Cunningham LM, 2012, AM J EMERG MED, V30, P1630, DOI 10.1016/j.ajem.2012.02.015; Edelson DP, 2014, J HOSP MED, V9, P353, DOI 10.1002/jhm.2174; Halperin HR, 2010, AM J EMERG MED, V28, P195, DOI 10.1016/j.ajem.2009.10.006; KAY GN, 1983, J AM COLL CARDIOL, V2, P806; KERN KB, 1988, RESUSCITATION, V16, P241, DOI 10.1016/0300-9572(88)90111-6; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Kolar M, 2008, CRIT CARE, V12, DOI 10.1186/cc7009; Lah K, 2011, CRIT CARE, V15, DOI 10.1186/cc9417; MICHAEL JR, 1984, CIRCULATION, V69, P822, DOI 10.1161/01.CIR.69.4.822; NIEMANN JT, 1985, ANN EMERG MED, V14, P521, DOI 10.1016/S0196-0644(85)80774-5; NIEMANN JT, 1982, ANN EMERG MED, V11, P127, DOI 10.1016/S0196-0644(82)80236-9; Nolan JP, 2015, INTENS CARE MED, V41, P2039, DOI 10.1007/s00134-015-4051-3; OKAMOTO H, 1995, ACTA ANAESTH SCAND, V39, P79, DOI 10.1111/j.1399-6576.1995.tb05596.x; Opie L.H., 2004, HEART PHYSL CELL CIR, DOI 10.1161/01.CIR.0000143724.99618.; Osorio J, 2012, AM J CARDIOL, V109, P670, DOI 10.1016/j.amjcard.2011.10.024; Osorio J, 2008, CIRC-ARRHYTHMIA ELEC, V1, P282, DOI 10.1161/CIRCEP.108.767855; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; Reynolds JC, 2010, PREHOSP EMERG CARE, V14, P78, DOI 10.3109/10903120903349796; SANDERS AB, 1985, AM J EMERG MED, V3, P11, DOI 10.1016/0735-6757(85)90003-8; SANDERS AB, 1985, J AM COLL CARDIOL, V6, P113, DOI 10.1016/S0735-1097(85)80261-8; SANDERS AB, 1989, JAMA-J AM MED ASSOC, V262, P1347, DOI 10.1001/jama.262.10.1347; Sidney S, 2013, CIRCULATION, V127, P21, DOI 10.1161/CIRCULATIONAHA.112.155911; Timerman S, 2004, RESUSCITATION, V61, P273, DOI 10.1016/j.resuscitation.2004.01.025; White L, 2010, CIRCULATION, V121, P91, DOI 10.1161/CIRCULATIONAHA.109.872366; Xue JK, 2013, WORLD J EMERG MED, V4, P183, DOI [10.5847/wjem.j.issn.1920-8642.2013.03.005, 10.5847/wjem.j.1920-8642.2013.03.005]; Yasunaga H, 2010, CRIT CARE, V14, DOI 10.1186/cc9319	31	3	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155212	10.1371/journal.pone.0155212	http://dx.doi.org/10.1371/journal.pone.0155212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168071	Green Submitted, Green Published, gold			2022-12-27	WOS:000376587300053
J	Baz-Davila, R; Espinoza-Jimenez, A; Rodriguez-Perez, MD; Zulueta, J; Varo, N; Montejo, A; Almeida-Gonzalez, D; Aguirre-Jaime, A; Cordoba-Lanus, E; Casanova, C				Baz-Davila, Rebeca; Espinoza-Jimenez, Adriana; del Cristo Rodriguez-Perez, Maria; Zulueta, Javier; Varo, Nerea; Montejo, Angela; Almeida-Gonzalez, Delia; Aguirre-Jaime, Armando; Cordoba-Lanus, Elizabeth; Casanova, Ciro			Role of HIF1A, VEGFA and VEGFR2 SNPs in the Susceptibility and Progression of COPD in a Spanish Population	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE-FACTOR; OBSTRUCTIVE PULMONARY-DISEASE; FACTOR-I; POLYMORPHISMS; ASSOCIATION; LUNG; DYSPNEA; RISK; GENE	Hypoxia is involved in the development of chronic inflammatory processes. Under hypoxic conditions HIF1A, VEGF and VEGFR2 are expressed and mediate the course of the resultant disease. The aim of the present study was to define the associations between tSNPs in these genes and COPD susceptibility and progression in a Spanish cohort. The T alleles in rs3025020 and rs833070 SNPs (VEGFA gene) were less frequent in the group of COPD cases and were associated with a lower risk of developing the disease (OR = 0.60; 95% CI = 0. 39-0.93; p = 0.023 and OR = 0.60; 95% CI = 0.38-0.96; p = 0.034, respectively) under a dominant model of inheritance. The haplotype in which both SNPs presented the T allele confirmed the association found (OR = 0.02; 95% CI = 0.00 to 0.66; p = 0.03). Moreover, patients with COPD carrying the T allele in homozygosis in rs3025020 SNP showed higher lung function values and this association remained constant during 3 years of follow-up. In conclusion, T allele in rs833070 and rs3025020 may confer a protective effect to COPD susceptibility in a Spanish population and the association of the SNP rs3025020 with lung function may be suggesting a role for VEGF in the progression of the disease.	[Baz-Davila, Rebeca; Espinoza-Jimenez, Adriana; del Cristo Rodriguez-Perez, Maria; Aguirre-Jaime, Armando; Cordoba-Lanus, Elizabeth; Casanova, Ciro] Hosp Univ Nuestra Senora de Candelaria, Res Unit, Santa Cruz De Tenerife, Spain; [Zulueta, Javier] Univ Navarra Clin, Dept Pulm, Pamplona, Spain; [Varo, Nerea] Univ Navarra Clin, Biochem Anal Dept, Pamplona, Spain; [Montejo, Angela; Casanova, Ciro] Hosp Univ Nuestra Senora de Candelaria, Dept Pulm, Santa Cruz De Tenerife, Spain; [Almeida-Gonzalez, Delia] Hosp Univ Nuestra Senora de Candelaria, Dept Immunol, Santa Cruz De Tenerife, Spain	University of Navarra; University of Navarra	Baz-Davila, R; Cordoba-Lanus, E (corresponding author), Hosp Univ Nuestra Senora de Candelaria, Res Unit, Santa Cruz De Tenerife, Spain.	reb_bd@hotmail.com; elizabeth-cordoba@hotmail.com	Zulueta, Javier J/GXZ-5810-2022; Zulueta, Javier J/H-5127-2011; del Cristo Rodriguez Perez, Maria/AAD-4214-2020; Córdoba-Lanús, Elizabeth/B-8573-2014; Varo, Nerea/AAB-3569-2019	Zulueta, Javier J/0000-0003-3182-3555; Varo, Nerea/0000-0002-2362-9472; Cordoba-Lanus, Elizabeth/0000-0001-5534-8280	Fondo de Investigacion en Salud-Instituto Carlos III [09/00977]; European Regional Development Funds	Fondo de Investigacion en Salud-Instituto Carlos III; European Regional Development Funds(European Commission)	This work was supported by Fondo de Investigacion en Salud-Instituto Carlos III 09/00977, http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/quienes-somos.shtml, author who received the funding: CC. Project was co-financed by the European Regional Development Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Habboubi HH, 2011, EUR CYTOKINE NETW, V22, P154, DOI 10.1684/ecn.2011.0289; Al-Habboubi HH, 2012, EUR J HAEMATOL, V89, P403, DOI 10.1111/ejh.12003; Almawi WY, 2013, HUM REPROD, V28, P2628, DOI 10.1093/humrep/det308; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boeck L, 2015, RESPIRATION; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Leon AC, 2008, REV ESP SALUD PUBLIC, V82, P519, DOI 10.1590/S1135-57272008000500007; Ding YP, 2015, INT J CHRONIC OBSTR, V10, DOI 10.2147/COPD.S86721; Ding YP, 2015, INT J CHRONIC OBSTR, V10, P7, DOI 10.2147/COPD.S73042; Fregel R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-181; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Li QF, 2004, ACTA BIOCH BIOPH SIN, V36, P133, DOI 10.1093/abbs/36.2.133; Maca-Meyer N, 2004, ANN HUM GENET, V68, P600, DOI 10.1046/j.1529-8817.2003.00125.x; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Morcillo-Suarez C, 2008, BIOINFORMATICS, V24, P1643, DOI 10.1093/bioinformatics/btn241; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Papaioannou AI, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-128; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruggiero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016982; Sakao S, 2003, CHEST, V124, P323, DOI 10.1378/chest.124.1.323; Scharte M, 2003, AM J PHYSIOL-GASTR L, V284, pG373, DOI 10.1152/ajpgi.00076.2002; Semenza Gregg L, 2005, Proc Am Thorac Soc, V2, P68, DOI 10.1513/pats.200404-029MS; Sharma S, 2009, EUR RESPIR J, V33, P1287, DOI 10.1183/09031936.00113008; Simpson A, 2012, AM J RESP CRIT CARE, V185, P1197, DOI 10.1164/rccm.201112-2191OC; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669	31	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154998	10.1371/journal.pone.0154998	http://dx.doi.org/10.1371/journal.pone.0154998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163696	Green Published, gold, Green Submitted			2022-12-27	WOS:000376585700039
J	Petrov, PD; Bonet, ML; Reynes, B; Oliver, P; Palou, A; Ribot, J				Petrov, Petar D.; Luisa Bonet, M.; Reynes, Barbara; Oliver, Paula; Palou, Andreu; Ribot, Joan			Whole Blood RNA as a Source of Transcript-Based Nutrition- and Metabolic Health-Related Biomarkers	PLOS ONE			English	Article							RETINOIC ACID TREATMENT; MONONUCLEAR-CELLS; VITAMIN-A; GENE-EXPRESSION; ADIPOSE-TISSUE; RETINOBLASTOMA PROTEIN; ACTIVATED RECEPTOR; INSULIN-RESISTANCE; LIPID-METABOLISM; DIET	Blood cells are receiving an increasing attention as an easily accessible source of transcript-based biomarkers. We studied the feasibility of using mouse whole blood RNA in this context. Several paradigms were studied: (i) metabolism-related transcripts known to be affected in rat tissues and peripheral blood mononuclear cells (PBMC) by fasting and upon the development of high fat diet (HFD)-induced overweight were assessed in whole blood RNA of fasted rats and mice and of HFD-fed mice; (ii) retinoic acid (RA)-responsive genes in tissues were assessed in whole blood RNA of control and RA-treated mice; (iii) lipid metabolism-related transcripts previously identified in PBMC as potential biomarkers of metabolic health in a rat model were assessed in whole blood in an independent model, namely retinoblastoma haploinsufficient (Rb+/-) mice. Blood was collected and stored in RNAlater (R) at -80 degrees C until analysis of selected transcripts by real-time RT-PCR. Comparable changes with fasting were detected in the expression of lipid metabolism-related genes when RNA from either PBMC or whole blood of rats or mice was used. HFD-induced excess body weight and fat mass associated with expected changes in the expression of metabolism-related genes in whole blood of mice. Changes in gene expression in whole blood of RA-treated mice reproduced known transcriptional actions of RA in hepatocytes and adipocytes. Reduced expression of Fasn, Lrp1, Rxrb and Sorl1 could be validated as early biomarkers of metabolic health in young Rb+/- mice using whole blood RNA. Altogether, these results support the use of whole blood RNA in studies aimed at identifying blood transcript-based biomarkers of nutritional/metabolic status or metabolic health. Results also support reduced expression of Fasn, Lrp1, Rxrb and Sorl1 in blood cells at young age as potential biomarkers of metabolic robustness.	[Palou, Andreu] Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigen, Palma De Mallorca, Spain; CIBER Fisiopatol Obesidad & Nutr CIBERobn, Palma De Mallorca, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Palou, A (corresponding author), Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigen, Palma De Mallorca, Spain.	andreu.palou@uib.es	Bonet, M.Luisa/H-6722-2015; Oliver, Paula/H-6285-2015; Reynés, Bàrbara/AAZ-7441-2020; Palou, Andreu/K-9881-2014; Ribot, Joan/L-2224-2014	Bonet, M.Luisa/0000-0002-8698-0630; Oliver, Paula/0000-0002-7821-8806; Reynés, Bàrbara/0000-0003-3988-7780; Palou, Andreu/0000-0002-0295-4452; Ribot, Joan/0000-0003-4460-9371; Petrov, Petar/0000-0001-9697-4317	European Union [244995]; Conselleria de Educacio, Cultura y Universidades, Government of the Balearic Islands, Spain	European Union(European Commission); Conselleria de Educacio, Cultura y Universidades, Government of the Balearic Islands, Spain	The research leading to these results has received funding from the European Union's Seventh Framework Programme for research, technological development, and demonstration under Grant Agreement No. 244995 (BIOCLAIMS Project). P. D. Petrov was granted with a PhD fellowship by Conselleria de Educacio, Cultura y Universidades, Government of the Balearic Islands, Spain.	ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; Amengual J, 2008, OBESITY, V16, P585, DOI 10.1038/oby.2007.104; Amengual J, 2012, INT J BIOCHEM CELL B, V44, P2019, DOI 10.1016/j.biocel.2012.07.026; Amengual J, 2010, CELL PHYSIOL BIOCHEM, V25, P657, DOI 10.1159/000315085; Baine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017014; Berry DC, 2012, DIABETES, V61, P1112, DOI 10.2337/db11-1620; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bonet ML, 2003, CELL MOL LIFE SCI, V60, P1311, DOI 10.1007/s00018-003-2290-x; Bonet ML, 2000, J ENDOCRINOL, V166, P511, DOI 10.1677/joe.0.1660511; Bouwens M, 2007, AM J CLIN NUTR, V86, P1515, DOI 10.1093/ajcn/86.5.1515; Burczynski ME, 2006, PHARMACOGENOMICS, V7, P187, DOI 10.2217/14622416.7.2.187; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caimari A, 2010, INT J OBESITY, V34, P831, DOI 10.1038/ijo.2010.17; Caimari A, 2010, J NUTR BIOCHEM, V21, P1127, DOI 10.1016/j.jnutbio.2009.10.001; Caimari A, 2010, OMICS, V14, P129, DOI 10.1089/omi.2009.0092; Chang DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064456; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Corssmit EPM, 2001, METABOLISM, V50, P742, DOI 10.1053/meta.2001.24195; de Mello VDF, 2012, MOL NUTR FOOD RES, V56, P1160, DOI 10.1002/mnfr.201100685; Debey-Pascher S, 2011, J MOL DIAGN, V13, P452, DOI 10.1016/j.jmoldx.2011.03.006; EISEN EJ, 1981, GROWTH, V45, P100; Felipe F, 2005, BBA-MOL BASIS DIS, V1740, P258, DOI 10.1016/j.bbadis.2004.11.014; Felipe F, 2004, DIABETES, V53, P882, DOI 10.2337/diabetes.53.4.882; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Fricano MM, 2011, INT J MOL SCI, V12, P2502, DOI 10.3390/ijms12042502; Konieczna J, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0366-2; Konieczna J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09088; Kucherlapati R, 2012, CLIN CANCER RES, V18, P625, DOI 10.1158/1078-0432.CCR-11-2021; Larose M, 1996, J BIOL CHEM, V271, P31533, DOI 10.1074/jbc.271.49.31533; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; Manoel-Caetano FS, 2012, GENE, V511, P151, DOI 10.1016/j.gene.2012.09.090; Manolescu DC, 2010, J NUTR, V140, P311, DOI 10.3945/jn.109.115147; Mendez-David I, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00124; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Mercader J, 2009, AM J PHYSIOL-ENDOC M, V297, pE184, DOI 10.1152/ajpendo.00163.2009; Oliver P, 2013, PFLUG ARCH EUR J PHY, V465, P459, DOI 10.1007/s00424-013-1246-8; Ozpolat B, 2005, LEUKEMIA LYMPHOMA, V46, P1497, DOI 10.1080/10428190500174737; Palou M, 2008, PFLUG ARCH EUR J PHY, V456, P825, DOI 10.1007/s00424-008-0461-1; Palou M, 2011, J NUTR BIOCHEM, V22, P574, DOI 10.1016/j.jnutbio.2010.05.001; Petrov PD, 2016, J CELL PHYSIOL, V231, P1941, DOI 10.1002/jcp.25299; Petrov PD, 2015, AM J PHYSIOL-ENDOC M, V308, pE172, DOI 10.1152/ajpendo.00308.2014; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puigserver P, 1996, BIOCHEM J, V317, P827, DOI 10.1042/bj3170827; Reynes B, 2016, BRIT J NUTR IN PRESS; Reynes B, 2015, AM J PHYSIOL-REG I, V309, pR824, DOI 10.1152/ajpregu.00221.2015; Reynes B, 2015, OBESITY, V23, P28, DOI 10.1002/oby.20918; Rhoades R., 2013, MED PHYSL PRINCIPLES, V4th; Ribot J, 2005, BBA-MOL BASIS DIS, V1740, P249, DOI 10.1016/j.bbadis.2004.10.013; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; STEGER G, 1994, NUCLEIC ACIDS RES, V22, P2760, DOI 10.1093/nar/22.14.2760; Tirone TA, 2001, WORLD J SURG, V25, P461, DOI 10.1007/s002680020338; Tourniaire F, 2015, J LIPID RES, V56, P1100, DOI 10.1194/jlr.M053652; van Ommen B, 2009, MOL NUTR FOOD RES, V53, P795, DOI 10.1002/mnfr.200800390; Voigt A, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0477-z; Xue JC, 1996, MOL CELL BIOL, V16, P1567	57	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155361	10.1371/journal.pone.0155361	http://dx.doi.org/10.1371/journal.pone.0155361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163124	gold, Green Published, Green Submitted			2022-12-27	WOS:000376585700045
J	Scott, F; Jardim, E; Millar, CP; Cervino, S				Scott, Finlay; Jardim, Ernesto; Millar, Colin P.; Cervino, Santiago			An Applied Framework for Incorporating Multiple Sources of Uncertainty in Fisheries Stock Assessments	PLOS ONE			English	Article							NATURAL MORTALITY; MANAGEMENT IMPLICATIONS; MODEL SELECTION; GROWTH; SIZE; INFORMATION; ESTIMATORS	Estimating fish stock status is very challenging given the many sources and high levels of uncertainty surrounding the biological processes (e.g. natural variability in the demographic rates), model selection (e.g. choosing growth or stock assessment models) and parameter estimation. Incorporating multiple sources of uncertainty in a stock assessment allows advice to better account for the risks associated with proposed management options, promoting decisions that are more robust to such uncertainty. However, a typical assessment only reports the model fit and variance of estimated parameters, thereby underreporting the overall uncertainty. Additionally, although multiple candidate models may be considered, only one is selected as the 'best' result, effectively rejecting the plausible assumptions behind the other models. We present an applied framework to integrate multiple sources of uncertainty in the stock assessment process. The first step is the generation and conditioning of a suite of stock assessment models that contain different assumptions about the stock and the fishery. The second step is the estimation of parameters, including fitting of the stock assessment models. The final step integrates across all of the results to reconcile the multi-model outcome. The framework is flexible enough to be tailored to particular stocks and fisheries and can draw on information from multiple sources to implement a broad variety of assumptions, making it applicable to stocks with varying levels of data availability The Iberian hake stock in International Council for the Exploration of the Sea (ICES) Divisions VIIIc and IXa is used to demonstrate the framework, starting from length-based stock and indices data. Process and model uncertainty are considered through the growth, natural mortality, fishing mortality, survey catchability and stock-recruitment relationship. Estimation uncertainty is included as part of the fitting process. Simple model averaging is used to integrate across the results and produce a single assessment that considers the multiple sources of uncertainty.	[Scott, Finlay; Jardim, Ernesto; Millar, Colin P.] European Commiss, Joint Res Ctr, Inst Protect & Secur Citizen, Maritime Affairs Unit, Via Enrico Fermi 2749, I-21027 Ispra, VA, Italy; [Millar, Colin P.] Marine Scotland, Freshwater Lab, Faskally PH16 5LB, Pitlochry, Scotland; [Cervino, Santiago] Ctr Oceanog Vigo, Inst Espanol Oceanog, Subida Radio Faro 50, Vigo 36390, Spain	European Commission Joint Research Centre; EC JRC ISPRA Site; Spanish Institute of Oceanography	Scott, F (corresponding author), European Commiss, Joint Res Ctr, Inst Protect & Secur Citizen, Maritime Affairs Unit, Via Enrico Fermi 2749, I-21027 Ispra, VA, Italy.	finlay.scott@jrc.ec.europa.eu	Cerviño, Santiago/E-5808-2010; Jardim, Ernesto/X-9764-2019	Cerviño, Santiago/0000-0003-4146-0890; 				Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; [Anonymous], 2014, BENCHM WORKSH SO MEG; [Anonymous], 2008, MODEL SELECTION MODE; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2010, BENCHM WORKSH ROUNDF, V36; Begley J, 2004, ANN SCI C; Bentley N, 2015, ICES J MAR SCI, V72, P186, DOI 10.1093/icesjms/fsu023; Breiman L., 1984, CLASSIFICATION REGRE; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Butterworth D. S., 1996, REPORT INT WHALING C, V46, P637; Cadrin SX, 2015, ICES J MAR SCI, V72, P1, DOI 10.1093/icesjms/fsu228; Carnell R, 2013, TRAINGEL PROVIDES ST; Cervino S, 2014, FISH RES, V160, P112, DOI 10.1016/j.fishres.2013.11.010; Cervino S, 2013, FISH RES, V138, P168, DOI 10.1016/j.fishres.2012.07.016; Cotter AJR, 2004, FISH FISH, V5, P235, DOI 10.1111/j.1467-2679.2004.00157.x; de Pontual H, 2006, ICES J MAR SCI, V63, P1674, DOI 10.1016/j.icesjms.2006.07.007; Dickey-Collas M, 2014, ICES J MAR SCI, V71, P128, DOI 10.1093/icesjms/fst075; Fernandez C, 2010, ICES J MAR SCI, V67, P1185, DOI 10.1093/icesjms/fsq029; Francis RICC, 1997, CAN J FISH AQUAT SCI, V54, P1699, DOI 10.1139/cjfas-54-8-1699; Froese R, 2015, FISHBASE WORLD WIDE; Geromont HF, 2015, ICES J MAR SCI, V72, P262, DOI 10.1093/icesjms/fsu017; Gislason H, 2010, FISH FISH, V11, P149, DOI 10.1111/j.1467-2979.2009.00350.x; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; HASTIE T, 2009, SPRINGER SERIES STAT; Hewitt DA, 2005, FISH B-NOAA, V103, P433; Hilborn R, 2003, SCI MAR, V67, P15, DOI 10.3989/scimar.2003.67s115; HILBORN R, 1992; Hjort J., 1926, Journal du Conseil Copenhague, V1, P5; Hofert M, 2014, COPULA MULTIVARIATE; International Whaling Commission, 2008, 1 INT RMP WORKSH N A; Jardim E, 2015, ICES J MAR SCI, V72, P232, DOI 10.1093/icesjms/fsu050; Jardim E, 2013, FISH RES, V140, P105, DOI 10.1016/j.fishres.2012.12.006; Jensen AL, 1996, CAN J FISH AQUAT SCI, V53, P820, DOI 10.1139/cjfas-53-4-820; Kell LT, 2007, ICES J MAR SCI, V64, P640, DOI 10.1093/icesjms/fsm012; Kenchington TJ, 2014, FISH FISH, V15, P533, DOI 10.1111/faf.12027; Maechler M, 2015, DIPTEST HARTIGANS DI; Millar CP, 2015, ICES J MAR SCI, V72, P93, DOI 10.1093/icesjms/fsu043; Nelsen R.B., 2013, INTRO COPULAS, V2nd; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Sethi SA, 2010, FISH FISH, V11, P341, DOI 10.1111/j.1467-2979.2010.00363.x; Shepherd JG, 1999, ICES J MAR SCI, V56, P584, DOI 10.1006/jmsc.1999.0498; Sklar A., 1959, PUBL I STAT U PARIS, V8, P229, DOI DOI 10.1007/978-3-642-33590-7; Stewart IJ, 2015, ICES J MAR SCI, V72, P2187, DOI 10.1093/icesjms/fsv061; Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076; Therneau T, 2015, RPART RECURSIVE PART; Thorpe RB, 2015, METHODS ECOL EVOL, V6, P49, DOI 10.1111/2041-210X.12292; VETTER EF, 1988, FISH B-NOAA, V86, P25; von Bertalanffy L, 1934, ROUX ARCH DEV BIOL, V131, P613, DOI 10.1007/BF00650112; Weinberg JR, 2014, GUIDANCE STOCK ASSES; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	50	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154922	10.1371/journal.pone.0154922	http://dx.doi.org/10.1371/journal.pone.0154922			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163586	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700004
J	Kim, JK; Kim, HS; Park, J; Jeong, CW; Ku, JH; Kim, HH; Kwak, C				Kim, Jung Kwon; Kim, Hyung Suk; Park, Juhyun; Jeong, Chang Wook; Ku, Ja Hyeon; Kim, Hyun Hoe; Kwak, Cheol			Perioperative Blood Transfusion as a Significant Predictor of Biochemical Recurrence and Survival after Radical Prostatectomy in Patients with Prostate Cancer	PLOS ONE			English	Article							MORTALITY; CYSTECTOMY; IMPACT; METAANALYSIS; CARCINOMA; OUTCOMES; SURGERY	Purpose There have been conflicting reports regarding the association of perioperative blood transfusion (PBT) with oncologic outcomes including recurrence rates and survival outcomes in prostate cancer. We aimed to evaluate whether perioperative blood transfusion (PBT) affects biochemical recurrence-free survival (BRFS), cancer-specific survival (CSS), and overall survival (OS) following radical prostatectomy (RP) for patients with prostate cancer. Materials and Methods A total of 2,713 patients who underwent RP for clinically localized prostate cancer between 1993 and 2014 were retrospectively analyzed. We performed a comparative analysis based on receipt of transfusion (PBT group vs. no-PBT group) and transfusion type (autologous PBT vs. allogeneic PBT). Univariate and multivariate Cox-proportional hazard regression analysis were performed to evaluate variables associated with BRFS, CSS, and OS. The Kaplan-Meier method was used to calculate survival estimates for BRFS, CSS, and OS, and log-rank test was used to conduct comparisons between the groups. Results The number of patients who received PBT was 440 (16.5%). Among these patients, 350 (79.5%) received allogeneic transfusion and the other 90 (20.5%) received autologous transfusion. In a multivariate analysis, allogeneic PBT was found to be statistically significant predictors of BRFS, CSS, and OS; conversely, autologous PBT was not. The Kaplan-Meier survival analysis showed significantly decreased 5-year BRFS (79.2% vs. 70.1%, log-rank, p = 0.001), CSS (98.5% vs. 96.7%, log-rank, p = 0.012), and OS (95.5% vs. 90.6%, log-rank, p < 0.001) in the allogeneic PBT group compared to the no-allogeneic PBT group. In the autologous PBT group, however, none of these were statistically significant compared to the no-autologous PBT group. Conclusions We found that allogeneic PBT was significantly associated with decreased BRFS, CSS, and OS. This provides further support for the immunomodulation hypothesis for allogeneic PBT.	[Kim, Jung Kwon; Kim, Hyung Suk; Park, Juhyun; Jeong, Chang Wook; Ku, Ja Hyeon; Kim, Hyun Hoe; Kwak, Cheol] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital	Kwak, C (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea.	mdrafael@snu.ac.kr		Park, Juhyun/0000-0002-5549-9756				Abel EJ, 2014, EUR UROL, V66, P1139, DOI 10.1016/j.eururo.2014.08.051; Amato A, 2006, COCHRANE DB SYST REV, DOI 10.1002/1465158.CD005033.pub2; Boehm K, 2015, WORLD J UROL, V33, P801, DOI 10.1007/s00345-014-1351-0; Buddeberg F, 2008, BEST PRACT RES-CLIN, V22, P503, DOI 10.1016/j.bpa.2008.05.003; Chalfin HJ, 2014, TRANSFUSION, V54, P2168, DOI 10.1111/trf.12611; Chhatre S, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001353; DAVIES AH, 1991, ANN ROY COLL SURG, V73, P116; Engel O, 2015, WORLD J UROL, V33, P1769, DOI 10.1007/s00345-015-1531-6; Ford BS, 2008, UROL ONCOL-SEMIN ORI, V26, P364, DOI 10.1016/j.urolonc.2007.06.004; Gallina A, 2007, BJU INT, V100, P1249, DOI 10.1111/j.1464-410X.2007.07147.x; HEAL JM, 1988, AM J SURG, V156, P374, DOI 10.1016/S0002-9610(88)80190-9; JAHNSON S, 1994, BRIT J UROL, V74, P779, DOI 10.1111/j.1464-410X.1994.tb07125.x; JAKOBSEN EB, 1994, EUR UROL, V26, P145; Korets R, 2014, J ENDOUROL, V28, P1418, DOI 10.1089/end.2014.0225; LIEWALD F, 1990, EUR J CANCER, V26, P327, DOI 10.1016/0277-5379(90)90230-Q; Linder BJ, 2014, BJU INT, V114, P368, DOI 10.1111/bju.12535; Linder BJ, 2013, EUR UROL, V63, P839, DOI 10.1016/j.eururo.2013.01.004; Lloyd JC, 2010, BJU INT, V105, P347, DOI 10.1111/j.1464-410X.2009.08792.x; MCCLINTON S, 1990, BRIT J SURG, V77, P140, DOI 10.1002/bjs.1800770208; Morgan TM, 2013, UROL ONCOL-SEMIN ORI, V31, P871, DOI 10.1016/j.urolonc.2011.07.012; Moschini M, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.12.016; Motoyama S, 2004, J SURG ONCOL, V87, P26, DOI 10.1002/jso.20064; NESS PM, 1992, TRANSFUSION, V32, P31, DOI 10.1046/j.1537-2995.1992.32192116429.x; Novara G, 2012, EUR UROL, V62, P431, DOI 10.1016/j.eururo.2012.05.044; OEFELEIN MG, 1995, J UROLOGY, V154, P442, DOI 10.1016/S0022-5347(01)67070-8; Ojima T, 2009, J GASTROINTEST SURG, V13, P1821, DOI 10.1007/s11605-009-0973-9; Paul R, 2006, UROLOGY, V67, P137, DOI 10.1016/j.urology.2005.07.020; Prasad SM, 2008, UROLOGY, V72, P647, DOI 10.1016/j.urology.2008.03.067; Shiba H, 2009, J GASTROINTEST SURG, V13, P1636, DOI 10.1007/s11605-009-0963-y; Soubra A, 2015, CLIN GENITOURIN CANC, V13, pE173, DOI 10.1016/j.clgc.2014.12.006; Tewari A, 2012, EUR UROL, V62, P1, DOI 10.1016/j.eururo.2012.02.029; Tollefson MK, 2014, J UROLOGY, V191, P646, DOI 10.1016/j.juro.2013.10.062; VELAGAPUDI SRC, 1994, UROLOGY, V43, P821, DOI 10.1016/0090-4295(94)90143-0; Wang CC, 2009, ANN SURG ONCOL, V16, P1832, DOI 10.1245/s10434-009-0448-y; Yeoh TY, 2014, TRANSFUSION, V54, P2175, DOI 10.1111/trf.12595	35	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154918	10.1371/journal.pone.0154918	http://dx.doi.org/10.1371/journal.pone.0154918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159369	Green Published, gold, Green Submitted			2022-12-27	WOS:000376576700025
J	Li, Y; Hu, HX; Butterworth, MB; Tian, JB; Zhu, MX; O'Neil, RG				Li, Yue; Hu, Hongxiang; Butterworth, Michael B.; Tian, Jin-Bin; Zhu, Michael X.; O'Neil, Roger G.			Expression of a Diverse Array of Ca2+-Activated K+ Channels (SK1/3, IK1, BK) that Functionally Couple to the Mechanosensitive TRPV4 Channel in the Collecting Duct System of Kidney	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; SMALL-CONDUCTANCE; APICAL MEMBRANE; DISTAL NEPHRON; EPOXYEICOSATRIENOIC ACIDS; INTERCALATED CELLS; CA2+ SENSITIVITY; PROTEIN-KINASES; BETA-SUBUNITS; SMOOTH-MUSCLE	The voltage- and Ca2+-activated, large conductance K+ channel (BK, maxi-K) is expressed in the collecting duct system of kidney where it underlies flow- and Ca2+-dependent K+ excretion. To determine if other Ca2+-activated K+ channels (KCa) may participate in this process, mouse kidney and the K+-secreting mouse cortical collecting duct (CCD) cell line, mCCDcl1, were assessed for TRPV4 and KCa channel expression and cross-talk. qPCR mRNA analysis and immunocytochemical staining demonstrated TRPV4 and KCa expression in mCCDcl1 cells and kidney connecting tubule (CNT) and CCD. Three subfamilies of KCa channels were revealed: the high Ca2+-binding affinity small-conductance SK channels, SK1 and SK3, the intermediate conductance channel, IK1, and the low Ca2+-binding affinity, BK channel (BK alpha subunit). Apparent expression levels varied in CNT/CCD where analysis of CCD principal cells (PC) and intercalated cells (IC) demonstrated differential staining: SK1:PC<IC, and SK3:PC>IC, IK1:PC>IC, BK alpha:PC = IC, and TRPV4:PC>IC. Patch clamp analysis and fluorescence Ca2+ imaging of mCCDcl1 cells demonstrated potent TRPV4-mediated Ca2+ entry and strong functional cross-talk between TRPV4 and KCa channels. TRPV4-mediated Ca2+ influx activated each KCa channel, as evidenced by selective inhibition of KCa channels, with each active KCa channel enhancing Ca2+ entry (due to membrane hyperpolarization). Transepithelial electrical resistance (TEER) analysis of confluent mCCDcl1 cells grown on permeable supports further demonstrated this crosstalk where TRPV4 activation induce a decrease in TEER which was partially restored upon selective inhibition of each KCa channel. It is concluded that SK1/SK3 and IK1 are highly expressed along with BKa in CNT and CCD and are closely coupled to TRPV4 activation as observed in mCCDcl1 cells. The data support a model in CNT/CCD segments where strong cross talk between TRPV4-mediated Ca2+ influx and each KCa channel leads to enhance Ca2+ entry which will support activation of the low Ca2+-binding affinity BK channel to promote BK-mediated K+ secretion.	[Li, Yue; Hu, Hongxiang; Tian, Jin-Bin; Zhu, Michael X.; O'Neil, Roger G.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Butterworth, Michael B.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA	University of Texas System; University of Texas Health Science Center Houston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	O'Neil, RG (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	roger.g.oneil@uth.tmc.edu	Tian, JinBin/B-7001-2019; tian, jinbin/L-6006-2019	Tian, JinBin/0000-0002-5516-7778; 	American Heart Association [14GRNT20380916]; National Institutes of Health [R01-DK098401, R01-DK102843]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098401, R01DK102843] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The American Heart Association, Grant # 14GRNT20380916 (to RGO), URL: www.heart.org; The National Institutes of Health, Grant # R01-DK098401 (to RGO), URL:www.nih.gov; The National Institutes of Health, Grant # R01-DK102843 (to MBB), URL:www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Bailey MA, 2006, KIDNEY INT, V70, P51, DOI 10.1038/sj.ki.5000388; Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; Barfod ET, 2001, AM J PHYSIOL-CELL PH, V280, pC836, DOI 10.1152/ajpcell.2001.280.4.C836; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Berrout J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095149; Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; Berrout J, 2012, BRAIN RES, V1436, P1, DOI 10.1016/j.brainres.2011.11.044; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Campbell WB, 2006, AM J PHYSIOL-HEART C, V290, pH64, DOI 10.1152/ajpheart.00516.2005; Catalan MA, 2014, CELL CALCIUM, V55, P362, DOI 10.1016/j.ceca.2014.01.005; Chen S, 2014, J NEUROSCI, V34, P8219, DOI 10.1523/JNEUROSCI.0936-14.2014; Edinger RS, 2014, J AM SOC NEPHROL, V25, P2445, DOI 10.1681/ASN.2013090931; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; Estilo G, 2008, AM J PHYSIOL-RENAL, V295, pF780, DOI 10.1152/ajprenal.00002.2008; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Fodstad H, 2009, AM J PHYSIOL-RENAL, V296, pF966, DOI 10.1152/ajprenal.90475.2008; Frindt G, 2004, AM J PHYSIOL-RENAL, V287, pF1030, DOI 10.1152/ajprenal.00169.2004; FRINDT G, 1987, AM J PHYSIOL, V252, pF458, DOI 10.1152/ajprenal.1987.252.3.F458; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GARDOS G, 1958, BIOCHIM BIOPHYS ACTA, V30, P653, DOI 10.1016/0006-3002(58)90124-0; GIANGIACOMO KM, 1992, BIOCHEMISTRY-US, V31, P6719, DOI 10.1021/bi00144a011; Grimm PR, 2007, AM J PHYSIOL-RENAL, V293, pF350, DOI 10.1152/ajprenal.00018.2007; Grimm PR, 2009, AM J PHYSIOL-RENAL, V297, pF420, DOI 10.1152/ajprenal.00191.2009; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gueguinou M, 2014, BBA-MOL CELL RES, V1843, P2322, DOI 10.1016/j.bbamcr.2014.02.019; Hayashi M, 2009, J MED INVESTIG, V56, P354, DOI 10.2152/jmi.56.354; HIRSCH J, 1993, PFLUG ARCH EUR J PHY, V422, P492, DOI 10.1007/BF00375077; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Holtzclaw JD, 2011, CURR OPIN NEPHROL HY, V20, P512, DOI 10.1097/MNH.0b013e3283488889; Holtzclaw JD, 2010, J AM SOC NEPHROL, V21, P634, DOI 10.1681/ASN.2009080817; Imig JD, 2013, PROSTAG OTH LIPID M, V104, P2, DOI 10.1016/j.prostaglandins.2013.01.002; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; Jin M, 2012, CELL CALCIUM, V51, P131, DOI 10.1016/j.ceca.2011.11.011; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14294, DOI 10.1021/bi991206j; Jin Y, 2007, AM J PHYSIOL-RENAL, V293, pF1299, DOI 10.1152/ajprenal.00293.2007; Kaufman JS, 1996, MINER ELECTROL METAB, V22, P242; KORBMACHER C, 1993, J GEN PHYSIOL, V102, P761, DOI 10.1085/jgp.102.4.761; Li DM, 2006, P NATL ACAD SCI USA, V103, P19569, DOI 10.1073/pnas.0609555104; Li K, 2010, AM J PHYSIOL-REG I, V299, pR590, DOI 10.1152/ajpregu.00207.2009; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Lin MT, 2015, PULM CIRC, V5, P279, DOI 10.1086/680166; Liu W, 2007, AM J PHYSIOL-RENAL, V293, pF227, DOI 10.1152/ajprenal.00057.2007; Liu W, 2009, AM J PHYSIOL-RENAL, V297, pF904, DOI 10.1152/ajprenal.90685.2008; Lu M, 2000, J GEN PHYSIOL, V116, P299, DOI 10.1085/jgp.116.2.299; Ma Y, 2015, BBA-MOL BASIS DIS, V1852, P552, DOI 10.1016/j.bbadis.2014.12.010; Mamenko M, 2013, J BIOL CHEM, V288, P20306, DOI 10.1074/jbc.M113.466797; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; PACHA J, 1991, AM J PHYSIOL, V261, pF696, DOI 10.1152/ajprenal.1991.261.4.F696; Palmer LG, 2007, AM J PHYSIOL-RENAL, V292, pF966, DOI 10.1152/ajprenal.00191.2006; Pluznick JL, 2006, AM J PHYSIOL-RENAL, V291, pF517, DOI 10.1152/ajprenal.00118.2006; Pluznick JL, 2005, AM J PHYSIOL-RENAL, V288, pF846, DOI 10.1152/ajprenal.00340.2004; Rieg T, 2007, KIDNEY INT, V72, P566, DOI 10.1038/sj.ki.5002369; Rodan AR, 2011, AM J PHYSIOL-RENAL, V300, pF821, DOI 10.1152/ajprenal.00742.2010; Rodan AR, 2009, CURR OPIN NEPHROL HY, V18, P350, DOI 10.1097/MNH.0b013e32832c75d8; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; ROMEY G, 1984, J PHYSIOL-PARIS, V79, P259; Sackin H, 2003, BIOPHYS J, V84, P910, DOI 10.1016/S0006-3495(03)74908-X; Satlin LM, 2004, CURR OPIN NEPHROL HY, V13, P445, DOI 10.1097/01.mnh.0000133979.17311.21; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Sorensen CM, 2012, AM J PHYSIOL-RENAL, V302, pF505, DOI 10.1152/ajprenal.00052.2011; Sun P, 2009, J AM SOC NEPHROL, V20, P513, DOI 10.1681/ASN.2008040427; Taniguchi J, 1998, J MEMBRANE BIOL, V164, P35, DOI 10.1007/s002329900391; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Wang WH, 2009, PFLUG ARCH EUR J PHY, V458, P157, DOI 10.1007/s00424-008-0593-3; WANG WH, 1990, AM J PHYSIOL, V259, pF494, DOI 10.1152/ajprenal.1990.259.3.F494; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; Wen DH, 2014, KIDNEY INT, V86, P139, DOI 10.1038/ki.2014.14; Wen DH, 2013, AM J PHYSIOL-RENAL, V305, pF463, DOI 10.1152/ajprenal.00171.2013; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2013, J CARDIOVASC PHARM, V61, P102, DOI 10.1097/FJC.0b013e318279ba20; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005; Zheng XD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000080	87	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155006	10.1371/journal.pone.0155006	http://dx.doi.org/10.1371/journal.pone.0155006			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159616	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000376576700029
J	Paine, MRL; Kim, J; Bennett, RV; Parry, RM; Gaul, DA; Wang, MD; Matzuk, MM; Fernandez, FM				Paine, Martin R. L.; Kim, Jaeyeon; Bennett, Rachel V.; Parry, R. Mitchell; Gaul, David A.; Wang, May D.; Matzuk, Martin M.; Fernandez, Facundo M.			Whole Reproductive System Non-Negative Matrix Factorization Mass Spectrometry Imaging of an Early-Stage Ovarian Cancer Mouse Model	PLOS ONE			English	Article							CHOLESTEROL SULFATE; FALLOPIAN-TUBE; TOF-SIMS; TISSUE; LYSOPHOSPHOLIPIDS; CLASSIFICATION; RESOLUTION; PLASMA; IMAGES	High-grade serous carcinoma (HGSC) is the most common and deadliest form of ovarian cancer. Yet it is largely asymptomatic in its initial stages. Studying the origin and early progression of this disease is thus critical in identifying markers for early detection and screening purposes. Tissue-based mass spectrometry imaging (MSI) can be employed as an unbiased way of examining localized metabolic changes between healthy and cancerous tissue directly, at the onset of disease. In this study, we describe MSI results from DicerPten double-knockout (DKO) mice, a mouse model faithfully reproducing the clinical nature of human HGSC. By using non-negative matrix factorization (NMF) for the unsupervised analysis of desorption electrospray ionization (DESI) datasets, tissue regions are segregated based on spectral components in an unbiased manner, with alterations related to HGSC highlighted. Results obtained by combining NMF with DESI-MSI revealed several metabolic species elevated in the tumor tissue and/or surrounding blood-filled cyst including ceramides, sphingomyelins, bilirubin, cholesterol sulfate, and various lysophospholipids. Multiple metabolites identified within the imaging study were also detected at altered levels within serum in a previous metabolomic study of the same mouse model. As an example workflow, features identified in this study were used to build an oPLS-DA model capable of discriminating between DKO mice with early-stage tumors and controls with up to 88% accuracy.	[Paine, Martin R. L.; Bennett, Rachel V.; Gaul, David A.; Fernandez, Facundo M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kim, Jaeyeon; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Parry, R. Mitchell] Appalachian State Univ, Dept Comp Sci, Boone, NC 28608 USA; [Gaul, David A.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Gaul, David A.; Fernandez, Facundo M.] Georgia Inst Technol, Integrated Canc Res Ctr, Atlanta, GA 30332 USA; [Wang, May D.] Georgia Inst Technol, Walter H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [Fernandez, Facundo M.] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Kim, Jaeyeon] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	University System of Georgia; Georgia Institute of Technology; Baylor College of Medicine; University of North Carolina; Appalachian State University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University System of Georgia; Georgia Institute of Technology; Indiana University System; Indiana University Bloomington	Fernandez, FM (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.; Fernandez, FM (corresponding author), Georgia Inst Technol, Integrated Canc Res Ctr, Atlanta, GA 30332 USA.; Fernandez, FM (corresponding author), Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA.	facundo.fernandez@chemistry.gatech.edu	Wang, May Dongmei/AAF-2065-2021; Gaul, David/AAX-3797-2020; Fernandez, Facundo Martin/B-7015-2008	Wang, May Dongmei/0000-0003-3961-3608; Fernandez, Facundo Martin/0000-0002-0302-2534; Paine, Martin Robert Lloyd/0000-0002-9360-1969; Gaul, David/0000-0002-9308-1895	Ovarian Cancer Research Fund (OCRF) Program Project Development; Marsha Rivkin Foundation; NATIONAL CANCER INSTITUTE [R00CA179137] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund (OCRF) Program Project Development; Marsha Rivkin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Ovarian Cancer Research Fund (OCRF) Program Project Development grant (http://http://www.ocrf.org) and a Challenge Grant from the Marsha Rivkin Foundation (http://http://www.marsharivkin.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge support from an Ovarian Cancer Research Fund (OCRF) Program Project Development grant and a Challenge Grant from the Marsha Rivkin Foundation. We also thank Prof. Paul Farnsworth for his invaluable help with developing an ROI Matlab GUI for investigating MSI data.	Alexandrov T, 2010, J PROTEOME RES, V9, P6535, DOI 10.1021/pr100734z; [Anonymous], 2014, FEATURE EXTRACTION A; [Anonymous], 2015, SEER CANC STAT FACTS; Assinder SJ, 2009, BIOCHEM J, V417, P411, DOI 10.1042/BJ20081610; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bennett RV, 2014, ANAL CHEM, V86, P3756, DOI 10.1021/ac5007816; Berek J.S, 2003, HOLLAND FREI CANC ME, V6th; Berry KAZ, 2011, CHEM REV, V111, P6491, DOI 10.1021/cr200280p; Bhoola S, 2006, OBSTET GYNECOL, V107, P1399, DOI 10.1097/01.AOG.0000220516.34053.48; Broersen A, 2008, J AM SOC MASS SPECTR, V19, P823, DOI 10.1016/j.jasms.2008.02.015; Bruand J, 2011, J PROTEOME RES, V10, P4734, DOI 10.1021/pr2005378; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Campbell DI, 2012, ANAL BIOANAL CHEM, V404, P389, DOI 10.1007/s00216-012-6173-6; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Chughtai K, 2013, J LIPID RES, V54, P333, DOI 10.1194/jlr.M027961; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; Cooks RG, 2006, SCIENCE, V311, P1566, DOI 10.1126/science.1119426; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Dubey M, 2009, SURF INTERFACE ANAL, V41, P645, DOI 10.1002/sia.3056; Eberlin LS, 2012, CANCER RES, V72, P645, DOI 10.1158/0008-5472.CAN-11-2465; Eberlin LS, 2010, ANAL CHEM, V82, P3430, DOI 10.1021/ac9029482; El Ayed M, 2010, MED SCI MONITOR, V16, pBR233; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Gerbig S, 2012, ANAL BIOANAL CHEM, V403, P2315, DOI 10.1007/s00216-012-5841-x; Gustafsson JOR, 2011, INT J MOL SCI, V12, P773, DOI 10.3390/ijms12010773; Hanselmann M, 2008, ANAL CHEM, V80, P9649, DOI 10.1021/ac801303x; Hayasaka T, 2011, ANAL BIOANAL CHEM, V401, P183, DOI 10.1007/s00216-011-4778-9; Jones CM, 2015, J PROTEOME RES, V14, P917, DOI 10.1021/pr5009948; Jones EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024913; Kanto T, 2001, J IMMUNOL, V167, P3773, DOI 10.4049/jimmunol.167.7.3773; Kiguchi K, 1998, CLIN CANCER RES, V4, P2985; Kim J, 2015, ENDOCRINOLOGY, V156, P1975, DOI 10.1210/en.2014-1977; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Klinkert I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2737770; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Liu Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-186; Mansfield JR, 1997, ANAL CHEM, V69, P3370, DOI 10.1021/ac970206r; Meding Stephan, 2013, J Proteome Res, V12, P308, DOI 10.1021/pr300996x; Meding S, 2012, J PROTEOME RES, V11, P1996, DOI 10.1021/pr200784p; Ollinger R, 2007, CELL CYCLE, V6, P3078, DOI 10.4161/cc.6.24.5022; Oskouian B, 2010, ADV EXP MED BIOL, V688, P185; Park JW, 2009, SURF INTERFACE ANAL, V41, P694, DOI 10.1002/sia.3049; Parry RM, 2013, J AM SOC MASS SPECTR, V24, P646, DOI 10.1007/s13361-012-0572-y; Parry RM, 2009, IEEE ENG MED BIO, P6731, DOI 10.1109/IEMBS.2009.5332854; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Rompp A, 2010, ANGEW CHEM INT EDIT, V49, P3834, DOI 10.1002/anie.200905559; Seeley EH, 2011, TRENDS BIOTECHNOL, V29, P136, DOI 10.1016/j.tibtech.2010.12.002; Seidman JD, 2011, GYNECOL ONCOL, V120, P470, DOI 10.1016/j.ygyno.2010.11.020; Shen ZZ, 2001, GYNECOL ONCOL, V83, P25, DOI 10.1006/gyno.2001.6357; Shimma S, 2007, J CHROMATOGR B, V855, P98, DOI 10.1016/j.jchromb.2007.02.037; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; Sutphen R, 2004, CANCER EPIDEM BIOMAR, V13, P1185; Switzer P., 1984, MIN MAX AUTOCORRELAT; Wiseman JM, 2005, ANGEW CHEM, V117, P7256; Wiseman JM, 2006, ANGEW CHEM INT EDIT, V45, P7188, DOI 10.1002/anie.200602449; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wu CP, 2013, MASS SPECTROM REV, V32, P218, DOI 10.1002/mas.21360; Xiao YJ, 2000, ANN NY ACAD SCI, V905, P242; Xiong XC, 2012, CHINESE J ANAL CHEM, V40, P663, DOI 10.1016/S1872-2040(11)60544-6	63	17	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154837	10.1371/journal.pone.0154837	http://dx.doi.org/10.1371/journal.pone.0154837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159635	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700018
J	Tramullas, M; Finger, BC; Dinan, TG; Cryan, JF				Tramullas, Monica; Finger, Beate C.; Dinan, Timothy G.; Cryan, John F.			Obesity Takes Its Toll on Visceral Pain: High-Fat Diet Induces Toll-Like Receptor 4-Dependent Visceral Hypersensitivity	PLOS ONE			English	Article							PSEUDO-AFFECTIVE RESPONSES; NEUROPATHIC PAIN; COLORECTAL DISTENSION; SELECTIVELY PROTECTS; PSYCHOSOCIAL STRESS; INSULIN-RESISTANCE; INNATE IMMUNITY; GUT MICROBIOTA; RAT MODEL; ACTIVATION	Exposure to high-fat diet induces both, peripheral and central alterations in TLR4 expression. Moreover, functional TLR4 is required for the development of high-fat diet-induced obesity. Recently, central alterations in TLR4 expression have been associated with the modulation of visceral pain. However, it remains unknown whether there is a functional interaction between the role of TLR4 in diet-induced obesity and in visceral pain. In the present study we investigated the impact of long-term exposure to high-fat diet on visceral pain perception and on the levels of TLR4 and Cd11b (a microglial cell marker) protein expression in the prefrontal cortex (PFC) and hippocampus. Peripheral alterations in TLR4 were assessed following the stimulation of spleenocytes with the TLR4-agonist LPS. Finally, we evaluated the effect of blocking TLR4 on visceral nociception, by administering TAK-242, a selective TLR4-antagonist. Our results demonstrated that exposure to high-fat diet induced visceral hypersensitivity. In parallel, enhanced TLR4 expression and microglia activation were found in brain areas related to visceral pain, the PFC and the hippocampus. Likewise, peripheral TLR4 activity was increased following long-term exposure to high-fat diet, resulting in an increased level of pro-inflammatory cytokines. Finally, TLR4 blockage counteracted the hyperalgesic phenotype present in mice fed on high-fat diet. Our data reveal a role for TLR4 in visceral pain modulation in a model of diet-induced obesity, and point to TLR4 as a potential therapeutic target for the development of drugs to treat visceral hypersensitivity present in pathologies associated to fat diet consumption.	[Tramullas, Monica; Dinan, Timothy G.; Cryan, John F.] Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork, Ireland; [Finger, Beate C.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland; [Dinan, Timothy G.] Natl Univ Ireland Univ Coll Cork, Dept Psychiat & Neurobehav Sci, Cork, Ireland; [Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland	University College Cork; University College Cork; University College Cork; University College Cork	Cryan, JF (corresponding author), Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork, Ireland.; Cryan, JF (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland.	j.cryan@ucc.ie	Cryan, John F./A-6950-2013; Dinan, Timothy/ABA-8284-2020; Tramullas, Mónica/F-6153-2016	Cryan, John F./0000-0001-5887-2723; Tramullas, Mónica/0000-0002-2447-8928; Dinan, Timothy/0000-0002-2316-7220	Science Foundation Ireland (APC Microbiome) [SFI/12/RC/2273]; Health Research Board of Ireland [HRA_POR/2011/23, HRA_POR/2012/32]; European Community's Seventh Framework Programme Grant My New Gut [FP7/2007-2013]	Science Foundation Ireland (APC Microbiome)(Science Foundation Ireland); Health Research Board of Ireland; European Community's Seventh Framework Programme Grant My New Gut	The authors are supported in part by Science Foundation Ireland in the form of a centre grant (APC Microbiome) under (Grant Number SFI/12/RC/2273); by the Health Research Board of Ireland (Grant Numbers HRA_POR/2011/23 and HRA_POR/2012/32) and received funding from the European Community's Seventh Framework Programme Grant My New Gut under Grant Agreement No. FP7/2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson S, 2006, J PAIN, V7, P108, DOI 10.1016/j.jpain.2005.09.003; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bettoni I, 2008, GLIA, V56, P1312, DOI 10.1002/glia.20699; Brades S, 2009, GASTROENTEROLOGY, V136, P1339, DOI 10.1053/j.gastro.2008.12.044; Bradesi S, 2010, NEUROGASTROENT MOTIL, V22, P499, DOI 10.1111/j.1365-2982.2010.01491.x; Buckman LB, 2014, BRAIN BEHAV IMMUN, V35, P33, DOI 10.1016/j.bbi.2013.06.007; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; CARUANA BJ, 1991, GASTROENTEROLOGY, V100, P465, DOI 10.1016/0016-5085(91)90217-9; Chan YK, 2013, ANN NUTR METAB, V63, P28, DOI 10.1159/000354902; Christianson JA, 2007, NAT PROTOC, V2, P2624, DOI 10.1038/nprot.2007.392; Clarke G, 2012, ALIMENT PHARM THER, V35, P403, DOI 10.1111/j.1365-2036.2011.04965.x; Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790; Das V, 2015, PROG MOL BIOL TRANSL, V131, P1, DOI 10.1016/bs.pmbts.2015.01.003; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dogukan A, 2010, J RENAL NUTR, V20, P112, DOI 10.1053/j.jrn.2009.04.009; Finger BC, 2011, NEUROSCIENCE, V192, P351, DOI 10.1016/j.neuroscience.2011.06.072; Finger BC, 2012, PSYCHONEUROENDOCRINO, V37, P729, DOI 10.1016/j.psyneuen.2011.06.015; Gibney SM, 2010, NEUROSCIENCE, V165, P675, DOI 10.1016/j.neuroscience.2009.08.076; Golovatscka V, 2012, NEUROIMMUNOMODULAT, V19, P367, DOI 10.1159/000342092; Gosselin RD, 2010, GASTROENTEROLOGY, V138, P2418, DOI 10.1053/j.gastro.2010.03.003; Grabauskas G, 2011, DIABETES, V60, P1743, DOI 10.2337/db10-1507; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Groover AL, 2013, PAIN, V154, P2658, DOI 10.1016/j.pain.2013.07.052; Guilford BL, 2011, EXP DIABETES RES, DOI 10.1155/2011/848307; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Li Y, 2015, BRAIN BEHAV IMMUN, V49, P255, DOI 10.1016/j.bbi.2015.06.003; Lin JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12549; Liu PY, 2012, GASTROENTEROLOGY, V142, P165, DOI 10.1053/j.gastro.2011.09.041; London LEE, 2014, J NUTR, V144, P1956, DOI 10.3945/jn.114.191627; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Mahony SMO, 2013, BEHAV BRAIN RES, V253, P310, DOI 10.1016/j.bbr.2013.07.023; Manna P, 2015, METAB SYNDR RELAT D, V13, P423, DOI 10.1089/met.2015.0095; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Mayer EA, 2006, GASTROENTEROLOGY, V131, P1925, DOI 10.1053/j.gastro.2006.10.026; McAllan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088904; McKernan DP, 2010, NEUROGASTROENT MOTIL, V22, P1029, DOI 10.1111/j.1365-2982.2010.01520.x; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; NESS TJ, 1990, PAIN, V43, P377, DOI 10.1016/0304-3959(90)90035-C; Nicotra L, 2012, EXP NEUROL, V234, P316, DOI 10.1016/j.expneurol.2011.09.038; O'Mahony Siobhain M, 2012, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0940s61; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Pan RR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/523896; Pierre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065061; Quigley EMM, 2008, J CLIN GASTROENTEROL, V42, pS85, DOI 10.1097/MCG.0b013e31816244ca; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Schomberg D, 2012, EXP NEUROL, V234, P262, DOI 10.1016/j.expneurol.2011.12.021; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shubayev VI, 2010, TRANSLATIONAL PAIN R; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Tammpere A, 2005, PAIN, V116, P220, DOI 10.1016/j.pain.2005.04.012; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tramullas M, 2014, BIOL PSYCHIAT, V76, P340, DOI 10.1016/j.biopsych.2013.11.004; Tramullas M, 2012, STRESS, V15, P281, DOI 10.3109/10253890.2011.622816; Tramullas M, 2010, J NEUROSCI, V30, P1502, DOI 10.1523/JNEUROSCI.2584-09.2010; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vallejo R, 2010, PAIN PRACT, V10, P167, DOI 10.1111/j.1533-2500.2010.00367.x; Verdu EF, 2006, GUT, V55, P182, DOI 10.1136/gut.2005.066100; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Wang YS, 2015, PAIN PHYSICIAN, V18, pE615; Wang Z, 2009, PAIN, V145, P120, DOI 10.1016/j.pain.2009.05.025; Wieser V, 2013, ARCH IMMUNOL THER EX, V61, P119, DOI 10.1007/s00005-012-0210-1; Wu FX, 2010, INT J MED SCI, V7, P251; Zhao Y, 2015, INT J CLIN EXP MED, V8, P11202	73	22	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155367	10.1371/journal.pone.0155367	http://dx.doi.org/10.1371/journal.pone.0155367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159520	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700061
J	Hatta, T; Giambini, H; Sukegawa, K; Yamanaka, Y; Sperling, JW; Steinmann, SP; Itoi, E; An, KN				Hatta, Taku; Giambini, Hugo; Sukegawa, Koji; Yamanaka, Yoshiaki; Sperling, John W.; Steinmann, Scott P.; Itoi, Eiji; An, Kai-Nan			Quantified Mechanical Properties of the Deltoid Muscle Using the Shear Wave Elastography: Potential Implications for Reverse Shoulder Arthroplasty	PLOS ONE			English	Article							ROTATOR CUFF MUSCLE; IN-VIVO; ULTRASOUND ELASTOGRAPHY; FOLLOW-UP; DESIGN; LATERALIZATION; FEASIBILITY; RELIABILITY; PROSTHESIS; TENSION	The deltoid muscle plays a critical role in the biomechanics of shoulders undergoing reverse shoulder arthroplasty (RSA). However, both pre- and postoperative assessment of the deltoid muscle quality still remains challenging. The purposes of this study were to establish a novel methodology of shear wave elastography (SWE) to quantify the mechanical properties of the deltoidmuscle, and to investigate the reliability of this technique using cadaveric shoulders for the purpose of RSA. Eight fresh-frozen cadaveric shoulders were obtained. The deltoid muscles were divided into 5 segments (A1, A2, M, P1 and P2) according to the muscle fiber orientation and SWE values were measured for each segment. Intra-and inter-observer reliability was evaluated using intraclass correlation coefficient (ICC). To measure the response of muscle tension during RSA, the humeral shaft was osteotomized and subsequently elongated by an external fixator (intact to 15mm elongation). SWE of the deltoid muscle was measured under each stretch condition. Intra-and inter-observer reliability of SWE measurements for all regions showed 0.761-0.963 and 0.718-0.947 for ICC(2,1). Especially, SWE measurements for segments A2 and M presented satisfactory repeatability. Elongated deltoid muscles by the external fixator showed a progressive increase in passive stiffness for all muscular segments. Especially, SWE outcomes of segments A2 and M reliably showed an exponential growth upon stretching (R-2 = 0.558 and 0.593). Segmental measurements using SWE could be reliably and feasibly used to quantitatively assess the mechanical properties of the deltoid muscle, especially in the anterior and middle portions. This novel technique based on the anatomical features may provide helpful information of the deltoid muscle properties during treatment of RSA.	[Hatta, Taku; Giambini, Hugo; Sukegawa, Koji; Yamanaka, Yoshiaki; An, Kai-Nan] Mayo Clin, Biomech Lab, Div Orthoped Res, Rochester, MN USA; [Giambini, Hugo; Sperling, John W.; Steinmann, Scott P.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Itoi, Eiji] Tohoku Univ, Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 980, Japan	Mayo Clinic; Mayo Clinic; Tohoku University	An, KN (corresponding author), Mayo Clin, Biomech Lab, Div Orthoped Res, Rochester, MN USA.	an.kainan@mayo.edu	Hatta, Taku/AEI-5559-2022		National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R21 AR065550]; National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program [T32-AR56950]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065550, T32AR056950] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R21 AR065550. The authors would also like to acknowledge the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program T32-AR56950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur A.M., 2005, GRANTS ATLAS ANATOMY, V11th edition; Berhouet J, 2015, J SHOULDER ELB SURG, V24, P569, DOI 10.1016/j.jse.2014.09.022; Brandenburg JE, 2015, J ULTRAS MED, V34, P663, DOI 10.7863/ultra.34.4.663; Chakouch MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138873; Costantini O, 2015, J SHOULDER ELB SURG, V24, P1120, DOI 10.1016/j.jse.2014.11.040; Crosby LA, 2011, CLIN ORTHOP RELAT R, V469, P2544, DOI 10.1007/s11999-011-1881-3; Debernard L, 2011, J BIOMECH, V44, P397, DOI 10.1016/j.jbiomech.2010.10.025; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Frankle M, 2005, J BONE JOINT SURG AM, V87A, P1697, DOI 10.2106/JBJS.D.02813; GIAT Y, 1994, J BIOMECH, V27, P1005, DOI 10.1016/0021-9290(94)90217-8; Giles JW, 2015, CLIN ORTHOP RELAT R, V473, P3615, DOI 10.1007/s11999-015-4526-0; Guery J, 2006, J BONE JOINT SURG AM, V88A, P1742, DOI 10.2106/JBJS.E.00851; Hamilton MA, 2015, J ORTHOP RES, V33, P605, DOI 10.1002/jor.22803; Hartzler RU, 2014, ARTHROSC TEC, V3, pE719, DOI 10.1016/j.eats.2014.09.005; Hatta T, 2015, J BIOMECH, V48, P3853, DOI 10.1016/j.jbiomech.2015.09.038; Hatta T, 2014, J ULTRAS MED, V33, P1641, DOI 10.7863/ultra.33.9.1641; Henninger HB, 2012, J SHOULDER ELB SURG, V21, P1128, DOI 10.1016/j.jse.2011.07.034; Henninger HB, 2012, J SHOULDER ELB SURG, V21, P483, DOI 10.1016/j.jse.2011.01.040; Hettrich CM, 2015, J SHOULDER ELB SURG, V24, P1774, DOI 10.1016/j.jse.2015.06.011; Hoang PD, 2005, J BIOMECH, V38, P1333, DOI 10.1016/j.jbiomech.2004.05.046; Itoigawa Y, 2015, CLIN ANAT, V28, P213, DOI 10.1002/ca.22498; Katz D, 2016, INT ORTHOP, V40, P99, DOI 10.1007/s00264-015-2976-3; Koo TK, 2015, J BIOMECH, V48, P3539, DOI 10.1016/j.jbiomech.2015.05.038; Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009; Koo TKK, 2002, CLIN BIOMECH, V17, P390, DOI 10.1016/S0268-0033(02)00031-1; Ladermann A, 2015, INT ORTHOP, V39, P2205, DOI 10.1007/s00264-015-2984-3; Meyer DC, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-247; Miyamoto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124311; Muraki T, 2012, J SHOULDER ELB SURG, V21, P1160, DOI 10.1016/j.jse.2011.08.042; Reinold MM, 2007, J ATHL TRAINING, V42, P464; Sakoma Y, 2011, J ANAT, V218, P185, DOI 10.1111/j.1469-7580.2010.01325.x; Schwartz C, 2014, J SHOULDER ELB SURG, V23, P873, DOI 10.1016/j.jse.2013.08.020; Sirveaux F, 2004, J BONE JOINT SURG BR, V86B, P388, DOI 10.1302/0301-620X.86B3.14024; Walch G, 2009, J SHOULDER ELB SURG, V18, P495, DOI 10.1016/j.jse.2008.12.002; Werner CML, 2005, J BONE JOINT SURG AM, V87A, P1476, DOI 10.2106/JBJS.D.02342; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	36	17	18	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155102	10.1371/journal.pone.0155102	http://dx.doi.org/10.1371/journal.pone.0155102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152934	Green Published, gold, Green Submitted			2022-12-27	WOS:000375677000070
J	Roth, S; Spalinger, MR; Gottier, C; Biedermann, L; Zeitz, J; Lang, S; Weber, A; Rogler, G; Scharl, M				Roth, Sofia; Spalinger, Marianne R.; Gottier, Claudia; Biedermann, Luc; Zeitz, Jonas; Lang, Silvia; Weber, Achim; Rogler, Gerhard; Scharl, Michael			Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION; VACCINIUM-MYRTILLUS; CROHNS-DISEASE; PATHOGENESIS; INTERLEUKIN-10; EXTRACT; INNATE; CELLS; RECEPTOR	Background/Aims We previously demonstrated that anthocyanin-rich bilberry extract (ARBE) inhibits IFN-gamma-induced signalling and downstream effects in human monocytic cells and ameliorates disease activity in ulcerative colitis (UC) patients. Here, we studied the molecular mechanisms of ARBE-mediated effects in vitro and by analysing colonic tissue and serum samples of UC patients treated with an oral anthocyanin-rich bilberry preparation during an open label clinical trial. Methods Colon specimens obtained during an open pilot study using ARBE for the treatment of mild-to-moderate UC were analyzed by immunohistochemistry. Cytokine levels in patients' serum were quantified by ELISA. Cell culture experiments were performed using THP-1 monocytic cells. Results ARBE treatment inhibited the expression of IFN-gamma-receptor 2 in human THP-1 monocytic cells. Colon biopsies of UC patients who responded to the 6-week long ARBE treatment revealed reduced amounts of the pro-inflammatory cytokines IFN-gamma and TNF-alpha. Levels of phosphorylated (activated) p65-NF-kappa B were reduced in these patients. Further, patients with successful ARBE treatment featured enhanced levels of Th17-cell specific cytokine IL-22 and immunoregulatory cytokine IL-10 as well as reduced serum levels of TNF-alpha and MCP-1, but enhanced levels of IL-17A, in contrast to patients that did not reach remission after ARBE treatment. Conclusions Our data suggest a molecular mechanism underlying the anti-inflammatory effects of ARBE treatment in UC patients by modulating T-cell cytokine signalling and inhibiting IFN-gamma signal transduction. These data are of particular interest, since ARBE is a promising therapeutic approach for the treatment of IBD.	[Roth, Sofia; Spalinger, Marianne R.; Gottier, Claudia; Biedermann, Luc; Zeitz, Jonas; Lang, Silvia; Rogler, Gerhard; Scharl, Michael] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Weber, Achim] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Rogler, Gerhard; Scharl, Michael] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Scharl, M (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.; Scharl, M (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.	michael.scharl@usz.ch	Biedermann, Luc/J-2654-2017	Scharl, Michael/0000-0002-6729-1469; Weber, Achim/0000-0003-0073-3637	Swiss National Science Foundation [314730-146204, CRSII3_154488/1]; Swiss IBD Cohort [3347CO-108792]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss IBD Cohort	This research was supported by research grants from the Swiss National Science Foundation to MS (Grant No. 314730-146204 and Grant No. CRSII3_154488/1) and the Swiss IBD Cohort (Grant No. 3347CO-108792) to GR. The funding institutions had no role in study design and data interpretation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bernstein CN, 2008, GUT, V57, P1185, DOI 10.1136/gut.2007.122143; Biedermann L, 2013, J CROHNS COLITIS, V7, P271, DOI 10.1016/j.crohns.2012.07.010; Blouin CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00267; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Braat H, 2003, EXPERT OPIN BIOL TH, V3, P725, DOI 10.1517/eobt.3.5.725.21237; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Chen JH, 2008, NUTR CANCER, V60, P43, DOI 10.1080/01635580802381279; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Coskun M, 2013, PHARMACOL RES, V76, P1, DOI 10.1016/j.phrs.2013.06.007; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Feagan BG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000544.pub3; Galvez Julio, 2014, ISRN Inflamm, V2014, P928461, DOI 10.1155/2014/928461; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Jennings A, 2012, AM J CLIN NUTR, V96, P781, DOI 10.3945/ajcn.112.042036; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; KUCHARZIK T, 1995, CLIN EXP IMMUNOL, V100, P452; Lindsay JO, 2001, ALIMENT PHARM THER, V15, P1709, DOI 10.1046/j.1365-2036.2001.01093.x; MacDonald TT, 2012, INFLAMM BOWEL DIS, V18, P2180, DOI 10.1002/ibd.22967; Mannon P, 2012, GUT, V61, P1765, DOI 10.1136/gutjnl-2012-303461; Marlow GJ, 2013, WORLD J GASTROENTERO, V19, P3931, DOI 10.3748/wjg.v19.i25.3931; Mauray A, 2010, GENES NUTR, V5, P343, DOI 10.1007/s12263-010-0171-0; Minaiyan M, 2011, IRAN J PHARM RES, V10, P97; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Olsen T, 2011, CYTOKINE, V56, P633, DOI 10.1016/j.cyto.2011.08.036; Osman N, 2008, DIGEST DIS SCI, V53, P2464, DOI 10.1007/s10620-007-0174-x; Piberger H, 2011, MOL NUTR FOOD RES, V55, P1724, DOI 10.1002/mnfr.201100380; Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912; Rismo R, 2012, SCAND J GASTROENTERO, V47, P538, DOI 10.3109/00365521.2012.667146; Rodriguez-Mateos A, 2014, ARCH TOXICOL, V88, P1803, DOI 10.1007/s00204-014-1330-7; Roth S, 2014, DIGESTION, V90, P179, DOI 10.1159/000366055; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Serra FCO, 2013, PLOS ONE, V8, P1, DOI [10.1371/journal.pone.0063915, 10.1371/journal.pone.0073001]; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Spalinger MR, 2013, GASTROENTEROLOGY, V144, P978, DOI 10.1053/j.gastro.2013.01.048; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Timmer A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub3; Triebel S, 2012, J AGR FOOD CHEM, V60, P8902, DOI 10.1021/jf3028842; Wachtel-Galor S., 2011, HERBAL MED BIOMOLECU, Vsecond, P1; Wang LK, 2014, INT J MOL SCI, V15, P16226, DOI 10.3390/ijms150916226; Wu LM, 2011, ELECTRON J QUAL THEO, P1, DOI 10.1007/978-3-642-20847-8_1; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002	50	48	50	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154817	10.1371/journal.pone.0154817	http://dx.doi.org/10.1371/journal.pone.0154817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152519	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000375677000039
J	Ye, ZK; Liu, Y; Cui, XL; Liu, LH				Ye, Zhi-Kang; Liu, Ying; Cui, Xiang-Li; Liu, Li-Hong			Critical Appraisal of the Quality of Clinical Practice Guidelines for Stress Ulcer Prophylaxis	PLOS ONE			English	Article							CONFLICTS-OF-INTEREST; ILL PATIENTS	Background and Objective Inappropriate use of stress ulcer prophylaxis (SUP) is common in many hospitals. High-quality clinical practice guidelines (CPGs) produce better patient outcomes and promote cost-effective clinical care. Thus, the objective of this study was to evaluate the quality of CPGs for SUP. Methods A search was conducted for SUP CPGs using PubMed, Embase, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature database (CBM), guideline web-sites and Google (until March 1, 2015). The quality of CPGs was independently assessed by two assessors using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument, and the specific recommendations in the CPGs were summarized and evaluated. Results A total of 7 CPGs for SUP were included. The highest median scores were in the clarity of presentation domain (89%), and the lowest median scores were in the editorial independence domain (0%). The rigor of development, stakeholder involvement, and applicability domains all scored below 40%. The specific recommendations for SUP varied, and the recommendations were inconsistent with the supporting evidence. Conclusions The overall quality of CPGs for SUP was relatively low, and no specific SUP CPG can be recommended. Not only should the AGREE II instrument be used to determine the quality of CPGs, but also the recommendations should be appraised based on supporting evidence, which would contribute to the development of high-quality CPGs.	[Ye, Zhi-Kang; Liu, Ying; Cui, Xiang-Li; Liu, Li-Hong] Capital Med Univ, Beijing Chao Yang Hosp, Dept Pharm, Beijing, Peoples R China	Capital Medical University	Liu, LH (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Pharm, Beijing, Peoples R China.	hongllh@126.com	liu, li/HGC-0900-2022					Alhazzani W, 2013, CRIT CARE MED, V41, P693, DOI 10.1097/CCM.0b013e3182758734; Alsultan Mohammed S, 2010, Saudi J Gastroenterol, V16, P275, DOI 10.4103/1319-3767.70614; [Anonymous], 2009, APPR GUID RES EV; Armstrong, 1999, AM J HEALTH-SYST PH, V56, P347, DOI DOI 10.1093/AJHP/56.4.347; Bez C, 2013, J EVAL CLIN PRACT, V19, P374, DOI 10.1111/j.1365-2753.2012.01838.x; Chen D, 2014, J YANGTZE U NAT SCI, V11, P21; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; Daley RJ, 2004, CRIT CARE MED, V32, P2008, DOI 10.1097/01.CCM.0000142398.73762.20; Eastern Association for the Surgery of Trauma, 2008, PRACT MAN GUID STRES; Grimshaw J, 1995, Qual Health Care, V4, P55, DOI 10.1136/qshc.4.1.55; Hahn DL, 2009, ANN FAM MED, V7, P364, DOI 10.1370/afm.995; Holmer HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058625; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Janicki T, 2007, J HOSP MED, V2, P86, DOI 10.1002/jhm.177; Khalili H, 2010, J MANAGE CARE PHARM, V16, P114, DOI 10.18553/jmcp.2010.16.2.114; Madsen KR, 2014, DAN MED J, V61; National Institute for Health and Clinical Excellence, 2012, GUID MAN; Neuman J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5621; Norris SL, 2012, J CLIN EPIDEMIOL, V65, P725, DOI 10.1016/j.jclinepi.2011.12.011; Norris SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025153; Orlando Regional Medical Center, 2011, STRESS ULC PROPH; Quenot JP, 2008, INTENS CARE MED, V34, P1393, DOI 10.1007/s00134-008-1059-y; Sheikh-Taha Marwan, 2012, World J Gastrointest Pharmacol Ther, V3, P93, DOI 10.4292/wjgpt.v3.i6.93; Tasaka CL, 2014, ANN PHARMACOTHER, V48, P462, DOI 10.1177/1060028013517088; Vanderbilt University Medical Center, 2005, GASTR STRESS ULC PRO; Wan H, 2014, STRAIT PHARM J, V26, P97; World Health Organization, 2014, WHO HDB GUID DEV, V2nd; Zeitoun Abeer, 2011, World J Gastrointest Pharmacol Ther, V2, P27, DOI 10.4292/wjgpt.v2.i4.27; 萧树东, 2002, [中华医学杂志, National Medical Journal of China], V82, P1000	29	22	24	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155020	10.1371/journal.pone.0155020	http://dx.doi.org/10.1371/journal.pone.0155020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152836	Green Published, gold, Green Submitted			2022-12-27	WOS:000375677000061
J	Allman, WR; Liu, LH; Coleman, AS; Akkoyunlu, M				Allman, Windy R.; Liu, Lunhua; Coleman, Adam S.; Akkoyunlu, Mustafa			MRL Strains Have a BAFFR Mutation without Functional Consequence	PLOS ONE			English	Article							FAMILY-MEMBER BIM; B-CELLS; SYSTEMIC AUTOIMMUNITY; DISEASE-ACTIVITY; TACI EXPRESSION; MESSENGER-RNA; IPR GENE; RECEPTOR; MICE; SURVIVAL	It has been shown that B cell activating factor receptor (BAFFR) is critical for B cell development and survival. In this study, we sought to evaluate the expression and function of BAFFR across multiple stains of mice that vary in their potential to develop systemic autoimmune disease. The inability of a commercial antibody to bind to BAFFR in the autoimmune prone mouse strains, MRL and MRL/Lpr led to the discovery of a mutation in TNFRSF13C gene (encoding BAFFR) that resulted in a Pro44Ser substitution in the N-terminus near the BAFF binding site in these strains. To define the biological consequences of mutant BAFFR, we compared the expression and activity of BAFFR in MRL and MRL/Lpr mice to BALB/c, which express the consensus version of TNFRSF13C. B cells from MRL and MRL/Lpr mice expressed mutant BAFFR on surface and were capable of responding to BAFF as exhibited by BAFF-mediated reduction in apoptosis and NF-kappa B2 activation. Signaling through MAPK ERK1/2 was not significantly induced by BAFF in MRL/Lpr mice; however, MAPK ERK1/2 signaling was intact in MRL mice. The inability of MRL/Lpr B cells to significantly activate ERK1/2 in response to BAFF was due to the high basal activity of the signaling pathway in these cells. In fact, basal activity of ERK1/2 in B cells correlated with the degree of autoimmune susceptibility exhibited by each strain. In addition, aged MRL/Lpr mice with severe autoimmune disease had high BAFF levels, low surface BAFFR, and high basal NF-kappa B2 activation, a pattern which is attributed to the high frequency of antibody secreting cells. We conclude that P44S BAFFR mutation does not hinder BAFFR function or enhance B cell activity in MRL/Lpr and MRL mice and that other susceptibility loci on the MRL background contributed to the hyperactivity of these cells.	[Allman, Windy R.; Liu, Lunhua; Coleman, Adam S.; Akkoyunlu, Mustafa] US FDA, Lab Bacterial Polysaccharides, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Akkoyunlu, M (corresponding author), US FDA, Lab Bacterial Polysaccharides, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Mustafa.Akkoyunlu@fda.hhs.gov	Akkoyunlu, Mustafa/I-5712-2012; Akkoyunlu, Mustafa/ABC-9013-2020	Akkoyunlu, Mustafa/0000-0001-9958-4031	Office of Women's Health, US Food and Drug Administration; Oak Ridge Institute for Science and Education (Oak Ridge, TN)	Office of Women's Health, US Food and Drug Administration; Oak Ridge Institute for Science and Education (Oak Ridge, TN)	This work was supported by funds from the Office of Women's Health, US Food and Drug Administration. W.R.A. and A.S.C. were supported by postdoctoral fellowships from the Oak Ridge Institute for Science and Education (Oak Ridge, TN).	Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; CHU JL, 1993, J EXP MED, V178, P723, DOI 10.1084/jem.178.2.723; Chu VT, 2009, ARTHRITIS RHEUM-US, V60, P2083, DOI 10.1002/art.24628; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Cohen Philip L, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1520s52; Craxton A, 2005, J EXP MED, V202, P1363, DOI 10.1084/jem.20051283; Darce JR, 2007, J IMMUNOL, V179, P7276, DOI 10.4049/jimmunol.179.11.7276; Davidson A, 2010, CURR OPIN IMMUNOL, V22, P732, DOI 10.1016/j.coi.2010.09.010; Deng Y, 2014, CURR OPIN RHEUMATOL, V26, P482, DOI 10.1097/BOR.0000000000000086; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Harless SM, 2001, CURR BIOL, V11, P1986, DOI 10.1016/S0960-9822(01)00598-X; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; IZUI S, 1984, J IMMUNOL, V133, P227; Jacob CO, 2013, ARTHRITIS RHEUM-US, V65, P1043, DOI 10.1002/art.37846; Ju SQ, 2006, CLIN BIOCHEM, V39, P1131, DOI 10.1016/j.clinbiochem.2006.09.010; Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976; Kanswal S, 2011, J IMMUNOL, V186, P2430, DOI 10.4049/jimmunol.1002976; Katsenelson N, 2007, EUR J IMMUNOL, V37, P1785, DOI 10.1002/eji.200636800; KELLEY VE, 1985, CLIN IMMUNOL IMMUNOP, V37, P220, DOI 10.1016/0090-1229(85)90153-9; Kim HM, 2003, NAT STRUCT BIOL, V10, P342, DOI 10.1038/nsb925; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mayne CG, 2008, EUR J IMMUNOL, V38, P587, DOI 10.1002/eji.200737817; Mayne CG, 2009, EUR J IMMUNOL, V39, P589, DOI 10.1002/eji.200838569; Milner JD, 2015, BLOOD, V125, P591, DOI 10.1182/blood-2014-09-602763; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Nijnik A, 2006, INT IMMUNOL, V18, P1127, DOI 10.1093/intimm/dxl047; Otipoby KL, 2008, P NATL ACAD SCI USA, V105, P12435, DOI 10.1073/pnas.0805460105; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; PISETSKY DS, 1982, J IMMUNOL, V128, P2322; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Rauch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005456; Rowland SL, 2010, J IMMUNOL, V185, P4570, DOI 10.4049/jimmunol.1001708; Santiago-Raber ML, 2004, AUTOIMMUN REV, V3, P33, DOI 10.1016/S1568-9972(03)00062-4; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015; Sellam J, 2007, ANN RHEUM DIS, V66, P790, DOI 10.1136/ard.2006.065656; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Uslu K, 2014, J IMMUNOL, V192, P3582, DOI 10.4049/jimmunol.1203468; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wither JE, 2000, CLIN IMMUNOL, V94, P51, DOI 10.1006/clim.1999.4806; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018; Zhao LD, 2010, LUPUS, V19, P1534, DOI 10.1177/0961203310375268	53	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154518	10.1371/journal.pone.0154518	http://dx.doi.org/10.1371/journal.pone.0154518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149280	Green Published, gold			2022-12-27	WOS:000375676800037
J	Dillon, CB; Fitzgerald, AP; Kearney, PM; Perry, IJ; Rennie, KL; Kozarski, R; Phillips, CM				Dillon, Christina B.; Fitzgerald, Anthony P.; Kearney, Patricia M.; Perry, Ivan J.; Rennie, Kirsten L.; Kozarski, Robert; Phillips, Catherine M.			Number of Days Required to Estimate Habitual Activity Using Wrist-Worn GENEActiv Accelerometer: A Cross-Sectional Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACTIVITY PATTERNS; NORMAL-WEIGHT; PEDOMETER; PREDICT; VARIABILITY; OVERWEIGHT	Introduction Objective methods like accelerometers are feasible for large studies and may quantify variability in day-to-day physical activity better than self-report. The variability between days suggests that day of the week cannot be ignored in the design and analysis of physical activity studies. The purpose of this paper is to investigate the optimal number of days needed to obtain reliable estimates of weekly habitual physical activity using the wrist-worn GENEActiv accelerometer. Methods Data are from a subsample of the Mitchelstown cohort; 475 (44.6% males; mean aged 59.6 +/- 5.5 years) middle-aged Irish adults. Participants wore the wrist GENEActiv accelerometer for 7-consecutive days. Data were collected at 100Hz and summarised into a signal magnitude vector using 60s epochs. Each time interval was categorised according to intensity based on validated cut-offs. Spearman pairwise correlations determined the association between days of the week. Repeated measures ANOVA examined differences in average minutes across days. Intraclass correlations examined the proportion of variability between days, and Spearman-Brown formula estimated intra-class reliability coefficient associated with combinations of 1-7 days. Results Three hundred and ninety-seven adults (59.7 +/- 5.5yrs) had valid accelerometer data. Overall, men were most sedentary on weekends while women spent more time in sedentary behaviour on Sunday through Tuesday. Post hoc analysis found sedentary behaviour and light activity levels on Sunday to differ to all other days in the week. Analysis revealed greater than 1 day monitoring is necessary to achieve acceptable reliability. Monitoring frame duration for reliable estimates varied across intensity categories, (sedentary (3 days), light (2 days), moderate (2 days) and vigorous activity (6 days) and MVPA (2 days)). Conclusion These findings provide knowledge into the behavioural variability in weekly activity patterns of middle-aged adults. Since Sunday differed from all other days in the week this suggests that day of the week cannot be overlooked in the design and analysis of physical activity studies and thus should be included in the study monitoring frames. Collectively our data suggest that six days monitoring, inclusive of Saturday and Sunday, are needed to reliably capture weekly habitual activity in all activity intensities using the wrist-worn GENEActiv accelerometer.	[Dillon, Christina B.; Perry, Ivan J.; Phillips, Catherine M.] Natl Univ Ireland Univ Coll Cork, HRB Ctr Diet & Hlth Res, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Fitzgerald, Anthony P.; Kearney, Patricia M.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Western Gateway Bldg,Western Rd, Cork, Ireland; [Fitzgerald, Anthony P.] Natl Univ Ireland Univ Coll Cork, Dept Stat, Western Gateway Bldg,Western Rd, Cork, Ireland; [Rennie, Kirsten L.; Kozarski, Robert] Univ Hertfordshire, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England	Health Research Board - Ireland; University College Cork; University College Cork; University College Cork; University of Hertfordshire	Dillon, CB (corresponding author), Natl Univ Ireland Univ Coll Cork, HRB Ctr Diet & Hlth Res, Dept Epidemiol & Publ Hlth, Cork, Ireland.	c.dillon@ucc.ie	Fitzgerald, Tony/AAB-5331-2020; Kearney, Patricia M/AAE-8501-2020	Perry, Ivan/0000-0002-4965-9792; Kearney, Patricia/0000-0001-9599-3540; Phillips, Catherine/0000-0003-4916-4463; Fitzgerald, Tony/0000-0001-6437-5686	Health Research Board, Ireland [HRC/2007/13]	Health Research Board, Ireland	Authors acknowledge the Health Research Board, Ireland (reference HRC/2007/13) for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowski T, 2008, MED SCI SPORT EXER, V40, pS544, DOI 10.1249/MSS.0b013e31817c6651; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Clemes SA, 2007, INT J OBESITY, V31, P261, DOI 10.1038/sj.ijo.0803420; Clemes SA, 2008, MED SCI SPORT EXER, V40, P1589, DOI 10.1249/MSS.0b013e318177eb96; Clemes SA, 2008, PREV MED, V46, P325, DOI 10.1016/j.ypmed.2007.11.013; Ellis K, 2015, MED SCI SPORTS EXERC; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Fairclough SJ, 2015, MED SCI SPORTS EXERC; GRETEBECK RJ, 1992, MED SCI SPORT EXER, V24, P1167; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Kang MS, 2012, J PHYS ACT HEALTH, V9, P336, DOI 10.1123/jpah.9.3.336; Kang M, 2009, RES Q EXERCISE SPORT, V80, P131, DOI 10.1080/02701367.2009.10599546; Kearney PM, 2013, INT J EPIDEMIOL, V42, P1253, DOI 10.1093/ije/dys131; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Schaefer SE, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130262; Scheers T, 2012, EUR J APPL PHYSIOL, V112, P1653, DOI 10.1007/s00421-011-2131-9; Snedecor G.W., 1989, AMES IOWA STATE U PR; Togo F, 2008, MED SCI SPORT EXER, V40, P1058, DOI 10.1249/MSS.0b013e318167469a; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Tudor-Locke C, 2004, ANN BEHAV MED, V28, P158, DOI 10.1207/s15324796abm2803_3; van Hees VT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022922	24	69	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0109913	10.1371/journal.pone.0109913	http://dx.doi.org/10.1371/journal.pone.0109913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149674	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800001
J	Holmes, AP; Yu, TY; Tull, S; Syeda, F; Kuhlmann, SM; O'Brien, SM; Patel, P; Brain, KL; Pavlovic, D; Brown, NA; Fabritz, L; Kirchhof, P				Holmes, Andrew P.; Yu, Ting Y.; Tull, Samantha; Syeda, Fahima; Kuhlmann, Stefan M.; O'Brien, Sian-Marie; Patel, Pushpa; Brain, Keith L.; Pavlovic, Davor; Brown, Nigel A.; Fabritz, Larissa; Kirchhof, Paulus			A Regional Reduction in I-to and I-KACh in the Murine Posterior Left Atrial Myocardium Is Associated with Action Potential Prolongation and Increased Ectopic Activity	PLOS ONE			English	Article							PULMONARY VEIN; CATHETER ABLATION; CANINE RIGHT; FIBRILLATION; MECHANISM; REPOLARIZATION; HETEROGENEITY; CONDUCTION; K+; ARRHYTHMOGENESIS	Background The left atrial posterior wall (LAPW) is potentially an important area for the development and maintenance of atrial fibrillation. We assessed whether there are regional electrical differences throughout the murine left atrial myocardium that could underlie regional differences in arrhythmia susceptibility. Methods We used high-resolution optical mapping and sharp microelectrode recordings to quantify regional differences in electrical activation and repolarisation within the intact, superfused murine left atrium and quantified regional ion channel mRNA expression by Taqman Low Density Array. We also performed selected cellular electrophysiology experiments to validate regional differences in ion channel function. Results Spontaneous ectopic activity was observed during sustained 1Hz pacing in 10/19 intact LA and this was abolished following resection of LAPW (0/19 resected LA, P<0.001). The source of the ectopic activity was the LAPW myocardium, distinct from the pulmonary vein sleeve and LAA, determined by optical mapping. Overall, LAPW action potentials (APs) were ca. 40% longer than the LAA and this region displayed more APD heterogeneity. mRNA expression of Kcna4, Kcnj3 and Kcnj5 was lower in the LAPW myocardium than in the LAA. Cardiomyocytes isolated from the LAPW had decreased I-to and a reduced I-KACh current density at both positive and negative test potentials. Conclusions The murine LAPW myocardium has a different electrical phenotype and ion channel mRNA expression profile compared with other regions of the LA, and this is associated with increased ectopic activity. If similar regional electrical differences are present in the human LA, then the LAPW may be a potential future target for treatment of atrial fibrillation.	[Holmes, Andrew P.; Yu, Ting Y.; Tull, Samantha; Syeda, Fahima; Kuhlmann, Stefan M.; O'Brien, Sian-Marie; Patel, Pushpa; Brain, Keith L.; Pavlovic, Davor; Fabritz, Larissa; Kirchhof, Paulus] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Yu, Ting Y.] Univ Birmingham, Coll Engn Phys Sci, Phys Sci Imaging Biomed Sci, Sch Chem, Birmingham, W Midlands, England; [Brown, Nigel A.] Univ London, London, England; [Fabritz, Larissa; Kirchhof, Paulus] Hosp Univ Munster, Dept Cardiovasc Med, Munster, Germany; [Fabritz, Larissa; Kirchhof, Paulus] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Kirchhof, Paulus] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of London; University of Munster; University of Birmingham	Fabritz, L (corresponding author), Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England.; Fabritz, L (corresponding author), Hosp Univ Munster, Dept Cardiovasc Med, Munster, Germany.; Fabritz, L (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England.	l.fabritz@bham.ac.uk	tull, samantha p/A-9825-2013; Brain, Keith L./AFU-7168-2022; Kirchhof, Paulus/AAT-7074-2021	Brain, Keith L./0000-0002-0906-7012; Kirchhof, Paulus/0000-0002-1881-0197; Holmes, Andrew/0000-0001-9270-9401; Tull, Samantha/0000-0001-9337-4690; Fabritz, Larissa/0000-0002-9241-1733	European Union [EUTRAF 251057, CATCH ME 633193]; British Heart Foundation [FS/13/43/30324]; Leducq Foundation; Boehringer Ingelheim Fonds MD student fellowship; MRC [MC_PC_14107] Funding Source: UKRI; Medical Research Council [MC_PC_14107] Funding Source: researchfish	European Union(European Commission); British Heart Foundation(British Heart Foundation); Leducq Foundation(Leducq Foundation); Boehringer Ingelheim Fonds MD student fellowship(Boehringer Ingelheim); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by European Union (EUTRAF 251057), (CATCH ME 633193), British Heart Foundation (FS/13/43/30324), and Leducq Foundation. S.K. was supported by a Boehringer Ingelheim Fonds MD student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Arora R, 2007, J AM COLL CARDIOL, V49, P1340, DOI 10.1016/j.jacc.2006.10.075; Bingen BO, 2013, CIRCULATION, V128, P2732, DOI 10.1161/CIRCULATIONAHA.113.005019; Burashnikov A, 2004, AM J PHYSIOL-HEART C, V286, pH2393, DOI 10.1152/ajpheart.01242.2003; Dominguez JN, 2012, CIRC RES, V111, P1323, DOI 10.1161/CIRCRESAHA.112.271247; Egorov YV, 2015, J CARDIOVASC ELECTR, V26, P1130, DOI 10.1111/jce.12738; Feng JL, 1998, CIRC RES, V83, P541, DOI 10.1161/01.RES.83.5.541; Galli D, 2008, DEVELOPMENT, V135, P1157, DOI 10.1242/dev.014563; Gong DM, 2008, CELL PHYSIOL BIOCHEM, V21, P385, DOI 10.1159/000129631; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Jalife J, 2002, CARDIOVASC RES, V54, P204, DOI 10.1016/S0008-6363(02)00223-7; Kumagai K, 2004, J AM COLL CARDIOL, V43, P2281, DOI 10.1016/j.jacc.2004.01.051; Li DS, 2001, CIRC RES, V88, P1168, DOI 10.1161/hh1101.091266; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; Lin XM, 2015, J PHYSIOL-LONDON, V593, P1389, DOI 10.1113/jphysiol.2014.277699; Lomax AE, 2003, BRIT J PHARMACOL, V140, P576, DOI 10.1038/sj.bjp.0705474; Miyauchi Y, 2005, HEART RHYTHM, V2, P1339, DOI 10.1016/j.hrthm.2005.09.015; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Nygren A, 2004, AM J PHYSIOL-HEART C, V287, pH2634, DOI 10.1152/ajpheart.00380.2004; Patterson E, 2006, J AM COLL CARDIOL, V47, P1196, DOI 10.1016/j.jacc.2005.12.023; Ravens U, 2011, CARDIOVASC RES, V89, P776, DOI 10.1093/cvr/cvq398; Ridler ME, 2011, CAN J CARDIOL, V27, P112, DOI 10.1016/j.cjca.2010.12.002; Sanders P, 2005, CIRCULATION, V112, P789, DOI 10.1161/CIRCULATIONAHA.104.517011; Sanders P, 2004, J CARDIOVASC ELECTR, V15, P364, DOI 10.1046/j.1540-8167.2004.03300.x; SPACH MS, 1989, CIRC RES, V65, P1612, DOI 10.1161/01.RES.65.6.1612; Vigmond EJ, 2004, HEART RHYTHM, V1, P334, DOI 10.1016/j.hrthm.2004.03.077; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Walters TE, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1189, DOI 10.1161/CIRCEP.114.001894; Webb S, 2001, CARDIOL YOUNG, V11, P632, DOI 10.1017/S1047951101000993; Yamada M, 2002, J PHARMACOL EXP THER, V300, P681, DOI 10.1124/jpet.300.2.681; Yu TY, 2014, PROG BIOPHYS MOL BIO, V115, P340, DOI 10.1016/j.pbiomolbio.2014.07.012; Yuan L, 2014, AM J PHYSIOL-HEART C, V306, pH1204, DOI 10.1152/ajpheart.00405.2013	32	22	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154077	10.1371/journal.pone.0154077	http://dx.doi.org/10.1371/journal.pone.0154077			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149380	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000375676800018
J	Zhang, HB; Plutzky, J; Shubina, M; Turchin, A				Zhang, Huabing; Plutzky, Jorge; Shubina, Maria; Turchin, Alexander			Drivers of the Sex Disparity in Statin Therapy in Patients with Coronary Artery Disease: A Cohort Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; LIPID-LOWERING THERAPY; HEART-DISEASE; SECONDARY PREVENTION; GENDER DISPARITIES; ELDERLY-PATIENTS; CARE; MANAGEMENT; ADHERENCE; WOMEN	Background Women are less likely to be prescribed statins than men. Existing reports explain only a fraction of this difference. We conducted a study to identify factors that account for sex differences in statin therapy among patients with coronary artery disease (CAD). Methods and Results We retrospectively studied 24,338 patients with CAD who were followed for at least a year between 2000 and 2011 at two academic medical centers. Women (9,006 / 37% of study patients) were less likely to either have initiated statin therapy (81.9% women vs. 87.7% men) or to have persistent statin therapy at the end of follow-up (67.0% women vs. 71.4% men). Women were older (72.9 vs. 68.4 years), less likely to have ever smoked (49.8% vs. 65.6%), less likely to have been evaluated by a cardiologist (57.5% vs. 64.5%) and more likely to have reported an adverse reaction to a statin (27.1% vs. 21.7%) (p < 0.0001 for all). In multivariable analysis, patients with history of smoking (OR 1.094; p 0.017), younger age (OR 1.013 /year), cardiologist evaluation (OR 1.337) and no reported adverse reactions to statins (OR 1.410) were more likely (p < 0.0001 for all) to have persistent statin therapy. Together, these four factors accounted for 90.4% of the sex disparity in persistent statin therapy. Conclusions Several specific factors appear to underlie divergent statin therapy in women vs. men. Identifying such drivers may facilitate programmatic interventions and stimulate further research to overcome sex differences in applying proven interventions for cardiovascular risk reduction.	[Zhang, Huabing] Chinese Acad Med Sci, Dept Endocrinol, Key Lab Endocrinol, Minist Hlth,Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Plutzky, Jorge; Turchin, Alexander] Harvard Univ, Sch Med, Boston, MA USA; [Plutzky, Jorge; Shubina, Maria; Turchin, Alexander] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Turchin, Alexander] Harvard Clin Res Inst, Boston, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Turchin, A (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Turchin, A (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Turchin, A (corresponding author), Harvard Clin Res Inst, Boston, MA USA.	aturchin@partners.org	Zhang, Huabing/ABD-6216-2020; Plutzky, Jorge/V-3410-2019	Zhang, Huabing/0000-0001-6259-7584; 	National Library of Medicine [5RC1LM010460]; Chinese National Key Program of Clinical Science [WBYZ2011873]; Peking Union Medical College Hospital [pumch-2013-060]; National Natural Science Foundation of China [NSFC71432004]; Brigham and Women's Hospital Linda Joy Pollin Women's Heart Center	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Chinese National Key Program of Clinical Science; Peking Union Medical College Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Brigham and Women's Hospital Linda Joy Pollin Women's Heart Center	AT: National Library of Medicine (5RC1LM010460). http://www.nlm.nih.gov. HZ: Chinese National Key Program of Clinical Science (WBYZ2011873), http://www.nhfpc.gov.cn. HZ: Young Scientific Research Fund of Peking Union Medical College Hospital (pumch-2013-060), http://www.pumch.cn/. HZ: National Natural Science Foundation of China (NSFC71432004), http://www.nsfc.gov.cn. JP: Brigham and Women's Hospital Linda Joy Pollin Women's Heart Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afilalo J, 2008, J AM COLL CARDIOL, V51, P37, DOI 10.1016/j.jacc.2007.06.063; Arnold SV, 2011, CIRCULATION, V124, P2405, DOI 10.1161/CIRCULATIONAHA.111.038265; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bhattacharjee S, 2012, DRUG AGING, V29, P971, DOI 10.1007/s40266-012-0032-1; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Buettner C, 2008, J GEN INTERN MED, V23, P1182, DOI 10.1007/s11606-008-0636-7; Chen CY, 2014, J ATHEROSCLER THROMB, V21, pS20; Chokshi NP, 2012, AM J CARDIOL, V110, P1477, DOI 10.1016/j.amjcard.2012.06.058; Cook NL, 2009, CIRCULATION, V119, P2463, DOI 10.1161/CIRCULATIONAHA.108.825133; Driscoll A, 2011, INTERN MED J, V41, P730, DOI 10.1111/j.1445-5994.2011.02534.x; Efron B, 1993, INTRODUCTION TO THE; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Ferrara A, 2008, DIABETES CARE, V31, P69, DOI 10.2337/dc07-1244; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Frey P, 2011, AM J CARDIOL, V107, P145, DOI 10.1016/j.amjcard.2010.09.006; Gholizadeh L, 2008, HEALTH CARE WOMEN IN, V29, P3, DOI 10.1080/07399330701723756; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Gouni-Berthold I, 2008, DIABETES CARE, V31, P1389, DOI 10.2337/dc08-0194; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gutierrez J, 2012, ARCH INTERN MED, V172, P909, DOI 10.1001/archinternmed.2012.2145; Hippisley-Cox J, 2010, HEART, V96, P939, DOI 10.1136/hrt.2010.199034; Ho PM, 2004, J AM COLL CARDIOL, V43, P1517, DOI 10.1016/j.jacc.2003.12.037; Hochberg Y, 1988, A SHARPER BONFERRONI, P800; Johansen ME, 2014, ANN FAM MED, V12, P215, DOI 10.1370/afm.1641; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Kostis WJ, 2012, J AM COLL CARDIOL, V59, P572, DOI 10.1016/j.jacc.2011.09.067; Lewey J, 2013, AM HEART J, V165, P665, DOI 10.1016/j.ahj.2013.02.011; Lewis WR, 2009, CIRC-CARDIOVASC QUAL, V2, P633, DOI 10.1161/CIRCOUTCOMES.108.824763; Ma J, 2005, PLOS MED, V2, P434, DOI 10.1371/journal.pmed.0020123; McAlister FA, 2007, QUAL SAF HEALTH CARE, V16, P6, DOI 10.1136/qshc.2006.018648; Metz CNB, 2006, J AM COLL CARDIOL, V47, p21S, DOI 10.1016/j.jacc.2004.12.084; Mills EJ, 2011, QJM-INT J MED, V104, P109, DOI 10.1093/qjmed/hcq165; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Morrell J, 2011, EUR J CARDIOV PREV R, V18, P270, DOI 10.1097/HJR.0b013e32833cca34; Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Murphy NF, 2006, HEART, V92, P1047, DOI 10.1136/hrt.2005.069419; Naicker K, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-123; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Rothman KJ, 2012, EPIDEMIOLOGY INTRO, V2; Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Skentzos Stephen, 2011, AMIA Annu Symp Proc, V2011, P1270; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor F, 2012, ARCH INTERN MED, V172, P919, DOI 10.1001/archinternmed.2012.2434; Victor BM, 2014, AM J CARDIOL, V113, P1611, DOI 10.1016/j.amjcard.2014.02.018; Vimalananda VG, 2013, J GEN INTERN MED, V28, pS529, DOI 10.1007/s11606-013-2340-5; Vimalananda VG, 2011, WOMEN HEALTH ISS, V21, pS176, DOI 10.1016/j.whi.2011.04.009; Virani SS, 2015, AM J CARDIOL, V115, P21, DOI 10.1016/j.amjcard.2014.09.041; Vulic D, 2010, AM J CARDIOVASC DRUG, V10, P109, DOI 10.2165/11535240-000000000-00000; Wenger NK, 2008, HEART, V94, P434, DOI 10.1136/hrt.2007.122325; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	57	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155228	10.1371/journal.pone.0155228	http://dx.doi.org/10.1371/journal.pone.0155228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148965	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800124
J	Abukres, SH; Hoti, K; Hughes, JD				Abukres, Salem Hasn; Hoti, Kreshnik; Hughes, Jeffery David			Avoiding Treatment Interruptions: What Role Do Australian Community Pharmacists Play?	PLOS ONE			English	Article							WESTERN-AUSTRALIA; GENERAL-PRACTICE; ATTITUDES; VIGNETTES; IMPACT; CHART; CARE	Objective To explore the reported practice of Australian community pharmacists when dealing with medication supply requests in absence of a valid prescription. Methods Self-administered questionnaire was posted to 1490 randomly selected community pharmacies across all Australian states and territories. This sample was estimated to be a 20% of all Australian community pharmacies. Results Three hundred eighty five pharmacists participated in the study (response rate achieved was 27.9% (there were 111 undelivered questionnaires). Respondents indicated that they were more likely to provide medications to regular customers without a valid prescription compared to non-regular customers (p<0.0001). However, supply was also influenced by the type of prescription and the medication requested. In the case of type of prescription (Standard, Authority or Private) this relates to the complexity/probability of obtaining a valid prescription from the prescriber at a later date (i.e. supply with an anticipated prescription). Decisions to supply and/or not supply related to medication type were more complex. For some cases, including medication with potential for abuse, the practice and/or the method of supply varied significantly according to age and gender of the pharmacist, and pharmacy location (p<0.05). Conclusions Although being a regular customer does not guarantee a supply, results of this study reinforce the importance for patients having a regular pharmacy, where pharmacists were more likely to continue medication supply in cases of patients presenting without a valid prescription. We would suggest, more flexible legislation should be implemented to allow pharmacists to continue supplying of medication when obtaining a prescription is not practical.	[Abukres, Salem Hasn; Hoti, Kreshnik; Hughes, Jeffery David] Curtin Univ, Sch Pharm, Perth, WA 6845, Australia; [Hoti, Kreshnik] Univ Prishtina, Fac Med, Dept Pharm, Prishtina, Kosovo, Serbia	Curtin University; Universiteti i Prishtines	Hoti, K (corresponding author), Curtin Univ, Sch Pharm, Perth, WA 6845, Australia.; Hoti, K (corresponding author), Univ Prishtina, Fac Med, Dept Pharm, Prishtina, Kosovo, Serbia.	kreshnik.hoti@uni-pr.edu	Hoti, Kreshnik/AAA-4562-2021					Abu-Omar SM, 2000, INT J PHARM PRACT, V8, P135, DOI DOI 10.1111/J.2042-7174.2000.TB00998.X; Abukres SH, 2015, PEERJ, V3, DOI 10.7717/peerj.924; Abukres SH, 2014, PATIENT PREFER ADHER, V8, P1143, DOI 10.2147/PPA.S66719; Australian Government Department of Health, 2014, SUPPL MED WHAT PHARM; Australian Government Department of Health, 2015, 2 PRESCR MED INF PBS; Australian Government Department of Health, 2015, PBS FREQ ASK QUEST; Australian Government Department of Health, 2015, PBS COP SAF NET AM 2; Australian Institute of Health and Welfare, 2016, RUR REM METR AR RRMA; Barbero-Gonzalez A, 2006, Aten Primaria, V37, P78, DOI 10.1157/13084485; Bessell T, IMPROVING AUSTR ACCE; Cates ME, 2005, ANN PHARMACOTHER, V39, P1450, DOI 10.1345/aph.1G009; Evans SC, 2015, INT J CLIN HLTH PSYC, V15, P160, DOI 10.1016/j.ijchp.2014.12.001; Garth B, 2014, AUST FAM PHYSICIAN, V43, P404; Hamrosi KK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-183; Health Workforce Australia, 2014, HLTH WORKF AUSTR PHA; Hoti K, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-25; Hoti Kreshnik, 2011, Int J Pharm Pract, V19, P5, DOI 10.1111/j.2042-7174.2010.00077.x; Hoti K, 2010, PHARM WORLD SCI, V32, P610, DOI 10.1007/s11096-010-9400-2; Hynd A, 2009, AUST NZ J PUBL HEAL, V33, P246, DOI 10.1111/j.1753-6405.2009.00383.x; Kahan M, 2011, CAN FAM PHYSICIAN, V57, pE448; Law Michael R, 2012, Can Pharm J (Ott), V145, P17, DOI 10.3821/1913-701X-145.1.17; Monheit B, 2010, AUST FAM PHYSICIAN, V39, P540; Morecroft C, 2014, EVALUATION ROLE COMM; Morrison RS, 2000, NEW ENGL J MED, V342, P1023, DOI 10.1056/NEJM200004063421406; Murray M, 2000, Fam Pract Manag, V7, P45; NHS Direct Wales, 2015, PHARM FREQ ASK QUEST; Ong AD, 2000, J APPL SOC PSYCHOL, V30, P1691, DOI 10.1111/j.1559-1816.2000.tb02462.x; Parliament of Victoria, 2014, INQ COMM PHARM VICT; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Puspitasari HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113337; Rutten GMJ, 2006, J EVAL CLIN PRACT, V12, P491, DOI 10.1111/j.1365-2753.2006.00699.x; Sampson F, 2008, BRIT J GEN PRACT, V58, P641, DOI 10.3399/bjgp08X330780; Scott A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-126; Sinnott SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064914; Smith JD, 2013, RURAL REMOTE HEALTH, V13; Starkweather J., 2011, MULTINOMIAL LOGISTIC; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481	37	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154992	10.1371/journal.pone.0154992	http://dx.doi.org/10.1371/journal.pone.0154992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27170997	Green Published, gold			2022-12-27	WOS:000376588600019
J	Duan, ZF; Niedziela, T; Lugowski, C; Cao, BY; Wang, TW; Xu, LL; Yang, BP; Liu, B; Wang, L				Duan, Zhifeng; Niedziela, Tomasz; Lugowski, Czeslaw; Cao, Boyang; Wang, Tianwei; Xu, Lingling; Yang, Baopeng; Liu, Bin; Wang, Lei			Genetic Diversity of O-Antigens in Hafnia alvei and the Development of a Suspension Array for Serotype Detection	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE; POLYSACCHARIDE; ESCHERICHIA; SHIGELLA	Hafnia alvei is a facultative and rod-shaped gram-negative bacterium that belongs to the Enterobacteriaceae family. Although it has been more than 50 years since the genus was identified, very little is known about variations among Hafnia species. Diversity in O-antigens (O-polysaccharide, OPS) is thought to be a major factor in bacterial adaptation to different hosts and situations and variability in the environment. Antigenic variation is also an important factor in pathogenicity that has been used to define clones within a number of species. The genes that are required to synthesize OPS are always clustered within the bacterial chromosome. A serotyping scheme including 39 O-serotypes has been proposed for H. alvei, but it has not been correlated with known OPS structures, and no previous report has described the genetic features of OPS. In this study, we obtained the genome sequences of 21 H. alvei strains (as defined by previous immunochemical studies) with different lipopolysaccharides. This is the first study to show that the O-antigen gene cluster in H. alvei is located between mpo and gnd in the chromosome. All 21 of the OPS gene clusters contain both the wzx gene and the wzy gene and display a large number of polymorphisms. We developed an O serotype-specific wzy-based suspension array to detect all 21 of the distinct OPS forms we identified in H. alvei. To the best of our knowledge, this is the first report to identify the genetic features of H. alvei antigenic variation and to develop a molecular technique to identify and classify different serotypes.	[Duan, Zhifeng; Cao, Boyang; Wang, Tianwei; Xu, Lingling; Yang, Baopeng; Liu, Bin; Wang, Lei] Nankai Univ, TEDA Coll, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China; [Duan, Zhifeng; Cao, Boyang; Wang, Tianwei; Xu, Lingling; Yang, Baopeng; Liu, Bin; Wang, Lei] Nankai Univ, TEDA Inst Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Duan, Zhifeng; Cao, Boyang; Wang, Tianwei; Xu, Lingling; Yang, Baopeng; Liu, Bin; Wang, Lei] Nankai Univ, TEDA Coll, Tianjin Res Ctr Funct Genom & Biochips, Tianjin 300071, Peoples R China; [Duan, Zhifeng; Cao, Boyang; Wang, Tianwei; Xu, Lingling; Yang, Baopeng; Liu, Bin; Wang, Lei] Nankai Univ, TEDA Coll, Tianjin Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China; [Niedziela, Tomasz; Lugowski, Czeslaw] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland; [Lugowski, Czeslaw] Univ Opole, Dept Biotechnol & Mol Biol, Opole, Poland	Nankai University; Nankai University; Nankai University; Nankai University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; University of Opole	Wang, L (corresponding author), Nankai Univ, TEDA Coll, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China.; Wang, L (corresponding author), Nankai Univ, TEDA Inst Biol Sci & Biotechnol, Tianjin 300071, Peoples R China.; Wang, L (corresponding author), Nankai Univ, TEDA Coll, Tianjin Res Ctr Funct Genom & Biochips, Tianjin 300071, Peoples R China.; Wang, L (corresponding author), Nankai Univ, TEDA Coll, Tianjin Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China.	wanglei@nankai.edu.cn	Wang, Lei/C-5176-2009	Wang, Lei/0000-0003-4427-0881; Lugowski, Czeslaw/0000-0002-2336-0530; Niedziela, Tomasz/0000-0002-9333-3175	National Key Program for Infectious Diseases of China [2013ZX10004216-001-001, 2013ZX10004221]; National 973 Program of China [2013CB733904, 2012CB721101, 2012CB721001]; International Science & Technology Cooperation Program of China [2013DFR30640]; National Science Foundation of China (NSFC) Program [31030002, 31371259, 31270133]	National Key Program for Infectious Diseases of China; National 973 Program of China(National Basic Research Program of China); International Science & Technology Cooperation Program of China; National Science Foundation of China (NSFC) Program	This work was supported by the National Key Program for Infectious Diseases of China (2013ZX10004216-001-001 and 2013ZX10004221), a National 973 Program of China Grant (2013CB733904, 2012CB721101 and 2012CB721001), the International Science & Technology Cooperation Program of China (2013DFR30640), and the National Science Foundation of China (NSFC) Program (31030002, 31371259 and 31270133). The authors thank Prof. Andrzej Gamian and Dr. Stefan Rowinski of the Hirszfeld Institute of Immunology and Experimetal Therapy, Wroclaw, Poland for their assistance with obtaining and handling of the bacterial strains from the Polish Collection of Microorganisms. The authors also gratefully acknowledge the leading role of Prof. Elzbieta Romanowska in the structural investigations of H. alvei O-antigens throughout the years.	Aizohairy A.M., 2008, J CELL MOL BIOL, V7, P81; Altschul S, 1997, EVID-BASED COMPL ALT, V1, P301; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2003, J BIOL CHEM; [Anonymous], [No title captured]; Bobleter O, 1998, CHEMINFORM, P29; Cao BY, 2013, APPL ENVIRON MICROB, V79, P6647, DOI 10.1128/AEM.01957-13; Cunneen MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067646; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; EDWARDS U, 1992, FEMS MICROBIOL LETT, V96, P161; Gao YH, 2010, J EPIDEMIOL, V20, P313, DOI 10.2188/jea.JE20090133; Gunthard H, 1973, CLIN INFECT DIS, V95, P8465; Hu DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070329; Huys G, 2003, INT J SYST EVOL MICR, V53, P807, DOI 10.1099/ijs.0.02475-0; Janda JM, 1999, J CLIN MICROBIOL, V37, P2399, DOI 10.1128/JCM.37.8.2399-2401.1999; Janda JM, 2006, CLIN MICROBIOL REV, V19, P12, DOI 10.1128/CMR.19.1.12-28.2006; JANN B, 1990, CURR TOP MICROBIOL, V150, P19; Katzenellenbogen E, 2001, FEMS IMMUNOL MED MIC, V30, P223; Katzenellenbogen E, 2013, CARBOHYD RES, V367, P5, DOI 10.1016/j.carres.2012.11.012; Kneidinger B, 2003, J BIOL CHEM, V278, P3615, DOI 10.1074/jbc.M203867200; Knirel' IA, 1995, BIOKHIMIYA, V59, P1784; KNIREL YA, 1988, CARBOHYD RES, V179, P51, DOI 10.1016/0008-6215(88)84109-0; Knirel YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P41, DOI 10.1007/978-3-7091-0733-1_3; Korres H, 2005, BIOCHEM BIOPH RES CO, V328, P1252, DOI 10.1016/j.bbrc.2005.01.087; Linard B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-11; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Liu B, 2010, GLYCOBIOLOGY, V20, P679, DOI 10.1093/glycob/cwq015; MOLLER V, 1954, ACTA PATHOL MIC SC, V35, P259; Momtaz H, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-8; Nilsson G, 1998, EUR J BIOCHEM, V255, P116, DOI 10.1046/j.1432-1327.1998.2550116.x; Pfostl A, 2008, BIOCHEM J, V410, P187, DOI 10.1042/BJ20071044; ROBBINS PW, 1965, J BIOL CHEM, V240, P375; ROMANOWSKA A, 1988, FEMS (Federation of European Microbiological Societies) Microbiology Immunology, V47, P151, DOI 10.1111/j.1574-6968.1988.tb02368.x; Romanowska E, 2000, FEMS IMMUNOL MED MIC, V27, P219, DOI 10.1016/S0928-8244(99)00187-X; Sakazaki R, 1962, JAPANESE J MED SCI B, V14, P223; Silveira S. A., 2012, 2012 IEEE Symposium on Biological Data Visualization (BioVis 2012), P49, DOI 10.1109/BioVis.2012.6378592; Tallon LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-788; Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20	38	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155115	10.1371/journal.pone.0155115	http://dx.doi.org/10.1371/journal.pone.0155115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171009	Green Published, gold, Green Submitted			2022-12-27	WOS:000376588600060
J	Gartzia, M; Fillat, F; Perez-Cabello, F; Alados, CL				Gartzia, Maite; Fillat, Federico; Perez-Cabello, Fernando; Alados, Concepcion L.			Influence of Agropastoral System Components on Mountain Grassland Vulnerability Estimated by Connectivity Loss	PLOS ONE			English	Article							NATURAL-RESOURCE MANAGEMENT; STRUCTURAL EQUATION MODELS; WOODY PLANT ENCROACHMENT; CENTRAL SPANISH PYRENEES; SUB-ALPINE GRASSLANDS; LAND-COVER CHANGE; CLIMATE-CHANGE; AGRICULTURAL ABANDONMENT; SHRUB ENCROACHMENT; ECOLOGICAL-SYSTEMS	Over the last decades, global changes have altered the structure and properties of natural and semi-natural mountain grasslands. Those changes have contributed to grassland loss mainly through colonization by woody species at low elevations, and increases in biomass and greenness at high elevations. Nevertheless, the interactions between agropastoral components; i.e., ecological (grassland, environmental, and geolocation properties), social, and economic components, and their effects on the grasslands are still poorly understood. We estimated the vulnerability of dense grasslands in the Central Pyrenees, Spain, based on the connectivity loss (CL) among grassland patches that has occurred between the 1980s and the 2000s, as a result of i) an increase in biomass and greenness (CL-IBG), ii) woody encroachment (CL-WE), or iii) a decrease in biomass and greenness (CL-DBG). The environmental and grassland components of the agropastoral system were associated with the three processes, especially CL-IBG and CL-WE, in relation with the succession of vegetation toward climax communities, fostered by land abandonment and exacerbated by climate warming. CL-IBG occurred in pasture units that had a high proportion of dense grasslands and low current livestock pressure. CL-WE was most strongly associated with pasture units that had a high proportion of woody habitat and a large reduction in sheep and goat pressure between the 1930s and the 2000s. The economic component was correlated with the CL-WE and the CL-DBG; specifically, expensive pastures were the most productive and could maintain the highest rates of livestock grazing, which slowed down woody encroachment, but caused grassland degradation and DBG. In addition, CL-DBG was associated with geolocation of grasslands, mainly because livestock tend to graze closer to passable roads and buildings, where they cause grassland degradation. To properly manage the grasslands, an integrated management plan must be developed that includes an understanding of all components of the agropastoral system and takes into account all changes that have occurred in dense mountain grasslands. Addressing the problems individually risks the improvement of some grasslands and the deterioration of others.	[Gartzia, Maite; Fillat, Federico] CSIC, Inst Pirenaico Ecol, Jaca, Huesca, Spain; [Perez-Cabello, Fernando] Univ Zaragoza, Dept Geog & Spatial Management, Zaragoza, Spain; [Perez-Cabello, Fernando] Univ Zaragoza, Aragon Univ Res Inst Environm Sci IUCA, Zaragoza, Spain; [Alados, Concepcion L.] CSIC, Inst Pirenaico Ecol, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); University of Zaragoza; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Gartzia, M (corresponding author), CSIC, Inst Pirenaico Ecol, Jaca, Huesca, Spain.	maitegartzia@yahoo.es	Alados, Concepción L/K-8085-2014; Pérez-Cabello, Fernando/M-5228-2014	Alados, Concepción L/0000-0002-6227-861X; Pérez-Cabello, Fernando/0000-0003-4831-4060; Gartzia, Maite/0000-0002-6245-3393	Spanish National Park organization (project Dinamica de la interaccion pasto-arbusto y su efecto en la conservacion de las comunidades vegetales subalpinas del Parque Nacional de Ordesa y Monte Perdido a lo largo de un gradiente climatico) [125/2010 MMAMRM]; European Community (project Land and Ecosystem Degradation and Desertification: Assessing the Fit of Responses) [FW7 ENV.2009.2.1.3.2]	Spanish National Park organization (project Dinamica de la interaccion pasto-arbusto y su efecto en la conservacion de las comunidades vegetales subalpinas del Parque Nacional de Ordesa y Monte Perdido a lo largo de un gradiente climatico); European Community (project Land and Ecosystem Degradation and Desertification: Assessing the Fit of Responses)	The Spanish National Park organization (project Dinamica de la interaccion pasto-arbusto y su efecto en la conservacion de las comunidades vegetales subalpinas del Parque Nacional de Ordesa y Monte Perdido a lo largo de un gradiente climatico. Ref.: 125/2010 MMAMRM) and the European Community (project Land and Ecosystem Degradation and Desertification: Assessing the Fit of Responses, FW7 ENV.2009.2.1.3.2) provided financial support.	Akbulut B, 2012, CAMB J ECON, V36, P1143, DOI 10.1093/cje/bes034; Alados CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114561; Aldezabal A, 1992, INFORME FINAL; Aldezabal A, 2012, NUEVOS RETOS GANADER, P325; Alofs KM, 2014, PLANT ECOL, V215, P1139, DOI 10.1007/s11258-014-0372-5; [Anonymous], 2012, PIRINEOS, DOI DOI 10.3989/Pirineos.2012.167005; Axelsson R, 2013, AMBIO, V42, P215, DOI 10.1007/s13280-012-0376-0; Barbaro L, 2004, J ENVIRON MANAGE, V72, P261, DOI 10.1016/j.jenvman.2004.05.006; Bolli JC, 2007, SILVA FENN, V41, P55, DOI 10.14214/sf.307; Bracchetti L, 2012, LANDSCAPE URBAN PLAN, V104, P157, DOI 10.1016/j.landurbplan.2011.09.005; Brandt JS, 2013, BIOL CONSERV, V158, P116, DOI 10.1016/j.biocon.2012.07.026; Camacho O, 2008, REV GEOGR ALP, V96, P89; Carlson BZ, 2014, ECOL APPL, V24, P1213, DOI 10.1890/13-0910.1; Cuadrat J.M., 2007, ATLAS CLIM TICO ARAG, Vfirst; de Frutos A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118837; Dlamini W, 2011, GLOBAL CHANGE BIOL, V17, P1425, DOI 10.1111/j.1365-2486.2010.02317.x; ECDGE, 2013, INT MAN EUR UN HAB E; EEA, 2016, EUNIS ANNEX 1 HAB TY; Felipe-Lucia MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132232; Fernandez-Gimenez M, 2012, PIRINEOS, V167, P143, DOI DOI 10.3989/Pirineos.2012.167007; Fernandez-Gimenez ME, 2012, HUM ECOL, V40, P287, DOI 10.1007/s10745-012-9463-x; Fillat F, 2008, PASTOS DEL PIRINEO; Fondevilla C, 2016, ECOL MODEL, V322, P101, DOI 10.1016/j.ecolmodel.2015.11.016; Fraser MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089054; Gao JG, 2014, QUATERN INT, V336, P108, DOI 10.1016/j.quaint.2013.09.035; Garcia-Gonzalez R., 2008, PASTOS DEL PIRINEO, P229; GARCIAGONZALEZ R, 1990, MT RES DEV, V10, P241, DOI 10.2307/3673604; GarciaRuiz JM, 1996, LANDSCAPE ECOL, V11, P267, DOI 10.1007/BF02059854; Gartzia M, 2016, APPL GEOGR, V66, P1, DOI 10.1016/j.apgeog.2015.11.007; Gartzia M, 2014, PROG PHYS GEOG, V38, P201, DOI 10.1177/0309133314524429; Gartzia M, 2013, MT RES DEV, V33, P63, DOI 10.1659/MRD-JOURNAL-D-12-00011.1; Gazol A, 2012, ECOGRAPHY, V35, P944, DOI 10.1111/j.1600-0587.2012.07627.x; Goetz O., 2010, HDB PARTIAL LEAST SQ, P411, DOI [10.1007/978-3-540-32827-8_33, DOI 10.1007/978-3-540-32827-8]; Gomez Garcia Rodrigo, 2007, COMUNICACION DESARRO, P389; Grace JB, 2008, ENVIRON ECOL STAT, V15, P191, DOI 10.1007/s10651-007-0047-7; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; GRACE JB, 2006, 20061363 US GEOL SUR; HARDISKY MA, 1983, PHOTOGRAMM ENG REM S, V49, P77; Herrmann SM, 2014, ECOL SOC, V19, DOI 10.5751/ES-06710-190329; HIC, 2010, HAB INT COM; Hodgson JG, 2005, BIOL CONSERV, V122, P263, DOI 10.1016/j.biocon.2004.07.016; Huber R, 2013, ECOL SOC, V18, DOI 10.5751/ES-05499-180336; IGN, 2014, SPAN NAT U GEOGR MIN; James LF, 2003, ARID LAND RES MANAG, V17, P319, DOI 10.1080/713936118; Jauregui BM, 2009, RANGELAND ECOL MANAG, V62, P119, DOI 10.2111/07-120.1; Kachergis E, 2014, RANGELAND ECOL MANAG, V67, P183, DOI 10.2111/REM-D-12-00066.1; Karnieli A, 2013, INT J REMOTE SENS, V34, P6243, DOI 10.1080/01431161.2013.793865; Kasari L, 2013, TUEXENIA, P293; Kinzig AP, 2006, ECOL SOC, V11; Komac B, 2013, J ENVIRON MANAGE, V121, P160, DOI 10.1016/j.jenvman.2013.01.038; Komac B, 2014, J NAT CONSERV, V22, P247, DOI 10.1016/j.jnc.2014.01.005; Kozak J, 2003, MT RES DEV, V23, P369, DOI 10.1659/0276-4741(2003)023[0369:FCCITW]2.0.CO;2; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kullman L, 2010, AMBIO, V39, P159, DOI 10.1007/s13280-010-0021-8; Lamarque P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107572; Lasanta-Martinez T, 2005, APPL GEOGR, V25, P47, DOI 10.1016/j.apgeog.2004.11.001; Li A, 2012, LANDSCAPE ECOL, V27, P969, DOI 10.1007/s10980-012-9751-2; [Liu Linshan 刘林山], 2006, Journal of Geographical Sciences, V16, P131, DOI 10.1007/s11442-006-0201-4; Lopez-i-Gelats F, 2015, SPAN J AGRIC RES, V13, DOI 10.5424/sjar/2015134-6960; Lopez-Moreno JI, 2010, INT J CLIMATOL, V30, P1026, DOI 10.1002/joc.1945; Lopez-Moreno JI, 2005, ARCT ANTARCT ALP RES, V37, P253, DOI 10.1657/1523-0430(2005)037[0253:RVOSDI]2.0.CO;2; Luick R, 1998, J APPL ECOL, V35, P979, DOI 10.1111/j.1365-2664.1998.tb00018.x; Luoto M, 2003, AMBIO, V32, P447, DOI 10.1639/0044-7447(2003)032[0447:LOPSRA]2.0.CO;2; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Mairota P, 2014, ENVIRON CONSERV, V41, P144, DOI 10.1017/S037689291300043X; Meisser M, 2014, CZECH J ANIM SCI, V59, P84, DOI 10.17221/7232-CJAS; Molinillo M, 1997, ENVIRON MANAGE, V21, P587, DOI 10.1007/s002679900051; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Numata I, 2007, REMOTE SENS ENVIRON, V109, P314, DOI 10.1016/j.rse.2007.01.013; Odriozola I, 2014, GEODERMA, V235, P347, DOI 10.1016/j.geoderma.2014.08.002; Olsson EGA, 2000, LANDSCAPE ECOL, V15, P155, DOI 10.1023/A:1008173628016; Parolo G, 2011, GRASS FORAGE SCI, V66, P541, DOI 10.1111/j.1365-2494.2011.00810.x; Paudel KP, 2010, REMOTE SENS ENVIRON, V114, P1845, DOI 10.1016/j.rse.2010.03.011; Pellissier L, 2013, APPL VEG SCI, V16, P227, DOI 10.1111/j.1654-109X.2012.01215.x; Perez-Cabello F., 2011, ZUBIA, V23, P79; Peringer A, 2013, ECOL SOC, V18, DOI 10.5751/ES-05600-180311; Pornaro C, 2013, BIOL CONSERV, V161, P213, DOI 10.1016/j.biocon.2013.02.019; Poyatos R, 2003, MT RES DEV, V23, P362, DOI 10.1659/0276-4741(2003)023[0362:LUALCC]2.0.CO;2; Reid RS, 2014, ANNU REV ENV RESOUR, V39, P217, DOI 10.1146/annurev-environ-020713-163329; Rose L, 2013, GRASS FORAGE SCI, V68, P386, DOI 10.1111/gfs.12001; Rouse J. W., 1974, P 3 EARTH RES TECHN, P301; Saura S, 2012, CONEFOR 2 6 SOFTWARE; Saura S., 2011, ECOLOGICAL INDICATOR, V11, P407, DOI DOI 10.1016/J.EC0LIND.2010.06.011; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Saura S, 2007, LANDSCAPE URBAN PLAN, V83, P91, DOI 10.1016/j.landurbplan.2007.03.005; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schirmel J, 2011, J INSECT CONSERV, V15, P633, DOI 10.1007/s10841-010-9362-7; Sebastia MT, 2008, APPL VEG SCI, V11, P215, DOI 10.3170/2008-7-18358; SITAR, 2014, LAND INF SYST AR; Sitko I, 2008, MT RES DEV, V28, P263, DOI 10.1659/mrd.0963; TUCKER CJ, 1980, REMOTE SENS ENVIRON, V10, P23, DOI 10.1016/0034-4257(80)90096-6; Van Dyke C, 2015, PROG PHYS GEOG, V39, P594, DOI 10.1177/0309133315581700; Verburg PH, 2009, LANDSCAPE ECOL, V24, P1167, DOI 10.1007/s10980-009-9355-7; Vicente-Serrano SM, 2004, ENVIRON MANAGE, V34, P802, DOI 10.1007/s00267-003-0022-5; Walker B, 2004, ECOL SOC, V9; Wehn S, 2011, LANDSCAPE URBAN PLAN, V102, P177, DOI 10.1016/j.landurbplan.2011.04.003; Wohl E, 2014, ENVIRON MANAGE, V53, P14, DOI 10.1007/s00267-013-0093-x; Wurstten A, 2014, EUR J WILDLIFE RES, V60, P35, DOI 10.1007/s10344-013-0748-1; Xie YC, 2012, SCI WORLD J, DOI 10.1100/2012/169724; Xu MY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096604, 10.1371/journal.pone.0101061]; Zhang MA, 2007, ECOL ECON, V62, P19, DOI 10.1016/j.ecolecon.2006.11.005; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	103	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155193	10.1371/journal.pone.0155193	http://dx.doi.org/10.1371/journal.pone.0155193			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171181	Green Published, gold, Green Submitted			2022-12-27	WOS:000376588600074
J	Wen, LL; Lin, CY; Chou, HC; Chang, CC; Lo, HY; Juan, SH				Wen, Li-Li; Lin, Chien-Yu; Chou, Hsiu-Chu; Chang, Chih-Cheng; Lo, Hau-Yin; Juan, Shu-Hui			Perfluorooctanesulfonate Mediates Renal Tubular Cell Apoptosis through PPARgamma Inactivation	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; L-CARNITINE; PERFLUOROALKYL CHEMICALS; ENDOTHELIAL-CELLS; HYPERTENSIVE-RATS; GENE-EXPRESSION; HUMAN SIRT1; PPAR-GAMMA; SULFONATE; ACID	Perfluorinated chemicals (PFCs) are ubiquitously distributed in the environments including stainless pan-coating, raincoat, fire extinguisher, and semiconductor products. The PPAR family has been shown to contribute to the toxic effects of PFCs in thymus, immune and excretory systems. Herein, we demonstrated that perfluorooctanesulfonate (PFOS) caused cell apoptosis through increasing ratio of Bcl-xS/xL, cytosolic cytochrome C, and caspase 3 activation in renal tubular cells (RTCs). In addition, PFOS increased transcription of inflammatory cytokines (i.e., TNF alpha, ICAM1, and MCP1) by NF kappa B activation. Conversely, PFOS reduced the mRNA levels of antioxidative enzymes, such as glutathione peroxidase, catalase, and superoxide dismutase, as a result of reduced PPAR gamma transactivational activity by using reporter and chromatin immuoprecipitation (ChIP) assays. PFOS reduced the protein interaction between PPAR gamma and PPAR gamma coactivator-1 alpha (PGC1 alpha) by PPAR gamma deacetylation through Sirt1 upregulation, of which the binding of PPAR gamma and PGC1 alpha to a peroxisome proliferator response element (PPRE) in the promoter regions of these antioxidative enzymes was alleviated in the ChIP assay. Furthermore, Sirt1 also deacetylated p53 and then increased the binding of p53 to Bax, resulting in increased cytosolic cytochrome C. The effect of PPAR gamma inactivation by PFOS was validated using the PPAR gamma antagonist GW9662, whereas the adverse effects of PFOS were prevented by PPAR gamma overexpression and activators, rosiglitozone and L-carnitine, in RTCs. The in vitro finding of protective effect of L-carnitine was substantiated in vivo using Balb/c mice model subjected to PFOS challenge. Altogether, we provide in vivo and in vitro evidence for the protective mechanism of L-carnitine in eliminating PFOS-mediated renal injury, at least partially, through PPAR gamma activation.	[Wen, Li-Li; Chou, Hsiu-Chu; Chang, Chih-Cheng; Lo, Hau-Yin; Juan, Shu-Hui] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Wen, Li-Li] En Chu Kong Hosp, Dept Clin Lab, New Taipei, Taiwan; [Wen, Li-Li] Yuanpei Univ, Dept Med Lab Sci & Biotechnol, Hsinchu, Taiwan; [Lin, Chien-Yu] En Chu Kong Hosp, Dept Internal Med, New Taipei, Taiwan; [Lin, Chien-Yu] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Chou, Hsiu-Chu] Taipei Med Univ, Coll Med, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan; [Chang, Chih-Cheng; Lo, Hau-Yin; Juan, Shu-Hui] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan	Taipei Medical University; Fu Jen Catholic University; Taipei Medical University; Taipei Medical University	Juan, SH (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.; Juan, SH (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan.	juansh@tmu.edu.tw			Ministry of Science and Technology of Taiwan [MOST103-2314-B-585-002, NSC102-2320-B-038-030-MY3]; En-Chu-Kong Hospital [ECKH 10303, ECKH10304]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); En-Chu-Kong Hospital	This study was supported by grants from Ministry of Science and Technology of Taiwan; www.most.gov.tw (MOST103-2314-B-585-002; NSC102-2320-B-038-030-MY3) and En-Chu-Kong Hospital; www.eck.org.tw/index.aspx?siteid=218&ver=admi (a regional hospital in the Taipei County; ECKH 10303; ECKH10304). Additionally, authors Li-Li Wen and Chien-Yu Lin receive salaries from En-Chu-Kong Hospital. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 2009, REPROD TOXICOL, V27, P258, DOI 10.1016/j.reprotox.2008.05.061; Best CJM, 1999, IN VITRO CELL DEV-AN, V35, P205, DOI 10.1007/s11626-999-0028-2; Biegel LB, 2001, TOXICOL SCI, V60, P44, DOI 10.1093/toxsci/60.1.44; Bjork JA, 2008, TOXICOLOGY, V251, P8, DOI 10.1016/j.tox.2008.06.007; Butenhoff JL, 2004, TOXICOL SCI, V82, P394, DOI 10.1093/toxsci/kfh302; Byles V, 2010, INT J BIOL SCI, V6, P599; Chen HH, 2009, NEPHROL DIAL TRANSPL, V24, P3042, DOI 10.1093/ndt/gfp258; Costa G, 2009, J OCCUP ENVIRON MED, V51, P364, DOI 10.1097/JOM.0b013e3181965d80; Cui L, 2009, ARCH ENVIRON CON TOX, V56, P338, DOI 10.1007/s00244-008-9194-6; Davenport AM, 2014, J MOL BIOL, V426, P526, DOI 10.1016/j.jmb.2013.10.009; DELARCO JE, 1978, J CELL PHYSIOL, V94, P335, DOI 10.1002/jcp.1040940311; DeWitt J, 2009, CRIT REV TOXICOL, V39, P76, DOI [10.1080/10408440802209804, 10.1080/10408440802209804 ]; Gamm M, 2011, MOL PLANT MICROBE IN, V24, P1061, DOI 10.1094/MPMI-02-11-0040; Gilliland FD, 1996, AM J IND MED, V29, P560; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Han X, 2005, DRUG CHEM TOXICOL, V28, P197, DOI 10.1081/DCT-200052547; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Houde M, 2006, ENVIRON SCI TECHNOL, V40, P3463, DOI 10.1021/es052580b; Hu WY, 2003, COMP BIOCHEM PHYS C, V135, P77, DOI 10.1016/S1532-0456(03)00043-7; Juan SH, 2005, BIOCHEM PHARMACOL, V69, P41, DOI 10.1016/j.bcp.2004.09.015; Kennedy GL, 2004, CRIT REV TOXICOL, V34, P351, DOI 10.1080/10408440490464705; Lau C, 2003, TOXICOL SCI, V74, P382, DOI 10.1093/toxsci/kfg122; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lee FP, 2010, J CELL PHYSIOL, V224, P837, DOI 10.1002/jcp.22192; Lin CY, 2009, DIABETES CARE, V32, P702, DOI 10.2337/dc08-1816; Matsumoto Takayuki, 2008, Journal of Smooth Muscle Research, V44, P41, DOI 10.1540/jsmr.44.41; Midgett K, 2015, J APPL TOXICOL, V35, P459, DOI 10.1002/jat.3037; Miguel-Carrasco JL, 2010, EUR J PHARMACOL, V632, P65, DOI 10.1016/j.ejphar.2010.01.017; Okazaki M, 2010, ENDOCR J, V57, P403, DOI 10.1507/endocrj.K10E-004; Olsen GW, 2009, TOXICOLOGY, V256, P65, DOI 10.1016/j.tox.2008.11.008; Olsen GW, 1999, J OCCUP ENVIRON MED, V41, P799, DOI 10.1097/00043764-199909000-00012; Pang PH, 2008, J CELL PHYSIOL, V215, P161, DOI 10.1002/jcp.21299; Pisano C, 2010, CLIN CANCER RES, V16, P3944, DOI 10.1158/1078-0432.CCR-10-0964; Qian Y, 2010, J TOXICOL ENV HEAL A, V73, P819, DOI 10.1080/15287391003689317; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Seacat AM, 2003, TOXICOLOGY, V183, P117, DOI 10.1016/S0300-483X(02)00511-5; Shankar A, 2011, AM J EPIDEMIOL, V174, P893, DOI 10.1093/aje/kwr171; Steenland K, 2010, ENVIRON HEALTH PERSP, V118, P1100, DOI 10.1289/ehp.0901827; Steenland K, 2010, ENVIRON HEALTH PERSP, V118, P229, DOI 10.1289/ehp.0900940; Steenland K, 2009, AM J EPIDEMIOL, V170, P1268, DOI 10.1093/aje/kwp279; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Sue YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104079; Sutton TA, 2009, MICROVASC RES, V77, P4, DOI 10.1016/j.mvr.2008.09.004; Takacs ML, 2007, TOXICOL SCI, V95, P108, DOI 10.1093/toxsci/kfl135; Wang Y, 2011, TOXICOL LETT, V204, P174, DOI 10.1016/j.toxlet.2011.04.029; Zambrano S, 2014, AM J HYPERTENS, V27, P460, DOI 10.1093/ajh/hpt268	49	26	27	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155190	10.1371/journal.pone.0155190	http://dx.doi.org/10.1371/journal.pone.0155190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171144	gold, Green Published			2022-12-27	WOS:000376588600099
J	Martin, MS; Potter, BK; Crocker, AG; Wells, GA; Colman, I				Martin, Michael S.; Potter, Beth K.; Crocker, Anne G.; Wells, George A.; Colman, Ian			Yield and Efficiency of Mental Health Screening: A Comparison of Screening Protocols at Intake to Prison	PLOS ONE			English	Article							PRIMARY-CARE; TASK-FORCE; DEPRESSION; VALIDATION; DISORDERS; ILLNESS; TOOLS; HOPELESSNESS; ASSOCIATION; RECEPTION	Background The value of screening for mental illness has increasingly been questioned in low prevalence settings due to high false positive rates. However, since false positive rates are related to prevalence, screening may be more effective in higher prevalence settings, including correctional institutions. We compared the yield (i.e. newly detected cases) and efficiency (i.e. false positives) of five screening protocols to detect mental illness in prisons against the use of mental health history taking (the prior approach to detecting mental illness). Methods and Findings We estimated the accuracy of the six approaches to detect an Axis I disorder among a sample of 467 newly admitted male inmates (83.1% participation rate). Mental health history taking identified only 41.0% (95% CI 32.1, 50.6) of all inmates with mental illness. Screening protocols identified between 61.9 and 85.7% of all cases, but referred between 2 and 3 additional individuals who did not have a mental illness for every additional case detected compared to the mental health history taking approach. In low prevalence settings (i.e. 10% or less) the screening protocols would have had between 4.6 and 16.2 false positives per true positive. Conclusions While screening may not be practical in low prevalence settings, it may be beneficial in jails and prisons where the prevalence of mental illness is higher. Further consideration of the context in which screening is being implemented, and of the impacts of policies and clinical practices on the benefits and harms of screening is needed to determine the effectiveness of screening in these settings.	[Martin, Michael S.; Potter, Beth K.; Wells, George A.; Colman, Ian] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Crocker, Anne G.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Crocker, Anne G.] Douglas Mental Hlth Univ Inst, Res Ctr, Montreal, PQ, Canada	University of Ottawa; McGill University	Martin, MS (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada.	mmart007@uottawa.ca	Wells, George A/M-4549-2017; Martin, Michael S./AAA-1290-2020	Wells, George A/0000-0002-2289-9139; Martin, Michael S./0000-0002-5056-618X; Colman, Ian/0000-0001-5924-0277; Crocker, Anne/0000-0003-0571-8890	Vanier Canada Graduate Scholarship; Canada Research Chairs program	Vanier Canada Graduate Scholarship; Canada Research Chairs program(Canada Research Chairs)	The authors thank Correctional Service of Canada (CSC) for providing the data for this project. CSC had no role in the conduct of this study or the decision/approval to publish. The views are those of the authors, and do not necessarily reflect the position of CSC. Mr. Martin is supported by a Vanier Canada Graduate Scholarship, and Dr. Colman is supported by the Canada Research Chairs program.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5; Beaudette J., 2015, NATL PREVALENCE MENT; Biometrics Research Department, 2012, STRUCT CLIN INT DSM; Bland RC, 2013, CAN MED ASSOC J, V185, P753, DOI 10.1503/cmaj.130634; Brooker C, 2009, J FORENSIC PSYCHI PS, V20, pS102, DOI 10.1080/14789940802638333; Cepoiu M, 2008, J GEN INTERN MED, V23, P25, DOI 10.1007/s11606-007-0428-5; Correctional Service of Canada, 2010, PROF CAN OFF; Cuijpers P, 2009, BRIT J GEN PRACT, V59, P120, DOI 10.3399/bjgp09X395139; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT, V18; Edwards KA, 2000, INT J OFFENDER THER, V44, P480, DOI 10.1177/0306624X00444006; Evans C, 2010, PSYCHIAT SERV, V61, P923, DOI 10.1176/ps.2010.61.9.923; Fazel S., 2012, British Journal of Psychiatry, V200, P364, DOI 10.1192/bjp.bp.111.096370; Fernandez A, 2007, BRIT J PSYCHIAT, V190, P172, DOI 10.1192/bjp.bp.106.023507; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Goldberg D, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-14; Gollapudi S., 2011, CORRECTIONAL MENTAL; HALL RCW, 1995, PSYCHOSOMATICS, V36, P267, DOI 10.1016/S0033-3182(95)71666-8; Hampton LM, 2014, JAMA PSYCHIAT, V71, P1006, DOI 10.1001/jamapsychiatry.2014.436; Harris R, 2011, EPIDEMIOL REV, V33, P20, DOI 10.1093/epirev/mxr005; HART SD, 1993, LAW HUMAN BEHAV, V17, P611, DOI 10.1007/BF01044685; Hassan L, 2012, PSYCHIAT SERV, V63, P1218, DOI 10.1176/appi.ps.201100344; Hassan L, 2011, BRIT J PSYCHIAT, V198, P37, DOI 10.1192/bjp.bp.110.080333; Hayes A, 2014, J FORENSIC PSYCHI PS, V25, P371, DOI 10.1080/14789949.2014.911947; Joffres M, 2013, CAN MED ASSOC J, V185, P775, DOI 10.1503/cmaj.130403; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kisely S, 2006, BRIT J PSYCHIAT, V189, P79, DOI 10.1192/bjp.bp.105.019869; Lash TL, 2009, APPL QUANTITATIVE BI; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; Martin MS, 2014, J FORENSIC PSYCHI PS, V25, P733, DOI 10.1080/14789949.2014.955811; Martin MS, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-275; Martin MS, 2013, CRIM BEHAV MENT HEAL, V23, P6, DOI 10.1002/cbm.1853; Mills J. F., 2004, PSYCHOL SERV, V1, P83, DOI DOI 10.1037/1541-1559.1.1.83; Mills J. F., 2003, DEPRESSION HOPELESSN; Mills JF, 2005, LEGAL CRIMINOL PSYCH, V10, P1, DOI 10.1348/135532504X15295; Naglieri J., 1997, GAMA GEN ABILITY MEA; Noga H, 2013, MANUAL POLICE MENTAL; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Pillai K, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0711-2; Powitzky R., 2011, CORRECTIONAL MENTAL; Raffle AE, 2007, SCREENING EVIDENCE P, DOI [10.1093/acprof:oso/9780199214495.001.0001, DOI 10.1093/ACPR0F:0S0/9780199214495.001.0001]; Schilders MR, 2014, J FORENSIC PSYCHI PS, V25, P480, DOI 10.1080/14789949.2014.933862; Senior J, 2013, PSYCHOL MED, V43, P1511, DOI 10.1017/S0033291712002073; Steadman HJ, 2005, PSYCHIAT SERV, V56, P816, DOI 10.1176/appi.ps.56.7.816; Swets J A, 2000, Psychol Sci Public Interest, V1, P1, DOI 10.1111/1529-1006.001; Taylor PJ, 2010, CRIM BEHAV MENT HEAL, V20, P215, DOI 10.1002/cbm.774; TEPLIN LA, 1990, J CONSULT CLIN PSYCH, V58, P233, DOI 10.1037/0022-006X.58.2.233; Thombs BD, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-13; Thombs BD, 2013, CAN J PSYCHIAT, V58, P692, DOI 10.1177/070674371305801207; Thombs BD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4825; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	50	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154106	10.1371/journal.pone.0154106	http://dx.doi.org/10.1371/journal.pone.0154106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CD	27167222	Green Submitted, Green Published, gold			2022-12-27	WOS:000376587300107
J	Seidel, UK; Gronewold, J; Wicking, M; Bellebaum, C; Hermann, DM				Seidel, Ulla K.; Gronewold, Janine; Wicking, Manon; Bellebaum, Christian; Hermann, Dirk M.			Vascular Risk Factors and Diseases Modulate Deficits of Reward-Based Reversal Learning in Acute Basal Ganglia Stroke	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; PARKINSONS-DISEASE; DEMENTIA; MEMORY	Background Besides motor function, the basal ganglia have been implicated in feedback learning. In patients with chronic basal ganglia infarcts, deficits in reward-based reversal learning have previously been described. Methods We re-examined the acquisition and reversal of stimulus-stimulus-reward associations and acquired equivalence in eleven patients with acute basal ganglia stroke (8 men, 3 women; 57.8 +/- 13.3 years), whose performance was compared eleven healthy subjects of comparable age, sex distribution and education, who were recruited outside the hospital. Eleven hospitalized patients with a similar vascular risk profile as the stroke patients but without stroke history served as clinical control group. Results In a neuropsychological assessment 7 +/- 3 days post-stroke, verbal and spatial short-term and working memory and inhibition control did not differ between groups. Compared with healthy subjects, control patients with vascular risk factors exhibited significantly reduced performance in the reversal phase (F[2,30] = 3.47; p = 0.044; post-hoc comparison between risk factor controls and healthy controls: p = 0.030), but not the acquisition phase (F[2,30] = 1.01; p = 0.376) and the acquired equivalence (F[2,30] = 1.04; p = 0.367) tasks. In all tasks, the performance of vascular risk factor patients closely resembled that of basal ganglia stroke patients. Correlation studies revealed a significant association of the number of vascular risk factors with reversal learning (r = -0.33, p = 0.012), but not acquisition learning (r = -0.20, p = 0.121) or acquired equivalence (r = -0.22, p = 0.096). Conclusions The previously reported impairment of reward-based learning may be attributed to vascular risk factors and associated diseases, which are enriched in stroke patients. This study emphasizes the necessity of appropriate control subjects in cognition studies.	[Seidel, Ulla K.; Gronewold, Janine; Wicking, Manon; Hermann, Dirk M.] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany; [Bellebaum, Christian] Univ Dusseldorf, Inst Expt Psychol, Dusseldorf, Germany	University of Duisburg Essen; Heinrich Heine University Dusseldorf	Hermann, DM (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany.	dirk.hermann@uk-essen.de	Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk/GZB-9350-2022	Hermann, Dirk M./0000-0003-0198-3152; 				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Antonelli F, 2014, HUM BRAIN MAPP, V35, P2499, DOI 10.1002/hbm.22344; Bellebaum C, 2008, BRAIN, V131, P829, DOI 10.1093/brain/awn011; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; DAUM I, 1995, CORTEX, V31, P413, DOI 10.1016/S0010-9452(13)80057-3; Gluck MA, 2002, LEARN MEMORY, V9, P408, DOI 10.1101/lm.45202; Haid T, 2010, Z NEUROPSYCHOL, V21, P206; HARRINGTON DL, 1990, J CLIN EXP NEUROPSYC, V12, P323, DOI 10.1080/01688639008400978; Harting C, 2000, WECHSLER MEMORY SCAL; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Horn R, 2006, WECHSLER ADULT INTEL; Huber W, 1983, AACHENER APHASIE TES; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; JACKSON GM, 1995, NEUROPSYCHOLOGIA, V33, P577, DOI 10.1016/0028-3932(95)00010-Z; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Miwa K, 2014, NEUROLOGY, V82, P1051, DOI 10.1212/WNL.0000000000000251; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Unverzagt FW, 2011, NEUROLOGY, V77, P1729, DOI 10.1212/WNL.0b013e318236ef23; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Zimmermann P., 2009, TAP TESTBATTERIE AUF	23	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155267	10.1371/journal.pone.0155267	http://dx.doi.org/10.1371/journal.pone.0155267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8BN	27163585	gold, Green Published, Green Submitted			2022-12-27	WOS:000376585700044
J	Krzan, M; Vianello, R; Marsavelski, A; Repic, M; Zaksek, M; Kotnik, K; Fijan, E; Mavri, J				Krzan, Mojca; Vianello, Robert; Marsavelski, Aleksandra; Repic, Matej; Zaksek, Maja; Kotnik, Kristina; Fijan, Estera; Mavri, Janez			The Quantum Nature of Drug-Receptor Interactions: Deuteration Changes Binding Affinities for Histamine Receptor Ligands	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGES; DENSITY FUNCTIONALS; CRYSTAL-STRUCTURE; AQUEOUS-SOLUTION; STRUCTURAL BASIS; ACTIVATION; CATALYSIS; TRANSITION	In this article we report a combined experimental and computational study concerning the effects of deuteration on the binding of histamine and two other histaminergic agonists to 3H-tiotidine-labeled histamine H2 receptor in neonatal rat astrocytes. Binding affinities were measured by displacing radiolabeled tiotidine from H2 receptor binding sites present on cultured neonatal rat astrocytes. Quantum-chemical calculations were performed by employing the empirical quantization of nuclear motion within a cluster model of the receptor binding site extracted from the homology model of the entire H2 receptor. Structure of H2 receptor built by homology modelling is attached in the supporting information (S1 Table) Experiments clearly demonstrate that deuteration affects the binding by increasing the affinity for histamine and reducing it for 2-methylhistamine, while basically leaving it unchanged for 4-methylhistamine. Ab initio quantum-chemical calculations on the cluster system extracted from the homology H2 model along with the implicit quantization of the acidic N-H and O-H bonds demonstrate that these changes in the binding can be rationalized by the altered strength of the hydrogen bonding upon deuteration known as the Ubbelohde effect. Our computational analysis also reveals a new mechanism of histamine binding, which underlines an important role of Tyr250 residue. The present work is, to our best knowledge, the first study of nuclear quantum effects on ligand receptor binding. The ligand H/D substitution is relevant for therapy in the context of perdeuterated and thus more stable drugs that are expected to enter therapeutic practice in the near future. Moreover, presented approach may contribute towards understanding receptor activation, while a distant goal remains in silico discrimination between agonists and antagonists based on the receptor structure.	[Krzan, Mojca; Zaksek, Maja; Kotnik, Kristina; Fijan, Estera] Univ Ljubljana, Fac Med, Dept Pharmacol & Expt Toxicol, Ljubljana, Slovenia; [Vianello, Robert; Marsavelski, Aleksandra] Rudjer Boskovic Inst, Computat Organ Chem & Biochem Grp, Zagreb, Croatia; [Repic, Matej; Mavri, Janez] Natl Inst Chem, Lab Biocomp & Bioinformat, Ljubljana, Slovenia; [Repic, Matej] Krka Dd Pharmaceutial, Novo Mesto, Slovenia	University of Ljubljana; Rudjer Boskovic Institute; National Institute of Chemistry - Slovenia	Mavri, J (corresponding author), Natl Inst Chem, Lab Biocomp & Bioinformat, Ljubljana, Slovenia.	janez.mavri@ki.si	Vianello, Robert/J-3938-2012; Marsavelski, Aleksandra/Y-1781-2018	Vianello, Robert/0000-0003-1779-4524; Marsavelski, Aleksandra/0000-0003-1139-7173	Slovenian Agency for Research [P1-012, P3-067, J1-2014]; European Commission [PCIG12-GA-2012-334493]; Croatian Science Foundation [I-3376-2014]	Slovenian Agency for Research(Slovenian Research Agency - Slovenia); European Commission(European CommissionEuropean Commission Joint Research Centre); Croatian Science Foundation	Financial support from the Slovenian Agency for Research was received through grants P1-012, P3-067 and J1-2014. RV gratefully acknowledges the European Commission for an individual FP7 Marie Curie Career Integration Grant (contract number PCIG12-GA-2012-334493). AM wishes to thank the Croatian Science Foundation for a doctoral stipend through the Career Development Project for Young Researchers (Contract No. I-3376-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BIRDSALL NJM, 1991, TRENDS PHARMACOL SCI, V12, P9, DOI 10.1016/0165-6147(91)90481-7; Block E, 2015, P NATL ACAD SCI USA, V112, pE2766, DOI 10.1073/pnas.1503054112; Borstnar R, 2012, J CHEM THEORY COMPUT, V8, P3864, DOI 10.1021/ct300119u; Braun-Sand S, 2008, BBA-BIOENERGETICS, V1777, P441, DOI 10.1016/j.bbabio.2008.03.001; Case D. A., 2012, AMBER 2012; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; de Souza JM, 2007, J PHYS CHEM B, V111, P5034, DOI 10.1021/jp070366z; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Dohlman HG, 2015, J BIOL CHEM, V290, P19469, DOI 10.1074/jbc.R115.675728; Don CG, 2014, J COMPUT CHEM, V35, P2279, DOI 10.1002/jcc.23757; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Dror RO, 2010, J GEN PHYSIOL, V135, P555, DOI 10.1085/jgp.200910373; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Franco MI, 2011, P NATL ACAD SCI USA, V108, P3797, DOI 10.1073/pnas.1012293108; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Frisch G. W., 2013, GAUSSIAN 09; Gant TG, 2014, J MED CHEM, V57, P3595, DOI 10.1021/jm4007998; GANTZ I, 1992, J BIOL CHEM, V267, P20840; Gentry PR, 2015, J BIOL CHEM, V290, P19478, DOI 10.1074/jbc.R115.662759; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Glowacki DR, 2012, NAT CHEM, V4, P169, DOI [10.1038/NCHEM.1244, 10.1038/nchem.1244]; Hettinger TP, 2011, P NATL ACAD SCI USA, V108, pE349, DOI 10.1073/pnas.1103992108; Jazayeri A, 2015, J BIOL CHEM, V290, P19489, DOI 10.1074/jbc.R115.668251; Kamerlin SCL, 2010, FEBS LETT, V584, P2759, DOI 10.1016/j.febslet.2010.04.062; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Liao RZ, 2011, BIOCHEMISTRY-US, V50, P1505, DOI 10.1021/bi101493p; Mavri J, 2008, J PHYS CHEM B, V112, P5950, DOI 10.1021/jp0758420; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; Modena D., 2011, ADV LIFE SCI, V1, P1; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perdan-Pirkmajer K, 2010, J MOL MODEL, V16, P1151, DOI 10.1007/s00894-009-0624-9; Plosnik A, 2015, CHEMOSPHERE, V135, P325, DOI 10.1016/j.chemosphere.2015.04.075; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roth BL, 2015, J BIOL CHEM, V290, P19471, DOI 10.1074/jbc.R115.654764; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saxena M, 2015, SAR QSAR ENVIRON RES, V26, P739, DOI 10.1080/1062936X.2015.1088572; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; Sever M, 2007, COMPUT BIOL MED, V37, P1051, DOI 10.1016/j.compbiomed.2006.09.010; Sham YY, 2000, PROTEINS, V39, P393, DOI 10.1002/(SICI)1097-0134(20000601)39:4<393::AID-PROT120>3.3.CO;2-8; Shonberg J, 2015, BIOORGAN MED CHEM, V23, P3880, DOI 10.1016/j.bmc.2014.12.034; Silva JR, 2010, J GEN PHYSIOL, V135, P575, DOI 10.1085/jgp.200910358; Stare J, 2011, J PHYS CHEM B, V115, P5999, DOI 10.1021/jp111175e; Sun XQ, 2011, J MOL GRAPH MODEL, V29, P693, DOI 10.1016/j.jmgm.2010.12.001; Tehan BG, 2014, PHARMACOL THERAPEUT, V143, P51, DOI 10.1016/j.pharmthera.2014.02.004; UBBELOHDE AR, 1955, ACTA CRYSTALLOGR, V8, P71, DOI 10.1107/S0365110X55000340; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P43516, DOI 10.1074/jbc.M112.395137; Vianello R, 2012, NEW J CHEM, V36, P954, DOI 10.1039/c2nj20877f; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wheeler SE, 2012, WIRES COMPUT MOL SCI, V2, P204, DOI 10.1002/wcms.72; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang J, 2012, MED CHEM, V8, P1084; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a; Zhao Y, 2011, J CHEM THEORY COMPUT, V7, P669, DOI 10.1021/ct1006604	66	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154002	10.1371/journal.pone.0154002	http://dx.doi.org/10.1371/journal.pone.0154002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159606	Green Submitted, gold, Green Published			2022-12-27	WOS:000376576700007
J	Li, BS; Gan, AH; Chen, XL; Wang, XY; He, WF; Zhang, XH; Huang, RX; Zhou, SZ; Song, XX; Xu, AG				Li, Bingsheng; Gan, Aihua; Chen, Xiaolong; Wang, Xinying; He, Weifeng; Zhang, Xiaohui; Huang, Renxiang; Zhou, Shuzhu; Song, Xiaoxiao; Xu, Angao			Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review	PLOS ONE			English	Review							METHYLATED SEPT9 DNA; GENE METHYLATION; PROMOTER HYPERMETHYLATION; QUANTIFYING HETEROGENEITY; POTENTIAL MARKER; TEST ACCURACY; SERUM DNA; PLASMA; BIOMARKER; STATISTICS	DNA hypermethylation in blood is becoming an attractive candidate marker for colorectal cancer (CRC) detection. To assess the diagnostic accuracy of blood hypermethylation markers for CRC in different clinical settings, we conducted a meta-analysis of published reports. Of 485 publications obtained in the initial literature search, 39 studies were included in the meta-analysis. Hypermethylation markers in peripheral blood showed a high degree of accuracy for the detection of CRC. The summary sensitivity was 0.62 [95% confidence interval (CI), 0.56-0.67] and specificity was 0.91 (95% CI, 0.89-0.93). Subgroup analysis showed significantly greater sensitivity for the methylated Septin 9 gene (SEPT9) subgroup (0.75; 95% CI, 0.67-0.81) than for the non-methylated SEPT9 subgroup (0.58; 95% CI, 0.52-0.64). Sensitivity and specificity were not affected significantly by target gene number, CRC staging, study region, or methylation analysis method. These findings show that hypermethylation markers in blood are highly sensitive and specific for CRC detection, with methylated SEPT9 being particularly robust. The diagnostic performance of hypermethylation markers, which have varied across different studies, can be improved by marker optimization. Future research should examine variation in diagnostic accuracy according to nonneoplastic factors.	[Li, Bingsheng; Gan, Aihua; He, Weifeng; Zhang, Xiaohui] Huizhou First Hosp, Dept Gastroenterol, Huizhou 516003, Peoples R China; [Chen, Xiaolong] Hainan Prov Peoples Hosp, Dept Gastroenterol, Haikuo 570100, Peoples R China; [Wang, Xinying] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China; [Huang, Renxiang; Zhou, Shuzhu; Xu, Angao] Huizhou First Hosp, Huizhou Med Inst, Huizhou 516003, Peoples R China; [Song, Xiaoxiao] Kunming Med Univ, Sch Publ Hlth, Kunming 650500, Peoples R China	Southern Medical University - China; Kunming Medical University	Xu, AG (corresponding author), Huizhou First Hosp, Huizhou Med Inst, Huizhou 516003, Peoples R China.	1102066844@qq.com	li, bing/GWQ-9617-2022		Natural Science Foundation of Guangdong Province [2015A030310057]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by Natural Science Foundation of Guangdong Province (2015A030310057).	Ahlquist DA, 2010, GASTROENTEROLOGY, V138, P2127, DOI 10.1053/j.gastro.2010.01.055; Ashktorab H, 2014, CURR COLORECT CANC R, V10, P425, DOI 10.1007/s11888-014-0245-2; Baig Jawed Altaf, 2009, J Ayub Med Coll Abbottabad, V21, P72; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Cassinotti E, 2012, INT J CANCER, V131, P1153, DOI 10.1002/ijc.26484; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Danese E, 2013, BRIT J CANCER, V109, P807, DOI 10.1038/bjc.2013.351; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Dwamena B., 2007, MIDAS STATA MODULE M; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Grady WM, 2001, CANCER RES, V61, P900; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Harbord RM, 2008, J CLIN EPIDEMIOL, V61, P1095, DOI 10.1016/j.jclinepi.2007.09.013; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; He QO, 2010, CANCER GENET CYTOGEN, V202, P1, DOI 10.1016/j.cancergencyto.2010.05.018; Herbst A, 2012, TUMOR BIOL, V33, P297, DOI 10.1007/s13277-012-0346-y; Herbst A, 2011, AM J GASTROENTEROL, V106, P1110, DOI 10.1038/ajg.2011.6; Hibi K, 2011, CANCER LETT, V311, P96, DOI 10.1016/j.canlet.2011.07.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffmann AC, 2009, J CANCER RES CLIN, V135, P1231, DOI 10.1007/s00432-009-0564-x; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Johnson DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098238; Kang Qian, 2014, Zhonghua Yi Xue Za Zhi, V94, P3839; Kostin P. A., 2010, Voprosy Onkologii (St. Petersburg), V56, P162; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lange CPE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050266; Lee BB, 2009, CLIN CANCER RES, V15, P6185, DOI 10.1158/1078-0432.CCR-09-0111; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Lee J, 2015, KOREAN J RADIOL, V16, P1188, DOI 10.3348/kjr.2015.16.6.1188; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Leung WK, 2005, AM J GASTROENTEROL, V100, P2274, DOI 10.1111/j.1572-0241.2005.50412.x; Li L, 2012, J EPIDEMIOL, V22, P384, DOI 10.2188/jea.JE20120003; Li YK, 2012, CHIN J CURR ADV GEN, V15, P519; Liu WW, 2010, CLIN CHIM ACTA, V411, P940, DOI 10.1016/j.cca.2010.03.003; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Melotte V, 2015, CANCER PREV RES, V8, P157, DOI 10.1158/1940-6207.CAPR-14-0198; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Oh T, 2013, J MOL DIAGN, V15, P498, DOI 10.1016/j.jmoldx.2013.03.004; Pedersen SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125041; Pedersen SK, 2014, EPIGENETICS-US, V9, P1071, DOI 10.4161/epi.29046; Potter NT, 2014, CLIN CHEM, V60, P1183, DOI 10.1373/clinchem.2013.221044; Roperch JP, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-566; Sabbioni Silvia, 2003, Mol Diagn, V7, P201, DOI 10.2165/00066982-200307030-00010; Sakamoto J, 2010, CANCER EPIDEMIOL, V34, P194, DOI 10.1016/j.canep.2010.01.004; Shirahata A, 2014, ANTICANCER RES, V34, P4121; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sterne J., 2009, COMPRAR METAANALYSIS; Summers T, 2013, J CANCER, V4, P210, DOI 10.7150/jca.5839; Tanzer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009061; Takane K, 2014, CANCER MED-US, V3, P1235, DOI 10.1002/cam4.273; Tang D, 2011, CLIN INVEST MED, V34, pE88; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; van Enst WA, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-70; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Wang YC, 2008, WORLD J GASTROENTERO, V14, P3074, DOI 10.3748/wjg.14.3074; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wu PP, 2011, CHINESE J CANCER RES, V23, P283, DOI 10.1007/s11670-011-0283-0; [许示心 XU Shixin], 2008, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V28, P229; Yang H, 2013, CAN J GASTROENTEROL, V27, P467, DOI 10.1155/2013/258030; [叶晓兵 Ye Xiaobing], 2010, [第二军医大学学报, Academic Journal of Second Military Medical University], V31, P842; Yuan Y, 2015, PANMINERVA MED, V57, P55; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhang X, 2015, WORLD J GASTROENTERO, V21, P2629, DOI 10.3748/wjg.v21.i9.2629; [张学松 Zhang Xuesong], 2014, [中国癌症杂志, China Oncology], V24, P501; ZHANG Z, 2006, CANC RES CLIN, V18, P228; Zheng Y., 2010, J MED POSTGRADUATES, V3, P016; Zhou Y, 2014, STAT MED, V33, P2701, DOI 10.1002/sim.6115; Zoratto F, 2014, TUMOR BIOL, V35, P6195, DOI 10.1007/s13277-014-1845-9; Zou HZ, 2002, CLIN CANCER RES, V8, P188; 鹿亚超, 2006, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V29, P143; 2014, CHIN J GASTROENTEROL, V34, P726	76	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155095	10.1371/journal.pone.0155095	http://dx.doi.org/10.1371/journal.pone.0155095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158984	gold, Green Published, Green Submitted			2022-12-27	WOS:000376576700043
J	Seref-Ferlengez, Z; Maung, S; Schaffler, MB; Spray, DC; Suadicani, SO; Thi, MM				Seref-Ferlengez, Zeynep; Maung, Stephanie; Schaffler, Mitchell B.; Spray, David C.; Suadicani, Sylvia O.; Thi, Mia M.			P2X7R-Panx1 Complex Impairs Bone Mechanosignaling under High Glucose Levels Associated with Type-1 Diabetes	PLOS ONE			English	Article							P2X(7) RECEPTOR; OSTEOBLAST FUNCTION; INSULIN; PANNEXIN; ATP; EXPRESSION; RELEASE; GAP; OSTEOCYTES; RESORPTION	Type 1 diabetes (T1D) causes a range of skeletal problems, including reduced bone density and increased risk for bone fractures. However, mechanisms underlying skeletal complications in diabetes are still not well understood. We hypothesize that high glucose levels in T1D alters expression and function of purinergic receptors (P2Rs) and pannexin 1 (Panx1) channels, and thereby impairs ATP signaling that is essential for proper bone response to mechanical loading and maintenance of skeletal integrity. We first established a key role for P2X7 receptor-Panx1 in osteocyte mechanosignaling by showing that these proteins are co-expressed to provide a major pathway for flow-induced ATP release. To simulate in vitro the glucose levels to which bone cells are exposed in healthy vs. diabetic bones, we cultured osteoblast and osteocyte cell lines for 10 days in medium containing 5.5 or 25 mM glucose. High glucose effects on expression and function of P2Rs and Panx1 channels were determined by Western Blot analysis, quantification of Ca2+ responses to P2R agonists and oscillatory fluid shear stress (+/- 10 dyne/cm(2)), and measurement of flow-induced ATP release. Diabetic C57BL/6J-Ins2(Akita) mice were used to evaluate in vivo effects of high glucose on P2R and Panx1. Western blotting indicated altered P2X7R, P2Y(2)R and P2Y(4)R expression in high glucose exposed bone cells, and in diabetic bone tissue. Moreover, high glucose blunted normal P2R- and flow-induced Ca2+ signaling and ATP release from osteocytes. These findings indicate that T1D impairs load-induced ATP signaling in osteocytes and affects osteoblast function, which are essential for maintaining bone health.	[Seref-Ferlengez, Zeynep; Maung, Stephanie; Thi, Mia M.] Albert Einstein Coll Med, Dept Orthopaed Surg, Bronx, NY 10467 USA; [Seref-Ferlengez, Zeynep; Maung, Stephanie; Thi, Mia M.] Montefiore Med Ctr, Dept Orthopaed Surg, 111 E 210th St, Bronx, NY 10467 USA; [Spray, David C.; Suadicani, Sylvia O.; Thi, Mia M.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Seref-Ferlengez, Zeynep; Maung, Stephanie; Spray, David C.; Suadicani, Sylvia O.; Thi, Mia M.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Suadicani, Sylvia O.] Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA; [Seref-Ferlengez, Zeynep; Maung, Stephanie; Spray, David C.; Suadicani, Sylvia O.; Thi, Mia M.] Albert Einstein Coll Med, Labs Musculoskeletal Orthoped Res Einstein Montef, Bronx, NY 10467 USA; [Schaffler, Mitchell B.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; City University of New York (CUNY) System; City College of New York (CUNY)	Thi, MM (corresponding author), Albert Einstein Coll Med, Dept Orthopaed Surg, Bronx, NY 10467 USA.; Thi, MM (corresponding author), Montefiore Med Ctr, Dept Orthopaed Surg, 111 E 210th St, Bronx, NY 10467 USA.; Thi, MM (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA.; Thi, MM (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.; Thi, MM (corresponding author), Albert Einstein Coll Med, Labs Musculoskeletal Orthoped Res Einstein Montef, Bronx, NY 10467 USA.	mia.thi@einstein.yu.edu	Thi, Mia Mia/K-8772-2019	Spray, David/0000-0001-8368-5073	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Disease [DK091466, DK081435]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057139, AR041210]; National Institutes of Health [S10 RR020949]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057139, R01AR041210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, R01DK081435, R01DK091466, P30DK020541] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Lynda Bonewald (University of Missouri-Kansas City) for providing MLO-Y4 cells. This work was supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Disease [DK091466 (to MMT, SOS and ZS), DK081435 (to SOS and MMT)], the National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057139 (to MBS, DCS and MMT) and AR041210 (to MBS)], and equipment from a shared instrumentation grant from the National Institutes of Health (S10 RR020949).	Albright F., 1948, PARATHYROID GLANDS M; Balint E, 2001, BONE, V28, P21, DOI 10.1016/S8756-3282(00)00426-9; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Barth K, 2010, HISTOCHEM CELL BIOL, V134, P31, DOI 10.1007/s00418-010-0716-8; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Botolin S, 2006, J CELL BIOCHEM, V99, P411, DOI 10.1002/jcb.20842; BOUILLON R, 1995, J CLIN ENDOCR METAB, V80, P1194, DOI 10.1210/jc.80.4.1194; Brandao-Burch Andrea, 2012, Front Endocrinol (Lausanne), V3, P41, DOI 10.3389/fendo.2012.00041; Brown SA, 2004, CLIN DIABETES, V22, P10, DOI [10.2337/diaclin.22.1.10, DOI 10.2337/DIACLIN.22.1.10]; Bugger H, 2009, DIABETES, V58, P1986, DOI 10.2337/db09-0259; Cieslak M, 2014, ACTA BIOCHIM POL, V61, P655; Coe LM, 2013, J CELL PHYSIOL, V228, P689, DOI 10.1002/jcp.24177; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; Dixon SJ, 2000, DRUG DEVELOP RES, V49, P187, DOI 10.1002/(SICI)1098-2299(200003)49:3<187::AID-DDR9>3.0.CO;2-F; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Espallargues M, 2001, OSTEOPOROSIS INT, V12, P811, DOI 10.1007/s001980170031; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gallagher J. A., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P432; Gallagher J. A., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P125; Garcia-Hernandez A, 2012, BONE, V50, P276, DOI 10.1016/j.bone.2011.10.032; Gartland A, 2001, J BONE MINER RES, V16, P846, DOI 10.1359/jbmr.2001.16.5.846; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Genetos DC, 2005, J BONE MINER RES, V20, P41, DOI 10.1359/jbmr.041009; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gunczler P, 2001, J PEDIATR ENDOCR MET, V14, P525; Hoebertz A, 2003, TRENDS PHARMACOL SCI, V24, P290, DOI 10.1016/S0165-6147(03)00123-8; Hoebertz A, 2002, J CELL BIOCHEM, V86, P413, DOI 10.1002/jcb.10236; HOUGH S, 1981, ENDOCRINOLOGY, V108, P2228, DOI 10.1210/endo-108-6-2228; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Irwin R, 2006, ENDOCRINOLOGY, V147, P5760, DOI 10.1210/en.2006-0700; Kakoki M, 2006, J CLIN INVEST, V116, P1302, DOI 10.1172/JCI26958; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295, DOI 10.1007/BF03343726; Kennedy OD, 2014, BONE, V64, P132, DOI 10.1016/j.bone.2014.03.049; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; KRAKAUER JC, 1995, DIABETES, V44, P775, DOI 10.2337/diabetes.44.7.775; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072; Maggio ABR, 2010, J PEDIATR ENDOCR MET, V23, P697; McCabe LR, 2007, J CELL BIOCHEM, V102, P1343, DOI 10.1002/jcb.21573; Negoro H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106269; Oei L, 2015, CURR OSTEOPOROS REP, V13, P106, DOI 10.1007/s11914-015-0260-5; Orriss Isabel, 2011, Front Biosci (Schol Ed), V3, P1038; Orriss IR, 2006, BONE, V39, P300, DOI 10.1016/j.bone.2006.02.063; Orriss IR, 2012, BONE, V51, P389, DOI 10.1016/j.bone.2012.06.013; Orriss IR, 2010, CURR OPIN PHARMACOL, V10, P322, DOI 10.1016/j.coph.2010.01.003; Parajuli A, 2015, BONE, V81, P152, DOI 10.1016/j.bone.2015.07.012; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pellegatti P, 2011, FASEB J, V25, P1264, DOI 10.1096/fj.10-169854; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Reilly GC, 2003, BIORHEOLOGY, V40, P591; Sandilos JK, 2012, J PHYSIOL-LONDON, V590, P6257, DOI 10.1113/jphysiol.2012.240911; SASAKI T, 1991, ANAT REC, V231, P25, DOI 10.1002/ar.1092310105; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Suadicani SO, 2004, GLIA, V48, P217, DOI 10.1002/glia.20071; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Suadicani SO, 2009, ASN NEURO, V1, DOI 10.1042/AN20090001; Thi MM, 2013, P NATL ACAD SCI USA, V110, P21012, DOI 10.1073/pnas.1321210110; Thi MM, 2012, J MEMBRANE BIOL, V245, P401, DOI 10.1007/s00232-012-9462-2; Thi MM, 2010, AM J PHYSIOL-CELL PH, V299, pC994, DOI 10.1152/ajpcell.00544.2009; Thi MM, 2010, J BIOL CHEM, V285, P30931, DOI 10.1074/jbc.M110.114975; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yan WB, 2013, FRONT MED-PRC, V7, P81, DOI 10.1007/s11684-013-0243-9; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zayzafoon M, 2000, J CELL BIOCHEM, V79, P301, DOI 10.1002/1097-4644(20001101)79:2<301::AID-JCB130>3.0.CO;2-0; Zhen DH, 2010, J DIABETES COMPLICAT, V24, P334, DOI 10.1016/j.jdiacomp.2009.05.002	74	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155107	10.1371/journal.pone.0155107	http://dx.doi.org/10.1371/journal.pone.0155107			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159053	Green Published, gold			2022-12-27	WOS:000376576700044
J	Ayele, TA; Azale, T; Alemu, K; Abdissa, Z; Mulat, H; Fekadu, A				Ayele, Tadesse Awoke; Azale, Telake; Alemu, Kassahun; Abdissa, Zewditu; Mulat, Haregewoin; Fekadu, Abel			Prevalence and Associated Factors of Antenatal Depression among Women Attending Antenatal Care Service at Gondar University Hospital, Northwest Ethiopia	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; POSTNATAL DEPRESSION; RISK-FACTORS; MATERNAL DEPRESSION; INCOME COUNTRIES; PREGNANCY; COMMUNITY; SYMPTOMS; ILLNESS; GROWTH	Background Depression is the most prevalent psychiatric disorder during pregnancy and is associated with psychosocial and clinical obstetric factors. Depressive disorders are not only common and chronic among women throughout the world but also principal sources of disability. The scarce information and limited attention to the problem might aggravate the consequence of the problem and can limit the intervention to be taken. Therefore, the current study was conducted to determine the prevalence and identify associated factors for antenatal depression. Methods Institutional based cross-sectional study was conducted by taking a sample of 388 pregnant women coming for ANC service at Gondar University Hospital. Systematic random sampling technique was employed to recruit the study participants. Structured, pretested and interview administered questionnaire was used to collect related information while Beck Depression Inventory (BDI) was used to assess individuals depression condition. A cut off point with high sensitivity and specificity was determined and internal consistency of the tool was checked (Cronbach alpha = 0.82). Ep Info V. 2002 and STATA 12 were used for data entry and analyses, respectively. Adjusted Odds Ratio with its 95% CI was used to declare the statistical significance of the factors. Results Depression among pregnant women was found to be 23%(95% CI: 18.48%, 26.86%). Factors significantly associated with depression were: woman's age (20 to 29, AOR = 0.18,95% CI:0.07,0.49), occupation (housewife, AOR = 2.57,95% CI:1.21,5.46, merchant and daily laborers, AOR = 3.44 (1.38,8.58), previous pregnancy (No, AOR = 4.74,95% CI:1.58,14.17) and previous ANC follow up pattern (irregular, AOR = 11.43,95% CI:3.68,35.49), no follow up, AOR = 11.98, 95% CI:4.73,30.33). Conclusion Depression symptoms are common in pregnant mothers in the study area and interventions that would address the aforementioned factors would benefit to tackle further complications.	[Ayele, Tadesse Awoke; Alemu, Kassahun; Fekadu, Abel] Univ Gondar, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Azale, Telake] Univ Gondar, Coll Med & Hlth Sci, Dept Reprod Hlth, Gondar, Ethiopia; [Abdissa, Zewditu] Univ Gondar, Coll Med & Hlth Sci, Dept Anesthesia, Gondar, Ethiopia; [Mulat, Haregewoin] Univ Gondar, Coll Med & Hlth Sci, Dept Psychiat, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar	Alemu, K (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia.	alemukass@yahoo.com	Dadi, Abel Fekadu/AAU-3433-2020	Dadi, Abel Fekadu/0000-0001-9967-7713; Wassie, Abebaw Fekadu/0000-0003-2219-0952	University of Gondar	University of Gondar	This work was supported by the University of Gondar, research and community service project. University of Gondar was not involved in data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas S, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.16640; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Black MM, 2007, J CHILD PSYCHOL PSYC, V48, P764, DOI 10.1111/j.1469-7610.2007.01752.x; Caliskan D, 2007, J PSYCHOSOM OBST GYN, V28, P195, DOI 10.1080/01674820701450649; Center on the Developing Child at Harvard University, 2009, 8 HARV U CTR DEV CHI; Cooper P.J., 2004, S AFRICAN J PSYCHOL, V34, P113, DOI [10.1177/008124630403400107, DOI 10.1177/008124630403400107]; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Da Costa D, 2000, J AFFECT DISORDERS, V59, P31, DOI 10.1016/S0165-0327(99)00128-7; Dawson DA, 2005, COMPR PSYCHIAT, V46, P405, DOI 10.1016/j.comppsych.2005.01.006; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Golbasi Z, 2010, MATERN CHILD HLTH J, V14, P485, DOI 10.1007/s10995-009-0459-0; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Jebena MG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0699-5; Kaaya S F, 2010, Tanzan J Health Res, V12, P23; Koleva H, 2011, ARCH WOMEN MENT HLTH, V14, P99, DOI 10.1007/s00737-010-0184-0; Lawrie TA, 1998, S AFR MED J, V88, P1340; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Marcus Sheila M, 2009, Can J Clin Pharmacol, V16, pe15; Megabiaw B, 2013, ETHIOPIA BMC PSYCHIA, V13; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Mohammad KI, 2011, MIDWIFERY, V27, pE238, DOI 10.1016/j.midw.2010.10.008; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Organization WH, 2010, WORLD HLTH REP; Pajulo M, 2001, J AFFECT DISORDERS, V65, P9, DOI 10.1016/S0165-0327(00)00265-2; Patel V, 2004, BMJ-BRIT MED J, V328, P820, DOI 10.1136/bmj.328.7443.820; Patel V, 2002, AM J PSYCHIAT, V159, P143; Qiu C., 2007, BMC WOMENS HEALTH, V7, DOI [10.1186/1472-6874-7-15, DOI 10.1186/1472-6874-7-15]; Rahman A, 2007, ARCH DIS CHILD, V92, P24, DOI 10.1136/adc.2005.086579; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rahman A, 2007, J AFFECT DISORDERS, V100, P115, DOI 10.1016/j.jad.2006.10.004; Rochat T, 2009, 9TH INTERNATIONAL AI; Ross J, 2010, ARCH DIS CHILD FETAL, V96; Rubertssona C, 2005, JOURNAL OF REPRODUCT, V23; Sawyer A, 2010, J AFFECT DISORDERS, V123, P17, DOI 10.1016/j.jad.2009.06.027; Servili C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-693; Stewart D.E., 2003, U HLTH NETWORK WOMEN; Wissart Janice, 2005, BMC Pregnancy Childbirth, V5, P15, DOI 10.1186/1471-2393-5-15; Zeng YC, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0452-7	40	42	43	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155125	10.1371/journal.pone.0155125	http://dx.doi.org/10.1371/journal.pone.0155125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KX	27153193	gold, Green Submitted, Green Published			2022-12-27	WOS:000375677000072
J	Chen, HY; Shen, ZJ; Chen, JD; Zhang, HW; Chen, XH				Chen, Hanyu; Shen, Zhengjie; Chen, Jiandong; Zhang, Haowen; Chen, Xiaohu			Chinese Herbal Medicine for Aspirin Resistance: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MYOCARDIAL-INFARCTION; RISK; DEFINITION; PREVALENCE; MECHANISMS; PLATELETS; CHILDREN; DISEASE; STROKE	Objectives To assess the effectiveness and safety of Chinese herbal medicine (CHM) for the treatment of aspirin resistance (AR). Methods A comprehensive research of seven electronic databases was performed for comparative studies evaluating CHM for AR. Two authors independently extracted data and assessed the methodological quality of the included trials using the Cochrane risk of bias tool. Data wasere synthesized by using RevMan 5.3 software. (PROSPERO Registration #CRD42015020182) Results 18 randomized controlled trials (RCTs) involving 1,460 patients were included. 15 RCTs reported significant difference in the reduction of platelet aggregation rate (PAR) induced by adenosine diphosphate (ADP) (P < 0.05), and 11 reported significant effect of CHM plus aspirin to reduce PAR induced by arachidonic acid (AA) (P < 0.05) compared with aspirin 100mg/d treatment. The pooling data of 3 RCTs showed the thromboxane B-2 (TXB2) in patients with CHM plus aspirin versus aspirin were significantly reduced (Random Effect model (RE), Standard Deviation (SD) = -95.93, 95% Confidential Interval (CI)[-118.25,-73.61], P < 0.00001). Subgroup analysis showed that TXB2 (Fixed Effect model (FE), SD = -89.23, 95% CI[-121.96,-56.49], P < 0.00001) had significant difference in Tongxinluo capsule plus aspirin versus aspirin. 2 RCTs reported the clinical effective rate, and the meta-analysis result showed a significant difference in intervention and control group (FE, Relative Risk (RR) = 1.67, 95% CI[1.15, 2.42], P = 0.007 < 0.05). In 4 trials, CHM plus aspirin had better effects of reducing the reoccurrence of cerebral infarction than aspirin (FE, RR = 0.24, 95% CI [0.11, 0.49], P < 0.0001). And one trial showed that CHM plus aspirin could decrease the National Institutes of Health Stroke Scale (NHISS) score (P < 0.05) and increase the Barthel Index (BI) score (P < 0.05). 4 trials stated that there were no adverse effects occurred in intervention group, and analysis showed significant difference of CHM or CHM plus aspirin in reducing the occurrence of adverse events (FE, RR = 0.22, 95% CI[0.13, 0.39], P < 0.00001). 5 trials claimed that the CHM monotherapy and CHM adjunctive therapy for AR did not add the risk of bleeding (FE, RR = 0.50, 95% CI[0.20, 1.22], P = 0.13 > 0.05). Conclusions CHM may be effective and safe as an alternative and collaborative therapy for AR. However, the current evidence and potential promising findings should be interpreted with caution due to poor and varying methodological quality of included studies and the heterogeneity of interventions. Thus, further exploration of this strategy with adequately powered RCTs is warranted.	[Chen, Hanyu; Shen, Zhengjie; Zhang, Haowen] Nanjing Univ Chinese Med, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China; [Chen, Hanyu; Chen, Jiandong; Zhang, Haowen; Chen, Xiaohu] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Cardiol, Jiangsu Prov Hosp Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Shen, Zhengjie] Nanjing Univ Chinese Med, Translat Med Ctr, Key Lab Famous Doctors Proved Recipe Evaluat & Tr, State Adm Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Chen, XH (corresponding author), Nanjing Univ Chinese Med, Affiliated Hosp, Dept Cardiol, Jiangsu Prov Hosp Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China.	chenxhdoctor@126.com			National Natural Science Foundation of China [81273943]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	CXH received the funding from the National Natural Science Foundation of China (NO.81273943), available from http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list.	Bishopric NH, 2013, J AM COLL CARDIOL, V62, P1277, DOI 10.1016/j.jacc.2013.06.024; Chadha DS, 2014, CATHETER CARDIOVASC; Chai ZQ, 2008, PRACTICAL J MED PHAR, V04, P387; Cheng G, 2013, SHANXI MED J, V42, P1388; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; Floyd CN, 2014, PHARMACOL THERAPEUT, V141, P69, DOI 10.1016/j.pharmthera.2013.08.005; Guo H Y, 2012, CHINESE J MODERN DRU, V6, P74; Hankey GJ, 2006, LANCET, V367, P606, DOI 10.1016/S0140-6736(06)68040-9; Harrison P, 2007, THROMB RES, V120, P323, DOI 10.1016/j.thromres.2006.11.012; Heistein LC, 2008, PEDIATR CARDIOL, V29, P285, DOI 10.1007/s00246-007-9098-7; Huang H.M., 2014, GUIDE CHINA MED, P19; Huang LF, 2014, THROMB RES, V133, P848, DOI 10.1016/j.thromres.2014.02.009; Hurlen M, 2000, THROMB RES, V99, P487, DOI 10.1016/S0049-3848(00)00277-2; Krasopoulos G, 2008, BMJ-BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Kuliczkowski W, 2009, EUR HEART J, V30, P426, DOI 10.1093/eurheartj/ehn562; Larsen SB, 2013, THROMB HAEMOSTASIS, V109, P920, DOI 10.1160/TH12-09-0666; Lee JJ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-137; Liu AJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/890950; Liu DF, 2015, J NINGXIA MED U, V29, P205; Liu HQ, 2008, J LIAONING U TRADITI, V10, P109; Liu L, 2014, THROMB RES, V134, P866, DOI 10.1016/j.thromres.2014.07.019; Liu Q. K., 2010, ZHEJIANG J TRADITION, V45, P320; Ma XJ, 2012, CHINESE J MISDIAGNOS, V12, P530; Maione F, 2015, FITOTERAPIA, V100, P174, DOI 10.1016/j.fitote.2014.11.024; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; Phankingthongkum Rewat, 2013, Journal of the Medical Association of Thailand, V96, pS146; Sirachainan N, 2015, THROMB RES, V135, P916, DOI 10.1016/j.thromres.2015.03.003; Song SJ, 2008, SHANDONG MED J, V48, P13; Su W, 2012, CHINA PHARM, V21, P26; Tu X P, 2013, J NINGXIA MED U, V35, P172; Wang J, 2012, CHINA MED HERALD, V9, P17; Wen Dan, 2014, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V26, P585, DOI 10.3760/cma.j.issn.2095-4352.2014.08.013; Yi XY, 2013, INT J STROKE, V8, P535, DOI 10.1111/j.1747-4949.2012.00929.x; Yin Cheng-hua, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P380; Zhang HX, 2014, ARCH GERONTOL GERIAT, V59, P491, DOI 10.1016/j.archger.2014.04.005; Zhang JH, 2010, SENSOR LETT, V8, P16, DOI 10.1166/sl.2010.1194; Zhang K, 2013, J LIAONING U TCM, V15, P21; Zhang Lei, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P594; Zhang X, 2013, J INTERNAL MED CONCE, V8, P200; 吴同和, 2012, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V23, P1586	40	4	5	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154897	10.1371/journal.pone.0154897	http://dx.doi.org/10.1371/journal.pone.0154897			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153119	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000045
J	Curkic, I; Schutz, M; Oberhettinger, P; Diard, M; Claassen, M; Linke, D; Hardt, WD				Curkic, Ismeta; Schuetz, Monika; Oberhettinger, Philipp; Diard, Mederic; Claassen, Manfred; Linke, Dirk; Hardt, Wolf-Dietrich			Epitope-Tagged Autotransporters as Single-Cell Reporters for Gene Expression by a Salmonella Typhimurium wbaP Mutant	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; GREEN FLUORESCENT PROTEIN; III SECRETION SYSTEM; ESCHERICHIA-COLI; VIRULENCE; TIME; HETEROGENEITY; OPTIMIZATION; ENVIRONMENT; INDUCTION	Phenotypic diversity is an important trait of bacterial populations and can enhance fitness of the existing genotype in a given environment. To characterize different subpopulations, several studies have analyzed differential gene expression using fluorescent reporters. These studies visualized either single or multiple genes within single cells using different fluorescent proteins. However, variable maturation and folding kinetics of different fluorophores complicate the study of dynamics of gene expression. Here, we present a proof-of-principle study for an alternative gene expression system in a wbaP mutant of Salmonella Typhimurium (S. Tm) lacking the O-sidechain of the lipopolysaccharide. We employed the hemagglutinin (HA)-tagged inverse autotransporter invasin (invA(HA)) as a transcriptional reporter for the expression of the type three secretion system 1 (T1) in S. Tm. Using a two-reporter approach with GFP and the InvA(HA) in single cells, we verify that this reporter system can be used for T1 gene expression analysis, at least in strains lacking the O-antigen (wbaP), which are permissive for detection of the surface-exposed HA-epitope. When we placed the two reporters gfp and invA(HA) under the control of either one or two different promoters of the T1 regulon, we were able to show correlative expression of both reporters. We conclude that the invA(HA) reporter system is a suitable tool to analyze T1gene expression in S. Tm and propose its applicability as molecular tool for gene expression studies within single cells.	[Curkic, Ismeta; Diard, Mederic; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, Dept Biol, CH-8092 Zurich, Switzerland; [Schuetz, Monika; Oberhettinger, Philipp] Univ Tubingen, Inst Microbiol & Hyg, Tubingen, Germany; [Claassen, Manfred] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Linke, Dirk] Univ Oslo, EVOGENE Sect, Dept Biosci, Oslo, Norway	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eberhard Karls University of Tubingen; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oslo	Hardt, WD (corresponding author), ETH, Inst Microbiol, Dept Biol, CH-8092 Zurich, Switzerland.	hardt@micro.biol.ethz.ch	Diard, Mederic/AAA-3067-2020; Linke, Dirk/F-9147-2010	Linke, Dirk/0000-0003-3150-6752; Claassen, Manfred/0000-0002-4583-9083; Hardt, Wolf-Dietrich/0000-0002-9892-6420				Ackermann M, 2013, ISME J, V7, P465, DOI 10.1038/ismej.2012.131; Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Ackermann M, 2015, NAT REV MICROBIOL, V13, P497, DOI 10.1038/nrmicro3491; An YF, 2010, ANAL BIOCHEM, V402, P203, DOI 10.1016/j.ab.2010.03.040; Arnoldini M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001928; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cummings LA, 2006, MOL MICROBIOL, V61, P795, DOI 10.1111/j.1365-2958.2006.05271.x; Curtiss R, 2004, MODULATION IMMUNE RE; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diard M, 2013, NATURE, V494, P353, DOI 10.1038/nature11913; Duerr CU, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000567; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Grassl GA, 2003, INT J MED MICROBIOL, V293, P41, DOI 10.1078/1438-4221-00243; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Ilg K, 2009, INFECT IMMUN, V77, P2568, DOI 10.1128/IAI.01537-08; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kong QK, 2011, INFECT IMMUN, V79, P4227, DOI 10.1128/IAI.05398-11; Leo JC, 2015, INT J MED MICROBIOL, V305, P276, DOI 10.1016/j.ijmm.2014.12.011; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Moest TP, 2013, CURR OPIN MICROBIOL, V16, P38, DOI 10.1016/j.mib.2012.11.006; Neuenschwander M, 2007, HIG THROUGHPUT ASSAY; Oberhettinger P, 2015, J BIOL CHEM, V290, P1837, DOI 10.1074/jbc.M114.604769; Oberhettinger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047069; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Saini S, 2010, PLOS PATHOG, V6, DOI [10.1371/annotation/df7e26bc-4c62-43b4-865f-a39274d98ab3, 10.1371/journal.ppat.1001025]; Sanchez-Vargas FM, 2011, TRAVEL MED INFECT DI, V9, P263, DOI 10.1016/j.tmaid.2011.11.001; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Temme K, 2008, J MOL BIOL, V377, P47, DOI 10.1016/j.jmb.2007.12.044; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Wendland M, 2002, FEBS LETT, V521, P105, DOI 10.1016/S0014-5793(02)02834-X; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154828	10.1371/journal.pone.0154828	http://dx.doi.org/10.1371/journal.pone.0154828			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149272	gold, Green Published			2022-12-27	WOS:000375676800067
J	Kirsch, LP; Snagg, A; Heerey, E; Cross, ES				Kirsch, Louise P.; Snagg, Arielle; Heerey, Erin; Cross, Emily S.			The Impact of Experience on Affective Responses during Action Observation	PLOS ONE			English	Article							FACIAL REACTIONS; ELECTROPHYSIOLOGICAL INDEXES; ELECTROMYOGRAPHIC ACTIVITY; AESTHETIC PERCEPTION; DANCE; SIMULATION; EMPATHY; SMILE; FACES	Perceiving others in action elicits affective and aesthetic responses in observers. The present study investigates the extent to which these responses relate to an observer's general experience with observed movements. Facial electromyographic (EMG) responses were recorded in experienced dancers and non-dancers as they watched short videos of movements performed by professional ballet dancers. Responses were recorded from the corrugator supercilii (CS) and zygomaticus major (ZM) muscles, both of which show engagement during the observation of affect-evoking stimuli. In the first part of the experiment, participants passively watched the videos while EMG data were recorded. In the second part, they explicitly rated how much they liked each movement. Results revealed a relationship between explicit affective judgments of the movements and facial muscle activation only among those participants who were experienced with the movements. Specifically, CS activity was higher for disliked movements and ZM activity was higher for liked movements among dancers but not among non-dancers. The relationship between explicit liking ratings and EMG data in experienced observers suggests that facial muscles subtly echo affective judgments even when viewing actions that are not intentionally emotional in nature, thus underscoring the potential of EMG as a method to examine subtle shifts in implicit affective responses during action observation.	[Kirsch, Louise P.; Heerey, Erin; Cross, Emily S.] Bangor Univ, Wales Inst Cognit Neurosci, Sch Psychol, Bangor, Gwynedd, Wales; [Kirsch, Louise P.] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Snagg, Arielle] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA; [Heerey, Erin] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Cross, Emily S.] Radboud Univ Nijmegen, Dept Social & Cultural Psychol, Inst Behav Sci, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Bangor University; University of London; University College London; Claremont Colleges; Pomona College; Western University (University of Western Ontario); Radboud University Nijmegen	Kirsch, LP; Cross, ES (corresponding author), Bangor Univ, Wales Inst Cognit Neurosci, Sch Psychol, Bangor, Gwynedd, Wales.; Kirsch, LP (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.; Cross, ES (corresponding author), Radboud Univ Nijmegen, Dept Social & Cultural Psychol, Inst Behav Sci, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	l.kirsch@ucl.ac.uk; e.cross@bangor.ac.uk	Cross, Emily S./B-4565-2009; Kirsch, Louise P/AAF-5311-2020	Cross, Emily S./0000-0002-1671-5698; Kirsch, Louise P/0000-0002-8418-776X	Pomona College Summer Undergraduate Research Program internship travel grant; Future Research Leaders Award from the Economic and Social Research Council [ES/K001892/1]; VENI award from the Netherlands Organisation for Scientific Research [451-11-002]; Marie Curie Career Integration grant [CIG11-2012-322256]; Economic and Social Research Council [ES/K001892/1] Funding Source: researchfish; ESRC [ES/K001892/1] Funding Source: UKRI	Pomona College Summer Undergraduate Research Program internship travel grant; Future Research Leaders Award from the Economic and Social Research Council; VENI award from the Netherlands Organisation for Scientific Research; Marie Curie Career Integration grant; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by a Pomona College Summer Undergraduate Research Program internship travel grant to A.S. and a Future Research Leaders Award from the Economic and Social Research Council (ES/K001892/1; www.esrc.ac.uk), a VENI award from the Netherlands Organisation for Scientific Research (451-11-002; www.nwo.nl), and a Marie Curie Career Integration grant (CIG11-2012-322256; http://ec.europa.eu/research/mariecurieactions/) to E.S.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaibou A, 2008, NEUROPSYCHOLOGIA, V46, P1104, DOI 10.1016/j.neuropsychologia.2007.10.019; Blasing B, 2010, NEUROCOGNITION OF DANCE: MIND, MOVEMENT AND MOTOR SKILLS, P1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; CACIOPPO JT, 1990, AM PSYCHOL, V45, P16, DOI 10.1037/0003-066X.45.1.16; Calvo-Merino B, 2008, CONSCIOUS COGN, V17, P911, DOI 10.1016/j.concog.2007.11.003; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Cannon PR, 2010, COGNITION EMOTION, V24, P681, DOI 10.1080/02699930902927698; Chatterjee A, 2014, TRENDS COGN SCI, V18, P370, DOI 10.1016/j.tics.2014.03.003; Christensen J. F., 2016, J EXPT PSYCHOL HUMAN; Christensen JF, 2013, PSYCHOL AESTHET CREA, V7, P76, DOI 10.1037/a0031827; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00102; Cross ES, 2012, PHENOMENOL COGN SCI, V11, P5, DOI 10.1007/s11097-010-9190-y; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Forster M, 2013, EMOTION, V13, P280, DOI 10.1037/a0030115; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Gerger G, 2011, PSYCHOL AESTHET CREA, V5, P241, DOI 10.1037/a0024154; Grezes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055885; Heerey EA, 2013, PSYCHOL SCI, V24, P1446, DOI 10.1177/0956797612472203; Heller AS, 2011, NEUROIMAGE, V58, P930, DOI 10.1016/j.neuroimage.2011.06.057; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Jacobsen T, 2003, COGN AFFECT BEHAV NE, V3, P289, DOI 10.3758/CABN.3.4.289; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; Jola C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033343; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; Kirsch LP, 2015, ANN NY ACAD SCI, V1337, P130, DOI 10.1111/nyas.12634; Kirsch LP, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00521; Kirsch LP, 2016, NEUROSCIENCE BIOBEHA; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Lee TW, 2008, CEREB CORTEX, V18, P104, DOI 10.1093/cercor/bhm035; Mojzisch A, 2006, SOC NEUROSCI-UK, V1, P184, DOI 10.1080/17470910600985621; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Orgs G, 2013, CONSCIOUS COGN, V22, P603, DOI 10.1016/j.concog.2013.03.010; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Roye A, 2008, J PSYCHOPHYSIOL, V22, P41, DOI 10.1027/0269-8803.22.1.41; Schacht A, 2008, COGN AFFECT BEHAV NE, V8, P132, DOI 10.3758/CABN.8.2.132; Soussignan R, 2013, EMOTION, V13, P330, DOI 10.1037/a0029892; Ticini LF, 2015, AESTHETICS EMBODIED, P103, DOI DOI 10.1007/978-94-017-9379-7_7; Ticini LF, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00391; Topolinski S, 2009, COGNITION EMOTION, V23, P260, DOI 10.1080/02699930801994112; Van Boxtel A, 2001, PSYCHOPHYSIOLOGY, V38, P22, DOI 10.1017/S004857720199016X; van Boxtel A., 2010, P MEAS BEH 2010 EIND, P104, DOI DOI 10.1145/1931344.1931382; WHITTLESEA BWA, 1993, J EXP PSYCHOL LEARN, V19, P1235, DOI 10.1037/0278-7393.19.6.1235; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Winkielman P., 2002, EMOTIONAL COGNITION, V44, P111, DOI DOI 10.1075/AICR.44.05WIN	53	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154681	10.1371/journal.pone.0154681	http://dx.doi.org/10.1371/journal.pone.0154681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27149106	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800046
J	Low, LA; Bauer, LC; Klaunberg, BA				Low, Lucie A.; Bauer, Lucy C.; Klaunberg, Brenda A.			Comparing the Effects of Isoflurane and Alpha Chloralose upon Mouse Physiology	PLOS ONE			English	Article							RESTING-STATE FMRI; FUNCTIONAL CONNECTIVITY; ANESTHETIZED RAT; BOLD FMRI; SOMATOSENSORY CORTEX; PHARMACOLOGICAL MRI; FOREPAW STIMULATION; BLOOD-FLOW; AWAKE RATS; BRAIN	Functional magnetic resonance imaging of mice requires that the physiology of the mouse (body temperature, respiration and heart rates, blood pH level) be maintained in order to prevent changes affecting the outcomes of functional scanning, namely blood oxygenation level dependent (BOLD) measures and cerebral blood flow (CBF). The anesthetic used to sedate mice for scanning can have major effects on physiology. While alpha chloralose has been commonly used for functional imaging of rats, its effects on physiology are not well characterized in the literature for any species. In this study, we anesthetized or sedated mice with isoflurane or alpha chloralose for up to two hours, and monitored physiological parameters and arterial blood gasses. We found that, when normal body temperature is maintained, breathing rates for both drugs decrease over the course of two hours. In addition, alpha chloralose causes a substantial drop in heart rate and blood pH with severe hypercapnia (elevated blood CO2) that is not seen in isoflurane-treated animals. We suggest that alpha chloralose does not maintain normal mouse physiology adequately for functional brain imaging outcome measures.	[Low, Lucie A.; Bauer, Lucy C.] NIH, Natl Ctr Complementary & Integrat Hlth, Bldg 10, Bethesda, MD 20892 USA; [Klaunberg, Brenda A.] NINDS, NIH Mouse Imaging Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Low, LA (corresponding author), NIH, Natl Ctr Complementary & Integrat Hlth, Bldg 10, Bethesda, MD 20892 USA.	lucie.low@nih.gov		Low, Lucie/0000-0001-6082-8625	Division of Intramural Research at the National Center for Complementary and Integrative Health (NCCIH); NIH Mouse Imaging Facility at the National Institute for Neurological Disorders and Stroke (NINDS); National Center for Complementary & Integrative Health [ZIAAT000027] Funding Source: NIH RePORTER	Division of Intramural Research at the National Center for Complementary and Integrative Health (NCCIH); NIH Mouse Imaging Facility at the National Institute for Neurological Disorders and Stroke (NINDS); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the Division of Intramural Research at the National Center for Complementary and Integrative Health (NCCIH), and the NIH Mouse Imaging Facility at the National Institute for Neurological Disorders and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; Argmann CA, 2001, CURRENT PROTOCOLS MO; Baek K, 2016, BRAIN STRUCT FUNCT, V221, P2801, DOI 10.1007/s00429-015-1073-0; BALIS GU, 1964, PSYCHOPHARMACOLOGIA, V6, P1, DOI 10.1007/BF00710911; Baltes C, 2011, NMR BIOMED, V24, P439, DOI 10.1002/nbm.1613; Bruijnzeel AW, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu011; Bruns A, 2009, MAGN RESON MED, V61, P1451, DOI 10.1002/mrm.21779; Chao THH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097305; Chen YY, 2010, SOMATOSENS MOT RES, V27, P69, DOI 10.3109/08990220.2010.508222; Chin CL, 2008, BRIT J PHARMACOL, V153, P367, DOI 10.1038/sj.bjp.0707506; Ciobanu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032645; Constantinides Christakis, 2011, ILAR J, V52, pe21; Dahan A, 2003, BRIT J ANAESTH, V91, P40, DOI 10.1093/bja/aeg150; DALKARA T, 1995, J CEREBR BLOOD F MET, V15, P631, DOI 10.1038/jcbfm.1995.78; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Fox J., 2006, MOUSE BIOMEDICAL RES; Grandjean J, 2014, NEUROIMAGE, V102, P838, DOI 10.1016/j.neuroimage.2014.08.043; Guilfoyle DN, 2013, J NEUROSCI METH, V214, P144, DOI 10.1016/j.jneumeth.2013.01.019; HOLZGREFE HH, 1987, LAB ANIM SCI, V37, P587; Hoyt R., 2007, MOUSE BIOMEDICAL RES, V2nd, P23; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Iannetti GD, 2007, MAGN RESON IMAGING, V25, P978, DOI 10.1016/j.mri.2007.03.018; Itoh K, 2008, NEUROSCIENCE, V154, P732, DOI 10.1016/j.neuroscience.2008.03.080; Jonckers E, 2014, MAGN RESON MED, V72, P1103, DOI 10.1002/mrm.24990; Koretsky AP, 2012, NEUROIMAGE, V62, P602, DOI 10.1016/j.neuroimage.2012.01.005; Lewis NCS, 2014, J APPL PHYSIOL, V116, P1189, DOI 10.1152/japplphysiol.00114.2014; Liang ZF, 2015, NEUROIMAGE, V104, P89, DOI 10.1016/j.neuroimage.2014.10.013; Liang ZF, 2014, NEUROIMAGE, V103, P485, DOI 10.1016/j.neuroimage.2014.08.050; Madularu D, 2015, PSYCHONEUROENDOCRINO, V56, P200, DOI 10.1016/j.psyneuen.2015.02.022; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; McGuill M. W., 1989, ILAR News, V31, P5; MITCHELL JH, 1972, KIDNEY INT, V1, P375, DOI 10.1038/ki.1972.48; Muir WW, 2007, HDB VET ANESTHESIA; Nair G, 2004, MAGN RESON MED, V52, P430, DOI 10.1002/mrm.20158; Nasrallah FA, 2014, NEUROIMAGE, V86, P417, DOI 10.1016/j.neuroimage.2013.10.025; Nasrallah FA, 2014, NEUROIMAGE, V84, P27, DOI 10.1016/j.neuroimage.2013.08.004; Nasrallah FA, 2012, NMR BIOMED, V25, P1209, DOI 10.1002/nbm.2790; Peeters RR, 2001, MAGN RESON IMAGING, V19, P821, DOI 10.1016/S0730-725X(01)00391-5; Rao S, 2000, AM J PHYSIOL-CELL PH, V279, pC1, DOI 10.1152/ajpcell.2000.279.1.C1; Schroeter A, 2014, NEUROIMAGE, V94, P372, DOI 10.1016/j.neuroimage.2014.01.046; Schwarzkopf TM, 2013, EXP BIOL MED, V238, P84, DOI 10.1258/ebm.2012.012261; Scipioni RL, 1997, LAB ANIM SCI, V47, P293; Shah YB, 2005, PSYCHOPHARMACOLOGY, V180, P761, DOI 10.1007/s00213-005-2214-6; Sharp PS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12621; Shih YYI, 2008, MED ENG PHYS, V30, P953, DOI 10.1016/j.medengphy.2007.12.004; Silva AC, 2002, P NATL ACAD SCI USA, V99, P15182, DOI 10.1073/pnas.222561899; SILVERMAN J, 1993, LAB ANIM SCI, V43, P210; Sommers MG, 2009, NMR BIOMED, V22, P414, DOI 10.1002/nbm.1351; Szczesny G, 2004, LAB ANIM-UK, V38, P64, DOI 10.1258/00236770460734416; Tanaka Tadashi, 2005, J Anesth, V19, P277, DOI 10.1007/s00540-005-0341-1; Thompson GJ, 2015, J NEUROPHYSIOL, V114, P114, DOI 10.1152/jn.00235.2015; Thompson SJ, 2012, NEUROSCI LETT, V520, P131, DOI 10.1016/j.neulet.2012.03.015; UEKI M, 1992, ACTA ANAESTH SCAND, V36, P318, DOI 10.1111/j.1399-6576.1992.tb03474.x; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; WHITE WJ, 1987, VET CLIN N AM-SMALL, V17, P989, DOI 10.1016/S0195-5616(87)50102-4; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001; Zuurbier CJ, 2014, EXP BIOL MED, V239, P737, DOI 10.1177/1535370214524877	57	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154936	10.1371/journal.pone.0154936	http://dx.doi.org/10.1371/journal.pone.0154936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148970	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800094
J	Malhame, I; Cormier, M; Sugarman, J; Schwartzman, K				Malhame, Isabelle; Cormier, Maxime; Sugarman, Jordan; Schwartzman, Kevin			Latent Tuberculosis in Pregnancy: A Systematic Review	PLOS ONE			English	Review							GAMMA RELEASE ASSAY; ISONIAZID TREATMENT; WOMEN; EPIDEMIOLOGY; PREVENTION; INFECTION; RISK	Background In countries with low tuberculosis (TB) incidence, immigrants from higher incidence countries represent the major pool of individuals with latent TB infection (LTBI). The antenatal period represents an opportunity for immigrant women to access the medical system, and hence for potential screening and treatment of LTBI. However, such screening and treatment during pregnancy remains controversial. Objectives In order to further understand the prevalence, natural history, screening and management of LTBI in pregnancy, we conducted a systematic literature review addressing the screening and treatment of LTBI, in pregnant women without known HIV infection. Methods A systematic review of 4 databases (Embase, Embase Classic, Medline, Cochrane Library) covering articles published from January 1st 1980 to April 30th 2014. Articles in English, French or Spanish with relevant information on prevalence, natural history, screening tools, screening strategies and treatment of LTBI during pregnancy were eligible for inclusion. Articles were excluded if (1) Full text was not available (2) they were case series or case studies (3) they focused exclusively on prevalence, diagnosis and treatment of active TB (4) the study population was exclusively HIV-infected. Results Of 4,193 titles initially identified, 208 abstracts were eligible for review. Of these, 30 articles qualified for full text review and 22 were retained: 3 cohort studies, 2 case-control studies, and 17 cross-sectional studies. In the USA, the estimated prevalence of LTBI ranged from 14 to 48% in women tested, and tuberculin skin test (TST) positivity was associated with ethnicity. One study suggested that incidence of active TB was significantly increased during the 180 days postpartum (Incidence rate ratio, 1.95 (95% CI 1.24-3.07). There was a high level of adherence with both skin testing (between 90-100%) and chest radiography (93-100%.). In three studies from low incidence settings, concordance between TST and an interferon-gamma release assay was 77, 88 and 91% with kappa values ranging from 0.26 to 0.45. In low incidence settings, an IGRA may be more specific and less sensitive than TST, and results do not appear to be altered by pregnancy. The proportion of women who attended follow-up visits after positive tuberculin tests varied from 14 to 69%, while 5 to 42% of those who attended follow-up visits completed a minimum of 6 months of isoniazid treatment. One study raised the possibility of an association of pregnancy/post-partum state with INH hepatitis (risk ratio 2,5, 95% CI 0.8-8.2) and fatal hepatotoxicity (rate ratio 4.0, 95% CI 0.2-258). One study deemed INH safe during breastfeeding based on peak concentrations in plasma and breast milk after INH administration. Conclusion Pregnancy is an opportunity to screen for LTBI. Interferon-gamma release assays are likely comparable to tuberculin skin tests and may be used during pregnancy. Efforts should be made to improve adherence with follow-up and treatment post-partum. Further data are needed with respect to safety and feasibility of antepartum INH therapy, and with respect to alternative treatment regimens.	[Malhame, Isabelle; Cormier, Maxime; Schwartzman, Kevin] McGill Univ, Dept Med, Montreal, PQ, Canada; [Malhame, Isabelle; Cormier, Maxime; Sugarman, Jordan; Schwartzman, Kevin] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Malhame, Isabelle; Cormier, Maxime; Sugarman, Jordan; Schwartzman, Kevin] McGill Int TB Ctr, Montreal, PQ, Canada	McGill University; McGill University	Schwartzman, K (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Schwartzman, K (corresponding author), Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada.; Schwartzman, K (corresponding author), McGill Int TB Ctr, Montreal, PQ, Canada.	kevin.schwartzman@mcgill.ca		Cormier, Maxime/0000-0003-4608-6690				[Anonymous], 2015, GLOBAL TUBERCULOSIS; [Anonymous], 2015, LATENT TUBERCULOSIS; [Anonymous], 2015, TUBERCULOSIS EPIDEMI; [Anonymous], 2015, TREATMENT OPTIONS LA; Boggess KA, 2000, OBSTET GYNECOL, V96, P757, DOI 10.1016/S0029-7844(00)01039-5; Chehab BM, 2010, USE OF THE QUANTIFER; Cheng VCC, 2003, EUR J CLIN MICROBIOL, V22, P313, DOI 10.1007/s10096-003-0927-1; Crampin AC, 2004, INT J TUBERC LUNG D, V8, P194; Cruz CA, 2005, AM J OBSTET GYNECOL, V192, P1455, DOI 10.1016/j.ajog.2004.12.042; Dick Menzies M, 2014, CANADIAN TUBERCULOSI; Efferen LS, 2007, CURR OPIN PULM MED, V13, P205, DOI 10.1097/MCP.0b013e3280f6ceee; Espinal MA, 1996, J INFECT DIS, V173, P488, DOI 10.1093/infdis/173.2.488; FRANKS AL, 1989, PUBLIC HEALTH REP, V104, P151; Gebreegziabiher D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/364137; Jackson TD, 2001, AM J OBSTET GYNECOL, V184, P1090, DOI 10.1067/mob.2001.114921; Kwara A, 2008, CHEST, V133, P862, DOI 10.1378/chest.07-2024; Lighter-Fisher J, 2012, OBSTET GYNECOL, V120, P398, DOI 10.1097/AOG.0b013e3182617fe8; Magann EF, 1996, PRIMARY CARE UPDATE, V3, P143; Mathad JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092308; Mathad JS, 2012, CLIN INFECT DIS, V55, P1532, DOI 10.1093/cid/cis732; Medchill MT, 1999, AM J OBSTET GYNECOL, V180, P1579, DOI 10.1016/S0002-9378(99)70054-2; Meints L, 2010, J REPROD MED, V55, P382; METERSKY ML, 1993, CHEST, V103, P364, DOI 10.1378/chest.103.2.364; Ormerod P, 2001, THORAX, V56, P494, DOI 10.1136/thorax.56.6.494; Sackoff JE, 2006, AM J OBSTET GYNECOL, V194, P451, DOI 10.1016/j.ajog.2005.07.054; Schwartz N, 2009, AM J PERINAT, V26, P447, DOI 10.1055/s-0029-1214244; SEPULVEDA RL, 1995, TUBERCLE LUNG DIS, V76, P28, DOI 10.1016/0962-8479(95)90576-6; Sheriff FG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-52; Singh N, 2008, BRIT J CLIN PHARMACO, V65, P418, DOI 10.1111/j.1365-2125.2007.03061.x; Slopen ME, 2011, J PUBLIC HEALTH MAN, V17, P421, DOI 10.1097/PHH.0b013e31820759b8; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Worjoloh A, 2011, OBSTET GYNECOL, V118, P1363, DOI 10.1097/AOG.0b013e31823834a9; Zenner D, 2012, AM J RESP CRIT CARE, V185, P779, DOI 10.1164/rccm.201106-1083OC; 1996, INT J GYNAECOLOGY OB, V54, P187	35	38	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154825	10.1371/journal.pone.0154825	http://dx.doi.org/10.1371/journal.pone.0154825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149116	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800066
J	Chen, BK; Yang, YT; Cheng, X; Bian, J; Bennett, CL				Chen, Brian K.; Yang, Y. Tony; Cheng, Xi; Bian, John; Bennett, Charles L.			Petitioning the FDA to Improve Pharmaceutical, Device and Public Health Safety by Ordinary Citizens: A Descriptive Analysis	PLOS ONE			English	Article								The United States Constitution protects the right of citizens to petition the government for "a redress of grievances." This right has important implications for citizens desiring to advance the public health by petitioning administrative agencies, such as the Food and Drug Administration, to take safety actions. We examined a total of 1,915 petitions filed between 2001 and 2013 to investigate the outcomes of citizen petitions that address public health concerns. We found that most petitions were filed by manufacturers against other manufacturers. Only 346 (18%) of all petitions were submitted by individuals and non-profit organizations, and 178 (87.3%) of these petitions with a final response were denied. On average, these petitions required 2.85 years for a final agency decision, and many decisions remain pending 10-13 years after their initial submission. The great majority of the approved requests included some form of risk communication, such as labeling changes, boxed warnings or placement of a drug into a Risk Evaluation and Mitigation Strategy. As a policy instrument to improve the safety of medical and food products, the citizen petition process requires sophisticated legal and scientific expertise, and may not represent a viable route for ordinary citizens to petition the FDA to "redress grievances."	[Chen, Brian K.; Cheng, Xi] Univ S Carolina, Arnold Sch Publ Hlth, Dept Hlth Serv Policy & Management, Columbia, SC 29208 USA; [Yang, Y. Tony] George Mason Univ, Coll Hlth & Human Serv, Fairfax, VA 22030 USA; [Bian, John; Bennett, Charles L.] Univ S Carolina, South Carolina Coll Pharm, South Carolina Ctr Econ Excellence Medicat Safety, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; George Mason University; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chen, BK (corresponding author), Univ S Carolina, Arnold Sch Publ Hlth, Dept Hlth Serv Policy & Management, Columbia, SC 29208 USA.	bchen@mailbox.sc.edu		Chen, Brian/0000-0001-6384-1673	American Cancer Society [IRG-13-043-01]; National Institute of Health [1R01CA165609-01A1]; South Carolina SmartState Program; NATIONAL CANCER INSTITUTE [R01CA165609] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina SmartState Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded partly by the American Cancer Society (IRG-13-043-01), the National Institute of Health (1R01CA165609-01A1), the South Carolina SmartState Program, and an unrestricted grant from Doris Levkoff Meddin to the South Carolina College of Pharmacy Center for Medication Safety and Efficacy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton TM, 2015, WALL STREET J; Carrier Michael A., 2012, CARDOZO L REV, V34, P249; Chen B, 2012, J ONCOLOGY PRACTICE; James WPT, SCOUT STUDY RISK BEN	4	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155259	10.1371/journal.pone.0155259	http://dx.doi.org/10.1371/journal.pone.0155259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171162	gold, Green Published			2022-12-27	WOS:000376588600100
J	Doucet, GE; He, XS; Sperling, M; Sharan, A; Tracy, JI				Doucet, Gaelle E.; He, Xiaosong; Sperling, Michael; Sharan, Ashwini; Tracy, Joseph I.			Gray Matter Abnormalities in Temporal Lobe Epilepsy: Relationships with Resting-State Functional Connectivity and Episodic Memory Performance	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; DEFAULT-MODE NETWORK; STRUCTURAL CONNECTIVITY; CEREBRAL-CORTEX; ATROPHY; HIPPOCAMPUS; CAPACITY; PATTERNS; ANTERIOR; DORSAL	Temporal lobe epilepsy (TLE) affects multiple brain regions through evidence from both structural (gray matter; GM) and functional connectivity (FC) studies. We tested whether these structural abnormalities were associated with FC abnormalities, and assessed the ability of these measures to explain episodic memory impairments in this population. A resting-state and T1 sequences were acquired on 94 (45 with mesial temporal pathology) TLE patients and 50 controls, using magnetic resonance imaging (MRI) technique. A voxel-based morphometry analysis was computed to determine the GM volume differences between groups (right, left TLE, controls). Resting-state FC between the abnormal GM volume regions was computed, and compared between groups. Finally, we investigated the relation between EM, GM and FC findings. Patients with and without temporal pathology were analyzed separately. The results revealed reduced GM volume in multiple regions in the patients relative to the controls. Using FC, we found the abnormal GM regions did not display abnormal functional connectivity. Lastly, we found in left TLE patients, verbal episodic memory was associated with abnormal left posterior hippocampus volume, while in right TLE, non-verbal episodic memory was better predicted by resting-state FC measures. This study investigated TLE abnormalities using a multi-modal approach combining GM, FC and neurocognitive measures. We did not find that the GM abnormalities were functionally or abnormally connected during an interictal resting state, which may reflect a weak sensitivity of functional connectivity to the epileptic network. We provided evidence that verbal and non-verbal episodic memory in left and right TLE patients may have distinct relationships with structural and functional measures. Lastly, we provide data suggesting that in the setting of occult, non-lesional right TLE pathology, a coupling of structural and functional abnormalities in extra-temporal/non-ictal regions is necessary to produce reductions in episodic memory recall. The latter, in particular, demonstrates the complex structure/function interactions at work when trying to understand cognition in TLE, suggesting that subtle network effects can emerge bearing specific relationships to hemisphere and the type of pathology.	[Doucet, Gaelle E.; He, Xiaosong; Sperling, Michael; Tracy, Joseph I.] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Sharan, Ashwini] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Tracy, JI (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	joseph.tracy@jefferson.edu	Doucet, Gaelle/H-9367-2019; He, Xiaosong/J-5580-2019	Doucet, Gaelle/0000-0003-4120-0474; He, Xiaosong/0000-0002-7941-2918				Barron DS, 2013, NEUROIMAGE-CLIN, V2, P25, DOI 10.1016/j.nicl.2012.11.004; Bonilha L, 2005, NEUROIMAGE, V25, P1016, DOI 10.1016/j.neuroimage.2004.11.050; Bonilha L, 2004, ARCH NEUROL-CHICAGO, V61, P1379, DOI 10.1001/archneur.61.9.1379; Bonilha L, 2007, HUM BRAIN MAPP, V28, P1376, DOI 10.1002/hbm.20373; Bonilha L, 2010, EPILEPSIA, V51, P519, DOI 10.1111/j.1528-1167.2009.02506.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Centeno M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00093; Chiang SR, 2016, EPILEPSY RES, V120, P37, DOI 10.1016/j.eplepsyres.2015.12.002; Coan AC, 2014, EPILEPSIA, V55, P1187, DOI 10.1111/epi.12670; Coan AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085843; Concha L, 2009, J NEUROL NEUROSUR PS, V80, P312, DOI 10.1136/jnnp.2007.139287; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Delis DC., 2000, CALIFORNIA VERBAL LE; DeMaster D, 2014, CEREB CORTEX, V24, P3036, DOI 10.1093/cercor/bht160; Doucet G, 2013, HUM BRAIN MAPP, V34, P2202, DOI 10.1002/hbm.22059; Doucet G, 2013, BRAIN CONNECT, V3, P398, DOI 10.1089/brain.2013.0158; Doucet GE, 2013, BRAIN COGNITION, V83, P171, DOI 10.1016/j.bandc.2013.08.001; Doucet GE, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00023; Focke NK, 2008, NEUROIMAGE, V40, P728, DOI 10.1016/j.neuroimage.2007.12.031; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Santana MTCG, 2014, SEIZURE-EUR J EPILEP, V23, P274, DOI 10.1016/j.seizure.2013.12.006; Gross DW, 2011, EPILEPSIA, V52, P32, DOI 10.1111/j.1528-1167.2011.03149.x; Hagemann G, 2002, J NEUROL, V249, P1651, DOI 10.1007/s00415-002-0843-9; Haneef Z, 2014, EPILEPSIA, V55, P137, DOI 10.1111/epi.12476; Hermann Bruce, 2002, CNS Spectr, V7, P343; Holmes MJ, 2013, BRAIN CONNECT, V3, P22, DOI 10.1089/brain.2012.0103; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Keller SS, 2008, EPILEPSIA, V49, P741, DOI 10.1111/j.1528-1167.2007.01485.x; Keller SS, 2002, J NEUROL NEUROSUR PS, V73, P648, DOI 10.1136/jnnp.73.6.648; Labate A, 2010, EPILEPSIA, V51, P506, DOI 10.1111/j.1528-1167.2009.02310.x; McCormick C, 2014, NEUROIMAGE-CLIN, V5, P188, DOI 10.1016/j.nicl.2014.05.008; McCormick C, 2013, EPILEPSIA, V54, P809, DOI 10.1111/epi.12098; Morgan VL, 2010, EPILEPSY RES, V88, P168, DOI 10.1016/j.eplepsyres.2009.10.018; Norman KA, 2010, HIPPOCAMPUS, V20, P1217, DOI 10.1002/hipo.20855; Pail M, 2010, EPILEPSIA, V51, P511, DOI 10.1111/j.1528-1167.2009.02324.x; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Persson J, 2014, NEUROIMAGE, V99, P215, DOI 10.1016/j.neuroimage.2014.05.038; Pustina D, 2015, HUM BRAIN MAPP, V36, P85, DOI 10.1002/hbm.22614; Pustina D, 2014, EPILEPSIA, V55, P1406, DOI 10.1111/epi.12721; Riederer F, 2008, NEUROLOGY, V71, P419, DOI 10.1212/01.wnl.0000324264.96100.e0; Sequeira KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053204; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; SPERLING MR, 1992, NEUROLOGY, V42, P416, DOI 10.1212/WNL.42.2.416; Tian LX, 2007, NEUROIMAGE, V36, P684, DOI 10.1016/j.neuroimage.2007.03.044; Tousseyn S, 2015, EPILEPSIA; Tracy J., 2015, COGNITIVE PLASTICITY; Tracy JI, 2007, NEUROLOGY, V68, P1101, DOI 10.1212/01.wnl.0000242582.83632.73; Voets NL, 2009, HUM BRAIN MAPP, V30, P4070, DOI 10.1002/hbm.20830; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yoo JY, 2014, EPILEPSIA, V55, P289, DOI 10.1111/epi.12505; Zhang ZQ, 2010, BRAIN RES, V1323, P152, DOI 10.1016/j.brainres.2010.01.042; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2	55	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154660	10.1371/journal.pone.0154660	http://dx.doi.org/10.1371/journal.pone.0154660			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171178	Green Published, gold, Green Submitted			2022-12-27	WOS:000376588600067
J	Thai, DH; Huckemann, S; Gottschlich, C				Duy Hoang Thai; Huckemann, Stephan; Gottschlich, Carsten			Filter Design and Performance Evaluation for Fingerprint Image Segmentation	PLOS ONE			English	Article							2-DIMENSIONAL FRINGE PATTERNS; MCCLELLAN TRANSFORMATIONS; NATURAL DEMODULATION; ENHANCEMENT	Fingerprint recognition plays an important role in many commercial applications and is used by millions of people every day, e.g. for unlocking mobile phones. Fingerprint image segmentation is typically the first processing step of most fingerprint algorithms and it divides an image into foreground, the region of interest, and background. Two types of error can occur during this step which both have a negative impact on the recognition performance: 'true' foreground can be labeled as background and features like minutiae can be lost, or conversely 'true' background can be misclassified as foreground and spurious features can be introduced. The contribution of this paper is threefold: firstly, we propose a novel factorized directional bandpass (FDB) segmentation method for texture extraction based on the directional Hilbert transform of a Butterworth bandpass (DHBB) filter interwoven with soft-thresholding. Secondly, we provide a manually marked ground truth segmentation for 10560 images as an evaluation benchmark. Thirdly, we conduct a systematic performance comparison between the FDB method and four of the most often cited fingerprint segmentation algorithms showing that the FDB segmentation method clearly outperforms these four widely used methods. The benchmark and the implementation of the FDB method are made publicly available.	[Duy Hoang Thai; Huckemann, Stephan; Gottschlich, Carsten] Univ Gottingen, Inst Math Stochast, Goldschmidtstr 7, D-37077 Gottingen, Germany; [Duy Hoang Thai] SAMSI, 19 TW Alexander Dr, Res Triangle Pk, NC 27709 USA	University of Gottingen	Thai, DH (corresponding author), Univ Gottingen, Inst Math Stochast, Goldschmidtstr 7, D-37077 Gottingen, Germany.; Thai, DH (corresponding author), SAMSI, 19 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	dhthai@samsi.info			German Research Foundation (DFG); Open Access Publication Funds of the University of Gottingen; National Science Foundation [DMS-1127914]; Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences; Niedersachsen Vorab of the Volkswagen Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of the University of Gottingen; National Science Foundation(National Science Foundation (NSF)); Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences; Niedersachsen Vorab of the Volkswagen Foundation	The authors gratefully acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Funds of the University of Gottingen. D.H Thai is supported by the National Science Foundation under Grant DMS-1127914 to the Statistical and Applied Mathematical Sciences Institute. S. Huckemann and C. Gottschlich gratefully acknowledge the support of the Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences and the Niedersachsen Vorab of the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Funds of the University of Gottingen. D.H Thai is supported by the National Science Foundation under Grant DMS-1127914 to the Statistical and Applied Mathematical Sciences Institute. S. Huckemann and C. Gottschlich gratefully acknowledge the support of the Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences and the Niedersachsen Vorab of the Volkswagen Foundation. The authors would like to thank Benjamin Eltzner, Axel Munk, Gerlind Plonka-Hoch and Yvo Pokern for their valuable comments.	Bartunek JS, 2008, CISP 2008: FIRST INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING, VOL 5, PROCEEDINGS, P756, DOI 10.1109/CISP.2008.774; Bartunek JS, 2006, CONF REC ASILOMAR C, P598; Bartunek JS, 2013, IEEE T IMAGE PROCESS, V22, P644, DOI 10.1109/TIP.2012.2220373; Bartunek JS, 2016, FINGERPRINT IMAGE EN; Bazen Asker M, 2001, PRORISC 2001 WORKSHO, P276; Candes E, 2006, MULTISCALE MODEL SIM, V5, P861, DOI 10.1137/05064182X; Cao K, 2014, IEEE T PATTERN ANAL, V36, P1847, DOI 10.1109/TPAMI.2014.2302450; Chaudhury KN, 2009, IEEE T SIGNAL PROCES, V57, P3411, DOI 10.1109/TSP.2009.2020767; Chen XJ, 2004, EURASIP J APPL SIG P, V2004, P480, DOI 10.1155/S1110865704309194; Chikkerur S, 2007, PATTERN RECOGN, V40, P198, DOI 10.1016/j.patcog.2006.05.036; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Felsberg M, 2001, IEEE T SIGNAL PROCES, V49, P3136, DOI 10.1109/78.969520; Ferreira PM, 2015, LECT NOTES COMPUT SC, V9117, P245, DOI 10.1007/978-3-319-19390-8_28; Fronthaler H, 2008, IEEE T IMAGE PROCESS, V17, P354, DOI 10.1109/TIP.2007.916155; Ghafoor M, 2014, IET IMAGE PROCESS, V8, P417, DOI 10.1049/iet-ipr.2013.0528; Gottschlich C, 2012, IET BIOMETRICS, V1, P105, DOI 10.1049/iet-bmt.2012.0003; Gottschlich C, 2015, P ISPA ZAGR CROAT, P85; Gottschlich C, 2014, 2014 IEEE/IAPR INTERNATIONAL JOINT CONFERENCE ON BIOMETRICS (IJCB 2014); Gottschlich C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148552; Gottschlich C, 2014, IET BIOMETRICS, V3, P291, DOI 10.1049/iet-bmt.2013.0065; Gottschlich C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110214; Gottschlich C, 2012, IEEE T IMAGE PROCESS, V21, P2220, DOI 10.1109/TIP.2011.2170696; Gottschlich C, 2011, IEEE T INF FOREN SEC, V6, P1165, DOI 10.1109/TIFS.2011.2143406; Gottschlich C, 2009, IEEE T INF FOREN SEC, V4, P802, DOI 10.1109/TIFS.2009.2033219; Hahn S.L., 1996, HILBERT TRANSFORMS S, VVolume 2; Haltmeier M, 2014, APPL COMPUT HARMON A, V36, P434, DOI 10.1016/j.acha.2013.07.004; Hauser S, 2014, INTERNATIONAL JOURNA, V12; Held S, 2010, IEEE T IMAGE PROCESS, V19, P653, DOI 10.1109/TIP.2009.2036713; Huckemann S, 2008, IEEE T PATTERN ANAL, V30, P1507, DOI 10.1109/TPAMI.2007.70826; Kocevar M, 2017, J REAL-TIME IMAGE PR, V13, P773, DOI 10.1007/s11554-014-0440-z; Larkin KG, 2001, J OPT SOC AM A, V18, P1862, DOI 10.1364/JOSAA.18.001862; Larkin KG, 2001, J OPT SOC AM A, V18, P1871, DOI 10.1364/JOSAA.18.001871; Larkin KG, 2007, OPT EXPRESS, V15, P8667, DOI 10.1364/OE.15.008667; Ma JW, 2010, IEEE SIGNAL PROC MAG, V27, P118, DOI 10.1109/MSP.2009.935453; Maio D, 2004, LECT NOTES COMPUT SC, V3072, P1; Maio D, 2002, INT C PATT RECOG, P811, DOI 10.1109/ICPR.2002.1048144; Maio D, 2002, IEEE T PATTERN ANAL, V24, P402, DOI 10.1109/34.990140; Maltoni D., 2009, HDB FINGERPRINT RECO; McClellan JH, 1973, P 7 ANN PRINC C INF, P247; MECKLENBRAUKER WFG, 1976, IEEE T CIRCUITS SYST, V23, P414, DOI 10.1109/TCS.1976.1084237; MEHTRE BM, 1987, PATTERN RECOGN, V20, P429, DOI 10.1016/0031-3203(87)90069-0; MEHTRE BM, 1989, PATTERN RECOGN, V22, P381, DOI 10.1016/0031-3203(89)90047-2; MERSEREAU RM, 1976, IEEE T CIRCUITS SYST, V23, P405, DOI 10.1109/TCS.1976.1084236; Nasri M, 2009, NEUROCOMPUTING, V72, P1012, DOI 10.1016/j.neucom.2008.04.016; Nimkar R., 2014, INT J COMPUTER APPL, V95, P20; Proakis J. G., 2007, DIGITAL SIGNAL PROCE; Sanam TF, 2013, EURASIP J AUDIO SPEE, DOI 10.1186/1687-4722-2013-25; Shen L, 2001, LECT NOTES COMPUT SC, V2091, P266; SHERLOCK BG, 1994, IEE P-VIS IMAGE SIGN, V141, P87, DOI 10.1049/ip-vis:19949924; Sonka M., 2008, IMAGE PROCESSING ANA; Sutthiwichaiporn P, 2013, PATTERN RECOGN, V46, P2465, DOI 10.1016/j.patcog.2013.02.002; Thai DH, 2016, EURASIP J IMAGE VIDE, DOI 10.1186/s13640-016-0110-0; Thai DH, GLOBAL VARIATIONAL M; Tseng CC, 2001, IEE P-VIS IMAGE SIGN, V148, P325, DOI 10.1049/ip-vis:20010410; Unser M, 2000, P IEEE, V88, P569, DOI 10.1109/5.843002; Unser M, 2011, IEEE T IMAGE PROCESS, V20, P2705, DOI 10.1109/TIP.2011.2138147; Unser M, 2010, IEEE T IMAGE PROCESS, V19, P636, DOI 10.1109/TIP.2009.2038832; Unser M, 2009, IEEE T IMAGE PROCESS, V18, P2402, DOI 10.1109/TIP.2009.2027628; Van De Ville D, 2005, IEEE T IMAGE PROCESS, V14, P1798, DOI 10.1109/TIP.2005.857249; Wang L, 2005, LECT NOTES ARTIF INT, V3584, P446; Wu CH, 2007, LECT NOTES COMPUT SC, V4642, P1095; Yang JC, 2013, IEEE T HUM-MACH SYST, V43, P235, DOI 10.1109/TSMCC.2011.2174049; Yi S, 2009, IEEE T IMAGE PROCESS, V18, P929, DOI 10.1109/TIP.2009.2013082; Zhang JY, 2013, IEEE T INF FOREN SEC, V8, P1261, DOI 10.1109/TIFS.2013.2267491; Zhu E, 2006, PATTERN RECOGN, V39, P1452, DOI 10.1016/j.patcog.2006.03.001	66	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154160	10.1371/journal.pone.0154160	http://dx.doi.org/10.1371/journal.pone.0154160			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171150	Green Published, Green Submitted, gold			2022-12-27	WOS:000376588600052
J	Kuo, HC; Li, SC; Guo, MMH; Huang, YH; Yu, HR; Huang, FC; Jiao, FY; Kuo, HC; Andrade, J; Chan, WC				Kuo, Ho-Chang; Li, Sung-Chou; Guo, Mindy Ming-Huey; Huang, Ying-Hsien; Yu, Hong-Ren; Huang, Fu-Chen; Jiao, Fuyong; Kuo, Hsing-Chun; Andrade, Jorge; Chan, Wen-Ching			Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease	PLOS ONE			English	Article							NEBULETTE MUTATIONS; RISK-FACTORS; TNF-ALPHA; LOCI; EXPRESSION; SINGLE; MODEL; MATRIX-METALLOPROTEINASE-9; LYMPHOCYTES; RETREATMENT	Kawasaki disease (KD) or Kawasaki syndrome is known as a vasculitis of small to medium-sized vessels, and coronary arteries are predominantly involved in childhood. Generally, 20-25% of untreated with IVIG and 3-5% of treated KD patients have been developed coronary artery lesions (CALs), such as dilatation and aneurysm. Understanding how coronary artery aneurysms (CAAs) are established and maintained in KD patients is therefore of great importance. Upon our previous genotyping data of 157 valid KD subjects, a genome-wide association study (GWAS) has been conducted among 11 (7%) CAA-developed KD patients to reveal five significant genetic variants passed pre-defined thresholds and resulted in two novel susceptibility protein-coding genes, which are NEBL (rs16921209 (P = 7.44 x 10(-9); OR = 32.22) and rs7922552 (P = 8.43 x 10(-9); OR = 32.0)) and TUBA3C (rs17076896 (P = 8.04 x 10(-9); OR = 21.03)). Their known functions have been reported to associate with cardiac muscle and tubulin, respectively. As a result, this might imply their putative roles of establishing CAAs during KD progression. Additionally, various model analyses have been utilized to determine dominant and recessive inheritance patterns of identified susceptibility mutations. Finally, all susceptibility genes hit by significant genetic variants were further investigated and the top three representative gene-ontology (GO) clusters were regulation of cell projection organization, neuron recognition, and peptidyl-threonine phosphorylation. Our results help to depict the potential routes of the pathogenesis of CAAs in KD patients and will facilitate researchers to improve the diagnosis and prognosis of KD in personalized medicine.	[Kuo, Ho-Chang; Guo, Mindy Ming-Huey; Huang, Ying-Hsien; Yu, Hong-Ren; Huang, Fu-Chen] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Guo, Mindy Ming-Huey; Huang, Ying-Hsien; Yu, Hong-Ren; Huang, Fu-Chen] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Li, Sung-Chou; Guo, Mindy Ming-Huey; Huang, Ying-Hsien; Yu, Hong-Ren; Huang, Fu-Chen; Chan, Wen-Ching] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Li, Sung-Chou; Chan, Wen-Ching] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Genom & Prote Core Lab, Kaohsiung, Taiwan; [Jiao, Fuyong] Shaanxi Prov Peoples Hosp, Childrens Hosp, Xian, Peoples R China; [Jiao, Fuyong] Xi An Jiao Tong Univ, Xian 710049, Peoples R China; [Kuo, Hsing-Chun] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Chan, Wen-Ching] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Xi'an Medical University; Xi'an Jiaotong University; Chang Gung University of Science & Technology; University of Chicago	Chan, WC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Chan, WC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Genom & Prote Core Lab, Kaohsiung, Taiwan.; Chan, WC (corresponding author), Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA.	wenching.chan@gmail.com	Kuo, Ho-Chang/AAQ-6644-2020; Andrade, Jorge/H-3104-2019; 于, 鴻仁/AAW-6827-2021; Li, Sung-Chou/AGZ-8626-2022	Kuo, Ho-Chang/0000-0002-3295-2984; Andrade, Jorge/0000-0003-3210-2186; 于, 鴻仁/0000-0003-1242-8760; Li, Sung-Chou/0000-0002-3016-9718; CHAN, WEN-CHING/0000-0003-0034-7277	Kaohsiung Chang Gung Memorial Hospital [CMRPG8C1082, CMRPG8B0212, CMRPG8D1561, CMRPG8D0521, CLRPG8D0112, CMRPG8D0032]; Ministry of Science and Technology, Taiwan [MOST 102-2314-B-182-053-MY3]; Biological Sciences Division at the University of Chicago; Institute for Translational Medicine, CTSA grant from the National Institutes of Health [UL1 TR000430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Kaohsiung Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Biological Sciences Division at the University of Chicago(University of Chicago); Institute for Translational Medicine, CTSA grant from the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This was supported by the grants from Kaohsiung Chang Gung Memorial Hospital (CMRPG8C1082, CMRPG8B0212, CMRPG8D1561 and CMRPG8D0521, CLRPG8D0112, and CMRPG8D0032). This study was partly supported by a grant from the Ministry of Science and Technology, Taiwan (MOST 102-2314-B-182-053-MY3). The Center for Research Informatics is funded by the Biological Sciences Division at the University of Chicago with additional funding provided by the Institute for Translational Medicine, CTSA grant number UL1 TR000430 from the National Institutes of Health.; We thank the Genomics & Proteomics Core Laboratory, Department of Medical Research, Kaohsiung Chang Gung Memorial Hospital for technical supports, as well as Kawasaki disease center, Kaohsiung Chang Gung Memorial Hospital for providing experimental data. This was supported by the grants from Kaohsiung Chang Gung Memorial Hospital (CMRPG8C1082, CMRPG8B0212, CMRPG8D1561 and CMRPG8D0521, CLRPG8D0112, and CMRPG8D0032). This study was partly supported by a grant from the Ministry of Science and Technology, Taiwan (MOST 102-2314-B-182-053-MY3). The Center for Research Informatics is funded by the Biological Sciences Division at the University of Chicago with additional funding provided by the Institute for Translational Medicine, CTSA grant number UL1 TR000430 from the National Institutes of Health.	Bowles NE, 2014, MOL GENET GENOM MED, V2, P356, DOI 10.1002/mgg3.79; Brown TJ, 2001, J INFECT DIS, V184, P940, DOI 10.1086/323155; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Burns JC, 1996, J AM COLL CARDIOL, V28, P253, DOI 10.1016/0735-1097(96)00099-X; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; Chang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072037; Chen YC, 2014, INT J PUBLIC ADM DIG, V1, P1, DOI 10.4018/ijpada.2014010101; Choi Yu Mi, 2012, Korean J Pediatr, V55, P18, DOI 10.3345/kjp.2012.55.1.18; Chopra N, 2011, CURR OPIN CARDIOL, V26, P196, DOI 10.1097/HCO.0b013e3283459893; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Duan JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103329; Gavin PJ, 2003, ARTERIOSCL THROM VAS, V23, P576, DOI 10.1161/01.ATV.0000065385.47152.FD; Guiducci S, 2011, CLIN EXP RHEUMATOL, V29, pS121; Guo MMH, 2015, ALLERGY, V70, P310, DOI 10.1111/all.12558; Hildebrand JM, 2011, IMMUNOL REV, V244, P55, DOI 10.1111/j.1600-065X.2011.01055.x; Hsueh KC, 2010, EUR J PEDIATR, V169, P713, DOI 10.1007/s00431-009-1099-5; Huang YC, 2010, INT J IMMUNOGENET, V37, P439, DOI 10.1111/j.1744-313X.2010.00943.x; Igarashi H, 2001, CLIN EXP RHEUMATOL, V19, P751; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kim JJ, 2013, J HUM GENET, V58, P521, DOI 10.1038/jhg.2013.43; Kim JJ, 2012, PEDIATR CARDIOL, V33, P513, DOI 10.1007/s00246-011-0143-1; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Kim T, 2007, EUR J PEDIATR, V166, P421, DOI 10.1007/s00431-006-0251-8; Ko TM, 2015, CIRC RES, V116, P876, DOI 10.1161/CIRCRESAHA.116.305834; Kuo HC, 2015, ARTHRITIS RHEUMATOL, V67, P828, DOI 10.1002/art.38976; Kuo HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091118; Kuo HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069685; Kuo HC, 2012, J CLIN IMMUNOL, V32, P746, DOI 10.1007/s10875-012-9668-1; Kuo HC, 2012, PEDIATR NEONATOL, V53, P4, DOI 10.1016/j.pedneo.2011.11.003; Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370; Kuo HC, 2011, J HUM GENET, V56, P161, DOI 10.1038/jhg.2010.154; Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x; Lau AC, 2009, CLIN EXP IMMUNOL, V157, P300, DOI 10.1111/j.1365-2249.2009.03949.x; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Lin IC, 2013, IMMUNOBIOLOGY, V218, P201, DOI 10.1016/j.imbio.2012.04.004; Lin IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038635; Lin MT, 2015, ARCH DIS CHILD, V100, P542, DOI 10.1136/archdischild-2014-306427; Lin MT, 2013, TRANSL RES, V161, P513, DOI 10.1016/j.trsl.2013.02.002; Lin Y. H., 2014, NANOMEDICINE, V1, P1, DOI DOI 10.1186/2045-3701-4-67; Lin YJ, 2009, ARTHRITIS RHEUM-US, V60, P604, DOI 10.1002/art.24261; Lin YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081384; Lou J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08194; Lou J, 2012, MOL BIOL REP, V39, P11137, DOI 10.1007/s11033-012-2022-0; Maiellaro-Rafferty K, 2013, J MOL CELL CARDIOL, V60, P151, DOI 10.1016/j.yjmcc.2013.04.021; Mastrototaro G, 2015, CARDIOVASC RES, V107, P216, DOI 10.1093/cvr/cvv156; Matsubara T, 2005, CLIN EXP IMMUNOL, V141, P381, DOI 10.1111/j.1365-2249.2005.02821.x; Minich LL, 2007, PEDIATRICS, V120, pE1434, DOI 10.1542/peds.2007-0815; NAOE S, 1991, ACTA PATHOL JAPON, V41, P785; Oates-Whitehead R M, 2003, Cochrane Database Syst Rev, pCD004000, DOI 10.1002/14651858.CD003511; Oharaseki T, 2014, MOD RHEUMATOL, V24, P120, DOI 10.3109/14397595.2013.854061; Onouchi Y, 2013, PHARMACOGENOMICS J, V13, P52, DOI 10.1038/tpj.2011.45; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Peng Q, 2012, PEDIATR CARDIOL, V33, P1046, DOI 10.1007/s00246-012-0223-x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purevjav E, 2010, J AM COLL CARDIOL, V56, P1493, DOI 10.1016/j.jacc.2010.05.045; Rowley AH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2323-5; Shendre A, 2014, GENES IMMUN, V15, P534, DOI 10.1038/gene.2014.47; Song D, 2009, EUR J PEDIATR, V168, P1315, DOI 10.1007/s00431-009-0925-0; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tacke CE, 2012, EXPERT REV ANTI-INFE, V10, P1203, DOI [10.1586/ERI.12.101, 10.1586/eri.12.101]; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Tseng WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105195; Wang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep05208; Wang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04247; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Yan YL, 2013, HUM GENET, V132, P669, DOI 10.1007/s00439-013-1279-2; Yeung RSM, 2010, CURR OPIN RHEUMATOL, V22, P551, DOI 10.1097/BOR.0b013e32833cf051; Youn Y, 2016, PEDIATR INFECT DIS J, V35, P457, DOI 10.1097/INF.0000000000001039; Zhou CZ, 2015, INT J CLIN EXP PATHO, V8, P15879	71	38	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154943	10.1371/journal.pone.0154943	http://dx.doi.org/10.1371/journal.pone.0154943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171184	Green Submitted, gold, Green Published			2022-12-27	WOS:000376588600062
J	Berardi, R; Santoni, M; Rinaldi, S; Nunzi, E; Smerilli, A; Caramanti, M; Morgese, F; Torniai, M; Savini, A; Fiordoliva, I; Onofri, A; Pistelli, M; Taccaliti, A; Cascinu, S				Berardi, Rossana; Santoni, Matteo; Rinaldi, Silvia; Nunzi, Emilia; Smerilli, Alessia; Caramanti, Miriam; Morgese, Francesca; Torniai, Mariangela; Savini, Agnese; Fiordoliva, Ilaria; Onofri, Azzurra; Pistelli, Mirco; Taccaliti, Augusto; Cascinu, Stefano			Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review andMeta-Analysis of Clinical Trials	PLOS ONE			English	Article							ADVANCED HEPATOCELLULAR-CARCINOMA; TREATMENT-RELATED MORTALITY; RANDOMIZED CONTROLLED-TRIALS; ADVANCED SOLID TUMORS; MAMMALIAN TARGET; PLUS PLACEBO; NECK-CANCER; OPEN-LABEL; SORAFENIB; CISPLATIN	Background Hyponatraemia has been reported with targeted therapies in cancer patients. Aim of the study was to perform an up-to-date meta-analysis in order to determine the incidence and relative risk (RR) in cancer patients treated with these agents. Materials and Methods The scientific literature regarding hyponatraemia was extensively reviewed using MEDLINE, PubMed, Embase and Cochrane databases. Eligible studies were selected according to PRISMA statement. Summary incidence, RR, and 95% Confidence Intervals were calculated using random-effects or fixed-effects models based on the heterogeneity of selected studies. Results 4803 potentially relevant trials were identified: of them, 13 randomized phase III studies were included in this meta-analysis. 6670 patients treated with 8 targeted agents were included: 2574 patients had hepatocellular carcinoma, whilst 4096 had other malignancies. The highest incidences of all-grade hyponatraemia were observed with the combination of brivanib and cetuximab (63.4) and pazopanib (31.7), while the lowest incidence was reported by afatinib (1.7). The highest incidence of high-grade hyponatraemia was reported by cetuximab (34.8), while the lowest incidences were reported by gefitinib (1.0). Summary RR of developing all-grade and high-grade hyponatraemia with targeted agents was 1.36 and 1.52, respectively. The highest RRs of all-grade and high-grade hyponatraemia were associated with brivanib (6.5 and 5.2, respectively). Grouping by drug category, the RR of high-grade hyponatraemia with angiogenesis inhibitors was 2.69 compared to anti-Epidermal Growth Factor Receptors agents (1.12). Conclusion Treatment with biological therapy in cancer patients is associated with a significant increased risk of hyponatraemia, therefore frequent clinical monitoring should be emphasized when managing targeted agents.	[Berardi, Rossana; Santoni, Matteo; Rinaldi, Silvia; Caramanti, Miriam; Morgese, Francesca; Torniai, Mariangela; Savini, Agnese; Fiordoliva, Ilaria; Onofri, Azzurra; Pistelli, Mirco; Cascinu, Stefano] Univ Politecn Marche, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Clin Oncol Med, Ancona, Italy; [Nunzi, Emilia] Univ Perugia, Dipartimento Med Sperimentale, I-06100 Perugia, Italy; [Smerilli, Alessia; Taccaliti, Augusto] A Azienda Osped Univ Osped Riuniti Umberto I GM L, Div Endocrinol, Ancona, Italy	Marche Polytechnic University; University of Perugia	Berardi, R (corresponding author), Univ Politecn Marche, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Clin Oncol Med, Ancona, Italy.	r.berardi@univpm.it	Berardi, Rossana/AAC-5216-2022; Torniai, Mariangela/N-6327-2019; Cascinu, Stefano/G-2399-2017; Berardi, Rossana/AAC-5758-2022; Cascinu, Stefano/AAN-1923-2020; Morgese, Francesca/AAC-4123-2022	Berardi, Rossana/0000-0002-9529-2960; Cascinu, Stefano/0000-0003-2215-0731; Morgese, Francesca/0000-0002-0994-3713; Pistelli, Mirco/0000-0002-9289-8537; FIORDOLIVA, ILARIA/0000-0002-0116-0730; Santoni, Matteo/0000-0001-7340-6173	Universita Politecnica Marche, Ancona, Italy	Universita Politecnica Marche, Ancona, Italy	This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector. The study was realized with authors' University funding (Universita Politecnica Marche, Ancona, Italy).	Argiris A, 2013, J CLIN ONCOL, V31, P1405, DOI 10.1200/JCO.2012.45.4272; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Cainap C, 2015, J CLIN ONCOL, V33, P172, DOI 10.1200/JCO.2013.54.3298; Castillo JJ, 2012, ONCOLOGIST, V17, P756, DOI 10.1634/theoncologist.2011-0400; Choueiri TK, 2013, ANN ONCOL, V24, P2092, DOI 10.1093/annonc/mdt155; Choueiri TK, 2010, J CLIN ONCOL, V28, P2280, DOI 10.1200/JCO.2009.27.2757; Crosby T, 2013, LANCET ONCOL, V14, P627, DOI 10.1016/S1470-2045(13)70136-0; Doshi SM, 2012, AM J KIDNEY DIS, V59, P222, DOI 10.1053/j.ajkd.2011.08.029; Flaherty KT, 2013, J CLIN ONCOL, V31, P373, DOI 10.1200/JCO.2012.42.1529; Gaafar RM, 2011, EUR J CANCER, V47, P2331, DOI 10.1016/j.ejca.2011.06.045; Grisk O, 2014, J HYPERTENS, V32, P2199, DOI 10.1097/HJH.0000000000000326; Gu JW, 2009, AM J PHYSIOL-REG I, V297, pR142, DOI 10.1152/ajpregu.90972.2008; Iacovelli R, 2014, BRIT J CLIN PHARMACO, V77, P929, DOI 10.1111/bcp.12231; Iacovelli R, 2014, CANCER TREAT REV, V40, P271, DOI 10.1016/j.ctrv.2013.09.003; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Je YJ, 2009, LANCET ONCOL, V10, P967, DOI 10.1016/S1470-2045(09)70222-0; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; Kaymakcalan MD, 2013, BRIT J CANCER, V108, P2478, DOI 10.1038/bjc.2013.278; Llovet JM, 2013, J CLIN ONCOL, V31, P3509, DOI 10.1200/JCO.2012.47.3009; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nishikawa H, 2015, J CANCER, V6, P482, DOI 10.7150/jca.11665; Ochi N, 2014, DRUG DES DEV THER, V8, P2401, DOI 10.2147/DDDT.S71419; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; Petereit C, 2011, Pneumologie, V65, P565, DOI 10.1055/s-0030-1256668; Qi WX, 2013, INT J CANCER, V132, P2967, DOI 10.1002/ijc.27979; Ramalingam SS, 2010, J CLIN ONCOL, V28, P56, DOI 10.1200/JCO.2009.24.9094; Richards CJ, 2011, J CLIN ONCOL, V29, P3450, DOI 10.1200/JCO.2010.34.4309; Santoni M, 2015, INT J CANCER, V136, P1, DOI 10.1002/ijc.28715; Santoni M, 2014, INT J CANCER, V135, P763, DOI 10.1002/ijc.28544; Schutz FAB, 2014, EUR UROL, V65, P723, DOI 10.1016/j.eururo.2013.10.013; Schutz FAB, 2012, J CLIN ONCOL, V30, P871, DOI 10.1200/JCO.2011.37.1195; Siu LL, 2013, J CLIN ONCOL, V31, P2477, DOI 10.1200/JCO.2012.46.0543; Sivendran S, 2012, CANCER TREAT REV, V38, P919, DOI 10.1016/j.ctrv.2012.05.001; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1	36	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0152079	10.1371/journal.pone.0152079	http://dx.doi.org/10.1371/journal.pone.0152079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167519	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300086
J	Gerits, E; Blommaert, E; Lippell, A; O'Neill, AJ; Weytjens, B; De Maeyer, D; Fierro, AC; Marchal, K; Marchand, A; Chaltin, P; Spincemaille, P; De Brucker, K; Thevissen, K; Cammue, BPA; Swings, T; Liebens, V; Fauvart, M; Verstraeten, N; Michiels, J				Gerits, Evelien; Blommaert, Eline; Lippell, Anna; O'Neill, Alex J.; Weytjens, Bram; De Maeyer, Dries; Fierro, Ana Carolina; Marchal, Kathleen; Marchand, Arnaud; Chaltin, Patrick; Spincemaille, Pieter; De Brucker, Katrijn; Thevissen, Karin; Cammue, Bruno P. A.; Swings, Toon; Liebens, Veerle; Fauvart, Maarten; Verstraeten, Natalie; Michiels, Jan			Elucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosa	PLOS ONE			English	Article							ESCHERICHIA-COLI; HIGH-INOCULUM; ANTIBIOTICS; DAPTOMYCIN; VANCOMYCIN; MECHANISM; PHARMACODYNAMICS; SUSCEPTIBILITY; IDENTIFICATION; COMBINATION	Nosocomial and community-acquired infections caused by multidrug resistant bacteria represent a major human health problem. Thus, there is an urgent need for the development of antibiotics with new modes of action. In this study, we investigated the antibacterial characteristics and mode of action of a new antimicrobial compound, SPI031 (N-alkylated 3, 6-dihalogenocarbazol 1-(sec-butylamino)-3-(3,6-dichloro-9H-carbazol-9-yl) propan-2-ol), which was previously identified in our group. This compound exhibits broad-spectrum antibacterial activity, including activity against the human pathogens Staphylococcus aureus and Pseudomonas aeruginosa. We found that SPI031 has rapid bactericidal activity (7-log reduction within 30 min at 4x MIC) and that the frequency of resistance development against SPI031 is low. To elucidate the mode of action of SPI031, we performed a macromolecular synthesis assay, which showed that SPI031 causes non-specific inhibition of macromolecular biosynthesis pathways. Liposome leakage and membrane permeability studies revealed that SPI031 rapidly exerts membrane damage, which is likely the primary cause of its antibacterial activity. These findings were supported by a mutational analysis of SPI031-resistant mutants, a transcriptome analysis and the identification of transposon mutants with altered sensitivity to the compound. In conclusion, our results show that SPI031 exerts its antimicrobial activity by causing membrane damage, making it an interesting starting point for the development of new antibacterial therapies.	[Gerits, Evelien; Blommaert, Eline; Fierro, Ana Carolina; De Brucker, Katrijn; Thevissen, Karin; Cammue, Bruno P. A.; Swings, Toon; Liebens, Veerle; Fauvart, Maarten; Verstraeten, Natalie; Michiels, Jan] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Leuven, Belgium; [Lippell, Anna; O'Neill, Alex J.] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Weytjens, Bram; De Maeyer, Dries; Fierro, Ana Carolina; Marchal, Kathleen] Univ Ghent, Dept Informat Technol, INTEC, iMINDS, B-9000 Ghent, Belgium; [Marchal, Kathleen] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Marchand, Arnaud; Chaltin, Patrick] Katholieke Univ Leuven, CISTIM Leuven Vzw, Bioincubator, Leuven, Belgium; [Chaltin, Patrick] Katholieke Univ Leuven, Res & Dev, Ctr Drug Design & Discovery CD3, Leuven, Belgium; [Spincemaille, Pieter] Univ Hosp Leuven, Dept Lab Med, Leuven, Belgium; [Cammue, Bruno P. A.] Univ Ghent VIB, Dept Plant Syst Biol, Ghent, Belgium; [Fauvart, Maarten] IMEC, Smart Syst & Emerging Technol Unit, Dept Life Sci Technol, Leuven, Belgium	KU Leuven; University of Leeds; Ghent University; IMEC; Ghent University; KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; IMEC	Michiels, J (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Leuven, Belgium.	Jan.Michiels@biw.kuleuven.be	Thevissen, Karin/B-7003-2015; Michiels, Jan/F-1601-2010; Marchal, Kathleen/O-7936-2017; Swings, Toon/AAA-5602-2019; Verstraeten, Natalie/AAJ-1464-2021; Fauvart, Maarten/B-1612-2010; Verstraeten, Natalie/AAH-3963-2019; Swings, Toon/Q-1179-2017; Marchal, Kathleen/B-5001-2013	Thevissen, Karin/0000-0003-0275-9072; Michiels, Jan/0000-0001-5829-0897; Marchal, Kathleen/0000-0002-2169-4588; Swings, Toon/0000-0002-1225-3377; Verstraeten, Natalie/0000-0002-9548-4647; Fauvart, Maarten/0000-0002-6256-9193; Verstraeten, Natalie/0000-0002-9548-4647; Swings, Toon/0000-0002-1225-3377; Marchal, Kathleen/0000-0002-2169-4588; O'Neill, Alex/0000-0003-3222-5493	European Commission [278425]; Interuniversity Attraction Poles Programme; Belgian Science Policy Office; FWO [G.0413.10, G.0471.12N, G0B2515N]; KU Leuven [IOFm/05/022]; imec	European Commission(European CommissionEuropean Commission Joint Research Centre); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); FWO(FWO); KU Leuven(KU Leuven); imec	This work was supported by the European Commission's Seventh Framework Programme (FP7/2007-2013) under the grant agreement COATIM (project no 278425), the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office and by the FWO (grants G.0413.10, G.0471.12N, G0B2515N to JM). KT acknowledges the receipt of a mandate of the 'Industrial Research Fund' of KU Leuven (IOFm/05/022). imec provided support in the form of salaries for author MF. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 2004, INS MALPR FIN REP HO; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bataineh H. A., 2006, Pakistan Journal of Medical Sciences, V22, P144; Blake KL, 2013, J ANTIMICROB CHEMOTH, V68, P12, DOI 10.1093/jac/dks373; Bollenbach T, 2015, CURR OPIN MICROBIOL, V27, P1, DOI 10.1016/j.mib.2015.05.008; BOYD A, 1995, J IND MICROBIOL, V15, P162, DOI 10.1007/BF01569821; Bulitta JB, 2010, ANTIMICROB AGENTS CH, V54, P2051, DOI 10.1128/AAC.00881-09; Butler MS, 2013, J ANTIBIOT, V66, P571, DOI 10.1038/ja.2013.86; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P565; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; De Maeyer D, 2015, NUCLEIC ACIDS RES, V43, pW244, DOI 10.1093/nar/gkv347; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Deresinski S, 2009, CLIN INFECT DIS, V49, P1072, DOI 10.1086/605572; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Falagas ME, 2010, DRUG RESIST UPDATE, V13, P132, DOI 10.1016/j.drup.2010.05.002; Galan-Vasquez Edgardo, 2011, Microb Inform Exp, V1, P3, DOI 10.1186/2042-5783-1-3; Gerits E, 2016, J ORTHOP RE IN PRESS; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; Hobbs JK, 2008, J ANTIMICROB CHEMOTH, V62, P1003, DOI 10.1093/jac/dkn321; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liebens V, 2014, BIOORG MED CHEM LETT, V24, P5404, DOI 10.1016/j.bmcl.2014.10.039; Liebens V, 2014, PATHOG DIS, V71, P39, DOI 10.1111/2049-632X.12174; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Moellering RC, 2006, ANN INTERN MED, V144, P368, DOI 10.7326/0003-4819-144-5-200603070-00014; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliva B, 2003, ANTIMICROB AGENTS CH, V47, P458, DOI 10.1128/AAC.47.2.458-466.2003; Ooi N, 2009, J ANTIMICROB CHEMOTH, V64, P735, DOI 10.1093/jac/dkp299; Palazzo ICV, 2005, J CLIN MICROBIOL, V43, P179, DOI 10.1128/JCM.43.1.179-185.2005; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Purssell A, 2013, MICROBIOL-SGM, V159, P2058, DOI 10.1099/mic.0.069286-0; Randall CP, 2013, ANTIMICROB AGENTS CH, V57, P637, DOI 10.1128/AAC.02005-12; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Steenackers H, 2014, MOLECULES, V19, P16707, DOI 10.3390/molecules191016707; Stickland HG, 2010, J PROTEOME RES, V9, P2957, DOI 10.1021/pr9011415; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Tam VH, 2005, J ANTIMICROB CHEMOTH, V55, P699, DOI 10.1093/jac/dki086; Tam VH, 2005, ANTIMICROB AGENTS CH, V49, P3624, DOI 10.1128/AAC.49.9.3624-3630.2005; Thevissen K, 2009, CURR MED CHEM, V16, P2205, DOI 10.2174/092986709788612701; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; Wright PM, 2014, ANGEW CHEM INT EDIT, V53, P8840, DOI 10.1002/anie.201310843; Yan JX, 2013, ANTIMICROB AGENTS CH, V57, P220, DOI 10.1128/AAC.01619-12; Yaraksa N, 2014, J ANTIBIOT, V67, P205, DOI 10.1038/ja.2013.114	65	29	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155139	10.1371/journal.pone.0155139	http://dx.doi.org/10.1371/journal.pone.0155139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167126	gold, Green Published			2022-12-27	WOS:000376587300033
J	Jia, L; Li, L; Li, HP; Liu, SY; Wang, XL; Bao, ZY; Li, TY; Zhuang, DM; Liu, YJ; Li, JY				Jia, Lei; Li, Lin; Li, Hanping; Liu, Siyang; Wang, Xiaolin; Bao, Zuoyi; Li, Tianyi; Zhuang, Daomin; Liu, Yongjian; Li, Jingyun		PLOS 1 Editors	Recombination Pattern Reanalysis of Some HIV-1 Circulating Recombination Forms Suggest the Necessity and Difficulty of Revision (vol 9, e107349, 2014)	PLOS ONE			English	Correction																		Jia L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107349; Kiwelu IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071131; Montavon C, 2002, J ACQ IMMUN DEF SYND, V29, P522, DOI 10.1097/00126334-200204150-00014; Zhang M. Y., 2007, THESIS; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25; Zhao J, 2009, IDENTIFICATION GENET, DOI [10.1089/aid.2009.0197, DOI 10.1089/AID.2009.0197]	6	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155750	10.1371/journal.pone.0155750	http://dx.doi.org/10.1371/journal.pone.0155750			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168068	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300020
J	Van Brusselen, D; de Onate, WA; Maiheu, B; Vranckx, S; Lefebvre, W; Janssen, S; Nawrot, TS; Nemery, B; Avonts, D				Van Brusselen, Daan; de Onate, Wouter Arrazola; Maiheu, Bino; Vranckx, Stijn; Lefebvre, Wouter; Janssen, Stijn; Nawrot, Tim S.; Nemery, Ben; Avonts, Dirk			Health Impact Assessment of a Predicted Air Quality Change by Moving Traffic from an Urban Ring Road into a Tunnel. The Case of Antwerp, Belgium	PLOS ONE			English	Article							FINE PARTICULATE MATTER; RESIDENTIAL PROXIMITY; LUNG DEVELOPMENT; POLLUTION; MORTALITY; RISK; ASSOCIATION; EXPOSURE; MODEL; VENTILATION	Background The Antwerp ring road has a traffic density of 300,000 vehicles per day and borders the city center. The 'Ringland project' aims to change the current 'open air ring road' into a 'filtered tunneled ring road', putting the entire urban ring road into a tunnel and thus filtering air pollution. We conducted a health impact assessment (HIA) to quantify the possible benefit of a 'filtered tunneled ring road', as compared to the 'open air ring road' scenario, on air quality and its long-term health effects. Materials and Methods We modeled the change in annual ambient PM2.5 and NO2 concentrations by covering 15 kilometers of the Antwerp ring road in high resolution grids using the RIO-IFDM street canyon model. The exposure-response coefficients used were derived from a literature review: all-cause mortality, life expectancy, cardiopulmonary diseases and childhood Forced Vital Capacity development (FVC). Results Our model predicts changes between -1.5 and +2 mu g/m(3) in PM2.5 within a 1,500 meter radius around the ring road, for the 'filtered tunneled ring road' scenario as compared to an 'open air ring road'. These estimated annual changes were plotted against the population exposed to these differences. The calculated change of PM2.5 is associated with an expected annual decrease of 21 deaths (95% CI 7 to 41). This corresponds with 11.5 deaths avoided per 100,000 inhabitants (95% CI 3.9-23) in the first 500 meters around the ring road every year. Of 356 schools in a 1,500 meter perimeter around the ring road changes between -10 NO2 and +0.17 mu g/m(3) were found, corresponding to FVC improvement of between 3 and 64ml among school-age children. The predicted decline in lung cancer mortality and incidence of acute myocardial infarction were both only 0.1 per 100,000 inhabitants or less. Conclusion The expected change in PM2,5 and NO2 by covering the entire urban ring road in Antwerp is associated with considerable health gains for the approximate 352,000 inhabitants living in a 1,500 meter perimeter around the current open air ring road.	[Van Brusselen, Daan; Avonts, Dirk] Univ Ghent, Dept Family Med & Primary Hlth Care, B-9000 Ghent, Belgium; [de Onate, Wouter Arrazola] VRGT Flemish Soc Resp Hlth, Brussels, Belgium; [Maiheu, Bino; Vranckx, Stijn; Lefebvre, Wouter; Janssen, Stijn] Vlaamse Instelling Technol Onderzoek, Flemish Inst Technol Res, Boeretang 200, B-2400 Mol, Belgium; [Nawrot, Tim S.] Hasselt Univ, Ctr Environm Sci, Hasselt, Belgium; [Nawrot, Tim S.; Nemery, Ben] Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium	Ghent University; VITO; Hasselt University; KU Leuven	Van Brusselen, D (corresponding author), Univ Ghent, Dept Family Med & Primary Hlth Care, B-9000 Ghent, Belgium.	daan.vanbrusselen@hotmail.com	Nawrot, Tim/AAA-4531-2019; Lefebvre, Wouter/F-5610-2015	Nemery, Benoit/0000-0003-0571-4689; Janssen, Stijn/0000-0003-2034-8162; Vranckx, Stijn/0000-0002-7203-3691; Nawrot, Tim/0000-0002-3583-3593; Lefebvre, Wouter/0000-0002-3277-3118	VITO; Ringland project; Flemish Government	VITO; Ringland project; Flemish Government(European Commission)	VITO, the Flemish Institute of Technologic Research has received a grant by the 'Ringland project' and by the Flemish Government to perform this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, CLEAN AIR EUR CAFE S; Balci MM, 2010, INT J CARDIOL, V144, P110, DOI 10.1016/j.ijcard.2008.12.111; Beckx C, 2009, ENVIRON PLANN B, V36, P1086, DOI 10.1068/b35044; Bentayeb M, 2015, EUR RESPIR J, V45, P1228, DOI 10.1183/09031936.00082414; Berkowicz R., 1997, MODELLING TRAFFIC PO; Boldo E, 2011, ENVIRON INT, V37, P342, DOI 10.1016/j.envint.2010.10.004; Boothe VL, 2008, J ENVIRON HEALTH, V70, P33; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Buekers J TR, 2012, MIRA MILIEURAPPORT V; Chen E, 2013, ANNU REV CLIN PSYCHO, V9, P723, DOI 10.1146/annurev-clinpsy-050212-185634; Chen TY, 1998, J WIND ENG IND AEROD, V73, P99, DOI 10.1016/S0167-6105(97)00281-X; Colella F, 2009, BUILD ENVIRON, V44, P2357, DOI 10.1016/j.buildenv.2009.03.020; Cooke RM, 2007, ENVIRON SCI TECHNOL, V41, P6598, DOI 10.1021/es0714078; Cross H, 1936, ENG EXP STN, P34; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Eckel SP, 2012, AM J EPIDEMIOL, V176, P214, DOI 10.1093/aje/kws001; Gan WQ, 2010, EPIDEMIOLOGY, V21, P642, DOI 10.1097/EDE.0b013e3181e89f19; Gauderman WJ, 2015, NEW ENGL J MED, V372, P905, DOI 10.1056/NEJMoa1414123; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gkatzoflias D, COPERT 4 COMPUTER PR; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Hall JV, 2008, J ENVIRON MANAGE, V88, P1003, DOI 10.1016/j.jenvman.2007.05.002; Hamra GB, 2014, ENVIRON HEALTH PERSP, V122, P906, DOI [10.1289/ehp.1408092, 10.1289/ehp/1408092]; Harris-Roxas B, 2011, ENVIRON IMPACT ASSES, V31, P396, DOI 10.1016/j.eiar.2010.03.003; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Islam T, 2007, THORAX, V62, P957, DOI 10.1136/thx.2007.078964; Janssen NAH, 2011, ENVIRON HEALTH PERSP, V119, P1691, DOI 10.1289/ehp.1003369; Janssen S, 2008, ATMOS ENVIRON, V42, P4884, DOI 10.1016/j.atmosenv.2008.02.043; Johnson PRS, 2005, ENVIRON HEALTH PERSP, V113, P1140, DOI 10.1289/ehp.7822; Kaiser J, 2000, SCIENCE, V289, P711; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Ketzel M J S, 2012, J CIVIL ENV ENG, pS1; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; Kunzli N, 2010, EUROPEAN RESP SOC RE, P31; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Lefebvre W, 2013, ATMOS ENVIRON, V77, P325, DOI 10.1016/j.atmosenv.2013.05.026; Lefebvre W, 2015, 2011RMAR45 VITO; Leksell I, 2001, RISK ANAL, V21, P843, DOI 10.1111/0272-4332.215156; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Maiheu B, 2015, 2015RMAR13 VITO; Mensink C, 2000, ATMOS ENVIRON, V34, P4595, DOI 10.1016/S1352-2310(00)00215-6; Nawrot T, 2014, FLANDERS; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; NHG standaard, 2012, NHG STAND AC COR SYN; Orru H, 2015, J EXPO SCI ENV EPID, V25, P524, DOI 10.1038/jes.2015.24; Parijs J APD, 2014, ENVIRON IMPACT ASSES, P39; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Pope III C.A., 1999, AIR POLLUTION HLTH, V31, P673, DOI DOI 10.1016/B978-012352335-8/50106-X; Rosenbloom JI, 2012, CIRCULATION, V125, P2197, DOI 10.1161/CIRCULATIONAHA.111.085811; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Tamosiunas A, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-20; Thompson AK, 2012, M5 E TUNNEL FILTRATI; Van Poppel M DE, 2012, METINGEN ULTRAFIJN S; Vankerkom J, 2009, MIMOSA; WHO European Centre for Environment and Health BO WHO Regional Office for Europe, 2011, BURD DIS ENV NOIS QU; Zhou R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112195	58	20	20	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154052	10.1371/journal.pone.0154052	http://dx.doi.org/10.1371/journal.pone.0154052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167124	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300044
J	Souday, V; Koning, NJ; Perez, B; Grelon, F; Mercat, A; Boer, C; Seegers, V; Radermacher, P; Asfar, P				Souday, Vincent; Koning, Nick J.; Perez, Bruno; Grelon, Fabien; Mercat, Alain; Boer, Christa; Seegers, Valerie; Radermacher, Peter; Asfar, Pierre			Enriched Air Nitrox Breathing Reduces Venous Gas Bubbles after Simulated SCUBA Diving: A Double-Blind Cross-Over Randomized Trial	PLOS ONE			English	Article							NEUTROPHIL ACTIVATION; BODY-FAT; DECOMPRESSION; DIVES; MICROPARTICLES; EMBOLI	Objective To test the hypothesis whether enriched air nitrox (EAN) breathing during simulated diving reduces decompression stress when compared to compressed air breathing as assessed by intravascular bubble formation after decompression. Methods Human volunteers underwent a first simulated dive breathing compressed air to include subjects prone to post-decompression venous gas bubbling. Twelve subjects prone to bubbling underwent a double-blind, randomized, cross-over trial including one simulated dive breathing compressed air, and one dive breathing EAN (36% O-2) in a hyperbaric chamber, with identical diving profiles (28 msw for 55 minutes). Intravascular bubble formation was assessed after decompression using pulmonary artery pulsed Doppler. Results Twelve subjects showing high bubble production were included for the cross-over trial, and all completed the experimental protocol. In the randomized protocol, EAN significantly reduced the bubble score at all time points (cumulative bubble scores: 1 [0-3.5] vs. 8 [4.5-10]; P < 0.001). Three decompression incidents, all presenting as cutaneous itching, occurred in the air versus zero in the EAN group (P = 0.217). Weak correlations were observed between bubble scores and age or body mass index, respectively. Conclusion EAN breathing markedly reduces venous gas bubble emboli after decompression in volunteers selected for susceptibility for intravascular bubble formation. When using similar diving profiles and avoiding oxygen toxicity limits, EAN increases safety of diving as compared to compressed air breathing.	[Souday, Vincent; Koning, Nick J.; Perez, Bruno; Grelon, Fabien; Mercat, Alain; Asfar, Pierre] Univ Hosp, Dept Med Intens Care & Hyperbar Med, Angers, France; [Koning, Nick J.; Asfar, Pierre] Univ Hosp, CNRS UMR 6214, INSERM U1083, Angers, France; [Seegers, Valerie] SFR Pole Sante, Interact Cellulaires & Applicat Therapeut & DRCI, Angers, France; [Seegers, Valerie] Univ Hosp, Angers, France; [Koning, Nick J.; Boer, Christa] Vrije Univ Amsterdam, Dept Anesthesiol, Med Ctr, Inst Cardiovasc Res, Amsterdam, Netherlands; [Radermacher, Peter] Univ Ulm Klinikum, Inst Anasthesiol Pathophysiol & Verfahrensentwick, Ulm, Germany	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Vrije Universiteit Amsterdam; Ulm University	Asfar, P (corresponding author), Univ Hosp, Dept Med Intens Care & Hyperbar Med, Angers, France.; Asfar, P (corresponding author), Univ Hosp, CNRS UMR 6214, INSERM U1083, Angers, France.	piasfar@chu-angers.fr	Mercat, Alain/AFU-4426-2022	Grelon, Fabien/0000-0002-2606-9933; Boer, Christa/0000-0002-7781-6951				[Anonymous], 1994, NONLINEAR WORLD; Beasley TM, 2009, J MOD APPL STAT METH, V8, P16, DOI 10.22237/jmasm/1241136180; Blatteau JE, 2012, EUR J APPL PHYSIOL, V112, P2257, DOI 10.1007/s00421-011-2195-6; Brubakk AO, 2005, J PHYSIOL-LONDON, V566, P901, DOI 10.1113/jphysiol.2005.089862; Brubakk AO, 2001, UNDERSEA HYPERBAR M, V28, P131; Cameron BA, 2007, AVIAT SPACE ENVIR MD, V78, P493; Carturan D, 2002, J APPL PHYSIOL, V93, P1349, DOI 10.1152/japplphysiol.00723.1999; DONALD K W, 1947, Br Med J, V1, ppassim; Durnin J. V., 1969, J PHYSL, V200, P105; Eatock B., 1984, UNDERSEA BIOMED RES, V11, P326; Eftedal O, 1997, UNDERSEA HYPERBAR M, V24, P293; Eftedal OS, 2007, UNDERSEA HYPERBAR M, V34, P99; Harris RJD, 2003, UNDERSEA HYPERBAR M, V30, P285; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Levett DZH, 2008, POSTGRAD MED J, V84, P571, DOI 10.1136/pgmj.2008.068320; Mollerlokken A, 2011, DIVING HYPERB MED, V41, P124; Nishi R. Y., 2003, BENNETT ELLIOTTS PHY, P501; Pollock NW, 2007, ANN DIVING REPORT; Schellart NAM, 2013, J APPL PHYSIOL, V114, P602, DOI 10.1152/japplphysiol.00949.2012; Schellart NAM, 2012, AVIAT SPACE ENVIR MD, V83, P951, DOI 10.3357/ASEM.3189.2012; Spencer MP, 1974, N0001473C0094 I ENV; Thom SR, 2015, J APPL PHYSIOL, V119, P427, DOI 10.1152/japplphysiol.00380.2015; Thom SR, 2013, J APPL PHYSIOL, V114, P1396, DOI 10.1152/japplphysiol.00106.2013; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Zanchi J, 2014, INT J SPORTS MED, V35, P465, DOI 10.1055/s-0033-1334968	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154761	10.1371/journal.pone.0154761	http://dx.doi.org/10.1371/journal.pone.0154761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163253	Green Published, gold			2022-12-27	WOS:000376585700018
J	Cosgrove, CA; Lacey, CJ; Cope, AV; Bartolf, A; Morris, G; Yan, C; Baden, S; Cole, T; Carter, D; Brodnicki, E; Shen, XY; Joseph, S; DeRosa, SC; Peng, LL; Yu, XS; Ferrari, G; Seaman, M; Montefiori, DC; Frahm, N; Tomaras, GD; Stohr, W; McCormack, S; Shattock, RJ				Cosgrove, Catherine A.; Lacey, Charles J.; Cope, Alethea V.; Bartolf, Angela; Morris, Georgina; Yan, Celine; Baden, Susan; Cole, Tom; Carter, Darrick; Brodnicki, Elizabeth; Shen, Xiaoying; Joseph, Sarah; DeRosa, Stephen C.; Peng, Lili; Yu, Xuesong; Ferrari, Guido; Seaman, Mike; Montefiori, David C.; Frahm, Nicole; Tomaras, Georgia D.; Stoehr, Wolfgang; McCormack, Sheena; Shattock, Robin J.			Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VAGINAL SHIV CHALLENGE; NEUTRALIZING ANTIBODIES; PROTECTION; RESPONSES; ENVELOPE; IMMUNIZATION; MACAQUES; CELLS; WOMEN	Background Defining optimal routes for induction of mucosal immunity represents an important research priority for the HIV-1 vaccine field. In particular, it remains unclear whether mucosal routes of immunization can improve mucosal immune responses. Methods In this randomized two center phase I clinical trial we evaluated the systemic and mucosal immune response to a candidate HIV-1 Clade C CN54gp140 envelope glycoprotein vaccine administered by intramuscular (IM), intranasal (IN) and intravaginal (IVAG) routes of administration in HIV negative female volunteers. IM immunizations were co-administered with Glucopyranosyl Lipid Adjuvant (GLA), IN immunizations with 0.5% chitosan and IVAG immunizations were administered in an aqueous gel. Results Three IM immunizations of CN54 gp140 at either 20 or 100 mu g elicited significantly greater systemic and mucosal antibodies than either IN or IVAG immunizations. Following additional intramuscular boosting we observed an anamnestic antibody response in nasally primed subjects. Modest neutralizing responses were detected against closely matched tier 1 clade C virus in the IM groups. Interestingly, the strongest CD4 T-cell responses were detected after IN and not IM immunization. Conclusions These data show that parenteral immunization elicits systemic and mucosal antibodies in women. Interestingly IN immunization was an effective prime for IM boost, while IVAG administration had no detectable impact on systemic or mucosal responses despite IM priming.	[Cosgrove, Catherine A.; Bartolf, Angela; Baden, Susan] Univ London, Ctr Infect, London, England; [Lacey, Charles J.; Morris, Georgina] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Lacey, Charles J.; Morris, Georgina] Univ York, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Cope, Alethea V.; Yan, Celine; Cole, Tom; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Dept Med, Mucosal Infect & Immun Grp, London, England; [Carter, Darrick] IDRI, Seattle, WA USA; [Brodnicki, Elizabeth; Joseph, Sarah; Stoehr, Wolfgang; McCormack, Sheena] UCL, Clin Trials Unit, MRC, London, England; [Shen, Xiaoying; Ferrari, Guido; Montefiori, David C.; Tomaras, Georgia D.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Ferrari, Guido; Montefiori, David C.; Tomaras, Georgia D.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [DeRosa, Stephen C.; Frahm, Nicole] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Peng, Lili; Yu, Xuesong] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, 1124 Columbia St, Seattle, WA 98104 USA; [Seaman, Mike] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, CAVD Neutralizing Antibody Lab, Boston, MA 02215 USA	University of London; University of Hull; University of York - UK; University of York - UK; Imperial College London; Medical Research Council Clinical Trials Unit; University of London; University College London; Duke University; Duke University; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Shattock, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Dept Med, Mucosal Infect & Immun Grp, London, England.	r.shattock@imperial.ac.uk	Ferrari, Guido/Z-2137-2019; Tomaras, Georgia/J-5041-2016; Cosgrove, Catherine/AGF-2877-2022; Ferrari, Guido/A-6088-2015; Carter, Darrick/N-3304-2016	Ferrari, Guido/0000-0001-7747-3349; Carter, Darrick/0000-0001-5901-3402; Stohr, Wolfgang/0000-0002-6533-2888	Bill and Melinda Gates Foundation; Wellcome Trust under the Grand Challenges in Global Health initiative; Central Service Facilities of Collaboration for AIDS Vaccine Discovery (CAVD) - Bill & Melinda Gates Foundation; Dormeur Investment Service Ltd; Medical Research Council [MC_UU_12023/23, MC_U122861400] Funding Source: researchfish; MRC [MC_U122861400] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust under the Grand Challenges in Global Health initiative(Wellcome Trust); Central Service Facilities of Collaboration for AIDS Vaccine Discovery (CAVD) - Bill & Melinda Gates Foundation; Dormeur Investment Service Ltd; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This trial was part of a research programme funded by a grant to St George's University of London by the Bill and Melinda Gates Foundation (www.grandchallenges.org) and the Wellcome Trust (www.wellcome.ac.uk) under the Grand Challenges in Global Health initiative. Exploratory immunological assessment was supported by the Central Service Facilities of Collaboration for AIDS Vaccine Discovery (CAVD) funded by the Bill & Melinda Gates Foundation. The authors gratefully acknowledge Dormeur Investment Service Ltd for providing funds to purchase equipment used in these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Buffa V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050529; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Clegg CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088979; Cranage MP, 2010, MUCOSAL IMMUNOL, V3, P57, DOI 10.1038/mi.2009.110; Cranage MP, 2011, VACCINE, V29, P1421, DOI 10.1016/j.vaccine.2010.12.034; Defawe OD, 2012, J IMMUNOL METHODS, V382, P117, DOI 10.1016/j.jim.2012.05.011; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; El-Kamary SS, 2010, J INFECT DIS, V202, P1649, DOI 10.1086/657087; Finak G, 2014, BIOSTATISTICS, V15, P87, DOI 10.1093/biostatistics/kxt024; GNANN JW, 1987, J VIROL, V61, P2639, DOI 10.1128/JVI.61.8.2639-2641.1987; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Huo ZM, 2005, INFECT IMMUN, V73, P8256, DOI 10.1128/IAI.73.12.8256-8265.2005; Huritz JL, 2008, AIDS, V22, P149, DOI 10.1097/QAD.0b013e3282f174ed; Kim JH, 2015, ANNU REV MED, V66, P423, DOI 10.1146/annurev-med-052912-123749; Klein K, 2014, J CONTROL RELEASE, V183, P43, DOI 10.1016/j.jconrel.2014.03.018; Klein K, 2013, J VIROL, V87, P11604, DOI 10.1128/JVI.01361-13; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; Lewis DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025165; Lewis DJM, 2014, J VIROL, V88, P11648, DOI 10.1128/JVI.01621-14; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McNeela EA, 2004, VACCINE, V22, P909, DOI 10.1016/j.vaccine.2003.09.012; Moog C, 2014, MUCOSAL IMMUNOL, V7, P46, DOI 10.1038/mi.2013.23; Pabst M, 2012, BIOL CHEM, V393, P719, DOI 10.1515/hsz-2012-0148; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Pollara J, 2013, CURR HIV RES, V11, P378, DOI 10.2174/1570162X113116660059; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Scherpenisse M, 2013, HUM VACC IMMUNOTHER, V9, P314, DOI 10.4161/hv.22693; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Schwarz TF, 2010, HUM VACCINES, V6, P1054, DOI 10.4161/hv.6.12.13399; Shen XY, 2015, J VIROL, V89, P8643, DOI 10.1128/JVI.03635-14; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Veazey R, HUM VACCIN IN PRESS; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253	40	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0152038	10.1371/journal.pone.0152038	http://dx.doi.org/10.1371/journal.pone.0152038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159166	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000376576700001
J	Samad, FA; Suliman, BA; Basha, SH; Manivasagam, T; Essa, MM				Samad, Firoz Abdul; Suliman, Bandar A.; Basha, Syed Hussain; Manivasagam, Thamilarasan; Essa, Musthafa Mohamed			A Comprehensive In Silico Analysis on the Structural and Functional Impact of SNPs in the Congenital Heart Defects Associated with NKX2-5 Gene-A Molecular Dynamic Simulation Approach	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PROTEIN-SEQUENCE; FORCE-FIELD; DISEASE; VARIANTS; MUTATION; STABILITY; DATABASE; SERVER	Congenital heart defects (CHD) presented as structural defects in the heart and blood vessels during birth contribute an important cause of childhood morbidity and mortality worldwide. Many Single nucletotide polymorphisms (SNPs) in different genes have been associated with various types of congenital heart defects. NKX 2-5 gene is one among them, which encodes a homeobox-containing transcription factor that plays a crucial role during the initial phases of heart formation and development. Mutations in this gene could cause different types of congenital heart defects, including Atrial septal defect (ASD), Atrial ventricular block (AVB), Tetralogy of fallot and ventricular septal defect. This highlights the importance of studying the impact of different SNPs found within this gene that might cause structural and functional modification of its encoded protein. In this study, we retrieved SNPs from the database (dbSNP), followed by identification of potentially deleterious Non-synonymous single nucleotide polymorphisms (nsSNPs) and prediction of their effect on proteins by computational screening using SIFT and Polyphen. Furthermore, we have carried out molecular dynamic simulation (MDS) in order to uncover the SNPs that would cause the most structural damage to the protein altering its biological function. The most important SNP that was found using our approach was rs137852685 R161P, which was predicted to cause the most damage to the structural features of the protein. Mapping nsSNPs in genes such as NKX 2-5 would provide valuable information about individuals carrying these polymorphisms, where such variations could be used as diagnostic markers.	[Samad, Firoz Abdul; Suliman, Bandar A.] Taibah Univ, Ctr Genet & Inherited Dis, Madinah, Saudi Arabia; [Suliman, Bandar A.] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Mol Biomed Program, Riyadh 11211, Saudi Arabia; [Basha, Syed Hussain] HUDA, HIG, Innovat Informat Technol, Hyderabad 500049, Andhra Pradesh, India; [Manivasagam, Thamilarasan] Annamalai Univ, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India; [Essa, Musthafa Mohamed] Sultan Qaboos Univ, Dept Food Sci & Nutr, Coll Agr & Marine Sci, Muscat, Oman; [Essa, Musthafa Mohamed] Sultan Qaboos Univ, Aging & Dementia Res Grp, Muscat, Oman	Taibah University; King Faisal Specialist Hospital & Research Center; Annamalai University; Sultan Qaboos University; Sultan Qaboos University	Samad, FA (corresponding author), Taibah Univ, Ctr Genet & Inherited Dis, Madinah, Saudi Arabia.; Essa, MM (corresponding author), Sultan Qaboos Univ, Dept Food Sci & Nutr, Coll Agr & Marine Sci, Muscat, Oman.; Essa, MM (corresponding author), Sultan Qaboos Univ, Aging & Dementia Res Grp, Muscat, Oman.	akannu@taibahu.edu.sa; drmdessa@gmail.com	Manivasagam, Thamilarasan/U-3209-2019; Syed, Hussain Basha/P-3973-2016; Essa, Mohamed/AAX-2596-2020	Manivasagam, Thamilarasan/0000-0003-4440-7323; Syed, Hussain Basha/0000-0002-7340-903X; Manivasagam, Thamilarasan/0000-0002-3948-8328; Musthafa Mohamed, Essa/0000-0001-7505-9785; Suliman, Bandar/0000-0003-0649-3419	Innovative Informatica Technologies	Innovative Informatica Technologies	Innovative Informatica Technologies provided support in the form of salary for author Syed Hussain Basha, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; [Anonymous], 2013, DESM MOL DYN SYST VE; [Anonymous], 2013, MAESTR VERS 9 6; Basha S.H., 2014, EUROPEAN J BIOTECHNO, V2, P30; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chitrala KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104242; Dinesh SM, 2010, GENET TEST MOL BIOMA, V14, P873, DOI 10.1089/gtmb.2010.0100; Doss CGP, 2012, APPL TRANSL GENOM, V1, P37, DOI 10.1016/j.atg.2012.06.002; Doss CGP, 2014, CELL BIOCHEM BIOPHYS, V70, P939, DOI 10.1007/s12013-014-0002-9; Doss CGP, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-10; Emahazion T, 2001, TRENDS GENET, V17, P407, DOI 10.1016/S0168-9525(01)02342-3; Feenstra B, 2012, NAT GENET, V44, P334, DOI 10.1038/ng.1067; Gittenberger-de Groot AC, 2014, ANN MED, V46, P640, DOI 10.3109/07853890.2014.959557; Glessner JT, 2014, CIRC RES, V115, P884, DOI 10.1161/CIRCRESAHA.115.304458; Hu XH, 2016, NAT PHYS, V12, P171, DOI [10.1038/nphys3553, 10.1038/NPHYS3553]; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamatani N, 2004, AM J HUM GENET, V75, P190, DOI 10.1086/422853; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Kumar A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003318; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064364; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Marian AJ, 2012, TRENDS CARDIOVAS MED, V22, P219, DOI 10.1016/j.tcm.2012.08.001; Masoodi TA, 2013, GENE, V512, P429, DOI 10.1016/j.gene.2012.08.026; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Offman M. N., 2011, PROTEIN ENG DESIGN S; Offman MN, 2010, J BIOL CHEM, V285, P42105, DOI 10.1074/jbc.M110.172098; Pavlopoulos GA, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-13; Posch MG, 2010, CLIN RES CARDIOL, V99, P137, DOI 10.1007/s00392-009-0095-0; Prokunina Ludmila, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007690; Rajendran V, 2014, J BIOMOL STRUCT DYN, V32, P209, DOI 10.1080/07391102.2012.759885; Rajendran V, 2012, AMINO ACIDS, V43, P603, DOI 10.1007/s00726-011-1108-7; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reddy SV, 2015, J BIOMOLECULAR STRUC, V11, P1; Schork NJ, 2000, CLIN GENET, V58, P250, DOI 10.1034/j.1399-0004.2000.580402.x; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Sidney S, 2013, CIRCULATION, V127, P21, DOI 10.1161/CIRCULATIONAHA.112.155911; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Wang J, 2011, GENET MOL RES, V10, P2905, DOI 10.4238/2011.November.29.1; Wijsman EM, 2012, HUM GENET, V131, P1555, DOI 10.1007/s00439-012-1190-2	45	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0153999	10.1371/journal.pone.0153999	http://dx.doi.org/10.1371/journal.pone.0153999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152669	Green Published, gold, Green Submitted			2022-12-27	WOS:000375677000007
J	Barve, S; La Sorte, FA				Barve, Sahas; La Sorte, Frank A.			Fruiting Season Length Restricts Global Distribution of Female-Only Parental Care in Frugivorous Passerine Birds	PLOS ONE			English	Article							MATING SYSTEMS; NEST PREDATION; LIFE-HISTORY; SEXUAL DICHROMATISM; CLUTCH SIZE; EVOLUTION; SELECTION; RESOURCES; COMMUNITIES; STRATEGIES	Food availability is known to influence parental care and mating systems in passerine birds. Altricial chicks make uni-parental care particularly demanding for passerines and parental investment is known to increase with decreasing food availability. We expect this to limit uni-parental passerines to habitats with the most consistent food availability. In passerine birds, species having uni-parental care are primarily female-only parental care (female-only care) and most passerine birds with female-only care are frugivores. We predict that frugivorous passerines with female-only care should be restricted to the most stable habitats characterized by longer fruiting season length. At a global scale, female-only care frugivores were distributed in areas with significantly longer fruiting seasons than non-female-only care frugivores. Female-only care species richness had a stronger spatial relationship with longer fruiting season than non-female-only care species richness. Verifying the lack of a phylogenetic signal driving this pattern, our findings indicate that the geographic distribution of female-only care, a geographically and phylogenetically widespread parental care system, is restricted by an extrinsic factor: fruiting season length. This reinstates the importance of food availability on the evolution and maintenance of parental care systems in passerine birds.	[Barve, Sahas] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Barve, Sahas; La Sorte, Frank A.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA	Cornell University; Cornell University	Barve, S (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA.; Barve, S (corresponding author), Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA.	sahasbarve@gmail.com						Auguie B, 2017, GRIDEXTRA MISCELLANE; Badyaev AV, 1997, OIKOS, V80, P128, DOI 10.2307/3546524; Badyaev AV, 1998, OIKOS, V82, P319, DOI 10.2307/3546972; Barea LP, 2012, EMU, V112, P39, DOI 10.1071/MU10082; Barve S, 2015, IBIS, V157, P299, DOI 10.1111/ibi.12233; BEEHLER BM, 1988, AM NAT, V131, P203, DOI 10.1086/284786; Bennett PM, 2002, VARIATION MATING SYS, P77; Biancucci L, 2010, J ANIM ECOL, V79, P1086, DOI 10.1111/j.1365-2656.2010.01720.x; BirdLife International, 2013, BIRDL CHECKL BIRDS W; BRADBURY J, 1986, ANIM BEHAV, V34, P1694, DOI 10.1016/S0003-3472(86)80257-3; BUCKLEY P. A., 1985, ORNITHOL MONOGR, V36, P865, DOI [10.2307/40168322, DOI 10.2307/40168322]; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cockburn A, 2013, LIFE MIND-PHILOS ISS, P223; DUNN PO, 1992, BEHAV ECOL, V3, P291, DOI 10.1093/beheco/3.4.291; Duong T, 2011, KS KERNEL SMOOTHING; FOSTER MS, 1974, AUK, V91, P722, DOI 10.2307/4084724; INTERNATIONAL BIRDLIFE, 2015, BIRD SPEC DISTR MAPS; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; KARR JR, 1971, ECOL MONOGR, V41, P207, DOI 10.2307/1942366; KARR JR, 1976, AM NAT, V110, P973, DOI 10.1086/283121; Kissling WD, 2009, GLOBAL ECOL BIOGEOGR, V18, P150, DOI 10.1111/j.1466-8238.2008.00431.x; Leisler B, 2002, AUK, V119, P379, DOI 10.1642/0004-8038(2002)119[0379:EOBSIA]2.0.CO;2; LEVEY DJ, 1988, ECOL MONOGR, V58, P251, DOI 10.2307/1942539; Martin T.E., 1992, Current Ornithology, V9, P163; Martin TE, 1996, EVOLUTION, V50, P2454, DOI 10.1111/j.1558-5646.1996.tb03631.x; MARTIN TE, 1985, OECOLOGIA, V66, P563, DOI 10.1007/BF00379351; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin TE, 2015, SCIENCE, V349, P966, DOI 10.1126/science.aad1173; Moegenburg SM, 2003, ECOLOGY, V84, P2600, DOI 10.1890/02-0063; Morton ES, 1973, AM NAT, P8; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; Owens IPF, 1999, P ROY SOC B-BIOL SCI, V266, P933, DOI 10.1098/rspb.1999.0726; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Remes V, 2015, P NATL ACAD SCI US; RICKLEFS RE, 1976, IBIS, V118, P179, DOI 10.1111/j.1474-919X.1976.tb03065.x; Rubenstein DR, 2011, P NATL ACAD SCI USA, V108, P10816, DOI 10.1073/pnas.1100303108; Ryder TB, 2006, AUK, V123, P247, DOI 10.1642/0004-8038(2006)123[0247:ATOTEH]2.0.CO;2; Sahr K., 2003, CARTOGR GEOGR INF SC, V30, P121, DOI [10.1559/152304003100011090, DOI 10.1559/152304003100011090]; Sahr K., 2011, ARCHIWUM FOTOGRAMETR, P22; Saracco JF, 2004, OECOLOGIA, V139, P235, DOI 10.1007/s00442-004-1493-7; SHUTLER D, 1990, EVOLUTION, V44, P1967, DOI 10.1111/j.1558-5646.1990.tb04303.x; Skutch A.F., 1985, ORNITHOLOGICAL MONOG, V36, P575, DOI [10.2307/40168306, DOI 10.2307/40168306]; Snow D-W, 1981, ASS TROPICAL BIOL CO, V13, P1, DOI DOI 10.2307/2387865; Ting S, 2008, GLOBAL ECOL BIOGEOGR, V17, P648, DOI 10.1111/j.1466-8238.2008.00408.x; VERNER J, 1964, EVOLUTION, V18, P252, DOI 10.2307/2406398; VERNER J, 1966, ECOLOGY, V47, P143, DOI 10.2307/1935753; Wand M.P., 1995, MONOGRAPHS STAT APPL, V60; Wegrzyn E, 2013, J AVIAN BIOL, V44, P383, DOI 10.1111/j.1600-048X.2013.05846.x; Westcott DA, 1997, ANIM BEHAV, V53, P235, DOI 10.1006/anbe.1996.0294; WITTENBERGER JF, 1976, AM NAT, V110, P779, DOI 10.1086/283102	55	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154871	10.1371/journal.pone.0154871	http://dx.doi.org/10.1371/journal.pone.0154871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149262	Green Submitted, Green Published, gold			2022-12-27	WOS:000375676800077
J	Gwon, YD; Kim, S; Cho, Y; Heo, Y; Cho, H; Park, K; Lee, HJ; Choi, J; Poo, H; Kim, YB				Gwon, Yong-Dae; Kim, Sehyun; Cho, Yeondong; Heo, Yoonki; Cho, Hansam; Park, Kihoon; Lee, Hee-Jung; Choi, Jiwon; Poo, Haryoung; Kim, Young Bong			Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1	PLOS ONE			English	Article							IMPROVED CROSS-PROTECTION; A VIRUS; IMMUNE-RESPONSES; GENE-TRANSFER; VECTOR; STRAIN; HEMAGGLUTININ; STANDARD; SUBTYPES; EPITOPE	An outbreak of influenza H1N1 in 2009, representing the first influenza pandemic of the 21st century, was transmitted to over a million individuals and claimed 18,449 lives. The current status in many countries is to prepare influenza vaccine using cell-based or egg-based killed vaccine. However, traditional influenza vaccine platforms have several limitations. To overcome these limitations, many researchers have tried various approaches to develop alternative production platforms. One of the alternative approach, we reported the efficacy of influenza HA vaccination using a baculoviral DNA vaccine (AcHERV-HA). However, the immune response elicited by the AcHERV-HA vaccine, which only targets the HA antigen, was lower than that of the commercial killed vaccine. To overcome the limitations of this previous vaccine, we constructed a human endogenous retrovirus (HERV) envelope-coated, baculovirus-based, virus-like-particle (VLP)-forming DNA vaccine (termed AcHERV-VLP) against pandemic influenza A/California/04/2009 (pH1N1). BALB/c mice immunized with AcHERV-VLP (1x10(7) FFU AcHERV-VLP, i.m.) and compared with mice immunized with the killed vaccine or mice immunized with AcHERV-HA. As a result, AcHERV-VLP immunization produced a greater humoral immune response and exhibited neutralizing activity with an intrasubgroup H1 strain (PR8), elicited neutralizing antibody production, a high level of interferon-gamma secretion in splenocytes, and diminished virus shedding in the lung after challenge with a lethal dose of influenza virus. In conclusion, VLP-forming baculovirus DNA vaccine could be a potential vaccine candidate capable of efficiently delivering DNA to the vaccinee and VLP forming DNA eliciting stronger immunogenicity than egg-based killed vaccines.	[Gwon, Yong-Dae; Kim, Sehyun; Cho, Yeondong; Heo, Yoonki; Cho, Hansam; Park, Kihoon; Lee, Hee-Jung; Choi, Jiwon; Kim, Young Bong] Konkuk Univ, Dept Bioind Technol, Seoul, South Korea; [Poo, Haryoung] Korea Res Inst Biosci & Biotechnol, Viral Dis Res Ctr, Daejeon, South Korea	Konkuk University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, YB (corresponding author), Konkuk Univ, Dept Bioind Technol, Seoul, South Korea.	kimera@konkuk.ac.kr		Gwon, Yong-Dae/0000-0002-0703-4188	iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries) from Ministry of Agriculture, Food and Rural Affairs [314003-02-2-SB010]; grant of Korea Health technology R&D Project through Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI15C1685]	iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries) from Ministry of Agriculture, Food and Rural Affairs; grant of Korea Health technology R&D Project through Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries) from Ministry of Agriculture, Food and Rural Affairs (314003-02-2-SB010), by a grant of the Korea Health technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea. (Grant Number: HI15C1685). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airenne KJ, 2013, MOL THER, V21, P739, DOI 10.1038/mt.2012.286; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Chen CY, 2010, VACCINE, V28, P7644, DOI 10.1016/j.vaccine.2010.09.048; Cho H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095961; Choi HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129761; Choi JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080762; Deml L, 2005, MOL IMMUNOL, V42, P259, DOI 10.1016/j.molimm.2004.06.028; Eibl R, 2014, ADV BIOCHEM ENG BIOT, V138, P99, DOI 10.1007/10_2013_186; Fabian G T, 2008, J S C Med Assoc, V104, P126; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gallorini S, 2014, VACCINE, V32, P2382, DOI 10.1016/j.vaccine.2013.12.043; Giles BM, 2011, VACCINE, V29, P3043, DOI 10.1016/j.vaccine.2011.01.100; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; HARMON MW, 1988, J CLIN MICROBIOL, V26, P333, DOI 10.1128/JCM.26.2.333-337.1988; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Huang P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-47; Huber VC, 2014, EXPERT REV VACCINES, V13, P31, DOI 10.1586/14760584.2014.852476; Jang YH, 2014, VIRUSES-BASEL, V6, P3159, DOI 10.3390/v6083159; Kawano M, 2014, VIROLOGY, V448, P159, DOI 10.1016/j.virol.2013.10.010; Kim MC, 2014, VACCINE, V32, P5824, DOI 10.1016/j.vaccine.2014.08.030; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; Lee HJ, 2012, ASIAN J ENDOSC SURG, V5, P5, DOI 10.1111/j.1758-5910.2011.00111.x; Lee HJ, 2010, VACCINE, V28, P1613, DOI 10.1016/j.vaccine.2009.11.044; Lee YT, 2014, CLIN EXP VACCINE RES, V3, P12, DOI 10.7774/cevr.2014.3.1.12; Liu YV, 2015, VACCINE, V33, P2152, DOI 10.1016/j.vaccine.2015.03.009; Lu HY, 2012, BIOENGINEERED, V3, P271, DOI 10.4161/bioe.20679; Ma CQ, 2014, VACCINE, V32, P6170, DOI 10.1016/j.vaccine.2014.08.086; McPherson CE, 2008, BIOLOGICALS, V36, P350, DOI 10.1016/j.biologicals.2008.08.001; Morokutti A, 2014, VACCINE, V32, P1897, DOI 10.1016/j.vaccine.2014.02.009; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Ross TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006032; Scalera NM, 2009, POSTGRAD MED, V121, P43, DOI 10.3810/pgm.2009.09.2051; Smith GE, 2013, VACCINE, V31, P4305, DOI 10.1016/j.vaccine.2013.07.043; Soema PC, 2015, EUR J PHARM BIOPHARM, V94, P251, DOI 10.1016/j.ejpb.2015.05.023; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Stech J, 2010, BUNDESGESUNDHEITSBLA, V53, P1231, DOI 10.1007/s00103-010-1166-0; Terajima M, 2012, J VIROL, V86, P10258, DOI 10.1128/JVI.00894-12; Uranowska K, 2014, ACTA BIOCHIM POL, V61, P541; Wei GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028309; World Health Organization, 2010, PAND H1N1 2009 UPD 1; World Health Organization, 2009, WORLD NOW START 2009; Wu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042363	47	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154824	10.1371/journal.pone.0154824	http://dx.doi.org/10.1371/journal.pone.0154824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149064	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800065
J	Zwolicki, A; Zmudczynska-Skarbek, K; Richard, P; Stempniewicz, L				Zwolicki, Adrian; Zmudczynska-Skarbek, Katarzyna; Richard, Pierre; Stempniewicz, Lech			Importance of Marine-Derived Nutrients Supplied by Planktivorous Seabirds to High Arctic Tundra Plant Communities	PLOS ONE			English	Article							STABLE-ISOTOPES; VEGETATION; COLONY; ISLAND; SEA; ECOSYSTEM; PATTERNS; NITROGEN; VARIABILITY; POPULATION	We studied the relative importance of several environmental factors for tundra plant communities in five locations across Svalbard (High Arctic) that differed in geographical location, oceanographic and climatic influence, and soil characteristics. The amount of marine-derived nitrogen in the soil supplied by seabirds was locally the most important of the studied environmental factors influencing the tundra plant community. We found a strong positive correlation between delta N-15 isotopic values and total N content in the soil, confirming the fundamental role of marine-derived matter to the generally nutrient-poor Arctic tundra ecosystem. We also recorded a strong correlation between the delta N-15 values of soil and of the tissues of vascular plants and mosses, but not of lichens. The relationship between soil delta N-15 values and vascular plant cover was linear. In the case of mosses, the percentage ground cover reached maximum around a soil delta N-15 value of 8 parts per thousand, as did plant community diversity. This soil delta N-15 value clearly separated the occurrence of plants with low nitrogen tolerance (e.g. Salix polaris) from those predominating on high N content soils (e.g. Cerastium arcticum, Poa alpina). Large colonies of planktivorous little auks have a great influence on Arctic tundra vegetation, either through enhancing plant abundance or in shaping plant community composition at a local scale.	[Zwolicki, Adrian; Zmudczynska-Skarbek, Katarzyna; Stempniewicz, Lech] Univ Gdansk, Dept Vertebrate Ecol & Zool, Wita Stwosza 59, PL-80308 Gdansk, Poland; [Richard, Pierre] Univ La Rochelle, Littoral Environm & Soc, UMR CNRS 7266, 2 Rue Olympe de Gouges, F-17000 La Rochelle, France	Fahrenheit Universities; University of Gdansk; La Rochelle Universite	Zwolicki, A (corresponding author), Univ Gdansk, Dept Vertebrate Ecol & Zool, Wita Stwosza 59, PL-80308 Gdansk, Poland.	adrian.zwolicki@ug.edu.pl	Richard, Pierre J/N-6482-2014	Richard, Pierre J/0000-0002-0393-9967; Zmudczynska-Skarbek, Katarzyna/0000-0003-2276-4565; Stempniewicz, Lech/0000-0001-9405-7320; Zwolicki, Adrian/0000-0003-2710-681X	Polish Ministry of Science and Higher Education [3290/B/P01/2009/36, 1883/P01/2007/32, IPY/25/2007]; Polish-Norwegian Research Fund (ALKEKONGE) [PNRF-234-AI-1/07]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish-Norwegian Research Fund (ALKEKONGE)	This work was funded by the Polish Ministry of Science and Higher Education (Grant Nos. 3290/B/P01/2009/36, 1883/P01/2007/32 and IPY/25/2007) and Polish-Norwegian Research Fund (Grant No. PNRF-234-AI-1/07, ALKEKONGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, STATISTICA DATA ANAL; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Ansari AH, 2013, BIOGEOCHEMISTRY, V113, P341, DOI 10.1007/s10533-012-9761-9; Bokhorst S, 2007, POLAR BIOL, V30, P1315, DOI 10.1007/s00300-007-0292-0; BROADY PA, 1989, HYDROBIOLOGIA, V172, P77, DOI 10.1007/BF00031614; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Burke Chantelle M., 2014, Marine Ornithology, V42, P17; Cannone N, 2004, POLAR BIOL, V27, P562, DOI 10.1007/s00300-004-0622-4; Carstensen J, 2012, J PLANKTON RES, V34, P951, DOI 10.1093/plankt/fbs059; Cazares E, 2005, MYCORRHIZA, V15, P405, DOI 10.1007/s00572-004-0342-1; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Cocks MP, 1998, POLAR BIOL, V20, P107, DOI 10.1007/s003000050283; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Delaux PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004487; Ellis J.C., 2011, P177; Ellis JC, 2006, J ANIM ECOL, V75, P565, DOI 10.1111/j.1365-2656.2006.01077.x; Erskine PD, 1998, OECOLOGIA, V117, P187, DOI 10.1007/s004420050647; EUROLA S, 1977, Aquilo Ser Botanica, V15, P1; Fort J, 2010, MAR ECOL PROG SER, V414, P293, DOI 10.3354/meps08721; Frenot Y, 1998, J VEG SCI, V9, P75, DOI 10.2307/3237225; GILLHAM ME, 1961, J ECOL, V49, P289, DOI 10.2307/2257263; GLIME J. M., 2007, BRYOPHYTE ECOLOGY, V1, P1; Gould WA, 1999, J VEG SCI, V10, P537, DOI 10.2307/3237188; Grime J., 1979, POPULATION DYNAMICS, P123; Harding JS, 2004, FRESHWATER BIOL, V49, P576, DOI 10.1111/j.1365-2427.2004.01210.x; Hawke DJ, 2007, NEW ZEAL J BOT, V45, P309; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hill PW, 2011, NAT CLIM CHANGE, V1, P50, DOI [10.1038/nclimate1060, 10.1038/NCLIMATE1060]; Hoffmann MH, 2012, NEW PHYTOL, V193, P474, DOI 10.1111/j.1469-8137.2011.03924.x; HOLM S, 1979, SCAND J STAT, V6, P65; Huiskes A, 2006, PLANT ECOL; Jakubas D, 2008, POL POLAR RES, V29, P45; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; KENNEDY AD, 1993, ARCTIC ALPINE RES, V25, P308, DOI 10.2307/1551914; Kolb G.S., 2011, P212; Kolb GS, 2010, MAR ECOL PROG SER, V417, P287, DOI 10.3354/meps08791; Kwasniewski S, 2010, PROG OCEANOGR, V87, P72, DOI 10.1016/j.pocean.2010.06.004; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; Nash TH., 1996, LICHEN BIOL; ODASZ AM, 1994, J VEG SCI, V5, P913, DOI 10.2307/3236203; Odum E.P., 1989, ECOLOGY OUR ENDANGER; Rannie W, 1986, ARCTIC, V39; Raup H, 1969, RELATION VASCULAR FL; Ryan P, 1989, POLAR BIOL, V10; Signa G, 2012, ESTUAR COAST SHELF S, V111, P27, DOI 10.1016/j.ecss.2012.06.008; Skrzypek G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136536; STAALAND H, 1983, HOLARCTIC ECOL, V6, P109; STEMPNIEWICZ L, 1990, COLON WATERBIRD, V13, P62, DOI 10.2307/1521421; Stempniewicz L, 2007, DEEP-SEA RES PT II, V54, P2934, DOI 10.1016/j.dsr2.2007.08.012; Summerhayes VS, 1928, J ECOL, V16, P193, DOI 10.2307/2255794; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thomas DN, 2008, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780199298112.001.0001; Tilman D, 1986, PLANT ECOLOGY, P51; WACE NM, 1961, ECOL MONOGR, V31, P337, DOI 10.2307/1950757; Wahren CHA, 2005, GLOBAL CHANGE BIOL, V11, P537, DOI 10.1111/j.1365-2486.2005.00927.x; Wait DA, 2005, J ARID ENVIRON, V60, P681, DOI 10.1016/j.jaridenv.2004.07.001; Walker M, 2015, ARCTIC ALPINE BIODIV, P320; Weydmann A, 2014, MAR ECOL PROG SER, V501, P41, DOI 10.3354/meps10694; Wojciechowska A, 2015, POLAR BIOL, V38, P1919, DOI 10.1007/s00300-015-1755-3; Wojczulanis-Jakubas K, 2011, POLAR BIOL, V34, P847, DOI 10.1007/s00300-010-0941-6; Wookey PA, 2009, GLOBAL CHANGE BIOL, V15, P1153, DOI 10.1111/j.1365-2486.2008.01801.x; Zelenskaya LA, 2006, RUSS J ECOL+, V37, P126, DOI 10.1134/S106741360602010X; Zmudczynska K, 2012, POLAR BIOL, V35, P1233, DOI 10.1007/s00300-012-1169-4; Zmudczynska-Skarbek K, 2015, J MARINE SYST, V144, P48, DOI 10.1016/j.jmarsys.2014.11.013; Zwolicki A, 2015, POLAR BIOL, V38, P1645, DOI 10.1007/s00300-015-1730-z; Zwolicki A, 2013, POLAR BIOL, V36, P363, DOI 10.1007/s00300-012-1265-5	69	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154950	10.1371/journal.pone.0154950	http://dx.doi.org/10.1371/journal.pone.0154950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149113	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800096
J	Alexander, JS; Gopalaswamy, AM; Shi, K; Hughes, J; Riordan, P				Alexander, Justine Shanti; Gopalaswamy, Arjun M.; Shi, Kun; Hughes, Joelene; Riordan, Philip			Patterns of Snow Leopard Site Use in an Increasingly Human-Dominated Landscape	PLOS ONE			English	Article							LARGE CARNIVORES; TIBETAN PLATEAU; PANTHERA-UNCIA; LAND-USE; OCCUPANCY; LIVESTOCK; CONFLICT; PEOPLE; QILIANSHAN; PREDATORS	Human population growth and concomitant increases in demand for natural resources pose threats to many wildlife populations. The landscapes used by the endangered snow leopard (Panthera uncia) and their prey is increasingly subject to major changes in land use. We aimed to assess the influence of 1) key human activities, as indicated by the presence of mining and livestock herding, and 2) the presence of a key prey species, the blue sheep (Pseudois nayaur), on probability of snow leopard site use across the landscape. In Gansu Province, China, we conducted sign surveys in 49 grid cells, each of 16 km(2) in size, within a larger area of 3392 km(2). We analysed the data using likelihood-based habitat occupancy models that explicitly account for imperfect detection and spatial auto-correlation between survey transect segments. The model-averaged estimate of snow leopard occupancy was high [0.75 (SE 0.10)], but only marginally higher than the naive estimate (0.67). Snow leopard segment-level probability of detection, given occupancy on a 500 m spatial replicate, was also high [0.68 (SE 0.08)]. Prey presence was the main determinant of snow leopard site use, while human disturbances, in the form of mining and herding, had low predictive power. These findings suggest that snow leopards continue to use areas very close to such disturbances, as long as there is sufficient prey. Improved knowledge about the effect of human activity on large carnivores, which require large areas and intact prey populations, is urgently needed for conservation planning at the local and global levels. We highlight a number of methodological considerations that should guide the design of such research.	[Alexander, Justine Shanti; Shi, Kun; Riordan, Philip] Beijing Forestry Univ, Sch Nat Conservat, Wildlife Inst, Beijing, Peoples R China; [Gopalaswamy, Arjun M.; Hughes, Joelene; Riordan, Philip] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England; [Riordan, Philip] Wildlife Borders UK, Gorebridge, Oxon, England; [Gopalaswamy, Arjun M.] Indian Stat Inst, Bangalore Ctr, Stat & Math Unit, Bengaluru, India; [Shi, Kun] Ecobridge Continental, Beijing, Peoples R China	Beijing Forestry University; University of Oxford; Indian Statistical Institute	Shi, K (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Wildlife Inst, Beijing, Peoples R China.; Shi, K (corresponding author), Ecobridge Continental, Beijing, Peoples R China.	kunshi@bjfu.edu.cn	Riordan, Philip/AAY-6420-2020	Riordan, Philip/0000-0001-6285-8596; Alexander, Justine Shanti/0000-0002-7474-9247	Second National Survey of Terrestrial Wildlife in China; State Forestry Administration of China; National Natural Science Foundation of China [31470567]; Starr Foundation	Second National Survey of Terrestrial Wildlife in China; State Forestry Administration of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Starr Foundation	We acknowledge support from the Second National Survey of Terrestrial Wildlife in China, State Forestry Administration of China, and National Natural Science Foundation of China (Grant No. 31470567). P.R. thanks the Starr Foundation for support during the undertaking of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2015, HIGH TRAIL EXAMINING; Alexander J, 2015, ORYX; Alexander JS, 2015, ORYX, P1; Alexander J, 2015, BIOL CONSERV, V187, P1, DOI 10.1016/j.biocon.2015.04.002; Alexander JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134815; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Cui XF, 2009, CLIMATIC CHANGE, V94, P47, DOI 10.1007/s10584-009-9556-8; Dagleish MP, 2007, J WILDLIFE DIS, V43, P512, DOI 10.7589/0090-3558-43.3.512; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; FOX JL, 1991, BIOL CONSERV, V55, P283, DOI 10.1016/0006-3207(91)90033-6; Gelman A, 2007, SCALING REGRESSION I, P1; Hines J., 2006, PRESENCE2 SOFTWARE E; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hughes J, 2015, MAMMALIA, V79, P241, DOI 10.1515/mammalia-2014-0038; Hussain S, 2003, ORYX, V37, P26, DOI 10.1017/S0030605303000085; Jackson, 1996, HOME RANGE MOVEMENTS; Jackson R., 2008, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2008.RLTS.T22732A9381126.en; Jackson R., 1984, INT PEDIGREE B SNOW, V4, P43; Jackson R. M., 1996, THESIS U LONDON, P233; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Li J, 2013, BIOL CONSERV, V166, P118, DOI 10.1016/j.biocon.2013.06.024; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; Lovari S, 2013, J ZOOL, V291, P127, DOI 10.1111/jzo.12053; Lovari S, 2013, ETHOL ECOL EVOL, V25, P1; Lyngdoh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088349; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McCarthy T, 2003, SNOW LEOPARD SURVIVA; McCarthy TM, 2005, BIOL CONSERV, V124, P527, DOI 10.1016/j.biocon.2005.03.003; Mccarthy TM., 2014, SNOW LEOPARD SURVIVA, P1; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Mordecai RS, 2011, J APPL ECOL, V48, P56, DOI 10.1111/j.1365-2664.2010.01921.x; Morrison CD, 2014, J WILDLIFE MANAGE, V78, P1394, DOI 10.1002/jwmg.799; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; Patil N, 2011, ORYX, V45, P472, DOI 10.1017/S0030605311001591; Quantum GIS Development Team, 2014, QUANT GIS GEOGR INF; Riordan P, 2015, ECOGRAPHY, V38; Riordan P., 2010, CATNEWS; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; SCHALLER GB, 1988, BIOL CONSERV, V45, P179, DOI 10.1016/0006-3207(88)90138-3; Schuette P, 2013, BIOL CONSERV, V157, P148, DOI 10.1016/j.biocon.2012.09.011; Sharma RK, 2015, BIOL CONSERV, V190, P8, DOI 10.1016/j.biocon.2015.04.026; Suryawanshi KR, 2013, J APPL ECOL, V50, P550, DOI 10.1111/1365-2664.12061; Taubmann J., 2015, ORYX, P1; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Wang GH, 2003, PLANT ECOL, V165, P169, DOI 10.1023/A:1022236115186; Wang XH, 2008, CATENA, V72, P56, DOI 10.1016/j.catena.2007.04.003; Whittington J, 2015, ANIM CONSERV, V18, P92, DOI 10.1111/acv.12140; Wolf M, 2009, J MAMMAL, V90, P604, DOI 10.1644/08-MAMM-A-002R1.1; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Zilla C, 2013, FRAGMENTATION COOPER	57	23	25	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155309	10.1371/journal.pone.0155309	http://dx.doi.org/10.1371/journal.pone.0155309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171203	Green Published, gold, Green Submitted			2022-12-27	WOS:000376588600098
J	Ding, FR; Li, XJ; Li, BH; Guo, JF; Zhang, YQ; Ding, J				Ding, Fangrui; Li, Xuejuan; Li, Baihong; Guo, Jifan; Zhang, Yanqin; Ding, Jie			Calpain-Mediated Cleavage of Calcineurin in Puromycin Aminonucleoside-Induced Podocyte Injury	PLOS ONE			English	Article							NEPHROTIC SYNDROME; GLOMERULAR PROTEIN; ALPORT-SYNDROME; CYCLOSPORINE-A; ACTIVATION; DISEASE; CYTOSKELETON; KIDNEY; GLOMERULOSCLEROSIS; PROTEOLYSIS	The calcineurin inhibitors cyclosporine A (CsA) and tacrolimus are widely used in the treatment of proteinuria diseases. As the direct target of these drugs, calcineurin has previously been demonstrated to play a role in proteinuria diseases. However, aside from its immune-related effects, the local status of calcineurin in renal inherent cells has not been fully explored in the settings of proteinuria disease and podocyte injury. In this study, calcineurin activity and protein expression in the well-known puromycin aminonucleoside (PAN)induced podocyte injury model were examined. Interestingly, we found that calcineurin activity was abnormally increased in PAN-treated podocytes, whereas the expression of the full-length 60-kDa calcineurin protein was decreased. This result suggests that there may be another activated form of calcineurin that is independent of the full-length phosphatase. To investigate whether calpain is involved in regulating calcineurin, we exposed PAN-treated podocytes to both pharmacological inhibitors of calpain and specific siRNAs against calpain. Calpain blockade reduced the enhanced calcineurin activity and restored the down-regulated expression of 60-kDa calcineurin. In addition, purified calpain protein was incubated with podocyte extracts, and a 45-kDa fragment of calcineurin was identified; this finding was confirmed in PAN-induced podocyte injury and calpain inhibition experiments. We conclude that calcineurin activity is abnormally increased during PAN-induced podocyte injury, whereas the expression of the full-length 60-kDa calcineurin protein is down-regulated due to over-activated calpain that cleaves calcineurin to form a 45-kDa fragment.	[Ding, Fangrui; Li, Xuejuan; Li, Baihong; Guo, Jifan; Zhang, Yanqin; Ding, Jie] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China	Peking University	Ding, J (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	djnc_5855@126.com			National Basic Research Program of China (973 Program) [2012CB517700]; National Nature Science Foundation of China [30830105, 81170657]; Nature Science Foundation of Beijing [7072080]; Beijing Key Laboratory of Molecular Diagnosis and Study of Pediatric Genetic Diseases	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Beijing; Beijing Key Laboratory of Molecular Diagnosis and Study of Pediatric Genetic Diseases	This work was supported by the following organizations: the National Basic Research Program of China (973 Program, no. 2012CB517700, www.nsfc.gov.cn), the National Nature Science Foundation of China (nos. 30830105 and 81170657, www.nsfc.gov.cn), and the Nature Science Foundation of Beijing (no. 7072080, http://www.bjnsf.org/) and the Beijing Key Laboratory of Molecular Diagnosis and Study of Pediatric Genetic Diseases (http://www.bjkw.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul HM, 2011, AGING CELL, V10, P103, DOI 10.1111/j.1474-9726.2010.00645.x; Altintas MM, 2014, J BIOL CHEM, V289, P17454, DOI 10.1074/jbc.M114.568998; Aragon E, 2016, LUPUS, V25, P399, DOI 10.1177/0961203315615220; Baumgartel K, 2012, LEARN MEMORY, V19, P375, DOI 10.1101/lm.027201.112; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Charbit M, 2007, PEDIATR NEPHROL, V22, P57, DOI 10.1007/s00467-006-0227-y; Chen D, 2003, J AM SOC NEPHROL, V14, P690, DOI 10.1097/01.ASN.0000046964.15831.16; Descazeaud V, 2012, J CELL MOL MED, V16, P218, DOI 10.1111/j.1582-4934.2011.01398.x; Ding FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112972; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Greenbaum LA, 2012, NAT REV NEPHROL, V8, P445, DOI 10.1038/nrneph.2012.115; Inaba A, 2016, PEDIATR NEPHROL, V31, P425, DOI 10.1007/s00467-015-3174-7; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Kumagai T, 2014, AM J PATHOL, V184, P2211, DOI 10.1016/j.ajpath.2014.05.005; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Oh J, 2011, KIDNEY INT, V80, P483, DOI 10.1038/ki.2011.105; Peltier J, 2006, J AM SOC NEPHROL, V17, P3415, DOI 10.1681/ASN.2006050542; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Qian W, 2011, J ALZHEIMERS DIS, V23, P617, DOI 10.3233/JAD-2010-100987; Ramachandran R, 2015, NEPHROLOGY, V20, P384, DOI 10.1111/nep.12392; Sethna CB, 2014, ADV CHRONIC KIDNEY D, V21, P194, DOI 10.1053/j.ackd.2014.01.010; SHALHOUB RJ, 1974, LANCET, V2, P556; Shiiki H, 1998, PATHOBIOLOGY, V66, P221, DOI 10.1159/000028027; Suzuki K, 1998, FEBS LETT, V433, P1, DOI 10.1016/S0014-5793(98)00856-4; Wang JC, 2012, CLIN LAB, V58, P1145, DOI 10.7754/Clin.Lab.2012.111108; Wang YG, 2014, TRENDS CARDIOVAS MED, V24, P14, DOI 10.1016/j.tcm.2013.05.004; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Zhou LL, 2015, NAT REV NEPHROL, V11, P535, DOI 10.1038/nrneph.2015.88	33	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155504	10.1371/journal.pone.0155504	http://dx.doi.org/10.1371/journal.pone.0155504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171192	Green Published, Green Submitted, gold			2022-12-27	WOS:000376588600022
J	Yang, QS; Cong, WX; Xi, Y; Wang, G				Yang, Qingsong; Cong, Wenxiang; Xi, Yan; Wang, Ge			Spectral X-Ray CT Image Reconstruction with a Combination of Energy-Integrating and Photon-Counting Detectors	PLOS ONE			English	Article							THRESHOLDING ALGORITHM; COMPUTED-TOMOGRAPHY; RESOLVED CT; MICRO-CT	The purpose of this paper is to develop an algorithm for hybrid spectral computed tomography (CT) which combines energy-integrating and photon-counting detectors. While the energy-integrating scan is global, the photon-counting scan can have a local field of view (FOV). The algorithm synthesizes both spectral data and energy-integrating data. Low rank and sparsity prior is used for spectral CT reconstruction. An initial estimation is obtained from the projection data based on physical principles of x-ray interaction with the matter, which provides a more accurate Taylor expansion than previous work and can guarantee the convergence of the algorithm. Numerical simulation with clinical CT images are performed. The proposed algorithm produces very good spectral features outside the FOV when no K-edge material exists. Exterior reconstruction of K-edge material can be partially achieved.	[Yang, Qingsong; Cong, Wenxiang; Xi, Yan; Wang, Ge] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	Wang, G (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.	wangg6@rpi.edu	Wang, Ge/AAH-8592-2020	Wang, Ge/0000-0002-2656-7705	NIH [U01 EB017140, R01 EB016977]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB017140, R01EB016977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH Grant U01 EB017140 and NIH Grant R01 EB016977. http://www.nibib.nih.gov/research-funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NG, 2010, EUR RADIOL, V20, P2126, DOI 10.1007/s00330-010-1768-9; Baturin P, 2012, PHYS MED BIOL, V57, P4117, DOI 10.1088/0031-9155/57/13/4117; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bennett JR, 2014, IEEE T BIO-MED ENG, V61, P246, DOI 10.1109/TBME.2013.2279673; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Chen CH, 2016, MATH PROGRAM, V155, P57, DOI 10.1007/s10107-014-0826-5; Chu JY, 2013, PHYS MED BIOL, V58, P7009, DOI 10.1088/0031-9155/58/19/7009; Feuerlein S, 2008, RADIOLOGY, V249, P1010, DOI 10.1148/radiol.2492080560; Fornaro J, 2011, INSIGHTS IMAGING, V2, P149, DOI 10.1007/s13244-010-0057-0; Gao H, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/11/115012; Goldstein T, 2014, SIAM J IMAGING SCI, V7, P1588, DOI 10.1137/120896219; Han DR, 2012, J OPTIMIZ THEORY APP, V155, P227, DOI 10.1007/s10957-012-0003-z; Persson M, 2014, PHYS MED BIOL, V59, P6709, DOI 10.1088/0022-3727/59/22/6709; Podgorsak EB, 2010, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-642-00875-7; Ronaldson JP, 2012, MED PHYS, V39, P6847, DOI 10.1118/1.4760773; Schmidt TG, 2011, MED PHYS, V38, P5657, DOI 10.1118/1.3641749; Shikhaliev PM, 2005, MED PHYS, V32, P427, DOI 10.1118/1.1854779; Shikhaliev PM, 2008, PHYS MED BIOL, V53, P1475, DOI 10.1088/0031-9155/53/5/020; Sourceforge, 2013, SPECTRUMGUI 2013; Taguchi K, 2009, ENABLING PHOTON COUN; Taguchi K, 2013, MED PHYS, V40, DOI 10.1118/1.4820371; Walsh MF, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/01/C01095; Wang X, 2011, PHYS MED BIOL, V56, P2791, DOI 10.1088/0031-9155/56/9/011; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Weinberg S., 1996, QUANTUM THEORY FIELD; Xu Q, 2012, IEEE T BIO-MED ENG, V59, P1711, DOI 10.1109/TBME.2012.2192119; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014	28	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155374	10.1371/journal.pone.0155374	http://dx.doi.org/10.1371/journal.pone.0155374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171153	Green Submitted, Green Published, gold			2022-12-27	WOS:000376588600129
J	Areta, JI; Piacentini, VD; Haring, E; Gamauf, A; Silveira, LF; Machado, E; Kirwan, GM				Ignacio Areta, Juan; Piacentini, Vitor de Q.; Haring, Elisabeth; Gamauf, Anita; Silveira, Luis Fabio; Machado, Erika; Kirwan, Guy M.			Tiny Bird, Huge Mystery-The Possibly Extinct Hooded Seedeater (Sporophila melanops) Is a Capuchino with a Melanistic Cap	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; CERRADO ECOTONE; SYSTEMATICS; RADIATION; EVOLUTION; BRAZIL; AVES	Known with certainty solely from a unique male specimen collected in central Brazil in the first quarter of the 19th century, the Critically Endangered (Possibly Extinct) Hooded Seedeater Sporophila melanops has been one of the great enigmas of Neotropical ornithology, arguably the only one of a host of long-lost species from Brazil to remain obstinately undiscovered. We reanalysed the morphology of the type specimen, as well as a female specimen postulated to represent the same taxon, and sequenced mitochondrial DNA (COI and Cyt-b) from both individuals. Furthermore, we visited the type locality, at the border between Goias and Mato Grosso, and its environs on multiple occasions at different seasons, searching for birds with similar morphology to the type, without success. Novel genetic and morphological evidence clearly demonstrates that the type of S. melanops is not closely related to Yellow-bellied Seedeater S. nigricollis, as has been frequently postulated in the literature, but is in fact a representative of one of the so-called capuchinos, a clade of attractively plumaged seedeaters that breed mostly in the Southern Cone of South America. Our morphological analysis indicates that S. melanops has a hitherto unreported dark-coffee throat and that it is probably a Dark-throated Seedeater S. ruficollis collected within its wintering range, acquiring breeding plumage and showing melanism on the cap feathers. Alternatively, it may be a melanistic-capped individual of a local population of seedeaters known to breed in the Esteros del Ibera, Corrientes, Argentina, to which the name S. ruficollis might be applicable, whilst the name S. plumbeiceps might be available for what is currently known as S. ruficollis. A hybrid origin for S. melanops cannot be ruled out from the available data, but seems unlikely. The purported female specimen of S. melanops pertains either to S. nigricollis or to Double-collared Seedeater S. caerulescens based on genetic and morphological data, and thus cannot be a female of S. melanops. We conclude that Sporophila melanops is not typical of any natural population of seedeaters, appears to have been collected far from its breeding grounds while overwintering in central Brazil, and should not be afforded any conservation status.	[Ignacio Areta, Juan] Consejo Nacl Invest Cient & Tecn, Inst Bio & Geociencias Noroeste Argentino IBIGEO, Rosario De Lerma, Salta, Argentina; [Piacentini, Vitor de Q.; Silveira, Luis Fabio; Machado, Erika] Univ Sao Paulo MZUSP, Museu Zool, Sao Paulo, Brazil; [Piacentini, Vitor de Q.] Drexel Univ, Acad Nat Sci, Dept Ornithol, Philadelphia, PA 19104 USA; [Haring, Elisabeth; Gamauf, Anita] Museum Nat Hist Vienna, Vienna, Austria; [Haring, Elisabeth; Gamauf, Anita] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Kirwan, Guy M.] Field Museum Nat Hist, Chicago, IL 60605 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Drexel University; University of Vienna; Field Museum of Natural History (Chicago)	Areta, JI (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Bio & Geociencias Noroeste Argentino IBIGEO, Rosario De Lerma, Salta, Argentina.	esporofila@yahoo.com.ar	Piacentini, Vitor Q./K-1199-2012; Silveira, Luis Fabio/F-8337-2012; Silveira, Luis/V-6161-2019	Silveira, Luis Fabio/0000-0003-2576-7657; Silveira, Luis/0000-0003-2576-7657; /0000-0002-6876-9452; Areta, Juan Ignacio/0000-0001-8588-3030	CONICET; FAPESP [06/60300-4]; CNPq; Conservation International; Birdfair / Royal Society for the Protection of Birds Research Fund for Endangered Birds; BirdLife International; Birdfair / RSPB Research Fund for Endangered Birds	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conservation International; Birdfair / Royal Society for the Protection of Birds Research Fund for Endangered Birds; BirdLife International; Birdfair / RSPB Research Fund for Endangered Birds	JIA's research was possible thanks to funding by CONICET. VQP's visit to NMW was part of his Ph.D. research, which was funded by FAPESP (grant n. 06/60300-4). LFS received a grant from CNPq. Fieldwork in November 2009 was funded by Conservation International. GMK's December 2008 / January 2009 fieldwork was conducted under the auspices of a privately developed project in search of Sporophila melanops, which was partially funded by the Birdfair / Royal Society for the Protection of Birds Research Fund for Endangered Birds. His July 2010 fieldwork, again in search of S. melanops, was entirely funded by BirdLife International. Nigel Collar, Fernando Pacheco and David Wege kindly served as referees for project applications, and Paul Donald speeded-up the review process to enable the Birdfair / RSPB Research Fund for Endangered Birds to make a grant in support of his work.	Areta JI, 2010, THESIS U NACL LA PLA; Areta JI, 2009, BIOTROPICA, V41, P66, DOI 10.1111/j.1744-7429.2008.00458.x; Areta JI, 2008, J FIELD ORNITHOL, V79, P352, DOI 10.1111/j.1557-9263.2008.00186.x; Azara F de, 1802, APUNTAMIENTOS HIST N; Baldwin SP, 1931, SCI PUBLICATIONS CLE, V2, P1, DOI [10.5962/ bhl.title.60247, DOI 10.5962/BHL.TITLE.60247]; BERTONI A. de WINKELRIED, 1939, REV SOC CIENT PARAGUAY, V4, P3; Bertoni A deW, 1914, FAUNA PARAGUAYA CATA; BirdLife International, 2015, SPEC FACTSH SPOR MEL; Campagna L, 2015, MOL ECOL, V24, P4238, DOI 10.1111/mec.13314; Campagna L, 2013, AUK, V130, P645, DOI 10.1525/auk.2013.13064; Campagna L, 2012, P ROY SOC B-BIOL SCI, V279, P1847, DOI 10.1098/rspb.2011.2170; Campagna L, 2010, MOL ECOL RESOUR, V10, P449, DOI 10.1111/j.1755-0998.2009.02799.x; CAVARZERE V, 2015, COTINGA, V37, P57; Collar NJ, 1992, THREATENED BIRDS AM; Dickinson EC., 2003, HOWARD MOORE COMPLET; Dornas T., 2013, ATUALIDADES ORN, V176, P58; Gill F., 2006, BIRDS WORLD RECOMMEN; Gwynne JA, 2010, BIRDS BRAZIL PANTANA; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hellmayr CE, 1938, FIELD MUS NAT HIS 13, V13; Hellmayr CE, 1904, VERHANDLUNGEN ZOOLOG, V54, P516; Hirschfeld E., 2007, RARE BIRDS YB 2008; Areta JI, 2012, WILSON J ORNITHOL, V124, P688, DOI 10.1676/1559-4491-124.4.688; Areta JI, 2011, CONDOR, V113, P664, DOI 10.1525/cond.2011.100058; Areta JI, 2011, CONDOR, V113, P678, DOI 10.1525/cond.2011.100059; Ignacio Areta Juan, 2011, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V131, P4; Kirwan GM, 2010, NEOTROP BIRDING, V4, P69; Kopuchian, 2016, NUESTRAS AVES, V61, P3; Lijtmaer DA, 2004, MOL PHYLOGENET EVOL, V33, P562, DOI 10.1016/j.ympev.2004.07.011; Lopez-Lanus B, 2015, GUIA AUDIORNIS AVES, P473; Machado E, 2011, ZOOTAXA, P49, DOI 10.11646/zootaxa.2781.1.4; Mason NA, 2013, ORNITOL NEOTROP, V24, P139; Meyer De Schauensee R, 1970, GUIDE BIRDS S AM; Parker Theodore A. Iii, 1996, P113; Paynter RA, 1970, CHECKLIST BIRDS WORL, V13; Piacentini VD, 2015, REV BRAS ORNITOL, V23, P91; Remsen Jr J.V., 2016, CLASSIFICATION BIRD; Ridgely R.S., 1989, BIRDS S AM, VI; Rising JD, 2011, HDB BIRDS WORLD, V16, P254; Schauensee R. M. de, 1952, Proceedings of the Academy of Natural Sciences of Philadelphia, V104, P153; Sclater PL, 1871, IBIS, V1, P1; Sibley CG, 1990, DISTRIBUTION TAXONOM; Sick H., 1997, ORNITOLOGIA BRASILEI; Sigrist T, 2006, AVES AMAZONIA BRASIL; Somenzari M, 2011, REV BRAS ORNITOL, V19, P260; Stattersfield AJ, 2000, THREAT BIRDS WORLD; Stiles F. Gary, 1997, Ornitologia Neotropical, V7, P75; Stiles FG, 2004, ORNITOL NEOTROP, V15, P17; Svensson L.A., 2006, IDENTIFICATION GUIDE; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VANZOLINI P. E., 1993, PAPEIS AVULSOS ZOOL, V38, P17; von Pelzeln A, 1871, ORNITHOLOGIE BRASILI	52	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154231	10.1371/journal.pone.0154231	http://dx.doi.org/10.1371/journal.pone.0154231			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168078	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300101
J	Jezmir, J; Cohen, T; Zignol, M; Nyakan, E; Hedt-Gauthier, BL; Gardner, A; Kamle, L; Injera, W; Carter, EJ				Jezmir, Julia; Cohen, Ted; Zignol, Matteo; Nyakan, Edwin; Hedt-Gauthier, Bethany L.; Gardner, Adrian; Kamle, Lydia; Injera, Wilfred; Carter, E. Jane			Use of Lot Quality Assurance Sampling to Ascertain Levels of Drug Resistant Tuberculosis in Western Kenya	PLOS ONE			English	Article							SCHISTOSOMA-MANSONI; RAPID ASSESSMENT; SURVEILLANCE; APPLICABILITY; TRACHOMA; BURDEN	Objective To classify the prevalence of multi-drug resistant tuberculosis (MDR-TB) in two different geographic settings in western Kenya using the Lot Quality Assurance Sampling (LQAS) methodology. Design The prevalence of drug resistance was classified among treatment-naive smear positive TB patients in two settings, one rural and one urban. These regions were classified as having high or low prevalence of MDR-TB according to a static, two-way LQAS sampling plan selected to classify high resistance regions at greater than 5% resistance and low resistance regions at less than 1% resistance. Results This study classified both the urban and rural settings as having low levels of TB drug resistance. Out of the 105 patients screened in each setting, two patients were diagnosed with MDR-TB in the urban setting and one patient was diagnosed with MDR-TB in the rural setting. An additional 27 patients were diagnosed with a variety of mono-and poly-resistant strains. Conclusion Further drug resistance surveillance using LQAS may help identify the levels and geographical distribution of drug resistance in Kenya and may have applications in other countries in the African Region facing similar resource constraints.	[Jezmir, Julia] Stanford Med Sch, Stanford, CA USA; [Jezmir, Julia; Nyakan, Edwin; Gardner, Adrian; Kamle, Lydia; Injera, Wilfred; Carter, E. Jane] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Cohen, Ted] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Zignol, Matteo] WHO, TB Monitoring & Evaluat, Global TB Programme, CH-1211 Geneva, Switzerland; [Hedt-Gauthier, Bethany L.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Gardner, Adrian] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Carter, E. Jane] Brown Univ, Alpert Sch Med, Providence, RI 02912 USA	Stanford University; Yale University; World Health Organization; Harvard University; Harvard Medical School; Indiana University System; Indiana University Bloomington; Brown University	Jezmir, J (corresponding author), Stanford Med Sch, Stanford, CA USA.; Jezmir, J (corresponding author), Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya.	jezmir@stanford.edu		Cohen, Ted/0000-0002-8091-7198	Global TB Programme, Monitoring and Evaluation, WHO; Fulbright U.S. Student Program; USAID-AMPATH (Academic Model Providing Access to Healthcare) Cooperative Agreement; National Institute Of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Global TB Programme, Monitoring and Evaluation, WHO; Fulbright U.S. Student Program; USAID-AMPATH (Academic Model Providing Access to Healthcare) Cooperative Agreement(United States Agency for International Development (USAID)); National Institute Of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was received from the Global TB Programme, Monitoring and Evaluation, WHO. JJ was supported by the Fulbright U.S. Student Program. EJC and AG receive support through the USAID-AMPATH (Academic Model Providing Access to Healthcare) Cooperative Agreement. TC receives support by Award Number U54GM088558 (TC) from the National Institute Of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooker S, 2005, TROP MED INT HEALTH, V10, P647, DOI 10.1111/j.1365-3156.2005.01446.x; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Cohen T, 2008, AM J RESP CRIT CARE, V177, P1302, DOI 10.1164/rccm.200801-175PP; Cohen T, 2012, AM J RESP CRIT CARE, V186, P399, DOI 10.1164/rccm.201203-0394PP; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Division of Leprosy Tuberculosis and Lung Disease (DLTLD), 2012, DLTLD ANN REP 2012; Dodge H.F., 1959, SAMPLING INSPECTION; Hedt BL, 2012, EPIDEMIOLOGY, V23, P293, DOI 10.1097/EDE.0b013e3182459455; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2013, UNAIDSJC25021E; LEMESHOW S, 1991, World Health Statistics Quarterly, V44, P115; Myatt M, 2005, B WORLD HEALTH ORGAN, V83, P756; Myatt M, 2003, B WORLD HEALTH ORGAN, V81, P877; Myatt M, 2008, ANTIVIR THER, V13, P37; National AIDS and STI Control Programme (NASCOP), 2012, KEN AIDS IND SURV 20; Rabarijaona LP, 2003, TROP MED INT HEALTH, V8, P322, DOI 10.1046/j.1365-3156.2003.01019.x; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; WHO, 2014, WHO REPORT, P2013; WHO, 2011, WHOHTMTB20126; World Health Organization, 2015, WHOHTMTB201513; World Health Organization, 2010, WHOHTMTB20103; Zignol M, 2011, CLIN INFECT DIS, V52, P901, DOI 10.1093/cid/cir081	21	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154142	10.1371/journal.pone.0154142	http://dx.doi.org/10.1371/journal.pone.0154142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167381	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300104
J	Kim, Y; Kim, TW; Park, YS; Jeong, EM; Lee, DS; Kim, IG; Chung, H; Hwang, YI; Lee, WJ; Yu, HG; Kang, JS				Kim, Yejin; Kim, Tae Wan; Park, Yun Seong; Jeong, Eui Man; Lee, Dong-Sup; Kim, In-Gyu; Chung, Hum; Hwang, Young-Il; Lee, Wang Jae; Yu, Hyeong Gon; Kang, Jae Seung			The Role of Interleukin-22 and Its Receptor in the Development and Pathogenesis of Experimental Autoimmune Uveitis	PLOS ONE			English	Article							PROINFLAMMATORY GENE-EXPRESSION; T-CELL; IL-22; CYSTEAMINE; CYTOKINES; DISEASE; IDENTIFICATION; UVEORETINITIS; INFLAMMATION; RECRUITMENT	IL-22 is a pro-and anti-inflammatory cytokine that is mainly produced by T cells and NK cells. Recent studies have reported the increased number of IL-22 producing T cells in patients with autoimmune noninfectious uveitis; however, the correlation between IL-22 and uveitis remains unclear. In this study, we aimed to determine the specific role of IL-22 and its receptor in the pathogenesis of uveitis. Serum concentration of IL-22 was significantly increased in uveitis patients. IL-22R alpha was expressed in the retinal pigment epithelial cell line, ARPE-19. To examine the effect of IL-22, ARPE-19 was treated with recombinant IL-22. The proliferation of ARPE-19 and the production of monocyte chemoattractant protein (MCP)-1 from ARPE-19 were clearly elevated. IL-22 induced MCP-1 which facilitated the migration of inflammatory cells. Moreover, IL-22 increased the IL-22R alpha expression in ARPE-19 through the activation of PI3K/Akt. Experimental animal models of uveitis induced by interphotoreceptor retinoid binding protein 1-20 (IRBP1-20) exhibited elevation of hyperplasia RPE and IL-22 production. When CD4(+) T cells from the uveitis patients were stimulated with IRBP1-20, the production of IL-22 definitely increased. In addition, we examine the regulatory role of cysteamine, which has an anti-inflammatory role in the cornea, in uveitis through the down-regulation of IL-22R alpha expression. Cysteamine effectively suppressed the IRBP1-20-induced IL-22R alpha expression and prevented the development of IRBP1-20-induced uveitis in the experimental animal model. These finding suggest that IL-22 and its receptor have a crucial role in the development and pathogenesis of uveitis by facilitating inflammatory cell infiltration, and that cysteamine may be a useful therapeutic drug in treating uveitis by down-regulating IL-22R alpha expression in RPE.	[Kim, Yejin; Park, Yun Seong; Lee, Dong-Sup; Hwang, Young-Il; Lee, Wang Jae; Kang, Jae Seung] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Kim, Tae Wan; Chung, Hum; Yu, Hyeong Gon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Kim, Tae Wan] Seoul Natl Univ, Med Res Ctr, Inst Rheumatol, Seoul, South Korea; [Kim, Tae Wan] Seoul Natl Univ, Med Res Ctr, Res Sensory Organs Inst, Seoul, South Korea; [Kim, Tae Wan] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Jeong, Eui Man; Kim, In-Gyu] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kang, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea.; Yu, HG (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	hgonyu@snu.ac.kr; genius29@snu.ac.kr	Kang, Jae Seung/J-5363-2012	Jeong, Eui Man/0000-0003-0692-2033; Yu, Hyeong Gon/0000-0002-1795-202X				Aggarwal S, 2001, J INTERF CYTOK RES, V21, P1047, DOI 10.1089/107999001317205178; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; Avichezer D, 2000, INVEST OPHTH VIS SCI, V41, P127; Bae S, 2013, ANTIOXID REDOX SIGN, V19, P2040, DOI 10.1089/ars.2012.4756; Trivella DBB, 2010, CELL MOL LIFE SCI, V67, P2909, DOI 10.1007/s00018-010-0380-0; Bhuyan ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089266; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Caspi R. R., 2003, CURRENT PROTOCOLS IM, V15, P1; Caspi RR, 2011, INVEST OPHTH VIS SCI, V52, P1873, DOI 10.1167/iovs.10-6909; CASPI RR, 1993, J NEUROIMMUNOL, V47, P177, DOI 10.1016/0165-5728(93)90028-W; Caspi RR, 1999, SPRINGER SEMINARS IM; Chang H, 2006, J IMMUNOL, V177, P3635, DOI 10.4049/jimmunol.177.6.3635; Dagkalis A, 2009, INVEST OPHTH VIS SCI, V50, P4288, DOI 10.1167/iovs.09-3434; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dubinsky R, 2006, MOVEMENT DISORD, V21, P530, DOI 10.1002/mds.20756; Gahl WA, 2003, EUR J PEDIATR, V162, pS38, DOI 10.1007/s00431-003-1349-x; Gahl WA, 2000, MOL GENET METAB, V71, P100, DOI 10.1006/mgme.2000.3062; GERY I, 1994, CURR OPIN IMMUNOL, V6, P938, DOI 10.1016/0952-7915(94)90017-5; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Ke Y, 2011, J IMMUNOL, V187, P2130, DOI 10.4049/jimmunol.1100482; Ke Y, 2010, J LEUKOCYTE BIOL, V88, P1241, DOI 10.1189/jlb.0610332; Kerr EC, 2008, PROG RETIN EYE RES, V27, P527, DOI 10.1016/j.preteyeres.2008.07.001; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Leung KW, 2009, MOL IMMUNOL, V46, P1374, DOI 10.1016/j.molimm.2008.12.001; Li ZQ, 2008, J IMMUNOL, V181, P5147, DOI 10.4049/jimmunol.181.7.5147; Mitra A, 2012, CYTOKINE, V60, P38, DOI 10.1016/j.cyto.2012.06.316; Miura-Takeda S, 2008, MICROBIOL IMMUNOL, V52, P601, DOI 10.1111/j.1348-0421.2008.00077.x; Murao K, 2000, BIOCHEM BIOPH RES CO, V276, P791, DOI 10.1006/bbrc.2000.3497; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pan HF, 2013, CYTOKINE GROWTH F R, V24, P51, DOI 10.1016/j.cytogfr.2012.07.002; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Salam OMEA, 2002, PHARMACOL RES, V45, P275, DOI 10.1006/phrs.2002.0955; Shin YJ, 2011, MOL VIS, V17, P3371; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Sugita S, 2013, J IMMUNOL, V190, P5799, DOI 10.4049/jimmunol.1202677; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2010, SEMINARS IMMUNOPATHO; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zhu XF, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-13	50	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154904	10.1371/journal.pone.0154904	http://dx.doi.org/10.1371/journal.pone.0154904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166675	Green Submitted, gold, Green Published			2022-12-27	WOS:000376587300098
J	Oliveira, HR; Tomas, D; Silva, M; Lopes, S; Viegas, W; Veloso, MM				Oliveira, Hugo R.; Tomas, Diana; Silva, Manuela; Lopes, Susana; Viegas, Wanda; Veloso, Maria Manuela			Genetic Diversity and Population Structure in Vicia faba L. Landraces and Wild Related Species Assessed by Nuclear SSRs	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEAT; SINGLE-NUCLEOTIDE POLYMORPHISM; MICROSATELLITE MARKERS; ISSR MARKERS; GERMPLASM; RESOURCES; SOFTWARE; DISTANCE	Faba bean (Vicia faba L.) is a facultative cross-pollinating legume crop with a great importance for food and feed due to its high protein content as well as the important role in soil fertility and nitrogen fixation. In this work we evaluated genetic diversity and population structure of faba bean accessions from the Western Mediterranean basin and wild related species. For that purpose we screened 53 V. faba, 2 V. johannis and 7 V. narbonensis accessions from Portugal, Spain and Morocco with 28 faba bean Single Sequence Repeats (SSR). SSR genotyping showed that the number of alleles detected per locus for the polymorphicmarkers ranged between 2 and 10, with Polymorphic Information Content (PIC) values between 0.662 and 0.071, and heterozygosity (HO) between 0-0.467. Heterozygosity and inbreeding coefficient levels indicate a higher level of inbreeding in wild related species than in cultivated Vicia. The analysis of molecular variance (AMOVA) showed a superior genetic diversity within accessions than between accessions even from distant regions. These results are in accordance to population structure analysis showing that individuals from the same accession can be genetically more similar to individuals from far away accessions, than from individuals from the same accession. In all three levels of analysis (whole panel of cultivated and wild accessions, cultivated faba bean accessions and Portuguese accessions) no population structure was observed based on geography or climatic factors. Differences between V. narbonensis and V. johannis are undetectable although these wild taxa are clearly distinct from V. faba accessions. Thus, a limited gene flow occurred between cultivated accessions and wild relatives. Contrastingly, the lack of population structure seems to indicate a high degree of gene flow between V. faba accessions, possibly explained by the partially allogamous habit in association with frequent seed exchange/introduction.	[Oliveira, Hugo R.] Univ Porto, Plant Biol CIBIO Ctr Invest Biodiversidade & Recu, Campus Agr Vairao, P-4485661 Vairao, Portugal; [Tomas, Diana; Silva, Manuela; Viegas, Wanda; Veloso, Maria Manuela] Univ Lisbon, Linking Landscape Environm Agr & Food LEAF, Inst Super Agron, P-1349017 Lisbon, Portugal; [Lopes, Susana] Univ Porto, CTM CIBIO Ctr Invest Biodiversidade & Recursos Ge, Campus Agr Vairao, P-4485661 Vairao, Portugal; [Veloso, Maria Manuela] INIAV, Unidade Invest Biotecnol & Recursos Genet, Quinta Marques, P-2784505 Oeiras, Portugal; [Oliveira, Hugo R.] Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England	Universidade do Porto; Universidade de Lisboa; Universidade do Porto; Instituto Nacional de Investigacao Agraria e Veterinaria, IP (INIAV); University of Manchester	Tomas, D (corresponding author), Univ Lisbon, Linking Landscape Environm Agr & Food LEAF, Inst Super Agron, P-1349017 Lisbon, Portugal.	dianarstomas@isa.uisboa.pt	Silva, Manuela/ABF-7085-2020; Silva, Manuela/GSN-4031-2022	Silva, Manuela/0000-0003-4677-870X; Oliveira, Hugo/0000-0002-5038-073X; Tomas, Diana/0000-0001-7866-3064; Viegas, Wanda/0000-0003-4660-1226	"Genomics and Evolutionary Biology" project - North Portugal Regional Operational Programme (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); Fundacao para a Ciencia e Tecnologia, Portugal (FCT) [SFRH/BD/93156/2013]; FCT Investigator Programme [IF/00834/2014]; FCT LEAF Unit [UID/AGR/04129/2013]	"Genomics and Evolutionary Biology" project - North Portugal Regional Operational Programme (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); Fundacao para a Ciencia e Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); FCT Investigator Programme(Portuguese Foundation for Science and Technology); FCT LEAF Unit	HRO was funded by the "Genomics and Evolutionary Biology" project co-financed by North Portugal Regional Operational Programme 2007/2013 (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF). DT was funded by Fundacao para a Ciencia e Tecnologia, Portugal (FCT) doctoral scholarship (SFRH/BD/93156/2013), Manuela Silva by the FCT Investigator Programme (IF/00834/2014). The research work was financed by the FCT LEAF Unit (UID/AGR/04129/2013). The authors acknowledge the following institutions and individuals for providing seeds: Instituto Nacional de Investigacao Agraria e Veterinaria (Portugal), Centro de Recursos Fitogeneticos INIA (Spain) and IPK (Germany).	Abdel-Razzak HS, 2012, LIFE SCI J, V9, P497; Abebe TD, 2013, GENET RESOUR CROP EV, V60, P1547, DOI 10.1007/s10722-012-9941-4; Abid G, 2015, PLANT MOL BIOL REP, V33, P1755, DOI 10.1007/s11105-015-0871-0; Akash MW, 2012, PLANT BREEDING, V131, P522, DOI 10.1111/j.1439-0523.2012.01969.x; Alghamdi SS, 2012, EUPHYTICA, V186, P609, DOI 10.1007/s10681-012-0658-4; Alo F, 2011, J HERED, V102, P315, DOI 10.1093/jhered/esr015; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; BIRCH ANE, 1985, ECON BOT, V39, P177, DOI 10.1007/BF02907843; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; CUBERO JI, 1974, THEOR APPL GENET, V45, P47, DOI 10.1007/BF00283475; da Costa LS, 2015, AN ACAD BRAS CIENC, V87, P1095, DOI 10.1590/0001-3765201520140064; Dikshit HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138101; Duc G, 2010, FIELD CROP RES, V115, P270, DOI 10.1016/j.fcr.2008.10.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gong YM, 2010, AM J BOT, V97, pE69, DOI 10.3732/ajb.1000166; Iqbal MJ, 2012, THEOR APPL GENET, V125, P517, DOI 10.1007/s00122-012-1850-6; Jing RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-44; Kaur S., 2014, Diversity, V6, P88, DOI 10.3390/d6010088; Kaur S, 2014, PLANT SCI, V217, P47, DOI 10.1016/j.plantsci.2013.11.014; Keneni G, 2012, PLANT MOL BIOL REP, V30, P654, DOI 10.1007/s11105-011-0374-6; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Kwon SJ, 2010, PLANT GENET RESOUR-C, V8, P204, DOI 10.1017/S1479262110000201; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Laurentin H, 2009, GENET RESOUR CROP EV, V56, P277, DOI 10.1007/s10722-008-9397-8; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Sanz AM, 2007, MOL GENET GENOMICS, V278, P433, DOI 10.1007/s00438-007-0261-x; METZ PLJ, 1993, EUPHYTICA, V66, P127, DOI 10.1007/BF00023517; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Oliveira HR, 2015, ARCHAEOLOGY FOOD ENC; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perdereau AC, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0202-x; Prance G. T., 2005, CULTURAL HIST PLANTS; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2010, FIGTREE V 1 3 1 I EV; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Suresh S, 2013, MOLECULES, V18, P1844, DOI 10.3390/molecules18021844; Terzopoulos PJ, 2008, FIELD CROP RES, V108, P39, DOI 10.1016/j.fcr.2008.02.015; Thudi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096758; Tomas D, 2015, EUC INT S PROT CROPS, P178; Veasey EA, 2008, GENET MOL BIOL, V31, P725, DOI 10.1590/S1415-47572008000400020; Webb A, 2016, PLANT BIOTECHNOL J, V14, P177, DOI 10.1111/pbi.12371; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Yahia Y, 2014, PLANT GENET RESOUR-C, V12, P278, DOI 10.1017/S1479262114000021; Yang T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-602; Zacarias AM, 2004, EUPHYTICA, V138, P49, DOI 10.1023/B:EUPH.0000047057.05642.74; Zeid M, 2003, THEOR APPL GENET, V107, P1304, DOI 10.1007/s00122-003-1350-9; Zhang X, 1998, CROP SCI, V38, P872, DOI 10.2135/cropsci1998.0011183X003800030041x; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary D, 1999, EVOLUTIONARY THEORY AND PROCESSES: MODERN PERSPECTIVES, P301; Zong X, 2010, PLANT BREEDING, V129, P508, DOI 10.1111/j.1439-0523.2009.01718.x; Zong XX, 2009, THEOR APPL GENET, V118, P971, DOI 10.1007/s00122-008-0954-5; Zong XX, 2009, THEOR APPL GENET, V118, P193, DOI 10.1007/s00122-008-0887-z	57	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154801	10.1371/journal.pone.0154801	http://dx.doi.org/10.1371/journal.pone.0154801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168146	Green Published, gold			2022-12-27	WOS:000376587300040
J	Pastorino, R; Milovanovic, S; Stojanovic, J; Efremov, L; Amore, R; Boccia, S				Pastorino, Roberta; Milovanovic, Sonja; Stojanovic, Jovana; Efremov, Ljupcho; Amore, Rosarita; Boccia, Stefania			Quality Assessment of Studies Published in Open Access and Subscription Journals: Results of a Systematic Evaluation	PLOS ONE			English	Article								Introduction Along with the proliferation of Open Access (OA) publishing, the interest for comparing the scientific quality of studies published in OA journals versus subscription journals has also increased. With our study we aimed to compare the methodological quality and the quality of reporting of primary epidemiological studies and systematic reviews and meta-analyses published in OA and non-OA journals. Methods In order to identify the studies to appraise, we listed all OA and non-OA journals which published in 2013 at least one primary epidemiologic study (case-control or cohort study design), and at least one systematic review or meta-analysis in the field of oncology. For the appraisal, we picked up the first studies published in 2013 with case-control or cohort study design from OA journals (Group A; n = 12), and in the same time period from non-OA journals (Group B; n = 26); the first systematic reviews and meta-analyses published in 2013 from OA journals (Group C; n = 15), and in the same time period from non-OA journals (Group D; n = 32). We evaluated the methodological quality of studies by assessing the compliance of case-control and cohort studies to Newcastle and Ottawa Scale (NOS) scale, and the compliance of systematic reviews and meta-analyses to Assessment of Multiple Systematic Reviews (AMSTAR) scale. The quality of reporting was assessed considering the adherence of case-control and cohort studies to STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) checklist, and the adherence of systematic reviews and meta-analyses to Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) checklist. Results Among case-control and cohort studies published in OA and non-OA journals, we did not observe significant differences in the median value of NOS score (Group A: 7 (IQR 7-8) versus Group B: 8 (7-9); p = 0.5) and in the adherence to STROBE checklist (Group A, 75% versus Group B, 80%; p = 0.1). The results did not change after adjustment for impact factor. The compliance with AMSTAR and adherence to PRISMA checklist were comparable between systematic reviews and meta-analyses published in OA and non-OA journals (Group C, 46.0% versus Group D, 55.0%; p = 0.06), (Group C, 72.0% versus Group D, 76.0%; p = 0.1), respectively). Conclusion The epidemiological studies published in OA journals in the field of oncology approach the same methodological quality and quality of reporting as studies published in non-OA journals.	[Pastorino, Roberta; Milovanovic, Sonja; Stojanovic, Jovana; Efremov, Ljupcho; Amore, Rosarita] Univ Cattolica Sacro Cuore, Inst Publ Hlth, Sect Hyg, Rome, Italy; [Efremov, Ljupcho] Katholieke Univ Leuven, Studies Coordinating Ctr, Res Unit Hypertens & Cardiovasc Epidemiol, Leuven, Belgium; [Boccia, Stefania] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli, Inst Publ Hlth, Sect Hyg, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; KU Leuven; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Pastorino, R (corresponding author), Univ Cattolica Sacro Cuore, Inst Publ Hlth, Sect Hyg, Rome, Italy.	roberta.pastorino@rm.unicatt.it	Boccia, Stefania/AAB-9533-2022; Boccia, Stefania/AFN-1666-2022; Stojanovic, Jovana/CAA-9967-2022; PASTORINO, Roberta/AAC-1866-2022; Stojanovic, Jovana/L-1346-2018	Boccia, Stefania/0000-0002-1864-749X; Boccia, Stefania/0000-0002-1864-749X; Stojanovic, Jovana/0000-0002-3984-5241; PASTORINO, Roberta/0000-0001-5013-0733; Stojanovic, Jovana/0000-0002-3984-5241; Efremov, Ljupcho/0000-0001-9595-3194; Amore, Rosarita/0000-0003-4070-1496	Italian Association for Research on Cancer (AIRC) [IG 2013 n. 14211]; PRECeDI project (RISE) [645740]; ERAWEB project	Italian Association for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); PRECeDI project (RISE); ERAWEB project	This work was supported by the Italian Association for Research on Cancer (AIRC, IG 2013 n. 14211) and PRECeDI project (RISE No 645740) to RP, and by the ERAWEB project to SM, JS and LE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Agrawal AA, 2014, TRENDS PLANT SCI, V19, P133, DOI 10.1016/j.tplants.2014.01.005; Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Butler D, 2008, NATURE, V454, P11, DOI 10.1038/454011a; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Crowe M, 2015, INT J MENT HEALTH NU, V24, P59, DOI 10.1111/inm.12098; Davis PM, 2011, FASEB J, V25, P2129, DOI 10.1096/fj.11-183988; Giglia E., 2010, IMPACT FACTOR OPEN A; Leopold SS, 2014, CLIN ORTHOP RELAT R, V472, P1665, DOI 10.1007/s11999-014-3615-9; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liesegang TJ, 2013, AM J OPHTHALMOL, V156, P423, DOI 10.1016/j.ajo.2013.04.033; Losos M., 2000, NEWCASTLE OTTAWA SCA, DOI DOI 10.1007/S10654-010-9491-Z; Markovac J, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu108; McVeigh ME, 2004, OPEN ACCESS J ISI CI, P25; Miguel S, 2011, J AM SOC INF SCI TEC, V62, P1130, DOI 10.1002/asi.21532; Nieminen Pentti, 2006, BMC Med Res Methodol, V6, P42, DOI 10.1186/1471-2288-6-42; Poltronieri E, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-4; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Suber P., 2007, WILL OPEN ACCESS UND; Tzarnas S, 2015, J SURG EDUC, V72, P283, DOI 10.1016/j.jsurg.2014.09.006; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	21	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154217	10.1371/journal.pone.0154217	http://dx.doi.org/10.1371/journal.pone.0154217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167982	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300082
J	Syvaranta, J; Scharnweber, K; Brauns, M; Hilt, S; Mehner, T				Syvaranta, Jari; Scharnweber, Kristin; Brauns, Mario; Hilt, Sabine; Mehner, Thomas			Assessing the Utility of Hydrogen, Carbon and Nitrogen Stable Isotopes in Estimating Consumer Allochthony in Two Shallow Eutrophic Lakes	PLOS ONE			English	Article							AQUATIC FOOD WEBS; ORGANIC-CARBON; TERRESTRIAL SUPPORT; NONEXCHANGEABLE HYDROGEN; ENVIRONMENTAL WATER; CHIRONOMID LARVAE; BIOGENIC METHANE; TRACING ORIGINS; C-13 ADDITION; SOURCE TRACER	Hydrogen stable isotopes (delta H-2) have recently been used to complement delta C-13 and delta N-15 in food web studies due to their potentially greater power to separate sources of organic matter in aquatic food webs. However, uncertainties remain regarding the use of delta 2H, since little is known about the potential variation in the amount of exchangeable hydrogen (Hex) among common sample materials or the patterns of delta H-2 when entire food webs are considered. We assessed differences in Hex among the typical sample materials in freshwater studies and used delta H-2, delta C-13 and delta N-15 to compare their effectiveness in tracing allochthonous matter in food webs of two small temperate lakes. Our results showed higher average amounts of H-ex in animal tissues (27% in fish and macroinvertebrates, 19% in zooplankton) compared to most plant material (15% in terrestrial plants and 8% in seston/periphyton), with the exception of aquatic vascular plants (23%, referred to as macrophytes). The amount of Hex correlated strongly with sample lipid content (inferred from C:N ratios) in fish and zooplankton samples. Overall, the three isotopes provided good separation of sources (seston, periphyton, macrophytes and allochthonous organic matter), particularly the delta H-2 followed by delta C-13. Aquatic macrophytes revealed unexpectedly high delta H-2 values, having more elevated delta H-2 values than terrestrial organic matter with direct implications for estimating consumer allochthony. Organic matter from macrophytes significantly contributed to the food webs in both lakes highlighting the need to include macrophytes as a potential source when using stable isotopes to estimate trophic structures and contributions from allochthonous sources.	[Syvaranta, Jari; Scharnweber, Kristin; Brauns, Mario; Mehner, Thomas] Leibniz Inst Freshwater Biol & Inland Fisheries, Dept Fish Biol & Ecol, Berlin, Germany; [Syvaranta, Jari] Aarhus Univ, Dept Biosci, Lake Ecol Sect, Silkeborg, Denmark; [Scharnweber, Kristin] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Scharnweber, Kristin] Uppsala Univ, Limnol, Uppsala, Sweden; [Brauns, Mario] UFZ Helmholtz Ctr Environm Res, Dept River Ecol, Magdeburg, Germany; [Hilt, Sabine] Leibniz Inst Freshwater Biol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Aarhus University; Uppsala University; Uppsala University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Syvaranta, J (corresponding author), Leibniz Inst Freshwater Biol & Inland Fisheries, Dept Fish Biol & Ecol, Berlin, Germany.; Syvaranta, J (corresponding author), Aarhus Univ, Dept Biosci, Lake Ecol Sect, Silkeborg, Denmark.	jarsyv@bios.au.dk	Hilt, Sabine/C-4783-2011; Brauns, Mario/M-7878-2014; Mehner, Thomas/B-8665-2008	Brauns, Mario/0000-0002-5012-9721; Mehner, Thomas/0000-0002-3619-165X	TERRALAC-project of the Wissenschaftsgemeinschaft Leibniz (WGL); IGB Fellowship program in Freshwater Science; Marie Sklodowska-Curie actions fellowship under the EU Horizon funding programme [660655]	TERRALAC-project of the Wissenschaftsgemeinschaft Leibniz (WGL); IGB Fellowship program in Freshwater Science; Marie Sklodowska-Curie actions fellowship under the EU Horizon funding programme	This study was financed by the TERRALAC-project of the Wissenschaftsgemeinschaft Leibniz (WGL) to SH and TM. JS was supported by the IGB Fellowship program in Freshwater Science and by the Marie Sklodowska-Curie actions fellowship (660655) under the EU Horizon 2020 funding programme.	[Anonymous], 2010, R LANG ENV STAT COMP; Babler AL, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00043.1; Batt RD, 2012, LIMNOL OCEANOGR, V57, P1443, DOI 10.4319/lo.2012.57.5.1443; Brauns M, 2011, J APPL ECOL, V48, P916, DOI 10.1111/j.1365-2664.2011.02007.x; Brett MT, 2009, P NATL ACAD SCI USA, V106, P21197, DOI 10.1073/pnas.0904129106; Brothers SM, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00247.1; Brothers SM, 2013, FRESHWATER BIOL, V58, P2264, DOI 10.1111/fwb.12207; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; Chesson LA, 2009, RAPID COMMUN MASS SP, V23, P1275, DOI 10.1002/rcm.4000; Cole JJ, 2006, ECOL LETT, V9, P558, DOI 10.1111/j.1461-0248.2006.00898.x; Cole JJ, 2012, LIMNOL OCEANOGR, V57, P1802, DOI 10.4319/lo.2012.57.6.1802; Cole JJ, 2011, P NATL ACAD SCI USA, V108, P1975, DOI 10.1073/pnas.1012807108; de Kluijver A, 2015, LIMNOL OCEANOGR, V60, P375, DOI 10.1002/lno.10040; Devlin SP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9787; Doucett RR, 2007, ECOLOGY, V88, P1587, DOI 10.1890/06-1184; Finlay JC, 2010, FRESHWATER BIOL, V55, P941, DOI 10.1111/j.1365-2427.2009.02327.x; France RL, 1996, VEGETATIO, V124, P67, DOI 10.1007/BF00045145; Graham CT, 2014, HYDROBIOLOGIA, V721, P45, DOI 10.1007/s10750-013-1636-0; Grey J, 2004, LIMNOL OCEANOGR, V49, P239, DOI 10.4319/lo.2004.49.1.0239; Grey J, 2001, LIMNOL OCEANOGR, V46, P505, DOI 10.4319/lo.2001.46.3.0505; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Hilt S, 2015, HYDROBIOLOGIA, V749, P31, DOI 10.1007/s10750-014-2143-7; Hobson KA, 2005, DIVERS DISTRIB, V11, P157, DOI 10.1111/j.1366-9516.2005.00149.x; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hondula KL, 2014, AQUAT SCI, V76, P217, DOI 10.1007/s00027-013-0331-6; Jardine TD, 2009, J N AM BENTHOL SOC, V28, P885, DOI 10.1899/09-046.1; Jones RI, 1998, P ROY SOC B-BIOL SCI, V265, P105, DOI 10.1098/rspb.1998.0270; Jones RI, 2008, ECOLOGY, V89, P857, DOI 10.1890/06-2010.1; Jones RI, 2011, FRESHWATER BIOL, V56, P213, DOI 10.1111/j.1365-2427.2010.02494.x; Kankaala P, 2010, FUND APPL LIMNOL, V177, P161, DOI 10.1127/1863-9135/2010/0177-0161; Karlsson J, 2005, LIMNOL OCEANOGR, V50, P538, DOI 10.4319/lo.2005.50.2.0538; Karlsson J, 2012, LIMNOL OCEANOGR, V57, P1042, DOI 10.4319/lo.2012.57.4.1042; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Mehner T, 2016, ECOSYSTEMS, V19, P311, DOI 10.1007/s10021-015-9933-2; Mendonca R, 2013, HYDROBIOLOGIA, V710, P205, DOI 10.1007/s10750-012-1366-8; Mjelde M, 1997, FRESHWATER BIOL, V37, P355, DOI 10.1046/j.1365-2427.1997.00159.x; NEWMAN RM, 1991, J N AM BENTHOL SOC, V10, P89, DOI 10.2307/1467571; Pace ML, 2004, NATURE, V427, P240, DOI 10.1038/nature02227; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Peipoch M, 2014, AQUAT SCI, V76, P203, DOI 10.1007/s00027-013-0330-7; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; PREJS A, 1978, EKOL POL-POL J ECOL, V26, P429; Qi HP, 2011, RAPID COMMUN MASS SP, V25, P2672, DOI 10.1002/rcm.5186; Ravinet M, 2010, OIKOS, V119, P409, DOI 10.1111/j.1600-0706.2009.17859.x; Scharnweber K, 2014, OIKOS, V123, P1439, DOI 10.1111/oik.01524; Scharnweber K, 2014, ECOLOGY, V95, P1496, DOI 10.1890/13-0390.1; Schimmelmann A, 1999, GEOCHIM COSMOCHIM AC, V63, P3751, DOI 10.1016/S0016-7037(99)00221-5; Sessions AL, 1999, ORG GEOCHEM, V30, P1193, DOI 10.1016/S0146-6380(99)00094-7; SMITH BN, 1970, PLANT PHYSIOL, V46, P738, DOI 10.1104/pp.46.5.738; SMITH BN, 1990, BOT ACTA, V103, P335, DOI 10.1111/j.1438-8677.1990.tb00171.x; Solomon CT, 2008, FRESHWATER BIOL, V53, P42, DOI 10.1111/j.1365-2427.2007.01866.x; Solomon CT, 2011, ECOLOGY, V92, P1115, DOI 10.1890/i0012-9658-92-5-1115; Solomon CT, 2009, OECOLOGIA, V161, P313, DOI 10.1007/s00442-009-1370-5; Soto DX, 2013, FUNCT ECOL, V27, P535, DOI 10.1111/1365-2435.12054; Soto DX, 2011, CAN J FISH AQUAT SCI, V68, P2011, DOI [10.1139/F2011-112, 10.1139/f2011-112]; Syvaranta J, 2006, FRESHWATER BIOL, V51, P1090, DOI 10.1111/j.1365-2427.2006.01557.x; Syvaranta J, 2011, AQUAT SCI, V73, P79, DOI 10.1007/s00027-010-0161-8; Syvaranta J, 2010, CAN J FISH AQUAT SCI, V67, P1721, DOI 10.1139/F10-091; Taipale S, 2007, ECOSYSTEMS, V10, P757, DOI 10.1007/s10021-007-9056-5; Terzer S, 2013, HYDROL EARTH SYST SC, V17, P4713, DOI 10.5194/hess-17-4713-2013; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 2000, ENVIRON SCI TECHNOL, V34, P2354, DOI 10.1021/es990804i; Wilkinson GM, 2015, LIMNOL OCEANOGR-METH, V13, P213, DOI 10.1002/lom3.10019; Wilkinson GM, 2013, FRESHWATER BIOL, V58, P2037, DOI 10.1111/fwb.12189; Wilkinson GM, 2013, GLOBAL BIOGEOCHEM CY, V27, P43, DOI 10.1029/2012GB004453	67	8	8	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155562	10.1371/journal.pone.0155562	http://dx.doi.org/10.1371/journal.pone.0155562			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167517	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300006
J	Yang, BY; Shan, B; Xue, XH; Wang, HY; Shan, WW; Ning, CC; Zhou, QJ; Chen, XJ; Luo, XZ				Yang, Bingyi; Shan, Boer; Xue, Xiaohong; Wang, Huaying; Shan, Weiwei; Ning, Chengcheng; Zhou, Qiongjie; Chen, Xiaojun; Luo, Xuezhen			Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models	PLOS ONE			English	Article							RISK; LYMPHADENECTOMY; DISSEMINATION; CARCINOMA; ACCURACY; TRIAL; TESTS	We aimed to evaluate the value of immunohistochemical markers and serum CA125 in predicting the risk of lymph node metastasis (LNM) in women with endometrial cancer and to identify a low-risk group of LNM. The medical records of 370 patients with endometrial endometrioid adenocarcinoma who underwent surgical staging in the Obstetrics & Gynecology Hospital of Fudan University were collected and retrospectively reviewed. Immunohistochemical markers were screened. A model using serum cancer antigen 125 (CA125) level, the immunohistochemical markers progesterone receptor (PR) and Ki67 was created for prediction of LNM. A predicted probability of 4% among these patients was defined as low risk. The developed model was externally validated in 200 patients from Shanghai Cancer Center. The efficiency of the model was compared with three other reported prediction models. Patients with serum CA125 <30.0 IU/mL, either or both of positive PR staining > 50% and Ki67 < 40% in cancer lesion were defined as low risk for LNM. The model showed good discrimination with an area under the receiver operating characteristic curve of 0.82. The model classified 61.9% (229/370) of patients as being at low risk for LNM. Among these 229 patients, 6 patients (2.6%) had LNM and the negative predictive value was 97.4% (223/229). The sensitivity and specificity of the model were 84.6% and 67.4% respectively. In the validation cohort, the model classified 59.5% (119/200) of patients as low-risk, 3 out of these 119 patients (2.5%) has LNM. Our model showed a predictive power similar to those of two previously reported prediction models. The prediction model using serum CA125 and the immunohistochemical markers PR and Ki67 is useful to predict patients with a low risk of LNM and has the potential to provide valuable guidance to clinicians in the treatment of patients with endometrioid endometrial cancer.	[Yang, Bingyi; Xue, Xiaohong; Shan, Weiwei; Ning, Chengcheng; Zhou, Qiongjie; Chen, Xiaojun; Luo, Xuezhen] Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China; [Yang, Bingyi; Xue, Xiaohong; Shan, Weiwei; Ning, Chengcheng; Zhou, Qiongjie; Chen, Xiaojun; Luo, Xuezhen] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China; [Shan, Boer; Wang, Huaying] Fudan Univ, Shanghai Canc Ctr, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Chen, XJ; Luo, XZ (corresponding author), Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China.; Chen, XJ; Luo, XZ (corresponding author), Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China.	chenxiaojun2013@sina.com; luoxuezhen2013@126.com			Science and Technology Commission of Shanghai Municipality [134119a4500]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by Science and Technology Commission of Shanghai Municipality (Grant No.: 134119a4500). This funder helped a lot in the data collection and the preparation of the final submitted manuscript. It would take responsibility for the publication fees of this paper.	Altay A, 2015, INT J GYNECOL CANCER, V25, P657, DOI 10.1097/IGC.0000000000000392; Ballester M, 2013, GYNECOL ONCOL, V130, P457, DOI 10.1016/j.ygyno.2013.06.001; Boronow RC, 1997, GYNECOL ONCOL, V66, P179, DOI 10.1006/gyno.1997.4732; Chen XJ, 2009, MODERN PATHOL, V22, P699, DOI 10.1038/modpathol.2009.25; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Frumovitz M, 2004, GYNECOL ONCOL, V95, P463, DOI 10.1016/j.ygyno.2004.07.016; Huang GS, 2007, AM J OBSTET GYNECOL, V196, P243, DOI 10.1016/j.ajog.2006.09.035; Kang S, 2012, J CLIN ONCOL, V30, P1329, DOI 10.1200/JCO.2011.38.2416; Kim CH, 2013, GYNECOL ONCOL, V131, P714, DOI 10.1016/j.ygyno.2013.09.027; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Mariani A, 2000, AM J OBSTET GYNECOL, V182, P1506, DOI 10.1067/mob.2000.107335; Mariani A, 2008, GYNECOL ONCOL, V109, P11, DOI 10.1016/j.ygyno.2008.01.023; Mariani A, 2009, INT J GYNECOL OBSTET, V105, P110, DOI 10.1016/j.ijgo.2009.02.008; Mitamura T, 2014, J GYNECOL ONCOL; Nikolaou M, 2014, J BUON, V19, P198; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Patsner Bruce, 2013, Obstet Gynecol Sci, V56, P281, DOI 10.5468/ogs.2013.56.5.281; Pelikan HMP, 2013, CANCER IMAGING, V13, P314, DOI 10.1102/1470-7330.2013.0032; Povolotskaya N, 2014, Surg Res Pract, V2014, P497478, DOI 10.1155/2014/497478; Seamon LG, 2010, GYNECOL ONCOL, V117, P6, DOI 10.1016/j.ygyno.2009.12.025; Tomisato S, 2014, J OBSTET GYNAECOL RE, V40, P1733, DOI 10.1111/jog.12399; Walsh CS, 2008, J NATL CANCER I, V100, P1660, DOI 10.1093/jnci/djn413	22	28	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155145	10.1371/journal.pone.0155145	http://dx.doi.org/10.1371/journal.pone.0155145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163153	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700035
J	Conde, MB; Mello, FCQ; Duarte, RS; Cavalcante, SC; Rolla, V; Dalcolmo, M; Loredo, C; Durovni, B; Armstrong, DT; Efron, A; Barnes, GL; Marzinke, MA; Savic, RM; Dooley, KE; Cohn, S; Moulton, LH; Chaisson, RE; Dorman, SE				Conde, Marcus B.; Mello, Fernanda C. Q.; Duarte, Rafael Silva; Cavalcante, Solange C.; Rolla, Valeria; Dalcolmo, Margareth; Loredo, Carla; Durovni, Betina; Armstrong, Derek T.; Efron, Anne; Barnes, Grace L.; Marzinke, Mark A.; Savic, Radojka M.; Dooley, Kelly E.; Cohn, Silvia; Moulton, Lawrence H.; Chaisson, Richard E.; Dorman, Susan E.			A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis	PLOS ONE			English	Article							POPULATION PHARMACOKINETICS; DOSE PHARMACOKINETICS; BACTERICIDAL ACTIVITY; RIFAMPIN; PHARMACODYNAMICS; CHEMOTHERAPY; SINGLE; DRUGS; MODEL	Background The combination of rifapentine and moxifloxacin administered daily with other anti-tuberculosis drugs is highly active in mouse models of tuberculosis chemotherapy. The objective of this phase 2 clinical trial was to determine the bactericidal activity, safety, and tolerability of a regimen comprised of rifapentine, moxifloxacin, isoniazid, and pyrazinamide administered daily during the first 8 weeks of pulmonary tuberculosis treatment. Methods Adults with sputum smear-positive pulmonary tuberculosis were randomized to receive either rifapentine (approximately 7.5 mg/kg) plus moxifloxacin (investigational arm), or rifampin (approximately 10 mg/kg) plus ethambutol (control) daily for 8 weeks, along with isoniazid and pyrazinamide. The primary endpoint was sputum culture status at completion of 8 weeks of treatment. Results 121 participants (56% of accrual target) were enrolled. At completion of 8 weeks of treatment, negative cultures using Lowenstein-Jensen (LJ) medium occurred in 47/60 (78%) participants in the investigational arm vs. 43/51 (84%, p = 0.47) in the control arm; negative cultures using liquid medium occurred in 37/47 (79%) in the investigational arm vs. 27/41 (66%, p = 0.23) in the control arm. Time to stable culture conversion was shorter for the investigational arm vs. the control arm using liquid culture medium (p = 0.03), but there was no difference using LJ medium. Median rifapentine area under the concentration-time curve (AUC0-24) was 313 mcg*h/mL, similar to recent studies of rifapentine dosed at 450-600 mg daily. Median moxifloxacin AUC0-24 was 28.0 mcg*h/mL, much lower than in trials where rifapentine was given only intermittently with moxifloxacin. The proportion of participants discontinuing assigned treatment for reasons other than microbiological ineligibility was higher in the investigational arm vs. the control arm (11/62 [18%] vs. 3/59 [5%], p = 0.04) although the proportions of grade 3 or higher adverse events were similar (5/62 [8%] in the investigational arm vs. 6/59 [10%, p = 0.76] in the control arm). Conclusion For intensive phase daily tuberculosis treatment in combination with isoniazid and pyrazinamide, a regimen containing moxifloxacin plus low dose rifapentine was at least as bactericidal as the control regimen containing ethambutol plus standard dose rifampin.	[Conde, Marcus B.; Mello, Fernanda C. Q.; Loredo, Carla] Univ Fed Rio de Janeiro, Inst Doencas Torax, Rio De Janeiro, Brazil; [Duarte, Rafael Silva] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil; [Cavalcante, Solange C.; Durovni, Betina] Municipal Hlth Secretariat, Rio De Janeiro, Brazil; [Cavalcante, Solange C.; Rolla, Valeria] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil; [Dalcolmo, Margareth] Fiocruz Rio de Janeiro, Minist Saude, Ctr Referencia Helio Fraga, Rio De Janeiro, Brazil; [Armstrong, Derek T.; Efron, Anne; Barnes, Grace L.; Marzinke, Mark A.; Dooley, Kelly E.; Cohn, Silvia; Chaisson, Richard E.; Dorman, Susan E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Savic, Radojka M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Moulton, Lawrence H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Johns Hopkins University; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dorman, SE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	dsusan1@jhmi.edu	de Q Mello, Fernanda C/I-2957-2013; Duarte, Rafael/AAK-7946-2020; Rolla, Valeria Cavalcanti/AAI-6078-2021; Conte, Marcus B/A-2501-2013	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; Conte, Marcus B/0000-0002-7249-4455	National Institutes of Health [U19AI045432, K23AI51528, K23AI080842, K24AI01637, K24AI104830, P30 AI094189]; International Clinical Operational Health Services Research Training Award (ICOHRTA); Tuberculosis Trials Consortium of the United States Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, K23AI080842, U19AI045432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Clinical Operational Health Services Research Training Award (ICOHRTA); Tuberculosis Trials Consortium of the United States Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Institutes of Health including U19AI045432 (R. E. Chaisson), K23AI51528 (S. E. Dorman), K23AI080842 (K. E. Dooley), K24AI01637 (R. E. Chaisson), K24AI104830 (S. E. Dorman), P30 AI094189, and an International Clinical Operational Health Services Research Training Award (ICOHRTA); and also by the Tuberculosis Trials Consortium of the United States Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Bemer-Melchior P, 2000, J ANTIMICROB CHEMOTH, V46, P571, DOI 10.1093/jac/46.4.571; Burman WJ, 2001, CLIN PHARMACOKINET, V40, P327, DOI 10.2165/00003088-200140050-00002; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Dawson R, 2015, INT J TUBERC LUNG D, V19, P780, DOI 10.5588/ijtld.14.0868; Diacon AH, 2007, ANTIMICROB AGENTS CH, V51, P2994, DOI 10.1128/AAC.01474-06; Dooley K, 2008, ANTIMICROB AGENTS CH, V52, P4037, DOI 10.1128/AAC.00554-08; Dooley KE, 2015, ANTIMICROB AGENTS CH, V59, P3399, DOI 10.1128/AAC.05128-14; Dorman SE, 2015, AM J RESP CRIT CARE, V191, P333, DOI 10.1164/rccm.201410-1843OC; Dorman SE, 2012, J INFECT DIS, V206, P1030, DOI 10.1093/infdis/jis461; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Gillespie SH, 1999, J ANTIMICROB CHEMOTH, V44, P393, DOI 10.1093/jac/44.3.393; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; GROSSET J, 1980, CLIN CHEST MED, V1, P231; HEIFETS LB, 1990, AM REV RESPIR DIS, V141, P626, DOI 10.1164/ajrccm/141.3.626; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; JI BH, 1993, AM REV RESPIR DIS, V148, P1541, DOI 10.1164/ajrccm/148.6_Pt_1.1541; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Keung A, 1999, INT J TUBERC LUNG D, V3, P437; Kjellsson MC, 2012, ANTIMICROB AGENTS CH, V56, P446, DOI 10.1128/AAC.05208-11; Langdon G, 2004, INT J TUBERC LUNG D, V8, P862; LONG MW, 1979, AM REV RESPIR DIS, V119, P879; Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796; Miyazaki E, 1999, ANTIMICROB AGENTS CH, V43, P85, DOI 10.1128/AAC.43.1.85; Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Peloquin CA, 1999, CHEST, V115, P12, DOI 10.1378/chest.115.1.12; Rosenthal IM, 2008, AM J RESP CRIT CARE, V178, P989, DOI 10.1164/rccm.200807-1029OC; Rosenthal IM, 2007, PLOS MED, V4, P1931, DOI 10.1371/journal.pmed.0040344; Rosenthal IM, 2012, ANTIMICROB AGENTS CH, V56, P4331, DOI 10.1128/AAC.00912-12; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Sirgel FA, 2005, AM J RESP CRIT CARE, V172, P128, DOI 10.1164/rccm.200411-1557OC; Sterling TR, 2015, CLIN INFECT DIS, V61, P527, DOI 10.1093/cid/civ323; Zvada SP, 2012, ANTIMICROB AGENTS CH, V56, P4471, DOI 10.1128/AAC.00404-12; Zvada SP, 2010, ANTIMICROB AGENTS CH, V54, P3390, DOI 10.1128/AAC.00345-10	36	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154778	10.1371/journal.pone.0154778	http://dx.doi.org/10.1371/journal.pone.0154778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159505	Green Submitted, Green Published, gold			2022-12-27	WOS:000376576700016
J	Granados-Garcia, V; Contreras, AM; Garcia-Pena, C; Salinas-Escudero, G; Thein, HH; Flores, YN				Granados-Garcia, Victor; Contreras, Ana M.; Garcia-Pena, Carmen; Salinas-Escudero, Guillermo; Thein, Hla-Hla; Flores, Yvonne N.			Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors	PLOS ONE			English	Article							VIRUS; DIAGNOSIS	Aim. We conducted a cost-effectiveness analysis of seven hepatitis C virus (HCV) testing strategies in blood donors. Methods. Three of the seven strategies were based on HCV diagnosis and reporting guidelines in Mexico and four were from previous and current recommendations outlined by the CDC. The strategies that were evaluated determine antibody levels according to the signal-to-cut-off (S/CO) ratio and use reflex Immunoblot (IMB) or HCV RNA tests to confirm true positive (TP) cases of chronic HCV infection. Costs were calculated from the perspective of the Mexican Institute of Social Security (IMSS). A decision tree model was developed to estimate the expected number of true positive cases and costs for the base-case scenarios and for the sensitivity analyses. Results. Base-case findings indicate an extended dominance of the CDC-USA2 and CDC-USA4 options by the IMSS Mexico3 and IMSS-Mexico1 alternatives. The probabilistic sensitivity analyses results suggest that for a willingness-to-pay (WTP) range of $0-9,000 USD the IMSS-Mexico1 strategy is the most cost-effective of all strategies ($5,000 USD per TP). The IMSS-Mexico3, IMSS-Mexico2, and CDC-USA3 strategies are also cost-effective strategies that cost between $7,800 and $8,800 USD per TP case detected. The CDC-USA1 strategy was very expensive and not cost-effective. Conclusions. HCV antibody testing strategies based on the classification of two or three levels of the S/CO are cost-effective procedures to identify patients who require reflex IMB or HCV RNA testing to confirm chronic HCV infection.	[Granados-Garcia, Victor] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud Area Envejec, Mexico City, DF, Mexico; [Contreras, Ana M.] Univ Guadalajara, Ctr Univ Ciencias Salud, Dept Salud Publ, Guadalajara 44430, Jalisco, Mexico; [Garcia-Pena, Carmen] Inst Nacl Geriatria, Direcc Invest, Mexico City, DF, Mexico; [Salinas-Escudero, Guillermo] Hosp Infantil Mexico Dr Federico Gomez, Ctr Estudios Econ & Sociales Salud, Mexico City, DF, Mexico; [Thein, Hla-Hla] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Flores, Yvonne N.] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Cuernavaca, Morelos, Mexico; [Flores, Yvonne N.] Univ Calif Los Angeles, Dept Hlth Policy & Management, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Flores, Yvonne N.] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA	Instituto Mexicano del Seguro Social; Universidad de Guadalajara; Hospital Infantil de Mexico Federico Gomez; University of Toronto; Instituto Mexicano del Seguro Social; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center	Granados-Garcia, V (corresponding author), Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud Area Envejec, Mexico City, DF, Mexico.	vic.granados@gmail.com	Granados-García, Víctor/AAR-5788-2020; García-Peña, Carmen/F-1468-2011	Granados-García, Víctor/0000-0002-9075-576X; García-Peña, Carmen/0000-0002-9380-6964; Salinas Escudero, Guillermo/0000-0003-4573-4844; Flores, Yvonne N./0000-0002-0601-357X; Thein, Hla-Hla/0000-0003-4950-187X	National Research Council of the Mexican Institute of Social Security [FIS/IMSS/PROT/MD15/1507]; NATIONAL CANCER INSTITUTE [K07CA197179] Funding Source: NIH RePORTER	National Research Council of the Mexican Institute of Social Security; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	A grant was obtained by VGG from the National Research Council of the Mexican Institute of Social Security (Grant number FIS/IMSS/PROT/MD15/1507).	Alter Miriam J, 2003, MMWR Recomm Rep, V52, P1; [Anonymous], 2012, DIARIO OFICIAL FEDER; BANXICO, 2014, EXCH RAT; Barreto AMEC, 2008, BRAZ J MED BIOL RES, V41, P126, DOI 10.1590/S0100-879X2008005000004; Cabezas-Fernandez Mt, 2012, Open Virol J, V6, P122, DOI 10.2174/1874357901206010122; Chapko MK, 2015, HEPATOLOGY, V62, P1396, DOI 10.1002/hep.27966; Contreras AM, 2012, REV INVEST CLIN, V64, P641; Contreras AM, 2011, SALUD PUBLICA MEXICO, V53, pS19; Contreras AM, 2010, TRANSFUSION, V50, P1335, DOI 10.1111/j.1537-2995.2009.02571.x; Contreras AM, 2008, TRANSFUSION, V48, P2540, DOI 10.1111/j.1537-2995.2008.01886.x; Deuffic-Burban S, 2009, GUT, V58, P105, DOI 10.1136/gut.2007.145516; Eddy DM, 2012, VALUE HEALTH, V15, P843, DOI 10.1016/j.jval.2012.04.012; Getchell JP, 2013, MMWR-MORBID MORTAL W, V62, P362; Gutelius B, 2010, GASTROENTEROLOGY, V139, P163, DOI 10.1053/j.gastro.2010.03.053; INEGI, 2014, MONTHL PRIC IND I NA; Loubiere S, 2003, INT J TECHNOL ASSESS, V19, P632, DOI 10.1017/S026646230300059X; Ly KN, 2012, ANN INTERN MED, V156, P840; McGibbon E, 2013, AM J MED, V126, P718, DOI 10.1016/j.amjmed.2013.01.031; Nelson-Jones, 2014, PRACTICAL COUNSELLIN; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Rongey CA, 2009, AM J PREV MED, V36, P235, DOI 10.1016/j.amepre.2008.10.013; Rosner B., 2010, FUNDAMENTALS BIOSTAT; Stein K, 2004, J PUBLIC HEALTH-UK, V26, P61, DOI 10.1093/pubmed/fdh109; Valdespino JL, 2007, SALUD PUBLICA MEX S3, V49, P8	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154625	10.1371/journal.pone.0154625	http://dx.doi.org/10.1371/journal.pone.0154625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159320	Green Submitted, Green Published, gold			2022-12-27	WOS:000376576700013
J	Hieke, S; Benner, A; Schlenk, RF; Schumacher, M; Bullinger, L; Binder, H				Hieke, Stefanie; Benner, Axel; Schlenk, Richard F.; Schumacher, Martin; Bullinger, Lars; Binder, Harald			Identifying Prognostic SNPs in Clinical Cohorts: Complementing Univariate Analyses by Resampling and Multivariable Modeling	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ACUTE MYELOID-LEUKEMIA; NON-HODGKIN-LYMPHOMA; VARIABLE SELECTION; REGRESSION-MODELS; SURVIVAL; PREDICTION; GENE; RISK; STRATEGIES	Clinical cohorts with time-to-event endpoints are increasingly characterized by measurements of a number of single nucleotide polymorphisms that is by a magnitude larger than the number of measurements typically considered at the gene level. At the same time, the size of clinical cohorts often is still limited, calling for novel analysis strategies for identifying potentially prognostic SNPs that can help to better characterize disease processes. We propose such a strategy, drawing on univariate testing ideas from epidemiological case-controls studies on the one hand, and multivariable regression techniques as developed for gene expression data on the other hand. In particular, we focus on stable selection of a small set of SNPs and corresponding genes for subsequent validation. For univariate analysis, a permutation-based approach is proposed to test at the gene level. We use regularized multivariable regression models for considering all SNPs simultaneously and selecting a small set of potentially important prognostic SNPs. Stability is judged according to resampling inclusion frequencies for both the univariate and the multivariable approach. The overall strategy is illustrated with data from a cohort of acute myeloid leukemia patients and explored in a simulation study. The multivariable approach is seen to automatically focus on a smaller set of SNPs compared to the univariate approach, roughly in line with blocks of correlated SNPs. This more targeted extraction of SNPs results in more stable selection at the SNP as well as at the gene level. Thus, the multivariable regression approach with resampling provides a perspective in the proposed analysis strategy for SNP data in clinical cohorts highlighting what can be added by regularized regression techniques compared to univariate analyses.	[Hieke, Stefanie; Schumacher, Martin] Univ Freiburg, Med Ctr, Inst Med Biometry & Stat, Freiburg, Germany; [Hieke, Stefanie] Univ Freiburg, Freiburg Ctr Data Anal & Modeling, Hugstetter Str 55, D-79106 Freiburg, Germany; [Benner, Axel] German Canc Res Ctr, Div Biostat, Heidelberg, Germany; [Schlenk, Richard F.; Bullinger, Lars] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Binder, Harald] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, D-55122 Mainz, Germany	University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Johannes Gutenberg University of Mainz	Hieke, S (corresponding author), Univ Freiburg, Med Ctr, Inst Med Biometry & Stat, Freiburg, Germany.; Hieke, S (corresponding author), Univ Freiburg, Freiburg Ctr Data Anal & Modeling, Hugstetter Str 55, D-79106 Freiburg, Germany.	hieke@imbi.uni-freiburg.de	Bullinger, Lars/AAL-7965-2020; Schlenk, Richard/AAG-3218-2019; Binder, Harald/C-7413-2009	Binder, Harald/0000-0002-5666-8662; Bullinger, Lars/0000-0002-5890-5510				Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder H, 2013, STAT MED, V32, P1778, DOI 10.1002/sim.5490; Binder H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-14; Binder H, 2008, STAT APPL GENET MOL, V7; Binder Harald, 2012, Stat Appl Genet Mol Biol, V11, DOI 10.1515/1544-6115.1694; Binder H, 2011, BIOMETRICAL J, V53, P170, DOI 10.1002/bimj.201000152; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Buhlmann P, 2003, J AM STAT ASSOC, V98, P324, DOI 10.1198/016214503000125; Bullinger L, 2010, LEUKEMIA, V24, P438, DOI 10.1038/leu.2009.263; Chapman J, 2008, GENET EPIDEMIOL, V32, P560, DOI 10.1002/gepi.20330; Chen BSE, 2006, GENET EPIDEMIOL, V30, P495, DOI 10.1002/gepi.20162; COX DR, 1972, J R STAT SOC B, V34, P187; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Hastie T, 2007, ELECTRON J STAT, V1, P1, DOI 10.1214/07-EJS004; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kottgen A, 2010, AM J KIDNEY DIS, V56, P743, DOI 10.1053/j.ajkd.2010.05.018; Kooperberg C, 2010, GENET EPIDEMIOL, V34, P643, DOI 10.1002/gepi.20509; Lan Q, 2011, BRIT J HAEMATOL, V153, P341, DOI 10.1111/j.1365-2141.2010.08424.x; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Mayr A, 2014, METHOD INFORM MED, V53, P419, DOI 10.3414/ME13-01-0122; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Neuman RJ, 2009, GENET EPIDEMIOL, V33, pS19, DOI 10.1002/gepi.20467; Ransohoff DF, 2007, J CLIN EPIDEMIOL, V60, P1205, DOI 10.1016/j.jclinepi.2007.04.020; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Sauerbrei W, 2014, BIOMETRICAL J, V12; Sauerbrei W, 2011, J BIOPHARM STAT, V21, P1206, DOI 10.1080/10543406.2011.629890; Scherag A, 2010, METHOD INFORM MED, V49, P632, DOI 10.3414/ME09-02-0055; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schwender H, 2011, BIOSTATISTICS, V12, P18, DOI 10.1093/biostatistics/kxq042; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Toyabe S, 2008, METHOD INFORM MED, V47, P522, DOI 10.3414/ME9129; Tutz G, 2007, COMPUT STAT DATA AN, V51, P6044, DOI 10.1016/j.csda.2006.11.041; Tutz G, 2006, BIOMETRICS, V62, P961, DOI 10.1111/j.1541-0420.2006.00578.x; van Wieringen WN, 2009, COMPUT STAT DATA AN, V53, P1590, DOI 10.1016/j.csda.2008.05.021; Wang R, 2010, BIOSTATISTICS, V11, P676, DOI 10.1093/biostatistics/kxq021; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Westfall Peter H, 2002, Methods Mol Biol, V184, P143; Ziegler A, 2008, BIOMETRICAL J, V50, P8, DOI 10.1002/bimj.200710398; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155226	10.1371/journal.pone.0155226	http://dx.doi.org/10.1371/journal.pone.0155226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159447	Green Published, gold			2022-12-27	WOS:000376576700049
J	Hansen, RH; Timm, AC; Timm, CM; Bible, AN; Morrell-Falvey, JL; Pelletier, DA; Simpson, ML; Doktycz, MJ; Retterer, ST				Hansen, Ryan H.; Timm, Andrea C.; Timm, Collin M.; Bible, Amber N.; Morrell-Falvey, Jennifer L.; Pelletier, Dale A.; Simpson, Michael L.; Doktycz, Mitchel J.; Retterer, Scott T.			Stochastic Assembly of Bacteria in Microwell Arrays Reveals the Importance of Confinement in Community Development	PLOS ONE			English	Article							VI SECRETION; CULTURE; GROWTH; FLOW	The structure and function of microbial communities is deeply influenced by the physical and chemical architecture of the local microenvironment and the abundance of its community members. The complexity of this natural parameter space has made characterization of the key drivers of community development difficult. In order to facilitate these characterizations, we have developed a microwell platform designed to screen microbial growth and interactions across a wide variety of physical and initial conditions. Assembly of microbial communities into microwells was achieved using a novel biofabrication method that exploits well feature sizes for control of innoculum levels. Wells with incrementally smaller size features created populations with increasingly larger variations in inoculum levels. This allowed for reproducible growth measurement in large (20 mu m diameter) wells, and screening for favorable growth conditions in small (5, 10 mu m diameter) wells. We demonstrate the utility of this approach for screening and discovery using 5 mu m wells to assemble P. aeruginosa colonies across a broad distribution of innoculum levels, and identify those conditions that promote the highest probability of survivial and growth under spatial confinement. Multi-member community assembly was also characterized to demonstrate the broad potential of this platform for studying the role of member abundance on microbial competition, mutualism and community succession.	[Hansen, Ryan H.] Kansas State Univ, Manhattan, KS 66506 USA; [Hansen, Ryan H.; Morrell-Falvey, Jennifer L.; Simpson, Michael L.; Doktycz, Mitchel J.; Retterer, Scott T.] Univ Tennessee, Knoxville, TN USA; [Timm, Andrea C.; Timm, Collin M.; Bible, Amber N.; Morrell-Falvey, Jennifer L.; Pelletier, Dale A.; Simpson, Michael L.; Doktycz, Mitchel J.; Retterer, Scott T.] Oak Ridge Natl Lab, Oak Ridge, TN USA	Kansas State University; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Retterer, ST (corresponding author), Univ Tennessee, Knoxville, TN USA.; Retterer, ST (corresponding author), Oak Ridge Natl Lab, Oak Ridge, TN USA.	rettererst@ornl.gov	Doktycz, Mitchel J/A-7499-2011; Simpson, Michael/A-8410-2011; Morrell-Falvey, Jennifer L/A-6615-2011; Retterer, Scott/A-5256-2011	Doktycz, Mitchel J/0000-0003-4856-8343; Simpson, Michael/0000-0002-3933-3457; Morrell-Falvey, Jennifer L/0000-0002-9362-7528; Pelletier, Dale/0000-0002-4321-7918; Webb, Amber/0000-0002-7431-0533; Retterer, Scott/0000-0001-8534-1979; Timm, Andrea/0000-0002-0570-9217	Genomic Science Program; U.S. Department of Energy; Office of Science; Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area; ORNL Laboratory Directed Research and Development	Genomic Science Program; U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area; ORNL Laboratory Directed Research and Development	This work was supported in part by the Genomic Science Program, U.S. Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area (http://pmi.ornl.gov) as well as ORNL Laboratory Directed Research and Development. Microwell arrays were fabricated and characterized at the Center for Nanophase Materials Sciences User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy. The authors would also like to thank the J. Mougous Laboratory (University of Washington, Seattle, WA) for the supply of P. aeruginosa strains used in these studies and Dr. B. Tseng Laboratory (University of Washington, Seattle, WA) for the supply of plasmids used to express GFP and mCherry in E. coli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin RH, 2010, CHEM SOC REV, V39, P1049, DOI 10.1039/b911230h; Boedicker JQ, 2008, LAB CHIP, V8, P1265, DOI 10.1039/b804911d; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Churski K, 2012, LAB CHIP, V12, P1629, DOI 10.1039/c2lc21284f; Connell JL, 2013, P NATL ACAD SCI USA, V110, P18380, DOI 10.1073/pnas.1309729110; Connell JL, 2012, NAT CHEM BIOL, V8, P10, DOI 10.1038/nchembio.749; Cornforth DM, 2014, P NATL ACAD SCI USA, V111, P4280, DOI 10.1073/pnas.1319175111; Drescher K, 2013, P NATL ACAD SCI USA, V110, P4345, DOI 10.1073/pnas.1300321110; Eun YJ, 2011, ACS CHEM BIOL, V6, P260, DOI 10.1021/cb100336p; Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110; Hansen RR, 2014, BIOSENSORS-BASEL, V4, P63, DOI 10.3390/bios4010063; Hansen RR, 2013, BIOMACROMOLECULES, V14, P3742, DOI 10.1021/bm4011358; Hansen RR, 2013, ANN BIOMED ENG, V41, P250, DOI 10.1007/s10439-012-0658-5; Hatch AC, 2011, LAB CHIP, V11, P3838, DOI 10.1039/c1lc20561g; Hol FJH, 2014, SCIENCE, V346, P438, DOI 10.1126/science.1251821; Ilic B, 2000, BIOMED MICRODEVICES, V2, P317, DOI 10.1023/A:1009911407093; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kirschner CM, 2012, ANNU REV MATER RES, V42, P211, DOI 10.1146/annurev-matsci-070511-155012; LeRoux M, 2012, P NATL ACAD SCI USA, V109, P19804, DOI 10.1073/pnas.1213963109; Leung K, 2012, P NATL ACAD SCI USA, V109, P7665, DOI 10.1073/pnas.1106752109; Lian M, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4765337; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; Murray JL, 2014, J MICROBIOL, V52, P188, DOI 10.1007/s12275-014-4067-3; Orth RN, 2003, BIOPHYS J, V85, P3066, DOI 10.1016/S0006-3495(03)74725-0; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017019; Park MC, 2011, LAB CHIP, V11, P79, DOI 10.1039/c01c00114g; Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65; Rottgermann PJF, 2014, SOFT MATTER, V10, P2397, DOI 10.1039/c3sm52419a; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Seitz R, 2005, APPL SURF SCI, V252, P154, DOI 10.1016/j.apsusc.2005.02.012; Short FL, 2014, TRENDS MICROBIOL, V22, P508, DOI 10.1016/j.tim.2014.05.007; Tan CP, 2010, MATERIALS, V3, P1803, DOI 10.3390/ma3031803; Timm CM, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4935938; Van der Meeren P, 2001, PLANT CELL TISS ORG, V65, P239, DOI 10.1023/A:1010698225362; Xavier JB, 2007, P NATL ACAD SCI USA, V104, P876, DOI 10.1073/pnas.0607651104; Young Jonathan W, 2011, Nat Protoc, V7, P80, DOI 10.1038/nprot.2011.432; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747; Zhang Y, 2013, BIOMATERIALS, V34, P4564, DOI 10.1016/j.biomaterials.2013.03.002; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155; Zhou JZ, 2014, P NATL ACAD SCI USA, V111, pE836, DOI 10.1073/pnas.1324044111	42	26	26	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155080	10.1371/journal.pone.0155080	http://dx.doi.org/10.1371/journal.pone.0155080			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152511	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000066
J	Umubyeyi, A; Persson, M; Mogren, I; Krantz, G				Umubyeyi, Aline; Persson, Margareta; Mogren, Ingrid; Krantz, Gunilla			Gender Inequality Prevents Abused Women from Seeking Care Despite Protection Given in Gender-Based Violence Legislation: A Qualitative Study from Rwanda	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; MENTAL-HEALTH; MULTILEVEL; RESOURCES; KARACHI; RISK	Objective Despite its burden on a person's life, Intimate Partner Violence (IPV) is known to be poorly recognised and managed in most countries and communities. This study aimed to explore health care professionals' experiences of the health care seeking processes of women exposed to intimate partner violence in Rwanda. Methods Six focus group discussions were conducted in three district hospitals and three mental health units in Rwanda. A sample of 43 health care professionals with various professions and length of work experience, who regularly took care of patients subjected to IPV, was selected for focus group discussions. The analysis was performed using qualitative content analysis. Results The theme "Gendered norms and values defeat the violence legislation in women's health care seeking when women are abused" expressed the health care professionals' experiences of the double-faced situation which women exposed to IPV met in their help seeking process. Positive initiatives to protect women were identified, but the potential for abused women to seek help and support was reduced because of poverty, gender inequality with prevailing strong norms of male superiority, and the tendency to keep abuse as a private family matter. Conclusion Legislative measures have been instituted to protect women from abuse. Still many Rwandan women do not benefit from these efforts. The role of the health care services needs to be reinforced as an important and available resource for help and support for abused women but further legislative changes are also needed. Initiatives to further improve gender equality, and institutionalised collaboration between different sectors in society would contribute to protecting women from IPV.	[Umubyeyi, Aline] Univ Rwanda, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kigali, Rwanda; [Persson, Margareta] Umea Univ, Dept Nursing, Umea, Sweden; [Mogren, Ingrid] Umea Univ, Dept Clin Sci Obstet & Gynecol, Umea, Sweden; [Krantz, Gunilla] Sahlgrens Acad, Sect Epidemiol & Social Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Krantz, Gunilla] Univ Gothenburg, Gothenburg, Sweden	University of Rwanda; Umea University; Umea University; University of Gothenburg; University of Gothenburg	Umubyeyi, A (corresponding author), Univ Rwanda, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kigali, Rwanda.	aumubyey@nursph.org	Umubyeyi, Aline/G-9485-2019	Umubyeyi, Aline/0000-0002-0960-5220	Swedish International Development Agency [SWE 2010-058]	Swedish International Development Agency	Funded by Swedish International Development Agency Grant number: SWE 2010-058 (http://www.sida.se/english/).	Ali TS, 2013, INT J BEHAV MED, V20, P131, DOI 10.1007/s12529-011-9201-6; Ali TS, 2012, INT J WOMENS HEALTH, V4, P577, DOI 10.2147/IJWH.S33325; Assembly UNG, 1993, ARES48104 ASS UNG; Choi SYP, 2008, J INTERPERS VIOLENCE, V23, P834, DOI 10.1177/0886260507313951; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Goodman LA, 2009, TRAUMA VIOLENCE ABUS, V10, P306, DOI 10.1177/1524838009339754; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Heise LL, 2015, LANCET GLOB HEALTH, V3, pE332, DOI 10.1016/S2214-109X(15)00013-3; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jonzon R, 2007, SCAND J PUBLIC HEALT, V35, P640, DOI 10.1080/14034940701431130; Kouyoumdjian FG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-566; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Kubai A, 2013, ETHNIC HEALTH, V18, P469, DOI 10.1080/13557858.2013.832012; Linos N, 2013, AM J PUBLIC HEALTH, V103, P148, DOI 10.2105/AJPH.2012.300829; Mannell J, 2015, GLOB PUBLIC HEALTH, P1; Michau L, 2015, LANCET, V385, P1672, DOI 10.1016/S0140-6736(14)61797-9; Nybergh L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-845; Odero M, 2014, J INTERPERS VIOLENCE, V29, P783, DOI 10.1177/0886260513505706; Puri M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-29; Rani Manju, 2004, Afr J Reprod Health, V8, P116, DOI 10.2307/3583398; Research IfPA, 2012, LEG POL FRAM CHILDR; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Stalmeijer RE, 2014, MED TEACH, V36, P923, DOI 10.3109/0142159X.2014.917165; Umubyeyi A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0315-7; Umubyeyi A, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-99; UNHCR, 2015, GHAN DOM VIOL INCL L; Unicef R, 2010, IS ON STOP CTR TRANS; United Nations (UN), 2010, COUNTR ASS VIOL WOM; Verduin F, 2013, J INTERPERS VIOLENCE, V28, P1839, DOI 10.1177/0886260512469106; World Health Organization, 2021, VIOL WOM PREV EST 20	31	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154540	10.1371/journal.pone.0154540	http://dx.doi.org/10.1371/journal.pone.0154540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KX	27152680	gold, Green Submitted, Green Published			2022-12-27	WOS:000375677000023
J	Yi, HJ; Chen, Y; Liu, J; Zhang, J; Guo, W; Xiao, WL; Yao, YC				Yi, Haijing; Chen, Yan; Liu, Jun; Zhang, Jie; Guo, Wei; Xiao, Weilie; Yao, Yuncong			Extraction and Separation of Active Ingredients in Schisandra chinensis (Turcz.) Baill and the Study of their Antifungal Effects	PLOS ONE			English	Article							OXIDATIVE STRESS; NATURAL-PRODUCTS; BOTANICAL INSECTICIDES; POLYPHENOL OXIDASE; KADSURA INTERIOR; LIGNANS; FRUIT; PLANTS; EXPRESSION; GOMISIN	Schisandra chinensis extracts (SEs) have traditionally been used as an oriental medicine for the treatment of various human diseases, however, their further application in the bio-control of plant disease remains poorly understood. This study was conducted to develop eco-friendly botanical pesticides from extracts of S. chinensis and assess whether they could play a key role in plant disease defense. Concentrated active fractions (SE-I, SE-II, and SE-III) were obtained from S. chinensis via specific extraction and separation. Then, lignan-like substances, such as Schisanhenol B, were detected via High-Performance Liquid Chromatography-ElectroSpray Ionization-Mass Spectrometry (HPLC-ESI-MS) analyses of the active fractions. Moreover, the results from biological tests on colony growth inhibition and spore germination indicated that SE-I, SE-II, and SE-III could inhibit hyphal growth and spore generation of three important plant pathogenic fungi (Monilinia fructicola, Fusarium oxysporum, and Botryosphaeria dothidea). The study of the mechanisms of resistant fungi revealed that the oxidation resistance system, including reactive oxygen species (ROS), malondialdehyde (MDA), catalase (CAT), and superoxide dismutase (SOD), was activated. The expression of genes related to defense, such as pathogenesis-related protein (PR4), a-farnesene synthase (AFS), polyphenol oxidase (PPO), and phenylalanine ammonia lyase (PAL) were shown to be up-regulated after treatment with SEs, which suggested an increase in apple immunity and that fruits were induced to effectively defend against the infection of pathogenic fungi (B. dothidea). This study revealed that SEs and their lignans represent promising resources for the development of safe, effective, and multi-targeted agents against pathogenic fungi.	[Yi, Haijing; Chen, Yan; Zhang, Jie; Guo, Wei; Yao, Yuncong] Beijing Agr Univ, Plant Sci & Technol Coll, Beijing 102206, Peoples R China; [Yi, Haijing; Chen, Yan; Zhang, Jie; Guo, Wei; Yao, Yuncong] Beijing Agr Univ, Beijing Key Lab New Technol Agr Applicat, Beijing 102206, Peoples R China; [Liu, Jun] Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China; [Xiao, Weilie] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Yao, YC (corresponding author), Beijing Agr Univ, Plant Sci & Technol Coll, Beijing 102206, Peoples R China.; Yao, YC (corresponding author), Beijing Agr Univ, Beijing Key Lab New Technol Agr Applicat, Beijing 102206, Peoples R China.	yaoyc_20@126.com			Beijing municipal education commission [KM201510020004]; Beijing municipality [IDHT20140509, IDHT20150503]; NSFC for Outstanding Young Scholar [81422046]; Beijing Collaborative innovation center for eco-environmental improvement with forestry and fruit trees' [CEFF-PXM2016-014207-000038]	Beijing municipal education commission(Beijing Municipal Commission of Education); Beijing municipality; NSFC for Outstanding Young Scholar; Beijing Collaborative innovation center for eco-environmental improvement with forestry and fruit trees'	The authors thank the Fruit Tree Key Laboratory at the Beijing University of Agriculture and the Beijing Nursery Engineering Research Center for Fruit Crops for providing basic experimental facilities. Financial support was provided by scientific research projects "Extraction and utilization of active ingredients in Schisandra chinensis (Turcz.) Baill and the study of their antifungal effect" (KM201510020004) of Beijing municipal education commission in 2015. Financial support was also provided by the project of construction of innovative teams and teacher career development for universities and colleges under Beijing municipality (IDHT20140509;IDHT20150503), and by the NSFC for Outstanding Young Scholar (81422046). Beijing Collaborative innovation center for eco-environmental improvement with forestry and fruit trees' (CEFF-PXM2016-014207-000038) also provide financial support.	Alexander JS, 2012, HYPERTENS RES, V35, P892, DOI 10.1038/hr.2012.101; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Cantrell CL, 2012, J NAT PROD, V75, P1231, DOI 10.1021/np300024u; Chang CY, 2009, PHYTOTHER RES, V23, P251, DOI 10.1002/ptr.2602; Chen DF, 1997, BIOORGAN MED CHEM, V5, P1715, DOI 10.1016/S0968-0896(97)00118-1; Chen DF, 2002, J NAT PROD, V65, P1242, DOI 10.1021/np0105127; Chen M, 2006, J NAT PROD, V69, P1697, DOI 10.1021/np060239e; Chen WW, 2011, PHYTOMEDICINE, V18, P1144, DOI 10.1016/j.phymed.2011.06.004; Cheng ZY, 2016, J CHROMATOGR SCI, V54, P246, DOI 10.1093/chromsci/bmv116; Cheng ZY, 2015, INT J BIOL MACROMOL, V76, P161, DOI 10.1016/j.ijbiomac.2015.01.048; Chiu PY, 2008, LIFE SCI, V82, P1092, DOI 10.1016/j.lfs.2008.03.006; Chiu PY, 2006, MOL CELL BIOCHEM, V289, P185, DOI 10.1007/s11010-006-9163-1; Choi EH, 2008, GENES NUTR, V2, P337, DOI 10.1007/s12263-007-0073-y; Chun JN, 2014, FITOTERAPIA, V97, P224, DOI 10.1016/j.fitote.2014.06.014; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; Copping LG, 2007, PEST MANAG SCI, V63, P524, DOI 10.1002/ps.1378; Cyong JC, 2000, AM J CHINESE MED, V28, P351, DOI 10.1142/S0192415X00000416; Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046; del Rio LA, 2011, ARCH BIOCHEM BIOPHYS, V506, P1, DOI 10.1016/j.abb.2010.10.022; Duke SO, 2010, TOXINS, V2, P1943, DOI 10.3390/toxins2081943; Giridharan VV, 2012, FREE RADICAL RES, V46, P50, DOI 10.3109/10715762.2011.638291; Giridharan VV, 2011, FREE RADICAL RES, V45, P950, DOI 10.3109/10715762.2011.571682; Hancke JL, 1999, FITOTERAPIA, V70, P451, DOI 10.1016/S0367-326X(99)00102-1; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; He F, 2012, TETRAHEDRON, V68, P440, DOI 10.1016/j.tet.2011.11.026; Hou WG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120151; Hu MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024990; Huang TH, 2005, J CHROMATOGR A, V1066, P239, DOI 10.1016/j.chroma.2005.01.025; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Isman MB, 2008, PEST MANAG SCI, V64, P8, DOI 10.1002/ps.1470; Jiang YM, 2015, CHEM-BIOL INTERACT, V231, P83, DOI 10.1016/j.cbi.2015.02.022; Jing L, 2014, J AGR FOOD CHEM, V62, P3011, DOI 10.1021/jf5006148; Kim EY, 2011, J ETHNOPHARMACOL, V134, P668, DOI 10.1016/j.jep.2011.01.019; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Koike ST, 2009, PLANT DIS, V93, P1077, DOI 10.1094/PDIS-93-10-1077A; Kudom AA, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.14201; Kwon DY, 2011, J ETHNOPHARMACOL, V135, P455, DOI 10.1016/j.jep.2011.03.037; Ladhari A, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6101; Lee HJ, 2015, MOL MED REP, V12, P2135, DOI 10.3892/mmr.2015.3618; Lee Kuo-Hsiung, 2012, J Tradit Complement Med, V2, P6; Lee S, 2007, PHYTOTHER RES, V21, P1187, DOI 10.1002/ptr.2233; [李斌 LI Bin], 2011, [食品科学, Food Science], V32, P79; Lv CJ, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.5801; Mansfield J.W., 2000, MECH RESISTANCE PLAN, P325; Marisa F, 2014, FREE RADICAL BIO MED, V75, pS30, DOI 10.1016/j.freeradbiomed.2014.10.760; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Nabavi SM, 2015, FOOD CHEM, V173, P339, DOI 10.1016/j.foodchem.2014.10.042; Opletal L, 2004, J CHROMATOGR B, V812, P357, DOI 10.1016/j.jchromb.2004.07.040; Pan SY, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-120; Panossian A, 2007, DRUG TARGET INSIGHT, V2, P39; Panossian A, 2008, J ETHNOPHARMACOL, V118, P183, DOI 10.1016/j.jep.2008.04.020; Park EJ, 2012, BIOCHEM PHARMACOL, V83, P378, DOI 10.1016/j.bcp.2011.11.002; Pinto MST, 2008, PHYTOCHEMISTRY, V69, P2297, DOI 10.1016/j.phytochem.2008.06.003; ROBAK J, 1988, POL J PHARMACOL PHAR, V40, P337; Rupasinghe HPV, 2001, PLANT PHYSIOL BIOCH, V39, P933, DOI 10.1016/S0981-9428(01)01316-X; Sarowar S, 2005, PLANT CELL REP, V24, P216, DOI 10.1007/s00299-005-0928-x; Stewart RJ, 2001, AUST J PLANT PHYSIOL, V28, P181, DOI 10.1071/PP00094; SWAIN T, 1977, ANNU REV PLANT PHYS, V28, P479, DOI 10.1146/annurev.pp.28.060177.002403; Tang W, 2012, PLANT DIS, V96, P486, DOI 10.1094/PDIS-08-11-0635; Thipyapong P, 2004, PLANTA, V220, P105, DOI 10.1007/s00425-004-1330-6; Tian K, 2005, J CHROMATOGR A, V1078, P181, DOI 10.1016/j.chroma.2005.05.018; Tomar A, 2009, HDB PESTICIDES, P67; Xue YB, 2015, PHYTOCHEMISTRY, V116, P253, DOI 10.1016/j.phytochem.2015.03.009; Yoo HH, 2007, PLANTA MED, V73, P444, DOI 10.1055/s-2007-967178; Yoon MY, 2013, PLANT PATHOLOGY J, V29, P1, DOI 10.5423/PPJ.RW.05.2012.0072; You Jyh-Sheng, 2006, Chang Gung Med J, V29, P63; Yu JL, 1998, GINSENG RES, P11; Zabka M, 2014, CHEMOSPHERE, V112, P443, DOI 10.1016/j.chemosphere.2014.05.014; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zhong S, 2015, J ETHNOPHARMACOL, V165, P73, DOI 10.1016/j.jep.2015.02.009	71	11	11	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154731	10.1371/journal.pone.0154731	http://dx.doi.org/10.1371/journal.pone.0154731			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152614	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000031
J	Zotova, NV; Chereshnev, VA; Gusev, EY				Zotova, N. V.; Chereshnev, V. A.; Gusev, E. Yu.			Systemic Inflammation: Methodological Approaches to Identification of the Common Pathological Process	PLOS ONE			English	Article							ORGAN FAILURE; SEPSIS	We defined Systemic inflammation (SI) as a "typical, multi-syndrome, phase-specific pathological process, developing from systemic damage and characterized by the total inflammatory reactivity of endotheliocytes, plasma and blood cell factors, connective tissue and, at the final stage, by microcirculatory disorders in vital organs and tissues." The goal of the work: to determine methodological approaches and particular methodical solutions for the problem of identification of SI as a common pathological process. SI can be defined by the presence in plasma of systemic proinflammatory cell stress products-cytokines and other inflammatory mediators, and also by the complexity of other processes signs. We have developed 2 scales: 1) The Reactivity Level scale (RL)-from 0 to 5 points: 0-normal level; RL-5 confirms systemic nature of inflammatory mediator release, and RL-2-4 defines different degrees of event probability. 2) The SI scale, considering additional criteria along with RL, addresses more integral criteria of SI: the presence of >= 5 points according to the SI scale proves the high probability of SI developing. To calculate the RL scale, concentrations of 4 cytokines (IL-6, IL-8, IL-10, TNF-alpha) and C-reactive protein in plasma were examined. Additional criteria of the SI scale were the following: D-dimers>500ng/ml, cortisol>1380 or <100nmol/l, troponin I >= 0.2ng/ml and/or myoglobin >= 800ng/ml. 422 patients were included in the study with different septic (n-207) and aseptic (n-215) pathologies. In 190 cases (of 422) there were signs of SI (lethality 38.4%, n-73). In only 5 of 78 cases, lethality was not confirmed by the presence of SI. SI was registered in 100% of cases with septic shock (n-31). There were not significant differences between AU-ROC of CR, SI scale and SOFA to predict death in patients with sepsis and trauma.	[Zotova, N. V.; Chereshnev, V. A.; Gusev, E. Yu.] UB RAS, Inst Immunol & Physiol, Lab Immunol Inflammat, Ekaterinburg, Russia; [Zotova, N. V.; Chereshnev, V. A.; Gusev, E. Yu.] Ural Fed Univ, Auto Fed State Autonomous Educ Inst Higher Profes, KCS Expt Physiol & Immunochem, Ekaterinburg, Russia	Institute of Immunology & Physiology UB RAS; Russian Academy of Sciences; Ural Federal University	Zotova, NV (corresponding author), UB RAS, Inst Immunol & Physiol, Lab Immunol Inflammat, Ekaterinburg, Russia.; Zotova, NV (corresponding author), Ural Fed Univ, Auto Fed State Autonomous Educ Inst Higher Profes, KCS Expt Physiol & Immunochem, Ekaterinburg, Russia.	zotovanat@mail.ru	Gusev, Evgeny/AAE-1536-2021; , Natalya/AAE-2870-2021; Chereshnev, Valeriy/P-7704-2017	, Natalya/0000-0001-9788-1243; Chereshnev, Valeriy/0000-0003-4329-147X	Act 211 Government of the Russian Federation [02.A03.21.0006]	Act 211 Government of the Russian Federation	This work was supported by Act 211 Government of the Russian Federation, contract no. 02.A03.21.0006.	Bezemer R, 2012, CRIT CARE, V16, DOI 10.1186/cc11236; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chereshnev VA, 2012, PATHOLOGY PHYSL EX 1, V4, P3; Chereshnev VA, 2014, PATHOLOGY PHYSL EX 4, V4, P4; Chereshnev VA, 2013, PATHOLOGY PHYSL EX 2, V1, P3; De Backer D., 2011, ANN INTENSIVE CARE, V1, P1; Gusev E. Yu, 2013, PATHOLOGY PHYSL EX 3, V3, P3; Liu B, 2013, CRIT CARE, V17, DOI 10.1186/cc13070; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Yurchenko LN, 2008, Russian Federation Patent, Patent No. [RF 2335771, 2335771]	11	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155138	10.1371/journal.pone.0155138	http://dx.doi.org/10.1371/journal.pone.0155138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153324	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000073
J	Bigaeva, E; van Doorn, E; Liu, H; Hak, E				Bigaeva, Emilia; van Doorn, Eva; Liu, Heng; Hak, Eelko			Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability	PLOS ONE			English	Article							IMMUNE-RESPONSES; PHASE-I; THERAPEUTIC VACCINES; IMMUNOGENICITY; ANTIBODY; FORMULATIONS; IMMUNIZATION; PROTEIN; CELLS; AD	Background and Objectives QS-21 shows in vitro hemolytic effect and causes side effects in vivo. New saponin adjuvant formulations with better toxicity profiles are needed. This study aims to evaluate the safety and tolerability of QS-21 and the improved saponin adjuvants (ISCOM, ISCOMATRIX and Matrix-M (TM)) from vaccine trials. Methods A systematic literature search was conducted from MEDLINE, EMBASE, Cochrane library and Clinicaltrials.gov. We selected for the meta-analysis randomized controlled trials (RCTs) of vaccines adjuvanted with QS-21, ISCOM, ISCOMATRIX or Matrix-M (TM), which included a placebo control group and reported safety outcomes. Pooled risk ratios (RRs) and their 95% confidence intervals (CIs) were calculated using a random-effects model. Jadad scale was used to assess the study quality. Results Nine RCTs were eligible for the meta-analysis: six trials on QS-21-adjuvanted vaccines and three trials on ISCOMATRIX-adjuvanted, with 907 patients in total. There were no studies on ISCOM or Matrix-M (TM) adjuvanted vaccines matching the inclusion criteria. Meta-analysis identified an increased risk for diarrhea in patients receiving QS-21-adjuvanted vaccines (RR 2.55, 95% CI 1.04-6.24). No increase in the incidence of the reported systemic AEs was observed for ISCOMATRIX-adjuvanted vaccines. QS-21- and ISCOMATRIX-adjuvanted vaccines caused a significantly higher incidence of injection site pain (RR 4.11, 95% CI 1.10-15.35 and RR 2.55, 95% CI 1.41-4.59, respectively). ISCOMATRIX-adjuvanted vaccines also increased the incidence of injection site swelling (RR 3.43, 95% CI 1.08-10.97). Conclusions Our findings suggest that vaccines adjuvanted with either QS-21 or ISCOMATRIX posed no specific safety concern. Furthermore, our results indicate that the use of ISCOMATRIX enables a better systemic tolerability profile when compared to the use of QS-21. However, no better local tolerance was observed for ISCOMATRIX-adjuvanted vaccines in immunized non-healthy subjects. This meta-analysis is limited by the relatively small number of individuals recruited in the included trials, especially in the control groups.	[Bigaeva, Emilia] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [van Doorn, Eva; Liu, Heng; Hak, Eelko] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands	University of Groningen; University of Groningen	Bigaeva, E (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	e.bigaeva@rug.nl	Bigaeva, Emilia/I-4889-2014					Adams MM, 2010, J AM CHEM SOC, V132, P1939, DOI 10.1021/ja9082842; Anderson JS, 2009, JAIDS-J ACQ IMM DEF, V52, P371, DOI 10.1097/QAI.0b013e3181b7354c; Azmi Fazren, 2014, Hum Vaccin Immunother, V10, P778; Barr IG, 1998, ADV DRUG DELIVER REV, V32, P247, DOI 10.1016/S0169-409X(98)00013-1; Bengtsson KL, 2013, EXPERT REV VACCINES, V12, P821, DOI 10.1586/14760584.2013.814822; Bengtsson KL, 2011, EXPERT REV VACCINES, V10, P401, DOI [10.1586/erv.11.25, 10.1586/ERV.11.25]; Cebon JS, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.9050; Chen JL, 2015, INT J CANCER, V136, pE590, DOI 10.1002/ijc.29118; Clegg CH, 2013, EXPERT REV VACCINES, V12, P767, DOI 10.1586/14760584.2013.811178; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; DALSGAARD K, 1970, Dansk Tidsskrift for Farmaci, V44, P327; Dey AK, 2011, EXPERT REV VACCINES, V10, P227, DOI 10.1586/ERV.10.142; Drane D, 2007, EXPERT REV VACCINES, V6, P761, DOI 10.1586/14760584.6.5.761; Drane D, 2009, HUM VACCINES, V5, P151, DOI 10.4161/hv.5.3.6614; Durier C, 2006, AIDS, V20, P1039, DOI 10.1097/01.aids.0000222077.68243.22; Frazer IH, 2004, VACCINE, V23, P172, DOI 10.1016/j.vaccine.2004.05.013; Garcia A, 2014, APMIS, V122, P257, DOI 10.1111/apm.12143; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Keefer MC, 1997, AIDS RES HUM RETROV, V13, P1163, DOI 10.1089/aid.1997.13.1163; Kensil C R, 1998, Expert Opin Investig Drugs, V7, P1475, DOI 10.1517/13543784.7.9.1475; Kersten GFA, 2003, VACCINE, V21, P915, DOI 10.1016/S0264-410X(02)00540-6; Kim SK, 1999, VACCINE, V18, P597, DOI 10.1016/S0264-410X(99)00316-3; Leroux-Roels G, 2010, VACCINE, V28, pC25, DOI 10.1016/j.vaccine.2010.07.021; Levast B, 2014, VACCINES-BASEL, V2, P297, DOI 10.3390/vaccines2020297; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; LIVINGSTON PO, 1994, VACCINE, V12, P1275, DOI 10.1016/S0264-410X(94)80052-2; LIVINGSTON PO, 1995, IMMUNOL REV, V145, P147, DOI 10.1111/j.1600-065X.1995.tb00080.x; Maraskovsky E, 2009, IMMUNOL CELL BIOL, V87, P371, DOI 10.1038/icb.2009.21; Mbawuike I, 2007, VACCINE, V25, P3263, DOI 10.1016/j.vaccine.2007.01.073; McKenzie A, 2010, HUM VACCINES, V6, P237, DOI 10.4161/hv.6.3.10754; Merck Sharp & Dohme Corp, STUD V950 PEOPL ALZH; Mohan T, 2013, INDIAN J MED RES, V138, P779; MOREIN B, 1995, CLIN IMMUNOTHER, V3, P461, DOI 10.1007/BF03259065; Morelli AB, 2012, J MED MICROBIOL, V61, P935, DOI 10.1099/jmm.0.040857-0; Moyle PM, 2013, CHEMMEDCHEM, V8, P360, DOI 10.1002/cmdc.201200487; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Osbourn A, 2011, NAT PROD REP, V28, P1261, DOI 10.1039/c1np00015b; Pearse MJ, 2005, ADV DRUG DELIVER REV, V57, P465, DOI 10.1016/j.addr.2004.09.006; Pedersen G, 2011, INFLUENZA OTHER RESP, V5, P426, DOI 10.1111/j.1750-2659.2011.00256.x; Pedersen GK, 2012, J INFECT DIS, V206, P158, DOI 10.1093/infdis/jis330; Pedersen GK, 2014, VACCINE, V32, P4550, DOI 10.1016/j.vaccine.2014.06.009; Pfizer Janssen Alzheimer Immunotherapy (JAI) Research and Development LLC, STUD EV ACC 001 SUBJ; Pfizer Janssen Alzheimer Immunotherapy (JAI) Research and Development LLC, STUD EV SAF TOL IMM; Pfizer Janssen Alzheimer Immunotherapy (JAI) Research and Development LLC, AM IM SAF STUD ACC 0; Pialoux G, 2001, AIDS, V15, P1239, DOI 10.1097/00002030-200107060-00005; Ragupathi G, 2011, EXPERT REV VACCINES, V10, P463, DOI [10.1586/erv.11.18, 10.1586/ERV.11.18]; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Reimer JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041451; Sun HX, 2009, VACCINE, V27, P4388, DOI 10.1016/j.vaccine.2009.05.032; Sun HX, 2009, VACCINE, V27, P1787, DOI 10.1016/j.vaccine.2009.01.091; Waite DC, 2001, VACCINE, V19, P3957, DOI 10.1016/S0264-410X(01)00142-6; Wald A, 2011, VACCINE, V29, P8520, DOI 10.1016/j.vaccine.2011.09.046; Weiss SA, 2014, CURR TREAT OPTION ON, V15, P269, DOI 10.1007/s11864-014-0283-7	56	22	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154757	10.1371/journal.pone.0154757	http://dx.doi.org/10.1371/journal.pone.0154757			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149269	Green Submitted, gold, Green Published			2022-12-27	WOS:000375676800057
J	Dong, CH; Wang, YJ; Wang, ZM; Wang, Y; Wu, SY; Du, QY; Wang, AM				Dong, Chenhui; Wang, Yunjiao; Wang, Ziming; Wang, Yu; Wu, Siyu; Du, Quanyin; Wang, Aimin			Damage Control Orthopedics Management as Vital Procedure in Elderly Patients with Femoral Neck Fractures Complicated with Chronic Renal Failure: A Retrospective Cohort Study	PLOS ONE			English	Article							HIP FRACTURE; POSTOPERATIVE COMPLICATIONS; 1-YEAR MORTALITY; SURGERY; SURVIVAL; RISK; ARTHROPLASTY; PROSTHESES; FRAGILITY; DISEASE	Background Chronic renal failure (CRF) predisposes to hip fractures in elderly patients, with high subsequent mortality. Selection and timing of the surgical procedure of such patients is a serious challenge. Many clinicians believe in earlier surgery as preferable and providing better outcomes. Damage control orthopedics (DCO) aids to adjust and optimize the overall condition of patients. Methods In 32 patients with femoral neck fractures complicated with CRF, we evaluated how the timing of the surgery determines the mortality rates if the DCO approach is applied. Preoperative ASA grading, POSSUM score, P-POSSUM score and DCO were carried out. Based on the assessment, timing of the surgery was ascertained. Results Of a total of 32 patients, twenty-nine patients were accepted for either early (< 48 hours; n = 18) or delayed (3-10 days; n = 10) surgery. Hip arthroplasty (total hip arthroplasty and hemiarthroplasty) was the principal surgery option. All patients survived operation and were followed up postoperatively with the average time of 30 days. Postoperative complications tended to occur at higher rates in the early vs. delayed surgery group (7/18 vs. 5/10). During follow up, a total of 3 patients died in both groups (2/18 in the early surgery and 1/10 in the delayed surgery group), mostly from multi-organ failures and acute respiratory distress syndrome. There was no significant difference in complication rates and Harris hip score between both groups. Conclusion In patients with femoral neck fracture complicated with CRF, delaying the surgery for several days does not increase the incidence of postoperative adverse events.	[Dong, Chenhui; Wang, Yunjiao; Wang, Ziming; Wang, Yu; Wu, Siyu; Du, Quanyin; Wang, Aimin] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Orthoped, Chongqing 400042, Peoples R China	Army Medical University	Wang, AM (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Orthoped, Chongqing 400042, Peoples R China.	trauma2@163.com						Bonicoli E, 2014, Musculoskelet Surg, V98, P201, DOI 10.1007/s12306-013-0294-8; Casey M, 2004, OSTEOPOROSIS INT, V15, P420, DOI 10.1007/s00198-003-1575-0; Garcia Flavio Luís, 2014, Rev. bras. ortop., V49, P540, DOI 10.1016/j.rboe.2014.07.004; Geiger F, 2007, ARCH ORTHOP TRAUM SU, V127, P959, DOI 10.1007/s00402-007-0423-7; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; Gjertsen JE, 2012, J BONE JOINT SURG BR, V94B, P1113, DOI 10.1302/0301-620X.94B8.29155; KATZ AI, 1969, MEDICINE, V48, P333, DOI 10.1097/00005792-196909000-00001; KIM KJ, 1993, CLIN ORTHOP RELAT R, P142; Kim SM, 2012, BONE, V50, P1343, DOI 10.1016/j.bone.2012.02.633; Leonard MB, 2009, SEMIN NEPHROL, V29, P133, DOI 10.1016/j.semnephrol.2009.01.006; Leung F, 2010, OSTEOPOROSIS INT, V21, pS529, DOI 10.1007/s00198-010-1391-2; Lin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132589; Liu LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136968; Liu SS, 2007, ANESTH ANALG, V104, P689, DOI 10.1213/01.ane.0000255040.71600.41; Liu Y, 2015, OSTEOPOROSIS INT, V26, P1029, DOI 10.1007/s00198-014-2931-y; Lizaur-Utrilla A, 2015, ARCH ORTHOP TRAUM SU, V135, P1663, DOI 10.1007/s00402-015-2328-1; Messina A, 2013, MINERVA ANESTESIOL, V79, P1021; Michel JP, 2002, AGING CLIN EXP RES, V14, P389; Nickolas TL, 2010, J AM SOC NEPHROL, V21, P1371, DOI 10.1681/ASN.2009121208; Papathanasopoulos A, 2009, INJURY, V40, P115, DOI 10.1016/j.injury.2008.09.002; Parker MJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000521.PUB2; Pedersen SJ, 2008, J AM GERIATR SOC, V56, P1831, DOI 10.1111/j.1532-5415.2008.01945.x; Roberts Craig S, 2005, Instr Course Lect, V54, P447; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; TAKAKURA Y, 1990, CLIN ORTHOP RELAT R, P209; Tseng CH, 2014, EUR J INTERN MED, V25, P956, DOI 10.1016/j.ejim.2014.10.017; Uzoigwe CE, 2013, INJURY, V44, P726, DOI 10.1016/j.injury.2012.08.025; Vidal EIO, 2012, OSTEOPOROSIS INT, V23, P2847, DOI 10.1007/s00198-012-1917-x; Waibel Brett H, 2012, Rev. Col. Bras. Cir., V39, P314; Wang TJ, 2008, CHIN J TRAUMATOL, V11, P89, DOI 10.1016/S1008-1275(08)60019-X; Weller I, 2005, J BONE JOINT SURG BR, V87B, P361, DOI 10.1302/0301-620X.87B3.15300; Zafeiropoulou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030975	34	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154906	10.1371/journal.pone.0154906	http://dx.doi.org/10.1371/journal.pone.0154906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149117	Green Submitted, gold, Green Published			2022-12-27	WOS:000375676800086
J	Truong, TN; Laureillard, D; Lacombe, K; Thi, HD; Hanh, PPT; Xuan, LTT; Thi, NC; Que, AL; Hai, VV; Nagot, N; Tuaillon, E; Dominguez, S; Lemoine, M				Tam Nguyen Truong; Laureillard, Didier; Lacombe, Karine; Huong Duong Thi; Phuc Pham Thi Hanh; Lien Truong Thi Xuan; Nga Chu Thi; Anh Luong Que; Vinh Vu Hai; Nagot, Nicolas; Tuaillon, Edouard; Dominguez, Stephanie; Lemoine, Maud			High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262)	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; INJECTION-DRUG USERS; TRANSIENT ELASTOGRAPHY; VIRUS-INFECTION; TREATMENT IMPACT; HAI PHONG; DISEASE; PEOPLE; ACCESS; PREVALENCE	Rationale and Aims Screening and treatment for chronic hepatitis C are very limited in Vietnam and clinical data on HCV-related liver disease in HIV-coinfected people are almost inexistent. This study aimed to assess the severity of liver fibrosis and its risk factors in HIV-HCV coinfected patients in Haiphong, Northern Vietnam. Methods A cross-sectional study was conducted at a HIV outpatient clinic. Consecutive HIV treated adults with positive HCV serology completed a standardised epidemiological questionnaire and had a comprehensive liver assessment including hepatic elastography (Fibroscan (R), Echosens). Results From February to March 2014, 104 HIV-HCV coinfected patients receiving anti-retroviral therapy (ART) were prospectively enrolled (99 males, median age: 35.8 (32.7-39.6) years, median CD4 count: 504 (361-624) /mm(3). Of them, 93 (89.4%) had detectable HCV RNA (median 6.19 (4.95-6.83 Log(10) IU/mL). Patients were mainly infected with genotypes 1a/1b (69%) and genotypes 6a/6e (26%). Forty-three patients (41.3%) had fibrosis >= F2 including 24 patients (23.1%) with extensive fibrosis (F3) and/or cirrhosis (F4). In univariate analysis, excessive alcohol consumption, estimated time duration from HCV infection, nevirapine and lopinavir-based ARV regimen and CD4 nadir were associated factors of extensive fibrosis/cirrhosis. Alcohol abuse was the only independent factor of extensive fibrosis in multivariate analysis. Using Fibroscan (R) as a gold standard, the high thresholds of AST-to-platelet ratio index (APRI) and fibrosis-4 score (FIB-4) had very good performances for the diagnosis of extensive fibrosis/cirrhosis (Se: 90 and 100%, Sp: 84 and 81%, AUROCs = 0.93, 95% CI: 0.86-0.99 and 0.96 (0.92-0.99), respectively). Conclusion In this study, nearly 25% of HIV-HCV coinfected patients successfully treated with ART have extensive fibrosis or cirrhosis, and therefore require urgently HCV treatment.	[Tam Nguyen Truong] Univ Med Pham Ngoc Thach, Ho Chi Minh City, Vietnam; [Tam Nguyen Truong; Laureillard, Didier; Nagot, Nicolas; Tuaillon, Edouard] INSERM U1058 Pathogenesis & Control Chron Infect, Montpellier, France; [Laureillard, Didier] Caremeau Univ Hosp, Dept Infect & Trop Dis, Nimes, France; [Lacombe, Karine] St Antoine Hosp, AP HP, Dept Infect & Trop Dis, Paris, France; [Lacombe, Karine] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [Huong Duong Thi] Univ Med & Pharm, Dept Publ Hlth, Hai Phong, Vietnam; [Phuc Pham Thi Hanh; Vinh Vu Hai] Viet Tiep Hosp, Dept Infect & Trop Dis, Hai Phong, Vietnam; [Lien Truong Thi Xuan] Inst Pasteur, Ho Chi Minh City, Vietnam; [Nga Chu Thi; Anh Luong Que] Viet Tiep Hosp, Dept Virol, Haiphong, Vietnam; [Nagot, Nicolas] Univ Hosp, Dept Epidemiol, Montpellier, France; [Tuaillon, Edouard] Univ Hosp, Dept Bacteriol & Virol, Montpellier, France; [Dominguez, Stephanie] Henri Mondor Hosp, AP HP, Dept Clin Immunol, Crteil, France; [Lemoine, Maud] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Hepatol, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Imperial College London	Lemoine, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Hepatol, London, England.	m.lemoine@imperial.ac.uk	HAI, Vinh VU/AAT-2844-2021	HAI, Vinh VU/0000-0001-6130-7864; Laureillard, Didier/0000-0002-0104-9047; Tuaillon, Edouard/0000-0001-5866-9530; Nagot, Nicolas/0000-0002-3493-2821	French Research Agency on HIV/AIDS and Viral Hepatitis [ANRS 12262]	French Research Agency on HIV/AIDS and Viral Hepatitis	This study was funded by the French Research Agency on HIV/AIDS and Viral Hepatitis (ANRS 12262).	Ahmed T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1404-3; [Anonymous], VIETN HIV AIDS EST P; [Anonymous], 2014, VIETN AIDS RESP RPOG; Arena U, 2013, HEPATOLOGY, V58, P65, DOI 10.1002/hep.26343; Avihingsanon A, 2014, J GASTROEN HEPATOL, V29, P1706, DOI 10.1111/jgh.12613; Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993; Bruggmann P, 2008, J VIRAL HEPATITIS, V15, P747, DOI 10.1111/j.1365-2893.2008.01010.x; Huy BV, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/581021; Cacoub P, 2008, J HEPATOL, V48, P765, DOI 10.1016/j.jhep.2008.01.025; Carton JA, 2011, ANTIVIR THER, V16, P27, DOI 10.3851/IMP1708; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Clatts MC, 2010, J URBAN HEALTH, V87, P278, DOI 10.1007/s11524-009-9417-9; de Ledinghen V, 2006, JAIDS-J ACQ IMM DEF, V41, P175; Ford N, 2012, CLIN INFECT DIS, V54, P1465, DOI 10.1093/cid/cis227; Gish RG, 2012, J GASTROEN HEPATOL, V27, P238, DOI 10.1111/j.1440-1746.2011.06974.x; Hagan LM, 2013, LIVER INT, V33, P68, DOI 10.1111/liv.12063; Hellard ME, 2012, MED J AUSTRALIA, V196, P638, DOI 10.5694/mja11.10981; Jayasekera CR, 2014, NEW ENGL J MED, V370, P1869, DOI 10.1056/NEJMp1400160; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Kallman JB, 2011, J VIRAL HEPATITIS, V18, P70, DOI 10.1111/j.1365-2893.2010.01278.x; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Lemoine M, 2014, ALIMENT PHARM THER, V39, P188, DOI 10.1111/apt.12561; Lemoine M, 2014, SEMIN LIVER DIS, V34, P89, DOI 10.1055/s-0034-1371082; Lemoine M, 2014, LIVER INT, V34, P12, DOI 10.1111/liv.12283; Macias J, 2008, J HEPATOL, V49, P916, DOI 10.1016/j.jhep.2008.07.031; Martin NK, 2015, J VIRAL HEPATITIS, V22, P399, DOI 10.1111/jvh.12338; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Nacro B, 2011, B WORLD HEALTH ORGAN, V89, P451, DOI 10.2471/BLT.10.081646; Obach D, 2015, HEPATOLOGY, V62, P31, DOI 10.1002/hep.27691; Pham DA, 2009, ASIAN PAC J ALLERGY, V27, P153; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schulte B, 2010, DRUG ALCOHOL DEPEN, V109, P248, DOI 10.1016/j.drugalcdep.2010.01.009; Sereno Leandro, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P311, DOI 10.1177/1545109712453939; Shi KQ, 2013, LIVER INT, V33, P62, DOI 10.1111/liv.12003; Solomon SS, 2015, LANCET INFECT DIS, V15, P36, DOI 10.1016/S1473-3099(14)71045-X; Tanimoto T, 2010, J MED VIROL, V82, P1355, DOI 10.1002/jmv.21787; Bich TH, 2009, GLOBAL HEALTH ACTION, V2, P28, DOI 10.3402/gha.v2i0.2017; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; Wang JH, 2009, J GASTROENTEROL, V44, P439, DOI 10.1007/s00535-009-0017-y; WHO, 2014, GUID SCREEN CAR TREA; World Health Organization, 2014, GLOB HEP PROGR GLOB; Ye SD, 2014, CURR HIV-AIDS REP, V11, P128, DOI 10.1007/s11904-014-0206-z; Zhang L, 2015, EUR J GASTROEN HEPAT, V27, P550, DOI 10.1097/MEG.0000000000000321	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0153744	10.1371/journal.pone.0153744	http://dx.doi.org/10.1371/journal.pone.0153744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148964	Green Submitted, Green Published, gold			2022-12-27	WOS:000375676800014
J	Heshmat, R; Qorbani, M; Babaki, AES; Djalalinia, S; Ataei-Jafari, A; Motlagh, ME; Ardalan, G; Arefirad, T; Rezaei, F; Asayesh, H; Kelishadi, R				Heshmat, Ramin; Qorbani, Mostafa; Babaki, Amir Eslami Shahr; Djalalinia, Shirin; Ataei-Jafari, Asal; Motlagh, Mohammad Esmaeil; Ardalan, Gelayol; Arefirad, Tahereh; Rezaei, Fatemeh; Asayesh, Hamid; Kelishadi, Roya			Joint Association of Screen Time and Physical Activity with Cardiometabolic Risk Factors in a National Sample of Iranian Adolescents: The CASPIANIII Study	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; CARDIOVASCULAR RISK; SEDENTARY BEHAVIORS; CHILDREN; OBESITY; PREVALENCE; OVERWEIGHT; POPULATION; MODERATE	Metabolic syndrome (MetS) and its contributing factors are considered important health problems in the pediatric age group. This study was designed to assess the joint association of ST and PA with cardiometabolic risk factors among Iranian adolescents. A representative sample of 5625 (50.2% boys) school students with a mean age of 14.73 (SD: 2.41) were selected through multistage random cluster sampling method from urban and rural areas of 27 provinces in Iran. ST and PA were assessed by self-administered validated questionnaires. Anthropometric measures (height, weight and waist circumference (WC)) and MetS components (abdominal obesity, elevated blood pressure (BP), low high-density lipoprotein cholesterol (HDL-C), elevated triglycerides (TG) and high fasting blood sugar (FBG)) were measured according to standardized protocols. MetS was defined according to the Adult Treatment Panel III criteria modified for the pediatric age group. Moreover, elevated total cholesterol (TC), elevated low-density lipoprotein cholesterol (LDL-C), and generalized obesity were considered as other cardiometabolic risk factors. Students with high ST levels had significantly higher body mass index z-score (BMI z-score), WC, TG, LDL-C, and BP as well as lower HDL-C level; whereas those with high PA levels had significantly higher HDL-C levels as well as lower BMI z-score, TC, and BP. Adolescents with low PA/high ST levels had significantly higher BMI, WC, LDL-C levels, as well as higher SBP and DBP compared to their other counterparts. In Multivariate model, joint effect of low PA/high ST (compared to the high PA/low ST group) increased the odds of overweight, abdominal obesity and low HDL-C and decreased the odds of elevated TC. The findings of this study showed that joint association of high ST and low PA have direct association with abdominal obesity, overweight and low HDL-C and indirect association with elevated TC.	[Heshmat, Ramin; Babaki, Amir Eslami Shahr; Ardalan, Gelayol] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Chron Dis Res Ctr, Tehran, Iran; [Qorbani, Mostafa] Alborz Univ Med Sci, Sch Med, Dept Community Med, Karaj, Iran; [Qorbani, Mostafa] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran; [Djalalinia, Shirin] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran; [Djalalinia, Shirin] Minist Hlth & Med Educ, Dev Res & Technol Ctr, Res & Technol, Tehran, Iran; [Ataei-Jafari, Asal] Islamic Azad Univ, Dept Nutr, Sci & Res Branch, Tehran, Iran; [Motlagh, Mohammad Esmaeil] Ahvaz Jundishapur Univ Med Sci, Dept Pediat, Ahvaz, Iran; [Arefirad, Tahereh] Islamic Azad Univ, Sci & Res Branch, Dept Exercise Physiol, Tehran, Iran; [Rezaei, Fatemeh] Jahrom Univ Med Sci, Sch Med, Dept Social Med, Jahrom, Iran; [Asayesh, Hamid] Qom Univ Med Sci, Dept Med Emergencies, Qom, Iran; [Kelishadi, Roya] Isfahan Univ Med Sci, Res Inst Primordial Prevent Non Communicable Dis, Child Growth & Dev Res Ctr, Dept Pediat, Esfahan, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Islamic Azad University; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Islamic Azad University; Isfahan University Medical Science	Qorbani, M (corresponding author), Alborz Univ Med Sci, Sch Med, Dept Community Med, Karaj, Iran.; Qorbani, M (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran.; Kelishadi, R (corresponding author), Isfahan Univ Med Sci, Res Inst Primordial Prevent Non Communicable Dis, Child Growth & Dev Res Ctr, Dept Pediat, Esfahan, Iran.	Mqorbani1379@yahoo.com; kelishadi@med.mui.ac.ir	Shao, Ruitai/AAU-7642-2021; motlagh, Mohammad Esmaiel/AAC-2653-2019; Heshmat, Ramin/S-7435-2017; Qorbani, Mostafa/M-8171-2017; Kelishadi, Roya/E-6154-2012	motlagh, Mohammad Esmaiel/0000-0002-2971-8660; Kelishadi, Roya/0000-0001-7455-1495; Qorbani, Mostafa/0000-0001-9465-7588				Altenburg TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053333; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Baygi F, 2015, IRAN J PEDIATR, V25, DOI 10.5812/ijp.182; Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Bryant MJ, 2007, OBES REV, V8, P197, DOI 10.1111/j.1467-789X.2006.00295.x; Byun W, 2012, J KOREAN MED SCI, V27, P388, DOI 10.3346/jkms.2012.27.4.388; Camhi SM, 2010, INT J PEDIATR OBES, V5, P122, DOI 10.3109/17477160903111763; Caro DH., 2012, IERI MONOGRAPH SERIE, V5, P9, DOI DOI 10.1787/9789264091504-EN; Chaput JP, 2013, APPL PHYSIOL NUTR ME, V38, P477, DOI 10.1139/apnm-2012-0382; Drenowatz Clemens, 2012, Front Med, V6, P428, DOI 10.1007/s11684-012-0232-4; Dunton GF, 2009, INT J OBESITY, V33, P1427, DOI 10.1038/ijo.2009.174; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Fisher A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018576; Gehani AA, 2014, EUR J PREV CARDIOL, V21, P400, DOI 10.1177/2047487312465525; Golden SH, 2002, DIABETES, V51, P3069, DOI 10.2337/diabetes.51.10.3069; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Hajian-Tilaki K. O., 2011, Eastern Mediterranean Health Journal, V17, P109; Hajian-Tilaki K, 2012, PUBLIC HEALTH NUTR, V15, P2246, DOI 10.1017/S1368980012001048; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Hinkley T, 2008, AM J PREV MED, V34, P435, DOI 10.1016/j.amepre.2008.02.001; Jari M, 2014, INT J PREVENTIVE MED, V5, P224; Kaler SN, 2006, INT J CIRCUMPOL HEAL, V65, P389, DOI 10.3402/ijch.v65i5.18139; Kelishadi R, 2008, CHILD CARE HLTH DEV, V34, P44, DOI 10.1111/j.1365-2214.2007.00744.x; Kelishadi R, 2007, ANN NUTR METAB, V51, P208, DOI 10.1159/000104139; Kelishadi R, 2007, B WORLD HEALTH ORGAN, V85, P19, DOI 10.2471/BLT.06.030783; Kelishadi R, 2007, EPIDEMIOL REV, V29, P62, DOI 10.1093/epirev/mxm003; Kelishadi R, 2007, INT J CARDIOL, V117, P340, DOI 10.1016/j.ijcard.2006.06.012; Kelishadi R, 2007, HORM RES, V67, P46, DOI 10.1159/000096121; Kelishadi R, 2014, ARCH IRAN MED, V17, P71, DOI 0141701/AIM.0011; Kelishadi R, 2013, ARCH MED SCI, V9, P210, DOI 10.5114/aoms.2013.34558; Kelishadi R, 2012, INT J PREVENTIVE MED, V3, P394; Khashayar P, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/702095; Li Y, 2008, BRIT J NUTR, V99, P565, DOI 10.1017/S0007114507797064; Liao Y, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-131; Martinez-Gomez D, 2012, MED CLIN-BARCELONA, V139, P290, DOI 10.1016/j.medcli.2012.04.017; Martinez-Gomez D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-274; McMahon SK, 2004, MED J AUSTRALIA, V180, P459, DOI 10.5694/j.1326-5377.2004.tb06023.x; MCNAMARA JR, 1987, CLIN CHIM ACTA, V166, P1, DOI 10.1016/0009-8981(87)90188-4; Mehrkash M, 2012, SE ASIAN J TROP MED, V43, P756; Mitchell JA, 2009, OBESITY, V17, P1596, DOI 10.1038/oby.2009.42; Molnar D, 2004, INT J OBESITY, V28, pS70, DOI 10.1038/sj.ijo.0802811; Nang EEK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-70; Park J, 2010, J KOREAN MED SCI, V25, P75, DOI 10.3346/jkms.2010.25.1.75; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Qorbani M, 2013, OBESITY FACTS, V6, P483, DOI 10.1159/000356011; Salmon J, 2006, MED J AUSTRALIA, V184, P64, DOI 10.5694/j.1326-5377.2006.tb00117.x; Shafiee G, 2013, J PEDIAT-BRAZIL, V89, P575, DOI 10.1016/j.jped.2013.03.020; Singh GM, 2012, CIRCULATION, V125, P2204, DOI 10.1161/CIRCULATIONAHA.111.058834; Steele RM, 2009, AM J CLIN NUTR, V90, P1185, DOI 10.3945/ajcn.2009.28153; Sugiyama T, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-35; Thomson M, 2008, AM J HEALTH PROMOT, V22, P329, DOI 10.4278/ajhp.22.5.329; Vereecken CA, 2006, PUBLIC HEALTH NUTR, V9, P244, DOI 10.1079/PHN2005847; Verona J, 2013, LIFE SCI, V93, P64, DOI 10.1016/j.lfs.2013.05.021; Wilmore JH, 2001, MED SCI SPORT EXER, V33, pS622, DOI 10.1097/00005768-200106001-00031; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	59	19	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154502	10.1371/journal.pone.0154502	http://dx.doi.org/10.1371/journal.pone.0154502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167372	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300056
J	Lowe, J; Watkins, WJ; Kotecha, SJ; Kotecha, S				Lowe, John; Watkins, W. John; Kotecha, Sarah J.; Kotecha, Sailesh			Physical Activity and Sedentary Behavior in Preterm-Born 7-Year Old Children	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; SCHOOL-AGE-CHILDREN; EXERCISE CAPACITY; AEROBIC CAPACITY; METAANALYSIS; SURVIVORS; PATTERNS; OUTCOMES; HEALTH; ASTHMA	Background Previous studies of preterm-born children (<37 weeks' gestation) have demonstrated decrements in lung function, exercise capacity, and increased respiratory symptoms compared to their term-born peers. However, it is unclear if these children have decreased levels of physical activity (PA) and increased sedentary behavior as a consequence of this increased respiratory morbidity. We therefore compared objectively measured PA in 7-year old preterm-born children with those born at term. Methods Children in the Millennium Cohort Study underwent assessment of PA at 7 years of age using accelerometry. 6422/12781 (50%) provided valid accelerometry and had gestational age data. A series of general linear models adjusted for confounders investigated the association between gestational age and levels of Total PA (average accelerometer counts per minute over the period of the recording), Moderate-to-Vigorous PA (MVPA) and sedentary behavior. Mediation analysis was performed to specifically investigate whether the observed association of gestational age on PA was mediated by respiratory symptoms. Results PA data were available for 79, 119, 275 and 5949 children born at 25-32, 33-34, 35-36 and 37-43 weeks' gestation respectively. Boys born at <= 32 weeks' gestation had modest but statistically significant reductions in MVPA when compared to term controls. This equated to a reduction of 9 minutes per day. No differences were found for Total PA or sedentary behavior. The association between gestational age and MVPA was not mediated by respiratory symptoms. In females, there was no association between gestational age and any measure of PA or sedentary behavior. Conclusions Boys born at <= 32 weeks' gestation took part in less MVPA than their term-born peers at 7 years of age. The differences were modest, but equated to a reduction of over 1 hour per week. Since PA levels have been shown to decline during childhood and adolescence, this vulnerable group deserves further surveillance.	[Lowe, John; Watkins, W. John; Kotecha, Sarah J.; Kotecha, Sailesh] Cardiff Univ, Sch Med, Dept Child Hlth, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Kotecha, S (corresponding author), Cardiff Univ, Sch Med, Dept Child Hlth, Cardiff CF10 3AX, S Glam, Wales.	kotechas@cardiff.ac.uk		Kotecha, Sailesh/0000-0003-3535-7627	MRC [MR/M022552/1] Funding Source: UKRI; Medical Research Council [MR/M022552/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Basterfield L, 2011, PEDIATRICS, V127, pE24, DOI 10.1542/peds.2010-1935; Been JV, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001596; Bolton CE, 2015, THORAX; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Burns YR, 2009, DEV MED CHILD NEUROL, V51, P136, DOI 10.1111/j.1469-8749.2008.03118.x; Chief medical officers of England Scotland Wales and Northern Island, 2011, START ACT STAY ACT R; Clemm H, 2012, PEDIATRICS, V129, pE97, DOI 10.1542/peds.2011-0326; Dahan-Oliel N, 2012, RES DEV DISABIL, V33, P1211, DOI 10.1016/j.ridd.2012.02.011; Edwards MO, 2015, PEDIATR PULM, V50, P293, DOI 10.1002/ppul.23117; Field A, 2013, DISCOVERING STAT USI; Glazebrook C, 2006, PEDIATRICS, V118, P2443, DOI 10.1542/peds.2006-1846; Green D, 2011, RES DEV DISABIL, V32, P1332, DOI 10.1016/j.ridd.2011.01.040; Greenough A, 2012, SEMIN FETAL NEONAT M, V17, P73, DOI 10.1016/j.siny.2012.01.009; Griffiths LR, 2013, TECHNICAL REPORT ENH; Griffiths LJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002893; Hansen K., 2014, MILLENNIUM COHORT ST; Joshi S, 2012, J PEDIAT; Kaseva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032430; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Kotecha SJ, 2012, THORAX, V67, P54, DOI 10.1136/thoraxjnl-2011-200329; Lovering Andrew T, 2014, Ann Am Thorac Soc, V11, P1528, DOI 10.1513/AnnalsATS.201312-466OC; Lowe J, 2015, J PEDIATR-US, V166, P877, DOI 10.1016/j.jpeds.2014.12.013; Mattocks C, 2010, ARCH DIS CHILD, V95, P509, DOI 10.1136/adc.2009.171918; Peacock JL, 2012, PEDIATR RES, V71, P305, DOI 10.1038/pr.2011.50; Poulsen G, 2011, J CLIN EPIDEMIOL, V64, P1444, DOI 10.1016/j.jclinepi.2011.03.007; Pulsford RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021822; Rich C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002290; Rich C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067206; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Siebel AL, 2012, CLIN EXP PHARMACOL P, V39, P944, DOI 10.1111/j.1440-1681.2012.05732.x; Svedenkrans J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080869; Universitity of London Institute of Education. Centre for Longitudinal Studies and University College London. Institute of Child Health, 2013, MILL COH STUD 4 SURV; University College London Institute of Education Centre for Longitudinal Studies, 2021, NEXT STEPS SWEEPS, V1, DOI [10.5255/UKDA-SN-4683-3, DOI 10.5255/UKDA-SN-4683-3]; University of London. Institute of Education. Centre for Longitudinal Studies, 2008, MILL COH STUD 2001 2, DOI [10.5255/UKDA-SN-5614-1, DOI 10.5255/UKDA-SN-5614-1]; Welsh L, 2010, THORAX, V65, P165, DOI 10.1136/thx.2008.107474	39	20	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155229	10.1371/journal.pone.0155229	http://dx.doi.org/10.1371/journal.pone.0155229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168339	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000376587300073
J	Reinartz, SM; van Tongeren, J; van Egmond, D; de Groot, EJJ; Fokkens, WJ; van Drunen, CM				Reinartz, Susanne M.; van Tongeren, Joost; van Egmond, Danielle; de Groot, Esther J. J.; Fokkens, Wytske J.; van Drunen, Cornelis M.			Dendritic Cell Subsets in Oral Mucosa of Allergic and Healthy Subjects	PLOS ONE			English	Article							T-CELLS; LANGERHANS CELLS; INHALED ANTIGEN; MAST-CELLS; NASAL; BLOOD; RATIO; SKIN; IMMUNOTHERAPY; INDUCTION	Immunohistochemistry was used to identify, enumerate, and describe the tissue distribution of Langerhans type (CD1a and CD207), myeloid (CD1c and CD141), and plasmacytoid (CD303 and CD304) dendritic cell subsets in oral mucosa of allergic and non-allergic individuals. Allergic individuals have more CD141+ myeloid cells in epithelium and more CD1a + Langerhans cells in the lamina propria compared to healthy controls, but similar numbers for the other DC subtypes. Our data are the first to describe the presence of CD303+ plasmacytoid DCs in human oral mucosa and a dense intraepithelial network of CD141+ DCs. The number of Langerhans type DCs (CD1a and CD207) and myeloid DCs (CD1c), was higher in the oral mucosa than in the nasal mucosa of the same individual independent of the atopic status.	[Reinartz, Susanne M.; van Tongeren, Joost; van Egmond, Danielle; de Groot, Esther J. J.; Fokkens, Wytske J.; van Drunen, Cornelis M.] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Reinartz, Susanne M.] Tergooi Hosp, Dept Otorhinolaryngol, Blaricum, Netherlands; [van Tongeren, Joost] MUMC, Dept Otorhinolaryngol, Maastricht, Netherlands	University of Amsterdam; Tergooi Blaricum; Maastricht University	van Tongeren, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; van Tongeren, J (corresponding author), MUMC, Dept Otorhinolaryngol, Maastricht, Netherlands.	joost.van.tongeren@mumc.nl	Fokkens, Wytske WJ/ABF-2185-2020	van Drunen, Cornelis M/0000-0001-5503-066X	InterUniversity Attraction Poles (Belgium); ZonMW (The Netherlands); Global Allergy and Asthma European Network (EU); Allergopharma; ALK-Abello; GlaxoSmithKline; HAL Allergy; MSD; Optinose UK	InterUniversity Attraction Poles (Belgium)(Belgian Federal Science Policy Office); ZonMW (The Netherlands)(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Global Allergy and Asthma European Network (EU); Allergopharma; ALK-Abello; GlaxoSmithKline(GlaxoSmithKline); HAL Allergy(HAL Allergy Group); MSD; Optinose UK	WF and CvD have received private sector support for research and/or clinical trials related to treatment of allergic and non-allergic rhinitis by Allergopharma, ALK-Abello, GlaxoSmithKline, HAL Allergy, MSD, Optinose UK, and public sector research support by InterUniversity Attraction Poles (Belgium), ZonMW (The Netherlands), and Global Allergy and Asthma European Network (EU). SR, JvT, DvE, EdG declare no conflict of interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam JP, 2008, ALLERGY, V63, P720, DOI 10.1111/j.1398-9995.2007.01611.x; Allam JP, 2011, ALLERGY, V66, P532, DOI 10.1111/j.1398-9995.2010.02510.x; Allam JP, 2008, J ALLERGY CLIN IMMUN, V121, P368, DOI 10.1016/j.jaci.2007.09.045; Allam JP, 2006, ALLERGY, V61, P166, DOI 10.1111/j.1398-9995.2005.00965.x; Allam JP, 2003, J ALLERGY CLIN IMMUN, V112, P141, DOI 10.1067/mai.2003.1607; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Braunstahl GJ, 2001, AM J RESP CRIT CARE, V164, P858, DOI 10.1164/ajrccm.164.5.2006082; Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Fukunaga T, 2009, CIRC J, V73, P1914, DOI 10.1253/circj.CJ-08-1193; Godthelp T, 1996, J ALLERGY CLIN IMMUN, V97, P800, DOI 10.1016/S0091-6749(96)80158-8; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kirsche H, 2010, ALLERGY, V65, P24, DOI 10.1111/j.1398-9995.2009.02174.x; KleinJan A, 1996, ALLERGY, V51, P614, DOI 10.1111/j.1398-9995.1996.tb02295.x; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Mascarell L, 2009, CLIN EXP ALLERGY, V39, P1910, DOI 10.1111/j.1365-2222.2009.03337.x; Mascarell L, 2008, J ALLERGY CLIN IMMUN, V122, P603, DOI 10.1016/j.jaci.2008.06.034; Novak N, 2011, ALLERGY, V66, P22, DOI 10.1111/j.1398-9995.2011.02626.x; Novak N, 2010, CLIN EXP IMMUNOL, V161, P28, DOI 10.1111/j.1365-2249.2010.04162.x; Novak N, 2008, TRENDS MOL MED, V14, P191, DOI 10.1016/j.molmed.2008.03.001; Nudel I, 2011, J IMMUNOL, V186, P891, DOI 10.4049/jimmunol.1002943; Reinartz SM, 2011, J ALLERGY CLIN IMMUN, V128, P887, DOI 10.1016/j.jaci.2011.06.001; Takagi T, 2011, AM J RESP CRIT CARE, V183, P31, DOI 10.1164/rccm.201001-0107OC; Ueda Y, 2003, HUM IMMUNOL, V64, P1144, DOI 10.1016/j.humimm.2003.08.342; van der Aar AMG, 2013, J INVEST DERMATOL, V133, P1240, DOI 10.1038/jid.2012.500; Van Pottelberge GR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-35; Van Pottelberge GR, 2010, EUR RESP J	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154409	10.1371/journal.pone.0154409	http://dx.doi.org/10.1371/journal.pone.0154409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166951	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300026
J	Riberholt, CG; Olesen, ND; Thing, M; Juhl, CB; Mehlsen, J; Petersen, TH				Riberholt, Christian Gunge; Olesen, Niels Damkjr; Thing, Mira; Juhl, Carsten Bogh; Mehlsen, Jesper; Petersen, Tue Hvass			Impaired Cerebral Autoregulation during Head Up Tilt in Patients with Severe Brain Injury	PLOS ONE			English	Article							BLOOD-FLOW-VELOCITY; BAROREFLEX SENSITIVITY; PRESSURE; ARTERY; VALIDATION; FLUCTUATIONS; DIAGNOSIS; DIAMETER; TABLE; MR	Early mobilization is of importance for improving long-term outcome for patients after severe acquired brain injury. A limiting factor for early mobilization by head-up tilt is orthostatic intolerance. The purpose of the present study was to examine cerebral autoregulation in patients with severe acquired brain injury and a low level of consciousness. Fourteen patients with severe acquired brain injury and orthostatic intolerance and fifteen healthy volunteers were enrolled. Blood pressure was evaluated by pulse contour analysis, heart rate and RR-intervals were determined by electrocardiography, middle cerebral artery velocity was evaluated by transcranial Doppler, and near-infrared spectroscopy determined frontal lobe oxygenation in the supine position and during head-up tilt. Cerebral autoregulation was evaluated as the mean flow index calculated as the ratio between middle cerebral artery mean velocity and estimated cerebral perfusion pressure. Patients with acquired brain injury presented an increase in mean flow index during head-up tilt indicating impaired autoregulation (P < 0.001). Spectral analysis of heart rate variability in the frequency domain revealed lower magnitudes of similar to 0.1 Hz spectral power in patients compared to healthy controls suggesting baroreflex dysfunction. In conclusion, patients with severe acquired brain injury and orthostatic intolerance during head-up tilt have impaired cerebral autoregulation more than one month after brain injury.	[Riberholt, Christian Gunge; Petersen, Tue Hvass] Rigshosp, Dept Neurorehabil, Res Unit Brain Injury Neuro Rehabil Copenhagen, TBI Unit, DK-2100 Copenhagen, Denmark; [Olesen, Niels Damkjr] Rigshosp, Dept Anaesthesia, DK-2100 Copenhagen, Denmark; [Olesen, Niels Damkjr] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Thing, Mira] Copenhagen Univ Hosp, Dept Paediat, Hvidovre, Denmark; [Juhl, Carsten Bogh] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Res Unit Musculoskeletal Funct & Physiotherapy, Odense, Denmark; [Juhl, Carsten Bogh] Copenhagen Univ Hosp Herlev & Gentofte, Dept Rehabil, Gentofte, Denmark; [Mehlsen, Jesper] Bispebjerg & Frederiksberg Hosp, Coordinating Res Ctr, Frederiksberg, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; University of Copenhagen; Bispebjerg Hospital	Riberholt, CG (corresponding author), Rigshosp, Dept Neurorehabil, Res Unit Brain Injury Neuro Rehabil Copenhagen, TBI Unit, DK-2100 Copenhagen, Denmark.	christian.riberholt@regionh.dk	Olesen, Niels D./AAM-8337-2020; Riberholt, Christian Gunge/AAC-9574-2019; Mehlsen, Jesper/AAA-5848-2022	Olesen, Niels D./0000-0003-1233-0413; Riberholt, Christian Gunge/0000-0002-6170-1869; 	University hospital Glostrup, Denmark; Danish Physical Therapy Association	University hospital Glostrup, Denmark; Danish Physical Therapy Association	CGR received two grants for support in analysing data as well as drafting the manuscript. First grant from University hospital Glostrup, Denmark www.glostruphospital.dk and second from the Danish Physical Therapy Association (www.fysio.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preperation of the manuscript.	Amjad AM, 1997, J NEUROSCI METH, V73, P69, DOI 10.1016/S0165-0270(96)02214-5; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; Carey BJ, 2003, STROKE, V34, P1871, DOI 10.1161/01.STR.0000081981.99908.F3; CONVERTINO VA, 1992, ACTA ASTRONAUT, V27, P123, DOI 10.1016/0094-5765(92)90188-O; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Diggle P, 1990, TIME SERIES BIOSTATI; Fontana J, 2015, NEUROCRIT CARE, V23, P355, DOI 10.1007/s12028-014-0104-7; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; GONZALEZ F, 1991, PARAPLEGIA, V29, P1, DOI 10.1038/sc.1991.1; Hancock SM, 2003, ANESTH ANALG, V96, P847, DOI 10.1213/01.ANE.0000047273.85729.A7; Hellstrom G, 1996, J APPL PHYSIOL, V81, P413, DOI 10.1152/jappl.1996.81.1.413; Henden PL, 2014, J NEUROSURG ANESTH, V26, P50, DOI 10.1097/ANA.0b013e3182a47b62; Hesse B, 2002, CLIN PHYSIOL FUNCT I, V22, P241, DOI 10.1046/j.1475-097X.2002.00425.x; Highton D, 2015, ANESTH ANALG, V121, P198, DOI 10.1213/ANE.0000000000000790; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Immink RV, 2006, EUR J APPL PHYSIOL, V96, P609, DOI 10.1007/s00421-006-0136-6; Kainerstorfer JM, 2015, J CEREBR BLOOD F MET, V35, P959, DOI 10.1038/jcbfm.2015.5; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; LEVINE BD, 1994, CIRCULATION, V90, P298, DOI 10.1161/01.CIR.90.1.298; Liu XY, 2015, J CEREBR BLOOD F MET, V35, P248, DOI 10.1038/jcbfm.2014.192; Luther MS, 2008, CLIN REHABIL, V22, P1034, DOI 10.1177/0269215508092821; Madsen PL, 1999, PROG NEUROBIOL, V58, P541, DOI 10.1016/S0301-0082(98)00093-8; Millet C, 2001, CLIN PHYSIOL, V21, P172, DOI 10.1046/j.1365-2281.2001.00315.x; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Newman M, 2012, CLIN REHABIL, V26, P1059, DOI 10.1177/0269215512443373; Ortega-Gutierrez S, 2014, J NEUROIMAGING, V24, P379, DOI 10.1111/jon.12019; Oudegeest-Sander MH, 2014, EXP PHYSIOL, V99, P586, DOI 10.1113/expphysiol.2013.076455; Petersen NH, 2014, NEUROCRIT CARE, V20, P60, DOI 10.1007/s12028-013-9898-y; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Rasmussen P, 2007, J CEREBR BLOOD F MET, V27, P1082, DOI 10.1038/sj.jcbfm.9600416; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; Riberholt CG, 2013, DAN MED J, V60; Saltin B., 1968, CIRCULATION, V38, P1, DOI 10.1161/01.CIR.38.1.1; Sato K, 2012, EXP PHYSIOL, V97, P1272, DOI 10.1113/expphysiol.2012.064774; Schreiber SJ, 2000, AM J NEURORADIOL, V21, P1207; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Valdueza JM, 1997, AM J NEURORADIOL, V18, P1929; van de Vooren H, 2007, J APPL PHYSIOL, V102, P1348, DOI 10.1152/japplphysiol.00158.2006; Yam AT, 2005, J CLIN NEUROSCI, V12, P643, DOI 10.1016/j.jocn.2004.08.017; Ziegler DW, 2016, J NEUROTRAUMA	44	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154831	10.1371/journal.pone.0154831	http://dx.doi.org/10.1371/journal.pone.0154831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168188	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300051
J	Waldenstrom, J; Westin, J; Nystrom, K; Christensen, P; Dalgard, O; Farkkila, M; Lindahl, K; Nilsson, S; Norkrans, G; Krarup, H; Norrgren, H; Buhl, MR; Stenmark, S; Lagging, M				Waldenstrom, Jesper; Westin, Johan; Nystrom, Kristina; Christensen, Peer; Dalgard, Olav; Farkkila, Martti; Lindahl, Karin; Nilsson, Staffan; Norkrans, Gunnar; Krarup, Henrik; Norrgren, Hans; Buhl, Mads Rauning; Stenmark, Stephan; Lagging, Martin			Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; RESISTANCE-ASSOCIATED VARIANTS; TREATMENT-NAIVE PATIENTS; INTERFERON-FREE THERAPY; SPONTANEOUS CLEARANCE; GENETIC-VARIATION; PLUS SOFOSBUVIR; IP-10 PREDICTS; HCV; COMBINATION	In this pilot study (RibaC), 58 hepatitis C virus (HCV) genotype 1 infected treatment-naive patients were randomized to (i) 2 weeks ribavirin double dosing concomitant with pegylated interferon-alpha (pegIFN-alpha), (ii) 4 weeks ribavirin mono-therapy prior to adding pegIFN-alpha, or (iii) standard-of-care (SOC) ribavirin dosing concurrent with pegIFN-alpha. Four weeks of ribavirin mono-therapy resulted in a mean 0.46 log(10) IU/mL HCV RNA reduction differentially regulated across IL28B genotypes (0.89 vs. 0.21 log(10) IU/mL for CC and CT/TT respectively; P = 0.006), increased likelihood of undetectable HCV RNA week 4 after initiating pegIFN-alpha and thus shortened treatment duration (P < 0.05), and decreased median IP-10 concentration from 550 to 345 pg/mL (P < 0.001). Both experimental strategies impacted on ribavirin concentrations, and high levels were achieved after one week of double dosing. However, by day 14, double dosing entailed a greater hemoglobin decline as compared to SOC (2.2 vs. 1.4 g/dL; P = 0.03). Conclusion: Ribavirin down-regulates IP-10, and may have an antiviral effect differently regulated across IL28B genotypes.	[Waldenstrom, Jesper; Westin, Johan; Nystrom, Kristina; Norkrans, Gunnar; Lagging, Martin] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Med, Gothenburg, Sweden; [Christensen, Peer] Univ Southern Denmark, Dept Infect Dis, Odense, Denmark; [Dalgard, Olav] Akershus Univ Hosp, Dept Infect Dis, Oslo, Norway; [Farkkila, Martti] Univ Helsinki, Dept Gastroenterol, Helsinki, Finland; [Lindahl, Karin] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Infect Dis, Stockholm, Sweden; [Nilsson, Staffan] Chalmers Univ Technol, Dept Math Sci, S-41296 Gothenburg, Sweden; [Krarup, Henrik] Aalborg Univ Hosp, Sect Mol Diagnost, Clin Biochem, Aalborg, Denmark; [Norrgren, Hans] Skane Univ Hosp, Dept Infect Dis, Lund, Sweden; [Buhl, Mads Rauning] Aarhus Univ, Dept Infect Dis, Aarhus, Denmark; [Stenmark, Stephan] Dept Communicable Dis Control Vasterbotten, Umea, Sweden	University of Gothenburg; University of Southern Denmark; University of Oslo; University of Helsinki; Karolinska Institutet; Karolinska University Hospital; Chalmers University of Technology; Aalborg University; Aalborg University Hospital; Lund University; Skane University Hospital; Aarhus University	Lagging, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Med, Gothenburg, Sweden.	martin.lagging@medfak.gu.se	Färkkilä, Martti/AAG-6970-2021; Nyström, Kristina/N-3125-2014	Färkkilä, Martti/0000-0002-0250-8559; Christensen, Peer Brehm/0000-0003-1394-058X; Lindahl, Karin/0000-0002-3759-8603; Krarup, Henrik/0000-0001-5294-2428; Nilsson, Staffan/0000-0003-4748-0446	Swedish Medical Research Council (Vetenskapsradet) [Diarienr 2008:2427, 2011:3821]; ALF Funds at the Sahlgrenska University Hospital [Diarienr ALFGBG-143271]; Roche affiliates in the Nordic region	Swedish Medical Research Council (Vetenskapsradet)(Swedish Medical Research Council (SMRC)Swedish Research Council); ALF Funds at the Sahlgrenska University Hospital; Roche affiliates in the Nordic region	This work was supported by the Swedish Medical Research Council (Vetenskapsradet; Diarienr 2008:2427 and 2011:3821), and ALF Funds at the Sahlgrenska University Hospital (Diarienr ALFGBG-143271). An unrestricted grant from Roche affiliates in the Nordic region also supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Ascioglu S, 2011, J ANTIMICROB CHEMOTH, V66, P1215, DOI 10.1093/jac/dkr136; Brochot E, 2014, NEW ENGL J MED, V370, P2446, DOI 10.1056/NEJMc1405191; Brochot E, 2010, ANTIVIR THER, V15, P687, DOI 10.3851/IMP1609; Bruchfeld A, 2002, THER DRUG MONIT, V24, P701, DOI 10.1097/00007691-200212000-00004; Chevaliez S, 2007, J VIROL, V81, P7732, DOI 10.1128/JVI.00382-07; Chu TW, 2012, GASTROENTEROLOGY, V142, P790, DOI 10.1053/j.gastro.2011.12.057; De Franceschi L, 2000, HEPATOLOGY, V31, P997, DOI 10.1053/he.2000.5789; DIBISCEGLIE AM, 1995, ANN INTERN MED, V123, P897, DOI 10.7326/0003-4819-123-12-199512150-00001; Dusheiko G, 1996, J HEPATOL, V25, P591, DOI 10.1016/S0168-8278(96)80225-X; Dusheiko G, 2008, ANTIVIR THER, V13, P23; Falconer K, 2010, SCAND J INFECT DIS, V42, P896, DOI 10.3109/00365548.2010.498019; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Feld JJ, 2010, GASTROENTEROLOGY, V139, P154, DOI 10.1053/j.gastro.2010.03.037; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Furusyo N, 2005, ANTIVIR RES, V67, P46, DOI 10.1016/j.antiviral.2005.04.001; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gowen BB, 2011, FUTURE MICROBIOL, V6, P1429, DOI [10.2217/fmb.11.132, 10.2217/FMB.11.132]; Grebely J, 2013, HEPATOLOGY, V57, P2124, DOI 10.1002/hep.26263; Hirotsu Y, 2015, HEPATOL INT, V9, P424, DOI 10.1007/s12072-015-9624-2; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Kwo PY, 2014, NEW ENGL J MED, V371, P2375, DOI 10.1056/NEJMoa1408921; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Lawitz E, 2015, LANCET, V385, P1075, DOI 10.1016/S0140-6736(14)61795-5; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lin JC, 2014, J INFECT DIS, V210, P1881, DOI 10.1093/infdis/jiu325; Lindahl K, 2005, HEPATOLOGY, V41, P275, DOI 10.1002/hep.20563; Lindstrom I, 2015, INFECT DIS-NOR, V47, P555, DOI 10.3109/23744235.2015.1028097; Loustaud-Ratti V, 2008, HEPATOLOGY, V47, P1453, DOI 10.1002/hep.22217; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Meissner EG, 2014, J CLIN INVEST, V124, P3352, DOI 10.1172/JCI75938; Mihm U, 2014, J VIRAL HEPATITIS, V21, P42, DOI 10.1111/jvh.12124; Morello J, 2008, J ANTIMICROB CHEMOTH, V62, P1174, DOI 10.1093/jac/dkn421; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; PARONI R, 1989, INT J CLIN PHARM TH, V27, P302; Pawlotsky JM, 2004, GASTROENTEROLOGY, V126, P703, DOI 10.1053/j.gastro.2003.12.002; Pedersen C, 2011, J VIRAL HEPATITIS, V18, P245, DOI 10.1111/j.1365-2893.2010.01303.x; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Quiles-Perez R, 2014, J MED VIROL, V86, P1886, DOI 10.1002/jmv.24035; Randolph AG, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000181; Rembeck K, 2014, HEPATOLOGY, V59, P2131, DOI 10.1002/hep.27009; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Rotman Y, 2014, GUT, V63, P161, DOI 10.1136/gutjnl-2012-303852; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarrazin C, 2015, J HEPATOL, V62, pS620, DOI 10.1016/S0168-8278(15)30976-4; Sarrazin C, 2014, HEPATOLOGY, V60, p1128A; Schaefer CJ, 2011, ANTIMICROB AGENTS CH, V55, P3125, DOI 10.1128/AAC.00131-11; Schvarcz R, 1995, J HEPATOL, V23, P17; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Werner JM, 2014, HEPATOLOGY, V60, P1160, DOI 10.1002/hep.27092; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	62	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155142	10.1371/journal.pone.0155142	http://dx.doi.org/10.1371/journal.pone.0155142			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167219	Green Submitted, Green Published, gold			2022-12-27	WOS:000376587300084
J	Deval, J; Fung, A; Stevens, SK; Jordan, PC; Gromova, T; Taylor, JS; Hong, J; Meng, J; Wang, GY; Dyatkina, N; Prhavc, M; Symons, JA; Beigelman, L				Deval, Jerome; Fung, Amy; Stevens, Sarah K.; Jordan, Paul C.; Gromova, Tatiana; Taylor, Joshua S.; Hong, Jin; Meng, Jia; Wang, Guangyi; Dyatkina, Natalia; Prhavc, Marija; Symons, Julian A.; Beigelman, Leo			Biochemical Effect of Resistance Mutations against Synergistic Inhibitors of RSV RNA Polymerase	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; VESICULAR STOMATITIS-VIRUS; HIV-1 REVERSE-TRANSCRIPTASE; L PROTEIN; MECHANISM; REPLICATION; INFECTION; SYSTEM; PRIMER; DRUGS	ALS-8112 is the parent molecule of ALS-8176, a first-in-class nucleoside analog prodrug effective in the clinic against respiratory syncytial virus (RSV) infection. The antiviral activity of ALS-8112 is mediated by its 5'-triphosphate metabolite (ALS-8112-TP, or 2'F-4'ClCH2-cytidine triphosphate) inhibiting the RNA polymerase activity of the RSV L-P protein complex through RNA chain termination. Four amino acid mutations in the RNA-dependent RNA polymerase (RdRp) domain of L (QUAD: M628L, A789V, L795I, and I796V) confer in vitro resistance to ALS-8112-TP by increasing its discrimination relative to natural CTP. In this study, we show that the QUAD mutations specifically recognize the ClCH2 group of ALS-8112-TP. Among the four mutations, A789V conferred the greatest resistance phenotype, which was consistent with its putative position in the active site of the RdRp domain. AZ-27, a non-nucleoside inhibitor of RSV, also inhibited the RdRp activity, with decreased inhibition potency in the presence of the Y1631H mutation. The QUAD mutations had no effect on the antiviral activity of AZ-27, and the Y1631H mutation did not significantly increase the discrimination of ALS-8112-TP. Combining ALS-8112 with AZ-27 in vitro resulted in significant synergistic inhibition of RSV replication. Overall, this is the first mechanistic study showing a lack of cross-resistance between mutations selected by different classes of RSV polymerase inhibitors acting in synergy, opening the door to future potential combination therapies targeting different regions of the L protein.	[Deval, Jerome; Fung, Amy; Stevens, Sarah K.; Jordan, Paul C.; Gromova, Tatiana; Taylor, Joshua S.; Hong, Jin; Meng, Jia; Wang, Guangyi; Dyatkina, Natalia; Prhavc, Marija; Symons, Julian A.; Beigelman, Leo] Alios BioPharma Inc, San Francisco, CA USA		Deval, J (corresponding author), Alios BioPharma Inc, San Francisco, CA USA.	jdeval@its.jnj.com						Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Boyce SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084808; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Deval J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004995; DeVincenzo JP, 2015, NEW ENGL J MED, V373, P2048, DOI 10.1056/NEJMoa1413275; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; Fearns R, 2002, J VIROL, V76, P1663, DOI 10.1128/JVI.76.4.1663-1672.2002; Gomez RS, 2014, IMMUNOL LETT, V162, P237, DOI 10.1016/j.imlet.2014.09.006; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hotard AL, 2012, VIROLOGY, V434, P129, DOI 10.1016/j.virol.2012.09.022; Jin ZN, 2013, P NATL ACAD SCI USA, V110, pE348, DOI 10.1073/pnas.1214924110; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Lam AM, 2014, ANTIMICROB AGENTS CH, V58, P6861, DOI 10.1128/AAC.03847-14; Lam AM, 2011, J VIROL, V85, P12334, DOI 10.1128/JVI.05639-11; Li J, 2016, J BIOL CHEM; Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018; Lij J, 2008, J VIROL, V82, P775, DOI 10.1128/JVI.02107-07; Mazur N, 2015, LANCET RESP MED, V3, P888, DOI 10.1016/S2213-2600(15)00255-6; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Morin B, 2013, CURR OPIN VIROL, V3, P103, DOI 10.1016/j.coviro.2013.03.008; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Noton SL, 2015, J VIROL, V89, P7786, DOI 10.1128/JVI.00530-15; Noton SL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002980; Noton SL, 2010, P NATL ACAD SCI USA, V107, P10226, DOI 10.1073/pnas.0913065107; Ogino T, 2007, MOL CELL, V25, P85, DOI 10.1016/j.molcel.2006.11.013; Ogino T, 2010, P NATL ACAD SCI USA, V107, P3463, DOI 10.1073/pnas.0913083107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Sluis-Cremer N, 2004, CURR HIV RES, V2, P323, DOI 10.2174/1570162043351093; Sudo K, 2005, ANTIVIR RES, V65, P125, DOI 10.1016/j.antiviral.2004.12.002; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tiong-Yip CL, 2014, ANTIMICROB AGENTS CH, V58, P3867, DOI 10.1128/AAC.02540-14; Wang GY, 2015, J MED CHEM, V58, P1862, DOI 10.1021/jm5017279	35	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154097	10.1371/journal.pone.0154097	http://dx.doi.org/10.1371/journal.pone.0154097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163448	Green Published, gold, Green Submitted			2022-12-27	WOS:000376585700010
J	Konopka, A; Zeug, A; Skupien, A; Kaza, B; Mueller, F; Chwedorowicz, A; Ponimaskin, E; Wilczynski, GM; Dzwonek, J				Konopka, Anna; Zeug, Andre; Skupien, Anna; Kaza, Beata; Mueller, Franziska; Chwedorowicz, Agnieszka; Ponimaskin, Evgeni; Wilczynski, Grzegorz M.; Dzwonek, Joanna			Cleavage of Hyaluronan and CD44 Adhesion Molecule Regulate Astrocyte Morphology via Rac1 Signalling	PLOS ONE			English	Article							OLIGODENDROCYTE PROGENITOR MATURATION; TUMOR-CELL-MIGRATION; CYTOSKELETON FUNCTION; EXTRACELLULAR-MATRIX; REACTIVE ASTROCYTES; NERVOUS-SYSTEM; WHITE-MATTER; RHO-GTPASE; ACTIVATION; EXPRESSION	Communication of cells with their extracellular environment is crucial to fulfill their function in physiological and pathophysiological conditions. The literature data provide evidence that such a communication is also important in case of astrocytes. Mechanisms that contribute to the interaction between astrocytes and extracellular matrix (ECM) proteins are still poorly understood. Hyaluronan is the main component of ECM in the brain, where its major receptor protein CD44 is expressed by a subset of astrocytes. Considering the fact that functions of astrocytes are tightly coupled with changes in their morphology (e.g.: glutamate clearance in the synaptic cleft, migration, astrogliosis), we investigated the influence of hyaluronan cleavage by hyaluronidase, knockdown of CD44 by specific shRNA and CD44 overexpression on astrocyte morphology. Our results show that hyaluronidase treatment, as well as knockdown of CD44, in astrocytes result in a "stellate"-like morphology, whereas overexpression of CD44 causes an increase in cell body size and changes the shape of astrocytes into flattened cells. Moreover, as a dynamic reorganization of the actin cytoskeleton is supposed to be responsible for morphological changes of cells, and this reorganization is controlled by small GTPases of the Rho family, we hypothesized that GTPase Rac1 acts as a downstream effector for hyaluronan and CD44 in astrocytes. We used FRET-based biosensor and a dominant negative mutant of Rac1 to investigate the involvement of Rac1 activity in hyaluronidase-and CD44-dependent morphological changes of astrocytes. Both, hyaluronidase treatment and knockdown of CD44, enhances Rac1 activity while overexpression of CD44 reduces the activity state in astrocytes. Furthermore, morphological changes were blocked by specific inhibition of Rac1 activity. These findings indicate for the first time that regulation of Rac1 activity is responsible for hyaluronidase and CD44-driven morphological changes of astrocytes.	[Konopka, Anna; Skupien, Anna; Chwedorowicz, Agnieszka; Wilczynski, Grzegorz M.; Dzwonek, Joanna] M Nencki Inst Expt Biol, Lab Mol & System Neuromorphol, Ul Pasteura 3, PL-02093 Warsaw, Poland; [Zeug, Andre; Mueller, Franziska; Ponimaskin, Evgeni] Hannover Med Sch, Ctr Physiol, Cellular Neurophysiol, D-30625 Hannover, Germany; [Kaza, Beata] M Nencki Inst Expt Biol, Neurobiol Ctr, Mol Neurobiol Lab, Ul Pasteura 3, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Hannover Medical School; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Dzwonek, J (corresponding author), M Nencki Inst Expt Biol, Lab Mol & System Neuromorphol, Ul Pasteura 3, PL-02093 Warsaw, Poland.	j.dzwonek@nencki.gov.pl	Zeug, Andre/X-3208-2019; Kaza, Beata/B-5308-2019	Zeug, Andre/0000-0001-9858-5841; Kaza, Beata/0000-0002-3630-6496; Wilczynski, Grzegorz/0000-0001-6667-0291; Dzwonek, Joanna/0000-0002-3834-2175; Skupien-Jaroszek, Anna/0000-0002-8448-3606; Muller, Franziska/0000-0003-0525-0714; Konopka, Anna/0000-0002-5487-6003; Chwedorowicz, Agnieszka/0000-0002-2509-5283; Ponimaskin, evgeni/0000-0002-4570-5130	National Science Center [2015/17/B/NZ4/02540, 7873/B/P01/2011/40]; Foundation for Polish Science [PARENT-BRIDGE/2011-3/2]; European Union Regional Development Fund [POIG 01.01.02-00-008/08]; DFG [Po732]	National Science Center(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union Regional Development Fund(European Commission); DFG(German Research Foundation (DFG))	J.D. and A.C. were supported by the National Science Center grant No 2015/17/B/NZ4/02540. G.M.W. was supported by the National Science Center grant No 7873/B/P01/2011/40. A.S. was supported by the Foundation for Polish Science PARENT-BRIDGE/2011-3/2 grant, co-financed from the European Union Regional Development Fund. A. K. was supported by the grant from European Regional Development Fund POIG 01.01.02-00-008/08. This work was supported by DFG grant Po732 to E.P. The authors declare no competing financial interests.	Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Back SA, 2011, ANN NEUROL, V70, P465, DOI 10.1002/ana.22484; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cargill R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.006; Dityatev A, 2011, CURR OPIN NEUROBIOL, V21, P353, DOI 10.1016/j.conb.2010.12.006; Duhr F, 2014, NAT CHEM BIOL, V10, P590, DOI [10.1038/NCHEMBIO.1547, 10.1038/nchembio.1547]; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P796, DOI 10.2307/2287161; GIRGRAH N, 1991, J NEUROPATH EXP NEUR, V50, P779, DOI 10.1097/00005072-199111000-00009; Hawkins BT, 2013, BRAIN RES, V1503, P89, DOI 10.1016/j.brainres.2013.01.049; Haydon PG, 2014, COLD SPRING HARBOR P; Herrlich P, 2000, ANN NY ACAD SCI, V910, P106; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; JENKINS HG, 1988, J NEUROCHEM, V51, P1641, DOI 10.1111/j.1471-4159.1988.tb01135.x; John GR, 2004, J NEUROSCI, V24, P2837, DOI 10.1523/JNEUROSCI.4789-03.2004; Kinoshita M, 2005, J CHROMATOGR B, V816, P289, DOI 10.1016/j.jchromb.2004.11.050; Li LX, 2010, GLIA, V58, P1157, DOI 10.1002/glia.20995; Lichtenstein MP, 2010, J ALZHEIMERS DIS, V22, P1135, DOI 10.3233/JAD-2010-101332; Lundgaard I, 2014, NEUROSCIENCE, V276, P161, DOI 10.1016/j.neuroscience.2013.10.050; Nolle A, 2011, HUM MOL GENET, V20, P4865, DOI 10.1093/hmg/ddr425; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Pannasch U, 2014, NAT NEUROSCI, V17, P549, DOI 10.1038/nn.3662; Patton BL, 1998, NATURE, V393, P698, DOI 10.1038/31502; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Preston M, 2013, ANN NEUROL, V73, P266, DOI 10.1002/ana.23788; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Racchetti G, 2012, GLIA, V60, P465, DOI 10.1002/glia.22280; Renner U, 2012, J CELL SCI, V125, P2486, DOI 10.1242/jcs.101337; Rosso L, 2007, CELL MOL NEUROBIOL, V27, P791, DOI 10.1007/s10571-007-9176-7; Roszkowska M, CD44 ADHESION UNPUB; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Skupien A, 2014, J CELL SCI, V127, P5038, DOI 10.1242/jcs.154542; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sosunov AA, 2014, J NEUROSCI, V34, P2285, DOI 10.1523/JNEUROSCI.4037-13.2014; Sosunov AA, 2013, J NEUROSCI, V33, P7439, DOI 10.1523/JNEUROSCI.4506-12.2013; Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Suidan HS, 1997, GLIA, V21, P244, DOI 10.1002/(SICI)1098-1136(199710)21:2<244::AID-GLIA7>3.0.CO;2-6; Summers L, 2013, MOL CELL NEUROSCI, V57, P93, DOI 10.1016/j.mcn.2013.10.007; Summers L, 2010, MOL CELL NEUROSCI, V44, P272, DOI 10.1016/j.mcn.2010.03.013; SUZUKI K, 1965, J NEUROPATH EXP NEUR, V24, P211, DOI 10.1097/00005072-196504000-00004; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; VOGEL H, 1992, J NEUROCYTOL, V21, P363, DOI 10.1007/BF01191704; Wang H, 2001, STROKE, V32, P1020, DOI 10.1161/01.STR.32.4.1020; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092	59	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155053	10.1371/journal.pone.0155053	http://dx.doi.org/10.1371/journal.pone.0155053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163367	gold, Green Submitted, Green Published			2022-12-27	WOS:000376585700012
J	Comim, FV; Gutierrez, K; Bridi, A; Bochi, G; Chemeris, R; Rigo, ML; Dau, AMP; Cezar, AS; Moresco, RN; Goncalves, PBD				Comim, Fabio V.; Gutierrez, Karina; Bridi, Alessandra; Bochi, Guilherme; Chemeris, Raisa; Rigo, Melania L.; Dau, Andressa Minussi P.; Cezar, Alfredo S.; Moresco, Rafael Noal; Dias Goncalves, Paulo Bayard			Effects of Adiponectin Including Reduction of Androstenedione Secretion and Ovarian Oxidative Stress Parameters In Vivo	PLOS ONE			English	Article							GRANULOSA-CELL STEROIDOGENESIS; FEMALE REPRODUCTION; INSULIN-RESISTANCE; EMBRYO DEVELOPMENT; RAT OVARY; EXPRESSION; RECEPTORS; WOMEN; PROTEIN; MICE	Adiponectin is the most abundantly produced human adipokine with anti-inflammatory, anti-oxidative, and insulin-sensitizing properties. Evidence from in vitro studies has indicated that adiponectin has a potential role in reproduction because it reduces the production of androstenedione in bovine theca cells in vitro. However, this effect on androgen production has not yet been observed in vivo. The current study evaluated the effect of adiponectin on androstenedione secretion and oxidative stress parameters in a rodent model. Seven-weekold female Balb/c mice (n = 33), previously treated with equine gonadotropin chorionic, were assigned to one of four different treatments: Group 1, control (phosphate-buffered saline); Group 2, adiponectin 0.1 mu g/mL; Group 3, adiponectin 1.0 mu g/mL; Group 4, adiponectin 5.0 mu g/mL. After 24 h, all animals were euthanized and androstenedione levels were measured in the serum while oxidative stress markers were quantified in whole ovary tissue. Female mice treated with adiponectin exhibited a significant reduction (about 60%) in serum androstenedione levels in comparison to controls. Androstenedione levels decreased from 0.78 +/- 0.4 ng/mL (mean +/- SD) in controls to 0.28 +/- 0.06 ng/mL after adiponectin (5 mu g/mL) treatment (P = 0.01). This change in androgen secretion after 24 hours of treatment was associated with a significant reduction in the expression of CYP11A1 and STAR (but not CYP17A1). In addition, ovarian AOPP product levels, a direct product of protein oxidation, decreased significantly in adiponectin-treated mice (5 mu g/mL); AOPP (mean +/- SD) decreased to 4.3 +/- 2.1 mu mol/L in comparison with that of the controls (11.5 +/- 1.7 mu mol/L; P = 0.0003). Our results demonstrated for the first time that acute treatment with adiponectin reduced the levels of a direct oxidative stress marker in the ovary as well as decreased androstenedione serum levels in vivo after 24 h.	[Comim, Fabio V.] Univ Fed Santa Maria, Dept Clin Med, Santa Maria, RS, Brazil; [Comim, Fabio V.; Gutierrez, Karina; Bridi, Alessandra; Chemeris, Raisa; Rigo, Melania L.; Dau, Andressa Minussi P.; Cezar, Alfredo S.; Dias Goncalves, Paulo Bayard] Univ Fed Santa Maria, Lab Biotechnol & Anim Reprod BioRep, Santa Maria, RS, Brazil; [Bochi, Guilherme; Moresco, Rafael Noal] Univ Fed Santa Maria, Lab Clin Biochem, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM)	Comim, FV (corresponding author), Univ Fed Santa Maria, Dept Clin Med, Santa Maria, RS, Brazil.; Comim, FV (corresponding author), Univ Fed Santa Maria, Lab Biotechnol & Anim Reprod BioRep, Santa Maria, RS, Brazil.	fabio.comim@ufsm.br	Moresco, Rafael/K-6118-2017; Gonçalves, Paulo B/G-9818-2012; Comim, Fabio Vasconcellos/L-1298-2015	Moresco, Rafael/0000-0003-3072-5080; Gonçalves, Paulo B/0000-0002-0671-1466; Comim, Fabio Vasconcellos/0000-0002-2726-233X	National Council for Scientific and Technological Development - Brazil (CNPq) [445019/2014-0]	National Council for Scientific and Technological Development - Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by National Council for Scientific and Technological Development - Brazil (CNPq) - grant (445019/2014-0) (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Barber TM, 2006, CLIN ENDOCRINOL, V65, P137, DOI 10.1111/j.1365-2265.2006.02587.x; Basini G, 2004, BIOFACTORS, V20, P61, DOI 10.1002/biof.5520200201; Bremer AA, 2008, FERTIL STERIL, V89, P1039, DOI 10.1016/j.fertnstert.2008.02.091; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Cai XJ, 2015, MOL MED REP, V11, P1715, DOI 10.3892/mmr.2014.2947; Caminos JE, 2008, ENDOCRINOLOGY, V149, P3390, DOI 10.1210/en.2007-1582; Chabrolle C, 2007, REPRODUCTION, V133, P719, DOI 10.1530/REP-06-0244; Cheng KKY, 2014, BEST PRACT RES CL EN, V28, P3, DOI 10.1016/j.beem.2013.06.006; Cheng XB, 2011, ENDOCRINE, V39, P6, DOI 10.1007/s12020-010-9375-8; Comim FV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080416; Comninos AN, 2014, HUM REPROD UPDATE, V20, P153, DOI 10.1093/humupd/dmt033; da Silveira RA, 2014, CLIN LAB, V60, P1703, DOI 10.7754/Clin.Lab.2014.131018; Diamanti-Kandarakis Evanthia, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000598; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Gonzalez F, 2012, J CLIN ENDOCR METAB, V97, P2836, DOI 10.1210/jc.2012-1259; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Hatzirodos N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097489; Lagaly DV, 2008, MOL CELL ENDOCRINOL, V284, P38, DOI 10.1016/j.mce.2008.01.007; Ledoux S, 2006, ENDOCRINOLOGY, V147, P5178, DOI 10.1210/en.2006-0679; Li S, 2014, TUMOR BIOL, V35, P3961, DOI 10.1007/s13277-013-1595-0; Liu L, 2000, BIOL REPROD, V62, P1745, DOI 10.1095/biolreprod62.6.1745; Lord E, 2005, J ANIM SCI, V83, P565; Maillard V, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-23; Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266; Matsui S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098040; Michalakis KG, 2010, FERTIL STERIL, V94, P1949, DOI 10.1016/j.fertnstert.2010.05.010; Moon HS, 2013, GUT, V62, P561, DOI 10.1136/gutjnl-2012-302092; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; O'Connor A, 2010, J CLIN ENDOCR METAB, V95, P1378, DOI 10.1210/jc.2009-1557; Park JI, 2012, ENDOCRINOLOGY, V153, P5512, DOI 10.1210/en.2012-1414; Psilopanagioti A, 2009, NEUROENDOCRINOLOGY, V89, P38, DOI 10.1159/000151396; Richards JS, 2012, FERTIL STERIL, V98, P471, DOI 10.1016/j.fertnstert.2012.04.050; Rizzo A, 2012, REPROD DOMEST ANIM, V47, P344, DOI 10.1111/j.1439-0531.2011.01891.x; Rodriguez-Pacheco F, 2007, ENDOCRINOLOGY, V148, P401, DOI 10.1210/en.2006-1019; Rovani MT, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0096-0; Rzepczynska IJ, 2011, BIOL REPROD, V84, P162, DOI 10.1095/biolreprod.110.087585; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shore SA, 2006, J ALLERGY CLIN IMMUN, V118, P389, DOI 10.1016/j.jaci.2006.04.021; Smolinska N, 2014, ANIM REPROD SCI, V146, P42, DOI 10.1016/j.anireprosci.2014.02.001; Tao T, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-99; Tatsch E, 2011, CLIN BIOCHEM, V44, P348, DOI 10.1016/j.clinbiochem.2010.12.011; Toulis KA, 2009, HUM REPROD UPDATE, V15, P297, DOI 10.1093/humupd/dmp006; Wang XM, 2014, MED SCI MONITOR, V20, P1792, DOI 10.12659/MSM.892299; Wen JP, 2008, BIOCHEM BIOPH RES CO, V371, P756, DOI 10.1016/j.bbrc.2008.04.146; Wickham EP, 2011, METABOLISM, V60, P366, DOI 10.1016/j.metabol.2010.02.019; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186	47	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154453	10.1371/journal.pone.0154453	http://dx.doi.org/10.1371/journal.pone.0154453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158926	Green Published, gold			2022-12-27	WOS:000376576700009
J	Milekovic, T; Mehring, C				Milekovic, Tomislav; Mehring, Carsten			Variance Based Measure for Optimization of Parametric Realignment Algorithms	PLOS ONE			English	Article							NEURAL VARIABILITY; NEURONAL-ACTIVITY; RESPONSE LATENCY; PREMOTOR CORTEX; SINGLE UNITS; SPIKE TRAINS; MOVEMENT; DIFFERENTIATION; PATTERNS	Neuronal responses to sensory stimuli or neuronal responses related to behaviour are often extracted by averaging neuronal activity over large number of experimental trials. Such trial-averaging is carried out to reduce noise and to diminish the influence of other signals unrelated to the corresponding stimulus or behaviour. However, if the recorded neuronal responses are jittered in time with respect to the corresponding stimulus or behaviour, averaging over trials may distort the estimation of the underlying neuronal response. Temporal jitter between single trial neural responses can be partially or completely removed using realignment algorithms. Here, we present a measure, named difference of time-averaged variance (dTAV), which can be used to evaluate the performance of a realignment algorithm without knowing the internal triggers of neural responses. Using simulated data, we show that using dTAV to optimize the parameter values for an established parametric realignment algorithm improved its efficacy and, therefore, reduced the jitter of neuronal responses. By removing the jitter more effectively and, therefore, enabling more accurate estimation of neuronal responses, dTAV can improve analysis and interpretation of the neural responses.	[Milekovic, Tomislav; Mehring, Carsten] Univ Freiburg, Bernstein Ctr Freiburg, Hansastr 9A, D-79104 Freiburg, Germany; [Milekovic, Tomislav; Mehring, Carsten] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Milekovic, Tomislav; Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, South Kensington Campus, London SW7 2AZ, England; [Milekovic, Tomislav; Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, South Kensington Campus, London SW7 2AZ, England; [Milekovic, Tomislav] Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland; [Milekovic, Tomislav] Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, CH-1015 Lausanne, Switzerland	University of Freiburg; University of Freiburg; Imperial College London; Imperial College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Milekovic, T (corresponding author), Univ Freiburg, Bernstein Ctr Freiburg, Hansastr 9A, D-79104 Freiburg, Germany.; Milekovic, T (corresponding author), Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.; Milekovic, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, South Kensington Campus, London SW7 2AZ, England.; Milekovic, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, South Kensington Campus, London SW7 2AZ, England.; Milekovic, T (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland.; Milekovic, T (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	tomislav.milekovic@epfl.ch	Milekovic, Tomislav/R-7972-2017; Mehring, Carsten/R-8986-2019	Milekovic, Tomislav/0000-0001-6769-6506; Mehring, Carsten/0000-0001-8125-5205	German Federal Ministry of Education and Research (BMBF) [01GQ0830]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF) grant 01GQ0830 to BFNT Freiburg and Tubingen..	Achtman N, 2007, J NEURAL ENG, V4, P336, DOI 10.1088/1741-2560/4/3/018; Bashashati Ali, 2007, Comput Intell Neurosci, P84386, DOI 10.1155/2007/84386; Brill MF, 2013, J NEUROSCI, V33, P2443, DOI 10.1523/JNEUROSCI.4268-12.2013; Canal L, 2005, COMPUT STAT DATA AN, V48, P803, DOI 10.1016/j.csda.2004.04.001; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Confais J, 2012, J NEUROSCI, V32, P15359, DOI 10.1523/JNEUROSCI.1768-12.2012; Cunningham JP, 2007, NEURAL CODING COMPUT; DAGNELIE G, 1989, VISUAL NEUROSCI, V3, P509, DOI 10.1017/S0952523800009858; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Gaona CM, 2011, J NEUROSCI, V31, P2091, DOI 10.1523/JNEUROSCI.4722-10.2011; Gunduz A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00089; Hasan BAS, 2010, MED BIOL ENG COMPUT, V48, P245, DOI 10.1007/s11517-009-0550-0; Hwang EJ, 2009, J NEUROSCI, V29, P14363, DOI 10.1523/JNEUROSCI.2081-09.2009; Knight K., 2000, C&H TEXT STAT SCI; Levine SP, 2000, IEEE T REHABIL ENG, V8, P180, DOI 10.1109/86.847809; Meier R, 2008, NEURAL NETWORKS, V21, P1085, DOI 10.1016/j.neunet.2008.06.019; Meyer A, 2012, J COMP PHYSIOL A, V198, P159, DOI 10.1007/s00359-011-0696-8; Milekovic T, 2015, NEUROIMAGE, V114, P338, DOI 10.1016/j.neuroimage.2015.04.008; Milekovic T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055235; Nawrot M, 1999, J NEUROSCI METH, V94, P81, DOI 10.1016/S0165-0270(99)00127-2; Nawrot MP, 2003, BIOL CYBERN, V88, P321, DOI 10.1007/s00422-002-0391-5; Pistohl T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054658; RADONS G, 1994, BIOL CYBERN, V71, P359, DOI 10.1007/BF00239623; REQUIN J, 1988, BIOL PSYCHOL, V26, P179, DOI 10.1016/0301-0511(88)90019-1; RICHMOND BJ, 1990, J NEUROPHYSIOL, V64, P370, DOI 10.1152/jn.1990.64.2.370; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SEAL J, 1983, BRAIN RES, V278, P382, DOI 10.1016/0006-8993(83)90279-2; Seidemann E, 1996, J NEUROSCI, V16, P752; Solis-Escalante T, 2008, J NEUROSCI METH, V175, P148, DOI 10.1016/j.jneumeth.2008.07.019; Soteropoulos DS, 2009, J NEUROPHYSIOL, V101, P402, DOI 10.1152/jn.90767.2008; STEINIER J, 1972, ANAL CHEM, V44, P1906, DOI 10.1021/ac60319a045; VAADIA E, 1988, SOMATOSENS MOT RES, V6, P207, DOI 10.3109/08990228809144674	33	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0153773	10.1371/journal.pone.0153773	http://dx.doi.org/10.1371/journal.pone.0153773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159490	gold, Green Submitted, Green Published			2022-12-27	WOS:000376576700005
J	Gerth, HU; Pohlen, M; Gorlich, D; Tholking, G; Kropff, M; Berdel, WE; Pavenstadt, H; Brand, M; Kumpers, P				Gerth, Hans U.; Pohlen, Michele; Goerlich, Dennis; Thoelking, Gerold; Kropff, Martin; Berdel, Wolfgang E.; Pavenstaedt, Hermann; Brand, Marcus; Kuempers, Philipp			Impact of High-Cut-Off Dialysis on Renal Recovery in Dialysis-Dependent Multiple Myeloma Patients: Results from a Case-Control Study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; FREE LIGHT-CHAINS; HEMODIALYSIS; FAILURE; CHEMOTHERAPY; THERAPY; REVERSIBILITY; NEPHROPATHY; IMPROVEMENT; IMPAIRMENT	Background High-cut-off hemodialysis (HCO-HD) can effectively reduce high concentrations of circulating serum free light chains (sFLC) in patients with dialysis-dependent acute kidney injury (AKI) due to multiple myeloma (MM). Therefore, the aim of this study was to analyze renal recovery in a retrospective single-center cohort of dialysis-dependent MM patients treated with either conventional HD (conv. HD) or HCO-HD. Methods and Results The final cohort consisted of 59 patients treated with HCO-HD (n = 42) or conv. HD (n = 17). A sustained sFLC response was detected in a significantly higher proportion of HCO-HD patients (83.3%) compared with conv. HD patients (29.4%; p = 0.007). The median duration of sFLC required to reach values < 1000 mg/l was 14.5 days in the HCO-HD group and 36 days in the conv. HD group. The corresponding rates of renal recovery were 64.3% and 29.4%, respectively (chi-squared test, p = 0.014). Multivariate regression and decision tree analysis (recursive partitioning) revealed HCO-HD (adjusted odds ratio [OR] 6.1 [95% confidence interval (CI) 1.5-24.5], p = 0.011) and low initial uric acid values (adjusted OR 1.3 [95% CI 1.0-1.7], p = 0.045) as independent and paramount variables associated with a favorable renal outcome. Conclusions In summary, the results from this retrospective case-control study suggest in addition to novel agent-based chemotherapy a benefit of HCO-HD in sFLC removal and renal outcome in dialysis-dependent AKI secondary to MM. This finding was especially pertinent in patients with low initial uric acid values, resulting in a promising renal recovery rate of 71.9%. Further prospective studies are warranted.	[Gerth, Hans U.; Thoelking, Gerold; Pavenstaedt, Hermann; Brand, Marcus; Kuempers, Philipp] Univ Hosp Muenster, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany; [Pohlen, Michele; Kropff, Martin; Berdel, Wolfgang E.] Univ Hosp Muenster, Dept Med Hematol & Oncol A, Munster, Germany; [Goerlich, Dennis] Univ Hosp Muenster, Inst Biostat & Clin Res, Munster, Germany	University of Munster; University of Munster; University of Munster	Gerth, HU (corresponding author), Univ Hosp Muenster, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany.	ulrich.gerth@ukmuenster.de	Görlich, Dennis/C-8950-2012	Görlich, Dennis/0000-0002-2574-9419				Dimopoulos MA, 2014, ANN ONCOL, V25, P195, DOI 10.1093/annonc/mdt483; Dimopoulos MA, 2013, LEUKEMIA, V27, P423, DOI 10.1038/leu.2012.182; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Haynes RJ, 2010, NEPHROL DIAL TRANSPL, V25, P419, DOI 10.1093/ndt/gfp488; Heyne N, 2012, ANN HEMATOL, V91, P729, DOI 10.1007/s00277-011-1383-0; Hutchison CA, 2007, J AM SOC NEPHROL, V18, P886, DOI 10.1681/ASN.2006080821; Hutchison CA, 2012, NEPHROL DIAL TRANSPL, V27, P3823, DOI 10.1093/ndt/gfr773; Hutchison CA, 2011, J AM SOC NEPHROL, V22, P1129, DOI 10.1681/ASN.2010080857; Hutchison CA, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-55; Hutchison CA, 2009, CLIN J AM SOC NEPHRO, V4, P745, DOI 10.2215/CJN.04590908; Jorres A, 2013, NEPHROL DIAL TRANSPL, V28, P2940, DOI 10.1093/ndt/gft297; Joung KW, 2014, J CARDIOTHOR VASC AN, V28, P1440, DOI 10.1053/j.jvca.2014.04.020; Khan R, 2015, LEUKEMIA, V29, P1195, DOI 10.1038/leu.2015.15; Knudsen LM, 2000, EUR J HAEMATOL, V65, P175, DOI 10.1034/j.1600-0609.2000.90221.x; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Ludwig H, 2010, J CLIN ONCOL, V28, P4635, DOI 10.1200/JCO.2010.28.1238; Murphy PT, 2014, BRIT J HAEMATOL, V165, P890, DOI 10.1111/bjh.12818; Najafi I, 2008, J NEPHROL, V21, P776; Otomo K, 2015, CLIN EXP NEPHROL; Peters NO, 2011, HEMODIAL INT, V15, P538, DOI 10.1111/j.1542-4758.2011.00587.x; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Tsakiris DJ, 2010, NEPHROL DIAL TRANSPL, V25, P1200, DOI 10.1093/ndt/gfp679; Yadav P, 2015, EUR J HAEMATOL; Zannetti BA, 2015, AM J HEMATOL, V90, P647, DOI 10.1002/ajh.24035	26	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154993	10.1371/journal.pone.0154993	http://dx.doi.org/10.1371/journal.pone.0154993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152520	gold, Green Submitted, Green Published			2022-12-27	WOS:000375677000057
J	Lal, A; Oku, Y; Someya, H; Miwakeichi, F; Tamura, Y				Lal, Amit; Oku, Yoshitaka; Someya, Hiroshi; Miwakeichi, Fumikazu; Tamura, Yoshiyasu			Emergent Network Topology within the Respiratory Rhythm-Generating Kernel Evolved In Silico	PLOS ONE			English	Article							PRE-BOTZINGER COMPLEX; PACEMAKER NEURONS; PREBOTZINGER COMPLEX; BUILDING-BLOCKS; NEURAL-NETWORKS; MODELS; MICROCIRCUITS; MOUSE; CONNECTIVITY; TRANSMISSION	We hypothesize that the network topology within the pre-Botzinger Complex (preBotC), the mammalian respiratory rhythm generating kernel, is not random, but is optimized in the course of ontogeny/phylogeny so that the network produces respiratory rhythm efficiently and robustly. In the present study, we attempted to identify topology of synaptic connections among constituent neurons of the preBotC based on this hypothesis. To do this, we first developed an effective evolutionary algorithm for optimizing network topology of a neuronal network to exhibit a 'desired characteristic'. Using this evolutionary algorithm, we iteratively evolved an in silico preBotC 'model' network with initial random connectivity to a network exhibiting optimized synchronous population bursts. The evolved 'idealized' network was then analyzed to gain insight into: (1) optimal network connectivity among different kinds of neurons-excitatory as well as inhibitory pacemakers, non-pacemakers and tonic neurons-within the preBotC, and (2) possible functional roles of inhibitory neurons within the preBotC in rhythm generation. Obtained results indicate that (1) synaptic distribution within excitatory subnetwork of the evolved model network illustrates skewed/heavy-tailed degree distribution, and (2) inhibitory subnetwork influences excitatory subnetwork primarily through non-tonic pacemaker inhibitory neurons. Further, since small-world (SW) network is generally associated with network synchronization phenomena and is suggested as a possible network structure within the preBotC, we compared the performance of SW network with that of the evolved model network. Results show that evolved network is better than SW network at exhibiting synchronous bursts.	[Lal, Amit] Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China; [Oku, Yoshitaka] Hyogo Coll Med, Dept Physiol, Nishinomiya, Hyogo 6638501, Japan; [Someya, Hiroshi] Tokai Univ, Sch Informat Sci & Technol, Hiratsuka, Kanagawa 2591292, Japan; [Miwakeichi, Fumikazu; Tamura, Yoshiyasu] Inst Stat Math, Dept Stat Modeling, Tachikawa, Tokyo 1908562, Japan; [Miwakeichi, Fumikazu; Tamura, Yoshiyasu] Grad Univ Adv Studies, Dept Stat Sci, Sch Multidisciplinary Sci, Tachikawa, Tokyo 1908562, Japan	Peking University; Hyogo College of Medicine; Tokai University; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Graduate University for Advanced Studies - Japan	Oku, Y (corresponding author), Hyogo Coll Med, Dept Physiol, Nishinomiya, Hyogo 6638501, Japan.	yoku@hyo-med.ac.jp			Institute of Statistical Mathematics cooperative research program [2011-ISM-CRP-2001, 2012-ISM-CRP-2001, 2013-ISM-CRP-2001, 2014-ISM-CRP-2001]; JST (Japan Science and Technology Agency) Strategic Japanese-German Cooperative Program in Computational Neuroscience [12000005]; Japan Society for Promotion of Science [24300108, 24500365]; JST Strategic Japanese-German Cooperative Program in Computational Neuroscience [12000005]; Grants-in-Aid for Scientific Research [26280109] Funding Source: KAKEN	Institute of Statistical Mathematics cooperative research program; JST (Japan Science and Technology Agency) Strategic Japanese-German Cooperative Program in Computational Neuroscience; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST Strategic Japanese-German Cooperative Program in Computational Neuroscience; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Institute of Statistical Mathematics cooperative research program (2011-ISM-CRP-2001, 2012-ISM-CRP-2001, 2013-ISM-CRP-2001, and 2014-ISM-CRP-2001), JST (Japan Science and Technology Agency) Strategic Japanese-German Cooperative Program in Computational Neuroscience (12000005) and Grant-in-Aid for Scientific Research from the Japan Society for Promotion of Science (24300108 and 24500365). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Institute of Statistical Mathematics cooperative research program (2011-ISM-CRP-2001, 2012-ISM-CRP-2001, 2013-ISM-CRP-2001, and 2014-ISM-CRP-2001), JST Strategic Japanese-German Cooperative Program in Computational Neuroscience (12000005) and Grant-in-Aid for Scientific Research from the Japan Society for Promotion of Science (24300108 and 24500365).	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; Butera RJ, 1999, J NEUROPHYSIOL, V82, P382, DOI 10.1152/jn.1999.82.1.382; Carroll MS, 2013, J NEUROPHYSIOL, V109, P296, DOI 10.1152/jn.00830.2011; Chartrand G, 1985, INTRO GRAPH THEORY; Del Negro CA, 2005, J NEUROSCI, V25, P446, DOI 10.1523/JNEUROSCI.2237-04.2005; Del Negro CA, 2001, J NEUROPHYSIOL, V86, P59, DOI 10.1152/jn.2001.86.1.59; Dunmyre JR, 2011, J COMPUT NEUROSCI, V31, P305, DOI 10.1007/s10827-010-0311-y; Eiben A. E., 2003, INTRO EVOLUTIONARY C, P53; Feldman JL, 2015, J PHYSIOL-LONDON, V593, P3, DOI 10.1113/jphysiol.2014.277632; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Gaiteri C, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00010; Hartelt N, 2008, MOL CELL NEUROSCI, V37, P425, DOI 10.1016/j.mcn.2007.10.011; Jasinski PE, 2013, EUR J NEUROSCI, V37, P212, DOI 10.1111/ejn.12042; Lal A, 2011, J COMPUT NEUROSCI, V30, P225, DOI 10.1007/s10827-010-0249-0; Lindsey BG, 2012, COMPR PHYSIOL, V2, P1619, DOI 10.1002/cphy.c110016; Mironov S, 2009, NEUROSCIENTIST, V15, P194, DOI 10.1177/1073858408329510; Mitra PP, 2014, NEURON, V83, P1273, DOI 10.1016/j.neuron.2014.08.055; Morgado-Valle C, 2010, J NEUROSCI, V30, P3634, DOI 10.1523/JNEUROSCI.3040-09.2010; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Pace RW, 2008, EUR J NEUROSCI, V28, P2434, DOI 10.1111/j.1460-9568.2008.06540.x; Purvis LK, 2007, J NEUROPHYSIOL, V97, P1515, DOI 10.1152/jn.00908.2006; Ramirez JM, 2012, COMPR PHYSIOL, V2, P2683, DOI 10.1002/cphy.c110033; Rekling JC, 2000, J NEUROSCI, V20, part. no.; Rubin JE, 2009, P NATL ACAD SCI USA, V106, P2939, DOI 10.1073/pnas.0808776106; Salathe M, 2005, J ROY SOC INTERFACE, V2, P533, DOI 10.1098/rsif.2005.0072; Shao XM, 1997, J NEUROPHYSIOL, V77, P1853, DOI 10.1152/jn.1997.77.4.1853; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Smith JC, 2013, TRENDS NEUROSCI, V36, P152, DOI 10.1016/j.tins.2012.11.004; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Toporikova N, 2011, J COMPUT NEUROSCI, V30, P515, DOI 10.1007/s10827-010-0274-z; Wang XY, 2014, ELIFE, V3, DOI 10.7554/eLife.03427; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winter SM, 2009, PFLUG ARCH EUR J PHY, V458, P459, DOI 10.1007/s00424-009-0647-1; Wittmeier S, 2008, P NATL ACAD SCI USA, V105, P18000, DOI 10.1073/pnas.0809377105	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154049	10.1371/journal.pone.0154049	http://dx.doi.org/10.1371/journal.pone.0154049			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152967	gold, Green Submitted, Green Published			2022-12-27	WOS:000375677000010
J	Startin, CM; Rodger, E; Fodor-Wynne, L; Hamburg, S; Strydom, A				Startin, Carla M.; Rodger, Erin; Fodor-Wynne, Lucy; Hamburg, Sarah; Strydom, Andre			Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS)	PLOS ONE			English	Article							EXECUTIVE FUNCTION; ALZHEIMERS-DISEASE; INTELLECTUAL DISABILITY; ADAPTIVE-BEHAVIOR; MEMORY DECLINE; FOLLOW-UP; ADULTS; DEMENTIA; POPULATION; ADOLESCENTS	Down syndrome (DS) is the most common genetic cause of intellectual disability (ID). Abilities relating to executive function, memory and language are particularly affected in DS, although there is a large variability across individuals. People with DS also show an increased risk of developing dementia. While assessment batteries have been developed for adults with DS to assess cognitive abilities, these batteries may not be suitable for those with more severe IDs, dementia, or visual / hearing difficulties. Here we report the development of an informant rated questionnaire, the Cognitive Scale for Down Syndrome (CSDS), which focuses on everyday abilities relating to executive function, memory and language, and is suitable for assessing these abilities in all adults with DS regardless of cognitive ability. Complete questionnaires were collected about 128 individuals with DS. After final question selection we found high internal consistency scores across the total questionnaire and within the executive function, memory and language domains. CS-DS scores showed a wide range, with minimal floor and ceiling effects. We found high interrater (n = 55) and test retest (n = 36) intraclass correlations. CS-DS scores were significantly lower in those aged 41+ with significant cognitive decline compared to those without decline. Across all adults without cognitive decline, CS-DS scores correlated significantly to measures of general abilities. Exploratory factor analysis suggested five factors within the scale, relating to memory, self-regulation / inhibition, self-direction /initiation, communication, and focussing attention. The CS-DS therefore shows good interrater and test retest reliability, and appears to be a valid and suitable informant rating tool for assessing everyday cognitive abilities in a wide range of individuals with DS. Such a questionnaire may be a useful outcome measure for intervention studies to assess improvements to cognition, in addition to detecting dementia-related cognitive decline. The CS-DS may also be a useful tool for other populations with ID.	[Startin, Carla M.; Rodger, Erin; Fodor-Wynne, Lucy; Hamburg, Sarah; Strydom, Andre] UCL, UCL Div Psychiat, London, England; [Startin, Carla M.; Rodger, Erin; Fodor-Wynne, Lucy; Hamburg, Sarah; Strydom, Andre] LonDownS Consortium, London, England; [Rodger, Erin] Univ Surrey, Fac Hlth & Med Sci, Guildford, England	University of London; University College London; University of Surrey	Startin, CM (corresponding author), UCL, UCL Div Psychiat, London, England.; Startin, CM (corresponding author), LonDownS Consortium, London, England.	carla.startin.09@ucl.ac.uk	Startin, Carla/H-9660-2019	Startin, Carla/0000-0001-9261-9924; Hamburg, Sarah/0000-0002-8142-3253; Strydom, Andre/0000-0002-2502-6704	Wellcome Trust [098330/Z/12/Z]; Baily Thomas Charitable Fund [TRUST/RNA/AC/KW/3111/5776]	Wellcome Trust(Wellcome TrustEuropean Commission); Baily Thomas Charitable Fund	This work was funded by a Wellcome Trust Strategic Award (grant number: 098330/Z/12/Z) conferred upon The London Down Syndrome (LonDownS) Consortium. The work is further supported by the Baily Thomas Charitable Fund (TRUST/RNA/AC/KW/3111/5776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2010, J INTELL DISABIL RES, V54, P393, DOI 10.1111/j.1365-2788.2010.01271.x; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Ball SL, 2008, BRIT J CLIN PSYCHOL, V47, P1, DOI 10.1348/014466507X230967; Ball SL, 2006, INT J GERIATR PSYCH, V21, P661, DOI 10.1002/gps.1545; Ball SL, 2004, J INTELL DISABIL RES, V48, P611, DOI 10.1111/j.1365-2788.2004.00630.x; Carducci F, 2013, FUNCT NEUROL, V28, P19, DOI 10.11138/FNeur/2013.28.1.019; Chene G, 2015, ALZHEIMERS DEMENT, V11, P310, DOI 10.1016/j.jalz.2013.10.005; Coppus A, 2006, J INTELL DISABIL RES, V50, P768, DOI 10.1111/j.1365-2788.2006.00842.x; d'Ardhuy XL, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00300; de Sola S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00708; Deb S, 2007, BRIT J PSYCHIAT, V190, P440, DOI 10.1192/bjp.bp.106.024984; Dekker AD, 2015, CORTEX, V73, P36, DOI 10.1016/j.cortex.2015.07.032; Edgin Jamie O, 2013, Wiley Interdiscip Rev Cogn Sci, V4, P307, DOI 10.1002/wcs.1221; Edgin JO, 2010, J NEURODEV DISORD, V2, P149, DOI 10.1007/s11689-010-9054-3; Edgin JO, 2010, J INTELL DISABIL RES, V54, P406, DOI 10.1111/j.1365-2788.2010.01278.x; Englund A, 2013, AM J MED GENET A, V161A, P642, DOI 10.1002/ajmg.a.35706; EVENHUIS HM, 1992, J INTELL DISABIL RES, V36, P337; Gedye A., 1995, DEMENTIA SCALE SYNDR; Gligorovic M, 2014, J INTELL DISABIL RES, V58, P233, DOI 10.1111/jir.12000; Hatton C, 2001, RES DEV DISABIL, V22, P273, DOI 10.1016/S0891-4222(01)00072-5; Holland AJ, 1998, BRIT J PSYCHIAT, V172, P493, DOI 10.1192/bjp.172.6.493; Jacola LM, 2014, J INTELL DISABIL RES, V58, P892, DOI 10.1111/jir.12089; Kaufman A., 2004, KAUFMANN BRIEF INTEL; Kittler P, 2006, J INTELL DISABIL RES, V50, P1, DOI 10.1111/j.1365-2788.2005.00715.x; Lanfranchi S, 2010, J INTELL DISABIL RES, V54, P308, DOI 10.1111/j.1365-2788.2010.01262.x; Margallo-Lana ML, 2007, J INTELL DISABIL RES, V51, P463, DOI 10.1111/j.1365-2788.2006.00902.x; McCarron M, 2014, J INTELL DISABIL RES, V58, P61, DOI 10.1111/jir.12074; O'Shea MF, 1996, COGNITIVE AFFECTIVE; Oliver C, 1998, PSYCHOL MED, V28, P1365, DOI 10.1017/S0033291798007417; Pennington BF, 2003, CHILD DEV, V74, P75, DOI 10.1111/1467-8624.00522; Pinter JD, 2001, NEUROLOGY, V56, P972, DOI 10.1212/WNL.56.7.972; Roberts JE, 2007, MENT RETARD DEV D R, V13, P26, DOI 10.1002/mrdd.20136; Roth RM., 2005, BRIEF A BEHAV RATING; Rowe J, 2006, BRIT J CLIN PSYCHOL, V45, P5, DOI 10.1348/014466505X29594; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Sinai A, ASSESSING SPEC UNPUB; Sparrow SS, 2007, VINELAND 2 VINELAND; Startin CM, LONDOWNS ASSES UNPUB; Teipel SJ, 2003, AM J PSYCHIAT, V160, P1870, DOI 10.1176/appi.ajp.160.10.1870; Tyrrell J, 2001, INT J GERIATR PSYCH, V16, P1168, DOI 10.1002/gps.502; Visu-Petra L, 2007, J INTELL DISABIL RES, V51, P942, DOI 10.1111/j.1365-2788.2007.01002.x; Wiseman FK, 2015, NAT REV NEUROSCI, V16, P564, DOI 10.1038/nrn3983; Witts P, 1998, BRIT J CLIN PSYCHOL, V37, P213, DOI 10.1111/j.2044-8260.1998.tb01295.x; Wu JH, 2013, EUR J HUM GENET, V21, P1016, DOI 10.1038/ejhg.2012.294; Zis P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097709; Zis P, 2012, J ALZHEIMERS DIS, V31, P277, DOI 10.3233/JAD-2012-120073	46	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154596	10.1371/journal.pone.0154596	http://dx.doi.org/10.1371/journal.pone.0154596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KX	27153191	Green Published, gold			2022-12-27	WOS:000375677000027
J	Wang, XZ; Zhang, WH; Miao, YX; Gao, LH				Wang, Xiaozhuo; Zhang, Weihua; Miao, Yanxiu; Gao, Lihong			Root-Zone Warming Differently Benefits Mature and Newly Unfolded Leaves of Cucumis sativus L. Seedlings under Sub-Optimal Temperature Stress	PLOS ONE			English	Article							STOMATAL CONDUCTANCE; XYLEM SAP; ABSCISIC-ACID; CHLOROPHYLL-FLUORESCENCE; HYDRAULIC CONDUCTIVITY; GROWTH; PHOTOSYNTHESIS; WATER; TOMATO; LIGHT	Sub-optimal temperature extensively suppresses crop growth during cool-season greenhouse production. Root-zone (RZ) warming is considered an economical option to alleviate crop growth reduction. In this study we cultivated cucumber seedlings in nutrient solution under different air-RZ temperature treatments to investigate the effects of RZ warming on seedling growth-and photosynthesis-related parameters in leaves. The air-RZ temperature treatments included sub-optimal RZ temperature 13 degrees C and sub-optimal air temperature 20/12 degrees C (day/night) (S13), RZ warming at 19 degrees C and sub-optimal air temperature (S19), and RZ warming at 19 degrees C and optimal air temperature 26/18 degrees C (day/night) (O19). In addition, for each air-RZ temperature treatment, half of the seedlings were also treated with 2% (m/m) polyethylene glycol (PEG) dissolved in nutrient solution to distinguish the effect of root-sourced water supply from RZ temperature. At the whole-plant level, S19 significantly increased the relative growth rate (RGR) by approximately 18% compared with S13, although the increase was less than in O19 (50%) due to delayed leaf emergence. S19 alleviated both diffusive and metabolic limitation of photosynthesis in mature leaves compared with S13, resulting in a photosynthetic rate similar to that in O19 leaves. In newly unfolded leaves, S19 significantly promoted leaf area expansion and alleviated stomatal limitation of photosynthesis compared with S13. PEG addition had a limited influence on RGR and leaf photosynthesis, but significantly suppressed new leaf expansion. Thus, our results indicate that under sub-optimal temperature conditions, RZ warming promotes cucumber seedling growth by differently benefiting mature and newly unfolded leaves. In addition, RZ warming enhanced root-sourced water supply, mainly promoting new leaf expansion, rather than photosynthesis.	[Wang, Xiaozhuo; Zhang, Weihua; Miao, Yanxiu; Gao, Lihong] China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China	China Agricultural University	Gao, LH (corresponding author), China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China.	gaolh@cau.edu.cn	zhang, weihua/GXV-1334-2022; Wang, Xiaozhuo/E-3160-2013	Wang, Xiaozhuo/0000-0001-8667-9162	Beijing Innovation Consortium of Agriculture Research System (Beijing Municipal Bureau of Agriculture) [BAIC01-2016]; Research Projects for the Areas of Public Interest (Ministry of Agriculture of the People's Republic of China) [201303014]	Beijing Innovation Consortium of Agriculture Research System (Beijing Municipal Bureau of Agriculture); Research Projects for the Areas of Public Interest (Ministry of Agriculture of the People's Republic of China)	This work was supported by the earmarked fund for the Beijing Innovation Consortium of Agriculture Research System (BAIC01-2016, http://www.bjny.gov.cn/, Beijing Municipal Bureau of Agriculture, received by LG) and the Research Projects for the Areas of Public Interest (Agriculture, 201303014, http://www.moa.gov.cn/, Ministry of Agriculture of the People's Republic of China, received by LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebooye OC, 2010, ACTA PHYSIOL PLANT, V32, P67, DOI 10.1007/s11738-009-0379-z; Ahn SJ, 1999, SCI HORTIC-AMSTERDAM, V81, P397, DOI 10.1016/S0304-4238(99)00042-4; Beyhan B, 2013, ENERG CONVERS MANAGE, V74, P446, DOI 10.1016/j.enconman.2013.06.047; BIGOT J, 1994, PLANT CELL ENVIRON, V17, P721, DOI 10.1111/j.1365-3040.1994.tb00164.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULDER HAM, 1989, PHYSIOL PLANTARUM, V75, P362, DOI 10.1111/j.1399-3054.1989.tb04639.x; Choi KJ, 1995, ACTA HORTIC, P161, DOI 10.17660/ActaHortic.1995.396.18; DELUCIA EH, 1992, NEW PHYTOL, V120, P543, DOI 10.1111/j.1469-8137.1992.tb01804.x; Dodd IC, 2000, J EXP BOT, V51, P239, DOI 10.1093/jexbot/51.343.239; DU YC, 1994, J JPN SOC HORTIC SCI, V63, P401, DOI 10.2503/jjshs.63.401; Erhard P., 2008, PAM APPL NOTES, V1, P21; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Fracheboud Y, 1999, J EXP BOT, V50, P1533, DOI 10.1093/jexbot/50.338.1533; Gao LH, 2010, HORTTECHNOLOGY, V20, P626, DOI 10.21273/HORTTECH.20.3.626; Hao HP, 2012, PLANT SOIL, V353, P367, DOI 10.1007/s11104-011-1037-y; He J, 2001, J EXP BOT, V52, P1323, DOI 10.1093/jexbot/52.359.1323; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; Hunt R., 1978, PLANT GROWTH ANAL, Vfirst; Jin SH, 2011, TREE PHYSIOL, V31, P1142, DOI 10.1093/treephys/tpr095; Jones DAG., 1978, ISHS ACT HORT 76 S M, V76, P167; Kawasaki Y, 2014, J JPN SOC HORTIC SCI, V83, P295, DOI 10.2503/jjshs1.MI-001; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Klughammer C., 2008, PAM APP NOTES, V1, P11, DOI DOI 10.1007/S00415-017-8571-3; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Kuwagata T, 2012, PLANT CELL PHYSIOL, V53, P1418, DOI 10.1093/pcp/pcs087; Lawlor DW, 2009, ANN BOT-LONDON, V103, P561, DOI [10.1093/aob/mcn244, 10.1093/aob/mcn256]; Lee SH, 2005, J EXP BOT, V56, P985, DOI 10.1093/jxb/eri092; Lee SH, 2004, PHYSIOL PLANTARUM, V120, P413, DOI 10.1111/j.0031-9317.2004.00248.x; Li H, 2013, PLANT PHYSIOL BIOCH, V71, P1, DOI 10.1016/j.plaphy.2013.06.018; Liang Y, 2007, PHYSIOL PLANTARUM, V131, P508, DOI 10.1111/j.1399-3054.2007.00974.x; Mahler H, 2007, PLANTA, V225, P1073, DOI 10.1007/s00425-006-0416-8; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Murai-Hatano M, 2008, PLANT CELL PHYSIOL, V49, P1294, DOI 10.1093/pcp/pcn104; NIE GY, 1992, PHYSIOL PLANTARUM, V85, P554, DOI 10.1111/j.1399-3054.1992.tb05826.x; Ntatsi G, 2014, ENVIRON EXP BOT, V97, P11, DOI 10.1016/j.envexpbot.2013.09.011; Paredes M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137472; Parry MAJ, 2002, ANN BOT-LONDON, V89, P833, DOI 10.1093/aob/mcf103; PAUL EMM, 1984, NEW PHYTOL, V98, P221, DOI 10.1111/j.1469-8137.1984.tb02732.x; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Poire R, 2010, PLANT CELL ENVIRON, V33, P408, DOI 10.1111/j.1365-3040.2009.02090.x; Rogiers SY, 2013, ANN BOT-LONDON, V111, P433, DOI 10.1093/aob/mcs298; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; SARTORY DP, 1984, HYDROBIOLOGIA, V114, P177, DOI 10.1007/BF00031869; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Sonoike K, 1999, J PHOTOCH PHOTOBIO B, V48, P136, DOI 10.1016/S1011-1344(99)00030-5; Sonoike K, 2011, PHYSIOL PLANTARUM, V142, P56, DOI 10.1111/j.1399-3054.2010.01437.x; Soto A, 2014, PLANT SCI, V227, P84, DOI 10.1016/j.plantsci.2014.07.004; Strand A, 1999, PLANT PHYSIOL, V119, P1387, DOI 10.1104/pp.119.4.1387; Strasser RJ, 2010, BBA-BIOENERGETICS, V1797, P1313, DOI 10.1016/j.bbabio.2010.03.008; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; Sun JL, 2014, ACTA PHYSIOL PLANT, V36, P2779, DOI 10.1007/s11738-014-1648-z; Suzuki K, 2008, PLANT CELL PHYSIOL, V49, P433, DOI 10.1093/pcp/pcn020; Suzuki K, 2011, PLANT CELL PHYSIOL, V52, P1697, DOI 10.1093/pcp/pcr104; TACHIBANA S, 1987, J JPN SOC HORTIC SCI, V55, P461, DOI 10.2503/jjshs.55.461; TACHIBANA S, 1982, J JPN SOC HORTIC SCI, V51, P299, DOI 10.2503/jjshs.51.299; Terashima I, 1998, PHYSIOL PLANTARUM, V103, P295, DOI 10.1034/j.1399-3054.1998.1030301.x; Tezara W, 1999, NATURE, V401, P914, DOI 10.1038/44842; Van Der Ploeg A, 2005, J HORTIC SCI BIOTECH, V80, P652; Venzhik YV, 2014, ACTA PHYSIOL PLANT, V36, P323, DOI 10.1007/s11738-013-1413-8; von Caemmerer S, 2013, PLANT CELL ENVIRON, V36, P1617, DOI 10.1111/pce.12098; Wan XC, 2004, PHYSIOL PLANTARUM, V122, P79, DOI 10.1111/j.1399-3054.2004.00385.x; Xu WF, 2013, NEW PHYTOL, V197, P139, DOI 10.1111/nph.12004; Yamazaki K, 1982, YOEKI SAIBAI ZENPEN; Zhang LD, 2013, SCI HORTIC-AMSTERDAM, V161, P81, DOI 10.1016/j.scienta.2013.06.029; Zhang YJ, 2011, PLANT BIOLOGY, V13, P362, DOI 10.1111/j.1438-8677.2010.00365.x; Zhang YP, 2008, PHOTOSYNTHETICA, V46, P356, DOI 10.1007/s11099-008-0065-1; Zhang YP, 2012, ACTA PHYSIOL PLANT, V34, P713, DOI 10.1007/s11738-011-0871-0; Zhou YH, 2007, J EXP BOT, V58, P1207, DOI 10.1093/jxb/erl291; 이재욱, 2003, Horticulture, Environment, and Biotechnology, V44, P639	71	16	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155298	10.1371/journal.pone.0155298	http://dx.doi.org/10.1371/journal.pone.0155298			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152599	gold, Green Submitted, Green Published			2022-12-27	WOS:000375677000083
J	Lievens, A; Jacchia, S; Kagkli, D; Savini, C; Querci, M				Lievens, A.; Jacchia, S.; Kagkli, D.; Savini, C.; Querci, M.			Measuring Digital PCR Quality: Performance Parameters and Their Optimization	PLOS ONE			English	Article								Digital PCR is rapidly being adopted in the field of DNA-based food analysis. The direct, absolute quantification it offers makes it an attractive technology for routine analysis of food and feed samples for their composition, possible GMO content, and compliance with labelling requirements. However, assessing the performance of dPCR assays is not yet well established. This article introduces three straightforward parameters based on statistical principles that allow users to evaluate if their assays are robust. In addition, we present post-run evaluation criteria to check if quantification was accurate. Finally, we evaluate the usefulness of Poisson confidence intervals and present an alternative strategy to better capture the variability in the analytical chain.	[Lievens, A.; Jacchia, S.; Kagkli, D.; Savini, C.; Querci, M.] Inst Hlth & Consumer Protect, European Commiss Joint Res Ctr, Mol Biol & Genom Unit, I-21027 Ispra, VA, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Lievens, A (corresponding author), Inst Hlth & Consumer Protect, European Commiss Joint Res Ctr, Mol Biol & Genom Unit, I-21027 Ispra, VA, Italy.	antoon.lievens@ec.europa.eu	Kagkli, Dafni-Maria/C-5987-2008	Kagkli, Dafni-Maria/0000-0002-7351-135X; Querci, Maddalena/0000-0002-0788-1627; Savini, Christian/0000-0002-4279-3761; Jacchia, Sara/0000-0002-7388-8958				[Anonymous], 2005, EVENT SPECIFIC METHO; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bennett MD, 1997, ANN BOT-LONDON, V80, P169, DOI 10.1006/anbo.1997.0415; CHARRON D, 2011, INSIGHT INNOV INT DE, P1; De Spiegelaere W, 2013, ANAL BIOCHEM, V439, P201, DOI 10.1016/j.ab.2013.04.024; Delobel C, 2013, QUANTITATIVE PCR MET, P1; Delobel C., 2008, EVENT SPECIFIC METHO, P1, DOI [10.2788/22173, DOI 10.2788/22173]; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; European Network of GMO Laboratories Joint Research Center EURL, 2015, DEF MIN PERF REQ AN; Fieller EC, 1932, BIOMETRIKA, V24, P428, DOI 10.2307/2331976; Jacobs BKM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-283; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Lievens A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr775; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mazzanti M, 2009, ROUTL EXPLOR ENVIRON, P1; Mazzara M, 2013, METHOD QUANTIFICATIO, P1; Mazzara M, 2008, EU RL GMFF GUIDANCE; Mazzara M, 2008, EVENT SPECIFIC METHO, P1; Mazzara M, 2007, EVENT SPECIFIC METHO, P1; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; R Core Team, 2021, R LANGUAGE ENV STAT; Sambrook J., 2001, MOL CLONING LAB MANU; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236	24	76	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0153317	10.1371/journal.pone.0153317	http://dx.doi.org/10.1371/journal.pone.0153317			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149415	gold, Green Published			2022-12-27	WOS:000375676800008
J	Sousa, E; Quintino, V; Palhas, J; Rodrigues, AM; Teixeira, J				Sousa, Eunice; Quintino, Victor; Palhas, Jael; Rodrigues, Ana Maria; Teixeira, Jose			Can Environmental Education Actions Change Public Attitudes? An Example Using the Pond Habitat and Associated Biodiversity	PLOS ONE			English	Article							TEMPORARY PONDS; CONSERVATION; ANIMALS; PERCEPTIONS; AMPHIBIANS; EXTINCTION; MANAGEMENT; KNOWLEDGE; FOLKLORE; CLIMATE	Ponds provide vital ecological services. They are biodiversity hotspots and important breading sites for rare and endangered species, including amphibians and dragonflies. Nevertheless, their number is decreasing due to habitat degradation caused by human activities. The "Ponds with Life" environmental education project was developed to raise public awareness and engagement in the study of ponds by promoting the direct contact between the public and nature, researchers and pedagogical hands-on exploration activities. A pre-post-project survey was set-up to assess the effects of the project on the environmental consciousness, knowledge and attitude changes towards ponds and the associated biodiversity of school students aged 15 to 18. The survey questions were based on Likert scales and their pre-post project comparisons used an innovative multivariate hypothesis testing approach. The results showed that the project improved the students' knowledge and attitudes towards ponds and associated biodiversity, especially the amphibians. Ponds can be found or constructed in urban areas and despite small sized, they proved to be interesting model habitats and living laboratories to foster environmental education, by encompassing a high number of species and a fast ecological succession.	[Sousa, Eunice; Teixeira, Jose] CIIMAR Interdisciplinary Ctr Marine & Environm Re, Oporto, Portugal; [Sousa, Eunice; Palhas, Jael; Teixeira, Jose] CIBIO InBIO Res Ctr Biodivers & Genet Resources, Associated Lab, Oporto, Portugal; [Sousa, Eunice; Quintino, Victor; Rodrigues, Ana Maria] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Sousa, Eunice; Quintino, Victor; Rodrigues, Ana Maria] Univ Aveiro, CESAM Res Ctr Environm & Marine Res, P-3800 Aveiro, Portugal	Universidade do Porto; Universidade de Aveiro; Universidade de Aveiro	Sousa, E (corresponding author), CIIMAR Interdisciplinary Ctr Marine & Environm Re, Oporto, Portugal.; Sousa, E (corresponding author), CIBIO InBIO Res Ctr Biodivers & Genet Resources, Associated Lab, Oporto, Portugal.; Sousa, E (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.; Sousa, E (corresponding author), Univ Aveiro, CESAM Res Ctr Environm & Marine Res, P-3800 Aveiro, Portugal.	esousa@ciimar.up.pt	Quintino, Victor/E-7436-2010; Rodrigues, Ana Maria/F-6968-2019; Rodrigues, Ana/GYQ-6273-2022	Quintino, Victor/0000-0001-6298-4285; Rodrigues, Ana Maria/0000-0003-4506-5783; Teixeira, Jose/0000-0002-2924-5314; Palhas, Jael/0000-0003-4808-3936; Sousa, Eunice/0000-0002-8679-0933	Ciencia Viva (Projecto Escolher Ciencia - Investigadores na Escola) [PEC99]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/73943/2010, SFRH/BPD/27173/2006, CESAM RU: UID/AMB/50017/2013]; FEDER;  [UID/AMB/50017/2013]	Ciencia Viva (Projecto Escolher Ciencia - Investigadores na Escola); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission); 	This work was supported by Ciencia Viva (Projecto Escolher Ciencia - Investigadores na Escola PEC99) and by Fundacao para a Ciencia e Tecnologia (SFRH/BD/73943/2010 PhD grant to ES, SFRH/BPD/27173/2006 post-doc grant to JT and through CESAM RU: UID/AMB/50017/2013). Thanks are due, for the financial support to CESAM (UID/AMB/50017/2013), to FCT/MEC through national funds, and the co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020.	Ajzen I., 1985, INTENTIONS ACTIONS T, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; [Anonymous], 2011, EURASIA J MATH SCI T, DOI [10.12973/ejmste/75207, DOI 10.12973/EJMSTE/75207]; Armstrong J., 1991, J ENVIRON EDUC, V22, P36, DOI [10.1080/00958964.1991.9943060, DOI 10.1080/00958964.1991.9943060]; Bagella S, 2012, CR BIOL, V335, P69, DOI 10.1016/j.crvi.2011.10.005; Ballouard JM, 2013, ANTHROZOOS, V26, P93, DOI 10.2752/175303713X13534238631560; Ballouard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023152; Batt S., 2009, BIOSCIENCE HORIZONS, V2, P180, DOI [https://doi.org/10.1093/biohorizons/hzp021, DOI 10.1093/BIOHORIZONS/HZP021]; Beja P, 2003, BIOL CONSERV, V114, P317, DOI 10.1016/S0006-3207(03)00051-X; Bord RJ, 2000, PUBLIC UNDERST SCI, V9, P205, DOI 10.1088/0963-6625/9/3/301; Cereghino R, 2008, HYDROBIOLOGIA, V597, P1, DOI 10.1007/s10750-007-9225-8; Ceriaco LMP, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-8; Ceriaco LMP, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-26; Chanson Janice, 2008, P33; Costa J. C., 1998, QUERCETEA, V0, P5; Cushing D.F., 2007, ENV ED RES, DOI [10.1080/13504620701581539, DOI 10.1080/13504620701581539]; Department of Trade and Industry, 2000, EXC OPP SCI INN POL; Dunlap R.E., 2008, J ENVIRON EDUC, V40, P1, DOI DOI 10.3200/J0EE.40.1.3-18; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; EPCN, 2008, THE POND MAN; FALK JH, 1983, J BIOL EDUC, V17, P137, DOI 10.1080/00219266.1983.9654522; Ferreira A., 2000, DADOS GEOQUIMICOS BA, V28; Ferreira M, 2013, BIOL CONSERV, V165, P179, DOI 10.1016/j.biocon.2013.05.029; Fischer A, 2007, BIOL CONSERV, V136, P271, DOI 10.1016/j.biocon.2006.11.024; FREY BS, 1986, J ECON PSYCHOL, V7, P137, DOI 10.1016/0167-4870(86)90001-2; Gallant AL, 2007, COPEIA, P967, DOI 10.1643/0045-8511(2007)7[967:GROHLA]2.0.CO;2; Gorley C.K., 2006, GETTING STARTED PRIM; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hug JW, 2010, ENVIRON EDUC RES, V16, P267; Jordan RC, 2011, CONSERV BIOL, V25, P1148, DOI 10.1111/j.1523-1739.2011.01745.x; Kaiser FG, 1999, J ENVIRON PSYCHOL, V19, P1, DOI 10.1006/jevp.1998.0107; Kassas M., 2002, Environmentalist, V22, P345, DOI 10.1023/A:1020766914456; Kellert S.R., 1996, VALUE LIFE BIOL DIVE; KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x; KELLERT SR, 1985, BIOL CONSERV, V31, P167, DOI 10.1016/0006-3207(85)90047-3; Knight AJ, 2008, J ENVIRON PSYCHOL, V28, P94, DOI 10.1016/j.jenvp.2007.10.001; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Lindemann-Matthies P, 2005, INT J SCI EDUC, V27, P655, DOI 10.1080/09500690500038116; Lindemann-Matthies P., 2002, J ENVIRON EDUC, V33, P22, DOI DOI 10.1080/00958960209600805; Manoli CC, 2007, J ENVIRON EDUC, V38, P1; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Pinto-Cruz C, 2011, ECOL INDIC, V11, P1658, DOI 10.1016/j.ecolind.2011.04.012; Prokop P, 2013, ANIM CONSERV, V16, P458, DOI 10.1111/acv.12014; Prokop P, 2010, ANTHROZOOS, V23, P21, DOI 10.2752/175303710X12627079939107; Prokop P, 2009, SOC ANIM, V17, P224, DOI 10.1163/156853009X445398; Serpell JA, 2004, ANIM WELFARE, V13, pS145; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Tanner C, 1999, J ENVIRON PSYCHOL, V19, P145, DOI 10.1006/jevp.1999.0121; TOMAZIC I, 2011, EURASIA J MATH SCI T, V7, P161, DOI DOI 10.12973/EJMSTE/75194; Tomazic Iztok, 2008, Acta Biologica Slovenica, V51, P39; van Weelie D, 2002, INT J SCI EDUC, V24, P1143, DOI 10.1080/09500690210134839; Wagler R., 2012, International Journal of Environmental & Science Education, V7, P313; WANDERSEE JH, 1986, J RES SCI TEACH, V23, P415, DOI 10.1002/tea.3660230504; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8; Woods B., 2000, J TOURISM STUDIES, V11, P25; Zacharias I, 2007, J ENVIRON BIOL, V28, P1; Zacharias I, 2010, BIODIVERS CONSERV, V19, P3827, DOI 10.1007/s10531-010-9933-7	57	18	18	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154440	10.1371/journal.pone.0154440	http://dx.doi.org/10.1371/journal.pone.0154440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27148879	Green Published, gold			2022-12-27	WOS:000375676800033
J	Realis-Doyelle, E; Pasquet, A; De Charleroy, D; Fontaine, P; Teletchea, F				Realis-Doyelle, Emilie; Pasquet, Alain; De Charleroy, Daniel; Fontaine, Pascal; Teletchea, Fabrice			Strong Effects of Temperature on the Early Life Stages of a Cold Stenothermal Fish Species, Brown Trout (Salmo trutta L.)	PLOS ONE			English	Article							FRESH-WATER FISH; YOLK-FEEDING FISH; RED-SEA BREAM; CLIMATE-CHANGE; THERMAL PHYSIOLOGY; GADUS-MORHUA; PAGRUS-MAJOR; EGG SIZE; SALAR L; GROWTH	Temperature is the main abiotic factor that influences the life cycle of poikilotherms. The present study investigated the thermal tolerance and phenotypic plasticity of several parameters (development time, morphometric measures, bioenergetics) for both embryos and fry of a cold stenothermal fish species, brown trout (Salmo trutta L.) in order to allow for a holistic evaluation of the potential effects of temperature. Five temperatures (4 degrees C, 6 degrees C, 8 degrees C, 10 degrees C, and 12 degrees C) were tested, and the effects of temperature were analyzed at three stages: hatching, emergence, and first food intake. A mean of 5,440 (S.E. +/- 573) eggs, coming from seven females and seven males (seven families) captured close to Linkebeek (Belgium), were used for each temperature. Maximum survival of well-formed fry at first food intake and better use of energy budget were found at 6 degrees C and 8 degrees C, temperatures at which the possible contribution to the next generation should therefore be greatest. At 12 degrees C, the experimental population fell dramatically (0.9% survival rate for well-formed fry at first food intake), and fry had almost no yolk sac at first food intake. The present results on survival at 12 degrees C are in accordance with predictions of a sharp decrease in brown trout numbers in France over the coming decades according to climate change projections (1 degrees C to 5 degrees C temperature rise by 2100 for France). At 10 degrees C, there was also a lower survival rate (55.4% at first food intake). At 4 degrees C, the survival rate was high (76.4% at first food intake), but the deformity rate was much higher (22% at first food intake) than at 6 degrees C, 8 degrees C, and 10 degrees C. The energetic budget showed that at the two extreme temperatures (4 degrees C and 12 degrees C) there was less energy left in the yolk sac at first food intake, suggesting a limited ability to survive starvation.	[Realis-Doyelle, Emilie; Pasquet, Alain; Fontaine, Pascal; Teletchea, Fabrice] Univ Lorraine, UR AFPA, USC INRA 340, F-54506 Vandoeuvre Les Nancy, France; [Pasquet, Alain] CNRS, Delegat Reg Ctr Est, 17 Rue Notre Dame Pauvres, F-54500 Vandoeuvre Les Nancy, France; [De Charleroy, Daniel] Inst Nat INBO, Dwersbos 28, B-1630 Linkebeek, Belgium	INRAE; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Teletchea, F (corresponding author), Univ Lorraine, UR AFPA, USC INRA 340, F-54506 Vandoeuvre Les Nancy, France.	fabrice.teletchea@univ-lorraine.fr			ONEMA (Office National de l'eau et des milieu aquatiques National Office for Water and Aquatic Environments)	ONEMA (Office National de l'eau et des milieu aquatiques National Office for Water and Aquatic Environments)	This work was supported by ONEMA (Office National de l'eau et des milieu aquatiques National Office for Water and Aquatic Environments) 2013-2015.	Acornley RM, 1999, HYDROL PROCESS, V13, P439, DOI 10.1002/(SICI)1099-1085(19990228)13:3<439::AID-HYP748>3.3.CO;2-5; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Baptist F, 2014, POISSONS EAU DOUCE H, P63; Barron JM, 2012, AQUACULTURE, V364, P67, DOI 10.1016/j.aquaculture.2012.07.037; Bidwell DA, 2001, J WORLD AQUACULT SOC, V32, P373, DOI 10.1111/j.1749-7345.2001.tb00463.x; BLAXTER JHS, 1992, NETH J ZOOL, V42, P336, DOI 10.1163/156854291X00379; Buisson L., 2009, THESIS U TOULOUSE; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Bustos CA, 2007, AQUACULTURE, V270, P535, DOI 10.1016/j.aquaculture.2007.03.032; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Cooke S, 2005, ENVIRON MANAGE, V33, P140; De Billy VD, 2002, J FISH BIOL, V60, P687, DOI 10.1006/jfbi.2002.1887; Dou SZ, 2005, J FISH BIOL, V66, P362, DOI 10.1111/j.0022-1112.2005.00601.x; ELLIOTT JM, 1984, J ANIM ECOL, V53, P327, DOI 10.2307/4360; EMBODY G. G., 1934, TRANS AMER FISH SOC, V64, P281, DOI 10.1577/1548-8659(1934)64[281:ROTTTI]2.0.CO;2; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Fruget J.-F., 2002, Revue des Sciences de l'Eau, V15, P209; Gaudin P, 1995, B FR PECHE PISCIC, V337, P338; Ginter K., 2012, OPEN J APPL SCI, V2, P168, DOI DOI 10.4236/OJAPPS.2012.23024; Gisbert E, 2004, J FISH BIOL, V64, P116, DOI 10.1111/j.1095-8649.2004.00289.x; Gray J, 1928, THE GROWTH OF FISH; Gustafsson P, 2010, ECOL FRESHW FISH, V19, P170, DOI 10.1111/j.1600-0633.2009.00401.x; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Holm J, 2005, ENVIRON TOXICOL CHEM, V24, P2373, DOI 10.1897/04-402R1.1; HUEY RB, 1979, AM ZOOL, V19, P357; IPCC, 2014, WORK GROUP 1 CONTR I; Isaak DJ, 2013, GLOBAL CHANGE BIOL, V19, P742, DOI 10.1111/gcb.12073; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Jeppesen E, 2012, HYDROBIOLOGIA, V694, P1, DOI 10.1007/s10750-012-1182-1; Johnston IA, 1997, CAN J ZOOL, V75, P64, DOI 10.1139/z97-008; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Jordaan A, 2006, J FISH BIOL, V68, P7, DOI 10.1111/j.0022-1112.2006.00857.x; Kaminski R, 2006, J FISH BIOL, V68, P1077, DOI 10.1111/j.0022-1112.2006.01008.x; KAMLER E, 1994, J FISH BIOL, V44, P311, DOI 10.1006/jfbi.1994.1029; Kamler E, 1998, J FISH BIOL, V53, P658, DOI 10.1006/jfbi.1998.0733; Kamler E, 2002, REV FISH BIOL FISHER, V12, P79, DOI 10.1023/A:1022603204337; Kamler E, 1992, FISH FISHERIES SERIE, V4, P267; Kamler E, 2008, REV FISH BIOL FISHER, V18, P143, DOI 10.1007/s11160-007-9070-x; Kihara M, 2002, AQUACULTURE, V212, P149, DOI 10.1016/S0044-8486(01)00871-7; KITAJIMA C, 1981, B JPN SOC SCI FISH, V47, P1289; Koumoundouros G., 2010, REC ADV AQUAC RES, V661, P125; Lahnsteiner F, 2012, J APPL ICHTHYOL, V28, P745, DOI 10.1111/j.1439-0426.2012.01934.x; Lahnsteiner F, 2011, AQUAC RES, V42, P288, DOI 10.1111/j.1365-2109.2010.02621.x; Linares-Casenave J, 2013, J APPL ICHTHYOL, V29, P958, DOI 10.1111/jai.12220; Loffler J, 2008, J FISH BIOL, V72, P233, DOI 10.1111/j.1095-8649.2007.01699.x; Martell DJ, 2005, J FISH BIOL, V66, P1558, DOI 10.1111/j.0022-1112.2005.00699.x; MCGURK MD, 1984, MAR BIOL, V84, P13, DOI 10.1007/BF00394522; McLeod IM, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot024; MEEUWIG I, 2013, T AM FISH SOC, V134, P119, DOI DOI 10.1577/FT03-206.1; Milla S, 2011, AQUAC RES, V42, P1061, DOI 10.1111/j.1365-2109.2010.02688.x; OCONNELL CP, 1981, AM ZOOL, V21, P429; Ojanguren AF, 2003, J FISH BIOL, V62, P580, DOI 10.1046/j.1095-8649.2003.00049.x; Ojanguren AF, 1999, AQUACULT INT, V7, P81, DOI 10.1023/A:1009214804949; Pepin P, 1997, CAN J FISH AQUAT SCI, V54, P2, DOI 10.1139/cjfas-54-S1-2; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; PETERSON RH, 1989, AQUACULTURE, V78, P35, DOI 10.1016/0044-8486(89)90004-5; PETERSON RH, 1977, J FISH RES BOARD CAN, V34, P31, DOI 10.1139/f77-004; Piou C, 2012, ECOL MODEL, V231, P37, DOI 10.1016/j.ecolmodel.2012.01.025; Poulet N, 2011, J FISH BIOL, V79, P1436, DOI 10.1111/j.1095-8649.2011.03084.x; Purtscher Ulrich, 2006, Archiv fuer Hydrobiologie Supplement, V158, P649; Radtke G, 2013, FOLIA ZOOL, V62, P247; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Rombough P.J., 1988, P59; Rougier T, 2014, ECOL MODEL, V283, P31, DOI 10.1016/j.ecolmodel.2014.03.019; Schiemer F, 2002, COMP BIOCHEM PHYS A, V133, P439, DOI 10.1016/S1095-6433(02)00246-5; Sfakianakis DG, 2006, AQUACULTURE, V254, P54, DOI 10.1016/j.aquaculture.2005.10.028; Shuter BJ, 2012, AQUAT SCI, V74, P637, DOI 10.1007/s00027-012-0274-3; Souchon Y, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012008; Teletchea F, 2010, J FISH BIOL, V77, P257, DOI 10.1111/j.1095-8649.2010.02689.x; Teletchea F, 2009, J FISH BIOL, V74, P652, DOI 10.1111/j.1095-8649.2008.02160.x; Teletchea F, 2007, CYBIUM, V31, P227; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P403, DOI 10.1007/s11160-008-9102-1; Trabelsi A, 2013, AQUAC RES, V44, P657, DOI 10.1111/j.1365-2109.2011.03070.x; Vernier M, 1969, FISH MARINE SERVICE, V3913; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151; Wood AH, 1932, J EXP BIOL, V9, P271; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Wrona FJ, 2006, AMBIO, V35, P359, DOI 10.1579/0044-7447(2006)35[359:CCEOAB]2.0.CO;2; Yamagami K., 1988, P447	83	37	37	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155487	10.1371/journal.pone.0155487	http://dx.doi.org/10.1371/journal.pone.0155487			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27170996	Green Published, Green Submitted, gold			2022-12-27	WOS:000376588600132
J	Sharma, S; Chowdhury, A; Tang, LL; Willes, L; Glynn, B; Quan, SF				Sharma, Sunil; Chowdhury, Anindita; Tang, Lili; Willes, Leslee; Glynn, Brian; Quan, Stuart F.			Hospitalized Patients at High Risk for Obstructive Sleep Apnea Have More Rapid Response System Events and Intervention Is Associated with Reduced Events	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; OUTCOMES; MORTALITY; PREVALENCE	Background Rapid response system (RRS) is a safety tool designed for early detection and intervention of a deteriorating patient on the general floor in the hospital. Obstructive sleep apnea (OSA) has been associated with significant cardiovascular complications. We hypothesized that patients with high-risk of OSA have higher rate of RRS events and intervention with positive airway pressure therapy in these patients can mitigate the RRS events. Methods As part of a clinical pathway, during a 15 month period, patients with BMI >= 30 kg/m(2) in select medical services were screened with a validated sleep questionnaire. Patients were characterized as high or low risk based on the screening questionnaire. RRS rates were compared between the groups. Subsequently the impact of PAP therapy on RRS events was evaluated. Results Out of the 2,590 patients screened, 1,973 (76%) were identified as high-risk. RRS rates calculated per 1,000 admissions, were 43.60 in the High-Risk OSA group versus 25.91 in the Low-Risk OSA Group. The PAP therapy compliant group had significantly reduced RRS event rates compared to non-compliant group and group with no PAP therapy (16.99 vs. 53.40 vs. 56.21) (p < 0.01). Conclusion In a large cohort of patients at a tertiary care hospital, we show an association of increased rate of RRS events in high-risk OSA patients and reduction of the risk with PAP intervention in the compliant group.	[Sharma, Sunil; Chowdhury, Anindita; Tang, Lili; Glynn, Brian] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Quan, Stuart F.] Harvard Univ, Sch Med, Boston, MA USA; [Quan, Stuart F.] Univ Arizona, Coll Med, Tucson, AZ USA; [Willes, Leslee] Willes Consulting Grp Inc, Encinitas, CA USA	Jefferson University; Harvard University; Harvard Medical School; University of Arizona	Sharma, S (corresponding author), Thomas Jefferson Univ, Philadelphia, PA 19107 USA.	Sunil.Sharma@jefferson.edu	Quan, Stuart/J-5026-2019	Quan, Stuart/0000-0002-9474-7679	RESMED corp.	RESMED corp.	Dr. Sunil Sharma has an unrestricted research grant from RESMED corp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boynton Grace, 2013, J Sleep Disord Treat Care, V2, DOI 10.4172/2325-9639.1000121; Chan PS, 2010, ARCH INTERN MED, V170, P18, DOI 10.1001/archinternmed.2009.424; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; Floras JS, 2014, J CARDIOL, V63, P3, DOI 10.1016/j.jjcc.2013.08.009; Gami AS, 2013, J AM COLL CARDIOL, V62, P610, DOI 10.1016/j.jacc.2013.04.080; Goring K, 2008, J CLIN SLEEP MED, V4, P105; Jean RE, 2015, J CRIT CARE, V30, P778, DOI 10.1016/j.jcrc.2015.03.016; Jennum P, 2015, NAT SCI SLEEP, V7, P43, DOI 10.2147/NSS.S75166; Lindenauer PK, 2014, CHEST, V145, P1032, DOI 10.1378/chest.13-1544; Lyons PG, 2015, J HOSP MED, V10, P592, DOI 10.1002/jhm.2404; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Nagappa M, 2015, ANESTH ANALG, V120, P1013, DOI 10.1213/ANE.0000000000000634; Proczko MA, 2014, J ANESTH, V28, P891, DOI 10.1007/s00540-014-1848-0; Sharma S, 2015, J CLIN SLEEP MED, V11, P717, DOI 10.5664/jcsm.4842; Sharma S, 2012, CLIN CARDIOL, V35, P641, DOI 10.1002/clc.22057; Silva GE, 2011, J CLIN SLEEP MED, V7, P468, DOI 10.5664/JCSM.1308; Spurr KF, 2008, SLEEP BREATH, V12, P229, DOI 10.1007/s11325-007-0166-2; Venkateshiah SB, 2012, CHEST, V141, P1337, DOI 10.1378/chest.11-2591; Winters BD, 2013, ANN INTERN MED, V158, P417, DOI 10.7326/0003-4819-158-5-201303051-00009; Yuan XD, 2015, SLEEP BREATH, V19, P911, DOI 10.1007/s11325-014-1091-9	22	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0153790	10.1371/journal.pone.0153790	http://dx.doi.org/10.1371/journal.pone.0153790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168330	Green Published, gold			2022-12-27	WOS:000376587300048
J	Masakhwe, C; Ochanda, H; Nyakoe, N; Ochiel, D; Waitumbi, J				Masakhwe, Clement; Ochanda, Horace; Nyakoe, Nancy; Ochiel, Daniel; Waitumbi, John			Frequency of Epstein - Barr Virus in Patients Presenting with Acute Febrile Illness in Kenya	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; LATENT MEMBRANE-PROTEIN; DNA LOAD; INFECTIOUS-MONONUCLEOSIS; BURKITTS-LYMPHOMA; UNKNOWN ORIGIN; NON-MALARIA; PCR ASSAY; EBV LOAD; TIME	Background Most acute febrile illnesses (AFI) are usually not associated with a specific diagnosis because of limitations of available diagnostics. This study reports on the frequency of EBV viremia and viral load in children and adults presenting with febrile illness in hospitals in Kenya. Methodology/Principal Findings A pathogen surveillance study was conducted on patients presenting with AFI (N = 796) at outpatient departments in 8 hospitals located in diverse regions of Kenya. Enrollment criterion to the study was fever without a readily diagnosable infection. All the patients had AFI not attributable to the common causes of fever in Kenyan hospitals, such as malaria or rick-ettsiae, leptospira, brucella and salmonella and they were hence categorized as having AFI of unknown etiology. EBV was detected in blood using quantitative TaqMan-based qPCR targeting a highly conserved BALF5 gene. The overall frequency of EBV viremia in this population was 29.2%, with significantly higher proportion in younger children of < 5years (33.8%, p = 0.039) compared to patients aged >= 5 years (26.3% for 5-15 years or 18.8% for > 15 years). With respect to geographical localities, the frequency of EBV viremia was higher in the Lake Victoria region (36.4%), compared to Kisii highland (24.6%), Coastal region (22.2%) and Semi-Arid region (25%). Furthermore, patients from the malaria endemic coastal region and the Lake Victoria region presented with significantly higher viremia than individuals from other regions of Kenya. Conclusions/Significance This study provides profiles of EBV in patients with AFI from diverse eco-regions of Kenya. Of significant interest is the high frequency of EBV viremia in younger children. The observed high frequencies of EBV viremia and elevated viral loads in residents of high malaria transmission areas are probably related to malaria induced immune activation and resultant expansion of EBV infected B-cells.	[Masakhwe, Clement; Ochanda, Horace] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya; [Masakhwe, Clement; Nyakoe, Nancy; Ochiel, Daniel; Waitumbi, John] Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya	University of Nairobi; Kenya Medical Research Institute	Waitumbi, J (corresponding author), Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya.	john.waitumbi@usamru-k.org		Masakhwe,PhD, Dr.Phitalis/0000-0003-4230-8460	US Armed Forces Health Surveillance Center, Division of Global Emerging Infection Surveillance Operations; Global Emerging Infection System (GEIS), division of the Armed Forces Health Surveillance Center	US Armed Forces Health Surveillance Center, Division of Global Emerging Infection Surveillance Operations; Global Emerging Infection System (GEIS), division of the Armed Forces Health Surveillance Center	Financial support for this study was from a grant from the US Armed Forces Health Surveillance Center, Division of Global Emerging Infection Surveillance Operations. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to acknowledge the scientists, technicians and staff of the Walter Reed Project. This work is published with the permission of the Director, Kenya Medical Research Institute. Clement Masakhwe was an MSc student in the School of Biological Sciences, University of Nairobi, Kenya. Financial support for this study was from a grant from the Global Emerging Infection System (GEIS), division of the Armed Forces Health Surveillance Center.	Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269; [Anonymous], 2013, J BIOMED LIFE SCI; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Bauer CC, 2005, J MED VIROL, V75, P54, DOI 10.1002/jmv.20237; BIGGAR RJ, 1978, INT J CANCER, V22, P239, DOI 10.1002/ijc.2910220304; Cameron B, 2006, J INFECT DIS, V193, P664, DOI 10.1086/500248; Centers for Disease Control and Prevention, 2014, EPST BARR VIR INF MO; Chan KH, 2001, J CLIN MICROBIOL, V39, P4152, DOI 10.1128/JCM.39.11.4152-4154;2001; Chow A, 2011, WORLD J PEDIATR, V7, P5, DOI 10.1007/s12519-011-0240-5; CORDIERBUSSAT M, 1993, VIRUS RES, V27, P55, DOI 10.1016/0168-1702(93)90112-Z; Crowcroft NS, 1998, J EPIDEMIOL COMMUN H, V52, P101, DOI 10.1136/jech.52.2.101; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Cunha BA, 2007, INFECT DIS CLIN N AM, V21, P867, DOI 10.1016/j.idc.2007.09.002; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; De Paschale M, 2011, WORLD J VIROL, V1, P31; Division of Malaria Control, 2010, 2010 KEN MALARIA IND; Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921; Gershburg E, 2005, J ANTIMICROB CHEMOTH, V56, P277, DOI 10.1093/jac/dki240; Hayes EC, 2015, AM J SOCIOL, V63, P670; Hess RD, 2004, J CLIN MICROBIOL, V42, P3381, DOI 10.1128/JCM.42.8.3381-3387.2004; Higgins CD, 2007, J INFECT DIS, V195, P474, DOI 10.1086/510854; Hjalgrim H, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P929; Hong JH, 2012, PEDIATR GASTROENTERO, V15, P38, DOI 10.5223/pghn.2012.15.1.38; Jiang J, 2013, VECTOR-BORNE ZOONOT, V13, P550, DOI 10.1089/vbz.2012.1123; JOSKE DJL, 1992, BLOOD, V80, P2610; Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11; Karcheva M, 2008, J IMAB, V14, P9; Karuniawati A, 2012, MED J INDONES, V21, P13; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Korir JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-66; LAM KMC, 1991, LANCET, V337, P876, DOI 10.1016/0140-6736(91)90203-2; Leenman EE, 2004, MODERN PATHOL, V17, P1564, DOI 10.1038/modpathol.3800228; Macsween KF, 2010, CLIN INFECT DIS, V50, P699, DOI 10.1086/650456; Mahende C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104197; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; Moormann AM, 2007, J INFECT DIS, V195, P799, DOI 10.1086/511984; Muhe L, 1999, ARCH DIS CHILD, V81, P216, DOI 10.1136/adc.81.3.216; [National AIDS and STI Control Programme National AIDS Control Council], 2014, KEN HIV COUNT PROF, P150; Njie R, 2009, J INFECT DIS, V199, P31, DOI 10.1086/594373; Odumade OA, 2011, CLIN MICROBIOL REV, V24, P193, DOI 10.1128/CMR.00044-10; Pembrey L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081881; Piriou ER, 2004, J IMMUNOL, V172, P6931, DOI 10.4049/jimmunol.172.11.6931; Piriou E, 2012, J INFECT DIS, V205, P906, DOI 10.1093/infdis/jir872; Piriou E, 2009, J MED VIROL, V81, P1088, DOI 10.1002/jmv.21485; Pitetti RD, 2003, PEDIATR INFECT DIS J, V22, P736, DOI 10.1097/01.inf.0000078157.90639.96; Priavali E, 2012, J MED MICROBIOL DIAG, V2, P10; Probert WS, 2004, J CLIN MICROBIOL, V42, P1290, DOI 10.1128/JCM.42.3.1290-1293.2004; Punjabi NH, 2012, AM J TROP MED HYG, V86, P46, DOI 10.4269/ajtmh.2012.10-0497; Rainey JJ, 2007, TROP MED INT HEALTH, V12, P936, DOI 10.1111/j.1365-3156.2007.01875.x; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; Snider CJ, 2012, PLOS ONE, V7, P1; Stevens SJC, 1999, J CLIN MICROBIOL, V37, P2852, DOI 10.1128/JCM.37.9.2852-2857.1999; Stevens SJC, 2005, J CLIN MICROBIOL, V43, P3066, DOI 10.1128/JCM.43.7.3066-3073.2005; SUMAYA CV, 1975, J INFECT DIS, V131, P403, DOI 10.1093/infdis/131.4.403; Sumba PO, 2010, BRIT J CANCER, V103, P1736, DOI 10.1038/sj.bjc.6605947; Valachis A, 2012, VIRUS ADAPT TREAT, V4, P23; Wick G, 1997, IMMUNOL REV, V160, P171, DOI 10.1111/j.1600-065X.1997.tb01037.x; World Health Organization, 2013, NATURE	60	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155308	10.1371/journal.pone.0155308	http://dx.doi.org/10.1371/journal.pone.0155308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163791	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700022
J	Li, XY; Bleisch, WV; Jiang, XL				Li, Xueyou; Bleisch, William V.; Jiang, Xuelong			Effects of Ethnic Settlements and Land Management Status on Species Distribution Patterns: A Case Study of Endangered Musk Deer (Moschus spp.) in Northwest Yunnan, China	PLOS ONE			English	Article							COST-EFFECTIVENESS; HABITAT SELECTION; PROTECTED AREAS; LARGE HERBIVORE; CONSERVATION; POPULATIONS; SCIENCE; DUNG; ABUNDANCE; HOTSPOTS	Understanding the status and spatial distribution of endangered species in biologically and ethnologically diverse areas is important to address correlates of cultural and biological diversity. We developed models for endangered musk deer (Moschus spp.) abundance indices in and around protected areas inhabited by different ethnic groups in northwest Yunnan China to address different anthropogenic and management-related questions. We found that prediction of relative abundance of musk deer was best accomplished using ethnicity of settlements, conservation status and poaching pressure in an area. Musk deer were around 5 times more abundant in Tibetan regions relative to Lisu regions. We found no significant negative correlates of gathering and transhumance activities on musk deer abundance. Hunting pressure showed no significant differences between protected and non-protected areas, but showed significant differences among ethnic groups. Hunting pressures in areas adjacent to Lisu settlements was 7.1 times more than in areas adjacent to Tibetan settlements. Our findings indicate protected areas in southwest China are not fully effective in deterring human disturbance caused by traditional practices. We suggest that conservation and management strategies should engage traditional culture and practices with a positive conservation impact. Better understanding of indigenous culture may open up new opportunities for species conservation in much wider tracts of unprotected and human-dominated lands. Traditional practices that are not destructive to biodiversity should be allowed as a way of providing a link between the local communities and protected areas thereby creating incentives for conservation.	[Li, Xueyou; Jiang, Xuelong] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Bleisch, William V.] China Explorat & Res Soc, Wong Chuk Hang, Hong Kong, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology	Jiang, XL (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	jiangxl@mail.kiz.ac.cn		Li, Xueyou/0000-0002-4705-6082	Special Program for Biodiversity Conservation; Ministry of Environmental Protection of China; Special Funds for Ecological Construction of Yunnan Province and the Second National Terrestrial Vertebrate Resources Survey of China [Forestry 2013-52]; China Exploration and Research Society (CERS); Symrise Corporation	Special Program for Biodiversity Conservation; Ministry of Environmental Protection of China; Special Funds for Ecological Construction of Yunnan Province and the Second National Terrestrial Vertebrate Resources Survey of China; China Exploration and Research Society (CERS); Symrise Corporation	The study was supported by the Special Program for Biodiversity Conservation, the Ministry of Environmental Protection of China, and the Special Funds for Ecological Construction of Yunnan Province and the Second National Terrestrial Vertebrate Resources Survey of China (Forestry [2013]-52) and partly funded by China Exploration and Research Society (CERS) and the Symrise Corporation.	Acevedo P, 2010, ECOL INDIC, V10, P1226, DOI 10.1016/j.ecolind.2010.04.006; Baker LR, 2014, BIODIVERS CONSERV, V23, P1895, DOI 10.1007/s10531-014-0694-6; Bhola N, 2012, J ANIM ECOL, V81, P1268, DOI 10.1111/j.1365-2656.2012.02000.x; Brandt JS, 2015, BIOL CONSERV, V181, P1, DOI 10.1016/j.biocon.2014.09.043; Buntaine Mark T., 2007, Environment Development and Sustainability, V9, P305, DOI 10.1007/s10668-006-9025-8; Campbell D, 2004, J APPL ECOL, V41, P1185, DOI 10.1111/j.0021-8901.2004.00964.x; Carter NH, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00191.1; da Fonseca G.A.B., 2004, HOTSPOTS REVISTED EA; Daniels MJ, 2006, MAMMAL REV, V36, P235, DOI 10.1111/j.1365-2907.2006.00091.x; Ens EJ, 2015, BIOL CONSERV, V181, P133, DOI 10.1016/j.biocon.2014.11.008; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Guan TP, 2015, BIOL CONSERV, V182, P63, DOI 10.1016/j.biocon.2014.11.041; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Jaeger T, 2013, REPORT MISSION 3 PAR; Jiang Z., 2015, CHINAS MAMMAL DIVERS; Karanth KU, 2013, P NATL ACAD SCI USA, V110, pE110, DOI 10.1073/pnas.1216623110; Khorozyan I, 2014, BIODIVERS CONSERV, V23, P1995, DOI 10.1007/s10531-014-0700-z; Klar N, 2008, BIOL CONSERV, V141, P308, DOI 10.1016/j.biocon.2007.10.004; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; Li XY, 2014, J NAT CONSERV, V22, P474, DOI 10.1016/j.jnc.2014.05.004; Li XY, 2014, POPUL ECOL, V56, P251, DOI 10.1007/s10144-013-0405-2; LI Z-X, 1981, Zoological Research, V2, P157; Licona M, 2011, ANIM CONSERV, V14, P206, DOI 10.1111/j.1469-1795.2010.00416.x; Liu ZJ, 2009, MOL ECOL, V18, P3831, DOI 10.1111/j.1365-294X.2009.04330.x; Marques FFC, 2001, J APPL ECOL, V38, P349, DOI 10.1046/j.1365-2664.2001.00584.x; McLoughlin PD, 2011, BASIC APPL ECOL, V12, P654, DOI 10.1016/j.baae.2011.09.001; Meng XX, 2012, SCIENCE, V335, P1168, DOI 10.1126/science.335.6073.1168-a; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olea PP, 2009, BIOL CONSERV, V142, P1844, DOI 10.1016/j.biocon.2009.03.024; Paudel PK, 2012, ANIM CONSERV, V15, P283, DOI 10.1111/j.1469-1795.2011.00514.x; Ribeiro EMS, 2015, J APPL ECOL, V52, P611, DOI 10.1111/1365-2664.12420; Shen XL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04785-170213; Shen XL, 2012, BIOL CONSERV, V145, P160, DOI 10.1016/j.biocon.2011.10.027; Silva AP, 2013, DIVERS DISTRIB, V19, P232, DOI 10.1111/ddi.12018; Smart JCR, 2004, MAMMAL REV, V34, P99, DOI 10.1046/j.0305-1838.2003.00026.x; Terborgh J, 2005, CONSERV BIOL, V19, P5, DOI 10.1111/j.1523-1739.2005.l08_2.x; Webbon CC, 2004, J APPL ECOL, V41, P768, DOI 10.1111/j.0021-8901.2004.00930.x; Wu RD, 2011, FRONT ECOL ENVIRON, V9, P383, DOI 10.1890/100093; Xu JC, 2007, CONSERV BIOL, V21, P318, DOI 10.1111/j.1523-1739.2006.00636.x; Yang QS, 2003, BIOL CONSERV, V109, P333, DOI 10.1016/S0006-3207(02)00159-3	42	8	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155042	10.1371/journal.pone.0155042	http://dx.doi.org/10.1371/journal.pone.0155042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159052	Green Published, gold, Green Submitted			2022-12-27	WOS:000376576700033
J	van de Kerk, M; Littles, CJ; Saucedo, O; Lorenzen, K				van de Kerk, Madelon; Littles, Chanda Jones; Saucedo, Omar; Lorenzen, Kai			The Effect of Latitudinal Variation on Shrimp Reproductive Strategies	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; BROWN SHRIMP; PENAEUS-AZTECUS; DECAPODA PENAEIDAE; WHITE SHRIMP; LIFE-HISTORY; POPULATION; TEXAS; GULF; LOUISIANA	Reproductive strategies comprise the timing and frequency of reproductive events and the number of offspring per reproductive event, depending on factors such as climate conditions. Therefore, species that exhibit plasticity in the allocation of reproductive effort can alter their behavior in response to climate change. Studying how the reproductive strategy of species varies along the latitudinal gradient can help us understand and predict how they will respond to climate change. We investigated the effects of the temporal allocation of reproductive effort on the population size of brown shrimp (Farfantepenaeus aztecus) along a latitudinal gradient. Multiple shrimp species exhibit variation in their reproductive strategies, and given the economic importance of brown shrimp to the commercial fishing sector of the Unites States, changes in the timing of their reproduction could have significant economic and social consequences. We used a stage-based, density-dependent matrix population model tailored to the life history of brown shrimp. Shrimp growth rates and environmental carrying capacity were varied based on the seasonal climate conditions at different latitudes, and we estimated the population size at equilibrium. The length of the growing season increased with decreasing latitude and the reproductive strategy leading to the highest population size changed from one annual birth pulse with high reproductive output to continuous low-output reproduction. Hence, our model confirms the classical paradigm of continuous reproduction at low latitudes, with increased seasonality of the breeding period towards the poles. Our results also demonstrate the potential for variation in climate to affect the optimal reproductive strategy for achieving maximum population sizes. Certainly, understanding these dynamics may inform more comprehensive management strategies for commercially important species like brown shrimp.	[van de Kerk, Madelon] Univ Florida, Dept Wildlife Ecol & Conservat, 110 Newins Ziegler Hall, Gainesville, FL 32611 USA; [Littles, Chanda Jones] Univ Florida, Sch Nat Resources & Environm, 103 Black Hall, Gainesville, FL 32611 USA; [Saucedo, Omar] Univ Florida, Dept Math, 358 Little Hall, Gainesville, FL 32611 USA; [Lorenzen, Kai] Univ Florida, Sch Forest Resources & Conservat, 7922 NW 71st St, Gainesville, FL 32653 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	van de Kerk, M (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, 110 Newins Ziegler Hall, Gainesville, FL 32611 USA.	m.vandekerk@ufl.edu	Saucedo, Omar/GOK-2512-2022; Lorenzen, Kai/A-3032-2015	Saucedo, Omar/0000-0003-3900-7712; Lorenzen, Kai/0000-0002-9691-3693	Integrative Graduate Education and Research Traineeship program under National Science Program [0801544]; QSE3 IGERT program	Integrative Graduate Education and Research Traineeship program under National Science Program; QSE3 IGERT program	Funding for this research was provided by an Integrative Graduate Education and Research Traineeship program under National Science Program grant 0801544.; We acknowledge the QSE<SUP>3</SUP> IGERT program and its participants for their helpful insights and support. We also thank the NOAA Fisheries Galveston Laboratory and the Louisiana Department of Wildlife and Fisheries for their assistance with data acquisition.	Aragon-Noriega EA, 2007, REV BIOL MAR OCEANOG, V42, P167; Baker R, 2014, FISH RES, V155, P74, DOI 10.1016/j.fishres.2014.02.026; BAUER RT, 1992, INVERTEBR REPROD DEV, V22, P193, DOI 10.1080/07924259.1992.9672272; BEUKEMA JJ, 1992, MAR ECOL PROG SER, V83, P157, DOI 10.3354/meps083157; Bye V.J., 1984, P187; Cailloulet CW, 2008, FISH RES, V92, P289, DOI 10.1016/j.fishres.2008.01.009; Castilho AL, 2007, REV BIOL TROP, V55, P39; Caswell, 2000, MATRIX POPULATION MO; CHILDERS D L, 1990, Climate Research, V1, P31, DOI 10.3354/cr001031; Cole JG, 2006, N AM J FISH MANAGE, V26, P789, DOI 10.1577/M05-182.1; Colihueque N, 2010, GENET MOL BIOL, V33, P578, DOI 10.1590/S1415-47572010000300032; da Costa RC, 2004, J CRUSTACEAN BIOL, V24, P274, DOI 10.1651/C-2437; da Costa RG, 2010, J MAR BIOL ASSOC UK, V90, P663, DOI 10.1017/S002531540999124X; Eliot J. A., 1981, NEUROENDOCRINOLOGY R, P377; Fisher RA, 1930, GENETICAL THEORY NAT; Gandy Ryan L, 2004, INVESTIGATIONS REPRO; GIESEL JT, 1976, ANNU REV ECOL SYST, V7, P57, DOI 10.1146/annurev.es.07.110176.000421; GRANT WE, 1979, T AM FISH SOC, V108, P1, DOI 10.1577/1548-8659(1979)108<1:ABMOTG>2.0.CO;2; Haas HL, 2004, ECOL APPL, V14, P1232, DOI 10.1890/03-5101; Haas HL, 2001, CAN J FISH AQUAT SCI, V58, P2258, DOI 10.1139/cjfas-58-11-2258; Huang L, 2011, ECOL ECON, V70, P688, DOI 10.1016/j.ecolecon.2010.11.003; Kawamichi T, 2010, J MAMMAL, V91, P905, DOI 10.1644/09-MAMM-A-207.1; Knudsen E.E., 1989, North American Journal of Fisheries Management, V9, P411, DOI 10.1577/1548-8675(1989)009<0411:EOAFCW>2.3.CO;2; LEGGETT WC, 1978, J FISH RES BOARD CAN, V35, P1469, DOI 10.1139/f78-230; Li JK, 2005, ESTUAR COAST SHELF S, V64, P261, DOI 10.1016/j.ecss.2005.02.019; Minello TJ, 2012, ESTUAR COAST, V35, P501, DOI 10.1007/s12237-011-9463-x; MINELLO TJ, 1992, MAR ECOL PROG SER, V90, P273, DOI 10.3354/meps090273; MINELLO TJ, 1989, T AM FISH SOC, V118, P693, DOI 10.1577/1548-8659(1989)118<0693:MOYBSP>2.3.CO;2; MINELLO TJ, 1983, J EXP MAR BIOL ECOL, V72, P211, DOI 10.1016/0022-0981(83)90107-7; Minello TJ, 2002, ECOL APPL, V12, P441; Nance James M., 1994, North American Journal of Fisheries Management, V14, P522, DOI 10.1577/1548-8675(1994)014<0522:FOITER>2.3.CO;2; NICHOLS JD, 1976, AM NAT, V110, P995, DOI 10.1086/283122; Onal H., 1991, American Journal of Agricultural Economics, V73, P1161, DOI 10.2307/1242444; Paramo J, 2014, REV BIOL TROP, V62, P513; Perez-Castaneda R, 2001, ESTUAR COAST SHELF S, V52, P631, DOI 10.1006/ecss.2001.0771; Reed DH, 2005, CONSERV BIOL, V19, P563, DOI 10.1111/j.1523-1739.2005.00444.x; ROSE CD, 1975, T AM FISH SOC, V104, P296, DOI 10.1577/1548-8659(1975)104<296:ECOPSI>2.0.CO;2; Simoes SM, 2013, J CRUSTACEAN BIOL, V33, P1, DOI 10.1163/1937240X-00002108; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; WARD JM, 1994, AM J AGR ECON, V76, P916, DOI 10.2307/1243751; WILLIAMS AUSTIN B., 1955, BULL MARINE SCI GULF AND CARIBBEAN, V5, P116; WINEMILLER KO, 1989, OECOLOGIA, V81, P225, DOI 10.1007/BF00379810; ZEINELDIN ZP, 1965, BIOL BULL-US, V129, P199, DOI 10.2307/1539778; ZEINELDIN ZP, 1986, MAR FISH REV, V48, P9; ZIMMERMAN RJ, 1984, ESTUARIES, V7, P421, DOI 10.2307/1351623	45	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155266	10.1371/journal.pone.0155266	http://dx.doi.org/10.1371/journal.pone.0155266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158895	Green Published, gold, Green Submitted			2022-12-27	WOS:000376576700053
J	Zhang, L; Wang, SB; Li, QG; Song, J; Hao, YQ; Zhou, L; Zheng, HQ; Dunwell, JM; Zhang, YM				Zhang, Li; Wang, Shi-Bo; Li, Qi-Gang; Song, Jian; Hao, Yu-Qi; Zhou, Ling; Zheng, Huan-Quan; Dunwell, Jim M.; Zhang, Yuan-Ming			An Integrated Bioinformatics Analysis Reveals Divergent Evolutionary Pattern of Oil Biosynthesis in High- and Low-Oil Plants	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; ACETYL-COA CARBOXYLASE; RAPE BRASSICA-NAPUS; CHAIN ACYL-COENZYME; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; LIPID-CONTENT; SEED-DEVELOPMENT; OVER-EXPRESSION; GENE	Seed oils provide a renewable source of food, biofuel and industrial raw materials that is important for humans. Although many genes and pathways for acyl-lipid metabolism have been identified, little is known about whether there is a specific mechanism for high-oil content in high-oil plants. Based on the distinct differences in seed oil content between four high-oil dicots (20 similar to 50%) and three low-oil grasses (<3%), comparative genome, transcriptome and differential expression analyses were used to investigate this mechanism. Among 4,051 dicot-specific soybean genes identified from 252,443 genes in the seven species, 54 genes were shown to directly participate in acyl-lipid metabolism, and 93 genes were found to be associated with acyl-lipid metabolism. Among the 93 dicot-specific genes, 42 and 27 genes, including CBM20-like SBDs and GPT2, participate in carbohydrate degradation and transport, respectively. 40 genes highly up-regulated during seed oil rapid accumulation period are mainly involved in initial fatty acid synthesis, triacylglyceride assembly and oil-body formation, for example, ACCase, PP, DGAT1, PDAT1, OLEs and STEROs, which were also found to be differentially expressed between high-and low-oil soybean accessions. Phylogenetic analysis revealed distinct differences of oleosin in patterns of gene duplication and loss between high-oil dicots and low-oil grasses. In addition, seed-specific GmGRF5, ABI5 and GmTZF4 were predicted to be candidate regulators in seed oil accumulation. This study facilitates future research on lipid biosynthesis and potential genetic improvement of seed oil content.	[Zhang, Li; Wang, Shi-Bo; Song, Jian; Hao, Yu-Qi; Zhou, Ling; Zhang, Yuan-Ming] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Shi-Bo; Zhang, Yuan-Ming] Huazhong Agr Univ, Coll Plant Sci & Technol, Stat Genom Lab, Wuhan 430070, Peoples R China; [Li, Qi-Gang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Zhou, Ling] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing 210014, Jiangsu, Peoples R China; [Zheng, Huan-Quan] McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada; [Dunwell, Jim M.] Univ Reading, Sch Agr Policy & Dev, Reading RG6 6AS, Berks, England	Nanjing Agricultural University; Huazhong Agricultural University; Chinese Academy of Sciences; Kunming Institute of Zoology; Jiangsu Academy of Agricultural Sciences; McGill University; University of Reading	Zhang, YM (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.; Zhang, YM (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Stat Genom Lab, Wuhan 430070, Peoples R China.	soyzhang@njau.edu.cn	Zhang, Yuan-Ming/AFQ-8637-2022; Zhang, Yuan-Ming/AAT-2899-2021; Dunwell, Jim/AAS-6217-2020	Zhang, Yuan-Ming/0000-0003-2317-2190; Zhang, Li/0000-0002-7862-6690; Dunwell, Jim/0000-0003-2147-665X; Zheng, Huanquan/0000-0003-2986-725X	National Natural Science Foundation of China [31571268]; Huazhong Agricultural University Scientific and Technological Self-innovation Foundation [2014RC020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong Agricultural University Scientific and Technological Self-innovation Foundation	This work was supported by the National Natural Science Foundation of China (grant 31571268), and Huazhong Agricultural University Scientific and Technological Self-innovation Foundation (Program No. 2014RC020).	Allen DK, 2013, PLANT PHYSIOL, V161, P1458, DOI 10.1104/pp.112.203299; Andre C, 2007, PLANT CELL, V19, P2006, DOI 10.1105/tpc.106.048629; Andriotis VME, 2010, PLANT J, V64, P128, DOI 10.1111/j.1365-313X.2010.04313.x; Andriotis VME, 2010, NEW PHYTOL, V185, P649, DOI 10.1111/j.1469-8137.2009.03113.x; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Aubert D, 1998, PLANT MOL BIOL, V36, P871, DOI 10.1023/A:1005938624418; Banas W, 2013, PLANTA, V237, P1627, DOI 10.1007/s00425-013-1870-8; Bao XM, 2000, PLANT J, V22, P39, DOI 10.1046/j.1365-313x.2000.00712.x; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; Baud S, 2009, PLANT J, V60, P933, DOI 10.1111/j.1365-313X.2009.04011.x; Baud S, 2009, PLANT PHYSIOL BIOCH, V47, P448, DOI 10.1016/j.plaphy.2008.12.006; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Bi YM, 2005, PLANT J, V44, P680, DOI 10.1111/j.1365-313X.2005.02568.x; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Branen JK, 2001, PLANT PHYSIOL, V127, P222, DOI 10.1104/pp.127.1.222; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen MJ, 2009, PLANT PHYSIOL, V150, P27, DOI 10.1104/pp.108.134882; Chen MX, 2012, PLANT CELL ENVIRON, V35, P2155, DOI 10.1111/j.1365-3040.2012.02546.x; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; Crowe AJ, 2000, PLANT SCI, V151, P171, DOI 10.1016/S0168-9452(99)00214-9; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; Dyson BC, 2015, PLANT CELL ENVIRON, V38, P1404, DOI 10.1111/pce.12495; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fischer K, 2011, PLANT PHYSIOL, V155, P1511, DOI 10.1104/pp.110.170241; Fu FF, 2010, PLANT PHYSIOL, V154, P927, DOI 10.1104/pp.110.159517; Fukuda N, 2013, PLANT MOL BIOL, V82, P473, DOI 10.1007/s11103-013-0075-7; Girke T, 2000, PLANT PHYSIOL, V124, P1570, DOI 10.1104/pp.124.4.1570; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-596; Hayden DM, 2011, PLANT J, V67, P1018, DOI 10.1111/j.1365-313X.2011.04654.x; Jain RK, 2000, BIOCHEM SOC T, V28, P958, DOI 10.1042/BST0280958; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Jessen D, 2015, PLANT PHYSIOL, V167, P351, DOI 10.1104/pp.114.250365; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jones SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059270; Kammerer B, 1998, PLANT CELL, V10, P105, DOI 10.1105/tpc.10.1.105; Ke J, 2000, PLANT PHYSIOL, V123, P497, DOI 10.1104/pp.123.2.497; Kim HU, 2002, J BIOL CHEM, V277, P22677, DOI 10.1074/jbc.M109298200; Kim Hye Joo, 2012, Evid Based Complement Alternat Med, V2012, P639469, DOI 10.1155/2012/639469; Kim JS, 2009, FASEB J, V23; Klaus D, 2004, PLANTA, V219, P389, DOI 10.1007/s00425-004-1236-3; Konishi T, 1996, PLANT CELL PHYSIOL, V37, P117, DOI 10.1093/oxfordjournals.pcp.a028920; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Lee J, 2011, PLANT BIOTECHNOL J, V9, P359, DOI 10.1111/j.1467-7652.2010.00562.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li YT, 2010, BIOTECHNOL BIOENG, V107, P258, DOI 10.1002/bit.22807; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Liu WX, 2013, THEOR APPL GENET, V126, P2289, DOI 10.1007/s00122-013-2135-4; Liu YF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-73; Lu SP, 2013, PLANT BIOTECHNOL J, V11, P380, DOI 10.1111/pbi.12028; Ma W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068887; Maeo K, 2009, PLANT J, V60, P476, DOI 10.1111/j.1365-313X.2009.03967.x; Maisonneuve S, 2010, PLANT PHYSIOL, V152, P670, DOI 10.1104/pp.109.148247; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; Meyer K, 2012, PLANT PHYSIOL, V159, P1221, DOI 10.1104/pp.112.198309; Mhaske V, 2005, PLANT PHYSIOL BIOCH, V43, P413, DOI 10.1016/j.plaphy.2005.01.013; Miquel M, 2014, PLANT PHYSIOL, V164, P1866, DOI 10.1104/pp.113.233262; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P785, DOI 10.1093/pcp/pcr035; Monke G, 2012, NUCLEIC ACIDS RES, V40, P8240, DOI 10.1093/nar/gks594; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; Niewiadomski P, 2005, PLANT CELL, V17, P760, DOI 10.1105/tpc.104.029124; Ohlrogge JB, 1997, ANNU REV PLANT PHYS, V48, P109, DOI 10.1146/annurev.arplant.48.1.109; Pedersen P., 2004, SOYBEAN GROWTH DEV; Pinot F, 2011, FEBS J, V278, P195, DOI 10.1111/j.1742-4658.2010.07948.x; Pouvreau B, 2011, PLANT PHYSIOL, V156, P674, DOI 10.1104/pp.111.173641; Raven P, 2010, BIOLOGY; Rawsthorne S, 2002, PROG LIPID RES, V41, P182, DOI 10.1016/S0163-7827(01)00023-6; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Rodriguez-Sanoja R, 2005, CURR OPIN MICROBIOL, V8, P260, DOI 10.1016/j.mib.2005.04.013; Roesler K, 1997, PLANT PHYSIOL, V113, P75, DOI 10.1104/pp.113.1.75; Sanjaya, 2011, PLANT BIOTECHNOL J, V9, P874, DOI 10.1111/j.1467-7652.2011.00599.x; Schwender J, 2012, PLANT PHYSIOL, V160, P1218, DOI 10.1104/pp.112.203927; Scotland RW, 2003, TAXON, V52, P101, DOI 10.2307/3647306; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shen B, 2010, PLANT PHYSIOL, V153, P980, DOI 10.1104/pp.110.157537; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Smooker AM, 2011, THEOR APPL GENET, V122, P1075, DOI 10.1007/s00122-010-1512-5; Song QX, 2013, J EXP BOT, V64, P4329, DOI 10.1093/jxb/ert238; Southall SM, 1999, FEBS LETT, V447, P58, DOI 10.1016/S0014-5793(99)00263-X; Sreenivasulu N, 2013, ANNU REV PLANT BIOL, V64, P189, DOI 10.1146/annurev-arplant-050312-120215; Sun LQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6372; Tan HL, 2011, PLANT PHYSIOL, V156, P1577, DOI 10.1104/pp.111.175000; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Tjellstrom H, 2015, J EXP BOT, V66, P1453, DOI 10.1093/jxb/eru500; Van Dongen SM, 2000, THESIS U UTRECHT NET; van Erp H, 2014, PLANT PHYSIOL, V165, P30, DOI 10.1104/pp.114.236430; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; Vanhercke T, 2013, FEBS LETT, V587, P364, DOI 10.1016/j.febslet.2012.12.018; Velmurugan N, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0117-7; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Wakao S, 2008, PLANT PHYSIOL, V146, P277, DOI 10.1104/pp.107.108423; Wang HY, 2007, PLANTA, V226, P773, DOI 10.1007/s00425-007-0524-0; Wang HW, 2007, PLANT J, V52, P716, DOI 10.1111/j.1365-313X.2007.03268.x; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang LH, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r39; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Weselake RJ, 2008, J EXP BOT, V59, P3543, DOI 10.1093/jxb/ern206; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Wu XL, 2014, J INTEGR PLANT BIOL, V56, P582, DOI 10.1111/jipb.12158; Yamamoto A, 2010, PLANT CELL PHYSIOL, V51, P2031, DOI 10.1093/pcp/pcq162; Ying JZ, 2012, MOL PLANT, V5, P865, DOI 10.1093/mp/ssr100; Zhao LF, 2010, PLANT J, V64, P1048, DOI 10.1111/j.1365-313X.2010.04396.x; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	110	15	16	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154882	10.1371/journal.pone.0154882	http://dx.doi.org/10.1371/journal.pone.0154882			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159078	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000376576700022
J	Reafee, W; Salim, N; Khan, A				Reafee, Waleed; Salim, Naomie; Khan, Atif			The Power of Implicit Social Relation in Rating Prediction of Social Recommender Systems	PLOS ONE			English	Article							MATRIX FACTORIZATION; NETWORK; INFERENCE	The explosive growth of social networks in recent times has presented a powerful source of information to be utilized as an extra source for assisting in the social recommendation problems. The social recommendation methods that are based on probabilistic matrix factorization improved the recommendation accuracy and partly solved the cold-start and data sparsity problems. However, these methods only exploited the explicit social relations and almost completely ignored the implicit social relations. In this article, we firstly propose an algorithm to extract the implicit relation in the undirected graphs of social networks by exploiting the link prediction techniques. Furthermore, we propose a new probabilistic matrix factorization method to alleviate the data sparsity problem through incorporating explicit friendship and implicit friendship. We evaluate our proposed approach on two real datasets, Last. Fm and Douban. The experimental results show that our method performs much better than the state-of-the-art approaches, which indicates the importance of incorporating implicit social relations in the recommendation process to address the poor prediction accuracy.	[Reafee, Waleed; Khan, Atif] Univ Teknol Malaysia, Dept Comp Sci, Fac Comp, Skudai, Johor, Malaysia; [Salim, Naomie] Univ Teknol Malaysia, Dept Informat Syst, Fac Comp, Skudai, Johor, Malaysia; [Reafee, Waleed] Int Univ Africa, Dept Math & Comp Sci, Fac Pure & Appl Sci, Khartoum, Sudan	Universiti Teknologi Malaysia; Universiti Teknologi Malaysia	Reafee, W (corresponding author), Univ Teknol Malaysia, Dept Comp Sci, Fac Comp, Skudai, Johor, Malaysia.; Reafee, W (corresponding author), Int Univ Africa, Dept Math & Comp Sci, Fac Pure & Appl Sci, Khartoum, Sudan.	reafee@gmail.com	Reafee, Waleed/AAF-7009-2019	Reafee, Waleed/0000-0001-8119-7324				Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Airoldi E.M., 2006, P INT BIOM SOC ANN M, P1; Al Falahi K, 2012, COMPUTATIONAL SOCIAL, P445; Al Hasan M, 2006, SDM06 WORKSH LINK AN; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Bartal A, 2009, SOC NETW AN MIN 2009; Bayrak AE, 2014, P 8 WORKSH SOC NETW; Bell RM, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P95; Bellogin A, 2013, P 10 C OP RES AR INF; Bergner Yoav, 2012, MODEL BASED COLLABOR; Breese J., 1998, P 14 C UNC ART INT M, P43; Cantador I., 2011, 2 WORKSH INF HET FUS; Deshpande M, 2004, ACM T INFORM SYST, V22, P143, DOI 10.1145/963770.963776; Gui-Rong Xue, 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P114; Hofmann T, 2003, P 26 ANN INT ACM SIG; Huang LW, 2013, J ZHEJIANG U-SCI C, V14, P711, DOI 10.1631/jzus.CIIP1303; Huang Z., 2005, P 5 ACM IEEE CS JOIN; Huang Z, 2006, WORKSH LINK AN KDD; Jamali Mohsen, 2010, P 4 ACM C REC SYST, P135, DOI DOI 10.1145/1864708.1864736; Jin Rong, 2004, P 27 ANN INT ACM SIG; Kashima H, 2006, DAT MIN 2006 ICDM 06; Koren Yehuda, 2008, KDD, P426, DOI DOI 10.1145/1401890.1401944; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Liu FK, 2010, EXPERT SYST APPL, V37, P4772, DOI 10.1016/j.eswa.2009.12.061; Liu JT, 2013, DECIS SUPPORT SYST, V55, P838, DOI 10.1016/j.dss.2013.04.002; Liu Y, 2007, ACM SIGKDD EXPLORATI, V9, P62, DOI DOI 10.1145/1345448.1345462; Ma H, 2009, P 32 INT ACM SIGIR C; Ma H, 2013, P 36 INT ACM SIGIR C; Ma H., 2008, P 17 ACM C INF KNOWL, P931; Ma H, 2011, ACM T INFORM SYST, V29, DOI 10.1145/1961209.1961212; Ma Hao, 2011, ACM WSDM, P287; Mnih A, 2007, PROBABILISTIC MATRIX; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025102; Ou Q, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021102; Parimi R, 2011, LECT NOTES ARTIF INT, V6635, P75, DOI 10.1007/978-3-642-20847-8_7; Reafee W, 2014, P 1 INT C ADV DAT IN; RESNICK P, 1994, 1994 ACM C COMPUTER, P175, DOI [DOI 10.1145/192844.192905, 10.1145/192844.192905]; Salton G, 1983, INTRO MODERN INFORM; Sarwar B., 2001, P 10 INT C WORLD WID, P285, DOI [DOI 10.1145/371920.372071, 10.1145/371920.372071]; Shen Y., 2012, P 18 ACM SIGKDD INT; Sun ZB, 2015, J SYST SOFTWARE, V99, P109, DOI 10.1016/j.jss.2014.09.019; Ungar L. H., 1998, AAAI WORKSH REC SYST; Wang T, 2014, P 23 ACM INT C C INF; Yamanishi Y, 2005, BIOINFORMATICS, V21, pI468, DOI 10.1093/bioinformatics/bti1012; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049126; Yang XW, 2013, IEEE T PARALL DISTR, V24, P642, DOI 10.1109/TPDS.2012.192; Zhang Y, 2013, KNOWL-BASED SYST, V54, P310, DOI 10.1016/j.knosys.2013.09.018; Zheng XY, 2016, CHINESE J ELECTRON, V25, P334, DOI 10.1049/cje.2016.03.021	51	15	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154848	10.1371/journal.pone.0154848	http://dx.doi.org/10.1371/journal.pone.0154848			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152663	gold, Green Submitted, Green Published			2022-12-27	WOS:000375677000041
J	Siletsky, SA; Rappaport, F; Poole, RK; Borisov, VB				Siletsky, Sergey A.; Rappaport, Fabrice; Poole, Robert K.; Borisov, Vitaliy B.			Evidence for Fast Electron Transfer between the High-Spin Haems in Cytochrome bd-I from Escherichia coli	PLOS ONE			English	Article							AEROBIC RESPIRATORY CHAINS; OXYGEN-REDUCING SITE; QUINOL OXIDASE BD; C-OXIDASE; ACTIVE-SITE; UBIQUINOL OXIDASE; TERMINAL OXIDASE; RHODOBACTER-SPHAEROIDES; PARACOCCUS-DENITRIFICANS; THERMUS-THERMOPHILUS	Cytochrome bd-I is one of the three proton motive force-generating quinol oxidases in the O-2-dependent respiratory chain of Escherichia coli. It contains one low-spin haem (b(558)) and the two high-spin haems (b(595) and d) as the redox-active cofactors. In order to examine the flash-induced intraprotein reverse electron transfer (the so-called ''electron backflow''), CO was photolyzed from the ferrous haem d in one-electron reduced (b(558)(3+)b(595)(3+)d(2+)-CO) cytochrome bd-I, and the fully reduced (b(558)(2+)b(595)(2+d2+)-CO) oxidase as a control. In contrast to the fully reduced cytochrome bd-I, the transient spectrum of one-electron reduced oxidase at a delay time of 1.5 mu s is clearly different from that at a delay time of 200 ns. The difference between the two spectra can be modeled as the electron transfer from haem d to haem b(595) in 3-4% of the cytochrome bd-I population. Thus, the interhaem electron back-flow reaction induced by photodissociation of CO from haem d in one-electron reduced cytochrome bd-I comprises two kinetically different phases: the previously unnoticed fast electron transfer from haem d to haem b(595) within 0.2-1.5 mu s and the slower well-defined electron equilibration with tau similar to 16 mu s. The major new finding of this work is the lack of electron transfer at 200 ns.	[Siletsky, Sergey A.; Borisov, Vitaliy B.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Rappaport, Fabrice] Univ Paris 06, Inst Biol Physicochim, Unite Mixte Rech 7141, CNRS, Paris, France; [Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	Lomonosov Moscow State University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Sheffield	Siletsky, SA; Borisov, VB (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.; Poole, RK (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	siletsky@belozersky.msu.su; r.poole@sheffield.ac.uk; bor@genebee.msu.su	Borisov, Vitaliy B/C-9504-2012; Siletsky, Sergey A./D-8076-2012	Borisov, Vitaliy B/0000-0002-3400-9068; 	UK Biotechnology and Biological Sciences Research Council [BB/H016805/1, BB/I004122/1]; Russian Foundation for Basic Research [14-04-00153, 15-04-06266]; Biotechnology and Biological Sciences Research Council [BB/H016805/1, BB/I004122/1] Funding Source: researchfish; BBSRC [BB/H016805/1, BB/I004122/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Research Grants from the UK Biotechnology and Biological Sciences Research Council (BB/H016805/1 and BB/I004122/1, to RKP), and the Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng) - research projects. 14-04-00153 (to VBB) and 15-04-06266 (to SAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELROTH P, 1995, BIOCHEMISTRY-US, V34, P2844; Allen RJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-946; Arutyunyan AM, 2008, BIOCHEMISTRY-US, V47, P1752, DOI 10.1021/bi701884g; Arutyunyan AM, 2012, BBA-BIOENERGETICS, V1817, P2087, DOI 10.1016/j.bbabio.2012.06.009; Azarkina N, 1999, J BIOL CHEM, V274, P32810, DOI 10.1074/jbc.274.46.32810; Azarkina N, 1997, FEBS LETT, V416, P171, DOI 10.1016/S0014-5793(97)01196-4; Beal D, 1999, REV SCI INSTRUM, V70, P202, DOI 10.1063/1.1149566; Belevich I, 2005, P NATL ACAD SCI USA, V102, P3657, DOI 10.1073/pnas.0405683102; Belevich I, 2007, J BIOL CHEM, V282, P28514, DOI 10.1074/jbc.M705562200; Beratan DN, 2008, P NATL ACAD SCI USA, V105, P403, DOI 10.1073/pnas.0711343105; Bloch DA, 2009, BBA-BIOENERGETICS, V1787, P1246, DOI 10.1016/j.bbabio.2009.05.003; Borisov V, 1999, BIOCHEMISTRY-US, V38, P740, DOI 10.1021/bi981908t; Borisov V, 1995, BIOCHEM MOL BIOL INT, V37, P975; Borisov VB, 2008, BIOCHEMISTRY-MOSCOW+, V73, P14, DOI 10.1134/S0006297908010021; Borisov VB, 2015, BIOCHEMISTRY-MOSCOW+, V80, P565, DOI 10.1134/S0006297915050077; Borisov VB, 2002, BIOCHEMISTRY-US, V41, P1654, DOI 10.1021/bi0158019; Borisov VB, 2001, J BIOL CHEM, V276, P22095, DOI 10.1074/jbc.M011542200; BORISOV VB, 1995, BIOCHEMISTRY-MOSCOW+, V60, P231; Borisov VB, 2008, BIOCHEMISTRY-US, V47, P7907, DOI 10.1021/bi800435a; Borisov VB, 2013, FEBS LETT, V587, P2214, DOI 10.1016/j.febslet.2013.05.047; Borisov VB, 2013, J INORG BIOCHEM, V118, P65, DOI 10.1016/j.jinorgbio.2012.09.016; Borisov VB, 2011, P NATL ACAD SCI USA, V108, P17320, DOI 10.1073/pnas.1108217108; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Chen HJ, 2015, BBA-GEN SUBJECTS, V1850, P318, DOI 10.1016/j.bbagen.2014.10.005; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; EINARSDOTTIR O, 1995, BIOCHEMISTRY-US, V34, P496, DOI 10.1021/bi00002a014; Forte E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23788; Fu HH, 2013, ENVIRON MICROBIOL, V15, P2198, DOI 10.1111/1462-2920.12091; Giuffre A, 2014, BBA-BIOENERGETICS, V1837, P1178, DOI 10.1016/j.bbabio.2014.01.016; Giuffre A, 2012, FEBS LETT, V586, P622, DOI 10.1016/j.febslet.2011.07.035; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; HILL JJ, 1993, P NATL ACAD SCI USA, V90, P5863, DOI 10.1073/pnas.90.12.5863; Hoeser J, 2014, FEBS LETT, V588, P1537, DOI 10.1016/j.febslet.2014.03.036; Hori H, 1996, J BIOL CHEM, V271, P9254, DOI 10.1074/jbc.271.16.9254; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jasaitis A, 2000, BIOCHEMISTRY-US, V39, P13800, DOI 10.1021/bi001165n; Jasaitis A, 2005, P NATL ACAD SCI USA, V102, P10882, DOI 10.1073/pnas.0503001102; Jasaitis A, 2007, P NATL ACAD SCI USA, V104, P20811, DOI 10.1073/pnas.0709876105; Junemann S, 1997, BIOCHEMISTRY-US, V36, P9323, DOI 10.1021/bi970055m; JUNEMANN S, 1995, J BIOL CHEM, V270, P16213, DOI 10.1074/jbc.270.27.16213; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; Kaila VRI, 2010, P NATL ACAD SCI USA, V107, P21470, DOI 10.1073/pnas.1005889107; Korshunov S, 2010, MOL MICROBIOL, V75, P1389, DOI 10.1111/j.1365-2958.2010.07059.x; Le Laz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086343; LORENCE RM, 1986, BIOCHEMISTRY-US, V25, P2314, DOI 10.1021/bi00357a003; Mason MG, 2009, NAT CHEM BIOL, V5, P94, DOI 10.1038/nchembio.135; Medvedev DM, 2000, J AM CHEM SOC, V122, P6571, DOI 10.1021/ja0000706; Melo AMP, 2016, BBA-BIOENERGETICS, V1857, P190, DOI 10.1016/j.bbabio.2015.11.001; MILLER MJ, 1986, METHOD ENZYMOL, V126, P87; Mogi T, 2006, BIOCHEMISTRY-US, V45, P15785, DOI 10.1021/bi0615792; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Moser CC, 2006, BBA-BIOENERGETICS, V1757, P1096, DOI 10.1016/j.bbabio.2006.04.015; Moser CC, 2010, BBA-BIOENERGETICS, V1797, P1573, DOI 10.1016/j.bbabio.2010.04.441; Namslauer A, 2002, BIOCHEMISTRY-US, V41, P10369, DOI 10.1021/bi025976y; Okuno D, 2003, J AM CHEM SOC, V125, P7209, DOI 10.1021/ja021302z; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Paulus A, 2012, J BIOL CHEM, V287, P8830, DOI 10.1074/jbc.M111.333542; Pilet E, 2004, P NATL ACAD SCI USA, V101, P16198, DOI 10.1073/pnas.0405032101; POOLE RK, 1987, FEBS LETT, V217, P49, DOI 10.1016/0014-5793(87)81240-1; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; Prytkova TR, 2007, SCIENCE, V315, P622, DOI 10.1126/science.1134862; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Rappaport F, 2010, BBA-BIOENERGETICS, V1797, P1657, DOI 10.1016/j.bbabio.2010.05.010; Regan JJ, 1998, J BIOENERG BIOMEMBR, V30, P35, DOI 10.1023/A:1020551326307; Rost B, 1999, BIOCHEMISTRY-US, V38, P7565, DOI 10.1021/bi990225q; ROTHERY RA, 1987, J GEN MICROBIOL, V133, P3247; Sharma P, 2012, APPL ENVIRON MICROB, V78, P6908, DOI 10.1128/AEM.01507-12; Siletsky SA, 2004, J BIOL CHEM, V279, P52558, DOI 10.1074/jbc.M407549200; Siletsky SA, 2007, BBA-BIOENERGETICS, V1767, P1383, DOI 10.1016/j.bbabio.2007.09.010; Siletsky SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095617; Siletsky SA, 2013, BBA-BIOENERGETICS, V1827, P1, DOI 10.1016/j.bbabio.2012.09.013; Siletsky SA, 2010, BIOCHEMISTRY-US, V49, P3060, DOI 10.1021/bi901719e; Sun J, 1996, BIOCHEMISTRY-US, V35, P2403, DOI 10.1021/bi9518252; SUN J, 1995, BIOCHEMISTRY-US, V34, P12144, DOI 10.1021/bi00038a007; Sun YH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00047; Szundi I, 2007, BIOCHEMISTRY-US, V46, P12568, DOI 10.1021/bi700728g; Tan ML, 2004, BIOPHYS J, V86, P1813, DOI 10.1016/S0006-3495(04)74248-4; TSUBAKI M, 1995, J BIOL CHEM, V270, P28565, DOI 10.1074/jbc.270.48.28565; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; VanOrsdel CE, 2013, J BACTERIOL, V195, P3640, DOI 10.1128/JB.00324-13; VERKHOVSKY MI, 1992, BIOCHEMISTRY-US, V31, P11860, DOI 10.1021/bi00162a026; Vos MH, 2000, P NATL ACAD SCI USA, V97, P1554, DOI 10.1073/pnas.030528197; Winstedt L, 2000, J BACTERIOL, V182, P3863, DOI 10.1128/JB.182.13.3863-3866.2000; Zhang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062629	86	16	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155186	10.1371/journal.pone.0155186	http://dx.doi.org/10.1371/journal.pone.0155186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152644	Green Accepted, Green Published, gold			2022-12-27	WOS:000375677000077
J	Geda, B; Berhane, Y; Assefa, N; Worku, A				Geda, Biftu; Berhane, Yemane; Assefa, Nega; Worku, Alemayehu			In Rural Eastern Ethiopia Hearing Loss Is the Most Frequent Disability during Childhood: A Community Based Survey	PLOS ONE			English	Article							10 QUESTIONS; PREVALENCE; DISORDERS; VALIDITY; CHILDREN	Background The type and extent of childhood disability in Ethiopia is unknown due to lack of accurate and reliable data. This study tried to assess the magnitude and types of disabilities among children 0-14 years of age in eastern Ethiopia. Methods We conducted a cross-sectional community-based study among households that are under demographic and health surveillance in eastern Ethiopia. The study population consisted of all children aged 0-14 year. A structured questionnaire was used to assess the type and severity of the disability. Results A total of 21,572 children in the age group 0-14 were screened for disability. Of which 586 (2.7%; 95% CI = 2.5%, 2.9%) had at least one kind of disability at the time of the survey. The proportion of disability increased as children were older; measured by the extended Mantel-Haenszel (M-H) chi square for linear trend (M-H = 48.74; P<0.001). Hearing impairment was the most common reported disability; 417 (71.2%; 95% CI = 67.5%, 74.9%). Among children with a disability, 179 (31.0%; 95% CI = 27.3%, 34.7%) had a combination of multiple disabilities and about a third, 200 (34.1%; 95% CI = 30.3%, 37.9%) had developed the disability during infancy. Magnitude of disability was higher among boys 335 (2.98%; 95% CIs = 2.66%, 3.30%) compared to girls 251 (2.44%; 95% CIs = 2.14%, 2.74%). Conclusion Childhood disability is a health challenge in the study area and is already common at an early age. Permanent disability among children may be prevented by an early screening program in the routine child health services and adequate care, especially for hearing impairment.	[Geda, Biftu; Assefa, Nega] Haramaya Univ, Coll Hlth & Med Sci, Sch Nursing & Midwifery, Harar, Ethiopia; [Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Haramaya University; Addis Continental Institute of Public Health; Addis Ababa University	Geda, B (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Sch Nursing & Midwifery, Harar, Ethiopia.	biftug@gmail.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339; Assefa, Nega/0000-0003-0341-2329	Haraamaya University	Haraamaya University	The authors received funding and technical support from Haraamaya University.; The authors would like to thank the Haramaya University for financial and technical support. We thank M.Miles "West Midlands, UK", Dr Marguerite Schneider, disability studies researcher, and the Alan J Flisher Centre for Public Mental Health, University of Cape Town, South Africa for material provision and guidance. Special thanks to the Eastern Hararghe zonal office, Kersa district office of Labor and Social Affairs, Education, Health and Women and Child Affairs, Kersa Health and Demographic Surveillance, and the study Kebele officials for facilitating the field work. We also thank all study respondents for their cooperation.	African Child Policy Forum A, 2011, LIV CHILDR DIS AFR G, P11; Assefa N, 2015, INT J EPIDEMIOL, P1; Bachani AM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005795; Berhane Y, 2008, ETHIOP J HEALTH DEV, V21, P204, DOI [10.4314/ejhd.v21i3.10050, DOI 10.4314/EJHD.V21I3.10050]; BERMAN S, 1995, PEDIATRICS, V96, P126; Biritwum R, 2000, W AFRICAN J MED, V20, P249; Blackburn CM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-21; Boog G, 2011, GYNECOL OBSTET FERTI, V39, P146, DOI 10.1016/j.gyobfe.2011.01.015; Brandt Jr. E.N., 1997, ENABLING AM ASSESSIN, P62; Cappa C, 2013, UNICEF WASH GROUP DI; Central Statistical Authority, 2008, 2007 POP HOUS CENS R, p[129, 373]; Couper J, 2002, SAMJ S AFR MED J, V92, P549; Dean A, 2011, OPENEPI OPEN SOURCE; Deng LB., 2003, ED SO SUDAN WAR STAT; DURKIN MS, 1994, EPIDEMIOLOGY, V5, P283, DOI 10.1097/00001648-199405000-00005; Etenesh A., 2000, INCLUSION CHILDREN D; Fitaw Y, 2006, DISABIL REHABIL, V28, P949, DOI 10.1080/09638280500404552; Gottlieb CA, 2009, LANCET, V374, P1831, DOI 10.1016/S0140-6736(09)61871-7; Houtrow AJ, 2014, PEDIATRICS, V134, P530, DOI 10.1542/peds.2014-0594; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Krefis AC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-201; Lewis I., 2009, ED DISABLED PEOPLE E; Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B; Milaat WA, 2001, DISABIL REHABIL, V23, P199; Miller C, 2005, MAINSTREAMING DISABI, P5; Ministry of Labor and Social Affairs, 2010, BAS STUD STAT PERS D, P14; MOELLER MP, 2000, PEDIATRICS, V106, pNIL83; Mont, 2007, 706 WORLD BANK, V706, P1; Muga Emily, 2003, Afr Health Sci, V3, P33; Nardo M, 2005, HDB CONSTRUCTING COM, P30; National Bureau of Statisitcs, 2011, TANZ 2008 DIS SURV R, P81; O'Shea TM, 2008, CLIN OBSTET GYNECOL, V51, P816, DOI 10.1097/GRF.0b013e3181870ba7; Olusanya BO, 2006, JAMA-J AM MED ASSOC, V296, P441, DOI 10.1001/jama.296.4.441; Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689; Shimizu Tomomi, 2011, Evid Based Complement Alternat Med, V2011, P976196, DOI 10.1155/2011/976196; Tamrat G, 2001, DISABIL REHABIL, V23, P799; TEKLEHAIMANOT R, 1990, NEUROEPIDEMIOLOGY, V9, P263, DOI 10.1159/000110783; Thorburn M, 1992, Int J Rehabil Res, V15, P115, DOI 10.1097/00004356-199206000-00003; UNICEF, 2007, PROM RIGHTS CHILDR D; UNICEF, 2013, STAT HIV PREV SEX RE, P1; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2011, DIS GLOB PICT WORLD, P10; WHO, 2006, PREV CHEM HUM HELM S, P13; World Health Organization, 2008, GLOB BURD DIS 2004 U, P31; Wu L, 2010, J HEALTH POPUL NUTR, V28, P585, DOI 10.3329/jhpn.v28i6.6607; ZAMAN SS, 1990, INT J EPIDEMIOL, V19, P613, DOI 10.1093/ije/19.3.613	47	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0152791	10.1371/journal.pone.0152791	http://dx.doi.org/10.1371/journal.pone.0152791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149094	gold, Green Submitted, Green Published			2022-12-27	WOS:000375676800005
J	Haviland-Jones, JM; McGuire, TR; Wilson, P				Haviland-Jones, Jeannette M.; McGuire, Terry R.; Wilson, Patricia			Testing for Individual Differences in the Identification of Chemosignals for Fear and Happy: Phenotypic Super-Detectors, Detectors and Non-Detectors	PLOS ONE			English	Article							ODOR IDENTIFICATION; SEX-DIFFERENCES; PLASTICITY; SIGNALS	Mood odor identification, explicit awareness of mood odor, may be an important emotion skill and part of a complex dual processing system. It has already been shown that mood odors have significant implicit effects, effects that occur without awareness. This study applies methods for examining human individual differences in the identification of chemosignals for fear and happy, important in itself, and a key to understanding the dual processing of emotion in the olfactory system. Axillary mood odors had been collected from 14 male donors during a mood induction task. Pads were collected after 12 and 24 minutes, creating two doses. Sixty -one participants (41 females) identified the mood odor chemosignals. On a single trial, participants identified 2 doses of fear, 2 doses of happy, and a sterile control. There were 15 trials. The first analysis (r(tt)) showed that the population was phenotypically heterogeneous, not homogeneous, in identification accuracy. It also showed that a minimum of 10 trials was needed for test reliability. The second analysis, Growth Mixture Modeling, found three distinct groups of detectors: (1) 49.49% were consistently accurate super detectors, (2) 32.52% were accurate above chance level detectors, and (3) 17.98% were non-detectors. Bayesian Posterior Analyses showed reliability of groups at or above 98%. No differences related to mood odor valence (fear or happy), dose (collection at 12 or 24 minutes) or gender were found. Implications for further study of genetic differences, learning and function of identification are noted. It appears that many people can be reliable in explicitly identifying fear and happy mood odors but this skill is not homogeneous.	[Haviland-Jones, Jeannette M.] Rutgers State Univ, Dept Psychol, New Brunswick, NJ USA; [McGuire, Terry R.] Rutgers State Univ, Dept Genet, New Brunswick, NJ 08903 USA; [Wilson, Patricia] La Salle Univ, Dept Psychol, Philadelphia, PA 19141 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Haviland-Jones, JM (corresponding author), Rutgers State Univ, Dept Psychol, New Brunswick, NJ USA.	baljones@rutgers.edu		tester22, sciencv/0000-0002-2791-7842; Holland, Sherri/0000-0003-2860-0668	Colgate Palmolive Company; Rutgers Research Council	Colgate Palmolive Company; Rutgers Research Council	Colgate Palmolive Company (http://www.colgate.com) only provided funding for sample collection. They received some of the sample. Their use or application of the samples, if any, does not involve the authors in any way. The authors are not and have not been employed by this company, nor is there presently a consultant agreement. The authors are not connected to patents, products, etc., if any exist. The Rutgers Research Council (https://ored.rutgers.edu/) provided funding for lab personnel support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; Barrett L.F., 2008, EMOTIONS, V3rd, P235; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; Cain WS, 1998, CHEM SENSES, V23, P309, DOI 10.1093/chemse/23.3.309; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Chen D, 2006, CHEM SENSES, V31, P415, DOI 10.1093/chemse/bjj046; de Groot JHB, 2015, PSYCHOL SCI, V26, P684, DOI 10.1177/0956797614566318; de Groot JHB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118211; de Groot JHB, 2012, PSYCHOL SCI, V23, P1417, DOI 10.1177/0956797612445317; DOTY RL, 1985, NEUROPSYCHOLOGIA, V23, P667, DOI 10.1016/0028-3932(85)90067-3; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Fredrickson BL, 2008, HDB EMOTIONS, V3, P777; Gilbert A.N., 1987, NATL GEOGR, V172, P514; Gilet AL., 2008, ENCEPHALE, V3, P233; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Hall Edward T, 1992, HIDDEN DIMENSION; Haviland-Jones J., 1999, AROMA CHOLOGY REV, V8, P11; Haviland-Jones J M, 2015, SIGNS SIGNALS SYMBOL, P363; Haviland-Jones J, 2013, EMOT SPACE SOC, V6, P91, DOI 10.1016/j.emospa.2011.10.002; HIRSCH J, 1956, PSYCHOL BULL, V53, P402, DOI 10.1037/h0040715; Horgan, 2000, GENDER EMOTION SOCIA, P97, DOI DOI 10.1017/CBO9780511628191.006; Huart C, 2013, MOLECULES, V18, P11586, DOI 10.3390/molecules180911586; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kahneman D., 2011, THINKING FAST SLOW; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Keller A, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-75; Keller H, 1910, SMELL FALLEN ANGEL W, P75; Li W, 2007, PSYCHOL SCI, V18, P1044, DOI 10.1111/j.1467-9280.2007.02023.x; Londono D, 2013, STAT APPL GENET MOL, V12, P241, DOI 10.1515/sagmb-2012-0070; Low C, 2007, J ROY ANTHROPOL INST, V13, pS71, DOI 10.1111/j.1467-9655.2007.00402.x; Lubke KT, 2015, HORM BEHAV, V68, P134, DOI 10.1016/j.yhbeh.2014.10.001; Lubke KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094314; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Lundstrom JN, 2009, HUM BRAIN MAPP, V30, P2571, DOI 10.1002/hbm.20686; Magidson J, 2004, HDB QUANTITATIVE MET, P175, DOI DOI 10.4135/9781412986311.N19; McGuire TR, 1993, HDB EMOTIONS, P155; Miyazawa T, 2009, CHEMOSENS PERCEPT, V2, P195, DOI 10.1007/s12078-009-9060-6; Mombaerts P, 2001, ANNU REV GENOM HUM G, V2, P493, DOI 10.1146/annurev.genom.2.1.493; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Muthen B, 1999, BIOMETRICS, V55, P463, DOI 10.1111/j.0006-341X.1999.00463.x; Ohla K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00607; Panksepp J, 2007, BEHAV BRAIN RES, V182, P231, DOI 10.1016/j.bbr.2007.02.015; Pause BM, 2012, CHEMOSENS PERCEPT, V5, P55, DOI 10.1007/s12078-011-9108-2; Pause BM, 1998, GENETICA, V104, P285, DOI 10.1023/A:1026462701154; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Razafindrazaka H, 2015, HUM BIOL, V87, P59, DOI 10.13110/humanbiology.87.1.0059; Tryon R., 1934, COMP PSYCHOL, DOI [10.1037/11453-013, DOI 10.1037/11453-013]; TRYON RC, 1957, PSYCHOL BULL, V54, P229, DOI 10.1037/h0047980; Vigil JM, 2009, BEHAV BRAIN SCI, V32, P375, DOI 10.1017/S0140525X09991075; Wang LW, 2004, J PHYSIOL-LONDON, V554, P236, DOI 10.1113/jphysiol.2003.054726; Zernecke R, 2011, J PSYCHOPHYSIOL, V25, P116, DOI 10.1027/0269-8803/a000047; Zhou W, 2009, PSYCHOL SCI, V20, P1118, DOI 10.1111/j.1467-9280.2009.02413.x; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x	55	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154495	10.1371/journal.pone.0154495	http://dx.doi.org/10.1371/journal.pone.0154495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149084	gold, Green Published			2022-12-27	WOS:000375676800035
J	Turel, O; Romashkin, A; Morrison, KM				Turel, Ofir; Romashkin, Anna; Morrison, Katherine M.			Health Outcomes of Information System Use Lifestyles among Adolescents: Videogame Addiction, Sleep Curtailment and Cardio-Metabolic Deficiencies	PLOS ONE			English	Article							DISEASE RISK-FACTORS; MEAN BLOOD-PRESSURE; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; CARDIOVASCULAR-DISEASE; CARDIOMETABOLIC RISK; SCREEN TIME; SOCIOECONOMIC-STATUS; INTERNET ADDICTION; INSULIN-RESISTANCE	Background and Objective Obesity is a rising problem among adolescents in modern societies; it results in long-term cardio-metabolic problems. Possible overlooked drivers of obesity and its consequent cardio-metabolic deficits include videogame addiction and the resulting curtailed sleep; both are growing problems among adolescents. The objective of this study is to examine possible associations among these concepts in adolescents, as a means to point to plausible interventions. Methods Data were collected from 94 adolescents who play videogames and are enrolled in outpatient clinics, using surveys, wearable sleep monitors (FitBit), physical exams, and blood tests at three points in time. These data were subjected to structural equation modeling (SEM) analyses and bootstrapping-based mediation testing procedures. Results Videogame addiction among adolescents was negatively associated with sleep duration (beta = -0.24). Sleep duration was negatively associated with obesity (beta = -0.30), which in turn was associated with elevated blood pressure (beta = 0.26), low high-density lipoprotein cholesterol (beta = -0.18), high triglycerides (beta = 0.61), and high insulin resistance (beta = 0.39). The model explained 36.2% of the variation in sleep duration, 32.7% of the variation in obesity, and between 12.8% and 28.1% of the variation in cardio-metabolic indicators. Post-hoc analyses indicated that curtailed sleep is a possible full mediator of the association between videogame addiction, abdominal obesity and the associated cardio-metabolic deficits. Conclusion The findings point to possible information systems use lifestyle-health links, which behooves researchers and practitioners to pay closer attention to possible adverse health outcomes of technology-related addictions. Interventions that target problematic video-gaming and sleep should be devised as a possible means for improving adolescents' long-term cardio-metabolic health.	[Turel, Ofir] Calif State Univ Fullerton, Dept Informat Syst & Decis Sci, Mihaylo Coll Business & Econ, Fullerton, CA 92634 USA; [Turel, Ofir] Univ So Calif, Dept Psychol, Brain & Creat Inst, Los Angeles, CA 90089 USA; [Romashkin, Anna; Morrison, Katherine M.] McMaster Univ, Dept Pediat, McMaster Children Hosp, Hamilton, ON, Canada; [Romashkin, Anna; Morrison, Katherine M.] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada	California State University System; California State University Fullerton; University of Southern California; McMaster University; McMaster University	Turel, O (corresponding author), Calif State Univ Fullerton, Dept Informat Syst & Decis Sci, Mihaylo Coll Business & Econ, Fullerton, CA 92634 USA.; Turel, O (corresponding author), Univ So Calif, Dept Psychol, Brain & Creat Inst, Los Angeles, CA 90089 USA.	oturel@fullerton.edu	Morrison, Katherine/AAO-8046-2021; Turel, Ofir/U-1716-2019	Morrison, Katherine/0000-0002-1737-256X; Turel, Ofir/0000-0002-6374-6382				American Psychiatric Association, 2013, INT GAM DIS DIAGN ST, P795; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; ANDERSON RE, 1993, COMMUN ACM, V36, P98, DOI 10.1145/151220.151231; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 1996, BRIT MED J, V312, P377; Ashwell M, 1996, BRIT MED J, V313, P559; Australian Computer Society, 2014, ACS COD PROF COND V; Boutouyrie P, 1999, CIRCULATION, V100, P1387, DOI 10.1161/01.CIR.100.13.1387; Byun S, 2009, CYBERPSYCHOL BEHAV, V12, P203, DOI 10.1089/cpb.2008.0102; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chaput JP, 2007, INT J PEDIATR OBES, V2, P188, DOI 10.1080/17477160701306144; Chaput JP, 2010, CURR OPIN CLIN NUTR, V13, P601, DOI 10.1097/MCO.0b013e32833ef30e; Cheung GW, 2008, ORGAN RES METHODS, V11, P296, DOI 10.1177/1094428107300343; Chiba Y, 2007, HYPERTENS RES, V30, P229, DOI 10.1291/hypres.30.229; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; DIJK DJ, 1989, SLEEP, V12, P500, DOI 10.1093/sleep/12.6.500; Drescher AA, 2011, J CLIN SLEEP MED, V7, P337, DOI 10.5664/JCSM.1182; Fan XT, 1999, STRUCT EQU MODELING, V6, P56, DOI 10.1080/10705519909540119; Ferreira AP, 2007, J PEDIAT-BRAZIL, V83, P21, DOI [10.2223/JPED.1562, 10.1590/S0021-75572007000100005]; Fullerton S, 2014, J OBES, V2014, DOI 10.1155/2014/287013; Gentile D, 2009, PSYCHOL SCI, V20, P594, DOI 10.1111/j.1467-9280.2009.02340.x; Hunt K, 2015, CNN             0121, V2015; Ivarsson M, 2013, PSYCHOSOM MED, V75, P390, DOI 10.1097/PSY.0b013e3182906a4c; Khoury M, 2013, J AM COLL CARDIOL, V62, P742, DOI 10.1016/j.jacc.2013.01.026; Kim KH, 2005, STRUCT EQU MODELING, V12, P368, DOI 10.1207/s15328007sem1203_2; King DL, 2013, J SLEEP RES, V22, P137, DOI 10.1111/j.1365-2869.2012.01060.x; Kuss DJ, 2013, COMPUT HUM BEHAV, V29, P959, DOI 10.1016/j.chb.2012.12.024; Le Heuzey MF, 2012, B ACAD NAT MED PARIS, V196, P15, DOI 10.1016/S0001-4079(19)31860-6; Lee JM, 2006, DIABETES CARE, V29, P2427, DOI 10.2337/dc06-0709; Lovejoy JC, 2009, OBES REV, V10, P154, DOI 10.1111/j.1467-789X.2008.00529.x; Lyons EJ, 2012, AM J CLIN NUTR, V96, P234, DOI 10.3945/ajcn.111.028423; Magee CA, 2014, JAMA PEDIATR, V168, P465, DOI 10.1001/jamapediatrics.2013.4183; Marques A, 2014, AM J HUM BIOL, V26, P844, DOI 10.1002/ajhb.22613; Marshall NS, 2008, SLEEP MED REV, V12, P289, DOI 10.1016/j.smrv.2008.03.001; Matheson DM, 2004, AM J CLIN NUTR, V79, P1088; Michigan Diabetes Research and Training Center, 2014, MDRTC LIP MEAS FACT; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Mullington JM, 2003, J NEUROENDOCRINOL, V15, P851, DOI 10.1046/j.1365-2826.2003.01069.x; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Rappley M, 2003, J DEV BEHAV PEDIATR, V24, P394; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Sadeh A, 2008, J PEDIATR PSYCHOL, V33, P406, DOI 10.1093/jpepsy/jsn018; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Scharrer E, 2014, J MEDIA PSYCHOL-GER, V26, P39, DOI 10.1027/1864-1105/a000109; Sepehr S, 2013, P 19 AM C INF SYST; Singh B, 2010, WORLD J DIABETES, V1, P36, DOI 10.4239/wjd.v1.i2.36; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Staiano AE, 2014, BRIT J SPORT MED, V48, P213, DOI 10.1136/bjsports-2012-091896; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Sung RYT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-324; Taheri S, 2006, ARCH DIS CHILD, V91, P881, DOI 10.1136/adc.2005.093013; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Tarafdar M, 2015, MIT SLOAN MANAGE REV, V56, P61; Taylor RW, 2007, AM J CLIN NUTR, P490; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Turel O, 2015, BEHAV INFORM TECHNOL, V34, P349, DOI 10.1080/0144929X.2014.936041; Turel O, 2011, MIS QUART, V35, P1043; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; van Rooij AJ, 2011, ADDICTION, V106, P205, DOI 10.1111/j.1360-0443.2010.03104.x; Vandewater EA, 2004, J ADOLESCENCE, V27, P71, DOI 10.1016/j.adolescence.2003.10.003; Weaver E, 2010, J CLIN SLEEP MED, V6, P184; Weinstein A, 2013, J BEHAV ADDICT, V2, P5; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; West KE, 2011, J APPL PHYSIOL, V110, P619, DOI 10.1152/japplphysiol.01413.2009; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wolfe J, 2014, J ADOLESCENCE, V37, P1003, DOI 10.1016/j.adolescence.2014.07.013; Wood B, 2013, APPL ERGON, V44, P237, DOI 10.1016/j.apergo.2012.07.008; Xiaoli C, 2008, OBESITY, P265, DOI [10.1038/oby.2007.63, DOI 10.1038/OBY.2007.63]; Xu ZC, 2012, EUR J INFORM SYST, V21, P321, DOI 10.1057/ejis.2011.56; Yamamoto S., 1999, ASIAN MED J, V42, P245	78	64	67	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154764	10.1371/journal.pone.0154764	http://dx.doi.org/10.1371/journal.pone.0154764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27149512	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800059
J	Wagner, A; Schabussova, I; Drinic, M; Akgun, J; Loupal, G; Kundi, M; Joachim, A; Wiedermann, U				Wagner, Angelika; Schabussova, Irma; Drinic, Mirjana; Akguen, Johnnie; Loupal, Gerhard; Kundi, Michael; Joachim, Anja; Wiedermann, Ursula			Oocyst-Derived Extract of Toxoplasma Gondii Serves as Potent Immunomodulator in a Mouse Model of Birch Pollen Allergy	PLOS ONE			English	Article							REGULATORY T-CELLS; AIRWAY INFLAMMATION; IMMUNE-RESPONSES; SUPPRESSOR-CELLS; DENDRITIC CELLS; I ALLERGY; ANIMAL-MODELS; MURINE MODEL; HAY-FEVER; INFECTION	Introduction Previously, we have shown that oral infection with Toxoplasma gondii oocysts prevented type I allergy in mice. Here we investigated whether the application of a T. gondii oocyst lysate antigen (OLA) could also reduce allergy development. BALB/c mice were immunised twice with OLA followed by sensitisation with the major birch pollen (BP) allergen Bet v 1 and an aerosol challenge with BP extract. Methods First, we tested OLA in vitro. Stimulation of splenocytes and bone marrow-derived dendritic cells (BMDC) with OLA led to the production of pro-inflammatory and regulatory cytokines such as IL-6, IFN-gamma and IL-10. Moreover, BMDC exposed to OLA upregulated the maturation markers CD40, CD80, CD86, and MHCII. Furthermore, OLA was recognised by TLR2-transfected human embryonic kidney cells. Results Immunisation of mice with OLA induced high levels of Toxoplasma-specific IgG antibodies in sera along with increased production of IFN-. and IL-10 in Toxoplasma-antigen restimulated splenocytes. OLA reduced allergic airway inflammation as manifested by significant reduction of eosinophils in bronchoalveolar fluids, decreased cellular infiltrates and mucus production in the lungs. Accordingly, Bet v 1-specific IgE was decreased in OLA-pretreated mice. The reduced allergic immune responses were accompanied by increased numbers of CD4(+)CD25(high)Foxp3(+) regulatory T cells in spleens as well as by increased numbers of granulocytic myeloid-derived suppressor cells in lungs when compared to sensitised controls suggesting that these two cell populations might be involved in the suppression of the allergic immune responses. Conclusion Our data demonstrate that pretreatment with the oocyst extract can exert anti-allergic effects comparable to T. gondii infection. Thus, the immunomodulatory properties of the parasite extract indicate that this extract and in the future defined molecules thereof might serve as immunomodulatory adjuvants in allergy treatment and prophylaxis.	[Wagner, Angelika; Schabussova, Irma; Drinic, Mirjana; Akguen, Johnnie; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Loupal, Gerhard] Univ Vet Med, Dept Pathobiol, Inst Pathol & Forens Vet Med, Vienna, Austria; [Kundi, Michael] Med Univ Vienna, Ctr Publ Hlth, Inst Environm Hlth, Vienna, Austria; [Joachim, Anja] Univ Vet Med, Inst Parasitol, Dept Pathobiol, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna	Wiedermann, U (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	ursula.wiedermann@meduniwien.ac.at		Wagner, Angelika/0000-0002-5447-9534; Wiedermann, Ursula/0000-0002-1302-3223; Schabussova, Irma/0000-0002-2109-2640	Austrian Science Fund [SFB F46]	Austrian Science Fund(Austrian Science Fund (FWF))	This project was financially supported by the Austrian Science Fund (SFB F46 "Towards prevention and therapy of allergy"). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara-Neves NM, 2012, J ALLERGY CLIN IMMUN, V129, P359, DOI 10.1016/j.jaci.2011.09.015; Araujo CA, 2008, CYTOKINE, V44, P335, DOI 10.1016/j.cyto.2008.09.005; Balic A, 2004, EUR J IMMUNOL, V34, P3047, DOI 10.1002/eji.200425167; Bates JHT, 2009, AM J PHYSIOL-LUNG C, V297, pL401, DOI 10.1152/ajplung.00027.2009; Campbell DE, 2015, J PAEDIATR CHILD H, V51, P91, DOI 10.1111/jpc.12806; Cardoso LS, 2010, CLIN EXP IMMUNOL, V160, P266, DOI 10.1111/j.1365-2249.2009.04084.x; DUBEY JP, 1970, J EXP MED, V132, P636, DOI 10.1084/jem.132.4.636; Dumetre A, 2004, J MICROBIOL METH, V56, P427, DOI 10.1016/j.mimet.2003.11.020; Esch KJ, 2013, CLIN MICROBIOL REV, V26, P58, DOI 10.1128/CMR.00067-12; Fenoy I, 2009, CLIN EXP IMMUNOL, V155, P275, DOI 10.1111/j.1365-2249.2008.03813.x; Fenoy IM, 2015, IMMUNOBIOLOGY, V220, P641, DOI 10.1016/j.imbio.2014.11.016; Fenoy IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043420; Fernandes JFC, 2010, CLIN IMMUNOL, V136, P148, DOI 10.1016/j.clim.2010.02.019; Finlay CM, 2014, IMMUNOL REV, V259, P206, DOI 10.1111/imr.12164; Fogarty AW, 2015, CLIN EXP ALLERGY, V45, P87, DOI 10.1111/cea.12339; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029998; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029955; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Herz U, 2004, METHODS, V32, P271, DOI 10.1016/j.ymeth.2003.08.013; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Hivroz C, 2012, CRIT REV IMMUNOL, V32, P139, DOI 10.1615/CritRevImmunol.v32.i2.30; Janse JJ, 2014, PEDIAT ALLERG IMM-UK, V25, P250, DOI 10.1111/pai.12175; Jeong YI, 2011, BIOCHEM BIOPH RES CO, V407, P793, DOI 10.1016/j.bbrc.2011.03.102; Layland LE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002379; Lehrer SB, 2004, J IMMUNOL METHODS, V284, P1, DOI 10.1016/j.jim.2003.08.017; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Magombedze G, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00206; Maizels RM, 2011, ADV IMMUNOL, V112, P73, DOI 10.1016/B978-0-12-387827-4.00003-6; Maizels Rick M., 2009, Journal of Biology (London), V8, P62, DOI 10.1186/jbiol166; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; McSorley HJ, 2012, EUR J IMMUNOL, V42, P2667, DOI 10.1002/eji.201142161; Nawijn MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055307; Platts-Mills TAE, 2015, J ALLERGY CLIN IMMUN, V136, P3, DOI 10.1016/j.jaci.2015.03.048; Raber PL, 2014, INT J CANCER, V134, P2853, DOI 10.1002/ijc.28622; Repa A, 2004, CLIN EXP IMMUNOL, V137, P12, DOI 10.1111/j.1365-2249.2004.02519.x; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Schabussova I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067544; Song C, 2014, SCAND J IMMUNOL, V79, P98, DOI 10.1111/sji.12140; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tilp C, 2013, INT J PARASITOL, V43, P319, DOI 10.1016/j.ijpara.2012.12.003; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; Van Ginderachter JA, 2010, EUR J IMMUNOL, V40, P2976, DOI 10.1002/eji.201040911; Voisin MB, 2004, INFECT IMMUN, V72, P5487, DOI 10.1128/IAI.72.9.5487-5492.2004; von Mutius E, 2010, CLIN EXP IMMUNOL, V160, P130, DOI 10.1111/j.1365-2249.2010.04138.x; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Winkler B, 2002, CLIN EXP ALLERGY, V32, P30, DOI 10.1046/j.0022-0477.2001.01214.x; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012; Zanin-Zhorov A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00211; Zenner L, 1998, EXP PARASITOL, V90, P86, DOI 10.1006/expr.1998.4301	55	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155081	10.1371/journal.pone.0155081	http://dx.doi.org/10.1371/journal.pone.0155081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149118	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800116
J	Wang, LL; Feng, CL; Mai, XQ; Jia, LN; Zhu, XR; Luo, WB; Luo, YJ				Wang, Lili; Feng, Chunliang; Mai, Xiaoqin; Jia, Lina; Zhu, Xiangru; Luo, Wenbo; Luo, Yue-Jia			The Impact of Perceptual Load on the Non-Conscious Processing of Fearful Faces	PLOS ONE			English	Article							TIME-COURSE; FACIAL EXPRESSION; SPATIAL ATTENTION; AMYGDALA; BRAIN; RESPONSES; ERP; EMOTION; SIGNALS	Emotional stimuli can be processed without consciousness. In the current study, we used event-related potentials (ERPs) to assess whether perceptual load influences non-conscious processing of fearful facial expressions. Perceptual load was manipulated using a letter search task with the target letter presented at the fixation point, while facial expressions were presented peripherally and masked to prevent conscious awareness. The letter string comprised six letters (X or N) that were identical (low load) or different (high load). Participants were instructed to discriminate the letters at fixation or the facial expression (fearful or neutral) in the periphery. Participants were faster and more accurate at detecting letters in the low load condition than in the high load condition. Fearful faces elicited a sustained positivity from 250 ms to 700 ms post-stimulus over fronto-central areas during the face discrimination and low-load letter discrimination conditions, but this effect was completely eliminated during high-load letter discrimination. Our findings imply that non-conscious processing of fearful faces depends on perceptual load, and attentional resources are necessary for non-conscious processing.	[Wang, Lili] Huaiyin Normal Univ, Sch Educ Sci, Huaian, Peoples R China; [Feng, Chunliang] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Mai, Xiaoqin] Renmin Univ China, Dept Psychol, Beijing, Peoples R China; [Jia, Lina] Jiangnan Univ, Sch Humanities, Wuxi, Peoples R China; [Zhu, Xiangru] Henan Univ, Inst Psychol & Behav, Kaifeng, Peoples R China; [Luo, Wenbo] Liaoning Normal Univ, Sch Psychol, Res Ctr Brain & Cognit Neurosci, Dalian, Peoples R China; [Luo, Yue-Jia] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China	Huaiyin Normal University; Beijing Normal University; Renmin University of China; Jiangnan University; Henan University; Liaoning Normal University; Shenzhen University	Mai, XQ (corresponding author), Renmin Univ China, Dept Psychol, Beijing, Peoples R China.; Luo, YJ (corresponding author), Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China.	maixq@ruc.edu.cn; luoyj@szu.edu.cn	Jia, li/GPW-8015-2022; li, jia/GVT-7587-2022		National Natural Science Foundation of China [31300869, 81471376]; National Basic Research Program of China (973 Program) [2014CB744600]; Nature Science Foundation of JiangSu Province [BK20130415]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Nature Science Foundation of JiangSu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Natural Science Foundation of China (31300869, 81471376), the National Basic Research Program of China (973 Program) (2014CB744600), and the Nature Science Foundation of JiangSu Province (Grants No BK20130415).	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Bahrami B, 2008, J VISION, V8, DOI 10.1167/8.3.12; Balconi M, 2009, MOTIV EMOTION, V33, P113, DOI 10.1007/s11031-009-9122-8; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; Eimer M, 2008, J NEUROPSYCHOL, V2, P165, DOI 10.1348/174866407X245411; Esslen M, 2004, NEUROIMAGE, V21, P1189, DOI 10.1016/j.neuroimage.2003.10.001; Fan J, 2011, NEUROIMAGE, V54, P2539, DOI 10.1016/j.neuroimage.2010.10.007; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hardee JE, 2008, SOC COGN AFFECT NEUR, V3, P47, DOI 10.1093/scan/nsn001; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Holmes A, 2006, NEUROSCI LETT, V394, P48, DOI 10.1016/j.neulet.2005.10.002; Japee S, 2009, EMOTION, V9, P59, DOI 10.1037/a0014487; Jenkins R, 2005, PSYCHON B REV, V12, P314, DOI 10.3758/BF03196378; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P318, DOI 10.1111/j.1469-8986.2007.00634.x; Lavie N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0205; Liddell BJ, 2004, J COGNITIVE NEUROSCI, V16, P479, DOI 10.1162/089892904322926809; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Lim SL, 2008, NEUROPSYCHOLOGIA, V46, P1267, DOI 10.1016/j.neuropsychologia.2007.12.003; Mitchell DGV, 2007, NEUROIMAGE, V34, P1299, DOI 10.1016/j.neuroimage.2006.10.012; Mohamed TN, 2009, NEUROREPORT, V20, P782, DOI 10.1097/WNR.0b013e32832b7e24; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Pegna AJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00088; Pegna AJ, 2008, INT J PSYCHOPHYSIOL, V70, P127, DOI 10.1016/j.ijpsycho.2008.08.007; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Silvert L, 2007, NEUROIMAGE, V38, P357, DOI 10.1016/j.neuroimage.2007.07.023; Smith ML, 2012, CEREB CORTEX, V22, P1748, DOI 10.1093/cercor/bhr250; Sokolov EN, 2000, INTEGR PHYS BEH SCI, V35, P81, DOI 10.1007/BF02688770; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Williams LM, 2006, J NEUROSCI, V26, P9264, DOI 10.1523/JNEUROSCI.1016-06.2006; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154	40	5	6	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154914	10.1371/journal.pone.0154914	http://dx.doi.org/10.1371/journal.pone.0154914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27149273	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800087
J	Bode, M; Williamson, DH; Weeks, R; Jones, GP; Almany, GR; Harrison, HB; Hopf, JK; Pressey, RL				Bode, Michael; Williamson, David H.; Weeks, Rebecca; Jones, Geoff P.; Almany, Glenn R.; Harrison, Hugo B.; Hopf, Jess K.; Pressey, Robert L.			Planning Marine Reserve Networks for Both Feature Representation and Demographic Persistence Using Connectivity Patterns	PLOS ONE			English	Article							GREAT-BARRIER-REEF; LARVAL DISPERSAL; CORAL TROUT; ASYMMETRIC CONNECTIVITY; PLECTROPOMUS-LEOPARDUS; CLIMATE-CHANGE; CONSERVATION; FISH; POPULATIONS; BIODIVERSITY	Marine reserve networks must ensure the representation of important conservation features, and also guarantee the persistence of key populations. For many species, designing reserve networks is complicated by the absence or limited availability of spatial and life-history data. This is particularly true for data on larval dispersal, which has only recently become available. However, systematic conservation planning methods currently incorporate demographic processes through unsatisfactory surrogates. There are therefore two key challenges to designing marine reserve networks that achieve feature representation and demographic persistence constraints. First, constructing a method that efficiently incorporates persistence as well as complementary feature representation. Second, incorporating persistence using a mechanistic description of population viability, rather than a proxy such as size or distance. Here we construct a novel systematic conservation planning method that addresses both challenges, and parameterise it to design a hypothetical marine reserve network for fringing coral reefs in the Keppel Islands, Great Barrier Reef, Australia. For this application, we describe how demographic persistence goals can be constructed for an important reef fish species in the region, the bar-cheeked trout (Plectropomus maculatus). We compare reserve networks that are optimally designed for either feature representation or demographic persistence, with a reserve network that achieves both goals simultaneously. As well as being practically applicable, our analyses also provide general insights into marine reserve planning for both representation and demographic persistence. First, persistence constraints for dispersive organisms are likely to be much harder to achieve than representation targets, due to their greater complexity. Second, persistence and representation constraints pull the reserve network design process in divergent directions, making it difficult to efficiently achieve both constraints. Although our method can be readily applied to the data-rich Keppel Islands case study, we finally consider the factors that limit the method's utility in information-poor contexts common in marine conservation.	[Bode, Michael] Univ Melbourne, Sch Bot, ARC Ctr Excellence Environm Decis, Melbourne, Vic 3010, Australia; [Bode, Michael; Williamson, David H.; Weeks, Rebecca; Jones, Geoff P.; Almany, Glenn R.; Harrison, Hugo B.; Hopf, Jess K.; Pressey, Robert L.] James Cook Univ, Australian Res Council Ctr Excellence Reef Studie, Townsville, Qld 4811, Australia; [Jones, Geoff P.; Hopf, Jess K.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Almany, Glenn R.] Univ Perpignan, CNRS, EPHE UPVD, F-66860 Perpignan, France	University of Melbourne; James Cook University; James Cook University; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia	Bode, M (corresponding author), Univ Melbourne, Sch Bot, ARC Ctr Excellence Environm Decis, Melbourne, Vic 3010, Australia.; Bode, M (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Reef Studie, Townsville, Qld 4811, Australia.	mbode@unimelb.edu.au	Bode, Michael/A-7116-2009; Harrison, Hugo/F-6830-2012; Bode, Michael/P-1333-2019; Jones, Geoffrey P./E-9306-2010; Weeks, Rebecca/C-2460-2013; Hopf, Jess/AAD-9244-2019	Bode, Michael/0000-0002-5886-4421; Harrison, Hugo/0000-0001-8831-0086; Bode, Michael/0000-0002-5886-4421; Jones, Geoffrey P./0000-0002-6244-1245; Weeks, Rebecca/0000-0002-0867-1007; Williamson, David/0000-0001-8447-039X; Hopf, Jess K/0000-0003-2207-2366	Australian Research Council (ARC) DECRA [DE130100572]; ARC Centre of Excellence for Environmental Decisions; ARC Centre of Excellence for Coral Reef Studies; ARC DECRA [DE130100572]	Australian Research Council (ARC) DECRA(Australian Research Council); ARC Centre of Excellence for Environmental Decisions(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); ARC DECRA(Australian Research Council)	MB was funded by Australian Research Council (ARC) DECRA DE130100572. MB was funded by ARC Centre of Excellence for Environmental Decisions. DW, RW, GJ, GA, HH, JH, RP were funded by ARC Centre of Excellence for Coral Reef Studies.; We thank R. Abesamis, P. Armsworth, M. Beger, S. Kininmonth, R. Magris, and E. Treml for discussions and ideas, and the editors, S. Planes, and an anonymous reviewer for useful comments on the manuscript. MB was funded by an ARC DECRA (DE130100572) and the ARC Centre of Excellence for Environmental Decisions. The workshop where these ideas were devised was funded by the ARC Centre of Excellence for Coral Reef Studies.	Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Almany GR, 2013, CURR BIOL, V23, P626, DOI 10.1016/j.cub.2013.03.006; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; [Anonymous], ASSESSMENT SOCIAL CH; Armsworth PR, 2002, ECOLOGY, V83, P1092, DOI 10.1890/0012-9658(2002)083[1092:RLPRAL]2.0.CO;2; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ban NC, 2012, CONSERV BIOL, V26, P799, DOI 10.1111/j.1523-1739.2012.01894.x; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Beger M, 2010, CONSERV LETT, V3, P359, DOI 10.1111/j.1755-263X.2010.00123.x; Benton TG, 2012, DISPERSAL ECOLOGY EV, P462; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Bode M, 2008, ECOL MODEL, V214, P201, DOI 10.1016/j.ecolmodel.2008.02.040; Bode M, 2012, MAR ECOL PROG SER, V466, P155, DOI 10.3354/meps09924; Bode M, 2011, P NATL ACAD SCI USA, V108, P16317, DOI 10.1073/pnas.1101019108; Bodin O, 2010, ECOL MODEL, V221, P2393, DOI 10.1016/j.ecolmodel.2010.06.017; Bullock JM, 2002, 42 S BRIT EC SOC; Buston PM, 2012, P ROY SOC B-BIOL SCI, V279, P1883, DOI 10.1098/rspb.2011.2041; Cadenhead NCR, 2016, CONSERV LETT, V9, P181, DOI 10.1111/conl.12202; Campbell RA, 2001, ECOL APPL, V11, P1763, DOI 10.1890/1051-0761(2001)011[1763:ELSEDF]2.0.CO;2; Ceia-Hasse A, 2014, ECOGRAPHY, V37, P679, DOI 10.1111/j.1600-0587.2013.00600.x; Costello C, 2010, P NATL ACAD SCI USA, V107, P18294, DOI 10.1073/pnas.0908057107; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; DINESEN Z D, 1983, Coral Reefs, V1, P229, DOI 10.1007/BF00304420; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; Drake PT, 2011, J MAR RES, V69, P1, DOI 10.1357/002224011798147615; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; FERREIRA BP, 1995, B MAR SCI, V56, P653; FERREIRA BP, 1994, FISH B-NOAA, V92, P46; Fordham DA, 2013, NAT CLIM CHANGE, V3, P899, DOI 10.1038/NCLIMATE1954; Fordham DA, 2013, ECOGRAPHY, V36, P956, DOI 10.1111/j.1600-0587.2013.00147.x; Gaines SD, 2003, ECOL APPL, V13, pS32; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Game ET, 2009, ECOL LETT, V12, P1336, DOI 10.1111/j.1461-0248.2009.01384.x; GBRMPA, 2004, GREAT BARR REEF MAR; GLYNN PW, 1976, ECOL MONOGR, V46, P431, DOI 10.2307/1942565; Grantham HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016552; Green AL, 2014, COASTAL; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Gregory SD, 2014, DIVERS DISTRIB, V20, P1044, DOI 10.1111/ddi.12208; Hamilton RJ, 2012, BIOL CONSERV, V145, P246, DOI 10.1016/j.biocon.2011.11.020; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Hastings A, 2003, ECOL APPL, V13, pS65; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; Hopf JK, 2015, ECOLOGICAL APPL; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; Jacobi MN, 2011, ECOL APPL, V21, P1861, DOI 10.1890/10-0915.1; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Kininmonth S, 2011, ECOLOGICAL IN PRESS, P1; Kleinhans D, 2011, J THEORETICAL BIOL; Leigh G.M., 2014, STOCK ASSESSMENT QUE; Leis JM, 2002, CORAL REEF FISHES DI; Lentini PE, 2013, CONSERV BIOL, V27, P796, DOI 10.1111/cobi.12060; Lubchenco J, 2003, ECOL APPL, V13, pS3; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Magris RA, 2014, BIOL CONSERV, V170, P207, DOI 10.1016/j.biocon.2013.12.032; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moberg F, 1999, ECOLOGICAL EC; Moffitt EA, 2011, BIOL CONSERV, V144, P306, DOI 10.1016/j.biocon.2010.09.008; Moilanen A., 2009, SPATIAL CONSERVATION; Moilanen A, 2011, J APPL ECOL, V48, P1543, DOI 10.1111/j.1365-2664.2011.02062.x; Mora C, 2015, ECOLOGY FISHES CORAL; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Paris CB, 2013, ENVIRON MODELL SOFTW, V42, P47, DOI 10.1016/j.envsoft.2012.12.006; Possingham HP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002052; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Russ GR, 1996, ECOL APPL, V6, P947, DOI 10.2307/2269497; Russ GR, 2004, ENVIRONMENTAL; Sadovy YJ, 1996, REEF FISHERIES, P15; Saenz-Agudelo P, 2011, P ROY SOC B-BIOL SCI, V278, P2954, DOI 10.1098/rspb.2010.2780; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Salomon Y, 2010, ECOL LETT, V13, P432, DOI 10.1111/j.1461-0248.2009.01436.x; Samoilys MA, 2001, LONG TERM MONITORING; Shanks AL, 2009, BIOL BULL-US, V216, P373; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Smith MD, 2003, J ENVIRON ECON MANAG, V46, P183, DOI 10.1016/S0095-0696(03)00024-X; Sutton SG, 2012, ECOL SOC, V17, DOI 10.5751/ES-04966-170306; Sutton SG, 2009, ENVIRON CONSERV, V36, P245, DOI 10.1017/S0376892909990270; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Treml EA, 2012, CONSERV LETT, V5, P441, DOI 10.1111/j.1755-263X.2012.00260.x; van Oppen MJH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003401; Vaughn D, 2010, INTEGR COMP BIOL, V50, P552, DOI 10.1093/icb/icq037; Vuilleumier S, 2006, P ROYAL SOC LONDON B; Watson James R., 2011, Proceedings of the National Academy of Sciences of the United States of America, V108, pE907; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; White JW, 2014, CONSERV LETT, V7, P533, DOI 10.1111/conl.12097; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327; Williamson DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114395; Williamson DH, 2014, ECOL EVOL, V4, P337, DOI 10.1002/ece3.934; Wilson K.A., 2009, SPATIAL CONSERVATION, P16; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	102	14	14	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154272	10.1371/journal.pone.0154272	http://dx.doi.org/10.1371/journal.pone.0154272			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168206	Green Published, gold, Green Accepted			2022-12-27	WOS:000376587300074
J	Cometti, C; Babault, N; Deley, G				Cometti, Carole; Babault, Nicolas; Deley, Gaelle			Effects of Constant and Doublet Frequency Electrical Stimulation Patterns on Force Production of Knee Extensor Muscles	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; FATIGUE; CONTRACTIONS; POTENTIATION; RECRUITMENT; ADAPTATIONS; RESPONSES; SUMMATION	This study compared knee extensors' neuromuscular fatigue in response to two 30-minute stimulation patterns: constant frequency train (CFT) and doublet frequency train (DFT). Fifteen men underwent two separate sessions corresponding to each pattern. Measurements included torque evoked by each contraction and maximal voluntary contractions (MVC) measured before and immediately after the stimulation sessions. In addition, activation level and torque evoked during doublets (Pd) and tetanic contractions at 80-Hz (P80) and 20-Hz (P20) were determined in six subjects. Results indicated greater mean torque during the DFT stimulation session as compared with CFT. But, no difference was obtained between the two stimulation patterns for MVC and evoked torque decreases. Measurements conducted in the subgroup depicted a significant reduction of Pd, P20 and P80. Statistical analyses also revealed bigger P20 immediate reductions after CFT than after DFT. We concluded that DFT could be a useful stimulation pattern to produce and maintain greater force with quite similar fatigue than CFT.	[Cometti, Carole; Babault, Nicolas; Deley, Gaelle] Univ Bourgogne Franche Comte, Fac Sci Sport, INSERM, Cognit Act & Plast Sensorimotrice U1093, Dijon, France; [Cometti, Carole; Babault, Nicolas; Deley, Gaelle] Univ Bourgogne Franche Comte, Fac Sci Sport, Ctr Expertise Performance, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne	Babault, N (corresponding author), Univ Bourgogne Franche Comte, Fac Sci Sport, INSERM, Cognit Act & Plast Sensorimotrice U1093, Dijon, France.; Babault, N (corresponding author), Univ Bourgogne Franche Comte, Fac Sci Sport, Ctr Expertise Performance, Dijon, France.	nicolas.babault@u-bourgogne.fr	Babault, Nicolas/D-7541-2013	Babault, Nicolas/0000-0001-6563-503X; Deley, Gaelle/0000-0002-8008-2282				Abbate F, 2002, AM J PHYSIOL-CELL PH, V283, pC42, DOI 10.1152/ajpcell.00416.2001; Behm DG, 1996, J APPL PHYSIOL, V81, P2267, DOI 10.1152/jappl.1996.81.5.2267; Belanger M, 2000, ARCH PHYS MED REHAB, V81, P1090, DOI 10.1053/apmr.2000.7170; Bickel CS, 2011, EUR J APPL PHYSIOL, V111, P2399, DOI 10.1007/s00421-011-2128-4; Bigland-Ritchie B, 2000, MUSCLE NERVE, V23, P1348, DOI 10.1002/1097-4598(200009)23:9<1348::AID-MUS5>3.0.CO;2-0; Binder-Macleod SA, 1998, MUSCLE NERVE, V21, P1145, DOI 10.1002/(SICI)1097-4598(199809)21:9<1145::AID-MUS5>3.0.CO;2-7; Binder-MacLeod SA, 2001, ACTA PHYSIOL SCAND, V172, P195, DOI 10.1046/j.1365-201x.2001.00864.x; BINDERMACLEOD SA, 1993, PHYS THER, V73, P902, DOI 10.1093/ptj/73.12.902; BINDERMACLEOD SA, 1991, MUSCLE NERVE, V14, P850, DOI 10.1002/mus.880140909; CAIRNS SP, 1995, MUSCLE NERVE, V18, P890, DOI 10.1002/mus.880180814; Chang YJ, 2011, NEUROREHAB NEURAL RE, V25, P423, DOI 10.1177/1545968310390224; Cohen J.E., 1988, STAT POWER ANAL BEHA; Darques JL, 2003, J APPL PHYSIOL, V95, P1476, DOI 10.1152/japplphysiol.00230.2003; Deley G, 2015, MUSCLE NERVE, V52, P260, DOI 10.1002/mus.24530; Deley G, 2015, SPORTS MED, V45, P71, DOI 10.1007/s40279-014-0250-2; Deley G, 2014, MUSCLE NERVE, V49, P760, DOI 10.1002/mus.24210; Doucet Barbara M., 2012, Yale Journal of Biology and Medicine, V85, P201; DUCHATEAU J, 1986, J MUSCLE RES CELL M, V7, P18, DOI 10.1007/BF01756198; Gondin J, 2011, J APPL PHYSIOL, V110, P433, DOI 10.1152/japplphysiol.00914.2010; Gorgey AS, 2009, J ORTHOP SPORT PHYS, V39, P684, DOI 10.2519/jospt.2009.3045; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; Ibitoye MO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149024; Isakov E, 1986, J Rehabil Res Dev, V23, P9; Jones DA, 1996, ACTA PHYSIOL SCAND, V156, P265, DOI 10.1046/j.1365-201X.1996.192000.x; KARU ZZ, 1995, IEEE T BIO-MED ENG, V42, P809, DOI 10.1109/10.398642; Kebaetse MB, 2001, MUSCLE NERVE, V24, P744, DOI 10.1002/mus.1065; Keeton RB, 2006, PHYS THER, V86, P1146, DOI 10.1093/ptj/86.8.1146; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Martin V, 2004, J APPL PHYSIOL, V97, P1923, DOI 10.1152/japplphysiol.00376.2004; Mohamad NI, 2012, J STRENGTH COND RES, V26, P269, DOI 10.1519/JSC.0b013e31821f48de; PARMIGGIANI F, 1981, J GEN PHYSIOL, V78, P295, DOI 10.1085/jgp.78.3.295; Peckham P, 2005, ANN REV BIOMED ENG; Ratkevicius A, 2002, MUSCLE NERVE, V25, P419, DOI 10.1002/mus.10064; Rattay F, 2003, NEUROMODULATION, V6, P42, DOI 10.1046/j.1525-1403.2003.03006.x; Russ DW, 1999, MUSCLE NERVE, V22, P874, DOI 10.1002/(SICI)1097-4598(199907)22:7<874::AID-MUS10>3.3.CO;2-G; Sandercock TG, 1997, J APPL PHYSIOL, V82, P1219, DOI 10.1152/jappl.1997.82.4.1219; Scott WB, 2007, MUSCLE NERVE, V35, P471, DOI 10.1002/mus.20717; Taylor JA, 2011, PM&R, V3, P817, DOI 10.1016/j.pmrj.2011.03.020; Theurel J, 2007, RESP PHYSIOL NEUROBI, V157, P341, DOI 10.1016/j.resp.2006.12.002; Wheeler GD, 2002, ARCH PHYS MED REHAB, V83, P1093, DOI 10.1053/apmr.2002.33656	40	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155429	10.1371/journal.pone.0155429	http://dx.doi.org/10.1371/journal.pone.0155429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167066	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300031
J	El Khattabi, LA; Rouillac-Le Sciellour, C; Le Tessier, D; Luscan, A; Coustier, A; Porcher, R; Bhouri, R; Nectoux, J; Serazin, V; Quibel, T; Mandelbrot, L; Tsatsaris, V; Vialard, F; Dupont, JM				El Khattabi, Laila Allach; Rouillac-Le Sciellour, Christelle; Le Tessier, Dominique; Luscan, Armelle; Coustier, Audrey; Porcher, Raphael; Bhouri, Rakia; Nectoux, Juliette; Serazin, Valerie; Quibel, Thibaut; Mandelbrot, Laurent; Tsatsaris, Vassilis; Vialard, Francois; Dupont, Jean-Michel			Could Digital PCR Be an Alternative as a Non-Invasive Prenatal Test for Trisomy 21: A Proof of Concept Study	PLOS ONE			English	Article							CONFINED PLACENTAL MOSAICISM; CELL-FREE DNA; FETAL; ANEUPLOIDY; DIAGNOSIS; IMPROVES	Objective NIPT for fetal aneuploidy by digital PCR has been hampered by the large number of PCR reactions needed to meet statistical requirements, preventing clinical application. Here, we designed an octoplex droplet digital PCR (ddPCR) assay which allows increasing the number of available targets and thus overcomes statistical obstacles. Method After technical optimization of the multiplex PCR on mixtures of trisomic and euploid DNA, we performed a validation study on samples of plasma DNA from 213 pregnant women. Molecular counting of circulating cell-free DNA was performed using a mix of hydrolysis probes targeting chromosome 21 and a reference chromosome. Results The results of our validation experiments showed that ddPCR detected trisomy 21 even when the sample's trisomic DNA content is as low as 5%. In a validation study of plasma samples from 213 pregnant women, ddPCR discriminated clearly between the trisomy 21 and the euploidy groups. Conclusion Our results demonstrate that digital PCR can meet the requirements for non-invasive prenatal testing of trisomy 21. This approach is technically simple, relatively cheap, easy to implement in a diagnostic setting and compatible with ethical concerns regarding access to nucleotide sequence information. These advantages make it a potential technique of choice for population-wide screening for trisomy 21 in pregnant women.	[El Khattabi, Laila Allach; Dupont, Jean-Michel] Univ Paris 05, INSERM, Inst Cochin, U1016,CNRS,UMR8104, Paris, France; [El Khattabi, Laila Allach; Le Tessier, Dominique; Luscan, Armelle; Coustier, Audrey; Bhouri, Rakia; Dupont, Jean-Michel] Hop Cochin Matern Port Royal, AP HP, Lab Cytogenet, Paris, France; [Rouillac-Le Sciellour, Christelle; Serazin, Valerie; Vialard, Francois] CHI Poissy St Germain, Federat Genet, Poissy, France; [Serazin, Valerie; Vialard, Francois] Univ Versailles St Quentin En Yvelines, Fac Sci Sante, GIG, Montigny Le Bretonneux, France; [Porcher, Raphael] Hop Hotel Dieu, Ctr Epidemiol Clin, Paris, France; [Nectoux, Juliette] Hop Cochin, AP HP, Lab Biochim & Genet Mol, 27 Rue Faubourg St Jacques, F-75674 Paris, France; [Quibel, Thibaut] CHI Poissy St Germain, Dept Obstet & Gynecol, Poissy, France; [Mandelbrot, Laurent] Hop Univ Paris Nord Val de Seine, Hop Louis Mourier, Serv Gynecol Obstet, Colombes, France; [Mandelbrot, Laurent] Univ Paris Diderot, Paris, France; [Tsatsaris, Vassilis] Hop Cochin Matern Port Royal, Dept Obstet & Gynecol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Chi of Poissy Saint Germain; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Chi of Poissy Saint Germain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	El Khattabi, LA; Dupont, JM (corresponding author), Univ Paris 05, INSERM, Inst Cochin, U1016,CNRS,UMR8104, Paris, France.; El Khattabi, LA; Dupont, JM (corresponding author), Hop Cochin Matern Port Royal, AP HP, Lab Cytogenet, Paris, France.; Vialard, F (corresponding author), CHI Poissy St Germain, Federat Genet, Poissy, France.; Vialard, F (corresponding author), Univ Versailles St Quentin En Yvelines, Fac Sci Sante, GIG, Montigny Le Bretonneux, France.	Laila.el-khattabi@cch.aphp.fr; francois.vialard@uvsq.fr; jean-michel.dupont@cch.aphp.fr	Luscan, Armelle/O-8081-2017; Mandelbrot, Laurent/AAD-3554-2019	Mandelbrot, Laurent/0000-0002-5883-7597; Porcher, Raphael/0000-0002-5277-4679; DUPONT, Jean-Michel/0000-0002-9680-3662; el khattabi, laila/0000-0003-1546-5276; Vialard, Francois/0000-0002-5774-2756	French Agence de la Biomedecine; Association Maternite et Medecine de la Reproduction charity	French Agence de la Biomedecine; Association Maternite et Medecine de la Reproduction charity	This work was funded by a grant from the French Agence de la Biomedecine (reference: AOR 2010 AMP, diagnostic prenatal et diagnostic genetique) and the Association Maternite et Medecine de la Reproduction charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffero GM, 2012, PRENATAL DIAG, V32, P1102, DOI 10.1002/pd.3965; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Cuckle H, 2013, PRENATAL DIAG, V33, P636, DOI 10.1002/pd.4157; de Jong A, 2015, BIOETHICS, V29, P46, DOI 10.1111/bioe.12122; de Jong A, 2011, HUM REPROD, V26, P2915, DOI 10.1093/humrep/der268; Dilba G, 2006, J STAT PLAN INFER, V136, P2640, DOI 10.1016/j.jspi.2004.11.009; Evans MI, 2012, FETAL DIAGN THER, V31, P244, DOI 10.1159/000337544; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2007, ANAL CHEM, V79, P7576, DOI 10.1021/ac0709394; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hua ZS, 2010, ANAL CHEM, V82, P2310, DOI 10.1021/ac902510u; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Juneau K, 2014, FETAL DIAGN THER, V36, P282, DOI 10.1159/000367626; Lestou VS, 1998, ARCH DIS CHILD-FETAL, V79, pF223, DOI 10.1136/fn.79.3.F223; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2013, REPROD BIOMED ONLINE, V27, P593, DOI 10.1016/j.rbmo.2013.08.008; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Stetten G, 2004, AM J MED GENET A, V131A, P232, DOI 10.1002/ajmg.a.30363; TABOR A, 1986, LANCET, V1, P1287; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236	22	28	32	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155009	10.1371/journal.pone.0155009	http://dx.doi.org/10.1371/journal.pone.0155009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167625	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300023
J	Garneau, AP; Marcoux, AA; Noel, M; Frenette-Cotton, R; Drolet, MC; Couet, J; Lariviere, R; Isenring, P				Garneau, Alexandre P.; Marcoux, Andree-Anne; Noel, Micheline; Frenette-Cotton, Rachelle; Drolet, Marie-Claude; Couet, Jacques; Lariviere, Richard; Isenring, Paul			Ablation of Potassium-Chloride Cotransporter Type 3 (Kcc3) in Mouse Causes Multiple Cardiovascular Defects and Isosmotic Polyuria	PLOS ONE			English	Article							K-CL COTRANSPORT; BLOOD-PRESSURE; NA+-K+-2CL(-) COTRANSPORTER; MICE LACKING; HYPERTENSION; MUTATIONS; SPAK; DISRUPTION; CONTRIBUTE; MYOCYTES	Inactivation of Kcc3 in a mixed 129/SvxC57BL/6 mouse background has been previously found to increase systemic blood pressure (BP) through presumed neurogenic mechanisms. Yet, while this background is generally not considered ideal to investigate the cardiovascular system, KCC3 is also expressed in the arterial wall and proximal nephron. In the current study, the effects of Kcc3 ablation was investigated in a pure rather than mixed C57BL/6J background under regular- and high-salt diets to determine whether they could be mediated through vasculogenic and nephrogenic mechanisms. Aortas were also assessed for reactivity to pharmacological agents while isolated from the influence of sympathetic ganglia. This approach led to the identification of unforeseen abnormalities such as lower pulse pressure, heart rate, aortic reactivity and aortic wall thickness, but higher diastolic BP, left ventricular mass and urinary output in the absence of increased catecholamine levels. Salt loading also led systolic BP to be higher, but to no further changes in hemodynamic parameters. Importantly, aortic vascular smooth muscle cells and cardiomyocytes were both found to express KCC3 abundantly in heterozygous mice. Hence, Kcc3 inactivation in our model caused systemic vascular resistance and ventricular mass to increase while preventing extracellular fluid volume to accumulate. Given that it also affected the physiological properties of aortas in vitro, vasculogenic mechanisms could therefore account for a number of the hemodynamic abnormalities observed.	[Garneau, Alexandre P.; Marcoux, Andree-Anne; Noel, Micheline; Frenette-Cotton, Rachelle; Lariviere, Richard; Isenring, Paul] Ctr Hosp Univ Quebec, Ctr Rech Hotel Dieu Quebec, Nephrol Res Grp, Quebec City, PQ, Canada; [Drolet, Marie-Claude; Couet, Jacques] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Valvulopathy Res Grp, Quebec City, PQ, Canada; [Garneau, Alexandre P.; Marcoux, Andree-Anne; Noel, Micheline; Frenette-Cotton, Rachelle; Drolet, Marie-Claude; Couet, Jacques; Lariviere, Richard; Isenring, Paul] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University	Isenring, P (corresponding author), Ctr Hosp Univ Quebec, Ctr Rech Hotel Dieu Quebec, Nephrol Res Grp, Quebec City, PQ, Canada.; Isenring, P (corresponding author), Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada.	paul.isenring@crhdq.ulaval.ca		Couet, Jacques/0000-0001-5409-8689	Canada Foundation for Innovation (CFI); Canadian Institutes of Health Research (CIHR) [IC087830, IC090498]; Kidney Foundation of Canada; Fonds de recherche du Quebec - Sante [22593]	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	Funding for this work came from Canada Foundation for Innovation (CFI); Canadian Institutes of Health Research (CIHR) [grant numbers: IC087830 and IC090498]; Kidney Foundation of Canada. Mister Alexandre P. Garneau was supported through a Master's Training Award from the Fonds de recherche du Quebec - Sante [award number 22593]. Dr. Paul Isenring holds a CFI-CIHR research chair in molecular physiology.	Acuna R, 2011, J HYPERTENS, V29, P475, DOI 10.1097/HJH.0b013e328341d0fd; Adragna NC, 2004, ADV EXP MED BIOL, V559, P379; Akar F, 1999, AM J PHYSIOL-CELL PH, V276, pC1383, DOI 10.1152/ajpcell.1999.276.6.C1383; Anfinogenova YJ, 2004, PFLUG ARCH EUR J PHY, V449, P42, DOI 10.1007/s00424-004-1316-z; Archer SL, 1996, CIRC RES, V78, P431, DOI 10.1161/01.RES.78.3.431; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; CANESSA M, 1994, HYPERTENSION, V23, P1022, DOI 10.1161/01.HYP.23.6.1022; Cruz DN, 2001, HYPERTENSION, V37, P1458, DOI 10.1161/01.HYP.37.6.1458; Daigle ND, 2009, J CELL PHYSIOL, V220, P680, DOI 10.1002/jcp.21814; Di Fulvio M, 2003, NITRIC OXIDE-BIOL CH, V9, P165, DOI 10.1016/j.niox.2003.11.004; Drolet MC, 2006, J AM COLL CARDIOL, V47, P850, DOI 10.1016/j.jacc.2005.09.049; Fava C, 2008, HUM MOL GENET, V17, P413, DOI 10.1093/hmg/ddm318; Garg P, 2007, AM J PHYSIOL-HEART C, V292, pH2100, DOI 10.1152/ajpheart.01402.2006; HARDER DR, 1981, CIRC RES, V49, P1237, DOI 10.1161/01.RES.49.6.1237; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Iemitsu M, 2001, AM J PHYSIOL-REG I, V281, pR2029, DOI 10.1152/ajpregu.2001.281.6.R2029; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Melander O, 2000, HYPERTENSION, V36, P389, DOI 10.1161/01.HYP.36.3.389; Mercado A, 2005, AM J PHYSIOL-RENAL, V289, pF1246, DOI 10.1152/ajprenal.00464.2004; Meyer JW, 2002, AM J PHYSIOL-HEART C, V283, pH1846, DOI 10.1152/ajpheart.00083.2002; MITANI A, 1992, AM J PHYSIOL, V263, pH333, DOI 10.1152/ajpheart.1992.263.2.H333; Plante E, 2006, J AM SOC ECHOCARDIOG, V19, P1520, DOI 10.1016/j.echo.2006.06.011; Prasad V, 2008, J BIOL CHEM, V283, P31303, DOI 10.1074/jbc.M803706200; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Rodan AR, 2010, J AM SOC NEPHROL, V21, P1812, DOI 10.1681/ASN.2010090926; Rust MB, 2006, CIRC RES, V98, P549, DOI 10.1161/01.RES.0000204449.83861.22; Takahashi N, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133604; Urena J, 1996, J PHYSIOL-LONDON, V496, P103, DOI 10.1113/jphysiol.1996.sp021668; Viitanen T, 2010, J PHYSIOL-LONDON, V588, P1527, DOI 10.1113/jphysiol.2009.181826; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059584; Yamamoto T, 2009, HEART VESSELS, V24, P54, DOI 10.1007/s00380-008-1071-8; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295	34	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154398	10.1371/journal.pone.0154398	http://dx.doi.org/10.1371/journal.pone.0154398			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166674	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300003
J	Guo, L; Liang, TM; Yu, JF; Zou, Q				Guo, Li; Liang, Tingming; Yu, Jiafeng; Zou, Quan			A Comprehensive Analysis of miRNA/isomiR Expression with Gender Difference	PLOS ONE			English	Article							CELL-DEATH; MICRORNA EXPRESSION; MIRNA EXPRESSION; RESOURCE; ADENYLATION; REPERTOIRE; APOPTOSIS; INFERENCE; PROFILES; NETWORK	Although microRNAs (miRNAs) have been widely studied as epigenetic regulation molecules, fewer studies focus on the gender difference at the miRNA and isomiR expression levels. In this study, we aim to understand the potential relationships between gender difference and miRNA/isomiR expression through a comprehensive analysis of small RNA-sequencing datasets based on different human diseases and tissues. Based on specific samples from males and females, we determined that some miRNAs may be diversely expressed between different tissues and genders. Thus, these miRNAs may exhibit inconsistent and even opposite expression between males and females. According to deregulated miRNA expression profiles, some dominantly expressed miRNA loci were selected to analyze isomiR expression patterns using rates of dominant isomiRs. In some miRNA loci, isomiRs showed statistical significance between tumor and normal samples and between males and females samples, suggesting that isomiR expression patterns are not always invariable but may vary between males and females, as well as among different tissues, tumors, and normal samples. The divergence implicates the fluctuation in the expression of miRNA and its detailed expression at the isomiR levels. The divergence also indicates that gender difference may be an important factor that affects the screening of disease-associated miRNAs and isomiRs. This study suggests that miRNA/isomiR expression and gender difference may be more complex than previously assumed and should be further studied according to specific samples from males or females.	[Guo, Li] Nanjing Univ Posts & Telecommun, Sch Geog & Biol Informat, Dept Bioinformat, Nanjing, Jiangsu, Peoples R China; [Liang, Tingming] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Yu, Jiafeng] Dezhou Univ, Inst Biophys, Shandong Prov Key Lab Funct Macromol Biophys, Dezhou, Peoples R China; [Zou, Quan] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China; [Zou, Quan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nanjing University of Posts & Telecommunications; Nanjing Normal University; Dezhou University; Tianjin University; Nankai University	Guo, L (corresponding author), Nanjing Univ Posts & Telecommun, Sch Geog & Biol Informat, Dept Bioinformat, Nanjing, Jiangsu, Peoples R China.; Zou, Q (corresponding author), Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China.; Zou, Q (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	lguo@njupt.edu.cn; zouquan@nclab.net	Liang, Tingming/ACL-6141-2022; Zou, Quan/A-7801-2015		National Natural Science Foundation of China [61301251, 31401009, 61370010]; Research Fund for the Doctoral Program of Higher Education of China [20133234120009]; National Natural Science Foundation of Jiangsu [BK20130885]; Natural Science Foundation of the Jiangsu Higher Education Institutions [13KJB330003]; State Key Laboratory of Medicinal Chemical Biology; Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NUPTSF [NY215068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of Jiangsu; Natural Science Foundation of the Jiangsu Higher Education Institutions; State Key Laboratory of Medicinal Chemical Biology; Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NUPTSF	This work has been supported by the National Natural Science Foundation of China (Nos. 61301251, 31401009 and 61370010), the Research Fund for the Doctoral Program of Higher Education of China (No. 20133234120009), the National Natural Science Foundation of Jiangsu (No. BK20130885), the Natural Science Foundation of the Jiangsu Higher Education Institutions (No. 13KJB330003), the State Key Laboratory of Medicinal Chemical Biology, Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics, the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and sponsored by NUPTSF (No. NY215068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Babapoor S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107502; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benderska N, 2015, INFLAMM BOWEL DIS, V21, P2039, DOI 10.1097/MIB.0000000000000453; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Dai RJ, 2014, THER CLIN RISK MANAG, V10, P151, DOI 10.2147/TCRM.S33517; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Eidelman Ofer, 2010, Hum Genomics Proteomics, V2010, P164906, DOI 10.4061/2010/164906; Fan HY, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/814598; Fan SJ, 2016, LEUKEMIA RES, V41, P62, DOI 10.1016/j.leukres.2015.11.016; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Freitak D, 2012, BIOL LETTERS, V8, P860, DOI 10.1098/rsbl.2012.0273; Guo L, 2014, CURR BIOINFORM, V9, P522, DOI 10.2174/1574893608666131120234836; Guo L, 2014, MOL BIOL REP, V41, P6649, DOI 10.1007/s11033-014-3548-0; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Huang FY, 2015, ONCOTARGET, V6, P34941, DOI 10.18632/oncotarget.5472; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langevin SM, 2010, CARCINOGENESIS, V31, P864, DOI 10.1093/carcin/bgq051; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li X, 2013, TOXICOL SCI, V135, P63, DOI 10.1093/toxsci/kft131; Li YH, 2015, NUCLEIC ACIDS RES, V43, pD578, DOI 10.1093/nar/gku903; Li YF, 2013, AUTOPHAGY, V9, P436, DOI 10.4161/auto.23096; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-104; Loher P, 2014, ONCOTARGET, V5, P8790, DOI 10.18632/oncotarget.2405; Lu KP, 2015, ONCOL REP, V34, P995, DOI 10.3892/or.2015.4025; Lu SF, 2009, NUCLEIC ACIDS RES, V37, P1878, DOI 10.1093/nar/gkp031; Miike K, 2010, PROTEOMICS, V10, P2678, DOI 10.1002/pmic.200900496; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Mork S, 2014, BIOINFORMATICS, V30, P392, DOI 10.1093/bioinformatics/btt677; Nalluri JJ, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S5-S12; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Prajapati P, 2015, BBA-MOL BASIS DIS, V1852, P451, DOI 10.1016/j.bbadis.2014.11.019; Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692; Tan GC, 2014, NUCLEIC ACIDS RES, V42, P9424, DOI 10.1093/nar/gku656; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.292; Wu D, 2015, AUTOPHAGY, V11, P1917, DOI 10.1080/15548627.2015.1089375; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang XM, 2014, RNA, V20, P989, DOI 10.1261/rna.044776.114; Zhou XD, 2015, JOINT BONE SPINE, V82, P166, DOI 10.1016/j.jbspin.2014.12.009; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024; Zou Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/416323	46	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154955	10.1371/journal.pone.0154955	http://dx.doi.org/10.1371/journal.pone.0154955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167065	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300001
J	Gao, HJ; Baldeosingh, R; Wu, XR; Fossett, N				Gao, Hongjuan; Baldeosingh, Rajkumar; Wu, Xiaorong; Fossett, Nancy			The Friend of GATA Transcriptional Co-Regulator, U-Shaped, Is a Downstream Antagonist of Dorsal-Driven Prohemocyte Differentiation in Drosophila	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TOLL-LIKE RECEPTORS; SIGNALING PATHWAY; PROGENITOR CELLS; LINEAGE COMMITMENT; VENTRAL PATTERN; IMMUNE-RESPONSE; LYMPH GLAND; GENE; BLOOD	Recent studies suggest that mammalian hematopoietic stem and progenitor cells (HSPCs) respond directly to infection and inflammatory signaling. These signaling pathways also regulate HSPCs during steady-state conditions (absence of infection), and dysregulation may lead to cancer or age-related loss of progenitor repopulation capacity. Toll-like receptors (TLRs) are a major class of pathogen recognition receptors, and are expressed on the surface of immune effector cells and HSPCs. TLR/NF-kappa B activation promotes HSPCs differentiation; however, the mechanisms by which this signaling pathway alters the intrinsic transcriptional landscape are not well understood. Although Drosophila prohemocytes are the functional equivalent of mammalian HSPCs, a prohemocyte-specific function for Toll signaling has not been reported. Using Drosophila transgenics, we identified prohemocyte-specific roles for Toll pathway members, Dorsal and Cactus. We showed that Dorsal is required to limit the size of the progenitor pool. Additionally, we showed that activation of Toll signaling in prohemocytes drives differentiation in a manner that is analogous to TLR/NF-kappa B-driven HSPC differentiation. This was accomplished by showing that over-expression of Dorsal, or knockdown of Cactus, promotes differentiation. We also investigated whether Dorsal and Cactus control prohemocyte differentiation by regulating a key intrinsic prohemocyte factor, U-shaped (Ush), which is known to promote multipotency and block differentiation. We showed that Dorsal repressed Ush expression levels to promote differentiation, whereas Cactus maintained Ush levels to block differentiation. Additionally, we showed that another Toll antagonist, Lesswright, also maintained the level of Ush to block differentiation and promote proliferative quiescence. Collectively, these results identify a novel role for Ush as a downstream target of Toll signaling.	[Gao, Hongjuan; Baldeosingh, Rajkumar; Wu, Xiaorong; Fossett, Nancy] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Gao, Hongjuan; Baldeosingh, Rajkumar; Wu, Xiaorong; Fossett, Nancy] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Baldeosingh, Rajkumar; Fossett, Nancy] Univ Maryland, Sch Med, Grad Program Life Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Fossett, N (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.; Fossett, N (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Fossett, N (corresponding author), Univ Maryland, Sch Med, Grad Program Life Sci, Baltimore, MD 21201 USA.	nfossett@som.umaryland		Baldeosingh, Rajkumar/0000-0002-8673-3285	National Institutes of Health, The National Institute of Diabetes and Digestive and Kidney Diseases, Public Health Service [DK072229]; National Institutes of Health, The National Institute of Diabetes and Digestive and Kidney Diseases Public Health Service [DK072229]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072229] Funding Source: NIH RePORTER	National Institutes of Health, The National Institute of Diabetes and Digestive and Kidney Diseases, Public Health Service; National Institutes of Health, The National Institute of Diabetes and Digestive and Kidney Diseases Public Health Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by the National Institutes of Health, The National Institute of Diabetes and Digestive and Kidney Diseases [www.niddk.nih.gov], Public Health Service grant DK072229 to NF.; We gratefully acknowledge our colleagues for providing fly strains and antibodies: M. Crozatier (University Paul Sabatier); T. Tokusumi and R. A. Schulz (University of Notre Dame); S. Govind (City College of New York); J. Skeath (Washington University School of Medicine; I. Ando (Biological Research Center of the Hungarian Academy of Sciences) and F. C. Kafatos (EMBL). This work was supported by National Institutes of Health, The National Institute of Diabetes and Digestive and Kidney Diseases www.niddk.nih.gov Public Health Service grant DK072229 to NF.	Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Boiko JR, 2012, CYTOKINE, V57, P1, DOI 10.1016/j.cyto.2011.10.005; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cantor AB, 2008, J EXP MED, V205, P611, DOI 10.1084/jem.20070544; Chiu HL, 2005, DEV BIOL, V288, P60, DOI 10.1016/j.ydbio.2005.08.008; Dearolf CR, 1998, BBA-REV CANCER, V1377, pM13, DOI 10.1016/S0304-419X(97)00031-0; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fossett N, 2003, P NATL ACAD SCI USA, V100, P11451, DOI 10.1073/pnas.1635050100; Fossett N, 2001, TRENDS CARDIOVAS MED, V11, P185, DOI 10.1016/S1050-1738(01)00092-5; Fossett N, 2001, P NATL ACAD SCI USA, V98, P7342, DOI 10.1073/pnas.131215798; Fossett N, 2013, BBA-GEN SUBJECTS, V1830, P2375, DOI 10.1016/j.bbagen.2012.06.005; Gao HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107768; Gao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074684; Gao HJ, 2011, GENESIS, V49, P105, DOI 10.1002/dvg.20711; Gao HJ, 2009, MOL CELL BIOL, V29, P6086, DOI 10.1128/MCB.00244-09; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; Ghosh S, 2015, DEV CELL, V33, P478, DOI 10.1016/j.devcel.2015.03.014; Govind S, 1996, BIOCHEM SOC T, V24, P39, DOI 10.1042/bst0240039; Gueguen G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003580; HASHIMOTO C, 1991, DEVELOPMENT, V111, P1021; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Huang L, 2005, DEV BIOL, V280, P407, DOI 10.1016/j.ydbio.2005.02.006; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kalamarz ME, 2012, BIOL OPEN, V1, P161, DOI [10.1242/bio.2012043, 10.1242/bio.2011043]; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Makhijani K, 2011, DEVELOPMENT, V138, P5379, DOI 10.1242/dev.067322; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; Megias J, 2012, STEM CELLS, V30, P1486, DOI 10.1002/stem.1110; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Muratoglu S, 2007, DEV BIOL, V311, P636, DOI 10.1016/j.ydbio.2007.08.015; Muratoglu S, 2006, DEV BIOL, V296, P561, DOI 10.1016/j.ydbio.2006.04.455; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Paddibhatla I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001234; Qiu P, 1998, DEVELOPMENT, V125, P1909; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Rebel VI, 1999, J EXP MED, V190, P1493, DOI 10.1084/jem.190.10.1493; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; Rezzoug F, 2008, J IMMUNOL, V180, P49, DOI 10.4049/jimmunol.180.1.49; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; ROTH S, 1991, DEVELOPMENT, V112, P371; Schmid MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102568; Sinenko SA, 2012, EMBO REP, V13, P83, DOI 10.1038/embor.2011.223; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Small C, 2012, JOVE-J VIS EXP, DOI 10.3791/3347; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tokusumi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006429; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Ward EJ, 2000, DEVELOPMENT, V127, P4959; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007	77	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155372	10.1371/journal.pone.0155372	http://dx.doi.org/10.1371/journal.pone.0155372			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163255	gold, Green Published			2022-12-27	WOS:000376585700042
J	Hernandez-de Sosa, N; Athanasiadis, G; Malouf, J; Laiz, A; Marin, A; Herrera, S; Farrerons, J; Soria, JM; Casademont, J				Hernandez-de Sosa, Nerea; Athanasiadis, Georgios; Malouf, Jorge; Laiz, Ana; Marin, Ana; Herrera, Silvia; Farrerons, Jordi; Soria, Jose Manuel; Casademont, Jordi			Genetic Contribution of Femoral Neck Bone Geometry to the Risk of Developing Osteoporosis: A Family-Based Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MINERAL DENSITY; HIP FRACTURE; LINKAGE ANALYSIS; PHOTON-ABSORPTIOMETRY; POSTMENOPAUSAL WOMEN; GENDER-DIFFERENCES; NUCLEAR FAMILIES; STRENGTH; MEN	Femoral neck geometry parameters are believed to be as good as bone mineral density as independent factors in predicting hip fracture risk. This study was conducted to analyze the roles of genetic and environmental factors in femoral properties measured in a sample of Spanish families with osteoporotic fractures and extended genealogy. The "Genetic Analysis of Osteoporosis (GAO) Project" involved 11 extended families with a total number of 376 individuals. We studied three categorical phenotypes of particular clinical interest and we used a Hip structural analysis based on DXA to analyze 17 strength and geometrical phenotypes of the hip. All the femoral properties had highly significant heritability, ranging from 0.252 to 0.586. The most significant correlations were observed at the genetic level (rho(G)). Osteoporotic fracture status (Affected 2) and, particularly, low bone mass and osteoporotic condition (Affected 3) had the highest number of significant genetic correlations with diverse femoral properties. In conclusion, our findings suggest that a relatively simple and easy to use method based on DXA studies can provide useful data on properties of the Hip in clinical practice. Furthermore, our results provide a strong motivation for further studies in order to improve the understanding of the pathophysiological mechanism underlying bone architecture and the genetics of osteoporosis.	[Hernandez-de Sosa, Nerea; Malouf, Jorge; Laiz, Ana; Marin, Ana; Herrera, Silvia; Farrerons, Jordi; Casademont, Jordi] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Internal Med, E-08193 Barcelona, Spain; [Athanasiadis, Georgios; Soria, Jose Manuel] Hosp Santa Creu & Sant Pau, Res Inst, Dept Genom Complex Dis, Barcelona, Spain; [Athanasiadis, Georgios] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Aarhus University	Hernandez-de Sosa, N (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Internal Med, E-08193 Barcelona, Spain.	nhernandezd@santpau.cat	Casademont, Jordi/A-6828-2010; LAIZ, ANA/AAD-4536-2019; Casademont, Jordi/GPK-8669-2022; Soria Fernández, José Manuel/AAD-6761-2019; Sierra, Jorge Malouf/AAF-9797-2020; Athanasiadis, Georgios/A-7745-2012; LAIZ, ANA/Z-4386-2019	Casademont, Jordi/0000-0002-8100-1827; LAIZ, ANA/0000-0002-2820-4801; Casademont, Jordi/0000-0002-8100-1827; Soria Fernández, José Manuel/0000-0002-6226-4293; Sierra, Jorge Malouf/0000-0001-5185-520X; Athanasiadis, Georgios/0000-0002-2927-4035; 	National Fund of Sanitary Investigations [FIS PI 11/01175, PI 14/01036]; Subprogama Nacional de Contratacion e Incorporacion de Investigadores Juan de la Cierva (Secretaria de Estado, Ministerio de Economia y Competitividad)	National Fund of Sanitary Investigations; Subprogama Nacional de Contratacion e Incorporacion de Investigadores Juan de la Cierva (Secretaria de Estado, Ministerio de Economia y Competitividad)	The project was supported by the National Fund of Sanitary Investigations (FIS PI 11/01175 and PI 14/01036). Georgios Athanasiadis was supported by the Subprogama Nacional de Contratacion e Incorporacion de Investigadores Juan de la Cierva (Secretaria de Estado, Ministerio de Economia y Competitividad).; The authors gratefully acknowledge the participation of all the families who participated in the GAO Project. Without them, this work could never have been accomplished. The Project was supported by the National Fund of Sanitary Investigations (FIS PI 11/01175 and PI 14/01036). Georgios Athanasiadis was supported by the Subprogama Nacional de Contratacion e Incorporacion de Investigadores Juan de la Cierva (Secretaria de Estado, Ministerio de Economia y Competitividad).	Ahlborg HG, 2005, J BONE MINER RES, V20, P1820, DOI 10.1359/JBMR.050519; Athanasiadis G, 2014, BONE, V60, P98, DOI 10.1016/j.bone.2013.12.010; Beck TJ, 2006, J BONE MINER RES, V21, P1425, DOI 10.1359/JBMR.060617; Beck TJ, 2000, J BONE MINER RES, V15, P2297, DOI 10.1359/jbmr.2000.15.12.2297; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Blangero J, 2003, J THROMB HAEMOST, V1, P1391, DOI 10.1046/j.1538-7836.2003.00310.x; Brown LB, 2004, GENET EPIDEMIOL, V27, P153, DOI 10.1002/gepi.20009; Danielson ME, 2013, OSTEOPOROSIS INT, V24, P1379, DOI 10.1007/s00198-012-2066-y; Demissie S, 2007, BONE, V40, P743, DOI 10.1016/j.bone.2006.09.020; Duan YB, 2003, J BONE MINER RES, V18, P1766, DOI 10.1359/jbmr.2003.18.10.1766; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Faulkner KG, 2006, OSTEOPOROSIS INT, V17, P593, DOI 10.1007/s00198-005-0019-4; Genant HK, 1996, J BONE MINER RES, V11, P707; Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806; Sosa NHD, 2014, CALCIFIED TISSUE INT, V94, P590, DOI 10.1007/s00223-014-9852-9; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jian WX, 2004, J HUM GENET, V49, P87, DOI 10.1007/s10038-003-0113-4; Jiang H, 2007, ACTA PHARMACOL SIN, V28, P375, DOI 10.1111/j.1745-7254.2007.00522.x; KALENDER WA, 1992, OSTEOPOROSIS INT, V2, P82, DOI 10.1007/BF01623841; Kaptoge S, 2003, BONE, V32, P561, DOI 10.1016/S8756-3282(03)00055-3; Karlsson KM, 1996, BONE, V18, P327, DOI 10.1016/8756-3282(96)00004-X; Keaveny TM, 2008, J BONE MINER RES, V23, P1974, DOI 10.1359/JBMR.080805; Kendall M, 1972, ADV THEORY STAT; Koller DL, 2010, J CLIN ENDOCR METAB, V95, P1802, DOI 10.1210/jc.2009-1903; LaCroix AZ, 2010, OSTEOPOROSIS INT, V21, P919, DOI 10.1007/s00198-009-1056-1; Li PY, 2004, ANN HUM GENET, V68, P154, DOI 10.1046/j.1529-8817.2003.00082.x; Lyles KW, 2008, OSTEOPOROSIS INT, V19, P1225, DOI 10.1007/s00198-008-0569-3; MARTIN RB, 1984, J BIOMECH, V17, P195, DOI 10.1016/0021-9290(84)90010-1; Melton LJ, 2005, OSTEOPOROSIS INT, V16, P460, DOI 10.1007/s00198-004-1820-1; Mitchell BD, 2003, BONE, V33, P839, DOI 10.1016/S8756-3282(03)00246-1; Moffett SP, 2005, J CLIN ENDOCR METAB, V90, P3491, DOI 10.1210/jc.2004-2235; Naganathan V, 2002, J BONE MINER RES, V17, P725, DOI 10.1359/jbmr.2002.17.4.725; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Piters E, 2012, CALCIFIED TISSUE INT, V90, P30, DOI 10.1007/s00223-011-9546-5; Qureshi AM, 2001, CALCIFIED TISSUE INT, V69, P67, DOI 10.1007/s002230010037; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Rivadeneira F, 2004, J BONE MINER RES, V19, P1280, DOI 10.1359/JBMR.040405; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SLEMENDA CW, 1991, J BONE MINER RES, V6, P561; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Tse KY, 2009, J ORTHOP RES, V27, P150, DOI 10.1002/jor.20721; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; Xiao P, 2006, J BONE MINER RES, V21, P1536, DOI 10.1359/JBMR.060717; Xiong DH, 2006, J BONE MINER RES, V21, P424, DOI 10.1359/JBMR.051202; Zhang H, 2011, OSTEOPOROSIS INT, V22, P2513, DOI 10.1007/s00198-010-1479-8; Zhao LJ, 2010, J BONE MINER RES, V25, P320, DOI 10.1359/jbmr.090726; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154833	10.1371/journal.pone.0154833	http://dx.doi.org/10.1371/journal.pone.0154833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163365	Green Published, gold			2022-12-27	WOS:000376585700023
J	Moriyama, K; Ohashi, Y; Motoyasu, A; Ando, T; Moriyama, K; Yorozu, T				Moriyama, Kumi; Ohashi, Yuki; Motoyasu, Akira; Ando, Tadao; Moriyama, Kiyoshi; Yorozu, Tomoko			Intrathecal Administration of Morphine Decreases Persistent Pain after Cesarean Section: A Prospective Observational Study	PLOS ONE			English	Article							DELIVERY	Purpose Chronic pain after cesarean section (CS) is a serious concern, as it can result in functional disability. We evaluated the prevalence of chronic pain after CS prospectively at a single institution in Japan. We also analyzed perioperative risk factors associated with chronic pain using logistic regression analyses with a backward-stepwise procedure. Materials and Methods Patients who underwent elective or emergency CS between May 2012 and May 2014 were recruited. Maternal demographics as well as details of surgery and anesthesia were recorded. An anesthesiologist visited the patients on postoperative day (POD) 1 and 2, and assessed their pain with the Prince Henry Pain Scale. To evaluate the prevalence of chronic pain, we contacted patients by sending a questionnaire 3 months post-CS. Results Among 225 patients who questionnaires, 69 (30.7%) of patients complained of persistent pain, although no patient required pain medication. Multivariate analyses identified lighter weight (p = 0.011) and non-intrathecal administration of morphine (p = 0.023) as determinant factors associated with persistent pain at 3 months. The adjusted odds ratio of intrathecal administration of morphine to reduce persistent pain was 0.424, suggesting that intrathecal administration of morphine could decrease chronic pain by 50%. In addition, 51.6% of patients had abnormal wound sensation, suggesting the development of neuropathic pain. Also, 6% of patients with abnormal wound sensation required medication, yet no patients with persistent pain required medication. Conclusion Although no effect on acute pain was observed, intrathecal administration of morphine significantly decreased chronic pain after CS.	[Moriyama, Kumi; Ohashi, Yuki; Motoyasu, Akira; Ando, Tadao; Moriyama, Kiyoshi; Yorozu, Tomoko] Kyorin Univ, Sch Med, Dept Anesthesiol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan	Kyorin University	Moriyama, K (corresponding author), Kyorin Univ, Sch Med, Dept Anesthesiol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	mokiyo@ks.kyorin-u.ac.jp	Moriyama, Kiyoshi/AAA-3764-2022	Moriyama, Kiyoshi/0000-0002-0387-5406				Creanga AA, 2015, OBSTET GYNECOL, V125, P5, DOI 10.1097/AOG.0000000000000564; Doering K, 2014, WOMEN BIRTH, V27, P121, DOI 10.1016/j.wombi.2013.11.005; Doi K, 2007, J ANESTH, V21, P439, DOI 10.1007/s00540-007-0519-9; Eisenach JC, 2008, PAIN, V140, P87, DOI 10.1016/j.pain.2008.07.011; Gadsden J, 2005, ANESTH ANALG, V101, pS62, DOI 10.1213/01.ANE.0000177100.08599.C8; Kainu JP, 2010, INT J OBSTET ANESTH, V19, P4, DOI 10.1016/j.ijoa.2009.03.013; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato R, 2008, J ANESTH, V22, P112, DOI 10.1007/s00540-007-0593-z; Liu TT, 2013, ANAESTH INTENS CARE, V41, P496, DOI 10.1177/0310057X1304100410; Loos MJ, 2008, OBSTET GYNECOL, V111, P839, DOI 10.1097/AOG.0b013e31816a4efa; Macrae WA, 2008, BRIT J ANAESTH, V101, P77, DOI 10.1093/bja/aen099; McCabe JM, 2012, ARCH INTERN MED, V172, P864, DOI 10.1001/archinternmed.2012.945; Nakamura M, 2011, J ORTHOP SCI, V16, P424, DOI 10.1007/s00776-011-0102-y; Nikolajsen L, 2004, ACTA ANAESTH SCAND, V48, P111, DOI 10.1111/j.1399-6576.2004.00271.x; Sng BL, 2009, ANAESTH INTENS CARE, V37, P748, DOI 10.1177/0310057X0903700513; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X	16	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155114	10.1371/journal.pone.0155114	http://dx.doi.org/10.1371/journal.pone.0155114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163790	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700028
J	Bissonnette, R; Suarez-Farinas, M; Li, X; Bonifacio, KM; Brodmerkel, C; Fuentes-Duculan, J; Krueger, JG				Bissonnette, Robert; Suarez-Farinas, Mayte; Li, Xuan; Bonifacio, Kathleen M.; Brodmerkel, Carrie; Fuentes-Duculan, Judilyn; Krueger, James G.			Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris	PLOS ONE			English	Article							ASSOCIATION; SERUM	Introduction There is a controversy surrounding the existence of palmoplantar pustulosis (PPP) and palmoplantar pustular psoriasis (PPPP) as separate clinical entities or as variants of the same clinical entity. We used gene expression microarray to compare gene expression in PPP and PPPP. Methodology/Principal findings Skin biopsies from subjects with PPP (3), PPPP (6), psoriasis vulgaris (10) and acral skin from normal subjects (7) were analyzed using gene expression microarray. Principal component analysis showed that PPP and PPPP were different from psoriasis vulgaris and normal acral skin. However gene expression of PPP and PPPP clustered together and could not be used to differentiate PPP from PPPP. Gene-wise comparison between PPP and PPPP found no gene to be differentially expressed at a false discovery rate lower than 0.05. Surprisingly we found a higher expression of several genes involved in neural pathways (e.g. GPRIN and ADAM23) in PPP/PPPP as compared to psoriasis vulgaris and normal acral skin. Immunohistochemistry confirmed those findings and showed a keratinocyte localization for those proteins. Conclusion significance PPP and PPPP could not be differentiated using gene expression microarray suggesting that they are not distinct clinical entities. Increased expression of GPRIN1, and ADAM23 in keratinocytes suggests that these proteins could be new therapeutic targets for PPP/PPPP.	[Bissonnette, Robert] Innovaderm Res, Montreal, PQ, Canada; [Suarez-Farinas, Mayte; Li, Xuan; Bonifacio, Kathleen M.; Fuentes-Duculan, Judilyn; Krueger, James G.] Rockefeller Univ, Lab Invest Dermatol, 1230 York Ave, New York, NY 10021 USA; [Brodmerkel, Carrie] Janssen Res & Dev LLC, Spring House, PA USA	Innovaderm Research Inc.; Rockefeller University; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Bissonnette, R (corresponding author), Innovaderm Res, Montreal, PQ, Canada.	rbissonnette@innovaderm.ca			Janssen Inc. Canada; Janssen Research & Development, LLC; Innovaderm Research	Janssen Inc. Canada; Janssen Research & Development, LLC; Innovaderm Research	This study was funded and medication provided by Janssen Inc. Canada. The funders (Janssen Inc. Canada) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Carrie Brodmerkel is employed by Janssen Research & Development, LLC. Janssen Research & Development, LLC provided support in the form of salary for author CB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Author Robert Bissonnette is employed by Innovaderm Research, Montreal. Innovaderm Research provided support in the form of salary for author RB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ammoury A, 2008, J EUR ACAD DERMATOL, V22, P392, DOI 10.1111/j.1468-3083.2007.02344.x; ASHURST PJC, 1964, BRIT J DERMATOL, V76, P169, DOI 10.1111/j.1365-2133.1964.tb14502.x; Bissonnette R, 2014, J EUR ACAD DERMATOL, V28, P1298, DOI 10.1111/jdv.12272; Brunasso AMG, 2013, BRIT J DERMATOL, V168, P1243, DOI 10.1111/bjd.12223; de Waal AC, 2011, J DERMATOL TREAT, V22, P102, DOI 10.3109/09546631003636817; ENFORS W, 1971, ACTA DERM-VENEREOL, V51, P289; Fu DJ, 2014, J INVEST DERMATOL, V134, P754, DOI 10.1038/jid.2013.356; Hagforsen E, 2010, BRIT J DERMATOL, V163, P572, DOI 10.1111/j.1365-2133.2010.09819.x; Hashigucci K, 1999, TISSUE ANTIGENS, V54, P288, DOI 10.1034/j.1399-0039.1999.540312.x; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanazawa N, 2013, J DERMATOL, V40, P749, DOI 10.1111/1346-8138.12227; Kim DY, 2013, J EUR ACAD DERMATOL, V27, P1559, DOI 10.1111/jdv.12203; Kingo K, 2007, BRIT J DERMATOL, V156, P646, DOI 10.1111/j.1365-2133.2006.07731.x; Li M, 2013, J INVEST DERMATOL, V133, P2637, DOI 10.1038/jid.2013.267; Mossner R, 2005, J INVEST DERMATOL, V124, P282, DOI 10.1111/j.0022-202X.2004.23556.x; Mrowietz U, 2011, BRIT J DERMATOL, V164, P942, DOI 10.1111/j.1365-2133.2011.10233.x; Murakami M, 2011, EXP DERMATOL, V20, P845, DOI 10.1111/j.1600-0625.2011.01325.x; Suarez-Farinas M, 2012, J INVEST DERMATOL, V132, P2552, DOI 10.1038/jid.2012.184	18	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155215	10.1371/journal.pone.0155215	http://dx.doi.org/10.1371/journal.pone.0155215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152848	gold, Green Published, Green Submitted			2022-12-27	WOS:000375677000079
J	Borselli, D; Lieutaud, A; Thefenne, H; Garnotel, E; Pages, JM; Brunel, JM; Bolla, JM				Borselli, Diane; Lieutaud, Aurelie; Thefenne, Helene; Garnotel, Eric; Pages, Jean-Marie; Brunel, Jean Michel; Bolla, Jean-Michel			Polyamino-Isoprenic Derivatives Block Intrinsic Resistance of P. aeruginosa to Doxycycline and Chloramphenicol In Vitro	PLOS ONE			English	Article							MULTIDRUG EFFLUX SYSTEM; PSEUDOMONAS-AERUGINOSA; MEXAB-OPRM; ANTIBIOTIC EFFLUX; MEXXY-OPRM; MEXCD-OPRJ; INHIBITORS; SUSCEPTIBILITY; MECHANISMS; BARRIER	Multidrug resistant bacteria have been a worldwide concern for decades. Though new molecules that effectively target Gram-positive bacteria are currently appearing on the market, a gap remains in the treatment of infections caused by Gram-negative bacteria. Therefore, new strategies must be developed against these pathogens. The aim of this study was to select an antibiotic for which a bacterium is naturally resistant and to use an escort molecule to restore susceptibility, similarly to the model of beta-lactam/beta-lactamase inhibitors. High-content screening was performed on the reference strain PA01, allowing the selection of four polyamino-isoprenic compounds that acted synergistically with doxycycline. They were assayed against clinical isolates and Multi-Drug-Resistant strains. One of these compounds was able to decrease the MIC of doxycycline on the reference strain, efflux pump overproducers and clinical isolates of P. aeruginosa, to the susceptibility level. Similar results were obtained using chloramphenicol as the antibiotic. Membrane permeation assays and real-time efflux experiments were used to characterize the mechanism of doxycycline potentiation. The results showed that the selected compound strongly decreases the efficiency of glucose-triggered efflux associated with a slight destabilization of the outer membrane. According to these data, targeting natural resistance may become an interesting way to combat MDR pathogens and could represent an alternative to already devised strategies.	[Borselli, Diane; Lieutaud, Aurelie; Thefenne, Helene; Garnotel, Eric; Pages, Jean-Marie; Bolla, Jean-Michel] Aix Marseille Univ, IRBA, TMCD2 UMR MD1, Fac Med, F-13385 Marseille, France; [Thefenne, Helene; Garnotel, Eric] Hop Instruct Armees Alphonse Laveran, F-13013 Marseille, France; [Brunel, Jean Michel] Aix Marseille Univ, Ctr Rech Cancerol Marseille, Inst Paoli Calmettes, CNRS,UM 105,Inserm,U1068,UMR7258, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Bolla, JM (corresponding author), Aix Marseille Univ, IRBA, TMCD2 UMR MD1, Fac Med, F-13385 Marseille, France.	jean-michel.bolla@univ-amu.fr	Bolla, Jean Michel/D-3885-2014; PAGES, jean-marie/F-2555-2013	Bolla, Jean Michel/0000-0003-3892-4340; PAGES, jean-marie/0000-0001-7092-7977; jean michel, brunel/0000-0002-9355-8980	Aix-Marseille University	Aix-Marseille University	Aix-Marseille University funded the work.	Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; Bassetti M, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-22; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Bolla J-M, 2012, PCT INT APPL; Brunel JM, 2013, BIOORGAN MED CHEM, V21, P1174, DOI 10.1016/j.bmc.2012.12.030; Butler MS, 2013, J ANTIBIOT, V66, P571, DOI 10.1038/ja.2013.86; Cox G, 2013, INT J MED MICROBIOL, V303, P287, DOI 10.1016/j.ijmm.2013.02.009; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; Dumas JL, 2006, FEMS MICROBIOL LETT, V254, P217, DOI 10.1111/j.1574-6968.2005.00008.x; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; HAMZEHPOUR MM, 1995, ANTIMICROB AGENTS CH, V39, P2392, DOI 10.1128/AAC.39.11.2392; Hocquet D, 2007, ANTIMICROB AGENTS CH, V51, P1582, DOI 10.1128/AAC.01334-06; Iino R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00040; Karaiskos I, 2014, EXPERT OPIN PHARMACO, V15, P1351, DOI 10.1517/14656566.2014.914172; Kohler T, 1997, MOL MICROBIOL, V23, P345, DOI 10.1046/j.1365-2958.1997.2281594.x; Kwon DH, 2006, ANTIMICROB AGENTS CH, V50, P1623, DOI 10.1128/AAC.50.5.1623-1627.2006; Lamers RP, 2012, PLOS ONE, V8; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Lieutaud A., 2013, Anti-Infective Agents, V11, P168; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Mamelli L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006443; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P2242, DOI 10.1128/AAC.44.9.2242-2246.2000; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Morita Y, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00422; Morita Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00408; Muller C, 2011, ANTIMICROB AGENTS CH, V55, P1211, DOI 10.1128/AAC.01252-10; Nitzan O, 2010, ISR MED ASSOC J, V12, P371; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Okamoto K, 2002, ANTIMICROB AGENTS CH, V46, P2696, DOI 10.1128/AAC.46.8.2696-2699.2002; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Renau TE, 2003, BIOORG MED CHEM LETT, V13, P2755, DOI 10.1016/S0960-894X(03)00556-0; Schweizer HP, 2012, EXPERT OPIN DRUG DIS, V7, P633, DOI 10.1517/17460441.2012.688949; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Verchere A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00306; Vettoretti L, 2009, ANTIMICROB AGENTS CH, V53, P1987, DOI 10.1128/AAC.01024-08; Xu ZQ, 2014, EXPERT OPIN INV DRUG, V23, P163, DOI 10.1517/13543784.2014.848853	39	21	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154490	10.1371/journal.pone.0154490	http://dx.doi.org/10.1371/journal.pone.0154490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152508	Green Published, gold			2022-12-27	WOS:000375677000021
J	Fu, ZR; Thorpe, M; Akula, S; Hellman, L				Fu, Zhirong; Thorpe, Michael; Akula, Srinivas; Hellman, Lars			Asp-ase Activity of the Opossum Granzyme B Supports the Role of Granzyme B as Part of Anti-Viral Immunity Already during Early Mammalian Evolution	PLOS ONE			English	Article							MAST-CELL CHYMASE; EXTENDED SUBSTRATE-SPECIFICITY; CLEAVAGE SPECIFICITY; SERINE PROTEASES; CYTOKINE RESPONSE; MOUSE; DEFENSE; FAMILY; LOCUS	Granzyme B is one of the key effector molecules in our defense against viruses and intracellular bacteria. This serine protease together with the pore forming protein perforin, induces caspase or Bid-dependent apoptosis in target cells. Here we present the first characterization of a granzyme B homolog, the grathepsodenase, in a non-placental mammal, the American opossum (Monodelphis domestica). The recombinant enzyme was produced in a human cell line and used to study its primary and extended cleavage specificity using a panel of chromogenic substrates and recombinant protein substrates. The opossum granzyme B was found to have a specificity similar to human granzyme B, although slightly less restrictive in its extended specificity. The identification of a granzyme B homolog with asp-ase (cleaving after aspartic acid) specificity in a non-placental mammal provides strong indications that caspase or Bid-dependent apoptosis by a serine protease with a conserved primary specificity has been part of anti-viral immunity since early mammalian evolution. This finding also indicates that an asp-ase together with a chymase were the first two serine protease genes to appear in the mammalian chymase locus.	[Fu, Zhirong; Thorpe, Michael; Akula, Srinivas; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Box 596, SE-75124 Uppsala, Sweden	Uppsala University	Hellman, L (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Box 596, SE-75124 Uppsala, Sweden.	Lars.Hellman@icm.uu.se	Akula, Srinivas/GYJ-1463-2022		Swedish National Research Council (Vetenskapsradet-NT) [621-2011-5007]	Swedish National Research Council (Vetenskapsradet-NT)	Funding provided by the Swedish National Research Council (Vetenskapsradet-NT), 621-2011-5007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad J, 2014, BIOL CHEM, V395, P1253, DOI 10.1515/hsz-2014-0174; Akula S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143091; Andersson MK, 2008, MOL IMMUNOL, V45, P2548, DOI 10.1016/j.molimm.2008.01.012; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2010, FEBS J, V277, P2255, DOI 10.1111/j.1742-4658.2010.07642.x; Azzi J, 2013, J IMMUNOL, V191, P2319, DOI 10.4049/jimmunol.1300851; Caputo A, 1999, PROTEINS, V35, P415, DOI 10.1002/(SICI)1097-0134(19990601)35:4<415::AID-PROT5>3.0.CO;2-7; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chahal G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129511; Fu ZR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131720; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Thorpe M, 2012, INT IMMUNOL, V24, P771, DOI 10.1093/intimm/dxs081; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; Waterhouse NJ, 2005, J BIOL CHEM, V280, P4476, DOI 10.1074/jbc.M410985200; Wernersson S, 2006, DEV COMP IMMUNOL, V30, P901, DOI 10.1016/j.dci.2005.10.014; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3	29	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154886	10.1371/journal.pone.0154886	http://dx.doi.org/10.1371/journal.pone.0154886			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152961	gold, Green Published, Green Submitted			2022-12-27	WOS:000375677000044
J	Ojikutu, BO; Pathak, S; Srithanaviboonchai, K; Limbada, M; Friedman, R; Li, SY; Mimiaga, MJ; Mayer, KH; Safren, SA				Ojikutu, Bisola O.; Pathak, Subash; Srithanaviboonchai, Kriengkrai; Limbada, Mohammed; Friedman, Ruth; Li, Shuying; Mimiaga, Matthew J.; Mayer, Kenneth H.; Safren, Steven A.		HIV Prevention Trials Network 063	Community Cultural Norms, Stigma and Disclosure to Sexual Partners among Women Living with HIV in Thailand, Brazil and Zambia (HPTN 063)	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ALCOHOL-USE DISORDERS; PREGNANT-WOMEN; SEROSTATUS DISCLOSURE; INFECTED WOMEN; INTERNALIZED STIGMA; DISCORDANT COUPLES; TRANSMISSION RISK; SOUTH-AFRICA; CONDOM USE	Background Serostatus disclosure may facilitate decreased HIV transmission between serodiscordant partners by raising risk awareness and heightening the need for prevention. For women living with HIV (WLWH), the decision to disclose may be influenced by culturally determined, community-level stigma and norms. Understanding the impact of community HIV stigma and gender norms on disclosure among WLWH in different countries may inform intervention development. Methods HPTN063 was a longitudinal, observational study of sexually active HIV-infected individuals, including heterosexual women, in care in Zambia, Thailand and Brazil. At baseline, a questionnaire measuring community HIV stigma and gender norms, anticipated stigma, demographic, partner/relationship characteristics, and intimate partner violence was administered. Longitudinal HIV disclosure to sexual partners was determined via audio-computer assisted self-interview (ACASI) at the baseline and quarterly during the one year following up. Logistic regression was conducted to identify the predictors of disclosure. Results Almost half (45%) of women living with HIV acknowledged perceived community HIV stigma (the belief that in their community HIV infection among women is associated with sex work and multiple sexual partners). Many women (42.9%) also acknowledged perceived community gender norms (the belief that traditional gender norms such as submissiveness to husbands/male sexual partners is necessary and that social status is lost if one does not procreate). HIV disclosure to current sex partners was reported by 67% of women. In multivariate analysis, among all women, those who were older [OR 0.16, 95% CI (0.06,0.48)], reported symptoms of severe depression [OR 0.53, 95% CI(0.31, 0.90)], endorsed anticipated stigma [OR 0.30, 95% CI(0.18, 0.50)], and were unmarried [OR 0.43, 95% CI(0.26,0.71)] were less likely to disclose to current partners. In an analysis stratified by marital status and cohabitation, unmarried [OR 0.41, 95% CI(0.20,0.82)] and non-cohabiting women [OR 0.31, 95% CI(0.13,0.73)] who perceived community HIV stigma were less likely to disclose to their sex partners. Conclusions Perceived community level HIV stigma, along with individual level factors such as anticipated stigma, depressive symptoms, and older age, predict non-disclosure of HIV status to sexual partners among WLWH in diverse geographic settings. Interventions to promote disclosure among women in serodiscordant relationships should incorporate community-level interventions to reduce stigma and promote gender equality.	[Ojikutu, Bisola O.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Ojikutu, Bisola O.; Mayer, Kenneth H.] Harvard Univ, Sch Med, Boston, MA USA; [Pathak, Subash; Li, Shuying] Univ Washington, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98195 USA; [Srithanaviboonchai, Kriengkrai] Chiang Mai Univ, Fac Med, Chiang Mai 50000, Thailand; [Srithanaviboonchai, Kriengkrai] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Limbada, Mohammed] Univ Zambia, Lusaka, Zambia; [Friedman, Ruth] Univ Calif Los Angeles, Los Angeles, CA USA; [Mimiaga, Matthew J.] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Mayer, Kenneth H.] Fenway Inst, Boston, MA USA; [Safren, Steven A.] Univ Miami, Miami, FL USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Chiang Mai University; Chiang Mai University; University of Zambia; University of California System; University of California Los Angeles; Brown University; University of Miami	Ojikutu, BO (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Ojikutu, BO (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	bojikutu@partners.org	., ksrithan/AAO-2228-2020	., ksrithan/0000-0002-1683-4259; London, Alex/0000-0002-6450-0309; limbada, mohammed/0000-0002-3736-1462; Ojikutu, Bisola/0000-0001-7957-8881	Division of AIDS (DAIDS), National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH) [UM1AI068619]; HPTN Scholar's Program; Harvard University Center for AIDS Research (HU CFAR) NIH [P30AI060354]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961, UM1AI069476, UM1AI068617] Funding Source: NIH RePORTER	Division of AIDS (DAIDS), National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HPTN Scholar's Program; Harvard University Center for AIDS Research (HU CFAR) NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HPTN 063 was funded by the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH) under Cooperative Agreement # UM1AI068619. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or The HIV Prevention Trials Network. The authors would also like to acknowledge the staff at the HPTN 063 study sites for their contributions to the study. Dr. Ojikutu was supported by the HPTN Scholar's Program. Drs. Mayer, Safren and Ojikutu were also supported by the Harvard University Center for AIDS Research (HU CFAR) NIH P30AI060354.	Adewuya AO, 2005, ALCOHOL ALCOHOLISM, V40, P575, DOI 10.1093/alcalc/agh197; Alemayehu M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-746; Babor TF, 2001, AUDIT ALCOHOL USE DI; Bachanas P, 2013, AIDS PATIENT CARE ST, V27, P425, DOI 10.1089/apc.2012.0388; Beyeza-Kashesya J, 2009, AFR HEALTH SCI, V9, P2; Buchberg MK, 2015, AIDS PATIENT CARE ST, V29, P126, DOI 10.1089/apc.2014.0227; Campbell C, 2013, AIDS CARE, V25, pS114, DOI 10.1080/09540121.2012.748170; Chemaitelly H, 2012, SEX TRANSM INFECT, V88, P51, DOI 10.1136/sextrans-2011-050114; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; Deribe K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-81; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Geary C, 2014, AIDS CARE, V26, P1419, DOI 10.1080/09540121.2014.921278; Jain A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18711; Jasseron C, 2013, AIDS BEHAV, V17, P488, DOI 10.1007/s10461-011-0084-y; Johnson M, 2015, AIDS CARE, V27, P1220, DOI 10.1080/09540121.2015.1046416; Kang SY, 2011, AIDS CARE, V23, P1467, DOI 10.1080/09540121.2011.565022; Katz S, 2005, AIDS PATIENT CARE ST, V19, P110, DOI 10.1089/apc.2005.19.110; Kelley AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019573; Klein J, 2003, OBSTET GYNECOL, V101, P987, DOI 10.1016/S0029-7844(03)00012-7; Longinetti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095440; Magidson JF, 2015, AIDS BEHAV; Makin JD, 2008, AIDS PATIENT CARE ST, V22, P907, DOI 10.1089/apc.2007.0194; Maman S, 2001, AIDS CARE, V13, P595, DOI 10.1080/09540120120063223; McGrath JW, 2007, AIDS CARE, V19, P418, DOI 10.1080/09540120600717668; Morrison MF, 2002, AM J PSYCHIAT, V159, P789, DOI 10.1176/appi.ajp.159.5.789; O'Connell AA, 2015, AIDS BEHAV, V19, P283, DOI 10.1007/s10461-014-0848-2; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Ojikutu B, 8 IAS C HIV PATH TRE; Osinde MO, 2012, INT J GYNECOL OBSTET, V118, P61, DOI 10.1016/j.ijgo.2012.02.008; Overstreet NM, 2013, AIDS CARE, V25, P466, DOI 10.1080/09540121.2012.720362; Patel R, 2012, AIDS CARE, V24, P358, DOI 10.1080/09540121.2011.608786; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Porter L, 2004, DEMOGRAPHY, V41, P465, DOI 10.1353/dem.2004.0025; Pulerwitz J, 2010, PUBLIC HEALTH REP, V125, P272, DOI 10.1177/003335491012500218; Quinn DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096977; Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815; ROBINS JM, 1995, J AM STAT ASSOC, V90, P122, DOI 10.2307/2291135; Roxby AC, 2013, AIDS PATIENT CARE ST, V27, P33, DOI 10.1089/apc.2012.0327; Rujumba J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17429; Scambler G., 1989, EPILEPSY; Serovich JM, 2001, AIDS EDUC PREV, V13, P355, DOI 10.1521/aeap.13.4.355.21424; SERWADDA D, 1995, AIDS, V9, P745, DOI 10.1097/00002030-199507000-00012; Shamu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109447; Sheth SS, 2015, AIDS CARE, V27, P350, DOI 10.1080/09540121.2014.998610; Siegel K, 2005, WOMEN HEALTH, V41, P63, DOI 10.1300/J013v41n04_04; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Simoni J. M., 2000, AIDS BEHAV, V4, P147, DOI [10.1023/A:1009508406855, DOI 10.1023/A:1009508406855]; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Sulstarova B, 2014, AIDS CARE, V8, P1; Tam M, 2015, AIDS CARE, V27, P436, DOI 10.1080/09540121.2014.997662; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; UNAIDS, 2000, OP HIV AIDS EP GUID; Valenzuela C, 2015, AIDS BEHAV, V19, P235, DOI 10.1007/s10461-014-0908-7; Villar-Loubet OM, 2013, CULT HEALTH SEX, V15, P253, DOI 10.1080/13691058.2012.716166; Vu L, 2015, AIDS BEHAV, V19, P1203, DOI 10.1007/s10461-014-0910-0; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; Wight RG, 2000, SOC SCI MED, V51, P759, DOI 10.1016/S0277-9536(00)00007-1; World Health Organization, 2012, GUID OR PREEXP PROPH; Zamudio-Haas Sophia, 2012, Reprod Health Matters, V20, P18, DOI 10.1016/S0968-8080(12)39637-7	59	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0153600	10.1371/journal.pone.0153600	http://dx.doi.org/10.1371/journal.pone.0153600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KX	27152618	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000005
J	Siqueira, CC; Valiengo, LL; Carvalho, AF; Santos-Silva, PR; Missio, G; de Sousa, RT; Di Natale, G; Gattaz, WF; Moreno, RA; Machado-Vieira, R				Siqueira, Cristiana Carvalho; Valiengo, Leandro L.; Carvalho, Andre F.; Santos-Silva, Paulo Roberto; Missio, Giovani; de Sousa, Rafael T.; Di Natale, Georgia; Gattaz, Wagner F.; Moreno, Ricardo Alberto; Machado-Vieira, Rodrigo			Antidepressant Efficacy of Adjunctive Aerobic Activity and Associated Biomarkers in Major Depression: A 4-Week, Randomized, Single-Blind, Controlled Clinical Trial	PLOS ONE			English	Article							PHYSICAL-EXERCISE; FITNESS; DISORDERS; SYMPTOMS	Background Major depressive disorder (MDD) is a highly prevalent, heterogeneous and systemic medical condition. Treatment options are limited, and recent studies have suggested that physical exercise can play an important role in the therapeutics of MDD. The aim of this study was to evaluate the antidepressant efficacy of adjunctive aerobic activity in association with pharmacotherapy (selective serotonin reuptake inhibitor) in symptomatic MDD as well as its association with physiological biomarkers. Methods In this randomized, single-blind, add-on, controlled clinical trial, 57 patients (18-55 years of age) were followed-up for 28 days. All patients were drug-free, had been diagnosed with symptomatic MDD and received flexible dose of sertraline during the trial. Patients were randomized to either a 4-week program (4x/week) of add-on aerobic exercise (exercise group, N = 29) or no activity (control group, N = 28). Depression severity was assessed using the Hamilton Rating Scale for Depression (HAM-D) as the primary outcome. At baseline and endpoint, all patients underwent a comprehensive metabolic/cardiopulmonary exercise testing-including determination of maximal oxygen uptake (VO(2)max), VO2 at the second ventilatory threshold (VO2-VT2), and oxygen pulse (O-2 pulse). Results Depression scores significantly decreased in both groups after intervention. Importantly, patients in the aerobic exercise group required lower sertraline dose compared to the control group (sertraline monotherapy). The VO(2)max and O-2 pulse parameters increased over time only in the exercise group and remained unchanged in the control group. Conclusions The present findings suggest that a 4-week training of aerobic exercise significantly improves functional capacity in patients with MDD and may be associated with antidepressant efficacy. This approach may also decrease the need for higher doses of antidepressants to achieve response. Further studies in unmedicated and treatment-resistant MDD patients are needed in order to confirm the utility of short-term aerobic exercise as an alternative therapeutic approach in MDD.	[Siqueira, Cristiana Carvalho; Valiengo, Leandro L.; de Sousa, Rafael T.; Di Natale, Georgia; Gattaz, Wagner F.; Machado-Vieira, Rodrigo] Univ Sao Paulo, Inst & Dept Psychiat, Lab Neurosci LIM 27, Sao Paulo, SP, Brazil; [de Sousa, Rafael T.; Machado-Vieira, Rodrigo] NIMH, Expt Therapeut & Pathophysiol Branch, Bethesda, MD 20892 USA; [Santos-Silva, Paulo Roberto] Univ Sao Paulo, Sch Med, Hosp Clin, Lab Movement Studies, Sao Paulo, SP, Brazil; [Gattaz, Wagner F.; Machado-Vieira, Rodrigo] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, Sao Paulo, SP, Brazil; [Missio, Giovani; Moreno, Ricardo Alberto] Univ Sao Paulo, Inst & Dept Psychiat, Mood Disorders Unit GRUDA, Sao Paulo, SP, Brazil; [Carvalho, Andre F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, Ceara, Brazil; [Carvalho, Andre F.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil	Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Ceara; Universidade Federal do Ceara	Machado-Vieira, R (corresponding author), Univ Sao Paulo, Inst & Dept Psychiat, Lab Neurosci LIM 27, Sao Paulo, SP, Brazil.; Machado-Vieira, R (corresponding author), NIMH, Expt Therapeut & Pathophysiol Branch, Bethesda, MD 20892 USA.; Machado-Vieira, R (corresponding author), Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, Sao Paulo, SP, Brazil.	machadovieirar@gmail.com	Machado-Vieira, Rodrigo/D-8293-2012; Valiengo, Leandro/D-7149-2011; Santos-Silva, Paulo Roberto/AAY-4269-2020; da Costa Lane Valiengo, Leandro/E-5406-2016	Machado-Vieira, Rodrigo/0000-0002-4830-1190; Valiengo, Leandro/0000-0002-7628-9993; Santos-Silva, Paulo Roberto/0000-0003-1223-5862; da Costa Lane Valiengo, Leandro/0000-0002-7628-9993; Gattaz, Wagner/0000-0001-5215-4077; Missio, Giovani/0000-0002-1588-5572	Sao Paulo Research Foundation (FAPESP) [2012/20002-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Support for this work was provided by grant 2012/20002-5, Sao Paulo Research Foundation (FAPESP). The grant was used to create the Physical Training Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 1994, DIAGN STAT MAN MENT; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Blumenthal JA, 2012, ACSMS HEALTH FIT J, V16, P14, DOI 10.1249/01.FIT.0000416000.09526.eb; Chalder M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2758; Cheik NC, 2003, REV BRAS CIENC MOV, V11, P45; Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Edvardsen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085276; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Josefsson T, 2014, SCAND J MED SCI SPOR, V24, P259, DOI 10.1111/sms.12050; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Knochel C, 2012, PROG NEUROBIOL, V96, P46, DOI 10.1016/j.pneurobio.2011.11.007; Krogh J, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00089; Krogh J, 2010, J AFFECT DISORDERS, V125, P189, DOI 10.1016/j.jad.2010.01.009; Mead GE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub4; Mota-Pereira J, 2011, J PSYCHIATR RES, V45, P1005, DOI 10.1016/j.jpsychires.2011.02.005; Reaburn P., 2013, J SCI MED SPORT; Rethorst CD, 2013, MOL PSYCHIATR, V18, P1119, DOI 10.1038/mp.2012.125; Rimer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub5; Schuch FB, 2011, J AFFECT DISORDERS, V133, P615, DOI 10.1016/j.jad.2011.04.030; Serra S., 1997, ARQ BRAS CARDIOL, V68; Silveira H, 2013, NEUROPSYCHOBIOLOGY, V67, P61, DOI [10.1159/000345160, 10.1159/0]; Sui XM, 2009, J PSYCHIATR RES, V43, P546, DOI 10.1016/j.jpsychires.2008.08.002; Tolmunen T, 2006, EUR J EPIDEMIOL, V21, P701, DOI 10.1007/s10654-006-9038-5; Trivedi MH, 2006, CLIN TRIALS, V3, P291, DOI 10.1191/1740774506cn151oa; World Health Organization, 2006, TECHN REC DEPR; Zarshenas Sareh, 2013, Depress Res Treat, V2013, P132684, DOI 10.1155/2013/132684	28	29	31	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154195	10.1371/journal.pone.0154195	http://dx.doi.org/10.1371/journal.pone.0154195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152523	Green Submitted, gold, Green Published			2022-12-27	WOS:000375677000012
J	Zha, J; Chi, XW; Yu, XL; Liu, XM; Liu, DQ; Zhu, J; Ji, H; Liu, RT				Zha, Jun; Chi, Xiao-wei; Yu, Xiao-lin; Liu, Xiang-meng; Liu, Dong-qun; Zhu, Jie; Ji, Hui; Liu, Rui-tian			Interleukin-1 beta-Targeted Vaccine Improves Glucose Control and beta-Cell Function in a Diabetic KK-A(y) Mouse Model	PLOS ONE			English	Article							INSULIN-RESISTANCE; XOMA 052; MONOCLONAL-ANTIBODY; IMMUNE-RESPONSES; PLA MICROSPHERES; INFLAMMATION; IL-1-BETA; MELLITUS; MICROPARTICLES; INTERLEUKIN-1	Interleukin-1 beta (IL-1 beta) has been implicated as a key proinflammatory cytokine involved in the pancreatic islet inflammation of type 2 diabetes mellitus (T2DM). Excess IL-1 beta impairs islet function by inducing insulin resistance and beta-cell apoptosis. Therefore, specifically reducing IL-1 beta activity provides a therapeutic improvement for T2DM by sustaining the inhibition of IL-1 beta-mediated islet inflammation. In this study, we developed an IL-1 beta-targeted epitope peptide vaccine adjuvanted with polylactic acidmicroparticles (1 beta EPP) and applied it to a diabetic KK-A(y) mouse model. Results showed that the 1 beta EPP elicited high antibody responses, which neutralized the biological activity of IL-1 beta, and induced barely detectable inflammatory activity. 1 beta EPP immunization reduced body weight gain, protected KK-A(y) mice from hyperglycemia, improved glucose tolerance and insulin sensitivity, and decreased the serum levels of free fatty acids, total cholesterol and triglyceride. Moreover, 1 beta EPP restored beta-cell mass; inhibited beta-cell apoptosis; decreased the expression of IL-1 beta; and interrupted NF-kappa B activation by reducing IKK beta and pRelA levels. These studies indicated that the IL-1 beta-targeted vaccine may be a promising immunotherapeutic for T2DM treatment.	[Zha, Jun; Yu, Xiao-lin; Liu, Xiang-meng; Liu, Dong-qun; Zhu, Jie; Liu, Rui-tian] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China; [Zha, Jun; Ji, Hui] China Pharmaceut Univ, Sch Pharm, Nanjing 210009, Jiangsu, Peoples R China; [Chi, Xiao-wei] Weifang Biomed Innovat & Entrepreneurship Serv Ct, Weifang, Peoples R China; [Liu, Xiang-meng] Qilu Univ Technol, Sch Bioengn, Jinan, Peoples R China	Chinese Academy of Sciences; Institute of Process Engineering, CAS; China Pharmaceutical University; Qilu University of Technology	Liu, RT (corresponding author), Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China.; Ji, H (corresponding author), China Pharmaceut Univ, Sch Pharm, Nanjing 210009, Jiangsu, Peoples R China.	huijicpu@163.com; rtliu@ipe.ac.cn			National Natural Science Foundation of China [81402837, 81371208]; National Science and Technology Major Projects of New Drugs [2014ZX09102045-005, 2014ZX09102041-007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects of New Drugs	This work was supported by grants from the National Natural Science Foundation of China (81402837 and 81371208), http://www.nsfc.gov.cn/, and the National Science and Technology Major Projects of New Drugs (2014ZX09102045-005 and 2014ZX09102041-007), http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal NK, 2014, WORLD J DIABETES, V5, P697, DOI 10.4239/wjd.v5.i5.697; Bachmann MF, 2011, PHILOS T R SOC B, V366, P2815, DOI 10.1098/rstb.2011.0103; Bertin-Maghit SM, 2005, VACCINE, V23, P4228, DOI 10.1016/j.vaccine.2005.03.030; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Boraschi D, 1999, METHODS, V19, P108, DOI 10.1006/meth.1999.0835; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cavelti-Weder C, 2012, DIABETES CARE, V35, P1654, DOI 10.2337/dc11-2219; Chen XM, 2014, INT IMMUNOPHARMACOL, V23, P592, DOI 10.1016/j.intimp.2014.10.010; Chen XM, 2014, MOL PHARMACEUT, V11, P1772, DOI 10.1021/mp400597z; Dhimolea E, 2010, MABS-AUSTIN, V2, P3, DOI 10.4161/mabs.2.1.10328; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Handa M, 2013, OBESITY, V21, P306, DOI 10.1002/oby.20004; Hensen J, 2013, DIABETES METAB, V39, P524, DOI 10.1016/j.diabet.2013.07.003; Kiechl S, 2013, NAT MED, V19, P358, DOI 10.1038/nm.3084; Lamb RE, 2008, INT J CLIN PRACT, V62, P1087, DOI 10.1111/j.1742-1241.2008.01789.x; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Moroki T, 2013, IN VIVO, V27, P465; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; Owyang AM, 2011, MABS-AUSTIN, V3, P49, DOI 10.4161/mabs.3.1.13989; Owyang AM, 2010, ENDOCRINOLOGY, V151, P2515, DOI 10.1210/en.2009-1124; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Roell MK, 2010, J BIOL CHEM, V285, P20607, DOI 10.1074/jbc.M110.115790; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sloan-Lancaster J, 2013, DIABETES CARE, V36, P2239, DOI 10.2337/dc12-1835; Spohn G, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.48; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Zhang WF, 2014, PHARM RES-DORDR, V31, P1015, DOI 10.1007/s11095-013-1224-z	30	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154298	10.1371/journal.pone.0154298	http://dx.doi.org/10.1371/journal.pone.0154298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152706	Green Submitted, Green Published, gold			2022-12-27	WOS:000375677000014
J	Takahashi, N; Davy, PMC; Gardner, LH; Mathews, J; Yamazaki, Y; Allsopp, RC				Takahashi, Natsumi; Davy, Philip M. C.; Gardner, Lauren H.; Mathews, Juanita; Yamazaki, Yuki; Allsopp, Richard C.			Hypoxia Inducible Factor 1 Alpha Is Expressed in Germ Cells throughout the Murine Life Cycle	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TELOMERASE ACTIVITY; STROMAL CELLS; SELF-RENEWAL; PROMOTES; DIFFERENTIATION; HIF-1-ALPHA; RACK1; PLURIPOTENCY; DEGRADATION	Pluripotent stem cells of the early embryo, and germ line cells, are essential to ensure uncompromised development to adulthood as well as species propagation, respectively. Recently, the transcription factor hypoxia inducible factor 1 alpha (Hif1 alpha) has been shown to have important roles in embryonic stem cells; in particular, regulation of conversion to glycolytic metabolism and, as we have shown, maintenance of functional levels of telomerase. In the present study, we sought to assess whether Hif1 alpha was also expressed in the primitive cells of the murine embryo. We observed expression of Hif1 alpha in pre-implantation embryos, specifically the 2-cell stage, morula, and blastocyst. Robust Hif1 alpha expression was also observed in male and female primordial germ cells. We subsequently assessed whether Hif1 alpha was expressed in adult male and female germ cells. In the testis, Hif1 alpha was robustly expressed in spermatogonial cells, in both juvenile (6-week old) and adult (3-month old) males. In the ovaries, Hif1 alpha was expressed in mature oocytes from adult females, as assessed both in situ and in individual oocytes flushed from super-ovulated females. Analysis of Hif1 alpha transcript levels indicates a mechanism of regulation during early development that involves stockpiling of Hif1 alpha protein in mature oocytes, presumably to provide protection from hypoxic stress until the gene is re-activated at the blastocyst stage. Together, these observations show that Hif1 alpha is expressed throughout the life-cycle, including both the male and female germ line, and point to an important role for Hif1 alpha in early progenitor cells.	[Takahashi, Natsumi; Davy, Philip M. C.; Gardner, Lauren H.; Mathews, Juanita; Yamazaki, Yuki; Allsopp, Richard C.] Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, Honolulu, HI 96822 USA	University of Hawaii System	Allsopp, RC (corresponding author), Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, Honolulu, HI 96822 USA.	allsopp@hawaii.edu		Mathews, Juanita/0000-0003-1200-4810	National Institute of Aging [R01AG037475]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by the National Institute of Aging R01AG037475 to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achi MV, 2000, BIOL REPROD, V63, P591, DOI 10.1095/biolreprod63.2.591; Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Blackburn EH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003558; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Coussens M, 2006, BIOL REPROD, V75, P785, DOI 10.1095/biolreprod.106.052167; Coussens M, 2010, P NATL ACAD SCI USA, V107, P13842, DOI 10.1073/pnas.0913834107; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Davy P, 2011, STEM CELLS BIOL REG, P203, DOI 10.1007/978-1-61779-002-7_9; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fedele Anthony O, 2002, Mol Interv, V2, P229, DOI 10.1124/mi.2.4.229; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Ji L, 2009, J CELL PHYSIOL, V221, P54, DOI 10.1002/jcp.21826; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Marti HH, 2002, MOL ENDOCRINOL, V16, P234, DOI 10.1210/me.16.2.234; Mathieu J, 2013, STEM CELLS, V31, P1737, DOI 10.1002/stem.1446; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Park IH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.87; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Ravindranath N, 1997, ENDOCRINOLOGY, V138, P4026, DOI 10.1210/en.138.9.4026; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Studer L, 2000, J NEUROSCI, V20, P7377; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Winkler T, 2013, J CLIN INVEST, V123, P1952, DOI 10.1172/JCI67146; Wright WE, 1996, DEV GENET, V18, P173; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	41	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154309	10.1371/journal.pone.0154309	http://dx.doi.org/10.1371/journal.pone.0154309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148974	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800024
J	Wang, Q; Xu, XJ; Zhu, XJ; Chen, L; Zhou, SJ; Huang, ZY; Zhou, BF				Wang, Qing; Xu, Xinjian; Zhu, Xiangjie; Chen, Lin; Zhou, Shujing; Huang, Zachary Y.; Zhou, Bingfeng			Low-Temperature Stress during Capped Brood Stage Increases Pupal Mortality, Misorientation and Adult Mortality in Honey Bees	PLOS ONE			English	Article							APIS-MELLIFERA L.; POLLINATOR DECLINES; REARING TEMPERATURE; SOCIAL INSECTS; HYMENOPTERA; THERMOREGULATION; SUSCEPTIBILITY; CONSEQUENCES; MECHANISMS; STABILITY	Honey bees (Apis mellifera) are key pollinators, playing a vital role in ecosystem maintenance and stability of crop yields. Recently, reduced honey bee survival has attracted intensive attention. Among all other honey bee stresses, temperature is a fundamental ecological factor that has been shown to affect honey bee survival. Yet, the impact of low temperature stress during capped brood on brood mortality has not been systematically investigated. In addition, little was known about how low temperature exposure during capped brood affects subsequent adult longevity. In this study, capped worker broods at 12 different developmental stages were exposed to 20 degrees C for 12, 24, 36, 48, 60, 72, 84 and 96 hours, followed by incubation at 35 degrees C until emergence. We found that longer durations of low temperature during capped brood led to higher mortality, higher incidences of misorientation inside cells and shorter worker longevity. Capped brood as prepupae and near emergence were more sensitive to low-temperature exposure, while capped larvae and mid-pupal stages showed the highest resistance to low-temperature stress. Our results suggest that prepupae and pupae prior to eclosion are the most sensitive stages to low temperature stress, as they are to other stresses, presumably due to many physiological changes related tometamorphosis happening during these two stages. Understanding how low-temperature stress affects honey bee physiology and longevity can improve honey bee management strategies.	[Wang, Qing; Xu, Xinjian; Zhu, Xiangjie; Chen, Lin; Zhou, Shujing; Huang, Zachary Y.; Zhou, Bingfeng] Fujian Agr & Forestry Univ, Coll Bee Sci, Fuzhou 350002, Fujian, Peoples R China; [Wang, Qing] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou 350002, Fujian, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Huang, Zachary Y.] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA; [Huang, Zachary Y.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Michigan State University; Michigan State University; Michigan State University	Huang, ZY; Zhou, BF (corresponding author), Fujian Agr & Forestry Univ, Coll Bee Sci, Fuzhou 350002, Fujian, Peoples R China.; Huang, ZY (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.; Huang, ZY (corresponding author), Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA.; Huang, ZY (corresponding author), Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA.	bees@msu.edu; bingfengfz@126.com	Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547	China Agriculture Research System [CARS-45-KXJ11]; Fujian Agriculture and Forestry University Doctoral Students Study Abroad Cooperative Research Plan [324-112110051]	China Agriculture Research System; Fujian Agriculture and Forestry University Doctoral Students Study Abroad Cooperative Research Plan	The project was supported by the China Agriculture Research System (CARS-45-KXJ11) and and Fujian Agriculture and Forestry University Doctoral Students Study Abroad Cooperative Research Plan 324-112110051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Becher MA, 2009, J COMP PHYSIOL A, V195, P673, DOI 10.1007/s00359-009-0442-7; Bennett MM, 2015, PHYSIOL BIOCHEM ZOOL, V88, P508, DOI 10.1086/682024; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Chacon-Almeida VML, 1999, ANN ENTOMOL SOC AM, V92, P549, DOI 10.1093/aesa/92.4.549; DEJONG D, 1983, J ECON ENTOMOL, V76, P766, DOI 10.1093/jee/76.4.766; Gontarski H., 1957, Z BIENENFORSCH, V3, P216; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Heinrich B., 1993, HOT BLOODED INSECTS; Himmer A, 1932, BIOL REV BIOL P CAMB, V7, P224; Himmer A., 1927, J COMP PHYSIOL A, V5, P375; Huang Zachary, 2012, Terrestrial Arthropod Reviews, V5, P175, DOI 10.1163/187498312X639568; Jay S. C., 1963, Journal of Apicultural Research London, V2, P117; JAY SC, 1963, CAN J ZOOLOG, V41, P717, DOI 10.1139/z63-043; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; KEN T, 2005, CURRENT ZOOLOGY, V51, P768; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; Kevan PG, 2001, CONSERV ECOL, V5; KRONENBERG F, 1982, J COMP PHYSIOL, V148, P65, DOI 10.1007/BF00688889; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; Mcmullan JB, 2005, APIDOLOGIE, V36, P97, DOI 10.1051/apido:2004073; Medrzycki P, 2010, J APICULT RES, V49, P52, DOI 10.3896/IBRA.1.49.1.07; Milbrath MO, 2015, J INVERTEBR PATHOL, V125, P9, DOI 10.1016/j.jip.2014.12.006; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; MYSER WILLARD C., 1954, ANN ENT SOC AMER, V47, P683; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Rueppell O, 2007, EXP GERONTOL, V42, P1020, DOI 10.1016/j.exger.2007.06.002; SEELEY TD, 1981, INSECT THERMOREGULAT; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; Steel RGD, 1980, PRINCIPLES PROCEDURE; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Thompson HM, 2007, PEST MANAG SCI, V63, P1081, DOI 10.1002/ps.1457; Weiss K., 1962, Z BIENENFORSCH, V6, P104; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Zhang J, 2011, J EXP BIOL, V214, P4021, DOI 10.1242/jeb.059535; Zhou BF, 2007, APICULTURE CHINA, V58, P5; [周冰峰 Zhou Bingfeng], 2011, [生态学报, Acta Ecologica Sinica], V31, P1387; Zhu XJ, 2006, NEW AGR TECHNOLOGY S, P57	41	54	61	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154547	10.1371/journal.pone.0154547	http://dx.doi.org/10.1371/journal.pone.0154547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149383	Green Published, gold			2022-12-27	WOS:000375676800038
J	Rzehak, P; Saffery, R; Reischl, E; Covic, M; Wahl, S; Grote, V; Xhonneux, A; Langhendries, JP; Ferre, N; Closa-Monasterolo, R; Verduci, E; Riva, E; Socha, P; Gruszfeld, D; Koletzko, B				Rzehak, Peter; Saffery, Richard; Reischl, Eva; Covic, Marcela; Wahl, Simone; Grote, Veit; Xhonneux, Annick; Langhendries, Jean-Paul; Ferre, Natalia; Closa-Monasterolo, Ricardo; Verduci, Elvira; Riva, Enrica; Socha, Piotr; Gruszfeld, Dariusz; Koletzko, Berthold		European Childhood Obesity Trial	Maternal Smoking during Pregnancy and DNA-Methylation in Children at Age 5.5 Years: Epigenome-Wide-Analysis in the European Childhood Obesity Project (CHOP)-Study	PLOS ONE			English	Article							PRENATAL NICOTINE EXPOSURE; GENE-EXPRESSION; QUANTILE NORMALIZATION; CIGARETTE-SMOKING; ASSOCIATION; PROTEIN; MYOSIN; DISORDERS; DISCOVERY; FRMD4A	Mounting evidence links prenatal exposure to maternal tobacco smoking with disruption of DNA methylation (DNAm) profile in the blood of infants. However, data on the postnatal stability of such DNAm signatures in childhood, as assessed by Epigenome Wide Association Studies (EWAS), are scarce. Objectives of this study were to investigate DNAm signatures associated with in utero tobacco smoke exposure beyond the 12th week of gestation in whole blood of children at age 5.5 years, to replicate previous findings in young European and American children and to assess their biological role by exploring databases and enrichment analysis. DNA methylation was measured in blood of 366 children of the multi-centre European Childhood Obesity Project Study using the Illumina Infinium HM450 Beadchip (HM450K). An EWAS was conducted using linear regression of methylation values at each CpG site against in utero smoke exposure, adjusted for study characteristics, biological and technical effects. Methylation levels at five HM450K probes in MYO1G (cg12803068, cg22132788, cg19089201), CNTNAP2 (cg25949550), and FRMD4A (cg11813497) showed differential methylation that reached epigenome-wide significance according to the false-discovery-rate (FDR) criteria (q-value<0.05). Whereas cg25949550 showed decreased methylation (-2% DNAm beta-value), increased methylation was observed for the other probes (9%: cg12803068; 5%: cg22132788; 4%: cg19089201 and 4%: cg11813497) in exposed relative to non-exposed subjects. This study thus replicates previous findings in children ages 3 to 5, 7 and 17 and confirms the postnatal stability of MYO1G, CNTNAP2 and FRMD4A differential methylation. The role of this differential methylation in mediating childhood phenotypes, previously associated with maternal smoking, requires further investigation.	[Rzehak, Peter; Covic, Marcela; Grote, Veit; Koletzko, Berthold] Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Div Metab & Nutr Med, Munich, Germany; [Saffery, Richard] Royal Childrens Hosp, Murdoch Childrens Res Inst, Canc & Dis Epigenet Res Grp, Flemington Rd, Parkville, Vic 3052, Australia; [Reischl, Eva; Wahl, Simone] Helmholtz Zentrum Muenchen, Inst Epidemiol 2, Res Unit Mol Epidemiol, Munich, Germany; [Xhonneux, Annick; Langhendries, Jean-Paul] CHC St Vincent, Liege, Belgium; [Ferre, Natalia; Closa-Monasterolo, Ricardo] Univ Rovira & Virgili, C St Llorenc 21, E-43201 Reus, Spain; [Verduci, Elvira; Riva, Enrica] Univ Milan, Milan, Italy; [Socha, Piotr; Gruszfeld, Dariusz] Childrens Mem Hlth Inst, Warsaw, Poland	University of Munich; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Universitat Rovira i Virgili; University of Milan; Children's Memorial Health Institute	Rzehak, P (corresponding author), Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Div Metab & Nutr Med, Munich, Germany.	Peter.Rzehak@med.uni-muenchen.de	Reischl, Eva/B-9311-2013; Luque, Veronica/AAC-9002-2019; Ferré, Natalia/ABE-5700-2020; Saffery, Richard/GLS-1976-2022; Grote, Veit/ABH-9605-2020	Reischl, Eva/0000-0003-4055-8060; Luque, Veronica/0000-0003-2615-8175; Ferré, Natalia/0000-0002-2838-1525; Saffery, Richard/0000-0002-9510-4181; Grote, Veit/0000-0001-7168-2385; /0000-0002-4586-8079; Socha, Piotr/0000-0002-1621-464X; Stolarczyk, Anna/0000-0002-7211-503X; Verduci, Elvira/0000-0003-2111-3111; Dobrzanska, Anna/0000-0003-2927-2344; Gruszfeld, Dariusz/0000-0002-2414-4928; Janas, Roman/0000-0003-2853-9676; Escribano, Joaquin/0000-0002-5041-459X	Commission of the European Community [QLRT-2001-00389, QLK1-CT-2002-30582, 007036]; European Union [289346]; European Research Council [322605 META-GROWTH]	Commission of the European Community(European Commission); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission)	The studies and research reported herein were partially supported by the Commission of the European Community, specific RTD Programme "Quality of Life and Management of Living Resources," within the 5th Framework Programme (research grant nos. QLRT-2001-00389 and QLK1-CT-2002-30582); the 6th Framework Programme contract no. 007036); the European Union's Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition under grant agreement no. 289346 and the European Research Council Advanced Grant ERC-2012-AdG - no. 322605 META-GROWTH. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Villaca Y, 2004, NEUROPSYCHOPHARMACOL, V29, P879, DOI 10.1038/sj.npp.1300401; Akuete K, 2011, PEDIATRICS, V128, pE623, DOI 10.1542/peds.2011-0640; Bakker H, 2011, EUR J EPIDEMIOL, V26, P763, DOI 10.1007/s10654-011-9621-2; Behl M, 2013, ENVIRON HEALTH PERSP, V121, P170, DOI 10.1289/ehp.1205404; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besingi W, 2014, HUM MOL GENET, V23, P2290, DOI 10.1093/hmg/ddt621; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Breton CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099716; Cao JR, 2011, INT J NEUROPSYCHOPH, V14, P157, DOI 10.1017/S1461145710000179; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Denisenko-Nehrbass N, 2003, EUR J NEUROSCI, V17, P411, DOI 10.1046/j.1460-9568.2003.02441.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Dumont RA, 2002, JARO-J ASSOC RES OTO, V3, P375, DOI 10.1007/s101620020049; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4; Gerard A, 2014, CELL, V158, P492, DOI 10.1016/j.cell.2014.05.044; Goldie SJ, 2012, CANCER RES, V72, P3424, DOI 10.1158/0008-5472.CAN-12-0423; Guida F, 2015, HUM MOL GENET, V24, P2349, DOI 10.1093/hmg/ddu751; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Herberth G, 2014, J ALLERGY CLIN IMMUN, V133, P543, DOI 10.1016/j.jaci.2013.06.036; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Huang WY, 2015, NUCLEIC ACIDS RES, V43, pD856, DOI 10.1093/nar/gku1151; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Ikenouchi J, 2010, P NATL ACAD SCI USA, V107, P748, DOI 10.1073/pnas.0908423107; Ivorra C, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0384-5; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kable JA, 2009, NEUROTOXICOL TERATOL, V31, P216, DOI 10.1016/j.ntt.2009.02.002; Kalkbrenner AE, 2012, ENVIRON HEALTH PERSP, V120, P1042, DOI 10.1289/ehp.1104556; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Key APF, 2007, ENVIRON HEALTH PERSP, V115, P623, DOI 10.1289/ehp.9521; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Koletzko B, 2009, AM J CLIN NUTR, V89, P1836, DOI 10.3945/ajcn.2008.27091; Kornblihtt AR, 2012, CELL RES, V22, P450, DOI 10.1038/cr.2012.22; Krumbiegel M, 2011, EUR J HUM GENET, V19, P186, DOI 10.1038/ejhg.2010.144; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kupers LK, 2015, INT J EPIDEMIOL; Ladd-Acosta C, 2016, ENVIRON RES, V144, P139, DOI 10.1016/j.envres.2015.11.014; Lee KWK, 2015, ENVIRON HEALTH PERSP, V123, P193, DOI 10.1289/ehp.1408614; Lehne B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0600-x; Marabita F, 2013, EPIGENETICS-US, V8, P333, DOI 10.4161/epi.24008; Maravillas-Montero JL, 2014, EUR J IMMUNOL, V44, P877, DOI 10.1002/eji.201343873; Markunas CA, 2014, ENVIRON HEALTH PERSP, V122, P1147, DOI 10.1289/ehp.1307892; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Motlagh MG, 2011, J ATTEN DISORD, V15, P593, DOI 10.1177/1087054710374576; Naik P, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0022-x; Novakovic B, 2014, EPIGENETICS-US, V9, P377, DOI 10.4161/epi.27248; O'Callaghan FV, 2009, AUST NZ J PUBL HEAL, V33, P371, DOI 10.1111/j.1753-6405.2009.00410.x; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; Pierce RA, 2001, J IMMUNOL, V167, P3223, DOI 10.4049/jimmunol.167.6.3223; Richmond RC, 2015, HUM MOL GENET, V17; Richmond RC, 2015, HUM MOL GENET, V24, P2201, DOI 10.1093/hmg/ddu739; Rodenas-Cuadrado P, 2014, EUR J HUM GENET, V22, P171, DOI 10.1038/ejhg.2013.100; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Touleimat N, 2012, EPIGENOMICS-UK, V4, P325, DOI [10.2217/epi.12.21, 10.2217/EPI.12.21]; Veljkovic E, 2011, TOXICOL IN VITRO, V25, P446, DOI 10.1016/j.tiv.2010.11.011; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wahl S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-232; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weber M, 2014, AM J CLIN NUTR; Yoon D, 2012, HUM GENET, V131, P1009, DOI 10.1007/s00439-011-1102-x; Zadro C, 2009, BBA-MOL BASIS DIS, V1792, P27, DOI 10.1016/j.bbadis.2008.10.017; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhu X, 2016, ENV HLTH PERSPECT	69	48	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155554	10.1371/journal.pone.0155554	http://dx.doi.org/10.1371/journal.pone.0155554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171005	Green Published, gold			2022-12-27	WOS:000376588600083
J	Faerber, SJ; Kaufmann, JM; Leder, H; Martin, EM; Schweinberger, SR				Faerber, Stella J.; Kaufmann, Jurgen M.; Leder, Helmut; Martin, Eva Maria; Schweinberger, Stefan R.			The Role of Familiarity for Representations in Norm-Based Face Space	PLOS ONE			English	Article							ATTRACTIVE FACES; VISUAL-ADAPTATION; RECOGNITION; DISTINCTIVENESS; AVERAGE; POWER; SHAPE	According to the norm-based version of the multidimensional face space model (nMDFS, Valentine, 1991), any given face and its corresponding anti-face (which deviates from the norm in exactly opposite direction as the original face) should be equidistant to a hypothetical prototype face (norm), such that by definition face and anti-face should bear the same level of perceived typicality. However, it has been argued that familiarity affects perceived typicality and that representations of familiar faces are qualitatively different (e.g., more robust and image-independent) from those for unfamiliar faces. Here we investigated the role of face familiarity for rated typicality, using two frequently used operationalisations of typicality (deviation-based: DEV), and distinctiveness (face in the crowd: FITC) for faces of celebrities and their corresponding anti-faces. We further assessed attractiveness, likeability and trustworthiness ratings of the stimuli, which are potentially related to typicality. For unfamiliar faces and their corresponding anti-faces, in line with the predictions of the nMDFS, our results demonstrate comparable levels of perceived typicality (DEV). In contrast, familiar faces were perceived much less typical than their anti-faces. Furthermore, familiar faces were rated higher than their anti-faces in distinctiveness, attractiveness, likability and trustworthiness. These findings suggest that familiarity strongly affects the distribution of facial representations in norm-based face space. Overall, our study suggests (1) that familiarity needs to be considered in studies of mental representations of faces, and (2) that familiarity, general distance-to-norm and more specific vector directions in face space make different and interactive contributions to different types of facial evaluations.	[Faerber, Stella J.; Kaufmann, Jurgen M.; Schweinberger, Stefan R.] Univ Jena, DFG Res Unit Person Percept, Jena, Germany; [Faerber, Stella J.; Kaufmann, Jurgen M.; Martin, Eva Maria; Schweinberger, Stefan R.] Univ Jena, Dept Gen Psychol & Cognit Neurosci, Jena, Germany; [Leder, Helmut] Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria; [Schweinberger, Stefan R.] Univ Jena, Michael Stifel Ctr Jena Data Driven & Simulat Sci, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Vienna; Friedrich Schiller University of Jena	Faerber, SJ (corresponding author), Univ Jena, DFG Res Unit Person Percept, Jena, Germany.; Faerber, SJ (corresponding author), Univ Jena, Dept Gen Psychol & Cognit Neurosci, Jena, Germany.	stella.faerber@uni-jena.de	Schweinberger, Stefan/A-1860-2009	Schweinberger, Stefan/0000-0001-5762-0188	Deutsche Forschungsgemeinschaft (German Research Foundation) [FOR1097, KA 2997/3-2]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	Funded by Deutsche Forschungsgemeinschaft (German Research Foundation), grant number FOR1097, received by Stefan Schweinberger and Deutsche Forschungsgemeinschaft (German Research Foundation), grant number KA 2997/3-2, received by Jurgen Kaufmann & Stefan Schweinberger.	ALLEY TR, 1991, PSYCHOL SCI, V2, P123, DOI 10.1111/j.1467-9280.1991.tb00113.x; Bindemann M, 2008, PSYCHOPHYSIOLOGY, V45, P535, DOI 10.1111/j.1469-8986.2008.00663.x; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; BRUCK M, 1991, MEM COGNITION, V19, P221, DOI 10.3758/BF03211146; Buckingham G, 2006, EVOL HUM BEHAV, V27, P381, DOI 10.1016/j.evolhumbehav.2006.03.001; Burton AM, 2011, BRIT J PSYCHOL, V102, P943, DOI 10.1111/j.2044-8295.2011.02039.x; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Burton AM, 2005, COGNITIVE PSYCHOL, V51, P256, DOI 10.1016/j.cogpsych.2005.06.003; Busey TA, 1998, PSYCHOL SCI, V9, P476, DOI 10.1111/1467-9280.00088; Caharel S, 2014, J COGNITIVE NEUROSCI, V26, P81, DOI 10.1162/jocn_a_00451; Carbon CC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00003; Castello MVD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136548; DeBruine LM, 2007, J EXP PSYCHOL HUMAN, V33, P1420, DOI 10.1037/0096-1523.33.6.1420; Faerber SJ, 2013, RES ENG DES, V24, P313, DOI 10.1007/s00163-012-0148-7; Faerber SJ, 2012, I-PERCEPTION, V3, P553, DOI 10.1068/i0506; Faerber SJ, 2010, ACTA PSYCHOL, V135, P191, DOI 10.1016/j.actpsy.2010.06.006; FRANKS JJ, 1971, J EXP PSYCHOL, V90, P65, DOI 10.1037/h0031349; Halberstadt J, 2006, PERS SOC PSYCHOL REV, V10, P166, DOI 10.1207/s15327957pspr1002_5; Halberstadt J, 2003, PSYCHON B REV, V10, P149, DOI 10.3758/BF03196479; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; JACOBY LL, 1989, J EXP PSYCHOL GEN, V118, P115, DOI 10.1037/0096-3445.118.2.115; Johnston RA, 2009, MEMORY, V17, P577, DOI 10.1080/09658210902976969; Kaufmann JM, 2009, J COGNITIVE NEUROSCI, V21, P625, DOI 10.1162/jocn.2009.21080; LANGLOIS JH, 1994, PSYCHOL SCI, V5, P214, DOI 10.1111/j.1467-9280.1994.tb00503.x; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Leopold DA, 2005, P ROY SOC B-BIOL SCI, V272, P897, DOI 10.1098/rspb.2004.3022; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Little AC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00019; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; PERRETT DI, 1994, NATURE, V368, P239, DOI 10.1038/368239a0; Potter T, 2008, PSYCHON B REV, V15, P615, DOI 10.3758/PBR.15.3.615; Ramon M, 2016, PEERJ, V4, DOI 10.7717/peerj.1465; Ramon M, 2015, PEERJ, V3, DOI 10.7717/peerj.850; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Rhodes G, 2003, PSYCHOL SCI, V14, P558, DOI 10.1046/j.0956-7976.2003.psci_1465.x; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 1999, PSYCHOL SCI, V10, P52, DOI 10.1111/1467-9280.00106; Rhodes G, 2007, VISION RES, V47, P2291, DOI 10.1016/j.visres.2007.05.012; Rhodes G, 2006, VISION RES, V46, P2977, DOI 10.1016/j.visres.2006.03.002; Rhodes G, 2009, PSYCHON B REV, V16, P503, DOI 10.3758/PBR.16.3.503; Said CP, 2011, PSYCHOL SCI, V22, P1183, DOI 10.1177/0956797611419169; SCHWEINBERGER SR, 1995, J EXP PSYCHOL LEARN, V21, P722, DOI 10.1037/0278-7393.21.3.722; Schweinberger SR, CORTEX IN PRESS; Schweinberger SR, 2014, PSYCHOL RUNDSCH, V65, P212, DOI 10.1026/0033-3042/a000225; Sofer C, 2015, PSYCHOL SCI, V26, P39, DOI 10.1177/0956797614554955; Tanaka J, 1998, COGNITION, V68, P199, DOI 10.1016/S0010-0277(98)00048-1; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Tsao DY, 2006, TRENDS COGN SCI, V10, P391, DOI 10.1016/j.tics.2006.07.009; VALENTINE T, 1986, CAN J PSYCHOL, V40, P300, DOI 10.1037/h0080101; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Watier NN, 2009, PERCEPTION, V38, P1497, DOI 10.1068/p6396; Wickham LHV, 2003, AM J PSYCHOL, V116, P455, DOI 10.2307/1423503; Wiese H, 2014, NEUROPSYCHOLOGIA, V56, P26, DOI 10.1016/j.neuropsychologia.2013.12.023; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zebrowitz LA, 2007, SOC COGNITION, V25, P306, DOI 10.1521/soco.2007.25.2.306	56	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155380	10.1371/journal.pone.0155380	http://dx.doi.org/10.1371/journal.pone.0155380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CD	27168323	Green Submitted, Green Published, gold			2022-12-27	WOS:000376587300097
J	Horacio, AN; Silva-Costa, C; Diamantino-Miranda, J; Lopes, JP; Ramirez, M; Melo-Cristino, J				Horacio, Andreia N.; Silva-Costa, Catarina; Diamantino-Miranda, Jorge; Lopes, Joana P.; Ramirez, Mario; Melo-Cristino, Jose		Portuguese Grp Study Streptococcal	Population Structure of Streptococcus pneumoniae Causing Invasive Disease in Adults in Portugal before PCV13 Availability for Adults: 2008-2011	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; MOLECULAR EPIDEMIOLOGY; TYPING METHODS; UNITED-STATES; SEROTYPE 19A; RESISTANT; INFECTIONS; CHILDREN; CLONES; PILUS	Among the 1660 isolates recovered from invasive pneumococcal disease (IPD) in adults (> = 18 yrs) in 2008-2011, a random sample of >= 50% of each serotype (n = 871) was chosen for MLST analysis and evaluation for the presence and type of pilus islands (PIs). The genetic diversity was high with 206 different sequence types (STs) detected, but it varied significantly between serotypes. The different STs represented 80 clonal complexes (CCs) according to goeBURST with the six more frequent accounting for more than half (50.6%) of the isolates-CC156 (serotypes 14, 9V and 23F), CC191 (serotype 7F), CC180 (serotype 3), CC306 (serotype 1), CC62 (serotypes 8 and 11A) and CC230 (serotype 19A). Most of the isolates (n = 587, 67.3%) were related to 29 Pneumococcal Molecular Epidemiology Network recognized clones. The overall proportion of isolates positive for any of the PIs was small (31.9%) and declined gradually during the study period (26.6% in 2011), mostly due to the significant decline of serotype 1 which is associated with PI-2. The changes in serotypes that occurred in adult IPD after the introduction of the seven-valent pneumococcal conjugate vaccine (PCV7) for children were mostly due to the expansion of previously circulating clones, while capsular switching was infrequent and not related to vaccine use. The reduction of IPD caused by PCV7 serotypes in the years following PCV7 implementation did not result in a decline of antimicrobial resistance in part due to the selection of resistant genotypes among serotypes 14 and 19A.	[Horacio, Andreia N.; Silva-Costa, Catarina; Diamantino-Miranda, Jorge; Lopes, Joana P.; Ramirez, Mario; Melo-Cristino, Jose; Portuguese Grp Study Streptococcal] Univ Lisbon, Fac Med, Inst Med Mol, Inst Microbiol, P-1699 Lisbon, Portugal	Universidade de Lisboa	Ramirez, M (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Inst Microbiol, P-1699 Lisbon, Portugal.	ramirez@fm.ul.pt	Melo-Cristino, Jose A G/H-3726-2013; Chaves, Catarina/AAM-9455-2020; Ramirez, Mario/B-4993-2008; Silva-Costa, Catarina/J-8167-2013	Melo-Cristino, Jose A G/0000-0001-8643-1722; Chaves, Catarina/0000-0003-0131-5728; Ramirez, Mario/0000-0002-4084-6233; Silva-Costa, Catarina/0000-0001-9681-0574; Miranda, Jorge/0000-0001-9128-2047; Figueiredo Marrao, Gina Maria/0000-0002-0808-278X; Toscano, Cristina/0000-0002-4674-6065; Bento, Ricardo/0000-0003-3749-4684	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/81205/2011, SFRH/BD/81766/2011]; Fundacao para a Ciencia e Tecnologia [PTDC/DTP-EPI/1759/2012, PTDC/DTP-EPI/1555/2014]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	A.N. Horacio and J. Diamantino-Miranda were supported by grants SFRH/BD/81205/2011and SFRH/BD/81766/2011, respectively, from Fundacao para a Ciencia e Tecnologia, Portugal. This work was partly supported by Fundacao para a Ciencia e Tecnologia (PTDC/DTP-EPI/1759/2012 and PTDC/DTP-EPI/1555/2014) and an unrestricted Investigator initiated project from Pfizer awarded to J. Melo-Cristino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Aguiar SI, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.12.20750; Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Aguiar SI, 2012, VACCINE, V30, P5487, DOI 10.1016/j.vaccine.2012.06.062; Aguiar SI, 2010, VACCINE, V28, P5167, DOI 10.1016/j.vaccine.2010.06.008; Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; Almeida ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090974; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettinger JA, 2010, VACCINE, V28, P2130, DOI 10.1016/j.vaccine.2009.12.026; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Caierao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111129; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Golden AR, 2015, J ANTIMICROB CHEMOTH, V70, P1960, DOI 10.1093/jac/dkv061; Harvey RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019650; Horacio AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073704; Horacio AN, 2012, VACCINE, V30, P218, DOI 10.1016/j.vaccine.2011.11.022; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Metcalf BJ, 2016, CLIN MICROBIOL INFEC, V22, DOI [10.1016/j.cmi.2015.08.027, 10.1016/j.cmi.2016.08.001]; Moschioni M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061003; Munoz-Almagro C, 2011, J INFECTION, V63, P151, DOI 10.1016/j.jinf.2011.06.002; Nakano S, 2016, VACCINE, V34, P67, DOI 10.1016/j.vaccine.2015.11.015; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pantosti A, 2002, CLIN INFECT DIS, V35, P205, DOI 10.1086/341250; Pichon B, 2013, J CLIN MICROBIOL, V51, P820, DOI 10.1128/JCM.01917-12; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ramirez M, 1999, MICROB DRUG RESIST, V5, P241, DOI 10.1089/mdr.1999.5.241; Regev-Yochay G, 2010, VACCINE, V28, P4842, DOI 10.1016/j.vaccine.2010.04.042; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Serrano I, 2005, J CLIN MICROBIOL, V43, P1706, DOI 10.1128/JCM.43.4.1706-1715.2005; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Simoes AS, 2011, J CLIN MICROBIOL, V49, P2810, DOI 10.1128/JCM.00517-11; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Wyres KL, 2013, J INFECT DIS, V207, P439, DOI 10.1093/infdis/jis703; Yildirim I, 2012, PEDIATR INFECT DIS J, V31, P1016, DOI 10.1097/INF.0b013e3182615615	40	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0153602	10.1371/journal.pone.0153602	http://dx.doi.org/10.1371/journal.pone.0153602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168156	gold, Green Submitted, Green Published			2022-12-27	WOS:000376587300078
J	Hu, DQ; Flick, RP; Gleich, SJ; Scanlon, MM; Zaccariello, MJ; Colligan, RC; Katusic, SK; Schroeder, DR; Hanson, AC; Buenvenida, SL; Wilder, RT; Sprung, J; Warner, DO				Hu, Danqing; Flick, Randall P.; Gleich, Stephen J.; Scanlon, Maura M.; Zaccariello, Michael J.; Colligan, Robert C.; Katusic, Slavica K.; Schroeder, Darrell R.; Hanson, Andrew C.; Buenvenida, Shonie L.; Wilder, Robert T.; Sprung, Juraj; Warner, David O.			Construction and Characterization of a Population-Based Cohort to Study the Association of Anesthesia Exposure with Neurodevelopmental Outcomes	PLOS ONE			English	Article							CHILDHOOD EXPOSURE; CHILDREN; RELIABILITY; PERFORMANCE	Exposure to general anesthesia at an early age has been associated with adverse neurodevelopmental outcomes in both animal and human studies, but some of these studies employed anesthetic agents that are no longer in clinical use. In this manuscript, we describe the methods used to construct a new population-based study cohort to study the association between early anesthetic exposure and subsequent neurodevelopmental outcomes. A birth cohort of all children born in Olmsted County, MN from January 1, 1996 to December 31, 2000 was identified. For each, school enrollment status in the Independent School District (ISD) 535 at age 5 or 6 and all episodes of anesthetic exposure before age 3 were identified. A study cohort was created by matching children enrolled in ISD 535 based on the propensity of receiving general anesthesia. Three analyses were performed to characterize the study cohort by comparing the birth and parental information, comorbidities, and socioeconomic status. The first analysis compared the characteristics of birth cohort children who were and were not enrolled in ISD 535. The second analysis evaluated the success of the propensity matching schemes in creating groups of children that were similar in measured characteristics except for anesthesia exposure. The third analysis compared the characteristics of children with anesthesia exposures who were and were not included in the final cohort based on propensity matching. Results of these analyses demonstrate only slight differences among the comparison groups, and therefore these are unlikely to compromise our future analysis of anesthetic exposure and neurodevelopmental outcomes.	[Flick, Randall P.; Gleich, Stephen J.; Scanlon, Maura M.; Buenvenida, Shonie L.; Wilder, Robert T.; Sprung, Juraj; Warner, David O.] Mayo Clin, Dept Anesthesiol, Rochester, MN USA; [Hu, Danqing] Mayo Clin, Mayo Grad Sch, Rochester, MN USA; [Zaccariello, Michael J.; Colligan, Robert C.] Mayo Clin, Dept Psychol, Rochester, MN USA; [Katusic, Slavica K.; Schroeder, Darrell R.; Hanson, Andrew C.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Warner, DO (corresponding author), Mayo Clin, Dept Anesthesiol, Rochester, MN USA.	warner.david@mayo.edu	hu, dq/K-9722-2016		Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD071907]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, https://www.nichd.nih.gov/Pages/index.aspx, Award Number: HD071907, Grant Recipient: David Warner. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels M, 2009, TWIN RES HUM GENET, V12, P246, DOI 10.1375/twin.12.3.246; Block RI, 2012, ANESTHESIOLOGY, V117, P494, DOI 10.1097/ALN.0b013e3182644684; Creeley C, 2013, BRIT J ANAESTH, V110, P29, DOI 10.1093/bja/aet173; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; Fall S, 2015, PSYCHIAT RES-NEUROIM, V233, P50, DOI 10.1016/j.pscychresns.2015.05.001; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Gleich SJ, 2015, CONTEMP CLIN TRIALS, V41, P45, DOI 10.1016/j.cct.2014.12.020; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Hansen TG, 2011, ANESTHESIOLOGY, V114, P1076, DOI 10.1097/ALN.0b013e31820e77a0; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Juhn YJ, 2011, J URBAN HEALTH, V88, P933, DOI 10.1007/s11524-011-9572-7; Murphy KL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00087; Northam S, 2006, JOGNN-J OBST GYN NEO, V35, P3, DOI 10.1111/J.1552-6909.2006.00016.x; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Ramage TM, 2013, BRIT J ANAESTH, V110, P39, DOI 10.1093/bja/aet103; Raper J, 2015, ANESTHESIOLOGY, V123, P1084, DOI 10.1097/ALN.0000000000000851; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Slikker W, 2007, TOXICOL SCI, V98, P145, DOI 10.1093/toxsci/kfm084; SNELL LM, 1992, AM J PERINAT, V9, P219, DOI 10.1055/s-2007-999325; Sprung J, 2012, MAYO CLIN PROC, V87, P120, DOI 10.1016/j.mayocp.2011.11.008; St Sauver JL, 2011, AM J EPIDEMIOL, V173, P1059, DOI 10.1093/aje/kwq482; Watkins ML, 1996, AM J PUBLIC HEALTH, V86, P731, DOI 10.2105/AJPH.86.5.731; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Zou XJ, 2011, NEUROTOXICOL TERATOL, V33, P592, DOI 10.1016/j.ntt.2011.06.003	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155288	10.1371/journal.pone.0155288	http://dx.doi.org/10.1371/journal.pone.0155288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167371	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300014
J	Roberts, BEI; Harris, WE; Hilton, GM; Marsden, SJ				Roberts, Beth E. I.; Harris, W. Edwin; Hilton, Geoff M.; Marsden, Stuart J.			Taxonomic and Geographic Bias in Conservation Biology Research: A Systematic Review of Wildfowl Demography Studies	PLOS ONE			English	Review							POPULATION; BIODIVERSITY; ECOLOGY; PRIORITIES; DIVERSITY; MAMMALS; GROWTH; THREAT	Demographic data are important to wildlife managers to gauge population health, to allow populations to be utilised sustainably, and to inform conservation efforts. We analysed published demographic data on the world's wildfowl to examine taxonomic and geographic biases in study, and to identify gaps in knowledge. Wildfowl (order: Anseriformes) are a comparatively well studied bird group which includes 169 species of duck, goose and swan. In all, 1,586 wildfowl research papers published between 1911 and 2010 were found using Web of Knowledge (WoK) and Google Scholar. Over half of the research output involved just 15 species from seven genera. Research output was strongly biased towards 'high income' countries, common wildfowl species, and measures of productivity, rather than survival and movement patterns. There were significantly fewer demographic data for the world's 31 threatened wildfowl species than for non-threatened species. Since 1994, the volume of demographic work on threatened species has increased more than for non-threatened species, but still makes up only 2.7% of total research output. As an aid to research prioritisation, a metric was created to reflect demographic knowledge gaps for each species related to research output for the species, its threat status, and availability of potentially useful surrogate data from congeneric species. According to the metric, the 25 highest priority species include thirteen threatened taxa and nine species each from Asia and South America, and six from Africa.	[Roberts, Beth E. I.; Harris, W. Edwin; Marsden, Stuart J.] Manchester Metropolitan Univ, Sch Sci & Environm, Div Biol & Conservat Biol, Manchester M15 6BH, Lancs, England; [Hilton, Geoff M.] Wildfowl & Wetlands Trust, Slimbridge, Glos, England	Manchester Metropolitan University	Roberts, BEI (corresponding author), Manchester Metropolitan Univ, Sch Sci & Environm, Div Biol & Conservat Biol, Manchester M15 6BH, Lancs, England.	b.roberts@mmu.ac.uk	Hilton, Geoff M/H-3086-2017	Hilton, Geoff M/0000-0001-9062-3030; Harris, Edwin/0000-0002-9038-8656; Marsden, Stuart/0000-0002-0205-960X	Wildfowl Wetlands Trust	Wildfowl Wetlands Trust	Beth E. I. Roberts' PhD is funded by Wildfowl & Wetlands Trust (www.wwt.org.uk).	Bamford AJ, 2015, BIRD CONSERV INT, V25, P97, DOI 10.1017/S0959270914000033; Barber PH, 2014, B MAR SCI, V90, P187, DOI 10.5343/bms.2012.1108; Barker GM, 2002, BIOL J LINN SOC, V76, P165, DOI 10.1111/j.1095-8312.2002.tb02081.x; Barnes RFW, 2002, AFR J ECOL, V40, P179, DOI 10.1046/j.1365-2028.2002.00376.x; Becker RA, 2015, ORIGINAL S CODE BECK; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; BirdLife International, 2013, STAT WORLDS BIRDS IN, V8, P20; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2006, ORYX, V40, P266, DOI 10.1017/S0030605306000950; Clark JA, 2002, SCIENCE, V297, P191; Coulson T, 2005, J ANIM ECOL, V74, P789, DOI 10.1111/j.1365-2656.2005.00975.x; de Lima RF, 2011, BIOL CONSERV, V144, P627, DOI 10.1016/j.biocon.2010.10.021; Fisher R, 2011, CONSERV LETT, V4, P64, DOI 10.1111/j.1755-263X.2010.00146.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Giles J, 2005, NATURE, V438, P554, DOI 10.1038/438554a; Githiru M, 2015, BIOL CONSERV, V191, P819, DOI 10.1016/j.biocon.2015.07.033; Green Rhys E., 1999, Bird Study, V46, pS279; Hoffmann M., 2008, Endangered Species Research, V6, P113, DOI 10.3354/esr00087; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; ISI Web of Knowledge, 2012, ISI WEB KNOWL SUIT D, V2, P1; IUCN, 2014, IUCN RED LIST THREAT; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Kear J, 2005, BIRD FAMILIES WORLD; Krapu GL, 2000, AUK, V117, P640, DOI 10.1642/0004-8038(2000)117[0640:TFORIT]2.0.CO;2; Lawler JJ, 2006, FRONT ECOL ENVIRON, V4, P473, DOI 10.1890/1540-9295(2006)4[473:CSAYRC]2.0.CO;2; LINDENMAYER DB, 1993, ENVIRON MANAGE, V17, P745, DOI 10.1007/BF02393895; Long PR, 2007, ANIM CONSERV, V10, P183, DOI 10.1111/j.1469-1795.2006.00087.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Mace GM, 1999, CONSERV BIOL, V13, P242, DOI 10.1046/j.1523-1739.1999.013002242.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; McCarthy MA, 2010, ECOL LETT, V13, P1280, DOI 10.1111/j.1461-0248.2010.01522.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; NICHOLS JD, 1995, ANNU REV ECOL SYST, V26, P177, DOI 10.1146/annurev.es.26.110195.001141; Pullin AS, 2004, BIOL CONSERV, V119, P245, DOI 10.1016/j.biocon.2003.11.007; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schmeller D, 2008, BIODIVERS CONSERV, V17, P3623, DOI 10.1007/s10531-008-9446-9; Sim IMW, 2011, J ANIM ECOL, V80, P159, DOI 10.1111/j.1365-2656.2010.01750.x; Skalski John R., 2005, P11, DOI 10.1016/B978-012088773-6/50003-1; Tordoff AW, 2008, BIRD CONSERV INT, V18, P38, DOI 10.1017/S0959270908000063; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Whitehead AL, 2008, BIOL CONSERV, V141, P2784, DOI 10.1016/j.biocon.2008.08.013; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; World Bank, 2013, WORLD DEV IND DAT, V7, P23; Zuur A, 2009, MIXED EFFECTS MODELS	47	24	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0153908	10.1371/journal.pone.0153908	http://dx.doi.org/10.1371/journal.pone.0153908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166624	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300093
J	Sayyah-Melli, M; Ghorbanihaghjo, A; Alizadeh, M; Kazemi-Shishvan, M; Ghojazadeh, M; Bidadi, S				Sayyah-Melli, Manizheh; Ghorbanihaghjo, Amir; Alizadeh, Mahasti; Kazemi-Shishvan, Maryamalsadat; Ghojazadeh, Morteza; Bidadi, Sanam			The Effect of High Dose Folic Acid throughout Pregnancy on Homocysteine (Hcy) Concentration and Pre-Eclampsia: A Randomized Clinical Trial	PLOS ONE			English	Article							PLASMA TOTAL HOMOCYSTEINE; PRETERM BIRTH; RISK; SUPPLEMENTATION; WOMEN; CANCER; HYPERTENSION; VITAMIN-B12; DISEASE; WEIGHT	Pre-eclampsia is a pregnancy-relatedmulti-systemic hypertensive disorder and affects at least 5% of pregnancies. This randomized clinical trial aimed at assessing the effect of low doses and high doses of folic acid on homocysteine (Hcy) levels, blood pressure, urea, creatinine and neonatal outcome. A randomized clinical trial was done at Alzahra Teaching Hospital, Tabriz University of Medical Sciences from April 2008 to March 2013. Four-hundred and sixty nulliparous pregnant women were randomly assigned into two groups. Group 1 (n = 230) received 0.5 mg of folic acid and group 2 (n = 230) received 5 mg of folic acid per daily. They were followed until delivery. Blood pressure and laboratory changes, including plasma Hcy levels, were measured and compared between the groups. Homocysteine concentrations were significantly higher at the time of delivery in group 1 (13.17 +/- 3.89 mu mol/l) than in group 2 (10.31 +/- 3.54, mu mol/l) (p<0.001). No statistically significant differences were observed in systolic and diastolic blood pressure (p = 0.84 and 0.15, respectively). Birth weight was significantly higher in group 2 (p = 0.031) and early abortion was significantly higher in group 1 than group 2 (p = 0.001). This study has provided evidence that a high dosage of folic acid supplements throughout pregnancy reduces Hcy concentrations at the time of delivery.	[Sayyah-Melli, Manizheh] Tabriz Univ Med Sci, DARC, Tabriz 5138665793, Iran; [Ghorbanihaghjo, Amir] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran; [Alizadeh, Mahasti] Tabriz Univ Med Sci, Social Determinants Hlth Res Ctr, Tabriz, Iran; [Kazemi-Shishvan, Maryamalsadat] Tabriz Univ Med Sci, Dept Community Med, Fac Med, Tabriz, Iran; [Ghojazadeh, Morteza; Bidadi, Sanam] Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Alizadeh, M (corresponding author), Tabriz Univ Med Sci, Social Determinants Hlth Res Ctr, Tabriz, Iran.	wrhrcenter@gmail.com	Alizadeh, Mahasti/F-3224-2018; Sayyah-Melli, Manizheh/L-7748-2017	ghorbanihaghjo, amir/0000-0001-6742-0526; Alizadeh, Mahasti/0000-0002-9754-2097; Ghojazadeh, Morteza/0000-0002-9946-9452	Tabriz University of Medical Sciences, Tabriz, Iran	Tabriz University of Medical Sciences, Tabriz, Iran	Funder for the study was the Drug Applied Research Center (DARC) from Tabriz University of Medical Sciences, Tabriz, Iran. The sponsor of the study had no role in study design, data collection, data analysis or interpretation. They reviewed this report prior to submission for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Acilmis YG, 2011, J OBSTET GYNAECOL RE, V37, P45, DOI 10.1111/j.1447-0756.2010.01317.x; Al-Jameil Noura, 2014, J Clin Med Res, V6, P1, DOI 10.4021/jocmr1682w; Banhidy F., 2011, ADV PREV MED, V2011, P127369, DOI [10.4061/2011/127369, DOI 10.4061/2011/127369]; Catov JM, 2009, AM J EPIDEMIOL, V169, P1304, DOI 10.1093/aje/kwp052; Charles DHM, 2005, PAEDIATR PERINAT EP, V19, P112, DOI 10.1111/j.1365-3016.2005.00633.x; Czeizel AE, 2010, EUR J OBSTET GYN R B, V148, P135, DOI 10.1016/j.ejogrb.2009.10.016; Czeizel AE, 2011, AM J CLIN NUTR, V94, P1651, DOI 10.3945/ajcn.111.026690; Daly Sean, 2005, Semin Vasc Med, V5, P190, DOI 10.1055/s-2005-872404; Dinavahi Rajani, 2004, J Clin Hypertens (Greenwich), V6, P494, DOI 10.1111/j.1524-6175.2004.03643.x; Fernandez Marisol, 2005, Invest Clin, V46, P187; Guilland JC, 2003, PATHOL BIOL, V51, P101, DOI 10.1016/S0369-8114(03)00104-4; Ji YL, 2014, NUTRIENTS, V6, P5900, DOI 10.3390/nu6125900; Kajdy A, 2008, GINEKOL POL, V79, P775; Kennedy D, 2012, CAN FAM PHYSICIAN, V58, P394; LaMarca BD, 2008, HYPERTENSION, V51, P982, DOI 10.1161/HYPERTENSIONAHA.107.108837; Laskowska M, 2013, MED SCI MONITOR, V19, P430, DOI 10.12659/MSM.883932; Li ZW, 2013, HYPERTENSION, V61, P873, DOI 10.1161/HYPERTENSIONAHA.111.00230; Loehrer FMT, 1997, J PHARMACOL EXP THER, V282, P845; Lopez-Quesada E, 2003, EUR J OBSTET GYN R B, V108, P45, DOI 10.1016/S0301-2115(02)00367-6; Manizheh SM, 2009, SAUDI MED J, V30, P88; Mujawar SA, 2011, INDIAN J CLIN BIOCHE, V26, P257, DOI 10.1007/s12291-011-0109-3; Myatt L, 2012, OBSTET GYNECOL, V119, P1234, DOI 10.1097/AOG.0b013e3182571669; Payne BA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001589; Pittschieler S, 2008, J NEUROL, V255, P1926, DOI 10.1007/s00415-008-0029-1; Piyathilake CJ, 2014, CANCER PREV RES, V7, P1128, DOI 10.1158/1940-6207.CAPR-14-0143; Qin XH, 2013, INT J CANCER, V133, P1033, DOI 10.1002/ijc.28038; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; Salehi-Pourmehr Hanieh, 2012, Iran J Nurs Midwifery Res, V17, P461; Sanlikan F, 2015, GINEKOL POL, V86, P287; Schaffer A, 2014, THROMB RES, V134, P288, DOI 10.1016/j.thromres.2014.05.025; Taylor CM, 2015, J EPIDEMIOL COMMUN H, V69, P789, DOI 10.1136/jech-2014-205324; Timmermans S, 2009, BRIT J NUTR, V102, P777, DOI 10.1017/S0007114509288994; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; Wang Jun, 2011, Zhonghua Fu Chan Ke Za Zhi, V46, P605; Wen S W, 2012, Pregnancy Hypertens, V2, P198, DOI 10.1016/j.preghy.2012.04.041; Wen SW, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/294312; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; Yanez P, 2013, ARCH GYNECOL OBSTET, V288, P1011, DOI 10.1007/s00404-013-2851-7	39	13	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154400	10.1371/journal.pone.0154400	http://dx.doi.org/10.1371/journal.pone.0154400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166794	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300096
J	Uzun, A; Schuster, J; McGonnigal, B; Schorl, C; Dewan, A; Padbury, J				Uzun, Alper; Schuster, Jessica; McGonnigal, Bethany; Schorl, Christoph; Dewan, Andrew; Padbury, James			Targeted Sequencing and Meta-Analysis of Preterm Birth	PLOS ONE			English	Article							PREMATURE RUPTURE; GROWTH-FACTOR; GENE; POLYMORPHISM; RARE; RISK; ASSOCIATION; PREDICTION; RECEPTOR; HERITABILITY	Understanding the genetic contribution(s) to the risk of preterm birth may lead to the development of interventions for treatment, prediction and prevention. Twin studies suggest heritability of preterm birth is 36-40%. Large epidemiological analyses support a primary maternal origin for recurrence of preterm birth, with little effect of paternal or fetal genetic factors. We exploited an "extreme phenotype" of preterm birth to leverage the likelihood of genetic discovery. We compared variants identified by targeted sequencing of women with 2-3 generations of preterm birth with term controls without history of preterm birth. We used a meta-genomic, bi-clustering algorithm to identify gene sets coordinately associated with preterm birth. We identified 33 genes including 217 variants from 5 modules that were significantly different between cases and controls. The most frequently identified and connected genes in the exome library were IGF1, ATM and IQGAP2. Likewise, SOS1, RAF1 and AKT3 were most frequent in the haplotype library. Additionally, SERPINB8, AZU1 and WASF3 showed significant differences in abundance of variants in the univariate comparison of cases and controls. The biological processes impacted by these gene sets included: cell motility, migration and locomotion; response to glucocorticoid stimulus; signal transduction; metabolic regulation and control of apoptosis.	[Uzun, Alper; Schuster, Jessica; McGonnigal, Bethany; Padbury, James] Women & Infants Hosp Rhode Isl, Dept Pediat, Providence, RI 02908 USA; [Uzun, Alper; Padbury, James] Brown Alpert Med Sch, Providence, RI USA; [Schorl, Christoph] Brown Univ, Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Dewan, Andrew] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Padbury, James] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA	Women & Infants Hospital Rhode Island; Brown University; Brown University; Yale University; Brown University	Padbury, J (corresponding author), Women & Infants Hosp Rhode Isl, Dept Pediat, Providence, RI 02908 USA.; Padbury, J (corresponding author), Brown Alpert Med Sch, Providence, RI USA.; Padbury, J (corresponding author), Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA.	jpadbury@wihri.org		Uzun, Alper/0000-0001-6489-8591; DeWan, Andrew/0000-0002-7679-8704; Schorl, Christoph/0000-0001-6132-3581	National Foundation March of Dimes [21-FY14-154]; Rhode Island Foundation [20133978]; National Institutes of Health [P30 GM114750-01, P20 RR18728, P30 GM103410]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103410, P30GM114750] Funding Source: NIH RePORTER	National Foundation March of Dimes; Rhode Island Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Foundation March of Dimes #21-FY14-154, the Rhode Island Foundation #20133978, and the National Institutes of Health #P30 GM114750-01, #P20 RR18728 and #P30 GM103410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Kristina M, 2004, Semin Fetal Neonatal Med, V9, P445, DOI 10.1016/j.siny.2004.04.001; Adams MM, 2000, JAMA-J AM MED ASSOC, V283, P1591, DOI 10.1001/jama.283.12.1591; Aidoo M, 2001, GENET EPIDEMIOL, V21, P201, DOI 10.1002/gepi.1029; Allen MC, 2000, PAEDIATR PERINAT EP, V14, P152, DOI 10.1046/j.1365-3016.2000.00255.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bezold KY, 2013, GENOME MED, V5, DOI 10.1186/gm438; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Crider KS, 2005, GENET MED, V7, P593, DOI 10.1097/01.gim.0000187223.69947.db; Demendi C, 2012, EUR J OBSTET GYN R B, V160, P40, DOI 10.1016/j.ejogrb.2011.10.005; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Ekwo E, 1998, J Assoc Acad Minor Phys, V9, P16; Fujimoto T, 2002, J BIOL CHEM, V277, P6296, DOI 10.1074/jbc.M107865200; Genc MR, 2002, AM J OBSTET GYNECOL, V187, P157, DOI 10.1067/mob.2002.122407; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Gordon AS, 2014, HUM MOL GENET, V23, P1957, DOI 10.1093/hmg/ddt588; Gusenleitner D, 2012, BIOINFORMATICS, V28, P2484, DOI 10.1093/bioinformatics/bts438; Gustafsson M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0082-6; Haataja R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001293; He ZX, 2014, AM J HUM GENET, V94, P33, DOI 10.1016/j.ajhg.2013.11.021; Iams JD, 1998, AM J OBSTET GYNECOL, V178, P1035, DOI 10.1016/S0002-9378(98)70544-7; Gracia-Aznarez FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055681; JOHNSTONE F, 1974, BMJ-BRIT MED J, V3, P659, DOI 10.1136/bmj.3.5932.659; Kalish RB, 2004, AM J OBSTET GYNECOL, V190, P702, DOI 10.1016/j.ajog.2003.09.066; Landau R, 2002, AM J OBSTET GYNECOL, V187, P1294, DOI 10.1067/mob.2002.128524; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Litchfield K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6973; Little J, 2009, AM J EPIDEMIOL, V170, P1382, DOI 10.1093/aje/kwp326; Lorenz E, 2002, PEDIATR RES, V52, P373, DOI 10.1203/01.PDR.0000025342.83436.53; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menon R, 2006, J SOC GYNECOL INVEST, V13, P531, DOI 10.1016/j.jsgi.2006.09.006; Mercer BM, 2000, AM J OBSTET GYNECOL, V183, P738, DOI 10.1067/mob.2000.106766; Mercer BM, 1996, AM J OBSTET GYNECOL, V174, P1885, DOI 10.1016/S0002-9378(96)70225-9; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Nadeau-Vallee M, 2015, J IMMUNOL, V195, P3402, DOI 10.4049/jimmunol.1500758; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ozkur M, 2002, INT J GYNECOL OBSTET, V77, P209, DOI 10.1016/S0020-7292(02)00035-8; Papazoglou D, 2004, ACTA OBSTET GYN SCAN, V83, P461, DOI 10.1111/j.0001-6349.2004.00403.x; Pennell CE, 2007, AM J OBSTET GYNECOL, V196, P107, DOI 10.1016/j.ajog.2006.03.109; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Roberts AK, 1999, AM J OBSTET GYNECOL, V180, P1297, DOI 10.1016/S0002-9378(99)70632-0; Rolett A, 2000, PAEDIATR PERINAT EP, V14, P211, DOI 10.1046/j.1365-3016.2000.00268.x; Romano JD, 2015, J BIOMED INFORM, V54, P10, DOI 10.1016/j.jbi.2015.01.002; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Simhan HN, 2003, AM J OBSTET GYNECOL, V189, P915, DOI 10.1067/S0002-9378(03)00843-3; Steinberg KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09124; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; Uzun A, 2013, GENOMICS, V101, P163, DOI 10.1016/j.ygeno.2012.12.005; Uzun A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar069; Velez DR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003283; Ventura SJ, 2013, MMWR-MORBID MORTAL W, V62, P71; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward K, 2005, OBSTET GYNECOL, V106, P1235, DOI 10.1097/01.AOG.0000189091.35982.85; Weinberg CR, 2009, AM J EPIDEMIOL, V170, P1373, DOI 10.1093/aje/kwp325; Witkin SS, 2003, AM J OBSTET GYNECOL, V189, P1413, DOI 10.1067/S0002-9378(03)00630-6; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	66	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155021	10.1371/journal.pone.0155021	http://dx.doi.org/10.1371/journal.pone.0155021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163930	Green Published, gold			2022-12-27	WOS:000376585700040
J	Goldenberg, SM; Brouwer, KC; Jimenez, TR; Miranda, SM; Mindt, MR				Goldenberg, Shira M.; Brouwer, Kimberly C.; Jimenez, Teresita Rocha; Miranda, Sonia Morales; Mindt, Monica Rivera			Enhancing the Ethical Conduct of HIV Research with Migrant Sex Workers: Human Rights, Policy, and Social Contextual Influences	PLOS ONE			English	Article							INJECTION-DRUG USERS; SEXUALLY-TRANSMITTED INFECTIONS; PREVENTION RESEARCH; ANDHRA-PRADESH; RISK-FACTORS; CONDOM USE; FEMALE; MIGRATION; HEALTH; VIOLENCE	Background Migrant sex workers are often highly marginalized and disproportionately experience health and social inequities, including high prevalence of HIV, sexually transmitted infections, and human rights violations. In recent years, research involving migrant sex workers has increased, yet many knowledge gaps remain regarding how best to protect research participant rights and welfare. Our objective was to identify key challenges and opportunities related to the responsible conduct of HIV research with migrant sex workers. Methods Focus groups and interviews conducted with 33 female sex workers >= 18 years old at the Guatemala-Mexico border from June 2013-February 2014 were analyzed. Participants were recruited through community outreach by a local HIV prevention organization to sex work establishments such as bars, hotels, street corners, and truck stops. Results Key themes influencing research engagement for migrant sex workers included researcher mistrust and fear related to research participation, rooted in the social isolation frequently faced by recent migrants; intersecting concerns related to immigration status, fear of criminalization, and compliance with sex work regulations; and perceived benefits and risks of HIV/STI testing for migrants (e.g., immigration implications, stigma) represent potential barriers and opportunities for the responsible conduct of research involving migrant sex workers. Conclusions Results highlight the intersection between the human rights vulnerabilities of migrant sex workers and barriers to research participation, including social isolation of migrants and policy/legal barriers related to immigration and sex work. Findings illustrate the need for researchers to develop population-tailored procedures to address fears related to immigration and criminalization, and to reinforce positive and non-stigmatizing relationships with migrant sex workers. Community-led efforts to reduce stigma and foster community organization and supports for migrant sex workers are recommended, as are broader policy shifts that move away from punitive legal approaches towards approaches that safeguard and prioritize the human rights of migrant sex workers.	[Goldenberg, Shira M.] Simon Fraser Univ, Fac Hlth Sci, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada; [Goldenberg, Shira M.] Univ British Columbia, St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat,Dept Med, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada; [Goldenberg, Shira M.; Mindt, Monica Rivera] Fordham Univ, HIV Prevent Res Eth Inst, 441 E Fordham Rd, Bronx, NY 10458 USA; [Brouwer, Kimberly C.; Jimenez, Teresita Rocha] Univ Calif San Diego, Div Global Publ Hlth, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Miranda, Sonia Morales] Univ Valle Guatemala, HIV Unit, Guatemala City, Guatemala; [Mindt, Monica Rivera] Fordham Univ, Dept Psychol, 441 Fordham Rd, Bronx, NY 10458 USA	Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Fordham University; University of California System; University of California San Diego; Universidad del Valle de Guatemala; Fordham University	Goldenberg, SM (corresponding author), Simon Fraser Univ, Fac Hlth Sci, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.; Goldenberg, SM (corresponding author), Univ British Columbia, St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat,Dept Med, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.; Goldenberg, SM (corresponding author), Fordham Univ, HIV Prevent Res Eth Inst, 441 E Fordham Rd, Bronx, NY 10458 USA.	sgoldenberg@cfenet.ubc.ca	Jiménez, Teresita Rocha/ABH-9751-2020; Goldenberg, Shira/C-9627-2009	Goldenberg, Shira/0000-0003-1633-9749; Rocha Jimenez, Teresita/0000-0003-2455-2865; Rivera Mindt, Monica/0000-0001-6350-321X	Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute/National Institutes of Drug Abuse [R25DA031608-01]; Canadian Institutes of Health Research; National Institute of Drug Abuse "Cruzando Fronteras [Crossing Borders]" [R01DA029899]; Michael Smith Foundation for Health Research/Women's Health Research Initiative; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029899, R25DA031608] Funding Source: NIH RePORTER	Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute/National Institutes of Drug Abuse; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Drug Abuse "Cruzando Fronteras [Crossing Borders]"; Michael Smith Foundation for Health Research/Women's Health Research Initiative; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute/National Institutes of Drug Abuse (R25DA031608-01; Director, Celia B. Fisher). SG was supported by the Canadian Institutes of Health Research and Michael Smith Foundation for Health Research/Women's Health Research Initiative. VM, KB, and the research infrastructure in Guatemala were supported by a National Institute of Drug Abuse grant, R01DA029899 "Cruzando Fronteras [Crossing Borders]". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge our Community Advisory Board, including representatives of Asociacion para la Educacion para la Vida (EDUCAVIDA), Organizacion de Mujeres en Superacion (OMES), Casa de la Mujer, Proyecto VIDA, and the Municipal Health Clinic in Tecun Uman, Guatemala. We also thank staff from EDUCAVIDA, Universidad del Valle de Guatemala, and the University of California, San Diego (UCSD), especially Teresita Rocha Jimenez, Brigida Garcia, Ana Vilma Matta, Marlene Lopez, Itzel Loya and Valerie Mercer (VM). We thank Celia Fisher and the RETI faculty and trainees for input on an earlier draft of this article. This research was funded by the Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute/National Institutes of Drug Abuse (R25DA031608-01; Director, Celia B. Fisher). SG was supported by the Canadian Institutes of Health Research and Michael Smith Foundation for Health Research/Women's Health Research Initiative. VM, KB, and the research infrastructure in Guatemala were supported by a National Institute of Drug Abuse grant, R01DA029899 "Cruzando Fronteras [Crossing Borders]".	Agust?n L., 2004, RES SEX WORK, V7, P6; Agustin L, 2006, J ETHN MIGR STUD, V32, P29, DOI 10.1080/13691830500335325; Anderson S, 2015, CULT HEALTH SEX, V17, P825, DOI 10.1080/13691058.2015.1008046; Angen MJ, 2000, QUAL HEALTH RES, V10, P378, DOI 10.1177/104973230001000308; Baumann A, 2011, FAM PROCESS, V50, P132, DOI 10.1111/j.1545-5300.2011.01351.x; Benach J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001043; Benach J, 2010, AM J IND MED, V53, P338, DOI 10.1002/ajim.20717; Benoit C, 2011, DEV KT NONPROFIT ORG, P15; Beyrer C, 2002, LANCET, V360, P246, DOI 10.1016/S0140-6736(02)09465-5; Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; Blanchard AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-234; Brennan D, 2005, INT MIGR, V43, P35, DOI 10.1111/j.0020-7985.2005.00311.x; Brouwer KC, 2009, J IMMIGR MINOR HEALT, V11, P1, DOI 10.1007/s10903-008-9119-5; Brown B, 2015, ETHICS BEHAV; Busza Joanna, 2004, HLTH HUMAN RIGHTS, V7, P231, DOI DOI 10.2307/4065357; Chabot C, 2012, J EMPIR RES HUM RES, V7, P20, DOI 10.1525/jer.2012.7.2.20; Choi SYP, 2011, SOCIOL HEALTH ILL, V33, P33, DOI 10.1111/j.1467-9566.2010.01265.x; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; Cwikel J, 2005, J SEX RES, V42, P306, DOI 10.1080/00224490509552286; Davidson P, 2012, AM J PUBLIC HEALTH, V102, P1254, DOI 10.2105/AJPH.2011.300418; Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909; Deren S, 2005, J URBAN HEALTH, V82, pIII13, DOI 10.1093/jurban/jti060; Donohue MC, 2011, BIOMETRIKA, V98, P685, DOI 10.1093/biomet/asr023; Fernandez Casanueva C, 2006, THESIS U ESSEX; Fernandez C, 2008, SPAN ECON REV, V10, P83, DOI 10.1007/s10108-007-9032-4; Fisher C. B., 2004, APPL DEV SCI, V8, P91, DOI DOI 10.1207/s1532480xads0803_3; Fisher Celia B, 2013, AJOB Prim Res, V4, P27; Fisher CB, 2011, SUBST USE MISUSE, V46, P728, DOI 10.3109/10826084.2010.528125; Gaines TL, 2013, GLOB PUBLIC HEALTH, V8, P405, DOI 10.1080/17441692.2013.779386; Global Network of Sex Work Projects, 2016, GOOD PRACTICE IN SEX; Goldenberg S, 2012, NAT HISP SCI NETW 12; Goldenberg S, 2014, ETHICS BEHAV; Goldenberg S, 2010, FIELD ACTIONS SCI RE, P1; Goldenberg S, 2013, INTERNATIONAL MIGRAT; Goldenberg S, 2008, HEALTH PLACE, V14, P718, DOI 10.1016/j.healthplace.2007.11.005; Goldenberg SM, 2008, CAN J PUBLIC HEALTH, V99, P350, DOI 10.1007/BF03403770; Goldenberg SM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2491-x; Goldenberg SM, 2015, LANCET PSYCHIAT, V2, P1048, DOI 10.1016/S2215-0366(15)00354-5; Goldenberg SM, 2015, LANCET GLOB HEALTH, V3, pE118, DOI 10.1016/S2214-109X(15)70082-3; Goldenberg SM, 2015, J IMMIGR MINOR HEALT, V17, P21, DOI 10.1007/s10903-014-0011-1; Goldenberg SM, 2014, J URBAN HEALTH, V91, P736, DOI 10.1007/s11524-014-9888-1; Goldenberg SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072982; Goldenberg SM, 2012, J IMMIGR MINOR HEALT, V14, P48, DOI 10.1007/s10903-011-9505-2; Goldenberg SM KA, STRUCTURAL IN PRESS; Goldenberg SM MJ, 2015, AIDS BEHAV; Goldenberg SM SJ, 2015, COMPLEXITIES MIGRATI; Guenter D, 2000, J MED ETHICS, V26, P37, DOI 10.1136/jme.26.1.37; Hong Y, 2009, AIDS CARE, V21, P212, DOI 10.1080/09540120801932165; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Johnston LG, 2012, INT J STD AIDS, V23, P5, DOI 10.1258/ijsa.2009.009446; Joint United Nations Programme on HIV/AIDS, 2012, ETH CONS BIOM HIV PR; Kerrigan D, 2014, LANCET; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Kliner M, 2012, J OCCUP HEALTH, V54, P9, DOI 10.1539/joh.11-0125-OA; Kostick KM, 2014, J EMPIR RES HUM RES, V9, P6, DOI 10.1525/jer.2014.9.1.6; Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411; Lippman SA, 2007, SOC SCI MED, V65, P2464, DOI 10.1016/j.socscimed.2007.07.002; Macklin R, 2012, AM J BIOETHICS, V12, P31, DOI 10.1080/15265161.2012.671889; MacQueen Kathleen M, 2004, Account Res, V11, P49, DOI 10.1080/08989620490280230; Magis-Rodriguez C, 2004, JAIDS-J ACQ IMM DEF, V37, pS215, DOI 10.1097/01.qai.0000141252.16099.af; Magis-Rodriguez C, 2009, JAIDS-J ACQ IMM DEF, V51, pS21, DOI 10.1097/QAI.0b013e3181a26433; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mccoy HV, 2009, PUBLIC HEALTH REP, V124, P790, DOI 10.1177/003335490912400605; Metzenrath S, 1998, RES SEX WORK, V1; Miller WM, 2013, SALUD PUBLICA MEXICO, V55, pS65; Minkler M., 2005, J URBAN HEALTH, V82, P3, DOI [DOI 10.1093/JURBAN/JTI034, 10.1093/jurban/jti034]; Minkler M., 2010, COMMUNITY BASED PART; MORGAN DL, 1988, FOCUS GROUPS QUALITA; Ojeda VD, 2012, J IMMIGR MINOR HEALT, V14, P107, DOI 10.1007/s10903-011-9512-3; Oransky M, 2009, SUBST USE MISUSE, V44, P1642, DOI [10.3109/10826080802543671, 10.1080/10826080802543671]; Overs C, 2013, HEALTH HUM RIGHTS, V15, P186; Pando MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054147; Paz-Bailey G, 2009, JAIDS-J ACQ IMM DEF, V51, pS26, DOI 10.1097/QAI.0b013e3181a2647b; Platt L, 2013, SEX TRANSM INFECT, V89, P311, DOI 10.1136/sextrans-2012-050491; Rachlis B, 2007, DRUG ALCOHOL DEPEN, V90, P107, DOI 10.1016/j.drugalcdep.2007.03.014; Ragsdale Kathleen, 2007, J Cult Divers, V14, P26; Reed E, 2012, Int J STD AIDS, V23, pe7, DOI 10.1258/ijsa.2009.009421; Reed E, 2014, J EMPIR RES HUM RES, V9, P19, DOI 10.1525/jer.2014.9.1.19; Reed E, 2011, SOC SCI MED, V72, P710, DOI 10.1016/j.socscimed.2010.12.009; Reed E, 2010, PUBLIC HEALTH REP, V125, P81, DOI 10.1177/00333549101250S412; Rennie S, 2010, J MED ETHICS, V36, P810, DOI 10.1136/jme.2010.035444; Richter M., 2012, J IMMIGR MINOR HEALT, P1; Rocha-Jimenez T, J IMMIGRANT IN PRESS; Rocha-Jimenez T, CULTURE HLT IN PRESS; Shagi C, 2008, AIDS CARE, V20, P1039, DOI 10.1080/09540120701842803; Shannon Kate, 2007, Harm Reduct J, V4, P20, DOI 10.1186/1477-7517-4-20; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shapiro K, 2005, J MED ETHICS, V31, P39, DOI 10.1136/jme.2004.008102; Shaver FM, 2005, J INTERPERS VIOLENCE, V20, P296, DOI 10.1177/0886260504274340; Sheikh A, 2006, PLOS MED, V3, P166, DOI 10.1371/journal.pmed.0030049; Simmons J, 2003, PRACTICING ANTHR, V25, P53, DOI DOI 10.17730/PRAA.25.3.B618587J4V174560; Singer M, 2001, ADDICT RES THEORY, V9, P365, DOI 10.3109/16066350109141759; Sirotin N, 2010, INT J DRUG POLICY, V21, P466, DOI 10.1016/j.drugpo.2010.08.002; Sirotin N, 2010, PUBLIC HEALTH REP, V125, P101, DOI 10.1177/00333549101250S414; Steen R, 2015, LANCET, V385, P94, DOI 10.1016/S0140-6736(14)60966-1; Strathdee SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002690; Strauss A., 1998, BASICS QUALITATIVE R; Terpstra J, 2011, HEALTH PROMOT PRACT, V12, P86, DOI 10.1177/1524839908330809; United Nations Office on Drugs & Crime, 2013, GLOB STUD HOM 2013; Urada L. A., 2014, APA HDB PSYCHOL, VII, P37; Urada LA, 2014, J EMPIR RES HUM RES, V9, P29, DOI 10.1525/jer.2014.9.1.29; Uribe-Salas F, 2003, SEX TRANSM DIS, V30, P266, DOI 10.1097/00007435-200303000-00018; Verma RK, 2010, AIDS BEHAV, V14, P31, DOI 10.1007/s10461-010-9731-y; Weine S, 2013, WOMEN HEALTH, V53, P56, DOI 10.1080/03630242.2012.739271; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019; WHO, 2012, GUID PREV TREATM HIV; Wirtz AL, 2015, JAIDS-J ACQ IMM DEF, V68, pS171, DOI 10.1097/QAI.0000000000000451; Wolffers I, 2002, CULT HEALTH SEX, V4, P459, DOI 10.1080/13691050110143356; World Health Organization, 2012, WHO GUID PREV TREATM; Ye XX, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-599; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914	111	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155048	10.1371/journal.pone.0155048	http://dx.doi.org/10.1371/journal.pone.0155048			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM7YQ	27159157	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700034
J	Lanza, A; Ravaud, P; Riveros, C; Dechartres, A				Lanza, Amy; Ravaud, Philippe; Riveros, Carolina; Dechartres, Agnes			Comparison of Estimates between Cohort and Case-Control Studies in Meta-Analyses of Therapeutic Interventions: A Meta-Epidemiological Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; ANTIDIABETIC MEDICATIONS; HEPATOCELLULAR CANCER; COLORECTAL-CANCER; CLINICAL-TRIALS; RISK; PREVENTION; STATINS	Background Observational studies are increasingly being used for assessing therapeutic interventions. Case-control studies are generally considered to have greater risk of bias than cohort studies, but we lack evidence of differences in effect estimates between the 2 study types. We aimed to compare estimates between cohort and case-control studies in meta-analyses of observational studies of therapeutic interventions by using a meta-epidemiological study. Methods We used a random sample of meta-analyses of therapeutic interventions published in 2013 that included both cohort and case-control studies assessing a binary outcome. For each meta-analysis, the ratio of estimates (RE) was calculated by comparing the estimate in case-control studies to that in cohort studies. Then, we used random-effects meta-analysis to estimate a combined RE across meta-analyses. An RE < 1 indicated that case-control studies yielded larger estimates than cohort studies. Results The final analysis included 23 meta-analyses: 138 cohort and 133 case-control studies. Treatment effect estimates did not significantly differ between case-control and cohort studies (combined RE 0.97 [95% CI 0.86-1.09]). Heterogeneity was low, with between-meta-analysis variance tau(2) = 0.0049. Estimates did not differ between case-control and prospective or retrospective cohort studies (RE = 1.05 [95% CI 0.96-1.15] and RE = 0.99 [95% CI, 0.83-1.19], respectively). Sensitivity analysis of studies reporting adjusted estimates also revealed no significant difference (RE = 1.03 [95% CI 0.91-1.16]). Heterogeneity was also low for these analyses. Conclusion We found no significant difference in treatment effect estimates between case-control and cohort studies assessing therapeutic interventions.	[Lanza, Amy; Ravaud, Philippe] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Ravaud, Philippe; Riveros, Carolina; Dechartres, Agnes] INSERM, U1153, Paris, France; [Ravaud, Philippe; Dechartres, Agnes] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Ravaud, Philippe; Riveros, Carolina; Dechartres, Agnes] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Ravaud, Philippe; Dechartres, Agnes] Cochrane France, Paris, France	Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Dechartres, A (corresponding author), INSERM, U1153, Paris, France.; Dechartres, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Dechartres, A (corresponding author), Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France.; Dechartres, A (corresponding author), Cochrane France, Paris, France.	agnes.dechartres@htd.aphp.fr	ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206				Ahn JS, 2013, WORLD J GASTROENTERO, V19, P2560, DOI 10.3748/wjg.v19.i16.2560; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; Bang CN, 2013, INT J CARDIOL, V167, P624, DOI 10.1016/j.ijcard.2012.08.056; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Billioud V, 2013, J CROHNS COLITIS, V7, P853, DOI 10.1016/j.crohns.2013.01.014; Brinton LA, 2014, J STEROID BIOCHEM, V142, P83, DOI 10.1016/j.jsbmb.2013.05.001; Deshpande A, 2013, J GASTROEN HEPATOL, V28, P235, DOI 10.1111/jgh.12065; Dong JY, 2013, NUTRIENTS, V5, P3551, DOI 10.3390/nu5093551; Giraudeau B, 2016, STAT MED, V35, P239, DOI 10.1002/sim.6627; Golder S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071813; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Gong JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081487; Grootendorst DC, 2010, NEPHRON CLIN PRACT, V114, pC173, DOI 10.1159/000262299; Hannan EL, 2008, JACC-CARDIOVASC INTE, V1, P211, DOI 10.1016/j.jcin.2008.01.008; Hargreave M, 2013, FERTIL STERIL, V100, P150, DOI 10.1016/j.fertnstert.2013.03.017; Havrilesky LJ, 2013, OBSTET GYNECOL, V122, P139, DOI 10.1097/AOG.0b013e318291c235; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Lee SH, 2014, OSTEOPOROSIS INT, V25, P1131, DOI 10.1007/s00198-013-2575-3; Lonjon G, 2014, ANN SURG, V259, P18, DOI 10.1097/SLA.0000000000000256; Phung OJ, 2013, DIABETIC MED, V30, P1160, DOI 10.1111/dme.12232; Richardson K, 2013, ANN INTERN MED, V159, P688, DOI 10.7326/0003-4819-159-10-201311190-00007; Silverman SL, 2009, AM J MED, V122, P114, DOI 10.1016/j.amjmed.2008.09.030; Singh S, 2014, GUT, V63, P1229, DOI 10.1136/gutjnl-2013-305997; Singh S, 2013, CANCER EPIDEM BIOMAR, V22, P2258, DOI 10.1158/1055-9965.EPI-13-0429; Singh S, 2013, AM J GASTROENTEROL, V108, P881, DOI 10.1038/ajg.2013.5; Singh S, 2013, GASTROENTEROLOGY, V144, P323, DOI 10.1053/j.gastro.2012.10.005; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Liu R, 2014, CURR MED RES OPIN, V30, P423, DOI 10.1185/03007995.2013.858622; Tleyjeh IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056498; Valkhoff VE, 2013, CAN J GASTROENTEROL, V27, P159, DOI 10.1155/2013/596015; Wang CH, 2014, CRIT CARE MED, V42, P954, DOI 10.1097/CCM.0000000000000050; Wang LH, 2013, J ENDOUROL, V27, P743, DOI 10.1089/end.2012.0599; Welton NJ, 2009, J R STAT SOC A STAT, V172, P119, DOI 10.1111/j.1467-985X.2008.00548.x; Yuhara H, 2014, J GASTROENTEROL, V49, P992, DOI 10.1007/s00535-013-0905-z; Zhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058821	36	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154877	10.1371/journal.pone.0154877	http://dx.doi.org/10.1371/journal.pone.0154877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159025	Green Published, gold			2022-12-27	WOS:000376576700021
J	Entezam, A; Khandaker, MU; Amin, YM; Ung, NM; Bradley, DA; Maah, J; Safari, MJ; Moradi, F				Entezam, A.; Khandaker, M. U.; Amin, Y. M.; Ung, N. M.; Bradley, D. A.; Maah, J.; Safari, M. J.; Moradi, F.			Thermoluminescence Response of Ge-Doped Cylindrical-, Flat- and Photonic Crystal Silica-Fibres to Electron and Photon Radiation	PLOS ONE			English	Article							OPTICAL-FIBER; BEAMS	Study has been made of the thermoluminescence (TL) response of silica-based Ge-doped cylindrical, flat and photonic crystal fibres (referred to herein as PCF-collapsed) to electron (6, 12 and 20 MeV) and photon (6, 10 MV) irradiation and 1.25 MeV gamma-rays, for doses from 0.1 Gy to 100 Gy. The electron and photon irradiations were delivered through use of a Varian Model 2100C linear accelerator located at the University of Malaya Medical Centre and.-rays delivered from a Co-60 irradiator located at the Secondary Standard Dosimetry Laboratory (SSDL), Malaysian Nuclear Agency. Tailor-made to be of various dimensions and dopant concentrations (6-10% Ge), the fibres were observed to provide TL yield linear with radiation dose, reproducibility being within 1-5%, with insensitivity to energy and angular variation. The sensitivity dependency of both detectors with respect to field size follows the dependency of the output factors. For flat fibres exposed to 6 MV X-rays, the 6% Ge-doped fibre provided the greatest TL yield while PCF-collapsed showed a response 2.4 times greater than that of the 6% Ge-doped flat fibres. The response of cylindrical fibres increased with core size. The fibres offer uniform response, high spatial resolution and sensitivity, providing the basis of promising TL systems for radiotherapy applications.	[Entezam, A.; Khandaker, M. U.; Amin, Y. M.; Moradi, F.] Univ Malaya, Fac Sci, Dept Phys, Kuala Lumpur 50603, Malaysia; [Ung, N. M.] Univ Malaya, Fac Med, Clin Oncol Unit, Kuala Lumpur 50603, Malaysia; [Bradley, D. A.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England; [Maah, J.] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur 50603, Malaysia; [Safari, M. J.] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; University of Surrey; Universiti Malaya; Universiti Malaya	Khandaker, MU (corresponding author), Univ Malaya, Fac Sci, Dept Phys, Kuala Lumpur 50603, Malaysia.	mu_khandaker@yahoo.com	Khandaker, Mayeen Uddin/F-5376-2011; Moradi, Farhad/A-9062-2019; UNG, NGIE MIN/B-9986-2010; Moradi, Farhad/O-4514-2019	Khandaker, Mayeen Uddin/0000-0003-3772-294X; Moradi, Farhad/0000-0002-9102-2533; Moradi, Farhad/0000-0002-9102-2533; Ung, Ngie Min/0000-0001-5700-3809	University of Malaya High Impact Research (HIR) Grant [UM.C/HIR/MOHE/SC/33]; University of Malaya [RP006D-13AFR]; Malaysian Ministry of Higher Education (MOHE)	University of Malaya High Impact Research (HIR) Grant; University of Malaya(Universiti Malaya); Malaysian Ministry of Higher Education (MOHE)	The work was supported by the University of Malaya High Impact Research (HIR) Grant (UM.C/HIR/MOHE/SC/33), and University of Malaya Research Grant No. RP006D-13AFR. The authors are indebted to the Malaysian Ministry of Higher Education (MOHE) and the University of Malaya for providing this support.	Abdul Sani SF, 2015, INT C APPL NUCL TECH; Abdulla YA, 2001, RADIAT PHYS CHEM, V61, P409, DOI 10.1016/S0969-806X(01)00282-1; Araki F, 2004, MED PHYS, V31, P1980, DOI 10.1118/1.1758351; Araki F, 2003, MED PHYS, V30, P1976, DOI 10.1118/1.1587451; Bradley DA, 2014, RADIAT PHYS CHEM, V104, P3, DOI 10.1016/j.radphyschem.2014.03.042; Bradley DA, 2012, APPL RADIAT ISOTOPES, V71, P2, DOI 10.1016/j.apradiso.2012.02.001; Bulinski K., 2004, POL J MED PHYS ENG, V10, P13; Espinosa G, 2006, RADIAT PROT DOSIM, V119, P197, DOI 10.1093/rpd/nci564; Faiz M.K., 1994, PHYS RAD THERAPY; Hashim S, 2009, APPL RADIAT ISOTOPES, V67, P423, DOI 10.1016/j.apradiso.2008.06.030; Hossein I., 2013, J APPL SPECTROSC, V80, P635; Izewska J, 2000, RADIOTHER ONCOL, V54, P65, DOI 10.1016/S0167-8140(99)00164-4; Jayachandran CA., 1971, PHYS MED BOIL, V11, P225; Mahdiraji GA, 2014, FIBER INTEGRATED OPT, V33, P85104; Mahdiraji GA, 2015, J LIGHTWAVE TECHNOL, V33, P3439, DOI 10.1109/JLT.2015.2406775; Miljanic S, 2002, RADIAT PROT DOSIM, V100, P437, DOI 10.1093/oxfordjournals.rpd.a005908; Noor NM, 2014, RADIAT PHYS CHEM, V98, P33, DOI 10.1016/j.radphyschem.2013.12.017; Noor NM, 2011, NUCL INSTRUM METH A, V652, P819, DOI 10.1016/j.nima.2010.09.085; Ong CL, 2014, RADIAT MEAS, V44, P158; Podgorsak E.B., 2005, RAD ONCOLOGY PHYS; Veneziani GR., 2010, P 7 EUR C LUM DET TR, V45, P646; Yu C, 1999, MED PHYS, V26, P1010, DOI 10.1118/1.598493; Yu MK, 1995, MED PHYS, V22, P2045, DOI 10.1118/1.597494; Yusof FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128544; Zahaimi NA, 2014, J PHYS CONF SER, V546, DOI 10.1088/1742-6596/546/1/012012	25	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0153913	10.1371/journal.pone.0153913	http://dx.doi.org/10.1371/journal.pone.0153913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149115	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800016
J	Pertl, L; Kern, S; Weger, M; Hausberger, S; Trieb, M; Gasser-Steiner, V; Haas, A; Scharnagl, H; Heinemann, A; Marsche, G				Pertl, Laura; Kern, Sabine; Weger, Martin; Hausberger, Silke; Trieb, Markus; Gasser-Steiner, Vanessa; Haas, Anton; Scharnagl, Hubert; Heinemann, Akos; Marsche, Gunther			High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration	PLOS ONE			English	Article							CHOLESTEROL EFFLUX CAPACITY; RISK-FACTORS; CARDIOVASCULAR-DISEASE; GENETIC-VARIANTS; HDL; ATHEROSCLEROSIS; ASSOCIATION; PREVALENCE; METABOLISM; BIOLOGY	Purpose High-density lipoproteins (HDL) have long been implicated in the pathogenesis of age-related macular degeneration (AMD). However, conflicting results have been reported with regard to the associations of AMD with HDL-cholesterol levels. The present study is the first to assess HDL composition and metrics of HDL function in patients with exudative AMD and control patients. Methods Blood samples were collected from 29 patients with exudative AMD and 26 age-matched control patients. Major HDL associated apolipoproteins were determined in apoB-depleted serum by immunoturbidimetry or ELISA, HDL-associated lipids were quantified enzymatically. To get an integrated measure of HDL quantity and quality, we assessed several metrics of HDL function, including cholesterol efflux capacity, anti-oxidative and anti-inflammatory activities using apoB-depleted serum from study participants. Results In our study, we observed that the HDL associated acute phase protein serum amyloid A (SAA) was significantly increased in AMD patients (p<0.01), whereas all other assessed apolipoproteins including ApoA-I, apoA-II, apoC-II, apoC-III and apoE as well as major HDL associated lipids were not altered. HDL efflux capacity, anti-oxidative capacity and arylesterase activity were not different in AMD patients when compared with the control group. The ability of apoB-depleted serum to inhibit monocyte NF-kappa B expression was significantly improved in AMD patients (mean difference (MD) -5.6, p<0.01). Moreover, lipoprotein-associated phospholipase A2 activity, a marker of vascular inflammation, was decreased in AMD subjects (MD -24.1, p<0.01). Conclusions The investigated metrics of HDL composition and HDL function were not associated with exudative AMD in this study, despite an increased content of HDL associated SAA in AMD patients. Unexpectedly, anti-inflammatory activity of apoB-depleted serum was even increased in our study. Our data suggest that the investigated parameters of serum HDL function showed no significant association with exudative AMD. However, we cannot exclude that alterations in locally produced HDL may be part of the AMD pathogenesis.	[Pertl, Laura; Weger, Martin; Hausberger, Silke; Gasser-Steiner, Vanessa; Haas, Anton] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Kern, Sabine; Trieb, Markus; Heinemann, Akos; Marsche, Gunther] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Scharnagl, Hubert] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Marsche, G (corresponding author), Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria.	gunther.marsche@medunigraz.at		Marsche, Gunther/0000-0002-2422-5381; Heinemann, Akos/0000-0002-8554-2372	Austrian Science Fund FWF (Fonds zur Forderung der wissenschaftlichen Forschung) [P22976-B18, W1241, P22521-B18]	Austrian Science Fund FWF (Fonds zur Forderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF))	Funding was provided by Austrian Science Fund FWF (Fonds zur Forderung der wissenschaftlichen Forschung): Grant P22976-B18 and W1241 to GM and P22521-B18 to A. Heinemann.	Artl A, 2000, ARTERIOSCL THROM VAS, V20, P763, DOI 10.1161/01.ATV.20.3.763; BANKA CL, 1995, J LIPID RES, V36, P1058; Birner-Gruenberger R, 2014, PROG LIPID RES, V56, P36, DOI 10.1016/j.plipres.2014.07.003; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Cho BJ, 2014, INVEST OPHTH VIS SCI, V55, P1101, DOI 10.1167/iovs.13-13096; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Cougnard-Gregoire A, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090973, DOI 10.1371/journal.pone.0090973]; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; Dashti N, 2006, BRIT J OPHTHALMOL, V90, P1028, DOI 10.1136/bjo.2006.093856; Fauser S, 2011, INVEST OPHTH VIS SCI, V52, P5525, DOI 10.1167/iovs.10-6827; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Grosjean J, 2006, BIOCHEM BIOPH RES CO, V340, P984, DOI 10.1016/j.bbrc.2005.12.095; Holzer M, 2013, BBA-MOL CELL BIOL L, V1831, P1442, DOI 10.1016/j.bbalip.2013.06.004; Holzer M, 2012, J LIPID RES, V53, P1618, DOI 10.1194/jlr.M027367; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Javadzadeh A, 2012, RETINA-J RET VIT DIS, V32, P658, DOI 10.1097/IAE.0b013e31822529b1; Jonasson F, 2014, OPHTHALMOLOGY, V121, P1766, DOI 10.1016/j.ophtha.2014.03.013; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Klein R, 2007, ARCH OPHTHALMOL-CHIC, V125, P534, DOI 10.1001/archopht.125.4.534; Klein R, 2014, AM J OPHTHALMOL, V158, P513, DOI 10.1016/j.ajo.2014.05.027; Li FT, 2014, OPHTHALMIC RES, V51, P210, DOI 10.1159/000357978; Marsche G, 2013, PHARMACOL THERAPEUT, V137, P341, DOI 10.1016/j.pharmthera.2012.12.001; Mulero J, 2014, CLIN HEMORHEOL MICRO, V58, P447, DOI 10.3233/CH-141807; Oczos J, 2013, AGE, V35, P1651, DOI 10.1007/s11357-012-9467-x; Paun CC, 2015, INVEST OPHTH VIS SCI, V56, P7766, DOI 10.1167/iovs.15-17035; Peter I, 2011, AM J OPHTHALMOL, V152, P1005, DOI 10.1016/j.ajo.2011.05.016; Pikuleva IA, 2014, PROG RETIN EYE RES, V41, P64, DOI 10.1016/j.preteyeres.2014.03.002; Reynolds R, 2010, OPHTHALMOLOGY, V117, P1989, DOI 10.1016/j.ophtha.2010.07.009; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Saemann MD, 2010, EUR J CLIN INVEST, V40, P1131, DOI 10.1111/j.1365-2362.2010.02361.x; So\ugut E, 2013, RETINA, V33, P1836, DOI [10.1097/IAE.0b013e318287da59, DOI 10.1097/IAE.0B013E318287DA59]; Stafforini DM, 2013, FREE RADICAL BIO MED, V59, P100, DOI 10.1016/j.freeradbiomed.2012.05.031; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Leeuwen R, 2004, AM J OPHTHALMOL, V137, P750, DOI 10.1016/S0002-9394(03)01089-4; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026871	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154397	10.1371/journal.pone.0154397	http://dx.doi.org/10.1371/journal.pone.0154397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171197	Green Published, gold, Green Submitted			2022-12-27	WOS:000376588600068
J	Vadstrup, K; Galsgaard, ED; Gerwien, J; Vester-Andersen, MK; Pedersen, JS; Rasmussen, J; Neermark, S; Kiszka-Kanowitz, M; Jensen, T; Bendtsen, F				Vadstrup, Kasper; Galsgaard, Elisabeth Douglas; Gerwien, Jens; Vester-Andersen, Marianne Kajbaek; Pedersen, Julie Steen; Rasmussen, Julie; Neermark, Soren; Kiszka-Kanowitz, Marianne; Jensen, Teis; Bendtsen, Flemming			Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug Effects	PLOS ONE			English	Article							IN-VITRO MODEL; C-REACTIVE PROTEIN; BOWEL-DISEASE; ENDOSCOPIC ACTIVITY; CYTOKINE PRODUCTION; BIOLOGIC THERAPY; ORGAN-CULTURE; ANIMAL-MODELS; TNF-ALPHA; EPIDEMIOLOGY	Crohn's disease (CD) is a chronic illness demanding better therapeutics. The marketed biologics only benefit some patients or elicit diminishing effect over time. To complement the known methods in drug development and to obtain patient specific drug responses, we optimized and validated a known human explant method to test drug candidates and pathophysiological conditions in CD intestinal biopsies. Mucosal biopsies from 27 CD patients and 6 healthy individuals were collected to validate an explant assay test where the polarized tissue was cultured on a novel metal mesh disk, slightly immersed in medium imitating an air-liquid interphase. After culture in high oxygen for 24 hours with or without biological treatment in the medium, biopsy integrity and penetration of antibodies was measured by immunohistochemistry (IHC). Nine cytokines were quantified in the conditioned medium as a read-out for degree of inflammation in individual biopsies and used to evaluate treatment efficacy. The biopsies were well-preserved, showing few structural changes. IHC revealed tissue penetration of antibodies demonstrating ability to test therapeutic antibodies. The cytokine release to the medium showed that the assay can distinguish between inflammation states and then validate the known effect of two treatment biologics confirmed by a detection panel of five specific cytokines. Our data also suggest that the assay would be able to indicate which patients are responders to anti-TNF-alpha therapeutics, and which are non-responders. This study demonstrates this version of an ex vivo culture as a valid and robust assay to assess inflammation in mucosal biopsies and test of the efficacy of novel drug candidates and current treatments on individual patients-potentially for a personalized medicine approach.	[Vadstrup, Kasper; Vester-Andersen, Marianne Kajbaek; Pedersen, Julie Steen; Rasmussen, Julie; Neermark, Soren; Kiszka-Kanowitz, Marianne; Bendtsen, Flemming] Hvidovre Univ Hosp, Div Med, Gastro Unit, DK-2650 Hvidovre, Denmark; [Vadstrup, Kasper; Bendtsen, Flemming] Univ Copenhagen, Panum Inst, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Vadstrup, Kasper; Galsgaard, Elisabeth Douglas; Gerwien, Jens; Jensen, Teis] Novo Nordisk AS, Biopharmaceut Res Unit, Malov, Denmark	University of Copenhagen; University of Copenhagen; Novo Nordisk	Vadstrup, K (corresponding author), Hvidovre Univ Hosp, Div Med, Gastro Unit, DK-2650 Hvidovre, Denmark.; Vadstrup, K (corresponding author), Univ Copenhagen, Panum Inst, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark.; Vadstrup, K (corresponding author), Novo Nordisk AS, Biopharmaceut Res Unit, Malov, Denmark.	kasper.vadstrup@regionh.dk		Vadstrup, Kasper/0000-0002-4041-0536; Neermark, Soren/0000-0002-0677-0140	Biopharmaceutical Research Unit, Novo Nordisk A/S, Denmark	Biopharmaceutical Research Unit, Novo Nordisk A/S, Denmark	This work was supported by the Biopharmaceutical Research Unit, Novo Nordisk A/S, Denmark by a non-restricted grant directly to FB. The study sponsor did not participate in the study design or in the collection, analysis, interpretation of data, or preparation of the manuscript. We agree with the following statement: The funder provided support in the form of salaries for authors EDG, JG and TJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Affronti A, 2015, EXPERT OPIN PHARMACO, V16, P63, DOI 10.1517/14656566.2015.981525; Agnholt J, 2003, CYTOKINE, V23, P76, DOI 10.1016/S1043-4666(03)00201-1; Ardizzone S, 2005, DRUGS, V65, P2253, DOI 10.2165/00003495-200565160-00002; Boucek RJ, 2015, J HEART LUNG TRANSPL, V34, P839, DOI 10.1016/j.healun.2014.07.010; BROWNING TH, 1969, J CLIN INVEST, V48, P1423, DOI 10.1172/JCI106108; Burisch J, 2013, CURR OPIN GASTROEN, V29, P357, DOI 10.1097/MOG.0b013e32836229fb; Busch Katharina, 2014, Curr Gastroenterol Rep, V16, P414, DOI 10.1007/s11894-014-0414-0; Caruso R, 2007, GASTROENTEROLOGY, V132, P166, DOI 10.1053/j.gastro.2006.09.053; Chen DY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3431; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Cohen LB, 2014, TRANSL RES, V163, P533, DOI 10.1016/j.trsl.2014.01.002; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; des Rieux A, 2007, EUR J PHARM SCI, V30, P380, DOI 10.1016/j.ejps.2006.12.006; Leal RF, 2015, GUT, V64, P233, DOI 10.1136/gutjnl-2013-306518; Ghadimi D, 2012, J LEUKOCYTE BIOL, V92, P895, DOI 10.1189/jlb.0611286; Harada Y, 1996, J ALLERGY CLIN IMMUN, V98, pS161, DOI 10.1016/S0091-6749(96)70063-5; HARVEY RF, 1980, LANCET, V1, P514; Holtta Veera, 2012, ISRN Gastroenterol, V2012, P505432, DOI 10.5402/2012/505432; Jones J, 2014, GASTROENTEROL CLIN N, V43, P425, DOI 10.1016/j.gtc.2014.05.004; Katz LH, 2014, CLIN RES HEPATOL GAS, V38, P491, DOI 10.1016/j.clinre.2014.01.010; Kemp R, 2013, BIODRUGS, V27, P585, DOI 10.1007/s40259-013-0045-2; Khanna PV, 2014, SEMIN IMMUNOPATHOL, V36, P541, DOI 10.1007/s00281-014-0444-6; Kurtovic Jelica, 2004, Trop Gastroenterol, V25, P9; Laass MW, 2014, AUTOIMMUN REV, V13, P467, DOI 10.1016/j.autrev.2014.01.029; Lemmens B, 2013, INFLAMM BOWEL DIS, V19, P1194, DOI 10.1097/MIB.0b013e318280e75f; Leonard F, 2012, ALTEX-ALTERN ANIM EX, V29, P275, DOI 10.14573/altex.2012.3.275; Leonard F, 2010, MOL PHARMACEUT, V7, P2103, DOI 10.1021/mp1000795; Lewis JD, 2014, NESTLE NUTR WORKS SE, V79, P1, DOI 10.1159/000360664; Li J, 2006, INT IMMUNOPHARMACOL, V6, P880, DOI 10.1016/j.intimp.2005.12.009; Magro F, 2014, EXPERT REV GASTROENT, V8, P393, DOI 10.1586/17474124.2014.893821; Manolakis Catherine S, 2014, Curr Gastroenterol Rep, V16, P402, DOI 10.1007/s11894-014-0402-4; Mosli MH, 2015, AM J GASTROENTEROL, V110, P802, DOI 10.1038/ajg.2015.120; Mosli MH, 2014, AM J GASTROENTEROL, V109, P994, DOI 10.1038/ajg.2014.110; Mudter J, 2012, ABDOM IMAGING, V37, P921, DOI 10.1007/s00261-012-9885-3; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Neurath MF, 2009, IMMUNITY, V31, P357, DOI 10.1016/j.immuni.2009.08.016; Niederreiter L, 2013, CURR DRUG TARGETS, V14, P1379, DOI 10.2174/13894501113146660229; Ogata H, 2003, CURR PHARM DESIGN, V9, P1107, DOI 10.2174/1381612033455035; Pedersen G, 2015, DAN MED J, V62; Raphael I, 2015, CYTOKINE, V74, P5, DOI 10.1016/j.cyto.2014.09.011; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P351, DOI 10.1016/j.cytogfr.2014.07.021; Shen C, 2005, ALIMENT PHARM THER, V21, P251, DOI 10.1111/j.1365-2036.2005.02309.x; Spottl T, 2006, EUR J GASTROEN HEPAT, V18, P901, DOI 10.1097/00042737-200608000-00017; Strober W, 2010, CURR OPIN GASTROEN, V26, P310, DOI 10.1097/MOG.0b013e328339d099; Sylvester FA, 2014, J PEDIATR GASTR NUTR, V59, P553, DOI 10.1097/MPG.0000000000000480; Tanoue T, 2008, BIOCHEM BIOPH RES CO, V374, P565, DOI 10.1016/j.bbrc.2008.07.063; Tsilingiri K, 2013, JOVE-J VIS EXP, DOI 10.3791/4368; Tsilingiri K, 2012, GUT, V61, P1007, DOI 10.1136/gutjnl-2011-300971; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; van Meer PJK, 2015, EUR J PHARMACOL, V759, P3, DOI 10.1016/j.ejphar.2015.02.055; Vazquez-Frias R, 2015, REV GASTROENTEROL ME, V80, P6, DOI 10.1016/j.rgmx.2014.11.001; Vossenkamper A, 2014, GASTROENTEROLOGY, V147, P172, DOI 10.1053/j.gastro.2014.03.049; Xu YH, 2008, CELL RES, V18, P1220, DOI 10.1038/cr.2008.310; Zarogoulidis Paul, 2014, J Nanomedine Biotherapeutic Discov, V4, P128	59	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155335	10.1371/journal.pone.0155335	http://dx.doi.org/10.1371/journal.pone.0155335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171179	Green Submitted, gold, Green Published			2022-12-27	WOS:000376588600155
J	Hou, QZ; Lensink, MF; Heringa, J; Feenstra, KA				Hou, Qingzhen; Lensink, Marc F.; Heringa, Jaap; Feenstra, K. Anton			CLUB-MARTINI: Selecting Favourable Interactions amongst Available Candidates, a Coarse-Grained Simulation Approach to Scoring Docking Decoys	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; FORCE-FIELD; PREDICTION; PRINCIPLES; ALGORITHMS; AFFINITY; GUIDE; WATER	Large-scale identification of native binding orientations is crucial for understanding the role of protein-protein interactions in their biological context. Measuring binding free energy is the method of choice to estimate binding strength and reveal the relevance of particular conformations in which proteins interact. In a recent study, we successfully applied coarse-grained molecular dynamics simulations to measure binding free energy for two protein complexes with similar accuracy to full-atomistic simulation, but 500-fold less time consuming. Here, we investigate the efficacy of this approach as a scoring method to identify stable binding conformations from thousands of docking decoys produced by protein docking programs. To test our method, we first applied it to calculate binding free energies of all protein conformations in a CAPRI (Critical Assessment of PRedicted Interactions) benchmark dataset, which included over 19000 protein docking solutions for 15 benchmark targets. Based on the binding free energies, we ranked all docking solutions to select the near-native binding modes under the assumption that the native-solutions have lowest binding free energies. In our top 100 ranked structures, for the 'easy' targets that have many near-native conformations, we obtain a strong enrichment of acceptable or better quality structures; for the 'hard' targets without near-native decoys, our method is still able to retain structures which have native binding contacts. Moreover, in our top 10 selections, CLUB-MARTINI shows a comparable performance when compared with other state-of-the-art docking scoring functions. As a proof of concept, CLUB-MARTINI performs remarkably well for many targets and is able to pinpoint near-native binding modes in the top selections. To the best of our knowledge, this is the first time interaction free energy calculated from MD simulations have been used to rank docking solutions at a large scale.	[Hou, Qingzhen; Heringa, Jaap; Feenstra, K. Anton] Vrije Univ Amsterdam, Ctr Integrat Bioinformat VU IBIVU, De Boelelaan 1081A, NL-1081 HV Amsterdam, Netherlands; [Lensink, Marc F.] Univ Lille, CNRS, UGSF Inst Struct & Funct Glycobiol UMR8576, F-59000 Lille, France	Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Feenstra, KA (corresponding author), Vrije Univ Amsterdam, Ctr Integrat Bioinformat VU IBIVU, De Boelelaan 1081A, NL-1081 HV Amsterdam, Netherlands.	k.a.feenstra@vu.nl	Feenstra, Anton/H-9195-2019; Hou, Qingzhen/HGE-9427-2022; Lensink, Marc F/A-1678-2008; Hou, Qingzhen/AAB-6481-2021	Feenstra, Anton/0000-0001-6755-9667; Hou, Qingzhen/0000-0002-7655-0899; Lensink, Marc F/0000-0003-3957-9470; 	Chinese Scholarship Council [2011627127]; CNRS FRABio Research Federation "Structural and Functional Biochemistry of Biomolecular Assemblies"	Chinese Scholarship Council(China Scholarship Council); CNRS FRABio Research Federation "Structural and Functional Biochemistry of Biomolecular Assemblies"	Qingzhen Hou is supported by Chinese Scholarship Council (No.2011627127). Marc Lensink acknowledges support from the CNRS FR3688 FRABio Research Federation "Structural and Functional Biochemistry of Biomolecular Assemblies". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Siewert-Jan Marrink, Xavier Periole and Tsjerk Wassenaar for stimulating and very insightful discussions on this work. The authors thank Netherlands Organisation for Scientific Research (NWO) for awarding 800.000 core-hours of computational time. We also thank Kamil Krystian Belau for help with the Coarse-grained MD simulations. QH is supported by Chinese Scholarship Council (No. 2011627127). MFL acknowledges support from the CNRS FR3688 FRABio Research Federation "Structural and Functional Biochemistry of Biomolecular Assemblies".	Ehrenberger T, 2015, METHODS MOL BIOL, V1278, P57, DOI 10.1007/978-1-4939-2425-7_4; Ezkurdia I, 2009, BRIEF BIOINFORM; Grinter SZ, 2014, J COMPUT CHEM, V35, P932, DOI 10.1002/jcc.23579; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang SY, 2014, DRUG DISCOV TODAY, V19, P1081, DOI 10.1016/j.drudis.2014.02.005; Isabet T, 2009, EMBO J, V28, P2835, DOI 10.1038/emboj.2009.209; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854; Khashan R, 2012, PROTEINS, V80, P2207, DOI 10.1002/prot.24110; Kruger DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089466; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Lensink MF, 2014, PROTEINS, V82, P3163, DOI 10.1002/prot.24678; Lensink MF, 2014, PROTEINS, V82, P620, DOI 10.1002/prot.24439; Lensink MF, 2013, PROTEINS, V81, P2082, DOI 10.1002/prot.24428; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Liu JF, 2013, J CHEM INF MODEL, V53, P1306, DOI 10.1021/ci400067c; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; May A, 2014, BIOINFORMATICS, V30, P326, DOI 10.1093/bioinformatics/btt675; Moal IH, 2013, CURR OPIN STRUC BIOL, V23, P862, DOI 10.1016/j.sbi.2013.06.017; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Tuncbag N, 2009, BRIEF BIOINFORM, V10, P217, DOI 10.1093/bib/bbp001; Vakser IA, 2014, BIOPHYS J, V107, P1785, DOI 10.1016/j.bpj.2014.08.033; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Vreven T, 2011, PROTEIN SCI, V20, P1576, DOI 10.1002/pro.687	30	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155251	10.1371/journal.pone.0155251	http://dx.doi.org/10.1371/journal.pone.0155251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166787	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300011
J	Wang, J; Zhu, Z; Zhang, L; Hou, DH; Wang, ML; Arif, B; Kou, Z; Wang, HL; Deng, F; Hu, ZH				Wang, Jun; Zhu, Zheng; Zhang, Lei; Hou, Dianhai; Wang, Manli; Arif, Basil; Kou, Zheng; Wang, Hualin; Deng, Fei; Hu, Zhihong			Genome Sequencing and Analysis of Catopsilia pomona nucleopolyhedrovirus: A Distinct Species in Group I Alphabaculovirus	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; ENVELOPE FUSION PROTEIN; NUCLEAR POLYHEDROSIS-VIRUS; NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; IDENTIFICATION; REPLICATION; GENES; BACULOVIRUSES; TRANSCRIPTION; GLYCOPROTEIN	The genome sequence of Catopsilia pomona nucleopolyhedrovirus (CapoNPV) was determined by the Roche 454 sequencing system. The genome consisted of 128,058 bp and had an overall G+C content of 40%. There were 130 hypothetical open reading frames (ORFs) potentially encoding proteins of more than 50 amino acids and covering 92% of the genome. Among all the hypothetical ORFs, 37 baculovirus core genes, 23 lepidopteran baculovirus conserved genes and 10 genes conserved in Group I alphabaculoviruses were identified. In addition, the genome included regions of 8 typical baculoviral homologous repeat sequences (hrs). Phylogenic analysis showed that CapoNPV was in a distinct branch of clade "a" in Group I alphabaculoviruses. Gene parity plot analysis and overall similarity of ORFs indicated that CapoNPV is more closely related to the Group I alphabaculoviruses than to other baculoviruses. Interesting, CapoNPV lacks the genes encoding the fibroblast growth factor (fgf) and ac30, which are conserved in most lepidopteran and Group I baculoviruses, respectively. Sequence analysis of the F-like protein of CapoNPV showed that some amino acids were inserted into the fusion peptide region and the pre-transmembrane region of the protein. All these unique features imply that CapoNPV represents a member of a new baculovirus species.	[Wang, Jun; Zhu, Zheng; Zhang, Lei; Hou, Dianhai; Wang, Manli; Kou, Zheng; Wang, Hualin; Deng, Fei; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Wang, Jun; Zhu, Zheng; Zhang, Lei; Hou, Dianhai; Wang, Manli; Kou, Zheng; Wang, Hualin; Deng, Fei; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, China Ctr Virus Culture Collect, Wuhan, Peoples R China; [Arif, Basil] Great Lakes Forestry Ctr, Canadian Forest Serv, Sault Ste Marie, ON, Canada	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre	Hu, ZH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.; Hu, ZH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, China Ctr Virus Culture Collect, Wuhan, Peoples R China.	huzh@wh.iov.cn	ZHU, ZHENG/P-2173-2016; Hu, Zhihong/AAS-2215-2020	ZHU, ZHENG/0000-0002-2035-0804; Hu, Zhihong/0000-0002-1560-0928; KOU, Zheng/0000-0003-4758-2872	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11030400]; National Science Foundation of China [31321001, 31130058]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB11030400) to ZH, and by grants from the National Science Foundation of China (No. 31321001 and 31130058) to ZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carstens EB, 2009, ARCH VIROL, V154, P1181, DOI 10.1007/s00705-009-0400-2; Carstens EB, 2007, J GEN VIROL, V88, P114, DOI 10.1099/vir.0.82384-0; Chen CJ, 1997, VIROLOGY, V227, P88, DOI 10.1006/viro.1996.8341; Chen YR, 2008, J GEN VIROL, V89, P2315, DOI 10.1099/vir.0.2008/001412-0; CHOI J, 1995, J VIROL, V69, P4548, DOI 10.1128/JVI.69.7.4548-4551.1995; Detvisitsakun C, 2006, VIROLOGY, V346, P258, DOI 10.1016/j.virol.2006.01.016; Detvisitsakun C, 2005, VIROLOGY, V336, P308, DOI 10.1016/j.virol.2005.03.013; Detvisitsakun C, 2007, VIROLOGY, V365, P70, DOI 10.1016/j.virol.2007.03.027; GUARINO LA, 1986, J VIROL, V60, P224, DOI 10.1128/JVI.60.1.224-229.1986; Guillen J, 2007, J PHYS CHEM B, V111, P13714, DOI 10.1021/jp073675y; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Hefferon KL, 1999, VIROLOGY, V258, P455, DOI 10.1006/viro.1999.9758; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Hilton S, 2008, ARCH VIROL, V153, P1527, DOI 10.1007/s00705-008-0148-0; HOHMANN AW, 1983, VIROLOGY, V125, P432, DOI 10.1016/0042-6822(83)90214-3; HONG T, 1994, VIROLOGY, V204, P210, DOI 10.1006/viro.1994.1525; Hu ZH, 1998, J GEN VIROL, V79, P2841, DOI 10.1099/0022-1317-79-11-2841; Hu ZH, 1998, VIRUS RES, V55, P71, DOI 10.1016/S0168-1702(98)00029-X; Huang JS, 2008, J GEN VIROL, V89, P922, DOI 10.1099/vir.0.83504-0; Huang JP TW, 1983, J CENTRAL S FORESTRY, V3, P136; IJkel WFJ, 2000, VIROLOGY, V275, P30, DOI 10.1006/viro.2000.0483; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Jiang Y, 2009, VIRUS RES, V142, P85, DOI 10.1016/j.virusres.2009.01.015; Kawaguchi Y, 2012, ACTA CRYSTALLOGR F, V68, P190, DOI 10.1107/S1744309111053164; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; KOOL M, 1993, J GEN VIROL, V74, P2661, DOI 10.1099/0022-1317-74-12-2661; Lauzon HAM, 2004, J VIROL, V78, P7023, DOI 10.1128/JVI.78.13.7023-7035.2004; Li ZF, 2009, J VIROL, V83, P10993, DOI 10.1128/JVI.01085-09; Lorizate M, 2008, BBA-BIOMEMBRANES, V1778, P1624, DOI 10.1016/j.bbamem.2007.12.018; LU A, 1995, J VIROL, V69, P975, DOI 10.1128/JVI.69.2.975-982.1995; Lung OY, 2003, J VIROL, V77, P328, DOI 10.1128/JVI.77.1.328-339.2003; Means JC, 2010, P NATL ACAD SCI USA, V107, P9825, DOI 10.1073/pnas.0913582107; Mitchell JK, 2013, J VIROL, V87, P12592, DOI 10.1128/JVI.02501-13; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; RODEMS SM, 1995, J VIROL, V69, P5368, DOI 10.1128/JVI.69.9.5368-5375.1995; Saez-Cirion A, 2003, FEBS LETT, V533, P47, DOI 10.1016/S0014-5793(02)03747-X; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; Sugiura N, 2011, J BIOL CHEM, V286, P29026, DOI 10.1074/jbc.M111.251157; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VOLKMAN LE, 1986, CURR TOP MICROBIOL, V131, P103; Westenberg M, 2004, J VIROL, V78, P6946, DOI 10.1128/JVI.78.13.6946-6954.2004; Westenberg M, 2002, J VIROL, V76, P178, DOI 10.1128/JVI.76.1.178-184.2002; WHITFORD M, 1989, J VIROL, V63, P1393, DOI 10.1128/JVI.63.3.1393-1399.1989; Xiang XW, 2011, VIRUS RES, V158, P72, DOI 10.1016/j.virusres.2011.03.012; Yang M, 1993, FOREST RES, V6; Zhang L, 2003, P INT C WEB SERV ICW, V1, DOI DOI 10.1109/HICSS.2003.1174613; Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086450	51	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155134	10.1371/journal.pone.0155134	http://dx.doi.org/10.1371/journal.pone.0155134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166956	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300041
J	Kumaran, NKP; Padmalal, D; Limaye, RB; Mohan, SV; Jennerjahn, T; Gamre, PG				Kumaran, Navnith K. P.; Padmalal, Damodaran; Limaye, Ruta B.; Mohan, Vishnu S.; Jennerjahn, Tim; Gamre, Pradeep G.			Tropical Peat and Peatland Development in the Floodplains of the Greater Pamba Basin, South-Western India during the Holocene	PLOS ONE			English	Article							KERALA SEDIMENTARY BASIN; QUATERNARY GEOLOGY; CLIMATE-CHANGE; SEA-LEVEL; VEGETATION; TERRESTRIAL; EVOLUTION; MONSOON; RECORD; COAST	Holocene sequences in the humid tropical region of Kerala, South-western (SW) India have preserved abundance of organic-rich sediments in the form of peat and its rapid development in a narrow time frame towards Middle Holocene has been found to be significant. The sub-coastal areas and flood plains of the Greater Pamba Basin have provided palaeorecords of peat indicating that the deposits are essentially formed within freshwater. The combination of factors like stabilized sea level and its subsequent fall since the Middle Holocene, topographic relief and climatic conditions led to rapid peat accumulation across the coastal lowlands. The high rainfall and massive floods coupled with a rising sea level must have inundated > 75% of the coastal plain land converting it into a veritable lagoon-lake system that eventually led to abrupt termination of the forest ecosystem and also converted the floodplains into peatland where accumulation of peat almost to 2.0-3.0 m thickness in coastal lowlands and river basins during the shorter interval in the Middle Holocene. Vast areas of the coastal plains of Kerala have been converted into carbon rich peatland during the Middle Holocene and transforming the entire coastal stretch and associated landforms as one of the relatively youngest peatlands in the extreme southern tip of India. Unlike the uninterrupted formation of peatlands of considerable extent during the Holocene in Southeast Asia, the south Peninsular Indian region has restricted and short intervals of peatlands in the floodplains and coastal lowlands. Such a scenario is attributed to the topographic relief of the terrain and the prevailing hydrological regimes and environmental conditions as a consequence of monsoon variability since Middle Holocene in SW India. Considering the tropical coastal lowlands and associated peatlands are excellent repositories of carbon, they are very important for regional carbon cycling and habitat diversity. The alarming rate of land modification and development is destabilizing these carbon pools resulting in large scale carbon emissions to the atmosphere and loss of low-latitude peat palaeorecords. Therefore, these palaeorecords are to be conserved and addressed for better understanding and utilizing the carbon pool for effective climate change adaptation. This communication is the first attempt of addressing the peat formation and peatland development during the Holocene from the tropical region of Peninsular India.	[Kumaran, Navnith K. P.; Limaye, Ruta B.; Gamre, Pradeep G.] Agharkar Res Inst, Palynol & Palaeoclimate Lab, Biodivers & Palaeobiol Grp, Pune 411004, Maharashtra, India; [Padmalal, Damodaran; Mohan, Vishnu S.] Natl Ctr Earth Sci Studies, Thuruvaikkal PO, Thiruvananthapuram 695011, Kerala, India; [Jennerjahn, Tim] Leibniz Ctr Trop Marine Ecol ZMT, Biogeochem & Geol, D-28359 Bremen, Germany	Department of Science & Technology (India); Agharkar Research Institute (ARI); Ministry of Earth Sciences (MoES) - India; National Centre for Earth Science Studies (NCESS); Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Kumaran, NKP (corresponding author), Agharkar Res Inst, Palynol & Palaeoclimate Lab, Biodivers & Palaeobiol Grp, Pune 411004, Maharashtra, India.	kpnkumaran@aripune.org	Jennerjahn, Tim/AAE-9146-2020; S, Venkata Mohan/E-8305-2010; Mohan, S Venkata/F-8757-2010	Jennerjahn, Tim/0000-0003-1022-5126; Kumaran, Navnith/0000-0002-3304-7898	CSIR, HRDG [21(0828)/10/EMR-II]; DST [SR/WOS-A/ES-08/2013]; Council of Scientific and Industrial Research (CSIR), New Delhi [09/909(0005)/2012-EMR-I]; Agharkar Research Institute, Pune, India	CSIR, HRDG(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Agharkar Research Institute, Pune, India(Department of Science & Technology (India))	The authors received no specific funding for this work. However, KPNK thanks the CSIR, HRDG for its support in the form of ES project [21(0828)/10/EMR-II] and financial support in the form of Women Scientist Scheme (SR/WOS-A/ES-08/2013) to RBL by the DST is acknowledged. VMS acknowledges Council of Scientific and Industrial Research (CSIR), New Delhi for Senior Research Fellowship [09/909(0005)/2012-EMR-I]. Financial assistance towards part of the publication fee has been provided by the Director Agharkar Research Institute, Pune, India.; The authors are indebted to Mr. NK Sukumaran Nair and Prof. MVS Nampoothiri of "Pamba Parirakshana Samithy (PPS)" for all their efforts while undertaking field work at Puvathur and adjacent locations in Pamba River Basin. The facilities and logistic support extended by the directors of ARI, Pune and NCESS, Thiruvananthapuram are acknowledged. KPNK thanks the CSIR, HRDG for its support in the form of ES project [21(0828)/10/EMR-II] and financial support in the form of Women Scientist Scheme (SR/WOS-A/ES-08/2013) to RBL by the DST is acknowledged. VMS acknowledges Council of Scientific and Industrial Research (CSIR), New Delhi for Senior Research Fellowship [09/909(0005)/2012-EMR-I]. Financial assistance towards part of the publication fee has been provided by the Director Agharkar Research Institute, Pune, India. Comments on the anatomical features of illustrated sub-fossil log given by Drs. Rashmi Srivastava and Anumeha Shukla are appreciated. The comments and suggestions of the reviewers are found to be useful while revising the original manuscript.	Agrawal DP, 1970, CURR SCI, V30, P219; Ajaykumar B, 2012, J EARTH SYST SCI, V121, P1093, DOI 10.1007/s12040-012-0210-x; ANDERSON JAR, 1975, REV PALAEOBOT PALYNO, V19, P291, DOI 10.1016/0034-6667(75)90049-4; Contreras-Rosales LA, 2014, QUATERNARY SCI REV, V102, P133, DOI 10.1016/j.quascirev.2014.08.010; El Wakeel SK., 1957, J CONS PERM INT EXPL, V22, P180, DOI [10.1093/icesjms/22.2.180, DOI 10.1093/ICESJMS/22.2.180]; Hass H., 1999, FOSSIL PLANT SPORES, P76; HEDGES JI, 1986, LIMNOL OCEANOGR, V31, P717, DOI 10.4319/lo.1986.31.4.0717; Jennerjahn TC, 2004, SCIENCE, V306, P2236, DOI 10.1126/science.1102490; Jennerjahn TC, 2004, ESTUAR COAST SHELF S, V60, P503, DOI 10.1016/j.ecss.2004.02.008; Kumaran KPN, 2008, CURR SCI INDIA, V95, P515; Kumaran KPN, 2013, QUATERN INT, V286, P3, DOI 10.1016/j.quaint.2012.03.010; Kumaran KPN, 2005, QUATERNARY RES, V64, P418, DOI 10.1016/j.yqres.2005.08.015; Kumaran NKP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093596; Lewis D. W., 1984, PRACTICAL SEDIMENTOL; Limaye RB, 2014, QUATERN INT, V325, P116, DOI 10.1016/j.quaint.2013.12.031; Limaye RB, 2010, QUATERN INT, V213, P79, DOI 10.1016/j.quaint.2009.09.016; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Moore P.D., 1991, BLACKWELL SCI PUBLI; Nair KM, 2006, J GEOL SOC INDIA, V67, P165; Nair KM, 2010, J ASIAN EARTH SCI, V37, P361, DOI 10.1016/j.jseaes.2009.09.004; Nair KM, 2009, TECTONIC HYDROLOGIC, P83; Nair KM, 2003, ESS23VES698 PCR DST, P1; Narayana AC, 2007, J COASTAL RES, P683; Padmalal D, 2014, QUATERN INT, V325, P162, DOI 10.1016/j.quaint.2013.12.032; Padmalal D, 2011, QUATERN INT, V237, P123, DOI 10.1016/j.quaint.2010.12.021; Padmalal D., 2013, CLIMATE CHANGE ISLAN, P191, DOI [DOI 10.1007/978-94-007-6016-5_13, 10.1007/978-94-007-6016-5_13]; Page S., 2010, PAGES (Past Global Changes) News, V18, P25; Pawar SD, 1983, SYSTEMATIC GEO UNPUB; Pejrup M., 1988, TIDE INFLUENCED SEDI, P289; Phadtare NR, 2006, J GEOL SOC INDIA, V68, P495; PICARD MD, 1971, J SEDIMENT PETROL, V41, P179; Rajagopalan G, 1997, CURR SCI INDIA, V73, P60; RAJENDRAN CP, 1989, J GEOL SOC INDIA, V33, P218; Ramachandra, 2011, INT J GEOL, V5, P86; Santosh V, 2006, THESIS KERALA U INDI; Shajan KP, 1998, THESIS COCHIN U SCI; Singh A, 2009, ADV INFORM SECUR, V44, P1, DOI 10.1007/978-0-387-89468-3_1; Srivastava G, 2016, PALAEOGEOGR PALAEOCL, V443, P57, DOI 10.1016/j.palaeo.2015.11.045; SUKUMAR R, 1993, NATURE, V364, P703, DOI 10.1038/364703a0; Tissot C., 1994, POLLEN WET EVERGREEN, P1; Tomalin V, 2004, INT J NAUT ARCHAEOL, V33, P253, DOI 10.1111/j.1095-9270.2004.00022.x; Traverse A., 2007, PALAEOPALYNOLOGY; Valdiya KS, 2002, PROG PHYS GEOG, V26, P360, DOI 10.1191/0309133302pp342ra; Vijayaraj R, 2015, J GEOL SOC INDIA, V86, P620, DOI 10.1007/s12594-015-0353-x	45	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154297	10.1371/journal.pone.0154297	http://dx.doi.org/10.1371/journal.pone.0154297			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163658	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700043
J	Meir-Hasson, Y; Keynan, JN; Kinreich, S; Jackont, G; Cohen, A; Podlipsky-Klovatch, I; Hendler, T; Intrator, N				Meir-Hasson, Yehudit; Keynan, Jackob N.; Kinreich, Sivan; Jackont, Gilan; Cohen, Avihay; Podlipsky-Klovatch, Ilana; Hendler, Talma; Intrator, Nathan			One-Class FMRI-Inspired EEG Model for Self-Regulation Training	PLOS ONE			English	Article							ALPHA-RHYTHM; DYNAMICS; RELAXATION; ANXIETY; ELECTROENCEPHALOGRAM; NEUROFEEDBACK; ARTIFACT; EEG/FMRI; SYSTEM	Recent evidence suggests that learned self-regulation of localized brain activity in deep limbic areas such as the amygdala, may alleviate symptoms of affective disturbances. Thus far self-regulation of amygdala activity could be obtained only via fMRI guided neurofeedback, an expensive and immobile procedure. EEG on the other hand is relatively inexpensive and can be easily implemented in any location. However the clinical utility of EEG neurofeedback for affective disturbances remains limited due to low spatial resolution, which hampers the targeting of deep limbic areas such as the amygdala. We introduce an EEG prediction model of amygdala activity from a single electrode. The gold standard used for training is the fMRI-BOLD signal in the amygdala during simultaneous EEG/fMRI recording. The suggested model is based on a time/frequency representation of the EEG data with varying time-delay. Previous work has shown a strong inhomogeneity among subjects as is reflected by the models created to predict the amygdala BOLD response from EEG data. In that work, different models were constructed for different subjects. In this work, we carefully analyzed the inhomogeneity among subjects and were able to construct a single model for the majority of the subjects. We introduce a method for inhomogeneity assessment. This enables us to demonstrate a choice of subjects for which a single model could be derived. We further demonstrate the ability to modulate brain-activity in a neurofeedback setting using feedback generated by the model. We tested the effect of the neurofeedback training by showing that new subjects can learn to down-regulate the signal amplitude compared to a sham group, which received a feedback obtained by a different participant. This EEG based model can overcome substantial limitations of fMRI-NF. It can enable investigation of NF training using multiple sessions and large samples in various locations.	[Meir-Hasson, Yehudit; Intrator, Nathan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Keynan, Jackob N.; Kinreich, Sivan; Jackont, Gilan; Cohen, Avihay; Podlipsky-Klovatch, Ilana; Hendler, Talma] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Funct Brain Imaging Unit, IL-69978 Tel Aviv, Israel; [Hendler, Talma; Intrator, Nathan] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Keynan, Jackob N.; Hendler, Talma] Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel; [Hendler, Talma] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Meir-Hasson, Y (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	yehudit.hasson@gmail.com			U.S. Department of Defense [W81XWH-11-2-0008]; European Union's Seventh Framework Programme [602186]; Israeli Center of Research Excellence and Israeli Science Foundation [51/11]; Adams Super Center for Brain Studies	U.S. Department of Defense(United States Department of Defense); European Union's Seventh Framework Programme; Israeli Center of Research Excellence and Israeli Science Foundation; Adams Super Center for Brain Studies	This study was supported by grants from the U.S. Department of Defense (grant No. W81XWH-11-2-0008 to TH and NI; http://www.defense.gov); the European Union's Seventh Framework Programme (grant No. 602186 to TH; http://ec.europa.eu/research/fp7/index_en.cfm); The Israeli Center of Research Excellence and Israeli Science Foundation (grant No. 51/11 to TH; http://www.i-core.org.il/The-ICORE-Program) and the Adams Super Center for Brain Studies (YMH; http://www.brain.tau.ac.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Bellinger C, 2012, 2012 11TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2012), VOL 2, P102, DOI 10.1109/ICMLA.2012.212; Ben-Simon E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003984; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Birbaumer N, 2013, TRENDS COGN SCI, V17, P295, DOI 10.1016/j.tics.2013.04.009; Boubela RN, 2015, SCI REPORTS, P5; Chan Philip, 2004, TOOLS ART INT 2004 I; Chen L.L., 2008, P 17 WORLD C INT FED; de Munck JC, 2007, NEUROIMAGE, V35, P1142, DOI 10.1016/j.neuroimage.2007.01.022; de Munck JC, 2009, NEUROIMAGE, V47, P69, DOI 10.1016/j.neuroimage.2009.04.029; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Efron B., 1994, INTRO BOOTSTRAP; Eichele T, 2005, P NATL ACAD SCI USA, V102, P17798, DOI 10.1073/pnas.0505508102; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Gruzelier J. H., 2014, NEUROSCI BIOBEHAV RE; Gruzelier JH, 2013, NEUROSCI BIOBEHAV RE; Gruzelier JH, 2014, INT J PSYCHOPHYSIOL; Haibo He, 2009, IEEE Transactions on Knowledge and Data Engineering, V21, P1263, DOI 10.1109/TKDE.2008.239; Haykin Simon, 2004, NEURAL NETWORKS, V2; Huster RJ, 2012, J NEUROSCI, V32, P6053, DOI 10.1523/JNEUROSCI.0447-12.2012; Jacobs GD, 1996, BIOFEEDBACK SELF-REG, V21, P121, DOI 10.1007/BF02284691; Jacobs GD, 2004, APPL PSYCHOPHYS BIOF, V29, P245, DOI 10.1007/s10484-004-0385-2; JACOBS GD, 1989, BEHAV MED, V15, P125, DOI 10.1080/08964289.1989.9934575; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Keynan JN, 2016, BIOL PSYCHIAT; Khan SS, 2014, KNOWL ENG REV, V29, P345, DOI 10.1017/S026988891300043X; Kinreich Sivan, 2012, Machine Learning and Interpretation in Neuroimaging. International Workshop (MLINI 2011). Held at NIPS 2011. Revised and Selected and Invited Contributions, P108, DOI 10.1007/978-3-642-34713-9_14; Kinreich S, 2014, NEUROIMAGE, V97, P19, DOI 10.1016/j.neuroimage.2014.04.044; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Lee EJ, 2012, COMPLEMENT THER MED, V20, P409, DOI 10.1016/j.ctim.2012.07.002; Meir-Hasson Y, 2014, NEUROIMAGE, V102, P128, DOI 10.1016/j.neuroimage.2013.11.004; Moore NC, 2005, J ADULT DEV, V12, P147, DOI 10.1007/s10804-005-7031-y; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Moya MM, 1996, NEURAL NETWORKS, V9, P463, DOI 10.1016/0893-6080(95)00120-4; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Peniston E., 1991, MED PSYCHOTHER, V4, P47; Raz G, 2012, NEUROIMAGE, V60, P1448, DOI 10.1016/j.neuroimage.2011.12.084; Ros T, 2013, NEUROIMAGE, V65, P324, DOI 10.1016/j.neuroimage.2012.09.046; Scheinost D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.24; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; SPILKER B, 1969, PSYCHOPHYSIOLOGY, V5, P683, DOI 10.1111/j.1469-8986.1969.tb02871.x; Valdes-Sosa PA, 2009, HUM BRAIN MAPP, V30, P2701, DOI 10.1002/hbm.20704; VOGEL G, 1966, ARCH GEN PSYCHIAT, V14, P238; Young KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088785; Zotev V, 2014, NEUROIMAGE, V85, P985, DOI 10.1016/j.neuroimage.2013.04.126; Zotev V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079184; Zumer JM, 2010, NEUROIMAGE, V49, P1479, DOI 10.1016/j.neuroimage.2009.09.020	53	17	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0154968	10.1371/journal.pone.0154968	http://dx.doi.org/10.1371/journal.pone.0154968			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163677	Green Submitted, Green Published, gold			2022-12-27	WOS:000376585700033
J	Hale, LP; Kant, EP; Greer, PK; Foster, WM				Hale, Laura P.; Kant, Erin Potts; Greer, Paula K.; Foster, W. Michael			RETRACTION: Iron Supplementation Decreases Severity of Allergic Inflammation in Murine Lung (Retraction of vol 7, e45667, 2012)	PLOS ONE			English	Retraction																		Hale LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045667	1	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155387	10.1371/journal.pone.0155387	http://dx.doi.org/10.1371/journal.pone.0155387			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159607	Green Published, gold, Green Submitted			2022-12-27	WOS:000376576700062
J	Li, C; Lesnik, KL; Fan, YZ; Liu, H				Li, Cheng; Lesnik, Keaton Larson; Fan, Yanzhen; Liu, Hong			Redox Conductivity of Current-Producing Mixed Species Biofilms	PLOS ONE			English	Article							MICROBIAL FUEL-CELLS; INTERSPECIES ELECTRON-TRANSFER; SHEWANELLA-ONEIDENSIS MR-1; GEOBACTER-SULFURREDUCENS; BACTERIAL NANOWIRES; TRANSPORT; PERFORMANCE; COMMUNITIES; BIOENERGY; POLYMERS	While most biological materials are insulating in nature, efficient extracellular electron transfer is a critical property of biofilms associated with microbial electrochemical systems and several microorganisms are capable of establishing conductive aggregates and biofilms. Though construction of these conductive microbial networks is an intriguing and important phenomenon in both natural and engineered systems, few studies have been published related to conductive biofilms/aggregates and their conduction mechanisms, especially in mixed-species environments. In the present study, current-producing mixed species biofilms exhibited high conductivity across non-conductive gaps. Biofilm growth observed on the inactive electrode contributed to overall power outputs, suggesting that an electrical connection was established throughout the biofilm assembly. Electrochemical gating analysis of the biofilms over a range of potentials (-600-200 mV, vs. Ag/AgCl) resulted in a peak-manner response with maximum conductance of 3437 +/- 271 mu S at a gate potential of -360 mV. Following removal of the electron donor (acetate), a 96.6% decrease in peak conductivity was observed. Differential responses observed in the absence of an electron donor and over varying potentials suggest a redox driven conductivity mechanism in mixed-species biofilms. These results demonstrated significant differences in biofilm development and conductivity compared to previous studies using pure cultures.	[Li, Cheng; Lesnik, Keaton Larson; Fan, Yanzhen; Liu, Hong] Oregon State Univ, Biol & Ecol Engn, Corvallis, OR 97333 USA	Oregon State University	Liu, H (corresponding author), Oregon State Univ, Biol & Ecol Engn, Corvallis, OR 97333 USA.	liuh@engr.orst.edu	Li, Cheng/J-8439-2019; Liu, Hong/D-5012-2009	Li, Cheng/0000-0003-1770-1738; 	U.S. National Science Foundation [CBET 0955124, PFI 1312301]; National Institutes of Health [1S10RR107903-01]	U.S. National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This publication was made possible by grant CBET 0955124 and PFI 1312301 from the U.S. National Science Foundation and in part by grant 1S10RR107903-01 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond DR, 2012, CHEMSUSCHEM, V5, P1099, DOI 10.1002/cssc.201100748; Cheng S, 2006, ELECTROCHEM COMMUN, V8, P489, DOI 10.1016/j.elecom.2006.01.010; DALTON EF, 1990, CHEM PHYS, V141, P143, DOI 10.1016/0301-0104(90)80026-T; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; Fan YZ, 2012, ENERG ENVIRON SCI, V5, P8273, DOI 10.1039/c2ee21964f; Fricke K, 2008, ENERG ENVIRON SCI, V1, P144, DOI 10.1039/b802363h; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Hugenholtz P, 2002, DESIGN EVALUATION 16; Janicek A, 2015, J POWER SOURCES, V280, P159, DOI 10.1016/j.jpowsour.2015.01.098; KANKARE J, 1992, J ELECTROANAL CHEM, V322, P167, DOI 10.1016/0022-0728(92)80074-E; Kato S, 2012, P NATL ACAD SCI USA, V109, P10042, DOI 10.1073/pnas.1117592109; Kato S, 2012, ENVIRON MICROBIOL, V14, P1646, DOI 10.1111/j.1462-2920.2011.02611.x; Kiely PD, 2011, CURR OPIN BIOTECH, V22, P378, DOI 10.1016/j.copbio.2011.03.003; Lesnik KL, 2014, APPL MICROBIOL BIOT, V98, P4187, DOI 10.1007/s00253-013-5502-9; Liu Y, 2012, CHEMSUSCHEM, V5, P1047, DOI 10.1002/cssc.201100734; Lovley DR, 2011, REV ENVIRON SCI BIO, V10, P101, DOI 10.1007/s11157-011-9236-9; Malvankar NS, 2015, ISME J, V9, P527, DOI 10.1038/ismej.2014.131; Malvankar NS, 2014, CURR OPIN BIOTECH, V27, P88, DOI 10.1016/j.copbio.2013.12.003; Malvankar NS, 2012, ENERG ENVIRON SCI, V5, P8651, DOI 10.1039/c2ee22330a; Malvankar NS, 2012, APPL ENVIRON MICROB, V78, P5967, DOI 10.1128/AEM.01803-12; Malvankar NS, 2012, ENERG ENVIRON SCI, V5, P5790, DOI 10.1039/c2ee03388g; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; McGlynn SE, 2015, NATURE, V526, P531, DOI 10.1038/nature15512; Morita M, 2011, MBIO, V2, DOI 10.1128/mBio.00159-11; OHSAKA T, 1987, J PHYS CHEM-US, V91, P3775, DOI 10.1021/j100298a012; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Reguera G, 2011, TRENDS MICROBIOL, V19, P105, DOI 10.1016/j.tim.2010.12.007; Richter H, 2009, ENERG ENVIRON SCI, V2, P506, DOI 10.1039/b816647a; Rotaru AE, 2014, APPL ENVIRON MICROB, V80, P4599, DOI 10.1128/AEM.00895-14; Rotaru AE, 2014, ENERG ENVIRON SCI, V7, P408, DOI 10.1039/c3ee42189a; Ruhl S, 2014, APPL ENVIRON MICROB, V80, P6583, DOI 10.1128/AEM.01826-14; Shrestha PM, 2014, BIORESOURCE TECHNOL, V174, P306, DOI 10.1016/j.biortech.2014.10.004; Sieber JR, 2012, ANNU REV MICROBIOL, V66, P429, DOI 10.1146/annurev-micro-090110-102844; Snider RM, 2012, P NATL ACAD SCI USA, V109, P15467, DOI 10.1073/pnas.1209829109; Strycharz-Glaven SM, 2012, ENERG ENVIRON SCI, V5, P6250, DOI 10.1039/c2ee03056j; Strycharz-Glaven SM, 2011, ENERG ENVIRON SCI, V4, P4366, DOI 10.1039/c1ee01753e; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Vanmaekelbergh D, 2007, ELECTROCHIM ACTA, V53, P1140, DOI 10.1016/j.electacta.2007.02.045; Vargas M, 2013, MBIO, V4, DOI 10.1128/mBio.00105-13	39	20	20	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155247	10.1371/journal.pone.0155247	http://dx.doi.org/10.1371/journal.pone.0155247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159497	gold, Green Submitted, Green Published			2022-12-27	WOS:000376576700050
J	Li, J; Qin, S; Yu, HJ; Zhang, J; Liu, N; Yu, Y; Hou, CX; Li, MW				Li, Juan; Qin, Sheng; Yu, Huanjun; Zhang, Jing; Liu, Na; Yu, Ye; Hou, Chengxiang; Li, Muwang			Comparative Transcriptome Analysis Reveals Different Silk Yields of Two Silkworm Strains	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; BOMBYX-MORI; GENE-EXPRESSION; FIBROIN GENE; BINDING; GLAND; PROTEIN; IDENTIFICATION; INHIBITION; BIOGENESIS	Cocoon and silk yields are the most important characteristics of sericulture. However, few studies have examined the genes that modulate these features. Further studies of these genes will be useful for improving the products of sericulture. JingSong (JS) and Lan10 (L10) are two strains having significantly different cocoon and silk yields. In the current study, RNA-Seq and quantitative polymerase chain reaction (qPCR) were performed on both strains in order to determine divergence of the silk gland, which controls silk biosynthesis in silkworms. Compared with L10, JS had 1375 differentially expressed genes (DEGs; 738 up-regulated genes and 673 down-regulated genes). Nine enriched gene ontology (GO) terms were identified by GO enrichment analysis based on these DEGs. KEGG enrichment analysis results showed that the DEGs were enriched in three pathways, which were mainly associated with the processing and biosynthesis of proteins. The representative genes in the enrichment pathways and ten significant DEGs were further verified by qPCR, the results of which were consistent with the RNA-Seq data. Our study has revealed differences in silk glands between the two silkworm strains and provides a perspective for understanding the molecular mechanisms determining silk yield.	[Li, Juan; Qin, Sheng; Yu, Huanjun; Zhang, Jing; Liu, Na; Yu, Ye; Hou, Chengxiang; Li, Muwang] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang 212018, Jiangsu, Peoples R China; [Qin, Sheng; Hou, Chengxiang; Li, Muwang] Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang 212018, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences	Li, MW (corresponding author), Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang 212018, Jiangsu, Peoples R China.; Li, MW (corresponding author), Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang 212018, Jiangsu, Peoples R China.	mwli@just.edu.cn	Qin, Sheng/HCH-0856-2022		National Natural Science Foundation of China [31372375]; Natural Science Foundation of JiangSu Province [BK20131240]; State Key Laboratory of Silkworm Genome Biology [sklsgb2013020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of JiangSu Province(Natural Science Foundation of Jiangsu Province); State Key Laboratory of Silkworm Genome Biology	This project was supported by the National Natural Science Foundation of China (grant No. 31372375), the Natural Science Foundation of JiangSu Province (BK20131240) and the Project of the State Key Laboratory of Silkworm Genome Biology (sklsgb2013020).; This project was supported by the National Natural Science Foundation of China (grant No. 31372375), the Natural Science Foundation of JiangSu Province (BK20131240) and the Project of the State Key Laboratory of Silkworm Genome Biology (sklsgb2013020). The manuscript was improved by Editage.	Ali V, 2006, MOL BIOCHEM PARASIT, V145, P71, DOI 10.1016/j.molbiopara.2005.09.008; Andrews S., 2010, REFERENCE SOURCE; Bai G, 2011, MOL MICROBIOL, V82, P180, DOI 10.1111/j.1365-2958.2011.07806.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Casasnovas JM, 1999, EMBO J, V18, P2911, DOI 10.1093/emboj/18.11.2911; Chen Y, 1990, J SERI SCI JPN JAPAN; Chen Z, 2004, SHENG WU HUA XUE YU, V32, P187; DELAUNAY J, 1972, EUR J BIOCHEM, V31, P561, DOI 10.1111/j.1432-1033.1972.tb02565.x; Engh RA, 2002, PHARMACOL THERAPEUT, V93, P99, DOI 10.1016/S0163-7258(02)00180-8; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Gordon A, 2010, FASTX TOOLKIT UNPUB; GUTHRIE C, 1988, ANNU REV GENET, V22, P387, DOI 10.1146/annurev.ge.22.120188.002131; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hou CX, 2013, GENET MOL RES, V12, P4171, DOI 10.4238/2013.October.7.3; Hou CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091189; Hou Y, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-45; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Ji MM, 2013, INSECT MOL BIOL, V22, P273, DOI 10.1111/imb.12019; Jin SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099200; Julien E, 2002, INSECT BIOCHEM MOLEC, V32, P377, DOI 10.1016/S0965-1748(01)00170-9; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim EJ, 2003, BIOCHEM BIOPH RES CO, V308, P523, DOI 10.1016/S0006-291X(03)01425-6; Kimoto M, 2012, DEV GENES EVOL, V222, P351, DOI 10.1007/s00427-012-0418-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leary DJ, 2001, FEBS LETT, V509, P145, DOI 10.1016/S0014-5793(01)03143-X; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li B, 2013, EUR J ENTOMOL, V110, P205, DOI 10.14411/eje.2013.031; Li MW, 2015, GENET MOL RES, V14, P11162, DOI 10.4238/2015.September.22.10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2011, CELL RES, V21, P934, DOI 10.1038/cr.2011.36; MAEKAWA H, 1980, DEV BIOL, V78, P394, DOI 10.1016/0012-1606(80)90343-7; Marshall A, 1998, NAT BIOTECHNOL, V16, P530, DOI 10.1038/nbt0698-530; MICHAILLE JJ, 1990, GENE, V86, P177, DOI 10.1016/0378-1119(90)90277-X; MICHAILLE JJ, 1986, BIOCHIMIE, V68, P1165, DOI 10.1016/S0300-9084(86)80060-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nag A, 2001, MOL CELL BIOL, V21, P6738, DOI 10.1128/MCB.21.20.6738-6747.2001; OKAMOTO H, 1982, J BIOL CHEM, V257, P5192; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sun W, 2012, SCI CHINA LIFE SCI, V55, P483, DOI 10.1007/s11427-012-4334-7; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010; Ujita M, 2005, BIOSCI BIOTECH BIOCH, V69, P1178, DOI 10.1271/bbb.69.1178; Ujita M, 2002, BIOSCI BIOTECH BIOCH, V66, P2264, DOI 10.1271/bbb.66.2264; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang X, 2016, INSECT BIOCHEM MOLEC, V68, P89, DOI 10.1016/j.ibmb.2015.11.003; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Xia QY, 2014, ANNU REV ENTOMOL, V59, P513, DOI 10.1146/annurev-ento-011613-161940; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043769; Zha XF, 2005, INSECT MOL BIOL, V14, P113, DOI 10.1111/j.1365-2583.2004.00536.x; Zhan SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-389; Zurovec M, 1998, J BIOL CHEM, V273, P15423, DOI 10.1074/jbc.273.25.15423	54	12	12	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155329	10.1371/journal.pone.0155329	http://dx.doi.org/10.1371/journal.pone.0155329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159277	Green Published, gold			2022-12-27	WOS:000376576700058
J	Bai, F; Fink, BD; Yu, LP; Sivitz, WI				Bai, Fan; Fink, Brian D.; Yu, Liping; Sivitz, William I.			Voltage-Dependent Regulation of Complex II Energized Mitochondrial Oxygen Flux	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; PERMEABILITY TRANSITION; REACTIVE OXYGEN; SUCCINATE-DEHYDROGENASE; EXTRA-MITOCHONDRIAL; LIVER; INHIBITION; MEMBRANE; BRAIN; OXALOACETATE	Oxygen consumption by isolated mitochondria is generally measured during state 4 respiration (no ATP production) or state 3 (maximal ATP production at high ADP availability). However, mitochondria in vivo do not function at either extreme. Here we used ADP recycling methodology to assess muscle mitochondrial function over intermediate clamped ADP concentrations. In so doing, we uncovered a previously unrecognized biphasic respiratory pattern wherein O-2 flux on the complex II substrate, succinate, initially increased and peaked over low clamped ADP concentrations then decreased markedly at higher clamped concentrations. Mechanistic studies revealed no evidence that the observed changes in O-2 flux were due to altered opening or function of the mitochondrial permeability transition pore or to changes in reactive oxygen. Based on metabolite and functional metabolic data, we propose a multifactorial mechanism that consists of coordinate changes that follow from reduced membrane potential (as the ADP concentration in increased). These changes include altered directional electron flow, altered NADH/NAD(+) redox cycling, metabolite exit, and OAA inhibition of succinate dehydrogenase. In summary, we report a previously unrecognized pattern for complex II energized O-2 flux. Moreover, our findings suggest that the ADP recycling approach might be more widely adapted for mitochondrial studies.	[Bai, Fan; Yu, Liping] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Fink, Brian D.; Sivitz, William I.] Univ Iowa, Dept Internal Med Endocrinol & Metab, Iowa City, IA 52242 USA; [Fink, Brian D.; Sivitz, William I.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, NMR Core Facil, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Sivitz, WI (corresponding author), Univ Iowa, Dept Internal Med Endocrinol & Metab, Iowa City, IA 52242 USA.; Sivitz, WI (corresponding author), Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USA.	william-sivitz@uiowa.edu		Fink, Brian/0000-0002-1149-7935; Yu, Liping/0000-0003-3536-6427; Sivitz, William/0000-0002-7829-0189	Merit Review Award from the United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development Service [5I01BX000285-06]; Iowa Affiliate Fraternal Order of the Eagles; Roy and Lucille Carver College of Medicine Pilot Funds; Veterans Affairs [I01BX000285] Funding Source: NIH RePORTER	Merit Review Award from the United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development Service; Iowa Affiliate Fraternal Order of the Eagles; Roy and Lucille Carver College of Medicine Pilot Funds; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review Award #5I01BX000285-06 from the United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development Service, by the Iowa Affiliate Fraternal Order of the Eagles, and by Roy and Lucille Carver College of Medicine Pilot Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Merit Review Award # 5I01BX000285-06 from the United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development Service, by the Iowa Affiliate Fraternal Order of the Eagles, and by Roy and Lucille Carver College of Medicine Pilot Funds. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	AZZONE GF, 1960, NATURE, V188, P552, DOI 10.1038/188552a0; Babot M, 2014, BBA-BIOENERGETICS, V1837, P1083, DOI 10.1016/j.bbabio.2014.02.018; BEATRICE MC, 1980, J BIOL CHEM, V255, P8663; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Blanchet L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114090; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRAWAND F, 1980, BIOCHIM BIOPHYS ACTA, V590, P285, DOI 10.1016/0005-2728(80)90199-1; Brekke E, 2012, GLIA, V60, P147, DOI 10.1002/glia.21265; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; CHANCE B, 1962, J BIOL CHEM, V237, P3540; DAVIS EJ, 1978, BIOCHEM BIOPH RES CO, V83, P1260, DOI 10.1016/0006-291X(78)91357-8; DAVIS EJ, 1974, FEBS LETT, V39, P9, DOI 10.1016/0014-5793(74)80004-9; DAVIS EJ, 1984, ARCH BIOCHEM BIOPHYS, V233, P573, DOI 10.1016/0003-9861(84)90481-8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deryabina YI, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1025, DOI 10.1023/B:BIRY.0000043545.32343.50; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Herlein JA, 2011, AM J PHYSIOL-REG I, V301, pR1616, DOI 10.1152/ajpregu.00395.2011; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; KUSTER U, 1976, BIOCHIM BIOPHYS ACTA, V440, P391, DOI 10.1016/0005-2728(76)90073-6; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Panov AV, 2010, B EXP BIOL MED+, V149, P187, DOI 10.1007/s10517-010-0904-5; Panov A, 2009, J BIOL CHEM, V284, P14448, DOI 10.1074/jbc.M900985200; Panov AV, 2011, AM J PHYSIOL-REG I, V300, pR844, DOI 10.1152/ajpregu.00528.2010; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; SCHOLLMEYER P, 1961, BIOCHEM BIOPH RES CO, V4, P43, DOI 10.1016/0006-291X(61)90252-2; Siemen D, 2013, IUBMB LIFE, V65, P255, DOI 10.1002/iub.1130; WALTER P, 1970, European Journal of Biochemistry, V12, P508, DOI 10.1111/j.1432-1033.1970.tb00880.x; WANDERS RJA, 1984, EUR J BIOCHEM, V142, P417, DOI 10.1111/j.1432-1033.1984.tb08303.x; WOJTCZAK L, 1969, BIOCHIM BIOPHYS ACTA, V191, P10, DOI 10.1016/0005-2744(69)90310-6; WOJTCZAK L, 1972, ACTA BIOCHIM POL, V19, P227; Yu Liping, 2015, Methods Mol Biol, V1264, P149, DOI 10.1007/978-1-4939-2257-4_14; Yu LP, 2014, J BIOENERG BIOMEMBR, V46, P33, DOI 10.1007/s10863-013-9530-z; Yu LP, 2013, DIABETES, V62, P1833, DOI 10.2337/db12-1152; ZEYLEMAKER WP, 1969, BIOCHIM BIOPHYS ACTA, V191, P229, DOI 10.1016/0005-2744(69)90242-3	37	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154982	10.1371/journal.pone.0154982	http://dx.doi.org/10.1371/journal.pone.0154982			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153112	Green Published, gold			2022-12-27	WOS:000375677000055
J	Valentin, LSS; Pereira, VFA; Pietrobon, RS; Schmidt, AP; Oses, JP; Portela, LV; Souza, DO; Vissoci, JRN; da Luz, VF; Trintoni, LMDD; Nielsen, KC; Carmona, MJC				Sanches Valentin, Livia Stocco; Angelim Pereira, Valeria Fontenelle; Pietrobon, Ricardo S.; Schmidt, Andre P.; Oses, Jean P.; Portela, Luis V.; Souza, Diogo O.; Nickenig Vissoci, Joao Ricardo; da Luz, Vinicius Fernando; de Araujo de Souza Trintoni, Leticia Maria; Nielsen, Karen C.; Carvalho Carmona, Maria Jose			Effects of Single Low Dose of Dexamethasone before Noncardiac and Nonneurologic Surgery and General Anesthesia on Postoperative Cognitive Dysfunction-A Phase III Double Blind, Randomized Clinical Trial	PLOS ONE			English	Article							POPULATION; DEPTH; POCD	Postoperative cognitive dysfunction (POCD) is a multifactorial adverse event most frequently in elderly patients. This study evaluated the effect of dexamethasone on POCD incidence after noncardiac and nonneurologic surgery. METHODS: One hundred and forty patients (ASA I-II; age 60-87 years) took part in a prospective phase III, double blind, randomized study involving the administration or not of 8 mg of IV dexamethasone before general anesthesia under bispectral index (BIS) between 35-45 or 46-55. Neuropsychological tests were applied preoperatively and on the 3rd, 7th, 21st, 90th and 180th days after surgery and compared with normative data. S100 beta was evaluated before and 12 hours after induction of anesthesia. The generalized estimating equations (GEE) method was applied, followed by the posthoc Bonferroni test considering P<0.05 as significant. RESULTS: On the 3rd postoperative day, POCD was diagnosed in 25.2% and 15.3% of patients receiving dexamethasone, BIS 35-45, and BIS 46-55 groups, respectively. Meanwhile, POCD was present in 68.2% and 27.2% of patients without dexamethasone, BIS 35-45 and BIS 46-55 groups (p<0.0001). Neuropsychological tests showed that dexamethasone associated to BIS 46-55 decreased the incidence of POCD, especially memory and executive function. The administration of dexamethasone might have prevented the postoperative increase in S100 beta serum levels. CONCLUSION: Dexamethasone can reduce the incidence of POCD in elderly patients undergoing surgery, especially when associated with BIS 46-55. The effect of dexamethasone on S100 beta might be related with some degree of neuroprotection.	[Sanches Valentin, Livia Stocco; Angelim Pereira, Valeria Fontenelle; da Luz, Vinicius Fernando; de Araujo de Souza Trintoni, Leticia Maria; Carvalho Carmona, Maria Jose] Univ Sao Paulo, Fac Med, Dept Anesthesia, LIM Lab Anesthesiol 8, Sao Paulo, SP, Brazil; [Pietrobon, Ricardo S.; Nickenig Vissoci, Joao Ricardo] Duke Univ Hlth Syst, Dept Surg, Durham, NC USA; [Schmidt, Andre P.; Portela, Luis V.; Souza, Diogo O.] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [Schmidt, Andre P.] Hosp Porto Alegre, Dept Anesthesia & Perioperat Med, Porto Alegre, RS, Brazil; [Oses, Jean P.] Univ Catolica Pelotas, Ctr Sci Life & Hlth, Pelotas, RS, Brazil; [Nielsen, Karen C.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Nickenig Vissoci, Joao Ricardo] Fac Inga, Dept Med, Maringa, Parana, Brazil	Universidade de Sao Paulo; Duke University; Universidade Federal do Rio Grande do Sul; Universidade Catolica de Pelotas; Universidade Federal de Pelotas; Duke University; Centro Universitario Inga (UNINGA)	Valentin, LSS (corresponding author), Univ Sao Paulo, Fac Med, Dept Anesthesia, LIM Lab Anesthesiol 8, Sao Paulo, SP, Brazil.	lssv@usp.br	Portela, Luis V/I-3410-2014; Oses, Jean Pierre/E-2534-2013; CARMONA, MARIA JOSÉ CARVALHO/G-3653-2014; Souza, Diogo/J-8894-2014	CARMONA, MARIA JOSÉ CARVALHO/0000-0002-3031-2924; Portela, Luis Valmor/0000-0001-6113-8466; Souza, Diogo/0000-0002-4322-0404; Oses, Jean Pierre/0000-0002-2012-273X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), [The state of Sao Paulo Research Foundation] [09/54233-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), [The state of Sao Paulo Research Foundation](Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Our Research was supported from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), [The state of Sao Paulo Research Foundation], no 09/54233-0. "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2009/54233-0, 2011-17932-8), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Programa DS e CAPES/Proap), Faculdade de Medicina (FMUSP), Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo (PRRG/USP).	Abdelmalak B, 2010, BMC ANESTHESIOL, V10, DOI 10.1186/1471-2253-10-11; Abildstrom H, 2000, ACTA ANAESTH SCAND, V44, P1246, DOI 10.1034/j.1399-6576.2000.441010.x; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Canet J, 2003, ACTA ANAESTH SCAND, V47, P1204, DOI 10.1046/j.1399-6576.2003.00238.x; Chen XG, 2001, ANESTH ANALG, V93, P1489, DOI 10.1097/00000539-200112000-00029; Cruz LN, 2013, CIENC SAUDE COLETIVA, V18, P1911, DOI 10.1590/S1413-81232013000700006; Damuleviciene G, 2010, MEDICINA-LITHUANIA, V46, P169, DOI 10.3390/medicina46030023; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Gaba V, 2007, ANESTH ANALG, V104, P1298, DOI 10.1213/01.ane.0000260372.38206.b3; Gomez-Hernandez J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-692; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Heyer EJ, 2003, ACTA ANAESTH SCAND, V47, P911; Jakobsson J, 2010, CURR OPIN ANESTHESIO, V23, P682, DOI 10.1097/ACO.0b013e32833ff302; Johnson T, 2002, ANESTHESIOLOGY, V96, P1351, DOI 10.1097/00000542-200206000-00014; Jungwirth B, 2009, MINI-REV MED CHEM, V9, P1568, DOI 10.2174/138955709791012229; Lopez OL, 2010, NEUROEPIDEMIOLOGY, V34, P63, DOI 10.1159/000264678; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; Rasmussen LS, 2005, ACTA ANAESTH SCAND, V49, P1573, DOI 10.1111/j.1399-6576.2005.00860.x; Strauss E, COMPENDIUM NEUROPSYC, V1, P1; Vachon P, 2003, CAN J VET RES, V67, P157; Yang GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078355	24	28	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0152308	10.1371/journal.pone.0152308	http://dx.doi.org/10.1371/journal.pone.0152308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152422	Green Published, gold, Green Submitted			2022-12-27	WOS:000375677000002
J	Cubells, JF; Schroeder, JP; Barrie, ES; Manvich, DF; Sadee, W; Berg, T; Mercer, K; Stowe, TA; Liles, LC; Squires, KE; Mezher, A; Curtin, P; Perdomo, DL; Szot, P; Weinshenker, D				Cubells, Joseph F.; Schroeder, Jason P.; Barrie, Elizabeth S.; Manvich, Daniel F.; Sadee, Wolfgang; Berg, Tiina; Mercer, Kristina; Stowe, Taylor A.; Liles, L. Cameron; Squires, Katherine E.; Mezher, Andrew; Curtin, Patrick; Perdomo, Dannie L.; Szot, Patricia; Weinshenker, David			Human Bacterial Artificial Chromosome (BAC) Transgenesis Fully Rescues Noradrenergic Function in Dopamine beta-Hydroxylase Knockout Mice	PLOS ONE			English	Article							NOREPINEPHRINE-DEFICIENT MICE; MESSENGER-RNA; LACKING NOREPINEPHRINE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; EXPRESSION; GENE; NORADRENALINE; PROMOTER	Dopamine beta-hydroxylase (DBH) converts dopamine (DA) to norepinephrine (NE) in noradrenergic/adrenergic cells. DBH deficiency prevents NE production and causes sympathetic failure, hypotension and ptosis in humans and mice; DBH knockout (Dbh -/-) mice reveal other NE deficiency phenotypes including embryonic lethality, delayed growth, and behavioral defects. Furthermore, a single nucleotide polymorphism (SNP) in the human DBH gene promoter (-970C>T; rs1611115) is associated with variation in serum DBH activity and with several neurological-and neuropsychiatric-related disorders, although its impact on DBH expression is controversial. Phenotypes associated with DBH deficiency are typically treated with L-3,4-dihydroxyphenylserine (DOPS), which can be converted to NE by aromatic acid decarboxylase (AADC) in the absence of DBH. In this study, we generated transgenic mice carrying a human bacterial artificial chromosome (BAC) encompassing the DBH coding locus as well as similar to 45 kb of upstream and similar to 107 kb of downstream sequence to address two issues. First, we characterized the neuroanatomical, neurochemical, physiological, and behavioral transgenic rescue of DBH deficiency by crossing the BAC onto a Dbh -/- background. Second, we compared human DBH mRNA abundance between transgenic lines carrying either a "C" or a "T" at position -970. The BAC transgene drove human DBH mRNA expression in a pattern indistinguishable from the endogenous gene, restored normal catecholamine levels to the peripheral organs and brain of Dbh -/- mice, and fully rescued embryonic lethality, delayed growth, ptosis, reduced exploratory activity, and seizure susceptibility. In some cases, transgenic rescue was superior to DOPS. However, allelic variation at the rs1611115 SNP had no impact on mRNA levels in any tissue. These results indicate that the human BAC contains all of the genetic information required for tissue-specific, functional expression of DBH and can rescue all measured Dbh deficiency phenotypes, but did not reveal an impact of the rs11115 variant on DBH expression in mice.	[Cubells, Joseph F.; Schroeder, Jason P.; Manvich, Daniel F.; Berg, Tiina; Mercer, Kristina; Stowe, Taylor A.; Liles, L. Cameron; Squires, Katherine E.; Mezher, Andrew; Curtin, Patrick; Weinshenker, David] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Cubells, Joseph F.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Emory Autism Ctr, Atlanta, GA USA; [Barrie, Elizabeth S.; Sadee, Wolfgang] Ohio State Univ, Coll Med, Ctr Pharmacogen, Columbus, OH 43210 USA; [Mercer, Kristina; Perdomo, Dannie L.] Emory Univ, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA; [Szot, Patricia] VA Puget Sound Hlth Care Syst, MIRECC, Seattle, WA USA; [Szot, Patricia] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Emory University; Emory University; University System of Ohio; Ohio State University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Weinshenker, D (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA.	dweinshenker@genetics.emory.edu	Barrie, Elizabeth S./AAB-8234-2019; Weinshenker, David/V-3998-2019; Cubells, Joe F./V-2543-2018	Barrie, Elizabeth S./0000-0002-1146-5001; Mezher, Andrew/0000-0002-9072-9510	National Institute of Neurological Disorders and Stroke [NS072712]; National Institute on Drug Abuse [DA027535, DA038453, DA015040]; National Institute of General Medical Sciences [GM 092655]; Ohio State University; Department of Veterans Affairs VISN 20 (Northwest Network) Mental Illness Research, Education, and Clinical Center (MIRECC);  [T32 DA015040]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038453, T32DA015040] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ohio State University(Ohio State University); Department of Veterans Affairs VISN 20 (Northwest Network) Mental Illness Research, Education, and Clinical Center (MIRECC)(US Department of Veterans Affairs); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Neurological Disorders and Stroke (NS072712 to JFC; http://www.ninds.nih.gov/), the National Institute on Drug Abuse (DA027535 and DA038453 to DW and DA015040 to DLP; https://www.drugabuse.gov/), the National Institute of General Medical Sciences (GM 092655 to WS; https://www.nigms.nih.gov/), the Ohio State University (Distinguished University Fellowship to ESB; http://www.gradsch.osu.edu/fellowship-program.html), and the Department of Veterans Affairs VISN 20 (Northwest Network) Mental Illness Research, Education, and Clinical Center (MIRECC) to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ellen Hess and Doug Bernhard for assistance with the HPLC experiments, and Dr. Michael J. Kuhar, Principal Investigator for T32 DA015040, which supported DLP for her role in the project.	Anderle P, 2006, J PHARMACOL EXP THER, V316, P636, DOI 10.1124/jpet.105.094615; Barrie ES, 2014, CIRC RES, V115, P1017, DOI 10.1161/CIRCRESAHA.116.304398; Bourdelat-Parks BN, 2005, PSYCHOPHARMACOLOGY, V183, P72, DOI 10.1007/s00213-005-0139-8; Chen YQ, 2011, AM J HYPERTENS, V24, P24, DOI 10.1038/ajh.2010.186; Chen YQ, 2010, J HYPERTENS, V28, P76, DOI 10.1097/HJH.0b013e328332bc87; Cryan JF, 2004, P NATL ACAD SCI USA, V101, P8186, DOI 10.1073/pnas.0401080101; Cubells JF, 2004, PSYCHOPHARMACOLOGY B; Gaval-Cruz M, 2008, PHARMACOL BIOCHEM BE, V89, P556, DOI 10.1016/j.pbb.2008.02.009; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; Hammerschmidt T, 2013, BIOL PSYCHIAT, V73, P454, DOI 10.1016/j.biopsych.2012.06.013; HOYLE GW, 1994, J NEUROSCI, V14, P2455; Hunsley MS, 2004, PHARMACOL BIOCHEM BE, V78, P765, DOI 10.1016/j.pbb.2004.05.008; in't Veld AJ Man, 1987, LANCET, V1, P183; Kim CH, 2002, AM J MED GENET, V108, P140, DOI 10.1002/ajmg.10196; KOBAYASHI K, 1989, NUCLEIC ACIDS RES, V17, P1089, DOI 10.1093/nar/17.3.1089; Kohnke MD, 2002, BIOL PSYCHIAT, V52, P1151; McMillan PJ, 2011, BRAIN RES, V1373, P240, DOI 10.1016/j.brainres.2010.12.015; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitchell HA, 2006, BIOL PSYCHIAT, V60, P1046, DOI 10.1016/j.biopsych.2006.03.057; Mitchell HA, 2008, PHARMACOL BIOCHEM BE, V91, P217, DOI 10.1016/j.pbb.2008.07.014; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Mustapic M, 2007, AM J MED GENET B, V144B, P1087, DOI 10.1002/ajmg.b.30526; Mustapic M, 2014, HUM MOL GENET, V23, P6375, DOI 10.1093/hmg/ddu332; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Olson VG, 2006, SCIENCE, V311, P1017, DOI 10.1126/science.1119311; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; ROBERTSON D, 1991, HYPERTENSION, V18, P1, DOI 10.1161/01.HYP.18.1.1; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Schank JR, 2006, NEUROPSYCHOPHARMACOL, V31, P2221, DOI 10.1038/sj.npp.1301000; Schroeder JP, 2010, NEUROPSYCHOPHARMACOL, V35, P2440, DOI 10.1038/npp.2010.127; Steiner RA, 2001, P NATL ACAD SCI USA, V98, P4184, DOI 10.1073/pnas.061445598; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Swoap SJ, 2006, J NEUROSCI, V26, P241, DOI 10.1523/JNEUROSCI.3721-05.2006; Swoap SJ, 2004, AM J PHYSIOL-REG I, V286, pR108, DOI 10.1152/ajpregu.00405.2003; Szot P, 1997, MOL BRAIN RES, V44, P46, DOI 10.1016/S0169-328X(96)00217-3; Szot P, 1999, J NEUROSCI, V19, P10985, DOI 10.1523/JNEUROSCI.19-24-10985.1999; Thomas SA, 1998, J NEUROCHEM, V70, P2468; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Weinshenker D, 2002, P NATL ACAD SCI USA, V99, P13873, DOI 10.1073/pnas.212519999; Weinshenker D, 2000, J NEUROSCI, V20, P3157, DOI 10.1523/JNEUROSCI.20-09-03157.2000; Weinshenker D, 2008, J NEUROCHEM, V105, P471, DOI 10.1111/j.1471-4159.2007.05145.x; WEINSHILBOUM R, 1971, CIRC RES, V28, P307, DOI 10.1161/01.RES.28.3.307; WEINSHILBOUM RM, 1975, AM J HUM GENET, V27, P573; WEINSHILBOUM RM, 1973, SCIENCE, V181, P943, DOI 10.1126/science.181.4103.943; Yang YP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng080; Zabetian CP, 2001, AM J HUM GENET, V68, P515, DOI 10.1086/318198	50	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154864	10.1371/journal.pone.0154864	http://dx.doi.org/10.1371/journal.pone.0154864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148966	Green Submitted, Green Published, gold			2022-12-27	WOS:000375676800074
J	Meaney, R; Hasking, P; Reupert, A				Meaney, Rebecca; Hasking, Penelope; Reupert, Andrea			Prevalence of Borderline Personality Disorder in University Samples: Systematic Review, Meta-Analysis and Meta-Regression	PLOS ONE			English	Review							GENDER-DIFFERENCES; SELF-REPORT; COMORBIDITY; COMMUNITY; FEATURES; ALCOHOL	Objective: To determine pooled prevalence of clinically significant traits or features of Borderline Personality Disorder among college students, and explore the influence of methodological factors on reported prevalence figures, and temporal trends. Data Sources: Electronic databases (1994-2014: AMED; Biological Abstracts; Embase; MEDLINE; Psy-cARTICLES; CINAHL Plus; Current Contents Connect; EBM Reviews; Google Scholar; Ovid Medline; Proquest central; PsychINFO; PubMed; Scopus; Taylor & Francis; Web of Science (1998-2014), and hand searches. Study Selection: Forty-three college-based studies reporting estimates of clinically significant BPD symptoms were identified (5.7% of original search). Data Extraction: One author (RM) extracted clinically relevant BPD prevalence estimates, year of publication, demographic variables, and method from each publication or through correspondence with the authors. Results: The prevalence of BPD in college samples ranged from 0.5% to 32.1%, with lifetime prevalence of 9.7% (95% CI, 7.7-12.0; p < .005). Methodological factors contributing considerable between-study heterogeneity in univariate meta-analyses were participant anonymity, incentive type, research focus and participant type. Study and sample characteristics related to between study heterogeneity were sample size, and self-identifying as Asian or "other" race. The prevalence of BPD varied over time: 7.8% (95% CI 4.2-13.9) between 1994 and 2000; 6.5% (95% CI 4.0-10.5) during 2001 to 2007; and 11.6%(95% CI 8.8-15.1) from 2008 to 2014, yet was not a source of heterogeneity (p = .09). Conclusions: BPD prevalence estimates are influenced by the methodological or study sample factors measured. There is a need for consistency in measurement across studies to increase reliability in establishing the scope and characteristics of those with BPD engaged in tertiary study.	[Meaney, Rebecca; Reupert, Andrea] Monash Univ, Fac Educ, Melbourne, Vic 3004, Australia; [Hasking, Penelope] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia	Monash University; Curtin University	Hasking, P (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia.	Penelope.Hasking@curtin.edu.au		Hasking, Penelope/0000-0002-0172-9288; Reupert, Andrea/0000-0003-1447-7769; Reupert, Andrea/0000-0003-2885-2814				Martinez AA, 2008, MED ORAL PATOL ORAL, V13, pE444; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; Arens EA, 2013, J PERS DISORD, V27, P196, DOI 10.1521/pedi.2013.27.2.196; Armstrong R, 2007, GUIDELINES SYSTEMATI; Banzhaf A, 2012, J PERS DISORD, V26, P368, DOI 10.1521/pedi.2012.26.3.368; BLASHFIELD R, 1992, COMPR PSYCHIAT, V33, P245, DOI 10.1016/0010-440X(92)90048-U; Borenstein M., 2009, INTRO METAANALYSIS; Caleb R, 2014, UNI COUNSELLING SERV; Cheavens JS, 2012, J CLIN PSYCHOL, V68, P477, DOI 10.1002/jclp.20870; Chien YL, 2011, COMPR PSYCHIAT, V52, P195, DOI 10.1016/j.comppsych.2010.03.009; Colman A., 2009, DICT PSYCHOL; Evans E, 2005, SUICIDE LIFE-THREAT, V35, P239, DOI 10.1521/suli.2005.35.3.239; First M. B., 1997, STRUCTURED CLIN INTE; Geiger PJ, 2014, PERS INDIV DIFFER, V59, P54, DOI 10.1016/j.paid.2013.11.005; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Gunderson JG, 2011, ARCH GEN PSYCHIAT, V68, P827, DOI 10.1001/archgenpsychiatry.2011.37; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Huprich SK, 2011, J PERS DISORD, V25, P557, DOI 10.1521/pedi.2011.25.5.557; Johnson DM, 2003, COMPR PSYCHIAT, V44, P284, DOI 10.1016/S0010-440X(03)00090-7; Kelley George A, 2012, World J Methodol, V2, P27, DOI 10.5662/wjm.v2.i4.27; Kernberg OF, 2009, AM J PSYCHIAT, V166, P505, DOI 10.1176/appi.ajp.2009.09020263; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; LORANGER AW, 1994, ARCH GEN PSYCHIAT, V51, P215; Maxwell SE, 2008, ANNU REV PSYCHOL, V59, P537, DOI 10.1146/annurev.psych.59.103006.093735; Meaney-Tavares R, 2013, J AM COLL HEALTH, V61, P303, DOI 10.1080/07448481.2013.791827; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Morey L.C., 1991, PERSONALITY ASSESSME; Norling DC, 2010, HDB CLIN PSYCHOL COM; Oltmanns TF, 2004, J RES PERS, V38, P216, DOI 10.1016/S0092-6566(03)00066-7; Pavony MT, 2013, J PERS DISORD, V27, P208, DOI 10.1521/pedi.2013.27.2.208; Peterson RA, 2001, J CONSUM RES, V28, P450, DOI 10.1086/323732; Pfohl B, 2009, J PERS DISORD, V23, P281, DOI 10.1521/pedi.2009.23.3.281; Pitman T, 2013, FUNDING CUTS POSE CH; Samuels J, 2011, INT REV PSYCHIATR, V23, P223, DOI 10.3109/09540261.2011.588200; Selby EA, 2013, PERSONAL DISORD, V4, P168, DOI 10.1037/a0029933; Siever LJ, 2002, BIOL PSYCHIAT, V51, P964, DOI 10.1016/S0006-3223(02)01326-4; Swannell SV, 2014, SUICIDE LIFE-THREAT, V44, P273, DOI 10.1111/sltb.12070; SWARTZ M, 1990, J PERSONALITY DISORD, V0004; Tadic A, 2009, PSYCHOPATHOLOGY, V42, P257, DOI 10.1159/000224149; Taylor J, 2008, PSYCHOL ASSESSMENT, V20, P351, DOI 10.1037/a0013452; Teisl MF, 2006, INT J PUBLIC OPIN R, V18, P364, DOI 10.1093/ijpor/edh106; Tomko RL, 2014, J PERS DISORD, V28, P734, DOI 10.1521/pedi_2012_26_093; Trull TJ, 2010, J PERS DISORD, V24, P412, DOI 10.1521/pedi.2010.24.4.412; United States Census Bureau, 2014, 281 COLL ENR SEX AG; Zanarini MC, 2003, J PERS DISORD, V17, P568, DOI 10.1521/pedi.17.6.568.25355; ZIMMERMAN M, 1990, ARCH GEN PSYCHIAT, V47, P527	49	38	38	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155439	10.1371/journal.pone.0155439	http://dx.doi.org/10.1371/journal.pone.0155439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM8CQ	27171206	Green Published, Green Submitted, gold			2022-12-27	WOS:000376588600109
J	Visser, C; Lashmar, SF; Van Marle-Koster, E; Poli, MA; Allain, D				Visser, Carina; Lashmar, Simon F.; Van Marle-Koster, Este; Poli, Mario A.; Allain, Daniel			Genetic Diversity and Population Structure in South African, French and Argentinian Angora Goats from Genome-Wide SNP Data	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; FLEECE TRAITS; SELECTION; CATTLE; TOOL	The Angora goat populations in Argentina (AR), France (FR) and South Africa (SA) have been kept geographically and genetically distinct. Due to country-specific selection and breeding strategies, there is a need to characterize the populations on a genetic level. In this study we analysed genetic variability of Angora goats from three distinct geographical regions using the standardized 50k Goat SNP Chip. A total of 104 goats (AR: 30; FR: 26; SA: 48) were genotyped. Heterozygosity values as well as inbreeding coefficients across all autosomes per population were calculated. Diversity, as measured by expected heterozygosity (HE) ranged from 0.371 in the SA population to 0.397 in the AR population. The SA goats were the only population with a positive average inbreeding coefficient value of 0.009. After merging the three datasets, standard QC and LD-pruning, 15 105 SNPs remained for further analyses. Principal component and clustering analyses were used to visualize individual relationships within and between populations. All SA Angora goats were separated from the others and formed a well-defined, unique cluster, while outliers were identified in the FR and AR breeds. Apparent admixture between the AR and FR populations was observed, while both these populations showed signs of having some common ancestry with the SA goats. LD averaged over adjacent loci within the three populations per chromosome were calculated. The highest LD values estimated across populations were observed in the shorter intervals across populations. The Ne for the Angora breed was estimated to be 149 animals ten generations ago indicating a declining trend. Results confirmed that geographic isolation and different selection strategies caused genetic distinctiveness between the populations.	[Visser, Carina; Lashmar, Simon F.; Van Marle-Koster, Este] Univ Pretoria, Dept Anim & Wildlife Sci, ZA-0002 Pretoria, South Africa; [Poli, Mario A.] CICVyA INTA, Inst Genet Ewald Favret, Hurlingham, Argentina; [Allain, Daniel] INRA, GenPhySe UMR1388, CS52627, F-31326 Castanet Tolosan, France	University of Pretoria; Instituto Nacional de Tecnologia Agropecuaria (INTA); INRAE	Visser, C (corresponding author), Univ Pretoria, Dept Anim & Wildlife Sci, ZA-0002 Pretoria, South Africa.	carina.visser@up.ac.za	Van Marle-Köster, Este/S-2197-2016; Allain, Daniel/AAT-6658-2020	Van Marle-Köster, Este/0000-0002-3672-6976; Lashmar, Simon/0000-0003-1798-6673; Visser, Carina/0000-0002-3335-4679	Instituto Nacional de Tecnologia Agropecuaria [PNBIO1131033]; National Research Foundation [KIC14011761093, TP13073024535]; University of Pretoria Genomics Research Institute	Instituto Nacional de Tecnologia Agropecuaria; National Research Foundation; University of Pretoria Genomics Research Institute	The Argentinian part (MP) of the project was financially supported by Instituto Nacional de Tecnologia Agropecuaria PNBIO1131033 project. The South African researchers acknowledge the National Research Foundation (grants KIC14011761093 (CV) and TP13073024535 (EVMK)) and the University of Pretoria Genomics Research Institute (CV) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD M, 2002, P 7 WORLD C GEN APPL; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allain D, 2006, SMALL RUMINANT RES, V65, P217, DOI 10.1016/j.smallrumres.2005.06.028; Allain D, 2003, LIVEST PROD SCI, V82, P129, DOI 10.1016/S0301-6226(03)00035-6; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Barbato M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00109; Brito L. F., 2014, P 10 WORLD C GEN APP; Brito LF, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0220-1; Buchmann R., 2014, GENESIS MANUAL; Cansdale G, 1970, ANIMALS BIBLE LANDS; Carillier C, 2013, J DAIRY SCI, V96, P7294, DOI 10.3168/jds.2013-6789; Corbin LJ, 2012, J ANIM BREED GENET, V129, P257, DOI 10.1111/j.1439-0388.2012.01003.x; Delport G. J., 1984, Proceedings of the 2nd World Congress on Sheep and Beef Cattle Breeding, 16-19 April 1984, Pretoria, South Africa., P393; Department of Agriculture Forestry and Fisheries, 2014, TRENDS AGR SECT; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gautier M, 2007, GENETICS, V177, P1059, DOI 10.1534/genetics.107.075804; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hunter L, 2001, SILK MOHAIR CASHMERE, P68; Janovsky E, 2015, AGR OUTLOOK 2015, P48; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Kijas JW, 2013, ANIM GENET, V44, P325, DOI 10.1111/age.12011; Larroque H, 2014, P 10 WORLD C GEN APP; Lashmar SF, 2015, S AFR J ANIM SCI, V45, P56, DOI 10.4314/sajas.v45i1.7; Lashmar SF, 2016, SMALL RUMIN IN PRESS; LEWONTIN RC, 1964, GENETICS, V49, P49; Lipkin E, 2009, GENETICS, V181, P691, DOI 10.1534/genetics.108.097402; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Makina SO, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00333; Mueller J, 1993, COMUNICACION TECNICA, V237; Pereira F, 2009, MOL BIOL EVOL, V26, P2765, DOI 10.1093/molbev/msp200; Petersen JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054997, 10.1371/journal.pone.0069819]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Schoeman SJ, 2010, LIVEST SCI, V130, P70, DOI 10.1016/j.livsci.2010.02.012; Snyman M. A., 1996, ANGORA GOAT MOHAIR, V38, P23; Snyman MA, 1996, LIVEST PROD SCI, V47, P1, DOI 10.1016/S0301-6226(96)01005-6; SVED J A, 1971, Theoretical Population Biology, V2, P125; Taddeo HR, 1998, SMALL RUMINANT RES, V28, P293, DOI 10.1016/S0921-4488(97)00091-6; Tosser-Klopp G, 2012, INT PLANT AN GEN C 2; Tosser-Klopp G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086227; VanLiere JM, 2008, THEOR POPUL BIOL, V74, P130, DOI 10.1016/j.tpb.2008.05.006; Visser C, 2014, SMALL RUMINANT RES, V121, P89, DOI 10.1016/j.smallrumres.2014.01.012; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	45	39	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154353	10.1371/journal.pone.0154353	http://dx.doi.org/10.1371/journal.pone.0154353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171175	Green Submitted, Green Published, gold			2022-12-27	WOS:000376588600059
J	Zhang, T; Yang, SB; Guo, R; Guo, JX				Zhang, Tao; Yang, Shaobo; Guo, Rui; Guo, Jixun			Warming and Nitrogen Addition Alter Photosynthetic Pigments, Sugars and Nutrients in a Temperate Meadow Ecosystem	PLOS ONE			English	Article							ELEMENTAL STOICHIOMETRY; SPECIES RICHNESS; CLIMATE-CHANGE; DEPOSITION; DROUGHT; ACCUMULATION; STEPPE; GROWTH; PHOSPHORUS; RESPONSES	Global warming and nitrogen (N) deposition have an important influence on terrestrial ecosystems; however, the influence of warming and N deposition on plant photosynthetic products and nutrient cycling in plants is not well understood. We examined the effects of 3 years of warming and N addition on the plant photosynthetic products, foliar chemistry and stoichiometric ratios of two dominant species, i.e., Leymus chinensis and Phragmites communis, in a temperate meadow in northeastern China. Warming significantly increased the chlorophyll content and soluble sugars in L. chinensis but had no impact on the carotenoid and fructose contents. N addition caused a significant increase in the carotenoid and fructose contents. Warming and N addition had little impact on the photosynthetic products of P. communis. Warming caused significant decreases in the N and phosphorus (P) concentrations and significantly increased the carbon (C):P and N:P ratios of L. chinensis, but not the C concentration or the C:N ratio. N addition significantly increased the N concentration, C:P and N:P ratios, but significantly reduced the C:N ratio of L. chinensis. Warming significantly increased P. communis C and P concentrations, and the C:N and C:P ratios, whereas N addition increased the C, N and P concentrations but had no impact on the stoichiometric variables. This study suggests that both warming and N addition have direct impacts on plant photosynthates and elemental stoichiometry, which may play a vital role in plant-mediated biogeochemical cycling in temperate meadow ecosystems.	[Zhang, Tao; Yang, Shaobo; Guo, Jixun] NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun, Peoples R China; [Guo, Rui] Chinese Acad Agr Sci, Key Lab Dryland Agr, Minist Agr, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China	Northeast Normal University - China; Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Zhang, T; Guo, JX (corresponding author), NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun, Peoples R China.	zhangt946@nenu.edu.cn; gjixun@nenu.edu.cn						Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bennett LT, 2003, PLANT ECOL, V164, P185, DOI 10.1023/A:1021253600712; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Contran N, 2013, PLANT BIOLOGY, V15, P157, DOI 10.1111/j.1438-8677.2012.00627.x; Cook C.W., 1986, RANGE RES BASIC PROB; Craine JM, 2008, NEW PHYTOL, V179, P829, DOI 10.1111/j.1469-8137.2008.02513.x; Cui QA, 2010, PLANT SOIL, V334, P209, DOI 10.1007/s11104-010-0375-5; De Boeck HJ, 2007, ENVIRON EXP BOT, V60, P95, DOI 10.1016/j.envexpbot.2006.07.001; De Schrijver A, 2011, GLOBAL ECOL BIOGEOGR, V20, P803, DOI 10.1111/j.1466-8238.2011.00652.x; Dijkstra FA, 2012, NEW PHYTOL, V196, P807, DOI 10.1111/j.1469-8137.2012.04349.x; EBELL LF, 1969, PHYTOCHEMISTRY, V8, P227, DOI 10.1016/S0031-9422(00)85818-5; Esmeijer-Liu AJ, 2009, PLANT SOIL, V316, P311, DOI 10.1007/s11104-008-9783-1; Fonty E, 2009, GLOBAL CHANGE BIOL, V15, P2360, DOI 10.1111/j.1365-2486.2009.01923.x; Geiger M, 1999, PLANT CELL ENVIRON, V22, P1177, DOI 10.1046/j.1365-3040.1999.00466.x; Granath G, 2009, OECOLOGIA, V159, P705, DOI 10.1007/s00442-008-1261-1; Han F, 2004, ACTA BOT BOREALI-OCC, V25, P2502; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; He CE, 2007, AGR ECOSYST ENVIRON, V121, P395, DOI 10.1016/j.agee.2006.12.016; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; IPCC, 2007, IPCC WGI 4 ASS REP C; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Jin B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-35; Liao XF, 2004, CHINESE J APPL ECOL, V15, P1349; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Moustakas M, 2011, PLANT GROWTH REGUL, V65, P315, DOI 10.1007/s10725-011-9604-z; Prieto P, 2009, ACTA PHYSIOL PLANT, V31, P729, DOI 10.1007/s11738-009-0285-4; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Ren F., 2010, ACTA ECOL SIN, V30, P166, DOI [10.1016/j.chnaes.2010.04.007, DOI 10.1016/J.CHNAES.2010.04.007]; Ren HY, 2011, ANN BOT-LONDON, V107, P145, DOI 10.1093/aob/mcq219; Richter A, 2005, NATURE, V437, P129, DOI 10.1038/nature04092; Rivas-Ubach A, 2012, P NATL ACAD SCI USA, V109, P4181, DOI 10.1073/pnas.1116092109; Sanaullah M, 2014, PLANT SOIL, V374, P767, DOI 10.1007/s11104-013-1890-y; Sardans J, 2008, PLANT SOIL, V306, P261, DOI 10.1007/s11104-008-9583-7; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Sardans J, 2008, GLOBAL CHANGE BIOL, V14, P2304, DOI 10.1111/j.1365-2486.2008.01656.x; Sardans J, 2012, PLANT PHYSIOL, V160, P1741, DOI 10.1104/pp.112.208785; Sardans J, 2012, BIOGEOCHEMISTRY, V111, P1, DOI 10.1007/s10533-011-9640-9; Shen HH, 2013, J PLANT ECOL, V6, P418, DOI 10.1093/jpe/rtt010; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Sun LT, 2013, J ATMOS SCI, V70, P2487, DOI 10.1175/JAS-D-12-0298.1; van den Berg LJL, 2011, GLOBAL CHANGE BIOL, V17, P1871, DOI 10.1111/j.1365-2486.2010.02345.x; Verheyen K, 2009, PLANT BIOLOGY, V11, P49, DOI 10.1111/j.1438-8677.2009.00214.x; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Yang YunFei, 1998, Acta Prataculturae Sinica, V7, P1; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100; Zhang NY, 2013, SOIL BIOL BIOCHEM, V65, P96, DOI 10.1016/j.soilbio.2013.05.015; Zhang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123160; Zhang Y, 2008, ATMOS ENVIRON, V42, P1035, DOI 10.1016/j.atmosenv.2007.12.015; Zhao CZ, 2009, CAN J FOREST RES, V39, P1, DOI 10.1139/X08-152; Zhao W, 2008, PLANT ECOL, V196, P85, DOI 10.1007/s11258-007-9336-3; Zhou LS, 2009, SOIL BIOL BIOCHEM, V41, P796, DOI 10.1016/j.soilbio.2009.01.019; Zhu T.C., 2004, YANG CAO	57	20	24	11	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155375	10.1371/journal.pone.0155375	http://dx.doi.org/10.1371/journal.pone.0155375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171176	gold, Green Published			2022-12-27	WOS:000376588600158
J	Aring;strom, DO; Aring;strom, C; Rekker, K; Indermitte, E; Orru, H				Astrom, Daniel Oudin; Astrom, Christofer; Rekker, Kaidi; Indermitte, Ene; Orru, Hans			High Summer Temperatures and Mortality in Estonia	PLOS ONE			English	Article							LAG NONLINEAR MODELS; HEAT WAVES; EUROPEAN CITIES; TIME-SERIES; CITY; DISPLACEMENT; MORBIDITY; DEATHS; IMPACT; COLD	Background On-going climate change is predicted to result in a growing number of extreme weather events-such as heat waves-throughout Europe. The effect of high temperatures and heat waves are already having an important impact on public health in terms of increased mortality, but studies from an Estonian setting are almost entirely missing. We investigated mortality in relation to high summer temperatures and the time course of mortality in a coastal and inland region of Estonia. Methods We collected daily mortality data and daily maximum temperature for a coastal and an inland region of Estonia. We applied a distributed lag non-linear model to investigate heat related mortality and the time course of mortality in Estonia. Results We found an immediate increase in mortality associated with temperatures exceeding the 75th percentile of summer maximum temperatures, corresponding to approximately 23 degrees C. This increase lasted for a couple of days in both regions. The total effect of elevated temperatures was not lessened by significant mortality displacement. Discussion We observed significantly increased mortality in Estonia, both on a country level as well as for a coastal region and an inland region with a more continental climate. Heat related mortality was higher in the inland region as compared to the coastal region, however, no statistically significant differences were observed. The lower risks in coastal areas could be due to lower maximum temperatures and cooling effects of the sea, but also better socioeconomic condition. Our results suggest that region specific estimates of the impacts of temperature extremes on mortality are needed.	[Astrom, Daniel Oudin; Astrom, Christofer; Rekker, Kaidi; Indermitte, Ene; Orru, Hans] Univ Tartu, Dept Family Med & Publ Hlth, Ulikooli 18, EE-50090 Tartu, Estonia; [Astrom, Daniel Oudin; Astrom, Christofer; Orru, Hans] Umea Univ, Dept Publ Hlth & Clin Med, Occupat & Environm Med, Umea, Sweden; [Astrom, Daniel Oudin] Lund Univ, Dept Clin Sci, Ctr Primary Hlth Care Res, Lund, Sweden; [Rekker, Kaidi] Tartu Hlth Care Coll, Tartu, Estonia	University of Tartu; Umea University; Lund University	Aring;strom, DO (corresponding author), Univ Tartu, Dept Family Med & Publ Hlth, Ulikooli 18, EE-50090 Tartu, Estonia.; Aring;strom, DO (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Occupat & Environm Med, Umea, Sweden.; Aring;strom, DO (corresponding author), Lund Univ, Dept Clin Sci, Ctr Primary Hlth Care Res, Lund, Sweden.	daniel.oudin_astrom@med.lu.se	Orru, Hans/B-1324-2019		EEA and Norway Grants Estonia grants within the project "Assessment of climate change impacts and elaboration adaptation instruments in the field of planning, land use, health and rescue management"; Estonian Ministry of Education and Research grant [IUT34-17]	EEA and Norway Grants Estonia grants within the project "Assessment of climate change impacts and elaboration adaptation instruments in the field of planning, land use, health and rescue management"; Estonian Ministry of Education and Research grant	This work was supported by EEA and Norway Grants Estonia grants within the project "Assessment of climate change impacts and elaboration adaptation instruments in the field of planning, land use, health and rescue management" and the Estonian Ministry of Education and Research grant IUT34-17 given to Hans Orru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Astrom DO, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0012-0; Astrom DO, 2011, MATURITAS, V69, P99, DOI 10.1016/j.maturitas.2011.03.008; Astrom DO, 1901, EVOLUTION MINIMUM MO, DOI [10.1289/ehp.1509692, DOI 10.1289/EHP.1509692]; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Barnett AG, 2010, ENVIRON RES, V110, P604, DOI 10.1016/j.envres.2010.05.006; Barriopedro D, 2011, SCIENCE, V332, P220, DOI 10.1126/science.1201224; D'Ippoliti D, 2010, RES IMPACT HEAT WAVE; de' Donato FK, 2015, INT J ENV RES PUB HE, V12, P15567, DOI 10.3390/ijerph121215006; Field C.B., 2012, MANAGING RISKS EXTRE; Franck U, 2013, METEOROL Z, V22, P167, DOI 10.1127/0941-2948/2013/0384; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A., 2015, LANCET; Gasparrini A, 2015, ENVIRON HEALTH PERSP, V123, P1200, DOI 10.1289/ehp.1409070; Gasparrini A, 2014, STAT MED, V33, P881, DOI 10.1002/sim.5963; Gasparrini A, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-1; Guo YM, 2014, EPIDEMIOLOGY, V25, P781, DOI 10.1097/EDE.0000000000000165; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Hanzlikova H, 2015, INT J BIOMETEOROL, V59, P1673, DOI 10.1007/s00484-015-0974-1; Hondula DM, 2013, J EPIDEMIOL COMMUN H, V67, P707, DOI 10.1136/jech-2012-202157; Kysely J, 2004, INT J BIOMETEOROL, V49, P91, DOI 10.1007/s00484-004-0218-2; Michelozzi P, 2006, J EPIDEMIOL COMMUN H, V60, P417, DOI 10.1136/jech.2005.040857; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Rekker K, 2013, EESTI ARST, V92; Rocklov J, 2011, OCCUP ENVIRON MED, V68, P531, DOI 10.1136/oem.2010.058818; Roose A SM, 2015, ASSESSMENT CLIMATE C; Saha MV, 2014, AM J EPIDEMIOL, V179, P467, DOI 10.1093/aje/kwt264; Schifano P, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-58; Shaposhnikov D, 2015, EPIDEMIOLOGY, V26, pE21, DOI 10.1097/EDE.0000000000000251; Vigotti MA, 2006, INT J BIOMETEOROL, V50, P335, DOI 10.1007/s00484-006-0035-x	32	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155045	10.1371/journal.pone.0155045	http://dx.doi.org/10.1371/journal.pone.0155045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167851	Green Published, gold			2022-12-27	WOS:000376587300045
J	Gao, X; Wang, YB; Randell, E; Pedram, P; Yi, YQ; Gulliver, W; Sun, G				Gao, Xiang; Wang, Yongbo; Randell, Edward; Pedram, Pardis; Yi, Yanqing; Gulliver, Wayne; Sun, Guang			Higher Dietary Choline and Betaine Intakes Are Associated with Better Body Composition in the Adult Population of Newfoundland, Canada	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; ENZYME-ACTIVITIES; FAT; SUPPLEMENTATION; OBESITY; WEIGHT; PERFORMANCE	Background Choline is an essential nutrient and betaine is an osmolyte and methyl donor. Both are important to maintain health including adequate lipid metabolism. Supplementation of dietary choline and betaine increase muscle mass and reduce body fat in animals. However, little data is available regarding the role of dietary choline and betaine on body composition in humans. Objective To investigate the association between dietary choline and betaine intakes with body composition in a large population based cross-sectional study. Design A total of 3214 subjects from the CODING (Complex Disease in Newfoundland population: Environment and Genetics) study were assessed. Dietary choline and betaine intakes were computed from the Willett Food Frequency questionnaire. Body composition was measured using dual-energy X-ray absorptiometry following a 12-hour fast. Major confounding factors including age, sex, total calorie intake and physical activity level were controlled in all analyses. Result Significantly inverse correlations were found between dietary choline and betaine intakes, with all obesity measurements: total percent body fat (%BF), percent trunk fat (%TF), percent android fat (%AF), percent gynoid fat (%GF) and anthropometrics: weight, body mass index, waist circumference, waist-to-hip ratio in both women and men (r range from -0.13 to -0.47 for choline and -0.09 to -0.26 for betaine, p<0.001 for all). Dietary choline intake had stronger association than betaine. Moreover, obese subjects had the lowest dietary choline and betaine intakes, with overweight subjects in the middle, and normal weight subjects consumed the highest dietary choline and betaine (p<0.001). Vice versa, when subjects were ranked according to dietary choline and betaine intakes, subjects with the highest intake of both had the lowest %TF, %AF, %GF, %BF and highest %LM among the groups in both sexes. Conclusion Our findings indicate that high dietary choline and betaine intakes are significantly associated with favorable body composition in humans.	[Gao, Xiang] Ocean Univ China, Coll Food Sci & Engn, 5 Yu Shan Rd, Qingdao, Shandong, Peoples R China; [Gao, Xiang; Wang, Yongbo; Randell, Edward; Pedram, Pardis; Yi, Yanqing; Gulliver, Wayne; Sun, Guang] Mem Univ Newfoundland, Fac Med, 300 Prince Philip Dr, St John, NF, Canada; [Wang, Yongbo] Dalian Med Univ, Affiliated Hosp 1, Dept Endocrinol, Dalian, Liaoning, Peoples R China	Ocean University of China; Memorial University Newfoundland; Dalian Medical University	Sun, G (corresponding author), Mem Univ Newfoundland, Fac Med, 300 Prince Philip Dr, St John, NF, Canada.	gsun@mun.ca			Canadian Institutes of Health Research (CIHR) [MOP192552]; National Natural Science Foundation of China [31371757]; State Key Program of National Natural Science Foundation of China [31330060]; China Scholarship Council	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This project has been funded by a Canadian Institutes of Health Research (CIHR) (operating grant: MOP192552) to Guang Sun. Xiang Gao was supported by grants from National Natural Science Foundation of China (No. 31371757), State Key Program of National Natural Science Foundation of China (No. 31330060) and supported by the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella JM, 2013, EUR J APPL PHYSIOL, V113, P793, DOI 10.1007/s00421-012-2492-8; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bray GA., 2003, CONT DIAGNOSIS MANAG; BUCHMAN AL, 1995, HEPATOLOGY, V22, P1399, DOI 10.1002/hep.1840220510; Cahill F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058278; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chen YM, 2015, INT J OBESITY, V39, P465, DOI 10.1038/ijo.2014.158; Cheskin LJ, 1999, SOUTHERN MED J, V92, P898, DOI 10.1097/00007611-199909000-00009; Cholewa JM, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-39; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; DAILY JW, 1995, J NUTR, V125, P1938, DOI 10.1093/jn/125.7.1938; Daily JW, 1998, J NUTR BIOCHEM, V9, P464, DOI 10.1016/S0955-2863(98)00044-8; del Favero S, 2012, AMINO ACIDS, V42, P2299, DOI 10.1007/s00726-011-0972-5; Eny KM, 2008, PHYSIOL GENOMICS, V33, P355, DOI 10.1152/physiolgenomics.00148.2007; Feng Jie, 2001, Journal of Zhejiang University (Agriculture and Life Sciences), V27, P107; Fontaine-Bisson B, 2014, AM J CLIN NUTR, V99, P384, DOI 10.3945/ajcn.113.073387; Fontaine-Bisson B, 2009, ATHEROSCLEROSIS, V204, P465, DOI 10.1016/j.atherosclerosis.2008.10.037; Food and Nutrition Board Institute of Medicine, 1998, DIET REF INT THIAM R, P390; Garcia OP, 2009, NUTR REV, V67, P559, DOI 10.1111/j.1753-4887.2009.00228.x; Hamlin Joanna C, 2013, Autism Res Treat, V2013, P578429, DOI 10.1155/2013/578429; Harmeyer J., 2002, Lohmann Information, P15; Hassan R. A., 2005, International Journal of Poultry Science, V4, P840; Hongu N, 2000, J NUTR, V130, P152, DOI 10.1093/jn/130.2.152; Hu FB, 2008, OBESITY EPIDEMIOLOGY, P275; Huang QC, 2008, ANIM FEED SCI TECH, V140, P365, DOI 10.1016/j.anifeedsci.2007.03.007; Huang QC, 2007, J ANIM PHYSIOL AN N, V91, P85, DOI 10.1111/j.1439-0396.2006.00644.x; Huang QC, 2006, LIVEST SCI, V105, P78, DOI 10.1016/j.livsci.2006.04.031; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Kennedy AP, 2009, OBESITY, V17, P2094, DOI 10.1038/oby.2009.101; KLESGES RC, 1992, AM J CLIN NUTR, V55, P818, DOI 10.1093/ajcn/55.4.818; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lawrence BV, 2002, J ANIM SCI, V80, P475; Leermakers ETM, 2015, NUTR REV, V73, P500, DOI 10.1093/nutrit/nuv010; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Liu L, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-49; Lovejoy JC, 1998, J WOMENS HEALTH, V7, P1247, DOI 10.1089/jwh.1998.7.1247; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; MORRIS MJ, 2014, NEUROSCI BIOBEHAV R, DOI DOI 10.1016/J.NEUBIOREV.2014.12.002; Nagata C, 2015, J NUTR, V145, P1787, DOI 10.3945/jn.114.209296; Najib S, 2005, J MOL ENDOCRINOL, V34, P119, DOI 10.1677/jme.1.01581; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Paradis AM, 2009, BRIT J NUTR, V101, P1103, DOI 10.1017/S0007114508055645; Garcia OP, 2013, NUTRIENTS, V5, P5012, DOI 10.3390/nu5125012; Pedram P, 2015, NUTRIENTS, V7, P223, DOI 10.3390/nu7010223; Penry JT, 2008, INT J SPORT NUTR EXE, V18, P191, DOI 10.1123/ijsnem.18.2.191; Pocock SJ, 2004, BMJ-BRIT MED J, V329, P883, DOI 10.1136/bmj.38250.571088.55; POLLMANN DS, 1980, J ANIM SCI, V51, P577, DOI 10.2527/jas1980.513577x; Rajaie S, 2011, ARYA ATHEROSCLER, V7, P78; Raubenheimer PJ, 2006, DIABETES, V55, P2015, DOI 10.2337/db06-0097; SAUNDERSON CL, 1990, BRIT J NUTR, V63, P339, DOI 10.1079/BJN19900120; Schoeller DA, 2005, J AM DIET ASSOC, V105, pS24, DOI 10.1016/j.jada.2005.02.025; Schwab U, 2002, AM J CLIN NUTR, V76, P961, DOI 10.1093/ajcn/76.5.961; Shea JL, 2012, NUTR METAB CARDIOVAS, V22, P741, DOI 10.1016/j.numecd.2010.11.009; Siljander-Rasi H, 2003, ANIM SCI, V76, P55, DOI 10.1017/S1357729800053315; SLATTERY ML, 1992, AM J CLIN NUTR, V55, P943, DOI 10.1093/ajcn/55.5.943; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; STOLL B, 1992, BIOCHEM J, V287, P217, DOI 10.1042/bj2870217; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Sun G, 2005, DIABETES, V54, P3336, DOI 10.2337/diabetes.54.11.3336; Sun G, 2005, AM J CLIN NUTR, V81, P74; Suter PM, 2005, CRIT REV CL LAB SCI, V42, P197, DOI 10.1080/10408360590913542; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Vennemann FBC, 2015, BRIT J NUTR, V114, P2046, DOI 10.1017/S0007114515003700; Wallace TC, 2016, J AM COLL NUTR, V35, P108, DOI 10.1080/07315724.2015.1080127; Westerterp KR, 1997, INT J OBESITY, V21, P184, DOI 10.1038/sj.ijo.0800385; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; World Health Organization (WHO), 2000, WHO TECHN REP SER, P256, DOI DOI 10.1007/978-0-387-71799-9_454; WU GC, 2012, J APPL MATH, DOI DOI 10.1155/2012/; Xing JY, 2011, MOL BIOL REP, V38, P1975, DOI 10.1007/s11033-010-0319-4; Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x	72	42	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155403	10.1371/journal.pone.0155403	http://dx.doi.org/10.1371/journal.pone.0155403			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27166611	gold, Green Published, Green Submitted			2022-12-27	WOS:000376587300046
J	Marschalek, J; Farr, A; Kiss, H; Hagmann, M; Gobl, CS; Trofaier, ML; Kueronya, V; Petricevic, L				Marschalek, Julian; Farr, Alex; Kiss, Herbert; Hagmann, Michael; Gobl, Christian S.; Trofaier, Marie-Louise; Kueronya, Verena; Petricevic, Ljubomir			Risk of Vaginal Infections at Early Gestation in Patients with Diabetic Conditions during Pregnancy: A Retrospective Cohort Study	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; PRETERM BIRTH; WOMEN; PREVALENCE; CANDIDIASIS; PREVENTION; FREQUENCY; MELLITUS; DELIVERY; FUNGI	Pregnant women with gestational diabetes mellitus (GDM) are reported to be at increased risk for infections of the genital tract. This study aimed to compare the prevalence of asymptomatic bacterial vaginosis (BV) and Candida colonization at early gestation between pregnant women with and without diabetic conditions during pregnancy. We included data from 8, 486 singleton pregnancies that underwent an antenatal infection screen-and-treat programme at our department. All women with GDM or pre-existing diabetes were retrospectively assigned to the diabetic group (DIAB), whereas non-diabetic women served as controls (CON). Prevalence for BV and Candida colonization was 9% and 14% in the DIAB group, and 9% and 13% in the CON group, respectively (n.s.). No significant difference regarding stillbirth and preterm delivery (PTD), defined as a delivery earlier than 37 + 0 (37 weeks plus 0 days) weeks of gestation was found. We could not find an increased risk of colonization with vaginal pathogens at early gestation in pregnant women with diabetes, compared to non-diabetic women. Large prospective studies are needed to evaluate the long-term risk of colonization with vaginal pathogens during the course of pregnancy in these women.	[Marschalek, Julian; Farr, Alex; Kiss, Herbert; Gobl, Christian S.; Trofaier, Marie-Louise; Kueronya, Verena; Petricevic, Ljubomir] Med Univ Vienna, Div Obstet & Fetomaternal Med, Dept Obstet & Gynaecol, Vienna, Austria; [Hagmann, Michael] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat IMS, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Petricevic, L (corresponding author), Med Univ Vienna, Div Obstet & Fetomaternal Med, Dept Obstet & Gynaecol, Vienna, Austria.	ljubomir.petricevic@meduniwien.ac.at						[Anonymous], 2007, Wien Klin Wochenschr, V119, P5; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Coustan DR, 2013, CLIN CHEM, V59, P1310, DOI 10.1373/clinchem.2013.203331; Farr A, 2015, BIRTH IN PRESS; Farr A, 2015, ACTA OBSTET GYN SCAN, V94, P989, DOI 10.1111/aogs.12697; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Guggenheimer J, 2000, ORAL SURG ORAL MED O, V89, P570, DOI 10.1067/moe.2000.104477; Hirji I, 2012, J DIABETES COMPLICAT, V26, P501, DOI 10.1016/j.jdiacomp.2012.06.012; HOOSEN AA, 1993, SEX TRANSM DIS, V20, P265, DOI 10.1097/00007435-199309000-00005; Kiss H, 2004, BMJ-BRIT MED J, V329, P371, DOI 10.1136/bmj.38169.519653.EB; Lamont RF, 2011, AM J OBSTET GYNECOL, V205, P177, DOI 10.1016/j.ajog.2011.03.047; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Mazziotti F, 1997, Ann Ist Super Sanita, V33, P343; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Nowakowska D, 2004, APMIS, V112, P374, DOI 10.1111/j.1600-0463.2004.apm1120608.x; Nowakowska D, 2004, ACTA OBSTET GYN SCAN, V83, P251, DOI 10.1111/j.0001-6349.2004.0361.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Ogden CL, 2013, NCHS DATA BRIEF, V131, P1; Parma M, 2014, ALTERN THER HEALTH M, V20, P52; Parveen N, 2008, JCPSP-J COLL PHYSICI, V18, P154, DOI 03.2008/JCPSP.154157; Petricevic L, 2008, BJOG-INT J OBSTET GY, V115, P1369, DOI 10.1111/j.1471-0528.2008.01882.x; Rahman T, 1991, Indian J Med Sci, V45, P212; Roberts CL, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-18; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Sacks DA, 2012, DIABETES CARE, V35, P526, DOI 10.2337/dc11-1641; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; SPERNOL R, 1985, WIEN MED WOCHENSCHR, V135, P65; STAMLER EF, 1990, AM J OBSTET GYNECOL, V163, P1217, DOI 10.1016/0002-9378(90)90694-3; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155182	10.1371/journal.pone.0155182	http://dx.doi.org/10.1371/journal.pone.0155182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167850	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300087
J	Miyamoto, T; Kashima, H; Yamada, Y; Kobara, H; Asaka, R; Ando, H; Higuchi, S; Ida, K; Mvunta, DH; Shiozawa, T				Miyamoto, Tsutomu; Kashima, Hiroyasu; Yamada, Yasushi; Kobara, Hisanori; Asaka, Ryoichi; Ando, Hirofumi; Higuchi, Shotaro; Ida, Koichi; Mvunta, David Hamisi; Shiozawa, Tanri			Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; NEUTROPHIL-GELATINASE; UP-REGULATION; OVARIAN-CANCER; PHASE-II; NGAL; EXPRESSION; INVASION; RECEPTOR; IRON	Purpose Lipocalin 2 (LCN2) is a secretory protein that is involved in various physiological processes including iron transport. We previously identified LCN2 as an up-regulated gene in endometrial carcinoma, and found that the overexpression of LCN2 and its receptor, SLC22A17, was associated with a poor prognosis. However, the functions and mechanism of action of LCN2 currently remain unclear. Methods The LCN2-overexpressing endometrial carcinoma cell lines, HHUA and RL95-2, and LCN2-low-expressing one, HEC1B, were used. The effects of LCN2 on cell migration, cell viability, and apoptosis under various stresses, including ultraviolet (UV) irradiation and cisplatin treatment, were examined using the scratch wound healing assay, WST-1 assay, and Apostrand assay, respectively. Results LCN2-silencing using shRNA method significantly reduced the migration ability of cells (p<0.05). Cytotoxic stresses significantly decreased the viability of LCN2-silenced cells more than that of control cells. In contrast, LCN2 overexpression was significantly increased cisplatin resistance. These effects were canceled by the addition of the iron chelator, deferoxamine. After UV irradiation, the expression of phosphorylated Akt (pAkt) was decreased in LCN2-silenced cells, and the PI3K inhibitor canceled the difference induced in UV sensitivity by LCN2. The cisplatin-induced expression of pAkt was not affected by LCN2; however, the expression of p53 and p21 was increased by LCN2-silencing. Conclusions These results indicated that LCN2 was involved in the migration and survival of endometrial carcinoma cells under various stresses in an iron-dependent manner. The survival function of LCN2 may be exerted through the PI3K pathway and suppression of the p53-p21 pathway. These functions of LCN2 may increase the malignant potential of endometrial carcinoma cells.	[Miyamoto, Tsutomu; Kashima, Hiroyasu; Yamada, Yasushi; Kobara, Hisanori; Asaka, Ryoichi; Ando, Hirofumi; Higuchi, Shotaro; Ida, Koichi; Mvunta, David Hamisi; Shiozawa, Tanri] Shinshu Univ, Sch Med, Dept Obstet & Gynecol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan	Shinshu University	Miyamoto, T (corresponding author), Shinshu Univ, Sch Med, Dept Obstet & Gynecol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	tmiya@shinshu-u.ac.jp	Asaka, Ryoichi/T-1762-2019; Mvunta, David/AAJ-8504-2021; ASAKA, RYOICHI/ADR-3444-2022; Miyamoto, Tsutomu/ADW-0798-2022	Mvunta, David/0000-0003-1729-9523; Miyamoto, Tsutomu/0000-0002-1513-9473; Asaka, Ryoichi/0000-0003-4450-5142; Ando, Hirofumi/0000-0001-6640-9886	JSPS [22591852, 25293339]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html) Grant Number 22591852 (HK), 25293339 (TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by JSPS KAKENHI Grant Number 22591852, 25293339.	Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; [Anonymous], TREND MORT RAT CANC; [Anonymous], 2015, UT NEOPL NCCN CLIN P; Batista LFZ, 2009, MOL CANCER RES, V7, P237, DOI 10.1158/1541-7786.MCR-08-0428; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Cho H, 2009, J HISTOCHEM CYTOCHEM, V57, P513, DOI 10.1369/jhc.2009.953257; Chung TW, 2013, BBA-MOL CELL RES, V1833, P3386, DOI 10.1016/j.bbamcr.2013.10.011; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Ding GX, 2015, PROSTATE, V75, P957, DOI 10.1002/pros.22978; Ferlay J, 2013, IARC CANCERBASE; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Halabian R, 2013, CELL STRESS CHAPERON, V18, P785, DOI 10.1007/s12192-013-0430-2; HINODE D, 1991, INFECT IMMUN, V59, P3060, DOI 10.1128/IAI.59.9.3060-3068.1991; HRABARENEVEY S, 1989, ONCOGENE, V4, P601; Hu LM, 2009, LAB INVEST, V89, P531, DOI 10.1038/labinvest.2009.17; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; ISHIWATA I, 1984, GYNECOL ONCOL, V17, P281, DOI 10.1016/0090-8258(84)90212-9; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kobara H, 2013, PLACENTA, V34, P1036, DOI 10.1016/j.placenta.2013.08.004; KURAMOTO H, 1972, Acta Obstetrica et Gynaecologica Japonica (English Edition), V19, P47; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; Lee EK, 2011, INT J ONCOL, V38, P325, DOI 10.3892/ijo.2010.854; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Leung L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046677; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Lin HH, 2011, INT J BIOL SCI, V7, P74, DOI 10.7150/ijbs.7.74; Miyamoto T, 2011, EXP MOL PATHOL, V91, P563, DOI 10.1016/j.yexmp.2011.06.002; Miyamoto T, 2011, HUM PATHOL, V42, P1265, DOI 10.1016/j.humpath.2010.07.027; Mowla SN, 2014, AGING CELL, V13, P773, DOI 10.1111/acel.12242; Nishida M, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P1103; Oza AM, 2011, J CLIN ONCOL, V29, P3278, DOI 10.1200/JCO.2010.34.1578; Ray-Coquard I, 2013, BRIT J CANCER, V108, P1771, DOI 10.1038/bjc.2013.183; RICHARDSON GS, 1984, GYNECOL ONCOL, V17, P213, DOI 10.1016/0090-8258(84)90080-5; Roudkenar MH, 2008, ARCH MED RES, V39, P560, DOI 10.1016/j.arcmed.2008.05.003; Roudkenar MH, 2007, J RADIAT RES, V48, P39, DOI 10.1269/jrr.06057; Salakos N, 2007, EUR J GYNAECOL ONCOL, V28, P239; Seth P, 2002, CANCER RES, V62, P4540; Shiozawa T, 2001, ENDOCRINOLOGY, V142, P4182, DOI 10.1210/en.142.10.4182; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; Surveillance Epidemiology and End Results (SEER) Program, TURN CANC DAT DISC; Wang GL, 2014, INT J BIOL SCI, V10, P798, DOI 10.7150/ijbs.9470; Wang PH, 2011, REPROD SCI, V18, P447, DOI 10.1177/1933719110395407; WAY DL, 1983, IN VITRO CELL DEV B, V19, P147; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Zhan M, 2004, HISTOL HISTOPATHOL, V19, P915, DOI 10.14670/HH-19.915; Zhang HH, 2007, J CLIN PATHOL, V60, P555, DOI 10.1136/jcp.2006.039297; Zheng LT, 2009, J NEUROCHEM, V111, P1238, DOI 10.1111/j.1471-4159.2009.06410.x	48	21	22	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155220	10.1371/journal.pone.0155220	http://dx.doi.org/10.1371/journal.pone.0155220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168162	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300057
J	Takenaka, N; Nihata, Y; Satoh, T				Takenaka, Nobuyuki; Nihata, Yuma; Satoh, Takaya			Rac1 Activation Caused by Membrane Translocation of a Guanine Nucleotide Exchange Factor in Akt2-Mediated Insulin Signaling in Mouse Skeletal Muscle	PLOS ONE			English	Article							STIMULATED GLUCOSE-UPTAKE; SMALL GTPASE RAC1; GLUT4 TRANSLOCATION; PLASMA-MEMBRANE; RALA DOWNSTREAM; PROTEIN; CELLS; ADIPOCYTES; PHOSPHORYLATION; TRANSPORT	Insulin-stimulated glucose uptake in skeletal muscle is mediated by the glucose transporter GLUT4, which is translocated to the plasma membrane following insulin stimulation. Several lines of evidence suggested that the protein kinase Akt2 plays a key role in this insulin action. The small GTPase Rac1 has also been implicated as a regulator of insulin-stimulated GLUT4 translocation, acting downstream of Akt2. However, the mechanisms whereby Akt2 regulates Rac1 activity remain obscure. The guanine nucleotide exchange factor FLJ00068 has been identified as a direct regulator of Rac1 in Akt2-mediated signaling, but its characterization was performed mostly in cultured myoblasts. Here, we provide in vivo evidence that FLJ00068 indeed acts downstream of Akt2 as a Rac1 regulator by using mouse skeletal muscle. Small interfering RNA knockdown of FLJ00068 markedly diminished GLUT4 translocation to the sarcolemma following insulin administration or ectopic expression of a constitutively activated mutant of either phosphoinositide 3-kinase or Akt2. Additionally, insulin and these constitutively activated mutants caused the activation of Rac1 as shown by immunofluorescent microscopy using a polypeptide probe specific to activated Rac1 in isolated gastrocnemius muscle fibers and frozen sections of gastrocnemius muscle. This Rac1 activation was also abrogated by FLJ00068 knockdown. Furthermore, we observed translocation of FLJ00068 to the cell periphery following insulin stimulation in cultured myoblasts. Localization of FLJ00068 in the plasma membrane in insulin-stimulated, but not unstimulated, myoblasts and mouse gastrocnemius muscle was further affirmed by subcellular fractionation and subsequent immunoblotting. Collectively, these results strongly support a critical role of FLJ00068 in Akt2-mediated Rac1 activation in mouse skeletal muscle insulin signaling.	[Takenaka, Nobuyuki; Nihata, Yuma; Satoh, Takaya] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Cell Biol Lab, Sakai, Osaka 591, Japan	Osaka Metropolitan University	Satoh, T (corresponding author), Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Cell Biol Lab, Sakai, Osaka 591, Japan.	tkysato@b.s.osakafu-u.ac.jp	Satoh, Takaya/K-2628-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan [24657140]; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation)	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number, 24657140; URL, https://www.jsps.go.jp/) to TS and a grant from the Naito Foundation (no grant number; URL, https://www.naito-f.or.jp/) to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamatsias D, 2011, J BIOL CHEM, V286, P43229, DOI 10.1074/jbc.M111.306621; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Baumeister MA, 2006, BIOCHEM J, V400, P563, DOI 10.1042/BJ20061020; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Bielnicki JA, 2011, J BIOL CHEM, V286, P35163, DOI 10.1074/jbc.M111.270918; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Chiu TT, 2013, J BIOL CHEM, V288, P17520, DOI 10.1074/jbc.M113.467647; Gupta M, 2013, J BIOL CHEM, V288, P14522, DOI 10.1074/jbc.M112.430371; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ishikawa K, 2005, AM J HUM GENET, V77, P280, DOI 10.1086/432518; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Khayat ZA, 2000, J CELL SCI, V113, P279; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; LEE AD, 1995, FEBS LETT, V361, P51, DOI 10.1016/0014-5793(95)00147-2; Li J, 2012, DEV CELL, V22, P1286, DOI 10.1016/j.devcel.2012.03.004; MARCUSOHN J, 1995, CURR BIOL, V5, P1296, DOI 10.1016/S0960-9822(95)00256-9; Nagano K, 2015, INT J BIOCHEM CELL B, V62, P62, DOI 10.1016/j.biocel.2015.02.013; Nozaki S, 2013, CELL SIGNAL, V25, P1361, DOI 10.1016/j.cellsig.2013.02.023; Nozaki S, 2012, CELL SIGNAL, V24, P2111, DOI 10.1016/j.cellsig.2012.07.013; Petsakou A, 2015, CELL, V162, P823, DOI 10.1016/j.cell.2015.07.010; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 2005, BIOCHEM BIOPH RES CO, V332, P880, DOI 10.1016/j.bbrc.2005.05.027; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Satoh T, 2014, INT J MOL SCI, V15, P18677, DOI 10.3390/ijms151018677; Sylow L, 2014, CELL SIGNAL, V26, P323, DOI 10.1016/j.cellsig.2013.11.007; Sylow L, 2013, DIABETES, V62, P1865, DOI 10.2337/db12-1148; Sylow L, 2013, DIABETES, V62, P1139, DOI 10.2337/db12-0491; Takenaka N, 2015, BIOCHEM J, V469, P445, DOI 10.1042/BJ20150218; Takenaka N, 2015, ANAL BIOCHEM, V476, P5, DOI 10.1016/j.ab.2014.09.013; Takenaka N, 2014, CELL SIGNAL, V26, P2460, DOI 10.1016/j.cellsig.2014.07.002; Takenaka N, 2014, FEBS J, V281, P1493, DOI 10.1111/febs.12719; Tsuchiya A, 2014, J PHARMACOL SCI, V126, P337, DOI 10.1254/jphs.14182FP; Ueda S, 2008, BIOL CELL, V100, P645, DOI 10.1042/BC20070160; Ueda S, 2010, FASEB J, V24, P2254, DOI 10.1096/fj.09-137380; Xie XY, 2011, CELL METAB, V14, P378, DOI 10.1016/j.cmet.2011.06.015; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	44	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155292	10.1371/journal.pone.0155292	http://dx.doi.org/10.1371/journal.pone.0155292			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163697	gold, Green Published, Green Submitted			2022-12-27	WOS:000376585700036
J	Kala, R; Tollefsbol, TO				Kala, Rishabh; Tollefsbol, Trygve O.			A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-alpha (ER alpha) Expression in ER alpha-Negative Breast Cancer Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITION; REACTIVATION; ACTIVATION; PROMOTER; SIRT1; HYPERMETHYLATION; METHYLATION; SENSITIVITY; MECHANISMS; COMPLEXES	Breast cancer is the second most common cancer and a leading cause of cancer death in women. Specifically, estrogen receptor-alpha (ER alpha)-negative breast cancers are clinically more aggressive and normally do not respond to conventional hormone-directed therapies such as tamoxifen. Although epigenetic-based therapies such as 5-aza-2'-deoxycytidine and/or trichostatin A as DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibitors, respectively, can regulate the expression of ER alpha, this can often lead to a number of side effects. Plant-based dietary compounds such as resveratrol and pterostilbene in novel combinatorial therapy provides new avenues to target these side effects and provide similar results with a higher level of safety. Here, we report that combinatorial resveratrol and pterostilbene leads to the reactivation of ER alpha expression in ER alpha-negative breast cancer cells in a time-dependent manner. Chromatin immunoprecipitation analysis of the ER alpha promoter in each cell type revealed an increase in enrichment of acetyl-H3, acetyl-H3lysine9 (H3K9) and acetyl-H4 active chromatin markers in the ER alpha promoter region after combinatorial treatment. This treatment also resulted in a significant change in HDAC and histone acetyl transferase (HAT) enzyme activity in these cells after 3 days of treatments. The combination resulted in a significant decrease in DNMT enzyme activity and 5-methylcytosine levels in MDA-MB-157 breast cancer cells. Moreover, reactivation of ER alpha expression by resveratrol combined with pterostilbene was found to sensitize ERa-dependent response to 17 beta-estradiol (E2)-mediated cellular proliferation and antagonist 4-hydroxytamoxifen (4-OHT)-mediated inhibition of cellular proliferation in ER alpha-negative breast cancer cells. E2 and 4-OHT further affected the ER alpha-responsive downstream progesterone receptor (PGR) gene in ER alpha reactivated MDA-MB-157 cells. Collectively, our findings provide a new and safer way of restoring ERa expression by regulating epigenetic mechanisms with the use of phyto-chemicals in combinatorial therapy. This combination can further provide effective treatment options for hormonal refractory breast cancer with available anti-hormonal therapy.	[Kala, Rishabh; Tollefsbol, Trygve O.] Univ Alabama Birmingham, Dept Biol, 1300 Univ Blvd, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Comprehens Ctr Hlth Aging, 1530 3rd Ave South, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Comprehens Canc, 1802 6th Ave South, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Nutr Obes Res Ctr, 1675 Univ Blvd, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Comprehens Diabet Ctr, 1825 Univ Blvd, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Tollefsbol, TO (corresponding author), Univ Alabama Birmingham, Dept Biol, 1300 Univ Blvd, Birmingham, AL 35294 USA.; Tollefsbol, TO (corresponding author), Univ Alabama Birmingham, Comprehens Ctr Hlth Aging, 1530 3rd Ave South, Birmingham, AL 35294 USA.; Tollefsbol, TO (corresponding author), Univ Alabama Birmingham, Ctr Comprehens Canc, 1802 6th Ave South, Birmingham, AL 35294 USA.; Tollefsbol, TO (corresponding author), Univ Alabama Birmingham, Nutr Obes Res Ctr, 1675 Univ Blvd, Birmingham, AL 35294 USA.; Tollefsbol, TO (corresponding author), Univ Alabama Birmingham, Comprehens Diabet Ctr, 1825 Univ Blvd, Birmingham, AL 35294 USA.	trygve@uab.edu	Kala, Rishabh/AAR-1625-2020	Tollefsbol, Trygve/0000-0002-0284-1511	NCI [ROI CA178441]; American Institute for Cancer Research [316184]; NATIONAL CANCER INSTITUTE [R01CA178441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the NCI (ROI CA178441) and the American Institute for Cancer Research (316184).	Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Gracia A, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0411-9; Kala R., 2012, J NUTR FOOD SCI S, VS5; Kala R, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1693-z; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Laird PW, 1996, ANNU REV GENET, V30, P441, DOI 10.1146/annurev.genet.30.1.441; Li YY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-9; Li YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-274; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Macaluso M, 2003, ONCOGENE, V22, P3511, DOI 10.1038/sj.onc.1206578; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Meeran SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037748; Meeran SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011457; Mirza S, 2013, J BREAST CANCER, V16, P23, DOI 10.4048/jbc.2013.16.1.23; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Saldanha SN, 2014, EXP CELL RES, V324, P40, DOI 10.1016/j.yexcr.2014.01.024; Saxena Neeraj K, 2010, Mol Cell Pharmacol, V2, P191; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Sharma D, 2005, MOL ENDOCRINOL, V19, P1740, DOI 10.1210/me.2004-0011; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang L, 2012, MOL MED REP, V6, P904, DOI 10.3892/mmr.2012.1001; Yang XW, 2001, CANCER RES, V61, P7025; Yang XW, 2000, CANCER RES, V60, P6890; Zhang HY, 2013, ONCOL LETT, V6, P161, DOI 10.3892/ol.2013.1331; Zhou Q, 2007, CANCER BIOL THER, V6, P64, DOI 10.4161/cbt.6.1.3549	26	49	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155057	10.1371/journal.pone.0155057	http://dx.doi.org/10.1371/journal.pone.0155057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159275	gold, Green Published			2022-12-27	WOS:000376576700036
J	Stikvoort, A; Sundin, M; Uzunel, M; Gertow, J; Sundberg, B; Schaffer, M; Mattsson, J; Uhlin, M				Stikvoort, Arwen; Sundin, Mikael; Uzunel, Mehmet; Gertow, Jens; Sundberg, Berit; Schaffer, Marie; Mattsson, Jonas; Uhlin, Michael			Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; VERSUS-HOST-DISEASE; FOLLOW-UP; NKT CELLS; T-CELLS; GRAFT; ACTIVATION; MECHANISMS; PROFILES; CHILDREN	Long-term stable mixed chimerism is a rare and poorly understood phenomenon post hematopoietic stem cell transplantation. This study aims to shed light on whether the two hematopoietic systems in patients with mixed chimerism remain functional. Additionally, we investigate possible immunologic differences in these individuals compared to patients with only donor derived immune cells. Patients with donor and mixed chimerism, at median 10 (5-16) years post-HSCT for non-malignant diseases, were assessed regarding clinical situation and immune system (phenotypical and functional). No difference in long-term outcome was seen in terms of general wellbeing, central phenotypic immune system features (e.g., differentiation status, CD4/CD8 ratio, B and NK-cell frequency) and antibody responses to immunizations. At a median of 10 years post transplantation, patients with mixed chimerism had significantly higher IgG3 and platelet levels. Additionally, these patients had higher NKT-cell levels (CD94+CD8+ and CD56+CD8+) than patients with donor chimerism. In depth phenotypic analysis of patients with mixed chimerism demonstrated recipient-derived fractions in most immune cell lineages (e.g., T-cell, B-cell and NK-cell subsets). Recipient cells were also capable of responding to mitogenic stimulation with production of several cytokines. In conclusion, long-term mixed chimerism did not negatively affect patient wellbeing and long-term outcome. Moreover, recipient-derived immunity may still be functional in these patients, suggesting an active state of tolerance and immunologic dependence on both hematopoietic systems.	[Stikvoort, Arwen; Sundberg, Berit; Mattsson, Jonas; Uhlin, Michael] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Stikvoort, Arwen; Uzunel, Mehmet; Gertow, Jens; Sundberg, Berit; Mattsson, Jonas; Uhlin, Michael] Karolinska Univ Hosp, Ctr Allogene Stem Cell Transplantat CAST, Stockholm, Sweden; [Sundin, Mikael] Karolinska Inst, Div Paediat, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Sundin, Mikael] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Hematol Immunol HSCT Sect, Stockholm, Sweden; [Schaffer, Marie; Uhlin, Michael] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Stikvoort, A; Uhlin, M (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.; Stikvoort, A; Uhlin, M (corresponding author), Karolinska Univ Hosp, Ctr Allogene Stem Cell Transplantat CAST, Stockholm, Sweden.; Uhlin, M (corresponding author), Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden.	arwen.stikvoort@ki.se; michael.uhlin@ki.se	; Sundin, Mikael/E-5942-2013	Stikvoort, Arwen/0000-0002-0251-5628; Sundin, Mikael/0000-0002-9871-0961	Vetenskapsradet (VR; Swedish research counsil) [2014-1839]	Vetenskapsradet (VR; Swedish research counsil)	This work was supported by Vetenskapsradet (VR; Swedish research counsil, 2014-1839, M Uhlin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh M, 2002, BLOOD, V99, P4618, DOI 10.1182/blood.V99.12.4618; Appleman LJ, 2001, J MOL MED, V78, P673, DOI 10.1007/s001090000180; Bader P, 2005, BONE MARROW TRANSPL, V35, P107, DOI 10.1038/sj.bmt.1704715; Baron F, 2006, LEUKEMIA, V20, P1690, DOI 10.1038/sj.leu.2404335; Berglund S, 2013, J IMMUNOTHER, V36, P432, DOI 10.1097/CJI.0b013e3182a802f6; Berglund S, 2009, INT J HEMATOL, V90, P526, DOI 10.1007/s12185-009-0398-y; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; Chang YJ, 2013, BLOOD REV, V27, P55, DOI 10.1016/j.blre.2012.11.002; Chapoval S, 2010, J LEUKOCYTE BIOL, V87, P1011, DOI 10.1189/jlb.1209772; CHATILA T, 1989, J IMMUNOL, V143, P1283; Childs RW, 2004, ANNU REV MED, V55, P459, DOI 10.1146/annurev.med.55.091902.104511; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Geneugelijk K, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/159479; Gertow J, 2010, CLIN EXP IMMUNOL, V162, P146, DOI 10.1111/j.1365-2249.2010.04212.x; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gor DO, 2003, NAT IMMUNOL, V4, P503, DOI 10.1038/ni0603-503; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; GOULMY E, 1976, LANCET, V2, P1206; Gratwohl A, 2002, BLOOD, V100, P3877, DOI 10.1182/blood.V100.12.3877; Gyurkocza B, 2014, BLOOD, V124, P344, DOI 10.1182/blood-2014-02-514778; Haines HL, 2014, BIOL BLOOD MARROW TR; Kojima S, 1996, BLOOD, V87, P1303, DOI 10.1182/blood.V87.4.1303.bloodjournal8741303; Lagrelius M, 2006, CYTOKINE, V33, P156, DOI 10.1016/j.cyto.2006.01.005; Leung B, 2011, J SURG RES, V167, P87, DOI 10.1016/j.jss.2010.09.038; Levine JE, 2014, BEST PRACT RES CL HA, V27, P283, DOI 10.1016/j.beha.2014.10.011; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Linn YC, 2003, LEUKEMIA LYMPHOMA, V44, P1457, DOI 10.1080/1042819031000083082; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Marie-Cardine A, 1999, CELL SIGNAL, V11, P705, DOI 10.1016/S0898-6568(99)00047-9; Mattsson J, 2000, LEUKEMIA, V14, P247, DOI 10.1038/sj.leu.2401669; McCann SR, 2005, TRANSFUS APHER SCI, V32, P55, DOI 10.1016/j.transci.2004.10.006; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; OLeary JG, 2015, AM J TRANSPLANTATION; Owen WE, 2003, AM J CLIN PATHOL, V119, P689, DOI 10.1309/ATLW4XBFT135NC56; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Remberger M, 2011, BIOL BLOOD MARROW TR, V17, P1688, DOI 10.1016/j.bbmt.2011.05.001; Ringden O, 2009, BRIT J HAEMATOL, V147, P614, DOI 10.1111/j.1365-2141.2009.07886.x; Saito AM, 2007, INTERNAL MED, V46, P1923, DOI 10.2169/internalmedicine.46.0249; Satwani P, 2008, BONE MARROW TRANSPL, V41, P173, DOI 10.1038/sj.bmt.1705923; Schaap N, 2002, LEUKEMIA, V16, P13, DOI 10.1038/sj.leu.2402343; Schauer U, 2003, CLIN DIAGN LAB IMMUN, V10, P202, DOI 10.1128/CDLI.10.2.202-207.2003; Schauer U, 2003, CLIN CHEM, V49, P1924, DOI 10.1373/clinchem.2003.022350; SNAPPER CM, 1992, J EXP MED, V175, P1367, DOI 10.1084/jem.175.5.1367; Stikvoort A, 2013, BIOL BLOOD MARROW TR, V19, P838, DOI 10.1016/j.bbmt.2013.02.015; Stroncek DF, 1996, TRANSFUSION, V36, P601, DOI 10.1046/j.1537-2995.1996.36796323059.x; Tarazona R, 2000, MECH AGEING DEV, V121, P77; Trinchieri G, 1998, Int Rev Immunol, V16, P365, DOI 10.3109/08830189809043002; Trinchieri Giorgio, 1992, Progress in Growth Factor Research, V4, P355, DOI 10.1016/0955-2235(92)90016-B; Uhlin M, 2005, P NATL ACAD SCI USA, V102, P9264, DOI 10.1073/pnas.0406333102; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Warren EH, 2013, TISSUE ANTIGENS, V81, P183, DOI 10.1111/tan.12090; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; Winiarski J, 1998, Pediatr Transplant, V2, P150; Winterling J, 2014, BONE MARROW TRANSPL, V49, P836, DOI 10.1038/bmt.2014.26; Wu Lan, 2011, Front Biosci (Schol Ed), V3, P236, DOI 10.2741/s148	55	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154737	10.1371/journal.pone.0154737	http://dx.doi.org/10.1371/journal.pone.0154737			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152621	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000032
J	Tsang, TK; Fang, VJ; Chan, KH; Ip, DKM; Leung, GM; Peiris, JSM; Cowling, BJ; Cauchemez, S				Tsang, Tim K.; Fang, Vicky J.; Chan, Kwok-Hung; Ip, Dennis K. M.; Leung, Gabriel M.; Peiris, J. S. Malik; Cowling, Benjamin J.; Cauchemez, Simon			Individual Correlates of Infectivity of Influenza A Virus Infections in Households	PLOS ONE			English	Article							PANDEMIC INFLUENZA; COMPARATIVE EPIDEMIOLOGY; SEASONAL INFLUENZA; SHEDDING DURATION; UNITED-STATES; H1N1 VIRUS; HONG-KONG; TRANSMISSION; COMMUNITY; STRATEGIES	Background Identifying individual correlates of infectivity of influenza virus is important for disease control and prevention. Viral shedding is used as a proxy measure of infectivity in many studies. However, the evidence for this is limited. Methods In a detailed study of influenza virus transmission within households in 2008-12, we recruited index cases with confirmed influenza infection from outpatient clinics, and followed up their household contacts for 7-10 days to identify secondary infections. We used individual-based hazard models to characterize the relationship between individual viral shedding and individual infectivity. Results We analyzed 386 households with 1147 household contacts. Index cases were separated into 3 groups according to their estimated level of viral shedding at symptom onset. We did not find a statistically significant association of virus shedding with transmission. Index cases in medium and higher viral shedding groups were estimated to have 21% (95% CI: -29%, 113%) and 44% (CI: -16%, 167%) higher infectivity, compared with those in the lower viral shedding group. Conclusions Individual viral load measured by RT-PCR in the nose and throat was at most weakly correlated with individual infectivity in households. Other correlates of infectivity should be examined in future studies.	[Tsang, Tim K.; Fang, Vicky J.; Ip, Dennis K. M.; Leung, Gabriel M.; Peiris, J. S. Malik; Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok-Hung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Li Ka Shing Fac Med, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France	University of Hong Kong; World Health Organization; University of Hong Kong; University of Hong Kong; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009; Chan, Kwok Hung/ABD-5399-2021; Peiris, Joseph Sriyal Malik/C-4380-2009; Ip, Dennis Kai Ming/C-4283-2009	Cowling, Benjamin John/0000-0002-6297-7154; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Tsang, Tim Kam Lun/0000-0001-5037-6776; Ip, Dennis Kai Ming/0000-0003-3592-8709; Leung, Gabriel/0000-0002-2503-6283	National Institute of Allergy and Infectious Diseases [HHSN266200700005C]; ADB (NIAID Centers for Excellence in Influenza Research and Surveillance) [N01-AI-70005]; Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Research Grants Council of the Hong Kong Special Administrative Region, China [T11-705/14N]; L'Oreal Hong Kong; National Institute of General Medical Sciences MIDAS initiative [1U01GM110721-01]; Laboratory of Excellence Integrative Biology of Emerging Infectious Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558, U01GM110721] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ADB (NIAID Centers for Excellence in Influenza Research and Surveillance); Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); L'Oreal Hong Kong; National Institute of General Medical Sciences MIDAS initiative; Laboratory of Excellence Integrative Biology of Emerging Infectious Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the National Institute of Allergy and Infectious Diseases under contract no. HHSN266200700005C; ADB No. N01-AI-70005 (NIAID Centers for Excellence in Influenza Research and Surveillance), a commissioned grant from the Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region, the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558), and the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. T11-705/14N). TKT was supported by a Research Scholarship from L'Oreal Hong Kong. SC thanks the National Institute of General Medical Sciences MIDAS initiative (grant 1U01GM110721-01) and the Laboratory of Excellence Integrative Biology of Emerging Infectious Diseases for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattarai A, 2011, CLIN INFECT DIS, V52, pS102, DOI 10.1093/cid/ciq026; Biggerstaff M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-480; Carcione D, 2011, EUROSURVEILLANCE, P16; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chang LY, 2011, EMERG INFECT DIS, V17, P1928, DOI 10.3201/eid1710.101662; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fielding JE, 2014, INFLUENZA OTHER RESP, V8, P142, DOI 10.1111/irv.12216; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ip DKM, 2012, J INFECT DIS, V205, P631, DOI 10.1093/infdis/jir803; Ip DK, 2015, CLIN INFECT DIS; Klick B, 2011, EPIDEMIOLOGY, V22, P793, DOI 10.1097/EDE.0b013e3182302e8e; Lau LLH, 2013, J INFECT DIS, V207, P1281, DOI 10.1093/infdis/jit034; Lau LLH, 2012, EPIDEMIOLOGY, V23, P531, DOI 10.1097/EDE.0b013e31825588b8; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Li CC, 2010, EMERG INFECT DIS, V16, P1265, DOI 10.3201/eid1608.091918; Loeb M, 2012, J INFECT DIS, V206, P1078, DOI 10.1093/infdis/jis450; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Looker C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013702; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Mohamed AG, 2012, INFLUENZA OTHER RESP, V6, pe25, DOI 10.1111/j.1750-2659.2011.00308.x; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Poon LLM, 2011, J CLIN VIROL, V52, P146, DOI 10.1016/j.jcv.2011.06.022; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Suess T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051653; Tsang TK, 2014, J INFECT DIS; Tsang TK, 2015, J INFECT DIS; Vaida F, 2009, J COMPUT GRAPH STAT, V18, P797, DOI 10.1198/jcgs.2009.07130; Xu CL, 2015, AM J EPIDEMIOL, V182, P705, DOI 10.1093/aje/kwv110	38	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154418	10.1371/journal.pone.0154418	http://dx.doi.org/10.1371/journal.pone.0154418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153194	gold, Green Published			2022-12-27	WOS:000375677000018
J	Chen, CW; Wei, XC; Lv, Z; Sun, XJ; Wang, SW; Zhang, Y; Jiao, Q; Wang, XH; Li, YP; Wei, L				Chen, Chongwei; Wei, Xiaochun; Lv, Zhi; Sun, Xiaojuan; Wang, Shaowei; Zhang, Yang; Jiao, Qiang; Wang, Xiaohu; Li, Yongping; Wei, Lei			Cyclic Equibiaxial Tensile Strain Alters Gene Expression of Chondrocytes via Histone Deacetylase 4 Shuttling	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; HDAC4; DIFFERENTIATION; TRANSCRIPTION; CARTILAGE; GROWTH; RUNX2; CHONDROGENESIS; OSTEOARTHRITIS; INDUCTION	Objectives This paper aims to investigate whether equibiaxial tensile strain alters chondrocyte gene expression via controlling subcellular localization of histone deacetylase 4 (HDAC4). Materials and Methods Murine chondrocytes transfected with GFP-HDAC4 were subjected to 3 h cyclic equibiaxial tensile strain (CTS, 6% strain at 0.25 Hz) by a Flexcell (R) FX-5000 (TM) Tension System. Fluorescence microscope and western blot were used to observe subcellular location of HDAC4. The gene expression was analyzed by real-time RT-PCR. The concentration of Glycosaminoglycans in culture medium was quantified by bimethylmethylene blue dye; Collagen II protein was evaluated by western blot. Cells phenotype was identified by immunohistochemistry. Cell viability was evaluated by live-dead cell detect kit. Okadaic acid, an inhibitor of HDAC4 nuclear relocation, was used to further validate whether HDAC4 nuclear relocation plays a role in gene expression in response to tension stimulation. Results 87.5% of HDAC4 was located in the cytoplasm in chondrocytes under no loading condition, but it was relocated to the nucleus after CTS. RT-PCR analysis showed that levels of mRNA for aggrecan, collagen II, LK1 and SOX9 were all increased in chondrocytes subjected to CTS as compared to no loading control chondrocytes; in contrast, the levels of type X collagen, MMP-13, IHH and Runx2 gene expression were decreased in the chondrocytes subjected to CTS as compared to control chondrocytes. Meanwhile, CTS contributed to elevation of glycosaminoglycans and collagen II protein, but did not change collagen I production. When Okadaic acid blocked HDAC4 relocation from the cytoplasm to nucleus, the changes of the chondrocytes induced by CTS were abrogated. There was no chondrocyte dead detected in this study in response to CTS. Conclusions CTS is able to induce HDAC4 relocation from cytoplasm to nucleus. Thus, CTS alters chondrocytes gene expression in association with the relocation of HDAC4 induced by CTS.	[Chen, Chongwei; Wei, Xiaochun; Lv, Zhi; Sun, Xiaojuan; Wang, Shaowei; Zhang, Yang; Jiao, Qiang; Wang, Xiaohu; Li, Yongping; Wei, Lei] Shanxi Med Univ, Hosp 2, Dept Orthopaed, Taiyuan, Shanxi, Peoples R China; [Chen, Chongwei; Wei, Xiaochun; Lv, Zhi; Sun, Xiaojuan; Wang, Shaowei; Zhang, Yang; Jiao, Qiang; Wang, Xiaohu; Li, Yongping; Wei, Lei] Shanxi Key Lab Bone & Soft Tissue Injury Repair, Taiyuan, Shanxi, Peoples R China; [Wang, Shaowei; Zhang, Yang; Wei, Lei] Brown Univ, Dept Orthopaed, Warren Alpert Med Sch, Rhode Isl Hosp, Providence, RI 02912 USA	Shanxi Medical University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Wei, L (corresponding author), Shanxi Med Univ, Hosp 2, Dept Orthopaed, Taiyuan, Shanxi, Peoples R China.; Wei, L (corresponding author), Shanxi Key Lab Bone & Soft Tissue Injury Repair, Taiyuan, Shanxi, Peoples R China.; Wei, L (corresponding author), Brown Univ, Dept Orthopaed, Warren Alpert Med Sch, Rhode Isl Hosp, Providence, RI 02912 USA.	lei_wei@brown.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases (US) [R01AR059142]; National Institute of General Medical Sciences (US) [P20GM104937]; National Natural Science Foundation of China [81572098]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (US); National Institute of General Medical Sciences (US); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project was supported by Grant R01AR059142 from National Institute of Arthritis and Musculoskeletal and Skin Diseases (US), P20GM104937 from National Institute of General Medical Sciences (US), and 81572098 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, ARTHRITIS RHEUM-US, V50, P3541, DOI 10.1002/art.20601; Agarwal S, 2001, ARTHRITIS RHEUM-US, V44, P608, DOI 10.1002/1529-0131(200103)44:3<608::AID-ANR109>3.3.CO;2-U; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bleuel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119816; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bougault C, 2009, NAT PROTOC, V4, P928, DOI 10.1038/nprot.2009.63; Bougault C, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-71; Cao K, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0491-3; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fitzsimons HL, 2015, NEUROBIOL LEARN MEM, V123, P149, DOI 10.1016/j.nlm.2015.06.006; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; Guan YJ, 2012, AM J PHYSIOL-CELL PH, V303, pC33, DOI 10.1152/ajpcell.00348.2011; Honda K, 2000, EUR J CELL BIOL, V79, P601, DOI 10.1078/0171-9335-00089; Huang J, 2007, GENE, V404, P101, DOI 10.1016/j.gene.2007.09.007; Kawakita K, 2012, OSTEOARTHR CARTILAGE, V20, P1603, DOI 10.1016/j.joca.2012.08.022; Li PC, 2014, FASEB J, V28, P3930, DOI 10.1096/fj.13-249318; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livyatan I, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.33; Madhavan S, 2006, OSTEOARTHR CARTILAGE, V14, P1023, DOI 10.1016/j.joca.2006.03.016; Martin M, 2009, INT J DEV BIOL, V53, P291, DOI 10.1387/ijdb.082698mm; Mathias RA, 2015, MOL CELL PROTEOMICS, V14, P456, DOI 10.1074/mcp.O114.046565; Matta C, 2014, CELL SIGNAL, V26, P2175, DOI 10.1016/j.cellsig.2014.06.013; McKinsey TA, 2006, MOL BIOL CELL, V17, P438, DOI 10.1091/mbc.E05-07-0612; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Moyer RF, 2014, OSTEOARTHR CARTILAGE, V22, P1989, DOI 10.1016/j.joca.2014.06.034; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Responte DJ, 2012, FASEB J, V26, P3614, DOI 10.1096/fj.12-207241; Telles Elphine, 2012, Front Biosci (Schol Ed), V4, P831; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Wang ZK, 2014, EPIGENOMICS-UK, V6, P139, DOI 10.2217/epi.13.73; Xu ZF, 2000, J IMMUNOL, V165, P453, DOI 10.4049/jimmunol.165.1.453; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhou JM, 2015, BBA-MOL CELL RES, V1853, P370, DOI 10.1016/j.bbamcr.2014.11.003	37	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154951	10.1371/journal.pone.0154951	http://dx.doi.org/10.1371/journal.pone.0154951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149270	gold, Green Published			2022-12-27	WOS:000375676800097
J	Giovani, PA; Salmon, CR; Martins, L; Leme, AFP; Reboucas, P; Rontani, RMP; Mofatto, LS; Sallum, EA; Nociti, FH; Kantovitz, KR				Giovani, Priscila A.; Salmon, Cristiane R.; Martins, Luciane; Paes Leme, Adriana F.; Reboucas, Pedro; Puppin Rontani, Regina M.; Mofatto, Luciana S.; Sallum, Enilson A.; Nociti, Francisco H., Jr.; Kantovitz, Kamila R.			Secretome Profiling of Periodontal Ligament from Deciduous and Permanent Teeth Reveals a Distinct Expression Pattern of Laminin Chains	PLOS ONE			English	Article							LARGE GENE LISTS; ROOT-RESORPTION; TOOTH RESORPTION; PROTEOMICS; DENTIN; CELLS; PERSPECTIVES; OSTEOPONTIN; INTEGRIN; ADHESION	It has been suggested that there are histological and functional distinctions between the periodontal ligament (PDL) of deciduous (DecPDL) and permanent (PermPDL) teeth. Thus, we hypothesized that DecPDL and PermPDL display differences in the constitutive expression of genes/proteins involved with PDL homeostasis. Primary PDL cell cultures were obtained for DecPDL (n = 3) and PermPDL (n = 3) to allow us to perform label-free quantitative secretome analysis. Although a highly similar profile was found between DecPDL and PermPDL cells, comparative secretome analysis evidenced that one of the most stickling differences involved cell adhesion molecules, including laminin subunit gamma 1 (LAMC1) and beta 2 (LAMB2). Next, total RNA and protein extracts were obtained from fresh PDL tissues of deciduous (n = 6) and permanent (n = 6) teeth, and Western blotting and qPCR analysis were used to validate our in vitro findings. Western blot analysis confirmed that LAMC1 was increased in DecPDL fresh tissues (p< 0.05). Furthermore, qPCR data analysis revealed that mRNA levels for laminin subunit beta 1 (LAMB1), beta 3 (LAMB3), LAMC1, and gamma 2 (LAMC2) were higher in DecPDL fresh tissues, whereas transcripts for LAMB2 were increased in PermPDL (p< 0.05). In conclusion, the differential expression of laminin chains in DecPDL and PermPDL suggests an involvement of laminin-dependent pathways in the control of physiological differences between them.	[Giovani, Priscila A.; Reboucas, Pedro; Puppin Rontani, Regina M.; Kantovitz, Kamila R.] Univ Estadual Campinas, Dept Pediat Dent, Piracicaba Dent Sch, Sao Paulo, Brazil; [Salmon, Cristiane R.; Martins, Luciane; Sallum, Enilson A.; Nociti, Francisco H., Jr.] Univ Estadual Campinas, Dept Prosthodont & Periodont, Piracicaba Dent Sch, Div Periodont, Sao Paulo, Brazil; [Paes Leme, Adriana F.] CNPEM, LNBio, Brazilian Biosci Natl Lab, Campinas, SP, Brazil; [Mofatto, Luciana S.] Univ Estadual Campinas, Inst Biol, Dept Genet, Campinas, SP, Brazil; [Kantovitz, Kamila R.] Sao Leopoldo Mandic Res Ctr, Dept Dent Mat, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Faculdade Sao Leopoldo Mandic	Kantovitz, KR (corresponding author), Univ Estadual Campinas, Dept Pediat Dent, Piracicaba Dent Sch, Sao Paulo, Brazil.; Kantovitz, KR (corresponding author), Sao Leopoldo Mandic Res Ctr, Dept Dent Mat, Campinas, SP, Brazil.	kamilark@yahoo.com.br	PUPPIN-RONTANI, regina/AAM-9962-2020; Mofatto, Luciana S/A-8914-2011; PUPPIN-RONTANI, REGINA/GVS-2045-2022; Martins, Luciane/C-9010-2016; Kantovitz, Kamila R/J-4567-2013; PUPPIN-RONTANI, regina/C-3994-2012; Martins, Luciane/AAG-5286-2019	PUPPIN-RONTANI, regina/0000-0002-1218-5159; Mofatto, Luciana S/0000-0002-2087-7251; Martins, Luciane/0000-0003-3635-7928; Kantovitz, Kamila R/0000-0003-2045-7924; PUPPIN-RONTANI, regina/0000-0002-1218-5159; Martins, Luciane/0000-0003-3635-7928; Nociti, Francisco/0000-0001-6809-8866				ALEXANDER S A, 1980, Pediatric Dentistry, V2, P287; Andreasen JO., 1988, P INT C BIOL MECH TO, P9; ANDUJAR MB, 1985, DIFFERENTIATION, V30, P111, DOI 10.1111/j.1432-0436.1985.tb00522.x; Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1; Borges AFS, 2007, APPL SURF SCI, V254, P1498, DOI 10.1016/j.apsusc.2007.07.018; Bosshardt DD, 2005, CELL TISSUE RES, V320, P399, DOI 10.1007/s00441-005-1106-8; Castagna A, 2012, EXPERT REV PROTEOMIC, V9, P201, DOI [10.1586/EPR.12.11, 10.1586/epr.12.11]; CATHELINEAU G, 1982, J PERIODONTOL, V53, P704, DOI 10.1902/jop.1982.53.11.704; Cordeiro MMR, 2011, INT J PAEDIATR DENT, V21, P361, DOI 10.1111/j.1365-263X.2011.01132.x; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Faccio R, 1998, BIOCHEM BIOPH RES CO, V249, P522, DOI 10.1006/bbrc.1998.9180; Fukushima H, 2003, EUR J ORAL SCI, V111, P346, DOI 10.1034/j.1600-0722.2003.00051.x; Holmberg J, 2013, CELL ADHES MIGR, V7, P111, DOI 10.4161/cam.22618; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iorio V, 2015, ADV WOUND CARE, V4, P250, DOI 10.1089/wound.2014.0533; ITOH K, 1976, ARCH HISTOL JAPON, V39, P379, DOI 10.1679/aohc1950.39.379; JOHNSEN D, 1978, ARCH ORAL BIOL, V23, P825, DOI 10.1016/0003-9969(78)90163-2; Kawahara R, 2014, J PROTEOME RES, V13, P2080, DOI 10.1021/pr401224u; Kim JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102893; Kiritsi D, 2013, CELL ADHES MIGR, V7, P135, DOI 10.4161/cam.22418; Lee A, 2004, AM J ORTHOD DENTOFAC, V126, P173, DOI 10.1016/j.ajodo.2004.02.009; Linsuwanont B, 2002, BONE, V31, P472, DOI 10.1016/S8756-3282(02)00856-6; Lossdorfer S, 2002, CALCIFIED TISSUE INT, V71, P45, DOI 10.1007/s00223-001-2086-7; McCulloch CA, 2006, PERIODONTOL 2000, V40, P173, DOI 10.1111/j.1600-0757.2005.00135.x; Ohshima M, 2006, CONNECT TISSUE RES, V47, P149, DOI 10.1080/03008200600685475; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Borges AFS, 2009, AM J DENT, V22, P30; Shigeyama Y, 1996, J DENT RES, V75, P1650, DOI 10.1177/00220345960750090601; Song JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061231; Wise GE, 2002, CRIT REV ORAL BIOL M, V13, P323, DOI 10.1177/154411130201300403; Wu YM, 1999, J DENT RES, V78, P681, DOI 10.1177/00220345990780020801; Yamada M, 2015, CURR TOP MEMBR, V76, P197, DOI 10.1016/bs.ctm.2015.07.002	33	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154957	10.1371/journal.pone.0154957	http://dx.doi.org/10.1371/journal.pone.0154957			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149379	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800098
J	Leon-Maldonado, L; Wentzell, E; Brown, B; Allen-Leigh, B; Torres-Ibarra, L; Salmeron, J; Billings, DL; Thrasher, JF; Lazcano-Ponce, E				Leon-Maldonado, Leith; Wentzell, Emily; Brown, Brandon; Allen-Leigh, Betania; Torres-Ibarra, Leticia; Salmeron, Jorge; Billings, Deborah L.; Thrasher, James F.; Lazcano-Ponce, Eduardo			Perceptions and Experiences of Human Papillomavirus (HPV) Infection and Testing among Low-Income Mexican Women	PLOS ONE			English	Article							CERVICAL-CANCER; INFORMATION; KNOWLEDGE; ATTITUDES; BELIEFS; IMPACT; COMMUNICATION; PREFERENCES; PREVENTION; MORTALITY	Background HPV infection causes cervical cancer, a major contributor to morbidity and mortality among low-income Mexican women. Human papillomavirus (HPV) DNA testing is now a primary screening strategy in Mexico's early cervical cancer detection program (ECDP). Research on Mexican women's perceptions of HPV and testing is necessary for establishing culturally appropriate protocols and educational materials. Here, we explore perceptions about HPV and HPV-related risk factors among low-income Mexican ECDP participants. Methods We conducted semi-structured interviews with 24 ECDP participants from two primary care health clinics in Michoacan state, Mexico. Interviews addressed women's understandings of and experiences with HPV and HPV testing. Analysis was inductive and guided by the Health Belief Model with a focus on gender. Results Women's confusion about HPV and HPV screening caused emotional distress. They understood HPV to be a serious disease that would always cause severe symptoms, often characterizing it as analogous to HIV or inevitably carcinogenic. Women also attributed it to men's sexual behaviors, specifically infidelity and poor hygiene. Women described both sexes' desire for sex as natural but understood men's negative practices of masculinity, like infidelity, as the causes of women's HPV infection. Some women believed dirty public bathrooms or heredity could also cause HPV transmission. Conclusions These results are consistent with prior findings that geographically and economically diverse populations lack clear understandings of the nature, causes, or symptoms of HPV, even among those receiving HPV testing. Our findings also reveal that local cultural discourse relating to masculinity, along with failure to provide sufficient education to low-income and indigenous-language speaking patients, exacerbate women's negative emotions surrounding HPV testing. While negative emotions did not deter women from seeking testing, they could be ameliorated with better health education and communication.	[Leon-Maldonado, Leith] CONACYT, Inst Nacl Cancerol, Ciudad De Mexico, Mexico; [Leon-Maldonado, Leith; Allen-Leigh, Betania; Torres-Ibarra, Leticia; Salmeron, Jorge; Thrasher, James F.; Lazcano-Ponce, Eduardo] Ctr Invest Salud Poblac, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Wentzell, Emily] Univ Iowa, Dept Anthropol, Iowa City, IA USA; [Brown, Brandon] Univ Calif Riverside, Dept Social Med & Populat Hlth, Sch Med, Riverside, CA 92521 USA; [Salmeron, Jorge] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Cuernavaca, Morelos, Mexico; [Billings, Deborah L.; Thrasher, James F.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA	Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Salud Publica; University of Iowa; University of California System; University of California Riverside; Instituto Mexicano del Seguro Social; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Lazcano-Ponce, E (corresponding author), Ctr Invest Salud Poblac, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico.	elazcano@insp.mx	León-Maldonado, Leith/AAH-7161-2020; Wentzell, Emily/AAF-7077-2021	Wentzell, Emily/0000-0002-0492-8442; Leon-Maldonado, Leith/0000-0003-2106-206X; Salmeron, Jorge/0000-0002-5113-299X				Almonte M, 2010, SALUD PUBLICA MEXICO, V52, P544, DOI 10.1590/S0036-36342010000600010; Anhang R, 2004, CA-CANCER J CLIN, V54, P248, DOI 10.3322/canjclin.54.5.248; [Anonymous], 2014, AN MIGR REM MEX 2015; [Anonymous], 2010, IND MARG ENT FED MUN; Arbyn M, 2009, EUR J CANCER, V45, P2671, DOI 10.1016/j.ejca.2009.07.016; Ayers S, 2007, CAMBRIDGE HANDBOOK OF PSYCHOLOGY, HEALTH AND MEDICINE, 2ND EDITION, P1; Boyatzis E, 1998, TRANSFORMING QUALITA; Brown L, 2007, Health Care Women Int, V28, P782, DOI 10.1080/07399330701563061; Campero L, 2014, SALUD PUBLICA MEXICO, V56, P511; CDI, NOMBR LENG PUEBL DIS; Cuzick J, 2006, VACCINE, V24, P90, DOI 10.1016/j.vaccine.2006.05.122; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; de Sousa LB, 2008, REV ESC ENFERM USP, V42, P733; Denny L, 2005, BJOG-INT J OBSTET GY, V112, P1204, DOI 10.1111/j.1471-0528.2005.00713.x; Duval B, 2007, VACCINE, V25, P7841, DOI 10.1016/j.vaccine.2007.08.041; Dyson S, 2010, SEX HEALTH, V7, P49, DOI 10.1071/SH09059; Ferreira Maria de Lourdes da Silva Marques, 2005, Ginecol Obstet Mex, V73, P531; Flores YN, 2011, CANCER CAUSE CONTROL, V22, P261, DOI 10.1007/s10552-010-9694-3; Friedman AL, 2007, HEALTH EDUC BEHAV, V34, P471, DOI 10.1177/1090198106292022; Goldsmith MR, 2007, J MED SCREEN, V14, P29, DOI 10.1258/096914107780154459; Gutmann M., 1996, MEANINGS MACHO BEING; Hirsch JS, 2007, AM J PUBLIC HEALTH, V97, P986, DOI 10.2105/AJPH.2006.088492; Jain N, 2006, FAM MED, V38, P483; Kahn JA, 2007, HEALTH PSYCHOL, V26, P192, DOI 10.1037/0278-6133.26.2.192; Keshavarz Z, 2011, ASIAN PAC J CANCER P, V12, P1517; Lamas M., 1999, PAPELES POBLAC, V5, P147; Lazcano-Ponce E, 2008, CANCER EPIDEM BIOMAR, V17, P2808, DOI 10.1158/1055-9965.EPI-07-2659; Leinonen M, 2009, JNCI-J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Leon-Maldonado L, 2014, SALUD PUBLICA MEXICO, V56, P19; Marlow LAV, 2014, WOMENS HEALTH, V10, P221, DOI [10.2217/WHE.14.12, 10.2217/whe.14.12]; McCaffery K, 2003, BRIT J CANCER, V88, P42, DOI 10.1038/sj.bjc.6600686; McCaffery K, 2005, J MED SCREEN, V12, P134, DOI 10.1258/0969141054855238; McCaffery K, 2006, SEX TRANSM INFECT, V82, P169, DOI 10.1136/sti.2005.016436; McSherry LA, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-73; Murphy J, 2008, J EPIDEMIOL COMMUN H, V62, pA21; Newton DC, 2008, J HEALTH PSYCHOL, V13, P864, DOI 10.1177/1359105308095058; Ngugi CW, 2012, HEALTH CARE WOMEN IN, V33, P595, DOI 10.1080/07399332.2011.646367; Palacio-Mejia LS, 2009, SALUD PUBLICA MEXICO, V51, pS208, DOI 10.1590/S0036-36342009000800011; Salmeron J, 2003, CANCER CAUSE CONTROL, V14, P505, DOI 10.1023/A:1024806707399; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Secretaria de Salud, 2008, PROGR ACC ESP 2007 2; SEOW A, 1995, PREV MED, V24, P134, DOI 10.1006/pmed.1995.1026; Smith-Oka V, 2012, RISK, REPRODUCTION, AND NARRATIVES OF EXPERIENCE, P103; Songthap A, 2009, SE ASIAN J TROP MED, V40, P1048; Strauss A., 2016, BASES INVESTIGACION; Torres-Sanchez LE, 2014, SALUD PUBLICA MEXICO, V56, P473; Verhoeven V, 2010, PATIENT EDUC COUNS, V81, P101, DOI 10.1016/j.pec.2009.12.006; Waller J, 2005, BRIT J CANCER, V92, P265, DOI 10.1038/sj.bjc.6602312; Waller J, 2007, SEX TRANSM INFECT, V83, P155, DOI 10.1136/sti.2006.023333; Waller J, 2009, PREV MED, V48, P415, DOI 10.1016/j.ypmed.2008.11.004; Wentzell E.A., 2013, MATURING MASCULINITI	51	16	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0153367	10.1371/journal.pone.0153367	http://dx.doi.org/10.1371/journal.pone.0153367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27149525	Green Submitted, gold, Green Published			2022-12-27	WOS:000375676800009
J	Reimer, M; Rempe, T; Diedrichs, C; Gierthmuhlen, J				Reimer, Maren; Rempe, Torge; Diedrichs, Carolina; Gierthmuehlen, Janne			Sensitization of the Nociceptive System in Complex Regional Pain Syndrome	PLOS ONE			English	Article							SYNDROME TYPE-I; IDENTIFYING NEUROPATHIC PAIN; 3-PHASE BONE-SCINTIGRAPHY; LEEDS ASSESSMENT; SYMPTOMS; SIGNS; VALIDATION; SCALE; MODULATION; MUSCLE	Background Complex regional pain syndrome type I (CRPS-I) is characterized by sensory, motor and autonomic abnormalities without electrophysiological evidence of a nerve lesion. Objective Aims were to investigate how sensory, autonomic and motor function change in the course of the disease. Methods 19 CRPS-I patients (17 with acute, 2 with chronic CRPS, mean duration of disease 5.7+/-8.3, range 1-33 months) were examined with questionnaires (LANSS, NPS, MPI, Quick DASH, multiple choice list of descriptors for sensory, motor, autonomic symptoms), motor and autonomic tests as well as quantitative sensory testing according to the German Research Network on Neuropathic Pain at two visits (baseline and 36+/-10.6, range 16-53 months later). Results CRPS-I patients had an improvement of sudomotor and vasomotor function, but still a great impairment of sensory and motor function upon follow-up. Although pain and mechanical detection improved upon follow-up, thermal and mechanical pain sensitivity increased, including the contralateral side. Increase in mechanical pain sensitivity and loss of mechanical detection were associated with presence of ongoing pain. Conclusions The results demonstrate that patients with CRPS-I show a sensitization of the nociceptive system in the course of the disease, for which ongoing pain seems to be the most important trigger. They further suggest that measured loss of function in CRPS-I is due to pain-induced hypoesthesia rather than a minimal nerve lesion. In conclusion, this article gives evidence for a pronociceptive pain modulation profile developing in the course of CRPS and thus helps to assess underlying mechanisms of CRPS that contribute to the maintenance of patients' pain and disability.	[Reimer, Maren; Rempe, Torge; Diedrichs, Carolina; Gierthmuehlen, Janne] Univ Hosp Schleswig Holstein, Div Neurol Pain Res & Therapy, Dept Neurol, Campus Kiel, Lubeck, Germany	University of Kiel; Schleswig Holstein University Hospital	Gierthmuhlen, J (corresponding author), Univ Hosp Schleswig Holstein, Div Neurol Pain Res & Therapy, Dept Neurol, Campus Kiel, Lubeck, Germany.	j.gierthmuehlen@neurologie.uni-kiel.de		Rempe, Torge/0000-0003-0538-1378	German Federal Ministry of Education and Research (BMBF) [01EM0501-01EM0512, 01EM0901-01EM0904]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry of Education and Research (BMBF, Grants 01EM0501-01EM0512, 01EM0901-01EM0904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkers M, 2010, J NEUROL, V257, P2086, DOI 10.1007/s00415-010-5664-7; Bean DJ, 2014, J PAIN, V15, P677, DOI 10.1016/j.jpain.2014.01.500; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034; Borchers AT, 2014, AUTOIMMUN REV, V13, P242, DOI 10.1016/j.autrev.2013.10.006; Bruehl S, 2010, ANESTHESIOLOGY, V113, P713, DOI 10.1097/ALN.0b013e3181e3db38; Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Flor H, 1990, Schmerz, V4, P82, DOI 10.1007/BF02527839; Freund W, 2011, CLIN J PAIN, V27, P796, DOI 10.1097/AJP.0b013e31821d9063; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; GEERTZEN JHB, 1994, ARCH PHYS MED REHAB, V75, P442, DOI 10.1016/0003-9993(94)90169-4; Geertzen JHB, 1998, ACTA ORTHOP SCAND, V69, P12, DOI 10.1080/17453674.1998.11744781; Gierthmuhlen J, 2014, NAT REV NEUROL, V10, P518, DOI 10.1038/nrneurol.2014.140; Gierthmuhlen J, 2012, PAIN, V153, P765, DOI 10.1016/j.pain.2011.11.009; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Harden RN, 2010, PAIN, V151, P870, DOI 10.1016/j.pain.2010.09.031; Harden RN, 2010, PAIN, V150, P268, DOI 10.1016/j.pain.2010.04.030; Harden RN, 2005, PROG PAIN RES MANAG, V32, P45; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Huge V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002742; Huygen FJPM, 2002, MEDIAT INFLAMM, V11, P47, DOI 10.1080/09629350210307; Janig W, 2003, LANCET NEUROL, V2, P687, DOI 10.1016/S1474-4422(03)00557-X; Kaki AM, 2005, REGION ANESTH PAIN M, V30, P422, DOI 10.1016/j.rapm.2005.05.013; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; Khan T, 2014, ARTIF INTELL MED, V60, P27, DOI 10.1016/j.artmed.2013.11.004; Leffler AS, 2000, EUR J PAIN, V4, P73, DOI 10.1053/eujp.1999.0160; Leffler AS, 2000, EUR J PAIN, V4, P57, DOI 10.1053/eujp.1999.0159; Linnman C, 2013, J NEUROIMMUNE PHARM, V8, P547, DOI 10.1007/s11481-012-9422-8; Magerl W, 2004, NEUROSCI LETT, V361, P136, DOI 10.1016/j.neulet.2003.12.001; Mainka T, 2014, PAIN, V155, P591, DOI 10.1016/j.pain.2013.12.014; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Moseley GL, 2006, NEUROLOGY, V67, P2129, DOI 10.1212/01.wnl.0000249112.56935.32; NATHAN PW, 1960, J NEUROL NEUROSUR PS, V23, P202, DOI 10.1136/jnnp.23.3.202; Negri E, 2002, Minerva Anestesiol, V68, P95; Oaklander AL, 2005, PROG PAIN RES MANAG, V32, P59; Oaklander AL, 2009, ANN NEUROL, V65, P629, DOI 10.1002/ana.21692; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Park SA, 2009, CLIN NUCL MED, V34, P773, DOI 10.1097/RLU.0b013e3181b7d980; Potter-Nerger M, 2009, EUR NEUROL, V62, P114, DOI 10.1159/000222783; Potter J, 2003, J ROY SOC MED, V96, P379, DOI 10.1258/jrsm.96.8.379; Rempe T, 2015, J MAGN RESON IMAGING, V41, P1046, DOI 10.1002/jmri.24627; Rempe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112325; Rog DJ, 2007, CLIN J PAIN, V23, P473, DOI 10.1097/AJP.0b013e31805d0c5d; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rosenfield J, 2001, Bull Hosp Jt Dis, V60, P155; Savaos S, 2009, RHEUMATOL INT, V29, P545, DOI 10.1007/s00296-008-0748-8; SHIMOYAMA I, 1990, ARCH NEUROL-CHICAGO, V47, P681, DOI 10.1001/archneur.1990.00530060095025; Terkelsen AJ, 2013, EXP NEUROL, V247, P456, DOI 10.1016/j.expneurol.2013.01.017; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; van der Laan L, 1998, NEUROLOGY, V51, P20, DOI 10.1212/WNL.51.1.20; Wuppenhorst N, 2010, CLIN J PAIN, V26, P182, DOI 10.1097/AJP.0b013e3181c20207; Yarnitsky D, 2014, PAIN, V155, P663, DOI 10.1016/j.pain.2013.11.005; Yucel A, 2004, J PAIN, V5, P427, DOI 10.1016/j.jpain.2004.07.001	54	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154553	10.1371/journal.pone.0154553	http://dx.doi.org/10.1371/journal.pone.0154553			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149519	Green Submitted, gold, Green Published			2022-12-27	WOS:000375676800039
J	Yap, J; Jin, AZ; Nyunt, SZ; Ng, TP; Richards, AM; Lam, CSP				Yap, Jonathan; Jin, Ai Zhen; Nyunt, Shwe Zin; Ng, Tze Pin; Richards, A. Mark; Lam, Carolyn S. P.			Longitudinal Community-Based Study of QT Interval and Mortality in Southeast Asians	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR MORTALITY; JAPANESE POPULATION; SUDDEN-DEATH; RISK; PROLONGATION; DURATION; MEN; ASSOCIATION; EXPERIENCE	Introduction The prognostic impact of QT interval prolongation has not been well studied in healthy Asians. We investigated the association between the QT interval with mortality and cardiovascular events in a healthy Southeast Asian population. Methods The QT interval corrected for heart rate using the Bazett's formula (QTc) was measured in 2536 (825 men, mean age 65.7 +/- 7.5 years) Singaporean adults free of cardiovascular disease in the population-based Singapore Longitudinal Ageing Study. Outcomes were all-cause mortality and incident cardiovascular events (cardiovascular mortality, myocardial infarction (MI) and/or stroke). Results Over a mean 7.78 years (19695 person-years) of follow-up, there were 202 deaths (45 from cardiovascular causes), 62 cases of myocardial infarction and 64 cases of stroke. Adjusting for age, sex, and cardiovascular risk factors, QTcB prolongation remained independently associated with increased all-cause mortality (HR(per standard deviation) 1.27 (1.10-1.48), p = 0.0015), as well as increased risk of cardiovascular events (HR 1.20 (1.01-1.43), p = 0.0415) and MI/stroke (HR 1.22 (1.01-1.47), p = 0.0455), but not cardiovascular mortality alone (HR 1.05 (0.77-1.44), p = 0.7562). Conclusions We provide the first community-based estimates of the independent association of QT prolongation with all-cause mortality and cardiovascular events in Southeast Asians.	[Yap, Jonathan; Lam, Carolyn S. P.] Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore; [Jin, Ai Zhen] Hlth Promot Board, Natl Registry Dis Off, Singapore, Singapore; [Nyunt, Shwe Zin; Ng, Tze Pin; Lam, Carolyn S. P.] Natl Univ Singapore, Singapore 117548, Singapore; [Richards, A. Mark; Lam, Carolyn S. P.] Natl Univ Singapore, Ctr Heart, Dept Cardiol, Singapore 117548, Singapore; [Richards, A. Mark] Natl Univ Hlth Syst, Cardiovasc Res Inst, Singapore, Singapore; [Richards, A. Mark] Univ Otago, Christchurch Heart Inst, Christchurch, New Zealand; [Lam, Carolyn S. P.] Duke NUS Grad Med Sch, Singapore, Singapore	National Heart Centre Singapore; National University of Singapore; National University of Singapore; National University of Singapore; University of Otago; National University of Singapore	Lam, CSP (corresponding author), Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore.; Lam, CSP (corresponding author), Natl Univ Singapore, Singapore 117548, Singapore.; Lam, CSP (corresponding author), Natl Univ Singapore, Ctr Heart, Dept Cardiol, Singapore 117548, Singapore.; Lam, CSP (corresponding author), Duke NUS Grad Med Sch, Singapore, Singapore.	carolyn.lam@duke-nus.edu.sg	Lam, Carolyn SP/ABD-6810-2021; Yap, Jonathan/AAJ-7266-2020	Lam, Carolyn SP/0000-0003-1903-0018; Yap, Jonathan/0000-0002-5227-8536	National Medical Research Council [NMRC/CIRG/1348/2012, CIRG14may017]; Ministry of Health, Health Services Research [HSRG0016/2010]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Health, Health Services Research	TPN was in receipt of grant support from National Medical Research Council (NMRC/CIRG/1348/2012), National Medical Research Council (CIRG14may017) and Ministry of Health, Health Services Research (HSRG0016/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildskov JA., 1985, EUR HEART J SUPPL, V6; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Beinart R, 2014, J AM COLL CARDIOL, V64, P2111, DOI 10.1016/j.jacc.2014.08.039; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; DEKKER JM, 1994, CIRCULATION, V90, P779, DOI 10.1161/01.CIR.90.2.779; Dekker JM, 2004, J AM COLL CARDIOL, V43, P565, DOI 10.1016/j.jacc.2003.09.040; Festa A, 1999, STROKE, V30, P1566, DOI 10.1161/01.STR.30.8.1566; GOLDBERG RJ, 1991, AM J CARDIOL, V67, P55, DOI 10.1016/0002-9149(91)90099-7; Haugaa KH, 2013, MAYO CLIN PROC, V88, P315, DOI 10.1016/j.mayocp.2013.01.013; MACFARLANE PW, 1994, J ELECTROCARDIOL, V27, P14, DOI 10.1016/S0022-0736(94)80039-1; Maebuchi D, 2010, HYPERTENS RES, V33, P916, DOI 10.1038/hr.2010.88; Montanez A, 2004, ARCH INTERN MED, V164, P943, DOI 10.1001/archinte.164.9.943; MUNGER RG, 1991, LANCET, V338, P280, DOI 10.1016/0140-6736(91)90419-P; Nakanishi S, 2004, AM J CARDIOL, V93, P1182, DOI 10.1016/j.amjcard.2004.01.055; Nielsen JB, 2014, EUR HEART J, V35, P1335, DOI 10.1093/eurheartj/ehu081; Noseworthy PA, 2012, ANN NONINVAS ELECTRO, V17, P340, DOI 10.1111/j.1542-474X.2012.00535.x; O'Neal WT, 2015, CLIN RES CARDIOL; PETERS RW, 1990, J CLIN EPIDEMIOL, V43, P167, DOI 10.1016/0895-4356(90)90180-W; SAGIE A, 1992, AM J CARDIOL, V70, P797, DOI 10.1016/0002-9149(92)90562-D; Sauer AJ, 2007, J AM COLL CARDIOL, V49, P329, DOI 10.1016/j.jacc.2006.08.057; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Soliman EZ, 2012, J AM COLL CARDIOL, V59, P1460, DOI 10.1016/j.jacc.2012.01.025; Tan CSH, 2011, EYE, V25, P1294, DOI 10.1038/eye.2011.144; Tosukhowong P, 1996, AM J NEPHROL, V16, P369, DOI 10.1159/000169027; Williams ES, 2012, AM HEART J, V164, P434, DOI 10.1016/j.ahj.2012.05.024; Zhang YY, 2011, ARCH INTERN MED, V171, P1727, DOI 10.1001/archinternmed.2011.433; Zhang YY, 2011, EPIDEMIOLOGY, V22, P660, DOI 10.1097/EDE.0b013e318225768b	27	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154901	10.1371/journal.pone.0154901	http://dx.doi.org/10.1371/journal.pone.0154901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27148971	Green Published, gold			2022-12-27	WOS:000375676800084
J	Chamorro-Moriana, G; Ridao-Fernandez, C; Ojeda, J; Benitez-Lugo, M; Sevillano, JL				Chamorro-Moriana, Gema; Ridao-Fernandez, Carmen; Ojeda, Joaquin; Benitez-Lugo, Marisa; Luis Sevillano, Jose			Reliability and Validity Study of the Chamorro Assisted Gait Scale for People with Sprained Ankles, Walking with Forearm Crutches	PLOS ONE			English	Article							WEIGHT-BEARING; INTERRATER RELIABILITY; TOOL; PERFORMANCE; VALIDATION; AMBULATION; CHILDREN; INJURY	Objective The aim of this study was to design and validate a functional assessment scale for assisted gait with forearm crutches (Chamorro Assisted Gait Scale-CHAGS) and to assess its reliability in people with sprained ankles. Design Thirty subjects who suffered from sprained ankle (anterior talofibular ligament first and second degree) were included in the study. A modified Delphi technique was used to obtain the content validity. The selected items were: pelvic and scapular girdle dissociation(1), deviation of Center of Gravity(2), crutch inclination(3), steps rhythm(4), symmetry of step length (5), cross support(6), simultaneous support of foot and crutch(7), forearm off(8), facing forward( 9) and fluency(10). Two raters twice visualized the gait of the sample subjects which were recorded. The criterion-related validity was determined by correlation between CHAGS and Coding of eight criteria of qualitative gait analysis (Viel Coding). Internal consistency and inter and intra-rater reliability were also tested. Results CHAGS obtained a high and negative correlation with Viel Coding. We obtained a good internal consistency and the intra-class correlation coefficients oscillated between 0.97 and 0.99, while the minimal detectable changes were acceptable. Conclusion CHAGS scale is a valid and reliable tool for assessing assisted gait with crutches in people with sprained ankles to perform partial relief of lower limbs.	[Chamorro-Moriana, Gema; Ridao-Fernandez, Carmen; Benitez-Lugo, Marisa] Univ Seville, Dept Physiotherapy, Res Grp Area Physiotherapy CTS 305, Seville, Spain; [Ojeda, Joaquin] Univ Seville, Dept Mech & Manufacture, Res Grp Mech Engn, Seville, Spain; [Luis Sevillano, Jose] Univ Seville, Res Grp Robot & Technol Comp, Dept Architecture & Technol Comp, Seville, Spain	University of Sevilla; University of Sevilla; University of Sevilla	Chamorro-Moriana, G (corresponding author), Univ Seville, Dept Physiotherapy, Res Grp Area Physiotherapy CTS 305, Seville, Spain.	gchamorro@us.es	Benítez-Lugo, María-Luisa/J-7487-2018; Ojeda, Joaquín/I-2380-2014; Ridao-Fernández, Carmen/X-5773-2019; Ojeda, Joaquín/AAA-3222-2021; Chamorro-Moriana, Gema/F-7398-2018; Sevillano, Jose Luis/K-2484-2013	Benítez-Lugo, María-Luisa/0000-0003-2058-8799; Ojeda, Joaquín/0000-0002-6894-197X; Ridao-Fernández, Carmen/0000-0003-4573-5185; Ojeda, Joaquín/0000-0002-6894-197X; Chamorro-Moriana, Gema/0000-0003-4592-0882; Sevillano, Jose Luis/0000-0002-1392-1832	Telefonica Chair "Intelligence in Networks" of the University of Seville, Spain	Telefonica Chair "Intelligence in Networks" of the University of Seville, Spain	This study was funded by the Telefonica Chair "Intelligence in Networks" of the University of Seville, Spain (http://institucional.us.es/catedratel/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo PA, 2009, BRAZ J PHYS THER, V13, P267, DOI 10.1590/S1413-35552009005000033; Bella GP, 2012, REV BRAS FISIOTER, V16, P134, DOI 10.1590/S1413-35552012000200009; Bridwell KH, 2005, SPINE, V30, P455, DOI 10.1097/01.brs.0000153393.82368.6b; BROSKY T, 1995, J ORTHOP SPORT PHYS, V21, P197, DOI 10.2519/jospt.1995.21.4.197; Carlson NR., 2012, PHYSIOL BEHAV; Chamorro-Moriana G, 2011, CUEST FISIOTER, V40, P155; Chamorro-Moriana G, 2009, Spanish patent, Patent No. [P200901942, 200901942]; Chamorro-Moriana G, 2013, GAIT POSTURE, V37, P564, DOI 10.1016/j.gaitpost.2012.09.018; Creaby MW, 2010, OSTEOARTHR CARTILAGE, V18, P1380, DOI 10.1016/j.joca.2010.08.013; Cremers J, 2012, PARKINSONISM RELAT D, V18, P759, DOI 10.1016/j.parkreldis.2012.03.012; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Davis A E, 1996, J Neurosci Nurs, V28, P204; Domholdt E., 2000, PHYS THERAPY RES PRI, V2nd ed.; Dunn A, 2015, STROKE RES TREAT, V2015, DOI 10.1155/2015/484813; Fischer J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-61; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Grunt S, 2010, GAIT POSTURE, V31, P489, DOI 10.1016/j.gaitpost.2010.02.006; Hale L, 2010, J INTELLECT DEV DIS, V35, P77, DOI 10.3109/13668251003702128; Hershko Erel, 2008, Am J Orthop (Belle Mead NJ), V37, pE92; Hol AM, 2010, ARCH ORTHOP TRAUM SU, V130, P547, DOI 10.1007/s00402-009-1017-3; Jackson AB, 2008, J SPINAL CORD MED, V31, P487, DOI 10.1080/10790268.2008.11753644; Jones A, 2008, CLINICS, V63, P197, DOI 10.1590/S1807-59322008000200007; Kim JS, 2011, CLIN REHABIL, V25, P134, DOI 10.1177/0269215510380822; Kloos AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030903; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lord SE, 1998, CLIN REHABIL, V12, P107, DOI 10.1191/026921598666182531; Malviya A, 2005, INJURY, V36, P556, DOI 10.1016/j.injury.2004.10.004; Morgan P, 2014, DISABIL REHABIL, V36, P1, DOI 10.3109/09638288.2013.775359; Navas-Vinagre I, 2015, REV MED INT SINDR DO; Nguyen VC, 2007, AM J PHYS MED REHAB, V86, P463, DOI 10.1097/PHM.0b013e31805b8193; Osaki Y, 2008, EXP BRAIN RES, V185, P121, DOI 10.1007/s00221-007-1139-1; Peterson DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090634; Pizzi A, 2007, J REHABIL MED, V39, P170, DOI 10.2340/16501977-0026; Polit D, 2003, NURSING RES PRINCIPL, P223; Reid S, 2011, ARCH PHYS MED REHAB, V92, P1060, DOI 10.1016/j.apmr.2011.02.014; Sedgman R, 1994, ADV REH IN C FAC HLT; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Thomas M, 2004, J NEUROL SCI, V217, P89, DOI 10.1016/j.jns.2003.09.005; Toro B, 2007, ARCH PHYS MED REHAB, V88, P321, DOI 10.1016/j.apmr.2006.12.028; Vasarhelyi A, 2006, GAIT POSTURE, V23, P99, DOI 10.1016/j.gaitpost.2004.12.005; Viel E., 2000, MARCHE HUMAINE COURS; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wellmon Robert, 2006, J Geriatr Phys Ther, V29, P74; Zimbelman J, 2012, ARCH PHYS MED REHAB, V93, P129, DOI 10.1016/j.apmr.2011.08.011	44	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155225	10.1371/journal.pone.0155225	http://dx.doi.org/10.1371/journal.pone.0155225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168236	Green Published, gold			2022-12-27	WOS:000376587300085
J	Rouffaer, LO; Lens, L; Haesendonck, R; Teyssier, A; Hudin, NS; Strubbe, D; Haesebrouck, F; Pasmans, F; Martel, A				Rouffaer, Lieze Oscar; Lens, Luc; Haesendonck, Roel; Teyssier, Aimeric; Hudin, Noraine Salleh; Strubbe, Diederik; Haesebrouck, Freddy; Pasmans, Frank; Martel, An			House Sparrows Do Not Constitute a Significant Salmonella Typhimurium Reservoir across Urban Gradients in Flanders, Belgium	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; WILD BIRDS; PASSER-DOMESTICUS; NEW-ZEALAND; VARIANT COPENHAGEN; AVIAN WILDLIFE; ENTERICA; PREVALENCE; INFECTION; EPIDEMIOLOGY	In recent decades major declines in urban house sparrow (Passer domesticus) populations have been observed in north-western European cities, whereas suburban and rural house sparrow populations have remained relatively stable or are recovering from previous declines. Differential exposure to avian pathogens known to cause epidemics in house sparrows may in part explain this spatial pattern of declines. Here we investigate the potential effect of urbanization on the development of a bacterial pathogen reservoir in free-ranging house sparrows. This was achieved by comparing the prevalence of Salmonella enterica subspecies enterica serotype Typhimurium in 364 apparently healthy house sparrows captured in urban, suburban and rural regions across Flanders, Belgium between September 2013 and March 2014. In addition 12 dead birds, received from bird rescue centers, were necropsied. The apparent absence of Salmonella Typhimurium in fecal samples of healthy birds, and the identification of only one house sparrow seropositive for Salmonella spp., suggests that during the winter of 2013-2014 these birds did not represent any considerable Salmonella Typhimurium reservoir in Belgium and thus may be considered naive hosts, susceptible to clinical infection. This susceptibility is demonstrated by the isolation of two different Salmonella Typhimurium strains from two of the deceased house sparrows: one DT99, typically associated with disease in pigeons, and one DT195, previously associated with a passerine decline. The apparent absence (prevalence: <1.3%) of a reservoir in healthy house sparrows and the association of infection with clinical disease suggests that the impact of Salmonella Typhimurium on house sparrows is largely driven by the risk of exogenous exposure to pathogenic Salmonella Typhimurium strains. However, no inference could be made on a causal relationship between Salmonella infection and the observed house sparrow population declines.	[Rouffaer, Lieze Oscar; Haesendonck, Roel; Haesebrouck, Freddy; Pasmans, Frank; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Lens, Luc; Teyssier, Aimeric; Hudin, Noraine Salleh; Strubbe, Diederik] Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium; [Hudin, Noraine Salleh] Univ Pendidikan Sultan Idris, Fac Sci & Math, Dept Biol Sci, Perak, Malaysia	Ghent University; Ghent University; Universiti Pendidikan Sultan Idris	Rouffaer, LO (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	Lieze.Rouffaer@UGent.be	Pasmans, Frank/D-3667-2014; Haesebrouck, Freddy/M-3857-2014; Strubbe, Diederik/J-4299-2015	Haesebrouck, Freddy/0000-0002-1709-933X; Strubbe, Diederik/0000-0002-2613-4985	Research Foundation Flanders (FWO); Interuniversity Attraction Poles Program SPEEDY; Belgian Science Policy Office	Research Foundation Flanders (FWO)(FWO); Interuniversity Attraction Poles Program SPEEDY; Belgian Science Policy Office(Belgian Federal Science Policy Office)	This work was supported by the Research Foundation Flanders (FWO): Aspirant to LOR and Interuniversity Attraction Poles Program SPEEDY initiated by the Belgian Science Policy Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley MR, 2002, NEW ZEAL VET J, V50, P170; Andres S, 2013, ZOONOSES PUBLIC HLTH, V60, P355, DOI 10.1111/j.1863-2378.2012.01542.x; [Anonymous], ISO65792002E; BARROW PA, 1992, EPIDEMIOL INFECT, V108, P231, DOI 10.1017/S0950268800049712; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; BRITTINGHAM MC, 1988, J WILDLIFE DIS, V24, P299, DOI 10.7589/0090-3558-24.2.299; CIZEK A, 1994, J VET MED B, V41, P320, DOI 10.1111/j.1439-0450.1994.tb00234.x; Connolly JH, 2006, NEW ZEAL VET J, V54, P329, DOI 10.1080/00480169.2006.36719; Daoust PY, 2000, CAN VET J, V41, P54; De Laet J, 2007, J ORNITHOL, V148, pS275, DOI 10.1007/s10336-007-0154-0; Devleesschauwer B, 2015, **DATA OBJECT**; Everaert J, 2007, ELECTROMAGN BIOL MED, V26, P63, DOI 10.1080/15368370701205693; Ewen JG, 2007, EMERG INFECT DIS, V13, P788, DOI 10.3201/eid1305.060824; FADDOUL GP, 1965, AVIAN DIS, V9, P377, DOI 10.2307/1588367; Giovannini S, 2013, VET PATHOL, V50, P597, DOI 10.1177/0300985812465328; Hamer SA, 2012, ZOONOSES PUBLIC HLTH, V59, P355, DOI 10.1111/j.1863-2378.2012.01462.x; HASSAN JO, 1991, AVIAN DIS, V35, P809, DOI 10.2307/1591614; Hernandez J, 2003, EMERG INFECT DIS, V9, P753; Horton RA, 2013, RES VET SCI, V95, P45, DOI 10.1016/j.rvsc.2013.02.008; Hyeon JY, 2012, POULTRY SCI, V91, P1222, DOI 10.3382/ps.2011-01936; Kamath V, 2014, INT J RENEWABLE ENER, V2, P17; Kirk JH, 2002, J AM VET MED ASSOC, V220, P359, DOI 10.2460/javma.2002.220.359; Krawiec M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0332-x; Lawson B, 2010, ECOHEALTH, V7, P294, DOI 10.1007/s10393-010-0349-3; Lawson B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088968; Lawson B, 2011, APPL ENVIRON MICROB, V77, P8139, DOI 10.1128/AEM.00131-11; Leyman B, 2011, VACCINE, V29, P3679, DOI 10.1016/j.vaccine.2011.03.004; Mainar-Jaime RC, 2013, J CLIN MICROBIOL, V51, P89, DOI 10.1128/JCM.02099-12; Morishita TY, 1999, AVIAN DIS, V43, P549, DOI 10.2307/1592655; Palmgren H, 2006, EPIDEMIOL INFECT, V134, P635, DOI 10.1017/S0950268805005261; Pasmans F, 2004, J CLIN MICROBIOL, V42, P2000, DOI 10.1128/JCM.42.5.2000-2002.2004; Pasmans F, 2003, INFECT IMMUN, V71, P6068, DOI 10.1128/IAI.71.10.6068-6074.2003; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Pennycott TW, 2006, VET REC, V158, P817, DOI 10.1136/vr.158.24.817; Pennycott TW, 2002, VET REC, V151, P563, DOI 10.1136/vr.151.19.563; Proux K, 1998, AVIAN PATHOL, V27, P161, DOI 10.1080/03079459808419318; Refsum T, 2003, J WILDLIFE DIS, V39, P64, DOI 10.7589/0090-3558-39.1.64; Refsum T, 2002, APPL ENVIRON MICROB, V68, P5600, DOI 10.1128/AEM.68.11.5600-5606.2002; Refsum T, 2002, APPL ENVIRON MICROB, V68, P5595, DOI 10.1128/AEM.68.11.5595-5599.2002; Shaw LM, 2008, J ORNITHOL, V149, P293, DOI 10.1007/s10336-008-0285-y; Stevenson M.A., 2015, EPIR TOOLS ANAL EPID; Summers-Smith J. Denis, 2003, British Birds, V96, P439; Uzzau S, 2000, EPIDEMIOL INFECT, V125, P229, DOI 10.1017/S0950268899004379; Vangestel C, 2010, BIOL J LINN SOC, V101, P41, DOI 10.1111/j.1095-8312.2010.01493.x; Vermeersch G, 2004, MEDEDELINGEN I NATUU, V23, P418	45	6	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155366	10.1371/journal.pone.0155366	http://dx.doi.org/10.1371/journal.pone.0155366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168186	Green Published, gold			2022-12-27	WOS:000376587300049
J	Wirth, JP; Rohner, F; Woodruff, BA; Chiwile, F; Yankson, H; Koroma, AS; Russel, F; Sesay, F; Dominguez, E; Petry, N; Shahab-Ferdows, S; de Onis, M; Hodges, MH				Wirth, James P.; Rohner, Fabian; Woodruff, Bradley A.; Chiwile, Faraja; Yankson, Hannah; Koroma, Aminata S.; Russel, Feimata; Sesay, Fatmata; Dominguez, Elisa; Petry, Nicolai; Shahab-Ferdows, Setareh; de Onis, Mercedes; Hodges, Mary H.			Anemia, Micronutrient Deficiencies, and Malaria in Children and Women in Sierra Leone Prior to the Ebola Outbreak - Findings of a Cross-Sectional Study	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; FOLATE-DEFICIENCY; YOUNG-CHILDREN; IRON; PREVALENCE; FERRITIN; BURDEN	To identify the factors associated with anemia and to document the severity of micronutrient deficiencies, malaria and inflammation, a nationally representative cross-sectional survey was conducted. A three-stage sampling procedure was used to randomly select children < 5 years of age and adult women from households in two strata (urban and rural). Household and individual data were collected, and blood samples from children and women were used to measure the prevalence of malaria, inflammation, and deficiencies of iron, vitamin A, folate, and vitamin B-12. 839 children and 945 non-pregnant women were included in the survey. In children, the prevalence rates of anemia (76.3%; 95% CI: 71.8, 80.4), malaria (52.6%; 95% CI: 46.0, 59.0), and acute and chronic inflammation (72.6%; 95% CI: 67.5, 77.1) were high. However, the prevalence of vitamin A deficiency (17.4%; 95% CI: 13.9, 21.6) was moderate, and the prevalence of iron deficiency (5.2%; 95% CI: 3.3, 8.1) and iron-deficiency anemia (3.8%; 95% CI: 2.5, 5.8) were low. Malaria and inflammation were associated with anemia, yet they explained only 25% of the population-attributable risk. In women, 44.8% (95% CI: 40.1, 49.5), 35.1% (95% CI: 30.1, 40.4), and 23.6%(95% CI: 20.4, 27.3) were affected by anemia, malaria, or inflammation, respectively. The prevalence rates of iron deficiency (8.3%; 95% CI: 6.2, 11.1), iron-deficiency anemia (6.1%; 95% CI: 4.4, 8.6), vitamin A deficiency (2.1%; 95% CI: 1.1, 3.1) and vitamin B12 deficiency (0.5%; 95% CI: 0.2, 1.4) were low, while folate deficiency was high (79.2%; 95% CI: 74.1, 83.5). Iron deficiency, malaria, and inflammation were significantly associated with anemia, but explained only 25% of cases of anemia. Anemia in children and women is a severe public health problem in Sierra Leone. Since malaria and inflammation only contributed to 25% of anemia, other causes of anemia, such as hemoglobinopathies, should also be explored.	[Wirth, James P.; Rohner, Fabian; Woodruff, Bradley A.; Petry, Nicolai] GroundWork, Crans Pres Celigny, Switzerland; [Chiwile, Faraja] UNICEF, Freetown, Sierra Leone; [Yankson, Hannah] WHO, Freetown, Sierra Leone; [Koroma, Aminata S.; Russel, Feimata] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Sesay, Fatmata; Hodges, Mary H.] Helen Keller Int, Freetown, Sierra Leone; [Dominguez, Elisa] WHO West Africa, Ouagadougou, Burkina Faso; [Shahab-Ferdows, Setareh] USDA ARS Western Human Nutr Res Ctr, Davis, CA USA; [de Onis, Mercedes] WHO Headquarters, Geneva, Switzerland	World Health Organization; Ministry of Health & Sanitation Sierra Leone; World Health Organization	Wirth, JP (corresponding author), GroundWork, Crans Pres Celigny, Switzerland.	james@groundworkhealth.org	Rohner, Fabian/I-5088-2019; amsalu, ribka/G-8780-2019	Rohner, Fabian/0000-0003-0579-6952; Wirth, James P/0000-0002-4733-0379	Sierra Leone's Ministry of Health and Sanitation; UNICEF; World Health Organization [SPHQ 15-APW-1834]; Food and Agriculture Organization; Canada's Ministry of Foreign Affairs, Trade and Development; Irish Aid; United States Agency for International Development; GroundWork; ARS [ARS-0426640] Funding Source: Federal RePORTER	Sierra Leone's Ministry of Health and Sanitation; UNICEF; World Health Organization(World Health Organization); Food and Agriculture Organization; Canada's Ministry of Foreign Affairs, Trade and Development; Irish Aid(CGIAR); United States Agency for International Development(United States Agency for International Development (USAID)); GroundWork; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding and in-kind contributions for data collection, laboratory analysis, and reporting were provided by Sierra Leone's Ministry of Health and Sanitation, UNICEF, the World Health Organization, the Food and Agriculture Organization, Canada's Ministry of Foreign Affairs, Trade and Development, Irish Aid, and the United States Agency for International Development. Funding for the development of this manuscript was provided by the World Health Organization to GroundWork (SPHQ 15-APW-1834) with in-kind contributions (i.e. labor) provided by GroundWork.	Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2011, VIT MIN NUTR INF SYS; Asare-Marfo D, 2013, PRIORITIZING COUNTRI; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; Diaz-Quijano FA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-14; Dunn JT., 1993, METHODS MEASURING IO; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Filmer D., 1998, ESTIMATING WEALTH EF; HERBERT V, 1994, AM J CLIN NUTR, V59, p1213S, DOI 10.1093/ajcn/59.5.1213S; HERBERT V, 1962, T ASSOC AM PHYSICIAN, V75, P307; Hodges MH, 2015, MATERN CHILD HLTH J; Hollm-Delgado MG, 2015, ELIFE, V4, DOI 10.7554/eLife.03925; Hurrell R, 2010, INT J VITAM NUTR RES, V80, P279, DOI 10.1024/0300-9831/a000035; Karakochuk CD, 2014, ELEVATED LEVELS IRON; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Larbi A., 2012, SIERRA LEONE COUNTRY; Liberia Institute of Statistics UNICEF, 2011, LIB NAT MICR SURV 20; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; McCuskee S, 2014, ANN GLOB HEALTH, V80, P458, DOI 10.1016/j.aogh.2015.01.003; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Merrill RD, 2011, J NUTR, V141, P944, DOI 10.3945/jn.111.138628; Metz J, 2008, FOOD NUTR BULL, V29, pS74, DOI 10.1177/15648265080292S111; Ministry of Health and Sanitation [Sierra Leone], 2010, SIERR LEON MAL CONTR; Ministry of Health and Sanitation (Sierra Leone) The United Nations Children's Fund Helen Keller International and World Health Organization, 2015, 2013 SIERR LEON MICR; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; National Malaria Control Programme (NMCP) [Sierra Leone] Statistics Sierra Leone (SSL) University of Sierra Leone Catholic Relief Services (CRS) ICF International, 2013, SIERR LEON MAL IND S; O'Donnell A, 2009, T ROY SOC TROP MED H, V103, P679, DOI 10.1016/j.trstmh.2009.03.023; Prentice AM, 2008, J NUTR, V138, P2537, DOI 10.3945/jn.108.098806; Rohner F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020074; Rohner F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138530; Rohner F, 2014, PUBLIC HEALTH NUTR, V17, P2016, DOI 10.1017/S136898001300222X; Sesay FF, 2014, INT HLTH; Shahab-Ferdows S, 2012, FASEB J, V26, P1030; Statistics Sierra Leone, 2014, SIERR LEON DEM HLTH; Statistics Sierra Leone Ministry of Health and Sanitation Sierra Leone ICF Macro, 2009, SIERR LEON DEM HLTH; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Tanumihardjo SA, 2012, REPORT PRIORITIES AS; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; United Nations Development Programme, 2015, HUM DEV REP; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WHO, 2011, WHONMHNHDNMN111; WHO, 2001, IRON DEFICIENCY ANAE; WHO UNICEF., 2014, DEF IMPR WAT SAN JOI; World Health Organization, 2014, GUID FORT FOODGR SAL; Wurie A T, 1996, West Afr J Med, V15, P201	51	39	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2016	11	5							e0155031	10.1371/journal.pone.0155031	http://dx.doi.org/10.1371/journal.pone.0155031			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8BN	27163254	Green Published, Green Submitted, gold			2022-12-27	WOS:000376585700006
J	Klement, RJ; Champ, CE; Otto, C; Kammerer, U				Klement, Rainer J.; Champ, Colin E.; Otto, Christoph; Kaemmerer, Ulrike			Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis	PLOS ONE			English	Article							CARBOHYDRATE RESTRICTION; PROSTATE-CANCER; TUMOR-GROWTH; KETONE-BODIES; CALORIC RESTRICTION; MOUSE; THERAPY; GLUCOSE; MODEL	Background Currently ketogenic diets (KDs) are hyped as an anti-tumor intervention aimed at exploiting the metabolic abnormalities of cancer cells. However, while data in humans is sparse, translation of murine tumor models to the clinic is further hampered by small sample sizes, heterogeneous settings and mixed results concerning tumor growth retardation. The aim was therefore to synthesize the evidence for a growth inhibiting effect of KDs when used as a monotherapy in mice. Methods We conducted a Bayesian random effects meta-analysis on all studies assessing the survival (defined as the time to reach a pre-defined endpoint such as tumor volume) of mice on an unrestricted KD compared to a high carbohydrate standard diet (SD). For 12 studies meeting the inclusion criteria either a mean survival time ratio (MR) or hazard ratio (HR) between the KD and SD groups could be obtained. The posterior estimates for the MR and HR averaged over four priors on the between-study heterogeneity tau(2) were MR = 0.85 (95% highest posterior density interval (HPDI) = [0.73, 0.97]) and HR = 0.55 (95% HPDI = [0.26, 0.87]), indicating a significant overall benefit of the KD in terms of prolonged mean survival times and reduced hazard rate. All studies that used a brain tumor model also chose a late starting point for the KD (at least one day after tumor initiation) which accounted for 26% of the heterogeneity. In this subgroup the KD was less effective (MR = 0.89, 95% HPDI = [0.76, 1.04]). Conclusions There was an overall tumor growth delaying effect of unrestricted KDs in mice. Future experiments should aim at differentiating the effects of KD timing versus tumor location, since external evidence is currently consistent with an influence of both of these factors.	[Klement, Rainer J.] Leopoldina Hosp Schweinfurt, Dept Radiotherapy & Radiat Oncol, Schweinfurt, Germany; [Champ, Colin E.] Univ Pittsburgh, Med Ctr, Dept Radiat Oncol, Pittsburgh, PA USA; [Otto, Christoph] Univ Hosp Wurzburg, Dept Gen Visceral Vasc & Pediat Surg, Wurzburg, Germany; [Kaemmerer, Ulrike] Univ Hosp Wurzburg, Dept Obstet & Gynaecol, Wurzburg, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wurzburg; University of Wurzburg	Klement, RJ (corresponding author), Leopoldina Hosp Schweinfurt, Dept Radiotherapy & Radiat Oncol, Schweinfurt, Germany.	rainer_klement@gmx.de	Klement, Rainer J/H-3484-2019; Champ, Colin/AAA-6842-2019	Klement, Rainer J/0000-0003-1401-4270; Champ, Colin/0000-0002-1879-7463				Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Allen BG, 2013, CLIN CANCER RES, V19, P3905, DOI 10.1158/1078-0432.CCR-12-0287; Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2090; Borghjid S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-69; CAHILL GF, 1976, CLIN ENDOCRINOL META, V5, P397, DOI 10.1016/S0300-595X(76)80028-X; Caso J, 2013, PROSTATE, V73, P449, DOI 10.1002/pros.22586; Dang MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133633; Fontana L, 2013, ONCOTARGET, V4, P2451, DOI 10.18632/oncotarget.1586; Freedland SJ, 2008, PROSTATE, V68, P11, DOI 10.1002/pros.20683; Gluschnaider U, 2014, CANC RES; Hao Guang-Wei, 2015, Asian Pac J Cancer Prev, V16, P2061; Healy ME, 2015, J HEPATOL, V62, P599, DOI 10.1016/j.jhep.2014.10.024; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Ho VW, 2011, CANCER RES, V71, P4484, DOI 10.1158/0008-5472.CAN-10-3973; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Hursting SD, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-10; Husain Z, 2013, J IMMUNOL, V191, P1486, DOI 10.4049/jimmunol.1202702; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; Kim HS, 2012, BJU INT, V110, P1062, DOI 10.1111/j.1464-410X.2012.10971.x; Klement RJ, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.2; Klement RJ, 2014, TRENDS MOL MED, V20, P471, DOI 10.1016/j.molmed.2014.07.001; Klement RJ, 2013, ONCOLOGIST, V18, P1056, DOI 10.1634/theoncologist.2013-0032; Lai M, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.30; Lamming DW, 2015, ONCOTARGET, V6, P31233, DOI 10.18632/oncotarget.5180; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Lin BQ, 2013, LUNG CANCER, V79, P111, DOI 10.1016/j.lungcan.2012.11.001; Lv MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115147; Mahoney LB, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-13; Martuscello RT, 2015, CLIN CANC RES; Masko EM, 2010, CANCER PREV RES, V3, P1124, DOI 10.1158/1940-6207.CAPR-10-0071; Maurer GD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-315; Mavropoulos JC, 2009, CANCER PREV RES, V2, P557, DOI 10.1158/1940-6207.CAPR-08-0188; Meidenbauer JJ, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0009-2; Moreschi C, 1909, Z IMMUNITATSFORSCH, V2, P651; Morscher RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129802; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Peterman MG, 1925, J AMER MED ASSOC, V84, P1979, DOI 10.1001/jama.1925.02660520007003; Poff AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127407; Poff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065522; Rieger J, 2014, INT J ONCOL, V44, P1843, DOI 10.3892/ijo.2014.2382; Schwartz K, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0129-1; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Shukla SK, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-18; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Spruance SL, 2004, ANTIMICROB AGENTS CH, V48, P2787, DOI 10.1128/AAC.48.8.2787-2792.2004; Stafford P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-74; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Van Alstyne EVN, 1913, J MED RES, V29, P217; Woolf EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130357; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Zhuang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108444	52	70	71	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155050	10.1371/journal.pone.0155050	http://dx.doi.org/10.1371/journal.pone.0155050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159218	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000376576700035
J	Tengvall, S; Eneljung, T; Jirholt, P; Turesson, O; Wing, K; Holmdahl, R; Kihlberg, J; Stern, A; Martensson, IL; Henningsson, L; Gustafsson, K; Gjertsson, I				Tengvall, Sara; Eneljung, Tove; Jirholt, Pernilla; Turesson, Olof; Wing, Kajsa; Holmdahl, Rikard; Kihlberg, Jan; Stern, Anna; Martensson, Inga-Lill; Henningsson, Louise; Gustafsson, Kenth; Gjertsson, Inger			Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis	PLOS ONE			English	Article							REGULATORY T-CELLS; II COLLAGEN; B-CELLS; DENDRITIC CELLS; SELF-TOLERANCE; INDUCTION; SUPPRESSION; AUTOIMMUNE; PEPTIDE; MICE	Here, we investigate induction of immunological tolerance by lentiviral based gene therapy in a mouse model of rheumatoid arthritis, collagen II-induced arthritis (CIA). Targeting the expression of the collagen type II (CII) to antigen presenting cells (APCs) induced antigen-specific tolerance, where only 5% of the mice developed arthritis as compared with 95% of the control mice. In the CII-tolerized mice, the proportion of Tregs as well as mRNA expression of SOCS1 (suppressors of cytokine signaling 1) increased at day 3 after CII immunization. Transfer of B cells or non-B cell APC, as well as T cells, from tolerized to naive mice all mediated a certain degree of tolerance. Thus, sustainable tolerance is established very early during the course of arthritis and is mediated by both B and non-B cells as APCs. This novel approach for inducing tolerance to disease specific antigens can be used for studying tolerance mechanisms, not only in CIA but also in other autoimmune diseases.	[Tengvall, Sara; Eneljung, Tove; Jirholt, Pernilla; Turesson, Olof; Stern, Anna; Martensson, Inga-Lill; Henningsson, Louise; Gjertsson, Inger] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Wing, Kajsa; Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Med Inflammat Res, Stockholm, Sweden; [Holmdahl, Rikard] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Kihlberg, Jan] Uppsala Univ, BMC, Dept Chem, Uppsala, Sweden; [Gustafsson, Kenth] UCL Inst Child Hlth, Mol & Cellular Immunol Sect, London, England; [Gjertsson, Inger] Sahlgrens Univ Hosp, Gothenburg, Sweden	University of Gothenburg; Karolinska Institutet; Southern Medical University - China; Uppsala University; University of London; University College London; Sahlgrenska University Hospital	Gjertsson, I (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.; Gjertsson, I (corresponding author), Sahlgrens Univ Hosp, Gothenburg, Sweden.	inger.gjertsson@rheuma.gu.se	Holmdahl, Rikard/AAI-7682-2020; Kihlberg, Jan/S-4739-2019	Martensson, Inga-Lill/0000-0003-3415-0560; Tengvall, Sara/0000-0001-6553-1951; Wing, Kajsa/0000-0001-7744-4847	Swedish Science Research Council (Medicinska Forskningsradet); Goteborg's Lakaresallskap; Svenska Lakaresallskapet; King Gustav V's 80 Year Foundation	Swedish Science Research Council (Medicinska Forskningsradet); Goteborg's Lakaresallskap; Svenska Lakaresallskapet; King Gustav V's 80 Year Foundation	This study was supported by grants from the Swedish Science Research Council (Medicinska Forskningsradet, Gjertsson, Martensson, Holmdahl), Goteborg's Lakaresallskap (Gjertsson), Svenska Lakaresallskapet (Gjertsson), King Gustav V's 80 Year Foundation (Gjertsson, Martensson). AFA Insurances* (*AFA Insurance is an organization owned by Sweden's labour market parties (Gjertsson, Martensson)). IngaBritt och Arne Lundbergs Forskningsstiftelse (Martensson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; This study was supported by grants from the Swedish Science Research Council (Medicinska Forskningsradet, Gjertsson, Martensson, Holmdahl), Goteborg's Lakaresallskap (Gjertsson), Svenska Lakaresallskapet (Gjertsson), King Gustav V's 80 Year Foundation (Gjertsson, Martensson). AFA Insurances* (*AFA Insurance is an organization owned by Sweden's labour market parties (Gjertsson, Martensson). IngaBritt och Arne Lundbergs Forskningsstiftelse (Martensson). Primer and probe sequences, and plasmid standards for real-time PCR quantification of the titin gene were kindly provided by Dr Anne Galy, Genethon, France. Plasmids pCMV Delta R8.74 and pMD.G2 produced Plasmid Factory, GmbH&Co. KG, Bielefeld, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Behrens M, 2011, J AUTOIMMUN, V37, P95, DOI 10.1016/j.jaut.2011.05.002; Billiau A, 2011, CYTOKINE GROWTH F R, V22, P339, DOI 10.1016/j.cytogfr.2011.11.003; Bouaziz JD, 2012, CURR MOL MED, V12, P519; Boyman O, 2014, NAT REV RHEUMATOL, V10, P612, DOI 10.1038/nrrheum.2014.123; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; BRUNSBERG U, 1994, EUR J IMMUNOL, V24, P1698, DOI 10.1002/eji.1830240736; Carranza F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040356; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Chu CQ, 1999, J AUTOIMMUN, V12, P35, DOI 10.1006/jaut.1998.0255; Cooles FAH, 2010, BEST PRACT RES CL RH, V24, P497, DOI 10.1016/j.berh.2010.01.007; Corthay A, 1998, EUR J IMMUNOL, V28, P2580, DOI 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; Dunussi-Joannopoulos K, 2005, BLOOD, V106, P2235, DOI 10.1182/blood-2004-11-4547; Dzhambazov B, 2006, J IMMUNOL, V176, P1525, DOI 10.4049/jimmunol.176.3.1525; Dzhambazov B, 2005, EUR J IMMUNOL, V35, P357, DOI 10.1002/eji.200425637; Eneljung T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/345092; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Fujimoto M, 2010, THERMODYNAMICS OF CRYSTALLINE STATES, P1, DOI 10.1007/978-1-4419-6688-9_1; Gjertsson I, 2009, MOL THER, V17, P632, DOI 10.1038/mt.2009.299; Hasselberg A, 2009, ARTHRITIS RHEUM-US, V60, P1672, DOI 10.1002/art.24566; Henningsson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049731; Huurman VAL, 2009, AM J TRANSPLANT, V9, P382, DOI 10.1111/j.1600-6143.2008.02479.x; Ito HO, 1997, CLIN EXP IMMUNOL, V108, P213, DOI 10.1046/j.1365-2249.1997.3721269.x; Jaen O, 2009, IMMUNOLOGY, V126, P35, DOI 10.1111/j.1365-2567.2008.02875.x; JANSSON L, 1993, CLIN EXP IMMUNOL, V94, P459, DOI 10.1111/j.1365-2249.1993.tb08218.x; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Kelchtermans H, 2009, ANN RHEUM DIS, V68, P744, DOI 10.1136/ard.2007.086066; KERVRAN A, 1990, REGUL PEPTIDES, V31, P41, DOI 10.1016/0167-0115(90)90194-2; KHARE SD, 1995, J IMMUNOL, V155, P3653; Larkin J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00469; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Liang Y, 2014, EUR J IMMUNOL, V44, P1265, DOI 10.1002/eji.201344369; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Mauri C, 1997, J IMMUNOL, V159, P5032; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2015, INT IMMUNOL; MICHAELSSON E, 1994, J EXP MED, V180, P745, DOI 10.1084/jem.180.2.745; MICHAELSSON E, 1992, EUR J IMMUNOL, V22, P1819, DOI 10.1002/eji.1830220722; Min SY, 2004, ARTHRITIS RES THER, V6, pR213, DOI 10.1186/ar1169; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Morlacchi S, 2011, BLOOD, V118, P984, DOI 10.1182/blood-2011-02-336115; Myers LK, 2002, ARTHRITIS RHEUM, V46, P3369, DOI 10.1002/art.10687; Myers LK, 1998, IMMUNOLOGY, V95, P631; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; NAGLERANDERSON C, 1986, P NATL ACAD SCI USA, V83, P7443, DOI 10.1073/pnas.83.19.7443; Nandakumar KS, 2008, ARTHRITIS RHEUM-US, V58, P184, DOI 10.1002/art.23049; Ning B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131152; Park MJ, 2012, CELL IMMUNOL, V278, P45, DOI 10.1016/j.cellimm.2012.06.009; Peck A, 2009, CLIN IMMUNOL, V132, P295, DOI 10.1016/j.clim.2009.03.522; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sharabi A, 2009, CLIN IMMUNOL, V133, P61, DOI 10.1016/j.clim.2009.06.010; Snir O, 2010, ARTHRITIS RHEUM-US, V62, P44, DOI 10.1002/art.25036; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; VANVOLLENHOVEN RF, 1988, CELL IMMUNOL, V115, P146, DOI 10.1016/0008-8749(88)90169-4; Veenbergen S, 2011, ANN RHEUM DIS, V70, P2167, DOI 10.1136/ard.2011.154815; Wright GP, 2009, P NATL ACAD SCI USA, V106, P19078, DOI 10.1073/pnas.0907396106; Yanaba K, 2007, J IMMUNOL, V179, P1369, DOI 10.4049/jimmunol.179.2.1369; Zhu P, 2006, CLIN IMMUNOL	63	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154630	10.1371/journal.pone.0154630	http://dx.doi.org/10.1371/journal.pone.0154630			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159398	gold, Green Published, Green Submitted			2022-12-27	WOS:000376576700014
J	Chauvigne, F; Fjelldal, PG; Cerda, J; Finn, RN				Chauvigne, Francois; Fjelldal, Per Gunnar; Cerda, Joan; Finn, Roderick Nigel			Auto-Adhesion Potential of Extraocular Aqp0 during Teleost Development	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEIN; WATER PERMEABILITY; ATLANTIC SALMON; AQUAPORIN 0; FUNCTIONAL EXPRESSION; EYE LENS; MIP; CHANNEL; ZEBRAFISH; EVOLUTION	AQP0 water channels are the most abundant proteins expressed in the mammalian lens fiber membranes where they are essential for lens development and transparency. Unlike other aquaporin paralogs, mammalian AQP0 has a low intrinsic water permeability, but can form cell-to-cell junctions between the lens fibers. It is not known whether the adhesive properties of AQP0 is a derived feature found only in mammals, or exists as a conserved ancestral trait in non-mammalian vertebrates. Here we show that a tetraploid teleost, the Atlantic salmon, expresses four Aqp0 paralogs in the developing lens, but also expresses significant levels of aqp0 mRNAs and proteins in the epithelia of the pronephros, presumptive enterocytes, gill filament and epidermis. Quantitative PCR reveals that aqp0 mRNA titres increase by three orders of magnitude between the onset of somitogenesis and pigmentation of the eye. Using in situ hybridization and specific antisera, we show that at least two of the channels (Aqp0a1, -0b1 and/or -0b2) are localized in the extraocular basolateral and apical membranes, while Aqp0a2 is lens-specific. Heterologous expression of the Aqp0 paralogs in adhesion-deficient mouse fibolast L-cells reveals that, as for human AQP0, each intact salmon channel retains cell-to-cell adhesive properties. The strongest Aqp0 interactions are auto-adhesion, suggesting that homo-octamers likely form the intercellular junctions of the developing lens and epithelial tissues. The present data are thus the first to show the adhesion potential of Aqp0 channels in a non-mammalian vertebrate, and further uncover a novel extraocular role of the channels during vertebrate development.	[Chauvigne, Francois; Finn, Roderick Nigel] Univ Bergen, Bergen High Technol Ctr, Dept Biol, N-5020 Bergen, Norway; [Chauvigne, Francois; Fjelldal, Per Gunnar; Finn, Roderick Nigel] Inst Marine Res, N-5817 Bergen, Norway; [Cerda, Joan] CSIC, Inst Recerca & Tecnol Agroalimentaries, Inst Ciencies Mar, E-08003 Barcelona, Spain	University of Bergen; Institute of Marine Research - Norway; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); IRTA	Chauvigne, F; Finn, RN (corresponding author), Univ Bergen, Bergen High Technol Ctr, Dept Biol, N-5020 Bergen, Norway.; Chauvigne, F; Finn, RN (corresponding author), Inst Marine Res, N-5817 Bergen, Norway.	francois.chauvigne@uib.no; nigel.finn@uib.no	Chauvigne, Francois/D-6854-2017; Cerdà, Joan/M-1099-2016; Finn, Roderick Nigel/Y-2916-2019	Chauvigne, Francois/0000-0001-5571-7517; Cerdà, Joan/0000-0003-2568-6398; Finn, Roderick Nigel/0000-0002-8776-3945	Research Council of Norway (RCN) [224816/E40, 254872/E40]; Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2013-41196-R]; RCN [224816/E40]	Research Council of Norway (RCN)(Research Council of Norway); Spanish Ministry of Economy and Competitiveness (MINECO); RCN	This work was supported by the Research Council of Norway (RCN) projects 224816/E40 and 254872/E40 to RNF, and the Spanish Ministry of Economy and Competitiveness (MINECO) grant no. AGL2013-41196-R to JC. FC was supported by postdoctoral fellowships from the RCN (224816/E40).	Ball LE, 2003, INVEST OPHTH VIS SCI, V44, P4820, DOI 10.1167/iovs.02-1317; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; BLOEMENDAL H, 1972, Cell Differentiation, V1, P91, DOI 10.1016/0045-6039(72)90032-2; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; BROEKHUYSE RM, 1974, EXP EYE RES, V19, P297, DOI 10.1016/0014-4835(74)90148-1; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Chandy G, 1997, J MEMBRANE BIOL, V159, P29, DOI 10.1007/s002329900266; Chang WJ, 2011, BIRTH DEFECTS RES C, V93, P205, DOI 10.1002/bdrc.20215; Chauvigne F, 2006, J EXP BIOL, V209, P372, DOI 10.1242/jeb.02006; Chauvigne F, 2015, FASEB J, V29, P2172, DOI 10.1096/fj.14-267625; Chauvigne F, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110783; Ching B, 2010, HEREDITY, V104, P224, DOI 10.1038/hdy.2009.108; COSTELLO MJ, 1989, INVEST OPHTH VIS SCI, V30, P975; Da Silva N, 2006, BIOL REPROD, V74, P427, DOI 10.1095/biolreprod.105.044735; Engel A, 2008, CURR OPIN STRUC BIOL, V18, P229, DOI 10.1016/j.sbi.2007.11.003; Engelund MB, 2013, J EXP BIOL, V216, P3873, DOI 10.1242/jeb.087890; Farjo R, 2008, INVEST OPHTH VIS SCI, V49, P511, DOI 10.1167/iovs.07-1013; Finn RN, 2015, BIOL BULL-US, V229, P6, DOI 10.1086/BBLv229n1p6; Finn RN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8814; Finn RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113686; Finn RN, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00044; FITZGERALD PG, 1983, J CELL BIOL, V97, P1491, DOI 10.1083/jcb.97.5.1491; Froger A, 2010, INVEST OPHTH VIS SCI, V51, P6582, DOI 10.1167/iovs.10-5626; Gonen T, 2004, J MOL BIOL, V342, P1337, DOI 10.1016/j.jmb.2004.07.076; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; Gorodilov YN, 1996, ENVIRON BIOL FISH, V47, P109, DOI 10.1007/BF00005034; Greiling TMS, 2009, DEV DYNAM, V238, P2254, DOI 10.1002/dvdy.21997; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Hermo L, 2004, J ANDROL, V25, P494; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Iandiev I, 2007, NEUROSCI LETT, V426, P81, DOI 10.1016/j.neulet.2007.08.036; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; JOHNSTONE R, 1995, THEOR APPL GENET, V90, P819, DOI 10.1007/BF00222017; KANEKO T, 1995, MAR BIOL, V122, P165, DOI 10.1007/BF00349290; Karasawa Kaoru, 2011, Vet J, V190, pe72, DOI 10.1016/j.tvjl.2010.12.027; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Klein C, 2013, ANAT REC, V296, P1115, DOI 10.1002/ar.22709; Kumari SS, 2015, BIOCHEM BIOPH RES CO, V462, P339, DOI 10.1016/j.bbrc.2015.04.138; Kumari SS, 2014, BIOCHEM BIOPH RES CO, V452, P986, DOI 10.1016/j.bbrc.2014.09.032; Kumari SS, 2011, BBA-MOL BASIS DIS, V1812, P1089, DOI 10.1016/j.bbadis.2011.04.001; Kumari SS, 2009, BIOCHEM BIOPH RES CO, V390, P1034, DOI 10.1016/j.bbrc.2009.10.103; Kumari SS, 2013, EXP EYE RES, V116, P371, DOI 10.1016/j.exer.2013.09.019; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Liu JL, 2011, J CELL SCI, V124, P198, DOI 10.1242/jcs.072652; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Madsen SS, 2011, FRONT PHYSIOL, V2, P1, DOI [10.3389/fphys.2011.00001, DOI 10.3389/FPHYS.2011.00001]; MICHEA LF, 1994, BIOCHEMISTRY-US, V33, P7663, DOI 10.1021/bi00190a021; MULDERS SM, 1995, J BIOL CHEM, V270, P9010, DOI 10.1074/jbc.270.15.9010; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nemeth-Cahalan KL, 2013, J GEN PHYSIOL, V141, P287, DOI 10.1085/jgp.201210884; Nemeth-Cahalan KL, 2004, J GEN PHYSIOL, V123, P573, DOI 10.1085/jgp.200308990; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Palanivelu DV, 2006, J MOL BIOL, V355, P605, DOI 10.1016/j.jmb.2005.10.032; Petrova RS, 2015, EXP EYE RES, V132, P124, DOI 10.1016/j.exer.2015.01.011; Reichow SL, 2013, NAT STRUCT MOL BIOL, V20, P1085, DOI 10.1038/nsmb.2630; Scheuring S, 2007, J STRUCT BIOL, V160, P385, DOI 10.1016/j.jsb.2007.07.009; Schey KL, 2014, BBA-GEN SUBJECTS, V1840, P1513, DOI 10.1016/j.bbagen.2013.10.037; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001; Smith AJ, 2014, J CELL BIOL, V204, P559, DOI 10.1083/jcb.201308118; Stavang JA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1814-8; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Tatsumi K, 2009, FEBS LETT, V583, P2077, DOI 10.1016/j.febslet.2009.05.035; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Tingaud-Sequeira A, 2009, AM J PHYSIOL-REG I, V296, pR1041, DOI 10.1152/ajpregu.91002.2008; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Varadaraj K, 2010, EXP EYE RES, V91, P393, DOI 10.1016/j.exer.2010.06.013; Varadaraj K, 2007, DEV DYNAM, V236, P1319, DOI 10.1002/dvdy.21125; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Virkki LV, 2001, AM J PHYSIOL-REG I, V281, pR1994, DOI 10.1152/ajpregu.2001.281.6.R1994; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; Zampighi GA, 2000, EXP EYE RES, V71, P415, DOI 10.1006/exer.2000.0895; ZAMPIGHI GA, 1989, J CELL BIOL, V108, P2255, DOI 10.1083/jcb.108.6.2255; Zampighi GA, 2002, EXP EYE RES, V75, P505, DOI 10.1006/exer.2002.2041; Zapater C, 2013, GEN COMP ENDOCR, V182, P24, DOI 10.1016/j.ygcen.2012.11.015	80	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154592	10.1371/journal.pone.0154592	http://dx.doi.org/10.1371/journal.pone.0154592			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153052	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000375677000026
J	Lentz, HHK; Koher, A; Hovel, P; Gethmann, J; Sauter-Louis, C; Selhorst, T; Conraths, FJ				Lentz, Hartmut H. K.; Koher, Andreas; Hoevel, Philipp; Gethmann, Joern; Sauter-Louis, Carola; Selhorst, Thomas; Conraths, Franz J.			Disease Spread through Animal Movements: A Static and Temporal Network Analysis of Pig Trade in Germany	PLOS ONE			English	Article							CLASSICAL SWINE-FEVER; MOUTH-DISEASE; GENERAL CONCEPTS; GLOBAL ANALYSIS; PATTERNS; RISK; TRANSMISSION; MODEL; VULNERABILITY; EPIDEMIOLOGY	Background Animal trade plays an important role for the spread of infectious diseases in livestock populations. The central question of this work is how infectious diseases can potentially spread via trade in such a livestock population. We address this question by analyzing the underlying network of animal movements. In particular, we consider pig trade in Germany, where trade actors (agricultural premises) form a complex network. Methodology The considered pig trade dataset spans several years and is analyzed with respect to its potential to spread infectious diseases. Focusing on measurements of network-topological properties, we avoid the usage of external parameters, since these properties are independent of specific pathogens. They are on the contrary of great importance for understanding any general spreading process on this particular network. We analyze the system using different network models, which include varying amounts of information: (i) static network, (ii) network as a time series of uncorrelated snapshots, (iii) temporal network, where causality is explicitly taken into account. Findings We find that a static network view captures many relevant aspects of the trade system, and premises can be classified into two clearly defined risk classes. Moreover, our results allow for an efficient allocation strategy for intervention measures using centrality measures. Data on trade volume do barely alter the results and is therefore of secondary importance. Although a static network description yields useful results, the temporal resolution of data plays an outstanding role for an in-depth understanding of spreading processes. This applies in particular for an accurate calculation of the maximum outbreak size.	[Lentz, Hartmut H. K.; Gethmann, Joern; Sauter-Louis, Carola; Conraths, Franz J.] Friedrich Loeffler Inst, Inst Epidemiol, Sudufer 10, D-17493 Greifswald, Germany; [Koher, Andreas; Hoevel, Philipp] Tech Univ Berlin, Inst Theoret Phys, Hardenbergstr 36, D-10623 Berlin, Germany; [Hoevel, Philipp] Humboldt Univ, Bernstein Ctr Computat Neurosci Berlin, Philippstr 13, D-10115 Berlin, Germany; [Selhorst, Thomas] Fed Res Inst Risk Assessment, Unit Epidemiol Stat & Math Modelling, Alt Marienfelde 17-21, D-12277 Berlin, Germany	Friedrich Loeffler Institute; Technical University of Berlin; Humboldt University of Berlin	Lentz, HHK (corresponding author), Friedrich Loeffler Inst, Inst Epidemiol, Sudufer 10, D-17493 Greifswald, Germany.	hartmut.lentz@fli.bund.de	Sauter-Louis, Carola/ABB-1186-2021	Sauter-Louis, Carola/0000-0002-6440-1933; Koher, Andreas/0000-0001-7049-9538; Lentz, Hartmut/0000-0002-1713-9506; Hoevel, Philipp/0000-0002-1370-4272; Conraths, Franz/0000-0002-7400-9409; Gethmann, Jorn/0000-0001-7455-803X	Deutsche Forschungsgemeinschaft [910]; Federal Ministry of Education and Research (BMBF), Germany [01GQ1001B]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	AK and PH acknowledge funding by the Deutsche Forschungsgemeinschaft in the framework of Collaborative Research Center 910. PH was partially supported by the Federal Ministry of Education and Research (BMBF), Germany (grant no. 01GQ1001B).	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; Bayerisches Staatsministerium fur Ernahrung Landwirtschaft und Forsten (StMELF), 2016, HERK INF TIE; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Bigras-Poulin M, 2007, PREV VET MED, V80, P143, DOI 10.1016/j.prevetmed.2007.02.004; Buttner K, 2013, PREV VET MED, V110, P418, DOI 10.1016/j.prevetmed.2013.01.008; Bundesministerium fur Ernahrung und Landwirtschaft, 2014, STAT JB ERN LANDW FO; Casteigts A, 2012, INT J PARALLEL EMERG, V27, P387, DOI [10.1080/17445760.2012.668546, 10.1007/978-3-642-22450-8_27]; Christley R. M., 2005, Society for Veterinary Epidemiology and Preventive Medicine. Proceedings of a meeting held at Nairn, Inverness, Scotland, 30th March-1st April 2005, P234; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Danon Leon, 2011, Interdiscip Perspect Infect Dis, V2011, P284909, DOI 10.1155/2011/284909; Dorogovtsev SN, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066110; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Ducheyne E, 2007, GEOSPATIAL HEALTH, V1, P177, DOI 10.4081/gh.2007.266; Dutta BL, 2014, PREV VET MED, V117, P79, DOI 10.1016/j.prevetmed.2014.09.005; European Commission, 2016, APPR EST LISTS APPR; FAO, 2016, EC AND SOC DEV DEP; Federal Ministry of Food; Agriculture (BMEL), 2015, UND FARM FACTS FIG G; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Fritzemeier J, 2000, VET MICROBIOL, V77, P29, DOI 10.1016/S0378-1135(00)00254-6; Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648; Grindrod P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046120; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Holme P, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60657-4; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Holten D, 2006, IEEE T VIS COMPUT GR, V12, P741, DOI 10.1109/TVCG.2006.147; Jones JH, 2003, NATURE, V423, P605, DOI 10.1038/423605a; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Konschake M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055223; Lentz HHK, 2011, PREV VET MED, V98, P176, DOI 10.1016/j.prevetmed.2010.10.011; Lentz HHK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.118701; Lentz HHK, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066111; Lentz HHK, 2013, THESIS HUMBOLDT U BE; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Martinez-Lopez B, 2011, VET MICROBIOL, V147, P300, DOI 10.1016/j.vetmic.2010.07.009; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Mayer D, 2008, ATMOS ENVIRON, V42, P466, DOI 10.1016/j.atmosenv.2007.09.069; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Natale F, 2011, PREV VET MED, V98, P111, DOI 10.1016/j.prevetmed.2010.11.013; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nicosia V, 2012, CHAOS, V22, DOI 10.1063/1.3697996; Noremark M, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-71; OIE, 2015, TERR AN HLTH COD; Olofsson E, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0070-2; Pan RK, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016105; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035108; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; Ribbens S, 2004, VET QUART, V26, P146, DOI 10.1080/01652176.2004.9695177; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Schwartz N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.015104; Skiena S. S., 2008, ALGORITHM DESIGN MAN; Stark KDC, 2006, BMC HEALTH SERV RES, V6, P1, DOI 10.1186/1472-6963-6-20; Thrusfield M., 2005, VET EPIDEMIOLOGY; Valdano E, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021005; Valdano E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004152; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009; Wang Y, 2013, PHYSICA A, V392, P3869, DOI 10.1016/j.physa.2013.03.042; Wang Y, 2012, NONLINEAR ANAL-REAL, V13, P543, DOI 10.1016/j.nonrwa.2011.07.033; WARSHALL S, 1962, J ACM, V9, P11, DOI 10.1145/321105.321107; Webb CR, 2005, PREV VET MED, V68, P3, DOI 10.1016/j.prevetmed.2005.01.003	67	60	61	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155196	10.1371/journal.pone.0155196	http://dx.doi.org/10.1371/journal.pone.0155196			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152712	Green Submitted, gold, Green Published			2022-12-27	WOS:000375677000078
J	Levering, J; Broddrick, J; Dupont, CL; Peers, G; Beeri, K; Mayers, J; Gallina, AA; Allen, AE; Palsson, BO; Zengler, K				Levering, Jennifer; Broddrick, Jared; Dupont, Christopher L.; Peers, Graham; Beeri, Karen; Mayers, Joshua; Gallina, Alessandra A.; Allen, Andrew E.; Palsson, Bernhard O.; Zengler, Karsten			Genome-Scale Model Reveals Metabolic Basis of Biomass Partitioning in a Model Diatom	PLOS ONE			English	Article							PHAEODACTYLUM-TRICORNUTUM; FUNCTIONAL-CHARACTERIZATION; EXTRACELLULAR-MATRIX; SIGNAL PEPTIDES; MARINE DIATOMS; AMINO-ACID; PROTEIN; NITROGEN; RECONSTRUCTION; LOCALIZATION	Diatoms are eukaryotic microalgae that contain genes from various sources, including bacteria and the secondary endosymbiotic host. Due to this unique combination of genes, diatoms are taxonomically and functionally distinct from other algae and vascular plants and confer novel metabolic capabilities. Based on the genome annotation, we performed a genome-scale metabolic network reconstruction for the marine diatom Phaeodactylum tricornutum. Due to their endosymbiotic origin, diatoms possess a complex chloroplast structure which complicates the prediction of subcellular protein localization. Based on previous work we implemented a pipeline that exploits a series of bioinformatics tools to predict protein localization. The manually curated reconstructed metabolic network iLB1027_lipid accounts for 1,027 genes associated with 4,456 reactions and 2,172 metabolites distributed across six compartments. To constrain the genome-scale model, we determined the organism specific biomass composition in terms of lipids, carbohydrates, and proteins using Fourier transform infrared spectrometry. Our simulations indicate the presence of a yet unknown glutamine-ornithine shunt that could be used to transfer reducing equivalents generated by photosynthesis to the mitochondria. The model reflects the known biochemical composition of P. tricornutum in defined culture conditions and enables metabolic engineering strategies to improve the use of P. tricornutum for biotechnological applications.	[Levering, Jennifer; Broddrick, Jared; Gallina, Alessandra A.; Palsson, Bernhard O.; Zengler, Karsten] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Broddrick, Jared] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Dupont, Christopher L.; Beeri, Karen; Allen, Andrew E.] J Craig Venter Inst, La Jolla, CA USA; [Peers, Graham; Gallina, Alessandra A.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Mayers, Joshua] Chalmers Univ Technol, Dept Biol & Biotechnol, Div Ind Biotechnol, S-41296 Gothenburg, Sweden; [Allen, Andrew E.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; J. Craig Venter Institute; Colorado State University; Chalmers University of Technology; University of California System; University of California San Diego; Scripps Institution of Oceanography	Zengler, K (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	kzengler@ucsd.edu	Allen, Andrew E/C-4896-2012	Allen, Andrew E/0000-0001-5911-6081; Peers, Graham/0000-0002-3590-7820; Zengler, Karsten/0000-0002-8062-3296; Levering, Jennifer/0000-0001-8491-9337; Broddrick, Jared/0000-0003-4871-4822	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-SC0008593, DOE-DE-SC0006719]; National Science Foundation [NSF-MCB-1024913]; Gordon and Betty Moore Foundation [GBMF3828]	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This material is based upon work supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, under Award Number DE-SC0008593 to CLD, AEA, and BOP and DOE-DE-SC0006719 to AEA and CLD. National Science Foundation (NSF-MCB-1024913) to AEA and CLD and Gordon and Betty Moore Foundation (GBMF3828) grants to AEA further supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi AS, 2006, J PHYCOL, V42, P363, DOI 10.1111/j.1529-8817.2006.00193.x; Abida H, 2015, PLANT PHYSIOL, V167, P118, DOI 10.1104/pp.114.252395; Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Apt KE, 2002, J CELL SCI, V115, P4061, DOI 10.1242/jcs.00092; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bailleul B, 2015, NATURE, V524, P366, DOI 10.1038/nature14599; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bozarth A, 2009, APPL MICROBIOL BIOT, V82, P195, DOI 10.1007/s00253-008-1804-8; BROWN MR, 1991, J EXP MAR BIOL ECOL, V145, P79, DOI 10.1016/0022-0981(91)90007-J; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Chauton MS, 2013, PLANT PHYSIOL, V161, P1034, DOI 10.1104/pp.112.206177; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; d'Ippolito G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0212-4; Daboussi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4831; Dal'Molin CGD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S4-S5; Dal'Molin CGD, 2010, PLANT PHYSIOL, V152, P579, DOI 10.1104/pp.109.148817; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Dolatabadi JEN, 2011, TRAC-TREND ANAL CHEM, V30, P1538, DOI 10.1016/j.trac.2011.04.015; Domergue F, 2003, PLANT PHYSIOL, V131, P1648, DOI 10.1104/pp.102.018317; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fabris M, 2012, PLANT J, V70, P1004, DOI 10.1111/j.1365-313X.2012.04941.x; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Fidalgo JP, 1995, CAH BIOL MAR, V36, P165; GEIDER RJ, 1986, J PHYCOL, V22, P39, DOI 10.1111/j.1529-8817.1986.tb02513.x; GHOSH S, 1988, ANAL BIOCHEM, V169, P227, DOI 10.1016/0003-2697(88)90278-3; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Gschloessl B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-393; Hay JO, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00724; HAYWARD J, 1965, PHYSIOL PLANTARUM, V18, P201, DOI 10.1111/j.1399-3054.1965.tb06883.x; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Hunt KA, 2014, BIOINFORMATICS, V30, P1569, DOI 10.1093/bioinformatics/btu021; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karas BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7925; Karas BJ, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-30; Kettles NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094795; Kilian O, 2004, J MOL EVOL, V58, P712, DOI 10.1007/s00239-004-2593-z; Kim J, 2016, PLANT J, V85, P161, DOI 10.1111/tpj.13081; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; King ZA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004321; Knoop H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003081; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Levering J, 2015, CURR OPIN BIOTECH, V36, P32, DOI 10.1016/j.copbio.2015.08.001; Levitan O, 2015, P NATL ACAD SCI USA, V112, P412, DOI 10.1073/pnas.1419818112; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; Liaud MF, 2000, MOL BIOL EVOL, V17, P213, DOI 10.1093/oxfordjournals.molbev.a026301; Lourenco SO, 1998, J PHYCOL, V34, P798, DOI 10.1046/j.1529-8817.1998.340798.x; Mayers JJ, 2013, BIORESOURCE TECHNOL, V148, P215, DOI 10.1016/j.biortech.2013.08.133; Mus F, 2013, APPL MICROBIOL BIOT, V97, P3625, DOI 10.1007/s00253-013-4747-7; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Osterlund T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-36; OWENS TG, 1986, PLANT PHYSIOL, V80, P732, DOI 10.1104/pp.80.3.732; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; RAVEN JA, 1987, NEW PHYTOL, V106, P357, DOI 10.1111/j.1469-8137.1987.tb00149.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Saha R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021784; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Sauls JT, 2014, BIOINFORMATICS, V30, P1036, DOI 10.1093/bioinformatics/btt747; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Singh D, 2015, BIOCHEM SOC T, V43, P1182, DOI 10.1042/BST20150152; Su WW, 2012, J PHYCOL, V48, P336, DOI 10.1111/j.1529-8817.2012.01128.x; Sunaga Y, 2015, J BIOSCI BIOENG, V119, P28, DOI 10.1016/j.jbiosc.2014.06.008; Tachibana M, 2011, PHOTOSYNTH RES, V109, P205, DOI 10.1007/s11120-011-9634-4; Tanaka Y, 2005, PLANT PHYSIOL, V138, P207, DOI 10.1104/pp.104.058982; Templeton DW, 2012, J CHROMATOGR A, V1270, P225, DOI 10.1016/j.chroma.2012.10.034; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Veith T, 2007, BBA-BIOENERGETICS, V1767, P1428, DOI 10.1016/j.bbabio.2007.09.004; Weyman PD, 2015, PLANT BIOTECHNOL J, V13, P460, DOI 10.1111/pbi.12254; Willis A, 2013, J PHYCOL, V49, P937, DOI 10.1111/jpy.12103; Yu ET, 2009, J APPL PHYCOL, V21, P669, DOI 10.1007/s10811-008-9400-y; ZoBell CE, 1935, P NATL ACAD SCI USA, V21, P517, DOI 10.1073/pnas.21.9.517	84	64	64	9	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155038	10.1371/journal.pone.0155038	http://dx.doi.org/10.1371/journal.pone.0155038			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152931	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000062
J	Salamone, M; Pavia, FC; Ghersi, G				Salamone, Monica; Pavia, Francesco Carfi; Ghersi, Giulio			Proteolytic Enzymes Clustered in Specialized Plasma-Membrane Domains Drive Endothelial Cells' Migration	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; MATRIX-METALLOPROTEINASE; PROTEASE; SEPRASE; ACTIVATION; VESICLES; INVASION; INVADOPODIA; INTEGRINS; ADHESION	In vitro cultured endothelial cells forming a continuous monolayer establish stable cell-cell contacts and acquire a "resting" phenotype; on the other hand, when growing in sparse conditions these cells acquire a migratory phenotype and invade the empty area of the culture. Culturing cells in different conditions, we compared expression and clustering of proteolytic enzymes in cells having migratory versus stationary behavior. In order to observe resting and migrating cells in the same microscopic field, a continuous cell monolayer was wounded. Increased expression of proteolytic enzymes was evident in cell membranes of migrating cells especially at sprouting sites and in shed membrane vesicles. Gelatin zymography and western blotting analyses confirmed that in migrating cells, expression of membrane-bound and of vesicle-associated proteolytic enzymes are increased. The enzymes concerned include MMP-2, MMP-9, MT1-MMP, seprase, DPP4 (DiPeptidyl Peptidase 4) and uPA. Shed membrane vesicles were shown to exert degradative activity on ECM components and produce substrates facilitating cell migration. Vesicles shed by migrating cells degraded ECM components at an increased rate; as a result their effect on cell migration was amplified. Inhibiting either Matrix Metallo Proteases (MMPs) or Serine Integral Membrane Peptidases (SIMPs) caused a decrease in the stimulatory effect of vesicles, inhibiting the spontaneous migratory activity of cells; a similar result was also obtained when a monoclonal antibody acting on DPP4 was tested. We conclude that proteolytic enzymes have a synergistic stimulatory effect on cell migration and that their clustering probably facilitates the proteolytic activation cascades needed to produce maximal degradative activity on cell substrates during the angiogenic process.	[Salamone, Monica] CNR, IAMC, UO Capo Granitola, Mazara Del Vallo, Trapani, Italy; [Pavia, Francesco Carfi] Univ Palermo, Dipartimento Ingn Civile Ambientale Aerosp Mat, Viale Sci,Ed 6, I-90128 Palermo, Italy; [Ghersi, Giulio] Univ Palermo, Dipartimento Sci & Tecnol Biol Chim & Farmaceut, Viale Sci,Ed 16, I-90128 Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); University of Palermo; University of Palermo	Ghersi, G (corresponding author), Univ Palermo, Dipartimento Sci & Tecnol Biol Chim & Farmaceut, Viale Sci,Ed 16, I-90128 Palermo, Italy.	giulio.ghersi@unipa.it	salamone, monica/P-7422-2018	salamone, monica/0000-0002-2274-927X; Ghersi, Giulio/0000-0001-7250-9808	University of Palermo [ORPA07Z5AH]	University of Palermo	This work was supported by the University of Palermo Ex. 60% research grant. Grant n. ORPA07Z5AH: Proteasi, motilita ed invasione cellulare.	ALEXANDER P, 1974, CANCER RES, V34, P2077; Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Brown GT, 2015, J PATHOL, V237, P273, DOI 10.1002/path.4586; Chan KT, 2007, METHOD ENZYMOL, V426, P47, DOI 10.1016/S0076-6879(07)26003-3; Chen DH, 2006, CANCER RES, V66, P9977, DOI 10.1158/0008-5472.CAN-06-1499; Chen WT, 2003, CURR TOP DEV BIOL, V54, P207, DOI 10.1016/S0070-2153(03)54010-8; Chen WT, 2003, CANCER METAST REV, V22, P259, DOI 10.1023/A:1023055600919; Chen WT, 1996, ENZYME PROTEIN, V49, P59, DOI 10.1159/000468616; Cheng HC, 2003, J BIOL CHEM, V278, P24600, DOI 10.1074/jbc.M303424200; DAINIAK N, 1991, BLOOD CELLS, V17, P376; Das T, 2015, NAT CELL BIOL, V17, P276, DOI 10.1038/ncb3115; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Dolo V, 1998, CANCER RES, V58, P4468; DOLO V, 1994, J SUBMICR CYTOL PATH, V26, P173; DUBOVY P, 1992, ARCH ORAL BIOL, V37, P1, DOI 10.1016/0003-9969(92)90145-X; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; Ghersi G, 2002, J BIOL CHEM, V277, P29231, DOI 10.1074/jbc.M202770200; Ghersi G, 2006, CANCER RES, V66, P4652, DOI 10.1158/0008-5472.CAN-05-1245; Goldstein LA, 1997, BBA-MOL BASIS DIS, V1361, P11, DOI 10.1016/S0925-4439(97)00032-X; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Knopf JD, 2015, BBA-MOL CELL RES, V1853, P2515, DOI 10.1016/j.bbamcr.2015.07.013; LAEMMLI UK, 1970, J MOL BIOL, V49, P99, DOI 10.1016/0022-2836(70)90379-7; Lafleur MA, 2002, J CELL SCI, V115, P3427; Lamoreaux WJ, 1998, MICROVASC RES, V55, P29, DOI 10.1006/mvre.1997.2056; Moali C, 2009, EUR J DERMATOL, V19, P552, DOI 10.1684/ejd.2009.0770; Mueller SC, 1999, J BIOL CHEM, V274, P24947, DOI 10.1074/jbc.274.35.24947; MUELLER SC, 1992, J CELL BIOL, V119, P1309, DOI 10.1083/jcb.119.5.1309; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Netzel-Arnett S, 2002, J BIOL CHEM, V277, P45154, DOI 10.1074/jbc.M206354200; PEPPER MS, 1993, J CELL BIOL, V122, P673, DOI 10.1083/jcb.122.3.673; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; POSTE G, 1980, P NATL ACAD SCI-BIOL, V77, P399, DOI 10.1073/pnas.77.1.399; Ren FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135544; Rosello C, 2004, ACTA BIOTHEOR, V52, P343, DOI 10.1023/B:ACBI.0000046602.58202.5e; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; TARIN D, 1967, INT J CANCER, V2, P195, DOI 10.1002/ijc.2910020302; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Vittorelli ML, 2003, CURR TOP DEV BIOL, V54, P411, DOI 10.1016/S0070-2153(03)54017-0; Webb SL, 2011, FRONT BIOSCI-LANDMRK, V16, P539, DOI 10.2741/3704; Zucker S, 1998, INT J CANCER, V75, P780, DOI 10.1002/(SICI)1097-0215(19980302)75:5<780::AID-IJC19>3.0.CO;2-A	42	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154709	10.1371/journal.pone.0154709	http://dx.doi.org/10.1371/journal.pone.0154709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152413	gold, Green Published, Green Submitted			2022-12-27	WOS:000375677000029
J	Xia, Y; Li, Y; Westover, KD; Sun, JM; Chen, HX; Zhang, JM; Fisher, DE				Xia, Yun; Li, Ying; Westover, Kenneth D.; Sun, Jiaming; Chen, Hongxiang; Zhang, Jianming; Fisher, David E.			Inhibition of Cell Proliferation in an NRAS Mutant Melanoma Cell Line by Combining Sorafenib and alpha-Mangostin	PLOS ONE			English	Article							ER STRESS; BRAF INHIBITION; RETINOIC ACID; P38 MAPK; APOPTOSIS; THERAPY; PIGMENTATION; COMBINATION; VEMURAFENIB; ACTIVATION	alpha-Mangostin is a natural product commonly used in Asia for cosmetic and medicinal applications including topical treatment of acne and skin cancer. Towards finding new pharmacological strategies that overcome NRAS mutant melanoma, we performed a cell proliferation-based combination screen using a collection of well-characterized small molecule kinase inhibitors and alpha-Mangostin. We found that alpha-Mangostin significantly enhances Sorafenib pharmacological efficacy against an NRAS mutant melanoma cell line. The synergistic effects of alpha-Mangostin and Sorafenib were associated with enhanced inhibition of activated AKT and ERK, induced ER stress, and reduced autophagy, eventually leading to apoptosis. The structure of alpha-Mangostin resembles several inhibitors of the Retinoid X receptor (RXR). MITF expression, which is regulated by RXR, was modulated by alpha-Mangostin. Molecular docking revealed that alpha-Mangostin can be accommodated by the ligand binding pocket of RXR and may thereby compete with RXR-mediated control of MITF expression. In summary, these data demonstrate an unanticipated synergy between alpha-Mangostin and sorafenib, with mechanistic actions that convert a known safe natural product to a candidate combinatorial therapeutic agent.	[Xia, Yun; Sun, Jiaming; Chen, Hongxiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Plast Surg, Wuhan, Hubei, Peoples R China; [Xia, Yun; Li, Ying; Chen, Hongxiang; Zhang, Jianming; Fisher, David E.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149 Bldg 13th ST, Charlestown, MA USA; [Li, Ying] Zhengzhou Univ, Affiliated Hosp 3, Clin Lab, 7 Front Kangfu ST, Zhengzhou 450052, Peoples R China; [Westover, Kenneth D.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Westover, Kenneth D.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Huazhong University of Science & Technology; Harvard University; Massachusetts General Hospital; Zhengzhou University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fisher, DE (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149 Bldg 13th ST, Charlestown, MA USA.	dfisher3@partners.org	Fisher, David/AAH-2878-2019; Westover, Ken/AAZ-1795-2020	Westover, Ken/0000-0003-3653-5923	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NIH [5PO1-CA163222, 5R01-AR043369]; NATIONAL CANCER INSTITUTE [P01CA163222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	DEF gratefully acknowledges grant support from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, and NIH (5PO1-CA163222 and 5R01-AR043369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnane L, 2006, METHOD ENZYMOL, V407, P597, DOI 10.1016/S0076-6879(05)07047-3; Becker JC, 2006, CANCER-AM CANCER SOC, V107, P2317, DOI 10.1002/cncr.22273; Beninati S, 2014, BIOCHEM BIOPH RES CO, V450, P1512, DOI 10.1016/j.bbrc.2014.07.031; Benjakul R, 2015, ANTICANCER DRUGS; Bhattacharya U, 2009, CANCER SCI, V100, P1971, DOI 10.1111/j.1349-7006.2009.01251.x; Carlino MS, 2014, BRIT J CANCER, V111, P292, DOI 10.1038/bjc.2014.287; Cesario RM, 2001, MOL ENDOCRINOL, V15, P1360, DOI 10.1210/me.15.8.1360; Chao AC, 2011, J AGR FOOD CHEM, V59, P2086, DOI 10.1021/jf1042757; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen JJ, 2014, LEUKEMIA LYMPHOMA, V55, P628, DOI 10.3109/10428194.2013.802312; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dal Lago L, 2008, ONCOLOGIST, V13, P845, DOI 10.1634/theoncologist.2007-0233; Dhomen N, 2009, HEMATOL ONCOL CLIN N, V23, P529, DOI 10.1016/j.hoc.2009.04.001; Dufey E, 2014, AM J PHYSIOL-CELL PH, V307, pC582, DOI 10.1152/ajpcell.00258.2014; Fedorenko IV, 2015, BRIT J CANCER, V112, P217, DOI 10.1038/bjc.2014.476; Fedorenko IV, 2013, ONCOGENE, V32, P3009, DOI 10.1038/onc.2012.453; Feige E, 2011, P NATL ACAD SCI USA, V108, pE924, DOI 10.1073/pnas.1106351108; Flaherty KT, 2010, CANCER-AM CANCER SOC, V116, P4, DOI 10.1002/cncr.24688; Hawkes HJK, 2014, BBA-GEN SUBJECTS, V1840, P303, DOI 10.1016/j.bbagen.2013.09.013; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Hsiao JJ, 2014, ARCH BIOCHEM BIOPHYS, V563, P28, DOI 10.1016/j.abb.2014.07.019; Hsieh SC, 2013, APOPTOSIS, V18, P1548, DOI 10.1007/s10495-013-0888-5; Inamoto T, 2011, CANCER BIOL THER, V12, P1018, DOI 10.4161/cbt.12.12.18135; Jalili A, 2011, J INVEST DERMATOL, V131, P1886, DOI 10.1038/jid.2011.136; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; Johnson DB, 2014, CLIN CANCER RES, V20, P4186, DOI 10.1158/1078-0432.CCR-13-3270; Johnson GL, 2014, CLIN CANCER RES, V20, P2516, DOI 10.1158/1078-0432.CCR-13-1081; Johnson JJ, 2012, CARCINOGENESIS, V33, P413, DOI 10.1093/carcin/bgr291; Kim G, 2014, CLIN CANCER RES, V20, P4994, DOI 10.1158/1078-0432.CCR-14-0776; Kwong LN, 2014, ONCOGENE, V33, P1, DOI 10.1038/onc.2013.34; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Lassen A, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-83; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Lee JH, 2014, EXP DERMATOL, V23, P125, DOI 10.1111/exd.12322; Li P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-138; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Niessner H, 2011, J INVEST DERMATOL, V131, P468, DOI 10.1038/jid.2010.297; Parkhitko AA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P355, DOI 10.1134/S0006297913040044; Paterson EK, 2013, EXP DERMATOL, V22, P202, DOI 10.1111/exd.12099; Puzanov I, 2015, CURR TREAT OPTION ON, V16, P330; Roesch A, 2014, ONCOGENE; Sato Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015119; Shan T, 2011, CURR MOL MED, V11, P666, DOI 10.2174/156652411797536679; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Sullivan RJ, 2014, HEMATOL ONCOL CLIN N, V28, P437, DOI 10.1016/j.hoc.2014.02.007; Takata M, 2006, J DERMATOL SCI, V43, P1, DOI 10.1016/j.jdermsci.2006.05.002; Wang GH, 2013, CANCER RES, V73, P307, DOI 10.1158/0008-5472.CAN-12-2038; Wang ZX, 2011, J INVEST DERMATOL, V131, P177, DOI 10.1038/jid.2010.290; Watabe H, 2002, J INVEST DERMATOL, V118, P35, DOI 10.1046/j.0022-202x.2001.01614.x; Wilson MA, 2014, CLIN CANCER RES, V20, P3328, DOI 10.1158/1078-0432.CCR-14-0093; Xu QH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/546353	51	11	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155217	10.1371/journal.pone.0155217	http://dx.doi.org/10.1371/journal.pone.0155217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152946	Green Submitted, gold, Green Published			2022-12-27	WOS:000375677000080
J	Baurecht, H; Hotze, M; Rodriguez, E; Manz, J; Weidinger, S; Cordell, HJ; Augustin, T; Strauch, K				Baurecht, Hansjoerg; Hotze, Melanie; Rodriguez, Elke; Manz, Judith; Weidinger, Stephan; Cordell, Heather J.; Augustin, Thomas; Strauch, Konstantin			Compare and Contrast Meta Analysis (CCMA): A Method for Identification of Pleiotropic Loci in Genome-Wide Association Studies	PLOS ONE			English	Article							PSORIASIS; TRAITS	In recent years, genome-wide association studies (GWAS) have identified many loci that are shared among common disorders and this has raised interest in pleiotropy. For performing appropriate analysis, several methods have been proposed, e.g. conducting a look-up in external sources or exploiting GWAS results by meta-analysis based methods. We recently proposed the Compare & Contrast Meta-Analysis (CCMA) approach where significance thresholds were obtained by simulation. Here we present analytical formulae for the density and cumulative distribution function of the CCMA test statistic under the null hypothesis of no pleiotropy and no association, which, conveniently for practical reasons, turns out to be exponentially distributed. This allows researchers to apply the CCMA method without having to rely on simulations. Finally, we show that CCMA demonstrates power to detect disease-specific, agonistic and antagonistic loci comparable to the frequently used Subset-Based Meta-Analysis approach, while better controlling the type I error rate.	[Baurecht, Hansjoerg; Hotze, Melanie; Rodriguez, Elke; Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venereol, Campus Kiel, Kiel, Germany; [Manz, Judith] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Res Unit Mol Epidemiol, Neuherberg, Germany; [Cordell, Heather J.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Augustin, Thomas] Univ Munich, Dept Stat, Munich, Germany; [Strauch, Konstantin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Strauch, Konstantin] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Genet Epidemiol, Munich, Germany	University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Newcastle University - UK; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Baurecht, H (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venereol, Campus Kiel, Kiel, Germany.	hbaurecht@dermatology.uni-kiel.de	Weidinger, Stephan/C-8461-2011; Rodríguez, Elke/C-4259-2013; Baurecht, Hansjorg/C-4035-2013	Weidinger, Stephan/0000-0003-3944-252X; Rodríguez, Elke/0000-0003-3692-3950; Cordell, Heather/0000-0002-1879-5572; Augustin, Thomas/0000-0002-1854-6226; Baurecht, Hansjorg/0000-0002-9265-5594	DFG Clusters of Excellence "Inflammation at Interfaces'' [EXC306, EXC306/2]; German Federal Ministry of Education and Research (BMBF) (sysINFLAME) [01ZX1306A]; Wellcome Trust Senior Research Fellowship in Basic Biomedical Science [102858/Z/13/Z]; Munich Center of Health Sciences (MC-Health); Ludwig-Maximilians-Universitat, as part of LMUinnovativ; Deutsche Forschungsgemeinschaft (German Research Foundation) [Str643/6-1]	DFG Clusters of Excellence "Inflammation at Interfaces''; German Federal Ministry of Education and Research (BMBF) (sysINFLAME); Wellcome Trust Senior Research Fellowship in Basic Biomedical Science(Wellcome Trust); Munich Center of Health Sciences (MC-Health); Ludwig-Maximilians-Universitat, as part of LMUinnovativ; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	The project received infrastructure support through the DFG Clusters of Excellence "Inflammation at Interfaces'' (grants EXC306 and EXC306/2), and was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (sysINFLAME, grant # 01ZX1306A), H.J.C. is supported by a Wellcome Trust Senior Research Fellowship in Basic Biomedical Science (102858/Z/13/Z). Furthermore, this work was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ, as well as by a grant of the Deutsche Forschungsgemeinschaft (German Research Foundation) to K.S. (Str643/6-1).	Arnold M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-490; Baurecht H, 2015, AM J HUM GENET, V96, P104, DOI 10.1016/j.ajhg.2014.12.004; Bhattacharjee S, 2013, ASSET R PACKAGE SUBS; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Borenstein M, 2009, INTRO METAANALYSIS, P156; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Ewens W, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b137845; Fahrmeir L, 2001, MULTIVARIATE STAT MO, P107; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Smart F., 2012, SIMULATING MULTINOMI; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	12	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154872	10.1371/journal.pone.0154872	http://dx.doi.org/10.1371/journal.pone.0154872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149374	Green Submitted, Green Published, gold			2022-12-27	WOS:000375676800078
J	Cho, YY; Lee, M; Kim, HC; Chung, JW; Kim, YH; Gwak, GY; Bae, SH; Kim, DY; Heo, J; Kim, YJ				Cho, Young Youn; Lee, Minjong; Kim, Hyo-Cheol; Chung, Jin Wook; Kim, Yun Hwan; Gwak, Geum-Youn; Bae, Si Hyun; Kim, Do Young; Heo, Jeong; Kim, Yoon Jun			Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis	PLOS ONE			English	Article							TRANSARTERIAL CHEMOEMBOLIZATION; Y-90 MICROSPHERES; HEPATIC RESECTION; YTTRIUM 90; SORAFENIB; EFFICACY; OUTCOMES	Background/Aims Limited treatment options are available for patients with hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT). Transarterial radioembolization using Yttrium-90 microspheres is a new treatment modality for HCC with PVT. For this analysis, we compared responses to treatment with radioembolization and with sorafenib. Methods We evaluated 32 patients who were part of a multicenter retrospective cohort. All patients had PVT without extrahepatic metastasis and were treated with radioembolization in one of six tertiary referral hospitals in Korea. We retrospectively enrolled another 31 consecutive PVT patients without extrahepatic metastasis from a single center who received sorafenib treatment to serve as the control group. We used inverse probability weighting (IPW) using propensity scores to adjust for the between-group differences in baseline characteristics. Results At 3 months, the response rate and disease control rate were 32.1% (9/32) and 57.1% (16/32), respectively, in the radioembolization group and 3.2% (1/31) and 41.9% (13/31) in the sorafenib group. Median overall survival (OS) and time to progression (TTP) were not significantly different between the radioembolization group and the sorafenib group (13.8 months and 10.0 months, P = 0.22; and 6.0 months and 6.0 months, P = 0.08; respectively). No differences in OS (P = 0.97) or TTP (P = 0.34) were observed after IPW was applied to balance the population characteristics. The sorafenib group showed significantly more grade 3/4 adverse effects than the radioembolization group (P < 0.01). Conclusion HCC patients with PVT who underwent radioembolization achieved comparable survival to patients who received sorafenib, even after application of IPW. The radioembolization group also experienced fewer severe adverse effects. Radioembolization can be considered a new treatment option for patients with HCC with PVT.	[Cho, Young Youn; Lee, Minjong; Kim, Yoon Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Cho, Young Youn; Lee, Minjong; Kim, Yoon Jun] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kim, Hyo-Cheol; Chung, Jin Wook] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Kim, Yun Hwan] Korea Univ, Coll Med, Anam Hosp, Dept Radiol, Seoul 136705, South Korea; [Gwak, Geum-Youn] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Bae, Si Hyun] Catholic Univ Korea, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea; [Kim, Do Young] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Heo, Jeong] Pusan Natl Univ, Internal Med, Coll Med, Pusan 609735, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Seoul St. Mary's Hospital; Yonsei University; Yonsei University Health System; Pusan National University	Kim, YJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.; Kim, YJ (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	yoonjun@snu.ac.kr	Gwak, Geum Youn/F-4605-2014	Kim, Yoon Jun/0000-0001-9141-7773; Kim, Hyo-Cheol/0000-0002-6016-247X; Cho, Young Youn/0000-0002-9384-5357; , minjong/0000-0002-3159-5444				Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; de la Torre MA, 2016, LIVER INT, V36, P1206, DOI 10.1111/liv.13098; El Fouly A, 2015, LIVER INT, V35, P627, DOI 10.1111/liv.12637; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Ghabril M, 2016, TRANSPLANTATION, V100, P126, DOI 10.1097/TP.0000000000000785; Gramenzi A, 2015, LIVER INT, V35, P1036, DOI 10.1111/liv.12574; Hilgard P, 2010, HEPATOLOGY, V52, P1741, DOI 10.1002/hep.23944; Kim DY, 2015, AM J CLIN ONCOL-CANC, V38, P495, DOI 10.1097/COC.0b013e3182a78dba; Kokabi N, 2015, CANCER-AM CANCER SOC, V121, P2164, DOI 10.1002/cncr.29275; Lee JM, 2016, CLIN MOL HEPATOL, V22, P160, DOI 10.3350/cmh.2016.22.1.160; Lin DX, 2011, J CANCER RES CLIN, V137, P139, DOI 10.1007/s00432-010-0868-x; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Luo J, 2011, ANN SURG ONCOL, V18, P413, DOI 10.1245/s10434-010-1321-8; Mazzaferro V, 2013, HEPATOLOGY, V57, P1826, DOI 10.1002/hep.26014; Memon K, 2013, J HEPATOL, V58, P73, DOI 10.1016/j.jhep.2012.09.003; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Pinter M, 2012, RADIOLOGY, V263, P590, DOI 10.1148/radiol.12111550; Salem R, 2011, GASTROENTEROLOGY, V140, P497, DOI 10.1053/j.gastro.2010.10.049; Salem R, 2010, GASTROENTEROLOGY, V138, P52, DOI 10.1053/j.gastro.2009.09.006; Sangro B, 2012, J HEPATOL, V56, P464, DOI 10.1016/j.jhep.2011.07.012; Sato K, 2006, CARDIOVASC INTER RAD, V29, P522, DOI 10.1007/s00270-005-0171-4; Schoniger-Hekele M, 2001, GUT, V48, P103, DOI 10.1136/gut.48.1.103; Shi J, 2010, ANN SURG ONCOL, V17, P2073, DOI 10.1245/s10434-010-0940-4; Woo HY, 2015, CLIN MOL HEPATOL, V21, P115, DOI 10.3350/cmh.2015.21.2.115; Yang HJ, 2014, RADIOLOGY, V271, P909, DOI 10.1148/radiol.13131760; Yoo JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113926; Yu SJ, 2015, WORLD J HEPATOL, V7, P1553, DOI 10.4254/wjh.v7.i11.1553	31	39	41	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154986	10.1371/journal.pone.0154986	http://dx.doi.org/10.1371/journal.pone.0154986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149067	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800105
J	Gatenby, R; Frieden, BR				Gatenby, Robert; Frieden, B. Roy			Investigating Information Dynamics in Living Systems through the Structure and Function of Enzymes	PLOS ONE			English	Article							ENZYMATIC HYDRIDE TRANSFER; MAXWELLS DEMON; SUBSTRATE	Enzymes are proteins that accelerate intracellular chemical reactions often by factors of 10(5) - 10(12)s(-1). We propose the structure and function of enzymes represent the thermodynamic expression of heritable information encoded in DNA with post-translational modifications that reflect intra- and extra-cellular environmental inputs. The 3 dimensional shape of the protein, determined by the genetically-specified amino acid sequence and post translational modifications, permits geometric interactions with substrate molecules traditionally described by the key-lock best fit model. Here we apply Kullback-Leibler (K-L) divergence as metric of this geometric "fit" and the information content of the interactions. When the K-L 'distance' between interspersed substrate p(n) and enzyme r(n) positions is minimized, the information state, reaction probability, and reaction rate are maximized. The latter obeys the Arrhenius equation, which we show can be derived from the geometrical principle of minimum K-L distance. The derivation is first limited to optimum substrate positions for fixed sets of enzyme positions. However, maximally improving the key/lock fit, called 'induced fit,' requires both sets of positions to be varied optimally. We demonstrate this permits and is maximally efficient if the key and lock particles p(n), r(n) are quantum entangled because the level of entanglement obeys the same minimized value of the Kullback-Leibler distance that occurs when all p(n) approximate to r(n). This implies interchanges p(n) reversible arrow br(n) randomly taking place during a reaction successively improves key/lock fits, reducing the activation energy E-a and increasing the reaction rate k. Our results demonstrate the summation of heritable and environmental information that determines the enzyme spatial configuration, by decreasing the K-L divergence, is converted to thermodynamic work by reducing Ea and increasing k of intracellular reactions. Macroscopically, enzyme information increases the order in living systems, similar to the Maxwell demon gedanken, by selectively accelerating specific reaction thus generating both spatial and temporal concentration gradients.	[Gatenby, Robert] H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL 33612 USA; [Gatenby, Robert] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL 33612 USA; [Frieden, B. Roy] Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Arizona	Gatenby, R (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL 33612 USA.; Gatenby, R (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL 33612 USA.	Robert.Gatenby@moffitt.org			National Cancer Institute [NIH/NCI 1 U54CA193489-01A1]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge support from the National Cancer Institute under grant NIH/NCI 1 U54CA193489-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert B J A, 2014, MOL BIOL CELL GARLAN; Alberts B, 2010, ESSENTIAL CELL BIOL, P120; [Anonymous], 2000, CELL MOL APPROACH; [Anonymous], 1959, INFORM THEORY STAT; FERNANDEZBELDA F, 1986, BIOCHEMISTRY-US, V25, P8083, DOI 10.1021/bi00372a043; Frieden BR, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042144; Frieden B Roy, 2013, Front Biosci (Elite Ed), V5, P1017; Frieden BR, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011128; Frieden BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022085; Gatenby RA, 2007, B MATH BIOL, V69, P635, DOI 10.1007/s11538-006-9141-5; Ghirlanda G, 2008, NATURE, V453, P164, DOI 10.1038/453164a; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Jacquod P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.150403; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KOSHLAND DE, 1960, ADV ENZYMOL REL S BI, V22, P45; Koshland DE, 1994, ANGEW CHEM INT EDIT, V33, P2735; Kullback S, 1951, INFORM SUFFICIENCY, P79, DOI [10.1214/aoms/1177729694, DOI 10.1214/AOMS/1177729694]; Lin F, 2004, LAB CHIP, V4, P164, DOI 10.1039/b313600k; Mandal D, 2012, P NATL ACAD SCI USA, V109, P11641, DOI 10.1073/pnas.1204263109; Maruyama K, 2009, REV MOD PHYS, V81, P1, DOI 10.1103/RevModPhys.81.1; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; Nagel ZD, 2010, CHEM REV, V110, pPR41, DOI 10.1021/cr1001035; Peacock DG, 1994, CHEM ENG; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sarovar M, 2010, NAT PHYS, V6, P462, DOI [10.1038/NPHYS1652, 10.1038/nphys1652]; Shenker OR, 2004, STUD HIST PHILOS M P, V35B, P537; Strait BJ, 1996, BIOPHYS J, V71, P148, DOI 10.1016/S0006-3495(96)79210-X; THOMA JA, 1960, J BIOL CHEM, V235, P2511; THOMA JA, 1960, J AM CHEM SOC, V82, P3329, DOI 10.1021/ja01498a025	30	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154867	10.1371/journal.pone.0154867	http://dx.doi.org/10.1371/journal.pone.0154867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149068	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800075
J	Hirschfeld, M; Blackburn, DC; Doherty-Bone, TM; Gonwouo, LN; Ghose, S; Rodel, MO				Hirschfeld, Mareike; Blackburn, David C.; Doherty-Bone, Thomas M.; Gonwouo, LeGrand Nono; Ghose, Sonia; Roedel, Mark-Oliver			Dramatic Declines of Montane Frogs in a Central African Biodiversity Hotspot	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; AMPHIBIAN CHYTRID FUNGUS; EMERGING INFECTIOUS-DISEASE; POPULATION DECLINES; CLIMATE-CHANGE; RAIN-FORESTS; CHYTRIDIOMYCOSIS; PATHOGEN; MORTALITY; CONSERVATION	Amphibian populations are vanishing worldwide. Declines and extinctions of many populations have been attributed to chytridiomycosis, a disease induced by the pathogenic fungus Batrachochytrium dendrobatidis (Bd). In Africa, however, changes in amphibian assemblages were typically attributed to habitat change. We conducted a retrospective study utilizing field surveys from 2004-2012 of the anuran faunas on two mountains in western Cameroon, a hotspot of African amphibian diversity. The number of species detected was negatively influenced by year, habitat degradation, and elevation, and we detected a decline of certain species. Because another study in this region revealed an emergence of Bd in 2008, we screened additional recent field-collected samples and also pre-decline preserved museum specimens for the presence of Bd supporting emergence before 2008. When comparing the years before and after Bd detection, we found significantly diminished frog species richness and abundance on both mountains after Bd emergence. Our analyses suggest that this may be the first disease-driven community-level decline in anuran biodiversity in Central Africa. The disappearance of several species known to tolerate habitat degradation, and a trend of stronger declines at higher elevations, are consistent with Bd-induced declines in other regions. Not all species decreased; populations of some species remained constant, and others increased after the emergence of Bd. This variation might be explained by species-specific differences in infection probability. Increased habitat protection and Bd-mitigation strategies are needed for sustaining diverse amphibian communities such as those on Mt. Manengouba, which contains nearly half of Cameroon's frog diversity.	[Hirschfeld, Mareike; Roedel, Mark-Oliver] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde Berlin, Invalidenstr 43, D-10115 Berlin, Germany; [Blackburn, David C.; Ghose, Sonia] Calif Acad Sci, Dept Herpetol, San Francisco, CA 94118 USA; [Doherty-Bone, Thomas M.] Royal Zool Soc Scotland, Edinburgh Zoo, Conservat Res & Act Amphibians Cameroon, Edinburgh, Midlothian, Scotland; [Gonwouo, LeGrand Nono] Cameroon Herpetol Conservat Biol Fdn CAMHERP CBF, POB 8218, Yaounde, Cameroon; [Blackburn, David C.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32605 USA; [Ghose, Sonia] Univ Calif Davis, Populat Biol Grad Grp, Davis, CA 95616 USA	Leibniz Institut fur Evolutions und Biodiversitatsforschung; California Academy of Sciences; State University System of Florida; University of Florida; University of California System; University of California Davis	Hirschfeld, M (corresponding author), Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde Berlin, Invalidenstr 43, D-10115 Berlin, Germany.	mail@mareikepetersen.de	Doherty-Bone, Thomas/L-7109-2016; Blackburn, David/L-3812-2019	Doherty-Bone, Thomas/0000-0002-8074-5955; Blackburn, David/0000-0002-1810-9886; Petersen, Mareike/0000-0001-8666-1931; Ghose, Sonia/0000-0001-5667-6876	Elsa Neumann Stipend (scholarship from the federal state of Berlin); German Academic Exchange Service; German Herpetological Society (DGHT Leipzig); Museum of Comparative Zoology (Harvard University); Project Exploration; California Academy of Science; US National Science Foundation [DEB 1202609]; Royal Zoological Society of Scotland; Zoological Society of London; University of Aberdeen; Mohammed bin Zayed Conservation Fund; European Association of Zoos Aquaria; Leibniz Association; Direct For Biological Sciences [1560667] Funding Source: National Science Foundation	Elsa Neumann Stipend (scholarship from the federal state of Berlin); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German Herpetological Society (DGHT Leipzig); Museum of Comparative Zoology (Harvard University); Project Exploration; California Academy of Science; US National Science Foundation(National Science Foundation (NSF)); Royal Zoological Society of Scotland; Zoological Society of London; University of Aberdeen; Mohammed bin Zayed Conservation Fund; European Association of Zoos Aquaria; Leibniz Association; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Elsa Neumann Stipend (scholarship from the federal state of Berlin), MH; German Academic Exchange Service, https://www.daad.de/en/, MH; German Herpetological Society (DGHT Leipzig), http://www.terraristik-leipzig.de/index.htm, MH; Museum of Comparative Zoology (Harvard University), http://www.mcz.harvard.edu/, DCB; Project Exploration, http://www.projectexploration.org/, DCB; California Academy of Science, http://www.calacademy.org/, DCB; US National Science Foundation (DEB 1202609), http://www.nsf.gov/, DCB; Royal Zoological Society of Scotland, http://www.rzss.org.uk/, DCB; Zoological Society of London, http://www.zsl.org/, TMD-B; University of Aberdeen, http://www.abdn.ac.uk/, TMD-B; Mohammed bin Zayed Conservation Fund, http://www.speciesconservation.org/, TMD-B; European Association of Zoos & Aquaria, http://www.eaza.net/, TMD-B. The publication of this article was funded by the Open Access fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adum GB, 2013, CONSERV BIOL, V27, P354, DOI 10.1111/cobi.12006; Akani Godfrey C., 2004, Applied Herpetology, V2, P1, DOI 10.1163/1570754041231604; Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; AMIET JL, 1980, ANN FS YAOUNDE, V27, P69; AMIET JL, 1975, ANN FS CAMEROUN, V20, P33; Balaz V, 2012, HERPETOL J, V22, P191; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Blackburn D.C., 2009, BREVIORA, V515, P1; Blackburn DC, 2008, ZOOL J LINN SOC-LOND, V154, P611, DOI 10.1111/j.1096-3642.2008.00397.x; Blackburn DC, 2010, AFR J HERPETOL, V59, P111, DOI 10.1080/04416651.2010.495674; Blaustein Andrew R., 2010, Diversity, V2, P281; Bletz MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08633; Bosch J, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0874; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Channing A, 2012, TADPOLES OF AFRICA T; Channing Alan, 2006, Journal of East African Natural History, V95, P117, DOI 10.2982/0012-8317(2006)95[117:TBARHO]2.0.CO;2; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Doherty-Bone TM, 2013, DIS AQUAT ORGAN, V102, P187, DOI 10.3354/dao02557; Doherty-Bone TM, 2008, HERPETOL J, V18, P115; Doherty-Bone TM, 2011, J NAT HIST, V45, P827, DOI 10.1080/00222933.2010.535921; Drew A, 2006, DIS AQUAT ORGAN, V68, P245, DOI 10.3354/dao068245; Ernst R, 2005, ECOLOGY, V86, P3111, DOI 10.1890/04-0800; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Gahl MK, 2012, CONSERV BIOL, V26, P135, DOI 10.1111/j.1523-1739.2011.01801.x; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gartshore M.E., 1986, P204; Gower DJ, 2013, ORYX, V47, P59, DOI 10.1017/S0030605311001426; Griffiths RA, 2008, CONSERV BIOL, V22, P852, DOI 10.1111/j.1523-1739.2008.00967.x; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Hero JM, 2004, HERPETOL J, V14, P175; Hillers A, 2008, CONSERV BIOL, V22, P762, DOI 10.1111/j.1523-1739.2008.00920.x; Hudson MA, 2016, BIOL CONSERV, V195, P37, DOI 10.1016/j.biocon.2015.12.041; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jarvis A, 2008, HOLE FILLED SEAMLESS; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kolby JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089660; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Mann RM, 2009, ENVIRON POLLUT, V157, P2903, DOI 10.1016/j.envpol.2009.05.015; Mapouyat L, 2014, ZOOTAXA, V 3765, P29, DOI 10.11646/zootaxa.3765.1.2; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Minter LR, 2004, SI MAB BIODIVERSITY, V9; Murray KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061061; Murray KA, 2011, P ROY SOC B-BIOL SCI, V278, P1515, DOI 10.1098/rspb.2010.1872; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; Nichols DK, 2001, J WILDLIFE DIS, V37, P1; Carnaval ACOD, 2006, ECOHEALTH, V3, P41, DOI 10.1007/s10393-005-0008-2; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Penner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056236; PERRET JEAN-LUC, 1966, ZOOL JAHRB ABT SYST OKOL GEOGR TIERE, V93, P289; Pfalzgraff T, 2015, SALAMANDRA, V51, P91; Phillott AD, 2013, CONSERV BIOL, V27, P1058, DOI 10.1111/cobi.12073; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342; Richards-Hrdlicka KL, 2012, METHODS ECOL EVOL, V3, P842, DOI 10.1111/j.2041-210X.2012.00228.x; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Roedder Dennis, 2009, Diversity, V1, P52; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Russell C, 2012, APPL GEOGR, V35, P247, DOI 10.1016/j.apgeog.2012.07.003; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schiotz A, 1999, TREEFROGS OF AFRICA; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thrusfield M., 1995, VETERINARY EPIDEMIOL; Todd BD, 2007, AM NAT, V170, P793, DOI 10.1086/521958; Van Sluys M, 2008, DIS AQUAT ORGAN, V81, P93, DOI 10.3354/dao01953; Weldon C., 2004, FROGLOG, V62, P2; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x; Zimkus BM, 2013, ZOOL SCR, V42, P591, DOI 10.1111/zsc.12029	81	26	26	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155129	10.1371/journal.pone.0155129	http://dx.doi.org/10.1371/journal.pone.0155129			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149624	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800120
J	Luo, YM; Cui, DY; Yu, XJ; Chen, S; Liu, XY; Tang, HY; Wang, XH; Liu, LB				Luo, Yuemei; Cui, Dongyao; Yu, Xiaojun; Chen, Si; Liu, Xinyu; Tang, Hongying; Wang, Xianghong; Liu, Linbo			Modeling of Mechanical Stress Exerted by Cholesterol Crystallization on Atherosclerotic Plaques	PLOS ONE			English	Article							CIRCUMFERENTIAL STRESS; BIOLOGICAL-MEMBRANES; STRUCTURAL-ANALYSIS; CORONARY; RUPTURE; CRYSTALS; RISK; CALCIFICATION; STABILITY; FREQUENCY	Plaque rupture is the critical cause of cardiovascular thrombosis, but the detailed mechanisms are not fully understood. Recent studies have found abundant cholesterol crystals in ruptured plaques, and it has been proposed that the rapid expansion of cholesterol crystals in a limited space during crystallization may contribute to plaque rupture. To evaluate the effect of cholesterol crystal growth on atherosclerotic plaques, we modeled the expansion of cholesterol crystals during the crystallization process in the necrotic core and estimated the stress on the thin cap with different arrangements of cholesterol crystals. We developed a two-dimensional finite element method model of atherosclerotic plaques containing expanding cholesterol crystals and investigated the effect of the magnitude and distribution of crystallization on the peak circumferential stress born by the cap. Using micro-optical coherence tomography (mu OCT), we extracted the cross-sectional geometric information of cholesterol crystals in human atherosclerotic aorta tissue ex vivo and applied the information to the model. The results demonstrate that (1) the peak circumference stress is proportionally dependent on the cholesterol crystal growth; (2) cholesterol crystals at the cap shoulder impose the highest peak circumference stress; and (3) spatial distributions of cholesterol crystals have a significant impact on the peak circumference stress: evenly distributed cholesterol crystals exert less peak circumferential stress on the cap than concentrated crystals.	[Luo, Yuemei; Cui, Dongyao; Yu, Xiaojun; Chen, Si; Liu, Xinyu; Tang, Hongying; Wang, Xianghong; Liu, Linbo] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Liu, Linbo] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liu, LB (corresponding author), Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore.; Liu, LB (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	liulinbo@ntu.edu.sg	Liu, Linbo/O-2572-2018	Liu, Linbo/0000-0001-6691-9253	Nanyang Technological University; National Research Foundation Singapore [NRF2013NRF-POC001-021, NRF-CRP13-2014-05]; National Medical Research Council Singapore [NMRC/ CBRG/ 0036/ 2013]; Ministry of Education Singapore [MOE2013-T2-2-107]	Nanyang Technological University(Nanyang Technological University); National Research Foundation Singapore(National Research Foundation, Singapore); National Medical Research Council Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education Singapore(Ministry of Education, Singapore)	Funding support comes from Nanyang Technological University (Startup grant: Linbo Liu) (LL), National Research Foundation Singapore (NRF2013NRF-POC001-021 and NRF-CRP13-2014-05)(LL), National Medical Research Council Singapore (NMRC/ CBRG/ 0036/ 2013)(LL), and Ministry of Education Singapore (MOE2013-T2-2-107)(LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Abela GS, 2006, SCANNING, V28, P1, DOI 10.1002/sca.4950280101; Abela GS, 2005, CLIN CARDIOL, V28, P413, DOI 10.1002/clc.4960280906; Bouvier A, 2013, PHYS MED BIOL, V58, P8457, DOI 10.1088/0031-9155/58/23/8457; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; CHENG GC, 1993, CIRCULATION, V87, P1179, DOI 10.1161/01.CIR.87.4.1179; Cheruvu PK, 2007, J AM COLL CARDIOL, V50, P940, DOI 10.1016/j.jacc.2007.04.086; Chu KK, 2014, CURR CARDIOVASC IMAG, V7, DOI 10.1007/s12410-014-9308-7; Cui DY, 2014, OPT LETT, V39, P6727, DOI 10.1364/OL.39.006727; DAVIES MJ, 1993, BRIT HEART J, V69, P377; Frink RJ, 2010, J INVASIVE CARDIOL, V22, P406; Groen HC, 2007, STROKE, V38, P2379, DOI 10.1161/STROKEAHA.107.484766; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; Kashiwagi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102669; Kolodgie FD, 2004, HEART, V90, P1385, DOI 10.1136/hrt.2004.041798; LEE RT, 1993, J AM COLL CARDIOL, V21, P777, DOI 10.1016/0735-1097(93)90112-E; Liu LB, 2011, NAT MED, V17, P1010, DOI 10.1038/nm.2409; LOREE HM, 1992, CIRC RES, V71, P850, DOI 10.1161/01.RES.71.4.850; Maehara A, 2002, J AM COLL CARDIOL, V40, P904, DOI 10.1016/S0735-1097(02)02047-8; Ohayon J, 2008, AM J PHYSIOL-HEART C, V295, pH717, DOI 10.1152/ajpheart.00005.2008; Regar E, 2003, Cardiovasc Radiat Med, V4, P198; RICHARDSON PD, 1989, LANCET, V2, P941; Tang DL, 2009, STROKE, V40, P3258, DOI 10.1161/STROKEAHA.109.558676; Tearney GJ, 2008, JACC-CARDIOVASC IMAG, V1, P752, DOI 10.1016/j.jcmg.2008.06.007; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wong KKL, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-7	28	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155117	10.1371/journal.pone.0155117	http://dx.doi.org/10.1371/journal.pone.0155117			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149381	gold, Green Published			2022-12-27	WOS:000375676800118
J	Sanz-Luque, E; Ocana-Calahorro, F; Galvan, A; Fernandez, E; de Montaigu, A				Sanz-Luque, Emanuel; Ocana-Calahorro, Francisco; Galvan, Aurora; Fernandez, Emilio; de Montaigu, Amaury			Characterization of a Mutant Deficient for Ammonium and Nitric Oxide Signalling in the Model System Chlamydomonas reinhardtii	PLOS ONE			English	Article							NITRATE REDUCTASE; TRANSCRIPTIONAL REGULATION; NITROGEN ASSIMILATION; TRUNCATED HEMOGLOBIN; STOMATAL CLOSURE; REPORTER GENE; ARABIDOPSIS; EXPRESSION; LUCIFERASE; GENERATION	The ubiquitous signalling molecule Nitric Oxide (NO) is characterized not only by the variety of organisms in which it has been described, but also by the wealth of biological processes that it regulates. In contrast to the expanding repertoire of functions assigned to NO, however, the mechanisms of NO action usually remain unresolved, and genes that work within NO signalling cascades are seldom identified. A recent addition to the list of known NO functions is the regulation of the nitrogen assimilation pathway in the unicellular alga Chlamydomonas reinhardtii, a well-established model organism for genetic and molecular studies that offers new possibilities in the search for mediators of NO signalling. By further exploiting a collection of Chlamydomonas insertional mutant strains originally isolated for their insensitivity to the ammonium (NH4+) nitrogen source, we found a mutant which, in addition to its ammonium insensitive (AI) phenotype, was not capable of correctly sensing the NO signal. Similarly to what had previously been described in the AI strain cyg56, the expression of nitrogen assimilation genes in the mutant did not properly respond to treatments with various NO donors. Complementation experiments showed that NON1 (NO Nitrate 1), a gene that encodes a protein containing no known functional domain, was the gene underlying the mutant phenotype. Beyond the identification of NON1, our findings broadly demonstrate the potential for Chlamydomonas reinhardtii to be used as a model system in the search for novel components of gene networks that mediate physiological responses to NO.	[Sanz-Luque, Emanuel; Ocana-Calahorro, Francisco; Galvan, Aurora; Fernandez, Emilio; de Montaigu, Amaury] Univ Cordoba, Dept Bioquim & Biol Mol, Campus Rabanales, Cordoba, Spain; [de Montaigu, Amaury] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany	Universidad de Cordoba; Max Planck Society	Fernandez, E; de Montaigu, A (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Campus Rabanales, Cordoba, Spain.; de Montaigu, A (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany.	bb1feree@uco.es; montaigu@mpipz.mpg.de	Fernandez, Emilio/H-2892-2015; Sanz-Luque, Emanuel/Z-2166-2019; de Montaigu, Amaury/A-4121-2018; Galvan Cejudo, Aurora/A-9483-2010	Sanz-Luque, Emanuel/0000-0002-7300-9730; de Montaigu, Amaury/0000-0003-1366-2989; Fernandez Reyes, Emilio/0000-0001-5957-5392; Galvan Cejudo, Aurora/0000-0002-7564-2281	Ministerio de Economia y Competitividad [BFU2008-01978, BFU2011-29338]	Ministerio de Economia y Competitividad(Spanish Government)	This work was funded by the Ministerio de Economia y Competitividad (http://www.mineco.gob.es/), grant numbers BFU2008-01978 and BFU2011-29338 to EF.	Antoniou C, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25479; BARLOW JJ, 1963, BIOCHEM BIOPH RES CO, V13, P61, DOI 10.1016/0006-291X(63)90163-3; Bloom AJ, 2015, CURR OPIN PLANT BIOL, V25, P10, DOI 10.1016/j.pbi.2015.03.002; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Chamizo-Ampudia A, 2016, PLANT CELL ENVIRON, V39, P2097, DOI 10.1111/pce.12739; Corpas FJ, 2015, NITRIC OXIDE-BIOL CH, V45, P15, DOI 10.1016/j.niox.2015.01.007; de Montaigu A, 2011, J EXP BOT, V62, P1425, DOI 10.1093/jxb/erq384; de Montaigu A, 2010, PLANT CELL, V22, P1532, DOI 10.1105/tpc.108.062380; Delledonne M, 2005, CURR OPIN PLANT BIOL, V8, P390, DOI 10.1016/j.pbi.2005.05.002; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Desikan R, 2002, P NATL ACAD SCI USA, V99, P16314, DOI 10.1073/pnas.252461999; Domingos P, 2015, MOL PLANT, V8, P506, DOI 10.1016/j.molp.2014.12.010; FERNANDEZ E, 1982, MOL GEN GENET, V186, P164, DOI 10.1007/BF00331846; Fernandez E, 2007, J EXP BOT, V58, P2279, DOI 10.1093/jxb/erm106; Frungillo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6401; Gonzalez-Ballester D, 2005, ANAL BIOCHEM, V340, P330, DOI 10.1016/j.ab.2005.01.031; Gonzalez-Ballester D, 2004, PLANT MOL BIOL, V56, P863, DOI 10.1007/s11103-004-5292-7; Gonzalez-Ballester D, 2005, PLANT PHYSIOL, V137, P522, DOI 10.1104/pp.104.050914; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Gutman BL, 2004, PLANT PHYSIOL, V135, P607, DOI 10.1104/pp.104.041491; Harris EH., 2009, CHLAMYDOMONAS SOURCE; Harris EH, 2001, ANNU REV PLANT PHYS, P1; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; Jin CW, 2009, ANN BOT-LONDON, V104, P9, DOI 10.1093/aob/mcp087; Jinkerson RE, 2015, PLANT J, V82, P393, DOI 10.1111/tpj.12801; Johnson EA, 2014, BIOCHEMISTRY-US, V53, P4573, DOI 10.1021/bi5005206; Leon R, 2007, ADV EXP MED BIOL, V616, P1; Loppes R, 1999, PLANT MOL BIOL, V41, P701, DOI 10.1023/A:1006381527119; Maathuis FJM, 2006, PLANT J, V45, P700, DOI 10.1111/j.1365-313X.2005.02616.x; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mur LAJ, 2011, PLANT SCI, V181, P509, DOI 10.1016/j.plantsci.2011.04.003; Ohresser M, 1997, CURR GENET, V31, P264, DOI 10.1007/s002940050204; PANEQUE A, 1966, BIOCHIM BIOPHYS ACTA, V128, P202, DOI 10.1016/0926-6593(66)90162-7; Rosales EP, 2011, PLANT PHYSIOL BIOCH, V49, P124, DOI 10.1016/j.plaphy.2010.10.009; Perez-Alegre M, 2005, MOL CELL BIOL, V25, P10628, DOI 10.1128/MCB.25.23.10628-10638.2005; Prieto R, 1996, MOL GEN GENET, V251, P461, DOI 10.1007/BF02172375; Sakihama Y, 2002, PLANT CELL PHYSIOL, V43, P290, DOI 10.1093/pcp/pcf034; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanz-Luque E, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00899; Sanz-Luque E, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1042638; Sanz-Luque E, 2015, PLANT J, V81, P467, DOI 10.1111/tpj.12744; Sanz-Luque E, 2013, J EXP BOT, V64, P3373, DOI 10.1093/jxb/ert175; Shao N, 2008, CURR GENET, V53, P381, DOI 10.1007/s00294-008-0189-7; Shao N, 2013, PLANT CELL, V25, P4209, DOI 10.1105/tpc.113.117390; Snell FD, 1949, COLORIMETRIC METHODS; Zhang R, 2014, PLANT CELL, V26, P1398, DOI 10.1105/tpc.114.124099	46	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0155128	10.1371/journal.pone.0155128	http://dx.doi.org/10.1371/journal.pone.0155128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149516	Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800119
J	Egana-Gorrono, L; Guardo, AC; Bargallo, ME; Planet, E; Vilaplana, E; Escriba, T; Perez, I; Gatell, JM; Garcia, F; Arnedo, M; Plana, M				Egana-Gorrono, Lander; Guardo, Alberto C.; Bargallo, Manel E.; Planet, Evarist; Vilaplana, Elisenda; Escriba, Tuixent; Perez, Inaki; Maria Gatell, Josep; Garcia, Felipe; Arnedo, Mireia; Plana M, Montserrat		HIV Controllers Consortium AIDS	MicroRNA Profile in CD8+T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression	PLOS ONE			English	Article							T-CELL DIFFERENTIATION; EXPRESSION; BIOINFORMATICS; ACTIVATION; EFFECTOR; SENSITIVITY; MIR-181A; ABSENCE; CD4(+); MEMORY	Background The relationship between host microRNAs (miRNA), viral control and immune response has not yet been elucidated in the field of HIV. The aim of this study was to assess the differential miRNA profile in CD8+ T-cells between HIV-infected individuals who differ in terms of viral replication control and immune response. Methods miRNA profile from resting and CD3/CD28-stimulated CD8+ T-cells from uninfected individuals (HIV-, n = 11), Elite Controllers (EC, n = 15), Viremic Controllers (VC, n = 15), Viremic Progressors (VP, n = 13) and HIV-infected patients on therapy (ART, n = 14) was assessed using Affymetrix miRNA 3.1 arrays. After background correction, quantile normalization and median polish summarization, normalized data were fit to a linear model. The analysis comprised: resting samples between groups; stimulated samples between groups; and stimulated versus resting samples within each group. Enrichment analyses of the putative target genes were perfomed using bioinformatic algorithms. Results A downregulated miRNA pattern was observed when resting samples from all infected groups were compared to HIV-. A miRNA downregulation was also observed when stimulated samples from EC, ART and HIV-groups were compared to VP, being hsa-miR-4492 the most downregulated. Although a preferential miRNA downregulation was observed when stimulated samples were compared to the respective resting samples, VP presented a differential miRNA expression pattern. In fact, hsa-miR-155 and hsa-miR-181a were downregulated in VP whereas in the other groups, either an upregulation or no differences were observed after stimulation, respectively. Overall, functional enrichment analysis revealed that the predicted target genes were involved in signal transduction pathways, metabolic regulation, apoptosis, and immune response. Conclusions Resting CD8+ T-cells do not exhibit a differential miRNA expression between HIV- infected individuals but they do differ from non-infected individuals. Moreover, a specific miRNA pattern is present in stimulated CD8+ T-cells from VP which could reflect a detrimental pattern in terms of CD8+ T-cell immune response.	[Egana-Gorrono, Lander; Vilaplana, Elisenda; Escriba, Tuixent; Arnedo, Mireia] Hosp Clin Barcelona, IDIBAPS, AIDS Res Grp, Grp Genom & Pharmacogen HIV, Barcelona, Spain; [Guardo, Alberto C.; Bargallo, Manel E.; Plana M, Montserrat] Hosp Clin Barcelona, IDIBAPS, Catalan Project Dev HIV Vaccine HIVACAT, Immunopathol & Cellular Immunol,AIDS Res Grp, Barcelona, Spain; [Planet, Evarist] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Vilaplana, Elisenda] Cent Univ Catalonia, Univ Vic, Dept Syst Biol, Vic, Spain; [Perez, Inaki; Maria Gatell, Josep; Garcia, Felipe] Univ Barcelona, Hosp Clin Barcelona, Dept Infect Dis, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University of Barcelona; Hospital Clinic de Barcelona	Plana, M (corresponding author), Hosp Clin Barcelona, IDIBAPS, Catalan Project Dev HIV Vaccine HIVACAT, Immunopathol & Cellular Immunol,AIDS Res Grp, Barcelona, Spain.	mplana@clinic.ub.es	, Felipe/F-4242-2014; IBIS, VIH/O-8856-2015; Valenzuela-Fernández, Agustín/P-1638-2019; Soriano, Vicente/O-5730-2018; Oteo, Jose A./AAB-3134-2020; gonzalez, cristina/U-2024-2019; Climent, Núria/AAF-8161-2021; Pineda, Juan A./AAO-9312-2021; Gatell, Jose M/ABC-3607-2020; Chueca, Natalia/T-9734-2019; Asensi Alvarez, Victor/AAH-2171-2020; Montero, Marta/H-7555-2017; Blanco Garcia, Francisco J/C-3192-2014; Alcami, Jose/T-2242-2018; Pulido, Federico/B-8417-2009; Rodriguez-Gallego, Esther/B-6581-2016; RAFII-EL-IDRISSI BENHNIA, MOHAMMED/F-3019-2015; Arribas, Jose/A-1595-2015; Masia, Mar/U-7510-2017; Gutierrez, Felix/Q-7880-2018	, Felipe/0000-0001-7658-5832; Valenzuela-Fernández, Agustín/0000-0002-2585-8703; Soriano, Vicente/0000-0002-4624-5199; Oteo, Jose A./0000-0001-7080-6542; gonzalez, cristina/0000-0002-6924-990X; Climent, Núria/0000-0002-0791-656X; Pineda, Juan A./0000-0002-3751-0296; Chueca, Natalia/0000-0002-3420-3290; Lopez Dupla, Jesus Miguel/0000-0002-9141-2523; Vidal, Francesc/0000-0002-6692-6186; Asensi Alvarez, Victor/0000-0003-4211-456X; Barreiro, Pablo/0000-0002-3819-5371; Navarro Ruiz, Andres/0000-0001-7009-280X; Montero, Marta/0000-0002-3432-5394; Blanco Garcia, Francisco J/0000-0001-9821-7635; Escriba, Tuixent/0000-0001-9467-7802; Benito, Jose/0000-0002-7172-049X; Alcami, Jose/0000-0003-0023-7377; Pulido, Federico/0000-0002-7414-8812; Rodriguez-Gallego, Esther/0000-0002-6363-2510; Sanjuan, Rafael/0000-0002-1844-545X; Veloso Esteban, Sergio/0000-0001-7943-1169; RAFII-EL-IDRISSI BENHNIA, MOHAMMED/0000-0001-7405-9476; Pernas, Maria/0000-0003-2966-0160; Gijon, Paloma/0000-0002-5011-1927; Padilla, Sergio/0000-0002-8420-7310; Arribas, Jose/0000-0002-7410-9450; Casado, Jose Luis/0000-0002-7639-8591; Calabuig, Eva/0000-0002-0177-0037; Mallolas Masferrer, Josep/0000-0002-8365-141X; De Los Santos Gil, Ignacio/0000-0001-7073-5211; Nogueras, Maria-Mercedes/0000-0001-5925-1929; Masia, Mar/0000-0001-9878-2458; Egana Gorrono, Lander/0000-0002-0378-7844; Vargas Laguna, Montserrat/0000-0001-7650-0587; PELAZAS GONZALEZ, RICARDO/0000-0002-1565-4520; Rubio Garcia, Rafael/0000-0001-8132-4303; ALBA ELVIRA, VERONICA/0000-0002-5925-9573; /0000-0001-7808-5479; PENARANDA VERA, MARIA/0000-0001-6290-3457; Gutierrez, Felix/0000-0002-9485-6867	HIVACAT (HIV Vaccine Research and Development Programme in Catalonia); Fundacion para la Investigacion y la Prevencion del Sida en Espana [FIPSE 09]; Fondo Europeo para el Desarrollo Regional (FEDER); Fondo de Investigacion Sanitaria (FIS) [PI070291, PI12/00969]; Red de Investigacion en Sida (RIS); Instituto de Salud Carlos III [ISCIII-RETIC RD06/0006/0000]; Spanish Health Department of the Instituto de Salud Carlos III (ISCIII); Health Department of the Catalan Government (Generalitat de Catalunya)	HIVACAT (HIV Vaccine Research and Development Programme in Catalonia); Fundacion para la Investigacion y la Prevencion del Sida en Espana; Fondo Europeo para el Desarrollo Regional (FEDER)(European Commission); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Red de Investigacion en Sida (RIS); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Health Department of the Instituto de Salud Carlos III (ISCIII); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya)	The authors are grateful to all the patients and donors who participated in the study and thank the Retrovirology and Viral Immunopathology Laboratory of the Institut d`Investigacions Biomediques August Pi I Sunyer (IDIBAPS). This work was partially supported by HIVACAT (HIV Vaccine Research and Development Programme in Catalonia), Fundacion para la Investigacion y la Prevencion del Sida en Espana (FIPSE 09), Fondo Europeo para el Desarrollo Regional (FEDER), Fondo de Investigacion Sanitaria (FIS; PI070291, PI12/00969), Red de Investigacion en Sida (RIS), and Instituto de Salud Carlos III (ISCIII-RETIC RD06/0006/0000). M. Plana and M. Arnedo are researchers from the Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and were supported by the Spanish Health Department of the Instituto de Salud Carlos III (ISCIII) and the Health Department of the Catalan Government (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Dudda JC, 2013, IMMUNITY, V38, P742, DOI 10.1016/j.immuni.2012.12.006; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Egana-Gorrono L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106360; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kroesen BJ, 2015, IMMUNOLOGY, V144, P1, DOI 10.1111/imm.12367; Li GJ, 2012, NAT MED, V18, P1518, DOI 10.1038/nm.2963; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liang Y, 2015, J LEUKOCYTE BIOL, V97, P487, DOI 10.1189/jlb.1RU0814-369R; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; O'Connell KA, 2009, TRENDS PHARMACOL SCI, V30, P631, DOI 10.1016/j.tips.2009.09.005; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Peris-Pertusa A, 2010, JAIDS-J ACQ IMM DEF, V55, P29, DOI 10.1097/QAI.0b013e3181e69609; Picker LJ, 2005, NAT IMMUNOL, V6, P430, DOI 10.1038/ni0505-430; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Turner M, 2008, BIOCHEM SOC T, V36, P531, DOI 10.1042/BST0360531; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Witwer KW, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-5; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu JQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-18; Xu CY, 2014, AIDS RES HUM RETROV, V30, P134, DOI [10.1089/aid.2013.0073, 10.1089/AID.2013.0073]; Xun M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0288-2; Zeller J M, 1996, J Assoc Nurses AIDS Care, V7, P15, DOI 10.1016/S1055-3290(96)80034-3; Zhang N, 2010, P NATL ACAD SCI USA, V107, P21629, DOI 10.1073/pnas.1016299107	46	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155245	10.1371/journal.pone.0155245	http://dx.doi.org/10.1371/journal.pone.0155245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171002	Green Published, Green Submitted, gold			2022-12-27	WOS:000376588600085
J	Windels, F; Yan, SZ; Stratton, PG; Sullivan, R; Crane, JW; Sah, P				Windels, Francois; Yan, Shanzhi; Stratton, Peter G.; Sullivan, Robert; Crane, James W.; Sah, Pankaj			Auditory Tones and Foot-Shock Recapitulate Spontaneous Sub-Threshold Activity in Basolateral Amygdala Principal Neurons and Interneurons	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; SLOW OSCILLATIONS; NEOCORTICAL NEURONS; SENSORY RESPONSES; CEREBRAL-CORTEX; SINGLE NEURONS; ISOFLURANE; STIMULI; HIPPOCAMPUS; PROJECTIONS	In quiescent states such as anesthesia and slow wave sleep, cortical networks show slow rhythmic synchronized activity. In sensory cortices this rhythmic activity shows a stereotypical pattern that is recapitulated by stimulation of the appropriate sensory modality. The amygdala receives sensory input from a variety of sources, and in anesthetized animals, neurons in the basolateral amygdala (BLA) show slow rhythmic synchronized activity. Extracellular field potential recordings show that these oscillations are synchronized with sensory cortex and the thalamus, with both the thalamus and cortex leading the BLA. Using whole-cell recording in vivo we show that the membrane potential of principal neurons spontaneously oscillates between up- and down-states. Footshock and auditory stimulation delivered during down-states evokes an up-state that fully recapitulates those occurring spontaneously. These results suggest that neurons in the BLA receive convergent input from networks of cortical neurons with slow oscillatory activity and that somatosensory and auditory stimulation can trigger activity in these same networks.	[Windels, Francois; Yan, Shanzhi; Stratton, Peter G.; Sullivan, Robert; Sah, Pankaj] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Windels, Francois; Stratton, Peter G.; Sah, Pankaj] Queensland Brain Inst, Asia Pacific Ctr Neuromodulat, Brisbane, Qld, Australia; [Crane, James W.] Charles Sturt Univ, Sch Biomed Sci, Bathurst, NSW 2795, Australia	University of Queensland; University of Queensland; Charles Sturt University	Windels, F (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.; Windels, F (corresponding author), Queensland Brain Inst, Asia Pacific Ctr Neuromodulat, Brisbane, Qld, Australia.	f.windels@uq.edu.au	Sullivan, Robert KP/A-8639-2012	Sullivan, Robert KP/0000-0003-3414-2448; Windels, Francois/0000-0001-5341-2197; Crane, James/0000-0002-4601-0189; Sah, Pankaj/0000-0001-5063-1589	Australian National Health and Medical Research Council [PG1006316]; Australian Research Council [CE140100007, SR120300015]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This research was supported by grants from the Australian National Health and Medical Research Council (PG1006316 to FW and PS) (https://www.nhmrc.gov.au/) and by the Australian Research Council (CE140100007, SR120300015 to PS) (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickart KC, 2014, NEUROPSYCHOLOGIA, V63, P235, DOI 10.1016/j.neuropsychologia.2014.08.013; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Contreras EJB, 2013, NEURON, V79, P555, DOI 10.1016/j.neuron.2013.06.013; Crane JW, 2009, J NEUROPHYSIOL, V102, P1379, DOI 10.1152/jn.00438.2009; David F, 2013, J NEUROSCI, V33, P19599, DOI 10.1523/JNEUROSCI.3169-13.2013; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Gao X, 2012, NEUROSCIENCE, V216, P57, DOI 10.1016/j.neuroscience.2012.04.062; HARTIKAINEN KM, 1995, ANESTH ANALG, V81, P1223, DOI 10.1097/00000539-199512000-00018; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Huang Lingyue, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P785; Hudetz AG, 2007, ANESTHESIOLOGY, V107, P983, DOI 10.1097/01.anes.0000291471.80659.55; Kasanetz F, 2008, P NATL ACAD SCI USA, V105, P8124, DOI 10.1073/pnas.0711113105; Kasanetz F, 2006, J PHYSIOL-LONDON, V577, P97, DOI 10.1113/jphysiol.2006.113050; KNUEPFER MM, 1995, AM J PHYSIOL-REG I, V268, pR666, DOI 10.1152/ajpregu.1995.268.3.R666; Lemieux M, 2014, J NEUROSCI, V34, P5689, DOI 10.1523/JNEUROSCI.1156-13.2014; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Likhtik E, 2006, J NEUROPHYSIOL, V96, P3257, DOI 10.1152/jn.00577.2006; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; MCDONALD AJ, 1984, J COMP NEUROL, V222, P589, DOI 10.1002/cne.902220410; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; MCDONALD AJ, 1992, BRAIN RES BULL, V28, P179, DOI 10.1016/0361-9230(92)90177-Y; Molle M, 2011, PROG BRAIN RES, V193, P93, DOI 10.1016/B978-0-444-53839-0.00007-7; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Pitkanen A., 2000, AMYGDALA FUNCTIONAL, V2; Potez S, 2008, J NEUROPHYSIOL, V99, P1394, DOI 10.1152/jn.01126.2007; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Ros H, 2009, J NEUROSCI, V29, P10309, DOI 10.1523/JNEUROSCI.2327-09.2009; SCHUTZE I, 1987, EXP NEUROL, V97, P499, DOI 10.1016/0014-4886(87)90109-9; Sharma AV, 2010, J NEUROPHYSIOL, V104, P932, DOI 10.1152/jn.01065.2009; Sheroziya M, 2014, J NEUROSCI, V34, P8875, DOI 10.1523/JNEUROSCI.4460-13.2014; Spampanato J, 2011, NEUROPHARMACOLOGY, V60, P765, DOI 10.1016/j.neuropharm.2010.11.006; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Villeneuve MY, 2003, J NEUROSCI METH, V129, P19, DOI 10.1016/S0165-0270(03)00198-5; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Windels F, 2010, J NEUROPHYSIOL, V104, P3433, DOI 10.1152/jn.00531.2010; Zhang Y, 2011, PHYSIOL RES, V60, P687, DOI 10.33549/physiolres.932086	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155192	10.1371/journal.pone.0155192	http://dx.doi.org/10.1371/journal.pone.0155192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171164	Green Published, Green Submitted, gold			2022-12-27	WOS:000376588600018
J	Zhai, LB; Wang, H; Gao, CE				Zhai, Linbo; Wang, Hua; Gao, Chuangen			A Spectrum Access Based on Quality of Service (QoS) in Cognitive Radio Networks	PLOS ONE			English	Article								The quality of service (QoS) is important issue for cognitive radio networks. In the cognitive radio system, the licensed users, also called primary users (PUs), are authorized to utilize the wireless spectrum, while unlicensed users, also called secondary users (SUs), are not authorized to use the wireless spectrum. SUs access the wireless spectrum opportunistically when the spectrum is idle. While SUs use an idle channel, the instance that PUs come back makes SUs terminate their communications and leave the current channel. Therefore, quality of service (QoS) is difficult to be ensured for SUs. In this paper, we first propose an analysis model to obtain QoS for cognitive radio networks such as blocking probability, completed traffic and termination probability of SUs. When the primary users use the channels frequently, QoS of SUs is difficult to be ensured, especially the termination probability. Then, we propose a channel reservation scheme to improve QoS of SUs. The scheme makes the terminated SUs move to the reserved channels and keep on communications. Simulation results show that our scheme can improve QoS of SUs especially the termination probability with a little cost of blocking probability in dynamic environment.	[Zhai, Linbo; Wang, Hua; Gao, Chuangen] Shandong Univ, Sch Comp Sci & Technol, Shun Hua Lu 1500, Jinan 250100, Peoples R China; [Zhai, Linbo] Shandong Normal Univ, Shandong Prov Key Lab Distributed Comp Software N, Jinan, Peoples R China	Shandong University; Shandong Normal University	Wang, H (corresponding author), Shandong Univ, Sch Comp Sci & Technol, Shun Hua Lu 1500, Jinan 250100, Peoples R China.	wanghua@sdu.edu.cn			Natural Science Foundation of Shandong Province, China [BS2015DX003]; China Postdoctoral Science Foundation [2014M561930]	Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported in part by Natural Science Foundation of Shandong Province, China (No. BS2015DX003), and in part by China Postdoctoral Science Foundation (No. 2014M561930).	Chen YY, 2011, 2011 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE (WCNC), P96, DOI 10.1109/WCNC.2011.5779113; Doost-Mohammady R, 2014, IEEE T WIREL COMMUN, V13, P3938, DOI 10.1109/TWC.2014.2319307; Fu YH, 2015, SENSORS-BASEL, V15, P23706, DOI 10.3390/s150923706; Jaafar W, 2014, IEEE T WIREL COMMUN, V13, P6219, DOI 10.1109/TWC.2014.2332161; Jha SC, 2011, IEEE T WIREL COMMUN, V10, P3414, DOI 10.1109/TWC.2011.072511.102196; Mihov Y.Y., 2011, 6 INT C SYST NETW CO, P99; Mihov YY, 2012, IEEE COMMUN LETT, V16, P678, DOI 10.1109/LCOMM.2012.031212.120175; Mishra V, 2014, IET NETW, V3, P74, DOI 10.1049/iet-net.2013.0032; Mitola J, 1999, IEEE PERS COMMUN, V6, P13, DOI 10.1109/98.788210; Presti F, 2010, IEEE CROWNCOM 2010, P1; Usman M, 2015, SENSORS-BASEL, V15, P18012, DOI 10.3390/s150818012; Zhao Y, 2014, J COMMUNICATIONS NET, V2, P193; Zhu XR, 2007, IEEE COMMUN LETT, V11, P304, DOI [10.1109/LCOM.2007.348282, 10.1109/LCOMM.2007.062058]	13	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155074	10.1371/journal.pone.0155074	http://dx.doi.org/10.1371/journal.pone.0155074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171196	Green Published, Green Submitted, gold			2022-12-27	WOS:000376588600007
J	de Souza, AR; Petrocelli, I; Lino-Neto, J; Santos, EF; Noll, FB; Turillazzi, S				de Souza, Andre Rodrigues; Petrocelli, Iacopo; Lino-Neto, Jose; Santos, Eduardo Fernando; Noll, Fernando Barbosa; Turillazzi, Stefano			Ontogenic Caste Differences in the Van der Vecht Organ of Primitively Eusocial Neotropical Paper Wasps	PLOS ONE			English	Article							LATITUDINAL GRADIENT; DOMINANCE HIERARCHY; COLONY CYCLE; SOCIAL WASPS; HYMENOPTERA; TRAITS; WORKER; EVOLUTION; BEHAVIOR; DEFENSE	Recent studies have reported incipient morphological caste dimorphism in the Van der Vecht organ size of some temperate Polistes paper wasps. Whether species other than the temperate ones show a similar pattern remains elusive. Here, we have studied some Neotropical Polistes species. By comparing females collected through the year, we showed caste related differences in the size of the Van der Vecht organ in P. ferreri (body size corrected Van der Vech organ size of queens = 0.45 +/- 0.06, workers = 0.38 +/- 0.07 mm(2), p = 0.0021), P. versicolor (body size corrected Van der Vech organ size of queens = 0.54 +/- 0.11, workers = 0.46 +/- 0.09 mm(2), p = 0.010), but not P. simillimus (body size corrected Van der Vech organ size of queens = 0.52 +/- 0.05, workers = 0.49 +/- 0.06 mm(2), p = 0.238). Therefore, it seems that queens and workers of some Neotropical Polistes have diverged in their ontogenic trajectory of the Van der Vecht organ size, providing clear evidence for incipient morphological caste dimorphism. As Polistes are distributed mostly in the tropics, we propose that physical caste differences may be widespread in the genus. Also, we highlight that morphological divergence in the queen-worker phenotypes may have started through differential selection of body structures, like the Van der Vecht organ.	[de Souza, Andre Rodrigues] Univ Fed Vicosa, Dept Entomol, BR-36570000 Vicosa, MG, Brazil; [Petrocelli, Iacopo; Turillazzi, Stefano] Univ Florence, Dipartimento Biol Evoluzionist Leo Pardi, Via Romana 17, I-50125 Florence, Italy; [Lino-Neto, Jose] Univ Fed Vicosa, Dept Biol Geral, BR-36570000 Vicosa, MG, Brazil; [Santos, Eduardo Fernando; Noll, Fernando Barbosa] Univ Estadual Paulista, Inst Biociencias Letras & Ciencias Exatas, Dept Zool & Bot, BR-15054000 Sao Paulo, Brazil	Universidade Federal de Vicosa; University of Florence; Universidade Federal de Vicosa; Universidade Estadual Paulista	de Souza, AR (corresponding author), Univ Fed Vicosa, Dept Entomol, BR-36570000 Vicosa, MG, Brazil.	andrebioufjf@gmail.com	Santos, Eduardo Fernando dos/AAM-9585-2020; NOLL, FERNANDO BARBOSA/N-1206-2019; dos Santos, Eduardo F/D-5735-2014; de Souza, André Rodrigues/C-9069-2015; FERNANDO, NOLL B/A-3606-2008	Santos, Eduardo Fernando dos/0000-0003-2486-0462; NOLL, FERNANDO BARBOSA/0000-0003-0207-1067; de Souza, André Rodrigues/0000-0002-1124-4874; FERNANDO, NOLL B/0000-0003-0207-1067	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [143246/2011-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. (proc. 143246/2011-9 to AR De Souza).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Berens AJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1410-y; Berens AJ, 2015, MOL BIOL EVOL, V32, P690, DOI 10.1093/molbev/msu330; Bouwma AM, 2007, BIOTROPICA, V39, P719, DOI 10.1111/j.1744-7429.2007.00321.x; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Dani FR, 2003, ETHOL ECOL EVOL, V15, P73; DANI FR, 1994, ETHOL ECOL EVOL, P67; DANI FR, 1992, BEHAV PROCESS, V28, P51, DOI 10.1016/0376-6357(92)90048-I; Dapporto L, 2007, CHEM SENSES, V32, P795, DOI 10.1093/chemse/bjm047; Dapporto L, 2007, CURR BIOL, V17, pR504, DOI 10.1016/j.cub.2007.05.002; Dapporto L, 2011, ZOOMORPHOLOGY, V130, P197, DOI 10.1007/s00435-011-0130-3; De Souza AR, 2012, INSECT SOC, V59, P463, DOI 10.1007/s00040-012-0240-z; De Souza AR, 2012, INSECT SOC, V59, P193, DOI 10.1007/s00040-011-0204-8; de Souza AR, 2008, SOCIOBIOLOGY, V52, P293; De Souza AR, 2012, ENTOMOL EXP APPL, V144, P244, DOI 10.1111/j.1570-7458.2012.01285.x; EICKWORT K, 1969, INSECT SOC, V16, P67, DOI 10.1007/BF02224464; Gadagkar R., 1991, P149; Gobbi N, 2006, NATURWISSENSCHAFTEN, V93, P487, DOI 10.1007/s00114-006-0140-z; Grazinoli DJ, 2010, SOCIOBIOLOGY, V56, P507; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; Hunt JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026641; Hunt JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010674; Hunt JH, 2003, J INSECT PHYSIOL, V49, P785, DOI 10.1016/S0022-1910(03)00115-X; Jandt JM, 2015, BEHAV ECOL, V26, P1274, DOI 10.1093/beheco/arv082; Jeanne R.L., 1991, P191; JEANNE RL, 1970, SCIENCE, V168, P1465, DOI 10.1126/science.168.3938.1465; JEANNE RL, 1979, ECOLOGY, V60, P1211, DOI 10.2307/1936968; Judd TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116199; Kapheim KM, 2012, P ROY SOC B-BIOL SCI, V279, P1437, DOI 10.1098/rspb.2011.1652; Karsai I, 2002, ENVIRON ENTOMOL, V31, P99, DOI 10.1603/0046-225X-31.1.99; KOJIMA J, 1993, INSECT SOC, V40, P403, DOI 10.1007/BF01253903; London KB, 2000, ETHOL ECOL EVOL, V12, P13, DOI 10.1080/03949370.2000.9728440; Matsuura M., 1990, BIOL VESPINE WASPS; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Noll Fernando B., 2004, American Museum Novitates, V3467, P1, DOI 10.1206/0003-0082(2004)467<0001:EOCINW>2.0.CO;2; O'Donnell S, 1998, ANNU REV ENTOMOL, V43, P323, DOI 10.1146/annurev.ento.43.1.323; Petrocelli I, 2015, ETHOLOGY, V121, P300, DOI 10.1111/eth.12339; Petrocelli I, 2013, J ZOOL SYST EVOL RES, V51, P274, DOI 10.1111/jzs.12028; Reeve H.K., 1991, P99; Richards O.W., 1978, SOCIAL WASPS AM EXCL; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Signorotti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097024; Sinzato DMS, 2011, REV CHIL HIST NAT, V84, P357, DOI 10.4067/S0716-078X2011000300004; Sinzato DMS, 2002, THESIS U FEDERAL JUI; Stern DL, 1999, DEVELOPMENT, V126, P1091; STRASSMANN JE, 1985, INSECT SOC, V32, P275, DOI 10.1007/BF02224916; Team RC, 2014, R LANG ENV STAT COMP; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2006, ANN ZOOL FENN, V43, P575; Tibbetts EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028173; Tibbetts EA, 2010, AM NAT, V175, P495, DOI 10.1086/651596; Toth AL, 2009, INSECT SOC, V56, P77, DOI 10.1007/s00040-008-1041-2; TURILLAZZI S, 1994, INSECT SOC, V41, P327, DOI 10.1007/BF01242304; TURILLAZZI S, 1979, MONIT ZOOL ITAL, V13, P67; Turillazzi S, 1979, MONIT ZOOL ITAL NS, V16, P75; Vaiserman AM, 2015, MOSCOW U BIOL SCI B, V70, P158; WILSON EO, 1979, P AM PHILOS SOC, V123, P204; Zara Fernando Jose, 2000, Naturalia (Rio Claro), V25, P301	58	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154521	10.1371/journal.pone.0154521	http://dx.doi.org/10.1371/journal.pone.0154521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167514	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300068
J	Fengler, VHI; Macheiner, T; Kessler, SM; Czepukojc, B; Gemperlein, K; Muller, R; Kiemer, AK; Magnes, C; Haybaeck, J; Lackner, C; Sargsyan, K				Fengler, Vera H. I.; Macheiner, Tanja; Kessler, Sonja M.; Czepukojc, Beate; Gemperlein, Katja; Mueller, Rolf; Kiemer, Alexandra K.; Magnes, Christoph; Haybaeck, Johannes; Lackner, Carolin; Sargsyan, Karine			Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease	PLOS ONE			English	Article							HIGH-FAT DIET; INDUCED HEPATIC STEATOSIS; BINDING-PROTEIN P62/IGF2BP2-2; DENK BODY FORMATION; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; GENE-EXPRESSION; CONFERS SUSCEPTIBILITY; FREE-CHOLESTEROL; INDUCED OBESITY	Although non-alcoholic and alcoholic fatty liver disease have been intensively studied, concerning pathophysiological mechanisms are still incompletely understood. This may be due to the use of different animal models and resulting model-associated variation. Therefore, this study aimed to compare three frequently used wild type mouse strains in their susceptibility to develop diet-induced features of non-alcoholic/alcoholic fatty liver disease. Fatty liver disease associated clinical, biochemical, and histological features in C57BL/6, CD-1, and 129Sv WT mice were induced by (i) high-fat diet feeding, (ii) ethanol feeding only, and (iii) the combination of high-fat diet and ethanol feeding. Hepatic and subcutaneous adipose lipid profiles were compared in CD-1 and 129Sv mice. Additionally hepatic fatty acid composition was determined in 129Sv mice. In C57BL/6 mice dietary regimens resulted in heterogeneous hepatic responses, ranging from pronounced steatosis and inflammation to a lack of any features of fatty liver disease. Liver-related serum biochemistry showed high deviations within the regimen groups. CD-1 mice did not exhibit significant changes in metabolic and liver markers and developed no significant steatosis or inflammation as a response to dietary regimens. Although 129Sv mice showed no weight gain, this strain achieved most consistent features of fatty liver disease, apparent from concentration alterations of liver-related serum biochemistry as well as moderate steatosis and inflammation as a result of all dietary regimens. Furthermore, the hepatic lipid profile as well as the fatty acid composition of 129Sv mice were considerably altered, upon feeding the different dietary regimens. Accordingly, diet-induced non-alcoholic/alcoholic fatty liver disease is most consistently promoted in 129Sv mice compared to C57BL/6 and CD-1 mice. As a conclusion, this study demonstrates the importance of genetic background of used mouse strains for modeling diet-induced non-alcoholic/alcoholic fatty liver disease.	[Fengler, Vera H. I.; Macheiner, Tanja; Sargsyan, Karine] Med Univ Graz, BioPersMed Biobank Graz, Graz, Austria; [Kessler, Sonja M.; Czepukojc, Beate; Kiemer, Alexandra K.] Univ Saarland, Dept Pharm, Pharmaceut Biol, D-66123 Saarbrucken, Germany; [Gemperlein, Katja; Mueller, Rolf] Univ Saarland, Dept Pharm, Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany; [Gemperlein, Katja; Mueller, Rolf] Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, Saarbrucken, Germany; [Magnes, Christoph] Joanneum Res, Inst Biomed & Hlth Sci, Graz, Austria; [Haybaeck, Johannes; Lackner, Carolin] Med Univ Graz, Inst Pathol, Graz, Austria	Medical University of Graz; Saarland University; Saarland University; Helmholtz Association; Medical University of Graz	Sargsyan, K (corresponding author), Med Univ Graz, BioPersMed Biobank Graz, Graz, Austria.	karine.sargsyan@medunigraz.at	Müller, Rolf/B-1559-2008; Sargsyan, Karine/CAG-8706-2022; Kiemer, Alexandra K./I-9300-2012; Kessler, Sonja M./AAC-9195-2021	Müller, Rolf/0000-0002-1042-5665; Kiemer, Alexandra K./0000-0002-7224-9900; Sargsyan, Karine/0000-0001-5853-4994; Magnes, Christoph/0000-0002-5153-7444; Kessler, Sonja M./0000-0002-8591-851X; Fengler, Vera/0000-0002-5124-1491	BioPersMed [COMET K-project] - Federal Ministry of Transport, Innovation and Technology (BMVIT) [825329]; Federal Ministry of Economics and Labor; Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Styrian Business Promotion Agency (SFG); Federal Ministry of Education and Research [O1KU1216F]	BioPersMed [COMET K-project] - Federal Ministry of Transport, Innovation and Technology (BMVIT); Federal Ministry of Economics and Labor; Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Styrian Business Promotion Agency (SFG); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by BioPersMed [COMET K-project 825329], which was funded by the Federal Ministry of Transport, Innovation and Technology (BMVIT), the Federal Ministry of Economics and Labor, the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ), and the Styrian Business Promotion Agency (SFG) (V.H.I.F. and K.S.) and by the Federal Ministry of Education and Research under the Project Number [O1KU1216F] (A.K.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2005, DIGEST DIS, V23, P255, DOI 10.1159/000090173; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Anstee QM, 2016, GASTROENTEROLOGY; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Clugston RD, 2011, J LIPID RES, V52, P2021, DOI 10.1194/jlr.M017368; Comhair TM, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-4; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Day CP, 2006, LIVER INT, V26, P1021, DOI 10.1111/j.1478-3231.2006.01323.x; Dongiovanni P, 2010, GUT, V59, P267, DOI 10.1136/gut.2009.190801; Dubuquoy C, 2011, J HEPATOL, V55, P145, DOI 10.1016/j.jhep.2010.10.024; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Farrell GC, 2014, LIVER INT, V34, P1084, DOI 10.1111/liv.12335; Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4; Gabele E, 2011, ALCOHOL CLIN EXP RES, V35, P1361, DOI 10.1111/j.1530-0277.2011.01472.x; Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Gyamfi MA, 2008, BIOCHEM PHARMACOL, V75, P981, DOI 10.1016/j.bcp.2007.09.030; Hanada S, 2008, HEPATOLOGY, V48, P943, DOI 10.1002/hep.22436; Haybaeck J, 2012, LAB INVEST, V92, P857, DOI 10.1038/labinvest.2012.49; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; HILL DB, 1992, J LAB CLIN MED, V119, P547; Holmen OL, 2014, NAT GENET, V46, P345, DOI 10.1038/ng.2926; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x; Jellema A, 2003, DIABETOLOGIA, V46, P990, DOI 10.1007/s00125-003-1126-4; Kahle M, 2013, MOL METAB, V2, P435, DOI 10.1016/j.molmet.2013.07.009; Kamada Y, 2011, AM J PHYSIOL-GASTR L, V301, pG1031, DOI 10.1152/ajpgi.00211.2011; Kasumov T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126910; Kessler SM, 2014, INT J MOL SCI, V15, P5762, DOI 10.3390/ijms15045762; Kirsch R, 2003, J GASTROEN HEPATOL, V18, P1272, DOI 10.1046/j.1440-1746.2003.03198.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Kugelmas M, 2003, HEPATOLOGY, V38, P413, DOI 10.1053/jhep.2003.50316; Laggai S, 2014, J LIPID RES, V55, P1087, DOI 10.1194/jlr.M045500; Laggai S, 2013, WORLD J HEPATOL, V5, P558, DOI 10.4254/wjh.v5.i10.558; Larter CZ, 2010, J GASTROEN HEPATOL, V25, P672, DOI 10.1111/j.1440-1746.2010.06253.x; Lieber CS, 2004, AM J CLIN NUTR, V79, P502; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Luo Y, 2015, AM J PHYSL ENDOCRINO; Maher JJ, 2011, ANTIOXID REDOX SIGN, V15, P535, DOI 10.1089/ars.2010.3749; Maina V, 2012, CLIN SCI, V122, P545, DOI 10.1042/CS20110366; Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209; McClain CJ, 2007, HEPATOLOGY, V45, P1343, DOI 10.1002/hep.21788; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Neuschwander-Tetri BA, 2005, AM J MED SCI, V330, P326, DOI 10.1097/00000441-200512000-00011; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Saito K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12466; Schultz A, 2015, FOOD FUNCT, V6, P1684, DOI [10.1039/C5FO00251F, 10.1039/c5fo00251f]; Shearn CT, 2013, J NUTR BIOCH; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Siddiqui RA, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0038-x; Simon Y, 2014, WORLD J GASTROENTERO, V20, P17839, DOI 10.3748/wjg.v20.i47.17839; Simon Y, 2014, GUT, V63, P861, DOI 10.1136/gutjnl-2013-305736; Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Syn WK, 2009, LIVER INT, V29, P1262, DOI 10.1111/j.1478-3231.2009.02036.x; van Rooyen DM, 2011, GASTROENTEROLOGY, V141, P1393, DOI 10.1053/j.gastro.2011.06.040; Vazquez-Chantada M, 2013, HEPATOLOGY, V57, P505, DOI 10.1002/hep.26052; Videla LA, 2004, FREE RADICAL BIO MED, V37, P1499, DOI 10.1016/j.freeradbiomed.2004.06.033; Volynets V, 2010, J LIPID RES, V51, P3414, DOI 10.1194/jlr.M007179; Wang X, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-234; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wilson CG, 2015, ENDOCRINOLOGY; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Yeh MM, 2007, AM J CLIN PATHOL, V128, P837, DOI 10.1309/RTPM1PY6YGBL2G2R; Zintzaras E, 2006, HEPATOLOGY, V43, P352, DOI 10.1002/hep.21023	83	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155163	10.1371/journal.pone.0155163	http://dx.doi.org/10.1371/journal.pone.0155163			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167736	Green Published, gold			2022-12-27	WOS:000376587300092
J	Gao, CC; Shen, Y; Jin, F; Miao, YJ; Qiu, XF				Gao, Cuicui; Shen, Yao; Jin, Fang; Miao, Yajing; Qiu, Xiaofei			Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells	PLOS ONE			English	Article							UROKINASE RECEPTOR; SELF-RENEWAL; METABOLISM; INHIBITION; PROGRESSION; RESPIRATION; GLYCOLYSIS; HYPOXIA; ATP	Recently, targeting cancer stem cells (CSCs) metabolism is becoming a promising therapeutic approach to improve cancer treatment outcomes. However, knowledge of the metabolic state of CSCs in small cell lung cancer is still lacking. In this study, we found that CSCs had significantly lower oxygen consumption rate and extracellular acidification rate than non-stem cancer cells. Meanwhile, this subpopulation of cells consumed less glucose, produced less lactate and maintained lower ATP levels. We also revealed that CSCs could produce more ATP through mitochondrial substrate-level phosphorylation during respiratory inhibition compared with non-stem cancer cells. Furthermore, they were more sensitive to suppression of oxidative phosphorylation. Therefore, oligomycin (inhibitor of oxidative phosphorylation) could severely impair sphere-forming and tumor-initiating abilities of CSCs. Our work suggests that CSCs represent metabolically inactive tumor subpopulations which sustain in a state showing low metabolic activity. However, mitochondrial substrate-level phosphorylation of CSCs may be more active than that of non-stem cancer cells. Moreover, CSCs showed preferential use of oxidative phosphorylation over glycolysis to meet their energy demand. These results extend our understanding of CSCs metabolism, potentially providing novel treatment strategies targeting metabolic pathways in small cell lung cancer.	[Gao, Cuicui; Shen, Yao; Jin, Fang; Qiu, Xiaofei] Tianjin Med Univ, Dept Pathol, Tianjin, Peoples R China; [Gao, Cuicui] Tianjin Med Univ, Gen Hosp, Dept Blood Transfus, Tianjin, Peoples R China; [Miao, Yajing] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Qiu, XF (corresponding author), Tianjin Med Univ, Dept Pathol, Tianjin, Peoples R China.	qiouxf@tijmu.edu.cn			Research Program of the Applied Basic and Cutting-edge Technologies of Tianjin [14JCZDJC35500]	Research Program of the Applied Basic and Cutting-edge Technologies of Tianjin	This study was supported by the Research Program of the Applied Basic and Cutting-edge Technologies of Tianjin under Contract No. 14JCZDJC35500.	Alamgeer M, 2013, RESPIROLOGY, V18, P757, DOI 10.1111/resp.12094; Amarasena IU, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006849.pub2; Amo T, 2008, GENE, V411, P69, DOI 10.1016/j.gene.2008.01.007; Mandujano-Tinoco EA, 2013, BBA-MOL CELL RES, V1833, P541, DOI 10.1016/j.bbamcr.2012.11.013; Chuang JH, 2013, INT J BIOCHEM CELL B, V45, P944, DOI 10.1016/j.biocel.2013.01.019; Ciavardelli D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.285; Fang R, 2012, J BIOL CHEM, V287, P23227, DOI 10.1074/jbc.M112.373084; Feng WG, 2014, STEM CELLS, V32, P1734, DOI 10.1002/stem.1662; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; GANESH S, 1994, LANCET, V344, P401, DOI 10.1016/S0140-6736(94)91427-3; GORLACH A, 1994, BBA-MOL BASIS DIS, V1227, P105, DOI 10.1016/0925-4439(94)90085-X; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Hao WS, 2010, J BIOL CHEM, V285, P12647, DOI 10.1074/jbc.M109.084194; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Isayev O, 2014, ONCOTARGET, V5, P5177, DOI 10.18632/oncotarget.2120; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Janne PA, 2002, CANCER-AM CANCER SOC, V95, P1528, DOI 10.1002/cncr.10841; Karachaliou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074611; Kim MJ, 1998, BLOOD, V91, P4106, DOI 10.1182/blood.V91.11.4106.411k40_4106_4117; Kiss G, 2014, FASEB J, V28, P1682, DOI 10.1096/fj.13-243030; Kiss G, 2013, FASEB J, V27, P2392, DOI 10.1096/fj.12-220202; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; KRAMAR R, 1984, AGENTS ACTIONS, V15, P660, DOI 10.1007/BF01966788; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Mason MG, 2006, P NATL ACAD SCI USA, V103, P708, DOI 10.1073/pnas.0506562103; Miao YJ, 2013, ONCOL REP, V29, P161, DOI 10.3892/or.2012.2095; Nakajima EC, 2013, MOL CARCINOGEN, V52, P329, DOI 10.1002/mc.21863; Noh H, 2013, THERANOSTICS, V3, P487, DOI 10.7150/thno.4218; O'Halloran TV, 2013, THERANOSTICS, V3, P496, DOI 10.7150/thno.4953; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Pasto A, 2014, ONCOTARGET, V5, P4305, DOI 10.18632/oncotarget.2010; Phillips D, 2009, BIOCHEMISTRY-US, V48, P7140, DOI 10.1021/bi900725c; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Qiu XF, 2012, CANCER LETT, V323, P161, DOI 10.1016/j.canlet.2012.04.004; Saga I, 2014, NEURO-ONCOLOGY, V16, P1048, DOI 10.1093/neuonc/nou096; Schwimmer C, 2005, J BIOL CHEM, V280, P30751, DOI 10.1074/jbc.M501831200; Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134; Shen YA, 2015, CELL CYCLE, V14, P86, DOI 10.4161/15384101.2014.974419; Shibuya K, 2015, ONCOTARGET, V6, P651, DOI 10.18632/oncotarget.2892; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sutherland RM, 1998, ACTA ONCOL, V37, P567, DOI 10.1080/028418698430278; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; VAUPEL P, 1989, CANCER RES, V49, P6449; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Ye J, 2014, TUMOR BIOL, V35, P3945, DOI 10.1007/s13277-013-1561-x; Yuan SQ, 2013, STEM CELLS, V31, P23, DOI 10.1002/stem.1273; Zhou YF, 2011, J BIOL CHEM, V286, P32843, DOI 10.1074/jbc.M111.260935	49	38	40	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154576	10.1371/journal.pone.0154576	http://dx.doi.org/10.1371/journal.pone.0154576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167619	Green Submitted, Green Published, gold			2022-12-27	WOS:000376587300010
J	Kinahan, DJ; Kearney, SM; Kilcawley, NA; Early, PL; Glynn, MT; Ducree, J				Kinahan, David J.; Kearney, Sinead M.; Kilcawley, Niamh A.; Early, Philip L.; Glynn, Macdara T.; Ducree, Jens			Density-Gradient Mediated Band Extraction of Leukocytes from Whole Blood Using Centrifugo-Pneumatic Siphon Valving on Centrifugal Microfluidic Discs	PLOS ONE			English	Article							ON-A-DISK; ROTATING-DISK; FLOW-CONTROL; PLATFORM; LAB; SEDIMENTATION; IMMUNOASSAY; DIAGNOSTICS; INTEGRATION; SEPARATION	Here we present retrieval of Peripheral Blood Mononuclear Cells by density-gradient medium based centrifugation for subsequent analysis of the leukocytes on an integrated microfluidic "Lab-on-a-Disc" cartridge. Isolation of white blood cells constitutes a critical sample preparation step for many bioassays. Centrifugo-pneumatic siphon valves are particularly suited for blood processing as they function without need of surface treatment and are 'low-pass', i.e., holding at high centrifugation speeds and opening upon reduction of the spin rate. Both 'hydrostatically' and 'hydrodynamically' triggered centrifugo-pneumatic siphon valving schemes are presented. Firstly, the geometry of the pneumatic chamber of hydrostatically primed centrifugo-pneumatic siphon valves is optimised to enable smooth and uniform layering of blood on top of the density-gradient medium; this feature proves to be key for efficient Peripheral Blood Mononuclear Cell extraction. A theoretical analysis of hydrostatically primed valves is also presented which determines the optimum priming pressure for the individual valves. Next, 'dual siphon' configurations for both hydrostatically and hydrodynamically primed centrifugo-pneumatic siphon valves are introduced; here plasma and Peripheral Blood Mononuclear Cells are extracted through a distinct siphon valve. This work represents a first step towards enabling on disc multi-parameter analysis. Finally, the efficiency of Peripheral Blood Mononuclear Cells extraction in these structures is characterised using a simplified design. A microfluidic mechanism, which we termed phase switching, is identified which affects the efficiency of Peripheral Blood Mononuclear Cell extraction.	[Kinahan, David J.; Kearney, Sinead M.; Kilcawley, Niamh A.; Early, Philip L.; Glynn, Macdara T.; Ducree, Jens] Dublin City Univ, Sch Phys Sci, Dublin 9, Ireland; [Kinahan, David J.; Kearney, Sinead M.; Kilcawley, Niamh A.; Early, Philip L.; Glynn, Macdara T.; Ducree, Jens] Dublin City Univ, Biomed Diagnost Inst, Dublin 9, Ireland	Dublin City University; Dublin City University	Kinahan, DJ; Ducree, J (corresponding author), Dublin City Univ, Sch Phys Sci, Dublin 9, Ireland.; Kinahan, DJ; Ducree, J (corresponding author), Dublin City Univ, Biomed Diagnost Inst, Dublin 9, Ireland.	david.kinahan@dcu.ie; jens.ducree@dcu.ie	Ducrée, Jens/M-4264-2014; Ducrée, Jens/AAL-4994-2021; Glynn, Macdara/J-9809-2019	Ducrée, Jens/0000-0002-0366-1897; Glynn, Macdara/0000-0002-6347-4348; Kinahan, David/0000-0003-1968-2016	Science Foundation Ireland [10/CE/B1821]; Enterprise Ireland [CF/2011/1317]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Enterprise Ireland	This work was funded by Science Foundation Ireland (www.sfi.ie) under Grant No 10/CE/B1821 and Enterprise Ireland (www.enterpriseireland.com) under Grant No CF/2011/1317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Science Foundation Ireland under Grant No 10/CE/B1821 and Enterprise Ireland under Grant No CF/2011/1317.	Abi-Samra K, 2011, LAB CHIP, V11, P723, DOI 10.1039/c0lc00160k; Aeinehvand MM, 2014, LAB CHIP, V14, P988, DOI 10.1039/c3lc51116b; Aguirre GR, MICROFLUIDICS AND NA, P1; Al-Faqheri W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058523; Boyum A., 1967, SCAND J CLIN LAB INV, V97, P77; Burger R, 2012, CURR OPIN CHEM BIOL, V16, P409, DOI 10.1016/j.cbpa.2012.06.002; Burger R, 2012, LAB CHIP, V12, P1289, DOI 10.1039/c2lc21170j; Chen JM, 2008, MICROFLUID NANOFLUID, V4, P427, DOI 10.1007/s10404-007-0196-x; Ducree J, 2007, J MICROMECH MICROENG, V17, pS103, DOI 10.1088/0960-1317/17/7/S07; Fuss I.J., 2009, ISOLATION WHOLE MONO; Garcia-Cordero JL, 2010, LAB CHIP, V10, P2680, DOI 10.1039/c004980h; Glynn M, 2014, JALA-J LAB AUTOM, V19, P285, DOI 10.1177/2211068213504759; Glynn MT, 2014, LAB CHIP, V14, P2844, DOI 10.1039/c4lc00264d; Godino N, 2013, LAB CHIP, V13, P685, DOI 10.1039/c2lc40722a; Gorkin R, 2010, LAB CHIP, V10, P1758, DOI 10.1039/b924109d; Gorkin R, 2012, LAB CHIP, V12, P2894, DOI 10.1039/c2lc20973j; Gorkin R, 2010, MICROFLUID NANOFLUID, V9, P541, DOI 10.1007/s10404-010-0571-x; Grumann M, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1834703; Gunther A, 2006, LAB CHIP, V6, P1487, DOI 10.1039/b609851g; Haeberle S, 2006, LAB CHIP, V6, P776, DOI 10.1039/b604145k; KANOF ME, 1991, CURRENT PROTOCOLS IM, P1; Kim TH, 2013, SENSOR ACTUAT B-CHEM, V178, P648, DOI 10.1016/j.snb.2013.01.011; Kinahan DJ, 2015, RSC ADV, V5, P1818, DOI 10.1039/c4ra14887h; Kinahan DJ, 2014, SENSOR ACTUAT A-PHYS, V215, P71, DOI 10.1016/j.sna.2013.11.010; Kinahan DJ, 2014, LAB CHIP, V14, P2249, DOI 10.1039/c4lc00380b; Kitsara M, 2014, MICROFLUID NANOFLUID, V16, P691, DOI 10.1007/s10404-013-1266-x; Lee BS, 2011, LAB CHIP, V11, P70, DOI [10.1039/c0lc00205d, 10.1039/c01c00205d]; Madou M, 2006, ANNU REV BIOMED ENG, V8, P601, DOI 10.1146/annurev.bioeng.8.061505.095758; Moore JL, 2011, MICROFLUID NANOFLUID, V10, P877, DOI 10.1007/s10404-010-0721-1; NOBLE P. B., 1967, CAN VET J, V8, P110; Nwankire CE, 2014, BIOSENSORS BIOELECTR; Nwankire CE, 2014, BIOSENS BIOELECTRON, V56, P352, DOI 10.1016/j.bios.2014.01.031; Nwankire CE, 2013, ANAL CHIM ACTA, V781, P54, DOI 10.1016/j.aca.2013.04.016; Riegger L, 2007, BIOMED MICRODEVICES, V9, P795, DOI 10.1007/s10544-007-9091-1; Schaff U.Y., 2010, 14 INT C MIN SYST CH; Schaff UY, 2011, CLIN CHEM, V57, P753, DOI 10.1373/clinchem.2011.162206; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwemmer F, 2015, LAB CHIP, V15, P1545, DOI 10.1039/c4lc01269k; Siegrist J, 2010, MICROFLUID NANOFLUID, V9, P55, DOI 10.1007/s10404-009-0523-5; Steigert J, 2007, BIOMED MICRODEVICES, V9, P675, DOI 10.1007/s10544-007-9076-0; Steigert J, 2006, SENSOR ACTUAT A-PHYS, V130, P228, DOI 10.1016/j.sna.2006.01.031; Strohmeier O., 2015, CHEM SOC REV; TAMUL KR, 1995, CLIN DIAGN LAB IMMUN, V2, P337, DOI 10.1128/CDLI.2.3.337-342.1995; Thio THG, 2013, MED BIOL ENG COMPUT, V51, P525, DOI 10.1007/s11517-012-1020-7; Zehnle S, 2012, LAB CHIP, V12, P5142, DOI 10.1039/c2lc40942a; Zhang JL, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/12/125025	46	39	41	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155545	10.1371/journal.pone.0155545	http://dx.doi.org/10.1371/journal.pone.0155545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167376	Green Published, Green Submitted, gold			2022-12-27	WOS:000376587300027
J	Morimoto, J; Pizzari, T; Wigby, S				Morimoto, Juliano; Pizzari, Tommaso; Wigby, Stuart			Developmental Environment Effects on Sexual Selection in Male and Female Drosophila melanogaster	PLOS ONE			English	Article							MALE MATE CHOICE; BODY-SIZE; LARVAL DENSITY; FERTILIZATION SUCCESS; SPERM COMPETITION; ADULT SIZE; FRUIT-FLY; FECUNDITY; OPPORTUNITY; FITNESS	The developmental environment can potentially alter the adult social environment and influence traits targeted by sexual selection such as body size. In this study, we manipulated larval density in male and female Drosophila melanogaster, which results in distinct adult size phenotypes-high (low) densities for small (large) adults-and measured sexual selection in experimental groups consisting of adult males and females from high, low, or a mixture of low and high larval densities. Overall, large adult females (those reared at low larval density) had more matings, more mates and produced more offspring than small females (those reared at high larval density). The number of offspring produced by females was positively associated with their number of mates (i.e. there was a positive female Bateman gradient) in social groups where female size was experimentally varied, likely due to the covariance between female productivity and mating rate. For males, we found evidence that the larval environment affected the relative importance of sexual selection via mate number (Bateman gradients), mate productivity, paternity share, and their covariances. Mate number and mate productivity were significantly reduced for small males in social environments where males were of mixed sizes, versus social environments where all males were small, suggesting that social heterogeneity altered selection on this subset of males. Males are commonly assumed to benefit from mating with large females, but in contrast to expectations we found that in groups where both the male and female size varied, males did not gain more offspring per mating with large females. Collectively, our results indicate sex-specific effects of the developmental environment on the operation of sexual selection, via both the phenotype of individuals, and the phenotype of their competitors and mates.	[Morimoto, Juliano; Pizzari, Tommaso; Wigby, Stuart] Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England	University of Oxford	Morimoto, J (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	juliano.morimotoborges@zoo.ox.ac.uk	Morimoto, Juliano/AAE-5517-2020; Wigby, Stuart/A-3916-2017	Morimoto, Juliano/0000-0003-3561-1920; Wigby, Stuart/0000-0002-2260-2948	Brazilian National Council for Scientific and Technological Development (CNPq); Natural Environment Research Council (NERC) [NE/J018937/1]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K014544/1]; Biotechnology and Biological Sciences Research Council [BB/K014544/1] Funding Source: researchfish; Natural Environment Research Council [NE/J018937/1, NE/H008047/1] Funding Source: researchfish; BBSRC [BB/K014544/1] Funding Source: UKRI; NERC [NE/J018937/1, NE/H008047/1] Funding Source: UKRI	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	JM was supported by a DPhil scholarship from the Brazilian National Council for Scientific and Technological Development (CNPq), TP by research grants from Natural Environment Research Council (NERC) and Biotechnology and Biological Sciences Research Council (BBSRC), SW by Natural Environment Research Council (NERC) (NE/J018937/1) and the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/K014544/1) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo SH, 2010, AM NAT, V175, P174, DOI 10.1086/649596; Amitin EG, 2007, J EVOLUTION BIOL, V20, P381, DOI 10.1111/j.1420-9101.2006.01184.x; [Anonymous], PARTITIONING PREDICT; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1994, SEXUAL SELECTION; ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; Baldal EA, 2005, MECH AGEING DEV, V126, P407, DOI 10.1016/j.mad.2004.09.035; Bangham J, 2002, ANIM BEHAV, V64, P915, DOI 10.1006/anbe.2002.1976; Bjork A, 2006, NATURE, V441, P742, DOI 10.1038/nature04683; BOHRNSTE.GW, 1969, J AM STAT ASSOC, V64, P1439, DOI 10.2307/2286081; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Brown GR, 2009, TRENDS ECOL EVOL, V24, P297, DOI 10.1016/j.tree.2009.02.005; Byrne PG, 2006, P ROY SOC B-BIOL SCI, V273, P917, DOI 10.1098/rspb.2005.3372; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Clancy David J., 2001, Drosophila Information Service, V84, P168; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; Collet J, 2012, P NATL ACAD SCI USA, V109, P8641, DOI 10.1073/pnas.1200219109; Collet JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2973; Cornwallis CK, 2010, TRENDS ECOL EVOL, V25, P145, DOI 10.1016/j.tree.2009.09.008; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; CREDLAND PF, 1986, ECOL ENTOMOL, V11, P41, DOI 10.1111/j.1365-2311.1986.tb00278.x; Cunningham EJA, 1998, ANIM BEHAV, V56, P1311, DOI 10.1006/anbe.1998.0953; Devigili A, 2015, NATURE COMMUNICATION, P6; EBERHARD WG, 1991, BIOL REV, V66, P1, DOI 10.1111/j.1469-185X.1991.tb01133.x; Edward DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056299; Edward DA, 2012, EVOLUTION, V66, P2646, DOI 10.1111/j.1558-5646.2012.01648.x; Edward DA, 2011, EVOLUTION, V65, P564, DOI 10.1111/j.1558-5646.2010.01151.x; Fricke C, 2010, EVOLUTION, V64, P2746, DOI 10.1111/j.1558-5646.2010.01022.x; Fritzsche K, 2013, EVOLUTION, V67, P1926, DOI 10.1111/evo.12086; Fu WM, 1998, DEVELOPMENT, V125, P2943; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Garcia-Navas V, 2014, BEHAV ECOL, V25, P228, DOI 10.1093/beheco/art111; Gerlach NM, 2012, BEHAV ECOL, V23, P1078, DOI 10.1093/beheco/ars077; Gillespie SR, 2014, EVOLUTION, V68, P3421, DOI 10.1111/evo.12526; HIHARA F, 1981, Zoological Magazine (Tokyo), V90, P307; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hosken DJ, 2008, CURR BIOL, V18, pR553, DOI 10.1016/j.cub.2008.04.028; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Janicke T, 2015, AM NAT, V185, P756, DOI 10.1086/681128; Jones A, 2003, INTEGR COMP BIOL, V43, P834; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; Jordan LA, 2014, AM NAT, V183, P638, DOI 10.1086/675755; Knight J, 2002, NATURE, V415, P254, DOI 10.1038/415254a; Lebigre C, 2012, EVOLUTION, V66, P3111, DOI 10.1111/j.1558-5646.2012.01677.x; Lefranc A, 2000, HEREDITAS, V132, P243, DOI 10.1111/j.1601-5223.2000.00243.x; Lemaitre JF, 2011, P ROY SOC B-BIOL SCI, V278, P1171, DOI 10.1098/rspb.2010.1828; Linklater JR, 2007, EVOLUTION, V61, P2027, DOI 10.1111/j.1558-5646.2007.00157.x; Long TAF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000254; Lupold S., 2010, BEHAV ECOL; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; Manier MK, 2010, SCIENCE, V328, P354, DOI 10.1126/science.1187096; McGraw LA, 2007, BIOL LETTERS, V3, P607, DOI 10.1098/rsbl.2007.0334; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Parker GA, 2015, CURRENT PERSPECTIVES, P119; Parker GA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0335; Parker PG, 2005, INTEGR COMP BIOL, V45, P895, DOI 10.1093/icb/45.5.895; Pelissie B, 2014, EVOLUTION, V68, P1320, DOI 10.1111/evo.12353; Pischedda A, 2012, P NATL ACAD SCI USA, V109, P2049, DOI 10.1073/pnas.1110841109; PITNICK S, 1991, ANIM BEHAV, V41, P735, DOI 10.1016/S0003-3472(05)80340-9; Pitnick S, 2002, P ROY SOC B-BIOL SCI, V269, P1821, DOI 10.1098/rspb.2002.2090; Prosser MR, 2002, BEHAV ECOL, V13, P800, DOI 10.1093/beheco/13.6.800; Ray-Mukherjee J, 2014, METHODS ECOL EVOL, V5, P320, DOI 10.1111/2041-210X.12166; Roff Derek, 2002, pi; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Seibold D.R., 1979, HUMAN COMMUNICATION, V5, P355, DOI [DOI 10.1111/J.1468-2958.1979.TB00649.X, 10.1111/j.1468-2958.1979.tb00649.x]; Sirot LK, 2009, BEHAV ECOL SOCIOBIOL, V63, P1505, DOI 10.1007/s00265-009-0806-6; Snyder BF, 2007, EVOLUTION, V61, P2457, DOI 10.1111/j.1558-5646.2007.00212.x; Stearns S., 1992, EVOLUTION LIFE HIST; STUBBS M, 1977, J ANIM ECOL, V46, P677, DOI 10.2307/3837; Tan CKW, 2012, ANIM BEHAV, V83, P1433, DOI 10.1016/j.anbehav.2012.03.015; TREVITT S, 1988, J INSECT PHYSIOL, V34, P821, DOI 10.1016/0022-1910(88)90157-6; Trivers RL, 1972, PARENTAL INVESTMENT, P153; Webster MS, 1995, EVOLUTION, V49, P1147, DOI [10.2307/2410439, 10.1111/j.1558-5646.1995.tb04441.x]; Wedell N, 2003, P ROY SOC B-BIOL SCI, V270, P2065, DOI 10.1098/rspb.2003.2479; Wigby S, 2016, FUNCT ECOL, V30, P410, DOI 10.1111/1365-2435.12515; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036; Worden BD, 2001, BEHAV ECOL, V12, P761, DOI 10.1093/beheco/12.6.761; Zar JH, 1999, BIOSTATISTICAL ANAL; Zikovitz AE, 2013, EVOLUTION, V67, P2849, DOI 10.1111/evo.12170; [No title captured]; [No title captured]	82	43	43	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154468	10.1371/journal.pone.0154468	http://dx.doi.org/10.1371/journal.pone.0154468			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167120	Green Published, gold			2022-12-27	WOS:000376587300028
J	Pinker, K; Andrzejewski, P; Baltzer, P; Polanec, SH; Sturdza, A; Georg, D; Helbich, TH; Karanikas, G; Grimm, C; Polterauer, S; Poetter, R; Wadsak, W; Mitterhauser, M; Georg, P				Pinker, Katja; Andrzejewski, Piotr; Baltzer, Pascal; Polanec, Stephan H.; Sturdza, Alina; Georg, Dietmar; Helbich, Thomas H.; Karanikas, Georgios; Grimm, Christoph; Polterauer, Stephan; Poetter, Richard; Wadsak, Wolfgang; Mitterhauser, Markus; Georg, Petra			Multiparametric [F-18]Fluorodeoxyglucose/[F-18]Fluoromisonidazole Positron Emission Tomography/Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study	PLOS ONE			English	Article							RADIATION-THERAPY; UTERINE CERVIX; GYNECOLOGIC MALIGNANCIES; PREDICTIVE ASSAY; FDG-PET; HYPOXIA; MRI; CARCINOMA; PIMONIDAZOLE; RADIOTHERAPY	Objectives To investigate fused multiparametric positron emission tomography/magnetic resonance imaging (MP PET/MRI) at 3T in patients with locally advanced cervical cancer, using high-resolution T2-weighted, contrast-enhanced MRI (CE-MRI), diffusion-weighted imaging (DWI), and the radiotracers [F-18]fluorodeoxyglucose ([F-18]FDG) and [F-18]fluoromisonidazol ([F-18]FMISO) for the non-invasive detection of tumor heterogeneity for an improved planning of chemo-radiation therapy (CRT). Materials and Methods Sixteen patients with locally advanced cervix were enrolled in this IRB approved and were examined with fused MP [F-18]FDG/[F-18]FMISO PET/MRI and in eleven patients complete data sets were acquired. MP PET/MRI was assessed for tumor volume, enhancement (EH)-kinetics, diffusivity, and [F-18]FDG/[F-18]FMISO-avidity. Descriptive statistics and voxel-by-voxel analysis of MRI and PET parameters were performed. Correlations were assessed using multiple correlation analysis. Results All tumors displayed imaging parameters concordant with cervix cancer, i.e. type II/III EH-kinetics, restricted diffusivity (median ADC 0.80x10(-3)mm(2)/sec), [F-18]FDG-(median SUV(max)16.2) and [F-18]FMISO-avidity (median SUV(max)3.1). In all patients, [F-18]FMISO PET identified the hypoxic tumor subvolume, which was independent of tumor volume. A voxel-by-voxel analysis revealed only weak correlations between the MRI and PET parameters (0.05-0.22), indicating that each individual parameter yields independent information and the presence of tumor heterogeneity. Conclusion MP [F-18]FDG/[F-18]FMISO PET/MRI in patients with cervical cancer facilitates the acquisition of independent predictive and prognostic imaging parameters. MP [F-18]FDG/[18F] FMISO PET/MRI enables insights into tumor biology on multiple levels and provides information on tumor heterogeneity, which has the potential to improve the planning of CRT.	[Pinker, Katja; Baltzer, Pascal; Polanec, Stephan H.; Helbich, Thomas H.] Med Univ Vienna, Div Mol & Gender Imaging, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Pinker, Katja; Andrzejewski, Piotr; Baltzer, Pascal; Polanec, Stephan H.; Georg, Dietmar; Georg, Petra] Med Univ Vienna, Christian Doppler Lab Med Radiat Res Radiat Oncol, Vienna, Austria; [Andrzejewski, Piotr; Sturdza, Alina; Georg, Dietmar; Poetter, Richard] Med Univ Vienna, Dept Radiat Oncol, Vienna, Austria; [Karanikas, Georgios; Wadsak, Wolfgang; Mitterhauser, Markus] Med Univ Vienna, Div Nucl Med, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Grimm, Christoph; Polterauer, Stephan] Med Univ Vienna, Dept Gynecol & Obstet, Vienna, Austria; [Grimm, Christoph; Polterauer, Stephan] Med Univ Vienna, Comprehens Canc Ctr Vienna, Gynecol Canc Unit, Vienna, Austria; [Pinker, Katja] Florida State Univ, Dept Sci Comp Med, Tallahassee, FL 32306 USA; [Georg, Petra] EBG MedAustron GmbH, Wiener Neustadt, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; State University System of Florida; Florida State University; EBG MedAustron	Pinker, K (corresponding author), Med Univ Vienna, Div Mol & Gender Imaging, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.; Pinker, K (corresponding author), Med Univ Vienna, Christian Doppler Lab Med Radiat Res Radiat Oncol, Vienna, Austria.; Pinker, K (corresponding author), Florida State Univ, Dept Sci Comp Med, Tallahassee, FL 32306 USA.	katja.pinker@meduniwien.ac.at	Wadsak, Wolfgang/K-7408-2019; Sturdza, Alina/AAP-1170-2020; Grimm, Christoph/GSJ-3020-2022; Polterauer, Stephan/AAG-1331-2021	Grimm, Christoph/0000-0003-2948-8129; Polterauer, Stephan/0000-0002-9649-4505; Baltzer, Pascal/0000-0002-3755-5398; Wadsak, Wolfgang/0000-0003-4479-8053; Mitterhauser, Markus/0000-0003-3173-5272; Polanec, Stephan/0000-0001-5504-4893; PINKER-DOMENIG, MD, EBBI, Katja/0000-0002-2722-7331; Georg, Dietmar/0000-0002-8327-3877; Potter, Richard/0000-0002-0703-572X	Medical Imaging Cluster of the Medical University of Vienna; Austrian Federal Ministry of Science, Research and Economy; Austrian National Foundation for Research, Technology and Development	Medical Imaging Cluster of the Medical University of Vienna; Austrian Federal Ministry of Science, Research and Economy; Austrian National Foundation for Research, Technology and Development	This scientific project was performed with the support of the Medical Imaging Cluster of the Medical University of Vienna. The financial support by the Austrian Federal Ministry of Science, Research and Economy and the Austrian National Foundation for Research, Technology and Development is gratefully acknowledged.; The financial support by the Austrian Federal Ministry of Science, Research and Economy and the Austrian National Foundation for Research, Technology and Development is gratefully acknowledged.	Al-Mansour Z, 2010, CURR OPIN ONCOL, V22, P503, DOI 10.1097/CCO.0b013e32833af426; Charles-Edwards EM, 2008, RADIOLOGY, V249, P541, DOI 10.1148/radiol.2491072165; Charles-Edwards Elizabeth M, 2006, Cancer Imaging, V6, P135, DOI 10.1102/1470-7330.2006.0021; Chen X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-693; Choi J, 2014, NUCL MED MOLEC IMAG, V48, P130, DOI 10.1007/s13139-013-0248-y; Dyk P, 2014, INT J RADIAT ONCOL, V90, P794, DOI 10.1016/j.ijrobp.2014.07.039; Ellingsen C, 2014, RADIOTHER ONCOL, V110, P335, DOI 10.1016/j.radonc.2013.10.018; Fleming S, 2014, CLIN RADIOL, V69, P1235, DOI 10.1016/j.crad.2014.07.006; Hammond EM, 2014, CLIN ONCOL-UK, V26, P277, DOI 10.1016/j.clon.2014.02.002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herrera FG, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00034; Hockel M, 1996, SEMIN RADIAT ONCOL, V6, P3, DOI 10.1016/S1053-4296(96)80031-2; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; HOCKEL M, 1993, RADIOTHER ONCOL, V26, P45, DOI 10.1016/0167-8140(93)90025-4; Hockel S, 2001, INT J ONCOL, V19, P827; Huang ZB, 2010, CANCER RES, V70, P463, DOI 10.1158/0008-5472.CAN-09-2501; Knausl B, 2012, Z MED PHYS, V22, P29, DOI 10.1016/j.zemedi.2010.12.003; Knocke TH, 1999, RADIOTHER ONCOL, V53, P99, DOI 10.1016/S0167-8140(99)00139-5; Lai CH, 2014, GYNECOL ONCOL, V135, P156, DOI 10.1016/j.ygyno.2014.07.092; Lazzari R, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.409; LeBihan D, 1990, Diagn Imaging (San Franc), V12, P136; Lee EYP, 2014, EUR RADIOL, V24, P1506, DOI 10.1007/s00330-014-3160-7; Lim K, 2008, INT J RADIAT ONCOL, V70, P126, DOI 10.1016/j.ijrobp.2007.06.033; Lin SY, 2015, INT J RADIAT ONCOL, V92, P577, DOI 10.1016/j.ijrobp.2015.02.027; Markovina S, 2015, INT J RADIAT ONCOL, V93, P597, DOI 10.1016/j.ijrobp.2015.04.026; Mayr NA, 2002, INT J RADIAT ONCOL, V52, P14, DOI 10.1016/S0360-3016(01)01808-9; Mayr NA, 2000, J MAGN RESON IMAGING, V12, P1027, DOI 10.1002/1522-2586(200012)12:6<1027::AID-JMRI31>3.0.CO;2-5; Mayr NA, 2010, INT J RADIAT ONCOL, V77, P502, DOI 10.1016/j.ijrobp.2009.04.084; Mayr NA, 2010, CANCER-AM CANCER SOC, V116, P903, DOI 10.1002/cncr.24822; Micco M, 2014, EUR J RADIOL, V83, P1169, DOI 10.1016/j.ejrad.2014.03.024; Naganawa S, 2005, EUR RADIOL, V15, P71, DOI 10.1007/s00330-004-2529-4; Nordsmark M, 2001, INT J RADIAT ONCOL, V49, P581, DOI 10.1016/S0360-3016(00)01493-0; Nordsmark M, 2003, RADIOTHER ONCOL, V67, P35, DOI 10.1016/S0167-8140(03)00010-0; Nordsmark M, 2006, RADIOTHER ONCOL, V80, P123, DOI 10.1016/j.radonc.2006.07.010; Nougaret S, 2013, AM J ROENTGENOL, V200, P261, DOI 10.2214/AJR.12.9713; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; Padhani AR, 2007, EUR RADIOL, V17, P861, DOI 10.1007/s00330-006-0431-y; Park JJ, 2015, RADIOLOGY, V274, P734, DOI 10.1148/radiol.14140920; Patel S, 2010, INSIGHTS IMAGING, V1, P309, DOI 10.1007/s13244-010-0042-7; Potter R, 2016, INT J RADIAT ONCOL, V94, P588, DOI 10.1016/j.ijrobp.2015.09.023; Rapisarda E, 2010, PHYS MED BIOL, V55, P4131, DOI 10.1088/0031-9155/55/14/012; Sala E, 2013, RADIOLOGY, V266, P717, DOI 10.1148/radiol.12120315; Salaa E, 2010, EUR J RADIOL, V76, P367, DOI 10.1016/j.ejrad.2010.01.026; Schuetz M, 2010, ACTA ONCOL, V49, P941, DOI 10.3109/0284186X.2010.510145; Solutions SM, 2007, BIOGR TRUE POINT PET; TOFTS PS, 1995, MAGN RESON MED, V33, P564, DOI 10.1002/mrm.1910330416; Vaupel P, 2001, Zentralbl Gynakol, V123, P192, DOI 10.1055/s-2001-14779; Woodhams Reiko, 2005, Magn Reson Med Sci, V4, P35, DOI 10.2463/mrms.4.35; Yankeelov TE, 2012, MAGN RESON IMAGING, V30, P1342, DOI 10.1016/j.mri.2012.06.001	50	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155333	10.1371/journal.pone.0155333	http://dx.doi.org/10.1371/journal.pone.0155333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167829	Green Submitted, gold, Green Published			2022-12-27	WOS:000376587300065
J	Wang, XY; Yu, HZ; Geng, L; Xu, JP; Yu, D; Zhang, SZ; Ma, Y; Fei, DQ				Wang, Xue-Yang; Yu, Hai-Zhong; Geng, Lei; Xu, Jia-Ping; Yu, Dong; Zhang, Shang-Zhi; Ma, Yan; Fei, Dong-Qiong			Comparative Transcriptome Analysis of Bombyx mori (Lepidoptera) Larval Midgut Response to BmNPV in Susceptible and Near-Isogenic Resistant Strains	PLOS ONE			English	Article							ANTIVIRAL ACTIVITY; GENE-EXPRESSION; DIGESTIVE JUICE; NPV RESISTANCE; CELL-DIVISION; DISEASE VIRUS; UP-REGULATION; SILKWORM; PROTEIN; KINASE	Bombyx mori nucleopolyhedrovirus (BmNPV) is one of the primary pathogens causing severe economic losses in sericulture. However, the molecular mechanism of silkworm resistance to BmNPV remains largely unknown. Here, the recurrent parent P50 (susceptible strain) and the near-isogenic line BC9 (resistance strain) were used in a comparative transcriptome study examining the response to infection with BmNPV. A total of 14,300 unigenes were obtained from two different resistant strains; of these, 869 differentially expressed genes (DEGs) were identified after comparing the four transcriptomes. Many DEGs associated with protein metabolism, cytoskeleton, and apoptosis may be involved in the host response to BmNPV infection. Moreover, some immunity related genes were also altered following BmNPV infection. Specifically, after removing genetic background and individual immune stress response genes, 22 genes were found to be potentially involved in repressing BmNPV infection. These genes were related to transport, virus replication, intracellular innate immune, and apoptosis. Our study provided an overview of the molecular mechanism of silkworm resistance to BmNPV infection and laid a foundation for controlling BmNPV in the future.	[Wang, Xue-Yang; Yu, Hai-Zhong; Geng, Lei; Xu, Jia-Ping; Yu, Dong; Zhang, Shang-Zhi; Ma, Yan; Fei, Dong-Qiong] Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China	Anhui Agricultural University	Xu, JP (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China.	jiapingxu@163.com	Xu, Jiaping/T-4327-2019; Wang, Xue-yang/ABB-8298-2021	Xu, Jiaping/0000-0001-9020-7248	Natural Science Foundation of China [31472148]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (31472148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11; Avey D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004993; Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Barrientos T, 2007, J BIOL CHEM, V282, P8393, DOI 10.1074/jbc.M607549200; Barry C, 2010, J BIOL CHEM, V285, P16424, DOI 10.1074/jbc.M110.118232; Bhat V, 2013, J MOL RECOGNIT, V26, P501, DOI 10.1002/jmr.2295; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Cheng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115032; Cheng Y, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.76; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Danaher RJ, 2001, J NEUROVIROL, V7, P163; de Nijs L, 2009, NAT NEUROSCI, V12, P1266, DOI 10.1038/nn.2390; Dlamini Z, 2015, EXP MOL PATHOL, V98, P574, DOI 10.1016/j.yexmp.2015.03.022; Emmett Stevan R., 2004, V296, P197; Follstaedt SC, 2008, J NEUROVIROL, V14, P376, DOI 10.1080/13550280802199898; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harries PA, 2010, MOL PLANT MICROBE IN, V23, P1381, DOI 10.1094/MPMI-05-10-0121; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hu Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-417; Hyodo K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004909; Johnson CP, 2010, J CELL BIOL, V191, P187, DOI 10.1083/jcb.201002089; Kang LQ, 2011, COMP BIOCHEM PHYS B, V158, P230, DOI 10.1016/j.cbpb.2010.12.001; Kim Y, 2014, VIROLOGY, V460, P180, DOI 10.1016/j.virol.2014.04.040; Kolliopoulou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121447; Lafferty MK, 2014, PATHOG DIS, V71, P81, DOI 10.1111/2049-632X.12117; Lek A, 2012, TRAFFIC, V13, P185, DOI 10.1111/j.1600-0854.2011.01267.x; Li MW, 2005, GENOME, V48, P802, DOI 10.1139/g05-053; Liu F, 2013, ISJ-INVERT SURVIV J, V10, P102; Liu L, 2012, J BIOL CHEM, V287, P11899, DOI 10.1074/jbc.M111.308064; Liu W, 2015, MOL IMMUNOL, V65, P391, DOI 10.1016/j.molimm.2015.02.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Martin R, 2007, YEAST, V24, P511, DOI 10.1002/yea.1489; Mogensen TH, 2003, J IMMUNOL, V170, P6224, DOI 10.4049/jimmunol.170.12.6224; Morikawa K, 2014, HEPATOLOGY, V59, P423, DOI 10.1002/hep.26671; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muylkens B, 2010, ARCH VIROL, V155, P1823, DOI 10.1007/s00705-010-0777-y; Nagaraju J, 2002, CURR SCI INDIA, V83, P415; Nakazawa H, 2004, VIROLOGY, V321, P154, DOI 10.1016/j.virol.2003.12.011; Narayanan K, 2004, CURR SCI INDIA, V86, P800; Neve RL, 2006, PHARMACOL THERAPEUT, V111, P99, DOI 10.1016/j.pharmthera.2005.09.005; Pan HY, 2014, AM J PHYSIOL-HEART C, V307, pH922, DOI 10.1152/ajpheart.00076.2014; Ponnuvel KM, 2012, ARCH INSECT BIOCHEM, V81, P90, DOI 10.1002/arch.21046; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Prasad SS, 2011, J LIPID RES, V52, P451, DOI 10.1194/jlr.M007575; Pulmanausarakul R, 2001, J VIROL, V75, P10800, DOI 10.1128/JVI.75.22.10800-10807.2001; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Rajan DP, 2000, J BIOL CHEM, V275, P14331, DOI 10.1074/jbc.275.19.14331; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sacco R, 2003, VIROLOGY, V317, P24, DOI 10.1016/j.virol.2003.08.028; Sagisaka A, 2010, VIRUS RES, V147, P166, DOI 10.1016/j.virusres.2009.10.015; Salgado MC, 2014, BBA-GENE REGUL MECH, V1839, P288, DOI 10.1016/j.bbagrm.2014.01.005; Sun JF, 2014, PROTEOMICS, V14, P1403, DOI 10.1002/pmic.201300404; Tanaka H, 2009, INSECT MOL BIOL, V18, P71, DOI 10.1111/j.1365-2583.2009.00851.x; TATERKA J, 1994, J CLIN INVEST, V94, P353, DOI 10.1172/JCI117329; Valenzuela-Miranda D, 2015, FISH SHELLFISH IMMUN, V45, P367, DOI 10.1016/j.fsi.2015.04.003; Volkman LE, 2007, CURR DRUG TARGETS, V8, P1075, DOI 10.2174/138945007782151379; Voss TG, 1996, VIROLOGY, V219, P291, DOI 10.1006/viro.1996.0249; Wagner LM, 2013, J VIROL, V87, P1010, DOI 10.1128/JVI.02844-12; Wang GB, 2015, J INVERTEBR PATHOL, V128, P37, DOI 10.1016/j.jip.2015.04.001; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wu K, 2016, DEV COMP IMMUNOL, V64, P65, DOI 10.1016/j.dci.2016.02.010; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Wu TB, 2015, RNA BIOL, V12, P479, DOI 10.1080/15476286.2015.1020272; Wu Y, 2013, FEBS LETT, V587, P600, DOI 10.1016/j.febslet.2013.01.072; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Xu JP, 2005, J APPL ENTOMOL, V129, P425, DOI 10.1111/j.1439-0418.2005.00995.x; Xu JP, 2005, J APPL ENTOMOL, V129, P27, DOI 10.1111/j.1439-0418.2005.00923.x; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Yang RZ, 2002, GENOMICS, V79, P445, DOI 10.1006/geno.2002.6722; Yao Q, 2003, J APPL ENTOMOL, V127, P134, DOI 10.1046/j.1439-0418.2003.00741.x; Yao Qin, 2005, Acta Entomologica Sinica, V48, P871; Yingvilasprasert W, 2014, DEV COMP IMMUNOL, V42, P302, DOI [10.1016/j.dci.2014.05.020, 10.1016/j.dci.2013.09.008]; ZHANG L, 1995, VIROLOGY, V206, P1099, DOI 10.1006/viro.1995.1033; Zhang Y, 2015, ARCH VIROL, V160, P1645, DOI 10.1007/s00705-015-2421-3; Zhao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031168; Zhou J, 2014, MOLECULES, V19, P177, DOI 10.3390/molecules19010177	82	39	41	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155341	10.1371/journal.pone.0155341	http://dx.doi.org/10.1371/journal.pone.0155341			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168061	Green Published, gold			2022-12-27	WOS:000376587300013
J	Zangerle, A; Renard, D; Iriarte, J; Jimenez, LES; Montoya, KLA; Juilleret, J; Mckey, D				Zangerle, Anne; Renard, Delphine; Iriarte, Jose; Suarez Jimenez, Luz Elena; Adame Montoya, Kisay Lorena; Juilleret, Jerome; Mckey, Doyle			The Surales, Self-Organized Earth-Mound Landscapes Made by Earthworms in a Seasonal Tropical Wetland	PLOS ONE			English	Article							MIMA-LIKE MOUNDS; SOUTH-AMERICA; ECOSYSTEM ENGINEERS; PATTERN-FORMATION; COASTAL SAVANNAS; VEGETATION; SOIL; LLANOS; EVOLUTION; ORIGINS	The formation, functioning and emergent properties of patterned landscapes have recently drawn increased attention, notably in semi-arid ecosystems. We describe and analyze a set of similarly spectacular landforms in seasonal tropical wetlands. Surales landscapes, comprised of densely packed, regularly spaced mounds, cover large areas of the Orinoco Llanos. Although descriptions of surales date back to the 1940's, their ecology is virtually unknown. From data on soil physical and chemical properties, soil macrofauna, vegetation and aerial imagery, we provide evidence of the spatial extent of surales and how they form and develop. Mounds are largely comprised of earthworm casts. Recognizable, recently produced casts account for up to one-half of total soil mass. Locally, mounds are relatively constant in size, but vary greatly across sites in diameter (0.5-5 m) and height (from 0.3 m to over 2 m). This variation appears to reflect a chronosequence of surales formation and growth. Mound shape (round to labyrinth) varies across elevational gradients. Mounds are initiated when large earthworms feed in shallowly flooded soils, depositing casts that form 'owers' above water level. Using permanent galleries, each earthworm returns repeatedly to the same spot to deposit casts and to respire. Over time, the tower becomes a mound. Because each earthworm has a restricted foraging radius, there is net movement of soil to the mound from the surrounding area. As the mound grows, its basin thus becomes deeper, making initiation of a new mound nearby more difficult. When mounds already initiated are situated close together, the basin between them is filled and mounds coalesce to form larger composite mounds. Over time, this process produces mounds up to 5 m in diameter and 2 m tall. Our results suggest that one earthworm species drives self-organizing processes that produce keystone structures determining ecosystem functioning and development.	[Zangerle, Anne] TUB, Inst Geookol, Langer Kamp 19c, D-38106 Braunschweig, Germany; [Zangerle, Anne; Mckey, Doyle] Univ Montpellier 3, Univ Montpellier, CNRS, CEFE UMR 5175,EPHE, 1919 Route Mende, F-34293 Montpellier 5, France; [Renard, Delphine] McGill Univ, Dept Geog & Nat Resource Sci, Montreal, PQ H3A 2T5, Canada; [Iriarte, Jose] Univ Exeter, Dept Archaeol, Coll Humanities, Exeter EX4 4QE, Devon, England; [Suarez Jimenez, Luz Elena; Adame Montoya, Kisay Lorena] Fdn Univ Int Trop Amer Unitropico, Cra 19, Yopal, Colombia; [Adame Montoya, Kisay Lorena] Lab Perifiton, BR-87020900 Maringa, PR, Brazil; [Adame Montoya, Kisay Lorena] Univ Estadual Maringa, Ave Colombo,5-790 Bloco G-90,Sala 8, Maringa, Parana, Brazil; [Juilleret, Jerome] Luxembourg Inst Sci & Technol, Environm Res & Innovat Dept, 41 Rue Brill, L-4422 Belvaux, Luxembourg; [Mckey, Doyle] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Universite Paul-Valery; McGill University; University of Exeter; Universidade Estadual de Maringa; Luxembourg Institute of Science & Technology; Institut Universitaire de France	Zangerle, A (corresponding author), TUB, Inst Geookol, Langer Kamp 19c, D-38106 Braunschweig, Germany.; Zangerle, A (corresponding author), Univ Montpellier 3, Univ Montpellier, CNRS, CEFE UMR 5175,EPHE, 1919 Route Mende, F-34293 Montpellier 5, France.	Zangerleanne@yahoo.fr		Suarez Jimenez, Luz Elena/0000-0002-5134-1898; Iriarte, Jose/0000-0002-8155-5360; Renard, Delphine/0000-0002-3228-4269	Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS) Mission pour l'Interdisciplinarite; National Research Fund Luxembourg (FNR); Marie Curie Actions of the European Commission (FP7-COFUND) [4886121]; program ECOS/COLCIENCIAS [M101PR03F2]; TOSCA committee ("Terre Solide, Ocean, Surfaces Continentales, Atmosphere") of the CNES (French National Center for Space Research)	Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS) Mission pour l'Interdisciplinarite; National Research Fund Luxembourg (FNR)(Luxembourg National Research Fund); Marie Curie Actions of the European Commission (FP7-COFUND); program ECOS/COLCIENCIAS; TOSCA committee ("Terre Solide, Ocean, Surfaces Continentales, Atmosphere") of the CNES (French National Center for Space Research)	Funding for field missions was supported by a grant to Doyle McKey from the Institut Universitaire de France, http://www.iufrance.fr/. Additional funding was supplied by a grant to Doyle McKey from the Centre National de la Recherche Scientifique (CNRS) Mission pour l'Interdisciplinarite, http://www.cnrs.fr/mi/. FNR/AFR of the CNRS; Anne Zangerle benefited from a grant for post-doctoral study by the National Research Fund Luxembourg (FNR), co-funded under the Marie Curie Actions of the European Commission (FP7-COFUND), Grant number (4886121), http://www.fnr.lu/. Work in Colombia was supported by a grant from the program ECOS/COLCIENCIAS to Anne Zangerle, Grant number (M101PR03F2), http://www.colciencias.gov.co/. And by a grant to Doyle McKey from the TOSCA committee ("Terre Solide, Ocean, Surfaces Continentales, Atmosphere") of the CNES (French National Center for Space Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvira D, 1999, PLANTAS LENOSAS PIED; Anderson J. M., 1993, TROPICAL SOIL BIOL F; [Anonymous], 2000, DARWINIANA; Badillo V., 1985, CLAVE FAMILIAS PLANT, V7ma; Bates M, 1984, GEOGR REV, V38, P555; Blancaneaux P., 1977, Cahiers ORSTOM, Pedologie, V15, P437; Bonachela JA, 2015, SCIENCE, V347, P651, DOI 10.1126/science.1261487; Bouche M.B., 1972, LOMBRICIENS FRANCE E; Bouche MB, 1977, ECOL B STOCKHOLM, V25, P122, DOI DOI 10.2307/20112572; BOUYOUCOS GJ, 1962, AGRON J, V54, P464, DOI 10.2134/agronj1962.00021962005400050028x; Bowman DMJS, 2010, J BIOGEOGR, V37, P201, DOI 10.1111/j.1365-2699.2009.02210.x; BROWN DA, 1984, J ARCHAEOL SCI, V11, P345, DOI 10.1016/0305-4403(84)90016-5; Buckland ST, 2007, BIOMETRICS, V63, P989, DOI 10.1111/j.1541-0420.2007.00798.x; Buol SW, 2003, SOIL CLASSIFICATION: A GLOBAL DESK REFERENCE, P3; Chacon-Moreno E., 2007, THESIS WAGENINGEN U; Cramer MD, 2015, J ARID ENVIRON, V119, P16, DOI 10.1016/j.jaridenv.2015.03.011; Cramer MD, 2014, PALAEOGEOGR PALAEOCL, V409, P72, DOI 10.1016/j.palaeo.2014.04.026; Cramer MD, 2012, PALAEOGEOGR PALAEOCL, V350, P189, DOI 10.1016/j.palaeo.2012.06.030; Deblauwe V, 2008, GLOBAL ECOL BIOGEOGR, V17, P715, DOI 10.1111/j.1466-8238.2008.00413.x; Duno de Stefano R, 2006, CATALOGO ANOTADO ILU; Escobar E, 1993, CLAVE PRINCIPALES PL, V227; FAO, 1966, REC ED LLAN OR COL, VIII; FAO, 2006, GUID SOIL DESCR; Fishkis O, 2010, GEODERMA, V157, P27, DOI 10.1016/j.geoderma.2010.03.012; Folgarait PJ, 2002, PLANT ECOL, V163, P1, DOI 10.1023/A:1020323813841; Forero E., 2005, ESTUDIOS LEGUMINOSAS; FREDLUND GG, 1994, J BIOGEOGR, V21, P321, DOI 10.2307/2845533; Fredlund GG, 2005, HIST ECOLOGY HDB, P335; Fuentes CL, 1999, MALEZAS CYPERACEAE A, P136; FURLEY PA, 1986, J BIOGEOGR, V13, P265, DOI 10.2307/2844925; Gabet EJ, 2014, GEOMORPHOLOGY, V206, P58, DOI 10.1016/j.geomorph.2013.09.018; Gentry A. H., 1993, FIELD GUIDE FAMILIES; Gentry AH, 1982, FLORA VENEZUELA, V8; Gonzalez V, 2003, MORICHALES CANANGU 1, P74; Goosen D, 1971, THESIS U AMSTERDAM; HAANTJENS H. A., 1965, AUSTRALIAN J SOIL RES, V3, P111, DOI 10.1071/SR9650111; HAASE R, 1989, BRITTONIA, V41, P80, DOI 10.2307/2807594; Hamilton SK, 2004, HYDROL PROCESS, V18, P2103, DOI 10.1002/hyp.5559; Hanagarth, 1993, ACERCA GEOECOLOGIA S; Hart D. M., 1997, Estado actual de los estudios de fitolitos en suelos y plantas. Primer Encuentro Europeo sobre el Estudio de Fitolitos, Madrid, Spain, 23-26 de Septiembre de 1996., P93; Hart Diane M., 2003, TERRA AUSTRALIS, V19, P83; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Huber O, 2006, SYST ASSOC SPEC VOL, P95; Iriarte J, 2010, J ARCHAEOL SCI, V37, P2984, DOI 10.1016/j.jas.2010.06.016; Iriarte J, 2009, QUATERN INT, V193, P99, DOI 10.1016/j.quaint.2007.10.008; Iriondo M, 2004, QUATERN INT, V114, P3, DOI 10.1016/S1040-6182(03)00037-5; IUSS Working Group WRB, 2015, WORLD SOIL RESOURCES, V106; JOHNSON DL, 1989, AM ANTIQUITY, V54, P370, DOI 10.2307/281712; JOHNSON DL, 1990, SOIL SCI, V149, P84, DOI 10.1097/00010694-199002000-00004; JONASSON S, 1988, OIKOS, V52, P101, DOI 10.2307/3565988; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Juggins S., 2003, C2 USER GUIDE SOFTWA, DOI DOI 10.1016/j.ecolind.2004.01.004; Kishne AS, 2014, J HYDROL, V513, P256, DOI 10.1016/j.jhydrol.2014.03.053; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Lavelle P, 2014, AGR ECOSYST ENVIRON, V185, P106, DOI 10.1016/j.agee.2013.12.020; Lejeune O, 2004, INT J QUANTUM CHEM, V98, P261, DOI 10.1002/qua.10878; Loranger G, 2003, EUR J SOIL SCI, V54, P17, DOI 10.1046/j.1365-2389.2003.00500.x; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Madella M, 2012, QUATERN INT, V275, P76, DOI 10.1016/j.quaint.2011.09.008; Mahecha Vega Gilberto E, 1997, 18343 COBAC; Malagon D., 1995, SUELOS COLOMBIA ORIG; Maraun M, 1999, PEDOBIOLOGIA, V43, P276; McKenzie RJ, 2006, BOT J LINN SOC, V151, P581, DOI 10.1111/j.1095-8339.2006.00544.x; Mckey D, 2010, P NATL ACAD SCI USA, V107, P7823, DOI 10.1073/pnas.0908925107; Mendoza Cifuentes H, 2004, RUBIACEAE COLOMBIA G; Mendoza H, 2006, GUIA ILUSTRADA GENER; Meron E, 2012, ECOL MODEL, V234, P70, DOI 10.1016/j.ecolmodel.2011.05.035; Montenegro H, 1987, REV SOC COLOMBIANA C, V17, P184; Moser K, 2007, WETLANDS, V27, P1081, DOI 10.1672/0277-5212(2007)27[1081:COMAII]2.0.CO;2; Murillo AJ, 2000, ANNONACEAS REGION AR; Nehren U, 2016, CATENA, V137, P173, DOI 10.1016/j.catena.2015.09.016; Nuutinen V, 2011, SOIL BIOL, V24, P123, DOI 10.1007/978-3-642-14636-7_8; Pearsall Deborah M., 1995, ARCHAEOLOGY LOWLAND, P113; Pearsall DM., 2000, PALAEOETHNOBOTANY HD; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1998, SMITHSONIAN CONTRIBU, P1, DOI [10.5479/si.0081024X.85, DOI 10.5479/SI.0081024X.85]; Ponge JF, 2005, BIOL REV, V80, P403, DOI 10.1017/S146479310500672X; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Quinones ML, 2001, DIVERSIDAD FAMILIAR; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renard D, 2013, SOIL BIOL BIOCHEM, V62, P46, DOI 10.1016/j.soilbio.2013.02.021; Renard D, 2012, PLANT SOIL, V351, P337, DOI 10.1007/s11104-011-0967-8; Rietkerk M, 1997, OIKOS, V79, P69, DOI 10.2307/3546091; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Romero-Ruiz MH, 2012, APPL GEOGR, V32, P766, DOI 10.1016/j.apgeog.2011.08.010; Sarmiento G, 2001, J BIOGEOGR, V28, P985, DOI 10.1046/j.1365-2699.2001.00601.x; Silva J, 1971, ACTA SCI VENEZOLANA, V22, P61; Silva LCR, 2010, PLANT SOIL, V336, P3, DOI 10.1007/s11104-010-0329-y; Soil Survey Staff, 1975, USDA SCS AGR HDB, V436; Taylor Charlotte M., 1992, Novon, V2, P259, DOI 10.2307/3391564; Topoliantz S, 2000, PLANT SOIL, V225, P39, DOI 10.1023/A:1026537632468; Torres R., 1991, Zootecnia Tropical, V9, P71; Troll C, 1936, LANDERKUNDLICHE FORS, P275; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Twiss PC, 1967, SOIL SCI SOC AM P, V33, P109; Velasquez E, 2007, PEDOBIOLOGIA, V51, P75, DOI 10.1016/j.pedobi.2007.01.002; Villarreal-Leal H, 2007, CARACTERIZACION BIOL; VINCELLI P, 1981, CESPEDESIA, V10, P7; VivianSmith G, 1997, J ECOL, V85, P71, DOI 10.2307/2960628; WASAWO D.P.S., 1959, EAST AFRICAN AGRIC JOUR, V25, P86; Watling J, 2013, QUATERN INT, V287, P162, DOI 10.1016/j.quaint.2012.10.030; Zangerle A, 2016, SOIL TILL RES, V155, P280, DOI 10.1016/j.still.2015.08.017	103	19	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154269	10.1371/journal.pone.0154269	http://dx.doi.org/10.1371/journal.pone.0154269			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168157	Green Published, gold			2022-12-27	WOS:000376587300099
J	Buerth, C; Mausberg, AK; Heininger, MK; Hartung, HP; Kieseier, BC; Ernst, JF				Buerth, Christoph; Mausberg, Anne K.; Heininger, Maximilian K.; Hartung, Hans-Peter; Kieseier, Bernd C.; Ernst, Joachim F.			Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; CELL-SURFACE DISPLAY; SACCHAROMYCES-CEREVISIAE; IMMUNE-RESPONSES; ACTINOBACILLUS-PLEUROPNEUMONIAE; ENCEPHALITOGENIC ANTIGENS; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; IN-VITRO; GM-CSF	Multiple sclerosis (MS) is an autoimmune disease that attacks myelinated axons in the central nervous system. Induction of oral tolerance is a potent mechanism to prevent autoimmunity. The food yeast Candida utilis was used to test the therapeutic potential of oral tolerance induction in an animal model of human multiple sclerosis (MS). We constructed a C. utilis strain, which displays a fusion peptide composed of the encephalitogenic MOG(35-55) peptide and the C. utilis Gas1 cell wall protein on its surface. By immunizing mice with MOG(35-55) peptide experimental autoimmune encephalomyelitis (EAE) was induced in a mouse model. Feeding of mice with C. utilis that expresses MOG(35-55) peptide on its surface was started seven days prior to immunization and was continued for ten days. Control animals were treated with wild-type fungus or left untreated. Untreated mice developed first clinical symptoms ten days post immunization (p. i.) with an ascending paralysis reaching maximal clinical disability at day 18 to 20 p. i.. Treatment with the wild-type strain demonstrated comparable clinical symptoms. In contrast, oral gavage of MOG(35-55)-presenting fungus ameliorated the development of EAE. In addition, incidence as well as maximal clinical disease severity were significantly reduced. Interestingly, reduction of disease severity also occurred in animals treated with heat-inactivated C. utilis cells indicating that tolerance induction was independent of fungal viability. Better disease outcome correlated with reduced demyelination and cellular inflammation in the spinal cord, lower T cell proliferation against rechallenge with MOG(35-55) and more regulatory T cells in the lymph nodes. Our data demonstrate successful that using the food approved fungus C. utilis presenting the immunogenic MOG(35-55) peptide on its surface induced an oral tolerance against this epitope in EAE. Further studies will reveal the nature and extent of an anti-inflammatory environment established by the treatment that prevents the development of an autoimmune disorder affecting the CNS.	[Buerth, Christoph; Ernst, Joachim F.] Univ Dusseldorf, Dept Biol, Inst Mol Mycol, Dusseldorf, Germany; [Mausberg, Anne K.; Heininger, Maximilian K.; Hartung, Hans-Peter; Kieseier, Bernd C.] Univ Dusseldorf, Fac Med, Dept Neurol, Res Grp Clin & Expt Neuroimmunol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Buerth, C (corresponding author), Univ Dusseldorf, Dept Biol, Inst Mol Mycol, Dusseldorf, Germany.; Mausberg, AK (corresponding author), Univ Dusseldorf, Fac Med, Dept Neurol, Res Grp Clin & Expt Neuroimmunol, Dusseldorf, Germany.	christoph.buerth@uni-duesseldorf.de; mausberg@uni-duesseldorf.de			Cluster of Industrial Biotechnology [NRW CLIB2021]	Cluster of Industrial Biotechnology	CB was funded by the Cluster of Industrial Biotechnology NRW CLIB2021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiani A, 2010, FEMS YEAST RES, V10, P1060, DOI 10.1111/j.1567-1364.2010.00665.x; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhowmick S, 2011, INT IMMUNOL, V23, P119, DOI 10.1093/intimm/dxq461; BITAR DM, 1988, CELL IMMUNOL, V112, P364, DOI 10.1016/0008-8749(88)90305-X; Buerth C, 2011, MICROBIOL-SGM, V157, P2493, DOI 10.1099/mic.0.049320-0; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; De Jesus M, 2015, IMMUNOL LETT, V168, P64, DOI 10.1016/j.imlet.2015.09.008; Faria AMC, 2006, CLIN DEV IMMUNOL, V13, P143, DOI 10.1080/17402520600876804; Farooq SM, 2014, BRAIN BEHAV IMMUN, V35, P64, DOI 10.1016/j.bbi.2013.09.016; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; HIGGINS PJ, 1988, J IMMUNOL, V140, P440; Kasarello K, 2015, MED SCI MONITOR, V21, P1587, DOI 10.12659/MSM.892764; Kieseier BC, 1998, BRAIN, V121, P159, DOI 10.1093/brain/121.1.159; Kim JM, 2010, BIOSCI BIOTECH BIOCH, V74, P1362, DOI 10.1271/bbb.90941; Kunigo M, 2015, APPL MICROBIOL BIOT, V99, P8055, DOI 10.1007/s00253-015-6703-1; Kunigo M, 2013, APPL MICROBIOL BIOT, V97, P7357, DOI 10.1007/s00253-013-4890-1; Kurtzman CP, 2011, YEASTS, V5th; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Leech MD, 2007, EUR J IMMUNOL, V37, P3576, DOI 10.1002/eji.200737148; Maassen CBM, 2003, VACCINE, V21, P4685, DOI 10.1016/S0264-410X(03)00522-X; Mausberg AK, 2009, GLIA, V57, P1341, DOI 10.1002/glia.20853; Mayer L, 2004, NAT REV IMMUNOL, V4, P407, DOI 10.1038/nri1370; MELAMED D, 1993, EUR J IMMUNOL, V23, P935, DOI 10.1002/eji.1830230426; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; Millington OR, 2004, J IMMUNOL, V173, P6059, DOI 10.4049/jimmunol.173.10.6059; Muller G, 2011, MOL MEMBR BIOL, V28, P186, DOI 10.3109/09687688.2011.562557; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; Rizzo LV, 1999, J IMMUNOL, V162, P2613; Rupp O, 2015, J BIOTECHNOL, V211, P20, DOI 10.1016/j.jbiotec.2015.06.423; Schreuder MP, 1996, VACCINE, V14, P383, DOI 10.1016/0264-410X(95)00206-G; Shin SJ, 2005, FEMS IMMUNOL MED MIC, V43, P155, DOI 10.1016/j.femsim.2004.07.004; Tanaka T, 2012, APPL MICROBIOL BIOT, V95, P577, DOI 10.1007/s00253-012-4175-0; Tomita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037226; Wasilenko JL, 2010, BIOTECHNOL PROGR, V26, P542, DOI 10.1002/btpr.343; Weiner HL, 2000, J CLIN INVEST, V106, P935, DOI 10.1172/JCI11348; WHITACRE CC, 1991, J IMMUNOL, V147, P2155	40	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155082	10.1371/journal.pone.0155082	http://dx.doi.org/10.1371/journal.pone.0155082			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159446	gold, Green Published			2022-12-27	WOS:000376576700038
J	Crystal, HA; Holman, S; Lui, YW; Baird, AE; Yu, H; Klein, R; Rojas-Soto, DM; Gustafson, DR; Stebbins, GT				Crystal, Howard A.; Holman, Susan; Lui, Yvonne W.; Baird, Alison E.; Yu, Hua; Klein, Ronald; Rojas-Soto, Diana Marcella; Gustafson, Deborah R.; Stebbins, Glenn T.			Association of the Fractal Dimension of Retinal Arteries and Veins with Quantitative Brain MRI Measures in HIV-Infected and Uninfected Women	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; DIFFUSION; SEGMENTATION; DISEASE; DEGENERATION; VESSELS; NETWORK; FILM; AGE	Objective The fractal dimension of retinal arteries and veins is a measure of the complexity of the vascular tree. We hypothesized that retinal fractal dimension would be associated with brain volume and white matter integrity in HIV-infected women. Design Nested case-control within longitudinal cohort study. Methods Women were recruited from the Brooklyn site of the Women's Interagency HIV study (WIHS); 34 HIV-infected and 21 HIV-uninfected women with analyzable MRIs and retinal photographs were included. Fractal dimension was determined using the SIVA software program on skeletonized retinal images. The relationship between predictors (retinal vascular measures) and outcomes (quantitative MRI measures) were analyzed with linear regression models. All models included age, intracranial volume, and both arterial and venous fractal dimension. Some models were adjusted for blood pressure, race/ethnicity, and HIV-infection. Results The women were 45.6 +/- 7.3 years of age. Higher arterial dimension was associated with larger cortical volumes, but higher venous dimension was associated with smaller cortical volumes. In fully adjusted models, venous dimension was significantly associated with fractional anisotropy (standardized beta = -0.41, p = 0.009) and total gray matter volume (beta = -0.24, p = 0.03), and arterial dimension with mean diffusivity (beta = -0.33, .p = 0.04) and fractional anisotropy (beta = 0.34, p = 0.03). HIV-infection was not associated with any retinal or MRI measure. Conclusions Higher venous fractal dimension was associated with smaller cortical volumes and lower fractional anisotropy, whereas higher arterial fractal dimension was associated with the opposite patterns. Longitudinal studies are needed to validate this finding.	[Crystal, Howard A.; Baird, Alison E.; Yu, Hua; Rojas-Soto, Diana Marcella; Gustafson, Deborah R.] SUNY Downstate Med Sch, Dept Neurol, Brooklyn, NY USA; [Holman, Susan] SUNY Downstate Med Sch, Dept Med, Brooklyn, NY USA; [Lui, Yvonne W.] NYU Langone Sch Med, Dept Radiol, New York, NY USA; [Klein, Ronald] Univ Wisconsin, Sch Med, Dept Ophthalmol, Madison, WI 53706 USA; [Stebbins, Glenn T.] Rush Univ, Sch Med, Dept Neurol Sci, Chicago, IL 60612 USA; [Rojas-Soto, Diana Marcella] Dartmouth Hitchcock Med Ctr, Dept Neurol, Hanover, NH USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; NYU Langone Medical Center; University of Wisconsin System; University of Wisconsin Madison; Rush University; Dartmouth College	Crystal, HA (corresponding author), SUNY Downstate Med Sch, Dept Neurol, Brooklyn, NY USA.	howard.crystal@downstate.edu			NIH;  [R21MH097639];  [U01 318345]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH097639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	SUNY Downstate Medical Center received salary support from the NIH for HC, DG, and SH. Funds from the NIH were used to support data collection of HY, AEB, YWL, RK, and GS. R21MH097639, https://www.niaid.nih.gov. U01 318345, https://www.niaid.nih.gov	Ances BM, 2014, CURR OPIN HIV AIDS, V9, P545, DOI 10.1097/COH.0000000000000112; Azemin MZC, 2011, IEEE T MED IMAGING, V30, P243, DOI 10.1109/TMI.2010.2076322; Azemin MZC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.04.010; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Cavallari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019150; Cheung CY, 2011, J HYPERTENS, V29, P1380, DOI 10.1097/HJH.0b013e328347266c; Clifford DB, 2013, LANCET INFECT DIS, V13, P976, DOI 10.1016/S1473-3099(13)70269-X; Cosatto VF, 2010, CURR EYE RES, V35, P850, DOI 10.3109/02713683.2010.490628; Crystal HA, 2011, J NEUROVIROL, V17, P469, DOI 10.1007/s13365-011-0052-3; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Jong FJ, 2011, NEUROLOGY, V76, P816, DOI 10.1212/WNL.0b013e31820e7baa; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Doubal FN, 2010, NEUROLOGY, V74, P1102, DOI 10.1212/WNL.0b013e3181d7d8b4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gangaputra S, 2013, RETINA-J RET VIT DIS, V33, P1393, DOI 10.1097/IAE.0b013e318286c952; Gangaputra S, 2012, RETINA-J RET VIT DIS, V32, P600, DOI 10.1097/IAE.0b013e318221592f; Hanff TC, 2014, STROKE, V45, P1012, DOI 10.1161/STROKEAHA.113.004166; Hessol NA, 2009, J WOMENS HEALTH, V18, P1627, DOI 10.1089/jwh.2008.1337; Hilal S, 2014, NEUROSCI LETT, V577, P95, DOI 10.1016/j.neulet.2014.06.024; Ikram MK, 2013, DIABETES CARE, V36, P750, DOI 10.2337/dc12-1554; Klein R, 2004, ARCH OPHTHALMOL-CHIC, V122, P1642, DOI 10.1001/archopht.122.11.1642; Liew G, 2011, EUR HEART J, V32, P422, DOI 10.1093/eurheartj/ehq431; MacGillivray TJ, 2007, P ANN INT IEEE EMBS, P6456; MAINSTER MA, 1990, EYE, V4, P235, DOI 10.1038/eye.1990.33; Pathai S, 2013, MECH AGEING DEV, V134, P338, DOI 10.1016/j.mad.2013.05.002; Pathai S, 2013, AGEING RES REV, V12, P490, DOI 10.1016/j.arr.2012.11.002; Pathai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051405; Pirici D, 2009, ROM J MORPHOL EMBRYO, V50, P381; Pirici D, 2011, NEUROBIOL AGING, V32, P1579, DOI 10.1016/j.neurobiolaging.2009.10.010; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; Yau PL, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/329602; Yau PL, 2014, JAMA PEDIATR, V168, DOI 10.1001/jamapediatrics.2014.2815	38	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154858	10.1371/journal.pone.0154858	http://dx.doi.org/10.1371/journal.pone.0154858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158911	Green Submitted, gold, Green Published			2022-12-27	WOS:000376576700020
J	Embade, N; Marino, Z; Diercks, T; Cano, A; Lens, S; Cabrera, D; Navasa, M; Falcon-Perez, JM; Caballeria, J; Castro, A; Bosch, J; Mato, JM; Millet, O				Embade, Nieves; Marino, Zoe; Diercks, Tammo; Cano, Ainara; Lens, Sabela; Cabrera, Diana; Navasa, Miquel; Falcon-Perez, Juan M.; Caballeria, Joan; Castro, Azucena; Bosch, Jaume; Mato, Jose M.; Millet, Oscar			Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum H-1-NMR Spectroscopy	PLOS ONE			English	Article							HEPATITIS-C VIRUS; MAGNETIC-RESONANCE-SPECTROSCOPY; NMR-BASED METABONOMICS; HEPATOCELLULAR-CARCINOMA; MASS-SPECTROMETRY; CLINICAL-APPLICATIONS; BIOMARKER DISCOVERY; ALCOHOLIC CIRRHOSIS; DISEASE; INFECTION	Several etiologies result in chronic liver diseases including chronic hepatitis C virus infection (HCV). Despite its high incidence and the severe economic and medical consequences, liver disease is still commonly overlooked due to the lack of efficient non-invasive diagnostic methods. While several techniques have been tested for the detection of fibrosis, the available biomarkers still present severe limitations that preclude their use in clinical diagnostics. Liver diseases have also been the subject of metabolomic analysis. Here, we demonstrate the suitability of H-1 NMR spectroscopy for characterizing the metabolism of liver fibrosis induced by HCV. Serum samples from HCV patients without fibrosis or with liver cirrhosis were analyzed by NMR spectroscopy and the results were submitted to multivariate and univariate statistical analysis. PLS-DA test was able to discriminate between advanced fibrotic and non-fibrotic patients and several metabolites were found to be up or downregulated in patients with cirrhosis. The suitability of the most significantly regulated metabolites was validated by ROC analysis. Our study reveals that choline, acetoacetate and low-density lipoproteins are the most informative biomarkers for predicting cirrhosis in HCV patients. Our results demonstrate that statistical analysis of H-1-NMR spectra is able to distinguish between fibrotic and non-fibrotic patients suffering from HCV, representing a novel diagnostic application for NMR spectroscopy.	[Embade, Nieves; Diercks, Tammo; Cabrera, Diana; Falcon-Perez, Juan M.; Mato, Jose M.; Millet, Oscar] CIC bioGUNE, Derio, Bizkaia, Spain; [Marino, Zoe; Lens, Sabela; Navasa, Miquel; Caballeria, Joan; Bosch, Jaume] Univ Barcelona, IDIBAPS, Hosp Clin, Liver Unit, Barcelona, Spain; [Cano, Ainara; Castro, Azucena] ONE WAY LIVER METABOLOM SL, Derio, Bizkaia, Spain; [Marino, Zoe; Lens, Sabela; Navasa, Miquel; Falcon-Perez, Juan M.; Caballeria, Joan; Bosch, Jaume; Mato, Jose M.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Falcon-Perez, Juan M.] Basque Fdn Sci, Ikerbasque, Bilbao, Bizkaia, Spain	CIC bioGUNE; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Basque Foundation for Science	Millet, O (corresponding author), CIC bioGUNE, Derio, Bizkaia, Spain.	omillet@cicbiogune.es	Lens, Sabela/L-4750-2018; Diercks, Tammo/AAT-3731-2021; Millet, Oscar/F-9696-2011; Diercks, Tammo/G-1167-2011; Falcon-Perez, Juan M/F-5920-2011; MATO, JOSE/A-5187-2011; Embade, Nieves/K-5190-2014	Lens, Sabela/0000-0003-4900-411X; Diercks, Tammo/0000-0002-5200-0905; Millet, Oscar/0000-0001-8748-4105; Diercks, Tammo/0000-0002-5200-0905; MATO, JOSE/0000-0003-1264-3153; Embade, Nieves/0000-0001-9878-3290; Cano, Ainara/0000-0001-6019-8926; CABRERA, DIANA/0000-0001-8468-1875	Government of the Autonomous Community of the Basque Country [SAF2014-52097R]; Ministry of Science and Technology MINECO [CTQ2012-32183/BQU]; National Institutes of Health [2R01AT001576-11A1]	Government of the Autonomous Community of the Basque Country; Ministry of Science and Technology MINECO; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by (1) Government of the Autonomous Community of the Basque Country, Grant Number SAF2014-52097R (Recipient: OM), https://www.euskadi.eus/r48-bopv2/es/bopv2/datos/2014/03/1401207a.pdf; (2) Ministry of Science and Technology MINECO, Grant Number CTQ2012-32183/BQU (Recipient: OM), http://www.idi.mineco.gob.es/stfls/eSede/Ficheros/2012/Anexo137_Investigacion_quimica_basica_Preseleccionados.pdf; and (3) National Institutes of Health, Grant Number 2R01AT001576-11A1 (Recipient: JMM), http://report.nih.gov/categorical_spending_project_listing.aspx?FY=2014&ARRA=N&DCat=Liver%20Cancer.	Aberg KM, 2009, ANAL BIOANAL CHEM, V394, P151, DOI 10.1007/s00216-009-2628-9; Ahn J, 2009, CANCER EPIDEM BIOMAR, V18, P2814, DOI 10.1158/1055-9965.EPI-08-1248; Amathieu R, 2016, WORLD J GASTROENTERO, V22, P417, DOI 10.3748/wjg.v22.i1.417; Amathieu R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089230; Amathieu R, 2011, J PROTEOME RES, V10, P3239, DOI 10.1021/pr200265z; Bachtiar Indra, 2010, BMC Res Notes, V3, P319, DOI 10.1186/1756-0500-3-319; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Beyoglu D, 2013, J HEPATOL, V59, P842, DOI 10.1016/j.jhep.2013.05.030; Bowers J, 2014, J CHROMATOGR B, V966, P154, DOI 10.1016/j.jchromb.2014.02.043; Charlotte F, 2010, HUM PATHOL, V41, P1178, DOI 10.1016/j.humpath.2009.10.025; Constantinou MA, 2007, TOXICOL APPL PHARM, V218, P11, DOI 10.1016/j.taap.2006.10.007; Corey KE, 2011, J VIRAL HEPATITIS, V18, pE366, DOI 10.1111/j.1365-2893.2011.01434.x; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Damink SWMO, 2002, NEUROCHEM INT, V41, P177, DOI 10.1016/S0197-0186(02)00040-2; Duarte IF, 2014, J PHARMACEUT BIOMED, V93, P17, DOI 10.1016/j.jpba.2013.09.025; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Erol A, 2005, MED HYPOTHESES, V65, P525, DOI 10.1016/j.mehy.2005.03.022; Ferolla SM, 2014, NUTRIENTS, V6, P5583, DOI 10.3390/nu6125583; FISCHER JE, 1976, SURGERY, V80, P77; Fukao T, 2014, J INHERIT METAB DIS, V37, P541, DOI 10.1007/s10545-014-9704-9; Gao HC, 2009, CANCER SCI, V100, P782, DOI 10.1111/j.1349-7006.2009.01086.x; Giannelli V, 2014, WORLD J GASTROENTERO, V20, P16795, DOI 10.3748/wjg.v20.i45.16795; Godoy MMG, 2010, J VIRAL HEPATITIS, V17, P854, DOI 10.1111/j.1365-2893.2009.01252.x; Goldstein NS, 2005, AM J CLIN PATHOL, V123, P382, DOI [10.1309/EY72F1EN0XCB1KXX, 10.1309/EY72F1EN9XCB1KXX]; Gou XJ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-123; Griffin JL, 2007, J PROTEOME RES, V6, P54, DOI 10.1021/pr0601640; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Kawaguchi Y, 2014, WORLD J GASTROENTERO, V20, P2888, DOI 10.3748/wjg.v20.i11.2888; Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013; MARTINEZ J, 1978, J CLIN INVEST, V61, P535, DOI 10.1172/JCI108964; Mehta SH, 2003, HEPATOLOGY, V38, P50, DOI 10.1053/jhep.2003.50291; Nahon P, 2012, CLIN CANCER RES, V18, P6714, DOI 10.1158/1078-0432.CCR-12-1099; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; O'Connell TM, 2013, METABOLITES, V3, P931, DOI 10.3390/metabo3040931; Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227; Qi SW, 2012, HEPATOL RES, V42, P677, DOI 10.1111/j.1872-034X.2011.00964.x; Ranjan P, 2006, LIVER INT, V26, P703, DOI 10.1111/j.1478-3231.2006.01283.x; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Saccenti E, 2014, METABOLOMICS, V10, P361, DOI 10.1007/s11306-013-0598-6; Sharma S, 2014, WORLD J GASTROENTERO, V20, P16820, DOI 10.3748/wjg.v20.i45.16820; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Visnegarwala F, 2005, J INFECTION, V50, P331, DOI 10.1016/j.jinf.2004.06.001; Wadhier MC, 2011, J CHROMATOGR A, V1218, P4537, DOI 10.1016/j.chroma.2011.05.039; Wang JB, 2014, J PROTEOME RES, V13, P3792, DOI 10.1021/pr500462f; Wei S, 2012, METABOLITES, V2, P701, DOI 10.3390/metabo2040701; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yin PY, 2006, J PROTEOME RES, V5, P2135, DOI 10.1021/pr060256p; Zhang AH, 2013, ANALYST, V138, P353, DOI 10.1039/c2an36382h; Zhang HY, 2016, MOLECULES, V21, DOI 10.3390/molecules21010126; Zhang XW, 2007, MASS SPECTROM REV, V26, P403, DOI 10.1002/mas.20132	58	39	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155094	10.1371/journal.pone.0155094	http://dx.doi.org/10.1371/journal.pone.0155094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27158896	Green Published, gold, Green Submitted			2022-12-27	WOS:000376576700042
J	Maghsoudlou, P; Georgiades, F; Smith, H; Milan, A; Shangaris, P; Urbani, L; Loukogeorgakis, SP; Lombardi, B; Mazza, G; Hagen, C; Sebire, NJ; Turmaine, M; Eaton, S; Olivo, A; Godovac-Zimmermann, J; Pinzani, M; Gissen, P; De Coppi, P				Maghsoudlou, Panagiotis; Georgiades, Fanourios; Smith, Holly; Milan, Anna; Shangaris, Panicos; Urbani, Luca; Loukogeorgakis, Stavros P.; Lombardi, Benedetta; Mazza, Giuseppe; Hagen, Charlotte; Sebire, Neil J.; Turmaine, Mark; Eaton, Simon; Olivo, Alessandro; Godovac-Zimmermann, Jasminka; Pinzani, Massimo; Gissen, Paul; De Coppi, Paolo			Optimization of Liver Decellularization Maintains Extracellular Matrix Micro-Architecture and Composition Predisposing to Effective Cell Seeding	PLOS ONE			English	Article							ACELLULAR MATRIX; PORCINE LIVER; IN-VITRO; PHASE; SCAFFOLD	Hepatic tissue engineering using decellularized scaffolds is a potential therapeutic alternative to conventional transplantation. However, scaffolds are usually obtained using decellularization protocols that destroy the extracellular matrix (ECM) and hamper clinical translation. We aim to develop a decellularization technique that reliably maintains hepatic microarchitecture and ECM components. Isolated rat livers were decellularized by detergent-enzymatic technique with (EDTA-DET) or without EDTA (DET). Histology, DNA quantification and proteomics confirmed decellularization with further DNA reduction with the addition of EDTA. Quantification, histology, immunostaining, and proteomics demonstrated preservation of extracellular matrix components in both scaffolds with a higher amount of collagen and glycosaminoglycans in the EDTA-DET scaffold. Scanning electron microscopy and X-ray phase contrast imaging showed microarchitecture preservation, with EDTA-DET scaffolds more tightly packed. DET scaffold seeding with a hepatocellular cell line demonstrated complete repopulation in 14 days, with cells proliferating at that time. Decellularization using DET preserves microarchitecture and extracellular matrix components whilst allowing for cell growth for up to 14 days. Addition of EDTA creates a denser, more compact matrix. Transplantation of the scaffolds and scaling up of the methodology are the next steps for successful hepatic tissue engineering.	[Maghsoudlou, Panagiotis; Georgiades, Fanourios; Milan, Anna; Shangaris, Panicos; Urbani, Luca; Loukogeorgakis, Stavros P.; Eaton, Simon; De Coppi, Paolo] UCL Inst Child Hlth, Dept Stem Cells & Regenerat Med, 30 Guilford St, London WC1N 1EH, England; [Maghsoudlou, Panagiotis; Georgiades, Fanourios; Milan, Anna; Shangaris, Panicos; Urbani, Luca; Loukogeorgakis, Stavros P.; Sebire, Neil J.; Eaton, Simon; De Coppi, Paolo] Great Ormond St Hosp Sick Children, 30 Guilford St, London WC1N 1EH, England; [Smith, Holly; Gissen, Paul] UCL, MRC Lab Mol Cell Biol, Mortimer St, London WC1E 6BT, England; [Lombardi, Benedetta; Godovac-Zimmermann, Jasminka] UCL, London Ctr Nephrol, London WC1N 1EH, England; [Mazza, Giuseppe; Pinzani, Massimo] UCL, Inst Liver & Digest Hlth, London WC1N 1EH, England; [Hagen, Charlotte; Olivo, Alessandro] UCL, Dept Med Phys & Bioengn, London WC1N 1EH, England; [Sebire, Neil J.] UCL Inst Child Hlth, Dept Histopathol, London WC1N 1EH, England; [Turmaine, Mark] UCL, Div Biosci, London WC1N 1EH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	De Coppi, P (corresponding author), UCL Inst Child Hlth, Dept Stem Cells & Regenerat Med, 30 Guilford St, London WC1N 1EH, England.; De Coppi, P (corresponding author), Great Ormond St Hosp Sick Children, 30 Guilford St, London WC1N 1EH, England.	p.decoppi@ucl.ac.uk	Shangaris, Panicos/AAJ-7725-2020; Georgiades, Fanourios/ABE-3638-2020; Eaton, Simon/C-4942-2008	Shangaris, Panicos/0000-0003-2750-8405; Georgiades, Fanourios/0000-0003-0440-2720; Eaton, Simon/0000-0003-0892-9204; Olivo, Alessandro/0000-0002-7150-2951; De Coppi, Paolo/0000-0002-1659-0207; Maghsoudlou, Panagiotis/0000-0002-9945-3901; Sebire, Neil/0000-0001-5348-9063; Milan, Anna/0000-0003-3397-6563; Urbani, Luca/0000-0002-4988-552X; Gissen, Paul/0000-0002-9712-6122	Medical Research Council; Royal College of Surgeons of England; Sparks Children's Medical Charity; British Foreign Office for the UK/USA Stem Cell Collaboration Award; Mittal Research Fund; EPSRC [EP/G004250/1, EP/I021884/1, EP/L001381/1]; Wellcome Trust; ERC [WT095662MA, ERC-2013-StG - 337057]; Great Ormond Street Hospital Children's Charity; Engineering and Physical Sciences Research Council [EP/L001381/1, EP/G004250/1, EP/I021884/1] Funding Source: researchfish; Medical Research Council [MC_CF12266] Funding Source: researchfish; National Institute for Health Research [RP_2014-04-046, NF-SI-0513-10046] Funding Source: researchfish; Sparks Charity [12WTUCL02] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal College of Surgeons of England; Sparks Children's Medical Charity; British Foreign Office for the UK/USA Stem Cell Collaboration Award; Mittal Research Fund; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome Trust); ERC(European Research Council (ERC)European Commission); Great Ormond Street Hospital Children's Charity; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Sparks Charity	The authors acknowledge support by grants from the Medical Research Council, the Royal College of Surgeons of England, the Sparks Children's Medical Charity, the British Foreign Office for the UK/USA Stem Cell Collaboration Award and the Mittal Research Fund. AO and CKH are funded by the EPSRC (grants EP/G004250/1, EP/I021884/1 and EP/L001381/1). HS and PG are supported by the Wellcome Trust and ERC (WT095662MA, ERC-2013-StG - 337057). SE and PDC are supported by Great Ormond Street Hospital Children's Charity. The authors would also like to thank the Royal Society/Wolfson Foundation for the tissue engineering laboratory refurbishment grant obtained for the Pediatric Surgery Department at UCL Institute of Child Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge support by grants from the Medical Research Council, the Royal College of Surgeons of England, the Sparks Children's Medical Charity, the British Foreign Office for the UK/USA Stem Cell Collaboration Award and the Mittal Research Fund. AO, and CKH are funded by the EPSRC (grants EP/G004250/1, EP/I021884/1 and EP/L001381/1). HS and PG are supported by the Wellcome Trust and ERC (WT095662MA, ERC-2013-StG-337057). The authors are grateful to the personnel of beamline ID17 at the European Synchrotron Radiation Facility (especially Dr. A. Bravin and Dr. E. Brun) and to Dr. P.C. Diemoz for their help in setting up and running the synchrotron experiment. The authors would like to thank Dr. Bertrand Vernay for his help with the quantitation in the vascular network imaging. SE and PDC are supported by Great Ormond Street Hospital Children's Charity. We would also like to thank the Royal Society/Wolfson Foundation for the tissue engineering laboratory refurbishment grant obtained for the Pediatric Surgery Department at UCL Institute of Child Health.	Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18; Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067; Barakat O, 2012, J SURG RES, V173, pE11, DOI 10.1016/j.jss.2011.09.033; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; Castelli E, 2011, RADIOLOGY, V259, P684, DOI 10.1148/radiol.11100745; Cheng Y, 2013, DIGESTION, V87, P189, DOI 10.1159/000349949; Conconi MT, 2005, TRANSPLANT INT, V18, P727, DOI 10.1111/j.1432-2277.2005.00082.x; De Kock J, 2011, ARCH TOXICOL, V85, P607, DOI 10.1007/s00204-011-0706-1; Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5; Fishman JM, 2012, ANN OTO RHINOL LARYN, V121, P129, DOI 10.1177/000348941212100210; Geiger T, 2010, MOL CELL PROTEOMICS, V9, P2252, DOI 10.1074/mcp.M110.001537; Kajbafzadeh AM, 2013, TISSUE ENG PART C-ME, V19, P642, DOI [10.1089/ten.TEC.2012.0334, 10.1089/ten.tec.2012.0334]; Li QY, 2016, BIOMATERIALS, V75, P37, DOI 10.1016/j.biomaterials.2015.10.011; Maghsoudlou P, 2013, JOVE-J VIS EXP, DOI 10.3791/50658; Maghsoudlou P, 2013, BIOMATERIALS, V34, P6638, DOI 10.1016/j.biomaterials.2013.05.015; Mazza G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13079; MEEZAN E, 1975, LIFE SCI, V17, P1721, DOI 10.1016/0024-3205(75)90119-8; MERTENS G, 1992, J BIOL CHEM, V267, P20435; Mirmalek-Sani SH, 2013, AM J PATHOL, V183, P558, DOI 10.1016/j.ajpath.2013.05.002; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Nari GA, 2013, REV ESP ENFERM DIG, V105, P138, DOI 10.4321/s1130-01082013000300004; Olivo A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772193; Orens Jonathan B, 2009, Proc Am Thorac Soc, V6, P13, DOI 10.1513/pats.200807-072GO; Orlando G, 2012, ANN SURG, V255, P867, DOI 10.1097/SLA.0b013e318243a4db; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Pan MM, 2013, J NANOMATER, V2013, DOI 10.1155/2013/760685; Park KM, 2012, TRANSPL P, V44, P1151, DOI 10.1016/j.transproceed.2012.03.017; Qattan AT, 2010, J PROTEOME RES, V9, P495, DOI 10.1021/pr9008332; Ren HZ, 2013, LIVER INT, V33, P448, DOI 10.1111/liv.12088; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shirakigawa N, 2012, J BIOSCI BIOENG, V114, P546, DOI 10.1016/j.jbiosc.2012.05.022; Shupe T, 2010, ORGANOGENESIS, V6, P134, DOI 10.4161/org.6.2.11546; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Soto-gutierrez A, 2011, WHOLE ORGAN REGENERA, P17; Totonelli G, 2013, PEDIATR SURG INT, V29, P87, DOI 10.1007/s00383-012-3194-3; Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Wang YF, 2011, HEPATOLOGY, V53, P293, DOI 10.1002/hep.24012	39	49	51	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155324	10.1371/journal.pone.0155324	http://dx.doi.org/10.1371/journal.pone.0155324			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159223	Green Published, Green Submitted, gold			2022-12-27	WOS:000376576700057
J	Snoek, KG; Reiss, IKM; Tibboel, J; van Rosmalen, J; Capolupo, I; van Heijst, A; Schaible, T; Post, M; Tibboel, D				Snoek, Kitty G.; Reiss, Irwin K. M.; Tibboel, Jeroen; van Rosmalen, Joost; Capolupo, Irma; van Heijst, Arno; Schaible, Thomas; Post, Martin; Tibboel, Dick			Sphingolipids in Congenital Diaphragmatic Hernia; Results from an International Multicenter Study	PLOS ONE			English	Article							PRETERM INFANTS; BRONCHOPULMONARY DYSPLASIA; PULMONARY-HYPERTENSION; LUNG DEVELOPMENT; SURFACTANT; APOPTOSIS; SPHINGOSINE; RECEPTORS; HYPEROXIA; CONSENSUS	Background Congenital diaphragmatic hernia is a severe congenital anomaly with significant mortality and morbidity, for instance chronic lung disease. Sphingolipids have shown to be involved in lung injury, but their role in the pathophysiology of chronic lung disease has not been explored. We hypothesized that sphingolipid profiles in tracheal aspirates could play a role in predicting the mortality/development of chronic lung disease in congenital diaphragmatic hernia patients. Furthermore, we hypothesized that sphingolipid profiles differ between ventilation modes; conventional mechanical ventilation versus high-frequency oscillation. Methods Sphingolipid levels in tracheal aspirates were determined at days 1, 3, 7 and 14 in 72 neonates with congenital diaphragmatic hernia, born after > 34 weeks gestation at four high-volume congenital diaphragmatic hernia centers. Data were collected within a multicenter trial of initial ventilation strategy (NTR 1310). Results 36 patients (50.0%) died or developed chronic lung disease, 34 patients (47.2%) by stratification were initially ventilated by conventional mechanical ventilation and 38 patients (52.8%) by high-frequency oscillation. Multivariable logistic regression analysis with correction for side of the defect, liver position and observed-to-expected lung-to-head ratio, showed that none of the changes in sphingolipid levels were significantly associated with mortality/development of chronic lung disease. At day 14, long-chain ceramides 18: 1 and 24: 0 were significantly elevated in patients initially ventilated by conventional mechanical ventilation compared to high-frequency oscillation. Conclusions We could not detect significant differences in temporal sphingolipid levels in congenital diaphragmatic hernia infants with mortality/development of chronic lung disease versus survivors without development of CLD. Elevated levels of ceramides 18: 1 and 24: 0 in the conventional mechanical ventilation group when compared to high-frequency oscillation could probably be explained by high peak inspiratory pressures and remodeling of the alveolar membrane.	[Snoek, Kitty G.; Tibboel, Jeroen; Tibboel, Dick] Erasmus MC, Sophia Childrens Hosp, Intens Care, Rotterdam, Netherlands; [Snoek, Kitty G.; Tibboel, Jeroen; Tibboel, Dick] Erasmus MC, Sophia Childrens Hosp, Dept Paediat Surg, Rotterdam, Netherlands; [Reiss, Irwin K. M.] Erasmus MC, Sophia Childrens Hosp, Dept Neonatol, Rotterdam, Netherlands; [van Rosmalen, Joost] Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [Capolupo, Irma] Bambino Gesu Pediat Hosp, Dept Med & Surg Neonatol, Rome, Italy; [van Heijst, Arno] Radboud Univ Nijmegen, Med Ctr, Dept Neonatol, Nijmegen, Netherlands; [Schaible, Thomas] Univ Klinikum Mannheim, Dept Neonatol, Mannheim, Germany; [Post, Martin] Hosp Sick Children, Res Inst, Program Physiol & Expt Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; IRCCS Bambino Gesu; Radboud University Nijmegen; Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Snoek, KG (corresponding author), Erasmus MC, Sophia Childrens Hosp, Intens Care, Rotterdam, Netherlands.	k.snoek@erasmusmc.nl	van Heijst, Arno/P-8527-2014; Capolupo, Irma/AAB-5949-2022	van Heijst, Arno/0000-0003-2276-0177; Capolupo, Irma/0000-0002-3090-2887; van Rosmalen, Joost/0000-0002-9187-244X	Stichting Sophia Wetenschappelijk Onderzoek (SSWO) [NTR 1310]; Willem H. Kroger foundation [549]	Stichting Sophia Wetenschappelijk Onderzoek (SSWO); Willem H. Kroger foundation	The VICI-trial (NTR 1310) was funded by Stichting Sophia Wetenschappelijk Onderzoek (SSWO), Willem H. Kroger foundation (grant number 549). Data were collected during this trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; Boucherat O, 2007, PLOS MED, V4, P1205, DOI 10.1371/journal.pmed.0040237; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Colby CE, 2004, J PEDIATR SURG, V39, P1632, DOI 10.1016/j.jpedsurg.2004.07.005; Duess JW, 2015, PEDIATR SURG INT, V31, P465, DOI 10.1007/s00383-015-3695-y; Esther van Mastrigt SZ, 2015, SPHINGOLIPIDS TRACHE; Hargitai B, 2001, PEDIATR RES, V50, P110, DOI 10.1203/00006450-200107000-00020; Hosford GE, 2003, AM J PHYSIOL-LUNG C, V285, pL161, DOI 10.1152/ajplung.00285.2002; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lally KP, 2013, J PEDIATR SURG, V48, P2408, DOI 10.1016/j.jpedsurg.2013.08.014; Lally KP, 2004, J PEDIATR SURG, V39, P829, DOI 10.1016/j.jpedsurg.2004.02.011; Lee J, 2015, APOPTOSIS, V20, P740, DOI 10.1007/s10495-015-1112-6; May M, 2004, EUR RESPIR J, V23, P113, DOI 10.1183/09031936.03.00038403; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Patel N, 2015, AM J PHYSIOL-LUNG C, V308, pL378, DOI 10.1152/ajplung.00261.2014; Pierro M, 2014, SEMIN FETAL NEONAT M, V19, P357, DOI 10.1016/j.siny.2014.09.008; Reiss I, 2010, NEONATOLOGY, V98, P354, DOI 10.1159/000320622; Snoek KG, 2015, ANN SURG; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Thomas W, 2014, PAEDIATR RESPIR REV, V15, P49, DOI 10.1016/j.prrv.2013.09.004; Tibboel J, 2014, CHEST, V145, P120, DOI 10.1378/chest.13-0967; Tibboel J, 2013, EUR RESPIR J, V42, P776, DOI 10.1183/09031936.00092212; van den Hout L, 2010, NEONATOLOGY, V98, P370, DOI 10.1159/000316974; Van Meurs K, 2004, J PEDIATR-US, V145, P312, DOI 10.1016/j.jpeds.2004.04.056; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL167, DOI 10.1152/ajplung.00185.2004; Yang Yang, 2011, Ther Adv Respir Dis, V5, P325, DOI 10.1177/1753465811406772; Yasuo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053927; Zimmer J, 2016, PEDIATR SURG INT, V32, P147, DOI 10.1007/s00383-015-3825-6	30	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155136	10.1371/journal.pone.0155136	http://dx.doi.org/10.1371/journal.pone.0155136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159222	Green Published, gold, Green Submitted			2022-12-27	WOS:000376576700046
J	Drozdova, PB; Tarasov, OV; Matveenko, AG; Radchenko, EA; Sopova, JV; Polev, DE; Inge-Vechtomov, SG; Dobrynin, PV				Drozdova, Polina B.; Tarasov, Oleg V.; Matveenko, Andrew G.; Radchenko, Elina A.; Sopova, Julia V.; Polev, Dmitrii E.; Inge-Vechtomov, Sergey G.; Dobrynin, Pavel V.			Genome Sequencing and Comparative Analysis of Saccharomyces cerevisiae Strains of the Peterhof Genetic Collection	PLOS ONE			English	Article							COPY NUMBER; NONSENSE-SUPPRESSION; POPULATION-STRUCTURE; DETERMINANT ISP+; SHUTTLE VECTORS; READ ALIGNMENT; UNIPRO UGENE; FACTOR ERF1; SUP35 GENE; YEAST	The Peterhof genetic collection of Saccharomyces cerevisiae strains (PGC) is a large laboratory stock that has accumulated several thousands of strains for over than half a century. It originated independently of other common laboratory stocks from a distillery lineage (race XII). Several PGC strains have been extensively used in certain fields of yeast research but their genomes have not been thoroughly explored yet. Here we employed whole genome sequencing to characterize five selected PGC strains including one of the closest to the progenitor, 15V-P4, and several strains that have been used to study translation termination and prions in yeast (25-25-2V-P3982, 1B-D1606, 74-D694, and 6P-33G-D373). The genetic distance between the PGC progenitor and S288C is comparable to that between two geographically isolated populations. The PGC seems to be closer to two bakery strains than to S288C-related laboratory stocks or European wine strains. In genomes of the PGC strains, we found several loci which are absent from the S288C genome; 15V-P4 harbors a rare combination of the gene cluster characteristic for wine strains and the RTM1 cluster. We closely examined known and previously uncharacterized gene variants of particular strains and were able to establish the molecular basis for known phenotypes including phenylalanine auxotrophy, clumping behavior and galactose utilization. Finally, we made sequencing data and results of the analysis available for the yeast community. Our data widen the knowledge about genetic variation between Saccharomyces cerevisiae strains and can form the basis for planning future work in PGC-related strains and with PGC-derived alleles.	[Drozdova, Polina B.; Tarasov, Oleg V.; Radchenko, Elina A.; Sopova, Julia V.; Inge-Vechtomov, Sergey G.] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg 199034, Russia; [Drozdova, Polina B.; Radchenko, Elina A.; Dobrynin, Pavel V.] Bioinformat Inst, St Petersburg, Russia; [Tarasov, Oleg V.] RAS, St Petersburg Sci Ctr, St Petersburg, Russia; [Matveenko, Andrew G.; Sopova, Julia V.; Inge-Vechtomov, Sergey G.] Russian Acad Sci, Vavilov Inst Gen Genet, St Petersburg Branch, St Petersburg 196140, Russia; [Matveenko, Andrew G.] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg 199034, Russia; [Sopova, Julia V.] St Petersburg State Univ, Inst Translat Biomed, St Petersburg 199034, Russia; [Polev, Dmitrii E.] St Petersburg State Univ, Res Resource Ctr Mol & Cell Technol, Res Pk, St Petersburg 199034, Russia; [Dobrynin, Pavel V.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, Res Pk, St Petersburg 199034, Russia; [Radchenko, Elina A.] Tufts Univ, Dept Biol, Medford, MA USA; [Polev, Dmitrii E.] St Petersburg State Univ, Res Resource Ctr Biobank, Res Pk, St Petersburg 199034, Russia	Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Vavilov Institute of General Genetics; Saint Petersburg State University; Saint Petersburg State University; Saint Petersburg State University; Saint Petersburg State University; Tufts University; Saint Petersburg State University	Drozdova, PB (corresponding author), St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg 199034, Russia.; Drozdova, PB (corresponding author), Bioinformat Inst, St Petersburg, Russia.	p.drozdova@spbu.ru	Drozdova, Polina/H-9490-2013; Radchenko, Elina/N-4420-2013; Dobrynin, Pavel/AAT-6762-2020; Sopova, Julia/AAE-8214-2021; Tarasov, Oleg V/H-7329-2013; Sopova, Julia/N-5112-2015; Polev, Dmitrii E/D-1386-2012; Matveenko, Andrew G./S-7876-2017	Drozdova, Polina/0000-0003-3955-6105; Radchenko, Elina/0000-0002-9350-1706; Dobrynin, Pavel/0000-0001-6995-5620; Sopova, Julia/0000-0002-7825-273X; Sopova, Julia/0000-0002-7825-273X; Polev, Dmitrii E/0000-0001-9679-2791; Matveenko, Andrew G./0000-0002-9458-0194; Oleg, Tarasov/0000-0003-1116-0336	Russian Foundation for Basic Research [14-04-31265, 15-29-02526]; Saint-Petersburg State University [1.38.426.2015, 1.37.291.2015, 15.61.2218.2013, 1.42.1394.2015]; Saint-Petersburg City Committee on Science and High School [15404, 15919]; Russian Science Foundation [14-50-00069]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Saint-Petersburg State University; Saint-Petersburg City Committee on Science and High School; Russian Science Foundation(Russian Science Foundation (RSF))	PBD acknowledges the Russian Foundation for Basic Research (www.rfbr.ru) for grant 14-04-31265. OVT and SGIV acknowledge the Russian Foundation for Basic Research for grant 15-29-02526. JVS acknowledges the Russian Science Foundation (www.rscf.ru) for grant 14-50-00069 and the Saint-Petersburg State University for grant 1.38.426.2015. PBD, AGM, EAR, and JVS acknowledge the Saint-Petersburg State University for research grant 1.37.291.2015. PBD and OVT acknowledge the Saint-Petersburg City Committee on Science and High School (knvsh.gov.spb.ru/) for grants 15404 and 15919, respectively. PBD, AGM, JVS, and SGIV acknowledge the Saint-Petersburg State University for research grant 15.61.2218.2013. PBD acknowledges the Saint-Petersburg State University for research grant 1.42.1394.2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenova AY, 2006, MOL BIOL+, V40, P758, DOI 10.1134/S0026893306050104; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Andrews S., 2010, FASTQC QUALITY CONTR; Andrianova VM, 2003, CATALOGUE PETERHOF G; Baker E, 2015, MOL BIOL EVOL, V32, P2818, DOI 10.1093/molbev/msv168; Balakrishnan R, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar062; BALDACCI G, 1982, EUR J BIOCHEM, V127, P411, DOI 10.1111/j.1432-1033.1982.tb06887.x; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergstrom A, 2014, MOL BIOL EVOL, V31, P872, DOI 10.1093/molbev/msu037; Bertram G, 2000, RNA, V6, P1236, DOI 10.1017/S1355838200000777; Borneman AR, 2016, G3-GENES GENOM GENET, V6, P957, DOI 10.1534/g3.115.025692; Borneman AR, 2015, GENETICS, V199, P281, DOI 10.1534/genetics.114.173633; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; BORTS RH, 1984, COLD SPRING HARB SYM, V49, P67, DOI 10.1101/SQB.1984.049.01.010; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; CALDERON IL, 1984, GENE, V29, P69, DOI 10.1016/0378-1119(84)90167-7; CARLSON M, 1983, MOL CELL BIOL, V3, P351, DOI 10.1128/MCB.3.3.351; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chabelskaya S, 2004, MOL GENET GENOMICS, V272, P297, DOI 10.1007/s00438-004-1053-1; Chabelskaya S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-71; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; CHERNOV IO, 1988, DOKL AKAD NAUK SSSR+, V301, P1227; Cherry J.M., 2011, NUCLEIC ACIDS RES; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Deregowska A, 2015, ONCOTARGET, V6, P30650, DOI 10.18632/oncotarget.5594; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Du ZQ, 2014, GENETICS, V197, P685, DOI 10.1534/genetics.114.163402; DUNLOP PC, 1975, J BACTERIOL, V122, P1017, DOI 10.1128/JB.122.3.1017-1024.1975; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; Fitzpatrick DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028684; Garrison E, 2012, ARXIV12073907QBIOGN; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Golosova O, 2014, PEERJ, V2, DOI 10.7717/peerj.644; GOTO K, 1990, AGR BIOL CHEM TOKYO, V54, P979, DOI 10.1080/00021369.1990.10870081; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Harris R. S., 2007, THESIS PENNSYLVANIA; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; INGE-VECHTOMOV S G, 1975, Genetika, V11, P121; INGE-VECHTOMOV S G, 1970, Genetika, V6, P103; INGE-VECHTOMOV S G, 1971, Genetika, V7, P113; Inge-Vechtomov SG, 1963, VESTN LENINGR U, V21, P117; INGEVECHTOMOV SG, 1988, GENETIKA+, V24, P1159; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Jung PP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-331; Kaiser C., 1994, METHODS YEAST GENETI; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kobayashi O, 1996, MOL GEN GENET, V251, P707, DOI 10.1007/s004380050220; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kumar C, 2003, YEAST, V20, P857, DOI 10.1002/yea.1012; LACROUTE F, 1968, J BACTERIOL, V95, P824, DOI 10.1128/JB.95.3.824-832.1968; Lada AG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003736; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JR, 2013, DNA RES, V20, P55, DOI 10.1093/dnares/dss033; LINDEGREN CC, 1949, YEAST CELL ITS GENET; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Liti G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-69; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu HP, 1996, GENETICS, V144, P967; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Majumdar S, 2004, EUR J BIOCHEM, V271, P753, DOI 10.1111/j.1432-1033.2003.03974.x; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Manente M, 2009, FEMS YEAST RES, V9, P673, DOI 10.1111/j.1567-1364.2009.00513.x; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MEIRA LB, 1995, NUCLEIC ACIDS RES, V23, P1614, DOI 10.1093/nar/23.9.1614; MORTIMER RK, 1966, GENETICS, V53, P165; MORTIMER RK, 1986, GENETICS, V113, P35; Moskalenko SE, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-2; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; Naumova ES, 2013, MICROBIOLOGY+, V82, P175, DOI 10.1134/S0026261713020112; NESS F, 1995, GENETICS, V140, P945; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Petrova A, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov033; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-475; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2012, FIGTREE; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rogoza T, 2010, P NATL ACAD SCI USA, V107, P10573, DOI 10.1073/pnas.1005949107; ROSE M, 1984, MOL GEN GENET, V193, P557, DOI 10.1007/BF00382100; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; SAMBUK EV, 1980, GENETIKA+, V16, P833; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1989, GENETICS, V122, P19; Simarov BV, 1967, ISSLED GENET, V3, P127; Smit A.F.A., 2015, REPEATMASKER OPEN 4; Song G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120671; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Strope PK, 2015, GENOME RES, V25, P762, DOI 10.1101/gr.185538.114; STRUHL K, 1984, P NATL ACAD SCI-BIOL, V81, P7865, DOI 10.1073/pnas.81.24.7865; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamazian G, 2015, CHROMOSOMER REFERENC; Thoden JB, 2001, J BIOL CHEM, V276, P20617, DOI 10.1074/jbc.M101304200; Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200; Timson DJ, 2005, FEBS J, V272, P6170, DOI 10.1111/j.1742-4658.2005.05017.x; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Volkov K. V., 2000, Genetika, V36, P155; Volkov KV, 2002, GENETICS, V160, P25; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wohlers TM, 1999, AM J HUM GENET, V64, P462, DOI 10.1086/302263; Wolfe KH, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002221; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yin Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003894; Zadorskii SP, 1998, DOKL AKAD NAUK+, V361, P825; Zadorsky SP, 2015, YEAST, V32, P479, DOI 10.1002/yea.3074; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x; Zhouravleva G, 2010, DOKL BIOCHEM BIOPHYS, V433, P209, DOI 10.1134/S1607672910040162	133	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154722	10.1371/journal.pone.0154722	http://dx.doi.org/10.1371/journal.pone.0154722			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152522	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000030
J	Gao, JM; Xie, YX; Jin, HY; Liu, Y; Bai, XY; Ma, DY; Zhu, YJ; Wang, CY; Guo, TC				Gao, Jianmin; Xie, Yingxin; Jin, Haiyang; Liu, Yuan; Bai, Xueying; Ma, Dongyun; Zhu, Yunji; Wang, Chenyang; Guo, Tiancai			Nitrous Oxide Emission and Denitrifier Abundance in Two Agricultural Soils Amended with Crop Residues and Urea in the North China Plain	PLOS ONE			English	Article							COMMUNITY COMPOSITION; NUTRIENT MANAGEMENT; RIBOSOMAL-RNA; N MANAGEMENT; N2O; FERTILIZATION; ROTATION; SYSTEM; NITRIFICATION; NITRIFIER	The application of crop residues combined with Nitrogen (N) fertilizer has been broadly adopted in China. Crop residue amendments can provide readily available C and N, as well as other nutrients to agricultural soils, but also intensify the N fixation, further affecting N2O emissions. N2O pulses are obviously driven by rainfall, irrigation and fertilization. Fertilization before rainfall or followed by flooding irrigation is a general management practice for a wheat-maize rotation in the North China Plain. Yet, little is known on the impacts of crop residues combined with N fertilizer application on N2O emission under high soil moisture content. A laboratory incubation experiment was conducted to investigate the effects of two crop residue amendments (maize and wheat), individually or in combination with N fertilizer, on N2O emissions and denitrifier abundance in two main agricultural soils (one is an alluvial soil, pH 8.55, belongs to Ochri-Aquic Cambosols, OAC, the other is a lime concretion black soil, pH 6.61, belongs to Hapli-Aquic Vertosols, HAV) under 80% WFPS (the water filled pore space) in the North China Plain. Each type soil contains seven treatments: a control with no N fertilizer application (CK, N0), 200 kg N ha(-1) (N200), 250 kg N ha(-1) (N250), maize residue plus N200 (MN200), maize residue plus N250 (MN250), wheat residue plus N200 (WN200) and wheat residue plus N250 (WN250). Results showed that, in the HAV soil, MN250 and WN250 increased the cumulative N2O emissions by 60% and 30% compared with N250 treatment, respectively, but MN200 and WN200 decreased the cumulative N2O emissions by 20% and 50% compared with N200. In the OAC soil, compared with N200 or N250, WN200 and WN250 increased the cumulative N2O emission by 40%-50%, but MN200 and MN250 decreased the cumulative N2O emission by 10%-20%. Compared with CK, addition of crop residue or N fertilizer resulted in significant increases in N2O emissions in both soils. The cumulative N2O emissions from the treatments of 250 kg N ha(-1) were 1.1-3.3 times higher than those of treatments with 200 kg N ha(-1) in both soils with adding equal amounts of the same type of crop residue. Abundance of the 16S rRNA gene did not significantly change in all treatments in two soils, but the nosZ and nirS genes were more abundant in soils amended with crop residues compared with CK or N-only treatments. N2O emission, however, were not related to the abundance of denitrifier containing nirS or nosZ. The research provided some information regarding the effect of crop residues with N fertilizer on N2O emissions and denitrifier abundances in two soils. Our results imply the property of crop residue and rate of N fertilizer are important influencing factors of N2O emission when crop residues combined with N fertilizer are applied to different agricultural soils.	[Gao, Jianmin; Xie, Yingxin; Jin, Haiyang; Liu, Yuan; Bai, Xueying; Ma, Dongyun; Zhu, Yunji; Wang, Chenyang; Guo, Tiancai] Henan Agr Univ, Natl Engn Res Ctr Wheat, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China; [Zhu, Yunji] Henan Agr Univ, Coll Resources & Environm, Zhengzhou 450002, Peoples R China	Henan Agricultural University; Henan Agricultural University	Guo, TC (corresponding author), Henan Agr Univ, Natl Engn Res Ctr Wheat, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China.	tcguo888@sina.com		Jin, Haiyang/0000-0002-0357-9877	National Natural Science Foundation of China [31272246]; Special Fund for Agro-scientific Research in the Public Interest [201203031, 201303102]; "Five-twelfth" National Science and Technology Support Program of China [2013BAD07B00, 2015BAD26B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; "Five-twelfth" National Science and Technology Support Program of China	This work was supported by the National Natural Science Foundation of China [grant number 31272246], the Special Fund for Agro-scientific Research in the Public Interest [grant numbers 201203031;201303102], and the "Five-twelfth" National Science and Technology Support Program of China [grant numbers 2013BAD07B00;2015BAD26B01].	Azam F, 2002, BIOL FERT SOILS, V35, P54, DOI 10.1007/s00374-001-0441-5; Baggs EM, 2000, SOIL USE MANAGE, V16, P82, DOI 10.1111/j.1475-2743.2000.tb00179.x; Begum N, 2014, BIOL FERT SOILS, V50, P499, DOI 10.1007/s00374-013-0865-8; Cavigelli MA, 2000, ECOLOGY, V81, P1402; Chen Z, 2012, J SCI FOOD AGR, V92, P1064, DOI 10.1002/jsfa.4533; Dandie CE, 2008, APPL ENVIRON MICROB, V74, P5997, DOI 10.1128/AEM.00441-08; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; EICHNER MJ, 1990, J ENVIRON QUAL, V19, P272, DOI 10.2134/jeq1990.00472425001900020013x; Fabrizzi KP, 2005, SOIL TILL RES, V81, P57, DOI 10.1016/j.still.2004.05.001; Frimpong KA, 2010, SOIL USE MANAGE, V26, P412, DOI 10.1111/j.1475-2743.2010.00293.x; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; He FF, 2007, NUTR CYCL AGROECOSYS, V77, P1, DOI 10.1007/s10705-006-6275-7; He P, 2009, AGRON J, V101, P1489, DOI 10.2134/agronj2009.0099; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Holtan-Hartwig L, 2000, SOIL BIOL BIOCHEM, V32, P833, DOI 10.1016/S0038-0717(99)00213-8; Huang Y, 2004, SOIL BIOL BIOCHEM, V36, P973, DOI 10.1016/j.soilbio.2004.02.009; IPCC [Intergovernmental Panel on Climate Change], 2007, CONTR WORK GROUP 3 4; Jiang D, 2012, RENEW SUST ENERG REV, V16, P1377, DOI 10.1016/j.rser.2011.12.012; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kaiser EA, 1998, SOIL BIOL BIOCHEM, V30, P1553, DOI 10.1016/S0038-0717(98)00036-4; Kong AYY, 2010, SOIL BIOL BIOCHEM, V42, P1523, DOI 10.1016/j.soilbio.2010.05.021; Kumar K, 2000, ADV AGRON, V68, P197; Lemke RL, 1998, SOIL SCI SOC AM J, V62, P1096, DOI 10.2136/sssaj1998.03615995006200040034x; Li XC, 2013, APPL SOIL ECOL, V64, P91, DOI 10.1016/j.apsoil.2012.10.003; Li XY, 2002, AGR WATER MANAGE, V54, P243, DOI 10.1016/S0378-3774(01)00172-X; Liu CY, 2011, AGR ECOSYST ENVIRON, V140, P226, DOI 10.1016/j.agee.2010.12.009; Ma J, 2009, SOIL BIOL BIOCHEM, V41, P1022, DOI 10.1016/j.soilbio.2009.01.024; Ma WK, 2008, SOIL BIOL BIOCHEM, V40, P1114, DOI 10.1016/j.soilbio.2007.12.004; Miller MN, 2008, SOIL BIOL BIOCHEM, V40, P2553, DOI 10.1016/j.soilbio.2008.06.024; Miller MN, 2012, GEODERMA, V170, P48, DOI 10.1016/j.geoderma.2011.11.022; Philippot L, 2005, CURR OPIN MICROBIOL, V8, P234, DOI 10.1016/j.mib.2005.04.003; Rizhiya EY, 2011, EURASIAN SOIL SCI+, V44, P1144, DOI 10.1134/S1064229311100115; ROBERTSON GP, 1987, SOIL BIOL BIOCHEM, V19, P187, DOI 10.1016/0038-0717(87)90080-0; Rousk J, 2007, FEMS MICROBIOL ECOL, V62, P258, DOI 10.1111/j.1574-6941.2007.00398.x; Ruser R, 2006, SOIL BIOL BIOCHEM, V38, P263, DOI 10.1016/j.soilbio.2005.05.005; Shan J, 2013, ATMOS ENVIRON, V71, P170, DOI 10.1016/j.atmosenv.2013.02.009; Sharma P, 2011, EUR J AGRON, V34, P46, DOI 10.1016/j.eja.2010.10.003; Shelp ML, 2000, COMMUN SOIL SCI PLAN, V31, P877, DOI 10.1080/00103620009370484; SMITH MS, 1979, SOIL BIOL BIOCHEM, V11, P261, DOI 10.1016/0038-0717(79)90071-3; Soest V.P.J, 1963, J ASS OFF AGR CHEM, V49, P546; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tatti E, 2014, AGR ECOSYST ENVIRON, V183, P47, DOI 10.1016/j.agee.2013.10.021; Vinten AJA, 2002, BIOL FERT SOILS, V36, P190, DOI 10.1007/s00374-002-0524-y; Wallenstein MD, 2006, ECOL APPL, V16, P2143, DOI 10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2; Wang YC, 2010, NUTR CYCL AGROECOSYS, V86, P105, DOI 10.1007/s10705-009-9276-5; Yao ZS, 2013, ATMOS ENVIRON, V79, P641, DOI 10.1016/j.atmosenv.2013.07.006; Yu YJ, 2014, BIOL FERT SOILS, V50, P105, DOI 10.1007/s00374-013-0839-x; Zhao RF, 2006, AGRON J, V98, P938, DOI 10.2134/agronj2005.0157; Zhen L, 2006, J ENVIRON MANAGE, V79, P409, DOI 10.1016/j.jenvman.2005.08.009; Zou JW, 2005, ATMOS ENVIRON, V39, P4755, DOI 10.1016/j.atmosenv.2005.04.028	50	26	27	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154773	10.1371/journal.pone.0154773	http://dx.doi.org/10.1371/journal.pone.0154773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152647	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000033
J	Sadato, A; Hayakawa, M; Adachi, K; Nakahara, I; Hirose, Y				Sadato, Akiyo; Hayakawa, Motoharu; Adachi, Kazuhide; Nakahara, Ichiro; Hirose, Yuichi			Large Residual Volume, Not Low Packing Density, Is the Most Influential Risk Factor for Recanalization after Coil Embolization of Cerebral Aneurysms	PLOS ONE			English	Article							GUGLIELMI DETACHABLE COILS; STENT-ASSISTED COILING; ANGIOGRAPHIC FOLLOW-UP; INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; IN-VITRO; RATIO; PREDICTORS; COMPACTION; STABILITY	Background Tight coil packing with density of at least 20%-25% is known to be important for preventing recanalization after embolization of cerebral aneurysms. However, large aneurysms sometimes recanalize regardless of the packing density, suggesting that the absolute residual volume which is determined by aneurysm volume and packing density may be more important risk factor for recanalization. To validate this hypothesis, we analyzed the factors affecting the outcomes of treated aneurysms at our institute. Methods and Findings We included 355 small and large aneurysms. The following six factors were obtained from every case: aneurysm volume (mL), neck size (mm), packing density (%), residual volume (mL), rupture status at presentation, and stent assistance (with or without stent). The data were then subjected to multivariate logistic regression analysis to identify significant risk factors for recanalization. Recanalization occurred in 61 aneurysms (17.2%). Significant predictors for recanalization were aneurysm volume (odds ratio, 15.3; P < 0.001) and residual volume (odds ratio, 30.9; P < 0.001), but not packing density (odds ratio, 0.98; P = 0.341). These results showed that for each 0.1-mL increase in aneurysm volume and residual volume, the risk of recanalization increased by 1.3 times and 1.4 times, respectively. Conclusions The most influential risk factor for recanalization after coil embolization was residual volume, not packing density. The larger the aneurysm volume, the greater the packing density has to be to minimize the residual volume and risk of recanalization. Since tight coil packing has already been aimed, further innovation of coil property or embolization technique may be needed. Otherwise, different treatment modality such as flow diverter or parent artery occlusion may have to be considered.	[Sadato, Akiyo; Hayakawa, Motoharu; Adachi, Kazuhide; Nakahara, Ichiro; Hirose, Yuichi] Fujita Hlth Univ, Dept Neurosurg, Toyoake, Aichi, Japan	Fujita Health University	Sadato, A (corresponding author), Fujita Hlth Univ, Dept Neurosurg, Toyoake, Aichi, Japan.	asadato@fujita-hu.ac.jp	Nakahara, Ichiro/G-3259-2010; Hirose, Yuichi/P-1731-2019	Nakahara, Ichiro/0000-0001-8909-2949; Hirose, Yuichi/0000-0002-1305-1830; ADACHI, KAZUHIDE/0000-0002-5275-8572				Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Chalouhi N, 2014, AM J NEURORADIOL, V35, P546, DOI 10.3174/ajnr.A3696; Chalouhi N, 2013, STROKE, V44, P1348, DOI 10.1161/STROKEAHA.111.000641; Cognard C, 1999, RADIOLOGY, V212, P348, DOI 10.1148/radiology.212.2.r99jl47348; Gallas S, 2005, AM J NEURORADIOL, V26, P1723; Goddard JK, 2005, AM J NEURORADIOL, V26, P1916; Grunwald IQ, 2007, NEURORADIOLOGY, V49, P41, DOI 10.1007/s00234-006-0153-5; Grunwald IQ, 2010, VASC ENDOVASC SURG, V44, P289, DOI 10.1177/1538574410363916; Hetts SW, 2014, AM J NEURORADIOL, V35, P698, DOI 10.3174/ajnr.A3755; Kai Y, 2005, NEUROSURGERY, V56, P785, DOI 10.1227/01.NEU.0000156790.28794.EA; Kawanabe Y, 2001, ACTA NEUROCHIR, V143, P451, DOI 10.1007/s007010170073; Lee JY, 2013, J KOREAN NEUROSURG S, V53, P342, DOI 10.3340/jkns.2013.53.6.342; Mascitelli JR, 2015, J CLIN NEUROSCI, V22, P1275, DOI 10.1016/j.jocn.2015.03.002; Mehra M, 2011, J NEUROINTERV SURG, V3, P131, DOI 10.1136/jnis.2010.004390; Murayama Y, 2003, J NEUROSURG, V98, P959, DOI 10.3171/jns.2003.98.5.0959; Quintana EM, 2015, J NEUROINTERV SURG, V7, P892, DOI 10.1136/neurintsurg-2014-011300; Ogilvy CS, 2015, NEUROSURGERY, V76, P390, DOI 10.1227/NEU.0000000000000651; Pierot L, 2012, AM J NEURORADIOL, V33, P1475, DOI 10.3174/ajnr.A3003; Piotin M, 2004, NEURORADIOLOGY, V46, P935, DOI 10.1007/s00234-004-1264-5; Piotin M, 2003, AM J NEURORADIOL, V24, P1446; Piotin M, 2007, RADIOLOGY, V243, P500, DOI 10.1148/radiol.2431060006; Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9; Ries T, 2007, AM J NEURORADIOL, V28, P1755, DOI 10.3174/ajnr.A0649; Sadato A, 2011, INTERV NEURORADIOL, V17, P154, DOI 10.1177/159101991101700203; Slob MJ, 2005, NEURORADIOLOGY, V47, P942, DOI 10.1007/s00234-005-1446-9; Sluzewski M, 2004, RADIOLOGY, V231, P653, DOI 10.1148/radiol.2313030460; Tamatani S, 2002, AM J NEURORADIOL, V23, P762; Teleb MS, 2014, J NEUROINTERV SURG, V6, P490, DOI 10.1136/neurintsurg-2013-010836; Uchiyama N, 2000, INTERV NEURORADIOL, V6, P59, DOI 10.1177/15910199000060S106; Willinsky RA, 2009, AM J NEURORADIOL, V30, P1035, DOI 10.3174/ajnr.A1488; Yagi K, 2005, NEUROL MED-CHIR, V45, P561, DOI 10.2176/nmc.45.561	31	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155062	10.1371/journal.pone.0155062	http://dx.doi.org/10.1371/journal.pone.0155062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27153192	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000064
J	Akinlua, JT; Meakin, R; Fadahunsi, P; Freemantle, N				Akinlua, James Tosin; Meakin, Richard; Fadahunsi, Philip; Freemantle, Nick			Beliefs of Health Care Providers, Lay Health Care Providers and Lay Persons in Nigeria Regarding Hypertension. A Systematic Mixed Studies Review	PLOS ONE			English	Review							QUALITATIVE RESEARCH; KNOWLEDGE; ILLNESS; MEDICATION; ADHERENCE; CULTURE; MODELS; TOOL	Background Hypertension is a major health risk factor for mortality globally, resulting in about 13% of deaths worldwide. In Nigeria, the high burden of hypertension remains an issue for urgent attention. The control of hypertension, among other factors, is strongly determined by personal beliefs about the illness and recommended treatment. Objective The aim of this review is to systematically synthesize available data from all types of studies on beliefs of the Nigerian populace about hypertension Methods We searched the following electronic databases; Medline, EMBase, PsycInfo, AMED from their inception till date for all relevant articles. A modified Kleinman's explanatory model for hypertension was used as a framework for extraction of data on beliefs about hypertension. Results The search yielded a total of 3,794 hits from which 16 relevant studies (2 qualitative, 11 quantitative and 3 mixed methods studies) met the inclusion criteria for the review. Overall, most health care providers (HCPs) believe that stress is a major cause of hypertension. Furthermore, reported cut-off point for uncomplicated hypertension differed widely among HCPs. Lay Health Care Providers such as Patent Medicine Vendors' beliefs about hypertension seem to be relatively similar to health care professionals in areas of risk factors for hypertension, course of hypertension and methods of treatment. Among Lay persons, misconception about hypertension was quite high. Although some Nigerians believed that life style habits such as alcohol intake, exercise levels, cigarette smoking were risk factors for developing hypertension, there was discordance between belief and practice of control of risk factors. However, beliefs across numerous ethnic groups and settings (urban/rural) in Nigeria have not been explored. Conclusion In order to achieve control of hypertension in Nigeria, interventions should be informed, among other factors, by adequate knowledge of beliefs regarding hypertension across the numerous ethnic groups in Nigeria, settings (rural/urban), age and sex.	[Akinlua, James Tosin; Meakin, Richard; Freemantle, Nick] UCL, Sch Med, Dept Primary Care & Populat Hlth, Royal Free Campus,Rowland Hill St, London NW3 2PF, England; [Fadahunsi, Philip] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Charing Cross Campus,Reynolds Bldg,St Dunstan Rd, London W6 8RP, England	University of London; University College London; UCL Medical School; Imperial College London	Freemantle, N (corresponding author), UCL, Sch Med, Dept Primary Care & Populat Hlth, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	Nicholas.freemantle@ucl.ac.uk		Meakin, Richard/0000-0003-2382-6844	NYSC Presidential Scholarship Scheme through the Nigerian Universities Commission/Tertiary Education Fund	NYSC Presidential Scholarship Scheme through the Nigerian Universities Commission/Tertiary Education Fund	This review forms part of research work towards a PhD (AKINLUA JT) at the University College London, funded by the NYSC Presidential Scholarship Scheme through the Nigerian Universities Commission/Tertiary Education Fund. The sponsor had no role in study design, data collection, analysis, interpretation, or writing of the report.	Adamu U.G., 2014, WORLD J CARDIOVASCUL, V4, P251; Adeniyi M.A., 2015, WORLD J PHARM SCI, V3, P368; Ai-Dharrab S A, 1996, J Family Community Med, V3, P57; Akinlua JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140021; Atulomah N.O., 2010, ACTA SATECH, V3, P143; Azubuike SO., 2014, ARCH MED HEALTH SCI, V2, P23, DOI [10.4103/2321-4848.133791, DOI 10.4103/2321-4848.133791]; Banning M, 2011, EUROPEAN J CANC CARE, V2, P78; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Beune EJAJ, 2006, J HUM HYPERTENS, V20, P946, DOI 10.1038/sj.jhh.1002094; Blumhagen D, 1984, CULT MED PSYCHIAT, P197; Boutin-Foster C, 2007, ETHNIC DIS, V17, P29; Bovet P, 2002, B WORLD HEALTH ORGAN, V80, P33; Campbell R, 2003, SOC SCI MED, V56, P671, DOI 10.1016/S0277-9536(02)00064-3; Chobanian A.V., 2003, JAMA-J AM MED ASSOC, V289, P256; Creswell J.W., 2007, DESIGNING CONDUCTING; Critical Appraisal Skills Programme (CASP), 2006, MAK SENS EV 1 QUEST; Crowe M, 2011, J CLIN EPIDEMIOL, V64, P79, DOI 10.1016/j.jclinepi.2010.02.008; De Maeseneer J, 2012, LANCET, V379, P1860, DOI 10.1016/S0140-6736(11)61135-5; Dixon-Woods Mary, 2007, J Health Serv Res Policy, V12, P42, DOI 10.1258/135581907779497486; Espíndola Cybele Ribeiro, 2006, Rev. psiquiatr. Rio Gd. Sul, V28, P265, DOI 10.1590/S0101-81082006000300006; Familoni BO, 2004, J NATL MED ASSOC, V96, P620; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Glynn L., 2010, COCHRANE DB SYST REV, V21; Good B, 1994, MED RATIONALITY EXPE; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; HEURTINROBERTS S, 1992, AM J HYPERTENS, V5, P787, DOI 10.1093/ajh/5.11.787; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 1997, PERCEPTIONS HLTH ILL, P155; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Ike SO, 2010, T ROY SOC TROP MED H, V104, P55, DOI 10.1016/j.trstmh.2009.07.029; Kane GA, 2007, CHILD CARE HLTH DEV, V33, P784, DOI 10.1111/j.1365-2214.2007.00750.x; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kleinman A., 1980, PATIENTS HEALERS CON; Lalande R, 1991, PSYCHOL MED, V23, P655; Leventhal H., 2003, SELF REGULATION HLTH, P138; Malpass A., 1982, SOC SCI MED, V29, P154; Milne A., 2021, J LONG TERM CARE, P401, DOI [https://doi.org/10.31389/jltc.102, DOI 10.31389/JLTC.102]; NICE, 2009, MED ADH INV PAT DEC; Odusola AO, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0624-z; Oke DA, 2004, J NATL MED ASSOC, V96, P1221; Okwuonu C. G., 2014, International Journal of Medicine and Biomedical Research, V3, P121; Okwuonu CG, 2014, INT J GEN MED, V7, P345, DOI 10.2147/IJGM.S63587; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; Organization WH, 2009, GLOB HLTH RISKS MORT; Osamor PE, 2011, J HEALTH POPUL NUTR, V29, P619; Osamor PE, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-36; Osamor PE, 2011, MED SOCIOLOGY ONLINE, V6, P5; Pelto PJ, 1997, MED ANTHROPOL Q, V11, P147, DOI 10.1525/maq.1997.11.2.147; Pluye P., 2011, PROPOSAL MIXED METHO; Pluye P, 2009, INT J NURS STUD, V46, P529, DOI 10.1016/j.ijnurstu.2009.01.009; Possidente CJ, 2005, AM J HEALTH-SYST PH, V62, P1311, DOI 10.1093/ajhp/62.12.1311; Powers WJ, 2015, STROKE, DOI DOI 10.1161/STR.0000000000000074; Rhodes T, 2008, ADDICTION, V103, P1593, DOI 10.1111/j.1360-0443.2008.02306.x; Shaw Rachel L, 2004, BMC Med Res Methodol, V4, P5, DOI 10.1186/1471-2288-4-5; Snow L., 1983, W J MED, V139, P82; Souto Q.R., 2014, MIX METH INT RES ASS; Taylor KD, 2012, ETHNIC HEALTH, V17, P615, DOI 10.1080/13557858.2013.771151; Teddlie C., 2003, HDB MIXED METHODS SO, P3, DOI DOI 10.4135/9781506335193; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Weiss, 1997, TRANSCULT PSYCHIATRY, V34, P235, DOI [DOI 10.1177/136346159703400204, 10.1177/136346159703400204]; Wright J, 2006, PHARM WORLD SCI, V28, P140, DOI 10.1007/s11096-006-9014-x; Zibaeenezhad MJ, 2007, IRAN RED CRESCENT ME, V9, P4	65	3	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154287	10.1371/journal.pone.0154287	http://dx.doi.org/10.1371/journal.pone.0154287			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27148880	Green Submitted, gold, Green Published			2022-12-27	WOS:000375676800023
J	Mendonca, AMC; Kritski, AL; Land, MGP; Sant'Anna, CC				Cabral Mendonca, Angela Marcia; Kritski, Afranio Lineu; Poirot Land, Marcelo Gerardin; Sant'Anna, Clemax Couto			Abandonment of Treatment for Latent Tuberculosis Infection and Socioeconomic Factors in Children and Adolescents: Rio De Janeiro, Brazil	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; ADHERENCE; HEALTH; CHEMOPROPHYLAXIS; CONTACTS; FAILURE	Background Routine data on the use of isoniazid preventive therapy (IPT) in children and adolescents are scarce in high tuberculosis (TB) burden countries. Objective To describe the factors related to abandonment of IPT in children and adolescents with latent tuberculosis infection (LTBI) receiving routine care. Methods Retrospective (2005-2009) descriptive study of 286 LTBI cases with indication of IPT and serviced at a pediatric hospital in the State of Rio de Janeiro, Brazil. Survival analysis of the risk of abandonment of IPT over six months was performed, including multivariate analysis using the Cox proportional hazards model. Results Out of the 245 cases of LTBI included, 62 abandoned IPT (25.3%; 95% CI: 20%-31%). On multivariate analysis, the variables related to the IPT abandonment hazard ratio were the Human Development Index (HDI) (hazard ratio-HR: 0.004; 0.000-0.569) of the place of residence and the contact with adults that were not undergoing anti-TB treatment (HR: 7.30; 1.00-53.3). Conclusion This study reveals the relevance of the relation of abandonment of IPT to the socioeconomic conditions at the place of residence and poor adherence to the active TB treatment. Educational measures to stimulate preventive treatment of child contacts and curative treatment of index cases should target the full familial setting.	[Cabral Mendonca, Angela Marcia] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Kritski, Afranio Lineu] Univ Fed Rio de Janeiro, Sch Med, Acad TB Programme, Rio De Janeiro, RJ, Brazil; [Poirot Land, Marcelo Gerardin; Sant'Anna, Clemax Couto] Univ Fed Rio de Janeiro, Sch Med, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Mendonca, AMC (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.	angelamcm@uol.com.br	Kritski, Afranio/I-6760-2016; land, marcelo g p/O-9286-2018; Anna, Clemax Sant/H-7923-2019	land, marcelo g p/0000-0001-9792-3167; Anna, Clemax Sant/0000-0001-8732-8065; kritski, afranio/0000-0002-5900-6007				Arinaminpathy N, 2010, J R SOC INTERFACE, V7, P1559, DOI 10.1098/rsif.2010.0072; Brazilian Ministry of Health. Secretariat of Health Surveillance, 2019, GEN COORD DEV EP SER, P740; David SG, 2000, J PEDIAT, V76, P413; Dessunti EM, 2013, REV ENFERM, V21; Dobler CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048900; Durovni B, 2010, AIDS, V24, pS49, DOI 10.1097/01.aids.0000391022.95412.a6; Fortunato I, 2011, INT J TUBERC LUNG D, V15, P1359, DOI 10.5588/ijtld.11.0092; Gomes SMJ, 2012, THESIS U FEDERAL ESP; Gomes VF, 2011, INT J TUBERC LUNG D, V15, P1637, DOI 10.5588/ijtld.10.0558; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Kleinbaum D, 1988, APPL REGRESSION ANAL; Li JH, 2010, INT J INFECT DIS, V14, pE292, DOI 10.1016/j.ijid.2009.05.007; Machado A, 2009, INT J TUBERC LUNG D, V13, P719; Marais BJ, 2009, CLIN CHEST MED, V30, P827, DOI 10.1016/j.ccm.2009.08.012; Ministerio da Saude, 2002, GUIA VIG EP, P100; Pinheiro ES, 2009, REV GEOGR ACAD, V3, P35; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; Reeves A, 2014, LANCET INFECT DIS, V14, P1105, DOI 10.1016/S1473-3099(14)70927-2; Rutherford ME, 2013, B WORLD HEALTH ORGAN, V91, P932, DOI 10.2471/BLT.13.118414; Rutherford Merrin E, 2012, BMC Res Notes, V5, P7, DOI 10.1186/1756-0500-5-7; Sant'Anna CC, 2002, TUBERCULOSE INFANCIA, P227; Sant'Anna Clemax C., 2000, J Pediatr (Rio J), V76, P109; Silva Adriana Rodrigues da, 2014, Esc. Anna Nery, V18, P386, DOI 10.5935/1414-8145.20140055; Silva Olga Maria Panhoca da, 2007, Ciênc. saúde coletiva, V12, P1209, DOI 10.1590/S1413-81232007000500018; Sneag DB, 2007, PEDIATR INFECT DIS J, V26, P1142, DOI 10.1097/INF.0b013e31814523e4; Soares CW, 2012, THESIS U FEDERAL PAR; Solomon MD, 2010, J GEN INTERN MED, V25, P280, DOI 10.1007/s11606-010-1286-0; Santos MDSG, 2007, REV LAT-AM ENFERM, V15, P762, DOI 10.1590/S0104-11692007000700008; Succi Regina Célia de M., 2014, Rev. paul. pediatr., V32, P02, DOI 10.1590/S0103-05822014000100001; Topley JM, 1996, ARCH DIS CHILD, V74, P140, DOI 10.1136/adc.74.2.140; van Zyl S, 2006, INT J TUBERC LUNG D, V10, P13; World Health Organisation, 2006, GUID NAT TUB PROGR M; World Health Organisation, 2015, GUID MAN LAT TUB INF; World Health Organization, 2013, ROADM CHILDH TUB ZER, P39; World Health Organization, 2014, GLOB TUB REP; Young J, 2012, PEDIATR INFECT DIS J, V31, pE147, DOI 10.1097/INF.0b013e318257f7c6	38	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154843	10.1371/journal.pone.0154843	http://dx.doi.org/10.1371/journal.pone.0154843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KV	27149514	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800069
J	Klinger-Strobel, M; Suesse, H; Fischer, D; Pletz, MW; Makarewicz, O				Klinger-Strobel, Mareike; Suesse, Herbert; Fischer, Dagmar; Pletz, Mathias W.; Makarewicz, Oliwia			A Novel Computerized Cell Count Algorithm for Biofilm Analysis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; SUSCEPTIBILITY; INFECTIONS; QUANTIFICATION; NITROXOLINE; IMAGES	Biofilms are the preferred sessile and matrix-embedded life form of most microorganisms on surfaces. In the medical field, biofilms are a frequent cause of treatment failure because they protect the bacteria from antibiotics and immune cells. Antibiotics are selected according to the minimal inhibitory concentration (MIC) based on the planktonic form of bacteria. Determination of the minimal biofilm eradicating concentration (MBEC), which can be up to 1,000-fold greater than the MIC, is not currently conducted as routine diagnostic testing, primarily because of the methodical hurdles of available biofilm assessing protocols that are time-and cost-consuming. Comparative analysis of biofilms is also limited as most quantitative methods such as crystal violet staining are indirect and highly imprecise. In this paper, we present a novel algorithm for assessing biofilm resistance to antibiotics that overcomes several of the limitations of alternative methods. This algorithm aims for a computer-based analysis of confocal microscope 3D images of biofilms after live/dead stains providing various biofilm parameters such as numbers of viable and dead cells and their vertical distributions within the biofilm, or biofilm thickness. The performance of this algorithm was evaluated using computer-simulated 2D and 3D images of coccal and rodent cells varying different parameters such as cell density, shading or cell size. Finally, genuine biofilms that were untreated or treated with nitroxoline or colistin were analyzed and the results were compared with quantitative microbiological standard methods. This novel algorithm allows a direct, fast and reproducible analysis of biofilms after live/dead staining. It performed well in biofilms of moderate cell densities in a 2D set-up however the 3D analysis remains still imperfect and difficult to evaluate. Nevertheless, this is a first try to develop an easy but conclusive tool that eventually might be implemented into routine diagnostics to determine the MBEC and to improve outcomes of patients with biofilm-associated infections.	[Klinger-Strobel, Mareike; Pletz, Mathias W.; Makarewicz, Oliwia] Jena Univ Hosp, Ctr Infect Dis & Infect Control, Erlanger Allee 101, D-07747 Jena, Germany; [Pletz, Mathias W.; Makarewicz, Oliwia] InfectoGnost Forsch Campus Jena eV, Zentrum Angew Forsch Jena, Philosophenweg 7, D-07743 Jena, Germany; [Suesse, Herbert] Univ Jena, Comp Vis Grp, Ernst Abbe Pl 2, D-07743 Jena, Germany; [Fischer, Dagmar] Univ Jena, Inst Pharm, Otto Schott Str 41, D-07745 Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Makarewicz, O (corresponding author), Jena Univ Hosp, Ctr Infect Dis & Infect Control, Erlanger Allee 101, D-07747 Jena, Germany.; Makarewicz, O (corresponding author), InfectoGnost Forsch Campus Jena eV, Zentrum Angew Forsch Jena, Philosophenweg 7, D-07743 Jena, Germany.	oliwia.makarewicz@med.uni-jena.de	Pletz, Mathias Wilhelm/H-9782-2019	Pletz, Mathias Wilhelm/0000-0001-8157-2753; Makarewicz, Oliwia/0000-0002-4404-1862	German Ministry of Education and Research [01EO1002, 13GW0096D]; German Research Foundation [PL320/3-1, FI899/4-1]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG))	The work was supported by a grant from the German Ministry of Education and Research (http://www.bmbf.de/), grant numbers 01EO1002 (OM, MKS) and 13GW0096D (OM), and the German Research Foundation (http://www.dfg.de/), grant numbers PL320/3-1 (MWP) and FI899/4-1 (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Al-Kadi OS, 2008, IEEE T BIO-MED ENG, V55, P1822, DOI 10.1109/TBME.2008.919735; Beyenal H, 2004, J MICROBIOL METH, V59, P395, DOI 10.1016/j.mimet.2004.08.003; Bleyer AJ, 2011, J AM SOC NEPHROL, V22, P1781, DOI 10.1681/ASN.2011080839; Cavaliere R, 2014, MICROBIOLOGYOPEN, V3, P557, DOI 10.1002/mbo3.187; CHEN CCH, 1972, ANTIMICROB AGENTS CH, V22, P331, DOI 10.1128/AAC.2.5.331; Hall-Stoodley L, 2012, FEMS IMMUNOL MED MIC, V65, P127, DOI 10.1111/j.1574-695X.2012.00968.x; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; JI L, 1989, PATTERN RECOGN LETT, V9, P201, DOI 10.1016/0167-8655(89)90055-X; Klinger-Strobel M, 2015, EXPERT OPIN DRUG DEL, V12, P1351, DOI 10.1517/17425247.2015.1007949; Kofoed MVW, 2012, SYST APPL MICROBIOL, V35, P513, DOI 10.1016/j.syapm.2011.12.001; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Li L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00258; Macia MD, 2014, CLIN MICROBIOL INFEC, V20, P981, DOI 10.1111/1469-0691.12651; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Moskowitz SM, 2004, J CLIN MICROBIOL, V42, P1915, DOI 10.1128/JCM.42.5.1915-1922.2004; Naber KG, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0628-7; Pompilio A, 2015, DIAGN MICR INFEC DIS, V82, P318, DOI 10.1016/j.diagmicrobio.2015.01.006; Sobke A, 2012, ANTIMICROB AGENTS CH, V56, P6021, DOI 10.1128/AAC.01484-12; Song B, 2006, MICROBIOL RES, V161, P355, DOI 10.1016/j.micres.2006.01.004; Stiefel P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0376-x; Susse H, 2014, BILDVERARBEITUNG OBJ, P211	22	22	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154937	10.1371/journal.pone.0154937	http://dx.doi.org/10.1371/journal.pone.0154937			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149069	Green Submitted, gold, Green Published			2022-12-27	WOS:000375676800095
J	Templeton, AJ; Gonzalez, LD; Vera-Badillo, FE; Tibau, A; Goldstein, R; Seruga, B; Srikanthan, A; Pandiella, A; Amir, E; Ocana, A				Templeton, Arnoud J.; Diez Gonzalez, Laura; Vera-Badillo, Francisco E.; Tibau, Ariadna; Goldstein, Robyn; Seruga, Bostjan; Srikanthan, Amirrtha; Pandiella, Atanasio; Amir, Eitan; Ocana, Alberto			Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression	PLOS ONE			English	Review							HEREDITARY BREAST-CANCER; TUMOR CHARACTERISTICS; 10-YEAR; POPULATION; PROGNOSIS; CARRIERS	Background Germline mutations in the BRCA1 and BRCA2 genes are the most frequent known hereditary causes of familial breast cancer. Little is known about the interaction of age at diagnosis, estrogen receptor (ER) and progesterone receptor (PgR) expression and outcomes in patients with BRCA1 or BRCA2 mutations. Methods A PubMed search identified publications exploring the association between BRCA mutations and clinical outcome. Hazard ratios (HR) for overall survival were extracted from multi-variable analyses. Hazard ratios were weighted and pooled using generic inverse-variance and random-effect modeling. Meta-regression weighted by total study sample size was conducted to explore the influence of age, ER and PgR expression on the association between BRCA mutations and overall survival. Results A total of 16 studies comprising 10,180 patients were included in the analyses. BRCA mutations were not associated with worse overall survival (HR 1.06, 95% CI 0.84-1.34, p = 0.61). A similar finding was observed when evaluating the influence of BRCA1 and BRCA2 mutations on overall survival independently (BRCA1: HR 1.20, 95% CI 0.89-1.61, p = 0.24; BRCA2: HR 1.01, 95% CI 0.80-1.27, p = 0.95). Meta-regression identified an inverse association between ER expression and overall survival (beta = -0.75, p = 0.02) in BRCA1 mutation carriers but no association with age or PgR expression (beta = -0.45, p = 0.23 and beta = 0.02, p = 0.97, respectively). No association was found for BRCA2 mutation status and age, ER, or PgR expression. Conclusion ER-expression appears to be an effect modifier in patients with BRCA1 mutations, but not among those with BRCA2 mutations.	[Templeton, Arnoud J.] Kantonsspital, Dept Med Oncol, St Gallen, Switzerland; [Templeton, Arnoud J.] Univ Basel, Fac Med, CH-4003 Basel, Switzerland; [Diez Gonzalez, Laura; Ocana, Alberto] Albacete Univ Hosp, Translat Res Unit, Albacete, Spain; [Vera-Badillo, Francisco E.] Queens Univ, Dept Oncol, Kingston, ON, Canada; [Tibau, Ariadna] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain; [Tibau, Ariadna] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Goldstein, Robyn; Srikanthan, Amirrtha; Amir, Eitan] Univ Toronto, Dept Med, Princess Margaret Canc Ctr, Div Med Oncol, Toronto, ON, Canada; [Goldstein, Robyn; Srikanthan, Amirrtha; Amir, Eitan] Univ Toronto, Dept Med, Princess Margaret Canc Ctr, Div Hematol, Toronto, ON, Canada; [Seruga, Bostjan] Inst Oncol, Dept Med Oncol, Ljubljana, Slovenia; [Pandiella, Atanasio] Univ Salamanca, CSIC, CIC, E-37008 Salamanca, Spain	Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Basel; University of Geneva; Queens University - Canada; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Institute of Oncology - Slovenia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); University of Salamanca	Templeton, AJ (corresponding author), Kantonsspital, Dept Med Oncol, St Gallen, Switzerland.; Templeton, AJ (corresponding author), Univ Basel, Fac Med, CH-4003 Basel, Switzerland.	arnoud.templeton@unibas.ch	Pandiella, Atanasio/O-5180-2014; Tibau, Ariadna/AGS-6563-2022; Amir, Eitan/L-6052-2019	Pandiella, Atanasio/0000-0002-4704-8971; Tibau, Ariadna/0000-0003-0229-6987; Templeton, Arnoud/0000-0002-0847-7087; Ocana, Alberto/0000-0002-1067-9630				Bayraktar S, 2013, CLIN EXP METASTAS, V30, P631, DOI 10.1007/s10585-013-9567-8; Bayraktar S, 2011, BREAST CANCER RES TR, V130, P145, DOI 10.1007/s10549-011-1711-z; Brekelmans CTM, 2007, EUR J CANCER, V43, P867, DOI 10.1016/j.ejca.2006.12.009; Budroni M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-62; Cortesi L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-90; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Goffin JR, 2003, CANCER-AM CANCER SOC, V97, P527, DOI 10.1002/cncr.11080; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Goodwin PJ, 2012, J CLIN ONCOL, V30, P19, DOI 10.1200/JCO.2010.33.0068; Hamann U, 2000, BREAST CANCER RES TR, V59, P185, DOI 10.1023/A:1006350518190; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huzarski T, 2013, J CLIN ONCOL, V31, P3191, DOI 10.1200/JCO.2012.45.3571; Lee EH, 2010, BREAST CANCER RES TR, V122, P11, DOI 10.1007/s10549-010-0859-2; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nilsson MP, 2014, BREAST CANCER RES TR, V144, P133, DOI 10.1007/s10549-014-2842-9; Rennert G, 2007, NEW ENGL J MED, V357, P115, DOI 10.1056/NEJMoa070608; Stoppa-Lyonnet D, 2000, J CLIN ONCOL, V18, P4053, DOI 10.1200/JCO.2000.18.24.4053; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Tutt A, 2014, SAN ANT BREAST CANC; van den Broek AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120189; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Verhoog LC, 1999, J CLIN ONCOL, V17, P3396, DOI 10.1200/JCO.1999.17.11.3396; Veronesi A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-70; Zhong Q, 2015, CLIN CANCER RES, V21, P211, DOI 10.1158/1078-0432.CCR-14-1816	25	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154789	10.1371/journal.pone.0154789	http://dx.doi.org/10.1371/journal.pone.0154789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149669	Green Published, gold, Green Submitted			2022-12-27	WOS:000375676800061
J	Bian, CY; Ma, CJ; Liu, XH; Gao, C; Liu, QR; Yan, ZX; Ren, YJ; Li, QQ				Bian, Chengyue; Ma, Changjian; Liu, Xinhui; Gao, Chao; Liu, Quanru; Yan, Zhenxing; Ren, Yujie; Li, Quanqi			Responses of Winter Wheat Yield and Water Use Efficiency to Irrigation Frequency and Planting Pattern	PLOS ONE			English	Article							GRAIN-YIELD; EVAPOTRANSPIRATION	A suitable planting pattern and irrigation strategy are essential for optimizing winter wheat yield and water use efficiency (WUE). The study aimed to evaluate the impact of planting pattern and irrigation frequency on grain yield and WUE of winter wheat. During the 20132014 and 2014-2015 winter wheat growing seasons in the North China Plain, the effects of planting patterns and irrigation frequencies were determined on tiller number, grain yield, and WUE. The two planting patterns tested were wide-precision and conventional-cultivation. Each planting pattern had three irrigation regimes: irrigation (120 mm) at the jointing stage; irrigation (60 mm) at both the jointing and heading stages; and irrigation (40 mm) at the jointing, heading, and milking stages. In our study, tiller number was significantly higher in the wide-precision planting pattern than in the conventional-cultivation planting pattern. Additionally, the highest grain yields and WUE were observed when irrigation was applied at the jointing stage (120 mm) or at the jointing and heading stages (60 mm each) in the wide-precision planting pattern. These results could be attributed to higher tiller numbers as well as reduced water consumption due to reduced irrigation frequency. In both growing seasons, applying 60 mm of water at jointing and heading stages resulted in the highest grain yield among the treatments. Based on our results, for winter wheat production in semi-humid regions, we recommend a wide-precision planting pattern with irrigation (60 mm) at both the jointing and heading stages.	[Bian, Chengyue; Ma, Changjian; Liu, Xinhui; Gao, Chao; Liu, Quanru; Yan, Zhenxing; Ren, Yujie; Li, Quanqi] Shandong Agr Univ, Coll Water Conservancy & Civil Engn, Tai An 271018, Shandong, Peoples R China; [Liu, Quanru] Shandong Water Conservancy Vocat Coll, Dept Water Conservancy Engn, Rizhao 276800, Peoples R China	Shandong Agricultural University	Li, QQ (corresponding author), Shandong Agr Univ, Coll Water Conservancy & Civil Engn, Tai An 271018, Shandong, Peoples R China.	quanqili@sdau.edu.cn			National Nature Science Foundation of China [31571603]; National Science and Technology Plan Project in Rural Areas of China [2013AA102903]; Development of Science and Technology Plan Projects in Shandong Province of China [2014GN111002]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Plan Project in Rural Areas of China; Development of Science and Technology Plan Projects in Shandong Province of China	This work was supported by National Nature Science Foundation of China (31571603) http://www.nsfc.gov.cn/; National Science and Technology Plan Project in Rural Areas of China (2013AA102903) http://www.most.gov.cn/; Development of Science and Technology Plan Projects in Shandong Province of China (2014GN111002) http://www.sdstc.gov.cn/.	Bandyopadhyay PK, 2005, IRRIGATION SCI, V23, P161, DOI 10.1007/s00271-005-0104-7; Cai T, 2014, FIELD CROP RES, V155, P172, DOI 10.1016/j.fcr.2013.09.008; Chen, 2013, J FOOD AGRIC ENVIRON, V11, P2593; Chen X, 2015, PHOTOSYNTHETICA, V53, P519, DOI 10.1007/s11099-015-0147-9; Du TS, 2013, J INTEGR AGR, V12, P509, DOI [10.1016/s2095-3119(13)60252-x, 10.1016/S2095-3119(13)60252-X]; Eberbach P, 2005, PLANT SOIL, V268, P195, DOI 10.1007/s11104-004-0271-y; Garcia-Tejero I, 2011, AGRON SUSTAIN DEV, V31, P779, DOI 10.1007/s13593-011-0025-1; Han HuiFang, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P109; [韩惠芳 HAN Huifang], 2010, [生态学报, Acta Ecologica Sinica], V30, P1548; Hu TT, 2009, AGR WATER MANAGE, V96, P208, DOI 10.1016/j.agwat.2008.07.011; [郎坤 Lang Kun], 2015, [生态学报, Acta Ecologica Sinica], V35, P5262; Li QQ, 2015, AGR WATER MANAGE, V153, P71, DOI 10.1016/j.agwat.2015.02.004; Li QuanQi, 2011, Transactions of the Chinese Society of Agricultural Engineering, V27, P33; Li QQ, 2010, AGR WATER MANAGE, V97, P1676, DOI 10.1016/j.agwat.2010.05.025; [李世清 Li Shiqing], 2003, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V23, P2031; Liu CM, 2002, AGR FOREST METEOROL, V111, P109, DOI 10.1016/S0168-1923(02)00015-1; Naresh R. K., 2012, International Journal of Life Sciences Biotechnology and Pharma Research, V1, P27; ROY SK, 1985, WHEAT GROWTH MODEL, V86, P59; Shan ChangJuan, 2006, Journal of Triticeae Crops, V26, P127; SHARMA BR, 1983, AGR WATER MANAGE, V6, P365, DOI 10.1016/0378-3774(83)90055-0; Sun HY, 2010, AGR WATER MANAGE, V97, P1139, DOI 10.1016/j.agwat.2009.06.004; Ta TH, 2012, HORTIC ENVIRON BIOTE, V53, P129, DOI 10.1007/s13580-012-0095-2; Yactayo W, 2013, AGR WATER MANAGE, V123, P65, DOI 10.1016/j.agwat.2013.03.009; [杨书运 YANG Shuyun], 2007, [麦类作物学报, Journal of triticeae crops], V27, P309; Zhang H, 1999, IRRIGATION SCI, V19, P37, DOI 10.1007/s002710050069; Zhang J, 2007, AGR WATER MANAGE, V92, P41, DOI 10.1016/j.agwat.2007.04.007; Zhang XY, 2005, AGRON J, V97, P783, DOI 10.2134/agronj2004.0194; Zhao DD, 2013, AGR WATER MANAGE, V118, P87, DOI 10.1016/j.agwat.2012.11.019; [赵丹丹 Zhao Dandan], 2012, [灌溉排水学报, Journal of Irrigation and Drainage], V31, P140	29	43	46	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154673	10.1371/journal.pone.0154673	http://dx.doi.org/10.1371/journal.pone.0154673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171202	gold, Green Published, Green Submitted			2022-12-27	WOS:000376588600117
J	Buhl, IK; Gerster, S; Delorenzi, M; Jensen, T; Jensen, PB; Bosman, F; Tejpar, S; Roth, A; Brunner, N; Hansen, A; Knudsen, S				Buhl, Ida Kappel; Gerster, Sarah; Delorenzi, Mauro; Jensen, Thomas; Jensen, Peter Buhl; Bosman, Fred; Tejpar, Sabine; Roth, Arnaud; Brunner, Nils; Hansen, Anker; Knudsen, Steen			Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; INDEPENDENT VALIDATION; FLUOROURACIL; 5-FLUOROURACIL; LEUCOVORIN; BIOMARKERS; EXPRESSION; THERAPY	Purpose This study evaluates whether gene signatures for chemosensitivity for irinotecan and 5-fluorouracil (5-FU) derived from in vitro grown cancer cell lines can predict clinical sensitivity to these drugs. Methods To test if an irinotecan signature and a SN-38 signature could identify patients who benefitted from the addition of irinotecan to 5-FU, we used gene expression profiles based on cell lines and clinical tumor material. These profiles were applied to expression data obtained from pretreatment formalin fixed paraffin embedded (FFPE) tumor tissue from 636 stage III colon cancer patients enrolled in the PETACC-3 prospective randomized clinical trial. A 5FU profile developed similarly was assessed by comparing the PETACC-3 cohort with a cohort of 359 stage II colon cancer patients who underwent surgery but received no adjuvant therapy. Results There was no statistically significant association between the irinotecan or SN-38 profiles and benefit from irinotecan. The 5-FU sensitivity profile showed a statistically significant association with relapse free survival (RFS) (hazard ratio (HR) = 0.54 (0.41-0.71), p<1e-05) and overall survival (HR = 0.47 (0.34-0.63), p<1e-06) in the PETACC-3 subpopulation. The effect of the 5-FU profile remained significant in a multivariable Cox Proportional Hazards model, adjusting for several relevant clinicopathological parameters. No statistically significant effect of the 5-FU profile was observed in the untreated cohort of 359 patients (relapse free survival, p = 0.671). Conclusion The irinotecan predictor had no predictive value. The 5-FU predictor was prognostic in stage III patients in PETACC-3 but not in stage II patients with no adjuvant therapy. This suggests a potential predictive ability of the 5-FU sensitivity profile to identify colon cancer patients who may benefit from 5-FU, however, any biomarker predicting benefit for adjuvant 5-FU must be rigorously evaluated in independent cohorts. Given differences between the two study cohorts, the present results should be further validated.	[Buhl, Ida Kappel; Brunner, Nils] Univ Copenhagen, Fac Hlth & Med Sci, Sect Mol Dis Biol, Copenhagen, Denmark; [Buhl, Ida Kappel; Jensen, Thomas; Jensen, Peter Buhl; Hansen, Anker; Knudsen, Steen] Med Prognosis Inst, Horsholm, Denmark; [Gerster, Sarah; Delorenzi, Mauro] SIB Swiss Inst Bioinformat, Bioinformat Core Facil, Lausanne, Switzerland; [Delorenzi, Mauro] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland; [Delorenzi, Mauro] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Bosman, Fred] Univ Lausanne, Univ Inst Pathol, Lausanne, Switzerland; [Tejpar, Sabine] Univ Hosp Gasthuisberg, Digest Oncol Unit, Leuven, Belgium; [Roth, Arnaud] Univ Hosp Geneva, Oncosurg Unit, Geneva, Switzerland; [Gerster, Sarah] Swiss Natl Sci Fdn, Bern, Switzerland	University of Copenhagen; Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne; University of Lausanne; KU Leuven; University Hospital Leuven; University of Geneva	Knudsen, S (corresponding author), Med Prognosis Inst, Horsholm, Denmark.	steen@medical-prognosis.com		Buhl, Ida Kappel/0000-0003-3299-1358; Bosman, Fred/0000-0002-1652-6977	Swiss National Science Foundation [SNF 320030_135421]; Danish Cancer Society;  [31176]; The Danish Cancer Society [R84-A5565, R72-A4566] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Danish Cancer Society(Danish Cancer Society); ; The Danish Cancer Society(Danish Cancer Society)	The work was partially supported by grant SNF 320030_135421 of the Swiss National Science Foundation. The Danish Cancer Society provided a scholarship for Ida K. Buhl and financial support to the project grant 31176.	ALLEY MC, 1988, CANCER RES, V48, P589; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Chen JJ, 2012, MOL CANCER THER, V11, P34, DOI 10.1158/1535-7163.MCT-11-0620; Ciaparrone M, 2006, ONCOLOGY-BASEL, V70, P366, DOI 10.1159/000098110; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; DeVita V, 2015, DEVITA HELLMANN ROSE; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Jensen NF, 2012, SCAND J GASTROENTERO, V47, P340, DOI 10.3109/00365521.2012.640835; Kennedy RD, 2011, J CLIN ONCOL, V29, P4620, DOI 10.1200/JCO.2011.35.4498; Kinoshita M, 2007, ANTICANCER RES, V27, P851; Knudsen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115538; Knudsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087415; Koopman M, 2009, EUR J CANCER, V45, P1935, DOI 10.1016/j.ejca.2009.04.023; LABIANCA R, 1995, LANCET, V345, P939; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Moorcraft SY, 2013, THER ADV GASTROENTER, V6, P381, DOI 10.1177/1756283X13491797; Petitprez A, 2013, CURR PHARM DESIGN, V19, P958, DOI 10.2174/138161213804547204; Reimers MS, 2013, GASTROENTEROL REP, V1, P166, DOI 10.1093/gastro/got022; Saltz LB, 2007, J CLIN ONCOL, V25, P3456, DOI 10.1200/JCO.2007.11.2144; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Van Cutsem E, 2009, J CLIN ONCOL, V27, P3117, DOI 10.1200/JCO.2008.21.6663; Venook A, 2014, COLORECTAL CANC ALL, P83; Wang WT, 2013, JNCI-J NATL CANCER I, V105, P1284, DOI 10.1093/jnci/djt202; Yamada H, 2008, ONCOL REP, V19, P729	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0155123	10.1371/journal.pone.0155123	http://dx.doi.org/10.1371/journal.pone.0155123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171152	Green Published, gold			2022-12-27	WOS:000376588600025
J	George, C; Goedecke, JH; Crowther, NJ; Jaff, NG; Kengne, AP; Norris, SA; Micklesfield, LK				George, Cindy; Goedecke, Julia H.; Crowther, Nigel J.; Jaff, Nicole G.; Kengne, Andre P.; Norris, Shane A.; Micklesfield, Lisa K.			The Role of Body Fat and Fat Distribution in Hypertension Risk in Urban Black South African Women	PLOS ONE			English	Article							BLOOD-PRESSURE; INCIDENT HYPERTENSION; ETHNIC-DIFFERENCES; HIGH PREVALENCE; MASS INDEX; ADULTS; AMERICAN; DISEASE; OBESITY; HEALTH	Developing countries are disproportionately affected by hypertension, with Black women being at greater risk, possibly due to differences in body fat distribution. The objectives of this study were: (1) To examine how different measures of body composition are associated with blood pressure (BP) and incident hypertension; (2) to determine the association between baseline or change in body composition, and hypertension; and (3) to determine which body composition measure best predicts hypertension in Black South African women. The sample comprised 478 non-hypertensive women, aged 29-53 years. Body fat and BP were assessed at baseline and 8.3 years later. Body composition was assessed using dual-energy X-ray absorptiometry (DXA) (n = 273) and anthropometry. Hypertension was diagnosed based on a systolic/diastolic BP >= 140/90 mmHg, or medication use at follow-up. All body composition measures increased (p<0.0001) between baseline and follow-up. SBP and DBP increased by >= 20%, resulting in a 57.1% cumulative incidence of hypertension. Both DXA- and anthropometric-derived measures of body composition were significantly associated with BP, explaining 3-5% of the variance. Baseline BP was the most important predictor of hypertension (adjusted OR: 98-123%). Measures of central adiposity were associated with greater odds (50-65%) of hypertension than total adiposity (44-45%). Only change in anthropometric-derived central fat mass predicted hypertension (adjusted OR: 32-40%). This study highlights that body composition is not a major determinant of hypertension in the sample of black African women. DXA measures of body composition do not add to hypertension prediction beyond anthropometry, which is especially relevant for African populations globally, taking into account the severely resource limited setting found in these communities.	[George, Cindy; Goedecke, Julia H.; Kengne, Andre P.] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Goedecke, Julia H.; Jaff, Nicole G.; Norris, Shane A.; Micklesfield, Lisa K.] Univ Witwatersrand, South African Med Res Council, Univ Witwatersrand Dev Pathways Hlth Res Unit, Dept Pediat,Fac Hlth Sci, Johannesburg, South Africa; [Crowther, Nigel J.; Jaff, Nicole G.] Univ Witwatersrand, Sch Med, Dept Chem Pathol, Natl Hlth Lab Serv, Johannesburg, South Africa	South African Medical Research Council; South African Medical Research Council; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	George, C (corresponding author), South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa.	cindy.george@mrc.ac.za	Micklesfield, Lisa/AAR-8262-2021; Norris, Shane/C-4664-2014; Kengne, Andre Pascal/ABB-3696-2020; Goedecke, Julia/J-8628-2013	Micklesfield, Lisa/0000-0002-4994-0779; Norris, Shane/0000-0001-7124-3788; Goedecke, Julia/0000-0001-6795-4771; George, Cindy/0000-0002-4561-0529; Crowther, Nigel/0000-0002-5766-1745; Kengne, Andre Pascal/0000-0002-5183-131X	South African Medical Research Council; National Health Laboratory Services; University of the Witwatersrand Iris Ellen Hodges Cardiovascular Research Trust; National Research Foundation (NRF) of South Africa; Wellcome Trust (UK); DST-NRF Professional Development Programme	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health Laboratory Services; University of the Witwatersrand Iris Ellen Hodges Cardiovascular Research Trust; National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); Wellcome Trust (UK)(Wellcome Trust); DST-NRF Professional Development Programme	South African Medical Research Council, National Health Laboratory Services, University of the Witwatersrand Iris Ellen Hodges Cardiovascular Research Trust, National Research Foundation (NRF) of South Africa, The Wellcome Trust (UK), which funded the Birth-to-20 study, and DST-NRF Professional Development Programme, which funds Dr. Cindy George. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2011, WHO NONCOMMUNICABLE; Bhurosy Trishnee, 2014, ScientificWorldJournal, V2014, P964236, DOI 10.1155/2014/964236; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Carson AP, 2011, HYPERTENSION, V57, P1101, DOI 10.1161/HYPERTENSIONAHA.110.168005; Coylewright M, 2008, HYPERTENSION, V51, P952, DOI 10.1161/HYPERTENSIONAHA.107.105742; Davis SR, 2012, CLIMACTERIC, V15, P419, DOI 10.3109/13697137.2012.707385; Ding JZ, 2004, AM J HYPERTENS, V17, P971, DOI 10.1016/j.amjhyper.2004.05.001; Duncan PR, 2014, S AFR J CLIN NUTR, V27, P56; Ellegard LH, 2009, EUR J CLIN NUTR, V63, P794, DOI 10.1038/ejcn.2008.35; Evans J, 2011, CLIN ENDOCRINOL, V74, P51, DOI 10.1111/j.1365-2265.2010.03883.x; Fernandez-Vega F, 2002, KIDNEY INT, V62, pS36, DOI 10.1046/j.1523-1755.62.s82.8.x; Gasevic D, 2015, CAN J CARDIOL, V31, P1169, DOI 10.1016/j.cjca.2015.06.017; Goedecke JH, 2013, J OBES, V2013, DOI 10.1155/2013/952916; Gouveia LAG, 2014, ARCH GERONTOL GERIAT, V59, P62, DOI 10.1016/j.archger.2014.02.005; Harlow SD, 2012, FERTIL STERIL, V97, P843, DOI 10.1016/j.fertnstert.2012.01.128; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Jaff NG, 2014, MENOPAUSE, V21, P1225, DOI [10.1097/GME.0000000000000235, 10.1097/gme.0000000000000235]; Lam BCC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122985; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li ZB, 2010, J HYPERTENS, V28, P715, DOI 10.1097/HJH.0b013e328336ed5b; Lima R, 2012, CURR HYPERTENS REP, V14, P254, DOI 10.1007/s11906-012-0260-0; Matsuzawa Y, 2008, INT J OBESITY, V32, pS83, DOI 10.1038/ijo.2008.243; Maximova K, 2011, J HYPERTENS, V29, P2075, DOI 10.1097/HJH.0b013e32834be614; Moges B, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-155; Moliner-Urdiales D, 2014, NUTR METAB CARDIOVAS, V24, P969, DOI 10.1016/j.numecd.2014.03.004; Monyeki KD, 2008, J HUM HYPERTENS, V22, P311, DOI 10.1038/jhh.2008.3; Nesbitt SD, 2005, CURR HYPERTENS REP, V7, P244, DOI 10.1007/s11906-005-0020-5; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ouyang XJ, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0032-5; Peer N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078567; Plank LD, 2005, CURR OPIN CLIN NUTR, V8, P305, DOI 10.1097/01.mco.0000165010.31826.3d; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Rush EC, 2007, INT J OBESITY, V31, P1232, DOI 10.1038/sj.ijo.0803576; SADHS, 2003, S AFR DEM HLTH SURV; Schutte AE, 2008, J HUM HYPERTENS, V22, P528, DOI 10.1038/jhh.2008.35; Schutte AE, 2012, INT J EPIDEMIOL, V41, P1114, DOI 10.1093/ije/dys106; Shihab HM, 2012, CIRCULATION, V126, P2983, DOI 10.1161/CIRCULATIONAHA.112.117333; Shisana O, 2013, S AFRICAN NATL HLTH; Shuger SL, 2008, AM J HYPERTENS, V21, P613, DOI 10.1038/ajh.2008.169; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Strandberg TE, 2003, CURR OPIN NEPHROL HY, V12, P293, DOI 10.1097/00041552-200305000-00011; Taddei S, 2009, CLIMACTERIC, V12, P36, DOI 10.1080/13697130903004758; Ware LJ, 2014, NUTR METAB CARDIOVAS, V24, P900, DOI 10.1016/j.numecd.2014.02.005; WHO, 2013, WHODCOWHD20132; Wildman RP, 2011, OBSTET GYN CLIN N AM, V38, P441, DOI 10.1016/j.ogc.2011.05.003; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	49	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2016	11	5							e0154894	10.1371/journal.pone.0154894	http://dx.doi.org/10.1371/journal.pone.0154894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CQ	27171011	Green Published, gold, Green Submitted			2022-12-27	WOS:000376588600145
J	Dodds, PS; Mitchell, L; Reagan, AJ; Danforth, CM				Dodds, Peter Sheridan; Mitchell, Lewis; Reagan, Andrew J.; Danforth, Christopher M.			Tracking Climate Change through the Spatiotemporal Dynamics of the Teletherms, the Statistically Hottest and Coldest Days of the Year	PLOS ONE			English	Article							TEMPERATURE; UNCERTAINTY; HIATUS; PHASE; CYCLE; MODEL	Instabilities and long term shifts in seasons, whether induced by natural drivers or human activities, pose great disruptive threats to ecological, agricultural, and social systems. Here, we propose, measure, and explore two fundamental markers of location-sensitive seasonal variations: the Summer and Winter Teletherms-the on-average annual dates of the hottest and coldest days of the year. We analyse daily temperature extremes recorded at 1218 stations across the contiguous United States from 1853-2012, and observe large regional variation with the Summer Teletherm falling up to 90 days after the Summer Solstice, and 50 days for the Winter Teletherm after the Winter Solstice. We show that Teletherm temporal dynamics are substantive with clear and in some cases dramatic shifts reflective of system bifurcations. We also compare recorded daily temperature extremes with output from two regional climate models finding considerable though relatively unbiased error. Our work demonstrates that Teletherms are an intuitive, powerful, and statistically sound measure of local climate change, and that they pose detailed, stringent challenges for future theoretical and computational models.	[Dodds, Peter Sheridan; Reagan, Andrew J.; Danforth, Christopher M.] Univ Vermont, Dept Math & Stat, Burlington, VT 05401 USA; [Dodds, Peter Sheridan; Reagan, Andrew J.; Danforth, Christopher M.] Univ Vermont, Vermont Ctr Complex Syst, Burlington, VT 05401 USA; [Dodds, Peter Sheridan; Reagan, Andrew J.; Danforth, Christopher M.] Univ Vermont, Computat Story Lab, Burlington, VT 05401 USA; [Dodds, Peter Sheridan; Reagan, Andrew J.; Danforth, Christopher M.] Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05401 USA; [Mitchell, Lewis] Univ Adelaide, Sch Math Sci, North Terrace Campus, Adelaide, SA 5005, Australia	University of Vermont; University of Vermont; University of Vermont; University of Vermont; University of Adelaide	Dodds, PS (corresponding author), Univ Vermont, Dept Math & Stat, Burlington, VT 05401 USA.; Dodds, PS (corresponding author), Univ Vermont, Vermont Ctr Complex Syst, Burlington, VT 05401 USA.; Dodds, PS (corresponding author), Univ Vermont, Computat Story Lab, Burlington, VT 05401 USA.; Dodds, PS (corresponding author), Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05401 USA.	peter.dodds@uvm.edu	Mitchell, Lewis/U-8250-2019; Mitchell, Lewis/W-1312-2018	Mitchell, Lewis/0000-0001-8191-1997; Mitchell, Lewis/0000-0001-8191-1997	National Science Foundation (NSF); U.S. Department of Energy (DoE); National Oceanic and Atmospheric Administration (NOAA); U.S. Environmental Protection Agency Office of Research and Development (EPA); Mathematics and Climate Research Network (MCRN), National Science Foundation (NSF) [DMS-0940271]; National Science Foundation (NSF) CAREER Award [0846668]; Division Of Mathematical Sciences [0940271] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); U.S. Department of Energy (DoE)(United States Department of Energy (DOE)); National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Environmental Protection Agency Office of Research and Development (EPA)(United States Environmental Protection Agency); Mathematics and Climate Research Network (MCRN), National Science Foundation (NSF); National Science Foundation (NSF) CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the North American Regional Climate Change Assessment Program (NARCCAP) for providing the model data used in this paper. NARCCAP is funded by the National Science Foundation (NSF), the U.S. Department of Energy (DoE), the National Oceanic and Atmospheric Administration (NOAA), and the U.S. Environmental Protection Agency Office of Research and Development (EPA). LM, AJR, and CMD were in part supported by the Mathematics and Climate Research Network (MCRN), National Science Foundation (NSF) Award # DMS-0940271. PSD was supported by National Science Foundation (NSF) CAREER Award # 0846668.	Antilla L, 2005, GLOBAL ENVIRON CHANG, V15, P338, DOI 10.1016/j.gloenvcha.2005.08.003; Arguez A, 2012, B AM METEOROL SOC, V93, P1687, DOI 10.1175/BAMS-D-11-00197.1; Barkemeyer R, 2015, NATURE CLIMATE CHANG; Betts AK, 2011, WEATHER, V66, P245, DOI 10.1002/wea.754; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Greasby TA, 2012, ASSESSING UNCE UNPUB; Greasby TA, 2011, J AGR BIOL ENVIR ST, V16, P571, DOI 10.1007/s13253-011-0072-8; Karl TR, 2015, SCIENCE, V348, P1469, DOI 10.1126/science.aaa5632; Lai K.K.R., 2016, NY TIMES; Lempert RJ, 2015, NAT CLIM CHANGE, V5, P914, DOI 10.1038/nclimate2745; Mann ME, 1996, GEOPHYS RES LETT, V23, P1111, DOI 10.1029/96GL01066; McKinnon KA, 2016, NATURE GEOSCI; Mearns L.O., 2009, EOS T AM GEOPHYS UN, V90, P311, DOI [10.1029/2009EO360002, DOI 10.1029/2009EO360002]; Mearns LO, 2012, B AM METEOROL SOC, V93, P1337, DOI 10.1175/BAMS-D-11-00223.1; Mearns LO, 2014, N AM REGIONAL CLIMAT; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sparks TH, 2002, INT J CLIMATOL, V22, P1715, DOI 10.1002/joc.821; Stainforth DA, 2005, NATURE, V433, P403, DOI 10.1038/nature03301; Stine AR, 2009, NATURE, V457, P435, DOI 10.1038/nature07675; Trenberth KE, 2015, SCIENCE, V349, P691, DOI 10.1126/science.aac9225	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0154184	10.1371/journal.pone.0154184	http://dx.doi.org/10.1371/journal.pone.0154184			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27167740	Green Published, gold, Green Submitted			2022-12-27	WOS:000376587300102
J	Midorikawa, K; Soukaloun, D; Akkhavong, K; Southivong, B; Rattanavong, O; Sengkhygnavong, V; Pyaluanglath, A; Sayasithsena, S; Nakamura, S; Midorikawa, Y; Murata, M				Midorikawa, Kaoru; Soukaloun, Douangdao; Akkhavong, Kongsap; Southivong, Bouavanh; Rattanavong, Oudayvone; Sengkhygnavong, Vikham; Pyaluanglath, Amphay; Sayasithsena, Saymongkhonh; Nakamura, Satoshi; Midorikawa, Yutaka; Murata, Mariko			APOE Genotype in the Ethnic Majority and Minority Groups of Laos and the Implications for Non-Communicable Diseases	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; RESTING HEART-RATE; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; RISK-FACTORS; DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; GENE POLYMORPHISM; COGNITIVE DECLINE; OLDER-ADULTS	Background Increasing age is associated with elevated risk of non-communicable diseases, including dementia and Alzheimer's disease (AD). The apolipoprotein E (APOE) epsilon 4 allele is a risk factor not only for AD, but also for cognitive decline, depressive symptoms, stroke, hypertension, coronary heart disease, cardiovascular disease, and diabetes. The Lao People's Democratic Republic (Laos) is undergoing development; consequently, life expectancy has risen. To evaluate the future risk of non-communicable diseases, we investigated APOE genotypes and anthropometric characteristics in the Laotian population. Methodology/Principal Findings Subjects were 455 members of the Lao Loum majority and 354 members of ethnic minorities. APOE genotypes, anthropometric characteristics, blood pressure, and blood glucose were recorded. To compare individual changes, health examination data collected 5 years apart were obtained from a subset of Lao Loum subjects. APOE epsilon 4 allele frequencies were higher among minorities (31.3%) than among Lao Loum (12.6%). In Lao Loum, but not in minorities, mean waist circumference and blood pressure increased significantly across age groups. Comparisons of health conditions between the beginning and end of the 5-year period revealed significant increases in obesity and blood glucose levels in Lao Loum. APOE epsilon 4 carriers exhibited significant increases in resting heart rate in both ethnic groups. Conclusions/Significance A higher epsilon 4 allele frequency was observed in Laotian minorities than in the Laotian majority. Furthermore, higher obesity, blood pressure and blood glucose were observed in the middle-aged ethnic majority. Therefore, given these genetic and non-communicable disease risk factors, it seems likely that as the Laotian population ages, elevated rates of non-communicable aging-related diseases, such as dementia, will also become more prevalent.	[Midorikawa, Kaoru; Murata, Mariko] Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Tsu, Mie 514, Japan; [Soukaloun, Douangdao; Rattanavong, Oudayvone; Sengkhygnavong, Vikham; Pyaluanglath, Amphay; Sayasithsena, Saymongkhonh] Minist Hlth, Mahosot Hosp, Viangchan, Laos; [Akkhavong, Kongsap] Minist Hlth, Natl Inst Publ Hlth, Viangchan, Laos; [Southivong, Bouavanh] Minist Hlth, Dept Hlth Care, Viangchan, Laos; [Nakamura, Satoshi] Hiroshima Bunka Gakuen Univ, Grad Sch Nursing Sci, Lab Epidemiol & Publ Hlth, Kure, Hiroshima, Japan; [Nakamura, Satoshi] Hiroshima Bunka Gakuen Univ, Fac Nursing, Kure, Hiroshima, Japan; [Midorikawa, Yutaka] Suzuka Univ Med Sci, Fac Hlth, Dept Med Nutr, Suzuka, Mie, Japan	Mie University	Murata, M (corresponding author), Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Tsu, Mie 514, Japan.	mmurata@doc.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [17590530, 23500953]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 17590530, No. 23500953). The funders had no role in study design, data collection and analysis, decision to publish, of preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Alharbi KK, 2014, DNA CELL BIOL, V33, P637, DOI 10.1089/dna.2014.2461; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bang OY, 2003, YONSEI MED J, V44, P401, DOI 10.3349/ymj.2003.44.3.401; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chen CH, 2010, NEUROBIOL AGING, V31, P732, DOI 10.1016/j.neurobiolaging.2008.06.014; Cheng D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007733; Christensen Helen, 2008, BMC Geriatr, V8, P14, DOI 10.1186/1471-2318-8-14; Christensen KD, 2008, GENET MED, V10, P207, DOI 10.1097/GIM.0b013e318164e4cf; Cooney MT, 2010, AM HEART J, V159, P612, DOI 10.1016/j.ahj.2009.12.029; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crean S, 2011, DEMENT GERIATR COGN, V31, P20, DOI 10.1159/000321984; de Bruijn RFAG, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0130-5; Llibre JD, 2010, MEDICC REV, V12, P20, DOI 10.37757/MR2010.V12.N3.6; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Elwood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081877; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Federation ID, 2006, IDF CONS WORLDW DEF; Goldman JS, 2011, GENET MED, V13, P597, DOI 10.1097/GIM.0b013e31821d69b8; Grandinetti A, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0161-2; Handley OJ, 2006, NEUROBIOL AGING, V27, P1425, DOI 10.1016/j.neurobiolaging.2005.08.001; Irie F, 2008, ARCH GEN PSYCHIAT, V65, P906, DOI 10.1001/archpsyc.65.8.906; Jensen MT, 2012, EUR J PREV CARDIOL, V19, P102, DOI 10.1177/1741826710394274; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; Kloppenborg RP, 2008, EUR J PHARMACOL, V585, P97, DOI 10.1016/j.ejphar.2008.02.049; Lopez MF, 2014, EXPERT REV PROTEOMIC, V11, P371, DOI 10.1586/14789450.2014.901892; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Prince M, 2015, WORLD ALZHEIMERS REP; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Ravona-Springer R, 2014, EUR NEUROPSYCHOPHARM, V24, P1303, DOI 10.1016/j.euroneuro.2014.05.001; Scuteri A, 2014, J ALZHEIMERS DIS, V42, pS401, DOI 10.3233/JAD-141416; Sery O, 2014, NEUROENDOCRINOL LETT, V35, P691; SIEST G, 1995, CLIN CHEM, V41, P1068; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; The World Health Organization, 2012, COMMUN DIS INTELL, P68; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; WHO, 2014, WORLD MAL 2014 LAO P; World Health Organization, 2015, WHO COUNTR COOP STRA WHO COUNTR COOP STRA; World Health Organization, 2014, NONC DIS COUNTR PROF; Yan HQ, 2015, GENET MOL RES, V14, P665, DOI 10.4238/2015.January.30.9; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009; Yousuf FA, 2015, PAK J PHARM SCI, V28, P1439	47	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2016	11	5							e0155072	10.1371/journal.pone.0155072	http://dx.doi.org/10.1371/journal.pone.0155072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM8CD	27168072	Green Published, gold			2022-12-27	WOS:000376587300005
J	Ding, J; Nie, M; Liu, JM; Hu, XY; Ma, LX; Deng, ZL; Wang, DZ				Ding, Jian; Nie, Mao; Liu, Jianming; Hu, Xiaoyun; Ma, Lixin; Deng, Zhong-Liang; Wang, Da-Zhi			Trbp Is Required for Differentiation of Myoblasts and Normal Regeneration of Skeletal Muscle	PLOS ONE			English	Article							RNA-BINDING-PROTEIN; EXPRESSION; MICRORNAS; MIR-206; DICER; PROLIFERATION; OBESITY; INJURY; CELLS; HEART	Global inactivation of Trbp, a regulator of miRNA pathways, resulted in developmental defects and postnatal lethality in mice. Recently, we showed that cardiac-specific deletion of Trbp caused heart failure. However, its functional role(s) in skeletal muscle has not been characterized. Using a conditional knockout model, we generated mice lacking Trbp in the skeletal muscle. Unexpectedly, skeletal muscle specific Trbp mutant mice appear to be phenotypically normal under normal physiological conditions. However, these mice exhibited impaired muscle regeneration and increased fibrosis in response to cardiotoxin-induced muscle injury, suggesting that Trbp is required for muscle repair. Using cultured myoblast cells we further showed that inhibition of Trbp repressed myoblast differentiation in vitro. The impaired myogenesis is associated with reduced expression of muscle-specific miRNAs, miR-1a and miR-133a. Together, our study demonstrated that Trbp participates in the regulation of muscle differentiation and regeneration.	[Ding, Jian; Nie, Mao; Liu, Jianming; Hu, Xiaoyun; Ma, Lixin; Wang, Da-Zhi] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Cardiol, 320 Longwood Ave, Boston, MA USA; [Nie, Mao; Deng, Zhong-Liang] Chongqing Med Univ, Affiliated Hosp 2, Dept Orthopaed Surg, Chongqing, Peoples R China; [Ma, Lixin] Hubei Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Wang, Da-Zhi] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Chongqing Medical University; Hubei University; Harvard University	Wang, DZ (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Cardiol, 320 Longwood Ave, Boston, MA USA.; Wang, DZ (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	dwang@enders.tch.harvard.edu	Ding, Jian/F-6996-2015; Nie, Mao/GZM-0399-2022	Ding, Jian/0000-0002-5578-5410; Nie, Mao/0000-0003-3295-3482	Muscular Dystrophy Association [294854]; NIH [HL085635, HL116919]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Muscular Dystrophy Association, 294854 to DZW, NIH, HL085635 to DZW, and NIH, HL116919 to DZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CI, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-59; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Carlson BM, 1982, MEDICINE AND SCIENCE, V15, P187; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; Chen X, 2009, J BIOL CHEM, V284, P5362, DOI 10.1074/jbc.M807523200; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Daniels SM, 2012, MICROBIOL MOL BIOL R, V76, P652, DOI 10.1128/MMBR.00012-12; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; Ding J, 2015, CELL CYCLE, V14, P3007, DOI 10.1080/15384101.2015.1084202; Ding J, 2015, NAT GENET, V47, P776, DOI 10.1038/ng.3324; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Goodarzi H, 2014, NATURE, V513, P256, DOI 10.1038/nature13466; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim Y, 2014, CELL REP, V9, P1061, DOI 10.1016/j.celrep.2014.09.039; Kropp J, 2015, BIOCHEM J, V466, P85, DOI 10.1042/BJ20141175; Lee HY, 2013, NUCLEIC ACIDS RES, V41, P6568, DOI 10.1093/nar/gkt361; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Nakamura T, 2015, CELL REP, V11, P295, DOI 10.1016/j.celrep.2015.03.021; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Polesskaya A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071927; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Seok HY, 2014, CIRC RES, V114, P1585, DOI 10.1161/CIRCRESAHA.114.303784; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Tao YZ, 2011, J CELL BIOL, V194, P551, DOI 10.1083/jcb.201010090; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684	33	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155349	10.1371/journal.pone.0155349	http://dx.doi.org/10.1371/journal.pone.0155349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159388	gold, Green Published, Green Submitted			2022-12-27	WOS:000376576700059
J	Stover, J; Bollinger, L; Izazola, JA; Loures, L; DeLay, P; Ghys, PD				Stover, John; Bollinger, Lori; Izazola, Jose Antonio; Loures, Luiz; DeLay, Paul; Ghys, Peter D.		Fast Track Modeling Working Grp	What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach	PLOS ONE			English	Article							HIV PREVENTION; ANTIRETROVIRAL THERAPY; MALE CIRCUMCISION; RANDOMIZED-TRIAL; MEN; TRANSMISSION; PROPHYLAXIS; SPECTRUM	In 2011 a new Investment Framework was proposed that described how the scale-up of key HIV interventions could dramatically reduce new HIV infections and AIDS-related deaths in low and middle income countries by 2015. This framework included ambitious coverage goals for prevention and treatment services for 2015, resulting in a reduction of new HIV infections by more than half, in line with the goals of the declaration of the UN High Level Meeting in June 2011. However, the approach suggested a leveling in the number of new infections at about 1 million annually-far from the UNAIDS goal of ending AIDS by 2030. In response, UNAIDS has developed the Fast-Track approach that is intended to provide a roadmap to the actions required to achieve this goal. The Fast-Track approach is predicated on a rapid scale-up of focused, effective prevention and treatment services over the next 5 years and then maintaining a high level of programme implementation until 2030. Fast-Track aims to reduce new infections and AIDS-related deaths by 90% from 2010 to 2030 and proposes a set of biomedical, behavioral and enabling intervention targets for 2020 and 2030 to achieve that goal, including the rapid scale-up initiative for antiretroviral treatment known as 90-90-90. Compared to a counterfactual scenario of constant coverage for all services at early-2015 levels, the Fast-Track approach would avert 18 million HIV infections and 11 million deaths from 2016 to 2030 globally. This paper describes the analysis that produced these targets and the estimated resources needed to achieve them in low-and middle-income countries. It indicates that it is possible to achieve these goals with a significant push to achieve rapid scale-up of key interventions between now and 2020. The annual resources required from all sources would rise to US$7.4Bn in low-income countries, US$8.2Bn in lower middle-income countries and US$10.5Bn in upper-middle-income-countries by 2020 before declining approximately 9% by 2030.	[Stover, John; Bollinger, Lori] Avenir Hlth, Glastonbury, CT USA; [Izazola, Jose Antonio; Loures, Luiz; Ghys, Peter D.] United Nations Joint Programme HIV AIDS UNAIDS, Geneva, Switzerland	UNAIDS	Stover, J (corresponding author), Avenir Hlth, Glastonbury, CT USA.	JStover@AvenirHealth.org		Lauer, Jeremy A/0000-0003-0652-0691; Williams, Brian/0000-0002-3174-4876	Bill and Melinda Gates Foundation [OPP1186285]; UNAIDS; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UNAIDS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Participation of JS and LB was sponsored by the Bill and Melinda Gates Foundation under Grant OPP1186285.; We are grateful to the Expert Group on ART costs for their contributions. The group included Meg Doherty, Gundo Weiler, Nathan Ford and Jos Perriens from WHO, Badara Samb from UNAIDS, Jennifer Cohn from Medecins sans Frontieres, Elya Tagar and Samantha Diamond from the Clinton Health Access Initiative, Sergio Bautista from the Mexican National Institute of Public Health, Andrew Philipps from University College London, Ruben Granich from the U.S. Government's Office of the Global AIDS Coordinator, Brian Williams from SACEMA and Gesine Meyer-Rath from Boston University. Ricardo Valladares from UNAIDS, provided valuable input on the estimation of program support costs, support, critical review and inputs to the execution of the country validation and the project in general. Karl Dehne provided guidance on modeling prevention services. John Blandford (CDC) provided crucial input on the assumptions and inputs for this modeling.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; [Anonymous], 2015, WORLD POPULATION PRO; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Bollinger L., 2013, RNM COMPUTER PROGRAM; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Karim QA, 2015, IAS 2015 VANC JUL; Pettifor A, 2015, IAS 2015 VANC JUL; Rollins N, 2012, SEX TRANSM INFECT, V88, pI44, DOI 10.1136/sextrans-2012-050709; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stover J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111956; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; United Nations General Assembly, 2011, POL DECL HIV AIDS IN; World Health Organization, 2015, GUID START ANT THER; Yiannoutsos CT, 2012, SEX TRANSM INFECT, V88, pI33, DOI 10.1136/sextrans-2012-050658	20	115	118	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0154893	10.1371/journal.pone.0154893	http://dx.doi.org/10.1371/journal.pone.0154893			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159260	gold, Green Published, Green Accepted			2022-12-27	WOS:000376576700024
J	Urushihara, Y; Kawasumi, K; Endo, S; Tanaka, K; Hirakawa, Y; Hayashi, G; Sekine, T; Kino, Y; Kuwahara, Y; Suzuki, M; Fukumoto, M; Yamashiro, H; Abe, Y; Fukuda, T; Shinoda, H; Isogai, E; Arai, T; Fukumoto, M				Urushihara, Yusuke; Kawasumi, Koh; Endo, Satoru; Tanaka, Kenichi; Hirakawa, Yasuko; Hayashi, Gohei; Sekine, Tsutomu; Kino, Yasushi; Kuwahara, Yoshikazu; Suzuki, Masatoshi; Fukumoto, Motoi; Yamashiro, Hideaki; Abe, Yasuyuki; Fukuda, Tomokazu; Shinoda, Hisashi; Isogai, Emiko; Arai, Toshiro; Fukumoto, Manabu			Analysis of Plasma Protein Concentrations and Enzyme Activities in Cattle within the Ex-Evacuation Zone of the Fukushima Daiichi Nuclear Plant Accident	PLOS ONE			English	Article							LOW DOSE-RATES; IONIZING-RADIATION; POWER-PLANT; ADAPTIVE RESPONSE; PREMATURE SENESCENCE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; SKELETAL-MUSCLE; DNA-DAMAGE; GAMMA-RAYS	The effect of the Fukushima Daiichi Nuclear Power Plant (FNPP) accident on humans and the environment is a global concern. We performed biochemical analyses of plasma from 49 Japanese Black cattle that were euthanized in the ex-evacuation zone set within a 20-km radius of FNPP. Among radionuclides attributable to the FNPP accident, germanium gamma-ray spectrometry detected photopeaks only from Cs-134 and Cs-137 (radiocesium) commonly in the organs and in soil examined. Radioactivity concentration of radiocesium was the highest in skeletal muscles. Assuming that the animal body was composed of only skeletal muscles, the median of internal dose rate from radiocesium was 12.5 mu Gy/day (ranging from 1.6 to 33.9 mu Gy/day). The median of external dose rate calculating from the place the cattle were caught was 18.8 mu Gy/day (6.0-133.4 mu Gy/day). The median of internal and external (total) dose rate of the individual cattle was 26.9 mu Gy/day (9.11-55.1 mu Gy/day). Plasma levels of malondialdehyde and superoxide dismutase activity were positively and glutathione peroxidase activity was negatively correlated with internal dose rate. Plasma alanine transaminase activity and percent activity of lactate dehydrogenase (LDH)-2, LDH-3 and LDH-4 were positively and LDH-1 was negatively correlated with both internal and total dose rate. These suggest that chronic exposure to low-dose rate of ionizing radiation induces slight stress resulting in modified plasma protein and enzyme levels.	[Urushihara, Yusuke; Hayashi, Gohei; Suzuki, Masatoshi; Fukumoto, Motoi; Fukumoto, Manabu] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Urushihara, Yusuke] Natl Inst Radiol Sci, Fukushima Project Headquarters, Chiba, Chiba 260, Japan; [Kawasumi, Koh; Hirakawa, Yasuko; Arai, Toshiro] Nippon Vet & Life Sci Univ, Sch Vet Med, Tokyo, Japan; [Endo, Satoru; Tanaka, Kenichi] Hiroshima Univ, Grad Sch Engn, Hiroshima, Japan; [Sekine, Tsutomu] Tohoku Univ, Inst Excellence Higher Educ, Sendai, Miyagi 980, Japan; [Kino, Yasushi] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 980, Japan; [Kuwahara, Yoshikazu] Tohoku Med & Pharmaceut Univ, Fac Med, Sendai, Miyagi, Japan; [Yamashiro, Hideaki] Niigata Univ, Fac Agr, Niigata, Niigata, Japan; [Abe, Yasuyuki; Isogai, Emiko] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Fukuda, Tomokazu] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Shinoda, Hisashi] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan	Tohoku University; National Institutes for Quantum Science & Technology; Nippon Veterinary & Life Science University; Hiroshima University; Tohoku University; Tohoku University; Tohoku Medical & Pharmaceutical University; Niigata University; Obihiro University of Agriculture & Veterinary Medicine; Tohoku University; Tohoku University	Fukumoto, M (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	manabu.fukumoto.a8@tohoku.ac.jp	Kino, Yasushi/U-3909-2017; Endo, Satoru/D-9091-2012; Fukumoto, Manabu/L-1444-2019; Kino, Yasushi/ABB-8627-2021; Hirakawa, Yukiko/M-6861-2013; Tanaka, Kenichi/K-6265-2015; Fukuda, Tomokazu/O-1257-2018	Kino, Yasushi/0000-0002-8359-9383; Endo, Satoru/0000-0001-5961-681X; Hirakawa, Yukiko/0000-0002-1320-9722; Fukuda, Tomokazu/0000-0001-8456-0483	Japan Society for the Promotion of Science [Kakenhi26253022, 15H01850]; Emergency Budget for the Reconstruction of Northeastern Japan; MEXT, Japan; Discretionary Expense of the President of Tohoku University; Nippon Life Insurance Foundation; Programme for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research [15H01850] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Emergency Budget for the Reconstruction of Northeastern Japan; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Discretionary Expense of the President of Tohoku University; Nippon Life Insurance Foundation(Nippon Life Insurance Foundation); Programme for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by grants from the Japan Society for the Promotion of Science (Kakenhi26253022, 15H01850), the Emergency Budget for the Reconstruction of Northeastern Japan, MEXT, Japan, Discretionary Expense of the President of Tohoku University, Nippon Life Insurance Foundation and the Programme for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry. The funders had no role in study rate of ionizing radiation induces slight stress resulting in modified plasma protein and enzyme levels.	Akimoto S, 2014, ECOL EVOL, V4, P355, DOI 10.1002/ece3.949; Akkose A, 2003, CLIN CHIM ACTA, V336, P13, DOI 10.1016/S0009-8981(02)00421-7; Al-Nimer Marwan S M, 2012, Int J Appl Basic Med Res, V2, P48, DOI 10.4103/2229-516X.96809; Bravard A, 1999, INT J RADIAT BIOL, V75, P639; Cimmery V., 2007, SAGA USER GUIDE UPDA; Coleman CN, 2013, RADIAT RES, V179, P1, DOI 10.1667/RR3224.1; DAWSON DM, 1964, SCIENCE, V143, P929, DOI 10.1126/science.143.3609.929; DOORNENBAL H, 1988, CAN J VET RES, V52, P99; Dursun H, 2006, J INT MED RES, V34, P193, DOI 10.1177/147323000603400209; Eckerman Keith F, 2008, Ann ICRP, V38, P3, DOI 10.1016/j.icrp.2009.02.001; Eken A, 2012, INT J RADIAT BIOL, V88, P648, DOI 10.3109/09553002.2012.702295; Endo S, 2012, J ENVIRON RADIOACTIV, V111, P18, DOI 10.1016/j.jenvrad.2011.11.006; Endo S, 2015, J RADIAT RES, V56, pI48, DOI 10.1093/jrr/rrv056; Fukuda T, 2015, ANIM SCI J, V86, P120, DOI 10.1111/asj.12301; Fukuda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054312; Fukumoto M, 2014, PATHOL INT, V64, P251, DOI 10.1111/pin.12170; Hiyama A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00570; Kaneko J. J., 1997, CLIN BIOCH DOMESTIC, P890; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Klucinski P, 2008, ANN AGR ENV MED, V15, P9; Koukourakis MI, 2014, BRIT J CANCER, V110, P2217, DOI 10.1038/bjc.2014.158; LATNER AL, 1966, SCIENCE, V154, P527; Malekirad AA, 2005, ENVIRON TOXICOL PHAR, V20, P215, DOI 10.1016/j.etap.2005.01.005; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Moller AP, 2005, P ROY SOC B-BIOL SCI, V272, P247, DOI 10.1098/rspb.2004.2914; Morgan WF, 2013, RADIAT RES, V179, P501, DOI 10.1667/RR3306.1; Ochiai K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05793; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Otsuka K, 2006, RADIAT RES, V166, P474, DOI 10.1667/RR0561.1; Romanenko A, 2000, INT J CANCER, V86, P790, DOI 10.1002/(SICI)1097-0215(20000615)86:6<790::AID-IJC6>3.0.CO;2-Q; Rombouts C, 2014, INT J RADIAT BIOL, V90, P560, DOI 10.3109/09553002.2014.905724; SANSOM BF, 1966, BIOCHEM J, V99, P677, DOI 10.1042/bj0990677; Serhatlioglu S, 2003, CELL BIOCHEM FUNCT, V21, P371, DOI 10.1002/cbf.1042; Takahashi S, 2015, J RADIAT RES, V56, pI36, DOI 10.1093/jrr/rrv069; Tanaka IB, 2007, RADIAT RES, V167, P417, DOI 10.1667/RR0728.1; Tanaka S, 2003, RADIAT RES, V160, P376, DOI 10.1667/RR3042; VESELL ES, 1961, J CLIN INVEST, V40, P586, DOI 10.1172/JCI104287; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; Yamaguchi T, 2013, J VET MED SCI, V75, P93, DOI 10.1292/jvms.12-0296; Yamashiro H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02850; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463	41	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2016	11	5							e0155069	10.1371/journal.pone.0155069	http://dx.doi.org/10.1371/journal.pone.0155069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM7YQ	27159386	gold, Green Submitted, Green Published			2022-12-27	WOS:000376576700037
J	Fierro, A; Edmondson, DE; Celis-Barros, C; Rebolledo-Fuentes, M; Zapata-Torres, G				Fierro, Angelica; Edmondson, Dale E.; Celis-Barros, Cristian; Rebolledo-Fuentes, Marco; Zapata-Torres, Gerald			Why p-OMe- and p-Cl-beta-Methylphenethylamines Display Distinct Activities uponMAO-B Binding	PLOS ONE			English	Article							MONOAMINE-OXIDASE-B; BENZYLAMINE ANALOGS; SELECTIVE-INHIBITION; MAO-A; SUBSTRATE; MECHANISMS; RESOLUTION; OXIDATION; ENERGIES; RESIDUES	Despite their structural and chemical commonalities, p-chloro-beta-methylphenethylamine and p-methoxy-beta-methylphenethylamine display distinct inhibitory and substrate activities upon MAO-B binding. Density Functional Theory (DFT) quantum chemical calculations reveal that beta-methylation and para-substitution underpin the observed activities sustained by calculated transition state energy barriers, attained conformations and key differences in their interactions in the enzyme's substrate binding site. Although both compounds meet substrate requirements, it is clear that beta-methylation along with the physicochemical features of the para-substituents on the aromatic ring determine the activity of these compounds upon binding to the MAO B-isoform. While data for a larger set of compounds might lend generality to our conclusions, our experimental and theoretical results strongly suggest that the contrasting activities displayed depend on the conformations adopted by these compounds when they bind to the enzyme.	[Fierro, Angelica] Pontificia Univ Catolica Chile, Fac Quim, Dept Quim Organ, Alameda 340, Santiago, Chile; [Edmondson, Dale E.] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA; [Edmondson, Dale E.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Celis-Barros, Cristian] Univ Andres Bello, Fac Ciencias Exactas, Dept Ciencias Quim, Santiago, Chile; [Rebolledo-Fuentes, Marco] Univ Chile, Fac Sci, Dept Chem, Santiago, Chile; [Zapata-Torres, Gerald] Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile	Pontificia Universidad Catolica de Chile; Emory University; Emory University; Universidad Andres Bello; Universidad de Chile; Universidad de Chile	Celis-Barros, C (corresponding author), Univ Andres Bello, Fac Ciencias Exactas, Dept Ciencias Quim, Santiago, Chile.; Zapata-Torres, G (corresponding author), Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile.	gzapata@uchile.cl	Celis Barros, Cristian/ABA-2702-2021; Fierro, Angelica/AAJ-2533-2020	Fierro, Angelica/0000-0002-6507-4188; Celis-Barros, Cristian/0000-0002-4685-5229	Fondecyt [1120280]; FONDO NACIONAL DE DESARROLLO CIENTIFICO Y TECNOLOGICO (FONDECYT) [1120280]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDO NACIONAL DE DESARROLLO CIENTIFICO Y TECNOLOGICO (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Funding was provided by Fondecyt Grant Number 1120280, GZT, Fondo Nacional de Desarollo Cientifico y Tecnologico, http://www.conicyt.cl/fondecyt/.; This research was supported by FONDO NACIONAL DE DESARROLLO CIENTIFICO Y TECNOLOGICO (FONDECYT) Grant 1120280.	Abad E, 2013, J PHYS CHEM B, V117, P14238, DOI 10.1021/jp4061522; Anslyn E. V., 2006, MODERN PHYS ORGANIC; Atalay VE, 2013, COMPUT BIOL CHEM, V47, P181, DOI 10.1016/j.compbiolchem.2013.08.007; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Binda C, 2005, J MED CHEM, V48, P8148, DOI 10.1021/jm0506266; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; Binda C, 2008, BIOCHEMISTRY-US, V47, P5616, DOI 10.1021/bi8002814; Binda C, 2007, J MED CHEM, V50, P5848, DOI 10.1021/jm070677y; Binda C, 2012, ACS MED CHEM LETT, V3, P39, DOI 10.1021/ml200196p; Binda C, 2011, INT REV NEUROBIOL, V100, P1, DOI 10.1016/B978-0-12-386467-3.00001-7; Binda C, 2011, J MED CHEM, V54, P909, DOI 10.1021/jm101359c; Bonivento D, 2010, J BIOL CHEM, V285, P36849, DOI 10.1074/jbc.M110.169482; Celis-Barros C, 2015, J COMPUT AID MOL DES, V29, P37, DOI 10.1007/s10822-014-9802-7; Contreras-Garcia J, 2011, J PHYS CHEM A, V115, P12983, DOI 10.1021/jp204278k; Contreras-Garcia J, 2011, J CHEM THEORY COMPUT, V7, P625, DOI 10.1021/ct100641a; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; De Colibus L, 2005, P NATL ACAD SCI USA, V102, P12684, DOI 10.1073/pnas.0505975102; Edmondson DE, 2009, BIOCHEMISTRY-US, V48, P4220, DOI 10.1021/bi900413g; Edmondson DE, 2000, BBA-PROTEIN STRUCT M, V1479, P52, DOI 10.1016/S0167-4838(00)00055-8; Esteban G, 2014, BBA-PROTEINS PROTEOM, V1844, P1104, DOI 10.1016/j.bbapap.2014.03.006; Frisch G. W., 2013, GAUSSIAN 09; Geha RM, 2002, J BIOL CHEM, V277, P17209, DOI 10.1074/jbc.M110920200; Heuson E, 2014, ORG BIOMOL CHEM, V12, P8689, DOI 10.1039/c4ob01377h; Hubalek F, 2005, J BIOL CHEM, V280, P15761, DOI 10.1074/jbc.M500949200; Johnson ER, 2010, J AM CHEM SOC, V132, P6498, DOI 10.1021/ja100936w; Kalgutkar AS, 2001, CHEM RES TOXICOL, V14, P1139, DOI 10.1021/tx010073b; KIM SK, 1991, NEUROPHARMACOLOGY, V30, P329, DOI 10.1016/0028-3908(91)90057-I; KINEMUCHI H, 1988, JPN J PHARMACOL, V46, P197, DOI 10.1254/jjp.46.197; Li M, 2006, BIOCHEMISTRY-US, V45, P4775, DOI 10.1021/bi051847g; Liao RZ, 2010, THESIS STOCKHOLM U S; Milczek EM, 2011, FEBS J, V278, P4860, DOI 10.1111/j.1742-4658.2011.08386.x; Milczek EM, 2008, J MED CHEM, V51, P8019, DOI 10.1021/jm8011867; Miller JR, 1999, BIOCHEMISTRY-US, V38, P13670, DOI 10.1021/bi990920y; Newton-Vinson P, 2000, PROTEIN EXPRES PURIF, V20, P334, DOI 10.1006/prep.2000.1309; PLETSCHER A, 1991, EXPERIENTIA, V47, P4, DOI 10.1007/BF02041242; Repic M, 2014, PROTEINS, V82, P3347, DOI 10.1002/prot.24690; Ross GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032036; Siegbahn PEM, 2009, J BIOL INORG CHEM, V14, P643, DOI 10.1007/s00775-009-0511-y; Son SY, 2008, P NATL ACAD SCI USA, V105, P5739, DOI 10.1073/pnas.0710626105; Song MS, 2013, PROG NEURO-PSYCHOPH, V44, P118, DOI 10.1016/j.pnpbp.2013.02.001; WALKER MC, 1994, BIOCHEMISTRY-US, V33, P7088, DOI 10.1021/bi00189a011; YANG HYT, 1973, J PHARMACOL EXP THER, V187, P365; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883; Zapata-Torres G, 2015, J CHEM INF MODEL, V55, P1349, DOI 10.1021/acs.jcim.5b00140; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	45	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154989	10.1371/journal.pone.0154989	http://dx.doi.org/10.1371/journal.pone.0154989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152414	Green Published, Green Submitted, gold			2022-12-27	WOS:000375677000056
J	Hematpoor, A; Liew, SY; Chong, WL; Azirun, MS; Lee, VS; Awang, K				Hematpoor, Arshia; Liew, Sook Yee; Chong, Wei Lim; Azirun, Mohd Sofian; Lee, Vannajan Sanghiran; Awang, Khalijah			Inhibition and Larvicidal Activity of Phenylpropanoids from Piper sarmentosum on Acetylcholinesterase against Mosquito Vectors and Their Binding Mode of Interaction	PLOS ONE			English	Article							AEDES-ALBOPICTUS; CULEX-QUINQUEFASCIATUS; CHEMICAL-COMPOSITION; AEGYPTI; CULICIDAE; IDENTIFICATION; CONSTITUENTS; REACTIVATION; EXTRACTS; SPECTRA	Aedes aegypti, Aedes albopictus and Culex quinquefasciatus are vectors of dengue fever and West Nile virus diseases. This study was conducted to determine the toxicity, mechanism of action and the binding interaction of three active phenylpropanoids from Piper sarmentosum (Piperaceae) toward late 3rd or early 4th larvae of above vectors. A bioassay guided-fractionation on the hexane extract from the roots of Piper sarmentosum led to the isolation and identification of three active phenylpropanoids; asaricin 1, isoasarone 2 and trans-asarone 3. The current study involved evaluation of the toxicity and acetylcholinesterase (AChE) inhibition of these compounds against Aedes aegypti, Aedes albopictus and Culex quinquefasciatus larvae. Asaricin 1 and isoasarone 2 were highly potent against Aedes aegypti, Aedes albopictus and Culex quinquefasciatus larvae causing up to 100% mortality at <= 15 mu g/mL concentration. The ovicidal activity of asaricin 1, isoasarone 2 and trans-asarone 3 were evaluated through egg hatching. Asaricin 1 and isoasarone 2 showed potent ovicidal activity. Ovicidal activity for both compounds was up to 95% at 25 mu g/mL. Asaricin 1 and isoasarone 2 showed strong inhibition on acetylcholinesterase with relative IC50 values of 0.73 to 1.87 mu g/mL respectively. These findings coupled with the high AChE inhibition may suggest that asaricin 1 and isoasarone 2 are neuron toxic compounds toward Aedes aegypti, Aedes albopictus and Culex quinquefasciatus. Further computational docking with Autodock Vina elaborates the possible interaction of asaricin 1 and isoasarone 2 with three possible binding sites of AChE which includes catalytic triads (CAS: S238, E367, H480), the peripheral sites (PAS: E72, W271) and anionic binding site (W83). The binding affinity of asaricin 1 and isoasarone 2 were relatively strong with asaricin 1 showed a higher binding affinity in the anionic pocket.	[Hematpoor, Arshia; Azirun, Mohd Sofian] Univ Malaya, Inst Biol Sci, Fac Sci Bldg, Kuala Lumpur, Malaysia; [Liew, Sook Yee; Chong, Wei Lim; Lee, Vannajan Sanghiran; Awang, Khalijah] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia; [Liew, Sook Yee; Awang, Khalijah] Univ Malaya, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Awang, K (corresponding author), Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia.; Awang, K (corresponding author), Univ Malaya, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur, Malaysia.	khalijah@um.edu.my	Chong, Wei Lim/AAY-2604-2021; AWANG, KHALIJAH/B-8781-2010; AZIRUN, MOHD SOFIAN/B-9127-2010; Lee, Vannajan Sanghiran/AAX-5564-2020; Liew, Sook Yee/R-1175-2016	AWANG, KHALIJAH/0000-0001-5971-6570; Liew, Sook Yee/0000-0002-1941-2780; Chong, Wei Lim/0000-0002-4178-2614	University of Malaya [UM.C/625/1/HIR/MOE/SC/37, PV085/2011A]	University of Malaya(Universiti Malaya)	This work was supported by University of Malaya research grants [UM.C/625/1/HIR/MOE/SC/37 and PV085/2011A]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE WN, 1969, BIOCHEM J, V115, P147, DOI 10.1042/bj1150147; [Anonymous], 2009, DISC STUD VERS 2 5 5; Bandyopadhyay P, 2014, BIOORG MED CHEM LETT, V24, P2934, DOI 10.1016/j.bmcl.2014.04.082; BRIGGS LH, 1957, ANAL CHEM, V29, P904, DOI 10.1021/ac60126a014; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chaithong U, 2006, J VECTOR ECOL, V31, P138, DOI 10.3376/1081-1710(2006)31[138:LEOPPO]2.0.CO;2; Chansang U, 2005, J VECTOR ECOL, V30, P195; Damsud T, 2013, PHYTOCHEM LETT, V6, P350, DOI 10.1016/j.phytol.2013.04.001; de Morals SM, 2007, BIOCHEM SYST ECOL, V35, P670, DOI 10.1016/j.bse.2007.05.002; Delfino RT, 2009, J BRAZIL CHEM SOC, V20, P407, DOI 10.1590/S0103-50532009000300003; Ehrich M, 2011, TOXICOL IN VITRO, V25, P301, DOI 10.1016/j.tiv.2010.09.010; Ellison M, 2008, J MOL BIOL, V377, P1216, DOI 10.1016/j.jmb.2008.01.082; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Feng G, 2014, PLANT DIS PESTS, V5, P38; Finney D.J., 1971, PROBIT ANAL; Govindarajan M, 2013, EXP PARASITOL, V134, P7, DOI 10.1016/j.exppara.2013.01.018; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Hartsel JA, 2012, BIOORG MED CHEM LETT, V22, P4593, DOI 10.1016/j.bmcl.2012.05.103; Hawkes NJ, 2005, PESTIC BIOCHEM PHYS, V81, P154, DOI 10.1016/j.pestbp.2004.11.003; Helinski MEH, 2012, J INSECT PHYSIOL, V58, P1307, DOI 10.1016/j.jinsphys.2012.07.003; Kamaraj C, 2010, PARASITOL RES, V106, P1071, DOI 10.1007/s00436-010-1750-0; KOHLHARDT M, 1978, J MOL CELL CARDIOL, V10, P573, DOI 10.1016/0022-2828(78)90015-9; MASUDA T, 1991, PHYTOCHEMISTRY, V30, P3227, DOI 10.1016/0031-9422(91)83180-S; Nardi F, 2008, COMP BIOCHEM PHYS A, V151, pS6, DOI 10.1016/j.cbpa.2008.05.056; Park IK, 2002, J AGR FOOD CHEM, V50, P1866, DOI 10.1021/jf011457a; PATRA A, 1981, J NAT PROD, V44, P668, DOI 10.1021/np50018a007; Pavia D.L., 2009, INTRO SPECTROSCOPY; Qin WQ, 2010, PESTIC BIOCHEM PHYS, V96, P132, DOI 10.1016/j.pestbp.2009.10.006; Rahman NNNA, 1999, J ETHNOPHARMACOL, V64, P249, DOI 10.1016/S0378-8741(98)00135-4; Ravaomanarivo Lala Harivelo Raveloson, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P798; Reegan Appadurai Daniel, 2015, Osong Public Health Res Perspect, V6, P64, DOI 10.1016/j.phrp.2014.08.009; Santos BVD, 1998, PHYTOCHEMISTRY, V49, P1381, DOI 10.1016/S0031-9422(98)00100-9; Scholte EJ, 2007, ACTA TROP, V102, P151, DOI 10.1016/j.actatropica.2007.04.011; Swale DR, 2013, PESTIC BIOCHEM PHYS, V106, P85, DOI 10.1016/j.pestbp.2013.03.005; Tanimori S, 2009, RES CHEM INTERMEDIAT, V35, P909, DOI 10.1007/s11164-009-0073-1; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vellosillo T, 2010, PLANT PHYSIOL, V154, P444, DOI 10.1104/pp.110.161273; Wahyuni D, 2015, PROCEDIA ENVIRON SCI, V23, P323, DOI 10.1016/j.proenv.2015.01.047; WHO, 1981, INSTR DET SUSC RES M, P1; WHO, 1960, INS RES VECT CONTR; Worek F, 2012, BIOCHEM PHARMACOL, V83, P1700, DOI 10.1016/j.bcp.2012.03.002; Worek F, 2011, CHEM-BIOL INTERACT, V194, P91, DOI 10.1016/j.cbi.2011.09.001	42	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155265	10.1371/journal.pone.0155265	http://dx.doi.org/10.1371/journal.pone.0155265			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES8DJ	27152416	Green Submitted, Green Published, gold			2022-12-27	WOS:000399782300001
J	Kim, JC; Ha, YJ; Tak, KH; Roh, SA; Kim, CW; Kim, TW; Kim, SK; Kim, SY; Cho, DH; Kim, YS				Kim, Jin Cheon; Ha, Ye Jin; Tak, Ka Hee; Roh, Seon Ae; Kim, Chan Wook; Kim, Tae Won; Kim, Seon-Kyu; Kim, Seon-Young; Cho, Dong-Hyung; Kim, Yong Sung			Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer	PLOS ONE			English	Article							GENE-EXPRESSION DATA; STEM-CELLS; COLON-CANCER; GROWTH; CARCINOGENESIS; PROGNOSIS; CARCINOMA; INVASION; CADHERIN; INSULIN	Using our data set (GSE50760) previously established by RNA sequencing, the present study aimed to identify upregulated genes associated with colorectal cancer (CRC) liver metastasis (CLM) and verify their biological behavior. The potential roles of candidate genes in tumors were assessed using cell proliferation and invasion assays. Tissue samples were collected from 18 CRC patients with synchronous CLM and two CRC cell lines (SW480 and SW620) were used for transfection and cloning. The roles of the genes identified in CLM were verified using immunohistochemistry in 48 nude mice after intrasplenic transplantation of CRC cells. mRNA and protein expression was determined by quantitative real-time reverse transcription polymerase chain reaction and western blot, respectively. Nine genes were initially selected according to the relevance of their molecular function and biological process and, finally, ALDH1A1 and IGFBP1 were chosen based on differential mRNA expression and a positive correlation with protein expression. The overexpression of ALDH1A1 and IGFBP1 significantly and time-dependently decreased cell proliferation (p <= 0.001-0.003) and suppressed invasiveness by >= 3-fold over control cells (p < 0.001) in the SW480 cell line, whereas they had a slight effect on reducing SW620 cell proliferation. The protein expression levels of E-cadherin, N-cadherin, claudin-1, and vimentin were significantly higher in CLM than in primary tumor tissues (p < 0.05). However, the cadherin switch, namely, N-cadherin overexpression with reduced E-cadherin expression, was not observed in CLM tissues and transfected CRC cells. Irrespective of reduced proliferation and invasion found on in vitro cell assays, persistent overexpression of beta-catenin, vimentin, and ZO-1 in IGFBP1-overexpressing SW480 cells possibly contributed to CLM development in mice implanted with IGFBP1-overexpressing SW480 cells (CLM occurrences: SW480/IGFBP1-transfected mice vs. SW480/vector- and SW480/ALDH1A1-transfected mice, 4/8 vs. 0/10, p = 0.023). In conclusion, ALDH1A1 and IGFBP1 are differentially overexpressed in CLM and may play a dual role, functioning as both tumor suppressors and metastasis promoters in CRC.	[Kim, Jin Cheon; Ha, Ye Jin; Tak, Ka Hee; Roh, Seon Ae; Kim, Chan Wook] Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea; [Kim, Tae Won] Univ Ulsan, Coll Med, Dept Med, Seoul, South Korea; [Kim, Jin Cheon; Ha, Ye Jin; Tak, Ka Hee; Roh, Seon Ae; Kim, Chan Wook; Kim, Tae Won; Cho, Dong-Hyung; Kim, Yong Sung] Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea; [Kim, Seon-Kyu; Kim, Seon-Young; Kim, Yong Sung] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Daejeon, South Korea; [Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch East West Med Sci, Gyeonggi Do, South Korea	University of Ulsan; University of Ulsan; University of Ulsan; Asan Medical Center; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyung Hee University	Kim, JC (corresponding author), Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea.; Kim, JC; Cho, DH; Kim, YS (corresponding author), Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea.; Kim, YS (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Daejeon, South Korea.; Cho, DH (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Gyeonggi Do, South Korea.	jckim@amc.seoul.kr; dhcho@khu.ac.kr; yongsung@kribb.re.kr		Kim, Seon-Kyu/0000-0002-4176-5187	Korea Research Foundation [2013R1A2A1A03070986]; Ministry of Science, ICT, and Future Planning; Korea Health 21 R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea [HI06C0868, HI13C1750]	Korea Research Foundation(National Research Foundation of Korea); Ministry of Science, ICT, and Future Planning; Korea Health 21 R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by grants from the Korea Research Foundation (2013R1A2A1A03070986), Ministry of Science, ICT, and Future Planning, and the Korea Health 21 R&D Project (HI06C0868 and HI13C1750), Ministry of Health, Welfare, and Family Affairs, Republic of Korea.	Ares Jr M, 2014, COLD SPRING HARB PRO, P1139, DOI [10.1101/pdb.top083352, DOI 10.1101/PDB.TOP083352]; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Calon A, 2014, SEMIN CANCER BIOL, V25, P15, DOI 10.1016/j.semcancer.2013.12.008; Catalano Veronica, 2011, Cancers (Basel), V3, P1929, DOI 10.3390/cancers3021929; Cho DH, 2010, MOL MED, V16, P271, DOI 10.2119/molmed.2009.00187; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; Dai B, 2014, INT J CLIN EXP PATHO, V7, P5645; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Golubovskaya VM, 2009, HISTOL HISTOPATHOL, V24, P503, DOI 10.14670/HH-24.503; Gonzalez-Gonzalez M, 2013, CANCER GENOM PROTEOM, V10, P19; Huerta S, 2009, NITRIC OXIDE-BIOL CH, V20, P182, DOI 10.1016/j.niox.2008.11.006; Kaihara T, 2003, J EXP CLIN CANC RES, V22, P117; Kim SK, 2014, MOL ONCOL, V8, P1653, DOI 10.1016/j.molonc.2014.06.016; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Lenz HJ, 2014, CANCER SCI, V105, P1087, DOI 10.1111/cas.12471; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ripple MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106257; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanders MA, 2011, FRONT BIOSCI-LANDMRK, V16, P1651, DOI 10.2741/3811; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Van den Eynden GG, 2013, CANCER RES, V73, P2031, DOI 10.1158/0008-5472.CAN-12-3931; Walsh N, 2008, J PROTEOMICS, V71, P561, DOI 10.1016/j.jprot.2008.09.002; Wang CG, 2011, CANCER BIOL THER, V11, P615, DOI 10.4161/cbt.11.7.14688; Wang XJ, 2012, J PROTEOME RES, V11, P1009, DOI 10.1021/pr200766z; Wirz W, 2008, DIFFERENTIATION, V76, P784, DOI 10.1111/j.1432-0436.2007.00260.x; Wolpin BM, 2009, J CLIN ONCOL, V27, P176, DOI 10.1200/JCO.2008.17.9945; Xu SL, 2014, INT J CLIN EXP PATHO, V7, P2976; Yumoto K, 2014, CLIN CANCER RES, V20, P3384, DOI 10.1158/1078-0432.CCR-13-0897	33	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0155160	10.1371/journal.pone.0155160	http://dx.doi.org/10.1371/journal.pone.0155160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152521	gold, Green Published, Green Submitted			2022-12-27	WOS:000375677000075
J	Meinders, M; Hoogenboezem, M; Scheenstra, MR; De Cuyper, IM; Papadopoulos, P; Nemeth, T; Mocsai, A; van den Berg, TK; Kuijpers, TW; Gutierrez, L				Meinders, Marjolein; Hoogenboezem, Mark; Scheenstra, Maaike R.; De Cuyper, Iris M.; Papadopoulos, Petros; Nemeth, Tamas; Mocsai, Attila; van den Berg, Timo K.; Kuijpers, Taco W.; Gutierrez, Laura			Repercussion of Megakaryocyte-Specific Gata1 Loss on Megakaryopoiesis and the Hematopoietic Precursor Compartment	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; IN-VIVO; MEGAKARYOBLASTIC LEUKEMIA; PLATELET ACTIVATION; CELL DEVELOPMENT; ERYTHROID-CELLS; GENE-EXPRESSION; DOWN-SYNDROME; STEM-CELLS; MOUSE	During hematopoiesis, transcriptional programs are essential for the commitment and differentiation of progenitors into the different blood lineages. GATA1 is a transcription factor expressed in several hematopoietic lineages and essential for proper erythropoiesis and megakaryopoiesis. Megakaryocyte-specific genes, such as GP1BA, are known to be directly regulated by GATA1. Mutations in GATA1 can lead to dyserythropoietic anemia and pseudo gray-platelet syndrome. Selective loss of Gata1 expression in adult mice results in macrothrombocytopenia with platelet dysfunction, characterized by an excess of immature megakaryocytes. To specifically analyze the impact of Gata1 loss in mature committed megakaryocytes, we generated Gata1-Lox vertical bar Pf4-Cre mice (Gata1cKO(MK)). Consistent with previous findings, Gata1cKO(MK) mice are macrothrombocytopenic with platelet dysfunction. Supporting this notion we demonstrate that Gata1 regulates directly the transcription of Syk, a tyrosine kinase that functions downstream of Clec2 and GPVI receptors in megakaryocytes and platelets. Furthermore, we show that Gata1cKO(MK) mice display an additional aberrant megakaryocyte differentiation stage. Interestingly, these mice present a misbalance of the multipotent progenitor compartment and the erythroid lineage, which translates into compensatory stress erythropoiesis and splenomegaly. Despite the severe thrombocytopenia, Gata1cKO(MK) mice display a mild reduction of TPO plasma levels, and Gata1cKO(MK) megakaryocytes show a mild increase in Pf4 mRNA levels; such a misbalance might be behind the general hematopoietic defects observed, affecting locally normal TPO and Pf4 levels at hematopoietic stem cell niches.	[Meinders, Marjolein; Scheenstra, Maaike R.; De Cuyper, Iris M.; van den Berg, Timo K.; Kuijpers, Taco W.; Gutierrez, Laura] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands; [Hoogenboezem, Mark] UvA, AMC, Sanquin Res & Landsteiner Lab, Dept Mol Cell Biol, Amsterdam, Netherlands; [Papadopoulos, Petros; Gutierrez, Laura] Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Dept Hematol, Madrid, Spain; [Nemeth, Tamas; Mocsai, Attila] Semmelweis Univ, Sch Med, Dept Physiol, Budapest, Hungary; [Nemeth, Tamas; Mocsai, Attila] Hungarian Acad Sci, MTA SE Lendulet Inflammat Physiol Res Grp, Budapest, Hungary; [Nemeth, Tamas; Mocsai, Attila] Semmelweis Univ, H-1085 Budapest, Hungary; [Kuijpers, Taco W.] UvA, Acad Med Ctr, Emma Childrens Hosp, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Hospital Clinico San Carlos; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Gutierrez, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands.; Gutierrez, L (corresponding author), Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Dept Hematol, Madrid, Spain.	lgutierrezg@salud.madrid.org	Gutiérrez, Laura/B-3780-2016; van den Berg, Timo K/AAC-2479-2022; Papadopoulos, Petros/B-1913-2015; Gutiérrez, Laura/P-9367-2019; Németh, Tamás/O-1968-2017	Gutiérrez, Laura/0000-0001-8443-900X; Papadopoulos, Petros/0000-0002-8342-329X; Németh, Tamás/0000-0001-6854-4301; Scheenstra, Maaike/0000-0001-5476-3562	Center for Translational Molecular Medicine (CTMM); project Innovative Coagulation Diagnostics (INCOAG) [01C-201]; Dutch Heart Foundation; Ramon y Cajal Fellowship [RYC-2013-12587]; Ministerio de Economia y Competitividad -Spain-; I+D Excelencia project grant [SAF2014-55231-P]; Fondos Feder; Hungarian Academy of Sciences	Center for Translational Molecular Medicine (CTMM); project Innovative Coagulation Diagnostics (INCOAG); Dutch Heart Foundation(Netherlands Heart Foundation); Ramon y Cajal Fellowship(Spanish Government); Ministerio de Economia y Competitividad -Spain-; I+D Excelencia project grant; Fondos Feder(European Commission); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This study was funded by the Center for Translational Molecular Medicine (CTMM, www.ctmm.nl), project Innovative Coagulation Diagnostics (INCOAG, grant 01C-201), the Dutch Heart Foundation, a Ramon y Cajal Fellowship (RYC-2013-12587; LG; Ministerio de Economia y Competitividad -Spain-), and an I+D Excelencia 2014 project grant (SAF2014-55231-P; LG and PP; Ministerio de Economia y Competitividad -Spain- and Fondos Feder). This project was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to TN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRD WC, 1994, J BIOL CHEM, V269, P883; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; BRODSKY I, 1966, CANCER RES, V26, P198; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Calaminus SDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051361; Crispino JD, 2005, SEMIN CELL DEV BIOL, V16, P137, DOI 10.1016/j.semcdb.2004.11.002; De Cuyper IM, 2013, BLOOD, V121, pE70, DOI 10.1182/blood-2012-06-437723; de Graaf CA, 2011, CELL CYCLE, V10, P1582, DOI 10.4161/cc.10.10.15619; de Graaf CA, 2010, P NATL ACAD SCI USA, V107, P21689, DOI 10.1073/pnas.1016166108; Drabek K, 2012, CELL REP, V2, P781, DOI 10.1016/j.celrep.2012.08.040; Dubart A, 1996, BLOOD, V87, P3711, DOI 10.1182/blood.V87.9.3711.bloodjournal8793711; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Ferreira R, 2007, BLOOD, V109, P5481, DOI 10.1182/blood-2006-11-060491; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Greene ME, 2003, BLOOD CELL MOL DIS, V31, P351, DOI 10.1016/j.bcmd.2003.08.001; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; Gutierrez L, 2007, BLOOD, V110, P1933, DOI 10.1182/blood-2006-09-048322; Hamlett I, 2008, BLOOD, V112, P2738, DOI 10.1182/blood-2008-03-146605; Harigae H, 1998, GENES CELLS, V3, P39, DOI 10.1046/j.1365-2443.1998.00166.x; HASHIMOTO Y, 1995, J BIOL CHEM, V270, P24532, DOI 10.1074/jbc.270.41.24532; Hughan SC, 2005, BLOOD, V105, P4369, DOI 10.1182/blood-2004-10-4098; Kehrel B, 1998, BLOOD, V91, P491; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Mazharian A, 2010, BLOOD, V116, P793, DOI 10.1182/blood-2010-03-275990; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; Meinders M, 2015, BLOOD, V125, P1957, DOI 10.1182/blood-2014-08-593343; Pertuy F, 2015, J THROMB HAEMOST, V13, P115, DOI 10.1111/jth.12784; Pimkin M, 2014, GENOME RES, V24, P1932, DOI 10.1101/gr.164178.113; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; SIMON MC, 1993, P SOC EXP BIOL MED, V202, P115; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Takahashi S, 1998, BLOOD, V92, P434, DOI 10.1182/blood.V92.2.434.414k24_434_442; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Vannucchi AM, 2005, BLOOD, V105, P3493, DOI 10.1182/blood-2004-04-1320; Vyas P, 1999, BLOOD, V93, P2867; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; WEISS MJ, 1995, EXP HEMATOL, V23, P99; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Whyatt David J., 1997, Genes and Function, V1, P11; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zingariello M, 2013, BLOOD, V121, P3345, DOI 10.1182/blood-2012-06-439661; ZUTTER MM, 1994, J BIOL CHEM, V269, P463	50	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2016	11	5							e0154342	10.1371/journal.pone.0154342	http://dx.doi.org/10.1371/journal.pone.0154342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KX	27152938	gold, Green Published, Green Accepted			2022-12-27	WOS:000375677000016
J	Feng, YX; Zhang, P; Zhang, ZB; Shi, JC; Jiao, ZH; Shao, B				Feng, Yixing; Zhang, Pin; Zhang, Zhaobin; Shi, Jiachen; Jiao, Zhihao; Shao, Bing			Endocrine Disrupting Effects of Triclosan on the Placenta in Pregnant Rats	PLOS ONE			English	Article							PERSONAL CARE PRODUCTS; GENE-EXPRESSION; URINARY CONCENTRATIONS; ENVIRONMENTAL PHENOLS; EXPOSURE; FETAL; TRICLOCARBAN; RECEPTOR; STEROIDOGENESIS; PROGESTERONE	Triclosan (TCS) is a broad-spectrum antimicrobial agent that is frequently used in pharmaceuticals and personal care products. Reports have shown that TCS is a potential endocrine disruptor; however, the potential effects of TCS on placental endocrine function are unclear. The aim of this study was to investigate the endocrine disrupting effects of TCS on the placenta in pregnant rats. Pregnant rats from gestational day (GD) 6 to GD 20 were treated with 0, 30, 100, 300 and 600 mg/kg/d TCS followed by analysis of various biochemical parameters. Of the seven tissues examined, the greatest bioaccumulation of TCS was observed in the placenta. Reduction of gravid uterine weight and the occurrence of abortion were observed in the 600 mg/kg/d TCS-exposed group. Moreover, hormone detection demonstrated that the serum levels of progesterone (P), estradiol (E2), testosterone (T), human chorionic gonadotropin (hCG) and prolactin (PRL) were decreased in groups exposed to higher doses of TCS. Real-time quantitative reverse transcriptase-polymerase chain reaction (Q-RT-PCR) analysis revealed a significant increase in mRNA levels for placental steroid metabolism enzymes, including UDP-glucuronosyltransferase 1A1 (UGT1A1), estrogen sulfotransferase 1E1 (SULT1E1), steroid 5 alpha-reductase 1 (SRD5A1) and steroid 5 alpha-reductase 2 (SRD5A2). Furthermore, the transcriptional expression levels of progesterone receptor (PR), estrogen receptor (ER alpha) and androgen receptor (AR) were up-regulated. Taken together, these data demonstrated that the placenta was a target tissue of TCS and that TCS induced inhibition of circulating steroid hormone production might be related to the altered expression of hormone metabolism enzyme genes in the placenta. This hormone disruption might subsequently affect fetal development and growth.	[Feng, Yixing; Zhang, Pin; Shi, Jiachen; Jiao, Zhihao] Beijing Ctr Dis Control & Prevent, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing, Peoples R China; [Zhang, Zhaobin] Peking Univ, Coll Urban & Environm Sci, MOE Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Shao, Bing] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Vet Med, Beijing 100094, Peoples R China	Peking University; China Agricultural University	Shao, B (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Vet Med, Beijing 100094, Peoples R China.	shaobingch@sina.com	shao, bing/L-8793-2019	Zhang, Zhaobin/0000-0003-0838-0872	National Natural Science Foundation of China [21177014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant number 21177014). The URL of National Natural Science Foundation of China is http://www.nsfc.gov.cn/. The author who received the funding is BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200; Allmyr M, 2008, SCI TOTAL ENVIRON, V393, P162, DOI 10.1016/j.scitotenv.2007.12.006; Allmyr M, 2006, SCI TOTAL ENVIRON, V372, P87, DOI 10.1016/j.scitotenv.2006.08.007; Boyd GR, 2003, SCI TOTAL ENVIRON, V311, P135, DOI 10.1016/S0048-9697(03)00138-4; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P303, DOI 10.1289/ehp.10768; Chen MJ, 2012, J ANAL TOXICOL, V36, P608, DOI 10.1093/jat/bks072; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Collier AC, 2012, PLACENTA, V33, P77, DOI 10.1016/j.placenta.2011.11.002; Crawford BR, 2012, REPROD TOXICOL, V34, P607, DOI 10.1016/j.reprotox.2012.09.008; Dhillon GS, 2015, INT J ENV RES PUB HE, V12, P5657, DOI 10.3390/ijerph120505657; DURKEE TJ, 1992, ENDOCRINOLOGY, V130, P1309, DOI 10.1210/en.130.3.1309; Foran CM, 2000, MAR ENVIRON RES, V50, P153, DOI 10.1016/S0141-1136(00)00080-5; Gee RH, 2008, J APPL TOXICOL, V28, P78, DOI 10.1002/jat.1316; Gu X, 2013, J UROLOGY, V190, P615, DOI 10.1016/j.juro.2013.03.024; Hanet N, 2008, STEROIDS, V73, P1242, DOI 10.1016/j.steroids.2008.06.005; Helbing CC, 2011, TOXICOL SCI, V123, P601, DOI 10.1093/toxsci/kfr127; Hevir N, 2011, CHEM-BIOL INTERACT, V191, P217, DOI 10.1016/j.cbi.2011.01.003; Honkisz E, 2012, REPROD TOXICOL, V34, P385, DOI 10.1016/j.reprotox.2012.05.094; Hsu TY, 2009, TAIWAN J OBSTET GYNE, V48, P262, DOI 10.1016/S1028-4559(09)60301-6; Huang L, 1999, Zhonghua Fu Chan Ke Za Zhi, V34, P275; Ishibashi H, 2004, AQUAT TOXICOL, V67, P167, DOI 10.1016/j.aquatox.2003.12.005; Itoh K, 2009, GEN COMP ENDOCR, V163, P285, DOI 10.1016/j.ygcen.2009.04.025; James MO, 2010, ENVIRON INT, V36, P942, DOI 10.1016/j.envint.2009.02.004; JAMESON JL, 1993, ENDOCR REV, V14, P203, DOI 10.1210/er.14.2.203; Jung EM, 2012, TOXICOL LETT, V208, P142, DOI 10.1016/j.toxlet.2011.10.017; Kanca H, 2008, THERIOGENOLOGY, V70, P1439, DOI 10.1016/j.theriogenology.2008.04.045; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kumar V, 2008, TOXICOLOGY, V250, P124, DOI 10.1016/j.tox.2008.06.012; Kumar V, 2009, REPROD TOXICOL, V27, P177, DOI 10.1016/j.reprotox.2008.12.002; Kurtzman JT, 2001, SEMIN REPROD MED, V19, P63, DOI 10.1055/s-2001-13912; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis GW, 2013, REPROD TOXICOL, V36, P71, DOI 10.1016/j.reprotox.2012.12.001; Lyman F L, 1969, IMS Ind Med Surg, V38, P64; Matsumura N, 2005, BIOL PHARM BULL, V28, P1748, DOI 10.1248/bpb.28.1748; PEPE GJ, 1995, ENDOCR REV, V16, P608, DOI 10.1210/er.16.5.608; Philippat C, 2013, ENVIRON HEALTH PERSP, V121, P1225, DOI 10.1289/ehp.1206335; Pycke BFG, 2014, ENVIRON SCI TECHNOL, V48, P8831, DOI 10.1021/es501100w; ROBY KF, 1993, PLACENTA, V14, P529, DOI 10.1016/S0143-4004(05)80206-1; Rodriguez PEA, 2010, J TOXICOL ENV HEAL A, V73, P1678, DOI 10.1080/15287394.2010.516241; SERONFERRE M, 1978, J CLIN ENDOCR METAB, V46, P834; Shi Y, 2013, J CHROMATOGR B, V934, P97, DOI 10.1016/j.jchromb.2013.07.003; Singer H, 2002, ENVIRON SCI TECHNOL, V36, P4998, DOI 10.1021/es025750i; Soares MJ, 2007, TRENDS ENDOCRIN MET, V18, P114, DOI 10.1016/j.tem.2007.02.005; Spencer T E, 2004, J Anim Sci, V82 E-Suppl, pE4; Spencer TE, 2004, BIOL REPROD, V71, P2, DOI 10.1095/biolreprod.103.024133; Stiles AR, 2010, CELL, V142, P196, DOI 10.1016/j.cell.2010.07.003; Stoker TE, 2010, TOXICOL SCI, V117, P45, DOI 10.1093/toxsci/kfq180; Sun M, 2012, AM J PHYSIOL-ENDOC M, V303, pE1373, DOI 10.1152/ajpendo.00421.2012; Veldhoen N, 2006, AQUAT TOXICOL, V80, P217, DOI 10.1016/j.aquatox.2006.08.010; Vonnahme KA, 2004, J PHYSIOL-LONDON, V554, P194, DOI 10.1113/jphysiol.2003.055061; Wang CF, 2015, ENVIRON POLLUT, V206, P195, DOI 10.1016/j.envpol.2015.07.001; Wang WS, 2014, PLACENTA, V35, P30, DOI 10.1016/j.placenta.2013.10.018; You LH, 2015, SCI TOTAL ENVIRON, V536, P955, DOI 10.1016/j.scitotenv.2015.06.041; YUE P, 1995, CIRCULATION, V91, P1154, DOI 10.1161/01.CIR.91.4.1154; Zhao JL, 2010, J HAZARD MATER, V179, P215, DOI 10.1016/j.jhazmat.2010.02.082	55	66	68	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154758	10.1371/journal.pone.0154758	http://dx.doi.org/10.1371/journal.pone.0154758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149376	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800058
J	Pelttari, LM; Khan, S; Vuorela, M; Kiiski, JI; Vilske, S; Nevanlinna, V; Ranta, S; Schleutker, J; Winqvist, R; Kallioniemi, A; Dork, T; Bogdanova, NV; Figueroa, J; Pharoah, PDP; Schmidt, MK; Dunning, AM; Garcia-Closas, M; Bolla, MK; Dennis, J; Michailidou, K; Wang, Q; Hopper, JL; Southey, MC; Rosenberg, EH; Fasching, PA; Beckmann, MW; Peto, J; dos-Santos-Silva, I; Sawyer, EJ; Tomlinson, I; Burwinkel, B; Surowy, H; Guenel, P; Truong, T; Bojesen, SE; Nordestgaard, BG; Benitez, J; Gonzalez-Neira, A; Neuhausen, SL; Anton-Culver, H; Brenner, H; Arndt, V; Meindl, A; Schmutzler, RK; Brauch, H; Bruning, T; Lindblom, A; Margolin, S; Mannermaa, A; Hartikainen, JM; Chenevix-Trench, G; Van Dyck, L; Janssen, H; Chang-Claude, J; Rudolph, A; Radice, P; Peterlongo, P; Hallberg, E; Olson, JE; Giles, GG; Milne, RL; Haiman, CA; Schumacher, F; Simard, J; Dumont, M; Kristensen, V; Borresen-Dale, AL; Zheng, W; Beeghly-Fadiel, A; Grip, M; Andrulis, IL; Glendon, G; Devilee, P; Seynaeve, C; Hooning, MJ; Collee, M; Cox, A; Cross, SS; Shah, M; Luben, RN; Hamann, U; Torres, D; Jakubowska, A; Lubinski, J; Couch, FJ; Yannoukakos, D; Orr, N; Swerdlow, A; Darabi, H; Li, JM; Czene, K; Hall, P; Easton, DF; Mattson, J; Blomqvist, C; Aittomaki, K; Nevanlinna, H				Pelttari, Liisa M.; Khan, Sofia; Vuorela, Mikko; Kiiski, Johanna I.; Vilske, Sara; Nevanlinna, Viivi; Ranta, Salla; Schleutker, Johanna; Winqvist, Robert; Kallioniemi, Anne; Doerk, Thilo; Bogdanova, Natalia V.; Figueroa, Jonine; Pharoah, Paul D. P.; Schmidt, Marjanka K.; Dunning, Alison M.; Garcia-Closas, Montserrat; Bolla, Manjeet K.; Dennis, Joe; Michailidou, Kyriaki; Wang, Qin; Hopper, John L.; Southey, Melissa C.; Rosenberg, Efraim H.; Fasching, Peter A.; Beckmann, Matthias W.; Peto, Julian; dos-Santos-Silva, Isabel; Sawyer, Elinor J.; Tomlinson, Ian; Burwinkel, Barbara; Surowy, Harald; Guenel, Pascal; Truong, Therese; Bojesen, Stig E.; Nordestgaard, Borge G.; Benitez, Javier; Gonzalez-Neira, Anna; Neuhausen, Susan L.; Anton-Culver, Hoda; Brenner, Hermann; Arndt, Volker; Meindl, Alfons; Schmutzler, Rita K.; Brauch, Hiltrud; Bruening, Thomas; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Hartikainen, Jaana M.; Chenevix-Trench, Georgia; Van Dyck, Laurien; Janssen, Hilde; Chang-Claude, Jenny; Rudolph, Anja; Radice, Paolo; Peterlongo, Paolo; Hallberg, Emily; Olson, Janet E.; Giles, Graham G.; Milne, Roger L.; Haiman, Christopher A.; Schumacher, Fredrick; Simard, Jacques; Dumont, Martine; Kristensen, Vessela; Borresen-Dale, Anne-Lise; Zheng, Wei; Beeghly-Fadiel, Alicia; Grip, Mervi; Andrulis, Irene L.; Glendon, Gord; Devilee, Peter; Seynaeve, Caroline; Hooning, Maartje J.; Collee, Margriet; Cox, Angela; Cross, Simon S.; Shah, Mitul; Luben, Robert N.; Hamann, Ute; Torres, Diana; Jakubowska, Anna; Lubinski, Jan; Couch, Fergus J.; Yannoukakos, Drakoulis; Orr, Nick; Swerdlow, Anthony; Darabi, Hatef; Li, Jingmei; Czene, Kamila; Hall, Per; Easton, Douglas F.; Mattson, Johanna; Blomqvist, Carl; Aittomaki, Kristiina; Nevanlinna, Heli		kConFab AOCS Investigators	RAD51B in Familial Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CONFER SUSCEPTIBILITY; GERMLINE MUTATIONS; OVARIAN; RISK; XRCC2; GENE; VARIANTS; ALLELES; COMPLEX	Common variation on 14q24.1, close to RAD51B, has been associated with breast cancer: rs999737 and rs2588809 with the risk of female breast cancer and rs1314913 with the risk of male breast cancer. The aim of this study was to investigate the role of RAD51B variants in breast cancer predisposition, particularly in the context of familial breast cancer in Finland. We sequenced the coding region of RAD51B in 168 Finnish breast cancer patients from the Helsinki region for identification of possible recurrent founder mutations. In addition, we studied the known rs999737, rs2588809, and rs1314913 SNPs and RAD51B haplotypes in 44,791 breast cancer cases and 43,583 controls from 40 studies participating in the Breast Cancer Association Consortium (BCAC) that were genotyped on a custom chip (iCOGS). We identified one putatively pathogenic missense mutation c.541C>T among the Finnish cancer patients and subsequently genotyped the mutation in additional breast cancer cases (n = 5259) and population controls (n = 3586) from Finland and Belarus. No significant association with breast cancer risk was seen in the meta-analysis of the Finnish datasets or in the large BCAC dataset. The association with previously identified risk variants rs999737, rs2588809, and rs1314913 was replicated among all breast cancer cases and also among familial cases in the BCAC dataset. The most significant association was observed for the haplotype carrying the risk-alleles of all the three SNPs both among all cases (odds ratio (OR): 1.15, 95% confidence interval (CI): 1.11-1.19, P = 8.88 x 10(-16)) and among familial cases (OR: 1.24, 95% CI: 1.16-1.32, P = 6.19 x 10(-11)), compared to the haplotype with the respective protective alleles. Our results suggest that loss-of-function mutations in RAD51B are rare, but common variation at the RAD51B region is significantly associated with familial breast cancer risk.	[Pelttari, Liisa M.; Khan, Sofia; Kiiski, Johanna I.; Vilske, Sara; Nevanlinna, Viivi; Ranta, Salla; Nevanlinna, Heli] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Pelttari, Liisa M.; Khan, Sofia; Kiiski, Johanna I.; Vilske, Sara; Nevanlinna, Viivi; Ranta, Salla; Mattson, Johanna; Blomqvist, Carl; Aittomaki, Kristiina; Nevanlinna, Heli] Helsinki Univ Hosp, Helsinki, Finland; [Vuorela, Mikko; Winqvist, Robert] Univ Oulu, Bioctr Oulu, Lab Canc Genet & Tumor Biol, Canc Res & Translat Med, Oulu, Finland; [Schleutker, Johanna; Kallioniemi, Anne] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland; [Schleutker, Johanna] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Schleutker, Johanna] Turku Univ Hosp, Dept Med Genet, Tyks Microbiol & Genet, FIN-20520 Turku, Finland; [Winqvist, Robert] Northern Finland Lab Ctr NordLab, Lab Canc Genet & Tumor Biol, Oulu, Finland; [Kallioniemi, Anne] Fimlab Labs, Tampere, Finland; [Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Bogdanova, Natalia V.] Hannover Med Sch, Radiat Oncol Res Unit, Hannover, Germany; [Figueroa, Jonine; Garcia-Closas, Montserrat] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Pharoah, Paul D. P.; Dunning, Alison M.; Shah, Mitul; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Pharoah, Paul D. P.; Bolla, Manjeet K.; Dennis, Joe; Michailidou, Kyriaki; Wang, Qin; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Schmidt, Marjanka K.; Rosenberg, Efraim H.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [Garcia-Closas, Montserrat; Swerdlow, Anthony] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Hopper, John L.; Giles, Graham G.; Milne, Roger L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Fasching, Peter A.; Beckmann, Matthias W.] Univ Erlangen Nurnberg, Comprehens Canc Ctr Erlangen EMN, Univ Hosp Erlangen, Dept Obstet & Gynaecol, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Peto, Julian; dos-Santos-Silva, Isabel] London Sch Hyg & Trop Med, Dept Noncommun Dis Epidemiol, London WC1, England; [Sawyer, Elinor J.] Kings Coll London, Guys Hosp, Res Oncol, London WC2R 2LS, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford NIHR Biomed Res Ctr, Oxford, England; [Burwinkel, Barbara; Surowy, Harald] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Burwinkel, Barbara; Surowy, Harald] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany; [Guenel, Pascal; Truong, Therese] INSERM, Ctr Res Epidemiol & Populat Hlth, Environm Epidemiol Canc, Villejuif, France; [Guenel, Pascal; Truong, Therese] Univ Paris 11, Villejuif, France; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Med & Hlth Sci, Copenhagen, Denmark; [Benitez, Javier; Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr, Human Canc Genet Program, Madrid, Spain; [Benitez, Javier] Ctr Invest Red Enfermedades Raras, Valencia, Spain; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Duarte, CA USA; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Brenner, Hermann; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann; Brauch, Hiltrud] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Meindl, Alfons] Tech Univ Munich, Div Gynaecol & Obstet, D-80290 Munich, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Hereditary Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Bruening, Thomas] Ruhr Univ Bochum, German Social Accid Insurance Inst, Inst Prevent & Occupat Med, Univ Str 150, Bochum, Germany; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Mannermaa, Arto; Hartikainen, Jaana M.] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Mannermaa, Arto; Hartikainen, Jaana M.] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Mannermaa, Arto; Hartikainen, Jaana M.] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, SF-70210 Kuopio, Finland; [Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Genet, Brisbane, Qld, Australia; [kConFab AOCS Investigators] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Van Dyck, Laurien] VIB, Vesalius Res Ctr, Leuven, Belgium; [Van Dyck, Laurien] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Janssen, Hilde] Univ Hosp Leuven, Leuven Canc Inst, Leuven Multidisciplinary Breast Ctr, Leuven, Belgium; [Chang-Claude, Jenny; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chang-Claude, Jenny] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg UCCH, Hamburg, Germany; [Radice, Paolo] Ist Nazl Tumori, Fdn IRCCS Ist Di Ricovero & Cura Carattere Sci, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Via Venezian 1, I-20133 Milan, Italy; [Peterlongo, Paolo] Italian Fdn Canc Res Oncol Mol, Fdn Ist FIRC, IFOM, Milan, Italy; [Hallberg, Emily; Olson, Janet E.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Haiman, Christopher A.; Schumacher, Fredrick] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Simard, Jacques; Dumont, Martine] Univ Laval, Ctr Hosp Univ Quebec Res Ctr, Genom Ctr, Quebec City, PQ, Canada; [Kristensen, Vessela; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Genet, N-0450 Oslo, Norway; [Kristensen, Vessela; Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, Oslo, Norway; [Kristensen, Vessela] Univ Oslo, Oslo Univ Hosp, Dept Clin Mol Biol, Oslo, Norway; [Zheng, Wei; Beeghly-Fadiel, Alicia] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA; [Grip, Mervi] Univ Oulu, Oulu Univ Hosp, Dept Surg, Oulu, Finland; [Andrulis, Irene L.; Glendon, Gord] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Seynaeve, Caroline; Hooning, Maartje J.] Erasmus MC Canc Inst, Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [Collee, Margriet] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Cox, Angela] Univ Sheffield, Dept Oncol, Sheffield Canc Res, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Sheffield, S Yorkshire, England; [Luben, Robert N.] Univ Cambridge, Dept Publ Hlth & Primary Care, Clin Gerontol, Cambridge, England; [Hamann, Ute; Torres, Diana] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [Torres, Diana] Pontificia Univ Javeriana, Inst Human Genet, Bogota, Colombia; [Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, IRRP, Mol Diagnost Lab, Athens, Greece; [Orr, Nick] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Swerdlow, Anthony] Inst Canc Res, Div Breast Canc Res, London SW3 6JB, England; [Darabi, Hatef; Li, Jingmei; Czene, Kamila; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Mattson, Johanna; Blomqvist, Carl] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Aittomaki, Kristiina] Univ Helsinki, Dept Clin Genet, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; Tampere University; University of Turku; University of Turku; Hannover Medical School; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; University of Cambridge; Netherlands Cancer Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Melbourne; University of Melbourne; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Irvine; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technical University of Munich; University of Cologne; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Ruhr University Bochum; Karolinska Institutet; Karolinska Institutet; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; University of Melbourne; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; Mayo Clinic; Cancer Council Victoria; University of Southern California; Laval University; University of Oslo; University of Oslo; University of Oslo; Vanderbilt University; University of Oulu; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; University of Sheffield; University of Sheffield; Helmholtz Association; German Cancer Research Center (DKFZ); Pontificia Universidad Javeriana; Pomeranian Medical University; Mayo Clinic; National Centre of Scientific Research "Demokritos"; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Karolinska Institutet; University of Helsinki; University of Helsinki	Nevanlinna, H (corresponding author), Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland.; Nevanlinna, H (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	heli.nevanlinna@hus.fi	DEVILEE, PETER/ABR-2140-2022; Zheng, Wei/O-3351-2013; truong, therese/A-2837-2013; Arndt, Volker/AAI-7282-2020; Garcia-Closas, Montserrat/AAZ-6930-2021; Taylor, Donna B/I-5714-2015; Van Dyck, Laurien/I-4018-2016; Margolin, Sara/AAX-9034-2020; Figueroa, Jonine/GWD-1322-2022; /AAM-5330-2020; Brenner, Hermann/ABE-6383-2020; Figueroa, Jonine/AAG-1065-2022; Jakubowska, Anna/O-8050-2014; Figueroa, Jonine/AFK-2752-2022; Guenel, Pascal/AAS-7688-2021; Gonzalez-Neira, Anna/C-5791-2015; Schmidt, Marjanka K/G-9058-2011; Devilee, Peter/GXV-8005-2022; zhang, weihua/GXV-1334-2022; Brenner, Hermann/B-4627-2017; Li, Jingmei/I-2904-2012; Simpson, Peter/F-1225-2010; Zheng, Wei/GQQ-8951-2022; Haviv, Izhak/E-3782-2015; Brüning, Thomas/G-8120-2015; Pharoah, Paul/V-6658-2019; Luben, Robert N/H-5519-2015; Brennan, Meagan E/P-8274-2019; Peterlongo, Paolo/Q-4717-2018; Dörk, Thilo/J-8620-2012; Bogdanova, Natalia V./Y-2205-2019; Arndt, Volker/B-4999-2014; Guenel, Pascal/H-3728-2018; Chenevix-Trench, Georgia/AAV-2014-2020; Fasching, Peter A/ABH-9912-2020; DeFazio, Anna/O-2385-2019; Rosenberg, Efraim/C-7180-2008; Hartikainen, Jaana M/E-6256-2015; Nordestgaard, Borge Gronne/ABF-1310-2020; Michailidou, Kyriaki/ABD-5122-2020; Saunders, Christobel/H-5779-2014; Thierry, Benjamin/B-2785-2009; Mann, Graham/G-4758-2014; Radice, Paolo/O-3119-2013; hayward, nicholas/C-1367-2015; Wyld, David/B-8893-2015; Jenkins, Mark/P-7803-2015; benitez, javier/H-5232-2015; Zeps, Nikolajs/C-4180-2013; Rogers, Peter/C-2651-2008; Scott, Rodney/B-2827-2013	Zheng, Wei/0000-0003-1226-070X; truong, therese/0000-0002-2943-6786; Arndt, Volker/0000-0001-9320-8684; Garcia-Closas, Montserrat/0000-0003-1033-2650; Taylor, Donna B/0000-0002-1481-1141; Van Dyck, Laurien/0000-0002-1373-7656; Figueroa, Jonine/0000-0002-5100-623X; Brenner, Hermann/0000-0002-6129-1572; Figueroa, Jonine/0000-0002-5100-623X; Jakubowska, Anna/0000-0002-5650-0501; Figueroa, Jonine/0000-0002-5100-623X; Guenel, Pascal/0000-0002-8359-518X; Gonzalez-Neira, Anna/0000-0002-5421-2020; Schmidt, Marjanka K/0000-0002-2228-429X; Brenner, Hermann/0000-0002-6129-1572; Li, Jingmei/0000-0001-8587-7511; Simpson, Peter/0000-0002-4816-8289; Haviv, Izhak/0000-0002-0837-5005; Brüning, Thomas/0000-0001-9560-5464; Pharoah, Paul/0000-0001-8494-732X; Luben, Robert N/0000-0002-5088-6343; Brennan, Meagan E/0000-0002-3281-7643; Peterlongo, Paolo/0000-0001-6951-6855; Dörk, Thilo/0000-0002-9458-0282; Arndt, Volker/0000-0001-9320-8684; Guenel, Pascal/0000-0002-8359-518X; Chenevix-Trench, Georgia/0000-0002-1878-2587; Fasching, Peter A/0000-0003-4885-8471; DeFazio, Anna/0000-0003-0057-4744; Rosenberg, Efraim/0000-0002-3859-6941; Hartikainen, Jaana M/0000-0001-8267-1905; Michailidou, Kyriaki/0000-0001-7065-1237; Saunders, Christobel/0000-0003-2281-9829; Winqvist, Robert/0000-0003-0932-9104; Thierry, Benjamin/0000-0002-6757-2842; Khan, Sofia/0000-0003-4185-8882; Carter, Jonathan/0000-0003-3871-2815; Brauch, Hiltrud/0000-0001-7531-2736; Lindeman, Geoffrey/0000-0001-9386-2416; Swerdlow, Anthony/0000-0001-5550-4159; Mann, Graham/0000-0003-1301-405X; Blomqvist, Carl/0000-0003-3041-1938; Radice, Paolo/0000-0001-6298-4111; Hacker, Neville/0000-0002-1445-2302; Nordestgaard, Borge/0000-0002-1954-7220; Kiiski, Johanna I./0000-0002-4089-7209; hayward, nicholas/0000-0003-4760-1033; Wyld, David/0000-0001-9523-4333; Beale, Philip/0000-0003-3628-4597; Jenkins, Mark/0000-0002-8964-6160; Surowy, Harald/0000-0002-3595-9188; Durocher, Francine/0000-0001-8012-4641; benitez, javier/0000-0002-0923-7202; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Zeps, Nikolajs/0000-0002-6404-6839; Byth Wilson, Karen/0000-0002-1253-6393; Yannoukakos, Drakoulis/0000-0001-7509-3510; friedlander, michael/0000-0003-3090-795X; Devilee, Peter/0000-0002-8023-2009; Southey, Melissa/0000-0002-6313-9005; Thorne, Heather/0000-0003-3610-2511; Cox, Angela/0000-0002-5138-1099; Rogers, Peter/0000-0002-7399-8997; Lubinski, Jan/0000-0003-2931-3003; Dunning, Alison Margaret/0000-0001-6651-7166; Margolin, Sara/0000-0002-5526-5570; Scott, Rodney/0000-0001-7724-3404; Simard, Jacques/0000-0001-6906-3390; Winship, Ingrid/0000-0001-8535-6003; Pelttari, Liisa/0000-0001-8091-9751; Obermair, Andreas/0000-0003-2199-1117; James, Paul/0000-0002-4361-4657; Schleutker, Johanna/0000-0002-1863-0305; Clarke, Christine/0000-0001-7568-111X; Perrin, Lewis/0000-0002-6119-8458; Bojesen, Stig/0000-0002-4061-4133	Helsinki University Hospital Research Fund; Academy of Finland [266528]; Finnish Cancer Society; Nordic Cancer Union; Sigrid Juselius Foundation; Orion-Farmos Research Foundation; Maud Kuistila Memorial Foundation; Biomedicum Helsinki Foundation; Alfred Kordelin Foundation; Paulo Foundation; Finnish Cultural Foundation; Cancer Research UK [C1287/A12014, C1287/A10118, C1287/A 10710, C12292/A11174, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565]; European Community [223175, HEALTH-F2-2009-223175]; European Community's Seventh Framework Programme [223175 (HEALTH-F2-2009223175)]; National Institutes of Health [CA128978]; Post-Cancer GWAS initiative [1U19 CA148537, 1U19 CA148065, 1U19 CA148112]; Department of Defence [W81XWH-10-1-0341]; Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer; Komen Foundation for the Cure; Breast Cancer Research Foundation; Ovarian Cancer Research Fund; National Cancer Institute (USA) [UM1 CA164920]; National Health and Medical Research Council of Australia; New South Wales Cancer Council; Victorian Health Promotion Foundation (Australia); Victorian Breast Cancer Research Consortium; Dutch Cancer Society [NKI 2007-3839, 2009 4363]; ELAN-Fond of the University Hospital of Erlangen; Breakthrough Breast Cancer; NHS; National Cancer Research Network (NCRN); NIHR Comprehensive Biomedical Research Centre; Guy's & St. Thomas' NHS Foundation Trust; King's College London, United Kingdom; Oxford Biomedical Research Centre; Dietmar-Hopp Foundation; Helmholtz Society; German Cancer Research Center (DKFZ); Fondation de France; Institut National du Cancer (INCa); Ligue Nationale contre le Cancer; Ligue contre le Cancer Grand Ouest; Agence Nationale de Securite Sanitaire (ANSES); Agence Nationale de la Recherche (ANR); Chief Physician Johan Boserup and Lise Boserup Fund; Danish Medical Research Council; Herlev Hospital; Instituto de Salud Carlos III; Red Tematica de Investigacion Cooperativa en Cancer; Asociacion Espanola Contra el Cancer; Fondo de Investigacion Sanitario [PI11/00923, PI12/00070]; Cancer Research UK [16565, 16561, 10118] Funding Source: researchfish; Cancer Foundation Finland sr [150147, 140163, 110135] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA176785, U01CA116167, P50CA116201, U01CA164973] Funding Source: NIH RePORTER	Helsinki University Hospital Research Fund; Academy of Finland(Academy of Finland); Finnish Cancer Society; Nordic Cancer Union; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Orion-Farmos Research Foundation; Maud Kuistila Memorial Foundation; Biomedicum Helsinki Foundation; Alfred Kordelin Foundation; Paulo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Cancer Research UK(Cancer Research UK); European Community(European Commission); European Community's Seventh Framework Programme(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Post-Cancer GWAS initiative; Department of Defence; Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer(Canadian Institutes of Health Research (CIHR)); Komen Foundation for the Cure(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; Ovarian Cancer Research Fund; National Cancer Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Cancer Council(Cancer Council New South Wales); Victorian Health Promotion Foundation (Australia); Victorian Breast Cancer Research Consortium; Dutch Cancer Society(KWF Kankerbestrijding); ELAN-Fond of the University Hospital of Erlangen; Breakthrough Breast Cancer; NHS; National Cancer Research Network (NCRN); NIHR Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Guy's & St. Thomas' NHS Foundation Trust; King's College London, United Kingdom; Oxford Biomedical Research Centre; Dietmar-Hopp Foundation; Helmholtz Society(Helmholtz Association); German Cancer Research Center (DKFZ)(Helmholtz Association); Fondation de France(Fondation de France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Ligue contre le Cancer Grand Ouest(Ligue nationale contre le cancer); Agence Nationale de Securite Sanitaire (ANSES)(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Chief Physician Johan Boserup and Lise Boserup Fund; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Herlev Hospital; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Red Tematica de Investigacion Cooperativa en Cancer; Asociacion Espanola Contra el Cancer; Fondo de Investigacion Sanitario; Cancer Research UK(Cancer Research UK); Cancer Foundation Finland sr; National Breast Cancer Foundation; The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The HEBCS was financially supported by the Helsinki University Hospital Research Fund, Academy of Finland (266528), the Finnish Cancer Society, The Nordic Cancer Union and the Sigrid Juselius Foundation. LMP received funding from Orion-Farmos Research Foundation, Maud Kuistila Memorial Foundation, Biomedicum Helsinki Foundation, Alfred Kordelin Foundation, Paulo Foundation and the Finnish Cultural Foundation. BCAC is funded by Cancer Research UK [C1287/A10118, C1287/A12014] and by the European Community's Seventh Framework Programme under grant agreement number 223175 (grant number HEALTH-F2-2009-223175) (COGS). Funding for the iCOGS infrastructure came from: the European Community's Seventh Framework Programme under grant agreement no 223175 (HEALTH-F2-2009223175) (COGS), Cancer Research UK (C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565), the National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 -the GAME-ON initiative), the Department of Defence (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure, the Breast Cancer Research Foundation, and the Ovarian Cancer Research Fund. The Australian Breast Cancer Family Study (ABCFS) was supported by grant UM1 CA164920 from the National Cancer Institute (USA). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. The ABCFS was also supported by the National Health and Medical Research Council of Australia, the New South Wales Cancer Council, the Victorian Health Promotion Foundation (Australia) and the Victorian Breast Cancer Research Consortium. J.L.H. is a National Health and Medical Research Council (NHMRC) Australia Fellow and a Victorian Breast Cancer Research Consortium Group Leader. M.C.S. is a NHMRC Senior Research Fellow and a Victorian Breast Cancer Research Consortium Group Leader. The ABCS study was supported by the Dutch Cancer Society [grants NKI 2007-3839; 2009 4363]. The work of the BBCC was partly funded by ELAN-Fond of the University Hospital of Erlangen. The BBCS is funded by Cancer Research UK and Breakthrough Breast Cancer and acknowledges NHS funding to the NIHR Biomedical Research Centre, and the National Cancer Research Network (NCRN). ES is supported by NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, United Kingdom. IT is supported by the Oxford Biomedical Research Centre. The BSUCH study was supported by the Dietmar-Hopp Foundation, the Helmholtz Society and the German Cancer Research Center (DKFZ). The CECILE study was funded by Fondation de France, Institut National du Cancer (INCa), Ligue Nationale contre le Cancer, Ligue contre le Cancer Grand Ouest, Agence Nationale de Securite Sanitaire (ANSES), Agence Nationale de la Recherche (ANR). The CGPS was supported by the Chief Physician Johan Boserup and Lise Boserup Fund, the Danish Medical Research Council and Herlev Hospital.; The CNIO-BCS was supported by the Instituto de Salud Carlos III, the Red Tematica de Investigacion Cooperativa en Cancer and grants from the Asociacion Espanola Contra el Cancer and the Fondo de Investigacion Sanitario (PI11/00923 and PI12/00070). The CTS was initially supported by the California Breast Cancer Act of 1993 and the California Breast Cancer Research Fund (contract 97-10500) and is currently funded through the National Institutes of Health (R01 CA77398). Collection of cancer incidence data was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885. HAC receives support from the Lon V Smith Foundation (LVS39420). The ESTHER study was supported by a grant from the Baden Wurttemberg Ministry of Science, Research and Arts. Additional cases were recruited in the context of the VERDI study, which was supported by a grant from the German Cancer Aid (Deutsche Krebshilfe). The GC-HBOC (German Consortium of Hereditary Breast and Ovarian Cancer) is supported by the German Cancer Aid (grant no 110837, coordinator: Rita K. Schmutzler). The GENICA was funded by the Federal Ministry of Education and Research (BMBF) Germany grants 01KW9975/5, 01KW9976/8, 01KW9977/0 and 01KW0114, the Robert Bosch Foundation, Stuttgart, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, the Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, as well as the Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany. The HMBCS was supported by a grant from the Friends of Hannover Medical School and by the Rudolf Bartling Foundation. Financial support for KARBAC was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, the Swedish Cancer Society, The Gustav V Jubilee foundation and Bert von Kantzows foundation. The KBCP was financially supported by the special Government Funding (EVO) of Kuopio University Hospital grants, Cancer Fund of North Savo, the Finnish Cancer Organizations, and by the strategic funding of the University of Eastern Finland. kConFab is supported by a grant from the National Breast Cancer Foundation, and previously by the National Health and Medical Research Council (NHMRC), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. Financial support for the AOCS was provided by the United States Army Medical Research and Materiel Command [DAMD17-01-1-0729], Cancer Council Victoria, Queensland Cancer Fund, Cancer Council New South Wales, Cancer Council South Australia, The Cancer Foundation of Western Australia, Cancer Council Tasmania and the National Health and Medical Research Council of Australia (NHMRC; 400413, 400281, 199600). G.C.T. and P.W. are supported by the NHMRC. RB was a Cancer Institute NSW Clinical Research Fellow. LMBC is supported by the "Stichting tegen Kanker" (232-2008 and 196-2010). Diether Lambrechts is supported by the FWO and the KULPFV/10/016-SymBioSysII. The MARIE study was supported by the Deutsche Krebshilfe e.V. [70-2892-BR I, 106332, 108253, 108419], the Hamburg Cancer Society, the German Cancer Research Center (DKFZ) and the Federal Ministry of Education and Research (BMBF) Germany [01KH0402].; MBCSG is supported by grants from the Italian Association for Cancer Research (AIRC) and by funds from the Italian citizens who allocated the 5/1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects "5x1000"). The MCBCS was supported by the NIH grants CA128978, CA116167, CA176785 an NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201], and the Breast Cancer Research Foundation and a generous gift from the David F. and Margaret T. Grohne Family Foundation and the Ting Tsung and Wei Fong Chao Foundation. MCCS cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further supported by Australian NHMRC grants 209057, 251553 and 504711 and by infrastructure provided by Cancer Council Victoria. Cases and their vital status were ascertained through the Victorian Cancer Registry (VCR). The MEC was support by NIH grants CA63464, CA54281, CA098758 and CA132839. The work of MTLGEBCS was supported by the Quebec Breast Cancer Foundation, the Canadian Institutes of Health Research for the " CIHR Team in Familial Risks of Breast Cancer" program - grant #CRN-87521 and the Ministry of Economic Development, Innovation and Export Trade -grant #PSR-SIIRI-701. The NBCS has received funding from the K.G. Jebsen Centre for Breast Cancer Research; the Research Council of Norway grant 193387/V50 (to AL Borresen-Dale and V.N. Kristensen) and grant 193387/H10 (to A-L Borresen-Dale and V.N. Kristensen), South Eastern Norway Health Authority (grant 39346 to A-L Borresen-Dale) and the Norwegian Cancer Society (to A-L Borresen-Dale and V.N. Kristensen). The NBHS was supported by NIH grant R01CA100374. Biological sample preparation was conducted the Survey and Biospecimen Shared Resource, which is supported by P30 CA68485. The OBCS was supported by research grants from the Finnish Cancer Foundation, the Academy of Finland (grant number 250083, 122715 and Center of Excellence grant number 251314), the Finnish Cancer Foundation, the Sigrid Juselius Foundation, the University of Oulu, the University of Oulu Support Foundation and the special Governmental EVO funds for Oulu University Hospital-based research activities. The Ontario Familial Breast Cancer Registry (OFBCR) was supported by grant UM1 CA164920 from the National Cancer Institute (USA). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. The ORIGO study was supported by the Dutch Cancer Society (RUL 1997-1505) and the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL CP16). The PBCS was funded by Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA. The pKARMA study was supported by Marit and Hans Rausings Initiative Against Breast Cancer. The RBCS was funded by the Dutch Cancer Society (DDHK 2004-3124, DDHK 2009-4318). The SASBAC study was supported by funding from the Agency for Science, Technology and Research of Singapore (A*STAR), the US National Institute of Health (NIH) and the Susan G. Komen Breast Cancer Foundation. The SBCS was supported by Yorkshire Cancer Research S295, S299, S305PA and Sheffield Experimental Cancer Medicine Centre.; SEARCH is funded by a programme grant from Cancer Research UK [C490/A10124] and supported by the UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge. SKKDKFZS is supported by the DKFZ. The SZBCS was supported by Grant PBZ_KBN_122/P05/2004. The TNBCC was supported by: a Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), a grant from the Breast Cancer Research Foundation, a generous gift from the David F. and Margaret T. Grohne Family Foundation, the Stefanie Spielman Breast Cancer fund and the OSU Comprehensive Cancer Center, the Hellenic Cooperative Oncology Group research grant (HR R_BG/04) and the Greek General Secretary for Research and Technology (GSRT) Program, Research Excellence II, the European Union (European Social Fund - ESF), and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - ARISTEIA. The UKBGS is funded by BreakthroughBreast Cancer and the Institute of Cancer Research (ICR), London. ICR acknowledges NHS funding to the NIHR Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albala JS, 1997, GENOMICS, V46, P476, DOI 10.1006/geno.1997.5062; Chun J, 2013, MOL CELL BIOL, V33, P387, DOI 10.1128/MCB.00465-12; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Date O, 2006, CANCER RES, V66, P6018, DOI 10.1158/0008-5472.CAN-05-2803; Figueroa JD, 2011, HUM MOL GENET, V20, P4693, DOI 10.1093/hmg/ddr368; Golmard L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-484; Hilbers FS, 2012, J MED GENET, V49, P618, DOI 10.1136/jmedgenet-2012-101191; Johnson J, 2011, BREAST CANCER RES TR, V129, P255, DOI 10.1007/s10549-011-1539-6; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kuchenbaecker KB, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0492-9; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; Orr N, 2012, NAT GENET, V44, P1182, DOI 10.1038/ng.2417; Park DJ, 2012, AM J HUM GENET, V90, P734, DOI 10.1016/j.ajhg.2012.02.027; Pelttari LM, 2012, J MED GENET, V49, P429, DOI 10.1136/jmedgenet-2012-100852; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shamseldin HE, 2012, J MED GENET, V49, P184, DOI 10.1136/jmedgenet-2011-100585; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Song H, 2015, J CLIN ONCOL; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Tischkowitz M, 2010, CANCER RES, V70, P7353, DOI 10.1158/0008-5472.CAN-10-1012; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Wadt KAW, 2015, FAM CANCER, V14, P337, DOI 10.1007/s10689-015-9781-4	33	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0153788	10.1371/journal.pone.0153788	http://dx.doi.org/10.1371/journal.pone.0153788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149063	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000375676800015
J	Takahashi, K; Sumarriva, K; Kim, R; Jiang, R; Brantley-Sieders, DM; Chen, J; Mernaugh, RL; Takahashi, T				Takahashi, Keiko; Sumarriva, Katherine; Kim, Rachel; Jiang, Rosie; Brantley-Sieders, Dana M.; Chen, Jin; Mernaugh, Raymond L.; Takahashi, Takamune			Determination of the CD148-Interacting Region in Thrombospondin-1	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; IN-VITRO; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; TYPE-1 REPEATS; ETA SUPPRESSES; GROWTH; ANGIOGENESIS; CD148; INHIBITION	CD148 is a transmembrane protein tyrosine phosphatase that is expressed in multiple cell types, including vascular endothelial cells and duct epithelial cells. Previous studies have shown a prominent role of CD148 to reduce growth factor signals and suppress cell proliferation and transformation. Further, we have recently shown that thrombospondin-1 (TSP1) serves as a functionally important ligand for CD148. TSP1 has multiple structural elements and interacts with various cell surface receptors that exhibit differing effects. In order to create the CD148-specific TSP1 fragment, here we investigated the CD148-interacting region in TSP1 using a series of TSP1 fragments and biochemical and biological assays. Our results demonstrate that: 1) CD148 binds to the 1st type 1 repeat in TSP1; 2) Trimeric TSP1 fragments that contain the 1st type repeat inhibit cell proliferation in A431D cells that stably express wild-type CD148 (A431D/CD148wt cells), while they show no effects in A431D cells that lack CD148 or express a catalytically inactive form of CD148. The anti-proliferative effect of the TSP1 fragment in A431D/CD148wt cells was largely abolished by CD148 knockdown and antagonized by the 1st, but not the 2nd and 3rd, type 1 repeat fragment. Furthermore, the trimeric TSP1 fragments containing the 1st type repeat increased the catalytic activity of CD148 and reduced phospho-tyrosine contents of EGFR and ERK1/2, defined CD148 substrates. These effects were not observed in the TSP1 fragments that lack the 1st type 1 repeat. Last, we demonstrate that the trimeric TSP1 fragment containing the 1st type 1 repeat inhibits endothelial cell proliferation in culture and angiogenesis in vivo. These effects were largely abolished by CD148 knockdown or deficiency. Collectively, these findings indicate that the 1st type 1 repeat interacts with CD148, reducing growth factor signals and inhibiting epithelial or endothelial cell proliferation and angiogenesis.	[Takahashi, Keiko; Sumarriva, Katherine; Kim, Rachel; Jiang, Rosie; Brantley-Sieders, Dana M.; Chen, Jin; Takahashi, Takamune] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Brantley-Sieders, Dana M.; Chen, Jin; Takahashi, Takamune] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Mernaugh, Raymond L.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Takahashi, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.; Takahashi, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	takamune.takahashi@vanderbilt.edu		Kim, Rachel/0000-0002-0538-5195; Chen, Jin/0000-0002-5557-2079; Peters, Katherine/0000-0002-8872-9271	National Institutes of Health (NIH) [DK97332, HL109715]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart, Lung, and Blood Institute (NHLBI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097332] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants DK97332 (TT) and HL109715 (TT); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [http://www.niddk.nih.gov/]; National Heart, Lung, and Blood Institute (NHLBI) [http://www.nhlbi.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Brunner PM, 2011, BLOOD, V117, P4154, DOI 10.1182/blood-2010-09-307694; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Dawson DW, 1999, MOL PHARMACOL, V55, P332, DOI 10.1124/mol.55.2.332; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; de la Fuente-Garcia MA, 1998, BLOOD, V91, P2800, DOI 10.1182/blood.V91.8.2800.2800_2800_2809; Engel J, 2004, INT J BIOCHEM CELL B, V36, P997, DOI 10.1016/j.biocel.2003.12.009; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Guo NH, 1997, CANCER RES, V57, P1735; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Hower AE, 2009, J NEUROCHEM, V110, P1635, DOI 10.1111/j.1471-4159.2009.06261.x; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Isenberg JS, 2008, CELL MOL LIFE SCI, V65, P728, DOI 10.1007/s00018-007-7488-x; Iuliano R, 2003, CANCER RES, V63, P882; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Klenotic PA, 2013, ARTERIOSCL THROM VAS, V33, P1655, DOI 10.1161/ATVBAHA.113.301523; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; Massa A, 2004, ANN NY ACAD SCI, V1030, P264, DOI 10.1196/annals.1329.033; OROURKE KM, 1992, J BIOL CHEM, V267, P24921; Ortuso F, 2013, ACS CHEM BIOL, V8, P1497, DOI 10.1021/cb3007192; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Takahashi K, 2012, P NATL ACAD SCI USA, V109, P1985, DOI 10.1073/pnas.1106171109; Takahashi T, 1999, J AM SOC NEPHROL, V10, P2135; Takahashi T, 2006, BLOOD, V108, P1234, DOI 10.1182/blood-2005-10-4296; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; Trapasso F, 2004, CARCINOGENESIS, V25, P2107, DOI 10.1093/carcin/bgh224; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; Youngblood V, 2015, MOL CANCER RES, V13, P524, DOI 10.1158/1541-7786.MCR-14-0142; Zhang L, 1997, EXP CELL RES, V235, P62, DOI 10.1006/excr.1997.3659; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007	46	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2016	11	5							e0154916	10.1371/journal.pone.0154916	http://dx.doi.org/10.1371/journal.pone.0154916			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KV	27149518	gold, Green Published, Green Submitted			2022-12-27	WOS:000375676800089
